Citrus Sinensis ID: 002969

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860--
Protein Sequence
MSSTGLSQIKITLKCFVIERRETSAKNMIMNDITSHPCYTNLFLIIFILFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGFCLGRNPIETDSSSSKHDETFTVNQVTVTMLNAR
Secondary Structure (PSIPRED)
ccccccHHHHHEEEEEEEEcccccHHHHHHHHHccccHHHHHHHHHHHHHccccEEccccccccccccccEEEccccEEEEEEccccccccEEEEEEEcccccccEEEEccccccccccccEEEEEcccEEEEcccccEEEEEccccccccEEEEEccccEEEEEccccccEEEEccccccccccccEEEEEEccccEEEEEEcccccccccccEEEEEEcccccEEEEEEccEEEEEEEccccEEEEcccccccccccEEEEEEEcccEEEEEEEEccccEEEEEEEcccccEEEEEEEcccccEEEEEcccccccccccccccccccccccccccccccccccccccccccccccccEEEccccccccccEEEEcccccccccccEEEccccHHHHHHHccccccEEcEEcccccccccEEEcccccccEEEEccccEEEEEEEEccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHccccccccccccccccccccccccHHHHHHHHHcccccccccccccccEEEEEEccccEEEEEEccccccHHHHHHHHHHHHHHHHcccccccEEcccccccEEEEEEEEcccccccEEcccccccccccHHHHHHHHHHHHHHHHHcccccccEEEEcccccccccccccccccccccccEEEcccccccccccEEEEEcccccHHHHcccccEEccccccHHHHHHHHHccccccccccccccccHHHHHHHHHHcccEEcccccccccccHHHHHHHHHccEEcccccccccccHHHHHHHHcccccccccccccEEEcccccccccccccccccccccccEEEEEEEcc
Secondary Structure Prediction (SSPRO)
cccccccEEEEEEEEEEEcccccHHHHHHHHHcHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccEEEccccEEEEEEEcccccccEEEEEEEEcccccEEEEEEccccccccccEEEEEEccEEEEEEccccEEEEEccccccccEEEEEccccEEEEEcccccEEEEcccccccccccccEccccccccccEEEEEcccccccccccEEEEEccccccEEEEEcccEEEEEccccccEEEEcccccccccEEEEEEEEEcccEEEEEEEEEcccEEEEEEEccccEEEEEEEEcccccEEEEEEccccccccHcccccccEEccccccccccccccccccHHHHHccccccccEEccccccccccEEEEccccccccccEEEcccccHHHHHHHHHHcccEEEEEEEccccccEEEEEcccHHHHHHcccccccEEEEEccHHHcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccEEEccccccccccccccccccEcHHHHHHHHccccccccccccccccEEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccccEEHcccHccccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccEEccHHcccccccEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHEEccccccccccccccccHHHHHHHHHHccccHHHHcHHHccccHHHHHHHHHHHHHHHHccccccccHHHEEEEccccccccccccccEEEEEcccccccccccccccccEccEEEEEEEccc
Coil and Loop (DISEMBL)
MSSTGLSQIKITLKCFVIERRETSAKNMimnditshpcytnLFLIIFILFPTIAISVDTLTATQnltygktlvssddvfelgffspgssgkwyigiWYKNIAQRTYVWVAnrddplanssgVLRIINQRiglfdgsqnlvwssnqtkatnpvaqlqdsgnfvlkeagsdeilwqsfdyptdtllpqmkigwdlkTGFEWYLTswkstddpstgdnsfkldfhgfpegflwnkqerkyrsgpwngvrfsgvpemkpieginfeffidqdhdVYYSFFIENKNLFSRlivspdgflqRFTWIEAnkiwnpfwyapkdqcdnygecgpfgicdtnaspvcqcmrgfepkdpqawslrdgsggcvrktelqcSEDKFLQlknmklpdtttsFVDYNMTLKECEAfcsrncsctayantnitggtgcvtwtgeLKDIRKYAEGGQDLYVRLAAsdigdganatpIIIGVTVGSAILILGLVACFLWRRKTLLgrqirkteprghpersqdLLLNQVVIsskrdysadktddlelplfdfETIVRatdnftdynklgqggfgivykgrlleGQEIAVKRLSrnsgqgieEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNilldkemtpkisdfgmarifggdqteqntkrvvgtygymspeyamdglFSVKSDVFSFGVLLLETVsgkknrgfyhsnneLNLLGHVWRLWKEGKVLEMVDssvdnypaneVLRCIHVGLLCvqenaeerpTMASVVLMLSsetatmpqpktpgfclgrnpietdsssskhdetfTVNQVTVTMLNAR
Flexible Loop (DISEMBL)
msstglsqikitlkCFVIERRETSAKNMIMNDITSHPCYTNLFLIIFILFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFfspgssgkwYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFlqlknmklpdtTTSFVDYNMTLKECEAFCSRNCSCTAYantnitggtgcVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLgrqirkteprghpersqdlllnQVVISSkrdysadktddlelplFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRlsrnsgqgieEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKasnilldkeMTPKISDFGMArifggdqteqntkrVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGFCLGRNPIEtdsssskhdetftvnqvtVTMLNAR
Low Complexity Region (SEG)
MSSTGLSQIKITLKCFVIERRETSAKNMIMNDITSHPCYTNlfliifilfPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGFCLGRNPIETDSSSSKHDETFTVNQVTVTMLNAR
Disordered region (IsUnstruct)
*******QIKITLKCFVIERRETSAKNMIMNDITSHPCYTNLFLIIFILFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSN*******VAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKST*******NSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQI**************LLLNQVVISS***YSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQEN*********VVL**************************************************
Disordered Region (DISOPRED)
********IKITLKCFVIERRETSAKNMIMNDITSHPCYTNLFLIIFILFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRK****************************DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGFCL**********************VTVTMLNAR
Disordered Region (DISEMBL)
MSSTGLSQIKITLKCFVIERRETSAKNMIMNDITSHPCYTNLFLIIFILFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIR*********RSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGFCLGRNPIE********DETFTVNQVTVTMLNAR
Disordered Region (DISPRO)
****GLSQIKITLKCFVIERRETSAKNMIMNDITSHPCYTNLFLIIFILFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQI*************DLLLNQVVIS********KTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGFCLGRN*************TFTVNQVTVTMLNA*
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSSTGLSQIKITLKCFVIERRETSAKNMIMNDITSHPCYTNLFLIIFILFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGFCLGRNPIETDSSSSKHDETFTVNQVTVTMLNAR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	862	2.2.26 [Sep-21-2011]
O81905	850	Receptor-like serine/thre	yes	no	0.938	0.951	0.630	0.0
Q39086	843	Receptor-like serine/thre	no	no	0.932	0.953	0.586	0.0
Q9S972	847	Receptor-like serine/thre	no	no	0.935	0.951	0.584	0.0
Q09092	857	Putative serine/threonine	N/A	no	0.953	0.959	0.538	0.0
P0DH86	853	G-type lectin S-receptor-	no	no	0.935	0.944	0.559	0.0
Q9ZT07	833	G-type lectin S-receptor-	no	no	0.922	0.954	0.473	0.0
O81832	783	G-type lectin S-receptor-	no	no	0.853	0.939	0.469	0.0
O81906	849	G-type lectin S-receptor-	no	no	0.931	0.945	0.457	0.0
Q9LPZ3	845	G-type lectin S-receptor-	no	no	0.926	0.945	0.448	0.0
O81833	815	G-type lectin S-receptor-	no	no	0.897	0.949	0.466	0.0

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score = 1046 bits (2705), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 524/831 (63%), Positives = 651/831 (78%), Gaps = 22/831 (2%)

Query: 51  PTIAISVDTLTATQNLTYGK--TLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVW 108
           P  +IS +TL+A+++LT     T+VS  +VFELGFF PG   +WY+GIWYK I++RTYVW
Sbjct: 23  PAYSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVW 82

Query: 109 VANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT--KATNP-VAQLQDSGNFVL-- 163
           VANRD PL++S G L+I +  + + D S   VWS+N T     +P VA+L D+GNFVL  
Sbjct: 83  VANRDTPLSSSIGTLKISDSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD 142

Query: 164 -KEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFH 222
            K +  D +LWQSFD+PTDTLLP+MK+GWD KTGF  ++ SWKS DDPS+GD SFKL+  
Sbjct: 143 SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETE 202

Query: 223 GFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNL 282
           GFPE FLWN++ R YRSGPWNG+RFSGVPEM+P E + F F   ++ +V YSF I   ++
Sbjct: 203 GFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKE-EVTYSFRITKSDV 261

Query: 283 FSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRG 342
           +SRL +S  G LQRFTWIE  + WN FWYAPKDQCD Y ECG +G CD+N SPVC C++G
Sbjct: 262 YSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKG 321

Query: 343 FEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTTTSFVDYNMTLKECEAF 401
           F+P++PQ W LRDGS GCVRKT L C   D F++LK MKLPDTTT+ VD  + +KECE  
Sbjct: 322 FKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQK 381

Query: 402 CSRNCSCTAYANTNITG-GTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPI 460
           C R+C+CTA+ANT+I G G+GCVTWTGEL DIR YA+GGQDLYVRLAA+D+ D  N +  
Sbjct: 382 CLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAK 441

Query: 461 IIGVTVG-SAILILGLVACFLWRRKTLLGRQIRKTEP-RGHPERSQDLLLNQVVISSKRD 518
           IIG ++G S +L+L  +  FLW+RK    R I    P   H  RS+DLL+N+VVISS+R 
Sbjct: 442 IIGSSIGVSVLLLLSFIIFFLWKRKQ--KRSILIETPIVDHQLRSRDLLMNEVVISSRRH 499

Query: 519 YS-ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN 577
            S  + TDDLELPL +FE +  AT+NF++ NKLGQGGFGIVYKG+LL+GQE+AVKRLS+ 
Sbjct: 500 ISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKT 559

Query: 578 SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI 637
           S QG +EFKNEV+LIA+LQH NLVRLL CCV+  EKML+YEY+EN SLDS +FDK+R+S 
Sbjct: 560 SVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSK 619

Query: 638 LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
           LNWQ RF+II GIARGLLYLHQDSRFRIIHRDLKASNILLDK MTPKISDFGMARIFG D
Sbjct: 620 LNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRD 679

Query: 698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNL 757
           +TE NT++VVGTYGYMSPEYAMDG+FS+KSDVFSFGVLLLE +S K+N+GFY+S+ +LNL
Sbjct: 680 ETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNL 739

Query: 758 LGHVWRLWKEGKVLEMVD----SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM 813
           LG VWR WKEGK LE++D     S   +  +E+LRCI +GLLCVQE AE+RPTM+ V+LM
Sbjct: 740 LGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILM 799

Query: 814 LSSETATMPQPKTPGFCLGRNPIETDSSSSKH--DETFTVNQVTVTMLNAR 862
           L SE+ T+PQPK PG+CL R+ ++TDSSSSK   DE++TVNQ+TV++L+AR
Sbjct: 800 LGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850

Involved in the regulation of cellular expansion and differentiation.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1

 Score =  954 bits (2466), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 484/825 (58%), Positives = 621/825 (75%), Gaps = 21/825 (2%)

Query: 54  AISVDTLTATQNLTYG--KTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVAN 111
           ++S +TL+AT++LT    KT++S   +FELGFF+P SS +WY+GIWYK I  RTYVWVAN
Sbjct: 24  SVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVAN 83

Query: 112 RDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT--KATNPVA-QLQDSGNFVLKEAGS 168
           RD+PL++S+G L+I    + +FD S   VWS+N T     +PVA +L D+GNF+L+++ +
Sbjct: 84  RDNPLSSSNGTLKISGNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDS-N 142

Query: 169 DEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGF 228
           + +LWQSFD+PTDTLL +MK+GWD KTGF   L SWK+TDDPS+G+ S KL+   FPE +
Sbjct: 143 NRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFY 202

Query: 229 LWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIV 288
           + +K+   YRSGPWNG+RFS VP    ++ + + F   ++ +V YS+ I   NL+SRL +
Sbjct: 203 ICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKE-EVTYSYRINKTNLYSRLYL 261

Query: 289 SPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDP 348
           +  G LQR TW E  + W   WY+PKD CDNY  CG FG CD+N+ P C C++GF+P + 
Sbjct: 262 NSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNE 321

Query: 349 QAWSLRDGSGGCVRKTELQC-SEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCS 407
           QAW LRDGS GC+RKT L C   D F +LK MKLPDTT + VD  + LK C+  C  +C+
Sbjct: 322 QAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCN 381

Query: 408 CTAYANTNI-TGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTV 466
           CTA+AN +I  GG+GCV WT E+ D+R YA+GGQDLYVRLAA+++ D       IIG ++
Sbjct: 382 CTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELEDKRIKNEKIIGSSI 441

Query: 467 G-SAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSAD--K 523
           G S +L+L  V    W+RK    R I    P     RSQD L+N VV+S +R Y++   K
Sbjct: 442 GVSILLLLSFVIFHFWKRKQ--KRSITIQTPNVDQVRSQDSLINDVVVS-RRGYTSKEKK 498

Query: 524 TDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIE 583
           ++ LELPL + E +  AT+NF++ NKLGQGGFGIVYKGRLL+G+EIAVKRLS+ S QG +
Sbjct: 499 SEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTD 558

Query: 584 EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRR 643
           EF NEVRLIAKLQH NLVRLLGCCV+  EKML+YEY+EN SLDS +FD+ RSS LNWQ+R
Sbjct: 559 EFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKR 618

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
           F+II GIARGLLYLHQDSR RIIHRDLKASN+LLDK MTPKISDFGMARIFG ++TE NT
Sbjct: 619 FDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANT 678

Query: 704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           +RVVGTYGYMSPEYAMDG+FS+KSDVFSFGVLLLE +SGK+N+GFY+SN +LNLLG VWR
Sbjct: 679 RRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWR 738

Query: 764 LWKEGKVLEMV-----DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET 818
            WKEG  LE+V     DS    +P +E+LRCI +GLLCVQE AE+RP M+SV++ML SET
Sbjct: 739 HWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSET 798

Query: 819 ATMPQPKTPGFCLGRNPIETDSSSS-KHDETFTVNQVTVTMLNAR 862
             +PQPK PGFC+GR+P+E DSSSS + D+  TVNQ+T+++++AR
Sbjct: 799 TAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  951 bits (2457), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 486/831 (58%), Positives = 621/831 (74%), Gaps = 25/831 (3%)

Query: 52  TIAISVDTLTATQNLTYG--KTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWV 109
             ++     +AT++LT    KT++S   +FELGFF+P SS +WY+GIWYK I  RTYVWV
Sbjct: 22  AFSVYASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWV 81

Query: 110 ANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT--KATNPVA-QLQDSGNFVLKEA 166
           ANRD+PL++S+G L+I +  + +FD S   VWS+N T     +PVA +L D GNFVL+++
Sbjct: 82  ANRDNPLSSSNGTLKISDNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDS 141

Query: 167 GSDE---ILWQSFDYPTDTLLPQMKIGWDLKTG-FEWYLTSWKSTDDPSTGDNSFKLDFH 222
            +++    LWQSFD+PTDTLL  MK+GWD K+G F   L SWK+TDDPS+GD S KL   
Sbjct: 142 KNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTS 201

Query: 223 GFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNL 282
           GFPE +++NK+   YRSGPW G RFS VP MKP++ I+   F + +  V YS+ +   N+
Sbjct: 202 GFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYID-NSFTENNQQVVYSYRVNKTNI 260

Query: 283 FSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRG 342
           +S L +S  G LQR TW+EA + W   WY+PKD CDNY ECG +G CD N SP+C C++G
Sbjct: 261 YSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKG 320

Query: 343 FEPKDPQAWSLRDGSGGCVRKTELQC-SEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAF 401
           FEP + QA +LRD S GCVRKT+L C   D F++LK M+LPDTT + VD  + LKECE  
Sbjct: 321 FEPMNEQA-ALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEER 379

Query: 402 CSRNCSCTAYANTNI-TGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPI 460
           C + C+CTA+ANT+I  GG+GCV W+G L DIR YA+GGQDLYVR+AA D+ D    +  
Sbjct: 380 CLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLEDKRIKSKK 439

Query: 461 IIGVTVG-SAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDY 519
           IIG ++G S +L+L  +    W+RK    R I    P     RSQD L+N++V +S R Y
Sbjct: 440 IIGSSIGVSILLLLSFIIFHFWKRKQ--KRSITIQTPIVDLVRSQDSLMNELVKAS-RSY 496

Query: 520 SA--DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN 577
           ++  +KTD LELPL +++ +  AT+NF+  NKLGQGGFGIVYKG LL+G+EIAVKRLS+ 
Sbjct: 497 TSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKM 556

Query: 578 SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI 637
           S QG +EF NEVRLIAKLQH NLVRLLGCCV+  EKML+YEY+EN SLDS +FD+ RSS 
Sbjct: 557 SSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSN 616

Query: 638 LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
           LNWQ+RF+II GIARGLLYLHQDSR RIIHRDLKASN+LLDK MTPKISDFGMARIFG +
Sbjct: 617 LNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGRE 676

Query: 698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNL 757
           +TE NT+RVVGTYGYMSPEYAMDG+FS+KSDVFSFGVLLLE +SGK+N+GFY+SN +LNL
Sbjct: 677 ETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNL 736

Query: 758 LGHVWRLWKEGKVLEMVDS-SVD----NYPANEVLRCIHVGLLCVQENAEERPTMASVVL 812
           LG VWR WKEGK LE+VD  ++D     +P +E+LRCI +GLLCVQE AE+RP M+SV++
Sbjct: 737 LGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMV 796

Query: 813 MLSSETATMPQPKTPGFCLGR-NPIETDSSSSKHDETFTVNQVTVTMLNAR 862
           ML SET  +PQPK PGFC+GR +     SSS++ D+  TVNQVT+++++AR
Sbjct: 797 MLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2

 Score =  923 bits (2386), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 459/853 (53%), Positives = 621/853 (72%), Gaps = 31/853 (3%)

Query: 35  SHPCYTNLFLIIFILFPTIAISVDTLTATQNLTYG--KTLVSSDDVFELGFFSPGSSGKW 92
           S+  +  +F+++ ++ P ++I ++TL++T++LT    KTLVS   +FE+GFF   S  +W
Sbjct: 11  SYMSFLLVFVVMILIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFFRTNS--RW 68

Query: 93  YIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNP- 151
           Y+G+WYK ++ RTYVWVANRD+PL+N+ G L+I    + L D S   VW +N T+     
Sbjct: 69  YLGMWYKKVSDRTYVWVANRDNPLSNAIGTLKISGNNLVLLDHSNKPVWWTNLTRGNERS 128

Query: 152 --VAQLQDSGNFVLKEAGSD---EILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKS 206
             VA+L  +GNFV++++ ++   E LWQSFDYPTDTLLP+MK+G++LKTG   +LTSW+S
Sbjct: 129 PVVAELLANGNFVMRDSSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRS 188

Query: 207 TDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFID 266
           +DDPS+G+ S+KL+    PE +L  +    +RSGPWNG+RFSG+PE + +  + + F I+
Sbjct: 189 SDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNF-IE 247

Query: 267 QDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKD-QCDNYGECGP 325
            + +V Y+F + N + +SRL +  +G+ QR TW  + +IWN FW +P D QCD Y  CGP
Sbjct: 248 NNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGP 307

Query: 326 FGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTT 385
           +  CD N SPVC C++GF P++ Q W  R  +GGC+R+T+L CS D F ++K MKLP+TT
Sbjct: 308 YAYCDVNTSPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSCSGDGFTRMKKMKLPETT 367

Query: 386 TSFVDYNMTLKECEAFCSRNCSCTAYANTNI-TGGTGCVTWTGELKDIRKYAEG---GQD 441
            + VD ++ +KEC+  C  +C+CTA+AN +I  GG+GCV WT  L+DIR YA     GQD
Sbjct: 368 MATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAIDGQD 427

Query: 442 LYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPE 501
           LYVRLAA+DI    NA+  II +TVG ++L+L ++ C LW+RK    R         + +
Sbjct: 428 LYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFC-LWKRKQ--KRAKASAISIANTQ 484

Query: 502 RSQDLLLNQVVISSKRDYSAD-KTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYK 560
           R+Q+L +N++V+SSKR++S + K ++LELPL + ET+V+AT+NF+  NKLGQGGFGIVYK
Sbjct: 485 RNQNLPMNEMVLSSKREFSGEYKFEELELPLIEMETVVKATENFSSCNKLGQGGFGIVYK 544

Query: 561 GRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM 620
           GRLL+G+EIAVKRLS+ S QG +EF NEV LIA+LQH NLV++LGCC+E DEKML+YEY+
Sbjct: 545 GRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKMLIYEYL 604

Query: 621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE 680
           EN SLDS +F K R S LNW  RF+I  G+ARGLLYLHQDSRFRIIHRDLK SNILLDK 
Sbjct: 605 ENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSNILLDKN 664

Query: 681 MTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETV 740
           M PKISDFGMARIF  D+TE NT +VVGTYGYMSPEYAM G+FS KSDVFSFGV++LE V
Sbjct: 665 MIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFGVIVLEIV 724

Query: 741 SGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD----SSVDNYPA----NEVLRCIHV 792
           SGKKNRGFY+ + E +LL +VW  WKEG+ LE+VD     S+ + P+     EVL+CI +
Sbjct: 725 SGKKNRGFYNLDYENDLLSYVWSRWKEGRALEIVDPVIVDSLSSQPSIFQPQEVLKCIQI 784

Query: 793 GLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGFCLGRNPIETDSSSS---KHDETF 849
           GLLCVQE AE RP M+SVV M  SE   +PQPK PG+C+ R+P E D SSS     +E++
Sbjct: 785 GLLCVQELAEHRPAMSSVVWMFGSEATEIPQPKPPGYCVRRSPYELDPSSSWQCDENESW 844

Query: 850 TVNQVTVTMLNAR 862
           TVNQ T ++++AR
Sbjct: 845 TVNQYTCSVIDAR 857

Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain.

Brassica oleracea var. acephala (taxid: 3713)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1

 Score =  892 bits (2306), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 467/834 (55%), Positives = 597/834 (71%), Gaps = 28/834 (3%)

Query: 51  PTIAISVDTLTATQNLTYG--KTLVSSDDVFELGFFSP-GSSGKWYIGIWYKNIAQRTYV 107
           P ++ISV+TL+AT++LT    KT+VS   VFELGFF   G S  WY+GIWYK I+QRTYV
Sbjct: 26  PDLSISVNTLSATESLTISSNKTIVSPGGVFELGFFRILGDS--WYLGIWYKKISQRTYV 83

Query: 108 WVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKA--TNPVAQLQDSGNFVLKE 165
           WVANRD PL+N  G+L+I N  + + D S   VWS+N T A  ++ VA+L D+GNFVL+ 
Sbjct: 84  WVANRDTPLSNPIGILKISNANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLRG 143

Query: 166 AG---SDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFH 222
           +    SDE LWQSFD+PTDTLLPQMK+G D K G   ++TSWKS+ DPS+G   FKL+  
Sbjct: 144 SKINESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETL 203

Query: 223 GFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNL 282
           G PE F +      YRSGPW+G+RFSG+ EM+  + I + F  +   +V Y+F + + N 
Sbjct: 204 GLPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYNF-TENREEVAYTFRVTDHNS 262

Query: 283 FSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRG 342
           +SRL ++  G L+ F W    + WN FW+ PKD CD YG CGP+  CD + SP C C++G
Sbjct: 263 YSRLTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCIKG 322

Query: 343 FEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFC 402
           F+P  PQ W+  D +G C RKT+L C ED+F +L NMK+P TT + VD  + LKECE  C
Sbjct: 323 FQPLSPQDWASGDVTGRCRRKTQLTCGEDRFFRLMNMKIPATTAAIVDKRIGLKECEEKC 382

Query: 403 SRNCSCTAYANTNI-TGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDG-ANATPI 460
             +C+CTAYAN++I  GG+GC+ W GE +DIR YA  GQDL+VRLAA++ G+       I
Sbjct: 383 KTHCNCTAYANSDIRNGGSGCIIWIGEFRDIRNYAADGQDLFVRLAAAEFGERRTIRGKI 442

Query: 461 IIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLL-NQVVISSKRDY 519
           I  +   S +L+L  +    W++K    R      P G+ +R Q+L++ N VV+SS R  
Sbjct: 443 IGLIIGISLMLVLSFIIYCFWKKKQKRARAT--AAPIGYRDRIQELIITNGVVMSSGRRL 500

Query: 520 SADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG 579
             ++ D       +FET+V AT+NF+D N LG+GGFGIVYKGRLL+GQEIAVKRLS  S 
Sbjct: 501 LGEEEDLELPLT-EFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQEIAVKRLSEMSS 559

Query: 580 QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSS-IL 638
           QG  EFKNEVRLIA+LQH NLVRLL CC+  DEK+L+YEY+EN SLDS +F+  +SS  L
Sbjct: 560 QGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSHLFETTQSSNKL 619

Query: 639 NWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           NWQ RF+II GIARGLLYLHQDSRF+IIHRDLKASN+LLDK MTPKISDFGMARIF  D+
Sbjct: 620 NWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISDFGMARIFERDE 679

Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
           TE NT++VVGTYGYMSPEYAM+G+FSVKSDVFSFGVL+LE VSGK+NRGF++S  + NLL
Sbjct: 680 TEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGKRNRGFHNSGQDNNLL 739

Query: 759 GHVWRLWKEGKVLE-------MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
           G+ W  WKEGK LE          SS+  +  +EVLRCI +GLLCVQE AE+RP M+SVV
Sbjct: 740 GYTWENWKEGKGLEIVDSIIVDSSSSMSLFQPHEVLRCIQIGLLCVQERAEDRPKMSSVV 799

Query: 812 LMLSSETATMPQPKTPGFCLGRNPIET--DSSSSKHD-ETFTVNQVTVTMLNAR 862
           LML SE   +PQPK PG+C+GR+ ++T   SSS+K D E+ TVNQ+TV+++NAR
Sbjct: 800 LMLGSEKGEIPQPKRPGYCVGRSSLDTADSSSSTKRDSESLTVNQITVSVINAR 853

Female specificity determinant of self-incompatibility.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3

 Score =  761 bits (1965), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 393/830 (47%), Positives = 531/830 (63%), Gaps = 35/830 (4%)

Query: 55  ISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDD 114
           ISVDT+   Q+L  G+ ++S+   F  GFFS G S   Y+GIWY  I+Q+T VWVANRD 
Sbjct: 17  ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76

Query: 115 PLANSSGVLRIINQ---RIGLFDGSQNLVWSSNQTKAT---NPVAQLQDSGNFVLKEAGS 168
           P+ ++SG+++  N+    +   D    L+WS+N + +      VA L D GN VL +  +
Sbjct: 77  PINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVT 136

Query: 169 DEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGF 228
               W+SFD+PTDT LP M++G+  K G +  LTSWKS  DP +GD   +++  GFP+  
Sbjct: 137 GRSFWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLI 196

Query: 229 LWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIV 288
           L+      +R G W G R+SGVPEM PI  I    F++ + +V +++ + + ++ +R +V
Sbjct: 197 LYKGVTPWWRMGSWTGHRWSGVPEM-PIGYIFNNSFVNNEDEVSFTYGVTDASVITRTMV 255

Query: 289 SPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPV--CQCMRGFEPK 346
           +  G + RFTWI  +K WN FW  PK+QCDNY  CGP G CD+ +S    C C+ GFEPK
Sbjct: 256 NETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPK 315

Query: 347 DPQAWSLRDGSGGCVRKTELQ-CSE-DKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSR 404
            P+ W LRD SGGC +K     CSE D F++LK MK+PDT+ + VD N+TLKEC+  C +
Sbjct: 316 FPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQRCLK 375

Query: 405 NCSCTAYANT---NITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIG-------DG 454
           NCSC AYA+    +  G  GC+ W G + D R Y   GQD Y+R+   ++         G
Sbjct: 376 NCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARWNRNGLSG 435

Query: 455 ANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVIS 514
                +I+   + + +L+  ++ C +        R+ RK+    H   S +         
Sbjct: 436 KRRVLLILISLIAAVMLLTVILFCVV--------RERRKSNR--HRSSSANFAPVPFDFD 485

Query: 515 SKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRL 574
               +  DK  + ELPLFD  TIV AT+NF+  NKLG GGFG VYKG L    EIAVKRL
Sbjct: 486 ESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRL 545

Query: 575 SRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR 634
           SRNSGQG+EEFKNEV+LI+KLQHRNLVR+LGCCVE++EKMLVYEY+ N+SLD  IF + +
Sbjct: 546 SRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQ 605

Query: 635 SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
            + L+W +R  I+ GIARG+LYLHQDSR RIIHRDLKASNILLD EM PKISDFGMARIF
Sbjct: 606 RAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIF 665

Query: 695 GGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
           GG+Q E  T RVVGT+GYM+PEYAM+G FS+KSDV+SFGVL+LE ++GKKN  F+  ++ 
Sbjct: 666 GGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFHEESS- 724

Query: 755 LNLLGHVWRLWKEGKVLEMVDSSVDN--YPANEVLRCIHVGLLCVQENAEERPTMASVVL 812
            NL+GH+W LW+ G+  E++D+ +D   Y   EV++CI +GLLCVQENA +R  M+SVV+
Sbjct: 725 -NLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVI 783

Query: 813 MLSSETATMPQPKTPGFCLGRNPIETDSSSSKHDETFTVNQVTVTMLNAR 862
           ML      +P PK P F   R     + +  K     +VN VT + +  R
Sbjct: 784 MLGHNATNLPNPKHPAFTSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4

 Score =  721 bits (1860), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 386/823 (46%), Positives = 518/823 (62%), Gaps = 87/823 (10%)

Query: 42  LFLIIFILFPTI--AISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYK 99
           L L+I  LF TI  A + D L A Q L  G T+VS    FE+GFFSPG S   Y+GIWYK
Sbjct: 7   LHLLIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYK 66

Query: 100 NIAQRTYVWVANRDDPLANSSGVLRII-NQRIGLFDGSQNLVWSS------NQTKATNPV 152
            I+ +T VWVANRD PL + SG L++  N  + LF+   +++WSS       +    NP+
Sbjct: 67  KISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPI 126

Query: 153 AQLQDSGNFVLKEAGSDE-ILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPS 211
            Q+ D+GN V++ +G D+  +WQS DYP D  LP MK G +  TG   +LTSW++ DDPS
Sbjct: 127 VQILDTGNLVVRNSGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPS 186

Query: 212 TGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDV 271
           TG+ + K+D +G P+ FL       +R+GPWNG+RF+G+P +KP     +E+   ++ +V
Sbjct: 187 TGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEE-EV 245

Query: 272 YYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDT 331
           YY++ +EN ++ +R+ ++P+G LQR+TW++  + WN +  A  D CD Y  CG +G C+ 
Sbjct: 246 YYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNI 305

Query: 332 NASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCS--EDKFLQLKNMKLPDTTTSFV 389
           N SP C+C++GF  K PQAW   D S GCVR+ +L C   ED FL++  +KLPDT TS+ 
Sbjct: 306 NESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWY 365

Query: 390 DYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAAS 449
           D NM L EC+  C RNC+C+AY+                                     
Sbjct: 366 DKNMDLNECKKVCLRNCTCSAYS-----------------------------------PF 390

Query: 450 DIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDL--- 506
           DI DG                       C LW      G  I   + R + E  QDL   
Sbjct: 391 DIRDGGKG--------------------CILW-----FGDLI---DIREYNENGQDLYVR 422

Query: 507 LLNQVVISSKRDYS-----ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKG 561
           L +  + + +R+ S       + +DLELP  D +T+  AT  F+  NKLGQGGFG VYKG
Sbjct: 423 LASSEIETLQRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKG 482

Query: 562 RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME 621
            L  GQE+AVKRLSR S QG+EEFKNE++LIAKLQHRNLV++LG CV+ +E+ML+YEY  
Sbjct: 483 TLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQP 542

Query: 622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM 681
           N+SLDS IFDK R   L+W +R  II GIARG+LYLH+DSR RIIHRDLKASN+LLD +M
Sbjct: 543 NKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDM 602

Query: 682 TPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
             KISDFG+AR  GGD+TE NT RVVGTYGYMSPEY +DG FS+KSDVFSFGVL+LE VS
Sbjct: 603 NAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVS 662

Query: 742 GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPAN--EVLRCIHVGLLCVQE 799
           G++NRGF +  ++LNLLGH WR + E K  E++D +V+    +  EVLR IH+GLLCVQ+
Sbjct: 663 GRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQ 722

Query: 800 NAEERPTMASVVLMLSSETATMPQPKTPGFCLGRNPIETDSSS 842
           + ++RP M SVV+++ S    +  P+ PGF   RN + +D+ S
Sbjct: 723 DPKDRPNM-SVVVLMLSSEMLLLDPRQPGFFNERNLLFSDTVS 764

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  707 bits (1825), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 394/861 (45%), Positives = 528/861 (61%), Gaps = 58/861 (6%)

Query: 39  YTNLFLIIFILFPTIAISVDTLTATQNLTYG---KTLVSSDDVFELGFFSPGSSGKWYIG 95
           Y +LFL  F+   ++A   +T+   ++L  G   K LVS    FELGFFSPGSS   ++G
Sbjct: 10  YLSLFLYFFLYESSMA--ANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLG 67

Query: 96  IWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDGSQNLVWSSNQTKAT----N 150
           IWY NI  +  VWVANR  P+++ SGVL I N   + L DG    VWSSN   +T    N
Sbjct: 68  IWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNN 127

Query: 151 PVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDP 210
            V  + D+GNFVL E  +D  +W+SF++PTDT LPQM++  + +TG      SW+S  DP
Sbjct: 128 RVVSIHDTGNFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDP 187

Query: 211 STGDNSFKLDFHGFPEGFLWN-KQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFI---- 265
           S G+ S  +D  G PE  LW   + RK+RSG WN   F+G+P M  +    + F +    
Sbjct: 188 SPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPP 247

Query: 266 DQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGP 325
           D+   VY+++   + ++  R  V  +G  +   W E  K W  F   P  +CD Y  CG 
Sbjct: 248 DETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGK 307

Query: 326 FGICDTNAS-PVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCS------EDKFLQLKN 378
           FGICD   S  +C C+ G+E      WS      GC R+T L+C       ED+FL LK+
Sbjct: 308 FGICDMKGSNGICSCIHGYEQVSVGNWSR-----GCRRRTPLKCERNISVGEDEFLTLKS 362

Query: 379 MKLPDTTTSFVDYNMTLKE-CEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAE 437
           +KLPD      ++N+   E C   C RNCSC AY+   + GG GC+ W  +L D++++  
Sbjct: 363 VKLPDF--EIPEHNLVDPEDCRERCLRNCSCNAYS---LVGGIGCMIWNQDLVDLQQFEA 417

Query: 438 GGQDLYVRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPR 497
           GG  L++RLA S++G+    T I + V V   ++++G+ A  LWR K       RK +  
Sbjct: 418 GGSSLHIRLADSEVGEN-RKTKIAVIVAVLVGVILIGIFALLLWRFK-------RKKDVS 469

Query: 498 GH--PERSQDLLLNQVVISSKRDYSA-----------DKTDDLELPLFDFETIVRATDNF 544
           G    + +   ++   +  SK   SA              +  ELP+F    I  AT++F
Sbjct: 470 GAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDF 529

Query: 545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
              N+LG+GGFG VYKG L +G+EIAVKRLS  SGQG++EFKNE+ LIAKLQHRNLVRLL
Sbjct: 530 CKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLL 589

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           GCC E +EKMLVYEYM N+SLD  +FD+ + ++++W+ RF+II GIARGLLYLH+DSR R
Sbjct: 590 GCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLR 649

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK SN+LLD EM PKISDFGMARIFGG+Q E NT RVVGTYGYMSPEYAM+GLFS
Sbjct: 650 IIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFS 709

Query: 725 VKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD-NYPA 783
           VKSDV+SFGVLLLE VSGK+N     S+   +L+G+ W L+  G+  E+VD  +      
Sbjct: 710 VKSDVYSFGVLLLEIVSGKRNTSL-RSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSK 768

Query: 784 NEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGF-CLGRNPIETD-SS 841
            E LRCIHV +LCVQ++A ERP MASV+LML S+TAT+  P+ P F    RN I+ + + 
Sbjct: 769 REALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFAL 828

Query: 842 SSKHDETFTVNQVTVTMLNAR 862
            S      + N++T T++  R
Sbjct: 829 DSSQQYIVSSNEITSTVVLGR 849

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3

 Score =  700 bits (1806), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 374/833 (44%), Positives = 536/833 (64%), Gaps = 34/833 (4%)

Query: 56  SVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDP 115
           S +T+  +Q+L  G  + S    F  GFFS G+S   Y+GIWY  ++++T VWVANRD P
Sbjct: 21  SDNTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHP 80

Query: 116 LANSSGVLRIINQRIGLFDGSQN---LVWSSN---QTKATNPVAQLQDSGNFVLKEAGSD 169
           + ++SG+++   +       S N    +WS++     +    VA+L D GN VL +  + 
Sbjct: 81  INDTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVTG 140

Query: 170 EILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFL 229
           +  W+SF++PT+TLLP MK G+  ++G +  +TSW+S  DP +G+ +++++  GFP+  +
Sbjct: 141 KSFWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQMMM 200

Query: 230 WNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVS 289
           +      +R+G W G R+SGVPEM      N  F  + D +V  ++ + + ++ +R++++
Sbjct: 201 YKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPD-EVSITYGVLDASVTTRMVLN 259

Query: 290 PDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPV--CQCMRGFEPKD 347
             G LQRF W   +K W  FW AP+D+CD Y  CG  G CD+ ++    C C+ G+EPK 
Sbjct: 260 ETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPKT 319

Query: 348 PQAWSLRDGSGGCVR-KTELQCS-EDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRN 405
           P+ W LRD S GC R K +  C+ ++ F +LK +K+P+T+   VD N+TLKECE  C +N
Sbjct: 320 PRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLKN 379

Query: 406 CSCTAYANT---NITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDI----GDGANAT 458
           CSC AYA+    +  G  GC+TW G + D R Y   GQD Y+R+  S++    G+GA+  
Sbjct: 380 CSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELARWNGNGASGK 439

Query: 459 PIIIGVTVG-SAILILGLVA--CFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISS 515
             ++ + +   A+++L L++  C+L +R+        +  P      S DL  + ++   
Sbjct: 440 KRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFIL--- 496

Query: 516 KRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLS 575
             +   DK+   ELPLF+  TI  AT+NF   NKLG GGFG VYKG L  G EIAVKRLS
Sbjct: 497 --EELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLS 554

Query: 576 RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARS 635
           ++SGQG+EEFKNEV+LI+KLQHRNLVR+LGCCVE +EKMLVYEY+ N+SLD  IF + + 
Sbjct: 555 KSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQR 614

Query: 636 SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
           + L+W +R  II GI RG+LYLHQDSR RIIHRDLKASN+LLD EM PKI+DFG+ARIFG
Sbjct: 615 AELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFG 674

Query: 696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
           G+Q E +T RVVGTYGYMSPEYAMDG FS+KSDV+SFGVL+LE ++GK+N  FY  +  L
Sbjct: 675 GNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAFYEES--L 732

Query: 756 NLLGHVWRLWKEGKVLEMVDSSV--DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM 813
           NL+ H+W  W+ G+ +E++D  +  + Y   EV++C+H+GLLCVQEN+ +RP M+SVV M
Sbjct: 733 NLVKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDMSSVVFM 792

Query: 814 LSSETATMPQPKTPGFCLGRNPIETDSSSSKH----DETFTVNQVTVTMLNAR 862
           L      +P PK P F  GR        SS +    + + T+N VT+T +  R
Sbjct: 793 LGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSSTINDVTLTDVQGR 845

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1

 Score =  698 bits (1801), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 388/831 (46%), Positives = 537/831 (64%), Gaps = 57/831 (6%)

Query: 53  IAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGK---WYIGIWYKNIAQRTYVWV 109
           +A+  + +T  + L  G TL S D VF+LGFFS     +    ++G+WY  +     VWV
Sbjct: 21  VALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWY--MEPFAVVWV 78

Query: 110 ANRDDPLANSSGVLRIIN-QRIGLFDGSQNLVWSSNQTKA------TNPVAQLQDSGNFV 162
           ANR++PL  +SG L + +   + LFDG    +WSS+ +         NP+ ++  SGN +
Sbjct: 79  ANRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLI 138

Query: 163 LKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFH 222
             + G + +LWQSFDYP +T+L  MK+G + KT  EW L+SWK+  DPS GD +  LD  
Sbjct: 139 SSD-GEEAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTR 197

Query: 223 GFPEGFLWNKQERKY--RSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENK 280
           G P+  L    +  Y  R G WNG+ F+G P M     +    F     +V YS+   ++
Sbjct: 198 GLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSWTPRHR 257

Query: 281 NLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNA--SPVCQ 338
            + SRL+++  G L RF   + N+ W     AP+D+CD Y  CG + +C  N+  +P C 
Sbjct: 258 -IVSRLVLNNTGKLHRFIQSKQNQ-WILANTAPEDECDYYSICGAYAVCGINSKNTPSCS 315

Query: 339 CMRGFEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTTTSFVDYN--MTL 395
           C++GF+PK  + W++  G+ GCV +    C + D F++   +KLPDT+ S+ D    MTL
Sbjct: 316 CLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNEMTL 375

Query: 396 KECEAFCSRNCSCTAYANTNI-TGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIG-D 453
           ++C+  CS NCSCTAYANT+I  GG GC+ W G+L D+R+Y+  GQD+Y+R+  + I   
Sbjct: 376 EDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVYIRMGFAKIEFK 435

Query: 454 GANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVI 513
           G     +++G  V  A++++ + ACF   RK ++ R   +   +G  E            
Sbjct: 436 GREVVGMVVGSVVAIAVVLVVVFACF---RKKIMKRYRGENFRKGIEE------------ 480

Query: 514 SSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKR 573
                      +DL+LP+FD +TI  ATD+F+  N LG+GGFG VYKG+L +GQEIAVKR
Sbjct: 481 -----------EDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKR 529

Query: 574 LSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKA 633
           LS NSGQG+EEFKNEV+LIAKLQHRNLVRLLGCC++ +E ML+YEYM N+SLD  IFD+ 
Sbjct: 530 LSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDER 589

Query: 634 RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
           RS+ L+W++R NII G+ARG+LYLHQDSR RIIHRDLKA N+LLD +M PKISDFG+A+ 
Sbjct: 590 RSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKS 649

Query: 694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN 753
           FGGDQ+E +T RVVGTYGYM PEYA+DG FSVKSDVFSFGVL+LE ++GK NRGF H+++
Sbjct: 650 FGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADH 709

Query: 754 ELNLLGHVWRLWKEGKVLEMVDSSVDNYPA--NEVLRCIHVGLLCVQENAEERPTMASVV 811
           +LNLLGHVW++W E + +E+ +       +   EVLRCIHV LLCVQ+  E+RPTMASVV
Sbjct: 710 DLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVV 769

Query: 812 LMLSSETATMPQPKTPGFCLGRNPIETDSSSSKHDETFTVNQVTVTMLNAR 862
           LM  S++ ++P P  PGF   RN  +  SS S   +    N+V++TML  R
Sbjct: 770 LMFGSDS-SLPHPTQPGFFTNRNVPDISSSLSLRSQ----NEVSITMLQGR 815

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	862
224076591	834	predicted protein [Populus trichocarpa]	0.935	0.966	0.727	0.0
255555127	834	S-locus-specific glycoprotein S6 precurs	0.958	0.990	0.706	0.0
224114151	831	predicted protein [Populus trichocarpa]	0.948	0.984	0.697	0.0
359496546	866	PREDICTED: receptor-like serine/threonin	0.960	0.956	0.677	0.0
357475991	852	Serine/threonine protein kinase [Medicag	0.952	0.963	0.634	0.0
157086542	850	At4g21380 [Arabidopsis thaliana]	0.938	0.951	0.636	0.0
1783312	847	receptor-like kinase [Brassica oleracea	0.945	0.962	0.620	0.0
391224306	851	ARK3 [Arabidopsis halleri]	0.938	0.950	0.633	0.0
2181188	847	serine /threonine kinase [Brassica olera	0.945	0.962	0.621	0.0
16040952	838	receptor kinase 5 [Brassica rapa]	0.941	0.968	0.620	0.0

>gi|224076591|ref|XP_002304966.1| predicted protein [Populus trichocarpa] gi|222847930|gb|EEE85477.1| predicted protein [Populus trichocarpa]

 Score = 1228 bits (3178), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 593/815 (72%), Positives = 686/815 (84%), Gaps = 9/815 (1%)

Query: 53  IAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANR 112
            A S+DTLTATQ+L  G+TL+S+   FELGFF+PG+S  WY+GIWYKNI  RTYVWVANR
Sbjct: 24  FASSLDTLTATQSLINGQTLISTSQGFELGFFTPGNSRNWYVGIWYKNIP-RTYVWVANR 82

Query: 113 DDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKE--AGSDE 170
           D PL+NSSG  +I NQ I LFD +  +VWSSNQT A NPV QL DSGN VLKE  + S +
Sbjct: 83  DKPLSNSSGTFKIFNQSIALFDLAGKVVWSSNQTNARNPVMQLLDSGNLVLKEQVSESGQ 142

Query: 171 ILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLW 230
            LWQSFDYPTDTLLP MK+GWDL TG + YL+SWKS++DP TGD SFKL++HGFPE FLW
Sbjct: 143 FLWQSFDYPTDTLLPDMKLGWDLNTGLDRYLSSWKSSEDPGTGDFSFKLEYHGFPEVFLW 202

Query: 231 NKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSP 290
              E +YRSGPWNG RFSGVPEMKP++ ++F F  +QD +VYYSF I  KNL+SRL V+ 
Sbjct: 203 KDNEIEYRSGPWNGQRFSGVPEMKPVDYLSFNFITEQD-EVYYSFHIATKNLYSRLTVTS 261

Query: 291 DGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQA 350
            G LQRF WI   + WN FWYAPKDQCDNY ECG +GICD+NASPVC+C++GF+PK+ QA
Sbjct: 262 SGLLQRFAWIPETQQWNKFWYAPKDQCDNYKECGAYGICDSNASPVCKCLKGFQPKNHQA 321

Query: 351 WSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTA 410
           W LRDGSGGCVRKT L+C +DKFL +KNMKLP +TTSFVD +M+LK CE  CSRNCSCTA
Sbjct: 322 WDLRDGSGGCVRKTNLECLKDKFLHMKNMKLPQSTTSFVDRSMSLKNCELLCSRNCSCTA 381

Query: 411 YANTNIT-GGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTVGSA 469
           YAN+NI+ GG+GCV WTGEL D+R+Y EGGQDLYVRLAASDIGDG +A  III + VG  
Sbjct: 382 YANSNISNGGSGCVIWTGELFDLRQYPEGGQDLYVRLAASDIGDGGSADTIIICIAVGIG 441

Query: 470 ILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADK-TDDLE 528
           ILIL L    +W+RK LL      T+ +G  ERSQDLLLN+VVI+ K+DYS +K TD+LE
Sbjct: 442 ILILSLTGFSIWKRKRLLS-VCNGTQQKGPQERSQDLLLNEVVIN-KKDYSGEKSTDELE 499

Query: 529 LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNE 588
           LPLFDF TI  AT NF D NKLG+GGFG V+KGRL+EGQE+AVKRLS+ SGQG EEFKNE
Sbjct: 500 LPLFDFSTIAAATGNFCDENKLGEGGFGCVHKGRLVEGQEVAVKRLSKKSGQGTEEFKNE 559

Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC 648
           VRLIA+LQHRNLVRLLGCC+EMDEK+L+YE+MENRSLDSV+F+KA+SS+LNWQRRFNIIC
Sbjct: 560 VRLIARLQHRNLVRLLGCCIEMDEKILIYEFMENRSLDSVLFNKAKSSLLNWQRRFNIIC 619

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
           G ARGLLYLHQDSRFRIIHRDLKASNILLD E TPKISDFGMARIFGGDQT+ NT+R+VG
Sbjct: 620 GTARGLLYLHQDSRFRIIHRDLKASNILLDGEWTPKISDFGMARIFGGDQTQANTRRIVG 679

Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG 768
           TYGYMSPEYAMDGLFSVKSDVFSFGVL+LE V G+KNRGFYHSN+ELNLLG+VWR WK+G
Sbjct: 680 TYGYMSPEYAMDGLFSVKSDVFSFGVLVLEIVCGEKNRGFYHSNSELNLLGNVWRQWKDG 739

Query: 769 KVLEMVDSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTP 827
             LE++D SV  +Y  +EVLRCI VGLLCVQE AE+RPTMAS VLMLSSETA+MPQPKTP
Sbjct: 740 NGLEVLDISVGSSYSPSEVLRCIQVGLLCVQERAEDRPTMASAVLMLSSETASMPQPKTP 799

Query: 828 GFCLGRNPIETDSSSSKHDETFTVNQVTVTMLNAR 862
           G+CLGR+P ETDSSSSK DE+FTVNQVTVT+L+AR
Sbjct: 800 GYCLGRSPFETDSSSSKQDESFTVNQVTVTVLDAR 834

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555127|ref|XP_002518601.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223542446|gb|EEF43988.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis]

 Score = 1217 bits (3149), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 594/841 (70%), Positives = 693/841 (82%), Gaps = 15/841 (1%)

Query: 30  MNDITSHPCYTNLFLII-FILF--PTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSP 86
           M  IT    +  +FL   F+ F  P  + S DTLT+TQ+L  G+TL+S+   FELGFF+P
Sbjct: 1   MKGITRRNHFNPIFLFFTFLSFYAPRFSFSSDTLTSTQSLINGQTLLSTRQKFELGFFTP 60

Query: 87  GSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT 146
           G+S  WY+GIWYKNI+ RTYVWVANRD+PL NSSG+ +I NQ I LFD   NL+WSSNQ 
Sbjct: 61  GNSKNWYVGIWYKNISDRTYVWVANRDNPLTNSSGIFKIFNQSIVLFDQGNNLIWSSNQI 120

Query: 147 KATNPVAQLQDSGNFVLKEAG-SDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWK 205
           KATNPV QL D+G+ VL+EA  +++ LWQSFDYPTDTLLP MK+GWDL      YL+SWK
Sbjct: 121 KATNPVMQLLDTGDLVLREANVNNQYLWQSFDYPTDTLLPDMKLGWDLNKSLHRYLSSWK 180

Query: 206 STDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFI 265
           S DDP  GD SFKLD+HGFPE FLWN   + YRSGPWNG+RFSGVPEMKP++ I+F+F  
Sbjct: 181 SKDDPGAGDYSFKLDYHGFPEIFLWNDGRKIYRSGPWNGLRFSGVPEMKPLDYISFDFVT 240

Query: 266 DQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGP 325
           +Q  +V+YSF I + + +SRL V+  G LQR+TWI   + WN FWYAPKDQCD+Y ECGP
Sbjct: 241 NQS-EVFYSFHISSNSTYSRLTVTSSGELQRYTWIPERQDWNSFWYAPKDQCDDYKECGP 299

Query: 326 FGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTT 385
           +GICD+NASPVC+CMRGFEPK+ QAW+LRDGSGGCVRKT+LQC  DKFL LKN+KLP+++
Sbjct: 300 YGICDSNASPVCKCMRGFEPKNLQAWNLRDGSGGCVRKTDLQCMNDKFLHLKNIKLPESS 359

Query: 386 TSFVDYNMTLKECEAFCSRNCSCTAYANTNIT-GGTGCVTWTGELKDIRKYAEGG-QDLY 443
           TSFVD  ++LK CE  C RNCSCTAYAN++I+ GGTGCV W GEL D+R+Y EGG QDLY
Sbjct: 360 TSFVDRIISLKICEELCLRNCSCTAYANSDISNGGTGCVLWFGELLDMRQYTEGGGQDLY 419

Query: 444 VRLAASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERS 503
           VRLAASDIGDG N   +IIG++VG   L+LGL ACF+W+R     R +RK E +G  ERS
Sbjct: 420 VRLAASDIGDGKNVAALIIGISVGIGTLLLGLAACFIWKR-----RSVRK-EQKGVQERS 473

Query: 504 QDLLLNQVVISSKRDYSADK-TDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGR 562
           Q+LLLN+VVISSKRDYS +K  D+LELPLFDF TI  ATDNF+D NKLGQGGFG VYKGR
Sbjct: 474 QNLLLNEVVISSKRDYSGEKDKDELELPLFDFGTIATATDNFSDENKLGQGGFGCVYKGR 533

Query: 563 LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN 622
           L+EGQ +AVKRLS+ S QGIEEFKNEV LIA+LQHRNLVRLLGCC+E +EK+L+YEYME+
Sbjct: 534 LVEGQVVAVKRLSKTSVQGIEEFKNEVNLIARLQHRNLVRLLGCCIETNEKVLIYEYMEH 593

Query: 623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT 682
           RSLDSVIF+ A+ S+LNWQRRFNI+CGIARGLLY+HQDSRFRIIHRDLKASNILLD E  
Sbjct: 594 RSLDSVIFNNAKRSLLNWQRRFNIVCGIARGLLYMHQDSRFRIIHRDLKASNILLDGEWN 653

Query: 683 PKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           PKISDFGMARIFGGDQTE +TKRVVGTYGYMSPEYAMDG FSVKSDVFSFGVL+LE VSG
Sbjct: 654 PKISDFGMARIFGGDQTEASTKRVVGTYGYMSPEYAMDGHFSVKSDVFSFGVLVLEIVSG 713

Query: 743 KKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD-SSVDNYPANEVLRCIHVGLLCVQENA 801
            KNRGFYHSN+ELNLLGH WRLWKE K LE++D S   ++  +EVLRCI VGLLCVQE A
Sbjct: 714 NKNRGFYHSNSELNLLGHAWRLWKEEKGLEILDSSVGSSFSPSEVLRCIQVGLLCVQERA 773

Query: 802 EERPTMASVVLMLSSETATMPQPKTPGFCLGRNPIETDSSSSKHDETFTVNQVTVTMLNA 861
           E+RPTM+SVVLMLSSE ATMP PKTPGFCLGRNP ETDSSS K DE++TVNQVTVTML+A
Sbjct: 774 EDRPTMSSVVLMLSSENATMPHPKTPGFCLGRNPFETDSSSGKQDESYTVNQVTVTMLDA 833

Query: 862 R 862
           R
Sbjct: 834 R 834

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224114151|ref|XP_002316682.1| predicted protein [Populus trichocarpa] gi|222859747|gb|EEE97294.1| predicted protein [Populus trichocarpa]

 Score = 1180 bits (3053), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 584/837 (69%), Positives = 691/837 (82%), Gaps = 19/837 (2%)

Query: 34  TSHPC--YTNLFLIIFILFPT-IAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSG 90
           T H C   T LF  I   F +  A S+DTLTAT++L  G+TL+S+   FELGFF+PG+S 
Sbjct: 6   TRHHCSITTLLFFTILSFFTSKFASSLDTLTATESLVNGQTLISTSQDFELGFFTPGNSR 65

Query: 91  KWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATN 150
            WY+GIWYKNI  RTYVWVANRD+PL NSSG  +I+NQ I LFD ++NL+WSSNQT A N
Sbjct: 66  NWYVGIWYKNIP-RTYVWVANRDNPLTNSSGTFKILNQSIVLFDRAENLIWSSNQTNARN 124

Query: 151 PVAQLQDSGNFVLKEAGSD--EILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTD 208
           PV QL DSGN VL++  SD  + LWQSFDYPTDTLLP MK GWDL TG   +L SWKS+D
Sbjct: 125 PVMQLLDSGNLVLRDQESDSGQFLWQSFDYPTDTLLPDMKFGWDLNTGVNRFLRSWKSSD 184

Query: 209 DPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQD 268
           DP TGD SFKL++HGFPE FL   QE KYRSGPWNG RFSGVPEM+P++ ++F F  +QD
Sbjct: 185 DPGTGDFSFKLEYHGFPEAFLLKDQEIKYRSGPWNGQRFSGVPEMEPVDYMSFNFITNQD 244

Query: 269 HDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGI 328
            +VYYSF I NK+L+SRL V+  G LQRF W+   + W+ FWYAPKDQCD+Y ECGP+GI
Sbjct: 245 -EVYYSFHISNKSLYSRLSVTSSGLLQRFAWVPETQQWSQFWYAPKDQCDDYRECGPYGI 303

Query: 329 CDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMKLPDTTTSF 388
           CD+NASPVC+CM+GF+PK+ QAW+LRDGS GCVR+T+L C +DKFL ++NMKLP++ T++
Sbjct: 304 CDSNASPVCKCMKGFQPKNIQAWNLRDGSSGCVRRTDLNCLKDKFLHMRNMKLPESETTY 363

Query: 389 VDYNMTLKECEAFCSRNCSCTAYANTNIT-GGTGCVTWTGELKDIRKYAEGGQDLYVRLA 447
           VD NM+LK+CE  CSRNCSCTAYAN+NI+ GG+GCV WTGEL D+R+Y +GGQDLYVRLA
Sbjct: 364 VDRNMSLKDCELMCSRNCSCTAYANSNISNGGSGCVFWTGELFDMRQYPKGGQDLYVRLA 423

Query: 448 ASDIGDGANATPIIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLL 507
           ASDIGDG++A  IIIG+ VG  ILIL L    +W+RK LL        P+   +RSQD L
Sbjct: 424 ASDIGDGSSAGTIIIGIAVGIGILILALSGFSIWKRKRLLS-----VCPQ---DRSQDFL 475

Query: 508 LNQVVISSKRDYSADKT-DDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEG 566
           LN VVIS K+DY+ +++ D+LELPL DF TI  AT+NF D NKLG+GGFG V+KGRL+EG
Sbjct: 476 LNGVVIS-KKDYTGERSPDELELPLLDFSTIATATNNFADENKLGEGGFGRVHKGRLVEG 534

Query: 567 QEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLD 626
           QE+AVKRLS+NS QG EEFKNEVRLIA++QHRNLVRLLGCCVE DEK+L+YE+MENRSLD
Sbjct: 535 QEVAVKRLSKNSVQGTEEFKNEVRLIARVQHRNLVRLLGCCVEKDEKILIYEFMENRSLD 594

Query: 627 SVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS 686
            V+F+KA+SS+LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD E TPKIS
Sbjct: 595 FVLFNKAKSSLLNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDHEWTPKIS 654

Query: 687 DFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNR 746
           DFGMAR+FGGDQ + NT RVVGTYGYMSPEYAMDGLFS KSDVFSFGVL+LE V G+KNR
Sbjct: 655 DFGMARMFGGDQIQANTVRVVGTYGYMSPEYAMDGLFSAKSDVFSFGVLVLEIVCGEKNR 714

Query: 747 GFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN-YPANEVLRCIHVGLLCVQENAEERP 805
           GFYHS +ELNLLGHVWR WK+GK LE++D+SV N Y   EVLRCI VGLLCVQE AE+RP
Sbjct: 715 GFYHSFSELNLLGHVWRQWKDGKGLEVLDTSVGNSYSPCEVLRCIQVGLLCVQEKAEDRP 774

Query: 806 TMASVVLMLSSETATMPQPKTPGFCLGRNPIETDSSSSKHDETFTVNQVTVTMLNAR 862
           TM+S VLMLSSETATMPQP+TPG+CLGR+P ETDSSSSK DE+F+VN VTVT+L+AR
Sbjct: 775 TMSSAVLMLSSETATMPQPRTPGYCLGRSPFETDSSSSKQDESFSVNHVTVTVLDAR 831

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496546|ref|XP_002270295.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera]

 Score = 1151 bits (2978), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 573/846 (67%), Positives = 676/846 (79%), Gaps = 18/846 (2%)

Query: 33  ITSHPCYTNLFLIIFILFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKW 92
           IT   CY  L      LFP I IS DT+TA Q++T G+TLVS+   FELGFFSPG S KW
Sbjct: 23  ITGFLCYNVLCFCFLTLFPIIVISGDTITANQSITNGQTLVSAGGDFELGFFSPGDS-KW 81

Query: 93  YIGIWYKNIAQRTYVWVANRDDP-LANSSGVLRIINQR--IGLFDGSQNLVWSSNQTKAT 149
           Y+GIWYKNI +   VWVANRD+P L NSSG +  I  R  I + D   ++ WS+N++ A 
Sbjct: 82  YVGIWYKNIPKERVVWVANRDNPILTNSSGSVVKIGDRGNIVIMDEDLHVFWSTNESTAV 141

Query: 150 NPVAQLQDSGNFVLKE---AGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKS 206
           NPVAQL D+GN V++E   A  +  LWQSFDY TDTLLP MK+GWD KTG   YLTSWKS
Sbjct: 142 NPVAQLLDTGNLVVREDKDADPENYLWQSFDYLTDTLLPGMKLGWDQKTGSNRYLTSWKS 201

Query: 207 TDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFID 266
            +DPS+GD SFKLD  GFPE F+WNKQE+KYRSGPWNGVRFSGVPEMK      F+F  +
Sbjct: 202 KEDPSSGDYSFKLDPRGFPEIFIWNKQEKKYRSGPWNGVRFSGVPEMKSSSVFTFDFEWN 261

Query: 267 QDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPF 326
           QD   YYS+ + NK++ SRL+VS  G LQR+TWIE  ++WN +W+APKDQCD+Y ECGP+
Sbjct: 262 QD-GAYYSYELTNKSITSRLMVSSAGSLQRYTWIETRQVWNLYWFAPKDQCDDYRECGPY 320

Query: 327 GICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTT 385
           GICDTN+SPVC+C RGFEPK+PQAW+LRDGS GC RKTE  C+  D FL LK MKLP+T 
Sbjct: 321 GICDTNSSPVCKCPRGFEPKNPQAWNLRDGSDGCSRKTEFDCNNGDGFLALKRMKLPETG 380

Query: 386 TSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEG--GQDLY 443
           +SFVD +M+LK+CE  C +NCSCT YAN  IT   GC+ WT +L D+R+YAEG  GQDLY
Sbjct: 381 SSFVDKSMSLKDCEMTCRKNCSCTGYANPEITSDKGCIIWTTDLLDMREYAEGEGGQDLY 440

Query: 444 VRLAASDIG--DGANATPIIIGVT---VGSAILILGLVACFLWRRKTLLGRQIRKTEPRG 498
           +R+AAS++G  +G+N T  II VT   VGSA+L+LGL  C+LW+RK +           G
Sbjct: 441 IRVAASELGSENGSNKTVKIIKVTCITVGSAVLLLGLGICYLWKRKKMKIIVAHIVSKPG 500

Query: 499 HPERSQDLLLNQVVISSKRDYSAD-KTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGI 557
             ERS D +LN+ VI SKRDY+ + KTD+LELPLFDF TIV AT+NF+D NKLGQGGFG 
Sbjct: 501 LSERSHDYILNEAVIPSKRDYTDEVKTDELELPLFDFGTIVLATNNFSDTNKLGQGGFGC 560

Query: 558 VYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY 617
           VYKG LLEG+EIAVKRL++NSGQGIEEF NEVRLIA+LQHRNLV+LLGCCVEM+EKML+Y
Sbjct: 561 VYKGMLLEGEEIAVKRLAKNSGQGIEEFMNEVRLIARLQHRNLVQLLGCCVEMEEKMLIY 620

Query: 618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL 677
           EYM+NRSLDS++FD+ +SS+L+W RRFNIICG+ARGLLYLHQDSRFRIIHRDLKASN+LL
Sbjct: 621 EYMQNRSLDSILFDEKKSSLLDWGRRFNIICGVARGLLYLHQDSRFRIIHRDLKASNVLL 680

Query: 678 DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLL 737
           D EM PKISDFGMARIFG DQTE NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVL+L
Sbjct: 681 DGEMNPKISDFGMARIFGRDQTEANTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLVL 740

Query: 738 ETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPAN-EVLRCIHVGLLC 796
           E +SGKKNRGFYH N+E NLLGH WRLW+EGK LE++DSSV    A  +VLRCI VGLLC
Sbjct: 741 EIISGKKNRGFYHLNDEHNLLGHAWRLWREGKGLELMDSSVSESCAPYDVLRCIQVGLLC 800

Query: 797 VQENAEERPTMASVVLMLSSETATMPQPKTPGFCLGRNPIETDSSSSKHDETFTVNQVTV 856
           VQE+AE+RP M+SVVLMLSSETAT+P PK PGFCLGR  +ETDSSSSK +ETFTVNQVTV
Sbjct: 801 VQEHAEDRPVMSSVVLMLSSETATLPLPKNPGFCLGRKLVETDSSSSKQEETFTVNQVTV 860

Query: 857 TMLNAR 862
           T+++AR
Sbjct: 861 TVMDAR 866

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357475991|ref|XP_003608281.1| Serine/threonine protein kinase [Medicago truncatula] gi|355509336|gb|AES90478.1| Serine/threonine protein kinase [Medicago truncatula]

 Score = 1073 bits (2776), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 541/852 (63%), Positives = 641/852 (75%), Gaps = 31/852 (3%)

Query: 39  YTNLFL------IIFILFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKW 92
           +T  FL      I F   P+ ++S +TLT +Q L+  +TL S   +F+L FFS  ++  W
Sbjct: 4   FTTFFLFCLSTSITFFSKPSTSVS-NTLTTSQFLSINQTLFSPKGIFQLTFFSY-NNFSW 61

Query: 93  YIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDGSQNLVWSSNQTKA--- 148
           Y+GI Y     +T VWVANR+ PL N +  L++ N   + + + S   +WSSNQT     
Sbjct: 62  YLGIRYNIDHDKTVVWVANRNTPLQNPTAFLKLTNTGNLIIINESNKTIWSSNQTNQNST 121

Query: 149 --TNPVAQLQDSGNFVL----KEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLT 202
             TNP+ QL DSGN V+     E      LWQSFDYPTDTLLP MK+GW+  T  E ++ 
Sbjct: 122 LNTNPILQLLDSGNLVVTTEPNENDPTNFLWQSFDYPTDTLLPGMKLGWNFDTNTETHIN 181

Query: 203 SWKSTD-DPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPI-EGIN 260
           SWK TD DPS GD SFK+D+HG PE FLWNK  R YRSGPWNG RFSGVPEM+P+ + I 
Sbjct: 182 SWKQTDQDPSIGDISFKMDYHGVPEIFLWNKNRRVYRSGPWNGKRFSGVPEMQPVTDSIQ 241

Query: 261 FEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNY 320
           F F ++ +H+VYYSF I  ++LFSRL V+  G LQR TWI +  IW  FWYAPKDQCDNY
Sbjct: 242 FSF-VENEHEVYYSFSIGKESLFSRLSVNSLGELQRLTWINSRNIWTKFWYAPKDQCDNY 300

Query: 321 GECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSEDKFLQLKNMK 380
            ECGPFG+CDTNASPVC C++GF PK+ QAW+LRDGS GC+R  EL C  DKFL + N+K
Sbjct: 301 KECGPFGVCDTNASPVCNCIKGFRPKNHQAWNLRDGSDGCLRNNELDCESDKFLHMVNVK 360

Query: 381 LPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNIT-GGTGCVTWTGELKDIRKYAEGG 439
           LP+T++ FV+ +M+L EC   C RNCSCT YAN  I  GG GCV W  EL DIR Y  GG
Sbjct: 361 LPETSSVFVNRSMSLVECGDLCKRNCSCTGYANIEIVDGGIGCVMWLDELIDIRIYPAGG 420

Query: 440 QDLYVRLAASDIGD----GANATPII--IGVTVGSA-ILILGLVACFLWRRKTLLGRQIR 492
           QDL+VRLAASD+GD    G++   I   IG+ VG A I+ L L  C+LWR+K L      
Sbjct: 421 QDLFVRLAASDVGDDGVGGSSDHKIARAIGIMVGGATIIFLVLGTCYLWRKKKLQCLLKG 480

Query: 493 KTEPRGHPERSQDLLLNQVVISSKRDYSADKT-DDLELPLFDFETIVRATDNFTDYNKLG 551
           K E RG  ERSQDLL+ + V +S R+ +++K  DDLELP FDF TI  AT+NF++ NKLG
Sbjct: 481 KREKRGSLERSQDLLMTEGVYTSNREQTSEKNMDDLELPFFDFNTITMATNNFSEENKLG 540

Query: 552 QGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD 611
           QGGFGIVYKGRL+EGQEIAVKRLS+NSGQG++EFKNEVRLI KLQHRNLVRLLGC  +MD
Sbjct: 541 QGGFGIVYKGRLIEGQEIAVKRLSKNSGQGVDEFKNEVRLIVKLQHRNLVRLLGCSFQMD 600

Query: 612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK 671
           EKMLVYEYMENRSLD+++FDKA+   L+WQ RFNII GIARGLLYLHQDSRFRIIHRDLK
Sbjct: 601 EKMLVYEYMENRSLDAILFDKAKRFSLDWQTRFNIISGIARGLLYLHQDSRFRIIHRDLK 660

Query: 672 ASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFS 731
           ASNILLD EM PKISDFGMARIFG DQTE NT RVVGTYGYMSPEYAMDG+FSVKSDVFS
Sbjct: 661 ASNILLDGEMNPKISDFGMARIFGTDQTEANTVRVVGTYGYMSPEYAMDGIFSVKSDVFS 720

Query: 732 FGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS-VDNYPANEVLRCI 790
           FGVL++E +SGKKNRGFY +N ELNLLGH W+LW EG  LE++DSS V++Y   EV RCI
Sbjct: 721 FGVLVMEIISGKKNRGFYSANKELNLLGHSWKLWNEGNALELIDSSIVNSYSPAEVFRCI 780

Query: 791 HVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGFCLGRNPIETDSSSSKHDETFT 850
            VGLLCVQE AE+RPTM+SVVLMLSSETAT+ QPK PGFCLG NP+ETDSSSSK DE+ T
Sbjct: 781 QVGLLCVQERAEDRPTMSSVVLMLSSETATIAQPKNPGFCLGSNPVETDSSSSKQDESCT 840

Query: 851 VNQVTVTMLNAR 862
           VNQVTVTM++ R
Sbjct: 841 VNQVTVTMVDGR 852

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|157086542|gb|ABV21214.1| At4g21380 [Arabidopsis thaliana]

 Score = 1072 bits (2772), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 529/831 (63%), Positives = 656/831 (78%), Gaps = 22/831 (2%)

Query: 51  PTIAISVDTLTATQNLTYGK--TLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVW 108
           P  +IS +TL+A+++LT     T+VS  +VFELGFF PG   +WY+GIWYK I++RTYVW
Sbjct: 23  PAYSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVW 82

Query: 109 VANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT--KATNP-VAQLQDSGNFVLKE 165
           VANRD PL++S G L+I +  + + D S   VWS+N T     +P VA+L D+GNFVL++
Sbjct: 83  VANRDTPLSSSIGTLKIFDSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD 142

Query: 166 A---GSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFH 222
           +    SD  LWQSFD+PTDTLLP+MK+GWD KTGF  ++ SWKS DDPS+GD SFKL+  
Sbjct: 143 SKNNDSDGFLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETE 202

Query: 223 GFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNL 282
           GFPE FLWN++ R YRSGPWNG+RFSGVPEM+P E + F F   ++ +V YSF +   ++
Sbjct: 203 GFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKE-EVTYSFRVTKSDV 261

Query: 283 FSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRG 342
           +SRL +S  G LQRFTWIE  + WN FWYAPKDQCD Y ECG +G CD+N SPVC C++G
Sbjct: 262 YSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKG 321

Query: 343 FEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTTTSFVDYNMTLKECEAF 401
           F+P++PQ W LRDGS GCVRKT L C   D F++LK MKLPDTTT+ VD  + +KECE  
Sbjct: 322 FKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQK 381

Query: 402 CSRNCSCTAYANTNITG-GTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPI 460
           C R+C+CTA+ANT+I G G+GCVTWTGEL DIR YA+GGQDLYVRLAA+D+ D  N +  
Sbjct: 382 CLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAK 441

Query: 461 IIGVTVG-SAILILGLVACFLWRRKTLLGRQIRKTEP-RGHPERSQDLLLNQVVISSKRD 518
           IIG ++G S +L+LG +  FLW+RK    R I    P   H  RS+DLL+N+VVISS+R 
Sbjct: 442 IIGSSIGVSVLLLLGFIIFFLWKRKQ--KRSILIETPIVDHQVRSRDLLMNEVVISSRRH 499

Query: 519 YS-ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN 577
            S  + TDDLELPL +FE +  AT+NF++ NKLGQGGFGIVYKG+LL+GQE+AVKRLS+ 
Sbjct: 500 ISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKT 559

Query: 578 SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI 637
           S QG +EFKNEV+LIA+LQH NLVRLL CCV+  EKML+YEY+EN SLDS +FDK+RSS 
Sbjct: 560 SVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRSSK 619

Query: 638 LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
           LNWQ RF+II GIARGLLYLHQDSRFRIIHRDLKASNILLDK MTPKISDFGMARIFG D
Sbjct: 620 LNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRD 679

Query: 698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNL 757
           +TE NT++VVGTYGYMSPEYAMDG++S+KSDVFSFGVLLLE +SGK+N+GFY+S+ +LNL
Sbjct: 680 ETEANTRKVVGTYGYMSPEYAMDGIYSMKSDVFSFGVLLLEIISGKRNKGFYNSDRDLNL 739

Query: 758 LGHVWRLWKEGKVLEMVD----SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM 813
           LG VWR WKEGK LE++D     S   +  +E+LRCI +GLLCVQE AEERPTM+ VVLM
Sbjct: 740 LGCVWRNWKEGKGLEIIDPIITGSSSTFRQHEILRCIQIGLLCVQERAEERPTMSLVVLM 799

Query: 814 LSSETATMPQPKTPGFCLGRNPIETDSSSSKH--DETFTVNQVTVTMLNAR 862
           L SE+ T+PQPK+PG+CLGR+P++TDSSSSK   DE++TVNQ+TV++L AR
Sbjct: 800 LGSESTTIPQPKSPGYCLGRSPLDTDSSSSKQRDDESWTVNQITVSVLEAR 850

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|1783312|emb|CAA67145.1| receptor-like kinase [Brassica oleracea var. acephala]

 Score = 1070 bits (2767), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 524/845 (62%), Positives = 654/845 (77%), Gaps = 30/845 (3%)

Query: 42  LFLIIFILFPTIAISVDTLTATQNLTYG--KTLVSSDDVFELGFFSPGSSGKWYIGIWYK 99
           +   + +LFP  + S +TL+AT++LT    KT+ S  ++FELGFF P SS +WY+GIWYK
Sbjct: 9   VLFSVLLLFPAFSFSANTLSATESLTISSNKTISSPGNIFELGFFKPSSSSRWYLGIWYK 68

Query: 100 NIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNP----VAQL 155
            I++RTYVWVANRD PL+ S+G L+I +  + + DGS   VWS+N T   +     VA+L
Sbjct: 69  AISKRTYVWVANRDHPLSTSTGTLKISDSNLVVVDGSDTAVWSTNLTGGGDVRSPVVAEL 128

Query: 156 QDSGNFVLKEAGSDE---ILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPST 212
            D+GNFVL+++ +++   +LWQSFD+PTDTLLP+MK+GWDLKTGF W+L SWKS DDPS+
Sbjct: 129 LDNGNFVLRDSNNNDPDIVLWQSFDFPTDTLLPEMKLGWDLKTGFNWFLRSWKSPDDPSS 188

Query: 213 GDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVY 272
           GD SFKL   GFPE FLWNK  + YRSGPWNG+RFSGVPEM+P + I F F    + +V 
Sbjct: 189 GDYSFKLKTRGFPEAFLWNKASQVYRSGPWNGIRFSGVPEMQPFDYIEFNF-TTSNQEVT 247

Query: 273 YSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTN 332
           YSF I   N++SRL +S  G LQRFTWIEA + WN FWYAPKDQCD+Y ECG +G CD+N
Sbjct: 248 YSFHITKDNMYSRLSLSSTGSLQRFTWIEAIQNWNQFWYAPKDQCDDYKECGTYGYCDSN 307

Query: 333 ASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTTTSFVDY 391
             PVC CMRGFEP++PQAW LRDGS GCVRKT L C+  D F++LK MKLPDT  + VD 
Sbjct: 308 TYPVCNCMRGFEPRNPQAWGLRDGSDGCVRKTALSCNGGDGFVRLKKMKLPDTAATSVDR 367

Query: 392 NMTLKECEAFCSRNCSCTAYANTNITGG-TGCVTWTGELKDIRKYAEGGQDLYVRLAASD 450
            + +KECE  C  +C+CTA+ANT+I GG +GCV WTG++ D R YA+GGQDLYVRLAA+D
Sbjct: 368 GIGIKECEEKCKSDCNCTAFANTDIRGGGSGCVVWTGDILDTRNYAKGGQDLYVRLAATD 427

Query: 451 IGDGANATPIIIGVTVGSAILILGLVACFL----WRRKTLLGRQIRKTEPRGHPERSQDL 506
           + D  N    IIG  +G ++L+L    CF+    W+RK    R I          RSQDL
Sbjct: 428 LEDTTNRNAKIIGSCIGVSVLLL---LCFIFYRFWKRKQ--KRSIAIETSFVDQVRSQDL 482

Query: 507 LLNQVVISSKRDYSA--DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL 564
           L+N+VVI   R + +  +KTDDLELPL DFE +  ATDNF++ NKLGQGGFGIVYKGRLL
Sbjct: 483 LMNEVVIPPNRRHISRENKTDDLELPLMDFEAVAIATDNFSNANKLGQGGFGIVYKGRLL 542

Query: 565 EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRS 624
           +GQEIAVKRLS+ S QG +EFKNEV+LIA+LQH NLVRLLGCCV+  EKML+YEY+EN S
Sbjct: 543 DGQEIAVKRLSKMSVQGTDEFKNEVKLIARLQHINLVRLLGCCVDEGEKMLIYEYLENLS 602

Query: 625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK 684
           LDS +FDK RS  LNWQ+RF+I  GIARGLLYLHQDSRFRIIHRDLKASN+LLDK+MTPK
Sbjct: 603 LDSHLFDKTRSCKLNWQKRFDITNGIARGLLYLHQDSRFRIIHRDLKASNVLLDKDMTPK 662

Query: 685 ISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKK 744
           ISDFGMARIFG D+TE NT++VVGTYGYMSPEYAMDG+FS KSDVFSFGVLLLE +SGK+
Sbjct: 663 ISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSTKSDVFSFGVLLLEIISGKR 722

Query: 745 NRGFYHSNNELNLLGHVWRLWKEGKVLEMV-----DSSVDNYPANEVLRCIHVGLLCVQE 799
           N+GFY+S+++LNLLG VWR WK+GK L++V     DSS   Y   E+LRCI +GLLCVQE
Sbjct: 723 NKGFYNSDHDLNLLGCVWRNWKKGKGLDIVDPIILDSSPSTYRPLEILRCIKIGLLCVQE 782

Query: 800 NAEERPTMASVVLMLSSETATMPQPKTPGFCLGRNPIETDSSSS--KHDETFTVNQVTVT 857
            A +RPTM+SVV+ML SETA +PQP+ PG+C+GR+P++TDSSSS  +HDE+++VNQ+TV+
Sbjct: 783 RANDRPTMSSVVMMLGSETAAIPQPEQPGYCVGRSPLDTDSSSSNQRHDESWSVNQMTVS 842

Query: 858 MLNAR 862
           +++ R
Sbjct: 843 VIDPR 847

Source: Brassica oleracea var. acephala

Species: Brassica oleracea

Genus: Brassica

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|391224306|emb|CCI61483.1| ARK3 [Arabidopsis halleri]

 Score = 1070 bits (2766), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 526/830 (63%), Positives = 656/830 (79%), Gaps = 21/830 (2%)

Query: 51  PTIAISVDTLTATQNLTYGK--TLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVW 108
           P  +IS +TL+A+++LT     T+VS  +VFELGFF PG   +WY+GIWYK I++RTYVW
Sbjct: 25  PAFSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLKSRWYLGIWYKTISKRTYVW 84

Query: 109 VANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT--KATNP-VAQLQDSGNFVLKE 165
           VANRD PL++S G L+I +  + + D S   VWS+N T   A +P VA+L D+GNFVL++
Sbjct: 85  VANRDTPLSSSIGTLKISDHNLVVLDQSDTPVWSTNLTGGDARSPLVAELLDNGNFVLRD 144

Query: 166 AGS---DEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFH 222
           + +   D +LWQSFD+PTDTLLP+MK+GWDLKTGF  ++ SWKS DDPS+GD  FKL+  
Sbjct: 145 SKNNNPDGVLWQSFDFPTDTLLPEMKLGWDLKTGFNRFIRSWKSPDDPSSGDFWFKLETE 204

Query: 223 GFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNL 282
           GFPE FLWN++ R YRSGPWNG+RFSGVPEM+P E + F F   ++ +V YSF +   ++
Sbjct: 205 GFPEVFLWNRESRVYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKE-EVTYSFRVTKSDI 263

Query: 283 FSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRG 342
           +SRL +S  G LQRFTWIE  + WN FWYAPKDQCD+Y ECG +G CD+N SPVC C++G
Sbjct: 264 YSRLSLSSTGLLQRFTWIETAQNWNQFWYAPKDQCDDYKECGIYGYCDSNTSPVCNCIKG 323

Query: 343 FEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTTTSFVDYNMTLKECEAF 401
           F+PK+PQ W LRDGS GCVRKT L C   D F++LK MKLPDTTT+ VD  + +KECE  
Sbjct: 324 FKPKNPQVWGLRDGSDGCVRKTVLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQK 383

Query: 402 CSRNCSCTAYANTNITGG-TGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPI 460
           C ++C+CTA+ANT+I GG +GCVTWTGEL DIR YA+GGQDLYVRLAA+D+ D  N +  
Sbjct: 384 CLKDCNCTAFANTDIRGGGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAK 443

Query: 461 IIGVTVGSAILIL-GLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDY 519
           IIG ++G ++LIL   +  FLW++K    R I          RS+DLL+N+VVISS+R  
Sbjct: 444 IIGSSIGVSVLILLSFIIFFLWKKKQ--KRSILIETATVDQVRSRDLLMNEVVISSRRHI 501

Query: 520 S-ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS 578
           S  + TDDLELPL +FE +  ATDNF+  NKLGQGGFGIVYKGRLL+GQEIAVKRLS+ S
Sbjct: 502 SRENNTDDLELPLMEFEEVAMATDNFSTVNKLGQGGFGIVYKGRLLDGQEIAVKRLSKTS 561

Query: 579 GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSIL 638
            QG +EFKNEV+LIA+LQH NLVRLL CCV+  EKML+YEY+EN SLDS +FDK+RSS L
Sbjct: 562 VQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRSSKL 621

Query: 639 NWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           NWQ RF+II GIARGLLYLHQDSRFRIIHRDLKASN+LLDK MTPKISDFGMARIFG D+
Sbjct: 622 NWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNVLLDKYMTPKISDFGMARIFGRDE 681

Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
           TE +T++VVGTYGYMSPEYAMDG+FS+KSDVFSFGVLLLE +SGK+N+GFY+S+ +LNLL
Sbjct: 682 TEASTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSDRDLNLL 741

Query: 759 GHVWRLWKEGKVLEMVD----SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
           G VWR WKEGK LE++D     S   +  +E+LRCI +GLLCVQE AE+RPTM+ VVLML
Sbjct: 742 GCVWRNWKEGKGLEIIDPIITESSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVVLML 801

Query: 815 SSETATMPQPKTPGFCLGRNPIETDSSSSKH--DETFTVNQVTVTMLNAR 862
            SE+ T+PQPK+PG+CLGR+P++TDSSSSK   DE++TVNQ+TV++L+AR
Sbjct: 802 GSESTTIPQPKSPGYCLGRSPLDTDSSSSKQRDDESWTVNQITVSVLDAR 851

Source: Arabidopsis halleri

Species: Arabidopsis halleri

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|2181188|emb|CAA73133.1| serine /threonine kinase [Brassica oleracea]

 Score = 1068 bits (2762), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 525/845 (62%), Positives = 652/845 (77%), Gaps = 30/845 (3%)

Query: 42  LFLIIFILFPTIAISVDTLTATQNLTYG--KTLVSSDDVFELGFFSPGSSGKWYIGIWYK 99
           +   + +LFP  + S +TL+AT++LT    KT+ S  ++FELGFF P SS +WY+GIWYK
Sbjct: 9   VLFSVLLLFPAFSFSSNTLSATESLTISSNKTISSPGNIFELGFFKPSSSSRWYLGIWYK 68

Query: 100 NIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNP----VAQL 155
            I++RTYVWVANRD PL+ S+G L+I +  + + DGS   VWS+N T   +     VA+L
Sbjct: 69  AISKRTYVWVANRDHPLSTSTGTLKISDSNLVVVDGSDTAVWSTNLTGGGDVRSPVVAEL 128

Query: 156 QDSGNFVLKEAGS---DEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPST 212
            D+GNFVL+++ +   D +LWQSFD+PTDTLLP+MK+GWDLKTGF W+L SWKS DDPS+
Sbjct: 129 LDNGNFVLRDSNNNDPDIVLWQSFDFPTDTLLPEMKLGWDLKTGFNWFLRSWKSPDDPSS 188

Query: 213 GDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVY 272
           GD SFKL   GFPE FLWNK  + YRSGPWNG+RFSGVPEM+P + I F F    + +V 
Sbjct: 189 GDYSFKLKTRGFPEAFLWNKASQVYRSGPWNGIRFSGVPEMQPFDYIEFNF-TTSNQEVT 247

Query: 273 YSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTN 332
           YSF I   N++SRL +S  G LQRFTWIEA + WN FWYAPKDQCD+Y ECG +G CD+N
Sbjct: 248 YSFHITKDNMYSRLSLSSTGSLQRFTWIEAIQNWNQFWYAPKDQCDDYKECGTYGYCDSN 307

Query: 333 ASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTTTSFVDY 391
             PVC CMRGFEP++PQAW LRDGS GCVRKT L C+  D F++LK MKLPDT  + VD 
Sbjct: 308 TYPVCNCMRGFEPRNPQAWGLRDGSDGCVRKTALSCNGGDGFVRLKKMKLPDTAATSVDR 367

Query: 392 NMTLKECEAFCSRNCSCTAYANTNITGG-TGCVTWTGELKDIRKYAEGGQDLYVRLAASD 450
            + +KECE  C  +C+CTA+ANT+I GG +GCV WTG++ D R YA+GGQDLYVRLAA+D
Sbjct: 368 GIGIKECEEKCKSDCNCTAFANTDIRGGGSGCVVWTGDILDTRNYAKGGQDLYVRLAATD 427

Query: 451 IGDGANATPIIIGVTVGSAILILGLVACFL----WRRKTLLGRQIRKTEPRGHPERSQDL 506
           + D  N    IIG  +G ++L+L    CF+    W+RK    R I          RSQDL
Sbjct: 428 LEDTTNRNAKIIGSCIGVSVLLL---LCFIFYRFWKRKQ--KRSIAIETSFVDQVRSQDL 482

Query: 507 LLNQVVISSKRDYSA--DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL 564
           L+N+VVI   R + +  +KTDDLELPL DFE +  ATDNF++ NKLGQGGFGIVYKGRLL
Sbjct: 483 LMNEVVIPPNRRHISRENKTDDLELPLMDFEAVAIATDNFSNANKLGQGGFGIVYKGRLL 542

Query: 565 EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRS 624
           +GQEIAVKRLS+ S QG +EFKNEV+LIA+LQH NLVRLLGCCV+  EKML+YEY+EN S
Sbjct: 543 DGQEIAVKRLSKMSVQGTDEFKNEVKLIARLQHINLVRLLGCCVDEGEKMLIYEYLENLS 602

Query: 625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK 684
           LDS +FDK RS  LNWQ+RF I  GIARGLLYLHQDSRFRIIHRDLKASN+LLDK+MTPK
Sbjct: 603 LDSHLFDKTRSCKLNWQKRFVITNGIARGLLYLHQDSRFRIIHRDLKASNVLLDKDMTPK 662

Query: 685 ISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKK 744
           ISDFGMARIFG D+TE NT++VVGTYGYMSPEYAMDG+FS KSDVFSFGVLLLE +SGK+
Sbjct: 663 ISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSTKSDVFSFGVLLLEIISGKR 722

Query: 745 NRGFYHSNNELNLLGHVWRLWKEGKVLEMV-----DSSVDNYPANEVLRCIHVGLLCVQE 799
           N+GFY+S+++LNLLG VWR WK+GK L++V     DSS   Y   E+LRCI +GLLCVQE
Sbjct: 723 NKGFYNSDHDLNLLGCVWRNWKKGKGLDIVDPIILDSSPSTYRPLEILRCIKIGLLCVQE 782

Query: 800 NAEERPTMASVVLMLSSETATMPQPKTPGFCLGRNPIETDSSSS--KHDETFTVNQVTVT 857
            A +RPTM+SVV+ML SETA +PQP+ PG+C+GR+P++TDSSSS  +HDE+++VNQ+TV+
Sbjct: 783 RANDRPTMSSVVMMLGSETAAIPQPEQPGYCVGRSPLDTDSSSSNQRHDESWSVNQMTVS 842

Query: 858 MLNAR 862
           +++ R
Sbjct: 843 VIDPR 847

Source: Brassica oleracea

Species: Brassica oleracea

Genus: Brassica

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|16040952|dbj|BAB69683.1| receptor kinase 5 [Brassica rapa]

 Score = 1066 bits (2757), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 524/844 (62%), Positives = 651/844 (77%), Gaps = 32/844 (3%)

Query: 42  LFLIIFILFPTIAISVDTLTATQNLTYG--KTLVSSDDVFELGFFSPGSSGKWYIGIWYK 99
           +   + +LFP  + S +TL+AT++LT    KT+ S  ++FELGFF P SS +WY+GIWYK
Sbjct: 4   VLFSVLLLFPAFSFSANTLSATESLTISSNKTISSPGNIFELGFFKPSSSSRWYLGIWYK 63

Query: 100 NIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNP----VAQL 155
            I++RTYVWVANRD PL+ S+G L+I +  + + DGS   VWS+N T   +     VA+L
Sbjct: 64  AISKRTYVWVANRDHPLSTSTGTLKISDSNLVVVDGSDTAVWSTNLTGGGDVRSPVVAEL 123

Query: 156 QDSGNFVLKEAGS---DEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPST 212
            D+GN VL+++ +   D +LWQSFD+PTDTLLP+MK+GWDLKTGF  +L SWKS DDPS+
Sbjct: 124 LDNGNLVLRDSNNNDPDGVLWQSFDFPTDTLLPEMKLGWDLKTGFNRFLRSWKSPDDPSS 183

Query: 213 GDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVY 272
           GD SFKL+  GFPE FLWNK  + YRSGPWNG+RFSGVPEM+P + I F F    + +V 
Sbjct: 184 GDYSFKLETRGFPEAFLWNKASQVYRSGPWNGIRFSGVPEMQPFDYIEFNF-TTSNQEVT 242

Query: 273 YSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTN 332
           YSF I   N++SRL +S  G LQRFTWIEA + WN FWYAPKDQCD Y ECG FG CD+N
Sbjct: 243 YSFHITKDNMYSRLSLSSTGSLQRFTWIEAIQNWNQFWYAPKDQCDEYKECGTFGYCDSN 302

Query: 333 ASPVCQCMRGFEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTTTSFVDY 391
             PVC CMRGFEP++PQAW+LRDGS GCVRKT L C+  D F++LK MKLPDT  + VD 
Sbjct: 303 TYPVCNCMRGFEPRNPQAWALRDGSDGCVRKTALSCNGGDGFVRLKKMKLPDTAATSVDR 362

Query: 392 NMTLKECEAFCSRNCSCTAYANTNITGG-TGCVTWTGELKDIRKYAEGGQDLYVRLAASD 450
            + +KECE  C  +C+CTA+ANT+I GG +GCV WTG++ D R YA+GGQDLYVRLAA+D
Sbjct: 363 GIGIKECEEKCKSDCNCTAFANTDIRGGGSGCVVWTGDILDTRNYAKGGQDLYVRLAATD 422

Query: 451 IGDGANATPIIIGVTVGSAILILGLVACFL----WRRKTLLGRQIRKTEPRGHPERSQDL 506
           + D  N    IIG  +G ++L+L    CF+    W+RK     Q R         RSQDL
Sbjct: 423 LEDTTNRNAKIIGSCIGVSVLLL---LCFIFYRFWKRK-----QKRSIAIETSFVRSQDL 474

Query: 507 LLNQVVISSKRDYS-ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE 565
           L+N+VVI S+R  S  +KTDD ELPL DFE +  ATDNFT+ NKLGQGGFGIVYKGRLL+
Sbjct: 475 LMNEVVIPSRRHISRENKTDDFELPLMDFEAVAIATDNFTNANKLGQGGFGIVYKGRLLD 534

Query: 566 GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL 625
           GQEIAVKRLS+ S QG +EFKNEV+LIA+LQH NLVRLLGCCV+  EKML+YEY+EN SL
Sbjct: 535 GQEIAVKRLSKMSVQGTDEFKNEVKLIARLQHINLVRLLGCCVDEGEKMLIYEYLENLSL 594

Query: 626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI 685
           DS +FDK RS  LNWQ+RF+I  GIARGLLYLHQDSRFRIIHRDLKASN+LLDK+MTPKI
Sbjct: 595 DSHLFDKTRSCKLNWQKRFDITNGIARGLLYLHQDSRFRIIHRDLKASNVLLDKDMTPKI 654

Query: 686 SDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKN 745
           SDFGMARIFG D+TE NT++VVGTYGYMSPEYAMDG+FS KSDVFSFGVLLLE +SGK+N
Sbjct: 655 SDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSTKSDVFSFGVLLLEIISGKRN 714

Query: 746 RGFYHSNNELNLLGHVWRLWKEGKVLEMV-----DSSVDNYPANEVLRCIHVGLLCVQEN 800
           +GFY+S+++LNLLG VWR WK+GK L++V     DSS   Y   E+LRCI +GLLCVQE 
Sbjct: 715 KGFYNSDHDLNLLGCVWRNWKKGKGLDIVDPIILDSSPSTYRPLEILRCIKIGLLCVQER 774

Query: 801 AEERPTMASVVLMLSSETATMPQPKTPGFCLGRNPIETDSSSS--KHDETFTVNQVTVTM 858
           A +RPTM+SVV+ML SET  +PQP+ PG+C+GR+P++TDSSSS  ++DE+++VNQ+TV++
Sbjct: 775 ANDRPTMSSVVMMLGSETTAIPQPEPPGYCVGRSPLDTDSSSSNQRNDESWSVNQMTVSV 834

Query: 859 LNAR 862
           ++ R
Sbjct: 835 IDPR 838

Source: Brassica rapa

Species: Brassica rapa

Genus: Brassica

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	862
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.939	0.952	0.630	2.6e-285
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.932	0.953	0.586	2e-262
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.933	0.950	0.591	2.6e-260
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.380	0.418	0.613	1.5e-210
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.386	0.408	0.632	1.4e-198
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.921	0.935	0.459	5e-186
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.919	0.941	0.449	4.7e-183
TAIR|locus:2200151	830	SD1-13 "S-domain-1 13" [Arabid	0.917	0.953	0.433	4.9e-172
TAIR|locus:2200888	804	AT1G61500 [Arabidopsis thalian	0.396	0.425	0.518	1.2e-164
TAIR|locus:2197664	804	AT1G61490 [Arabidopsis thalian	0.394	0.422	0.517	1.1e-163

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 2741 (969.9 bits), Expect = 2.6e-285, P = 2.6e-285
 Identities = 523/830 (63%), Positives = 651/830 (78%)

Query:    51 PTIAISVDTLTATQNLTYGK--TLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVW 108
             P  +IS +TL+A+++LT     T+VS  +VFELGFF PG   +WY+GIWYK I++RTYVW
Sbjct:    23 PAYSISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVW 82

Query:   109 VANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT--KATNP-VAQLQDSGNFVL-- 163
             VANRD PL++S G L+I +  + + D S   VWS+N T     +P VA+L D+GNFVL  
Sbjct:    83 VANRDTPLSSSIGTLKISDSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD 142

Query:   164 -KEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFH 222
              K +  D +LWQSFD+PTDTLLP+MK+GWD KTGF  ++ SWKS DDPS+GD SFKL+  
Sbjct:   143 SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETE 202

Query:   223 GFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNL 282
             GFPE FLWN++ R YRSGPWNG+RFSGVPEM+P E + F F   ++ +V YSF I   ++
Sbjct:   203 GFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKE-EVTYSFRITKSDV 261

Query:   283 FSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRG 342
             +SRL +S  G LQRFTWIE  + WN FWYAPKDQCD Y ECG +G CD+N SPVC C++G
Sbjct:   262 YSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKG 321

Query:   343 FEPKDPQAWSLRDGSGGCVRKTELQCSE-DKFLQLKNMKLPDTTTSFVDYNMTLKECEAF 401
             F+P++PQ W LRDGS GCVRKT L C   D F++LK MKLPDTTT+ VD  + +KECE  
Sbjct:   322 FKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQK 381

Query:   402 CSRNCSCTAYANTNITG-GTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPI 460
             C R+C+CTA+ANT+I G G+GCVTWTGEL DIR YA+GGQDLYVRLAA+D+ D  N +  
Sbjct:   382 CLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAK 441

Query:   461 IIGVTVG-SAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDY 519
             IIG ++G S +L+L  +  FLW+RK      I +T    H  RS+DLL+N+VVISS+R  
Sbjct:   442 IIGSSIGVSVLLLLSFIIFFLWKRKQKRSILI-ETPIVDHQLRSRDLLMNEVVISSRRHI 500

Query:   520 SADK-TDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS 578
             S +  TDDLELPL +FE +  AT+NF++ NKLGQGGFGIVYKG+LL+GQE+AVKRLS+ S
Sbjct:   501 SRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTS 560

Query:   579 GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSIL 638
              QG +EFKNEV+LIA+LQH NLVRLL CCV+  EKML+YEY+EN SLDS +FDK+R+S L
Sbjct:   561 VQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKL 620

Query:   639 NWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
             NWQ RF+II GIARGLLYLHQDSRFRIIHRDLKASNILLDK MTPKISDFGMARIFG D+
Sbjct:   621 NWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDE 680

Query:   699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
             TE NT++VVGTYGYMSPEYAMDG+FS+KSDVFSFGVLLLE +S K+N+GFY+S+ +LNLL
Sbjct:   681 TEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLL 740

Query:   759 GHVWRLWKEGKVLEMVD----SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
             G VWR WKEGK LE++D     S   +  +E+LRCI +GLLCVQE AE+RPTM+ V+LML
Sbjct:   741 GCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILML 800

Query:   815 SSETATMPQPKTPGFCLGRNPIETDSSSSKH--DETFTVNQVTVTMLNAR 862
              SE+ T+PQPK PG+CL R+ ++TDSSSSK   DE++TVNQ+TV++L+AR
Sbjct:   801 GSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 2525 (893.9 bits), Expect = 2.0e-262, P = 2.0e-262
 Identities = 484/825 (58%), Positives = 624/825 (75%)

Query:    54 AISVDTLTATQNLTYG--KTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVAN 111
             ++S +TL+AT++LT    KT++S   +FELGFF+P SS +WY+GIWYK I  RTYVWVAN
Sbjct:    24 SVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVAN 83

Query:   112 RDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT--KATNPVA-QLQDSGNFVLKEAGS 168
             RD+PL++S+G L+I    + +FD S   VWS+N T     +PVA +L D+GNF+L+++ +
Sbjct:    84 RDNPLSSSNGTLKISGNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDS-N 142

Query:   169 DEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGF 228
             + +LWQSFD+PTDTLL +MK+GWD KTGF   L SWK+TDDPS+G+ S KL+   FPE +
Sbjct:   143 NRLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFY 202

Query:   229 LWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIV 288
             + +K+   YRSGPWNG+RFS VP    ++ + + F   ++ +V YS+ I   NL+SRL +
Sbjct:   203 ICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKE-EVTYSYRINKTNLYSRLYL 261

Query:   289 SPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDP 348
             +  G LQR TW E  + W   WY+PKD CDNY  CG FG CD+N+ P C C++GF+P + 
Sbjct:   262 NSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNE 321

Query:   349 QAWSLRDGSGGCVRKTELQCS-EDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCS 407
             QAW LRDGS GC+RKT L C   D F +LK MKLPDTT + VD  + LK C+  C  +C+
Sbjct:   322 QAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCN 381

Query:   408 CTAYANTNI-TGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIIIGVTV 466
             CTA+AN +I  GG+GCV WT E+ D+R YA+GGQDLYVRLAA+++ D       IIG ++
Sbjct:   382 CTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELEDKRIKNEKIIGSSI 441

Query:   467 G-SAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSAD--K 523
             G S +L+L  V    W+RK    R I    P     RSQD L+N VV+S +R Y++   K
Sbjct:   442 GVSILLLLSFVIFHFWKRKQK--RSITIQTPNVDQVRSQDSLINDVVVS-RRGYTSKEKK 498

Query:   524 TDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIE 583
             ++ LELPL + E +  AT+NF++ NKLGQGGFGIVYKGRLL+G+EIAVKRLS+ S QG +
Sbjct:   499 SEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTD 558

Query:   584 EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRR 643
             EF NEVRLIAKLQH NLVRLLGCCV+  EKML+YEY+EN SLDS +FD+ RSS LNWQ+R
Sbjct:   559 EFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKR 618

Query:   644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
             F+II GIARGLLYLHQDSR RIIHRDLKASN+LLDK MTPKISDFGMARIFG ++TE NT
Sbjct:   619 FDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANT 678

Query:   704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
             +RVVGTYGYMSPEYAMDG+FS+KSDVFSFGVLLLE +SGK+N+GFY+SN +LNLLG VWR
Sbjct:   679 RRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWR 738

Query:   764 LWKEGKVLEMVDS-SVDN----YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET 818
              WKEG  LE+VD  ++D+    +P +E+LRCI +GLLCVQE AE+RP M+SV++ML SET
Sbjct:   739 HWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSET 798

Query:   819 ATMPQPKTPGFCLGRNPIETDSSSS-KHDETFTVNQVTVTMLNAR 862
               +PQPK PGFC+GR+P+E DSSSS + D+  TVNQ+T+++++AR
Sbjct:   799 TAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 2505 (886.9 bits), Expect = 2.6e-260, P = 2.6e-260
 Identities = 492/832 (59%), Positives = 626/832 (75%)

Query:    53 IAISV--DTLTATQNLTYG--KTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVW 108
             +A SV     +AT++LT    KT++S   +FELGFF+P SS +WY+GIWYK I  RTYVW
Sbjct:    21 LAFSVYASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVW 80

Query:   109 VANRDDPLANSSGVLRIINQRIGLFDGSQNLVWSSNQT--KATNPVA-QLQDSGNFVLKE 165
             VANRD+PL++S+G L+I +  + +FD S   VWS+N T     +PVA +L D GNFVL++
Sbjct:    81 VANRDNPLSSSNGTLKISDNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD 140

Query:   166 AGSDE---ILWQSFDYPTDTLLPQMKIGWDLKTG-FEWYLTSWKSTDDPSTGDNSFKLDF 221
             + +++    LWQSFD+PTDTLL  MK+GWD K+G F   L SWK+TDDPS+GD S KL  
Sbjct:   141 SKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRT 200

Query:   222 HGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKN 281
              GFPE +++NK+   YRSGPW G RFS VP MKP++ I+   F + +  V YS+ +   N
Sbjct:   201 SGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYID-NSFTENNQQVVYSYRVNKTN 259

Query:   282 LFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMR 341
             ++S L +S  G LQR TW+EA + W   WY+PKD CDNY ECG +G CD N SP+C C++
Sbjct:   260 IYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIK 319

Query:   342 GFEPKDPQAWSLRDGSGGCVRKTELQCS-EDKFLQLKNMKLPDTTTSFVDYNMTLKECEA 400
             GFEP + QA +LRD S GCVRKT+L C   D F++LK M+LPDTT + VD  + LKECE 
Sbjct:   320 GFEPMNEQA-ALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEE 378

Query:   401 FCSRNCSCTAYANTNI-TGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATP 459
              C + C+CTA+ANT+I  GG+GCV W+G L DIR YA+GGQDLYVR+AA D+ D    + 
Sbjct:   379 RCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLEDKRIKSK 438

Query:   460 IIIGVTVG-SAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRD 518
              IIG ++G S +L+L  +    W+RK    R I    P     RSQD L+N++V +S R 
Sbjct:   439 KIIGSSIGVSILLLLSFIIFHFWKRKQK--RSITIQTPIVDLVRSQDSLMNELVKAS-RS 495

Query:   519 YSA--DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSR 576
             Y++  +KTD LELPL +++ +  AT+NF+  NKLGQGGFGIVYKG LL+G+EIAVKRLS+
Sbjct:   496 YTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSK 555

Query:   577 NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSS 636
              S QG +EF NEVRLIAKLQH NLVRLLGCCV+  EKML+YEY+EN SLDS +FD+ RSS
Sbjct:   556 MSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSS 615

Query:   637 ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
              LNWQ+RF+II GIARGLLYLHQDSR RIIHRDLKASN+LLDK MTPKISDFGMARIFG 
Sbjct:   616 NLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGR 675

Query:   697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELN 756
             ++TE NT+RVVGTYGYMSPEYAMDG+FS+KSDVFSFGVLLLE +SGK+N+GFY+SN +LN
Sbjct:   676 EETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLN 735

Query:   757 LLGHVWRLWKEGKVLEMVDS-SVD----NYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
             LLG VWR WKEGK LE+VD  ++D     +P +E+LRCI +GLLCVQE AE+RP M+SV+
Sbjct:   736 LLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVM 795

Query:   812 LMLSSETATMPQPKTPGFCLGRNPIETDSSSS-KHDETFTVNQVTVTMLNAR 862
             +ML SET  +PQPK PGFC+GR+ +E DSSSS + D+  TVNQVT+++++AR
Sbjct:   796 VMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 1039 (370.8 bits), Expect = 1.5e-210, Sum P(2) = 1.5e-210
 Identities = 203/331 (61%), Positives = 253/331 (76%)

Query:   514 SSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKR 573
             SS+      + +DLELP  D +T+  AT  F+  NKLGQGGFG VYKG L  GQE+AVKR
Sbjct:   435 SSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKR 494

Query:   574 LSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKA 633
             LSR S QG+EEFKNE++LIAKLQHRNLV++LG CV+ +E+ML+YEY  N+SLDS IFDK 
Sbjct:   495 LSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKE 554

Query:   634 RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
             R   L+W +R  II GIARG+LYLH+DSR RIIHRDLKASN+LLD +M  KISDFG+AR 
Sbjct:   555 RRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLART 614

Query:   694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN 753
              GGD+TE NT RVVGTYGYMSPEY +DG FS+KSDVFSFGVL+LE VSG++NRGF +  +
Sbjct:   615 LGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEH 674

Query:   754 ELNLLGHVWRLWKEGKVLEMVDSSVDNY--PANEVLRCIHVGLLCVQENAEERPTMASVV 811
             +LNLLGH WR + E K  E++D +V+      +EVLR IH+GLLCVQ++ ++RP M+ VV
Sbjct:   675 KLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVV 734

Query:   812 LMLSSETATMPQPKTPGFCLGRNPIETDSSS 842
             LMLSSE   +  P+ PGF   RN + +D+ S
Sbjct:   735 LMLSSEMLLL-DPRQPGFFNERNLLFSDTVS 764

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 1117 (398.3 bits), Expect = 1.4e-198, Sum P(2) = 1.4e-198
 Identities = 215/340 (63%), Positives = 270/340 (79%)

Query:   525 DDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEE 584
             +DL+LP+FD +TI  ATD+F+  N LG+GGFG VYKG+L +GQEIAVKRLS NSGQG+EE
Sbjct:   481 EDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEE 540

Query:   585 FKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
             FKNEV+LIAKLQHRNLVRLLGCC++ +E ML+YEYM N+SLD  IFD+ RS+ L+W++R 
Sbjct:   541 FKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRM 600

Query:   645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
             NII G+ARG+LYLHQDSR RIIHRDLKA N+LLD +M PKISDFG+A+ FGGDQ+E +T 
Sbjct:   601 NIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTN 660

Query:   705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
             RVVGTYGYM PEYA+DG FSVKSDVFSFGVL+LE ++GK NRGF H++++LNLLGHVW++
Sbjct:   661 RVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKM 720

Query:   765 WKEGKVLEMVDSS--VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMP 822
             W E + +E+ +     +     EVLRCIHV LLCVQ+  E+RPTMASVVLM  S+++ +P
Sbjct:   721 WVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDSS-LP 779

Query:   823 QPKTPGFCLGRNPIETDSSSSKHDETFTVNQVTVTMLNAR 862
              P  PGF   RN  +  SS S   +    N+V++TML  R
Sbjct:   780 HPTQPGFFTNRNVPDISSSLSLRSQ----NEVSITMLQGR 815

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 1804 (640.1 bits), Expect = 5.0e-186, P = 5.0e-186
 Identities = 387/842 (45%), Positives = 521/842 (61%)

Query:    54 AISVDTLTATQNLTYG---KTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVA 110
             +++ +T+   ++L  G   K LVS    FELGFFSPGSS   ++GIWY NI  +  VWVA
Sbjct:    23 SMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDKAVVWVA 82

Query:   111 NRDDPLANSSGVLRIINQ-RIGLFDGSQNLVWSSNQTKAT----NPVAQLQDSGNFVLKE 165
             NR  P+++ SGVL I N   + L DG    VWSSN   +T    N V  + D+GNFVL E
Sbjct:    83 NRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTGNFVLSE 142

Query:   166 AGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFP 225
               +D  +W+SF++PTDT LPQM++  + +TG      SW+S  DPS G+ S  +D  G P
Sbjct:   143 TDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGVDPSGAP 202

Query:   226 EGFLWN-KQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFI----DQDHDVYYSFFIENK 280
             E  LW   + RK+RSG WN   F+G+P M  +    + F +    D+   VY+++   + 
Sbjct:   203 EIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDETGSVYFTYVPSDP 262

Query:   281 NLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASP-VCQC 339
             ++  R  V  +G  +   W E  K W  F   P  +CD Y  CG FGICD   S  +C C
Sbjct:   263 SVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFGICDMKGSNGICSC 322

Query:   340 MRGFEPKDPQAWSLRDGSGGCVRKTELQCS------EDKFLQLKNMKLPDTTTSFVDYNM 393
             + G+E      WS      GC R+T L+C       ED+FL LK++KLPD      ++N+
Sbjct:   323 IHGYEQVSVGNWSR-----GCRRRTPLKCERNISVGEDEFLTLKSVKLPDF--EIPEHNL 375

Query:   394 TLKE-CEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIG 452
                E C   C RNCSC AY+   + GG GC+ W  +L D++++  GG  L++RLA S++G
Sbjct:   376 VDPEDCRERCLRNCSCNAYS---LVGGIGCMIWNQDLVDLQQFEAGGSSLHIRLADSEVG 432

Query:   453 DGANAT-PIIIGVTVGSAILILGLVACFLWR---RKTLLGRQIRKTEPRGHPERSQDLLL 508
             +       +I+ V VG  ++++G+ A  LWR   +K + G    K           DL  
Sbjct:   433 ENRKTKIAVIVAVLVG--VILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVA--DLTK 488

Query:   509 NQVVISS---KRDYSAD--KTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRL 563
             ++   S+     D   +    +  ELP+F    I  AT++F   N+LG+GGFG VYKG L
Sbjct:   489 SKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVL 548

Query:   564 LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR 623
              +G+EIAVKRLS  SGQG++EFKNE+ LIAKLQHRNLVRLLGCC E +EKMLVYEYM N+
Sbjct:   549 EDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNK 608

Query:   624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP 683
             SLD  +FD+ + ++++W+ RF+II GIARGLLYLH+DSR RIIHRDLK SN+LLD EM P
Sbjct:   609 SLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNP 668

Query:   684 KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
             KISDFGMARIFGG+Q E NT RVVGTYGYMSPEYAM+GLFSVKSDV+SFGVLLLE VSGK
Sbjct:   669 KISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGK 728

Query:   744 KNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAE 802
             +N     S+   +L+G+ W L+  G+  E+VD  +       E LRCIHV +LCVQ++A 
Sbjct:   729 RNTSL-RSSEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAA 787

Query:   803 ERPTMASVVLMLSSETATMPQPKTPGFC-LGRNPIETDSS-SSKHDETFTVNQVTVTMLN 860
             ERP MASV+LML S+TAT+  P+ P F    RN I+ + +  S      + N++T T++ 
Sbjct:   788 ERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVL 847

Query:   861 AR 862
              R
Sbjct:   848 GR 849

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 1776 (630.2 bits), Expect = 4.7e-183, P = 4.7e-183
 Identities = 371/825 (44%), Positives = 513/825 (62%)

Query:    58 DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLA 117
             ++ T    +  G +L+S D+ FELGFF+P +S   Y+GIWYKNI  +T VWVANR+ PL 
Sbjct:    30 NSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIEPQTVVWVANREKPLL 89

Query:   118 NSSGVLRIINQ-RIGLFDGSQNLVWSSN-QTKATNPVAQLQDSGNFVL-KEAGSDEILWQ 174
             +  G L+I +   + + +G    +WS+N + ++ N VA L  +G+ VL  ++   +  W+
Sbjct:    90 DHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGDLVLCSDSDRRKWYWE 149

Query:   175 SFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQE 234
             SF+ PTDT LP M++  +   G       WKS  DPS G  S  +D  G  E  +W  ++
Sbjct:   150 SFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYSMGIDPVGALEIVIWEGEK 209

Query:   235 RKYRSGPWNGVRFSGVPEMKPIEGINFEFFI----DQDHDVYYSFFIENKNLFSRLIVSP 290
             RK+RSGPWN   F+G+P+M       + F +    D+D  VY+++   + + F R  + P
Sbjct:   210 RKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVYFTYVASDSSDFLRFWIRP 269

Query:   291 DGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNA---SPVCQCMRGFEPKD 347
             DG  ++F W +  + WN   + P  +C+ Y  CG + +CD +    S  C C+ GFEP  
Sbjct:   270 DGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDSKEFDSGKCSCIDGFEPVH 329

Query:   348 PQAWSLRDGSGGCVRKTELQCS-------EDKFLQLKNMKLPDTTTSFVDYNMTLKECEA 400
                W+ RD SGGC R+  L C+       ED F  LK +K+PD   S V +N + + C+ 
Sbjct:   330 QDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVLKGIKVPDFG-SVVLHNNS-ETCKD 387

Query:   401 FCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGA-NATP 459
              C+R+CSC AYA   +  G GC+ WT +L D+  +  GG  + +RLA S +G G  N+T 
Sbjct:   388 VCARDCSCKAYA---LVVGIGCMIWTRDLIDMEHFERGGNSINIRLAGSKLGGGKENSTL 444

Query:   460 IIIGVTVGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSK-RD 518
              II  +V  A L LGL    LW+ K  L   + K +         D++ N+   SS  + 
Sbjct:   445 WIIVFSVIGAFL-LGLCIWILWKFKKSLKAFLWKKKDI----TVSDIIENRDYSSSPIKV 499

Query:   519 YSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS 578
                D+ D  +LP+F F+++  AT +F + NKLGQGGFG VYKG   EG+EIAVKRLS  S
Sbjct:   500 LVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKS 559

Query:   579 GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSIL 638
              QG+EEFKNE+ LIAKLQHRNLVRLLGCC+E +EKML+YEYM N+SLD  +FD+++   L
Sbjct:   560 KQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSL 619

Query:   639 NWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
             +W++R+ +I GIARGLLYLH+DSR +IIHRDLKASNILLD EM PKISDFGMARIF   Q
Sbjct:   620 DWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQ 679

Query:   699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
                NT RVVGTYGYM+PEYAM+G+FS KSDV+SFGVL+LE VSG+KN  F  +++  +L+
Sbjct:   680 DHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHG-SLI 738

Query:   759 GHVWRLWKEGKVLEMVDSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE 817
             G+ W LW +GK  EM+D  V D     E +RCIHVG+LC Q++   RP M SV+LML S+
Sbjct:   739 GYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQ 798

Query:   818 TATMPQPKTPGFCLGRNPIETDSSSSKHDETFTVNQVTVTMLNAR 862
             T+ +P P+ P F    N  + + +   HD   +VN VT T +  R
Sbjct:   799 TSQLPPPRQPTFHSFLNSGDIELNFDGHDVA-SVNDVTFTTIVGR 842

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1672 (593.6 bits), Expect = 4.9e-172, P = 4.9e-172
 Identities = 361/832 (43%), Positives = 495/832 (59%)

Query:    53 IAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANR 112
             + ++ D +T +      +T+VS+   F  GFFSP +S   Y GIW+ NI  +T VWVAN 
Sbjct:    18 LCLATDVITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIWFNNIPVQTVVWVANS 77

Query:   113 DDPLANSSGVLRIINQ-RIGLFDGSQNLVWSSN---QTKATNPVAQLQDSGNFVLKEAGS 168
             + P+ +SSG++ I  +  + + DG   + WS+N      A    A+L ++GN VL    +
Sbjct:    78 NSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYARLLNTGNLVLLGTTN 137

Query:   169 --DEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPE 226
               DEILW+SF++P +  LP M +  D KTG    L SWKS  DPS G  S  L    FPE
Sbjct:   138 TGDEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLIPLPFPE 197

Query:   227 GFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGIN-FEFFIDQDHDVYYSFFIENKNLFSR 285
               +W      +RSGPWNG  F G+P M     IN FE  +  D+    S       L   
Sbjct:   198 LVVWKDDLLMWRSGPWNGQYFIGLPNMD--YRINLFELTLSSDNRGSVSMSYAGNTLLYH 255

Query:   286 LIVSPDGFLQRFTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTN--ASPVCQCMRGF 343
              ++  +G + +  W  A + W  +   P  +CD Y  CG F  C  N  ++P C C+RGF
Sbjct:   256 FLLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFNPGSTPPCMCIRGF 315

Query:   344 EPKDPQAWSLRDGSGGCVRKTELQCSE----------DKFLQLKNMKLPDTTTSFVDYNM 393
             +P+    W+  + + GCVRK  LQC            D F++++ MK+P           
Sbjct:   316 KPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVPHNPQRS---GA 372

Query:   394 TLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGD 453
               ++C   C +NCSCTAY+      G GC+ W+G L D+++++  G   Y+RLA S+   
Sbjct:   373 NEQDCPESCLKNCSCTAYS---FDRGIGCLLWSGNLMDMQEFSGTGVVFYIRLADSEFKK 429

Query:   454 GANATPIIIGVT--VGSAILILGLVACFLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQV 511
               N + I+I VT  VG A L  G V   LW+   +   + +    R   ER + L  N V
Sbjct:   430 RTNRS-IVITVTLLVG-AFLFAGTVVLALWK---IAKHREKNRNTRLLNERMEALSSNDV 484

Query:   512 VISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAV 571
                    Y        ELPLF+F+ +  AT+NF+  NKLGQGGFG VYKGRL EG +IAV
Sbjct:   485 GAILVNQYKLK-----ELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAV 539

Query:   572 KRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD 631
             KRLSR SGQG+EEF NEV +I+KLQHRNLVRLLG C+E +E+MLVYE+M    LD+ +FD
Sbjct:   540 KRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFD 599

Query:   632 KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
               +  +L+W+ RFNII GI RGL+YLH+DSR +IIHRDLKASNILLD+ + PKISDFG+A
Sbjct:   600 PVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLA 659

Query:   692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHS 751
             RIF G++ E +T RVVGTYGYM+PEYAM GLFS KSDVFS GV+LLE VSG++N  FY+ 
Sbjct:   660 RIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYND 719

Query:   752 NNELNLLGHVWRLWKEGKVLEMVDSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASV 810
                 NL  + W+LW  G+ + +VD  + +    NE+ RC+HVGLLCVQ++A +RP++A+V
Sbjct:   720 GQNPNLSAYAWKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATV 779

Query:   811 VLMLSSETATMPQPKTPGFCLGRNPIETDSSSSKHDETFTVNQVTVTMLNAR 862
             + MLSSE + +P+PK P F   R   E +SS    D   ++N V++T +  R
Sbjct:   780 IWMLSSENSNLPEPKQPAFIPRRGTSEVESSGQS-DPRASINNVSLTKITGR 830

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0009637 "response to blue light" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0016556 "mRNA modification" evidence=RCA

TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)]

 Score = 910 (325.4 bits), Expect = 1.2e-164, Sum P(2) = 1.2e-164
 Identities = 182/351 (51%), Positives = 245/351 (69%)

Query:   515 SKRDYSAD-KTDDLE-LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVK 572
             SK  +  D K  D+  L  FD  TI  AT+NF+  NKLGQGGFG VYKG+L +G+EIAVK
Sbjct:   460 SKDAWKNDLKPQDVPGLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVK 519

Query:   573 RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK 632
             RLS +SGQG EEF NE+ LI+KLQHRNLVR+LGCC+E +EK+L+YE+M N+SLD+ +FD 
Sbjct:   520 RLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDS 579

Query:   633 ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
              +   ++W +RF+II GIARGLLYLH DSR R+IHRDLK SNILLD++M PKISDFG+AR
Sbjct:   580 RKRLEIDWPKRFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLAR 639

Query:   693 IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSN 752
             ++ G + + NT+RVVGT GYMSPEYA  G+FS KSD++SFGVL+LE +SG+K   F +  
Sbjct:   640 MYQGTEYQDNTRRVVGTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGV 699

Query:   753 NELNLLGHVWRLWKEGKVLEMVDSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
                 L+ + W  W E + ++++D  + D+    EV RCI +GLLCVQ    +RP    ++
Sbjct:   700 EGKTLIAYAWESWSEYRGIDLLDQDLADSCHPLEVGRCIQIGLLCVQHQPADRPNTLELL 759

Query:   812 LMLSSETATMPQPKTPGFCLGRNPIETDSSSSKHDETFTVNQVTVTMLNAR 862
              ML++ T+ +P PK P F        T    S  ++  TVN +T +++  R
Sbjct:   760 AMLTT-TSDLPSPKQPTFAF-----HTRDDESLSNDLITVNGMTQSVILGR 804

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)]

 Score = 912 (326.1 bits), Expect = 1.1e-163, Sum P(2) = 1.1e-163
 Identities = 180/348 (51%), Positives = 248/348 (71%)

Query:   516 KRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLS 575
             + D  + +   LE   F+  TI  AT+NF+  NKLGQGGFG VYKG+L +G+EIAVK+LS
Sbjct:   464 RNDLKSKEVPGLEF--FEMNTIQTATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKQLS 521

Query:   576 RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARS 635
              +SGQG EEF NE+ LI+KLQHRNLVR+LGCC+E +EK+L+YE+M N+SLD+ +FD  + 
Sbjct:   522 SSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEGEEKLLIYEFMLNKSLDTFVFDARKK 581

Query:   636 SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
               ++W +RF+I+ GIARGLLYLH+DSR ++IHRDLK SNILLD++M PKISDFG+AR++ 
Sbjct:   582 LEVDWPKRFDIVQGIARGLLYLHRDSRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYE 641

Query:   696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
             G Q +  T+RVVGT GYMSPEYA  G+FS KSD++SFGVLLLE + G+K   F +     
Sbjct:   642 GTQCQDKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSYGEEGK 701

Query:   756 NLLGHVWRLWKEGKVLEMVDSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
              LL + W  W E K ++++D  + D+    EV RC+ +GLLCVQ    +RP    ++ ML
Sbjct:   702 TLLAYAWESWGETKGIDLLDQDLADSCRPLEVGRCVQIGLLCVQHQPADRPNTLELLAML 761

Query:   815 SSETATMPQPKTPGFCLGRNPIETDSSSSKHDETFTVNQVTVTMLNAR 862
             ++ T+ +P PK P F +     + +SS SK  + FTVN++T +M+  R
Sbjct:   762 TT-TSDLPSPKQPTFVVHSR--DDESSLSK--DLFTVNEMTQSMILGR 804

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q09092	SRK6_BRAOE	2, ., 7, ., 1, 1, ., 1	0.5381	0.9535	0.9591	N/A	no
O81905	SD18_ARATH	2, ., 7, ., 1, 1, ., 1	0.6305	0.9385	0.9517	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	862
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-59
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-58
pfam00954	110	pfam00954, S_locus_glycop, S-locus glycoprotein fa	6e-57
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-55
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-53
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-51
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-50
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-47
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-43
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-38
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-36
pfam01453	109	pfam01453, B_lectin, D-mannose binding lectin	6e-35
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-34
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-34
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-34
cd00028	116	cd00028, B_lectin, Bulb-type mannose-specific lect	2e-33
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-32
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-32
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-32
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-31
pfam08276	66	pfam08276, PAN_2, PAN-like domain	7e-31
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-31
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-30
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-30
smart00108	114	smart00108, B_lectin, Bulb-type mannose-specific l	2e-30
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-30
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-30
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-29
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-29
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-28
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-28
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-27
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-26
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-26
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-26
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-25
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-25
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-24
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-24
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-24
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-24
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-24
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-24
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-24
cd01098	84	cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain	7e-24
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-24
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	9e-24
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-23
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-23
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-23
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-23
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-23
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-23
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-22
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-22
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-22
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-22
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-22
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-22
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-22
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-22
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-22
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	9e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-21
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-21
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-21
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-21
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-21
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-21
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-21
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-21
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	8e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	8e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-20
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-20
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-20
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-20
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-20
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-20
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-20
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-20
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-19
pfam11883	48	pfam11883, DUF3403, Domain of unknown function (DU	2e-19
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-19
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-18
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-18
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-18
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-18
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-18
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-18
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-18
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-18
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-18
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-18
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-17
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-17
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-17
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-17
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-17
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-16
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-16
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-15
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	9e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-13
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-13
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-13
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-13
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-13
pfam12398	42	pfam12398, DUF3660, Receptor serine/threonine kina	3e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-12
smart00473	78	smart00473, PAN_AP, divergent subfamily of APPLE d	1e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-12
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-12
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-12
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-11
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-10
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	8e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	5e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	6e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.001
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	0.002
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.003
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.003
cd00054	38	cd00054, EGF_CA, Calcium-binding EGF-like domain,	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  201 bits (513), Expect = 7e-59
 Identities = 97/280 (34%), Positives = 135/280 (48%), Gaps = 42/280 (15%)

Query: 549 KLGQGGFGIVYKGRLL-----EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVR 602
           KLG+G FG VYKG+L      +  E+AVK L  + S Q IEEF  E R++ KL H N+V+
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           LLG C E +   +V EYME   L S +  +     L+     +    IARG+ YL     
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLESK-- 121

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
              IHRDL A N L+ + +  KISDFG++R ++  D   +   ++     +M+PE   +G
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEG 178

Query: 722 LFSVKSDVFSFGVLLLETVS-------GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV 774
            F+ KSDV+SFGVLL E  +       G  N               V    K G  L   
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE-------------EVLEYLKNGYRLPQ- 224

Query: 775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
                  P N       + L C  E+ E+RPT + +V +L
Sbjct: 225 -------PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  200 bits (510), Expect = 2e-58
 Identities = 99/274 (36%), Positives = 143/274 (52%), Gaps = 29/274 (10%)

Query: 549 KLGQGGFGIVYKGRLL-----EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVR 602
           KLG+G FG VYKG L      +  E+AVK L  + S Q IEEF  E R++ KL H N+V+
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           LLG C E +  M+V EYM    L   +  K R   L+     +    IARG+ YL   S+
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLE--SK 122

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
              IHRDL A N L+ + +  KISDFG++R ++  D  +    ++     +M+PE   +G
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEG 179

Query: 722 LFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN 780
            F+ KSDV+SFGVLL E  + G++    Y   +   +L ++    K+G  L         
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEE---PYPGMSNAEVLEYL----KKGYRLPK------- 225

Query: 781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
            P N       + L C  E+ E+RPT + +V +L
Sbjct: 226 -PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family

 Score =  190 bits (484), Expect = 6e-57
 Identities = 58/110 (52%), Positives = 81/110 (73%), Gaps = 1/110 (0%)

Query: 237 YRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQR 296
           +RSGPWNG+RFSG+PEM+ +    + F  + + +VYY++ + N +++SRL +S +G L+R
Sbjct: 1   WRSGPWNGIRFSGIPEMQKLSYYVYNF-TENNEEVYYTYRMTNNSIYSRLTLSSEGSLER 59

Query: 297 FTWIEANKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPK 346
           FTWI  ++ WN FW APKDQCD YG CGP+G CD N SP C C++GF PK
Sbjct: 60  FTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPK 109

In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  192 bits (490), Expect = 1e-55
 Identities = 95/287 (33%), Positives = 144/287 (50%), Gaps = 46/287 (16%)

Query: 548 NKLGQGGFGIVYKGRLLEGQ----EIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVR 602
            KLG+G FG VYKG+L        E+AVK L  + S +  ++F  E R++ KL H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVI------FDKARSSILNWQRRFNIICGIARGLLY 656
           LLG C E +   LV EYME   L   +      F     S L+ +   +    IA+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRVVGTYGYMSP 715
           L   S+ + +HRDL A N L+ +++  KISDFG++R ++  D   + T   +    +M+P
Sbjct: 121 LA--SK-KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176

Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVS-------GKKNRGFYHSNNELNLLGHVWRLWKEG 768
           E   DG+F+ KSDV+SFGVLL E  +       G  N           +L ++    ++G
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---------EVLEYL----RKG 223

Query: 769 KVLEMVDS-SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
             L   +    + Y   E++        C Q + E+RPT + +V  L
Sbjct: 224 YRLPKPEYCPDELY---ELMLS------CWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  184 bits (469), Expect = 2e-53
 Identities = 74/193 (38%), Positives = 109/193 (56%), Gaps = 11/193 (5%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSR-NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           LG+GGFG VY  R  + G+++A+K + + +S   +EE   E+ ++ KL H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            + +   LV EY E  SL  ++  K     L+      I+  I  GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 668 RDLKASNILLDK-EMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSV 725
           RDLK  NILLD      K++DFG++++   D  +   K +VGT  YM+PE  +  G +S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 726 KSDVFSFGVLLLE 738
           KSD++S GV+L E
Sbjct: 174 KSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  181 bits (461), Expect = 1e-51
 Identities = 94/282 (33%), Positives = 137/282 (48%), Gaps = 45/282 (15%)

Query: 549 KLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVR 602
           KLG+G FG VYKG L         ++AVK L   +  +  EEF  E  ++ KL H N+VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           LLG C + +   +V EYM    L    F +     L  +    +   IA+G+ YL   S+
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLD--FLRKHGEKLTLKDLLQMALQIAKGMEYLE--SK 121

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
              +HRDL A N L+ + +  KISDFG++R I+  D   +     +    +M+PE   DG
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIKWMAPESLKDG 179

Query: 722 LFSVKSDVFSFGVLLLETVS-GKKNRGFY--HSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
            F+ KSDV+SFGVLL E  + G++    Y   SN E+     +  L ++G  L       
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQP---YPGMSNEEV-----LELL-EDGYRLPR----- 225

Query: 779 DNYPAN------EVLRCIHVGLLCVQENAEERPTMASVVLML 814
              P N      E++      L C   + E+RPT + +V  L
Sbjct: 226 ---PENCPDELYELM------LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  176 bits (448), Expect = 6e-50
 Identities = 80/267 (29%), Positives = 126/267 (47%), Gaps = 23/267 (8%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQHRNLV 601
           +    KLG+G FG VY  R  + G+ +A+K + +   +   E    E++++ KL+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           RL     + D+  LV EY E   L  ++  K R  +   + RF  +  I   L YLH   
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLHS-- 115

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
              I+HRDLK  NILLD++   K++DFG+AR     +        VGT  YM+PE  +  
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGK 171

Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY 781
            +    D++S GV+L E ++GK    F   +  L L     +   + K          + 
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK--PPFPGDDQLLELF----KKIGKPKPPFPPPEWDISP 225

Query: 782 PANEVLRCIHVGLLCVQENAEERPTMA 808
            A +++R     LL    + E+R T  
Sbjct: 226 EAKDLIR----KLLVK--DPEKRLTAE 246

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  168 bits (427), Expect = 5e-47
 Identities = 77/200 (38%), Positives = 102/200 (51%), Gaps = 14/200 (7%)

Query: 549 KLGQGGFGIVYKGRLL-EGQEIAVKRL---SRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           KLG G FG VYK +    G+ +AVK L   S  S +       E+R++ +L H N+VRL+
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHPNIVRLI 64

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
               + D   LV EY E   L   +   +R   L+      I   I RGL YLH      
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNG 118

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE-YAMDGLF 723
           IIHRDLK  NILLD+    KI+DFG+A+      +   T   VGT  YM+PE       +
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGY 176

Query: 724 SVKSDVFSFGVLLLETVSGK 743
             K DV+S GV+L E ++GK
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  157 bits (399), Expect = 4e-43
 Identities = 74/273 (27%), Positives = 127/273 (46%), Gaps = 42/273 (15%)

Query: 548 NKLGQGGFGIVYKGRLLE-GQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
             LG+G FG VY     + G+ +AVK   LS +S + +E  + E+R+++ LQH N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 605 GCCVEMDEKML-VY-EYMENRSLDSVIFDKARSSILNWQRRF-----NIICG----IARG 653
           G   + ++  L ++ EY+   SL S++            ++F      +I      I  G
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL------------KKFGKLPEPVIRKYTRQILEG 113

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
           L YLH +    I+HRD+K +NIL+D +   K++DFG A+  G  +T + T  V GT  +M
Sbjct: 114 LAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM 773
           +PE      +   +D++S G  ++E  +GK    +    N +  L  +            
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGK--PPWSELGNPMAALYKI-----------G 217

Query: 774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPT 806
                   P +           C++ + ++RPT
Sbjct: 218 SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  144 bits (365), Expect = 1e-38
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 21/207 (10%)

Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           F    K+G+GGFG VYK R    G+E+A+K +   S +  E+  NE++++ K +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN------IICGIARGLLY 656
             G  ++ DE  +V E+    SL  +        + +  +         +   + +GL Y
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDL--------LKSTNQTLTESQIAYVCKELLKGLEY 113

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           LH      IIHRD+KA+NILL  +   K+ DFG++         +    +VGT  +M+PE
Sbjct: 114 LHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPE 167

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGK 743
                 +  K+D++S G+  +E   GK
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  136 bits (346), Expect = 4e-36
 Identities = 67/207 (32%), Positives = 111/207 (53%), Gaps = 17/207 (8%)

Query: 543 NFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+   + +G+G FG+VYKG  L  G  +A+K++S      + ++    E+ L+  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVI--FDKARSSILNWQRRFNIICGIARGLLYL 657
           +V+ +G     D   ++ EY EN SL  +I  F     S++        +  + +GL YL
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA-----VYVYQVLQGLAYL 115

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE- 716
           H+     +IHRD+KA+NIL  K+   K++DFG+A        +  +  VVGT  +M+PE 
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEV 170

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGK 743
             M G  S  SD++S G  ++E ++G 
Sbjct: 171 IEMSGA-STASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin

 Score =  128 bits (323), Expect = 6e-35
 Identities = 57/113 (50%), Positives = 72/113 (63%), Gaps = 8/113 (7%)

Query: 103 QRTYVWVANRDDPLANSSGVLRIINQRIG---LFDGSQNLVWSSN-QTKATNPVAQLQDS 158
            +T VWVANR +PL +SS  L + +   G   L+DG+  +VWSSN   K +  VA LQD 
Sbjct: 1   NQTVVWVANRLNPLTDSSYTLILQSD--GNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDD 58

Query: 159 GNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPS 211
           GN VL +  S ++LWQSFD+PTDTLLP  K G ++  G    LTSWKS  DPS
Sbjct: 59  GNLVLYDN-SGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109

These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  132 bits (333), Expect = 2e-34
 Identities = 67/203 (33%), Positives = 110/203 (54%), Gaps = 6/203 (2%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR 598
           R  + FT   KLG G FG V++G       +A+K L  +     ++F+ EV+ + +L+H+
Sbjct: 3   RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHK 62

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           +L+ L   C   +   ++ E ME  SL + +       +L      ++ C +A G+ YL 
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLE 121

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
           +      IHRDL A NIL+ +++  K++DFG+AR+   D    + K++   Y + +PE A
Sbjct: 122 EQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAA 176

Query: 719 MDGLFSVKSDVFSFGVLLLETVS 741
             G FS KSDV+SFG+LL E  +
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  132 bits (335), Expect = 2e-34
 Identities = 66/206 (32%), Positives = 109/206 (52%), Gaps = 15/206 (7%)

Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN 599
            + + +  K+G+G  G VYK      G+E+A+K++ R   Q  E   NE+ ++   +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPN 76

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG-IARGLLYLH 658
           +V      +  DE  +V EYM+  SL  +I        +N + +   +C  + +GL YLH
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN--FVRMN-EPQIAYVCREVLQGLEYLH 133

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSPE 716
                 +IHRD+K+ NILL K+ + K++DFG    F    T++ +KR  VVGT  +M+PE
Sbjct: 134 S---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKRNSVVGTPYWMAPE 186

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSG 742
                 +  K D++S G++ +E   G
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  130 bits (329), Expect = 8e-34
 Identities = 67/222 (30%), Positives = 105/222 (47%), Gaps = 27/222 (12%)

Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKR--LSRNSGQGIEEFKNEVRLIAKLQHRN 599
            +    ++G+G FG VY  R     ++  +K   LS  S +  E+  NEV+++ KL H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSS-------ILNW--QRRFNIICGI 650
           +++      E  +  +V EY +   L   I  + +         IL+W  Q        +
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--------L 112

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
              L YLH  SR +I+HRD+K  NI L      K+ DFG++++     T    K VVGT 
Sbjct: 113 CLALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVL--SSTVDLAKTVVGTP 167

Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSN 752
            Y+SPE   +  ++ KSD++S G +L E  + K    F   N
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLK--HPFEGEN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin

 Score =  124 bits (313), Expect = 2e-33
 Identities = 54/116 (46%), Positives = 68/116 (58%), Gaps = 5/116 (4%)

Query: 66  LTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRI 125
           L+ G+TLVSS  +FELGFF      + Y  I YK    RT VWVANRD+P   SS  L +
Sbjct: 4   LSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGS-SRTVVWVANRDNPS-GSSCTLTL 61

Query: 126 INQ-RIGLFDGSQNLVWSSNQTKATNP-VAQLQDSGNFVLKEAGSDEILWQSFDYP 179
            +   + ++DGS  +VWSSN T+     V  L D GN VL ++     LWQSFDYP
Sbjct: 62  QSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFDYP 116

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  127 bits (320), Expect = 2e-32
 Identities = 82/295 (27%), Positives = 126/295 (42%), Gaps = 49/295 (16%)

Query: 540 ATDNFTDYNKLGQGGFGIVYKG----RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLI 592
             D+ T    LG G FG VY+G    R  +  E+ V   +     S Q   +F  E  ++
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63

Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIIC 648
           +K  H+N+VRL+G   E   + ++ E M    L S + +      R S L  +       
Sbjct: 64  SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMAR-IFGGDQTEQNTK 704
            +A+G  YL +      IHRD+ A N LL         KI+DFGMAR I+      +  +
Sbjct: 124 DVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180

Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-------GKKNRGFYHSNNELNL 757
            ++    +M PE  +DG+F+ K+DV+SFGVLL E  S       G+ N+           
Sbjct: 181 AML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ----------- 228

Query: 758 LGHVWRLWKEGKVLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
                      +V+E V      + P         +   C Q   E+RP  A+++
Sbjct: 229 -----------EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  127 bits (320), Expect = 2e-32
 Identities = 76/227 (33%), Positives = 114/227 (50%), Gaps = 25/227 (11%)

Query: 550 LGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVR 602
           LG+G FG VYKG L           +A+K L  N   +  +EF+ E  L++ LQH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 603 LLGCCVEMDEKMLVYEYMENRSL----------DSVIF---DKARSSILNWQRRFNIICG 649
           LLG C +     +++EY+ +  L            V     D+   S L+     +I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRVVG 708
           IA G+ YL   S    +HRDL A N L+ + +T KISDFG++R I+  D     +K ++ 
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
              +M PE  + G F+ +SD++SFGV+L E  S      +  SN E+
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  129 bits (323), Expect = 4e-32
 Identities = 71/282 (25%), Positives = 127/282 (45%), Gaps = 20/282 (7%)

Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH-R 598
           ++    KLG+G FG VY  R    + +A+K L++   +  + +E F  E++++A L H  
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           N+V+L     +     LV EY++  SL+ ++    R   L+      I+  I   L YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 659 QDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTEQN----TKRVVGTYGYM 713
                 IIHRD+K  NILLD++    K+ DFG+A++     +  +        VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 714 SPEYAMDGLF---SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV 770
           +PE  +       S  SD++S G+ L E ++G        +++  +    +        +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 771 LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL 812
              +  S    P         +    + ++ + R + +S + 
Sbjct: 236 ASPLSPSN---PELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  125 bits (317), Expect = 4e-32
 Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 17/201 (8%)

Query: 549 KLGQGGFGIVYKGRL-LEGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
            LGQG  G+VYK R    G+  A+K++  +   +  ++   E++ +   +   +V+  G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR----GLLYLHQDSR 662
             +  E  +V EYM+  SL  ++    +   +       ++  IAR    GL YLH    
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLL---KKVGKIPEP----VLAYIARQILKGLDYLHTKRH 120

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             IIHRD+K SN+L++ +   KI+DFG++++   + T       VGT  YMSPE      
Sbjct: 121 --IIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPERIQGES 176

Query: 723 FSVKSDVFSFGVLLLETVSGK 743
           +S  +D++S G+ LLE   GK
Sbjct: 177 YSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  125 bits (315), Expect = 9e-32
 Identities = 73/227 (32%), Positives = 106/227 (46%), Gaps = 29/227 (12%)

Query: 550 LGQGGFGIVYKGR---LLEGQE---IAVKRLSRNSGQGIEE-FKNEVRLIAKLQHRNLVR 602
           LG+G FG V+ G    L    +   +AVK L   +     + F+ E  L+   QH N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 603 LLGCCVEMDEKMLVYEYMENRSL---------DSVIFDKARSSI--LNWQRRFNIICGIA 651
             G C E D  ++V+EYME+  L         D+       S +  L   +   I   IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-- 709
            G++YL   +    +HRDL   N L+  ++  KI DFGM+R    D    +  RV G   
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185

Query: 710 --YGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
               +M PE  M   F+ +SDV+SFGV+L E  +  K   +  SN E
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  121 bits (306), Expect = 7e-31
 Identities = 84/281 (29%), Positives = 119/281 (42%), Gaps = 41/281 (14%)

Query: 548 NKLGQGGFGIVYKGRLLE--GQEI--AVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVR 602
            +LG G FG V KG  L   G+E+  AVK L +     G +EF  E  ++A+L H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNIICGIARGLLYLHQ 659
           L+G C   +  MLV E      L   +  +     S +     +      +A G+ YL +
Sbjct: 61  LIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYL-E 112

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD----QTEQNTKRVVGTYGYMSP 715
              F  +HRDL A N+LL      KISDFGM+R  G      +     +  +  Y   +P
Sbjct: 113 SKHF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---AP 167

Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV 774
           E    G FS KSDV+S+GV L E  S G K  G       + +L    RL          
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---------- 217

Query: 775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS 815
               +  P         + L C +   E+RPT + +     
Sbjct: 218 -PRPEECPQE----IYSIMLSCWKYRPEDRPTFSELESTFR 253

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain

 Score =  115 bits (289), Expect = 7e-31
 Identities = 39/64 (60%), Positives = 47/64 (73%)

Query: 369 SEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGE 428
             D FL+L NMKLPDTT + VD ++ LKECE  C  NCSCTAYA  +I GG+GC+ WTGE
Sbjct: 3   GGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWTGE 62

Query: 429 LKDI 432
           L D+
Sbjct: 63  LVDM 66

Length = 66

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  121 bits (306), Expect = 9e-31
 Identities = 88/274 (32%), Positives = 127/274 (46%), Gaps = 46/274 (16%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLG G FG V+ G      ++AVK L +      E F  E +++ KL+H  LV+L   C 
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARS---SILNWQRRFNIICGIARGLLYLHQDSRFRI 665
           E +   +V EYM   SL     D  +S     L   +  ++   IA G+ YL        
Sbjct: 72  EEEPIYIVTEYMSKGSL----LDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNY 124

Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLF 723
           IHRDL A NIL+ + +  KI+DFG+AR+   D+    +  K  +    + +PE A  G F
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI---KWTAPEAANYGRF 181

Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFY--HSNNELNLLGHVWRLWKEGKVLEMVD-----S 776
           ++KSDV+SFG+LL E V+    R  Y   +N E               VLE V+      
Sbjct: 182 TIKSDVWSFGILLTEIVT--YGRVPYPGMTNRE---------------VLEQVERGYRMP 224

Query: 777 SVDNYPANEVLRCIHVGLL-CVQENAEERPTMAS 809
              N P       ++  +L C  ++ EERPT   
Sbjct: 225 RPPNCPEE-----LYDLMLQCWDKDPEERPTFEY 253

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  121 bits (305), Expect = 2e-30
 Identities = 85/288 (29%), Positives = 133/288 (46%), Gaps = 45/288 (15%)

Query: 550 LGQGGFGIVYKGRLL------EGQEIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVR 602
           LGQG FG+VY+G             +A+K ++ N+      EF NE  ++ +    ++VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARS-----------SILNWQRRFNIICGIA 651
           LLG        ++V E M    L S +    RS                Q+   +   IA
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYL----RSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRVVGTY 710
            G+ YL      + +HRDL A N ++ +++T KI DFGM R I+  D   +  K ++   
Sbjct: 130 DGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELNLLGHVWRLWKEG 768
            +M+PE   DG+F+ KSDV+SFGV+L E  T++ +  +G   SN E      V +   +G
Sbjct: 187 -WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL--SNEE------VLKFVIDG 237

Query: 769 KVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS 816
             L+         P N   + + +  +C Q N + RPT   +V  L  
Sbjct: 238 GHLD--------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  120 bits (303), Expect = 2e-30
 Identities = 73/216 (33%), Positives = 110/216 (50%), Gaps = 11/216 (5%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
              T   ++G G FG+V+ G  LE +++A+K + R      E+F  E +++ KL H  LV
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLV 62

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +L G C E     LV+E+ME+  L    + +A+    + +    +   +  G+ YL   +
Sbjct: 63  QLYGVCTERSPICLVFEFMEHGCLSD--YLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAM 719
              +IHRDL A N L+ +    K+SDFGM R    DQ  +   TK  V    + SPE   
Sbjct: 121 ---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV---KWSSPEVFS 174

Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
              +S KSDV+SFGVL+ E  S  K      SN+E+
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin

 Score =  115 bits (289), Expect = 2e-30
 Identities = 51/115 (44%), Positives = 68/115 (59%), Gaps = 6/115 (5%)

Query: 66  LTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRI 125
           L+ G+TLVS + +FELGFF+       Y  I YK+   RT VWVANRD+P+ + S  L +
Sbjct: 4   LSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYKSS-SRTVVWVANRDNPV-SDSCTLTL 60

Query: 126 INQ-RIGLFDGSQNLVWSSNQTKATNP-VAQLQDSGNFVLKEAGSDEILWQSFDY 178
            +   + L+DG   +VWSSN T A    V  L D GN V+ ++     LWQSFDY
Sbjct: 61  QSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDS-DGNFLWQSFDY 114

Length = 114

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  119 bits (301), Expect = 4e-30
 Identities = 59/196 (30%), Positives = 104/196 (53%), Gaps = 10/196 (5%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           KLG+G +G VYK    E GQ +A+K +       ++E   E+ ++ +     +V+  G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            +  +  +V EY    S+  ++  K  +  L  +    I+    +GL YLH +   + IH
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIH 122

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKS 727
           RD+KA NILL++E   K++DFG++        ++NT  V+GT  +M+PE   +  ++ K+
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNNKA 180

Query: 728 DVFSFGVLLLETVSGK 743
           D++S G+  +E   GK
Sbjct: 181 DIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 4e-30
 Identities = 77/278 (27%), Positives = 119/278 (42%), Gaps = 59/278 (21%)

Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           LG G FG+V+ G+     ++A+K + R      ++F  E +++ KL H NLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 610 MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRD 669
                +V EYM N  L +  + + R   L  +   ++   +   + YL  +     IHRD
Sbjct: 71  QRPIFIVTEYMANGCLLN--YLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125

Query: 670 LKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSVKS 727
           L A N L+ ++   K+SDFG+AR    DQ  + Q TK  V    +  PE      FS KS
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV---KWAPPEVFDYSRFSSKS 182

Query: 728 DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVL 787
           DV+SFGVL+                         W ++ EGK+        + +  +EV+
Sbjct: 183 DVWSFGVLM-------------------------WEVFSEGKM------PYERFSNSEVV 211

Query: 788 RCIHVGL-----------------LCVQENAEERPTMA 808
             +  G                   C  E  E+RP   
Sbjct: 212 ESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFK 249

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  119 bits (299), Expect = 6e-30
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 21/197 (10%)

Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           +G+G FG V  G    GQ++AVK L  +S    + F  E  ++  L+H NLV+LLG  ++
Sbjct: 14  IGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 610 MDEKMLVYEYMENRSLDSVIFDKARS---SILNWQRRFNIICGIARGLLYLHQDSRFRII 666
            +   +V EYM   SL     D  RS   +++   ++      +  G+ YL +      +
Sbjct: 72  GNPLYIVTEYMAKGSL----VDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFV 124

Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFS 724
           HRDL A N+L+ +++  K+SDFG+A+       E +  +  G     + +PE   +  FS
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFS 177

Query: 725 VKSDVFSFGVLLLETVS 741
            KSDV+SFG+LL E  S
Sbjct: 178 TKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  119 bits (300), Expect = 9e-30
 Identities = 80/292 (27%), Positives = 133/292 (45%), Gaps = 34/292 (11%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKL 595
            +     +LG+G FG V   R        G+++AVK L+ +   Q   +F+ E+ ++  L
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63

Query: 596 QHRNLVRLLGCCVEMDEK--MLVYEYMENRSLDSVI-FDKARSSILNWQRRFNIICGIAR 652
            H N+V+  G C +   +   L+ EY+ + SL   +   + +   +N +R       I +
Sbjct: 64  DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICK 120

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRVVGTY 710
           G+ YL      R IHRDL A NIL++ E   KISDFG+A++     D            +
Sbjct: 121 GMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177

Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRG-------FYHSNNELNLLGHVW 762
            Y +PE      FS  SDV+SFGV L E  + G  ++                 ++  + 
Sbjct: 178 WY-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236

Query: 763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
            L KEG+ L        + P +EV     +  LC +   ++RP+ A ++L++
Sbjct: 237 ELLKEGERL----PRPPSCP-DEVY---DLMKLCWEAEPQDRPSFADLILIV 280

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  118 bits (298), Expect = 1e-29
 Identities = 85/276 (30%), Positives = 134/276 (48%), Gaps = 38/276 (13%)

Query: 550 LGQGGFGIVYKGRLL-------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLV 601
           LG G FG VY+G              +AVK L + +  Q  +EF  E  L++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIARGLLYL 657
           +LLG C+  + + ++ E ME   L S + D    +    +L  +   +I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 658 HQDSRFRIIHRDLKASNILL-----DKEMTPKISDFGMAR-IFGGDQTEQNTKRVVGTYG 711
            +   F  IHRDL A N L+     D +   KI DFG+AR I+  D   +  + ++    
Sbjct: 123 -EQMHF--IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178

Query: 712 YMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKV 770
           +M+PE  +DG F+ +SDV+SFGVL+ E ++ G++    Y + N   +L HV      G  
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP---YPALNNQEVLQHV----TAGGR 231

Query: 771 LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPT 806
           L+         P N   +   +   C  ++  ERPT
Sbjct: 232 LQK--------PENCPDKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  119 bits (299), Expect = 1e-29
 Identities = 81/292 (27%), Positives = 139/292 (47%), Gaps = 46/292 (15%)

Query: 550 LGQGGFGIVYKGRLL-EGQ----EIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRL 603
           LG G FG VYKG  + EG+     +A+K L   +  +  +E  +E  ++A + H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 604 LGCCVEMDEK-MLVYEYMENRSLDSVIF---DKARS-SILNWQRRFNIICGIARGLLYLH 658
           LG C  +  +  L+ + M    L   +    D   S  +LNW  +      IA+G+ YL 
Sbjct: 75  LGIC--LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
           +    R++HRDL A N+L+      KI+DFG+A++   D+ E + +       +M+ E  
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 719 MDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD-S 776
           +  +++ KSDV+S+GV + E ++ G K    Y     + +   +    ++G+ L      
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKP---YEGIPAVEIPDLL----EKGERLPQPPIC 236

Query: 777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPG 828
           ++D Y          V + C   +AE RPT       L +E + M   + P 
Sbjct: 237 TIDVY---------MVLVKCWMIDAESRPTFKE----LINEFSKM--ARDPQ 273

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  114 bits (287), Expect = 2e-28
 Identities = 86/260 (33%), Positives = 131/260 (50%), Gaps = 25/260 (9%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLG G FG V+ G      ++A+K L + S    E F  E  L+ +LQH  LVRL    V
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAV-V 70

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
             +   ++ EYMEN SL  V F K    I L   +  ++   IA G+ ++ + +    IH
Sbjct: 71  TQEPIYIITEYMENGSL--VDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIH 125

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ-TEQNTKRVVGTYGYMSPEYAMDGLFSVK 726
           RDL+A+NIL+ + +  KI+DFG+AR+   ++ T +   +      + +PE    G F++K
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFTIK 183

Query: 727 SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEV 786
           SDV+SFG+LL E V+    R  Y       ++ ++ R ++      M     DN P    
Sbjct: 184 SDVWSFGILLTEIVT--YGRIPYPGMTNPEVIQNLERGYR------MPRP--DNCPE--- 230

Query: 787 LRCIHVGLLCVQENAEERPT 806
                +  LC +E  EERPT
Sbjct: 231 -ELYELMRLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 8e-28
 Identities = 78/265 (29%), Positives = 123/265 (46%), Gaps = 34/265 (12%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLG G FG V++G       +AVK L   +    ++F  E +++ KL+H  L++L   C 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
             +   +V E M+  SL   +   A  + L   +  ++   +A G+ YL   +    IHR
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQN---YIHR 127

Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT---YGYMSPEYAMDGLFSV 725
           DL A N+L+ +    K++DFG+AR+   D  E       G      + +PE A+   FS+
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSI 183

Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY---- 781
           KSDV+SFG+LL E V+  +      +N E               VL+ VD     Y    
Sbjct: 184 KSDVWSFGILLTEIVTYGRMPYPGMTNAE---------------VLQQVDQ---GYRMPC 225

Query: 782 PANEVLRCIHVGLLCVQENAEERPT 806
           P         + L C +E+ ++RPT
Sbjct: 226 PPGCPKELYDIMLDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  113 bits (284), Expect = 1e-27
 Identities = 65/227 (28%), Positives = 112/227 (49%), Gaps = 21/227 (9%)

Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN--EVRLIAKLQHRNL 600
           +    K+G+G +G+VYK R  L G+ +A+K++               E++L+ +L H N+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           ++LL       +  LV+E+M+   L  +I  K R   L      + +  + +GL + H  
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSH 117

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ---TEQNTKRVVGTYGYMSPEY 717
               I+HRDLK  N+L++ E   K++DFG+AR FG      T       V T  Y +PE 
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY-----VVTRWYRAPEL 169

Query: 718 AM-DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
            + D  +S   D++S G +  E +S    R  +   +E++ L  ++R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSR---RPLFPGKSEIDQLFKIFR 213

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 3e-27
 Identities = 65/197 (32%), Positives = 104/197 (52%), Gaps = 10/197 (5%)

Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRL-SRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V +GRL L G++   +A+K L + +S +   +F  E  ++ +  H N++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M++ EYMEN SLD   F +         +   ++ GIA G+ YL   S   
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDK--FLRENDGKFTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
            +HRDL A NIL++  +  K+SDFG++R     +    TK       + +PE      F+
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186

Query: 725 VKSDVFSFGVLLLETVS 741
             SDV+SFG+++ E +S
Sbjct: 187 SASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  111 bits (281), Expect = 3e-27
 Identities = 66/225 (29%), Positives = 113/225 (50%), Gaps = 20/225 (8%)

Query: 548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEF----KNEVRLIAKLQHRNLVR 602
            ++G+G +G VYK R  + G+ +A+K++        E F      E++L+ KL+H N+VR
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 603 LLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           L        +    +V+EYM++  L  ++ D         Q +   +  +  GL YLH +
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDH-DLTGLL-DSPEVKFTESQIKC-YMKQLLEGLQYLHSN 119

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM- 719
               I+HRD+K SNIL++ +   K++DFG+AR +    +   T RV+ T  Y  PE  + 
Sbjct: 120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLG 175

Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
              +  + D++S G +L E   GK     +  + EL  L  ++ L
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGK---PIFQGSTELEQLEKIFEL 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  109 bits (276), Expect = 1e-26
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 31/226 (13%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSR---NSGQGIEEFKNEVRLIAKL-Q 596
           D+F     +G+G F  V   +  E  +E A+K L +      + ++  K E  ++ +L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 597 HRNLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           H  +++L     + +E +  V EY  N  L   I    +   L+ +        I   L 
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALE 116

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV--------- 706
           YLH      IIHRDLK  NILLDK+M  KI+DFG A++   + + ++ K           
Sbjct: 117 YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 707 ---------VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
                    VGT  Y+SPE   +      SD+++ G ++ + ++GK
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  109 bits (274), Expect = 1e-26
 Identities = 68/204 (33%), Positives = 111/204 (54%), Gaps = 9/204 (4%)

Query: 543 NFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKR--LSRNSGQGIEEFKNEVRLIAKLQHRN 599
           +F   NK+G+G FG+V+K  R  + +  A+K+  LS+ + +  EE  +E R++AKL    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++R     ++  +  +V EY EN  L  ++    R   L   + +     I  GL +LH 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
               +I+HRD+K+ N+ LD     KI D G+A++   +    NT  +VGT  Y+SPE   
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCE 174

Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
           D  ++ KSDV++ GV+L E  +GK
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  108 bits (273), Expect = 4e-26
 Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 30/208 (14%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFK----NEVRLIAKLQHRNLVRL 603
           KLG+G +G+VYK R    G+ +A+K++ R      E        E+ L+ +L+H N+V+L
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKI-RLD-NEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRR--FNIICGIARGLLYLHQD 660
           L       +  LV+EY +   L   + DK    +  N  +   + ++ G+A    Y H  
Sbjct: 64  LDVIHTERKLYLVFEYCD-MDLKKYL-DKRPGPLSPNLIKSIMYQLLRGLA----YCHSH 117

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD 720
              RI+HRDLK  NIL++++   K++DFG+AR FG       T  VV T  Y +PE    
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV-TLWYRAPEI--- 169

Query: 721 GLFSVKS-----DVFSFGVLLLETVSGK 743
            L   K      D++S G +  E ++GK
Sbjct: 170 -LLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  107 bits (269), Expect = 7e-26
 Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 24/211 (11%)

Query: 548 NKLGQGGFGIVYK------GRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
             +G+G FG V K      G++L  +EI    ++    Q +    +EV ++ +L+H N+V
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQL---VSEVNILRELKHPNIV 62

Query: 602 RLLGCCVEMDEKML--VYEYMENRSLDSVI--FDKARSSILN---WQRRFNIICGIARGL 654
           R     ++   + L  V EY E   L  +I    K R  I     W+    I+  +   L
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR----ILTQLLLAL 118

Query: 655 LYLH--QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
              H   D    ++HRDLK +NI LD     K+ DFG+A+I G D      K  VGT  Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS--SFAKTYVGTPYY 176

Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           MSPE      +  KSD++S G L+ E  +  
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 1e-25
 Identities = 62/195 (31%), Positives = 96/195 (49%), Gaps = 6/195 (3%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLLGCC 607
           K+G+G FG VYKG L    E+AVK         +  +F  E  ++ +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           V+     +V E +   SL + +  K     +    + ++    A G+ YL   +    IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSL--DAAAGMEYLESKN---CIH 116

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKS 727
           RDL A N L+ +    KISDFGM+R   G     +         + +PE    G ++ +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176

Query: 728 DVFSFGVLLLETVSG 742
           DV+S+G+LL ET S 
Sbjct: 177 DVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 2e-25
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 16/211 (7%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G FG V   R  + G+  A+K L +      + +E    E  +++++ H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 606 CCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + +EK+ LV EY     L S +           + RF     I   L YLH      
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARF-YAAEIVLALEYLH---SLG 113

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           II+RDLK  NILLD +   K++DFG+A+          T    GT  Y++PE  +   + 
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKEL--SSEGSRTNTFCGTPEYLAPEVLLGKGYG 171

Query: 725 VKSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
              D +S GVLL E ++GK    FY  + + 
Sbjct: 172 KAVDWWSLGVLLYEMLTGK--PPFYAEDRKE 200

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  105 bits (263), Expect = 4e-25
 Identities = 76/271 (28%), Positives = 128/271 (47%), Gaps = 40/271 (14%)

Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLS-----RNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG G FG VY+G  L +G   AVK +S     +   + +++ + E+ L++KLQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVI--FDKARSS-ILNWQRRFNIICGIARGLLYLHQD 660
           LG   E D   +  E +   SL  ++  +       I  + R+      I  GL YLH  
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ------ILLGLEYLHDR 121

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN--TKRVVGTYGYMSPEYA 718
                +HRD+K +NIL+D     K++DFGMA+     Q  +    K   G+  +M+PE  
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSFKGSPYWMAPEVI 173

Query: 719 MD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
              G + + +D++S G  +LE  +GK          +L  +  V+++ +  ++  + D  
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWS------QLEGVAAVFKIGRSKELPPIPDHL 227

Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMA 808
            D   A + +        C+Q +   RPT A
Sbjct: 228 SDE--AKDFIL------KCLQRDPSLRPTAA 250

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  104 bits (262), Expect = 5e-25
 Identities = 84/282 (29%), Positives = 119/282 (42%), Gaps = 40/282 (14%)

Query: 549 KLGQGGFGIVYKGRLLEGQ----EIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRL 603
           KLG G FG+V +G           +AVK L  +    I ++F  E  ++  L H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG----IARGLLYLHQ 659
            G  V     M+V E     SL   +   A    L      + +C     IA G+ YL  
Sbjct: 62  YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFL-----ISTLCDYAVQIANGMRYLES 115

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG-GDQ--TEQNTKRVVGTYGYMSPE 716
               R IHRDL A NILL  +   KI DFG+ R     +     +   +V   + + +PE
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPE 170

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV- 774
                 FS  SDV+ FGV L E  + G++   +   +    L     ++ KEG+ LE   
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEEP--WAGLSGSQIL----KKIDKEGERLERPE 224

Query: 775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS 816
               D Y         +V L C   N  +RPT A++   L  
Sbjct: 225 ACPQDIY---------NVMLQCWAHNPADRPTFAALREFLPE 257

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  104 bits (262), Expect = 1e-24
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 12/207 (5%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           +   + ++LG+G  G V K RL     I A+K ++ +    ++ +   E+ +    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 600 LVRLLGCCVEMDEKML--VYEYMENRSLDSVIFD-KARSSILNWQRRFNIICGIARGLLY 656
           +V+  G  ++     +    EY E  SLDS+    K R   +  +    I   + +GL Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           LH     +IIHRD+K SNILL ++   K+ DFG++    G+          GT  YM+PE
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYMAPE 173

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGK 743
                 +S+ SDV+S G+ LLE    +
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  103 bits (259), Expect = 1e-24
 Identities = 80/270 (29%), Positives = 122/270 (45%), Gaps = 27/270 (10%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           +LG G FG+V+ G+     ++A+K +        E+F  E +++ KL H  LV+L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           +     +V E+MEN  L  + + + R   L+     ++   +  G+ YL ++S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCL--LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSVK 726
           DL A N L+      K+SDFGM R    D+  +    K  V    +  PE      +S K
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPV---KWSPPEVFNFSKYSSK 181

Query: 727 SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY-PANE 785
           SDV+SFGVL+ E  +  K      SN E               V+EM+      Y P   
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKKSNYE---------------VVEMISRGFRLYRPKLA 226

Query: 786 VLRCIHVGLLCVQENAEERPTMASVVLMLS 815
            +    V   C  E  E RPT A ++  ++
Sbjct: 227 SMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  103 bits (258), Expect = 1e-24
 Identities = 79/263 (30%), Positives = 131/263 (49%), Gaps = 30/263 (11%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLG G FG V+ G      ++AVK L   +   ++ F  E  L+  LQH  LVRL     
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           + +   ++ EYM   SL   +       +L   +  +    IA G+ Y+ + +    IHR
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKN---YIHR 127

Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFSVK 726
           DL+A+N+L+ + +  KI+DFG+AR+    +  + T R    +   + +PE    G F++K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184

Query: 727 SDVFSFGVLLLETVSGKKNRGFYHSNNE-LNLLGHVWRLWKEGKVLEMVDSSVDNYPAN- 784
           SDV+SFG+LL E V+  K      SN++ ++ L   +R+ +           ++N P   
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR-----------MENCPDEL 233

Query: 785 -EVLRCIHVGLLCVQENAEERPT 806
            ++++       C +E AEERPT
Sbjct: 234 YDIMK------TCWKEKAEERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 3e-24
 Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 17/205 (8%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLV 601
           FT    +G+G FG VYK       Q +A+K +     +  IE+ + E++ +++ +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 602 RLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +  G  ++   K+ ++ EY    S      D  +   L+      I+  +  GL YLH++
Sbjct: 63  KYYGSFLK-GSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSPEYA 718
                IHRD+KA+NILL +E   K++DFG++    G  T   +KR   VGT  +M+PE  
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGTPFWMAPEVI 170

Query: 719 MDGLFSVKSDVFSFGVLLLETVSGK 743
               +  K+D++S G+  +E   G+
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  103 bits (258), Expect = 3e-24
 Identities = 80/290 (27%), Positives = 133/290 (45%), Gaps = 49/290 (16%)

Query: 550 LGQGGFGIVYKGR---LLEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVR 602
           +GQG FG V++ R   LL  +    +AVK L    S     +F+ E  L+A+  H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARS---------------------SILNWQ 641
           LLG C       L++EYM    L+   F + RS                       L+  
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNE--FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTE 700
            +  I   +A G+ YL   S  + +HRDL   N L+ + M  KI+DFG++R I+  D  +
Sbjct: 131 EQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187

Query: 701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGH 760
            +    +    +M PE      ++ +SDV+++GV+L E  S      +  ++ E  ++ +
Sbjct: 188 ASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE--VIYY 244

Query: 761 VWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASV 810
           V    ++G VL        + P N  L   ++  LC  +   +RP+ AS+
Sbjct: 245 V----RDGNVL--------SCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  102 bits (256), Expect = 5e-24
 Identities = 60/221 (27%), Positives = 108/221 (48%), Gaps = 29/221 (13%)

Query: 535 ETIVRATD---NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVR 590
           + +V   D      ++ K+G+G  GIV        G+++AVK++     Q  E   NEV 
Sbjct: 9   QLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVV 68

Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN----- 645
           ++   QH N+V +    +  DE  +V E++E  +L  ++             R N     
Sbjct: 69  IMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVT----------HTRMNEEQIA 118

Query: 646 IIC-GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
            +C  + + L +LH      +IHRD+K+ +ILL  +   K+SDFG    F    +++  +
Sbjct: 119 TVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPR 171

Query: 705 R--VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           R  +VGT  +M+PE      +  + D++S G++++E V G+
Sbjct: 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  102 bits (255), Expect = 5e-24
 Identities = 71/224 (31%), Positives = 107/224 (47%), Gaps = 21/224 (9%)

Query: 549 KLGQGGFGIVYKGR---LLEGQE---IAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           +LG+G FG V+      LL  Q+   +AVK L   S    ++F+ E  L+  LQH+++VR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 603 LLGCCVEMDEKMLVYEYME----NRSL-----DSVIFDKARSSI---LNWQRRFNIICGI 650
             G C E    ++V+EYM     NR L     D+ I           L   +   I   I
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A G++YL   +    +HRDL   N L+ + +  KI DFGM+R        +   R +   
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
            +M PE  +   F+ +SD++SFGV+L E  +  K   +  SN E
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  102 bits (256), Expect = 6e-24
 Identities = 67/231 (29%), Positives = 121/231 (52%), Gaps = 19/231 (8%)

Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS-RNSGQGIEEFK-NEVRLIAKLQHRN 599
           ++T   K+G+G +G+VYKGR    GQ +A+K++   +  +G+      E+ L+ +LQH N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 600 LVRLLGCCVEMDEKMLVYEYME---NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           +V L    ++     L++E++     + LDS+   +   + L     + I+ GI    L+
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI----LF 116

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
            H     R++HRDLK  N+L+D +   K++DFG+AR F G      T  VV T  Y +PE
Sbjct: 117 CH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPE 171

Query: 717 YAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK 766
             +    +S   D++S G +  E  +    +  +H ++E++ L  ++R+  
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMAT---KKPLFHGDSEIDQLFRIFRILG 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

 Score = 96.0 bits (239), Expect = 7e-24
 Identities = 39/88 (44%), Positives = 52/88 (59%), Gaps = 8/88 (9%)

Query: 364 TELQC----SEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGG 419
           T L C    S D FL+L ++KLPD  ++     ++L+EC   C  NCSCTAYA  N  G 
Sbjct: 1   TPLNCGGDGSTDGFLKLPDVKLPDNASAIT--AISLEECREACLSNCSCTAYAYNN--GS 56

Query: 420 TGCVTWTGELKDIRKYAEGGQDLYVRLA 447
            GC+ W G L ++R  + GG  LY+RLA
Sbjct: 57  GGCLLWNGLLNNLRSLSSGGGTLYLRLA 84

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 9e-24
 Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 24/207 (11%)

Query: 550 LGQGGFGIVYKGRLLEG----QEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+G FG V +G+L +      ++AVK  +L  ++   IEEF +E   +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 604 LGCCVEMDEK------MLVYEYMENRSLDSVIFD---KARSSILNWQRRFNIICGIARGL 654
           +G C E          M++  +M++  L S +           L  Q     +  IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQN--TKRVVGTYG 711
            YL   S    IHRDL A N +L ++MT  ++DFG+++ I+ GD   Q    K  V    
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---K 180

Query: 712 YMSPEYAMDGLFSVKSDVFSFGVLLLE 738
           +++ E   D +++ KSDV++FGV + E
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWE 207

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  101 bits (254), Expect = 9e-24
 Identities = 68/200 (34%), Positives = 105/200 (52%), Gaps = 19/200 (9%)

Query: 550 LGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 605 GCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           G C     +   LV EY+   SL D +   + R   L+ ++       I +G+ YL    
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL---G 125

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG---TYGYMSPEYA 718
             R +HRDL   NIL++ E   KI DFG+ ++   D+ E    R  G    + Y +PE  
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESL 183

Query: 719 MDGLFSVKSDVFSFGVLLLE 738
            +  FSV SDV+SFGV+L E
Sbjct: 184 TESKFSVASDVWSFGVVLYE 203

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  101 bits (253), Expect = 1e-23
 Identities = 81/290 (27%), Positives = 133/290 (45%), Gaps = 39/290 (13%)

Query: 543 NFTDYNKLGQGGFGIVYK-------GRLLEGQEIAVKRLS-----RNSGQGIEEFKNEVR 590
            +     LG G FG VYK         LL  +EI V   +     R   + I +  +EV 
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 591 LIAK-LQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIIC 648
           +I + L+H N+VR     +E D   +V + +E   L +     K +      +R +NI  
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            +   L YLH++ R  I+HRDL  +NI+L ++    I+DFG+A+     Q E     VVG
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVG 175

Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG 768
           T  Y  PE   +  +  K+DV++FG +L +  + +     ++S N L+L           
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP---FYSTNMLSL----------- 221

Query: 769 KVLEMVDSSVDNYPANEVLRCIHVGLL---CVQENAEERPTMASVVLMLS 815
              ++V++  +  P  E +    V  +   C+  +AE RP +  V  M+S
Sbjct: 222 -ATKIVEAVYE--PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  101 bits (252), Expect = 1e-23
 Identities = 84/262 (32%), Positives = 129/262 (49%), Gaps = 29/262 (11%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           E +   +V EYM   SL  + F K      L   +  ++   IA G+ Y+    R   +H
Sbjct: 72  E-EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 125

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFSV 725
           RDL+A+NIL+ + +  K++DFG+AR+    +  + T R    +   + +PE A+ G F++
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           KSDV+SFG+LL E  +  K R  Y         G V R     +VL+ V+         E
Sbjct: 183 KSDVWSFGILLTELTT--KGRVPYP--------GMVNR-----EVLDQVERGYRMPCPPE 227

Query: 786 VLRCIHVGLL-CVQENAEERPT 806
               +H  +  C ++  EERPT
Sbjct: 228 CPESLHDLMCQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  100 bits (252), Expect = 2e-23
 Identities = 66/210 (31%), Positives = 105/210 (50%), Gaps = 19/210 (9%)

Query: 546 DYN---KLGQGGFGIVYKGRLLEGQE-IAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNL 600
           DY     +G G   +VY    L   E +A+KR+        ++E + EV+ +++  H N+
Sbjct: 2   DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV 61

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL----Y 656
           V+     V  DE  LV  Y+   SL  ++        L+      II  + + +L    Y
Sbjct: 62  VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDE----AIIATVLKEVLKGLEY 117

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM-ARIF-GGDQTEQNTKRVVGTYGYMS 714
           LH       IHRD+KA NILL ++ + KI+DFG+ A +  GGD+T +  K  VGT  +M+
Sbjct: 118 LH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174

Query: 715 PE-YAMDGLFSVKSDVFSFGVLLLETVSGK 743
           PE       +  K+D++SFG+  +E  +G 
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  100 bits (250), Expect = 2e-23
 Identities = 66/210 (31%), Positives = 106/210 (50%), Gaps = 19/210 (9%)

Query: 550 LGQGGFGIVYKGRLLEGQ------EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +G+G FGIV+  R    Q      +I V++++++     +   NE +++  L H N++  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
               +E    M+V EY    +L   I  K  +S+L+     +    I   L ++H     
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYI-QKRCNSLLDEDTILHFFVQILLALHHVHTKL-- 121

Query: 664 RIIHRDLKASNILLDK-EMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
            I+HRDLK  NILLDK +M  KI DFG+++I     ++     VVGT  Y+SPE      
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEGKP 177

Query: 723 FSVKSDVFSFGVLLLETVSGKKNRGFYHSN 752
           ++ KSD+++ G +L E  S K  R F  +N
Sbjct: 178 YNQKSDIWALGCVLYELASLK--RAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  100 bits (249), Expect = 3e-23
 Identities = 82/260 (31%), Positives = 127/260 (48%), Gaps = 25/260 (9%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLG G FG V+ G      ++AVK L   +    E F  E +++ KL+H  LV+L    V
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAV-V 70

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
             +   +V EYM   SL   + D      L      ++   +A G+ Y+    R   IHR
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126

Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFSVK 726
           DL+++NIL+   +  KI+DFG+AR+    +  + T R    +   + +PE A+ G F++K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 727 SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEV 786
           SDV+SFG+LL E V+  K R  Y   N   +L  V R ++               P +  
Sbjct: 184 SDVWSFGILLTELVT--KGRVPYPGMNNREVLEQVERGYRM------------PCPQDCP 229

Query: 787 LRCIHVGLLCVQENAEERPT 806
           +    + L C +++ EERPT
Sbjct: 230 ISLHELMLQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 99.3 bits (247), Expect = 3e-23
 Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 15/194 (7%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
            +G+G FG V +G    GQ++AVK +  +     + F  E  ++ KL H+NLVRLLG  +
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR-RFNIICGIARGLLYLHQDSRFRIIH 667
             +   +V E M   +L + +  + R+ +   Q  +F++   +A G+ YL      +++H
Sbjct: 70  H-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLESK---KLVH 123

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKS 727
           RDL A NIL+ ++   K+SDFG+AR+  G     N+K  V    + +PE      FS KS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPV---KWTAPEALKHKKFSSKS 178

Query: 728 DVFSFGVLLLETVS 741
           DV+S+GVLL E  S
Sbjct: 179 DVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 14/206 (6%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKN---EVRLIAKLQH 597
           D+     +LG G  G+V K      G+ +AVK +     +     K    E+ ++ K   
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNS 58

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             +V   G      +  +  EYM+  SLD  I  + +  I        I   + +GL YL
Sbjct: 59  PYIVGFYGAFYNNGDISICMEYMDGGSLD-KILKEVQGRIPERILGK-IAVAVLKGLTYL 116

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H   + +IIHRD+K SNIL++     K+ DFG++    G       K  VGT  YM+PE 
Sbjct: 117 H--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYMAPER 170

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGK 743
                +SVKSD++S G+ L+E  +G+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 99.4 bits (248), Expect = 5e-23
 Identities = 77/279 (27%), Positives = 134/279 (48%), Gaps = 30/279 (10%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS---RNSGQGIEEFKNEVRLIAKLQ 596
             NF    K+G+G F +VYK   LL+G+ +A+K++        +  ++   E+ L+ +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI--FDKARSSILN---WQRRFNIICGIA 651
           H N+++ L   +E +E  +V E  +   L  +I  F K +  I     W         + 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW----KYFVQLC 116

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG 711
             L ++H     RI+HRD+K +N+ +      K+ D G+ R F    T  ++   VGT  
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPY 171

Query: 712 YMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL 771
           YMSPE   +  ++ KSD++S G LL E  + +    FY    ++NL    + L K+ +  
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGD--KMNL----YSLCKKIEKC 223

Query: 772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASV 810
           +      D+Y  +E LR   +   C+  + E+RP ++ V
Sbjct: 224 DYPPLPADHY--SEELR--DLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 99.4 bits (247), Expect = 6e-23
 Identities = 74/227 (32%), Positives = 111/227 (48%), Gaps = 27/227 (11%)

Query: 549 KLGQGGFGIVYKGR---LLEGQE---IAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           +LG+G FG V+      L   Q+   +AVK L   S    ++F  E  L+  LQH ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 603 LLGCCVEMDEKMLVYEYMENRSL---------DSVIFDKARSSI-LNWQRRFNIICGIAR 652
             G CVE D  ++V+EYM++  L         D+V+  +      L   +  +I   IA 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG---- 708
           G++YL        +HRDL   N L+ + +  KI DFGM+R    D    +  RV G    
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRVGGHTML 184

Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
              +M PE  M   F+ +SDV+S GV+L E  +  K   +  SNNE+
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 98.9 bits (247), Expect = 9e-23
 Identities = 53/178 (29%), Positives = 91/178 (51%), Gaps = 24/178 (13%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRL-SRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL- 604
           ++G+G  GIV+K +  E G+ +A+K++  R    GI  +   E++ +   QH  +V+LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 605 -----GCCVEMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLH 658
                   V      LV EYM    L  V+ D+ R       +    ++    +G+ Y+H
Sbjct: 67  VFPHGSGFV------LVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMH 116

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
            +    I+HRDLK +N+L+  +   KI+DFG+AR+F  ++    + + V T  Y +PE
Sbjct: 117 AN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 69/212 (32%), Positives = 104/212 (49%), Gaps = 25/212 (11%)

Query: 543 NFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKR--LSRNSGQGIEEFKNEVRLIAKLQHRN 599
           +F    KLG+G +G VYK  RL + Q  A+K   L   S +  E+  NE+R++A + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 600 LVR-----LLGC--CVEMDEKMLVYEYMENRSLDSVIFD-KARSSILNWQRRFNIICGIA 651
           ++      L G   C+ M       EY     L   I   K +  ++  Q  + I   + 
Sbjct: 61  IISYKEAFLDGNKLCIVM-------EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG 711
           RGL  LH+    +I+HRDLK++NILL      KI D G++++      +   K  +GT  
Sbjct: 114 RGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPH 166

Query: 712 YMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           YM+PE      +S KSD++S G LL E  +  
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 98.8 bits (247), Expect = 1e-22
 Identities = 69/232 (29%), Positives = 117/232 (50%), Gaps = 34/232 (14%)

Query: 548 NKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN-----EVRLIAKLQHRNLV 601
            KLG+G + +VYK R    G+ +A+K++     +  ++  N     E++L+ +L+H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDK----ARSSILNWQRRFNIICGIARGLLYL 657
            LL          LV+E+ME   L+ VI DK      + I ++           RGL YL
Sbjct: 66  GLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLM------TLRGLEYL 118

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H  S + I+HRDLK +N+L+  +   K++DFG+AR FG    +  T +VV T  Y +PE 
Sbjct: 119 H--SNW-ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM-THQVV-TRWYRAPEL 173

Query: 718 AMDGLFSVKS-----DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
               LF  +      D++S G +  E +       F   +++++ LG ++  
Sbjct: 174 ----LFGARHYGVGVDMWSVGCIFAELLLRVP---FLPGDSDIDQLGKIFEA 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 64/204 (31%), Positives = 109/204 (53%), Gaps = 23/204 (11%)

Query: 548 NKLGQGGFGIVYKGR-LLEGQEIAVKRLS-RNSGQGIEEFK-NEVRLIAKLQ---HRNLV 601
            ++G+G +G VYK R L  G+ +A+K++    S +GI      E+ L+ +L+   H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 602 RLLGCC--VEMDEKM---LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           RLL  C     D ++   LV+E+++ + L + +  K     L  +   +++  + RG+ +
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVD-QDLATYL-SKCPKPGLPPETIKDLMRQLLRGVDF 122

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMS 714
           LH     RI+HRDLK  NIL+  +   KI+DFG+ARI+  +   T      VV T  Y +
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS-----VVVTLWYRA 174

Query: 715 PEYAMDGLFSVKSDVFSFGVLLLE 738
           PE  +   ++   D++S G +  E
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 98.2 bits (244), Expect = 2e-22
 Identities = 85/289 (29%), Positives = 141/289 (48%), Gaps = 37/289 (12%)

Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  + ++   
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK 704
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R I+  D   +  K
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 180

Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELNLLGHVW 762
            ++    +MSPE   DG+F+  SDV+SFGV+L E  T++ +  +G    +NE      V 
Sbjct: 181 GLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM---SNE-----QVL 231

Query: 763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
           R   EG +L+  D+  D     E++R      +C Q N + RP+   ++
Sbjct: 232 RFVMEGGLLDKPDNCPDML--FELMR------MCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 97.6 bits (243), Expect = 2e-22
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 21/213 (9%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLEGQ-EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN 599
            D   +   LG+G +GIVY  R L  Q  IA+K +     + ++    E+ L + L+HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK------ARSSILNWQRRFNIICGIARG 653
           +V+ LG   E     +  E +   SL +++  K         +I+ + ++      I  G
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ------ILEG 120

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDK-EMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L YLH +   +I+HRD+K  N+L++      KISDFG ++   G      T+   GT  Y
Sbjct: 121 LKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQY 175

Query: 713 MSPEYAMDGL--FSVKSDVFSFGVLLLETVSGK 743
           M+PE    G   +   +D++S G  ++E  +GK
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 97.6 bits (243), Expect = 2e-22
 Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 32/214 (14%)

Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQG---------IEEFKNEVRLIAKLQHRN 599
           +G G FG VY G     G+ +AVK++   S            ++    E+ L+ +LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF------NIICGIARG 653
           +V+ LG  ++ D   +  EY+   S+         +++LN    F      N +  I +G
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSV---------AALLNNYGAFEETLVRNFVRQILKG 118

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD--QTEQNTKR--VVGT 709
           L YLH      IIHRD+K +NIL+D +   KISDFG+++    +   T+ N  R  + G+
Sbjct: 119 LNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175

Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
             +M+PE      ++ K+D++S G L++E ++GK
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 71/223 (31%), Positives = 114/223 (51%), Gaps = 18/223 (8%)

Query: 548 NKLGQGGFGIVYKG-RLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           NK+G G FG VY    L  G+ +AVK  R+  N  + I+E  +E++++  L+H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 605 GCCVEMDEKMLVY-EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G  V   EK+ ++ EY    +L+ ++ +  R    +  R + +   +  GL YLH     
Sbjct: 66  GVEVH-REKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTL--QLLEGLAYLHSH--- 118

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT--KRVVGTYGYMSPEYAMDG 721
            I+HRD+K +NI LD     K+ DFG A     + T      + + GT  YM+PE    G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 722 LFSVK---SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                   +D++S G ++LE  +GK  R +   +NE  ++ HV
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGK--RPWSELDNEFQIMFHV 219

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 98.0 bits (244), Expect = 3e-22
 Identities = 71/205 (34%), Positives = 107/205 (52%), Gaps = 25/205 (12%)

Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIAKLQHRN 599
           FTD  ++G G FG VY  R +   + +A+K++S +  Q  E++++   EVR + +L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI--IC-GIARGLLY 656
            +   GC +      LV EY    + D  I +  +  +    +   I  IC G  +GL Y
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPL----QEVEIAAICHGALQGLAY 130

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           LH   R   IHRD+KA NILL +  T K++DFG A +     +       VGT  +M+PE
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPE 181

Query: 717 --YAMD-GLFSVKSDVFSFGVLLLE 738
              AMD G +  K DV+S G+  +E
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIE 206

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 97.1 bits (242), Expect = 3e-22
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 31/209 (14%)

Query: 550 LGQGGFGIVY----KGRLLEGQE--IAVKRL-SRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           LG+G FG V+    KG   EG E  + VK L          EF+ E+ +  KL H+N+VR
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 603 LLGCCVEMDEKMLVYEYME----------NRSLDSVIFDKARSSILNWQRRFNIICGIAR 652
           LLG C E +   ++ EY +           +S D    +K +   L+ +++  +   IA 
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKD----EKLKPPPLSTKQKVALCTQIAL 128

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG- 711
           G+ +L   S  R +HRDL A N L+  +   K+S   +++    D       ++      
Sbjct: 129 GMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK----DVYNSEYYKLRNALIP 181

Query: 712 --YMSPEYAMDGLFSVKSDVFSFGVLLLE 738
             +++PE   +  FS KSDV+SFGVL+ E
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWE 210

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 96.2 bits (239), Expect = 4e-22
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 17/198 (8%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLG G FG V+     +  ++AVK +   S   +E F  E  ++  LQH  LV+L    V
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAVV 70

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNII---CGIARGLLYLHQDSRFRI 665
             +   ++ E+M   SL     D  +S   + Q    +I     IA G+ ++ Q +    
Sbjct: 71  TKEPIYIITEFMAKGSL----LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---Y 123

Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLF 723
           IHRDL+A+NIL+   +  KI+DFG+AR+    +  + T R    +   + +PE    G F
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSF 180

Query: 724 SVKSDVFSFGVLLLETVS 741
           ++KSDV+SFG+LL+E V+
Sbjct: 181 TIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 97.1 bits (241), Expect = 6e-22
 Identities = 63/215 (29%), Positives = 114/215 (53%), Gaps = 15/215 (6%)

Query: 534 FETIVRATD---NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEV 589
             TIV   D    +T Y K+GQG  G V+    +  GQE+A+K+++       E   NE+
Sbjct: 8   LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC- 648
            ++ +L++ N+V  L   +  DE  +V EY+   SL  V+ +         + +   +C 
Sbjct: 68  LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD-----EAQIAAVCR 122

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
              + L +LH +   ++IHRD+K+ N+LL  + + K++DFG       +Q++++T  +VG
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177

Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           T  +M+PE      +  K D++S G++ +E V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 96.9 bits (241), Expect = 6e-22
 Identities = 72/241 (29%), Positives = 116/241 (48%), Gaps = 33/241 (13%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQE------------------IAVKRLSRNSGQGIE 583
              T   KLG+G FG V+     EG E                  +AVK L  ++ +   
Sbjct: 5   KRLTFKEKLGEGQFGEVHLCEA-EGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR 63

Query: 584 -EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI--------FDKAR 634
            +F  E++++++L+  N++RLL  C+  D   ++ EYMEN  L+  +         +KA 
Sbjct: 64  NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKAD 123

Query: 635 SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-I 693
              +++     +   IA G+ YL   S    +HRDL   N L+ K  T KI+DFGM+R +
Sbjct: 124 VVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180

Query: 694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN 753
           + GD       R V    +MS E  + G F+  SDV++FGV L E ++  K + +   ++
Sbjct: 181 YSGDYYRIQ-GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239

Query: 754 E 754
           E
Sbjct: 240 E 240

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 7e-22
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 23/214 (10%)

Query: 530 PLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKNE 588
           P  D+E I           ++G G +G VYK R +   E+ A+K +    G   E  + E
Sbjct: 1   PQEDYELI----------QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQE 50

Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC 648
           + ++ + +H N+V   G  +  D+  +V EY    SL   I+   R  +   Q  + +  
Sbjct: 51  ISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAY-VCR 108

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM-ARIFGGDQTEQNTKRVV 707
              +GL YLH+      IHRD+K +NILL ++   K++DFG+ A++     T    K  +
Sbjct: 109 ETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSFI 162

Query: 708 GTYGYMSPEYA---MDGLFSVKSDVFSFGVLLLE 738
           GT  +M+PE A     G +  K D+++ G+  +E
Sbjct: 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 96.7 bits (241), Expect = 7e-22
 Identities = 74/222 (33%), Positives = 112/222 (50%), Gaps = 34/222 (15%)

Query: 538 VRATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNS---GQGIEEFKNEVRLIA 593
            R+   F   N++G+G +GIVY+ R     EI A+K++  ++   G  I   + E+ L+ 
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLL 61

Query: 594 KLQHRNLVRLLGCCV--EMDEKMLVYEYMEN---RSLDSVI--FDKARSSILNWQRRFNI 646
            L+H N+V L    V   +D   LV EY E      LD++   F +++   L  Q     
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQ----- 116

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              + RGL YLH    F IIHRDLK SN+LL  +   KI+DFG+AR + G   +  T +V
Sbjct: 117 ---LLRGLQYLH--ENF-IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKV 169

Query: 707 VGTYGYMSPEYAMDGLFSVKS-----DVFSFGVLLLETVSGK 743
           V T  Y +PE     L    +     D+++ G +L E ++ K
Sbjct: 170 V-TLWYRAPEL----LLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 95.3 bits (237), Expect = 9e-22
 Identities = 62/193 (32%), Positives = 100/193 (51%), Gaps = 9/193 (4%)

Query: 548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           +KLG G +G VY+G   +    +AVK L +     +EEF  E  ++ +++H NLV+LLG 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
           C       ++ E+M   +L   + +  R   +N      +   I+  + YL + +    I
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 126

Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQ-TEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           HRDL A N L+ +    K++DFG++R+  GD  T     +      + +PE      FS+
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSI 184

Query: 726 KSDVFSFGVLLLE 738
           KSDV++FGVLL E
Sbjct: 185 KSDVWAFGVLLWE 197

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 65/222 (29%), Positives = 96/222 (43%), Gaps = 28/222 (12%)

Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QH 597
            T  F     +G+G +G VYK R  + GQ +A+K +        EE K E  ++ K   H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKYSNH 62

Query: 598 RNLVRLLGC------CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN-----I 646
            N+    G           D+  LV E     S    + D  +      +R        I
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVKGLRKKGKRLKEEWIAYI 118

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
           +    RGL YLH++   ++IHRD+K  NILL K    K+ DFG++     D T       
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNTF 173

Query: 707 VGTYGYMSPE-----YAMDGLFSVKSDVFSFGVLLLETVSGK 743
           +GT  +M+PE        D  +  +SDV+S G+  +E   GK
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 95.0 bits (236), Expect = 1e-21
 Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 13/193 (6%)

Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           +G+G FG V  G    G ++AVK +  ++    + F  E  ++ +L+H NLV+LLG  VE
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 610 MDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
               + +V EYM   SL   +  + RS +L           +   + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126

Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSD 728
           DL A N+L+ ++   K+SDFG+ +      T+   K  V    + +PE   +  FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPV---KWTAPEALREKKFSTKSD 181

Query: 729 VFSFGVLLLETVS 741
           V+SFG+LL E  S
Sbjct: 182 VWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 80/287 (27%), Positives = 124/287 (43%), Gaps = 41/287 (14%)

Query: 549 KLGQGGFGIVY-----------------KGRLLEGQEIAVKRLSRN-SGQGIEEFKNEVR 590
           KLG+G FG V+                          +AVK L  + S    E+F  EV+
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLD-----SVIFDKAR---SSILNWQR 642
           ++++L   N+ RLLG C       ++ EYMEN  L+      V         S  L++  
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 643 RFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQ 701
              +   IA G+ YL        +HRDL   N L+ K  T KI+DFGM+R ++  D   +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY-R 187

Query: 702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE--LNLLG 759
              R      +M+ E  + G F+ KSDV++FGV L E ++  + + + H  ++  +   G
Sbjct: 188 VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAG 247

Query: 760 HVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPT 806
           H +R       L          P N       + L C + + E+RPT
Sbjct: 248 HFFRDDGRQIYLPR--------PPNCPKDIYELMLECWRRDEEDRPT 286

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 94.9 bits (236), Expect = 1e-21
 Identities = 76/268 (28%), Positives = 124/268 (46%), Gaps = 29/268 (10%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           +LG G FG+V  G+     ++A+K +   S    +EF  E +++ KL H  LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           +     +V EYM N  L + + +  +       +   +   +  G+ YL      + IHR
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIHR 124

Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT---YGYMSPEYAMDGLFSV 725
           DL A N L+D +   K+SDFG++R    D+   +    VG+     +  PE  +   FS 
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSS 180

Query: 726 KSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPAN 784
           KSDV++FGVL+ E  S GK     ++++  +  +    RL++     E V +        
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYA-------- 232

Query: 785 EVLRCIHVGLLCVQENAEERPTMASVVL 812
                  +   C  E AEERPT   ++ 
Sbjct: 233 -------IMYSCWHEKAEERPTFQQLLS 253

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 95.9 bits (238), Expect = 2e-21
 Identities = 71/206 (34%), Positives = 109/206 (52%), Gaps = 14/206 (6%)

Query: 550 LGQGGFGIVYKGRLL-EGQEI----AVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRL 603
           LG G FG VYKG  + EG+ +    A+K L+  +G +   EF +E  ++A + H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           LG C+      LV + M +  L   + +   +  +  Q   N    IA+G++YL +    
Sbjct: 75  LGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER--- 128

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           R++HRDL A N+L+      KI+DFG+AR+  GD+ E N         +M+ E      F
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188

Query: 724 SVKSDVFSFGVLLLE--TVSGKKNRG 747
           + +SDV+S+GV + E  T  GK   G
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 95.1 bits (236), Expect = 2e-21
 Identities = 76/228 (33%), Positives = 113/228 (49%), Gaps = 25/228 (10%)

Query: 549 KLGQGGFGIVYKGRL-LEGQE----IAVKRLSR-NSGQGIEEFKNEVRLIAKLQHRNLVR 602
           +LG+  FG +YKG L L G +    +A+K L   N+ Q   EF+ E  L+A+L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIF--------------DKARSSILNWQRRFNIIC 648
           LLG   +     +++EY+    L   +               D    S L+     +I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRVV 707
            IA G+ YL   S F  +H+DL A NIL+ +++  KISD G++R I+  D      K ++
Sbjct: 132 QIAAGMEYL--SSHF-FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
               +M PE  M G FS  SD++SFGV+L E  S      +  SN E+
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 94.9 bits (236), Expect = 2e-21
 Identities = 63/221 (28%), Positives = 111/221 (50%), Gaps = 20/221 (9%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLS--RNSGQG----IEEFKNEVRLIAKLQHRNLVR 602
           LG G F   Y+ R +  G  +AVK+++  RN+       +E  + E+RL+A+L H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVI--FDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +LG   E     L  E+M   S+  ++  +   + +++      N    + RGL YLH++
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-----NYTEQLLRGLSYLHEN 122

Query: 661 SRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTEQN--TKRVVGTYGYMSPEY 717
              +IIHRD+K +N+L+D      +I+DFG A       T       +++GT  +M+PE 
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
                +    DV+S G +++E  + K        +N L L+
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 66/197 (33%), Positives = 107/197 (54%), Gaps = 13/197 (6%)

Query: 550 LGQGGFGIVYKGRLL--EGQEI--AVKRLSR-NSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G L+  +GQ+I  AVK L+R    + +E+F  E  ++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I  +  +  +     F +   +A+G+ YL      
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLASK--- 117

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGD-QTEQNTKRVVGTYGYMSPEYAMDG 721
           + +HRDL A N +LD+  T K++DFG+AR I+  +  +  N         +M+ E     
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 722 LFSVKSDVFSFGVLLLE 738
            F+ KSDV+SFGVLL E
Sbjct: 178 KFTTKSDVWSFGVLLWE 194

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 95.7 bits (239), Expect = 2e-21
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 33/212 (15%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---------EVRLIAKLQHRN 599
           +G G +G+V        G+++A+K++S         F +         E++L+  L+H N
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60

Query: 600 LVRLL-----GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           ++ LL         + ++  +V E ME   L  VI  K+   + +   ++  +  I RGL
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVI--KSPQPLTDDHIQY-FLYQILRGL 116

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN--TKRVVGTYGY 712
            YLH      +IHRDLK SNIL++     KI DFG+AR    D+ E+   T+ VV T  Y
Sbjct: 117 KYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWY 172

Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE  +    ++   D++S G +  E ++ K
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 94.7 bits (235), Expect = 3e-21
 Identities = 75/251 (29%), Positives = 116/251 (46%), Gaps = 44/251 (17%)

Query: 549 KLGQGGFGIVY----------KGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR 598
           +LG+G FG V+          K ++L    +AVK L   +    ++F+ E  L+  LQH 
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKML----VAVKALKDPTLAARKDFQREAELLTNLQHE 67

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-------------LNWQRRFN 645
           ++V+  G C + D  ++V+EYM++  L+  +      ++             L   +  +
Sbjct: 68  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           I   IA G++YL        +HRDL   N L+   +  KI DFGM+R    D    +  R
Sbjct: 128 IASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYR 180

Query: 706 VVG----TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
           V G       +M PE  M   F+ +SDV+SFGV+L E  +  K   F  SN E      V
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------V 234

Query: 762 WRLWKEGKVLE 772
                +G+VLE
Sbjct: 235 IECITQGRVLE 245

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 94.0 bits (233), Expect = 3e-21
 Identities = 84/261 (32%), Positives = 129/261 (49%), Gaps = 27/261 (10%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G      ++A+K L   +    E F  E +++ KL+H  LV L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V E+M   SL   +  +     L   +  ++   IA G+ Y+    R   IHR
Sbjct: 72  E-EPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126

Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFSVK 726
           DL+A+NIL+   +  KI+DFG+AR+    +  + T R    +   + +PE A+ G F++K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 727 SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEV 786
           SDV+SFG+LL E V+  K R  Y         G V R     +VLE V+           
Sbjct: 184 SDVWSFGILLTELVT--KGRVPYP--------GMVNR-----EVLEQVERGYRMPCPQGC 228

Query: 787 LRCIHVGL-LCVQENAEERPT 806
              +H  + LC +++ +ERPT
Sbjct: 229 PESLHELMKLCWKKDPDERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 94.3 bits (234), Expect = 4e-21
 Identities = 85/295 (28%), Positives = 140/295 (47%), Gaps = 37/295 (12%)

Query: 540 ATDNFTDYNKLGQGGFGIVYKG---RLLEGQ---EIAVKRLSRN-SGQGIEEFKNEVRLI 592
           + +  T   +LGQG FG+VY+G    +++G+    +AVK ++ + S +   EF NE  ++
Sbjct: 4   SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63

Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRR--------F 644
                 ++VRLLG   +    ++V E M +  L S +    R    N   R         
Sbjct: 64  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMI 122

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNT 703
            +   IA G+ YL+     + +HRDL A N ++  + T KI DFGM R I+  D   +  
Sbjct: 123 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 179

Query: 704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           K ++     M+PE   DG+F+  SD++SFGV+L E ++    + +   +NE         
Sbjct: 180 KGLLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNE--------- 228

Query: 764 LWKEGKVLEMV-DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE 817
                +VL+ V D    + P N   R   +  +C Q N + RPT   +V +L  +
Sbjct: 229 -----QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 93.9 bits (233), Expect = 5e-21
 Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 25/214 (11%)

Query: 549 KLGQGGFGIVYKGRLL------EGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLV 601
           +LG+  FG VYKG L       + Q +A+K L  +  G   EEFK+E  + ++LQH N+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIF-------------DKARSSILNWQRRFNIIC 648
            LLG   +     +++ Y  +  L   +              DK   S L      +I+ 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRVV 707
            IA G+ +L   S   ++H+DL   N+L+  ++  KISD G+ R ++  D  +     ++
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188

Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +MSPE  M G FS+ SD++S+GV+L E  S
Sbjct: 189 PIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 94.2 bits (234), Expect = 5e-21
 Identities = 80/305 (26%), Positives = 141/305 (46%), Gaps = 49/305 (16%)

Query: 549 KLGQGGFGIVYKGRLLEGQE-----------------IAVKRLSRNSGQGIE-EFKNEVR 590
           KLG+G FG V+   ++  Q+                 +AVK L  ++ +    +F  EV+
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDS-----VIFDKARSS--------- 636
           ++++L+  N++RLLG CV+ D   ++ EYMEN  L+       + DK  +          
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 637 --ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-I 693
              +++    ++   IA G+ YL   S    +HRDL   N L+ + +T KI+DFGM+R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Query: 694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN 753
           + GD       R V    +M+ E  + G F+  SDV++FGV L E +   K + +    +
Sbjct: 189 YAGDYYRIQ-GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD 247

Query: 754 E--LNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
           E  +   G  +R   +G+ + +           E++      L C   +  ERP+ + + 
Sbjct: 248 EQVIENAGEFFR--DQGRQVYLFRPPPCPQGLYELM------LQCWSRDCRERPSFSDIH 299

Query: 812 LMLSS 816
             L+ 
Sbjct: 300 AFLTE 304

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 93.8 bits (233), Expect = 6e-21
 Identities = 65/216 (30%), Positives = 111/216 (51%), Gaps = 21/216 (9%)

Query: 536 TIVRATD---NFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRL 591
           TIV   D    +T + K+GQG  G VY    +  GQE+A+K+++       E   NE+ +
Sbjct: 10  TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILV 69

Query: 592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIA 651
           + + +H N+V  L   +  DE  +V EY+   SL  V+ +               I  + 
Sbjct: 70  MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE--------GQIAAVC 121

Query: 652 RGLL----YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
           R  L    +LH +   ++IHRD+K+ NILL  + + K++DFG       +Q++++T  +V
Sbjct: 122 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MV 176

Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           GT  +M+PE      +  K D++S G++ +E V G+
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 92.7 bits (230), Expect = 8e-21
 Identities = 68/219 (31%), Positives = 115/219 (52%), Gaps = 25/219 (11%)

Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V++G L + G++   +A+K L    + +  ++F +E  ++ +  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDK--ARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           G   +    M++ EYMEN +LD  + D     SS     +   ++ GIA G+ YL   S 
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY----QLVGMLRGIAAGMKYL---SD 125

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPE 716
              +HRDL A NIL++  +  K+SDFG++R+   D     T     T G      + +PE
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT-----TSGGKIPIRWTAPE 180

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
                 F+  SDV+SFG+++ E +S  +   +  SN+E+
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV 219

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 92.7 bits (230), Expect = 8e-21
 Identities = 76/277 (27%), Positives = 131/277 (47%), Gaps = 37/277 (13%)

Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL L G+    +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLD+  F +         +   ++ GIA G+ YL   S   
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDA--FLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMG 126

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEYA 718
            +HRDL A NIL++  +  K+SDFG++R+      E + +    T G      + +PE  
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVL-----EDDPEAAYTTRGGKIPIRWTAPEAI 181

Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
               F+  SDV+S+G+++ E +S    R ++  +N+               V++ ++   
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMS-YGERPYWEMSNQ--------------DVIKAIEEGY 226

Query: 779 DNYPANEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
                 +    +H  +L C Q++  ERP    +V +L
Sbjct: 227 RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 92.6 bits (230), Expect = 1e-20
 Identities = 59/217 (27%), Positives = 109/217 (50%), Gaps = 37/217 (17%)

Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRL---SRNSGQG-------IEEFKNEVRLIAKLQHR 598
           +G+G +G VY    +  G+ +AVK++   +  +G+        ++  ++E+  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVI-----FDKARSSILNWQRRFNIICGIARG 653
           N+V+ LG     +   +  EY+   S+ S +     F++        Q        +  G
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLEG 120

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR----IFGGDQTEQNTKRVVGT 709
           L YLH      I+HRDLKA N+L+D +   KISDFG+++    I+  DQ    + +  G+
Sbjct: 121 LAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN--MSMQ--GS 173

Query: 710 YGYMSPE--YAMDGLFSVKSDVFSFGVLLLETVSGKK 744
             +M+PE  ++    +S K D++S G ++LE  +G++
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 74/277 (26%), Positives = 133/277 (48%), Gaps = 42/277 (15%)

Query: 550 LGQGGFG--IVYK----GRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+G FG   +Y+      L+  +E+ + RLS    +   +  NE+ +++ LQH N++  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVILSLLQHPNIIAY 64

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRR------FNIICGIARGLLYL 657
               ++ +  ++  EY    +L   I    R     ++        F I+  ++    Y+
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVS----YI 117

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H+     I+HRD+K  NI L K    K+ DFG+++I G + +   T  VVGT  YMSPE 
Sbjct: 118 HKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPEL 172

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                ++ KSD+++ G +L E ++ K+    + + N LNL   V ++ +       V S 
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRT---FDATNPLNL---VVKIVQ--GNYTPVVSV 224

Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
              Y + E++  +H     +Q++ E+RPT   V+   
Sbjct: 225 ---YSS-ELISLVHS---LLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 79/291 (27%), Positives = 129/291 (44%), Gaps = 54/291 (18%)

Query: 550 LGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLV 601
           LG+G FG V K   +      E   +AVK L  + + + + +  +E+ ++  + +H+N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR-------SSILNWQRRFNIIC------ 648
            LLG C +     +V EY  + +L    F +AR       S          +        
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRD--FLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 649 --GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              +ARG+ +L      + IHRDL A N+L+ ++   KI+DFG+AR    D    +  R 
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRK 190

Query: 707 VGT----YGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELNLLGH 760
                    +M+PE   D +++ +SDV+SFGVLL E  T+ G    G          +  
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--------PVEE 242

Query: 761 VWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
           +++L KEG  +E         P N      H+   C  E   +RPT   +V
Sbjct: 243 LFKLLKEGYRMEK--------PQNCTQELYHLMRDCWHEVPSQRPTFKQLV 285

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 63/194 (32%), Positives = 101/194 (52%), Gaps = 9/194 (4%)

Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRNLVRLLGCCV 608
           LG+G FG V+KG L +   +AVK    +  Q ++ +F +E R++ +  H N+V+L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           +     +V E +     D + F + +   L  ++        A G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 669 DLKASNILLDKEMTPKISDFGMARIF-GGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKS 727
           DL A N L+ +    KISDFGM+R    G  +    K++     + +PE    G +S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175

Query: 728 DVFSFGVLLLETVS 741
           DV+S+G+LL ET S
Sbjct: 176 DVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 91.5 bits (227), Expect = 2e-20
 Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 13/200 (6%)

Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V +GRL L G+    +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M++ E+MEN +LDS  F +         +   ++ GIA G+ YL   S   
Sbjct: 72  GVVTKSRPVMIITEFMENGALDS--FLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMN 126

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG---TYGYMSPEYAMDG 721
            +HRDL A NIL++  +  K+SDFG++R    D ++      +G      + +PE     
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 722 LFSVKSDVFSFGVLLLETVS 741
            F+  SDV+S+G+++ E +S
Sbjct: 187 KFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 71/228 (31%), Positives = 117/228 (51%), Gaps = 29/228 (12%)

Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFK-NEVRLIAKLQHRNL 600
           NF    KLG+G +  VYKGR     EI A+K +  ++ +G       E+ L+ +L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 601 VRLLGCCVEMDEKMLVYEYMEN---RSLDS----VIFDKARSSILNWQRRFNIICGIARG 653
           VRL       ++ MLV+EYM+    + +D+       D        +Q        + +G
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQ--------LLKG 112

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT--KRVVGTYG 711
           + + H++   R++HRDLK  N+L++K    K++DFG+AR FG      NT    VV T  
Sbjct: 113 IAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVV-TLW 165

Query: 712 YMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
           Y +P+  +    +S   D++S G ++ E ++G+    F  +NNE  LL
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPL--FPGTNNEDQLL 211

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 92.0 bits (228), Expect = 3e-20
 Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 30/219 (13%)

Query: 549 KLGQGGFGIVY---KGRLLEGQE------------IAVKRLSRNSGQGIE-EFKNEVRLI 592
           KLG+G FG V+      L E               +AVK L  +  +    +F  E++++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSIL---------NWQRR 643
           ++L++ N++RLLG CV  D   ++ EYMEN  L+  +  +   S           +    
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQN 702
             +   IA G+ YL   +    +HRDL   N L+    T KI+DFGM+R ++ GD     
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188

Query: 703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
             R V    +M+ E  + G F+  SDV++FGV L E  +
Sbjct: 189 -GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 91.4 bits (227), Expect = 3e-20
 Identities = 68/222 (30%), Positives = 100/222 (45%), Gaps = 32/222 (14%)

Query: 550 LGQGGFGIVY------KGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+GGFG V        G++   +++  KRL +  G+ +    NE +++ K+  R +V L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58

Query: 604 LGCCVEMDEKMLVYEYMENRSL-------DSVIFDKARSSILNWQRRFNIICGIARGLLY 656
                  D+  LV   M    L           F +AR+     Q    IICG    L +
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ----IICG----LEH 110

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           LHQ    RI++RDLK  N+LLD     +ISD G+A    G +     K   GT GYM+PE
Sbjct: 111 LHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPE 164

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGK---KNRGFYHSNNEL 755
                ++    D F+ G  L E ++G+   + R       EL
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 53/209 (25%), Positives = 114/209 (54%), Gaps = 23/209 (11%)

Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQG-IEEFKNEVRLIAKLQH---R 598
           +     +G+G +G VY+G+ +  G+ +A+K ++ ++    + + + EV L+++L+     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL--- 655
           N+ +  G  ++     ++ EY E  S+ +++    ++  +    ++  I  I R +L   
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPI--AEKY--ISVIIREVLVAL 114

Query: 656 -YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
            Y+H+     +IHRD+KA+NIL+      K+ DFG+A +   + ++++T   VGT  +M+
Sbjct: 115 KYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMA 169

Query: 715 PEYAMDG-LFSVKSDVFSFGVLLLETVSG 742
           PE   +G  +  K+D++S G+ + E  +G
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 45/205 (21%)

Query: 543 NFTDYN---KLGQGGFGIVYKGR-LLEGQEIAVKRL---SRNSGQGIEEFKNEVRLIAKL 595
              DY    KLG+G FG VYK R +  G+ +A+K++   +   G  I   + E++++ KL
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64

Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIF-------DKARSSILNWQR-RFN-- 645
           +H N+V L    ++M       E  +                D   S +L     +    
Sbjct: 65  KHPNVVPL----IDM-----AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES 115

Query: 646 -IIC---GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF------- 694
            I C    +  G+ YLH++    I+HRD+KA+NIL+D +   KI+DFG+AR +       
Sbjct: 116 QIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172

Query: 695 ---GGDQTEQNTKRVVGTYGYMSPE 716
              GG  T + T  VV T  Y  PE
Sbjct: 173 KGGGGGGTRKYTNLVV-TRWYRPPE 196

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 91.1 bits (227), Expect = 4e-20
 Identities = 73/240 (30%), Positives = 115/240 (47%), Gaps = 33/240 (13%)

Query: 549 KLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN--EVRLIAKLQ-HRNLVRLL 604
           +LG G FG VY  R  E  E+ A+K++ +      EE  N  EV+ + KL  H N+V+L 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
               E DE   V+EYME  +L  ++ D+          R +II  I +GL ++H+   F 
Sbjct: 65  EVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIR-SIIYQILQGLAHIHKHGFF- 121

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV----VGTYGYMSPEYAM- 719
             HRDLK  N+L+      KI+DFG+AR       E  ++      V T  Y +PE  + 
Sbjct: 122 --HRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWYRAPEILLR 172

Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELN-------LLGHV-WRLWKEGKVL 771
              +S   D+++ G ++ E  +    R  +  ++E++       +LG    + W EG  L
Sbjct: 173 STSYSSPVDIWALGCIMAELYTL---RPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 91.0 bits (226), Expect = 4e-20
 Identities = 59/196 (30%), Positives = 102/196 (52%), Gaps = 15/196 (7%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           LG G FG VYK +  E G   A K +   S + +E+F  E+ ++++ +H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLHQDSRFRIIH 667
             ++  ++ E+ +  +LDS++  +    +   Q R+  +C  +   L +LH     ++IH
Sbjct: 73  YENKLWILIEFCDGGALDSIM-LELERGLTEPQIRY--VCRQMLEALNFLH---SHKVIH 126

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM-----DGL 722
           RDLKA NILL  +   K++DFG++       T Q     +GT  +M+PE        D  
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAK--NKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184

Query: 723 FSVKSDVFSFGVLLLE 738
           +  K+D++S G+ L+E
Sbjct: 185 YDYKADIWSLGITLIE 200

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.3 bits (224), Expect = 6e-20
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 17/203 (8%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKR-----LSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LGQG FG VY    ++ G+E+AVK+      S  + + +   + E++L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 604 LGCCVEMDEKMLVY-EYMENRSLDSVIFDKARSSIL-NWQRRFNIICGIARGLLYLHQDS 661
            GC +  DE + ++ EYM   S+   +  KA  ++     R++     I  G+ YLH + 
Sbjct: 70  YGC-LRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTR--QILEGVEYLHSN- 123

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMA-RIFGGDQTEQNTKRVVGTYGYMSPEYAMD 720
              I+HRD+K +NIL D     K+ DFG + R+     +    K V GT  +MSPE    
Sbjct: 124 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181

Query: 721 GLFSVKSDVFSFGVLLLETVSGK 743
             +  K+DV+S G  ++E ++ K
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 90.8 bits (225), Expect = 7e-20
 Identities = 79/295 (26%), Positives = 135/295 (45%), Gaps = 57/295 (19%)

Query: 550 LGQGGFGIVYKGRLLEGQ------EIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVR 602
           LG+G FG V K      +       +AVK L  N+    + +  +E  L+ ++ H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDS------------VIFDKARSSI---------LNWQ 641
           L G C +    +L+ EY +  SL S            +  D  R+S          L   
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
              +    I+RG+ YL   +  +++HRDL A N+L+ +    KISDFG++R    D  E+
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR----DVYEE 180

Query: 702 NT--KRVVG--TYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNEL 755
           ++  KR  G     +M+ E   D +++ +SDV+SFGVLL E  T+ G    G        
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER--- 237

Query: 756 NLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASV 810
                ++ L K G  +E  ++      + E+   +   L C ++  ++RPT A +
Sbjct: 238 -----LFNLLKTGYRMERPENC-----SEEMYNLM---LTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 90.9 bits (225), Expect = 7e-20
 Identities = 59/202 (29%), Positives = 109/202 (53%), Gaps = 12/202 (5%)

Query: 544 FTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           +T + K+GQG  G VY    +  GQE+A+K+++       E   NE+ ++ + ++ N+V 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLHQDS 661
            L   +  DE  +V EY+   SL  V+ +         + +   +C    + L +LH + 
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALDFLHSN- 134

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
             ++IHRD+K+ NILL  + + K++DFG       +Q++++T  +VGT  +M+PE     
Sbjct: 135 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRK 190

Query: 722 LFSVKSDVFSFGVLLLETVSGK 743
            +  K D++S G++ +E V G+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 89.6 bits (222), Expect = 9e-20
 Identities = 67/200 (33%), Positives = 97/200 (48%), Gaps = 19/200 (9%)

Query: 549 KLGQGGFGIVY---------KGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN 599
           +LG+G FG VY         + RL   +EI V  L+ N      +   E +L++KL H  
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKLDHPA 63

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD-KARSSILNWQRRFNIICGIARGLLYLH 658
           +V+     +E D   ++ EY E R LD  + + K     L+  +       +  G+ Y+H
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
           Q    RI+HRDLKA NI L   +  KI DFG++R+  G      T    GT  YMSPE  
Sbjct: 124 QR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEAL 177

Query: 719 MDGLFSVKSDVFSFGVLLLE 738
               +  KSD++S G +L E
Sbjct: 178 KHQGYDSKSDIWSLGCILYE 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 90.5 bits (224), Expect = 9e-20
 Identities = 68/202 (33%), Positives = 102/202 (50%), Gaps = 19/202 (9%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN---EVRLIAKLQHRN 599
           F+D  ++G G FG VY  R +   E+ A+K++S +  Q  E++++   EVR + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
            ++  GC +      LV EY    + D +   +     L       +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE--Y 717
            +   +IHRD+KA NILL +    K+ DFG A I             VGT  +M+PE   
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVIL 184

Query: 718 AMD-GLFSVKSDVFSFGVLLLE 738
           AMD G +  K DV+S G+  +E
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIE 206

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 89.6 bits (222), Expect = 9e-20
 Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 34/219 (15%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGI------EEFKNEVRLIAKLQH 597
           +T    LG+G +G VY G   +GQ IAVK++  ++   +      E+ + EV L+  L+H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN-----IIC---- 648
            N+V+ LG C++ +   +  E++   S+         SSILN   RF      + C    
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSI---------SSILN---RFGPLPEPVFCKYTK 109

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR---IFGGDQTEQNT-K 704
            I  G+ YLH +    ++HRD+K +N++L      K+ DFG AR     G   T  N  K
Sbjct: 110 QILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166

Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            + GT  +M+PE   +  +  KSD++S G  + E  +GK
Sbjct: 167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 90.5 bits (224), Expect = 1e-19
 Identities = 81/270 (30%), Positives = 129/270 (47%), Gaps = 33/270 (12%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN---EVRLIAKLQHRN 599
           FTD  ++G G FG VY  R +   E+ A+K++S +  Q  E++++   EV+ + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
            +   GC +      LV EY    + D +   +     L       I  G  +GL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE--Y 717
            +   +IHRD+KA NILL +    K++DFG A I     +       VGT  +M+PE   
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVIL 194

Query: 718 AMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS 776
           AMD G +  K DV+S G+  +E    K       + N ++ L H+ +   E   L+  + 
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQ--NESPTLQSNEW 249

Query: 777 SVDNYPANEVLRCIHVGLLCVQENAEERPT 806
           S  +Y  N V  C+        +  ++RPT
Sbjct: 250 S--DYFRNFVDSCLQ-------KIPQDRPT 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 30/223 (13%)

Query: 551 GQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           G+G FG V   +  + +++ A+K +++        +    NE R++ +L H  LV L   
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68

Query: 607 CVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFN------IICGIARGLLYLHQ 659
             + +E M LV + +    L        R  +   + +F+       IC I   L YLH 
Sbjct: 69  -FQDEENMYLVVDLLLGGDL--------RYHLSQ-KVKFSEEQVKFWICEIVLALEYLHS 118

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
                IIHRD+K  NILLD++    I+DF +A        +  T    GT GYM+PE   
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPEVLC 172

Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGF-YHSNNELNLLGHV 761
              +SV  D +S GV   E + GK  R +  HS    + +   
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGK--RPYRGHSRTIRDQIRAK 213

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403)

 Score = 81.6 bits (202), Expect = 2e-19
 Identities = 32/48 (66%), Positives = 41/48 (85%), Gaps = 1/48 (2%)

Query: 816 SETATMPQPKTPGFCLGRNPIETDSSSSKH-DETFTVNQVTVTMLNAR 862
           SET  +PQPK PGFC+GR+P ETDSSSS   DE++TVNQVTV++++AR
Sbjct: 1   SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48

This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 29/208 (13%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVK--RLSRNSGQGIEEFK-NEVRLIAKLQHRNLVRLL 604
           K+G+G +G+VYK R  L G+ +A+K  RL     +G+      E+ L+ +L H N+VRLL
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLL 64

Query: 605 GCCVEMDEK--MLVYEYME---NRSLDSVIFDKARSSILN---WQRRFNIICGIARGLLY 656
              V   E    LV+E+++    + +DS         ++    +Q        + +G+ Y
Sbjct: 65  D--VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ--------LLQGIAY 114

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
            H     R++HRDLK  N+L+D+E   K++DFG+AR F G      T  VV T  Y +PE
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPE 169

Query: 717 YAMDG-LFSVKSDVFSFGVLLLETVSGK 743
             +    +S   D++S G +  E V+ +
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 88.2 bits (218), Expect = 4e-19
 Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 11/202 (5%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLV 601
           FT   ++G+G FG VYKG     +E+ A+K +     +  IE+ + E+ ++++     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           R  G  ++  +  ++ EY+   S      D  +   L       I+  I +GL YLH + 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
             R IHRD+KA+N+LL ++   K++DFG+A      Q ++NT   VGT  +M+PE     
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176

Query: 722 LFSVKSDVFSFGVLLLETVSGK 743
            +  K+D++S G+  +E   G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 88.0 bits (218), Expect = 4e-19
 Identities = 67/201 (33%), Positives = 94/201 (46%), Gaps = 16/201 (7%)

Query: 550 LGQGGFGIVYKGRLL-----EGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQHRNLVRL 603
           LG+G FG V            G+ +AVK L R  GQ     +K E+ ++  L H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 604 LGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            GCC E   K   L+ EY+   SL     D      LN  +       I  G+ YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSL----RDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ- 126

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRVVGTYGYMSPEYAMD 720
               IHRDL A N+LLD +   KI DFG+A+ +  G +  +  +       + + E   +
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184

Query: 721 GLFSVKSDVFSFGVLLLETVS 741
             FS  SDV+SFGV L E ++
Sbjct: 185 NKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 88.2 bits (218), Expect = 6e-19
 Identities = 59/204 (28%), Positives = 108/204 (52%), Gaps = 16/204 (7%)

Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           +T + K+GQG  G VY    +  GQE+A+++++       E   NE+ ++ + ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLHQDS 661
            L   +  DE  +V EY+   SL  V+ +         + +   +C    + L +LH + 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHSN- 135

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSPEYAM 719
             ++IHRD+K+ NILL  + + K++DFG    F    T + +KR  +VGT  +M+PE   
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
              +  K D++S G++ +E + G+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 87.8 bits (217), Expect = 6e-19
 Identities = 60/197 (30%), Positives = 103/197 (52%), Gaps = 15/197 (7%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           +LG G FG VYK +  E G   A K +   S + +E++  E+ ++A   H  +V+LLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLHQDSRFRII 666
               +  ++ E+    ++D+++ +  R      + +  +IC  +   L YLH     +II
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHS---MKII 132

Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM-----DG 721
           HRDLKA N+LL  +   K++DFG++      +T Q     +GT  +M+PE  M     D 
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190

Query: 722 LFSVKSDVFSFGVLLLE 738
            +  K+D++S G+ L+E
Sbjct: 191 PYDYKADIWSLGITLIE 207

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 26/208 (12%)

Query: 543 NFTDYNKLGQGGFGIVY--KGRLLEGQEIAVKR--LSRNSGQGIEEFKNEVRLIAKLQHR 598
            +    K+G+G FG +Y  K +  + +   +K   L++   +  E  K EV L+AK++H 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSL-------DSVIFDKARSSILNWQRRFNIICGIA 651
           N+V       E     +V EY +   L         V+F +    IL+W         I+
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE--DQILSW------FVQIS 111

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
            GL ++H     +I+HRD+K+ NI L K  M  K+ DFG+AR    + + +     VGT 
Sbjct: 112 LGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTP 166

Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
            Y+SPE   +  ++ K+D++S G +L E
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYE 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 88.0 bits (218), Expect = 1e-18
 Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 35/211 (16%)

Query: 548 NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRNLVRLLG 605
           N++G G  G VYK      G+  A+K +  N    +  +   E+ ++  + H N+V+   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK--- 136

Query: 606 CCVEM----DEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            C +M     E  ++ E+M+  SL+   I D+   + +  Q    I+ GIA    YLH  
Sbjct: 137 -CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ----ILSGIA----YLH-- 185

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY--- 717
            R  I+HRD+K SN+L++     KI+DFG++RI    QT       VGT  YMSPE    
Sbjct: 186 -RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGTIAYMSPERINT 242

Query: 718 -----AMDGLFSVKSDVFSFGVLLLETVSGK 743
                A DG      D++S GV +LE   G+
Sbjct: 243 DLNHGAYDGY---AGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 69/227 (30%), Positives = 122/227 (53%), Gaps = 18/227 (7%)

Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVK--RLSRNSGQGIEEFK-NEVRLIAKLQHR 598
           NF    K+G+G +G+VYK R  L G+ +A+K  RL   + +G+      E+ L+ +L H 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHP 59

Query: 599 NLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
           N+V+LL   +  + K+ LV+E++ ++ L   + D +  S +      + +  + +GL + 
Sbjct: 60  NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFC 116

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     R++HRDLK  N+L++ E   K++DFG+AR F G      T  VV T  Y +PE 
Sbjct: 117 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEI 171

Query: 718 AMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
            +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 215

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 60/197 (30%), Positives = 103/197 (52%), Gaps = 15/197 (7%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAV-KRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           +LG G FG VYK +  E   +A  K +   S + +E++  E+ ++A   H N+V+LL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG-IARGLLYLHQDSRFRII 666
              +   ++ E+    ++D+V+ +  R      + +  ++C      L YLH++   +II
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHEN---KII 125

Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM-----DG 721
           HRDLKA NIL   +   K++DFG++      +T Q     +GT  +M+PE  M     D 
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183

Query: 722 LFSVKSDVFSFGVLLLE 738
            +  K+DV+S G+ L+E
Sbjct: 184 PYDYKADVWSLGITLIE 200

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 86.6 bits (214), Expect = 2e-18
 Identities = 57/200 (28%), Positives = 104/200 (52%), Gaps = 12/200 (6%)

Query: 546 DYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +Y K+G+G  GIV   R    G+++AVK +     Q  E   NEV ++   QH+N+V + 
Sbjct: 25  NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLHQDSRF 663
              +  +E  ++ E+++  +L  ++     S     + +   +C  + + L YLH     
Sbjct: 85  KSYLVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQG-- 137

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
            +IHRD+K+ +ILL  +   K+SDFG       D  ++  K +VGT  +M+PE      +
Sbjct: 138 -VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRTPY 194

Query: 724 SVKSDVFSFGVLLLETVSGK 743
             + D++S G++++E V G+
Sbjct: 195 GTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 75/277 (27%), Positives = 135/277 (48%), Gaps = 30/277 (10%)

Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS---RNSGQGIEEFKNEVRLIAKLQHR 598
           NF    K+G+G F  VY+   LL+G  +A+K++        +   +   E+ L+ +L H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVI--FDKARSSILN---WQRRFNIICGIARG 653
           N+++     +E +E  +V E  +   L  +I  F K +  I     W + F  +C     
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW-KYFVQLCSALE- 120

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
               H  SR R++HRD+K +N+ +      K+ D G+ R F    T  ++  +VGT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM 773
           SPE   +  ++ KSD++S G LL E  + +    FY   +++NL    + L K+ +  + 
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FY--GDKMNL----YSLCKKIEQCDY 225

Query: 774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASV 810
                D+Y + E+ + ++   +C+  + E+RP +  V
Sbjct: 226 PPLPSDHY-SEELRQLVN---MCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 64/246 (26%), Positives = 111/246 (45%), Gaps = 40/246 (16%)

Query: 548 NKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN--------------EVRLI 592
             LG+G +G V K    L G+ +A+K++                           E++++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR 652
            +++H N++ L+   VE D   LV + M +  L  V+  K R +     +   I+  I  
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTE---SQVKCILLQILN 130

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD-------------QT 699
           GL  LH+      +HRDL  +NI ++ +   KI+DFG+AR +G               + 
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 700 EQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
           E+ T +VV T  Y +PE  M    +    D++S G +  E ++GK     +   NE++ L
Sbjct: 188 EEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP---LFPGENEIDQL 243

Query: 759 GHVWRL 764
           G ++ L
Sbjct: 244 GRIFEL 249

Length = 335

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 18/205 (8%)

Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS---RNSGQGIEEFKNEVRLIAKLQHR 598
           NF    K+G+G F  VY+   LL+ + +A+K++        +  ++   E+ L+ +L H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVI--FDKARSSILN---WQRRFNIICGIARG 653
           N+++ L   +E +E  +V E  +   L  +I  F K +  I     W + F  +C     
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW-KYFVQLCSAVE- 120

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
               H  SR R++HRD+K +N+ +      K+ D G+ R F    T  ++  +VGT  YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173

Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLE 738
           SPE   +  ++ KSD++S G LL E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYE 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 23/203 (11%)

Query: 549 KLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRNLVRLLGC 606
           ++G+G FG V+ GRL  +   +AVK         ++ +F  E R++ +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
           C +     +V E ++    D + F +     L  +    ++   A G+ YL        I
Sbjct: 62  CTQKQPIYIVMELVQGG--DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM--------SPEYA 718
           HRDL A N L+ ++   KISDFGM+R        +    V  + G M        +PE  
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR--------EEEDGVYASTGGMKQIPVKWTAPEAL 168

Query: 719 MDGLFSVKSDVFSFGVLLLETVS 741
             G +S +SDV+SFG+LL E  S
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 85.1 bits (210), Expect = 4e-18
 Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 18/205 (8%)

Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCV 608
           +G G +G VYKGR ++  ++A  ++   +G   EE K E+ ++ K   HRN+    G  +
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 609 E-----MDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           +     MD+++ LV E+    S+  +I    + + L  +    I   I RGL +LHQ   
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM--- 719
            ++IHRD+K  N+LL +    K+ DFG++     D+T       +GT  +M+PE      
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 187

Query: 720 --DGLFSVKSDVFSFGVLLLETVSG 742
             D  +  KSD++S G+  +E   G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 86.1 bits (214), Expect = 4e-18
 Identities = 72/214 (33%), Positives = 114/214 (53%), Gaps = 34/214 (15%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEI-AVKRLS---RNSGQGIEEFKNEVRLIAKL-QHRNLVR 602
            KLG+G +GIV+K      +E+ A+K++    RN+      F+ E+  + +L  H N+V+
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVK 71

Query: 603 LLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSIL-NWQRRFNIICGIARGLLYLHQ 659
           LL      ++K   LV+EYME   L +VI    R++IL +  +R+ I+  + + L Y+H 
Sbjct: 72  LLNVIKAENDKDIYLVFEYMET-DLHAVI----RANILEDVHKRY-IMYQLLKALKYIH- 124

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR-----VVGTYGYMS 714
            S   +IHRDLK SNILL+ +   K++DFG+AR     + E+N +       V T  Y +
Sbjct: 125 -SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLTDYVATRWYRA 180

Query: 715 PEYAMDGLFSVKS-----DVFSFGVLLLETVSGK 743
           PE     L          D++S G +L E + GK
Sbjct: 181 PEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 86.0 bits (213), Expect = 5e-18
 Identities = 68/225 (30%), Positives = 106/225 (47%), Gaps = 38/225 (16%)

Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN----- 587
           F T+   T+ + D   +G G FG+V   R  L GQ +A+K++       ++ F       
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAK 54

Query: 588 ----EVRLIAKLQHRNLVRLLGCCVEMDEKM-LVYEYME---NRSLDSVIFDKARSSILN 639
               E++L+  L+H N++ L    +   E +  V E +    +R L S   +K       
Sbjct: 55  RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFL 114

Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
           +Q        I RGL Y+H      ++HRDLK SNIL+++    KI DFG+ARI    Q 
Sbjct: 115 YQ--------ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QD 159

Query: 700 EQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGK 743
            Q T  V   Y Y +PE  +    + V+ D++S G +  E + GK
Sbjct: 160 PQMTGYVSTRY-YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 85.2 bits (211), Expect = 5e-18
 Identities = 70/244 (28%), Positives = 126/244 (51%), Gaps = 32/244 (13%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS-RNSGQG--IEEFKNEVRLIAK 594
           R  D F    ++G+G +G VYK R    G+ +A+K++   N  +G  I   + E++++ +
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQ 62

Query: 595 LQHRNLVRLLGCCVE----MDEK------MLVYEYMENR---SLDSVIFDKARSSILNWQ 641
           L HRN+V L     +    +D K       LV+EYM++     L+S +   +   I ++ 
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122

Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
           ++      +  GL Y H+ +    +HRD+K SNILL+ +   K++DFG+AR++  +++  
Sbjct: 123 KQ------LLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173

Query: 702 NTKRVVGTYGYMSPEYAM-DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGH 760
            T +V+ T  Y  PE  + +  +    DV+S G +L E  +    +  + +N EL  L  
Sbjct: 174 YTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT---KKPIFQANQELAQLEL 229

Query: 761 VWRL 764
           + RL
Sbjct: 230 ISRL 233

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 85.0 bits (211), Expect = 6e-18
 Identities = 65/212 (30%), Positives = 114/212 (53%), Gaps = 16/212 (7%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL---SRNSGQGIEEFKNEVRLIAK 594
           R+ D +   N++ +G +G+VY+ R  +  EI A+K+L       G  I   + E+ ++ K
Sbjct: 2   RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLK 60

Query: 595 LQHRNLVRLLGCCV--EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR 652
           LQH N+V +    V   +D+  +V EY+E+  L S++ +  +   L  + +  ++  +  
Sbjct: 61  LQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLM-ETMKQPFLQSEVKC-LMLQLLS 117

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           G+ +LH +    I+HRDLK SN+LL+     KI DFG+AR + G   +  T+ VV T  Y
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVV-TLWY 172

Query: 713 MSPEYAMD-GLFSVKSDVFSFGVLLLETVSGK 743
            +PE  +    +S   D++S G +  E ++ K
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 84.9 bits (210), Expect = 7e-18
 Identities = 70/233 (30%), Positives = 121/233 (51%), Gaps = 25/233 (10%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLS-RNSGQGIEEFK-NEVRLIAKLQHR 598
           D +    K+G+G +G+VYK R     E IA+K++      +G+      E+ L+ ++QH 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 599 NLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNII----CGIARG 653
           N+VRL    V  ++++ LV+EY++   LD     K   S  ++ +   +I      I RG
Sbjct: 62  NIVRLQDV-VHSEKRLYLVFEYLD---LD---LKKHMDSSPDFAKNPRLIKTYLYQILRG 114

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           + Y H     R++HRDLK  N+L+D+     K++DFG+AR F G      T  VV T  Y
Sbjct: 115 IAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWY 169

Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            +PE  +    +S   D++S G +  E V+    +  +  ++E++ L  ++R+
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVN---QKPLFPGDSEIDELFKIFRI 219

Length = 294

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 84.7 bits (209), Expect = 8e-18
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 17/205 (8%)

Query: 542 DNFTDYNKLGQGGFGIV-YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           D+F    K+G+G  GIV        G+++AVK++     Q  E   NEV ++    H N+
Sbjct: 25  DSFI---KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV 81

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V +    +  DE  +V E++E  +L  ++      + +N ++   +   + R L YLH  
Sbjct: 82  VDMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQ 137

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSPEYA 718
               +IHRD+K+ +ILL  +   K+SDFG    F    +++  KR  +VGT  +M+PE  
Sbjct: 138 G---VIHRDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKSLVGTPYWMAPEVI 190

Query: 719 MDGLFSVKSDVFSFGVLLLETVSGK 743
               +  + D++S G++++E + G+
Sbjct: 191 SRLPYGTEVDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 85.0 bits (210), Expect = 9e-18
 Identities = 65/218 (29%), Positives = 116/218 (53%), Gaps = 27/218 (12%)

Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 591 LIAKLQHRNLVRLLGCC----VEMDEKMLVYEYMENRSLDSVIFDKAR---SSILNWQRR 643
           ++A + + ++ RLLG C    V++  +++ +  +    LD V   K       +LNW   
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCL----LDYVREHKDNIGSQYLLNW--- 114

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
                 IA+G+ YL +    R++HRDL A N+L+      KI+DFG+A++ G D+ E + 
Sbjct: 115 ---CVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA 168

Query: 704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
           +       +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 9e-18
 Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 49/198 (24%)

Query: 549 KLGQGGFGIVYKGRLLE---GQEIAVKRL--SRNSGQGIEEFK-NEVRLIAKLQHRNLVR 602
            +G+G +G VYK +      G+E A+K+    +    GI +    E+ L+ +L+H N+V 
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 603 LLGCCVEMDEKM--LVYEYME---------NRSLDSV-IFDKARSSILNWQRRFNIICGI 650
           L+   +E  +K   L+++Y E         +R    V I      S+L WQ    I+ G+
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL-WQ----ILNGV 121

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIF--------GGDQ 698
                YLH +    ++HRDLK +NIL+  E       KI D G+AR+F          D 
Sbjct: 122 H----YLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD- 173

Query: 699 TEQNTKRVVGTYGYMSPE 716
                  VV T  Y +PE
Sbjct: 174 ------PVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 65/251 (25%), Positives = 123/251 (49%), Gaps = 25/251 (9%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLV 601
           FT   ++G+G FG V+KG     Q++ A+K +     +  IE+ + E+ ++++     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +  G  ++  +  ++ EY+   S      D  R+   +  +   ++  I +GL YLH + 
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
           +   IHRD+KA+N+LL ++   K++DFG+A      Q ++NT   VGT  +M+PE     
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 176

Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYH---------SNNELNLLGHVWRLWKEGKVLE 772
            +  K+D++S G+  +E   G+      H          NN   L G   + +K     E
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFK-----E 231

Query: 773 MVDSSVDNYPA 783
            +D+ ++  P+
Sbjct: 232 FIDACLNKDPS 242

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 21/204 (10%)

Query: 549 KLGQGGFG--IVYKGRLLEGQEIAVKRL--SRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           K+G+G FG  I+ K +  +G++  +K +  S+ S +  EE + EV +++ ++H N+V+  
Sbjct: 7   KIGEGSFGKAILVKSKE-DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDK-----ARSSILNWQRRFNIICGIARGLLYLHQ 659
               E     +V +Y E   L   I  +         IL+W   F  IC     L ++H 
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW---FVQIC---LALKHVHD 119

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
               +I+HRD+K+ NI L K+ T K+ DFG+AR+   + T +  +  +GT  Y+SPE   
Sbjct: 120 R---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPYYLSPEICE 174

Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
           +  ++ KSD+++ G +L E  + K
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 21/209 (10%)

Query: 544 FTDYNKLGQGGFGIV------YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           F  Y  LG+GGFG V        G++   +++  KR+ +  G+ +    NE +++ K+  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF---NIICGIARGL 654
           R +V L       D   LV   M    L   I+    +     +  F    I CG    L
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----L 115

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
             LHQ+   RI++RDLK  NILLD     +ISD G+A      QT    K  VGT GYM+
Sbjct: 116 EDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMA 169

Query: 715 PEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           PE   +  ++   D ++ G LL E ++G+
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 83.4 bits (206), Expect = 2e-17
 Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 26/217 (11%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSR--NSGQGIEEFKNEVRLIAKLQH 597
           FT    LG+G FG V + +L       Q++AVK L     S   IEEF  E   + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 598 RNLVRLLGCCVEMDEK------MLVYEYMENRSLDSVIFDKARSSI------LNWQRRFN 645
            N+++L+G  +    K      M++  +M++  L + +     S I      L  Q    
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL---MSRIGEEPFTLPLQTLVR 117

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK 704
            +  IA G+ YL   S    IHRDL A N +L++ MT  ++DFG+++ I+ GD   Q   
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174

Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
             +    +++ E   D +++  SDV++FGV + E ++
Sbjct: 175 SKLPV-KWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 83.9 bits (207), Expect = 2e-17
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 28/212 (13%)

Query: 550 LGQGGFGIVYKGRLLEG---QEIAVKRLSRNSGQGIE-EFKNEVRLIAKL-QHRNLVRLL 604
           +G+G FG V K R+ +     + A+KR+   + +    +F  E+ ++ KL  H N++ LL
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 605 GCCVEMDEKMLVYEYM----------ENRSLDS---VIFDKARSSILNWQRRFNIICGIA 651
           G C       L  EY           ++R L++        + +S L+ Q+  +    +A
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG 711
           RG+ YL Q    + IHRDL A NIL+ +    KI+DFG++R       E   K+ +G   
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLP 186

Query: 712 --YMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
             +M+ E     +++  SDV+S+GVLL E VS
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 83.9 bits (207), Expect = 2e-17
 Identities = 66/207 (31%), Positives = 100/207 (48%), Gaps = 19/207 (9%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN---EVRLIAKLQHRN 599
           F   +++G G FG VY        E+ AVK++S +  Q  E++++   EV+ + +L+H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
            +   GC ++     LV EY    + D +   +     L       I  G  +GL YLH 
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE--Y 717
            +   +IHRD+KA NILL +    K++DFG A               VGT  +M+PE   
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAPEVIL 190

Query: 718 AMD-GLFSVKSDVFSFGVLLLETVSGK 743
           AMD G +  K DV+S G+  +E    K
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERK 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 83.5 bits (206), Expect = 2e-17
 Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 15/204 (7%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           DNF    K+G+G  GIV    +   G+ +AVK++     Q  E   NEV ++   QH N+
Sbjct: 23  DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V +    +  DE  +V E++E  +L  ++      + +N ++   +   + + L  LH  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLKALSVLHAQ 135

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGM-ARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
               +IHRD+K+ +ILL  +   K+SDFG  A++    +     K +VGT  +M+PE   
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPELIS 189

Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
              +  + D++S G++++E V G+
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 83.4 bits (206), Expect = 2e-17
 Identities = 72/224 (32%), Positives = 102/224 (45%), Gaps = 33/224 (14%)

Query: 550 LGQGGFGIVY------KGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+GGFG V        G+L   +++  KRL +   +G E    E R++AK+  R +V L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVI---------FDKARSSILNWQRRFNIICGIARGL 654
                   +  LV   M    L   I         F + R+     Q    II G    L
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ----IISG----L 110

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
            +LHQ    RII+RDLK  N+LLD +   +ISD G+A      Q++  TK   GT G+M+
Sbjct: 111 EHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMA 165

Query: 715 PEYAMDGLFSVKSDVFSFGVLLLETVSGK---KNRGFYHSNNEL 755
           PE      +    D F+ GV L E ++ +   + RG    N EL
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 209

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 26/205 (12%)

Query: 550 LGQGGFGIVYKGRLLEGQE-----IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG G FG VYKG  +   E     +A+K L  N S +  +E  +E  ++A +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 604 LGCC----VEMDEKMLVYEYMENRSLDSVIFDKAR---SSILNWQRRFNIICGIARGLLY 656
           LG C    V++  +++ Y  +    LD V  +K R     +LNW         IA+G+ Y
Sbjct: 75  LGICLTSTVQLVTQLMPYGCL----LDYVRENKDRIGSQDLLNW------CVQIAKGMSY 124

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           L +    R++HRDL A N+L+      KI+DFG+AR+   D+TE +         +M+ E
Sbjct: 125 LEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVS 741
             +   F+ +SDV+S+GV + E ++
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 82.7 bits (204), Expect = 3e-17
 Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 550 LGQGGFGIVYKGRLL-EGQEI----AVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRL 603
           LG G FG V+KG  + EG  I    A+K +   SG Q  +E  + +  +  L H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           LG C       LV +     SL   +  +     L+ QR  N    IA+G+ YL +    
Sbjct: 75  LGIC-PGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           R++HR+L A NILL  +   +I+DFG+A +   D  +           +M+ E  + G +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188

Query: 724 SVKSDVFSFGVLLLETVS 741
           + +SDV+S+GV + E +S
Sbjct: 189 THQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 83.2 bits (206), Expect = 3e-17
 Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 35/196 (17%)

Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKR-LSRNSGQG--IEEFKNEVRLIAKLQH 597
             +    K+GQG FG V+K R     Q +A+K+ L  N  +G  I   + E++++  L+H
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLLKH 70

Query: 598 RNLVRLLGCCVEMDEK--------MLVYEYMENRSLDSVIFDKARSSILNWQRRFN---- 645
            N+V L+  C               LV+E+ E+        D A   + N   +F     
Sbjct: 71  ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH--------DLAGL-LSNKNVKFTLSEI 121

Query: 646 --IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG---GDQTE 700
             ++  +  GL Y+H   R +I+HRD+KA+NIL+ K+   K++DFG+AR F      +  
Sbjct: 122 KKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN 178

Query: 701 QNTKRVVGTYGYMSPE 716
           + T RVV T  Y  PE
Sbjct: 179 RYTNRVV-TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 19/201 (9%)

Query: 550 LGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEE-FKNEVRLIAKLQHRNLVRLLG 605
           LG GGFG V   ++  + +  A+K + +      G +E   +E  ++ +  H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 606 CCVEMDEK---MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
                D+K   ML+ EY     L +++ D+       +  RF I C +     YLH    
Sbjct: 60  -RTFKDKKYIYMLM-EYCLGGELWTILRDRGLFD--EYTARFYIAC-VVLAFEYLHNRG- 113

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             II+RDLK  N+LLD     K+ DFG A+        Q T    GT  Y++PE  ++  
Sbjct: 114 --IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS---GQKTWTFCGTPEYVAPEIILNKG 168

Query: 723 FSVKSDVFSFGVLLLETVSGK 743
           +    D +S G+LL E ++G+
Sbjct: 169 YDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 81.9 bits (202), Expect = 4e-17
 Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 39/280 (13%)

Query: 549 KLGQGGFGIVYKG--RLLEGQE-IAVKRLSRNSGQGI--EEFKNEVRLIAKLQHRNLVRL 603
           +LG G FG V KG  ++ + ++ +AVK L  ++      +E   E  ++ +L +  +VR+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G C E +  MLV E  E   L+  +    ++  +  +    ++  ++ G+ YL + +  
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG-----YMSPEYA 718
             +HRDL A N+LL  +   KISDFG+++  G D+     K    T+G     + +PE  
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK----THGKWPVKWYAPECM 170

Query: 719 MDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
               FS KSDV+SFGVL+ E  S G+K                 ++  K  +V +M++S 
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKP----------------YKGMKGNEVTQMIESG 214

Query: 778 VD-NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS 816
                P         +  LC     +ERP  A V L L +
Sbjct: 215 ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 82.4 bits (203), Expect = 4e-17
 Identities = 62/219 (28%), Positives = 109/219 (49%), Gaps = 15/219 (6%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLV 601
           FT   K+G+G FG V+KG     Q++ A+K +     +  IE+ + E+ ++++     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +  G  ++  +  ++ EY+   S      D      L+  +   I+  I +GL YLH + 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSPEYAM 719
           +   IHRD+KA+N+LL +    K++DFG+A    G  T+   KR   VGT  +M+PE   
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAPEVIK 174

Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
              +  K+D++S G+  +E   G+      H    L L+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 82.5 bits (204), Expect = 4e-17
 Identities = 63/221 (28%), Positives = 112/221 (50%), Gaps = 23/221 (10%)

Query: 536 TIVRATDNFTDYNKLGQGGFGIVYKGRLLEG-----QEIAVKRLSRNSGQ-GIEEFKNEV 589
            I R  D  T  + L +G FG ++ G L++      +E+ VK +  ++ +  +     E 
Sbjct: 2   AISR--DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQES 59

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEK-MLVYEYMENRSL-----DSVIFDKARSSILNWQRR 643
            L+  L H+N++ +L  C+E  E   ++Y YM   +L        + +      L+ Q+ 
Sbjct: 60  CLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL 119

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQ--TE 700
            ++   IA G+ YLH   +  +IH+D+ A N ++D+E+  KI+D  ++R +F  D     
Sbjct: 120 VHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176

Query: 701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            N  R V    +M+ E  ++  +S  SDV+SFGVLL E ++
Sbjct: 177 DNENRPVK---WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 82.5 bits (204), Expect = 4e-17
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 18/197 (9%)

Query: 549 KLGQGGFGIVYKGRLLEGQEI-AVKRLS-RNSGQGIEEFK-NEVRLIAKLQHRNLVRLLG 605
           K+G+G +G V+K +  E  EI A+KR+   +  +G+      E+ L+ +L+H+N+VRL  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 606 CCVEMDEKMLVYEYMEN---RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
                 +  LV+EY +    +  DS   D     +    + F  +  + +GL + H    
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIV----KSF--MFQLLKGLAFCHSH-- 118

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG- 721
             ++HRDLK  N+L++K    K++DFG+AR F G      +  VV T  Y  P+      
Sbjct: 119 -NVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFGAK 175

Query: 722 LFSVKSDVFSFGVLLLE 738
           L+S   D++S G +  E
Sbjct: 176 LYSTSIDMWSAGCIFAE 192

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 82.8 bits (205), Expect = 4e-17
 Identities = 69/206 (33%), Positives = 94/206 (45%), Gaps = 27/206 (13%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSR---NSGQGIEEFKNEVRLIAKL-QHRNLVRLL 604
           LG+G FG V    L    E+ AVK L +        +E    E R++A   +H  L +L 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 605 GCCVEMDEKMLVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
            C    D    V EY+    L      S  FD+ R+       RF     I  GL +LH+
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA-------RFYAAE-IVLGLQFLHE 114

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGTYGYMSPEY 717
                II+RDLK  N+LLD E   KI+DFGM +  I GG      T    GT  Y++PE 
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFCGTPDYIAPEI 167

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGK 743
                +    D ++ GVLL E ++G+
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN----EVRLIAKLQHRNLVRL 603
            +G+G +G+V K R    G+ +A+K+   +     E+ K     EV+++ +L+H N+V L
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNL 65

Query: 604 LGCCVEMDEKMLVYEYMENRSLD-------SVIFDKARSSILNWQRRFNIICGIARGLLY 656
                      LV+EY+E   L+        +  D  RS I  WQ        + + + Y
Sbjct: 66  KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYI--WQ--------LLQAIAY 115

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
            H      IIHRD+K  NIL+ +    K+ DFG AR     +        V T  Y +PE
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRA-RPASPLTDYVATRWYRAPE 171

Query: 717 YAM-DGLFSVKSDVFSFGVLLLETVSG 742
             + D  +    DV++ G ++ E + G
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 82.0 bits (202), Expect = 5e-17
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 23/209 (11%)

Query: 550 LGQGGFGIVYKGRLLEGQEI---AVK--RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           LG+G FG V +G+L +   I   AVK  +++  +   +E+F +E   + +  H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 605 GCCVEMDEK------MLVYEYMENRSLDSVIFDKA---RSSILNWQRRFNIICGIARGLL 655
           G C++  E       +++  +M++  L S +           L  Q     +  IA G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA-RIFGGDQTEQN--TKRVVGTYGY 712
           YL   S    IHRDL A N +L++ M   ++DFG++ +I+ GD   Q    K  V    +
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV---KW 180

Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
           ++ E   D +++ KSDV+SFGV + E  +
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 81.7 bits (202), Expect = 6e-17
 Identities = 60/219 (27%), Positives = 113/219 (51%), Gaps = 15/219 (6%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKR-LSRNSGQGIEEFK-NEVRLIAKLQHRNLVRLLG 605
            +G+G +G+V K +  E GQ +A+K+ L     + +++    E+R++ +L+H NLV L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
                    LV+E++++  LD +   +   + L+  R    +  I RG+ + H  +   I
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSHN---I 121

Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM-DGLFS 724
           IHRD+K  NIL+ +    K+ DFG AR       E  T   V T  Y +PE  + D  + 
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD-YVATRWYRAPELLVGDTKYG 179

Query: 725 VKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
              D+++ G L+ E ++G+     +  +++++ L H+ +
Sbjct: 180 RAVDIWAVGCLVTEMLTGEP---LFPGDSDIDQLYHIIK 215

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 82.5 bits (204), Expect = 1e-16
 Identities = 69/212 (32%), Positives = 101/212 (47%), Gaps = 39/212 (18%)

Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN---------EVRLIAKLQHRN 599
           +G G  GIV      + GQ +A+K+LSR        F+N         E+ L+  + H+N
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLSR-------PFQNVTHAKRAYRELVLMKLVNHKN 76

Query: 600 LVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGIA 651
           ++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI 
Sbjct: 77  IIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQ----MLCGIK 132

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG 711
               +LH      IIHRDLK SNI++  + T KI DFG+AR  G       T  VV  Y 
Sbjct: 133 ----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY- 182

Query: 712 YMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           Y +PE  +   +    D++S G ++ E + G 
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 81.2 bits (200), Expect = 1e-16
 Identities = 65/227 (28%), Positives = 114/227 (50%), Gaps = 22/227 (9%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQ-GIE-EFKNEVRLIAKLQ---HRNLVR 602
           ++G G +G VYK R    G  +A+K +   + + G+      EV L+ +L+   H N+VR
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 603 LLGCCVEM--DEKM---LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
           L+  C     D +    LV+E+++ + L + + DK     L  +   +++    RGL +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVD-QDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H +    I+HRDLK  NIL+      K++DFG+ARI+     +     VV T  Y +PE 
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            +   ++   D++S G +  E     + +  +  N+E + LG ++ L
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMF---RRKPLFCGNSEADQLGKIFDL 222

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 46/128 (35%), Positives = 66/128 (51%), Gaps = 13/128 (10%)

Query: 618 EYMENRSLDSVI--FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNI 675
           E+M+  SLD +          IL       I   +  GL YL+  +  RI+HRD+K SNI
Sbjct: 83  EFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY--NVHRIMHRDIKPSNI 135

Query: 676 LLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVL 735
           L++     K+ DFG++    G+         VGT  YMSPE    G ++VKSDV+S G+ 
Sbjct: 136 LVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGIS 191

Query: 736 LLETVSGK 743
           ++E   GK
Sbjct: 192 IIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 62/201 (30%), Positives = 103/201 (51%), Gaps = 14/201 (6%)

Query: 550 LGQGGFGIVYKGRL-----LEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+G FG V   R        G+++AVK L   + G  I + K E+ ++  L H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 604 LGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            G C E       L+ E++ + SL   +  + ++ I N +++      I +G+ YL   S
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKI-NLKQQLKYAVQICKGMDYL--GS 127

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-YGYMSPEYAMD 720
           R + +HRDL A N+L++ E   KI DFG+ +    D+     K  + +   + +PE  + 
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 721 GLFSVKSDVFSFGVLLLETVS 741
             F + SDV+SFGV L E ++
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 15/203 (7%)

Query: 550 LGQGGFGIVY------KGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LGQG FG VY       GR L  +++     S  + + +   + E++L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 604 LGCCVEMDEKMLV--YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            GC  +  EK L    EYM   S+   +  KA  ++     R      I  G+ YLH + 
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTR-KYTRQILEGMSYLHSN- 125

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMA-RIFGGDQTEQNTKRVVGTYGYMSPEYAMD 720
              I+HRD+K +NIL D     K+ DFG + R+     +    + V GT  +MSPE    
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183

Query: 721 GLFSVKSDVFSFGVLLLETVSGK 743
             +  K+DV+S G  ++E ++ K
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 80.4 bits (198), Expect = 2e-16
 Identities = 58/226 (25%), Positives = 114/226 (50%), Gaps = 23/226 (10%)

Query: 549 KLGQGGFGIVYKGRLLE--GQEIAVKRL---SRNSGQGIEEFKNE--VRLIAKLQHRNLV 601
           ++G+G +G V+K R L+  G+ +A+KR+   +   G  +   +    +R +   +H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 602 RLLGCCV----EMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           RL   C     + + K+ LV+E+++     +   DK     +  +   +++  + RGL +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQDL--TTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           LH     R++HRDLK  NIL+      K++DFG+ARI+     +     VV T  Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVW 762
             +   ++   D++S G +  E     + +  +  +++++ LG + 
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSDVDQLGKIL 222

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 83.7 bits (207), Expect = 2e-16
 Identities = 72/280 (25%), Positives = 131/280 (46%), Gaps = 30/280 (10%)

Query: 545 TDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
            + N + +G  G  YKG+ ++ G +  VK +  N    I    +E+  + KLQH N+V+L
Sbjct: 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEI--NDVNSIPS--SEIADMGKLQHPNIVKL 748

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G C       L++EY+E ++L  V+        L+W+RR  I  GIA+ L +LH     
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKIAIGIAKALRFLHCRCSP 802

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
            ++  +L    I++D +  P +    +  +   D           +  Y++PE       
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKC------FISSAYVAPETRETKDI 855

Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV--W-RLWKEGKVLEM-VDSSVD 779
           + KSD++ FG++L+E ++GK       ++ E  + G +  W R       L+M +D S+ 
Sbjct: 856 TEKSDIYGFGLILIELLTGKSP-----ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR 910

Query: 780 NYPA---NEVLRCIHVGLLCVQENAEERPTMASVVLMLSS 816
              +   NE++  +++ L C   +   RP    V+  L S
Sbjct: 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950

Length = 968

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 14/203 (6%)

Query: 549 KLGQGGFGIVYKG--RLLEGQ-EIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +LG G FG V KG  ++ + Q ++A+K L   + + + +E   E  ++ +L +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G C E +  MLV E      L+   F   +   +       ++  ++ G+ YL   +   
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNK--FLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGL 722
            +HRDL A N+LL  +   KISDFG+++  G D +     R  G +   + +PE      
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECINFRK 174

Query: 723 FSVKSDVFSFGVLLLETVS-GKK 744
           FS +SDV+S+G+ + E  S G+K
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 32/211 (15%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQG---IEEFKNEVRLIAKLQHRNLVRLLG 605
           + +G +G V+  +    G   A+K + +        +++   E  ++++ Q   +V+L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 606 CCVEMDEKM-LVYEYMENRSLDSVI-----FDK--ARSSILNWQRRFNIICGIARGLLYL 657
              +  + + LV EY+    L S++      D+  AR            I  I   L YL
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR----------IYIAEIVLALEYL 109

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFG------MARIFGGDQTEQNTKRVVGTYG 711
           H      IIHRDLK  NIL+D     K++DFG      + R    +  E+  KR+VGT  
Sbjct: 110 HS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 712 YMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           Y++PE  +    S   D +S G +L E + G
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 28/206 (13%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-------EVRLIAKLQHRNL 600
           K+G+G +G+V+K R  E GQ +A+K+   +     E+          E+R++ +L+H NL
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V L+       +  LV+EY ++  L+ +   +     +       II    + + + H+ 
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF---GGDQTEQNTKRVVGTYGYMSPEY 717
           +    IHRD+K  NIL+ K+   K+ DFG ARI    G D T+      V T  Y +PE 
Sbjct: 120 N---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD-----YVATRWYRAPEL 171

Query: 718 AM-DGLFSVKSDVFSFGVLLLETVSG 742
            + D  +    DV++ G +  E ++G
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 80.4 bits (199), Expect = 4e-16
 Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 27/222 (12%)

Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN---EV 589
            +T+    D + + + +G G +G V      + G+++A+K+LSR   Q     K    E+
Sbjct: 7   NKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR-PFQSAIHAKRTYREL 65

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKM------LVYEYMENRSLDSVIFDKARSSILNWQR- 642
           RL+  + H N++ LL                LV   M    L++++    +   L+    
Sbjct: 66  RLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIV----KCQKLSDDHI 120

Query: 643 RFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN 702
           +F ++  I RGL Y+H      IIHRDLK SNI ++++   KI DFG+AR      T+  
Sbjct: 121 QF-LVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDE 171

Query: 703 TKRVVGTYGYMSPEYAMDGLFSVKS-DVFSFGVLLLETVSGK 743
               V T  Y +PE  ++ +   ++ D++S G ++ E ++GK
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.9 bits (194), Expect = 5e-16
 Identities = 66/204 (32%), Positives = 107/204 (52%), Gaps = 17/204 (8%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRL-----SRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+G FG VY     + G+E+AVK++     S+ + + +   + E++L+  L+H  +V+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 604 LGCCVEMDEKML--VYEYMENRSLDSVIFDKARSSIL-NWQRRFNIICGIARGLLYLHQD 660
            GC  + +EK L    EYM   S+   +  KA  ++  N  RR+     I +G+ YLH +
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTR--QILQGVSYLHSN 125

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMA-RIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
               I+HRD+K +NIL D     K+ DFG + RI     +    K V GT  +MSPE   
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182

Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
              +  K+DV+S    ++E ++ K
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 6e-16
 Identities = 57/221 (25%), Positives = 105/221 (47%), Gaps = 37/221 (16%)

Query: 542 DNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN---------EVRL 591
             + + + +G+G +G+V        G ++A+K+        I  F++         E+++
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--------ISPFEHQTFCQRTLREIKI 56

Query: 592 IAKLQHRNLVRLL-----GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
           + + +H N++ +L           ++  +V E ME   L  +I    ++  L+       
Sbjct: 57  LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLI----KTQHLSNDHIQYF 111

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
           +  I RGL Y+H  +   ++HRDLK SN+LL+     KI DFG+ARI   D    +T  +
Sbjct: 112 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFL 166

Query: 707 ---VGTYGYMSPEYAMDGLFSVKS-DVFSFGVLLLETVSGK 743
              V T  Y +PE  ++     K+ D++S G +L E +S +
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 79.2 bits (195), Expect = 7e-16
 Identities = 66/222 (29%), Positives = 110/222 (49%), Gaps = 30/222 (13%)

Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRN-SGQGIEEFKNEVRLI 592
           D       LG+G FG V         K R  +   +AVK L  N + + + +  +E+ L+
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 593 AKL-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI-----------FDKARSS--IL 638
             + +H+N++ LLG C +     ++ EY    +L   +           FD  +     L
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 639 NWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           +++   +    +ARG+ YL  +SR R IHRDL A N+L+ ++   KI+DFG+AR  G   
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR--GVHD 186

Query: 699 TEQNTKRVVGTY--GYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
            +   K   G     +M+PE   D +++ +SDV+SFG+L+ E
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWE 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 78.6 bits (194), Expect = 7e-16
 Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 42/224 (18%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRL-SRNSGQGIEEFKNEVRLIAKLQH-R 598
           ++  D  ++G+G FG V K      G  +AVKR+ S    +  +    ++ ++ +     
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63

Query: 599 NLVRLLG-------C--CVE-MD---EK--MLVYEYMENRSLDSVIFDKARSSILNWQRR 643
            +V+  G       C  C+E MD   +K    VYE +    +   I  K           
Sbjct: 64  YIVKFYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGK----------- 111

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
             I     + L YL ++   +IIHRD+K SNILLD+    K+ DFG   I G        
Sbjct: 112 --IAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAK 164

Query: 704 KRVVGTYGYMSPE----YAMDGLFSVKSDVFSFGVLLLETVSGK 743
            R  G   YM+PE     A DG + V+SDV+S G+ L E  +GK
Sbjct: 165 TRDAGCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 78.9 bits (194), Expect = 8e-16
 Identities = 64/234 (27%), Positives = 111/234 (47%), Gaps = 31/234 (13%)

Query: 528 ELPLFDFETIVRATDNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSG 579
           E P ++F     + D  T    LG+G FG V         K +  E   +AVK L  ++ 
Sbjct: 6   EDPRWEF-----SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT 60

Query: 580 Q-GIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI-------- 629
           +  + +  +E+ ++  + +H+N++ LLG C +     ++ EY    +L   +        
Sbjct: 61  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 120

Query: 630 ---FDKARSS--ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK 684
              +D AR     + ++   +    +ARG+ YL      + IHRDL A N+L+ +    K
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 177

Query: 685 ISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
           I+DFG+AR        + T        +M+PE   D +++ +SDV+SFGVL+ E
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 22/205 (10%)

Query: 550 LGQGGFGIVYKGR---LLEGQ---EIAVKRL---SRNSGQGIEEFKNEVRLIAKL-QHRN 599
           LG G FG V +     L +     ++AVK L   + +S +  E   +E+++++ L  H N
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSELKIMSHLGNHEN 100

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V LLG C      +++ EY     L + +  K R S L  +   +    +A+G+ +L  
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLAS 159

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ---TEQNTKRVVGTYGYMSPE 716
            +    IHRDL A N+LL      KI DFG+AR    D     + N +  V    +M+PE
Sbjct: 160 KN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV---KWMAPE 213

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVS 741
              + +++ +SDV+S+G+LL E  S
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 23/207 (11%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRL-----SRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LGQG FG VY     + G+E+AVK++     S  + + +   + E++L+  L H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 604 LGCCVEMDEKML--VYEYMENRSLDSVIFDKARSSIL-NWQRRFNIICGIARGLLYLHQD 660
            GC  +  E+ L    E+M   S+   +  K+  ++  N  R++     I  G+ YLH +
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTR--QILEGVSYLHSN 125

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT----EQNTKRVVGTYGYMSPE 716
               I+HRD+K +NIL D     K+ DFG ++     QT        K V GT  +MSPE
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRL---QTICLSGTGMKSVTGTPYWMSPE 179

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGK 743
                 +  K+D++S G  ++E ++ K
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 78.3 bits (193), Expect = 2e-15
 Identities = 55/222 (24%), Positives = 106/222 (47%), Gaps = 34/222 (15%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           + D   LG G  G+V+     +  + +AVK++     Q ++    E+++I +L H N+V+
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 603 L--------------LGCCVEMDEKMLVYEYMEN---RSLDSVIFDKARSSILNWQRRFN 645
           +              +G   E++   +V EYME      L+     +  + +  +Q    
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ---- 122

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTEQN-- 702
               + RGL Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+ARI     + +   
Sbjct: 123 ----LLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYL 175

Query: 703 TKRVVGTYGYMSPEYAMDGLFSVKS-DVFSFGVLLLETVSGK 743
           ++ +V  + Y SP   +      K+ D+++ G +  E ++GK
Sbjct: 176 SEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 31/214 (14%)

Query: 544 FTDYNKLGQGGFGIV------YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           F  Y  LG+GGFG V        G++   +++  KR+ +  G+ +    NE +++ K+  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI-------FDKARSSILNWQRRFNIICGI 650
           R +V L       D   LV   M    L   I       FD+ R+     +    I CG 
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE----ITCG- 114

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA-RIFGGDQTEQNTKRVVGT 709
              L  LH   R RI++RDLK  NILLD     +ISD G+A  I  G    +  +  VGT
Sbjct: 115 ---LEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG----ETIRGRVGT 164

Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            GYM+PE   +  ++   D +  G L+ E + GK
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 17/207 (8%)

Query: 544 FTDYNKLGQGGFGIV------YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           F  Y  LG+GGFG V        G++   +++  KR+ +  G+ +    NE R++ K+  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNS 59

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
           R +V L       D   LV   M    L   I++       + QR       +  GL  L
Sbjct: 60  RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDL 118

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA-RIFGGDQTEQNTKRVVGTYGYMSPE 716
            ++   RI++RDLK  NILLD     +ISD G+A +I  G    +  +  VGT GYM+PE
Sbjct: 119 QRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG----ETVRGRVGTVGYMAPE 171

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGK 743
              +  ++   D +  G L+ E + G+
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 76.6 bits (188), Expect = 4e-15
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)

Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCV 608
           +G G +G VYKGR ++  ++A  ++   +    EE K E+ ++ K   HRN+    G  +
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 609 EM------DEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIIC-GIARGLLYLHQD 660
           +       D+  LV E+    S+ D V   K  +   +W      IC  I RGL +LH  
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW---IAYICREILRGLAHLHAH 140

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM- 719
              ++IHRD+K  N+LL +    K+ DFG++     D+T       +GT  +M+PE    
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIAC 195

Query: 720 ----DGLFSVKSDVFSFGVLLLETVSG 742
               D  +  +SD++S G+  +E   G
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 77.0 bits (189), Expect = 5e-15
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 27/212 (12%)

Query: 542 DNFTDYNKLGQGGFGIVYK-----GRLLEGQEI---AVKRLSRNSGQGIEEFKNEVRLIA 593
           D+F   ++LG G  G+V K       L+  +++    +K   RN      +   E++++ 
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRN------QIIRELQVLH 58

Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR--SSILNWQRRFNIICGIA 651
           +     +V   G      E  +  E+M+  SLD V+ +  R    IL       +   + 
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVL 113

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG 711
           RGL YL +  + +I+HRD+K SNIL++     K+ DFG++    G   +      VGT  
Sbjct: 114 RGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRS 167

Query: 712 YMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           YMSPE      +SV+SD++S G+ L+E   G+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 75.7 bits (187), Expect = 6e-15
 Identities = 69/222 (31%), Positives = 97/222 (43%), Gaps = 49/222 (22%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRN----SGQGIEEFKNEVRLIAKLQ 596
           D+F     LG G FG V   R     +  A+K LS+       Q +E   NE R++  ++
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59

Query: 597 HRNLVRLLGCCVEMDEKML--VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR-- 652
           H  LV L G     D+  L  V EY+    L    F   R S      RF     +AR  
Sbjct: 60  HPFLVNLYGS--FQDDSNLYLVMEYVPGGEL----FSHLRKS-----GRFPE--PVARFY 106

Query: 653 ------GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
                  L YLH      I++RDLK  N+LLD +   KI+DFG A+   G      T  +
Sbjct: 107 AAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTL 158

Query: 707 VGTYGYMSPE------YAMDGLFSVKSDVFSFGVLLLETVSG 742
            GT  Y++PE      Y      +V  D ++ G+L+ E ++G
Sbjct: 159 CGTPEYLAPEIILSKGYGK----AV--DWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 75.8 bits (186), Expect = 7e-15
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 23/210 (10%)

Query: 544 FTDYNKLGQGGFGIV------YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           F  Y  LG+GGFG V        G++   + +  KR+ +  G+ +    NE +++ K+  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF---NIICGIARGL 654
           + +V L       D   LV   M    L   I++         +  F    I+CG    L
Sbjct: 60  QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----L 115

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA-RIFGGDQTEQNTKRVVGTYGYM 713
             LH+++    ++RDLK  NILLD     +ISD G+A +I  G+         VGT GYM
Sbjct: 116 EDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYM 168

Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           +PE   +  +++  D +  G L+ E + G+
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 76.1 bits (187), Expect = 7e-15
 Identities = 67/205 (32%), Positives = 96/205 (46%), Gaps = 27/205 (13%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIA-KLQHRNLVRLL 604
           LG+G FG V   RL E G+  AVK L ++       +E    E R+++    H  L +L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 605 GCCVEMDEKMLVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
            C    D    V E++    L      S  FD+AR+     +        I   L++LH 
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--------ITSALMFLHD 114

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGTYGYMSPEY 717
                II+RDLK  N+LLD E   K++DFGM +  IF G    + T    GT  Y++PE 
Sbjct: 115 KG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIAPEI 167

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
             + L+    D ++ GVLL E + G
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 67/226 (29%), Positives = 107/226 (47%), Gaps = 46/226 (20%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRL--SRNSGQGIEEFKNEVRLIAKLQHR 598
           D+     +LG+G +G+V K R +  G  +AVKR+  + NS    +E K   RL+  L   
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS----QEQK---RLLMDL--- 50

Query: 599 NLVRLLGCCVEMDE---KML----VYEYME--NRSLDSV---IFDKARS---SILNWQRR 643
           ++      C         +     V+  ME  + SLD     ++DK  +    IL     
Sbjct: 51  DISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILG---- 106

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
             I   I + L YLH  S+  +IHRD+K SN+L+++    K+ DFG++    G   +   
Sbjct: 107 -KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVA 159

Query: 704 KRV-VGTYGYMSPE-----YAMDGLFSVKSDVFSFGVLLLETVSGK 743
           K +  G   YM+PE         G + VKSDV+S G+ ++E  +G+
Sbjct: 160 KTIDAGCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 28/212 (13%)

Query: 550 LGQGGFGIVYKGRLL-EGQEI--AVKRLSRNSGQGIE-EFKNEVRLIAKL-QHRNLVRLL 604
           +G+G FG V +  +  +G ++  A+K L   + +    +F  E+ ++ KL  H N++ LL
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 605 GCCVEMDEKMLVYEYM----------ENRSLDS---VIFDKARSSILNWQRRFNIICGIA 651
           G C       +  EY           ++R L++      +   +S L  Q+       +A
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG 711
            G+ YL  + +F  IHRDL A N+L+ + +  KI+DFG++R       E   K+ +G   
Sbjct: 130 TGMQYL-SEKQF--IHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGRLP 181

Query: 712 --YMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
             +M+ E     +++ KSDV+SFGVLL E VS
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.1 bits (184), Expect = 2e-14
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 26/212 (12%)

Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +  +   +AVK L  + + + + +  +E+ ++  + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 600 LVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN--IIC 648
           ++ LLG C         VE   K  + EY+  R    + +      +   Q  F   + C
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 649 G--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              +ARG+ YL      + IHRDL A N+L+ ++   KI+DFG+AR        + T   
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
                +M+PE   D +++ +SDV+SFGVLL E
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWE 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 74.3 bits (182), Expect = 4e-14
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 27/212 (12%)

Query: 542 DNFTDYNKLGQGGFGIVYK------GRLLEGQEI--AVKRLSRNSGQGIEEFKNEVRLIA 593
           D+F   ++LG G  G+V+K      G ++  + I   +K   RN      +   E++++ 
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN------QIIRELQVLH 58

Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR--SSILNWQRRFNIICGIA 651
           +     +V   G      E  +  E+M+  SLD V+    R    IL       +   + 
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVI 113

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG 711
           +GL YL +  + +I+HRD+K SNIL++     K+ DFG++    G   +      VGT  
Sbjct: 114 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRS 167

Query: 712 YMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           YMSPE      +SV+SD++S G+ L+E   G+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 73.9 bits (181), Expect = 4e-14
 Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 28/213 (13%)

Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRL-SRNSGQGIEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L S  + + + +  +E+ ++  + +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 600 LVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN--IIC 648
           ++ LLG C         VE   K  + EY+  R    + +    + +   Q  F   + C
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 649 G--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKR 705
              +ARG+ YL      + IHRDL A N+L+ ++   KI+DFG+AR I   D  ++ T  
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 706 VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
            +    +M+PE   D +++ +SDV+SFGVLL E
Sbjct: 203 RLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWE 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 73.9 bits (181), Expect = 6e-14
 Identities = 67/241 (27%), Positives = 115/241 (47%), Gaps = 28/241 (11%)

Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN---EVR 590
           +TI    + + + + +G G +G V        G  +AVK+LSR   Q I   K    E+R
Sbjct: 10  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 68

Query: 591 LIAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           L+  ++H N++ LL          E ++  LV   M    L++++    +   L      
Sbjct: 69  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQ 123

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
            +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+    
Sbjct: 124 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 175

Query: 705 RVVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
             V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + R
Sbjct: 176 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILR 232

Query: 764 L 764
           L
Sbjct: 233 L 233

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 73.2 bits (180), Expect = 7e-14
 Identities = 68/222 (30%), Positives = 100/222 (45%), Gaps = 47/222 (21%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIE-EFKNEVR--LIAKLQ-- 596
           D+F    +LG G  G+V K        I  ++L       I  E K  +R  +I +L+  
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKL-------IHLEIKPAIRNQIIRELKVL 53

Query: 597 HR----NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR---SSILNWQRRFNIICG 649
           H      +V   G      E  +  E+M+  SLD V+  KA     +IL       I   
Sbjct: 54  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPENILG-----KISIA 107

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG--------MARIFGGDQTEQ 701
           + RGL YL +  + +I+HRD+K SNIL++     K+ DFG        MA  F       
Sbjct: 108 VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF------- 158

Query: 702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
                VGT  YMSPE      ++V+SD++S G+ L+E   G+
Sbjct: 159 -----VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 73.1 bits (179), Expect = 7e-14
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 15/207 (7%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHR 598
           + +    KLG+G +  V+KGR  L    +A+K  RL    G      + EV L+  L+H 
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 64

Query: 599 NLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
           N+V L    V  D+ + LV+EY++ + L   + D    +I++       +  I RGL Y 
Sbjct: 65  NIVTLHDI-VHTDKSLTLVFEYLD-KDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYC 120

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H   R +++HRDLK  N+L+++    K++DFG+AR      T+  +  VV T  Y  P+ 
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDV 175

Query: 718 AM-DGLFSVKSDVFSFGVLLLETVSGK 743
            +    +S + D++  G +  E  SG+
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 72.1 bits (177), Expect = 8e-14
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 17/204 (8%)

Query: 549 KLGQGGFGIVYKG--RLLEGQEI--AVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRL 603
            +G+G FG VY+G     E ++I  AVK     +   + E+F  E  ++ +  H ++V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 604 LGCCVEMDE--KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +G   E      M +    E RS     + +     L+          ++  L YL   S
Sbjct: 73  IGVITENPVWIVMELAPLGELRS-----YLQVNKYSLDLASLILYSYQLSTALAYLE--S 125

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
           + R +HRD+ A N+L+      K+ DFG++R    D++     +      +M+PE     
Sbjct: 126 K-RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGKLPIKWMAPESINFR 183

Query: 722 LFSVKSDVFSFGVLLLETVS-GKK 744
            F+  SDV+ FGV + E +  G K
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVK 207

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 72.3 bits (177), Expect = 9e-14
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 23/204 (11%)

Query: 550 LGQGGFGIV------YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+GGFG V        G++   +++  KRL + SG+ +   + E+     L+  N   +
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI-----LEKVNSPFI 55

Query: 604 LGCCVEMDEKM---LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +      + K    LV   M    L   I++      L  +R  +    I  G+L+LH  
Sbjct: 56  VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHS- 113

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMA-RIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
               I++RD+K  N+LLD +   ++SD G+A  +  G    Q      GT GYM+PE   
Sbjct: 114 --MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA----GTNGYMAPEILK 167

Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
           +  +S   D F+ G  + E V+G+
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 72.3 bits (177), Expect = 1e-13
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 13/206 (6%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHR 598
           + +   +KLG+G +  VYKGR  L    +A+K  RL    G      + EV L+  L+H 
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 64

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           N+V L           LV+EY++ + L   + D   S  ++  + F  +  + RGL Y H
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH 121

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
              R +++HRDLK  N+L+++    K++DFG+AR      T+  +  VV T  Y  P+  
Sbjct: 122 ---RRKVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVV-TLWYRPPDIL 176

Query: 719 MDGL-FSVKSDVFSFGVLLLETVSGK 743
           +    +S + D++  G +  E  +G+
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 23/208 (11%)

Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRNLVRLLGCC 607
           LG G  G VYK   LL  + +AVK +  +    ++ +  +E+ ++ K     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
              +   +  E+M+  SLD  ++ K    +L       I   + +GL YL      +I+H
Sbjct: 69  FVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKILH 118

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKS 727
           RD+K SN+L++     K+ DFG++            K  VGT  YM+PE      + + S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 728 DVFSFGVLLLETVSGK-------KNRGF 748
           DV+S G+  +E   G+       KN+G 
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGS 202

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 29/208 (13%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN---EVRLIAKLQHR--NLVRL 603
           +G G  G VYK R  + G  +AVK++ R   +  EE K    ++ ++ K  H    +V+ 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLK-SHDCPYIVKC 79

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF---NIICGIARGLLYLHQD 660
            G  +   +  +  E M      S   DK    I           +   I + L YL + 
Sbjct: 80  YGYFITDSDVFICMELM------STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE- 132

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK-RVVGTYGYMSPEY-- 717
            +  +IHRD+K SNILLD     K+ DFG++    G   +   K R  G   YM+PE   
Sbjct: 133 -KHGVIHRDVKPSNILLDASGNVKLCDFGIS----GRLVDSKAKTRSAGCAAYMAPERID 187

Query: 718 --AMDGLFSVKSDVFSFGVLLLETVSGK 743
               +  + +++DV+S G+ L+E  +G+
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 42/213 (19%)

Query: 548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN--EVRLIAKLQ-HRNLVRL 603
            K+G+G F  V K +  + G+  A+K + +   + +E+  N  E++ + +L  H N++RL
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 604 L--------GC----CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIA 651
           +        G        MD  M +YE ++ R        + R     +Q        + 
Sbjct: 64  IEVLFDRKTGRLALVFELMD--MNLYELIKGRKR---PLPEKRVKSYMYQ--------LL 110

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGT 709
           + L ++H++    I HRD+K  NIL+  +   K++DFG  R        TE      + T
Sbjct: 111 KSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE-----YIST 161

Query: 710 YGYMSPEYAM-DGLFSVKSDVFSFGVLLLETVS 741
             Y +PE  + DG +  K D+++ G +  E +S
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 28/212 (13%)

Query: 550 LGQGGFGIVYKGRLLEG---QEIAVKRLSRNSGQGI-EEFKNEVRLIAKL-QHRNLVRLL 604
           +G+G FG V K R+ +     + A+KR+   + +    +F  E+ ++ KL  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 605 GCCVEMDEKMLVYEYM----------ENRSLDS---VIFDKARSSILNWQRRFNIICGIA 651
           G C       L  EY           ++R L++        + +S L+ Q+  +    +A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG 711
           RG+ YL   S+ + IHRDL A NIL+ +    KI+DFG++R       E   K+ +G   
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLP 174

Query: 712 --YMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
             +M+ E     +++  SDV+S+GVLL E VS
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 72.4 bits (177), Expect = 2e-13
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 27/221 (12%)

Query: 535 ETIVRATDNFTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSRNSGQGIEEFKN--EV 589
           +T+    + + +   +G G +G V   Y  RL   Q++AVK+LSR     I   +   E+
Sbjct: 8   KTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYREL 65

Query: 590 RLIAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRR 643
           RL+  ++H N++ LL            +E  LV   M     + V   K     + +   
Sbjct: 66  RLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF--- 122

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
             +I  + RGL Y+H      IIHRDLK SN+ ++++   +I DFG+AR     Q +   
Sbjct: 123 --LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEM 172

Query: 704 KRVVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
              V T  Y +PE  ++ + ++   D++S G ++ E + GK
Sbjct: 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 23/203 (11%)

Query: 550 LGQGGFGIVYKG--RLLEGQE--IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           LG G FG + +G  +L   +E  +A+  L    S +    F  E   + +  H N+VRL 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G     +  M+V EYM N +LDS  F +     L   +   ++ G+A G+ YL   S   
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDS--FLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMG 127

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEYA 718
            +H+ L A  +L++ ++  KIS F   +       E  ++ +  T        + +PE  
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQ-------EDKSEAIYTTMSGKSPVLWAAPEAI 180

Query: 719 MDGLFSVKSDVFSFGVLLLETVS 741
               FS  SDV+SFG+++ E +S
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 71.9 bits (176), Expect = 2e-13
 Identities = 67/219 (30%), Positives = 104/219 (47%), Gaps = 26/219 (11%)

Query: 550 LGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G FG V    L  +G+  AVK L ++       +E    E R++A       +  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 606 CCVEMDEKML-VYEYMENRSLDSVIFDKARSSILNWQRRF---NIICGIARGLLYLHQDS 661
           C  +  E +  V E++    L   I DK R  +  ++  F    I+CG    L +LH   
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAEIVCG----LQFLHSKG 116

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGTYGYMSPEYAM 719
              II+RDLK  N++LD++   KI+DFGM +  +FG    +       GT  Y++PE   
Sbjct: 117 ---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPDYIAPEILQ 169

Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
              ++   D +SFGVLL E + G+     +H ++E  L 
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSP---FHGDDEDELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 28/206 (13%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN----EVRLIAKLQHRNLVRLL 604
           +G+G +G+V K R  E +EI A+K+   +     EE K     E++++  L+  N+V L 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELK 66

Query: 605 GCCVEMDEKMLVYEYMENRSLD-------SVIFDKARSSILNWQRRFNIICGIARGLLYL 657
                  +  LV+EY+E   L+        V  +K RS I      + +I    + + + 
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI------YQLI----KAIHWC 116

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H++    I+HRD+K  N+L+      K+ DFG AR    + +  N    V T  Y SPE 
Sbjct: 117 HKND---IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPEL 172

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGK 743
            +   +    D++S G +L E   G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 25/211 (11%)

Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQH 597
           D+      +G G FG V+  R  +     A+K ++       +  +   NE R++ ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 598 RNLVRLLGCCVEMDEKML--VYEYMENRSLDSVIFDKARSSILNWQRRF---NIICGIAR 652
             ++RL     E D++ L  + EY+    L S +  +      N    F    I+C +  
Sbjct: 61  PFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALE- 115

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
              YLH      I++RDLK  NILLDKE   K++DFG A+     +    T  + GT  Y
Sbjct: 116 ---YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEY 164

Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           ++PE       +   D ++ G+L+ E + G 
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 40/96 (41%), Positives = 55/96 (57%), Gaps = 9/96 (9%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVV 707
           IA GL +LH      II+RDLK  N++LD E   KI+DFGM +  IFGG      T+   
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162

Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           GT  Y++PE      +    D ++FGVLL E ++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.5 bits (175), Expect = 3e-13
 Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 30/221 (13%)

Query: 550 LGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G FG V+   L    Q  A+K L ++       +E    E R+++       +  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 606 CCVEMDEKML-VYEYMENRSLDSVI-----FDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           C  +  E +  V EY+    L   I     FD  R++    +    IICG    L +LH 
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE----IICG----LQFLHS 114

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGTYGYMSPEY 717
                I++RDLK  NILLD +   KI+DFGM +  + G    +  T    GT  Y++PE 
Sbjct: 115 KG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEI 167

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
            +   ++   D +SFGVLL E + G+     +H ++E  L 
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSP---FHGHDEEELF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 69/233 (29%), Positives = 108/233 (46%), Gaps = 34/233 (14%)

Query: 549 KLGQGGFGIVYKGRLLEGQE---IAVKRLSRNSGQGIEEFKNEVRLIAKLQ----HRNLV 601
           +LGQG +GIV   R  E  E   +A+K+++    + I   K  +R +  L+    H+N+ 
Sbjct: 7   ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKIL-AKRALRELKLLRHFRGHKNIT 65

Query: 602 RLLGCCVEMD--------EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
               C  +MD        E  L  E ME   L  +I      +  ++Q   + I  I  G
Sbjct: 66  ----CLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQ---SFIYQILCG 117

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN--TKRVVGTYG 711
           L Y+H  +   ++HRDLK  N+L++ +   KI DFG+AR F  +  E        V T  
Sbjct: 118 LKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174

Query: 712 YMSPEYAMDGLFSVKS-DVFSFGVLLLETVSGK---KNRGFYHSNNE-LNLLG 759
           Y +PE  +      K+ DV+S G +L E +  K   K + +    N+ L +LG
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|204904 pfam12398, DUF3660, Receptor serine/threonine kinase

 Score = 64.3 bits (157), Expect = 3e-13
 Identities = 21/40 (52%), Positives = 31/40 (77%), Gaps = 1/40 (2%)

Query: 496 PRGHPERSQDLLLNQVVISSKRDYSAD-KTDDLELPLFDF 534
           P  + +R+QDLL+N +V+SSKR  S + KT++LELPL +F
Sbjct: 3   PIVNRQRNQDLLMNGMVLSSKRQLSGENKTEELELPLIEF 42

This domain family is found in eukaryotes, and is approximately 40 amino acids in length. The family is found in association with pfam00954, pfam01453, pfam00069, pfam08276. There is a conserved ELPL sequence motif. Length = 42

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 64/238 (26%), Positives = 113/238 (47%), Gaps = 26/238 (10%)

Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKR-LSRNSGQGIEEFK-NEVRLIAKLQHR 598
           D +    K+G+G +G VYK R    G+ +A+K+       +GI      E+ L+  L   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 599 N-LVRLLGCCVEMDEKM------LVYEYMEN---RSLDSVIFDKARSSILNWQRRFNIIC 648
             +VRLL     ++EK       LV+EY+++   + +DS      R       + F  + 
Sbjct: 61  IYIVRLL-DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF--MY 117

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTEQNTKRVV 707
            + +G+ + H+     ++HRDLK  N+L+DK+    KI+D G+ R F     +  T  +V
Sbjct: 118 QLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV 173

Query: 708 GTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            T  Y +PE  +    +S   D++S G +  E    +     +  ++EL  L H+++L
Sbjct: 174 -TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP---LFPGDSELQQLLHIFKL 227

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 70.8 bits (173), Expect = 4e-13
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 15/209 (7%)

Query: 540 ATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFK--NEVRLIAKLQ 596
           A  ++ +  KLG+G +  VYKG   + GQ +A+K +S  + +G+  F    E  L+  L+
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLK 61

Query: 597 HRNLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           H N+V LL   +   E +  V+EYM     D   +       L+       +  + RGL 
Sbjct: 62  HANIV-LLHDIIHTKETLTFVFEYMHT---DLAQYMIQHPGGLHPYNVRLFMFQLLRGLA 117

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y+H      I+HRDLK  N+L+      K++DFG+AR        Q     V T  Y  P
Sbjct: 118 YIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPP 172

Query: 716 EYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
           +  +    +S   D++  G + +E + G+
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 71.2 bits (174), Expect = 5e-13
 Identities = 68/206 (33%), Positives = 98/206 (47%), Gaps = 29/206 (14%)

Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           +G G  GIV      + G  +AVK+LSR   N       ++ E+ L+  + H+N++ LL 
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87

Query: 606 CCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIICGIARGLLY 656
                    E  +  LV E M+  +L  VI    D  R S L +Q    ++CGI     +
Sbjct: 88  VFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDHERMSYLLYQ----MLCGIK----H 138

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           LH      IIHRDLK SNI++  + T KI DFG+AR          T  VV  Y Y +PE
Sbjct: 139 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRY-YRAPE 192

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSG 742
             +   +    D++S G ++ E V G
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 70.6 bits (173), Expect = 5e-13
 Identities = 71/210 (33%), Positives = 97/210 (46%), Gaps = 35/210 (16%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVR-LIAKLQHRNLVRLL 604
           LG+G FG V    L    E  A+K L ++       +E    E R L    +H  L  L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 605 GCCVEMDEKML-VYEYMENRSL-----DSVIFDKARSSILNWQRRF---NIICGIARGLL 655
            C  +  E +  V EY+    L      S  FD+AR+       RF    IICG    L 
Sbjct: 63  -CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARA-------RFYAAEIICG----LQ 110

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGTYGYM 713
           +LH+     II+RDLK  N+LLDK+   KI+DFGM +  + G    E       GT  Y+
Sbjct: 111 FLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFCGTPDYI 163

Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           +PE      ++   D +SFGVLL E + G+
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 69.3 bits (169), Expect = 7e-13
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 24/214 (11%)

Query: 530 PLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNE 588
           P  D+E I R          +G G +G VYK R L  G+  AVK +    G      + E
Sbjct: 7   PQHDYELIQR----------VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQE 56

Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC 648
           + ++ + +H N+V   G  +  ++  +  EY    SL  +       S L    +   +C
Sbjct: 57  IFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL----QIAYVC 112

Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
               +GL YLH   +   +HRD+K +NILL      K++DFG+A       T    K  +
Sbjct: 113 RETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFI 167

Query: 708 GTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLE 738
           GT  +M+PE A    +G ++   D+++ G+  +E
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIE 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 69.7 bits (170), Expect = 8e-13
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 23/211 (10%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHR 598
           + +   +KLG+G +  V+KGR  L    +A+K  RL    G      + EV L+  L+H 
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHA 63

Query: 599 NLVRLLGCCVEMDEKMLVYEYMEN---RSLDSV--IFDKARSSILNWQRRFNIICGIARG 653
           N+V L           LV+EY+++   + LD+   +       I  +Q        + RG
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQ--------LLRG 115

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
           L Y H   + +I+HRDLK  N+L++++   K++DFG+AR      T+  +  VV T  Y 
Sbjct: 116 LSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVV-TLWYR 170

Query: 714 SPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            P+  +    +S   D++  G +L E  +G+
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 67/230 (29%), Positives = 106/230 (46%), Gaps = 29/230 (12%)

Query: 531 LFDFETIVRATDNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIEEFKNEV 589
           +   E++   TD +     +G+G +G VYK     +G   AVK L   S    EE + E 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69

Query: 590 RLIAKL-QHRNLVRLLGCCVEMDEKM-----LVYEYMENRSLDSVIFDKARSSILNWQRR 643
            ++  L  H N+V+  G   + D+ +     LV E     S+  ++       +L   +R
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQR 124

Query: 644 FN------IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
            +      I+ G   GL +LH +   RIIHRD+K +NILL  E   K+ DFG++      
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181

Query: 698 QTEQNTKRVVGTYGYMSPEY-----AMDGLFSVKSDVFSFGVLLLETVSG 742
           +  +NT   VGT  +M+PE        D  +  + DV+S G+  +E   G
Sbjct: 182 RLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains

 Score = 63.8 bits (155), Expect = 1e-12
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 5/81 (6%)

Query: 368 CSEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSR-NCSCTAYANTNITGGTGCVTWT 426
            S+D F++L N KLP  +   +    +L+EC + C   NCSC ++   N  G  GC+ W+
Sbjct: 1   KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNN--GTKGCLLWS 57

Query: 427 -GELKDIRKYAEGGQDLYVRL 446
              L D R +  GG DLY ++
Sbjct: 58  ESSLGDARLFPSGGVDLYEKI 78

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 23/204 (11%)

Query: 546 DYNKL---GQGGFG-IVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN 599
            YN L   G+G FG  +    +   Q+ A+K  RL ++S   +E+ + E  L+AK++H N
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPN 59

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK-----ARSSILNWQRRFNIICGIARGL 654
           +V             +V EY +   L   I  +        +IL W   F  +C    G+
Sbjct: 60  IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW---FVQMC---LGV 113

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
            ++H+    R++HRD+K+ NI L +    K+ DFG AR+         T   VGT  Y+ 
Sbjct: 114 QHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVP 168

Query: 715 PEYAMDGLFSVKSDVFSFGVLLLE 738
           PE   +  ++ KSD++S G +L E
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYE 192

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 24/214 (11%)

Query: 530 PLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNE 588
           P  DFE I R          +G G +G VYK R +  G+  A+K +    G+     + E
Sbjct: 7   PQEDFELIQR----------IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQE 56

Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC 648
           + ++   +H N+V   G  +  D+  +  E+    SL  +       S    + +   + 
Sbjct: 57  IIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLS----ESQIAYVS 112

Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
               +GL YLH   +   +HRD+K +NILL      K++DFG++       T    K  +
Sbjct: 113 RETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFI 167

Query: 708 GTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLE 738
           GT  +M+PE A     G ++   D+++ G+  +E
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIE 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 69.7 bits (170), Expect = 2e-12
 Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 29/213 (13%)

Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83

Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 139

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV  Y
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY 190

Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y +PE  +   +    D++S G ++ E + G 
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 51/158 (32%), Positives = 82/158 (51%), Gaps = 18/158 (11%)

Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQG-----IEEFKNEVRLIAKL 595
           + +   +KLG+G +  VYKGR  L GQ +A+K +     +G     I E      L+  L
Sbjct: 5   ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIRE----ASLLKDL 60

Query: 596 QHRNLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           +H N+V  L   +   + + LV+EY++   L   + D      ++  R F  +  + RGL
Sbjct: 61  KHANIV-TLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLF--LFQLLRGL 116

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            Y HQ    R++HRDLK  N+L+ +    K++DFG+AR
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 71.0 bits (174), Expect = 2e-12
 Identities = 52/190 (27%), Positives = 87/190 (45%), Gaps = 18/190 (9%)

Query: 566 GQEIAVKRLSRNSGQGIEE---FKNEVRLIAKLQHRNLVRLLGCCVEMDEKML-VYEYME 621
           G E+A+K L  ++ +   +   F+ E  L A+L H N+V LL         +  V+EY+ 
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL---D 678
            R+L  V+   A    L       ++  +   L   H      I+HRDLK  NI++    
Sbjct: 63  GRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116

Query: 679 KEMTPKISDFGMARIFGG-----DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFG 733
                K+ DFG+  +  G       T   T  V+GT  Y +PE       +  SD++++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 734 VLLLETVSGK 743
           ++ LE ++G+
Sbjct: 177 LIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 68.5 bits (168), Expect = 3e-12
 Identities = 52/220 (23%), Positives = 100/220 (45%), Gaps = 25/220 (11%)

Query: 532 FDFETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--E 588
           FD  +  +  +N      +G G +G+V        G+++A+K++           +   E
Sbjct: 1   FDVGSRYKPIEN------IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRE 54

Query: 589 VRLIAKLQHRNLVRLLGCCV----EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           ++++   +H N++ +         +  +  +V + ME+  L  +I      +     R F
Sbjct: 55  LKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLT-EEHIRYF 112

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT- 703
             +  + RGL Y+H  +   +IHRDLK SN+L++++   +I DFGMAR      TE    
Sbjct: 113 --LYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF 167

Query: 704 -KRVVGTYGYMSPE--YAMDGLFSVKSDVFSFGVLLLETV 740
               V T  Y +PE   ++   ++   D++S G +  E +
Sbjct: 168 MTEYVATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 68.4 bits (167), Expect = 3e-12
 Identities = 62/241 (25%), Positives = 115/241 (47%), Gaps = 28/241 (11%)

Query: 535 ETIVRATDNFTDYNKLGQGGFGIV-YKGRLLEGQEIAVKRLSR--NSGQGIEEFKNEVRL 591
           +TI    D + D  ++G G +G V        G ++A+K+L R   S    +    E+RL
Sbjct: 8   KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67

Query: 592 IAKLQHRNLVRLLGCCVEMDEKM-------LVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           +  ++H N++ LL      D  +       LV  +M    L  ++    +   L+  R  
Sbjct: 68  LKHMKHENVIGLLDVFTP-DLSLDRFHDFYLVMPFM-GTDLGKLM----KHEKLSEDRIQ 121

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
            ++  + +GL Y+H      IIHRDLK  N+ ++++   KI DFG+AR     QT+    
Sbjct: 122 FLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMT 173

Query: 705 RVVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
             V T  Y +PE  ++ + ++   D++S G ++ E ++GK     +  ++ L+ L  + +
Sbjct: 174 GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP---LFKGHDHLDQLMEIMK 230

Query: 764 L 764
           +
Sbjct: 231 V 231

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 25/231 (10%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIA---VKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLL 604
           ++G G FG V    +     +A   VK L  N+  +   EF  +      LQH N+++ L
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVI----FDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           G CVE    +LV+EY E   L S +    + +  S +L  QR   + C IA G+ ++H  
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMH-- 116

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARI-FGGDQTEQNTKRVVGTYGYMSPEYA- 718
            +   +H DL   N  L  ++T K+ D+G+    +  D  E    + V    +++PE   
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELVG 174

Query: 719 --MDGLFSVK----SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
               GL + +    S+V++ GV L E          Y   ++  +L HV +
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELFENAAQP--YSHLSDREVLNHVIK 223

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 68.3 bits (167), Expect = 4e-12
 Identities = 41/94 (43%), Positives = 57/94 (60%), Gaps = 7/94 (7%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGG-DQTEQNTKRVV 707
           +ARG+ +L   SR + IHRDL A NILL +    KI DFG+AR I+   D   +   R+ 
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237

Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+PE   D +++ +SDV+SFGVLL E  S
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 68.2 bits (166), Expect = 4e-12
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 33/215 (15%)

Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75

Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M+  +L  VI    D  R S L +Q    ++C
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQ----MLC 130

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV 
Sbjct: 131 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVT 181

Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y Y +PE  +   +    D++S G ++ E V  K
Sbjct: 182 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 67.6 bits (165), Expect = 5e-12
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 23/204 (11%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G FG V    L    E+ A+K L ++       ++    E R++A       +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 606 CCVEMDEKML-VYEYMENRSLDSVI-----FDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           CC +  +++  V EY+    L   I     FD+ RS       RF     +   L++LH+
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS-------RF-YAAEVTLALMFLHR 114

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
                +I+RDLK  NILLD E   K++DFGM +   G      T    GT  Y++PE   
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQ 169

Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
           +  +    D ++ GVL+ E ++G+
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 66.8 bits (163), Expect = 6e-12
 Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 18/205 (8%)

Query: 548 NKLGQGGFGIVYKG---RLLEGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRL 603
           +++G G FG V  G   R +    + VK L  ++       F  EV+   +L H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF--NIICGIARGLLYLHQDS 661
           LG C+E    +LV E+     L + +           Q+     + C +A GLL+LHQ  
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARI-FGGDQTEQNTKRVVGTYGYMSPEYA-- 718
               IH DL   N  L  +++ KI D+G+A   +  D         V    +++PE    
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEI 176

Query: 719 -MDGLFSVK----SDVFSFGVLLLE 738
               L        S+++S GV + E
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWE 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 67.5 bits (165), Expect = 8e-12
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 39/214 (18%)

Query: 550 LGQGGFGIVYK---GRLLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIAKLQHRNLVRL 603
           +G G FG+V+     R  +G+ +A+K++  N  Q +   K    E++++   +H N++  
Sbjct: 8   IGYGAFGVVWSVTDPR--DGKRVALKKMP-NVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64

Query: 604 L--------GCCVEMDEKMLVYEYMENRSLDSVIFDKARSS-----ILNWQRRFNIICGI 650
           L            E+    +V E M++  L  +I      S     +  +Q        I
Sbjct: 65  LDILQPPHIDPFEEI---YVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQ--------I 112

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
            RGL YLH      I+HRD+K  N+L++     KI DFG+AR+   D+++  T+ VV  Y
Sbjct: 113 LRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169

Query: 711 GYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            Y +PE  M    ++   D++S G +  E +  +
Sbjct: 170 -YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 66.6 bits (162), Expect = 9e-12
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 13/205 (6%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHR 598
           D++    KLG+G +  VYKG+  + G+ +A+K  RL    G      + E  L+  L+H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           N+V L       +   LV+EY+     D   +       L+ +     +  + RGL Y+H
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHT---DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
           Q  R+ I+HRDLK  N+L+      K++DFG+AR              V T  Y  P+  
Sbjct: 121 Q--RY-ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVL 175

Query: 719 MDGL-FSVKSDVFSFGVLLLETVSG 742
           +    +S   D++  G + +E + G
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.2 bits (164), Expect = 1e-11
 Identities = 41/154 (26%), Positives = 67/154 (43%), Gaps = 9/154 (5%)

Query: 588 EVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNII 647
           E  L+  + H +++R+    V      +V   + + S D   +   RS  L   +   I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             I  GL YLH     RIIHRD+K  NI ++      I D G A+             + 
Sbjct: 164 KQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217

Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
           GT    +PE      ++ K+D++S G++L E ++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 27/209 (12%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFK---NEVRLIAKLQHRN 599
           F    ++GQGG+G V+  +  +  EI A+KR+ ++    + E +    E  ++   +   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 600 LVRLLGCCVEMDEKMLVYEYM---ENRSLDSVIFDKARSSILNWQRRFNI---ICGIARG 653
           LV+LL    + +   L  EY+   + R+L +         +     RF +      +   
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN-----NLGVLSEDHARFYMAEMFEAVDA- 116

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
              LH       IHRDLK  N L+D     K++DFG+++   G  T  N+  VVG+  YM
Sbjct: 117 ---LH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS--VVGSPDYM 165

Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           +PE      +    D +S G +L E + G
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 64/231 (27%), Positives = 111/231 (48%), Gaps = 23/231 (9%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRL-----SRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +G+G +G V   R   +G++  +K+L     SR   +  E+   E +L+++L+H N+V  
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ---EAQLLSQLKHPNIVAY 64

Query: 604 LGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
                  D  + +V  + E   L   +  + +  +L   +       IA  L YLH+   
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMALQYLHEK-- 121

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I+HRDLK  N+ L +    K+ D G+AR+        +T  ++GT  YMSPE   +  
Sbjct: 122 -HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKP 178

Query: 723 FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM 773
           ++ KSDV++ G  + E  + K      H+ N  ++   V+R+  EGK+  M
Sbjct: 179 YNYKSDVWALGCCVYEMATLK------HAFNAKDMNSLVYRI-IEGKLPPM 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 66.2 bits (161), Expect = 2e-11
 Identities = 43/102 (42%), Positives = 62/102 (60%), Gaps = 10/102 (9%)

Query: 645 NIIC---GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGG-DQT 699
           ++IC    +ARG+ +L   SR + IHRDL A NILL +    KI DFG+AR I+   D  
Sbjct: 175 DLICYSFQVARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 231

Query: 700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            + + R+     +M+PE   D +++ +SDV+SFGVLL E  S
Sbjct: 232 RKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 65.5 bits (160), Expect = 3e-11
 Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 34/209 (16%)

Query: 550 LGQGGFGIV----YKGRLLEGQEIAVKRLSRN---SGQGIEEFKNEVRL---IAKLQHRN 599
           LG+G FG V    YK     G+  A+K L +    +   +E    E R+       +H  
Sbjct: 7   LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVI----FDKARSSILNWQRRFNIICGIARGLL 655
           LV L  C    D    V EY     L   I    F + R+        F   C +  GL 
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA-------VFYAAC-VVLGLQ 115

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGTYGYM 713
           YLH++   +I++RDLK  N+LLD E   KI+DFG+ +  +  GD+T        GT  ++
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST----FCGTPEFL 168

Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           +PE   +  ++   D +  GVL+ E + G
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 17/196 (8%)

Query: 552 QGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN--EVRLIAKLQHR--NLVRLLGC 606
           +G FG VY  +    G   A+K L ++      +  N    R I  +Q     + +L   
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
               D   LV EY+      S+I         +W +++  I  +  G+  LHQ     II
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---II 119

Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVK 726
           HRD+K  N+L+D+    K++DFG++R        +N K+ VGT  Y++PE  +       
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN-----GLEN-KKFVGTPDYLAPETILGVGDDKM 173

Query: 727 SDVFSFGVLLLETVSG 742
           SD +S G ++ E + G
Sbjct: 174 SDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 61/199 (30%), Positives = 91/199 (45%), Gaps = 23/199 (11%)

Query: 619 YMENRSLDSVIFDKARSSIL--NWQRRFNIIC---GIARGLLYLHQDSRFRIIHRDLKAS 673
           ++E +SL  V  ++A    L        ++IC    +A+G+ +L   SR + IHRDL A 
Sbjct: 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA--SR-KCIHRDLAAR 208

Query: 674 NILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFG 733
           NILL +    KI DFG+AR    D              +M+PE   D +++++SDV+SFG
Sbjct: 209 NILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 268

Query: 734 VLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHV 792
           VLL E  S G         + E        R  KEG  +   D     Y   E+ + +  
Sbjct: 269 VLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTRMRAPD-----YTTPEMYQTM-- 315

Query: 793 GLLCVQENAEERPTMASVV 811
            L C      +RPT + +V
Sbjct: 316 -LDCWHGEPSQRPTFSELV 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 65.3 bits (159), Expect = 3e-11
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 24/218 (11%)

Query: 536 TIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGI--EEFKNEVRLI 592
           T+    + +T   ++G G +G V        G+++A+K+LSR     I  +    E+ L+
Sbjct: 9   TVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLL 68

Query: 593 AKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
             +QH N++ LL          E  +  LV  YM+          K     L+  +   +
Sbjct: 69  KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD------LQKIMGHPLSEDKVQYL 122

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
           +  +  GL Y+H      IIHRDLK  N+ ++++   KI DFG+AR    + T       
Sbjct: 123 VYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----Y 174

Query: 707 VGTYGYMSPEYAMDGLFSVKS-DVFSFGVLLLETVSGK 743
           V T  Y +PE  ++ +   ++ D++S G ++ E ++GK
Sbjct: 175 VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 64.7 bits (157), Expect = 5e-11
 Identities = 58/220 (26%), Positives = 106/220 (48%), Gaps = 20/220 (9%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFK-NEVRLIAKLQHRNLVRLLGCC 607
           K+G+G +G VYK +  +G++     L +  G GI      E+ L+ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 608 VEMDEKM--LVYEYMENRSLDSVIF---DKARSSILNWQRRF--NIICGIARGLLYLHQD 660
           +   ++   L+++Y E+     + F    KA    +   R    +++  I  G+ YLH +
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127

Query: 661 SRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGD-QTEQNTKRVVGTYGYMSP 715
               ++HRDLK +NIL+  E       KI+D G AR+F    +   +   VV T+ Y +P
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 716 EYAMDGLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNE 754
           E  +      K+ D+++ G +  E ++ +     +H   E
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEP---IFHCRQE 221

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 63.8 bits (155), Expect = 5e-11
 Identities = 49/152 (32%), Positives = 74/152 (48%), Gaps = 15/152 (9%)

Query: 549 KLGQGGFGIVYKGRLLEG---QEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLL 604
           ++G G FG V  G +  G    ++ VK L  ++  Q   +F  E +    LQH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 605 GCCVEMDEKMLVYEYME----NRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           G C E+   +LV E+         L S    +         QR   + C IA GLL+LH+
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR---MACEIALGLLHLHK 118

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
           ++    IH DL   N LL  ++T KI D+G++
Sbjct: 119 NN---FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 64.7 bits (158), Expect = 6e-11
 Identities = 55/205 (26%), Positives = 107/205 (52%), Gaps = 22/205 (10%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN---EVRLIAKLQHRNLVRLLG 605
           +G+G +GIV   +  E  +++A+K+++ N+     + K    E++L+  L H N++ +  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIA-NAFDNRIDAKRTLREIKLLRHLDHENVIAIKD 71

Query: 606 CCVEMDEKM------LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
             +    +       +VYE M+   L  +I  ++  ++ +   ++  +  + RGL Y+H 
Sbjct: 72  I-MPPPHREAFNDVYIVYELMDT-DLHQII--RSSQTLSDDHCQY-FLYQLLRGLKYIHS 126

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
            +   ++HRDLK SN+LL+     KI DFG+AR    ++ +  T+ VV T  Y +PE  +
Sbjct: 127 AN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVV-TRWYRAPELLL 181

Query: 720 D-GLFSVKSDVFSFGVLLLETVSGK 743
           +   ++   DV+S G +  E +  K
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 63.7 bits (155), Expect = 6e-11
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 16/205 (7%)

Query: 548 NKLGQGGFGIVYKGR-LLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           ++LG+G +G VYK      G  +A+K  RL  +  +   +   E+ ++ K     +V   
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFY 65

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G         +  EYM+  SLD +      +  +       I   + +GL +L ++    
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY------A 718
           IIHRD+K +N+L++     K+ DFG++    G+      K  +G   YM+PE        
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGGPN 179

Query: 719 MDGLFSVKSDVFSFGVLLLETVSGK 743
            +  ++V+SDV+S G+ +LE   G+
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.9 bits (153), Expect = 8e-11
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 33/215 (15%)

Query: 550 LGQGGFGIVYKGRL---------LEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRN 599
           LGQG F  +YKG L           GQE++V      S       F     L+++L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLH 658
           LV+L G CV  DE ++V EY++   LD V   + ++++ L+W  + ++   +A  L YL 
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLD-VFLHREKNNVSLHW--KLDVAKQLASALHYLE 118

Query: 659 QDSRFRIIHRDLKASNILL-----DKEMTP--KISDFGMARIFGGDQTEQNTKRVVGTYG 711
                +++H ++   NIL+     ++   P  K+SD G+         E+  +R+     
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL--SREERVERI----P 169

Query: 712 YMSPEYAMDGLFSVKS--DVFSFGVLLLETVSGKK 744
           +++PE   +G  S+    D +SFG  LLE  S  +
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 39/109 (35%), Positives = 54/109 (49%), Gaps = 14/109 (12%)

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
           I  I   L +LHQ     II+RD+K  NILLD E    ++DFG+++ F  ++ E+     
Sbjct: 111 IAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER-AYSF 166

Query: 707 VGTYGYMSPEYAM--DGLFSVKSDVFSFGVLLLE--------TVSGKKN 745
            GT  YM+PE      G      D +S GVL  E        TV G++N
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN 215

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 36/94 (38%), Positives = 57/94 (60%), Gaps = 8/94 (8%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           I  GL ++H  +RF +++RDLK +NILLD+    +ISD G+A     D +++     VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGT 158

Query: 710 YGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSG 742
           +GYM+PE    G+ +   +D FS G +L + + G
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 28/223 (12%)

Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQE----IAVKRLSRNS----GQGIEEFKNEVRLIAK 594
           NF     LG G +G V+  R + G +     A+K L + +     +  E  + E +++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 595 LQHRNLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG-IAR 652
           ++    +  L    + D K+ L+ +Y+    L + +  + R      ++   I  G I  
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEIVL 116

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
            L +LH   +  II+RD+K  NILLD      ++DFG+++ F  D+ E+      GT  Y
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER-AYSFCGTIEY 172

Query: 713 MSPEYAM--DGLFSVKSDVFSFGVLLLE--------TVSGKKN 745
           M+P+     DG      D +S GVL+ E        TV G+KN
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN 215

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 62.4 bits (151), Expect = 3e-10
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 14/209 (6%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIAKLQHRNLVRLLG 605
           LG+G FG V   R    G+  A+K L +      +E  +   E R++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
                D    V EY+    L    F  +R  + +  R       I   L YLH     +I
Sbjct: 63  SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116

Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           ++RDLK  N++LDK+   KI+DFG+ +   G       K   GT  Y++PE   D  +  
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
             D +  GV++ E + G+    FY+ ++E
Sbjct: 175 AVDWWGLGVVMYEMMCGR--LPFYNQDHE 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 58/220 (26%), Positives = 107/220 (48%), Gaps = 20/220 (9%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFK-NEVRLIAKLQHRNLVRLLGCC 607
           K+G+G +G VYK +  +G++     L +  G GI      E+ L+ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 608 V-EMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY-----LHQD 660
           +   D K+ L+++Y E+     + F +A  +    ++   +  G+ + LLY     +H  
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 661 SRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGD-QTEQNTKRVVGTYGYMSP 715
               ++HRDLK +NIL+  E       KI+D G AR+F    +   +   VV T+ Y +P
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 716 EYAMDGLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNE 754
           E  +      K+ D+++ G +  E ++ +     +H   E
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEP---IFHCRQE 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 63.6 bits (155), Expect = 3e-10
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 39/220 (17%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN----EVRLIAKLQHRNLVRL 603
            +G+GG G VY     +  + +A+K++ R         K     E ++ A L H  +V +
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 604 LGCCVEMDEKMLVYEYMENRSL----------DSVIFDKA-RSSILNWQRRFNIICGIAR 652
              C + D       Y+E  +L          +S+  + A ++S+  +   F+ IC    
Sbjct: 68  YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC---A 124

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN---------- 702
            + Y+H  S+  ++HRDLK  NILL       I D+G A     ++ +            
Sbjct: 125 TIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181

Query: 703 ----TK--RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
               T   ++VGT  YM+PE  +    S  +D+++ GV+L
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVIL 221

Length = 932

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 16/200 (8%)

Query: 550 LGQGGFGIVYKGRLL----EGQEIAVKRLSRNSGQGIEEF--KNEVRLIAKLQHRNLVRL 603
           LGQG FG V+  R +     GQ  A+K L + + +  +    K E  ++A++ H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI-ICGIARGLLYLHQDSR 662
                   +  L+ +++    L    F +    ++  +      +  +A  L +LH    
Sbjct: 64  HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH---S 116

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             II+RDLK  NILLD+E   K++DFG+++       E+      GT  YM+PE      
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRG 174

Query: 723 FSVKSDVFSFGVLLLETVSG 742
            +  +D +SFGVL+ E ++G
Sbjct: 175 HTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 60.6 bits (147), Expect = 5e-10
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 28/210 (13%)

Query: 550 LGQGGFGIVYKGRLLE----GQ----EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           LGQG F  ++KG   E    G+    E+ +K L ++     E F     ++++L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
              G CV  DE ++V EY++  SLD+ +  K   +++N   +  +   +A  L +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120

Query: 662 RFRIIHRDLKASNILL-----DKEMTP---KISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
              + H ++ A N+LL      K   P   K+SD G++       T    + ++    ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS------ITVLPKEILLERIPWV 171

Query: 714 SPEYAMDGL-FSVKSDVFSFGVLLLETVSG 742
            PE   +    S+ +D +SFG  L E  SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 62.2 bits (151), Expect = 5e-10
 Identities = 32/91 (35%), Positives = 53/91 (58%)

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
           LL +H      +IHRD+K++NILL      K+ DFG ++++    ++   +   GT  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGKK 744
           +PE      +S K+D+FS GVLL E ++ K+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.6 bits (149), Expect = 6e-10
 Identities = 64/202 (31%), Positives = 91/202 (45%), Gaps = 19/202 (9%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIAKLQHRN--LVRL 603
           LG+G FG V         E+ A+K L ++       +E    E R++A L  +   L +L
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LSGKPPFLTQL 66

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
             C   MD    V EY+    L   I    R               IA GL +LH     
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLHSKG-- 121

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
            II+RDLK  N++LD E   KI+DFGM +  ++ G      TK   GT  Y++PE     
Sbjct: 122 -IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFCGTPDYIAPEIIAYQ 176

Query: 722 LFSVKSDVFSFGVLLLETVSGK 743
            +    D ++FGVLL E ++G+
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 36/94 (38%), Positives = 56/94 (59%), Gaps = 8/94 (8%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           I  GL ++H  +RF +++RDLK +NILLD+    +ISD G+A     D +++     VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGT 158

Query: 710 YGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSG 742
           +GYM+PE    G  +   +D FS G +L + + G
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 61.2 bits (148), Expect = 1e-09
 Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           +ARG+ +L   +    +HRDL A N+LL +    KI DFG+AR    D    +       
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
             +M+PE   D L++  SDV+S+G+LL E  S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 61.0 bits (148), Expect = 1e-09
 Identities = 40/111 (36%), Positives = 59/111 (53%), Gaps = 17/111 (15%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT---EQNTKRV 706
           +A+G+ +L   +    IHRD+ A N+LL      KI DFG+AR    D     + N +  
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277

Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKK-------NRGFY 749
           V    +M+PE   D +++V+SDV+S+G+LL E  S GK        N  FY
Sbjct: 278 V---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY 325

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 65/228 (28%), Positives = 102/228 (44%), Gaps = 31/228 (13%)

Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGI-EEFKNEVRL 591
           F++    +D +     +G+G +G V+K      G + AVK L  +    I EE + E  +
Sbjct: 10  FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPIHDIDEEIEAEYNI 67

Query: 592 IAKLQ-HRNLVRLLGCCVEMDEK-----MLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  L  H N+V+  G   + D K      LV E     S+  ++        L    R  
Sbjct: 68  LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERME 122

Query: 646 --IICGIAR----GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
             II  I      GL +LH +   + IHRD+K +NILL  E   K+ DFG++      + 
Sbjct: 123 EPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179

Query: 700 EQNTKRVVGTYGYMSPEY-----AMDGLFSVKSDVFSFGVLLLETVSG 742
            +NT   VGT  +M+PE       +D  +  + DV+S G+  +E   G
Sbjct: 180 RRNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 13/209 (6%)

Query: 550 LGQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIAKLQHRNLVRLLG 605
           LG+G FG ++       G+  A+K L +      +E  +   E R++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
                D    V EY     L    F  +R  + +  R       I   L YLH +    +
Sbjct: 63  SFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--V 117

Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           ++RDLK  N++LDK+   KI+DFG+ +   G +     K   GT  Y++PE   D  +  
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175

Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
             D +  GV++ E + G+    FY+ ++E
Sbjct: 176 AVDWWGLGVVMYEMMCGR--LPFYNQDHE 202

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.1 bits (145), Expect = 2e-09
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 13/199 (6%)

Query: 550 LGQGGFGIVYKGRLLEGQEI----AVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           +G+G +  V   RL + + I     VK+   N  + I+  + E  +  +  +   +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 606 CCVEMDEKML-VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
            C + + ++  V EY+    L   +F   R   L  +        I+  L YLH+     
Sbjct: 63  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 116

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           II+RDLK  N+LLD E   K++D+GM +   G +    T    GT  Y++PE      + 
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174

Query: 725 VKSDVFSFGVLLLETVSGK 743
              D ++ GVL+ E ++G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 13/199 (6%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIAKLQHRN-LVRLL 604
           LG+G FG V         E+ A+K L ++       +E    E R++A       L +L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
            C   +D    V EY+    L   ++   +       +       I+ GL +LH+     
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--- 121

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           II+RDLK  N++LD E   KI+DFGM +    D     T+   GT  Y++PE      + 
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYG 179

Query: 725 VKSDVFSFGVLLLETVSGK 743
              D +++GVLL E ++G+
Sbjct: 180 KSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 24/208 (11%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEE---FKNEVRLIAKLQHRNLVRLLG 605
           +G+G +G+V        G+++A+K++  +  + + +      E++L+  L+H ++V +  
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 606 CCV-----EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             +     E  +  +V+E ME+  L  VI  KA   +     +F  +  + R L Y+H  
Sbjct: 67  IMLPPSRREFKDIYVVFELMES-DLHQVI--KANDDLTPEHHQF-FLYQLLRALKYIHTA 122

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARI-FGGDQTEQNTKRVVGTYGYMSPEYAM 719
           + F   HRDLK  NIL + +   KI DFG+AR+ F    T       V T  Y +PE   
Sbjct: 123 NVF---HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC- 178

Query: 720 DGLFSVKS----DVFSFGVLLLETVSGK 743
            G F  K     D++S G +  E ++GK
Sbjct: 179 -GSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 14/209 (6%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIAKLQHRNLVRLLG 605
           LG+G FG V   R    G+  A+K L +      +E  +   E R++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
                D    V EY     L    F  +R  +   +R       I   L YLH      +
Sbjct: 63  AFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSALEYLHSRD---V 116

Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           ++RD+K  N++LDK+   KI+DFG+ +   G       K   GT  Y++PE   D  +  
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
             D +  GV++ E + G+    FY+ ++E
Sbjct: 175 AVDWWGLGVVMYEMMCGR--LPFYNQDHE 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 3e-09
 Identities = 60/250 (24%), Positives = 97/250 (38%), Gaps = 65/250 (26%)

Query: 533 DFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSR----NSGQGIEEFKN 587
           DFE I            +G+G FG V+  R  +  ++ A+K L +       Q I   + 
Sbjct: 2   DFEVIKV----------IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRA 50

Query: 588 EVRLIAKLQHRNLVRLLGCCVEMDEKML--VYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           E  ++A      +V+L       DE+ L  V EYM    L            +N   R +
Sbjct: 51  ERDILADADSPWIVKLY--YSFQDEEHLYLVMEYMPGGDL------------MNLLIRKD 96

Query: 646 IICG------IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA-------- 691
           +         IA  +L L    +   IHRD+K  NIL+D +   K++DFG+         
Sbjct: 97  VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156

Query: 692 -----------------RIFGGDQTEQNTKR--VVGTYGYMSPEYAMDGLFSVKSDVFSF 732
                             +   D  ++  +    VGT  Y++PE      + ++ D +S 
Sbjct: 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSL 216

Query: 733 GVLLLETVSG 742
           GV+L E + G
Sbjct: 217 GVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 58.5 bits (141), Expect = 7e-09
 Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 41/216 (18%)

Query: 548 NKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIEEFKNEVRLIAK-LQHRNLVRLLG 605
           N +G G FG+VY+   ++  E +A+K++ ++      ++KN   LI K L H N++ L  
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126

Query: 606 C----CVEMDEKML------------VYEYMENRSLDSVIFDKARSSILNWQRRFNIICG 649
                C + +EK +            V++YM++ + ++         + ++Q        
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ-------- 178

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLD-KEMTPKISDFGMAR-IFGGDQTEQNTKRVV 707
           + R L Y+H  S+F I HRDLK  N+L+D    T K+ DFG A+ +  G    Q +   +
Sbjct: 179 LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG----QRSVSYI 231

Query: 708 GTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSG 742
            +  Y +PE  +    ++   D++S G ++ E + G
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 58.0 bits (140), Expect = 9e-09
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 9/95 (9%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT---EQNTKRV 706
           +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D     + N +  
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
           V    +M+PE   + +++ +SDV+S+G+LL E  S
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 13/212 (6%)

Query: 550 LGQGGFGIVYKGRLLEGQEI----AVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           +G+G +  V   RL +  +I     VK+   +  + I+  + E  +  +      +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 606 CCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
            C +   ++ LV EY+    L   +F   R   L  +        I   L +LH+     
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHERG--- 116

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           II+RDLK  N+LLD +   K++D+GM +   G      T    GT  Y++PE      + 
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174

Query: 725 VKSDVFSFGVLLLETVSGKKNRGFYHSNNELN 756
              D ++ GVL+ E ++G+        N ++N
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 57.8 bits (139), Expect = 2e-08
 Identities = 49/182 (26%), Positives = 89/182 (48%), Gaps = 25/182 (13%)

Query: 571 VKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE---YMENRSLD- 626
           + +  +   +   + +NE+  + +L H N++++        E++L  E   YM  +  D 
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDF 247

Query: 627 ---SVIFDKA---RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE 680
              S ++D+A   +   L  Q R  I+  +   + Y+H     ++IHRD+K  NI L+ +
Sbjct: 248 DLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCD 303

Query: 681 MTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE-YAMDGLFSVKSDVFSFGVLLLET 739
               + DFG A  F  ++ E      VGT    SPE  A DG   + +D++S G++LL+ 
Sbjct: 304 GKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDM 361

Query: 740 VS 741
           +S
Sbjct: 362 LS 363

Length = 501

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 55.6 bits (134), Expect = 5e-08
 Identities = 44/174 (25%), Positives = 70/174 (40%), Gaps = 29/174 (16%)

Query: 588 EVRLIAKLQHRNLVRLLG--------CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILN 639
           E+ ++  + HR ++ L+         C V    K  ++ Y++            RS  L 
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVD------------RSGPLP 183

Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
            ++   I   +   L YLH      IIHRD+K  NI LD+     + DFG A        
Sbjct: 184 LEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240

Query: 700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE------TVSGKKNRG 747
                   GT    SPE      +  K+D++S G++L E      T+ GK+ + 
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294

Length = 392

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 55.2 bits (133), Expect = 6e-08
 Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 18/211 (8%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN---EVRLIAKLQHRNLVRLLG 605
           LG+G FG V   R     +  A+K L +      +E  +   E R++   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
                D    V EY     L    F  +R  + +  R       I   L YLH      +
Sbjct: 63  SFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALGYLH---SCDV 116

Query: 666 IHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           ++RDLK  N++LDK+   KI+DFG+ +  I  G       K   GT  Y++PE   D  +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFCGTPEYLAPEVLEDNDY 172

Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
               D +  GV++ E + G+    FY+ ++E
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 54.8 bits (132), Expect = 8e-08
 Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 22/204 (10%)

Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSR----NSGQGIEEFKNEVRLIAKLQHRNLV 601
           LG+GG+G V++ R + G +     A+K L +     + +     K E  ++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 602 RLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            L+    +   K+ L+ EY+    L        R  I         +  I+  L +LHQ 
Sbjct: 64  DLI-YAFQTGGKLYLILEYLSGGEL---FMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGTYGYMSPEYA 718
               II+RDLK  NILLD +   K++DFG+ +  I  G      T    GT  YM+PE  
Sbjct: 120 G---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEYMAPEIL 172

Query: 719 MDGLFSVKSDVFSFGVLLLETVSG 742
           M        D +S G L+ + ++G
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 51/210 (24%), Positives = 93/210 (44%), Gaps = 25/210 (11%)

Query: 544 FTDYN---KLGQGGFGIVYKGRLLEGQ--EIAVKRLSRNS---GQGIEEFKNEVRLIAKL 595
           + D+N    LG G FG V            +A+KR  ++     + ++   +E +++  +
Sbjct: 29  YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88

Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI---AR 652
            H   V L G   +     LV E++    +    F     + L   +RF    G    A+
Sbjct: 89  NHPFCVNLYGSFKDESYLYLVLEFV----IGGEFF-----TFLRRNKRFPNDVGCFYAAQ 139

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
            +L         I++RDLK  N+LLDK+   K++DFG A++      +  T  + GT  Y
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEY 194

Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           ++PE  ++      +D ++ G+ + E + G
Sbjct: 195 IAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 32/173 (18%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           +A G+ +L   +    +HRDL A N+L+ +    KI DFG+AR    D    +       
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKK------NRGFYHSNNELNLLGHV 761
             +M+PE   + L++  SDV+SFG+LL E  T+ G        N  FY      N +   
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY------NAIKRG 358

Query: 762 WRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
           +R+ K               PA+       +   C +E  E RP  + +V ++
Sbjct: 359 YRMAK---------------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 65/238 (27%), Positives = 100/238 (42%), Gaps = 39/238 (16%)

Query: 516 KRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIV----YKGRLLEGQEIAV 571
           K  Y   K D     L DFE  +  T        LG G FG V    +KG    G+  A+
Sbjct: 2   KAAYMFTKPDTSSWKLSDFE--MGET--------LGTGSFGRVRIAKHKGT---GEYYAI 48

Query: 572 KRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML--VYEYMENRSLD 626
           K L +      + ++    E  ++ +L H  +V ++  C   DE  +  + E++    L 
Sbjct: 49  KCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM--CSFQDENRVYFLLEFVVGGEL- 105

Query: 627 SVIFDKARSS--ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK 684
              F   R +    N   +F     +     YLH      II+RDLK  N+LLD +   K
Sbjct: 106 ---FTHLRKAGRFPNDVAKF-YHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVK 158

Query: 685 ISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           ++DFG A+     +    T  + GT  Y++PE           D ++ GVLL E ++G
Sbjct: 159 VTDFGFAK-----KVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 13/98 (13%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVV 707
           I+  L +LH+     II+RDLK  N+LLD E   K++D+GM +  I  GD     T    
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFC 157

Query: 708 GTYGYMSPEY--AMDGLFSVKSDVFSFGVLLLETVSGK 743
           GT  Y++PE     D  FSV  D ++ GVL+ E ++G+
Sbjct: 158 GTPNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 75/253 (29%), Positives = 111/253 (43%), Gaps = 30/253 (11%)

Query: 508 LNQVVISSKRDYSA-DKTDDLELPLFDFETIVRATDNFT----DYNK---LGQGGFGIVY 559
           LN +V+    D+ A  K  +++  L  +E IVR          DY+    +G+G FG V 
Sbjct: 3   LNSLVLD--LDFPALRKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQ 60

Query: 560 KGRLLEGQEI-AVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML- 615
             R    Q++ A+K LS+     +    F  E R I    +   V  L C  + D+K L 
Sbjct: 61  LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ-DDKYLY 119

Query: 616 -VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASN 674
            V EYM    L +++ +        W + +      A  +L L       +IHRD+K  N
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE--KWAKFYT-----AEVVLALDAIHSMGLIHRDVKPDN 172

Query: 675 ILLDKEMTPKISDFGMARIFGGDQTEQ-NTKRVVGTYGYMSPEY----AMDGLFSVKSDV 729
           +LLDK    K++DFG       D+T        VGT  Y+SPE       DG +  + D 
Sbjct: 173 MLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230

Query: 730 FSFGVLLLETVSG 742
           +S GV L E + G
Sbjct: 231 WSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 54.7 bits (131), Expect = 2e-07
 Identities = 84/316 (26%), Positives = 131/316 (41%), Gaps = 74/316 (23%)

Query: 523 KTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGI 582
           K DD E  L ++E I           K+G G FG V+  +    QE    +    S +G+
Sbjct: 4   KYDDGESRLNEYEVI----------KKIGNGRFGEVFLVKHKRTQEFFCWKAI--SYRGL 51

Query: 583 EEFKN-----EVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI 637
           +E +      EV ++ +L+H+N+VR +   +    + L Y  ME        F  A    
Sbjct: 52  KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL-YILME--------FCDAGDLS 102

Query: 638 LNWQRRFNI--------ICGIARGLL----YLHQ----DSRFRIIHRDLKASNILLDKEM 681
            N Q+ + +        I  I R LL    Y H      +  R++HRDLK  NI L   +
Sbjct: 103 RNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162

Query: 682 -----------------TPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
                              KI DFG+++  G    E      VGT  Y SPE  +    S
Sbjct: 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKS 219

Query: 725 V--KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR-----LWKEGKVLEMVDSS 777
              KSD+++ G ++ E  SGK    F+ +NN   L+  + R     +  + K L ++  +
Sbjct: 220 YDDKSDMWALGCIIYELCSGKTP--FHKANNFSQLISELKRGPDLPIKGKSKELNILIKN 277

Query: 778 VDNYPANE---VLRCI 790
           + N  A E    L+C+
Sbjct: 278 LLNLSAKERPSALQCL 293

Length = 1021

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 53.3 bits (128), Expect = 3e-07
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 23/203 (11%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVR--------LIAKLQHRNL 600
           +G+G FG V   +   +G+  AVK L + +   I + K E +        L+  ++H  L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKA---ILK-KKEQKHIMAERNVLLKNVKHPFL 58

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQ 659
           V L       D+   V +Y+    L    F   R  S    + RF     IA  L YLH 
Sbjct: 59  VGLHYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARF-YAAEIASALGYLHS 114

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
                II+RDLK  NILLD +    ++DFG+ +   G +  + T    GT  Y++PE   
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLR 169

Query: 720 DGLFSVKSDVFSFGVLLLETVSG 742
              +    D +  G +L E + G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 41/198 (20%), Positives = 94/198 (47%), Gaps = 24/198 (12%)

Query: 557 IVYKGRLLEGQEIAVKRL---SRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK 613
            +YKG     +E+ ++      +     I+  +NE++ + ++   N++++ G  +++ + 
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 614 M----LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ-DSRFRIIHR 668
           +    L+ EY     L  V+ DK +   L+++ + ++     +GL  L++  ++    ++
Sbjct: 94  LPRLSLILEYCTRGYLREVL-DKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNK---PYK 147

Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS---V 725
           +L + + L+ +    KI   G+ +I      +      V    Y S +   D +FS   +
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKN-----VNFMVYFSYKMLND-IFSEYTI 201

Query: 726 KSDVFSFGVLLLETVSGK 743
           K D++S GV+L E  +GK
Sbjct: 202 KDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 53.2 bits (128), Expect = 3e-07
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 25/214 (11%)

Query: 543 NFTDYNK---LGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEE---FKNEVRLIAKL 595
              D++    +G+G FG V   R    +++ A+K LS+       +   F  E  ++A  
Sbjct: 41  KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100

Query: 596 QHRNLVRLLGCCVEMDEKML--VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
               +V+L       D+K L  V EYM    L +++ +        W R +      A  
Sbjct: 101 NSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE--KWARFY-----TAEV 151

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD-QTEQNTKRVVGTYGY 712
           +L L        IHRD+K  N+LLDK    K++DFG       +     +T   VGT  Y
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT--AVGTPDY 209

Query: 713 MSPEYAM----DGLFSVKSDVFSFGVLLLETVSG 742
           +SPE       DG +  + D +S GV L E + G
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 52.7 bits (126), Expect = 4e-07
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 13/198 (6%)

Query: 550 LGQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVR----LIAKLQHRNLVRLL 604
           +G+G FG ++   R  +G   AVK L + +    +E  + +     L+  L+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
                 ++   V +Y+    L    F   R       R       +A  + YLH      
Sbjct: 63  YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLHS---LN 116

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           II+RDLK  NILLD +    ++DFG+ +   G + E+ T    GT  Y++PE      + 
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174

Query: 725 VKSDVFSFGVLLLETVSG 742
              D +  G +L E + G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 52.2 bits (125), Expect = 5e-07
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 2/93 (2%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
            A  L  L    +F +I+RDLK  NILLD +    + DFG+ ++   D  + NT    GT
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156

Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
             Y++PE  +   ++   D ++ GVLL E ++G
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 52.3 bits (125), Expect = 5e-07
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 19/211 (9%)

Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQE----IAVKRLSR----NSGQGIEEFKNEVRLIAK 594
           NF     LG G +G V+  R + G +     A+K L +       + +E  + E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 595 LQHRNLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG-IAR 652
           ++    +  L    + + K+ L+ +Y+    + + ++ +   S    +       G I  
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS----EDEVRFYSGEIIL 116

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
            L +LH   +  I++RD+K  NILLD E    ++DFG+++ F  ++ E+ T    GT  Y
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIEY 172

Query: 713 MSPEYAMDGLFSVKS-DVFSFGVLLLETVSG 742
           M+PE         K+ D +S G+L+ E ++G
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 51.7 bits (124), Expect = 8e-07
 Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 28/218 (12%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIAKLQH 597
            +F   + +G+G FG V   R     +I A+K + ++   + + +  F+ E  +++    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSV------IFDKARSSILNWQRRFNIICGIA 651
             + +L     + D   LV EY     L S+       FD+  +       +F +    A
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA-------QFYL----A 109

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG 711
             +L +H   +   +HRD+K  N+L+D+    K++DFG A     ++   N+K  VGT  
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTPD 168

Query: 712 YMSPEY--AMDG----LFSVKSDVFSFGVLLLETVSGK 743
           Y++PE    M+G     + V+ D +S GV+  E + G+
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.5 bits (123), Expect = 9e-07
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 6/99 (6%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IA  +L +H   +   +HRD+K  N+LLD     +++DFG       D T Q++   VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-AVGT 166

Query: 710 YGYMSPEY--AMD---GLFSVKSDVFSFGVLLLETVSGK 743
             Y+SPE   AM+   G +  + D +S GV + E + G+
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 51.1 bits (122), Expect = 1e-06
 Identities = 58/236 (24%), Positives = 95/236 (40%), Gaps = 61/236 (25%)

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           NI+ G  RGL YLHQ+     IHR++KAS+IL+  +    +S  G++ ++   +  Q  K
Sbjct: 105 NILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAK 159

Query: 705 RV-------VGTYGYMSPEYAMDGL--FSVKSDVFSFGVLLLETVSG------------- 742
            V            ++SPE     L  ++VKSD++S G+   E  +G             
Sbjct: 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML 219

Query: 743 -KKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENA 801
            +K +G  +S  ++           E   ++   S VD+     V+              
Sbjct: 220 LQKLKGPPYSPLDITTFPC------EESRMKNSQSGVDSGIGESVVA------------- 260

Query: 802 EERPTMASVVLMLSSETATMPQPKT--PGF------CLGRNPIETDSSSSKHDETF 849
                 A +   ++SE    P  KT  P F      CL ++P +  S+SS     F
Sbjct: 261 ------AGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 13/198 (6%)

Query: 550 LGQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVR----LIAKLQHRNLVRLL 604
           +G+G FG ++   R L+G+  AVK L +      +E K+ +     L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
                 ++   V +++    L    F   R       R       IA  L YLH      
Sbjct: 63  YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---IN 116

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           I++RDLK  NILLD +    ++DFG+ +   G      T    GT  Y++PE      + 
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174

Query: 725 VKSDVFSFGVLLLETVSG 742
              D +  G +L E + G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 51.1 bits (122), Expect = 1e-06
 Identities = 41/164 (25%), Positives = 69/164 (42%), Gaps = 24/164 (14%)

Query: 588 EVRLIAKLQHRNLVRLLG--------CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILN 639
           E  ++  + H ++++L G        C +    K  +Y Y+  +       + A   IL 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKR------NIAICDILA 186

Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
            +R       + R + YLH++   RIIHRD+KA NI ++      + DFG A  F  D  
Sbjct: 187 IER------SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDIN 236

Query: 700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
                   GT    +PE      +    D++S G++L E  +  
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 3/94 (3%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           IA  +L L    ++ I++RDLK  NILLD      + DFG+++    D    NT    GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGT 159

Query: 710 YGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSG 742
             Y++PE  +D   ++   D +S GVL+ E   G
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 46/214 (21%), Positives = 81/214 (37%), Gaps = 38/214 (17%)

Query: 550 LGQGGFGIVYK----GRLLEGQEIAVKRLSRNSGQGIEEFK---NEVRLIAKLQHRNLVR 602
                   + K      L+     AVK+++ +S    E+ K    E+    +LQH N++ 
Sbjct: 10  FEDLMIVHLAKHKPTNTLV-----AVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 603 LLGCCVEMDEKMLVYEYMENRS----LDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
            +   +   E  +V   M   S    L +   +      +       I+  +   L Y+H
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIA-----FILKDVLNALDYIH 118

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------- 711
                  IHR +KAS+ILL  +    +S    +            +RVV  +        
Sbjct: 119 SKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSM---IKHGKRQRVVHDFPKSSVKNL 172

Query: 712 -YMSPEYAMDGL--FSVKSDVFSFGVLLLETVSG 742
            ++SPE     L  ++ KSD++S G+   E  +G
Sbjct: 173 PWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 43/165 (26%), Positives = 76/165 (46%), Gaps = 20/165 (12%)

Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI---------FDKARSS 636
           ++E+  +A   H  +V+        D+ +L+ EY     L+  I         F +    
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 637 ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
           +L +Q        I   L  +H  SR +++HRDLK++NI L      K+ DFG ++ +  
Sbjct: 173 LLFYQ--------IVLALDEVH--SR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221

Query: 697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
             +        GT  Y++PE      +S K+D++S GV+L E ++
Sbjct: 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 46/223 (20%)

Query: 550 LGQGGFGIVYKGRLL--------EGQEIAVKRLSRNSGQGIE-----------------E 584
           LGQG    +Y GRL         E +      L   +  G E                  
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 585 FKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRR 643
           F     L++++ H +L  + G CV   E ++V E++E+  LD V   K +  + + W  +
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD-VCLRKEKGRVPVAW--K 119

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-----MTP--KISDFGMARIFGG 696
             +   +A  L YL   +   ++H ++ A NILL +       +P  K+SD G++  F  
Sbjct: 120 ITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTA 174

Query: 697 DQTEQNTKRVVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLE 738
              E+  +R+     +++PE    G   S  +D +SFG  LLE
Sbjct: 175 LSREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLE 213

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.0 bits (117), Expect = 6e-06
 Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 6/99 (6%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           +A  +L +    +   +HRD+K  N+LLDK    +++DFG       D T Q+    VGT
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV-AVGT 166

Query: 710 YGYMSPEY--AMD---GLFSVKSDVFSFGVLLLETVSGK 743
             Y+SPE   AM+   G +  + D +S GV + E + G+
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 19/156 (12%)

Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++ H+++V L G CV   E ++V E++E   LD  +F   +S +L    +F +   +
Sbjct: 57  MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQL 114

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILL-----DKEMTP--KISDFGMARIFGGDQTEQNT 703
           A  L YL       ++H ++   NILL     D E  P  K+SD G+        T  + 
Sbjct: 115 ASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP------ITVLSR 165

Query: 704 KRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLE 738
           +  V    +++PE   D    S+ +D +SFG  L E
Sbjct: 166 QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWE 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 55/200 (27%), Positives = 85/200 (42%), Gaps = 17/200 (8%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKNEVR----LIAKLQHRNLVRLL 604
           +G+G FG V   R    ++  AVK L + +    +E K+ +     L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
                 D+   V +Y+    L    +   R       R       IA  L YLH      
Sbjct: 63  FSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAEIASALGYLHS---LN 116

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN--TKRVVGTYGYMSPEYAMDGL 722
           I++RDLK  NILLD +    ++DFG+ +    +  E N  T    GT  Y++PE      
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 723 FSVKSDVFSFGVLLLETVSG 742
           +    D +  G +L E + G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 46.5 bits (110), Expect = 4e-05
 Identities = 30/81 (37%), Positives = 41/81 (50%), Gaps = 5/81 (6%)

Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY----AMDG 721
           IHRD+K  N+LLDK    K++DFG       +   +     VGT  Y+SPE       DG
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDG 222

Query: 722 LFSVKSDVFSFGVLLLETVSG 742
            +  + D +S GV L E + G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 33/147 (22%), Positives = 56/147 (38%), Gaps = 15/147 (10%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV--RLLGC 606
            L  G    VY     +  +  +K     S +   + + EV ++  L  + L   ++L  
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKIN--PSREKGADREREVAILQLLARKGLPVPKVLAS 61

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
                   L+ E++E  +LD V          + + + +I   +A  L  LHQ     + 
Sbjct: 62  GESDGWSYLLMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLC 111

Query: 667 HRDLKASNILLDKEMTPKISDFGMARI 693
           H DL   NIL+D      I D+  A  
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 45.1 bits (106), Expect = 1e-04
 Identities = 30/83 (36%), Positives = 46/83 (55%), Gaps = 6/83 (7%)

Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY--AMD--- 720
           +HRD+K  NIL+D     +++DFG       D T Q++   VGT  Y+SPE   AM+   
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAMEDGK 182

Query: 721 GLFSVKSDVFSFGVLLLETVSGK 743
           G +  + D +S GV + E + G+
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 16/102 (15%)

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI---------FGG----DQTE 700
           L YLH    + I+HRDLK  N+L+      K++DFG+++I         + G    D  E
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
              K+V GT  Y++PE  +   +    D ++ G++L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.3 bits (107), Expect = 1e-04
 Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 16/84 (19%)

Query: 615 LVYEYMENRSLDSVI-----FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRD 669
           LV EY+    + S++     FD+  +       ++  I  +A  L YLH+     IIHRD
Sbjct: 81  LVMEYLIGGDVKSLLHIYGYFDEEMA------VKY--ISEVALALDYLHRHG---IIHRD 129

Query: 670 LKASNILLDKEMTPKISDFGMARI 693
           LK  N+L+  E   K++DFG++++
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.3 bits (105), Expect = 2e-04
 Identities = 33/129 (25%), Positives = 53/129 (41%), Gaps = 36/129 (27%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM------------ARIFGG- 696
           IA  +L +    +   IHRD+K  N+LLD +   K+SDFG+             RI    
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166

Query: 697 --------DQTEQNTKR---------------VVGTYGYMSPEYAMDGLFSVKSDVFSFG 733
                        ++KR                VGT  Y++PE  +   ++ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226

Query: 734 VLLLETVSG 742
           V++ E + G
Sbjct: 227 VIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 47/180 (26%), Positives = 77/180 (42%), Gaps = 38/180 (21%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQGIEEFKNEVRL----- 591
           D+F    KLG+G FG+VYK  L+        +  +K+ +   G  +E + NE R+     
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNE-RVRRACP 188

Query: 592 --IAKLQHRNLVRLLGCCVEMDEKMLVYEY---------MENR----SLDSVIFDKARSS 636
              A   +  L  +     + DE  LV+ Y         M+++    +++  +  K +  
Sbjct: 189 NSCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDL 246

Query: 637 ILNWQRRFNIICGIARGLLY----LHQDSRFRIIHRDLKASNILLD-KEMTPKISDFGMA 691
               +R   II  I R +L+    LH      I+HRD+K  NI+      + KI D G A
Sbjct: 247 PKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 41.9 bits (99), Expect = 5e-04
 Identities = 30/114 (26%), Positives = 48/114 (42%), Gaps = 26/114 (22%)

Query: 586 KNEVRLIAKLQHRNLVRLLGCC------VEMDEKMLVYEYMENRSLDSVIFDKARSSILN 639
           + E R++AK       R  G        V+ D  ++V EY+E   L   + ++AR  +L 
Sbjct: 47  RREARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL-EEARPDLL- 98

Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
             R    +  + +    LH   +  I+H DL  SNI+L         DFG+   
Sbjct: 99  --REVGRL--VGK----LH---KAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140

Length = 204

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 43.0 bits (101), Expect = 6e-04
 Identities = 57/233 (24%), Positives = 101/233 (43%), Gaps = 36/233 (15%)

Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAK 594
           E I  +T  F   + LG+G FG V +    + +E    ++ RN  +   + K E++ + K
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEK 181

Query: 595 LQHRNLVRLLGCCVEMDEK---MLVYEYMENRSLD-SVIFDKARSSILNWQRR---FN-- 645
                 VR      +  ++   M +  Y +N +    ++  K    +L+W  +   F+  
Sbjct: 182 ------VRQ----ADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHR 231

Query: 646 ----IICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKIS-----DFGMARI 693
               II      L Y H  +   ++H DLK  NIL+   D  + P  +     D    RI
Sbjct: 232 HLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRI 289

Query: 694 --FGGDQTEQNTKR-VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
              GG   E++++  +V T  Y SPE  +   +   +D++S G ++ E  +GK
Sbjct: 290 CDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 42.2 bits (99), Expect = 0.001
 Identities = 41/165 (24%), Positives = 69/165 (41%), Gaps = 30/165 (18%)

Query: 587 NEVRLIAKLQHRNLVRLLG--------CCVEMDEKMLVYEYMENRSLDSVIFDKARSSIL 638
           +E RL+ +L H  ++ LL         C V    +  +Y Y+            AR   L
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYL-----------GARLRPL 257

Query: 639 NWQRRFNIICGIARGLL----YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
              +    +  +AR LL    Y+H +    IIHRD+K  N+L++      + DFG A   
Sbjct: 258 GLAQ----VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFA 310

Query: 695 GGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLET 739
            G  +      + GT    +PE      ++   D++S G+++ E 
Sbjct: 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA 355

Length = 461

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.6 bits (97), Expect = 0.001
 Identities = 35/126 (27%), Positives = 54/126 (42%), Gaps = 33/126 (26%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTE-------- 700
           IA  +L +    +   IHRD+K  N+LLD +   K+SDFG+   +    +TE        
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166

Query: 701 ---------QNTKR---------------VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
                     N+KR                VGT  Y++PE  M   ++   D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 737 LETVSG 742
            E + G
Sbjct: 227 YEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.5 bits (97), Expect = 0.001
 Identities = 55/249 (22%), Positives = 96/249 (38%), Gaps = 55/249 (22%)

Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNS---GQGIEEFKNEVRLIAKLQHRN 599
           F     LG G FG V   R ++ + + A+K L +        +   K E  ++A+  +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +VRL     + D    V +Y+    + S++    R  I         I  +   +  +H 
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMGIFPEDLARFYIAELTCAVESVH- 118

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF----------GGDQTEQNT------ 703
             +   IHRD+K  NIL+D++   K++DFG+   F           GD   Q++      
Sbjct: 119 --KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176

Query: 704 -----------------------------KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGV 734
                                          +VGT  Y++PE  +   ++   D +S GV
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236

Query: 735 LLLETVSGK 743
           +L E + G+
Sbjct: 237 ILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 40.6 bits (96), Expect = 0.002
 Identities = 31/100 (31%), Positives = 45/100 (45%), Gaps = 10/100 (10%)

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNT 703
            II  +   L  LH   +  IIH D+K  N+L D+      + D+G+ +I G        
Sbjct: 113 KIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD-- 167

Query: 704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
               GT  Y SPE      + V  D ++ GVL  E ++GK
Sbjct: 168 ----GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.0 bits (97), Expect = 0.003
 Identities = 33/161 (20%), Positives = 61/161 (37%), Gaps = 38/161 (23%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEF---------KNEVRLIAKLQHR 598
           + +G+G    + KG  L    +  +R+ +  G    E          + E RL+      
Sbjct: 339 HLIGKGAEADIKKGEYLGRDAVIKERVPK--GYRHPELDERLRTERTRAEARLL------ 390

Query: 599 NLVRLLGCC------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR 652
           +  R  G        V+ +EK +V EY+  + L  V+                ++  +  
Sbjct: 391 SEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLEG-----------NPELVRKVGE 439

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
            +  LH   +  I+H DL  SN ++  +    I DFG+ + 
Sbjct: 440 IVAKLH---KAGIVHGDLTTSNFIVRDDRLYLI-DFGLGKY 476

Length = 535

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 35/126 (27%), Positives = 54/126 (42%), Gaps = 33/126 (26%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTE-------- 700
           IA  +L +    +   IHRD+K  N+LLD +   K+SDFG+   +    +TE        
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166

Query: 701 ---------QNTKR---------------VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
                     N+KR                VGT  Y++PE  M   ++   D +S GV++
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 737 LETVSG 742
            E + G
Sbjct: 227 YEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|238011 cd00054, EGF_CA, Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins

 Score = 35.3 bits (82), Expect = 0.004
 Identities = 10/33 (30%), Positives = 15/33 (45%), Gaps = 1/33 (3%)

Query: 315 DQCDNYGECGPFGIC-DTNASPVCQCMRGFEPK 346
           D+C +   C   G C +T  S  C C  G+  +
Sbjct: 3   DECASGNPCQNGGTCVNTVGSYRCSCPPGYTGR 35

Many of these proteins require calcium for their biological function and calcium-binding sites have been found to be located at the N-terminus of particular EGF-like domains; calcium-binding may be crucial for numerous protein-protein interactions. Six conserved core cysteines form three disulfide bridges as in non calcium-binding EGF domains, whose structures are very similar. EGF_CA can be found in tandem repeat arrangements. Length = 38

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	862
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.98
PHA03210	501	serine/threonine kinase US3; Provisional	99.98
PLN00009	294	cyclin-dependent kinase A; Provisional	99.98
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.98
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.98
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.98
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.98
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.98
PHA02882	294	putative serine/threonine kinase; Provisional	99.98
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.98
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.98
KOG0586	596	consensus Serine/threonine protein kinase [General	99.98
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.98
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.98
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
PF00954	110	S_locus_glycop: S-locus glycoprotein family; Inter	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.94
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.89
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	99.89
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
PRK09188	365	serine/threonine protein kinase; Provisional	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.85
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.79
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.77
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.76
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.75
PRK12274	218	serine/threonine protein kinase; Provisional	99.73
PRK10345	210	hypothetical protein; Provisional	99.71
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.7
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.69
PRK14879	211	serine/threonine protein kinase; Provisional	99.66
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.65
smart00090	237	RIO RIO-like kinase.	99.65
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.64
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.63
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.63
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	99.62
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.59
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.55
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.55
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.54
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.48
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.45
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	99.42
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.38
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.25
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.23
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	99.19
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.17
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.17
KOG1243	690	consensus Protein kinase [General function predict	99.11
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.04
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.0
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.99
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.91
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.88
KOG3087	229	consensus Serine/threonine protein kinase [General	98.86
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.75
COG4248	637	Uncharacterized protein with protein kinase and he	98.74
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.72
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.69
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.5
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.44
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.44
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.41
PRK09902	216	hypothetical protein; Provisional	98.33
smart00473	78	PAN_AP divergent subfamily of APPLE domains. Apple	98.27
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.17
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.17
PF01636	239	APH: Phosphotransferase enzyme family This family	98.07
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.05
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.04
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	98.03
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.99
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.98
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.88
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	97.79
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.78
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	97.75
PLN02876	822	acyl-CoA dehydrogenase	97.71
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.7
PRK10593	297	hypothetical protein; Provisional	97.68
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.52
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.47
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.47
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.45
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.35
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.22
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.05
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.03
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	97.02
PLN02236	344	choline kinase	96.8
PRK05231	319	homoserine kinase; Provisional	96.73
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.67
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.55
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.53
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.31
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.13
cd01100	73	APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d	95.91
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.89
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.69
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.66
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.59
PLN02756	418	S-methyl-5-thioribose kinase	94.99

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-52  Score=457.81  Aligned_cols=287  Identities=45%  Similarity=0.786  Sum_probs=254.5

Q ss_pred             CCCccChHHHHHHcccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEE
Q 002969          528 ELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC  607 (862)
Q Consensus       528 ~~~~~~~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~  607 (862)
                      ....|++.++..||++|...++||+|+||.||+|.+.++..||||++.....+...+|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45679999999999999999999999999999999999999999988765443145699999999999999999999999


Q ss_pred             EeCC-ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEe
Q 002969          608 VEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS  686 (862)
Q Consensus       608 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~  686 (862)
                      .+.+ +++||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 499999999999999999876544 78999999999999999999999998899999999999999999999999


Q ss_pred             cccceeecCCCCcccccccc-cccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH
Q 002969          687 DFGMARIFGGDQTEQNTKRV-VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW  765 (862)
Q Consensus       687 DFGla~~~~~~~~~~~~~~~-~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~  765 (862)
                      |||+|+.....  ....... .||.+|+|||++..+..+.|+|||||||+|+||++|+++.+.........+..|++..+
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999654321  1111112 79999999999999999999999999999999999999877655555666899999999


Q ss_pred             hcCceeeeecccCC--CCCh-HHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          766 KEGKVLEMVDSSVD--NYPA-NEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       766 ~~~~~~~~id~~~~--~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .+++..+++|+.+.  .++. .+...+..++.+|++.+|++||+|.||+++|+.+
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            99999999999984  4454 6788899999999999999999999999999665

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-44  Score=389.97  Aligned_cols=256  Identities=32%  Similarity=0.473  Sum_probs=211.6

Q ss_pred             cccceeeccccEEEEEeEecCCcEEEEEEeccCCc--cchHHHHHHHHHHHhcccCCceEEEEEEEeCC-ceEEEEEecc
Q 002969          545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-EKMLVYEYME  621 (862)
Q Consensus       545 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~lV~E~~~  621 (862)
                      ...+.||+|+||+||+|.+.....||||++.....  ...++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            44467999999999999996555599999976532  22669999999999999999999999999987 7999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC-CeeEecccceeecCCCCcc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~  700 (862)
                      +|+|..+++.. +...+++..+++++.|||+||.|||++++  ||||||||+||||+.++ ++||+|||+++......  
T Consensus       124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--  198 (362)
T KOG0192|consen  124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--  198 (362)
T ss_pred             CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence            99999999775 45569999999999999999999999874  99999999999999998 99999999998764322  


Q ss_pred             cccccccccccccChhhhc--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          701 QNTKRVVGTYGYMSPEYAM--DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~--~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                      .......||+.|||||++.  ...|+.|+||||||++||||+||+.||.....      ...+......+..        
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~R--------  264 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLR--------  264 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCC--------
Confidence            2233368999999999999  56999999999999999999999999754322      1222222222221        


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                      ...+......+..++.+||+.||+.||++.|++..|+.+..
T Consensus       265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence            23344477788999999999999999999999999987643

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-44  Score=387.98  Aligned_cols=252  Identities=33%  Similarity=0.503  Sum_probs=212.6

Q ss_pred             cccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCC
Q 002969          545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRS  624 (862)
Q Consensus       545 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs  624 (862)
                      ...+.||+|.||.||.|.++....||+|.++.. ....++|.+|+++|++|+|+|||+++|+|..++..+||+|||+.|+
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs  287 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS  287 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence            445799999999999999988889999999765 3445789999999999999999999999999999999999999999


Q ss_pred             hhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccccc
Q 002969          625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK  704 (862)
Q Consensus       625 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  704 (862)
                      |.++|.. ..+..+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+|||||+.+..+.... ..
T Consensus       288 Ll~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~-~~  362 (468)
T KOG0197|consen  288 LLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA-SE  362 (468)
T ss_pred             HHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee-cC
Confidence            9999976 34456999999999999999999999998   9999999999999999999999999999554333322 22


Q ss_pred             cccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCCh
Q 002969          705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA  783 (862)
Q Consensus       705 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~  783 (862)
                      ...-+..|.|||.+..+.|+.|||||||||+||||+| |+.|+.....       .++.+.+..|..+        ..|.
T Consensus       363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-------~ev~~~le~GyRl--------p~P~  427 (468)
T KOG0197|consen  363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-------EEVLELLERGYRL--------PRPE  427 (468)
T ss_pred             CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-------HHHHHHHhccCcC--------CCCC
Confidence            2344779999999999999999999999999999999 6666433222       2233334444332        3366


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          784 NEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       784 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .++..+.++|..||+.+|++|||++.+...|+..
T Consensus       428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            7888999999999999999999999999999876

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=368.52  Aligned_cols=248  Identities=29%  Similarity=0.408  Sum_probs=208.6

Q ss_pred             ccccceeeccccEEEEEeEecC-CcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCc-eEEEEEec
Q 002969          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE-KMLVYEYM  620 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-~~lV~E~~  620 (862)
                      ++..+.||+|..|+|||+++.. ++.+|+|.+... .....+++.+|++++++.+||+||+++|.|..... ..++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            4456799999999999999876 677899999655 34456789999999999999999999999999884 99999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      .+|||++++...   +.+++...-+|+.+|++||.|||+..  +||||||||+||||+..|++||+|||.+..+.+.   
T Consensus       161 DgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  161 DGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             CCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            999999999654   34899999999999999999999632  4999999999999999999999999999877543   


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCC--CCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYH--SNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~--~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                       .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....  .....+++.++            ++...
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I------------v~~pp  299 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI------------VDEPP  299 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH------------hcCCC
Confidence             3445789999999999999999999999999999999999999976531  11222222222            22223


Q ss_pred             CCCChH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          779 DNYPAN-EVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       779 ~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ...|.. .+.++.+++..||++||.+||++.|+++
T Consensus       300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            344454 7889999999999999999999999986

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-42  Score=379.98  Aligned_cols=247  Identities=26%  Similarity=0.391  Sum_probs=212.7

Q ss_pred             ccccccceeeccccEEEEEeEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ..|...+.||+|||+.+|+++. ..|+.||+|++.+.   .....+...+|+++.++|+|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688899999999999999988 67999999999764   3445678899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      |+|++++|..++.   +++.+++.++..+..||+.||.|||+++   |+|||||..|+||+++.++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999985   4556999999999999999999999998   999999999999999999999999999988543


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      .  ......+|||.|+|||++.....+..+||||+|||||-|+.|++||+...       +...++.++...        
T Consensus       172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------vkety~~Ik~~~--------  234 (592)
T KOG0575|consen  172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------VKETYNKIKLNE--------  234 (592)
T ss_pred             c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-------HHHHHHHHHhcC--------
Confidence            3  33445899999999999999999999999999999999999999975321       222222222211        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       ...|...+.+..+||.++|+.+|.+||++++|+.
T Consensus       235 -Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  235 -YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             -cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             1234456678889999999999999999999995

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7e-43  Score=398.39  Aligned_cols=259  Identities=31%  Similarity=0.480  Sum_probs=218.4

Q ss_pred             ccccccceeeccccEEEEEeEecC------CcEEEEEEeccCCcc-chHHHHHHHHHHHhcccCCceEEEEEEEeCCceE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  614 (862)
                      .+....+.||+|+||.||+|+...      .+.||||.++..... ..++|++|++++..++|||||+|+|+|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            344556899999999999997532      456999999887655 7889999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhccC-----------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCe
Q 002969          615 LVYEYMENRSLDSVIFDKAR-----------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  683 (862)
                      +|+|||..|+|.++|.....           ...|+..+.+.||.|||.||+||-++.   +|||||..+|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence            99999999999999964321           223889999999999999999999987   9999999999999999999


Q ss_pred             eEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHH
Q 002969          684 KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVW  762 (862)
Q Consensus       684 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~  762 (862)
                      ||+||||++.+...+.......-.-+.+|||||.++.++|+.+||||||||+|||+++ |+.|+.....+       ++.
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-------EVI  715 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-------EVI  715 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-------HHH
Confidence            9999999998765544433323345789999999999999999999999999999998 66675433322       233


Q ss_pred             HHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       763 ~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      +.+..+++        -..|.+++.++++||..||+.+|.+||+++||-..|....
T Consensus       716 e~i~~g~l--------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  716 ECIRAGQL--------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             HHHHcCCc--------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence            44444443        3557888999999999999999999999999999998864

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=358.26  Aligned_cols=197  Identities=33%  Similarity=0.569  Sum_probs=178.3

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .+|...++||+|+|++||+|++.. +..||||.+...  .....+-+..|+.+|+.++|||||++++++...+..+||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            568888899999999999999865 789999999766  55567788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC------CCeeEeccccee
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE------MTPKISDFGMAR  692 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~------~~~kL~DFGla~  692 (862)
                      ||.+|+|.++++.+.   .+++.....++.|||.||++||+++   ||||||||+||||+..      -.+||+|||+|+
T Consensus        90 yC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             eCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            999999999997654   4899999999999999999999998   9999999999999764      468999999999


Q ss_pred             ecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCC
Q 002969          693 IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRG  747 (862)
Q Consensus       693 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~  747 (862)
                      .+..   .......+|++-|||||+++.++|+.|+|+||+|+|||++++|+.||.
T Consensus       164 ~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~  215 (429)
T KOG0595|consen  164 FLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD  215 (429)
T ss_pred             hCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence            8753   333445799999999999999999999999999999999999999964

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-43  Score=390.07  Aligned_cols=268  Identities=28%  Similarity=0.405  Sum_probs=221.7

Q ss_pred             cccccceeeccccEEEEEeEecC----CcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ...+.++||.|.||+||+|+++-    ...||||.++.. .+....+|+.|+.||.+++||||++|.|+.......++|.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            34566899999999999998864    346999999876 4567789999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      |||+||+|+.+|+.+.  ..+++.++.-++++||.||.||-+.+   +|||||.++||||+.+..+|++||||++.+..+
T Consensus       710 EyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence            9999999999996554  45999999999999999999999998   999999999999999999999999999987554


Q ss_pred             Cccc-ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          698 QTEQ-NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       698 ~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      .... .+..-.-+.+|.|||.+..++++.+|||||||++|||.++ |.+|+-.....+       +.+.+.++-      
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-------VIkaIe~gy------  851 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VIKAIEQGY------  851 (996)
T ss_pred             CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-------HHHHHHhcc------
Confidence            4221 1111223679999999999999999999999999999776 888853222211       222222221      


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCCCCCCCCccc
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGFC  830 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~  830 (862)
                       + ...|++++..+.+||+.|||+|-.+||++.+|+.+|++++..+...+..+-.
T Consensus       852 -R-LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~  904 (996)
T KOG0196|consen  852 -R-LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPE  904 (996)
T ss_pred             -C-CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCC
Confidence             1 3457889999999999999999999999999999999987766655555443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.4e-42  Score=358.64  Aligned_cols=251  Identities=25%  Similarity=0.365  Sum_probs=202.7

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCcc-------chHHHHHHHHHHHhcccCCceEEEEEEEeCCce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQ-------GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  613 (862)
                      +.|.+.+.||+|+||.|-+|... .++.||||++++....       ......+|+++|++|+|||||++++++...+..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            46778899999999999999654 5999999999764211       123356999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC---CCeeEecccc
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGM  690 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kL~DFGl  690 (862)
                      |+||||++||.|.+.+..+.   .+.+....-++.|++.|+.|||++|   |+||||||+|||+..+   ..+||+|||+
T Consensus       252 YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             EEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccch
Confidence            99999999999999986543   3777777889999999999999999   9999999999999765   7899999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcCCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhc
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL---FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE  767 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  767 (862)
                      |+..+   ........+||+.|.|||++.+..   +..|+|+||+||+||-+++|.+||.....+.  .+.+.    +..
T Consensus       326 AK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQ----I~~  396 (475)
T KOG0615|consen  326 AKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQ----ILK  396 (475)
T ss_pred             hhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHH----Hhc
Confidence            99864   334455689999999999998764   3348899999999999999999986433322  12111    222


Q ss_pred             CceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          768 GKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       768 ~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ++...     ..........+..+||.+||..||++||++.|+++
T Consensus       397 G~y~f-----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  397 GRYAF-----GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             Ccccc-----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            22111     02234556788999999999999999999999985

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-41  Score=339.10  Aligned_cols=258  Identities=26%  Similarity=0.424  Sum_probs=209.8

Q ss_pred             ccccccceeeccccEEEEEeEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEE-EEEeCCc-eEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLG-CCVEMDE-KMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g-~~~~~~~-~~lV  616 (862)
                      .+|.++++||+|.||+||++.. .+|..+|.|.+.-.  +.+..++...|+.+|++|+|||||++++ -+.+... +++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            4578889999999999999964 56899999998744  4556678899999999999999999998 5666555 8999


Q ss_pred             EEeccCCChhhhhhh-ccCCCCCCHhhHHHHHHHHHHHhHHhhhcCC-CcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          617 YEYMENRSLDSVIFD-KARSSILNWQRRFNIICGIARGLLYLHQDSR-FRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      ||++..|+|...+.. +.....++++.+++++.|+++||.++|..-+ -.|+||||||.||+|+.+|.+||+||||++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999965 3445679999999999999999999998421 13999999999999999999999999999998


Q ss_pred             CCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          695 GGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       695 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ....  ......+|||.||+||.+.+.+|+.||||||+||++|||+.-++||...   +   +. ...+.+..+.     
T Consensus       179 ~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n---~~-~L~~KI~qgd-----  244 (375)
T KOG0591|consen  179 SSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---N---LL-SLCKKIEQGD-----  244 (375)
T ss_pred             cchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---c---HH-HHHHHHHcCC-----
Confidence            5433  3344579999999999999999999999999999999999999997432   2   21 2222233321     


Q ss_pred             cccCCCCC-hHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          775 DSSVDNYP-ANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       775 d~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                         ....| .-.+..+..++..|+..||+.||+...+++.+..
T Consensus       245 ---~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  245 ---YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             ---CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence               12233 4567889999999999999999986666655544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=346.79  Aligned_cols=242  Identities=26%  Similarity=0.355  Sum_probs=202.3

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .++|+.+++||+|+||.||.++..+ ++.+|+|++++.   .....+...+|..+|.+++||.||+++..|++.+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            3679999999999999999998766 788999999765   234577889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      +||+.||.|..+|.+.   ..+++..+.-++.+|+.||.|||+.+   ||||||||+|||||++|+++|+||||++....
T Consensus       104 ld~~~GGeLf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQRE---GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            9999999999999544   34888888889999999999999998   99999999999999999999999999986432


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                        ....+...+||+.|||||++.+..|+..+|.||||+++|||++|.+||.....   ....    +....++       
T Consensus       178 --~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~---~~~~----~~I~~~k-------  241 (357)
T KOG0598|consen  178 --DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV---KKMY----DKILKGK-------  241 (357)
T ss_pred             --CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH---HHHH----HHHhcCc-------
Confidence              23344458999999999999999999999999999999999999999743221   1111    1112221       


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCC
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERP  805 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP  805 (862)
                       +...+.-...+..+++.+.|+.+|++|.
T Consensus       242 -~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 -LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence             2233333566788999999999999995

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-40  Score=386.91  Aligned_cols=257  Identities=33%  Similarity=0.497  Sum_probs=213.0

Q ss_pred             ccccceeeccccEEEEEeEecC--Cc----EEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          544 FTDYNKLGQGGFGIVYKGRLLE--GQ----EIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~~--~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .+..+.||+|.||.||.|...+  +.    .||||.+++. +.+...+|.+|+.+|++++|||||+++|+|.+....+++
T Consensus       694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~  773 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL  773 (1025)
T ss_pred             eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence            4556899999999999998654  32    4899999776 456788999999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhcc----CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          617 YEYMENRSLDSVIFDKA----RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      +|||++|+|..+|++..    +...|...+.+.++.|||+|+.|||+++   +|||||.++|+||++...+||+|||||+
T Consensus       774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlAr  850 (1025)
T KOG1095|consen  774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLAR  850 (1025)
T ss_pred             ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhH
Confidence            99999999999997642    2456999999999999999999999997   9999999999999999999999999999


Q ss_pred             ecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          693 IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       693 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      .+...+.........-+..|||||.+..+.|+.|+|||||||+|||++| |..||......+       +...+.++.. 
T Consensus       851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-------v~~~~~~ggR-  922 (1025)
T KOG1095|consen  851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-------VLLDVLEGGR-  922 (1025)
T ss_pred             hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-------HHHHHHhCCc-
Confidence            6655444333333445679999999999999999999999999999999 666654322211       1111222221 


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                             -..|..++..+.+||..||+.+|++||++..|++.+..+.
T Consensus       923 -------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  923 -------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             -------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence                   2346678889999999999999999999999999887763

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.8e-39  Score=319.52  Aligned_cols=280  Identities=25%  Similarity=0.400  Sum_probs=224.0

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ++|...++||+|.||.||+|+.. .|+.||||+++...  ..-.....+|++.|+.++|+||+.++++|.+.+..-||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            35777899999999999999865 48999999997652  2224567899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      ||+ .+|+..+.++  ...++..++..++.++++||+|||.+.   |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus        82 fm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            997 5899888554  456889999999999999999999998   9999999999999999999999999999987654


Q ss_pred             cccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeee----
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM----  773 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~----  773 (862)
                      ......  +-|..|.|||++.+. .|+..+|+||.|||+.||+.|.+-   .+++.+.+.+..+++.+......+.    
T Consensus       156 ~~~~~~--V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~---fpG~sDidQL~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  156 RIQTHQ--VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPF---FPGDSDIDQLSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             cccccc--eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCC---CCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence            444332  678999999999875 699999999999999999998764   5667777888888877765432221    


Q ss_pred             --ecc---------cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCCCCCCCCccccCCC
Q 002969          774 --VDS---------SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGFCLGRN  834 (862)
Q Consensus       774 --id~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~~~~~  834 (862)
                        -|.         .....-.....++++|+..|+..||.+|++++|++++=  -....|.|-.|...+.+.
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~--yf~~~P~pt~~~~lp~p~  300 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP--YFKSLPLPTPPSKLPIPS  300 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch--hhhcCCCCCChhhCcCCc
Confidence              111         11123334556678999999999999999999998752  223455555555444333

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=350.15  Aligned_cols=265  Identities=28%  Similarity=0.430  Sum_probs=217.3

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCcc-chHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      .....+.++||+|-||+|.++....+..||||+++..... ...+|.+|+++|.+++||||++++|+|..++..++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            3445677899999999999999988899999999877544 458999999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      |++|+|..+|..+.-.. +.-...++|+.|||.||+||.+.+   +|||||.++|+|++.++++||+|||+++.+...+.
T Consensus       617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence            99999999997664332 566777889999999999999987   99999999999999999999999999997765555


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh--CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS--GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      .....+.+-+.+|||||.+..++++.++|||+||+++||+++  ...|++...   +...++..-..+..+.. +.    
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~~~~~~~~-~~----  764 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGEFFRDQGR-QV----  764 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhhhcCCCCc-ce----
Confidence            555555677899999999999999999999999999999876  445543222   22222322222222211 11    


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      +...|..++..++++++.||..+-++||++++|...|.+.
T Consensus       765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1334566778899999999999999999999999988664

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-39  Score=345.40  Aligned_cols=262  Identities=25%  Similarity=0.402  Sum_probs=210.4

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeC--CceEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKML  615 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~l  615 (862)
                      .+.|+.+++||+|.||.||+|+.. .|+.||+|+++...  +.......+||.+|++|+||||++|.+...+.  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            356788899999999999999865 48899999997654  44566778999999999999999999999876  68999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      |+|||+. +|.-++..  ..-.+++.++..++.||+.||+|+|..+   |+|||||..|||||.+|.+||+|||||+++.
T Consensus       196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999985 77777643  2345999999999999999999999998   9999999999999999999999999999887


Q ss_pred             CCCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee---
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL---  771 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---  771 (862)
                      .......+ ..+-|..|.|||++.+. .|+.++|+||.||||.||+.|++.+   ....+.+.+..++++.......   
T Consensus       270 ~~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~---~G~tEveQl~kIfklcGSP~e~~W~  345 (560)
T KOG0600|consen  270 PSGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL---QGRTEVEQLHKIFKLCGSPTEDYWP  345 (560)
T ss_pred             CCCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc---CCccHHHHHHHHHHHhCCCChhccc
Confidence            65554434 35669999999999886 6999999999999999999999874   4555666677776665432211   


Q ss_pred             --eeecccC----CCC-------ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 --EMVDSSV----DNY-------PANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 --~~id~~~----~~~-------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        ++.....    ..+       ....+...++|+..+|..||.+|.|+.++++
T Consensus       346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence              1111000    011       1223345778999999999999999999885

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=344.36  Aligned_cols=257  Identities=27%  Similarity=0.410  Sum_probs=208.2

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCC--ceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD--EKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--~~~lV~E  618 (862)
                      .++...+.||+|+||.||++...+ |...|||.+........+.+.+|+++|.+++|||||+++|......  .++++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            356677899999999999998765 8899999997664444677999999999999999999999855544  5899999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC-CCCeeEecccceeecCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-EMTPKISDFGMARIFGGD  697 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~  697 (862)
                      |+++|+|.+++.+...  .+++..+..++.||++||+|||+++   ||||||||+||||+. ++.+||+|||++......
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999976543  5999999999999999999999998   999999999999999 799999999999877541


Q ss_pred             -CcccccccccccccccChhhhcCCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          698 -QTEQNTKRVVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       698 -~~~~~~~~~~gt~~y~APE~l~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                       ..........||+.|||||++.++. ...++|||||||++.||+||++||...     .....+......+.       
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~-------  239 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED-------  239 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC-------
Confidence             1222233478999999999999643 345999999999999999999998643     11222222222221       


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                       ....++...+.+..+++.+|++.+|++|||++|++...-.
T Consensus       240 -~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  240 -SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             -CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence             1124455667788899999999999999999999986533

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.9e-39  Score=356.39  Aligned_cols=261  Identities=30%  Similarity=0.439  Sum_probs=205.4

Q ss_pred             cccccccceeeccccEEEEEeEec------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCC-
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD-  611 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~-  611 (862)
                      .++|+..++||+|+||.||+|...      .+..||||+++... ....+.+.+|+.++.++ +||||++++++|...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            467888999999999999999742      24679999997543 23456789999999999 8999999999887644 


Q ss_pred             ceEEEEEeccCCChhhhhhhccC---------------------------------------------------------
Q 002969          612 EKMLVYEYMENRSLDSVIFDKAR---------------------------------------------------------  634 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------  634 (862)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999999864321                                                         


Q ss_pred             --CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccccccccccccc
Q 002969          635 --SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY  712 (862)
Q Consensus       635 --~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y  712 (862)
                        ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              124778889999999999999999988   999999999999999999999999999865433222222234567889


Q ss_pred             cChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHH
Q 002969          713 MSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIH  791 (862)
Q Consensus       713 ~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~  791 (862)
                      +|||++.+..++.++||||||+++|||++ |..|+.......      ........+..        ...+...+..+.+
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~--------~~~~~~~~~~l~~  308 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTR--------MRAPENATPEIYR  308 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCC--------CCCCCCCCHHHHH
Confidence            99999999999999999999999999997 888875422211      11112222211        1123344567889


Q ss_pred             HHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          792 VGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       792 li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      ++.+||+.+|++||++.||++.|+.+.
T Consensus       309 li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         309 IMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.1e-39  Score=327.34  Aligned_cols=260  Identities=20%  Similarity=0.359  Sum_probs=205.2

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCc--cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      +.|+.+.++|+|+||.|||++..+ |+.||||++....+  ...+-.++|+++|++++|+|+|.++.+|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            467778899999999999999876 89999999965532  334567899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |++..-|+++-. ..  .-++...+.+++.|+++|+.|+|+++   +|||||||+||||+.++.+||+|||+|+.+..  
T Consensus        82 ~~dhTvL~eLe~-~p--~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--  153 (396)
T KOG0593|consen   82 YCDHTVLHELER-YP--NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--  153 (396)
T ss_pred             ecchHHHHHHHh-cc--CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence            999866666542 22  23788889999999999999999998   99999999999999999999999999998853  


Q ss_pred             cccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHH-----------Hh
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL-----------WK  766 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~-----------~~  766 (862)
                      .....+..+.|..|+|||++.+ -.|...+||||+||++.||++|.+-|   ++.++.+.+-.+.+.           +.
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~---PG~SDiDQLy~I~ktLG~L~prhq~iF~  230 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW---PGRSDIDQLYLIRKTLGNLIPRHQSIFS  230 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC---CCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence            3334445678999999999988 68999999999999999999999864   344444444443332           22


Q ss_pred             cCceeeee-cccC------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          767 EGKVLEMV-DSSV------DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       767 ~~~~~~~i-d~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ......-+ -+..      +.-.+.....+++++..||+.||++|++.+|++.
T Consensus       231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            22211111 0111      1111233346789999999999999999999883

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=349.96  Aligned_cols=252  Identities=26%  Similarity=0.354  Sum_probs=211.4

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~  614 (862)
                      ..++|.+.+.||+|+|++|++|+..+ ++++|||++.+.   .+...+....|-.+|.+| .||.|++|+..|.+...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            34678999999999999999998655 889999999764   234456677899999999 7999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      +|+||+++|+|.++|.+.+   .+++.....++.+|+.||+|||+.|   ||||||||+|||||+|+++||+|||.|+.+
T Consensus       151 FvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             EEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999996653   4899999999999999999999998   999999999999999999999999999988


Q ss_pred             CCCCcc---------cc--cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHH
Q 002969          695 GGDQTE---------QN--TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR  763 (862)
Q Consensus       695 ~~~~~~---------~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~  763 (862)
                      ......         ..  ....+||..|.+||++.....+..+|+|+||||||+|+.|++||.   ..++...+..+..
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFr---a~NeyliFqkI~~  301 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFR---AANEYLIFQKIQA  301 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCc---cccHHHHHHHHHH
Confidence            653322         11  145899999999999999999999999999999999999999963   2233223332221


Q ss_pred             HHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          764 LWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       764 ~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                                   .--.+++..+..+.+|+.+.|..||.+|+|.+||-++
T Consensus       302 -------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  302 -------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                         1123455556788899999999999999999999864

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-39  Score=351.79  Aligned_cols=258  Identities=28%  Similarity=0.471  Sum_probs=208.3

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +.+...+.||+|.||+||+|++.  ..||||++...  ..+..+.|++|+.++++-+|.||+-+.|+|..... .+|..+
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw  468 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW  468 (678)
T ss_pred             HHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence            44566789999999999999884  47999999765  34578899999999999999999999999988777 999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      ++|.+|..+|+..+  ..++..+.++||.|||+||.|||.++   |||||||..||+|.++++|||+||||+..-..-..
T Consensus       469 CeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g  543 (678)
T KOG0193|consen  469 CEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG  543 (678)
T ss_pred             ccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence            99999999996544  45899999999999999999999998   99999999999999999999999999975433222


Q ss_pred             ccccccccccccccChhhhcC---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          700 EQNTKRVVGTYGYMSPEYAMD---GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ........|...|||||++..   .+|++.+||||||+++|||++|..||.....+       .+.-++..|..+    +
T Consensus       544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-------qIifmVGrG~l~----p  612 (678)
T KOG0193|consen  544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-------QIIFMVGRGYLM----P  612 (678)
T ss_pred             ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-------heEEEecccccC----c
Confidence            233334567889999999964   36999999999999999999999997521111       111111111111    1


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      .+.....++..++.+|+..||..++++||.+.+|+.+|+.+.
T Consensus       613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~  654 (678)
T KOG0193|consen  613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL  654 (678)
T ss_pred             cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence            122334556778999999999999999999999999888873

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=346.65  Aligned_cols=260  Identities=25%  Similarity=0.373  Sum_probs=211.4

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHH--HHHHHHHHHhcc-cCCceEEEEEEEeCC-ceEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEE--FKNEVRLIAKLQ-HRNLVRLLGCCVEMD-EKML  615 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~--~~~E~~~l~~l~-HpnIv~l~g~~~~~~-~~~l  615 (862)
                      .++|...++||.|.||.||+|+-. .++.||||++++.... +++  =.+|++.|++|+ |||||++..++.+.+ .+++
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            467888899999999999999765 4889999999876433 333  257999999998 999999999999988 9999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      |||||+ .+|..++.++  +..+++..+..|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+||||||.+.
T Consensus        88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence            999996 6899998654  667999999999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ...   ..+..+.|..|+|||++.. +.|+.+.|+||+|||++|+.+-++-|   ++.++.+.+-.+.+.+.........
T Consensus       162 Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF---PG~sE~Dqi~KIc~VLGtP~~~~~~  235 (538)
T KOG0661|consen  162 SKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF---PGASEIDQIYKICEVLGTPDKDSWP  235 (538)
T ss_pred             cCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC---CCCcHHHHHHHHHHHhCCCccccch
Confidence            433   2334678999999998765 67999999999999999999988764   4555555555555554433221111


Q ss_pred             -----------------cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          775 -----------------DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       775 -----------------d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                                       ...+...-+..+.++++++.+|++.||++|||+.|.+++
T Consensus       236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                             111122223467789999999999999999999999974

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-38  Score=332.83  Aligned_cols=261  Identities=24%  Similarity=0.366  Sum_probs=209.3

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .+.|+..++||.|.-++||+|+... ++.||||++..+. ....+.+++|+..|+.++||||++++..|..+..+++||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            3578888999999999999997654 7899999997653 3347899999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      ||.+||+.+++...-... +++..+..|+.++++||.|||++|   .||||||+.||||+++|.+||+|||.+..+....
T Consensus       105 fMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999997765544 899999999999999999999998   9999999999999999999999999876654332


Q ss_pred             ccc--ccccccccccccChhhhcC--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          699 TEQ--NTKRVVGTYGYMSPEYAMD--GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       699 ~~~--~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ...  .....+||+.|||||+++.  ..|+.|+||||||++..||.+|+.||..+++..-      ....+ .+......
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------Ll~tL-qn~pp~~~  253 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------LLLTL-QNDPPTLL  253 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------HHHHh-cCCCCCcc
Confidence            221  1145689999999999654  4699999999999999999999999876654321      11111 11111000


Q ss_pred             cccC-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          775 DSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       775 d~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      -... .+........+.+++..||++||.+|||++++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            0000 1112233447889999999999999999999984

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.8e-37  Score=339.18  Aligned_cols=264  Identities=27%  Similarity=0.423  Sum_probs=204.4

Q ss_pred             ccccccceeeccccEEEEEeEecC-----------------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-----------------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRL  603 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l  603 (862)
                      ++|...++||+|+||.||++...+                 +..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467888999999999999997532                 2369999987643 3345679999999999999999999


Q ss_pred             EEEEEeCCceEEEEEeccCCChhhhhhhcc----------------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEe
Q 002969          604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKA----------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH  667 (862)
Q Consensus       604 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH  667 (862)
                      ++++.+.+..++||||+++++|.+++....                ....+++..+++++.||+.||+|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999885421                1134788889999999999999999998   999


Q ss_pred             cccCCcceEecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCC--CC
Q 002969          668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK--KN  745 (862)
Q Consensus       668 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~--~p  745 (862)
                      |||||+|||++.++.+||+|||+++.+.............++..|+|||++....++.++||||||+++|||+++.  .|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            9999999999999999999999998764333222223345678999999999889999999999999999999854  44


Q ss_pred             CCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          746 RGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       746 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      +....   ...........+..... ..    ....+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus       242 ~~~~~---~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELT---DEQVIENAGEFFRDQGR-QV----YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCC---HHHHHHHHHHHhhhccc-cc----cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            33221   22222222222211110 00    011223445678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-38  Score=350.08  Aligned_cols=258  Identities=32%  Similarity=0.431  Sum_probs=207.0

Q ss_pred             ccccccceeeccccEEEEEeEecCC----cE-EEEEEecc---CCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEG----QE-IAVKRLSR---NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~----~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  613 (862)
                      ++....++||+|+||.||+|++...    .. ||||..+.   .......+|.+|+++|++++|||||+++|++....+.
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            3445558999999999999987542    23 89999874   2466788999999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++|||++.||+|.++|.....  .++..+++.++.+.|.||+|||+.+   ++||||.++|+|++.++.+||+||||++.
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence            999999999999999965443  5999999999999999999999998   99999999999999999999999999875


Q ss_pred             cCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHH-hcCcee
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLW-KEGKVL  771 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~-~~~~~~  771 (862)
                      -..  .........-+..|+|||.+....|+.++|||||||++||+++ |..|+....   ..    .+...+ ..+.. 
T Consensus       312 ~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~---~~----~v~~kI~~~~~r-  381 (474)
T KOG0194|consen  312 GSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK---NY----EVKAKIVKNGYR-  381 (474)
T ss_pred             Ccc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC---HH----HHHHHHHhcCcc-
Confidence            321  1111101235679999999999999999999999999999999 777753221   11    111111 22221 


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCC
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATM  821 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  821 (862)
                             ...+...+.++..++.+||+.+|++||+|.++.+.|+.+....
T Consensus       382 -------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  382 -------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             -------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence                   1223455667788999999999999999999999998875443

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-38  Score=342.73  Aligned_cols=250  Identities=30%  Similarity=0.439  Sum_probs=211.7

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      ..|...++||+|+-|.||.++.. .++.||||++........+-..+|+.+|+..+|+|||+++..+...+++++|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            45777789999999999999754 48899999998776666778899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++|+|-+.+...    .+++.++..|+.++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+..... 
T Consensus       353 ~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  353 EGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             CCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            999999988433    3899999999999999999999998   99999999999999999999999999988765444 


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                       .....+||+.|||||+.....|.+|.||||||++++||+-|++||-.      .+.+..++.....+. .+      -.
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln------E~PlrAlyLIa~ng~-P~------lk  490 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN------ENPLRALYLIATNGT-PK------LK  490 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC------CChHHHHHHHhhcCC-CC------cC
Confidence             33347899999999999999999999999999999999999999643      122333333222222 11      12


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .+...+..+.+++.+||+.|+++||++.|+|+.
T Consensus       491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            344556788999999999999999999999973

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.6e-37  Score=347.98  Aligned_cols=259  Identities=26%  Similarity=0.390  Sum_probs=204.3

Q ss_pred             ccccccceeeccccEEEEEeEe------cCCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~  613 (862)
                      ++|+..++||+|+||.||+|+.      ..+..||||+++... ....+.+.+|+.++..+ +||||++++++|.+.+..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4688889999999999999963      235689999996543 33456788999999999 899999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccC-----------------------------------------------------------
Q 002969          614 MLVYEYMENRSLDSVIFDKAR-----------------------------------------------------------  634 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~-----------------------------------------------------------  634 (862)
                      ++||||+++|+|.+++.....                                                           
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            999999999999999854221                                                           


Q ss_pred             -------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          635 -------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       635 -------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                                   ...+++..+.+++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.......
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                         124788899999999999999999987   9999999999999999999999999998764332222


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      ......++..|+|||++.+..++.++||||||+++|||++ |..|+......  .    ...+.+..+..        ..
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~----~~~~~~~~~~~--------~~  337 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--S----KFYKMIKEGYR--------ML  337 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--H----HHHHHHHhCcc--------CC
Confidence            2222345678999999999999999999999999999998 77775432211  1    12222222211        01


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .+...+.++.+++.+||+.+|++||++.||+++|++.
T Consensus       338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            1222345788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-38  Score=338.02  Aligned_cols=247  Identities=28%  Similarity=0.439  Sum_probs=204.8

Q ss_pred             ccChHHHHHHcccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeC
Q 002969          531 LFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM  610 (862)
Q Consensus       531 ~~~~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~  610 (862)
                      ...|++|       ..++-||+|+.|.||+|++ .++.||||+++.-.       ..+|+-|++|+||||+.+.|+|...
T Consensus       120 eiPFe~I-------sELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqs  184 (904)
T KOG4721|consen  120 EIPFEEI-------SELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQS  184 (904)
T ss_pred             cCCHHHh-------hhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCC
Confidence            3456665       3457899999999999998 57899999985322       3578889999999999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccc
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  690 (862)
                      ..+++|||||..|-|.++|...   ..+.......+..+||.||.|||.+.   |||||||.-||||..+..+||+|||.
T Consensus       185 PcyCIiMEfCa~GqL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGT  258 (904)
T KOG4721|consen  185 PCYCIIMEFCAQGQLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGT  258 (904)
T ss_pred             ceeEEeeeccccccHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccc
Confidence            9999999999999999999543   34788888999999999999999997   99999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV  770 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  770 (862)
                      ++.+...   .....+.||..|||||++.+.+.++|+|||||||+||||+||.-||...+..                .+
T Consensus       259 S~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----------------AI  319 (904)
T KOG4721|consen  259 SKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----------------AI  319 (904)
T ss_pred             hHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----------------ee
Confidence            9876432   2333578999999999999999999999999999999999999996321111                00


Q ss_pred             eeeec-ccC-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          771 LEMVD-SSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       771 ~~~id-~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .=-+. ..+ ...|..++.-+.-|+++||+..|.+||++.+++..|+-.
T Consensus       320 IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  320 IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            00111 112 245667778888899999999999999999999999765

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1e-37  Score=336.97  Aligned_cols=246  Identities=26%  Similarity=0.407  Sum_probs=208.6

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ++|.+++.||+|.||.||||+.+. .+.||+|.+.+.  .+...+.+.+|+++++.++|||||.+++.|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            578889999999999999998765 788999999765  34467789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+.+ +|..+|....   .+++..+..|+.++..||.|||+..   |+|||+||+|||++..+.+|++|||+|+.+... 
T Consensus        82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-  153 (808)
T ss_pred             hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence            9987 9999996544   4999999999999999999999997   999999999999999999999999999976432 


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                       ......+.||+.|||||+..+++|+..+|.||+|||+||+.+|++||..   .+...++    +.+..         ..
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a---~si~~Lv----~~I~~---------d~  216 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA---RSITQLV----KSILK---------DP  216 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH---HHHHHHH----HHHhc---------CC
Confidence             2333457899999999999999999999999999999999999999631   1111111    11111         11


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..++......+.+++...|++||..|.+-.+++.
T Consensus       217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            2345567788999999999999999999999985

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-37  Score=329.02  Aligned_cols=268  Identities=25%  Similarity=0.337  Sum_probs=205.4

Q ss_pred             ccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhc--ccCCceEEEEEEEeCC----ceEEEE
Q 002969          544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL--QHRNLVRLLGCCVEMD----EKMLVY  617 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~HpnIv~l~g~~~~~~----~~~lV~  617 (862)
                      ....+.||+|+||.||||++. ++.||||++...   ..+.|.+|-.+.+..  +|+||+++++.-....    ++.||+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            344578999999999999985 599999999653   456788888887764  8999999999977665    789999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc------CCCcEEecccCCcceEecCCCCeeEecccce
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD------SRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  691 (862)
                      ||.++|+|.++|..    ..++|....+|+..+++||+|||+.      .+++|+|||||++||||.+|+++.|+|||||
T Consensus       288 ~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             eeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            99999999999954    4599999999999999999999976      3578999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcCCC-CC-----ccccchhHHHHHHHHHhCCCCCCCCCCCcch----------
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL-FS-----VKSDVFSFGVLLLETVSGKKNRGFYHSNNEL----------  755 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~s-----~ksDVwSlGvil~elltG~~p~~~~~~~~~~----------  755 (862)
                      ..+............+||.+|||||++.+.. +.     .+.||||+|.+||||++.-.-......++.+          
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h  443 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH  443 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence            9987666666666689999999999997653 22     3689999999999999964432111111111          


Q ss_pred             hHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCC
Q 002969          756 NLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATM  821 (862)
Q Consensus       756 ~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  821 (862)
                      .-++..+..+...+....+.....  ....+..+.+.+..||..||+.|.|+.=|-+.+..+....
T Consensus       444 Pt~e~mq~~VV~kK~RP~~p~~W~--~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  444 PTLEEMQELVVRKKQRPKIPDAWR--KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             CCHHHHHHHHHhhccCCCChhhhh--cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            112333333222222111111111  1245566789999999999999999999999988874433

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=337.18  Aligned_cols=248  Identities=26%  Similarity=0.362  Sum_probs=205.6

Q ss_pred             HcccccccceeeccccEEEEEeEec-CCcEEEEEEeccC----Cc-cchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCc
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN----SG-QGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDE  612 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~  612 (862)
                      ..++|...+.||+|+||.|+.|+.. .+..||+|++.+.    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            3467899999999999999999765 4799999977654    12 33556778999999998 9999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC-CCeeEecccce
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMA  691 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFGla  691 (862)
                      .++||||+.+|+|.+++.+.   ..+.+.+..+++.|++.|++|+|+.+   |+||||||+|||++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            99999999999999999663   34888999999999999999999998   9999999999999999 99999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcCCC-CC-ccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL-FS-VKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK  769 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~s-~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  769 (862)
                      ....  .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||..   .....+..    .+..+ 
T Consensus       169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d---~~~~~l~~----ki~~~-  238 (370)
T KOG0583|consen  169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD---SNVPNLYR----KIRKG-  238 (370)
T ss_pred             cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC---ccHHHHHH----HHhcC-
Confidence            8763  2223344578999999999999977 86 789999999999999999999754   11112221    11111 


Q ss_pred             eeeeecccCCCCChHH-HHHHHHHHHhccccCCCCCCCHHHHH
Q 002969          770 VLEMVDSSVDNYPANE-VLRCIHVGLLCVQENAEERPTMASVV  811 (862)
Q Consensus       770 ~~~~id~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~evl  811 (862)
                              .-.++... +.++..|+.+|++.+|.+|+++.||+
T Consensus       239 --------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  239 --------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             --------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence                    11223333 77889999999999999999999999

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.2e-36  Score=329.30  Aligned_cols=245  Identities=19%  Similarity=0.321  Sum_probs=198.8

Q ss_pred             cceeeccccEEEEEeEecCCcEEEEEEeccCCccc---hHHHHHHHHHHHhcccCCceEEEEEEEe----CCceEEEEEe
Q 002969          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG---IEEFKNEVRLIAKLQHRNLVRLLGCCVE----MDEKMLVYEY  619 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~g~~~~----~~~~~lV~E~  619 (862)
                      ...|++|+++.||+|+. +++.||||+++......   .+.|.+|+.+|++++||||++++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36899999999999988 68899999997653322   5778899999999999999999999877    3567899999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc-CCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      +++|+|.+++...   ..+++...++++.+++.||.|||+. +   ++||||||+|||+++++.+||+|||+++.+....
T Consensus       104 ~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        104 CTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            9999999999643   3588999999999999999999985 5   7899999999999999999999999998653221


Q ss_pred             cccccccccccccccChhhhcC--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMD--GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                           ....++..|+|||++.+  ..++.++|||||||++|||++|+.||....   ......    .......      
T Consensus       178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~---~~~~~~----~i~~~~~------  239 (283)
T PHA02988        178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT---TKEIYD----LIINKNN------  239 (283)
T ss_pred             -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC---HHHHHH----HHHhcCC------
Confidence                 12457889999999976  689999999999999999999999975321   111211    1111110      


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      . ...+...+..+.+++.+||+.||++||+++||++.|+..
T Consensus       240 ~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        240 S-LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             C-CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            0 112334566788999999999999999999999999865

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-38  Score=333.04  Aligned_cols=247  Identities=26%  Similarity=0.400  Sum_probs=211.6

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ..|+..++||+|.||.||+|.... ++.||+|++... ....+++..+|+.++.+++|+||.+++|.+..+..+.++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            356777899999999999998765 778999999765 455678899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +.+|++.+.|..   ...+++....-|+.+++.||.|||.++   .+|||||+.||||..+|.+||+|||.+..+.....
T Consensus        93 ~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            999999999843   334588888889999999999999998   99999999999999999999999999988754433


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc-C
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS-V  778 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~-~  778 (862)
                      ..  ...+||+-|||||++....|+.|+||||||++.+||.+|.+|+...++..                ++-++.+. .
T Consensus       167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~P  228 (467)
T KOG0201|consen  167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAP  228 (467)
T ss_pred             cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCC
Confidence            33  55899999999999998899999999999999999999999987655533                33333332 2


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..+.......+.+++..||.+||+.||++.++++
T Consensus       229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            3344466778999999999999999999999985

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.7e-37  Score=346.49  Aligned_cols=259  Identities=29%  Similarity=0.437  Sum_probs=204.2

Q ss_pred             ccccccceeeccccEEEEEeEec------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~  613 (862)
                      ++|+..++||+|+||.||+|+..      +++.||||+++... ....+.+.+|+.+++.+ +|+||++++++|......
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            46888899999999999998742      24579999997543 33456788999999999 899999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccC-----------------------------------------------------------
Q 002969          614 MLVYEYMENRSLDSVIFDKAR-----------------------------------------------------------  634 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~-----------------------------------------------------------  634 (862)
                      ++||||+++|+|.+++.....                                                           
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            999999999999999854211                                                           


Q ss_pred             --------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccccccc
Q 002969          635 --------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV  706 (862)
Q Consensus       635 --------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  706 (862)
                              ...+++.++++++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+............
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                    124778889999999999999999987   999999999999999999999999999865433222112223


Q ss_pred             cccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHH
Q 002969          707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE  785 (862)
Q Consensus       707 ~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~  785 (862)
                      .++..|+|||++.+..++.++|||||||++|||++ |+.|+.......      ........+.     .   ...+...
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~~-----~---~~~~~~~  340 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRGY-----Q---MSRPDFA  340 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHccc-----C---ccCCCCC
Confidence            45678999999999999999999999999999997 999875322211      1111111111     0   0112223


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          786 VLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       786 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      +.++.+++.+||+.+|++||++.+|+++|+++
T Consensus       341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            56788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.3e-37  Score=329.16  Aligned_cols=250  Identities=35%  Similarity=0.541  Sum_probs=196.1

Q ss_pred             ccceeeccccEEEEEeEec-----CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          546 DYNKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       546 ~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ..+.||.|.||.||+|.+.     .+..|+||.++... ....+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3478999999999999886     25679999996543 33478999999999999999999999999988889999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++|+|.++|... ....+++.++++|+.||++||+|||+.+   ++|+||+++|||+++++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999765 2345899999999999999999999987   99999999999999999999999999987733323


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                      ............|+|||.+....++.++||||||+++|||++ |+.|+...   .....    ...+.++..        
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~----~~~~~~~~~--------  223 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEI----IEKLKQGQR--------  223 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHH----HHHHHTTEE--------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccc----ccccccccc--------
Confidence            222333456789999999999999999999999999999999 66775332   21122    222233222        


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML  814 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  814 (862)
                      ...+...+..+.+++..||+.+|++||++.+|++.|
T Consensus       224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            122334566788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.9e-37  Score=329.74  Aligned_cols=257  Identities=30%  Similarity=0.487  Sum_probs=208.1

Q ss_pred             ccccccceeeccccEEEEEeEecC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  614 (862)
                      ++|+..+.||+|+||.||+|....      .+.||+|.+.... ....++|.+|++++.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467888999999999999997643      2579999986543 334567899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhccC-------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC
Q 002969          615 LVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM  681 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~  681 (862)
                      +++||+++++|.+++.....             ...+++.+++.++.|+++||+|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999999865321             145888999999999999999999998   99999999999999999


Q ss_pred             CeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHH
Q 002969          682 TPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGH  760 (862)
Q Consensus       682 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~  760 (862)
                      .+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..|+.....   .    .
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~----~  234 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---Q----E  234 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---H----H
Confidence            999999999987643332222333456788999999999999999999999999999998 8888643221   1    1


Q ss_pred             HHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          761 VWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       761 ~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      ....+..+.        ....+...+.++.+|+.+||+.+|++||++.||++.|++
T Consensus       235 ~~~~i~~~~--------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 VIEMIRSRQ--------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHcCC--------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            222222221        122344566789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.1e-36  Score=327.76  Aligned_cols=250  Identities=28%  Similarity=0.380  Sum_probs=201.8

Q ss_pred             ccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          544 FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      |+..+.||+|+||.||++... +++.||+|++....   ......+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            677789999999999999864 58899999986532   23345678999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++|+|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++..+.... 
T Consensus        82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            99999998875432 235889999999999999999999998   9999999999999999999999999998753221 


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||........   ..........         ...
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~---------~~~  222 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKE---------DQE  222 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhc---------ccc
Confidence              12234689999999999999999999999999999999999999754322111   1111111111         111


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPT-----MASVVL  812 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  812 (862)
                      .++...+..+.+|+.+||+.||++||+     ++++++
T Consensus       223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            233344567889999999999999997     888886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-37  Score=308.48  Aligned_cols=236  Identities=28%  Similarity=0.367  Sum_probs=202.3

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..+.||.|+||.|.+++.+. |.-+|+|++.+..   -...+...+|..+|+.+.||.++++.+.+.+.+..++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            468888999999999999998875 6789999997653   345677889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||.+||.|.++|++..   .+++....-+|.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||.|+.+.. 
T Consensus       124 eyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-  196 (355)
T ss_pred             eccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence            9999999999996544   3899999999999999999999998   99999999999999999999999999987632 


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                          .+-..+|||.|+|||+++...+..++|.|||||++|||+.|.+||....+   ..    +++.+.+++        
T Consensus       197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~----iY~KI~~~~--------  257 (355)
T KOG0616|consen  197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQ----IYEKILEGK--------  257 (355)
T ss_pred             ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HH----HHHHHHhCc--------
Confidence                35568999999999999999999999999999999999999999743222   22    233333332        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCC
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEER  804 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~R  804 (862)
                       -.+|.-...++.+|+...|+.|-.+|
T Consensus       258 -v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  258 -VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence             23455566778899999999999888

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.4e-36  Score=325.57  Aligned_cols=255  Identities=25%  Similarity=0.343  Sum_probs=204.0

Q ss_pred             ccccccceeeccccEEEEEeEec----CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ++|++.+.||+|+||.||+|.+.    .+..||+|+++... ....+.|.+|+.++++++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46888899999999999999753    35689999987653 33456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++++|.+++...  ...+++.+++.++.||+.||+|||+.+   ++||||||+|||++.++.+|++|||.+.....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            9999999999998643  235889999999999999999999988   99999999999999999999999998765322


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ... .......++..|+|||.+.+..++.++||||||+++||+++ |+.|+....   ....    .+...++..     
T Consensus       160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~---~~~~----~~~~~~~~~-----  226 (266)
T cd05064         160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS---GQDV----IKAVEDGFR-----  226 (266)
T ss_pred             cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC---HHHH----HHHHHCCCC-----
Confidence            111 11112335678999999999999999999999999999775 988864321   1111    122222211     


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                         ...+...+..+.+++.+||+.+|++||+++||++.|++.
T Consensus       227 ---~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 ---LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence               112344566788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.5e-36  Score=327.32  Aligned_cols=257  Identities=28%  Similarity=0.461  Sum_probs=207.6

Q ss_pred             ccccccceeeccccEEEEEeEecC------CcEEEEEEeccCCcc-chHHHHHHHHHHHhcccCCceEEEEEEEeCCceE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  614 (862)
                      ++|.+.+.||+|+||.||+|+..+      ++.||||+++..... ..+.+.+|++++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457888999999999999997643      478999999765444 4678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhcc-----------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCe
Q 002969          615 LVYEYMENRSLDSVIFDKA-----------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  683 (862)
                      +||||+++++|.+++....           ....+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999996532           1245788999999999999999999998   9999999999999999999


Q ss_pred             eEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHH
Q 002969          684 KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVW  762 (862)
Q Consensus       684 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~  762 (862)
                      ||+|||+++.+.............+++.|+|||++.+..++.++||||||+++|||++ |..|+.....   ......  
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~--  236 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIEC--  236 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH--
Confidence            9999999986543322222223345788999999999999999999999999999998 9888643221   112211  


Q ss_pred             HHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       763 ~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                        ...+.        ....+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus       237 --~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         237 --ITQGR--------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             --HHcCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence              11111        112233455678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.3e-37  Score=330.89  Aligned_cols=254  Identities=20%  Similarity=0.271  Sum_probs=203.3

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ..++|+.+++||+|+||.||+++..+ |..+|+|++++.   .....+..+.|-.+|...++|+||+|+..|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            45689999999999999999998765 889999999876   34567889999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||++||++..+|...   ..|++.....++.+++-|++.||+.|   ||||||||+|+|||..|++||+||||+.-+.
T Consensus       219 iMEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            99999999999999543   45899999999999999999999998   9999999999999999999999999985431


Q ss_pred             CC----------------------Ccc-----cc------------------cccccccccccChhhhcCCCCCccccch
Q 002969          696 GD----------------------QTE-----QN------------------TKRVVGTYGYMSPEYAMDGLFSVKSDVF  730 (862)
Q Consensus       696 ~~----------------------~~~-----~~------------------~~~~~gt~~y~APE~l~~~~~s~ksDVw  730 (862)
                      ..                      ...     ..                  ....+|||.|||||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            10                      000     00                  1135799999999999999999999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCC---H
Q 002969          731 SFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPT---M  807 (862)
Q Consensus       731 SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~  807 (862)
                      |||||+|||+.|.+||....+.+.       ++.+...+..-.     .........+..+||.+|+. ||++|..   +
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T-------~rkI~nwr~~l~-----fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~  439 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQET-------YRKIVNWRETLK-----FPEEVDLSDEAKDLITRLLC-DPENRLGSKGA  439 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHHHhhhcc-----CCCcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence            999999999999999754333322       222111110000     00112233678899999999 9999975   6


Q ss_pred             HHHHH
Q 002969          808 ASVVL  812 (862)
Q Consensus       808 ~evl~  812 (862)
                      +||-+
T Consensus       440 ~EIK~  444 (550)
T KOG0605|consen  440 EEIKK  444 (550)
T ss_pred             HHHhc
Confidence            66653

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.8e-36  Score=321.83  Aligned_cols=254  Identities=29%  Similarity=0.448  Sum_probs=206.5

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      ++|+..++||+|+||.||+|...+++.||+|++.... ...+.+.+|+.++++++|+||+++++++...+..++++||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            5788889999999999999998888899999986533 345789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +++|.+++.... ...+++..++.++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++......... 
T Consensus        85 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-  159 (261)
T cd05072          85 KGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-  159 (261)
T ss_pred             CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence            999999986542 345888999999999999999999987   999999999999999999999999999876432211 


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      ......++..|+|||++....++.++||||||+++|||++ |+.|+...   ........    ......        ..
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~---~~~~~~~~----~~~~~~--------~~  224 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM---SNSDVMSA----LQRGYR--------MP  224 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC---CHHHHHHH----HHcCCC--------CC
Confidence            1122345678999999998889999999999999999998 88886432   11112211    111110        01


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      .....+..+.+++.+|++.+|++||+++++++.|++
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            112344678899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.2e-36  Score=375.64  Aligned_cols=260  Identities=25%  Similarity=0.455  Sum_probs=207.1

Q ss_pred             ccccccceeeccccEEEEEeEe-cCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      ..|...++||+|+||.||+|+. .++..||||++.....    ....|++.+++++|||||+++++|.+.+..++||||+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            4567778999999999999987 4688999999864332    2235688999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++|+|.+++.      .++|.++.+|+.|||+||+|||....++|+||||||+||+++.++.+++. ||........   
T Consensus       766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---  835 (968)
T PLN00113        766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---  835 (968)
T ss_pred             CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence            9999999984      28899999999999999999997655679999999999999999888875 6655432111   


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC-
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD-  779 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~-  779 (862)
                         ....+++.|+|||++.+..++.++|||||||++|||++|+.|+..... .......+.............+++.+. 
T Consensus       836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccC
Confidence               123578999999999999999999999999999999999999743222 223344444333333333344454442 


Q ss_pred             --CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          780 --NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       780 --~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                        ..+..+..++.+++.+||+.+|++||+|+||++.|++...
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence              2345667788899999999999999999999999998743

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.9e-36  Score=326.32  Aligned_cols=259  Identities=28%  Similarity=0.424  Sum_probs=204.1

Q ss_pred             HcccccccceeeccccEEEEEeEec------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCc
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE  612 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  612 (862)
                      ++++|+..++||+|+||.||+|...      .+..||+|++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999998753      24679999986432 2345578999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhccC-------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeE
Q 002969          613 KMLVYEYMENRSLDSVIFDKAR-------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL  685 (862)
                      .++|+||+++++|.+++.....       ...+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999864321       224678889999999999999999987   999999999999999999999


Q ss_pred             ecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHH
Q 002969          686 SDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRL  764 (862)
Q Consensus       686 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~  764 (862)
                      +|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..|+....   ...    ..+.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~---~~~----~~~~  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS---NEQ----VLRF  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHH----HHHH
Confidence            99999876543322222222345778999999999999999999999999999999 677754221   111    1112


Q ss_pred             HhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       765 ~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      ..++..        ...+...+..+.+++.+||+.+|++||++.|+++.|++
T Consensus       234 ~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 VMEGGL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHcCCc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            222111        11223345678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=334.90  Aligned_cols=253  Identities=21%  Similarity=0.283  Sum_probs=204.0

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|++.++||+|+||.||+|+..+ ++.||||+++...   ....+.+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            368888999999999999998765 7899999997542   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            999999999998543   34889999999999999999999998   99999999999999999999999999976532 


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                          ......|++.|+|||++.+..++.++|||||||++|||++|+.|+.....   ......+    ..... ....+.
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i----~~~~~-~~~~~~  221 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---NETWENL----KYWKE-TLQRPV  221 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH---HHHHHHH----Hhccc-cccCCC
Confidence                22345789999999999999999999999999999999999999753221   1111111    11100 000011


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ........+.++.+++.+||+.+|++||++.|+++.
T Consensus       222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            111112345678899999999999999999999965

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.1e-36  Score=332.67  Aligned_cols=261  Identities=25%  Similarity=0.325  Sum_probs=203.2

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .++|+..++||+|+||.||+++... +..+|+|++.... ....+++.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            3678899999999999999998764 7789999987543 3345679999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++++|.+++...   ..+++..+..++.|++.||+|||+.+  .|+||||||+|||++.++.+||+|||++..+... 
T Consensus        84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            99999999998543   24889999999999999999999853  3999999999999999999999999998765322 


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc------e--
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK------V--  770 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~--  770 (862)
                         ......|+..|+|||++.+..++.++|||||||++|||++|+.|+......   .+..........+.      .  
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK---ELEAIFGRPVVDGEEGEPHSISP  231 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhcccccccccCCccccCc
Confidence               122356899999999999999999999999999999999999997532211   11110000000000      0  


Q ss_pred             ----------------------ee----eecccCCC-CChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          771 ----------------------LE----MVDSSVDN-YPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       771 ----------------------~~----~id~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                                            .+    +....... .......++.+|+.+||+.||++||++.||++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                  00    00000000 111245678999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=347.89  Aligned_cols=267  Identities=25%  Similarity=0.312  Sum_probs=217.1

Q ss_pred             HcccccccceeeccccEEEEEeEecCC-cEEEEEEeccCCccchHHHHHHHHHHHhcc-cCCceEEEEE-EEe------C
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLEG-QEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGC-CVE------M  610 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~-~~~------~  610 (862)
                      ...++++.+.|.+|||+.||.++...+ .++|+|++--.++...+..++|+++|++|+ |+|||.+++. ...      .
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            345677889999999999999998776 999999998778888999999999999997 9999999993 221      2


Q ss_pred             CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccc
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  690 (862)
                      -+.+|+||||++|.|-+++..+.... |++.++++|+.++++|+++||... ++|||||||-+||||+.+++.||+|||.
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence            35789999999999999997655544 999999999999999999999985 7999999999999999999999999999


Q ss_pred             eeecCCCCc-ccccc------cccccccccChhhh---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHH
Q 002969          691 ARIFGGDQT-EQNTK------RVVGTYGYMSPEYA---MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGH  760 (862)
Q Consensus       691 a~~~~~~~~-~~~~~------~~~gt~~y~APE~l---~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~  760 (862)
                      |........ .....      ...-|+.|+|||.+   .+..+++|+|||+|||+||-|+....||+.            
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~------------  260 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE------------  260 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc------------
Confidence            864322221 11100      12348999999987   467899999999999999999999999742            


Q ss_pred             HHHHHhcCceeeeecccCCCC-ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc-CCCCCCCCC
Q 002969          761 VWRLWKEGKVLEMVDSSVDNY-PANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET-ATMPQPKTP  827 (862)
Q Consensus       761 ~~~~~~~~~~~~~id~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~-~~~~~p~~p  827 (862)
                             .....+++..+.-. .+.+...+.+||..||+.||++||++-+|+..+-.+. .+.|.++.+
T Consensus       261 -------sg~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~  322 (738)
T KOG1989|consen  261 -------SGKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY  322 (738)
T ss_pred             -------CcceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence                   22345555555322 3578899999999999999999999999998887653 234444433

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.5e-36  Score=328.02  Aligned_cols=260  Identities=27%  Similarity=0.439  Sum_probs=209.7

Q ss_pred             ccccccceeeccccEEEEEeEec------CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      .+|...+.||+|+||.||+++..      +...+++|++........+.+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            35777789999999999999743      345689999876665556789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcc-------------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC
Q 002969          616 VYEYMENRSLDSVIFDKA-------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT  682 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~  682 (862)
                      ||||+++++|.+++....             ....+++..+++++.||+.||+|||+.+   ++||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999986532             1234889999999999999999999998   999999999999999999


Q ss_pred             eeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHH
Q 002969          683 PKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHV  761 (862)
Q Consensus       683 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~  761 (862)
                      +||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....   ..    .
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~----~  234 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TE----V  234 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HH----H
Confidence            99999999976543322222223456788999999999999999999999999999999 8888643221   11    1


Q ss_pred             HHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          762 WRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       762 ~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                      .+....+...        ..+...+..+.+++.+||+.+|++||++.+|+++|+.+..
T Consensus       235 ~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         235 IECITQGRVL--------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHHHhCCCCC--------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            2222222211        1223345678899999999999999999999999998843

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-36  Score=334.30  Aligned_cols=246  Identities=26%  Similarity=0.331  Sum_probs=209.0

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      -|+..+.||.|+-|.|-+|++.. |+.+|||++.+.   .........+|+.+|+.+.|||++++++++.+..++|||.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            36677899999999999998765 999999999765   23345567899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++|-|.+++..++   .+.+.+..+++.||+.|+.|+|..+   |+||||||+|+|||..+++||+|||+|..-.   
T Consensus        93 yv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~---  163 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV---  163 (786)
T ss_pred             ecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc---
Confidence            999999999996654   4899999999999999999999998   9999999999999999999999999997632   


Q ss_pred             cccccccccccccccChhhhcCCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFS-VKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      .......-+|.+.|.|||++.+.+|. .++||||.|||||.|++|+.||+   .++-..++..    +..         .
T Consensus       164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlK----V~~---------G  227 (786)
T KOG0588|consen  164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLK----VQR---------G  227 (786)
T ss_pred             CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHH----HHc---------C
Confidence            22233446899999999999999985 79999999999999999999975   2222223222    222         2


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ..+.|...+.++.+|+.+|+..||+.|.|++||+++
T Consensus       228 ~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  228 VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            234567778889999999999999999999999985

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-36  Score=335.37  Aligned_cols=245  Identities=22%  Similarity=0.282  Sum_probs=201.6

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..+.||+|+||.||+|+... ++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            468888999999999999998764 789999998653   2234567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            999999999998643   34788888999999999999999998   999999999999999999999999999875322


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                           .....|++.|+|||++.+..++.++|||||||++|||++|+.|+...   ....    ..+...++.        
T Consensus       172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~---~~~~----~~~~i~~~~--------  231 (329)
T PTZ00263        172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD---TPFR----IYEKILAGR--------  231 (329)
T ss_pred             -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC---CHHH----HHHHHhcCC--------
Confidence                 12357899999999999999999999999999999999999997421   1111    122222221        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPT-----MASVVLM  813 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~  813 (862)
                       ...+.....++.+++.+||+.||++||+     +++++..
T Consensus       232 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        232 -LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             -cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence             1122334557789999999999999996     7888743

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.5e-36  Score=327.50  Aligned_cols=259  Identities=29%  Similarity=0.451  Sum_probs=208.2

Q ss_pred             ccccccceeeccccEEEEEeEec------CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ++|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46888899999999999999742      245689999876665667789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcc----------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeE
Q 002969          616 VYEYMENRSLDSVIFDKA----------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL  685 (862)
                      |+||+++++|.+++....          +...+++.++++++.|++.||+|||+.+   ++||||||+|||+++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            999999999999986432          2234899999999999999999999988   999999999999999999999


Q ss_pred             ecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHH
Q 002969          686 SDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRL  764 (862)
Q Consensus       686 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~  764 (862)
                      +|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+.....   ...    ...
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~----~~~  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEV----IEC  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHH----HHH
Confidence            99999986543322222222345778999999998899999999999999999998 8887542211   111    122


Q ss_pred             HhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       765 ~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      ...+...        ..+...+.++.+++.+||+.+|.+||++.||+..|+++.
T Consensus       235 i~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         235 ITQGRVL--------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HHcCCcC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            2222211        112234457899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.1e-36  Score=340.71  Aligned_cols=260  Identities=27%  Similarity=0.393  Sum_probs=206.4

Q ss_pred             cccccccceeeccccEEEEEeEecC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCc
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDE  612 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~  612 (862)
                      .++|.+.++||+|+||.||+|+...      +..||||+++... ....+.+.+|+++++++. ||||+++++++.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            4678888999999999999997532      3469999997543 334567999999999996 9999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhccC----------------------------------------------------------
Q 002969          613 KMLVYEYMENRSLDSVIFDKAR----------------------------------------------------------  634 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  634 (862)
                      .++||||+++|+|.+++.....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999998854311                                                          


Q ss_pred             -----------------------------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC
Q 002969          635 -----------------------------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK  679 (862)
Q Consensus       635 -----------------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~  679 (862)
                                                         ...+++..+++++.||++||+|||+.+   |+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                               124778888999999999999999987   999999999999999


Q ss_pred             CCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHH
Q 002969          680 EMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLL  758 (862)
Q Consensus       680 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~  758 (862)
                      ++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+.     
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-----  347 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-----  347 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-----
Confidence            99999999999987643322222223456788999999999999999999999999999997 888864322111     


Q ss_pred             HHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          759 GHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       759 ~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                       ........+..        ...+...+..+.+++.+||+.+|++||++.+|+++|+.+
T Consensus       348 -~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         348 -TFYNKIKSGYR--------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             -HHHHHHhcCCC--------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence             11112222111        111233456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.6e-36  Score=334.74  Aligned_cols=241  Identities=24%  Similarity=0.286  Sum_probs=197.0

Q ss_pred             ceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCC
Q 002969          548 NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR  623 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g  623 (862)
                      +.||+|+||.||+++.. +++.||+|+++..   .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999875 4889999999754   2334567889999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccccc
Q 002969          624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT  703 (862)
Q Consensus       624 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  703 (862)
                      +|.+++...   ..+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~  152 (323)
T cd05571          81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM  152 (323)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence            999888543   35889999999999999999999998   999999999999999999999999998753221  1222


Q ss_pred             ccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCCh
Q 002969          704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA  783 (862)
Q Consensus       704 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~  783 (862)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.|+...   +......    ....+.         ..++.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~---~~~~~~~----~~~~~~---------~~~p~  216 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHEKLFE----LILMEE---------IRFPR  216 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC---CHHHHHH----HHHcCC---------CCCCC
Confidence            3457999999999999999999999999999999999999997421   1111111    111111         12233


Q ss_pred             HHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 002969          784 NEVLRCIHVGLLCVQENAEERP-----TMASVVL  812 (862)
Q Consensus       784 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  812 (862)
                      ....++.+++.+||+.||++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            4566788999999999999999     8999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=331.27  Aligned_cols=245  Identities=24%  Similarity=0.276  Sum_probs=201.5

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..++||+|+||.||+++.. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888899999999999999876 48899999986432   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++...   ..+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            999999999998543   34888999999999999999999998   999999999999999999999999999865321


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                           .....|++.|+|||++.+..++.++|||||||++|||++|+.|+...   ......    +....+.        
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~---~~~~~~----~~i~~~~--------  214 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD---NPFGIY----EKILAGK--------  214 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHH----HHHHhCC--------
Confidence                 22356899999999999999999999999999999999999997432   111111    1111111        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPT-----MASVVLM  813 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~  813 (862)
                       ...+......+.+++.+||+.||.+||+     +.|+++.
T Consensus       215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence             1123334567889999999999999995     8888864

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-36  Score=321.60  Aligned_cols=256  Identities=29%  Similarity=0.440  Sum_probs=206.5

Q ss_pred             ccccccceeeccccEEEEEeEecC----CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ++|+..+.||+|+||.||+|++..    ...||||+++... .....+|.+|+.++++++||||+++++++.+.+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568888999999999999998743    3579999986543 33456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++++|.+++....  ..+++.++++++.|++.||+|||+.+   |+|+||||+|||+++++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            99999999999985432  35899999999999999999999987   99999999999999999999999999987752


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ...........++..|+|||.+.+..++.++||||||+++|||++ |..|+....   ....    ......+..     
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~---~~~~----~~~~~~~~~-----  226 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS---NQDV----IKAVEDGYR-----  226 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC---HHHH----HHHHHcCCC-----
Confidence            222222222345678999999999999999999999999999998 888863221   1111    112221110     


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                         ...+...+..+.+++.+|++.+|++||++.||++.|+++
T Consensus       227 ---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         227 ---LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               111234456788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.1e-36  Score=319.73  Aligned_cols=252  Identities=29%  Similarity=0.433  Sum_probs=202.7

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      ++|+..+.||+|+||.||+++..++..+|+|.+... ....+++.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            457788999999999999999888889999988643 3335678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +++|.+++....  ..+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            999999885432  35889999999999999999999998   999999999999999999999999998765322211 


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...   .....+..    ...+..        ..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~---~~~~~~~~----i~~~~~--------~~  221 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK---SNYEVVEM----ISRGFR--------LY  221 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC---CHHHHHHH----HHCCCC--------CC
Confidence            1122335668999999998889999999999999999999 88886422   11122222    222111        01


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      .+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus       222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            12223457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-36  Score=319.42  Aligned_cols=255  Identities=29%  Similarity=0.446  Sum_probs=206.8

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      .++|+..++||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688889999999999999998778899999986543 34567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.+......
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999986543 345899999999999999999999988   999999999999999999999999999876522111


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                       .......+..|+|||++.+..++.++||||||++++||++ |+.|+...   ......    ........        .
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~----~~~~~~~~--------~  223 (261)
T cd05068         160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM---TNAEVL----QQVDQGYR--------M  223 (261)
T ss_pred             -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC---CHHHHH----HHHHcCCC--------C
Confidence             1111223468999999999999999999999999999999 88876422   111111    11111110        1


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      ..+...+..+.+++.+|++.+|++||++.+|++.|+.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            1223445678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.3e-36  Score=331.16  Aligned_cols=256  Identities=26%  Similarity=0.448  Sum_probs=203.2

Q ss_pred             ccccccceeeccccEEEEEeEecC-Cc----EEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ----EIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      .+|+..+.||+|+||.||+|++.. ++    .||+|+++... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            468888999999999999998643 33    48999986543 34567899999999999999999999999764 5789


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ++||+++|+|.+++....  ..+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            999999999999986532  34888999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ............++..|+|||++.+..++.++||||||+++|||++ |+.|+....   ..    ........+..    
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~---~~----~~~~~~~~~~~----  229 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---AS----EISSILEKGER----  229 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HH----HHHHHHhCCCC----
Confidence            4333222222334678999999999999999999999999999998 888864321   11    11112221110    


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                          ...+.....++.+++.+||+.+|++||++.+++..|....
T Consensus       230 ----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         230 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                1112334567889999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.8e-36  Score=348.76  Aligned_cols=252  Identities=19%  Similarity=0.228  Sum_probs=204.8

Q ss_pred             cccccceeeccccEEEEEeEecC--CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      .|...+.||+|+||.||+|....  ++.||+|++..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            48888999999999999997543  5678888876555555667889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhc-cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          621 ENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       621 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      ++|+|.+++... .....+++.++..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988643 23345889999999999999999999987   99999999999999999999999999987654332


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+...   .......    ....+.        ..
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~---~~~~~~~----~~~~~~--------~~  289 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP---SQREIMQ----QVLYGK--------YD  289 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC---CHHHHHH----HHHhCC--------CC
Confidence            22334467999999999999999999999999999999999999997421   1111111    111111        11


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..+...+..+.+++.+||+.+|++||++.+++.
T Consensus       290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            122334567889999999999999999999874

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.7e-36  Score=325.75  Aligned_cols=264  Identities=22%  Similarity=0.304  Sum_probs=200.9

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ++|++.+.||+|+||.||+++... ++.||||++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            368888999999999999998864 7789999986542  3345678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |++++.+..+...   ...+++..+..++.||+.||+|||+.+   ++||||||+||+++.++.+||+|||++..+....
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            9998877655422   235889999999999999999999987   9999999999999999999999999998764322


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHH--------HHHHhcCce
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV--------WRLWKEGKV  770 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~~  770 (862)
                      . .......|++.|+|||++.+..++.++|||||||++|||++|+.|+......+....+...        .+.+.....
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            1 1222356899999999999989999999999999999999999987542221111111100        011111000


Q ss_pred             e-eeecccC-------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          771 L-EMVDSSV-------DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       771 ~-~~id~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      . ....+..       .......+..+.+++.+||+.||++||+++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0 0000000       0111123456889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-36  Score=331.54  Aligned_cols=245  Identities=27%  Similarity=0.399  Sum_probs=208.4

Q ss_pred             HHHcccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCc
Q 002969          538 VRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDE  612 (862)
Q Consensus       538 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~  612 (862)
                      ....++|..+++||+|.||.|+++..+. ++.+|||.+++.   .....+..+.|.+++.... ||.++.++.++...++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            3455789999999999999999998875 778999999876   4567788999999998885 9999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      +++||||..||++..+.    +...+++..+.-++..|+.||.|||+++   ||+||||.+|||||.+|.+||+||||++
T Consensus       444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence            99999999999954433    3345999999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          693 IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       693 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      .-..  ....+..++||+.|||||++.+..|+.++|.|||||+||||+.|+.||.   .+++.++.+.+..   +     
T Consensus       517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~---gddEee~FdsI~~---d-----  583 (694)
T KOG0694|consen  517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP---GDDEEEVFDSIVN---D-----  583 (694)
T ss_pred             ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC---CCCHHHHHHHHhc---C-----
Confidence            6421  3345667899999999999999999999999999999999999999964   3444444443311   1     


Q ss_pred             eecccCCCCChHHHHHHHHHHHhccccCCCCCCCH
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTM  807 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  807 (862)
                           -..+|...+.+.+.++.++|..+|++|..+
T Consensus       584 -----~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 -----EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -----CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                 024566778889999999999999999876

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.2e-36  Score=321.24  Aligned_cols=257  Identities=29%  Similarity=0.469  Sum_probs=211.2

Q ss_pred             HcccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ...+|+..++||.|+||.||+|+..+++.+++|.+........+++..|+.+++.++|+||+++++++...+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34568888999999999999999888999999999776655677899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|.+++.... ...+++.++..++.||+.||+|||+.+   ++|+||||+||++++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999996543 345899999999999999999999988   99999999999999999999999999976643221


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                      ..  ....++..|+|||.+.+..++.++||||||+++++|++ |+.|+....   ....+..    ...+..        
T Consensus       160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~----~~~~~~--------  222 (261)
T cd05148         160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQ----ITAGYR--------  222 (261)
T ss_pred             cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHH----HHhCCc--------
Confidence            11  12345678999999998899999999999999999998 788864322   1112221    111110        


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ...+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            112334556788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.9e-36  Score=305.38  Aligned_cols=273  Identities=25%  Similarity=0.366  Sum_probs=213.4

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCcc--chHHHHHHHHHHHhcccCCceEEEEEEEe--CCceEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQ--GIEEFKNEVRLIAKLQHRNLVRLLGCCVE--MDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~lV  616 (862)
                      +.|+.+++|++|.||.||+|+... ++.||+|+++...+.  -.-...+|+.+|.+.+|||||.+-.+...  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            468888999999999999998765 778999999765322  22356899999999999999999888753  4678999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||++. +|.+++..-.  ..+...+..-+..|+++|++|||...   |+|||||++|+|+...|.+||+|||||+.+..
T Consensus       156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999975 8888885433  45888899999999999999999998   99999999999999999999999999998854


Q ss_pred             CCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      .  ....+..+-|..|.|||++.+. .|+...|+||+|||+.|++++++-+   ....+.+.+..+++.+....  +.+-
T Consensus       230 p--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf---~G~sE~dQl~~If~llGtPt--e~iw  302 (419)
T KOG0663|consen  230 P--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF---PGKSEIDQLDKIFKLLGTPS--EAIW  302 (419)
T ss_pred             C--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC---CCCchHHHHHHHHHHhCCCc--cccC
Confidence            3  2233446779999999999885 5999999999999999999998864   45666677777777664322  1111


Q ss_pred             ccC-----------C---------CCChH-HHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCCCCCCCCcc
Q 002969          776 SSV-----------D---------NYPAN-EVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGF  829 (862)
Q Consensus       776 ~~~-----------~---------~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~  829 (862)
                      +.+           .         .+... ....-.+|+..+|..||.+|-|++|.++.  +-....|.|..|.+
T Consensus       303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~  375 (419)
T KOG0663|consen  303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSM  375 (419)
T ss_pred             CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhh
Confidence            111           0         11111 23456789999999999999999998863  23345566666654

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7.2e-36  Score=322.88  Aligned_cols=257  Identities=29%  Similarity=0.435  Sum_probs=204.5

Q ss_pred             ccccccceeeccccEEEEEeEe-----cCCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRL-----LEGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      +.|+..++||+|+||.||+|+.     ..++.+++|.+.... .....++.+|+.++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577789999999999999974     245789999997533 3345678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccC--------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC
Q 002969          616 VYEYMENRSLDSVIFDKAR--------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM  681 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~  681 (862)
                      ||||+++++|.+++.....              ...+++.+.+.++.|++.||+|||+.+   ++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            9999999999999853321              234788999999999999999999998   99999999999999999


Q ss_pred             CeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHH
Q 002969          682 TPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGH  760 (862)
Q Consensus       682 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~  760 (862)
                      .+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+....   ...    
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~---~~~----  234 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---NQE----  234 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHH----
Confidence            999999999987643332222233445778999999998889999999999999999998 877753211   111    


Q ss_pred             HHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          761 VWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       761 ~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      +.+.......        ...+...+.++.+++.+|++.+|++||++.+|+++|..
T Consensus       235 ~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 VIEMVRKRQL--------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHcCCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1122222111        11233445678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8.8e-36  Score=323.31  Aligned_cols=260  Identities=22%  Similarity=0.310  Sum_probs=198.9

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ++|+..++||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888899999999999999875 47899999986543 23345778999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++ +|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-  157 (288)
T cd07871          85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-  157 (288)
T ss_pred             CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence            985 888887543  234788999999999999999999998   9999999999999999999999999997653221 


Q ss_pred             ccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc---------
Q 002969          700 EQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK---------  769 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---------  769 (862)
                       .......+++.|+|||++.+ ..++.++|||||||++|||++|+.|+.....   ...+..+.+......         
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV---KEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHHhhcccc
Confidence             11223467899999999876 5689999999999999999999999753222   122222221111000         


Q ss_pred             ---eeeeecccC-----CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          770 ---VLEMVDSSV-----DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       770 ---~~~~id~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                         ......+..     .........++.+++.+||+.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence               000000000     0011123456789999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=9.8e-36  Score=328.46  Aligned_cols=241  Identities=23%  Similarity=0.290  Sum_probs=196.0

Q ss_pred             ceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCC
Q 002969          548 NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR  623 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g  623 (862)
                      +.||+|+||.||+++.. +++.||+|+++..   .......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999865 4889999999754   2334567788999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccccc
Q 002969          624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT  703 (862)
Q Consensus       624 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  703 (862)
                      +|..++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            998888543   35889999999999999999999998   9999999999999999999999999987532211  122


Q ss_pred             ccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCCh
Q 002969          704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA  783 (862)
Q Consensus       704 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~  783 (862)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.|+...   +.......+    ....         ...+.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~---~~~~~~~~~----~~~~---------~~~p~  216 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELI----LMEE---------IRFPR  216 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHH----hcCC---------CCCCC
Confidence            2357899999999999999999999999999999999999996432   111111111    1110         11233


Q ss_pred             HHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 002969          784 NEVLRCIHVGLLCVQENAEERP-----TMASVVL  812 (862)
Q Consensus       784 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  812 (862)
                      ..+.++.+++.+||+.+|++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            4456788999999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6e-36  Score=330.85  Aligned_cols=242  Identities=24%  Similarity=0.280  Sum_probs=197.1

Q ss_pred             ceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCC
Q 002969          548 NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR  623 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g  623 (862)
                      +.||+|+||.||+++.. +++.||+|++...   .......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999865 4889999999754   2334567889999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccccc
Q 002969          624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT  703 (862)
Q Consensus       624 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  703 (862)
                      +|..++...   ..+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~  152 (328)
T cd05593          81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM  152 (328)
T ss_pred             CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence            999888543   35889999999999999999999998   999999999999999999999999998753221  1122


Q ss_pred             ccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCCh
Q 002969          704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA  783 (862)
Q Consensus       704 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~  783 (862)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||....   .....    +.....         ....+.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~---~~~~~----~~~~~~---------~~~~p~  216 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLF----ELILME---------DIKFPR  216 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC---HHHHH----HHhccC---------CccCCC
Confidence            33578999999999999999999999999999999999999974321   11111    111110         012233


Q ss_pred             HHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 002969          784 NEVLRCIHVGLLCVQENAEERP-----TMASVVLM  813 (862)
Q Consensus       784 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  813 (862)
                      ....++.+++.+||+.||++||     ++.|+++.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            4556788999999999999997     89998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-35  Score=318.75  Aligned_cols=256  Identities=25%  Similarity=0.420  Sum_probs=202.9

Q ss_pred             ccccceeeccccEEEEEeEecC----CcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCc-----
Q 002969          544 FTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE-----  612 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-----  612 (862)
                      |+..+.||+|+||.||+|++..    +..||+|+++...  ....+++.+|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999998753    3679999987542  3345689999999999999999999999876554     


Q ss_pred             -eEEEEEeccCCChhhhhhhcc---CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecc
Q 002969          613 -KMLVYEYMENRSLDSVIFDKA---RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDF  688 (862)
Q Consensus       613 -~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF  688 (862)
                       .++++||+++++|..++....   ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             799999999999999985432   2245899999999999999999999987   999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhc
Q 002969          689 GMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKE  767 (862)
Q Consensus       689 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  767 (862)
                      |+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+...   .......    ....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~---~~~~~~~----~~~~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV---ENHEIYD----YLRH  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC---CHHHHHH----HHHc
Confidence            99987644332222222335678999999988899999999999999999999 77775322   1112221    1222


Q ss_pred             CceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          768 GKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       768 ~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      +.        ....+...+.++.+++.+||+.+|++||++.||++.|+.+
T Consensus       231 ~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GN--------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CC--------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11        1122344566889999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9e-36  Score=317.41  Aligned_cols=252  Identities=29%  Similarity=0.444  Sum_probs=203.0

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      ++|+..+.||+|+||.||+|+..++..+|+|.+.... ...++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4577889999999999999988777789999986443 345679999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +++|.+++....  ..+++.++++++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            999999986533  25899999999999999999999998   999999999999999999999999998865432211 


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....   .....    ....+..        ..
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~----~~~~~~~--------~~  221 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVE----KVSQGLR--------LY  221 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHH----HHhcCCC--------CC
Confidence            1112235678999999998889999999999999999998 8888643221   11111    1111111        11


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      .+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            12223567889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-36  Score=330.32  Aligned_cols=239  Identities=21%  Similarity=0.263  Sum_probs=194.1

Q ss_pred             eeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCCh
Q 002969          550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (862)
Q Consensus       550 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL  625 (862)
                      ||+|+||.||+++..+ ++.||+|++...   .......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            7999999999998764 788999998653   234456788999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccccccc
Q 002969          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR  705 (862)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  705 (862)
                      .+++...   ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            9998543   34889999999999999999999998   9999999999999999999999999987542221  12234


Q ss_pred             ccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHH
Q 002969          706 VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE  785 (862)
Q Consensus       706 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~  785 (862)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.|+...   ...    ...+....+.         ...+...
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~---~~~----~~~~~~~~~~---------~~~~~~~  216 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE---NVN----EMYRKILQEP---------LRFPDGF  216 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC---CHH----HHHHHHHcCC---------CCCCCcC
Confidence            57899999999999999999999999999999999999997432   111    1111111111         1223345


Q ss_pred             HHHHHHHHHhccccCCCCCCC---HHHHHH
Q 002969          786 VLRCIHVGLLCVQENAEERPT---MASVVL  812 (862)
Q Consensus       786 ~~~l~~li~~cl~~dP~~RPt---~~evl~  812 (862)
                      ...+.+++.+||+.||++||+   +.|++.
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            567889999999999999985   566654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.8e-36  Score=324.17  Aligned_cols=256  Identities=29%  Similarity=0.429  Sum_probs=203.6

Q ss_pred             cccccceeeccccEEEEEeEecC------CcEEEEEEeccCCcc-chHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      +|+..++||+|+||.||+|+..+      ++.||+|+++..... ..+.+.+|+.++.+++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            46667899999999999998643      467999999755332 34678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcc-------------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC
Q 002969          616 VYEYMENRSLDSVIFDKA-------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT  682 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~  682 (862)
                      ++||+++++|.+++....             ....+++..+.+++.|+++||+|||+.+   ++||||||.|||+++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            999999999999985321             1234788889999999999999999988   999999999999999999


Q ss_pred             eeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHH
Q 002969          683 PKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHV  761 (862)
Q Consensus       683 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~  761 (862)
                      +||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+...   ....    .
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~---~~~~----~  235 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY---SNQD----V  235 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---CHHH----H
Confidence            99999999886543322222223445789999999998899999999999999999998 77675322   1111    1


Q ss_pred             HHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          762 WRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       762 ~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      ......+.        ....+...+..+.+++.+||+.+|++||+++||++.|+.
T Consensus       236 ~~~i~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 IEMIRNRQ--------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHcCC--------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            22222221        112234456678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-36  Score=331.78  Aligned_cols=251  Identities=26%  Similarity=0.367  Sum_probs=213.6

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCc-eEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE-KMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-~~lV~  617 (862)
                      ++|..++++|+|+||.++..+++. ++.+++|++...  .....+...+|+.++++++|||||.+.+.+.+.+. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            578888999999999999997754 778999988654  34455678899999999999999999999999888 99999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      +|++||+|.+.+.... ...++++.+++++.|++.|+.|||+..   |+|||||+.||++..+..+||+|||+|+.+..+
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999996544 567999999999999999999999776   999999999999999999999999999998654


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      .  ......+||+.||.||++.+.+|..|+|||||||++|||++-+++|....   -..++..+.            ...
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~---m~~Li~ki~------------~~~  222 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN---MSELILKIN------------RGL  222 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc---hHHHHHHHh------------hcc
Confidence            4  23445789999999999999999999999999999999999999864322   222332221            112


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ....+..++.++..++..|++.+|+.||++.+++.+
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            345567788899999999999999999999999864

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.8e-36  Score=332.97  Aligned_cols=245  Identities=22%  Similarity=0.292  Sum_probs=201.4

Q ss_pred             ccccccceeeccccEEEEEeEecC--CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ++|+..++||+|+||.||+|+...  +..||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            468888999999999999997644  368999998643   233456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++|+|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       110 ~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            9999999999998543   34889999999999999999999998   99999999999999999999999999987532


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      .     .....||+.|+|||++.+..++.++|||||||++|||++|+.|+...   +.....    +....+.       
T Consensus       184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~---~~~~~~----~~i~~~~-------  244 (340)
T PTZ00426        184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN---EPLLIY----QKILEGI-------  244 (340)
T ss_pred             C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC---CHHHHH----HHHhcCC-------
Confidence            1     22357899999999999988999999999999999999999997432   111111    1111111       


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERP-----TMASVVLM  813 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  813 (862)
                        ..++......+.+++.+|++.+|++|+     +++|+++.
T Consensus       245 --~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 --IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence              112333455678999999999999995     89998864

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-36  Score=317.78  Aligned_cols=255  Identities=26%  Similarity=0.374  Sum_probs=201.1

Q ss_pred             HHHcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--------------ccchHHHHHHHHHHHhcccCCceE
Q 002969          538 VRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--------------GQGIEEFKNEVRLIAKLQHRNLVR  602 (862)
Q Consensus       538 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------------~~~~~~~~~E~~~l~~l~HpnIv~  602 (862)
                      .+..++|+..+.||+|.||.|-+|+.. +++.||||++.+..              ....+..++|+.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            345578999999999999999999865 48899999996531              112468899999999999999999


Q ss_pred             EEEEEEe--CCceEEEEEeccCCChhhhhhhccCCCC-CCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC
Q 002969          603 LLGCCVE--MDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK  679 (862)
Q Consensus       603 l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~  679 (862)
                      |+.+..+  .+..|||+||+..|.+...-    ..+. ++..+..+++.++..||+|||.++   ||||||||.|+||++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence            9999865  56789999999988875432    2233 899999999999999999999998   999999999999999


Q ss_pred             CCCeeEecccceeecCCC---CcccccccccccccccChhhhcCCC----CCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 002969          680 EMTPKISDFGMARIFGGD---QTEQNTKRVVGTYGYMSPEYAMDGL----FSVKSDVFSFGVLLLETVSGKKNRGFYHSN  752 (862)
Q Consensus       680 ~~~~kL~DFGla~~~~~~---~~~~~~~~~~gt~~y~APE~l~~~~----~s~ksDVwSlGvil~elltG~~p~~~~~~~  752 (862)
                      +|++||+|||.+..+...   .........+||+.|+|||.+.++.    .+.+.||||+||+||.|+.|+.||.   .+
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~---~~  322 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF---DD  322 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc---cc
Confidence            999999999999876322   1122223478999999999987743    3568899999999999999999963   22


Q ss_pred             cchhHHHHHHHHHhcCceeeeecccC-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 002969          753 NELNLLGHVWRLWKEGKVLEMVDSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML  814 (862)
Q Consensus       753 ~~~~l~~~~~~~~~~~~~~~~id~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  814 (862)
                      ....+.+.+    .        ...+ ....+++..++.+|++++|++||+.|.+..+|..+.
T Consensus       323 ~~~~l~~KI----v--------n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  323 FELELFDKI----V--------NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             hHHHHHHHH----h--------cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            222222222    1        1111 112234567888999999999999999999997654

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=298.77  Aligned_cols=263  Identities=23%  Similarity=0.275  Sum_probs=211.2

Q ss_pred             HcccccccceeeccccEEEEEeEe-cCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeC-----Cce
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-----DEK  613 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~  613 (862)
                      ..++|++.++||+|||+-||.++. .+++.+|+|++.-...+..+..++|++..++++|||++++++++..+     ...
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            346899999999999999999984 45788999999877777888999999999999999999999887543     348


Q ss_pred             EEEEEeccCCChhhhhhhc-cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          614 MLVYEYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      |++++|...|+|.+.+... .++..+++.+.++|+.+|++||++||+.. ++++||||||.|||+.+++.++|.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence            9999999999999998654 34457999999999999999999999986 589999999999999999999999999987


Q ss_pred             ecCCCCcc-------cccccccccccccChhhhc---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHH
Q 002969          693 IFGGDQTE-------QNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVW  762 (862)
Q Consensus       693 ~~~~~~~~-------~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~  762 (862)
                      ...-....       +.......|..|.|||++.   +...++++|||||||+||+|+.|..||+....           
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-----------  246 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-----------  246 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence            54321111       1112234688999999874   45678999999999999999999999753211           


Q ss_pred             HHHhcCcee--eeecccCC-CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          763 RLWKEGKVL--EMVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       763 ~~~~~~~~~--~~id~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                          .|...  ......+. .-....++.+.+++.+|+|.||.+||++.+++..++.+.
T Consensus       247 ----~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 ----QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ----cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                22222  22222221 112237788999999999999999999999999988763

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.7e-36  Score=332.14  Aligned_cols=260  Identities=30%  Similarity=0.439  Sum_probs=204.1

Q ss_pred             ccccccceeeccccEEEEEeEecC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEEEEEEEe-CCc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVE-MDE  612 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~-~~~  612 (862)
                      ++|++.++||+|+||.||+|...+      ++.||+|+++... ....+.+..|+.++.++ +|+||++++++|.. ...
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            478889999999999999996422      4689999986543 23346788899999999 89999999998865 456


Q ss_pred             eEEEEEeccCCChhhhhhhccC----------------------------------------------------------
Q 002969          613 KMLVYEYMENRSLDSVIFDKAR----------------------------------------------------------  634 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  634 (862)
                      .++++||+++++|.+++.....                                                          
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            7899999999999999854321                                                          


Q ss_pred             CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccccccccccccccC
Q 002969          635 SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS  714 (862)
Q Consensus       635 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~A  714 (862)
                      ...+++..+.+++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.............++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            125789999999999999999999987   99999999999999999999999999987643322222233456778999


Q ss_pred             hhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHH
Q 002969          715 PEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVG  793 (862)
Q Consensus       715 PE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li  793 (862)
                      ||++.+..++.++|||||||++|||++ |..|+......+      ...+....+..        ...+.....++.+++
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~--------~~~~~~~~~~~~~l~  309 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTR--------MRAPEYATPEIYSIM  309 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCC--------CCCCccCCHHHHHHH
Confidence            999999999999999999999999998 888864322111      11112222111        111223456788999


Q ss_pred             HhccccCCCCCCCHHHHHHHhccCc
Q 002969          794 LLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       794 ~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      .+||+.+|++||++.||+++|+.+.
T Consensus       310 ~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         310 LDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHH
Confidence            9999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.9e-36  Score=348.28  Aligned_cols=260  Identities=23%  Similarity=0.297  Sum_probs=207.9

Q ss_pred             HHHHHcccccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCC-
Q 002969          536 TIVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-  611 (862)
Q Consensus       536 ~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-  611 (862)
                      ++....++|++.++||+|+||.||+++.. +++.||||++...  .......+.+|+.++..++|+|+++++..+...+ 
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            33445578999999999999999999764 5899999998654  3344567889999999999999999988775433 


Q ss_pred             -------ceEEEEEeccCCChhhhhhhcc-CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCe
Q 002969          612 -------EKMLVYEYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (862)
Q Consensus       612 -------~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  683 (862)
                             ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence                   2579999999999999986533 2346889999999999999999999987   9999999999999999999


Q ss_pred             eEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHH
Q 002969          684 KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR  763 (862)
Q Consensus       684 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~  763 (862)
                      ||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.|+...   ....    ...
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~---~~~~----~~~  255 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE---NMEE----VMH  255 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC---CHHH----HHH
Confidence            999999998765433333334467999999999999999999999999999999999999997432   1111    111


Q ss_pred             HHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          764 LWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       764 ~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ....+.        ....+...+.++.+++.+||+.+|++||++.+++..
T Consensus       256 ~~~~~~--------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        256 KTLAGR--------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHhcCC--------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            111111        122334456678899999999999999999999863

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1e-35  Score=332.43  Aligned_cols=248  Identities=27%  Similarity=0.368  Sum_probs=195.0

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ++|+..++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34566789999999999999875 48899999986543 33456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|....       ...+..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.....
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999986532       3566778899999999999999998   99999999999999999999999999987643221


Q ss_pred             ccccccccccccccChhhhcC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          700 EQNTKRVVGTYGYMSPEYAMD-----GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                        ......|+..|+|||++..     ...+.++|||||||++|||++|+.||......+...+...    ...       
T Consensus       224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~----~~~-------  290 (353)
T PLN00034        224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA----ICM-------  290 (353)
T ss_pred             --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH----Hhc-------
Confidence              1223578999999998743     2345689999999999999999999763222211111111    100       


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                       ......+.....++.+++.+||+.+|++||++.||++.
T Consensus       291 -~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        291 -SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             00112233455678999999999999999999999974

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.6e-35  Score=319.63  Aligned_cols=259  Identities=24%  Similarity=0.363  Sum_probs=195.3

Q ss_pred             cccccceeeccccEEEEEeEec--CCcEEEEEEeccCC--ccchHHHHHHHHHHHhc---ccCCceEEEEEEEe-----C
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL--EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKL---QHRNLVRLLGCCVE-----M  610 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~HpnIv~l~g~~~~-----~  610 (862)
                      +|+..+.||+|+||.||+|+..  +++.||+|+++...  ......+.+|+.+++.+   +||||+++++++..     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            6888899999999999999863  36789999986542  22334566788877776   69999999999853     4


Q ss_pred             CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccc
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  690 (862)
                      ...++|+||++ ++|.+++.... ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence            56899999997 58988885433 234889999999999999999999998   99999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc-
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK-  769 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-  769 (862)
                      ++.....   .......|++.|+|||.+.+..++.++|||||||++|||++|++|+...   ...+.+..+........ 
T Consensus       157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~---~~~~~~~~i~~~~~~~~~  230 (290)
T cd07862         157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS---SDVDQLGKILDVIGLPGE  230 (290)
T ss_pred             eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC---CHHHHHHHHHHHhCCCCh
Confidence            9875432   2223456899999999999989999999999999999999999986532   22223333322211000 


Q ss_pred             --ee-------eeecccC----CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          770 --VL-------EMVDSSV----DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       770 --~~-------~~id~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        ..       .......    ..........+.+++.+||+.+|++||++.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence              00       0000000    0111223456779999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-35  Score=332.68  Aligned_cols=258  Identities=17%  Similarity=0.185  Sum_probs=195.7

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      .++|+..++||+|+||.||++.... ++.||+|+...      +.+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            3579999999999999999998754 78899997532      3567899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +. ++|..++...   ..+++.+++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       165 ~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-  236 (391)
T PHA03212        165 YK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-  236 (391)
T ss_pred             CC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence            95 6888877543   34889999999999999999999998   9999999999999999999999999997542211 


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc----chhHHHHHHHHHhcCc------
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN----ELNLLGHVWRLWKEGK------  769 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~----~~~l~~~~~~~~~~~~------  769 (862)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+.......    ....+..+.+......      
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            112233579999999999999999999999999999999999998753221100    0111111111110000      


Q ss_pred             -----------eeeeecccCCCC-----ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          770 -----------VLEMVDSSVDNY-----PANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       770 -----------~~~~id~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                                 ............     ....+.++.+|+.+||+.||++|||++|+++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                       000000000000     0123457889999999999999999999985

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.5e-35  Score=316.90  Aligned_cols=255  Identities=28%  Similarity=0.426  Sum_probs=205.3

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      ..|+..++||+|+||.||+|...+ ++.||+|++... ....+++.+|++++++++||||+++++++...+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            347777899999999999998754 788999998643 334678899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++.... ...+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999999985433 345899999999999999999999987   999999999999999999999999999876432211


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                       ......++..|+|||.+.+..++.++||||||+++|||++ |..|+....   ..    ..++.......        .
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~---~~----~~~~~~~~~~~--------~  224 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LS----QVYELLEKGYR--------M  224 (263)
T ss_pred             -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HH----HHHHHHHCCCC--------C
Confidence             1111234568999999999999999999999999999998 888864221   11    12222222110        1


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ..+...+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus       225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            22333456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=328.68  Aligned_cols=254  Identities=28%  Similarity=0.443  Sum_probs=212.5

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      +....++||-|.||.||.|.++. .-.||||.++.+. -..++|+.|+.+|+.++|||+|+|+|+|......|+|.|||.
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC  346 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence            45666899999999999999976 5679999996654 457899999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +|+|.++|....+ ..++...++.++.||+.||+||...+   +|||||.++|+||.++..+|++||||++.+..+....
T Consensus       347 yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA  422 (1157)
T KOG4278|consen  347 YGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA  422 (1157)
T ss_pred             CccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence            9999999976544 34777788999999999999999988   9999999999999999999999999999886543322


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                       .....-+..|.|||-+....++.|+|||+|||+|||+.| |-.|+..   -+    +..++.++..+..++        
T Consensus       423 -HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG---id----lSqVY~LLEkgyRM~--------  486 (1157)
T KOG4278|consen  423 -HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG---ID----LSQVYGLLEKGYRMD--------  486 (1157)
T ss_pred             -ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC---cc----HHHHHHHHhcccccc--------
Confidence             222234678999999999999999999999999999998 5555422   11    234445555544333        


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      -+..++..+++||+.||+.+|.+||++.|+-+.++..
T Consensus       487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            2566788999999999999999999999999888764

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.9e-35  Score=323.67  Aligned_cols=248  Identities=24%  Similarity=0.325  Sum_probs=196.9

Q ss_pred             ceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      +.||+|+||.||+++... ++.||+|+++..   .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            479999999999998764 788999999754   233456678899988877 799999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      ++|..++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~  152 (329)
T cd05618          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDT  152 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCc
Confidence            9998887543   34889999999999999999999998   999999999999999999999999998753221  112


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc--chhHHHHHHHHHhcCceeeeecccCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN--ELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.|+.......  ......+..+......         ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---------~~  223 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---------IR  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC---------CC
Confidence            234578999999999999999999999999999999999999985322211  1111222222222211         12


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCC------HHHHHH
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPT------MASVVL  812 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~  812 (862)
                      .+......+.+++.+||+.||++||+      +.++++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            33445567889999999999999998      567654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.3e-35  Score=320.59  Aligned_cols=256  Identities=27%  Similarity=0.419  Sum_probs=204.3

Q ss_pred             ccccccceeeccccEEEEEeEec------CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      .+|...++||+|+||.||++...      ++..+|+|.+........+.+.+|+++++.++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45677799999999999999642      255789999877666667789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccC------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCe
Q 002969          616 VYEYMENRSLDSVIFDKAR------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  683 (862)
                      ++||+++++|.+++.....            ...+++..++.++.||+.||+|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999999865321            134889999999999999999999988   9999999999999999999


Q ss_pred             eEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHH
Q 002969          684 KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVW  762 (862)
Q Consensus       684 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~  762 (862)
                      ||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..|+.....   ....    
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~----  234 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TEAI----  234 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HHHH----
Confidence            9999999986543322222222345678999999999999999999999999999998 8887532111   1111    


Q ss_pred             HHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       763 ~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      .....+..        ...+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus       235 ~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         235 ECITQGRE--------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHcCcc--------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            11111111        1112234567889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-35  Score=322.11  Aligned_cols=265  Identities=25%  Similarity=0.375  Sum_probs=202.1

Q ss_pred             ccccccceeeccccEEEEEeEecC---------------CcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE---------------GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLG  605 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~---------------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g  605 (862)
                      ++|++.++||+|+||.||+++..+               ...||+|+++.. .....+.|.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            478888999999999999987532               235899998754 2334567999999999999999999999


Q ss_pred             EEEeCCceEEEEEeccCCChhhhhhhccC---------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceE
Q 002969          606 CCVEMDEKMLVYEYMENRSLDSVIFDKAR---------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNIL  676 (862)
Q Consensus       606 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NIL  676 (862)
                      ++...+..++||||+++++|.+++.....         ...+++..++.++.|+++||+|||+.+   ++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            99999999999999999999999854321         123688899999999999999999998   999999999999


Q ss_pred             ecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchh
Q 002969          677 LDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELN  756 (862)
Q Consensus       677 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~  756 (862)
                      +++++.+||+|||++..+.............++..|+|||++.+..++.++||||||++++||+++..+..+.... ...
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~-~~~  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS-DEQ  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC-hHH
Confidence            9999999999999997654332222222334577899999999999999999999999999999854332222111 112


Q ss_pred             HHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       757 l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      .+....+.+......     .....+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus       241 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIENTGEFFRNQGRQ-----IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHhhhhcccc-----ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            222221111111000     001112234568899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.2e-35  Score=325.23  Aligned_cols=248  Identities=22%  Similarity=0.299  Sum_probs=198.3

Q ss_pred             ceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      ++||+|+||.||+++... ++.||||+++..   .....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            479999999999998764 789999999754   233456788999999998 799999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      ++|..++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~  152 (329)
T cd05588          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT  152 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence            9998887543   34899999999999999999999998   999999999999999999999999998743211  122


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc--chhHHHHHHHHHhcCceeeeecccCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN--ELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.|+......+  .........+...+..         ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---------~~  223 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ---------IR  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC---------CC
Confidence            234578999999999999999999999999999999999999986432221  1112222222222221         12


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCC------HHHHHH
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPT------MASVVL  812 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~  812 (862)
                      .+...+.++.+++.+||+.||++||+      +.++++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            23344567889999999999999997      677774

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.6e-35  Score=319.29  Aligned_cols=264  Identities=28%  Similarity=0.418  Sum_probs=206.4

Q ss_pred             cccccccceeeccccEEEEEeEecC-----------------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-----------------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVR  602 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~  602 (862)
                      ..+|+..++||+|+||.||+++..+                 +..||+|++.... ....+++.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578889999999999999987643                 2458999987653 335678999999999999999999


Q ss_pred             EEEEEEeCCceEEEEEeccCCChhhhhhhcc--------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcc
Q 002969          603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKA--------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASN  674 (862)
Q Consensus       603 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~N  674 (862)
                      +++++...+..++++||+++++|.+++....        ....+++..++.++.|+++||+|||+.+   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999986543        1235899999999999999999999987   9999999999


Q ss_pred             eEecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh--CCCCCCCCCCC
Q 002969          675 ILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS--GKKNRGFYHSN  752 (862)
Q Consensus       675 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt--G~~p~~~~~~~  752 (862)
                      |+++.++.++|+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++  +..|+...   
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~---  237 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL---  237 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc---
Confidence            9999999999999999986643333233334456789999999998899999999999999999998  44554321   


Q ss_pred             cchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          753 NELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       753 ~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      .....+......+........     ...+...+.++.+++.+||+.+|++||++.||++.|.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         238 TDQQVIENAGHFFRDDGRQIY-----LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ChHHHHHHHHhcccccccccc-----CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            122222222222111111110     1122334567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1e-35  Score=323.27  Aligned_cols=259  Identities=29%  Similarity=0.438  Sum_probs=207.4

Q ss_pred             cccccccceeeccccEEEEEeEecC------CcEEEEEEeccC-CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCc
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDE  612 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~  612 (862)
                      .++|+..+.||+|+||.||++....      ...+|+|++... ......++.+|+.++.++ +|+||+++++++...+.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            4568888999999999999997643      357999998754 233456788999999999 79999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhc-------------cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC
Q 002969          613 KMLVYEYMENRSLDSVIFDK-------------ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK  679 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~  679 (862)
                      .+++|||+++++|.+++...             .....+++..+++++.|++.||+|||+.+   |+||||||+|||++.
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence            99999999999999998643             22346899999999999999999999987   999999999999999


Q ss_pred             CCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHH
Q 002969          680 EMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLL  758 (862)
Q Consensus       680 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~  758 (862)
                      ++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+.....       
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------  240 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-------  240 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-------
Confidence            99999999999987644322222222345678999999999999999999999999999998 8887542211       


Q ss_pred             HHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          759 GHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       759 ~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ....+....+..        ...+......+.+++.+|++.+|++||++.|+++.|+++
T Consensus       241 ~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         241 EELFKLLKEGYR--------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HHHHHHHHcCCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            112222222211        122334456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.9e-35  Score=317.36  Aligned_cols=255  Identities=25%  Similarity=0.429  Sum_probs=199.5

Q ss_pred             cccceeeccccEEEEEeEecCCc---EEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeC------Cce
Q 002969          545 TDYNKLGQGGFGIVYKGRLLEGQ---EIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM------DEK  613 (862)
Q Consensus       545 ~~~~~LG~G~fg~Vy~~~~~~~~---~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~------~~~  613 (862)
                      .+.++||+|+||.||+|+..+..   .+|+|.++..  .....+.+.+|+++++.++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            45689999999999999876532   5899988654  334567889999999999999999999987542      246


Q ss_pred             EEEEEeccCCChhhhhhhc---cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccc
Q 002969          614 MLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  690 (862)
                      ++++||+++|+|.+++...   .....+++.....++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999987432   12345889999999999999999999987   99999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCc
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGK  769 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  769 (862)
                      ++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...   ....+    ......+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~~~----~~~~~~~~  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV---ENSEI----YDYLRQGN  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHH----HHHHHcCC
Confidence            987643322111222345778999999999999999999999999999999 77776431   11122    22222221


Q ss_pred             eeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          770 VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       770 ~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ..        ..+...+..+.+++.+||+.+|++||++.||++.|+.+
T Consensus       232 ~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RL--------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11        11233455688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-36  Score=315.45  Aligned_cols=275  Identities=25%  Similarity=0.337  Sum_probs=209.9

Q ss_pred             CCCCccChHHHHHHcccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHh--cccCCceEEE
Q 002969          527 LELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAK--LQHRNLVRLL  604 (862)
Q Consensus       527 ~~~~~~~~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~  604 (862)
                      ..+|.+-..+|.+   +....+.||+|.||+||+|++ .|+.||||++....   .+.+.+|.++.+.  |+|+||+.++
T Consensus       199 SGlplLVQRTiar---qI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFI  271 (513)
T KOG2052|consen  199 SGLPLLVQRTIAR---QIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFI  271 (513)
T ss_pred             CCchhHhHHhhhh---eeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhh
Confidence            4566666666543   667789999999999999988 68999999996443   4567788888776  4999999999


Q ss_pred             EEEEeCC----ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc-----CCCcEEecccCCcce
Q 002969          605 GCCVEMD----EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-----SRFRIIHRDLKASNI  675 (862)
Q Consensus       605 g~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-----~~~~ivHrDlkp~NI  675 (862)
                      +.-..+.    .++||.+|.+.|||.++|..    ..++....++++..+|.||++||.+     ++|.|.|||||++||
T Consensus       272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNI  347 (513)
T KOG2052|consen  272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNI  347 (513)
T ss_pred             hccccCCCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccE
Confidence            8865443    57899999999999999954    4589999999999999999999954     789999999999999


Q ss_pred             EecCCCCeeEecccceeecCCCC--cccccccccccccccChhhhcCCC----C--CccccchhHHHHHHHHHhC-----
Q 002969          676 LLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGL----F--SVKSDVFSFGVLLLETVSG-----  742 (862)
Q Consensus       676 Ll~~~~~~kL~DFGla~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~----~--s~ksDVwSlGvil~elltG-----  742 (862)
                      ||..++.+.|+|+|||.......  ........+||.+|||||++.+.-    +  -..+||||||.++||+...     
T Consensus       348 LVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~gg  427 (513)
T KOG2052|consen  348 LVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGG  427 (513)
T ss_pred             EEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCC
Confidence            99999999999999998765432  223334568999999999986532    2  1368999999999998762     


Q ss_pred             -----CCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC--CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          743 -----KKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD--NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       743 -----~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                           +.||...  .....-+++..+.+-.    +.+.+.+.  ....+....+.++|+.||..||.-|-|+--+-+.|.
T Consensus       428 i~eey~~Pyyd~--Vp~DPs~eeMrkVVCv----~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~  501 (513)
T KOG2052|consen  428 IVEEYQLPYYDV--VPSDPSFEEMRKVVCV----QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLA  501 (513)
T ss_pred             EehhhcCCcccC--CCCCCCHHHHhcceee----cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHH
Confidence                 2343221  1111122333333322    33333332  224456778889999999999999999999999998


Q ss_pred             cCc
Q 002969          816 SET  818 (862)
Q Consensus       816 ~~~  818 (862)
                      ++.
T Consensus       502 ~l~  504 (513)
T KOG2052|consen  502 KLS  504 (513)
T ss_pred             HHh
Confidence            874

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.2e-35  Score=317.39  Aligned_cols=256  Identities=28%  Similarity=0.401  Sum_probs=201.0

Q ss_pred             ccccccceeeccccEEEEEeEecC-Cc----EEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ----EIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ++|+..+.||+|+||.||+|+... ++    .+++|++.... .....++..|+..+++++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            467788999999999999998643 43    47888875443 234567888888999999999999999875 456789


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ++||+++|+|.+++....  ..+++..+..++.||+.||+|||+.+   ++||||||+|||+++++.+||+|||+++.+.
T Consensus        86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            999999999999996432  35899999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.|+......       ...+.+..+...   
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~---  230 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------EVPDLLEKGERL---  230 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCcC---
Confidence            3332222333456788999999999999999999999999999998 88886432211       111112222111   


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                           ..+......+.+++.+|++.+|++||++.|+++.|....
T Consensus       231 -----~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         231 -----AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence                 111223456788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.6e-35  Score=314.33  Aligned_cols=248  Identities=27%  Similarity=0.391  Sum_probs=196.5

Q ss_pred             ceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCCh
Q 002969          548 NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL  625 (862)
                      ++||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++|+||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999875 58889999886543 33456799999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccccccc
Q 002969          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR  705 (862)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  705 (862)
                      .+++...  ...+++..++.++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            9998543  235889999999999999999999988   99999999999999999999999999876432211111111


Q ss_pred             ccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChH
Q 002969          706 VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPAN  784 (862)
Q Consensus       706 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~  784 (862)
                      ...+..|+|||.+.+..++.++||||||+++|||++ |..|+......   .    .........        ....+..
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~----~~~~~~~~~--------~~~~~~~  220 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---Q----TREAIEQGV--------RLPCPEL  220 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---H----HHHHHHcCC--------CCCCccc
Confidence            123467999999999999999999999999999998 77775422111   1    111111110        0122333


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          785 EVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       785 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      .+..+.+++.+|++.+|++||++.||+++|.
T Consensus       221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            4567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-35  Score=318.69  Aligned_cols=257  Identities=29%  Similarity=0.440  Sum_probs=206.0

Q ss_pred             ccccccceeeccccEEEEEeEecC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  614 (862)
                      ++|+..+.||+|+||.||+|....      +..||+|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            578888999999999999997643      3679999986543 234567889999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhccC-------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEec
Q 002969          615 LVYEYMENRSLDSVIFDKAR-------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISD  687 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  687 (862)
                      +||||+++++|.+++.....       ...+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECC
Confidence            99999999999999865322       234788999999999999999999987   99999999999999999999999


Q ss_pred             ccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHh
Q 002969          688 FGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWK  766 (862)
Q Consensus       688 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~  766 (862)
                      ||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.|+....   ....    .+...
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---~~~~----~~~~~  235 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS---NEEV----LKFVI  235 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC---HHHH----HHHHh
Confidence            999986643332222223456789999999998899999999999999999998 888764221   1111    11222


Q ss_pred             cCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          767 EGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       767 ~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      .+.        ....+...+.++.+++.+||+.+|++|||+.++++.|+.
T Consensus       236 ~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         236 DGG--------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             cCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            211        112233346788899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.1e-35  Score=327.59  Aligned_cols=261  Identities=22%  Similarity=0.318  Sum_probs=195.2

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCC-----ceE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-----EKM  614 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~  614 (862)
                      +|+..++||+|+||.||+|+.. +++.||||++...  ......++.+|++++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999865 4889999998643  2234457889999999999999999999886432     479


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      +||||++ ++|.+++...   ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999996 6888887533   34899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCc-ccccccccccccccChhhhcC--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHH-------
Q 002969          695 GGDQT-EQNTKRVVGTYGYMSPEYAMD--GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL-------  764 (862)
Q Consensus       695 ~~~~~-~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~-------  764 (862)
                      ..... ........|++.|+|||++.+  ..++.++|||||||++|||++|+.|+......   .....+...       
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~  230 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV---HQLDLITDLLGTPSPE  230 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCCHH
Confidence            32221 112233578999999999876  67899999999999999999999987532211   111111000       


Q ss_pred             ----HhcCceee---eeccc----CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          765 ----WKEGKVLE---MVDSS----VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       765 ----~~~~~~~~---~id~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                          +......+   .+...    ...........+.+++.+||+.+|++||+++|+++.
T Consensus       231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                00000000   00000    000011234567899999999999999999999963

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.9e-35  Score=326.06  Aligned_cols=259  Identities=25%  Similarity=0.335  Sum_probs=200.5

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .++|+..++||+|+||.||+++... +..+|+|++.... ....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            3678999999999999999998764 7788999886542 3345678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++++|.+++...   ..+++.....++.|+++||.|||+..  +++||||||+|||++.++.+||+|||++..+... 
T Consensus        84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            99999999998543   34788899999999999999999753  3999999999999999999999999998765321 


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee-------
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL-------  771 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-------  771 (862)
                         ......|+..|+|||++.+..++.++|||||||++|||++|+.|+........    .........+...       
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  230 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL----ELMFGCPVEGDPAESETSPR  230 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH----HHHhcCcccCCccccccCcc
Confidence               12234689999999999998999999999999999999999999753221110    0000000000000       


Q ss_pred             ----------------------ee----ecccCCCC-ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 ----------------------EM----VDSSVDNY-PANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 ----------------------~~----id~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                                            ..    +....... ......++.+|+.+||+.||++||++.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                                  00    00000000 0113456889999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6e-35  Score=319.13  Aligned_cols=262  Identities=23%  Similarity=0.326  Sum_probs=197.8

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc-cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .++|+..++||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467899999999999999999876 478999999865432 234567889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |++ ++|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 5777776443  234788889999999999999999998   9999999999999999999999999987643221


Q ss_pred             cccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce-------
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV-------  770 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-------  770 (862)
                        .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||....  +....+..+.........       
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK--DIQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc--cHHHHHHHHHHHhCCCChhhccchh
Confidence              12223467899999999876 457899999999999999999999975322  111222222211111000       


Q ss_pred             -eeeec-ccCCCC-C---------hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          771 -LEMVD-SSVDNY-P---------ANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       771 -~~~id-~~~~~~-~---------~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       ..... ...... +         ......+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             00000 000000 0         012345779999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-35  Score=315.47  Aligned_cols=252  Identities=27%  Similarity=0.349  Sum_probs=202.4

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      +|+..++||+|+||.||++... +++.||||++....   ......+.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3777899999999999999875 47899999986532   2234567889999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++++|.+++.... ...+++..+..++.|+++||.|||+.+   ++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            999999998885432 245899999999999999999999998   9999999999999999999999999998753222


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                      .   .....|+..|+|||++.+..++.++||||+|+++|||++|+.|+......   .....+.....         ...
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~---~~~~~~~~~~~---------~~~  221 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK---VKREEVERRVK---------EDQ  221 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh---hHHHHHHHHhh---------hcc
Confidence            1   12346899999999999989999999999999999999999997532221   11111111111         111


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERP-----TMASVVLM  813 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  813 (862)
                      ..++...+..+.+++.+||+.||++||     +++++++.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            223344566788999999999999999     88898753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.1e-35  Score=320.51  Aligned_cols=258  Identities=28%  Similarity=0.431  Sum_probs=204.6

Q ss_pred             cccccceeeccccEEEEEeEecC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      +|+..+.||+|+||.||+|+...      ...+++|.+.... ....+++.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            46777899999999999997532      3568898886543 2345679999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcc---------------------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcc
Q 002969          616 VYEYMENRSLDSVIFDKA---------------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASN  674 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~N  674 (862)
                      ++||+.+++|.+++....                     ....+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999885421                     1134788999999999999999999987   9999999999


Q ss_pred             eEecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCc
Q 002969          675 ILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNN  753 (862)
Q Consensus       675 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~  753 (862)
                      ||+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||++++||++ |..|+....   
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---  234 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA---  234 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence            9999999999999999986543322222222345678999999998899999999999999999998 888864221   


Q ss_pred             chhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          754 ELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       754 ~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      .    ...+........        ...+...+.++.+++.+||+.+|++||++.|+++.|+++.
T Consensus       235 ~----~~~~~~~~~~~~--------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         235 P----ERLFNLLKTGYR--------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             H----HHHHHHHhCCCC--------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            1    122222222110        1122334567889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.7e-35  Score=318.18  Aligned_cols=247  Identities=27%  Similarity=0.340  Sum_probs=197.2

Q ss_pred             eeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCCh
Q 002969          550 LGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (862)
Q Consensus       550 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL  625 (862)
                      ||+|+||+||+++.. +++.||+|++....   ....+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999865 47899999986542   22346778899999999999999999999999999999999999999


Q ss_pred             hhhhhhc-cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccccc
Q 002969          626 DSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK  704 (862)
Q Consensus       626 ~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  704 (862)
                      ..++... .....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            9887543 23346899999999999999999999998   99999999999999999999999999987643222  122


Q ss_pred             cccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChH
Q 002969          705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPAN  784 (862)
Q Consensus       705 ~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~  784 (862)
                      ...|++.|+|||.+.+..++.++||||||+++|||++|+.|+........   .........        .. ....+..
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~--------~~-~~~~~~~  223 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQRIL--------ND-SVTYPDK  223 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh---HHHHHHhhc--------cc-CCCCccc
Confidence            35689999999999999999999999999999999999999753222111   011111000        00 1122334


Q ss_pred             HHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 002969          785 EVLRCIHVGLLCVQENAEERP-----TMASVVLM  813 (862)
Q Consensus       785 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  813 (862)
                      .+..+.+++.+||+.+|++||     +++++++.
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            566788999999999999999     77888853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-35  Score=313.55  Aligned_cols=251  Identities=29%  Similarity=0.445  Sum_probs=201.7

Q ss_pred             cccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      +|+..+.||+|+||.||+++...+..+|+|++.... ...+.+.+|+.++++++||||+++++++...+..++|+||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            577889999999999999988777789999986432 2345788999999999999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      ++|.+++....  ..+++..++.++.||++||+|||+.+   ++||||||+||++++++.+||+|||+++......... 
T Consensus        84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-  157 (256)
T cd05059          84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-  157 (256)
T ss_pred             CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence            99999986433  25899999999999999999999998   9999999999999999999999999998653221111 


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY  781 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~  781 (862)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....   ....    .....+..        ...
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~----~~~~~~~~--------~~~  222 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVV----ESVSAGYR--------LYR  222 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHH----HHHHcCCc--------CCC
Confidence            111223457999999999999999999999999999999 7777643211   1111    11221110        111


Q ss_pred             ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          782 PANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       782 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      +...+.++.+++.+||+.+|++||++.||++.|.
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            2335667889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.9e-35  Score=326.22  Aligned_cols=241  Identities=26%  Similarity=0.327  Sum_probs=195.0

Q ss_pred             ceeeccccEEEEEeEec----CCcEEEEEEeccC----CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          548 NKLGQGGFGIVYKGRLL----EGQEIAVKRLSRN----SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ++||+|+||.||+++..    .++.||||+++..    .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            68999999999999753    4788999998753    223345678999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|.+++...   ..+.+..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (323)
T cd05584          82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-  154 (323)
T ss_pred             CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence            9999999988543   34778888889999999999999998   9999999999999999999999999987542221 


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                       .......|++.|+|||++.+..++.++||||||+++|||++|+.|+....   ......    ....+.         .
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~---~~~~~~----~~~~~~---------~  217 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN---RKKTID----KILKGK---------L  217 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC---HHHHHH----HHHcCC---------C
Confidence             12223578999999999999889999999999999999999999974321   111111    111111         1


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERP-----TMASVVL  812 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  812 (862)
                      ..+......+.+++.+||+.+|++||     ++.++++
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            22334456788999999999999999     8888876

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.4e-35  Score=317.88  Aligned_cols=257  Identities=30%  Similarity=0.441  Sum_probs=202.9

Q ss_pred             cccccccceeeccccEEEEEeEecC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  613 (862)
                      +++|...+.||+|+||.||+|...+      +..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678888999999999999998754      4678999886443 33456799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccC----CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC---CeeEe
Q 002969          614 MLVYEYMENRSLDSVIFDKAR----SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM---TPKIS  686 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kL~  686 (862)
                      ++||||+++++|.+++.....    ...+++..+++++.||++||+|||+.+   ++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999865432    235899999999999999999999998   99999999999998754   69999


Q ss_pred             cccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHH
Q 002969          687 DFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLW  765 (862)
Q Consensus       687 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  765 (862)
                      |||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.|+.....   ....    ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~----~~~  234 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVM----EFV  234 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HHH
Confidence            9999987633222111222234568999999999999999999999999999997 8888642211   1111    111


Q ss_pred             hcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          766 KEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       766 ~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      ....        ....+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus       235 ~~~~--------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 TGGG--------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1111        01123344567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.9e-35  Score=324.99  Aligned_cols=252  Identities=23%  Similarity=0.303  Sum_probs=199.6

Q ss_pred             cccccceeeccccEEEEEeEec----CCcEEEEEEeccC----CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCce
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRN----SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~  613 (862)
                      +|+..++||+|+||.||+++..    .++.||+|++.+.    .....+.+..|+.++.++ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4778899999999999998753    4788999998653    223456788999999999 599999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++||||+++|+|.+++...   ..+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            9999999999999998543   34889999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      +...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.|+.........   ..+.+.....    
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~----  226 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILKC----  226 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhcC----
Confidence            5332221 22235789999999999875 4788999999999999999999997543222211   1111111110    


Q ss_pred             eecccCCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQENAEERP-----TMASVVLM  813 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  813 (862)
                        +   ...+......+.+++.+||+.||++||     +++++++.
T Consensus       227 --~---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         227 --D---PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             --C---CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence              1   122334456788999999999999999     77788753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.8e-35  Score=332.40  Aligned_cols=253  Identities=21%  Similarity=0.272  Sum_probs=196.3

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .|+.+++||+|+||+||+|+... ++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            57888999999999999998754 7899999996542   3345678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++|+|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            99999999998543   34788888899999999999999988   9999999999999999999999999976432100


Q ss_pred             c---------------------------------------------ccccccccccccccChhhhcCCCCCccccchhHH
Q 002969          699 T---------------------------------------------EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFG  733 (862)
Q Consensus       699 ~---------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlG  733 (862)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                             0001235799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHh--ccccCCCCCCCHHHHH
Q 002969          734 VLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLL--CVQENAEERPTMASVV  811 (862)
Q Consensus       734 vil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~evl  811 (862)
                      |++|||++|+.||......   ....   +.........      .........++.+++.+  |+..+|..||++.|++
T Consensus       236 ~il~elltG~~Pf~~~~~~---~~~~---~i~~~~~~~~------~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l  303 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPT---ETQL---KVINWENTLH------IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK  303 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHH---HHHH---HHHccccccC------CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence            9999999999997532211   1111   1111000000      00111234567778877  5566777799999998


Q ss_pred             HH
Q 002969          812 LM  813 (862)
Q Consensus       812 ~~  813 (862)
                      ..
T Consensus       304 ~h  305 (381)
T cd05626         304 AH  305 (381)
T ss_pred             cC
Confidence            64

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.1e-35  Score=319.24  Aligned_cols=263  Identities=26%  Similarity=0.415  Sum_probs=203.0

Q ss_pred             ccccccceeeccccEEEEEeEec-----CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEe--CCceE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE--MDEKM  614 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~  614 (862)
                      .+|++.+.||+|+||.||++...     .++.||+|++........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46788899999999999999742     477899999977666667789999999999999999999998754  34678


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      +|+||+++++|.+++...  ...+++..+..++.|+++||+|||+.+   ++||||||+||++++++.+||+|||+++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999998543  235899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCccc-ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCC-------cc--hhHHHHHHHH
Q 002969          695 GGDQTEQ-NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSN-------NE--LNLLGHVWRL  764 (862)
Q Consensus       695 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~-------~~--~~l~~~~~~~  764 (862)
                      ....... ......++..|+|||++.+..++.++||||||++++||++|..+.......       ..  ..........
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            4322211 111122345699999999889999999999999999999987764321100       00  0001111111


Q ss_pred             HhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       765 ~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ..+..        ....+...+.++.+++.+||+.+|++|||+.||++.|+.+
T Consensus       239 ~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         239 LKNNG--------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HhcCC--------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            11110        0112233456788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.6e-35  Score=317.64  Aligned_cols=263  Identities=27%  Similarity=0.405  Sum_probs=202.3

Q ss_pred             ccccccceeeccccEEEEEeEec-----------------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-----------------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRL  603 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-----------------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l  603 (862)
                      ++|++.++||+|+||.||+++..                 +...+|+|++.... ....++|.+|+.++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56888999999999999998532                 13468999987543 3345689999999999999999999


Q ss_pred             EEEEEeCCceEEEEEeccCCChhhhhhhccC--------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcce
Q 002969          604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKAR--------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNI  675 (862)
Q Consensus       604 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NI  675 (862)
                      ++++...+..++||||+++++|.+++.....        ...+++.++..++.||+.||+|||+.+   ++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999999865321        134778899999999999999999998   99999999999


Q ss_pred             EecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh--CCCCCCCCCCCc
Q 002969          676 LLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS--GKKNRGFYHSNN  753 (862)
Q Consensus       676 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt--G~~p~~~~~~~~  753 (862)
                      |++.++.++|+|||+++.+.............++..|+|||....+.++.++|||||||++|||++  |..|+.....  
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~--  239 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD--  239 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence            999999999999999986543322222222344678999999988899999999999999999998  5556432211  


Q ss_pred             chhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          754 ELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       754 ~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                       ..........+..... ..    ....+...+..+.+++.+||+.+|++||++.||++.|.
T Consensus       240 -~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         240 -EQVIENTGEFFRDQGR-QV----YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             -HHHHHHHHHHHhhccc-cc----cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence             1122211111111100 00    01112234567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.8e-35  Score=321.83  Aligned_cols=248  Identities=24%  Similarity=0.327  Sum_probs=198.8

Q ss_pred             ceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      ++||+|+||.||+++... ++.||+|+++...   ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            479999999999998754 7889999997542   33456788999999888 699999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      ++|..++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~  152 (327)
T cd05617          81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT  152 (327)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence            9999887543   34899999999999999999999998   999999999999999999999999998753211  112


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP  782 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~  782 (862)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||................+......         ...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------~~~p  223 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP---------IRIP  223 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC---------CCCC
Confidence            2345789999999999999999999999999999999999999864333332222333333332211         1223


Q ss_pred             hHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 002969          783 ANEVLRCIHVGLLCVQENAEERPTM------ASVVL  812 (862)
Q Consensus       783 ~~~~~~l~~li~~cl~~dP~~RPt~------~evl~  812 (862)
                      ...+..+.+++.+||+.||++||++      .+++.
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  259 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS  259 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence            3345677899999999999999984      57654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.7e-35  Score=311.66  Aligned_cols=253  Identities=30%  Similarity=0.473  Sum_probs=202.9

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      ++|++.++||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            46788899999999999999988888999999865433 3467999999999999999999999875 466899999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +++|.+++.... ...+++.++..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++..+.......
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            999999986532 334889999999999999999999988   9999999999999999999999999998764322111


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |..|+...   ........    .....        ...
T Consensus       160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~---~~~~~~~~----~~~~~--------~~~  223 (260)
T cd05070         160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---NNREVLEQ----VERGY--------RMP  223 (260)
T ss_pred             -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC---CHHHHHHH----HHcCC--------CCC
Confidence             112235668999999988899999999999999999999 77776421   11112211    11110        011


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      .+...+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            233445678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.3e-35  Score=327.90  Aligned_cols=242  Identities=23%  Similarity=0.281  Sum_probs=195.6

Q ss_pred             ceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCC
Q 002969          548 NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR  623 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g  623 (862)
                      +.||+|+||.||+++.. .++.||+|++...   ......++..|+++++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999865 5889999999754   2334567788999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhh-cCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ-DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       624 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      +|..++...   ..+++..+..++.||+.||+|||+ .+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            999888543   358999999999999999999997 56   9999999999999999999999999987542221  12


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP  782 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~  782 (862)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.|+....   .....    +......         ..++
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~---~~~~~----~~i~~~~---------~~~p  216 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLF----ELILMEE---------IRFP  216 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC---HHHHH----HHHhcCC---------CCCC
Confidence            223568999999999999999999999999999999999999974321   11111    1111110         1223


Q ss_pred             hHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 002969          783 ANEVLRCIHVGLLCVQENAEERP-----TMASVVLM  813 (862)
Q Consensus       783 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  813 (862)
                      .....++.+++.+||+.||++|+     ++.++++.
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            34456788999999999999996     89999854

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.8e-35  Score=310.92  Aligned_cols=250  Identities=27%  Similarity=0.401  Sum_probs=204.7

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +|+..+.||+|++|.||+++.. +++.|++|.+...  .....+++.+|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            3677789999999999999875 4789999998643  334567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|.+++.... ...+++..+++++.|+++||.|||+.+   ++|+||||+||++++++.+||+|||+++.+.....
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999999986542 345889999999999999999999987   99999999999999999999999999987643322


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                        ......+++.|+|||++.+..++.++||||||++++||++|+.|+....   ......    ....+        ...
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~----~~~~~--------~~~  219 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALIL----KIIRG--------VFP  219 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHH----HHHcC--------CCC
Confidence              1223467889999999999999999999999999999999999975322   111111    11111        112


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ..+......+.+++.+||+.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            2223455678999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.2e-35  Score=316.89  Aligned_cols=266  Identities=28%  Similarity=0.392  Sum_probs=201.4

Q ss_pred             ccccceeeccccEEEEEeEe-----cCCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeC--CceEE
Q 002969          544 FTDYNKLGQGGFGIVYKGRL-----LEGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKML  615 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~l  615 (862)
                      |...+.||+|+||.||+++.     .+++.||+|.++... ....+.|.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37789999999999988642     347789999987543 23457788999999999999999999998764  35789


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      +|||+++++|.+++...    .+++.++..++.|+++||+|||+.+   ++||||||+|||+++++.+||+|||+++.+.
T Consensus        86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            99999999999998542    3899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccc-cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          696 GDQTEQN-TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       696 ~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ....... .....++..|+|||.+.+..++.++||||||++++||++|..|+......- .................+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhh
Confidence            3222111 112235667999999998899999999999999999999999864322110 00000000000000011111


Q ss_pred             cccC-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          775 DSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       775 d~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      +... ...+...+..+.+++.+||+.+|++||++++|+++|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            1111 122344567889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.9e-35  Score=312.80  Aligned_cols=254  Identities=28%  Similarity=0.431  Sum_probs=203.0

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      ++|++.++||+|+||.||+|+..++..||+|+++... ...++|.+|++++++++||||+++++.+. ....++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            4688899999999999999988777789999997533 23467899999999999999999999874 456899999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +++|.+++.... ...+++..+..++.|+++||+|||+.+   ++||||||+||++++++.+||+|||+++.+.......
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            999999996432 345789999999999999999999987   9999999999999999999999999998764332211


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                       .....++..|+|||+..+..++.++||||||+++|||++ |+.|+....   ......    ....+.        ...
T Consensus       160 -~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~---~~~~~~----~~~~~~--------~~~  223 (262)
T cd05071         160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLD----QVERGY--------RMP  223 (262)
T ss_pred             -ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---hHHHHH----HHhcCC--------CCC
Confidence             122345678999999998899999999999999999999 777753221   111111    111110        011


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .+...+..+.+++.+|++.+|++||++.+++++|+..
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            2234556788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.1e-35  Score=318.77  Aligned_cols=258  Identities=28%  Similarity=0.448  Sum_probs=204.4

Q ss_pred             cccccccceeeccccEEEEEeEec------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  613 (862)
                      .++|+..+.||+|+||.||+++..      ++..||+|++.... ....+++.+|+.++++++||||+++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            357888899999999999999863      35789999987543 33456799999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcc-------------------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcc
Q 002969          614 MLVYEYMENRSLDSVIFDKA-------------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASN  674 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~N  674 (862)
                      ++++||+++++|.+++....                   ....+++.+++.++.||+.||+|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999986421                   1134788889999999999999999987   9999999999


Q ss_pred             eEecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCc
Q 002969          675 ILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNN  753 (862)
Q Consensus       675 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~  753 (862)
                      |+++.++.+||+|||+++.+..............+..|+|||.+.+..++.++|||||||++|||++ |..|+...   .
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~---~  237 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM---A  237 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---C
Confidence            9999999999999999886543322111222234667999999998999999999999999999998 77675321   1


Q ss_pred             chhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          754 ELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       754 ~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      ...    .......+..        ...+...+.++.+++.+||+.+|++||++.||++.|++
T Consensus       238 ~~~----~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         238 HEE----VIYYVRDGNV--------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHH----HHHHHhcCCC--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            111    1122222221        11233445678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.8e-35  Score=312.63  Aligned_cols=259  Identities=22%  Similarity=0.368  Sum_probs=207.5

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|++.++||+|+||.||+|+.. +++.||||.++..   ......++.+|+++++.++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            46888899999999999999875 5889999987542   2334457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcc-CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          618 EYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      ||+++++|.+++.... +...+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999999885432 2345888999999999999999999988   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+......    ... ..........      
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~-~~~~~~~~~~------  225 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFS-LCQKIEQCDY------  225 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHH-HHHHHhcCCC------
Confidence            221  122346788999999999888999999999999999999999996422111    111 1111111110      


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                       ........+..+.+++.+||+.+|++||++.||++.|+++
T Consensus       226 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         226 -PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             -CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence             0111233456788999999999999999999999999775

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-35  Score=329.39  Aligned_cols=253  Identities=23%  Similarity=0.300  Sum_probs=203.5

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..++||+|+||.||+|+.. +++.||||+++...   ......+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888899999999999999876 48899999997542   245567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++...   ..+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998654   45889999999999999999999987   999999999999999999999999999866433


Q ss_pred             C---------------------------cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 002969          698 Q---------------------------TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYH  750 (862)
Q Consensus       698 ~---------------------------~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~  750 (862)
                      .                           .........||+.|+|||++.+..++.++|||||||++|||++|+.|+....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0011223568999999999999999999999999999999999999975322


Q ss_pred             CCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 002969          751 SNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPT-MASVVLM  813 (862)
Q Consensus       751 ~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~  813 (862)
                      .   ....    ..+..... ..   ... .....+.++.+++.+|++ +|++||+ +.|+++.
T Consensus       235 ~---~~~~----~~i~~~~~-~~---~~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 L---QETY----NKIINWKE-SL---RFP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             H---HHHH----HHHhccCC-cc---cCC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            1   1111    11111000 00   000 111146678899999997 9999999 9999974

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.6e-35  Score=317.84  Aligned_cols=260  Identities=26%  Similarity=0.382  Sum_probs=207.2

Q ss_pred             cccccccceeeccccEEEEEeEecC-----CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEe-CCce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE-MDEK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~  613 (862)
                      .++|+..+.||+|+||.||+|...+     +..|++|++.... ....+.+.+|+.++++++|+||+++++++.+ ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678888999999999999998766     6789999986542 3346778999999999999999999998876 5678


Q ss_pred             EEEEEeccCCChhhhhhhccCC-----CCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecc
Q 002969          614 MLVYEYMENRSLDSVIFDKARS-----SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDF  688 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF  688 (862)
                      ++++||+++++|.+++......     ..+++..++.++.||+.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998654322     46899999999999999999999987   999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhc
Q 002969          689 GMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKE  767 (862)
Q Consensus       689 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  767 (862)
                      |+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.|+...   ....+.    .....
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---~~~~~~----~~~~~  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI---DPFEMA----AYLKD  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC---CHHHHH----HHHHc
Confidence            99986543322211222345678999999998899999999999999999999 88886432   111111    11222


Q ss_pred             CceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          768 GKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       768 ~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      +..       . ..+...+.++.+++.+||+.+|++||++.||++.|+.+.
T Consensus       235 ~~~-------~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         235 GYR-------L-AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             CCC-------C-CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            110       0 112223567889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.3e-35  Score=325.63  Aligned_cols=245  Identities=27%  Similarity=0.371  Sum_probs=195.3

Q ss_pred             ccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHH---HhcccCCceEEEEEEEeCCceEEE
Q 002969          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLI---AKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      |++.++||+|+||.||+++... ++.||||+++...   ....+.+.+|++++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            5667899999999999998754 8899999997542   33445677777665   456799999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++++|...+..    ..+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            999999999888743    35899999999999999999999998   99999999999999999999999999875322


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      .  ........|++.|+|||.+.+..++.++|||||||++|||++|+.|+...   +.......    ...+.       
T Consensus       154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~---~~~~~~~~----i~~~~-------  217 (324)
T cd05589         154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD---DEEEVFDS----IVNDE-------  217 (324)
T ss_pred             C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC---CHHHHHHH----HHhCC-------
Confidence            1  12223457899999999999999999999999999999999999997432   11112111    11111       


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERP-----TMASVVLM  813 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  813 (862)
                        ...+...+..+.+++.+||+.||++||     ++.++++.
T Consensus       218 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         218 --VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence              112334456788999999999999999     57777653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-35  Score=328.93  Aligned_cols=252  Identities=20%  Similarity=0.279  Sum_probs=199.1

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..++||+|+||.||+++... ++.||||++...   .....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            368889999999999999998764 789999999653   2334567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            999999999998643   34899999999999999999999998   999999999999999999999999998765321


Q ss_pred             Cccc------------------------------------ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh
Q 002969          698 QTEQ------------------------------------NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS  741 (862)
Q Consensus       698 ~~~~------------------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt  741 (862)
                      ....                                    .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1100                                    0112468999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 002969          742 GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPT---MASVVL  812 (862)
Q Consensus       742 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~  812 (862)
                      |..||....   .......+   ........     . ......+..+.+++.+|+. +|.+|++   +.|+++
T Consensus       235 G~~Pf~~~~---~~~~~~~i---~~~~~~~~-----~-~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         235 GYPPFCSDN---PQETYRKI---INWKETLQ-----F-PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCC---HHHHHHHH---HcCCCccC-----C-CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999974322   11111111   11000000     0 0011234567789999996 9999998   999886

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.8e-35  Score=325.00  Aligned_cols=246  Identities=27%  Similarity=0.336  Sum_probs=197.4

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccC-CceEEEEEEEeCCceEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHR-NLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~Hp-nIv~l~g~~~~~~~~~lV~  617 (862)
                      +|+..+.||+|+||.||+|+..+ ++.||||++...   .....+.+..|++++..++|+ +|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            47788999999999999998765 678999999754   234556788999999999765 5888999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            999999999988543   34788999999999999999999998   999999999999999999999999998753211


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                        ........||+.|+|||++.+..++.++|||||||++|||++|+.|+...   ........    ..+..        
T Consensus       155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~---~~~~~~~~----i~~~~--------  217 (324)
T cd05587         155 --GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE---DEDELFQS----IMEHN--------  217 (324)
T ss_pred             --CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHH----HHcCC--------
Confidence              11223457899999999999999999999999999999999999997432   11122211    11111        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTM-----ASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~  812 (862)
                       ..++...+.++.+++.+||+.+|++||+.     .++++
T Consensus       218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence             12233445678899999999999999976     56654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.3e-35  Score=323.26  Aligned_cols=240  Identities=26%  Similarity=0.329  Sum_probs=191.7

Q ss_pred             ceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      ++||+|+||.||+|+..+ ++.||||+++...   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999998765 7789999997542   23445566677777654 899999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      |+|..++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            9999888543   34888999999999999999999988   9999999999999999999999999997643222  22


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP  782 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~  782 (862)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.|+....   .......    ....         ....+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~---~~~~~~~----i~~~---------~~~~~  216 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED---EDELFDS----ILND---------RPHFP  216 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC---HHHHHHH----HHcC---------CCCCC
Confidence            334578999999999999999999999999999999999999975321   1111111    1111         11223


Q ss_pred             hHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 002969          783 ANEVLRCIHVGLLCVQENAEERPTMA-SVV  811 (862)
Q Consensus       783 ~~~~~~l~~li~~cl~~dP~~RPt~~-evl  811 (862)
                      .....++.+++.+||+.+|++||++. +++
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            34456778999999999999999875 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.9e-35  Score=312.20  Aligned_cols=254  Identities=23%  Similarity=0.368  Sum_probs=201.0

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      ++|++.++||+|+||.||+|+.. +++.||+|++........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            46888999999999999999864 57889999997655555667889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++...   ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++..+..... 
T Consensus        89 ~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06646          89 GGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-  161 (267)
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence            999999988543   34889999999999999999999987   99999999999999999999999999987632211 


Q ss_pred             cccccccccccccChhhhc---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          701 QNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                       ......++..|+|||.+.   ...++.++||||||+++|||++|+.|+........      .... ...   ....+.
T Consensus       162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~------~~~~-~~~---~~~~~~  230 (267)
T cd06646         162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLM-SKS---NFQPPK  230 (267)
T ss_pred             -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh------heee-ecC---CCCCCC
Confidence             122346788999999884   34578899999999999999999998642211110      0000 000   000000


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML  814 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  814 (862)
                      . ......+..+.+++.+||+.+|++||++++|++.|
T Consensus       231 ~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         231 L-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             C-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1 11123456788999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.5e-35  Score=321.13  Aligned_cols=259  Identities=28%  Similarity=0.431  Sum_probs=206.8

Q ss_pred             cccccccceeeccccEEEEEeEec--------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeC
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL--------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM  610 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~  610 (862)
                      .++|++.+.||+|+||.||+++..        ++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            457888899999999999999742        24579999986542 34567899999999999 899999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhccC-------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl  677 (862)
                      ...++||||+++++|.+++.....             ...+++.+++.++.||++||+|||+.+   ++||||||+|||+
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            999999999999999999965321             235788899999999999999999998   9999999999999


Q ss_pred             cCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchh
Q 002969          678 DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELN  756 (862)
Q Consensus       678 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~  756 (862)
                      +.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..|+...   .   
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---~---  244 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI---P---  244 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC---C---
Confidence            9999999999999987644332222223345678999999998899999999999999999998 66665321   1   


Q ss_pred             HHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       757 l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                       .....+....+..        ...+...+..+.+++.+||+.+|++||++.||++.|.++
T Consensus       245 -~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         245 -VEELFKLLKEGHR--------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             -HHHHHHHHHcCCc--------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence             1122222222211        112234566788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=321.84  Aligned_cols=255  Identities=26%  Similarity=0.394  Sum_probs=211.1

Q ss_pred             HcccccccceeeccccEEEEEeEecC---Cc--EEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCce
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE---GQ--EIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~---~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  613 (862)
                      ..+..+..++||+|-||.||+|...+   |+  .||||..+.+ .....+.|..|+.+|++++|||||+|+|+|.+ ...
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~  465 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM  465 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence            34455666899999999999997543   33  4899999874 45567899999999999999999999999976 578


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++|||.++.|.|..+|..+.  ..|+......++.||..||+|||+..   +|||||.++||||.....+||+||||++.
T Consensus       466 WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             eEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence            99999999999999996543  35888899999999999999999987   99999999999999999999999999998


Q ss_pred             cCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      +..+...... ...-+..|||||.+.-..++.++|||.|||.+||++. |.+||......+                +.-
T Consensus       541 ~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI~  603 (974)
T KOG4257|consen  541 LEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VIG  603 (974)
T ss_pred             ccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eEE
Confidence            8654433332 3445789999999999999999999999999999876 888875433222                222


Q ss_pred             eeccc-CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          773 MVDSS-VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       773 ~id~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .+... ....|+.++..+..|+.+||..+|.+||++.|+...|+.+
T Consensus       604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence            23322 2456888999999999999999999999999998777553

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.7e-35  Score=324.64  Aligned_cols=242  Identities=26%  Similarity=0.338  Sum_probs=195.6

Q ss_pred             ceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      ++||+|+||.||+|+... ++.||||++...   .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            479999999999998765 789999998754   233456678899999876 799999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      ++|...+...   ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~  152 (321)
T cd05591          81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT  152 (321)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence            9999888543   34889999999999999999999998   9999999999999999999999999987643221  12


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP  782 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~  782 (862)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.|+...   ........+    ..+.         ...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~---~~~~~~~~i----~~~~---------~~~p  216 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD---NEDDLFESI----LHDD---------VLYP  216 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC---CHHHHHHHH----HcCC---------CCCC
Confidence            23356899999999999999999999999999999999999997532   222222221    1111         1122


Q ss_pred             hHHHHHHHHHHHhccccCCCCCC-------CHHHHHHH
Q 002969          783 ANEVLRCIHVGLLCVQENAEERP-------TMASVVLM  813 (862)
Q Consensus       783 ~~~~~~l~~li~~cl~~dP~~RP-------t~~evl~~  813 (862)
                      .....++.+++.+||+.+|++||       ++.++++.
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            23456788999999999999999       88888753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.5e-35  Score=318.49  Aligned_cols=260  Identities=29%  Similarity=0.442  Sum_probs=204.0

Q ss_pred             HcccccccceeeccccEEEEEeEecC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCc
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE  612 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  612 (862)
                      ..++|++.++||+|+||.||+|...+      +..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            35678999999999999999996532      4579999886543 2234568899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhccC-------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeE
Q 002969          613 KMLVYEYMENRSLDSVIFDKAR-------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL  685 (862)
                      .++||||+++|+|.+++.....       ...+++..+.+++.||+.||+|||+.+   ++||||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999964321       234567788999999999999999988   999999999999999999999


Q ss_pred             ecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHH
Q 002969          686 SDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRL  764 (862)
Q Consensus       686 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~  764 (862)
                      +|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+...   ......    +.
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~---~~~~~~----~~  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL---SNEQVL----KF  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC---CHHHHH----HH
Confidence            99999986543222222222345678999999999999999999999999999998 66675321   111111    11


Q ss_pred             HhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       765 ~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ...+.        ....+...+..+.+++.+||+.+|++||++.++++.|.+.
T Consensus       234 ~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         234 VMDGG--------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHcCC--------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            11111        1112233456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5e-35  Score=321.82  Aligned_cols=240  Identities=27%  Similarity=0.346  Sum_probs=192.7

Q ss_pred             ceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      ++||+|+||.||+|+... ++.||+|+++...   ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            479999999999998764 7899999997542   23455677788888765 899999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      ++|..++...   ..+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  152 (316)
T cd05620          81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR  152 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence            9999988543   34888999999999999999999998   999999999999999999999999998753211  122


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP  782 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~  782 (862)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.|+...   +...+..    .....         ....+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~---~~~~~~~----~~~~~---------~~~~~  216 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD---DEDELFE----SIRVD---------TPHYP  216 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHH----HHHhC---------CCCCC
Confidence            23457899999999999999999999999999999999999997432   2212221    11111         11223


Q ss_pred             hHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 002969          783 ANEVLRCIHVGLLCVQENAEERPTMA-SVV  811 (862)
Q Consensus       783 ~~~~~~l~~li~~cl~~dP~~RPt~~-evl  811 (862)
                      .....++.+++.+||+.||++||++. +++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            33456788999999999999999985 565

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-36  Score=295.83  Aligned_cols=249  Identities=26%  Similarity=0.336  Sum_probs=209.4

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .++|++.+.||+|-||.||.|+.+. +-.||+|++.+.   ..+...++++|+++-..|+||||++++++|.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            3678999999999999999998765 567999999654   234567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      +||.++|.|...|... +...+++.....++.|+|.||.|+|..+   ++||||||+|+|++.++..||+|||-+..-. 
T Consensus       101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            9999999999999643 3445889999999999999999999987   9999999999999999999999999886531 


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                         .......+||..|.|||...+..++.++|+|++|++.||++.|.+||....   ..+.+..+.+    -   +    
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k----~---~----  238 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRK----V---D----  238 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHH----c---c----
Confidence               333345799999999999999999999999999999999999999975322   2222222211    1   1    


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                        -.+|...+..+.++|.+|+..+|.+|.+..|++..
T Consensus       239 --~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  239 --LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             --ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence              12345667788999999999999999999999864

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5e-35  Score=319.73  Aligned_cols=258  Identities=27%  Similarity=0.429  Sum_probs=205.3

Q ss_pred             ccccccceeeccccEEEEEeEec------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~  613 (862)
                      ++|...+.||+|+||.||+++..      .+..||||+++... ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            56888899999999999999742      24579999987543 33456789999999999 799999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++|+||+++++|.+++.... ...+++.++..++.|++.||+|||+.+   ++|+||||+|||++.++.+||+|||+++.
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence            99999999999999986433 234899999999999999999999987   99999999999999999999999999986


Q ss_pred             cCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      +.............++..|+|||.+.+..++.++||||||+++|||++ |..|+......+      ...+....+..  
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~~~--  262 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEGYR--  262 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcCCc--
Confidence            643322212222345778999999999999999999999999999998 888864322111      11112221110  


Q ss_pred             eecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                            ...+...+.++.+++.+|++.+|++||++.||++.|++.
T Consensus       263 ------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         263 ------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                  011222345788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.7e-35  Score=324.53  Aligned_cols=241  Identities=28%  Similarity=0.369  Sum_probs=194.5

Q ss_pred             ceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      ++||+|+||.||+++... ++.||||++...   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999998764 788999998753   234456778899998877 699999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      ++|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            9999888543   34889999999999999999999998   9999999999999999999999999987542211  12


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP  782 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~  782 (862)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   .....    +....+.         ...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~----~~i~~~~---------~~~~  216 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLF----EAILNDE---------VVYP  216 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHH----HHHhcCC---------CCCC
Confidence            233578999999999999999999999999999999999999975321   11121    1121111         1122


Q ss_pred             hHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 002969          783 ANEVLRCIHVGLLCVQENAEERPTM------ASVVL  812 (862)
Q Consensus       783 ~~~~~~l~~li~~cl~~dP~~RPt~------~evl~  812 (862)
                      .....++.+++.+||+.||++||++      +++++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~  252 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR  252 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence            3345678899999999999999998      66654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.9e-35  Score=318.82  Aligned_cols=258  Identities=27%  Similarity=0.423  Sum_probs=205.1

Q ss_pred             ccccccceeeccccEEEEEeEecC--------CcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCC
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE--------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD  611 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~  611 (862)
                      ++|.+.+.||+|+||.||+++...        ...+|+|.+.... .....++.+|+.+++++ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            578899999999999999997532        3469999997542 34456788999999999 7999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhccC-------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec
Q 002969          612 EKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~  678 (862)
                      ..++|+||+++++|.+++.....             ...+++.++++++.|++.||+|||+.+   ++||||||+|||++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence            99999999999999999965421             234889999999999999999999987   99999999999999


Q ss_pred             CCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhH
Q 002969          679 KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNL  757 (862)
Q Consensus       679 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l  757 (862)
                      .++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+....       
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-------  247 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------  247 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-------
Confidence            999999999999876543221111222234568999999999899999999999999999998 777753211       


Q ss_pred             HHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          758 LGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       758 ~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .....+....+..        ...+...+.++.+++.+|++.+|++||++.+|++.|+.+
T Consensus       248 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         248 VEELFKLLKEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             HHHHHHHHHcCCC--------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            1122222222211        122334456788999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.3e-35  Score=323.58  Aligned_cols=260  Identities=27%  Similarity=0.418  Sum_probs=205.8

Q ss_pred             ccccccceeeccccEEEEEeEecC--------CcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCC
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE--------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD  611 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~  611 (862)
                      .+|++.+.||+|+||.||+++...        ...||+|.++... ....+++.+|+.+++++ +||||+++++++.+.+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            368888999999999999997421        2368999886542 33467899999999999 7999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhcc-------------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec
Q 002969          612 EKMLVYEYMENRSLDSVIFDKA-------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~  678 (862)
                      ..++++||+++++|.+++....             ....+++.+++.++.||++||+|||+.+   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999986532             2235888999999999999999999988   99999999999999


Q ss_pred             CCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhH
Q 002969          679 KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNL  757 (862)
Q Consensus       679 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l  757 (862)
                      .++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..|+...   ..   
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~---  242 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI---PV---  242 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC---CH---
Confidence            999999999999987643322222222334568999999999999999999999999999998 77775321   11   


Q ss_pred             HHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          758 LGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       758 ~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                       ....+....+..        ...+...+..+.+++.+|++.+|++||++.|+++.|+.+..
T Consensus       243 -~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         243 -EELFKLLKEGHR--------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             -HHHHHHHHcCCC--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence             112222222111        11233445678899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.6e-35  Score=331.96  Aligned_cols=259  Identities=27%  Similarity=0.406  Sum_probs=204.5

Q ss_pred             ccccccceeeccccEEEEEeEec------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~  613 (862)
                      ++|...++||+|+||.||+|++.      .++.||||+++... ....+.+.+|++++.++. ||||+++++++...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            45777899999999999999853      24679999997653 233457889999999997 99999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccC-----------------------------------------------------------
Q 002969          614 MLVYEYMENRSLDSVIFDKAR-----------------------------------------------------------  634 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~-----------------------------------------------------------  634 (862)
                      ++|+||+++|+|.++++....                                                           
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            999999999999999864321                                                           


Q ss_pred             ------------------------------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec
Q 002969          635 ------------------------------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (862)
Q Consensus       635 ------------------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~  678 (862)
                                                          ...+++..+++++.||++||+|||+.+   ++||||||+|||++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence                                                124677788999999999999999987   99999999999999


Q ss_pred             CCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhH
Q 002969          679 KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNL  757 (862)
Q Consensus       679 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l  757 (862)
                      +++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+    
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~----  349 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE----  349 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH----
Confidence            999999999999986533222122223456788999999998889999999999999999998 888864322111    


Q ss_pred             HHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          758 LGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       758 ~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                        ........+..        ...+...+.++.+++.+||+.+|++||+++||++.|+.+
T Consensus       350 --~~~~~~~~~~~--------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         350 --QFYNAIKRGYR--------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             --HHHHHHHcCCC--------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              11111111110        112333456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.3e-35  Score=323.37  Aligned_cols=246  Identities=28%  Similarity=0.339  Sum_probs=197.6

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      +|+..+.||+|+||.||+|+... ++.||||++....   ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            47778999999999999998765 6789999987542   23345677788888887 5899999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++|+|.+++...   ..+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            999999999888543   34889999999999999999999998   999999999999999999999999999754321


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                        ........||+.|+|||++.+..++.++|||||||++|||++|+.|+...   +...+...    ..+..        
T Consensus       155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~---~~~~~~~~----i~~~~--------  217 (323)
T cd05616         155 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQS----IMEHN--------  217 (323)
T ss_pred             --CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC---CHHHHHHH----HHhCC--------
Confidence              11223457899999999999999999999999999999999999997532   22222222    11111        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTM-----ASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~  812 (862)
                       ..++...+.++.+++.+|++.+|++|++.     .++.+
T Consensus       218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~  256 (323)
T cd05616         218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  256 (323)
T ss_pred             -CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence             12233456678899999999999999984     66653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1e-34  Score=313.16  Aligned_cols=255  Identities=28%  Similarity=0.415  Sum_probs=202.1

Q ss_pred             ccccccceeeccccEEEEEeEec-CCc----EEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQ----EIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ++|+..++||+|+||.||+|+.. +++    .||+|++.... ....+++.+|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            46888899999999999999854 344    48999986543 3345678899999999999999999999875 45789


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ++||+++|+|.+++...  ...+++..++.++.||++||+|||+.+   ++||||||+|||+++++.+||+|||+++.+.
T Consensus        86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence            99999999999998643  235899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....   ..+    ...+..+..    
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~----~~~~~~~~~----  229 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REI----PDLLEKGER----  229 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHH----HHHHHCCCc----
Confidence            3322222222334678999999999999999999999999999998 8888643211   111    111222111    


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                          ...+...+.++.+++.+||+.+|++||++.++++.|+..
T Consensus       230 ----~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         230 ----LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             ----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                111233456788999999999999999999999999877

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9.7e-35  Score=309.89  Aligned_cols=253  Identities=31%  Similarity=0.464  Sum_probs=203.9

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      ++|+..++||+|+||.||+|...+++.||+|.+.... ...+++.+|+.++++++|+||+++++++. .+..++++||++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME   83 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence            5688889999999999999998889999999986543 34568999999999999999999999864 567899999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +++|.+++.... ...+++.++..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++......... 
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05067          84 NGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-
Confidence            999999885433 345899999999999999999999987   999999999999999999999999999876422211 


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      ......++..|+|||.+....++.++||||||++++|+++ |+.|+....   ......    ....+..        ..
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~----~~~~~~~--------~~  223 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT---NPEVIQ----NLERGYR--------MP  223 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC---hHHHHH----HHHcCCC--------CC
Confidence            1112345678999999998899999999999999999999 888864221   111111    1111110        11


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      .+...+.++.+++.+|++.+|++||++++++..|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            122345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.2e-35  Score=307.91  Aligned_cols=256  Identities=23%  Similarity=0.357  Sum_probs=199.8

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCC-----ceEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-----EKMLV  616 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~lV  616 (862)
                      .|...+++|.|+||.||+|.+.+ ++.||||++..+.+.    -.+|+++|++++|||||+|+.+|....     ...||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            56777999999999999998866 689999999655432    247999999999999999999886543     23589


Q ss_pred             EEeccCCChhhhhhhc-cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC-CCeeEecccceeec
Q 002969          617 YEYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIF  694 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~~~  694 (862)
                      ||||+. +|..++... ..+..++...+.-+..||.+||+|||+.+   |+||||||+|+|+|.+ |.+||+|||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999985 788887542 12234677777779999999999999987   9999999999999977 99999999999988


Q ss_pred             CCCCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee--
Q 002969          695 GGDQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL--  771 (862)
Q Consensus       695 ~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--  771 (862)
                      ......   ....-|.-|+|||++.+. .|+.+.||||.||++.||+-|++-|   .+++..+.+..+.+.+......  
T Consensus       177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF---pG~s~~dQL~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF---PGDSSVDQLVEIIKVLGTPTREDI  250 (364)
T ss_pred             ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc---CCCCHHHHHHHHHHHhCCCCHHHH
Confidence            544333   234558899999999885 6999999999999999999999875   3455556666666665432211  


Q ss_pred             --------eeecccCC-----C-CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 --------EMVDSSVD-----N-YPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 --------~~id~~~~-----~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                              +...+.+.     . .......+.++|+.++|+.+|.+|.++.|++.
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                    11111111     1 33455678899999999999999999999985

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.1e-35  Score=326.95  Aligned_cols=254  Identities=20%  Similarity=0.259  Sum_probs=195.4

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..++||+|+||+||+++... ++.||||+++...   ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            468888999999999999998754 7899999996532   234467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++|+|.+++...   ..+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            999999999998643   35899999999999999999999998   999999999999999999999999998765321


Q ss_pred             Ccc---------------------------------cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCC
Q 002969          698 QTE---------------------------------QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKK  744 (862)
Q Consensus       698 ~~~---------------------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~  744 (862)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123579999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccc--cCCCCCCCHHHHHHH
Q 002969          745 NRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQ--ENAEERPTMASVVLM  813 (862)
Q Consensus       745 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPt~~evl~~  813 (862)
                      ||...   ........    +......-.+.+     ......++.+++.+++.  .++..||+++||++.
T Consensus       235 Pf~~~---~~~~~~~~----i~~~~~~~~~p~-----~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         235 PFCSE---TPQETYKK----VMNWKETLIFPP-----EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCC---CHHHHHHH----HHcCcCcccCCC-----cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            97432   11111111    111110000000     01123456666666443  344567999999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-35  Score=308.98  Aligned_cols=250  Identities=35%  Similarity=0.522  Sum_probs=205.1

Q ss_pred             ceeeccccEEEEEeEecC----CcEEEEEEeccCCcc-chHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      ++||+|+||.||++....    +..|++|.++..... ..+++.+|++.++.++|+|++++++++......++|+||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999998764    778999999765433 367899999999999999999999999999999999999999


Q ss_pred             CChhhhhhhccC------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          623 RSLDSVIFDKAR------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       623 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      ++|.+++.....      ...+++.++..++.|+++||+|||+.+   ++|+||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999965421      356999999999999999999999988   99999999999999999999999999987754


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ...........++..|+|||.+....++.++||||||++++||++ |..|+...   .....    .+....+.      
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~~~~~----~~~~~~~~------  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL---SNEEV----LEYLRKGY------  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC---CHHHH----HHHHHcCC------
Confidence            432233334567889999999998899999999999999999999 58886533   11111    22222211      


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                        ....+...+.++.+++.+||+.+|++||++.|+++.|+
T Consensus       225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 --RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              11223344678889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-35  Score=327.14  Aligned_cols=238  Identities=25%  Similarity=0.291  Sum_probs=192.7

Q ss_pred             ceeeccccEEEEEeEe----cCCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          548 NKLGQGGFGIVYKGRL----LEGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      +.||+|+||.||+++.    ..++.||+|++....  ......+..|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6899999999999875    247899999997542  2234567889999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +++|.+++...   ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  .
T Consensus        82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            99999988543   34899999999999999999999998   9999999999999999999999999987653221  1


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY  781 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~  781 (862)
                      ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+...   +.......+    ....         ...
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~---~~~~~~~~i----~~~~---------~~~  217 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK---DRKETMTMI----LKAK---------LGM  217 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC---CHHHHHHHH----HcCC---------CCC
Confidence            223457899999999999988999999999999999999999997432   111111111    1111         122


Q ss_pred             ChHHHHHHHHHHHhccccCCCCCCCHHH
Q 002969          782 PANEVLRCIHVGLLCVQENAEERPTMAS  809 (862)
Q Consensus       782 ~~~~~~~l~~li~~cl~~dP~~RPt~~e  809 (862)
                      +...+..+.+++.+||+.||++||++.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            3344567889999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.7e-35  Score=321.33  Aligned_cols=241  Identities=27%  Similarity=0.343  Sum_probs=192.8

Q ss_pred             ceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      +.||+|+||.||+|+... ++.||||+++...   ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            479999999999998765 7889999997542   23445667788888765 899999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      |+|.+++...   ..+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            9999988543   34888999999999999999999998   9999999999999999999999999987532211  12


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP  782 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~  782 (862)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.|+....   .......    .....         ..++
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~----i~~~~---------~~~~  216 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD---EEELFQS----IRMDN---------PCYP  216 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC---HHHHHHH----HHhCC---------CCCC
Confidence            234578999999999999999999999999999999999999974321   1112111    11111         1122


Q ss_pred             hHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 002969          783 ANEVLRCIHVGLLCVQENAEERPTMA-SVVL  812 (862)
Q Consensus       783 ~~~~~~l~~li~~cl~~dP~~RPt~~-evl~  812 (862)
                      .....++.+++.+||+.+|++||++. ++.+
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            23455778999999999999999997 6653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.6e-35  Score=310.24  Aligned_cols=246  Identities=29%  Similarity=0.430  Sum_probs=196.3

Q ss_pred             eeeccccEEEEEeEec---CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCC
Q 002969          549 KLGQGGFGIVYKGRLL---EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR  623 (862)
Q Consensus       549 ~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g  623 (862)
                      +||+|+||.||+|.+.   +++.+|+|+++...  ....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            6899999999999643   46789999986543  234578999999999999999999999885 45678999999999


Q ss_pred             ChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc-c
Q 002969          624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ-N  702 (862)
Q Consensus       624 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~  702 (862)
                      +|.+++...   ..+++..+..++.|++.||+|||+.+   ++||||||.||+++.++.+||+|||+++.+....... .
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            999998543   34889999999999999999999988   9999999999999999999999999998764332211 1


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY  781 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~  781 (862)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.|+....   ....    ......+..        ...
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~----~~~i~~~~~--------~~~  219 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK---GNEV----TQMIESGER--------MEC  219 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHH----HHHHHCCCC--------CCC
Confidence            112234678999999988889999999999999999998 888864321   1111    112222111        122


Q ss_pred             ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          782 PANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       782 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      +...+.++.+++.+||+.+|++||++.+|++.|++
T Consensus       220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            33456678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.6e-34  Score=310.01  Aligned_cols=254  Identities=26%  Similarity=0.362  Sum_probs=192.8

Q ss_pred             ceeeccccEEEEEeEecC---CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCC
Q 002969          548 NKLGQGGFGIVYKGRLLE---GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR  623 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g  623 (862)
                      +.||+|+||.||+|+..+   +..+|+|+++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            369999999999998654   3579999886543 233457889999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccC--CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          624 SLDSVIFDKAR--SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       624 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +|.+++.....  ...+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999965332  234677788899999999999999988   9999999999999999999999999987543332222


Q ss_pred             ccccccccccccChhhhcCC-------CCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeee
Q 002969          702 NTKRVVGTYGYMSPEYAMDG-------LFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~-------~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  773 (862)
                      ......++..|+|||++.+.       .++.++||||||+++|||++ |+.|+......+   .....   .. +.....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~---~~-~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT---VR-EQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH---hh-cccCCC
Confidence            22334578889999998642       35789999999999999996 998875432211   11111   11 111111


Q ss_pred             ecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       774 id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      .++.   ........+.+++..|+ .+|++||+++||++.|+
T Consensus       231 ~~~~---~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPR---LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCc---cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1111   11223445778999998 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-34  Score=318.08  Aligned_cols=259  Identities=27%  Similarity=0.426  Sum_probs=205.0

Q ss_pred             ccccccceeeccccEEEEEeEec--------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCC
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL--------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD  611 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~  611 (862)
                      ++|.+.++||+|+||.||+++..        ....+|+|+++... ....+++..|+.+++++ +||||+++++++....
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            56788899999999999999742        24568999987542 34466789999999999 6999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhcc-------------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec
Q 002969          612 EKMLVYEYMENRSLDSVIFDKA-------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~  678 (862)
                      ..++++||+++++|.+++....             ....+++.++.+++.||+.||+|||+.+   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence            9999999999999999996532             1245889999999999999999999987   99999999999999


Q ss_pred             CCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhH
Q 002969          679 KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNL  757 (862)
Q Consensus       679 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l  757 (862)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+....   ..  
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~---~~--  243 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---VE--  243 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC---HH--
Confidence            999999999999986643222111222234567999999999999999999999999999999 777753221   11  


Q ss_pred             HHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          758 LGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       758 ~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                        ........+..        ...+...+.++.+++.+||+.+|++||++.|+++.|.++.
T Consensus       244 --~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         244 --ELFKLLREGHR--------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             --HHHHHHHcCCC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence              12222222211        1123344567889999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.6e-35  Score=318.44  Aligned_cols=256  Identities=28%  Similarity=0.400  Sum_probs=201.5

Q ss_pred             ccccccceeeccccEEEEEeEecC-C--cEEEEEEeccC-CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-G--QEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ++|++.+.||+|+||.||+|...+ +  ..+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            468888999999999999998754 3  24788888643 334456789999999999 799999999999999999999


Q ss_pred             EEeccCCChhhhhhhcc-------------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCe
Q 002969          617 YEYMENRSLDSVIFDKA-------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  683 (862)
                      +||+++++|.+++....             ....+++..+..++.||+.||+|||+.+   ++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999986432             1134888999999999999999999987   9999999999999999999


Q ss_pred             eEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHH
Q 002969          684 KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVW  762 (862)
Q Consensus       684 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~  762 (862)
                      ||+|||++......   ........+..|+|||++....++.++|||||||++|||++ |..|+.....   ...    .
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~----~  228 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AEL----Y  228 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH----H
Confidence            99999998643211   11111223557999999998899999999999999999997 8888643211   111    1


Q ss_pred             HHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       763 ~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      .....+.        ....+...+..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus       229 ~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         229 EKLPQGY--------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             HHHhcCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1111111        01122334567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.5e-34  Score=307.45  Aligned_cols=258  Identities=25%  Similarity=0.411  Sum_probs=208.7

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..+.||+|+||.||+|... +++.||+|.++..   .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888899999999999999887 6889999988642   2334678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhc-cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          618 EYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       618 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      ||+++++|.+++... .....+++.+++.++.++++||+|||+.+   ++||||+|+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999998653 22345899999999999999999999988   99999999999999999999999999886543


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....    .... .......+.       
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~-~~~~~~~~~-------  224 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYS-LCKKIEKCD-------  224 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHH-HHhhhhcCC-------
Confidence            221  12234678899999999988999999999999999999999998643211    1111 111111111       


Q ss_pred             cCCCCCh-HHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          777 SVDNYPA-NEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       777 ~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                       ....+. .....+.+++.+||+.+|++||++.+|+++|.++
T Consensus       225 -~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         225 -YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             -CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence             111122 4456788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.1e-34  Score=312.74  Aligned_cols=245  Identities=25%  Similarity=0.310  Sum_probs=193.0

Q ss_pred             eeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCCh
Q 002969          550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (862)
Q Consensus       550 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL  625 (862)
                      ||+|+||.||+++... ++.+|+|++....   ......+..|++++++++||||+++++++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            6999999999998754 8899999986432   22334566799999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccccccc
Q 002969          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR  705 (862)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  705 (862)
                      .+++.... ...+++..+..++.||+.||+|||+.+   ++||||||+||+++.++.++|+|||++..+....   ....
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            98885433 234889999999999999999999988   9999999999999999999999999998764321   1223


Q ss_pred             ccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHH
Q 002969          706 VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE  785 (862)
Q Consensus       706 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~  785 (862)
                      ..|+..|+|||++.+..++.++|||||||++|||++|+.|+........  . ....+.....        .........
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~-~~~~~~~~~~--------~~~~~~~~~  222 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--K-EELKRRTLED--------EVKFEHQNF  222 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--H-HHHHHHhhcc--------ccccccccC
Confidence            4688999999999998999999999999999999999999753222111  1 1111111111        111111234


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          786 VLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       786 ~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      +.++.+++.+||+.||++||++.|+++
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchh
Confidence            556889999999999999999977654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.3e-34  Score=306.76  Aligned_cols=247  Identities=28%  Similarity=0.378  Sum_probs=198.5

Q ss_pred             ceeeccccEEEEEeEecCCcEEEEEEeccCCc-cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCChh
Q 002969          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLD  626 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~  626 (862)
                      ++||+|+||.||+|...+++.+|+|+++.... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            47999999999999988889999999876533 23457889999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccccccc
Q 002969          627 SVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV  706 (862)
Q Consensus       627 ~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  706 (862)
                      +++....  ..+++..++.++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++.......... ....
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~  154 (250)
T cd05085          81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK  154 (250)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence            9885432  34789999999999999999999988   9999999999999999999999999987643222111 1112


Q ss_pred             cccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHH
Q 002969          707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE  785 (862)
Q Consensus       707 ~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~  785 (862)
                      .++..|+|||++....++.++||||||+++||+++ |..|+....   ...    .......+..        ...+...
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~---~~~----~~~~~~~~~~--------~~~~~~~  219 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT---NQQ----AREQVEKGYR--------MSCPQKC  219 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC---HHH----HHHHHHcCCC--------CCCCCCC
Confidence            34568999999998899999999999999999998 888864321   111    1111111110        1223345


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          786 VLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       786 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      +..+.+++.+|++.+|++||++.|+++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            568889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-34  Score=303.08  Aligned_cols=263  Identities=25%  Similarity=0.379  Sum_probs=205.9

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc--cchHHHHHHHHHHHhcccCC-ceEEEEEEEeCC------
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRN-LVRLLGCCVEMD------  611 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~Hpn-Iv~l~g~~~~~~------  611 (862)
                      ..|...++||+|+||+||+|+.. .|+.||+|+++...+  .......+|+.++++++|+| |+++++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            45666688999999999999865 488999999976643  24456789999999999999 999999998877      


Q ss_pred             ceEEEEEeccCCChhhhhhhccCC-CCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccc
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  690 (862)
                      ..++|+||++ -+|..++...... ..++...+..+..||++||+|||+++   |+||||||+||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            7889999996 5888888554422 34666888999999999999999998   99999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK  769 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  769 (862)
                      |+.+.-...  .....++|.-|.|||++.+. .|+...||||+|||+.||+++++-|   +...+.+.+..+++.+....
T Consensus       167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LF---pG~se~~ql~~If~~lGtP~  241 (323)
T KOG0594|consen  167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLF---PGDSEIDQLFRIFRLLGTPN  241 (323)
T ss_pred             HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCC---CCCcHHHHHHHHHHHcCCCC
Confidence            996642222  23345789999999999987 7999999999999999999987754   44555666667766654432


Q ss_pred             ee------eeeccc--CCCC--C----h---HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          770 VL------EMVDSS--VDNY--P----A---NEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       770 ~~------~~id~~--~~~~--~----~---~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ..      ...+..  ....  +    .   ....+..+++.+||+.+|.+|.+++.++++
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            11      111111  0111  0    1   111367899999999999999999999976

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.9e-34  Score=309.82  Aligned_cols=250  Identities=23%  Similarity=0.330  Sum_probs=198.6

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      +|+..++||+|+||.||+|+.. .++.||+|++... .....+++.+|++++++++||||+++++++...+..++|+||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            5777899999999999999864 5788999998654 2334567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|..+.       .+++..+..++.|++.||+|||+.+   |+|+||||+|||++.++.+||+|||++..+...   
T Consensus        82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---  148 (279)
T cd06619          82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---  148 (279)
T ss_pred             CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence            999997542       3678888899999999999999998   999999999999999999999999999865322   


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                       ......++..|+|||++.+..++.++||||||+++|||++|+.|+................+......     ....  
T Consensus       149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--  220 (279)
T cd06619         149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL--  220 (279)
T ss_pred             -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC--
Confidence             12235688999999999999999999999999999999999999754322221111111111111110     0111  


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .......++.+++.+|++.+|++||+++|+++.
T Consensus       221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            112234568899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-35  Score=329.21  Aligned_cols=253  Identities=20%  Similarity=0.261  Sum_probs=196.4

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..++||+|+||.||+++.. +++.||||++...   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36888899999999999999765 4889999998653   2334567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999998543   34788888899999999999999998   999999999999999999999999999643211


Q ss_pred             Ccc------------c---------------------------------ccccccccccccChhhhcCCCCCccccchhH
Q 002969          698 QTE------------Q---------------------------------NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSF  732 (862)
Q Consensus       698 ~~~------------~---------------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSl  732 (862)
                      ...            .                                 ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000            0                                 0012468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCC---CCHHH
Q 002969          733 GVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEER---PTMAS  809 (862)
Q Consensus       733 Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~e  809 (862)
                      ||++|||++|+.||.....   ......+.   ........     . .......++.+++.+|++ +|.+|   |++.|
T Consensus       235 Gvil~elltG~~Pf~~~~~---~~~~~~i~---~~~~~~~~-----p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         235 GAIMFECLIGWPPFCSENS---HETYRKII---NWRETLYF-----P-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             chhhhhhhcCCCCCCCCCH---HHHHHHHH---ccCCccCC-----C-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            9999999999999743221   11111111   10000000     0 011234567889999997 66665   69999


Q ss_pred             HHHH
Q 002969          810 VVLM  813 (862)
Q Consensus       810 vl~~  813 (862)
                      +++.
T Consensus       302 ~l~h  305 (377)
T cd05629         302 IKSH  305 (377)
T ss_pred             HhcC
Confidence            8874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6e-35  Score=328.11  Aligned_cols=254  Identities=21%  Similarity=0.225  Sum_probs=200.4

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ..++|+..++||+|+||.||+++... ++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            34678999999999999999998764 789999998643   22344567899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||+++|+|.+++...    .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+.
T Consensus       121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            99999999999988532    3778888899999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccChhhhcCC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDG----LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      .... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||....   ......    ........
T Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~----~i~~~~~~  265 (370)
T cd05596         194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYS----KIMDHKNS  265 (370)
T ss_pred             CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC---HHHHHH----HHHcCCCc
Confidence            3221 112235789999999998653    47899999999999999999999974321   111111    11111100


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEE--RPTMASVVLM  813 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  813 (862)
                       .   .. ......+.++.+++.+||+.+|++  ||++.|++..
T Consensus       266 -~---~~-~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         266 -L---TF-PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -C---CC-CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence             0   00 111234567889999999999988  9999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.1e-34  Score=310.86  Aligned_cols=256  Identities=28%  Similarity=0.464  Sum_probs=203.9

Q ss_pred             ccccccceeeccccEEEEEeEecC-C---cEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-G---QEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ++|+..+.||+|+||.||+|+... +   ..+|+|+++... ....+++..|++++++++|||++++++++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            467778999999999999998753 3   369999986552 33456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++++|.+++....  ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          85 TEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            99999999999985432  45899999999999999999999988   99999999999999999999999999986643


Q ss_pred             CCccccc-ccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          697 DQTEQNT-KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       697 ~~~~~~~-~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ....... .....+..|+|||++....++.++||||||+++|||++ |+.|+....   ...    ..+......     
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~---~~~----~~~~i~~~~-----  227 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS---NHE----VMKAINDGF-----  227 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC---HHH----HHHHHhcCC-----
Confidence            2221111 11223457999999998889999999999999999997 999864321   111    222222211     


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                         ....+...+..+.+++.+|++.+|++||++.+|++.|+++
T Consensus       228 ---~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 ---RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               0111223456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6e-35  Score=321.48  Aligned_cols=241  Identities=29%  Similarity=0.335  Sum_probs=195.5

Q ss_pred             ceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      +.||+|+||.||+++... ++.||||+++..   .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999998765 778999999754   233456778899999888 699999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      ++|..++...   ..+++.++..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~  152 (318)
T cd05570          81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVT  152 (318)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCc
Confidence            9999888543   24899999999999999999999998   999999999999999999999999998753211  112


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP  782 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~  782 (862)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.|+...   +.....    .......         ...+
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~---~~~~~~----~~i~~~~---------~~~~  216 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD---DEDELF----QSILEDE---------VRYP  216 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC---CHHHHH----HHHHcCC---------CCCC
Confidence            23356899999999999999999999999999999999999997432   111111    1111111         1123


Q ss_pred             hHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 002969          783 ANEVLRCIHVGLLCVQENAEERPTM-----ASVVL  812 (862)
Q Consensus       783 ~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~  812 (862)
                      ...+..+.+++.+||+.||++||++     .++++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            3345678899999999999999999     88875

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.6e-35  Score=323.44  Aligned_cols=252  Identities=21%  Similarity=0.277  Sum_probs=200.4

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..++||+|+||.||+++.. +++.||+|+++...   ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888899999999999999875 48899999997542   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++...  ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999998654  235889999999999999999999998   999999999999999999999999999876433


Q ss_pred             CcccccccccccccccChhhhc------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAM------DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      ... ......||+.|+|||++.      ...++.++|||||||++|||++|+.|+.....   ......+   .......
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i---~~~~~~~  228 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---AKTYNNI---MNFQRFL  228 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---HHHHHHH---HcCCCcc
Confidence            222 223346899999999986      45678999999999999999999999743211   1111111   1111100


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .     . ......+..+.+|+..|++ +|++||++.+++.
T Consensus       229 ~-----~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         229 K-----F-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             C-----C-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            0     0 0112345677889999998 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.9e-35  Score=329.99  Aligned_cols=251  Identities=22%  Similarity=0.296  Sum_probs=194.4

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .|+..++||+|+||.||+|+... ++.||+|++....   ....+.+.+|++++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            57888999999999999998754 7889999986542   3345678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++|+|.+++...   ..+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            99999999998543   34788888899999999999999998   9999999999999999999999999976432100


Q ss_pred             c---------------------------------------------ccccccccccccccChhhhcCCCCCccccchhHH
Q 002969          699 T---------------------------------------------EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFG  733 (862)
Q Consensus       699 ~---------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlG  733 (862)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001234689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCC---HHHH
Q 002969          734 VLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPT---MASV  810 (862)
Q Consensus       734 vil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ev  810 (862)
                      |++|||++|+.||.....   ....   ...........      .........++.+++.+|+ .+|++|++   +.|+
T Consensus       236 vil~elltG~~Pf~~~~~---~~~~---~~i~~~~~~~~------~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei  302 (382)
T cd05625         236 VILYEMLVGQPPFLAQTP---LETQ---MKVINWQTSLH------IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI  302 (382)
T ss_pred             HHHHHHHhCCCCCCCCCH---HHHH---HHHHccCCCcC------CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence            999999999999753221   1111   11111000000      0111223456677777765 49999997   8887


Q ss_pred             HH
Q 002969          811 VL  812 (862)
Q Consensus       811 l~  812 (862)
                      ++
T Consensus       303 ~~  304 (382)
T cd05625         303 KA  304 (382)
T ss_pred             hc
Confidence            75

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6.7e-35  Score=324.58  Aligned_cols=260  Identities=28%  Similarity=0.420  Sum_probs=201.7

Q ss_pred             ccccccceeeccccEEEEEeEe------cCCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeC-Cc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM-DE  612 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~-~~  612 (862)
                      ++|+..++||+|+||.||+|+.      ..++.||||+++... ......+.+|+.++.++ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5788999999999999999963      346789999997543 33456788999999999 689999999988654 46


Q ss_pred             eEEEEEeccCCChhhhhhhccC----------------------------------------------------------
Q 002969          613 KMLVYEYMENRSLDSVIFDKAR----------------------------------------------------------  634 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------  634 (862)
                      .++++||+++|+|.+++.....                                                          
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            7899999999999999864211                                                          


Q ss_pred             ------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccccccccc
Q 002969          635 ------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG  708 (862)
Q Consensus       635 ------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  708 (862)
                            ...+++.++.+++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++..+.............+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                  123678888999999999999999988   99999999999999999999999999986533222222222345


Q ss_pred             cccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHH
Q 002969          709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVL  787 (862)
Q Consensus       709 t~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~  787 (862)
                      +..|+|||.+.+..++.++||||||+++|||++ |..|+.......      .......++...        ..+.....
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~--------~~~~~~~~  309 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRM--------RAPDYTTP  309 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCC--------CCCCCCCH
Confidence            678999999999999999999999999999997 888864322111      111122222111        11122345


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          788 RCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       788 ~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      ++.+++..||+.+|++||++.||++.|+.+.
T Consensus       310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            6889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.5e-34  Score=309.52  Aligned_cols=259  Identities=23%  Similarity=0.368  Sum_probs=207.0

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..+.||+|+||.||+++.. +++.+|||.+...   .....+++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46778899999999999999864 6889999988643   2234568899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhcc-CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          618 EYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      ||+++++|.+++.... ....+++..++.++.||++||+|||+.+   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999886422 2346899999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++|..|+.....+    .. ...+...+..     .+
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~-~~~~~~~~~~-----~~  226 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LY-SLCKKIEQCD-----YP  226 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HH-HHhhhhhcCC-----CC
Confidence            221  122346788999999999889999999999999999999999996421111    11 1111111100     00


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                        .......+..+.+++.+||+.+|++||||.+|++++++.
T Consensus       227 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         227 --PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             --CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence              111223556788999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.1e-34  Score=307.45  Aligned_cols=253  Identities=29%  Similarity=0.442  Sum_probs=201.9

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      ++|...++||+|++|.||++....+..+|+|++.... ...+.+.+|++++++++|+|++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            4578889999999999999998777789999886433 34567899999999999999999999875 466899999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +++|.+++.... ...+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.++|+|||++......... 
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            999999986532 334789999999999999999999987   999999999999999999999999999876432211 


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...   ........    ...+..        ..
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~~~----~~~~~~--------~~  223 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---VNREVLEQ----VERGYR--------MP  223 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHH----HHcCCC--------CC
Confidence            1112345678999999998899999999999999999999 88876421   11111111    111100        11


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      .+...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            223445678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9.6e-35  Score=311.56  Aligned_cols=255  Identities=26%  Similarity=0.427  Sum_probs=201.9

Q ss_pred             cccccceeeccccEEEEEeEecC-C---cEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-G---QEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      .|+..+.||+|+||.||+|+... +   ..||||++... .....++|..|+.++++++||||+++++++.+....++|+
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46777999999999999998754 3   35999998754 3345678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++...  ...+++.+++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..+...
T Consensus        85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence            999999999998543  235899999999999999999999988   999999999999999999999999998765432


Q ss_pred             Cccccccc-cc--ccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeee
Q 002969          698 QTEQNTKR-VV--GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       698 ~~~~~~~~-~~--gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  773 (862)
                      ........ ..  .+..|+|||.+.+..++.++||||||+++||+++ |..|+....   ......    ......    
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~---~~~~~~----~i~~~~----  228 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---NQDVIN----AIEQDY----  228 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC---HHHHHH----HHHcCC----
Confidence            22111111 11  2457999999999999999999999999999886 888864221   111111    111110    


Q ss_pred             ecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       774 id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                         . ...+.+.+..+.+++.+||+.+|++||++.+|+.+|++.
T Consensus       229 ---~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 ---R-LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ---c-CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence               0 111233456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.5e-34  Score=318.96  Aligned_cols=241  Identities=27%  Similarity=0.359  Sum_probs=193.7

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCceEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      +|+..+.||+|+||.||+++.. +++.||+|++...   .....+.+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677789999999999999865 4889999999754   2334567888999998886 577888999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++|+|.+++...   ..+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            999999999988543   34899999999999999999999988   999999999999999999999999998754222


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.|+...   ........+    .+..        
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~---~~~~~~~~i----~~~~--------  217 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE---DEDELFQSI----MEHN--------  217 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHH----HhCC--------
Confidence            1  1223356899999999999999999999999999999999999997532   111222211    1111        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTM  807 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  807 (862)
                       ..++...+.++.+++.+||+.+|.+|++.
T Consensus       218 -~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 -VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence             12233445678899999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.9e-35  Score=315.02  Aligned_cols=263  Identities=26%  Similarity=0.407  Sum_probs=204.2

Q ss_pred             ccccccceeeccccEEEEEeEe-----cCCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeC--Cce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRL-----LEGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~  613 (862)
                      ..|+..++||+|+||.||+++.     ..+..||+|.++... ....+.+.+|++++++++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3567889999999999999974     247789999987553 34456899999999999999999999998875  568


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++||||+++++|.+++....  ..+++..++.++.||+.||+|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            89999999999999985432  35899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc-cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCC--------CcchhHHHHHHHH
Q 002969          694 FGGDQTE-QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHS--------NNELNLLGHVWRL  764 (862)
Q Consensus       694 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~--------~~~~~l~~~~~~~  764 (862)
                      +...... .......++..|+|||.+.+..++.++||||||+++|||++++.|......        .............
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6433221 111234567789999999988899999999999999999998765321100        0001111111112


Q ss_pred             HhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       765 ~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ..++..        ...+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       239 ~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGKR--------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCcc--------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            222111        112234567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.2e-35  Score=329.07  Aligned_cols=252  Identities=22%  Similarity=0.273  Sum_probs=196.2

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      +|++.++||+|+||.||+++... ++.||||++....   ....+.+.+|++++++++||||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            68889999999999999998754 7899999986432   2345678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++|+|.+++...   ..+++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          82 YIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            99999999998543   34788888899999999999999998   9999999999999999999999999985432100


Q ss_pred             c-----------------------------------------ccccccccccccccChhhhcCCCCCccccchhHHHHHH
Q 002969          699 T-----------------------------------------EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLL  737 (862)
Q Consensus       699 ~-----------------------------------------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~  737 (862)
                      .                                         ........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence            0                                         00011347999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCC---CHHHHHHH
Q 002969          738 ETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERP---TMASVVLM  813 (862)
Q Consensus       738 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl~~  813 (862)
                      ||++|+.||......   .....+    ..... ..   . .......+..+.+++.+|+ .+|.+|+   ++.|+++.
T Consensus       236 ell~G~~Pf~~~~~~---~~~~~i----~~~~~-~~---~-~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         236 EMLVGQPPFLADTPA---ETQLKV----INWET-TL---H-IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             ehhhCCCCCCCCCHH---HHHHHH----hccCc-cc---c-CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999997532211   111111    11000 00   0 0111223456677787766 4999999   89999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.4e-34  Score=325.71  Aligned_cols=260  Identities=22%  Similarity=0.332  Sum_probs=197.1

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCC-----ceE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-----EKM  614 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~  614 (862)
                      +|+..++||+|+||.||++... +++.||||++...  .....+++.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            3678899999999999999864 5889999998653  2234567889999999999999999999998776     789


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      +|+||+. ++|.+.+..   ...+++..+..++.||++||+|||+.+   ++||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 577777643   235899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee--
Q 002969          695 GGDQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL--  771 (862)
Q Consensus       695 ~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--  771 (862)
                      ...... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||.....   ...+..+..........  
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~g~~~~~~~  229 (372)
T cd07853         154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP---IQQLDLITDLLGTPSLEAM  229 (372)
T ss_pred             ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcCCCCHHHH
Confidence            432221 12234578899999998874 578999999999999999999999753221   11121111111000000  


Q ss_pred             --------eee---------cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          772 --------EMV---------DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       772 --------~~i---------d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                              +.+         .............++.+|+.+||+.||++|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                    000         000011122335678899999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-34  Score=309.03  Aligned_cols=252  Identities=29%  Similarity=0.476  Sum_probs=199.4

Q ss_pred             ccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccch--HHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGI--EEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      |+..+.||+|+||+||+++... ++.+|+|++........  ....+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5667899999999999998876 56899999977643322  23456999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++.   +...+++..+..++.||++||++||+.+   ++|+||||+||++++++.++|+|||++...  ....
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SENN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TSTT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--cccc
Confidence            9999999996   2345899999999999999999999998   999999999999999999999999999865  1222


Q ss_pred             cccccccccccccChhhhc-CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          701 QNTKRVVGTYGYMSPEYAM-DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                      .......++..|+|||++. +..++.++||||||+++++|++|..|+......+..........   . ..    ... .
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~---~-~~----~~~-~  223 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK---R-PL----PSS-S  223 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH---T-HH----HHH-T
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc---c-cc----ccc-c
Confidence            2333457889999999998 78899999999999999999999999754311111111111110   0 00    000 0


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .........+.+++.+||+.+|++||++.++++
T Consensus       224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            001111378899999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-34  Score=307.45  Aligned_cols=255  Identities=32%  Similarity=0.478  Sum_probs=206.2

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      .++|++.++||+|+||.||++...+++.+|||.+.... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            45788889999999999999998888899999986543 34578999999999999999999999999989999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++.... ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++..+......
T Consensus        84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            9999999986533 245899999999999999999999998   999999999999999999999999999876432111


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                       .......+..|+|||.+.+..++.++||||||++++|+++ |+.|+..   ..........    ..+.        ..
T Consensus       160 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~---~~~~~~~~~~----~~~~--------~~  223 (261)
T cd05034         160 -AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG---MTNREVLEQV----ERGY--------RM  223 (261)
T ss_pred             -hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHH----HcCC--------CC
Confidence             1112234568999999998899999999999999999998 8888632   1111222221    1110        01


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      ..+...+.++.+++.+|++.+|++||+++++++.|+.
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1122335678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.9e-34  Score=316.17  Aligned_cols=260  Identities=24%  Similarity=0.344  Sum_probs=198.0

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ++|...++||+|+||.||+|+.. .++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888899999999999999875 47789999987543 23345678999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++ +|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            985 787777443  234788999999999999999999998   99999999999999999999999999976532221


Q ss_pred             ccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce--------
Q 002969          700 EQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV--------  770 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--------  770 (862)
                        ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.|+......   +....+.+.+.....        
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE---DELHLIFRLLGTPTEETWPGISS  234 (309)
T ss_pred             --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHHHHhhhcc
Confidence              1223457889999998865 46889999999999999999999997543222   122222211110000        


Q ss_pred             -eeeecccCC--------CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          771 -LEMVDSSVD--------NYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       771 -~~~id~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       .+..+....        ......+.++.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence             000000000        011223456789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.5e-34  Score=308.11  Aligned_cols=256  Identities=26%  Similarity=0.386  Sum_probs=201.6

Q ss_pred             HHcccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       539 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      .+++.+.....||+|+||.||+|+..+ +..|++|.+........+.+.+|+.++++++|+||+++++++...+..++|+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            355666666899999999999998654 6789999987766666778999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC-CCCeeEecccceeecCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-EMTPKISDFGMARIFGG  696 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~  696 (862)
                      ||+++++|.+++.........++..+..++.||++||+|||+.+   |+||||||+||+++. ++.+||+|||++..+..
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            99999999999965432222378888899999999999999987   999999999999976 67999999999876532


Q ss_pred             CCcccccccccccccccChhhhcCCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGL--FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~--~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ...  ......++..|+|||++.+..  ++.++||||||+++|||++|+.|+........     ..+..        ..
T Consensus       162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-----~~~~~--------~~  226 (268)
T cd06624         162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-----AMFKV--------GM  226 (268)
T ss_pred             CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-----hHhhh--------hh
Confidence            221  122245788999999986643  78999999999999999999999643211110     00000        00


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .......+.....++.+++.+||+.+|++||++.|++.
T Consensus       227 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         227 FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            00112233445567889999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-35  Score=304.72  Aligned_cols=263  Identities=24%  Similarity=0.363  Sum_probs=202.6

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEe-----CCc
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE-----MDE  612 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~~~  612 (862)
                      ...|...+.||+|+||.|..+.... ++.||||++...  .....++-.+|+++|+.++|+||+.+++.+..     -..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            3456667899999999999997654 889999999743  44456788999999999999999999999865     456


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      .|+|+|+| ..+|...+...   ..|+......+++||++||.|+|+.+   ++||||||.|+|++.+..+||+|||+|+
T Consensus       101 vYiV~elM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence            89999999 46888888433   33888999999999999999999998   9999999999999999999999999999


Q ss_pred             ecCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcC---
Q 002969          693 IFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG---  768 (862)
Q Consensus       693 ~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---  768 (862)
                      ...........+..+.|..|.|||++.. ..|+.+.||||.||||.||++|++-|...+   ..+.+..+.......   
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d---~v~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD---YVHQLQLILELLGTPSEE  250 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc---hHHHHHHHHHhcCCCCHH
Confidence            8755423333345678999999998865 579999999999999999999998765322   222222222221111   


Q ss_pred             --------ceeeeeccc--C-----CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          769 --------KVLEMVDSS--V-----DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       769 --------~~~~~id~~--~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                              +....+...  .     ...-+......++|+.+||..||.+|+|++|.++.
T Consensus       251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                    111111100  0     11123455678899999999999999999999863

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-34  Score=307.14  Aligned_cols=249  Identities=29%  Similarity=0.430  Sum_probs=204.7

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      ++|+..+.||+|+||.||+|.. .++.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++|+||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            4678889999999999999986 478999999976544 56789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +++|.+++..... ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.......  
T Consensus        84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            9999999865432 35899999999999999999999998   99999999999999999999999999987532211  


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                         ....+..|+|||.+....++.++||||||++++|+++ |..|+....   ...+    ......+..        ..
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~----~~~~~~~~~--------~~  219 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDV----VPHVEKGYR--------ME  219 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC---HHHH----HHHHhcCCC--------CC
Confidence               2234668999999998889999999999999999997 888864321   1111    111221110        11


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      .+...+..+.+++.+||+.+|++||++.|++++|++
T Consensus       220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            223345678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-35  Score=306.29  Aligned_cols=247  Identities=23%  Similarity=0.382  Sum_probs=207.3

Q ss_pred             ccccccceeeccccEEEEEeEe-cCCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      .+|++.+.||+|.||.|-++.. ..|+.||||.+++.   +++..-..++|+++|..|+||||+.++.+|...+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4678889999999999999975 66999999999765   4556667899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||..+|.|.+++....   .|++.+...++.||..|+.|+|.+.   ++|||||.+|||||.++++||+||||+..+...
T Consensus       133 EYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  133 EYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            9999999999996543   4999999999999999999999997   999999999999999999999999999876432


Q ss_pred             CcccccccccccccccChhhhcCCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFS-VKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                         ...+.++|++.|.+||++.+.+|. +.+|-|||||+||-|+.|..||+..   +...++..+    ..+..      
T Consensus       207 ---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~---Dhk~lvrQI----s~GaY------  270 (668)
T KOG0611|consen  207 ---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR---DHKRLVRQI----SRGAY------  270 (668)
T ss_pred             ---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc---hHHHHHHHh----hcccc------
Confidence               233457999999999999999984 8899999999999999999997532   222222222    22211      


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML  814 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  814 (862)
                          ..++.+....-||++||-.||++|-|+.+|....
T Consensus       271 ----rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  271 ----REPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             ----cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                1223344566899999999999999999998754

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.6e-34  Score=309.60  Aligned_cols=256  Identities=28%  Similarity=0.434  Sum_probs=203.4

Q ss_pred             ccccccceeeccccEEEEEeEecC----CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .+|++.+.||+|+||.||+|+...    +..+|+|.++... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            467888999999999999997642    3369999986543 33456889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++++|.+++....  ..+++.+++.++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||++..+..
T Consensus        84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            99999999999985432  35889999999999999999999988   99999999999999999999999999987643


Q ss_pred             CCcccc-cccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          697 DQTEQN-TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       697 ~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ...... .....++..|+|||.+.+..++.++||||||+++||+++ |..|+.....   ....    ....++..    
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~----~~~~~~~~----  227 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVI----KAIEEGYR----  227 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHH----HHHhCCCc----
Confidence            322111 111223568999999998899999999999999999886 9988643221   1111    11222110    


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                          ...+...+..+.+++.+|++.+|++||+|.++++.|+++
T Consensus       228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 ----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                011223456778999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.1e-34  Score=308.87  Aligned_cols=254  Identities=24%  Similarity=0.339  Sum_probs=190.3

Q ss_pred             ceeeccccEEEEEeEecC---CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCC
Q 002969          548 NKLGQGGFGIVYKGRLLE---GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR  623 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g  623 (862)
                      ++||+|+||.||+|+...   ...+++|.+.... ......|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997544   3468888876443 334567889999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccC--CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          624 SLDSVIFDKAR--SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       624 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +|.+++.....  ....++.....++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999965432  233567788899999999999999998   9999999999999999999999999987543222211


Q ss_pred             ccccccccccccChhhhcC-------CCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeee
Q 002969          702 NTKRVVGTYGYMSPEYAMD-------GLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~-------~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  773 (862)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |..|+...   .......   ....+. ....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~---~~~~~~~---~~~~~~-~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL---SDEQVLK---QVVREQ-DIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC---CHHHHHH---HHhhcc-CccC
Confidence            2223345778999998743       356889999999999999999 66665322   1111111   111111 1111


Q ss_pred             ecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       774 id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      ..+   ..+......+.+++..|+ .+|++||+++||++.|.
T Consensus       231 ~~~---~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKP---QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCC---cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            111   222334556677888888 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.4e-34  Score=307.64  Aligned_cols=240  Identities=23%  Similarity=0.356  Sum_probs=188.6

Q ss_pred             ceeeccccEEEEEeEecC-------------CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceE
Q 002969          548 NKLGQGGFGIVYKGRLLE-------------GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  614 (862)
                      +.||+|+||.||+|+...             ...|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999997532             2258999887655555668899999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC-------eeEec
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT-------PKISD  687 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~-------~kL~D  687 (862)
                      +|+||+++++|+.++...  ...+++..+++++.||++||+|||+.+   |+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999999887543  235899999999999999999999987   999999999999987664       89999


Q ss_pred             ccceeecCCCCcccccccccccccccChhhhc-CCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHH
Q 002969          688 FGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM-DGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLW  765 (862)
Q Consensus       688 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  765 (862)
                      ||++......      ....++..|+|||.+. +..++.++||||||+++|||++ |..|+......+       .....
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~  222 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------KERFY  222 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------HHHHH
Confidence            9998754321      1235678899999887 4678999999999999999984 766643211110       11111


Q ss_pred             hcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          766 KEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       766 ~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                       ....         ........++.+++.+||+.+|++||++.+|++.|+
T Consensus       223 -~~~~---------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 -EGQC---------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             -hcCc---------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence             1100         011123456789999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.3e-34  Score=323.15  Aligned_cols=254  Identities=20%  Similarity=0.226  Sum_probs=198.5

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ..++|+..++||+|+||.||+++... ++.+|+|++.+.   .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            35679999999999999999998765 788999998642   22334568899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||+++|+|.+++...    .+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++..+.
T Consensus       121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            99999999999988432    3788889999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccChhhhcCC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDG----LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      .... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||....   .......+   .......
T Consensus       194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~---~~~~~~~i---~~~~~~~  266 (370)
T cd05621         194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS---LVGTYSKI---MDHKNSL  266 (370)
T ss_pred             cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC---HHHHHHHH---HhCCccc
Confidence            3221 122345799999999998764    37889999999999999999999974321   11111111   1111100


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEE--RPTMASVVLM  813 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  813 (862)
                      .      .......+..+.+++..|++.++.+  ||++.|+++.
T Consensus       267 ~------~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         267 N------FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             C------CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            0      0011223556778999999865543  8999999975

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.1e-34  Score=309.77  Aligned_cols=250  Identities=28%  Similarity=0.370  Sum_probs=199.5

Q ss_pred             ccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      |+..++||+|+||.||++.... ++.||||.+....   ....+.+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            6677899999999999998764 7899999986542   22335678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|.+++.... ...+++.++..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++....... 
T Consensus        82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            99999999885433 234889999999999999999999987   9999999999999999999999999987653222 


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                        ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+..............   .....         ..
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~---~~~~~---------~~  222 (285)
T cd05630         157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER---LVKEV---------QE  222 (285)
T ss_pred             --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh---hhhhh---------hh
Confidence              11234689999999999999999999999999999999999999754222111111111   11100         01


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPT-----MASVVL  812 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  812 (862)
                      ..+.....++.+++.+||+.+|++||+     +.|+++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            122334556789999999999999999     888886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.4e-34  Score=306.72  Aligned_cols=248  Identities=27%  Similarity=0.415  Sum_probs=196.0

Q ss_pred             eeeccccEEEEEeEec---CCcEEEEEEeccCCc-cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCC
Q 002969          549 KLGQGGFGIVYKGRLL---EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRS  624 (862)
Q Consensus       549 ~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs  624 (862)
                      .||+|+||.||+|.+.   .+..||+|++..... ...+.|.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999764   345799999876533 34567999999999999999999999885 457899999999999


Q ss_pred             hhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc-c
Q 002969          625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-T  703 (862)
Q Consensus       625 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~  703 (862)
                      |.+++...  ...+++..+++++.||++||+|||+.+   ++||||||+|||++.++.+||+|||+++.+........ .
T Consensus        81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            99998543  345899999999999999999999987   99999999999999999999999999986543322111 1


Q ss_pred             ccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCC
Q 002969          704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP  782 (862)
Q Consensus       704 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~  782 (862)
                      ....++..|+|||.+....++.++||||||+++||+++ |+.|+.....   ..    +...+..+..        ...+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~----~~~~~~~~~~--------~~~~  220 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---PE----VMSFIEQGKR--------LDCP  220 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---HH----HHHHHHCCCC--------CCCC
Confidence            11233578999999988889999999999999999996 8888643211   11    1122222211        1223


Q ss_pred             hHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          783 ANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       783 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ...+.++.+++.+||+.+|++||++.+|.+.|+..
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            44567888999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-34  Score=326.34  Aligned_cols=261  Identities=19%  Similarity=0.220  Sum_probs=201.0

Q ss_pred             cccccccceeeccccEEEEEeEecC---CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ..+|++.++||+|+||.||++...+   ++.||+|.+...     +.+.+|++++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            3579999999999999999997533   567999988543     34568999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      |++. ++|.+++..   ...+++.+++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       166 e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9996 678887732   345899999999999999999999998   999999999999999999999999999876544


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceee-----
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE-----  772 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-----  772 (862)
                      ..........||+.|+|||++....++.++|||||||++|||++|+.|+...........+..+.+.+......-     
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            333333346799999999999999999999999999999999999999754333322222222222221110000     


Q ss_pred             --------eecccC-CCC-------ChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          773 --------MVDSSV-DNY-------PANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       773 --------~id~~~-~~~-------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                              ...... ..+       ......++.+++.+||+.+|++||++.|++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                    000000 000       01224567789999999999999999999874

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8.1e-35  Score=321.19  Aligned_cols=237  Identities=24%  Similarity=0.265  Sum_probs=188.2

Q ss_pred             ceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHH-HHHhcccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVR-LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      +.||+|+||.||+|+.. +++.||+|++....   .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999875 48899999996532   223344555554 56778999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      ++|..++...   ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (323)
T cd05575          81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT  152 (323)
T ss_pred             CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence            9999988543   35888999999999999999999998   999999999999999999999999998753221  122


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP  782 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~  782 (862)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.|+...   +......    ......         ...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~---~~~~~~~----~i~~~~---------~~~~  216 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---DTAEMYD----NILNKP---------LRLK  216 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC---CHHHHHH----HHHcCC---------CCCC
Confidence            33457899999999999999999999999999999999999997432   1111111    111111         1122


Q ss_pred             hHHHHHHHHHHHhccccCCCCCCCHH
Q 002969          783 ANEVLRCIHVGLLCVQENAEERPTMA  808 (862)
Q Consensus       783 ~~~~~~l~~li~~cl~~dP~~RPt~~  808 (862)
                      ...+..+.+++.+||+.+|++||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            33466788999999999999999884

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.4e-34  Score=327.16  Aligned_cols=261  Identities=20%  Similarity=0.236  Sum_probs=197.7

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ..+|.+.++||+|+||.||++.... ++.||||...      ...+.+|++++++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4578999999999999999998765 7889999643      23467899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +. ++|.+++...  ...+++.+++.|+.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 6888877543  235899999999999999999999998   99999999999999999999999999987643322


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCC-cchhHHHHHHHHHhcCcee--eee--
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSN-NELNLLGHVWRLWKEGKVL--EMV--  774 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~--~~i--  774 (862)
                      ........||..|+|||++.+..++.++|||||||+||||++|..++...... ........+.+.+......  +..  
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            22223457999999999999999999999999999999999988764221111 1111111222222211100  000  


Q ss_pred             --------------cccCCCCC-------hHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          775 --------------DSSVDNYP-------ANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       775 --------------d~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                                    ........       ......+.+|+.+||+.||++|||+.|+++.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                          00000000       0123367789999999999999999999974

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.8e-34  Score=310.79  Aligned_cols=239  Identities=23%  Similarity=0.340  Sum_probs=187.1

Q ss_pred             eeeccccEEEEEeEecC-------------------------CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEE
Q 002969          549 KLGQGGFGIVYKGRLLE-------------------------GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL  603 (862)
Q Consensus       549 ~LG~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l  603 (862)
                      +||+|+||.||+|.+..                         ...|++|++.........+|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         13589999876555556688999999999999999999


Q ss_pred             EEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC--
Q 002969          604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM--  681 (862)
Q Consensus       604 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~--  681 (862)
                      ++++.+....++||||+++++|..++...  ...+++..+++++.||++||+|||+.+   |+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            99999999999999999999999988543  235889999999999999999999987   99999999999997654  


Q ss_pred             -----CeeEecccceeecCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHH-hCCCCCCCCCCCcc
Q 002969          682 -----TPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETV-SGKKNRGFYHSNNE  754 (862)
Q Consensus       682 -----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~ell-tG~~p~~~~~~~~~  754 (862)
                           .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+......+ 
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-  229 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-  229 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence                 3799999988643211      11346778999998876 56899999999999999985 6888764322211 


Q ss_pred             hhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          755 LNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       755 ~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                        .. .   .....          ...+......+.+++.+||+.+|++||++.+|++.|+
T Consensus       230 --~~-~---~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 --KE-R---FYEKK----------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             --HH-H---HHHhc----------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence              11 1   11110          0111122346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-34  Score=306.88  Aligned_cols=252  Identities=26%  Similarity=0.402  Sum_probs=202.3

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-----ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-----GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ++|...+.||+|++|.||++... .++.+|+|.+....     ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46888899999999999999865 48899999886432     1234578899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      |+||+++++|.+++...   ..+++..+.+++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||+++.+.
T Consensus        82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            99999999999988543   34788999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCcccc-cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          696 GDQTEQN-TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       696 ~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ....... .....++..|+|||++.+..++.++||||||+++|||++|+.|+...   +.   ...........      
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~---~~---~~~~~~~~~~~------  223 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF---EA---MAAIFKIATQP------  223 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc---ch---HHHHHHHhccC------
Confidence            3221111 12345788999999999988999999999999999999999986421   11   11111111110      


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                        .....+......+.+++.+||+.+|++||++.|+++.
T Consensus       224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         224 --TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence              1122334455678899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.4e-34  Score=316.35  Aligned_cols=255  Identities=29%  Similarity=0.425  Sum_probs=200.1

Q ss_pred             ccccccceeeccccEEEEEeEecC-Cc--EEEEEEeccC-CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ--EIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ++|++.+.||+|+||.||+|+..+ +.  .+++|+++.. .....+++.+|++++.++ +||||+++++++.+.+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            467888999999999999998654 43  4688877643 234456888999999999 899999999999999999999


Q ss_pred             EEeccCCChhhhhhhcc-------------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCe
Q 002969          617 YEYMENRSLDSVIFDKA-------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  683 (862)
                      +||+++++|.+++....             ....+++.+++.++.||++||+|||+.+   ++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999986432             1235889999999999999999999988   9999999999999999999


Q ss_pred             eEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHH
Q 002969          684 KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVW  762 (862)
Q Consensus       684 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~  762 (862)
                      ||+|||+++....   .........+..|+|||++.+..++.++||||||++++||++ |..|+.....   ....    
T Consensus       164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~----  233 (303)
T cd05088         164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELY----  233 (303)
T ss_pred             EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HHHH----
Confidence            9999999864211   111111234668999999988889999999999999999998 8888642211   1111    


Q ss_pred             HHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       763 ~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .....+.        ....+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       234 ~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         234 EKLPQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             HHHhcCC--------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1111110        0111223445678999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3e-34  Score=310.13  Aligned_cols=261  Identities=24%  Similarity=0.350  Sum_probs=198.4

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +|+..+.||+|++|.||+|+.. .++.||+|+++...  ....+.+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4677889999999999999875 48899999986542  23346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      ++ ++|.+++........+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 688888765444456899999999999999999999988   99999999999999999999999999976532211


Q ss_pred             ccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcC----------
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG----------  768 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----------  768 (862)
                        ......+++.|+|||++.+. .++.++||||||++++||++|+.|+......   .......+.+...          
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI---DQLFRIFRILGTPTEDVWPGVTS  231 (285)
T ss_pred             --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHhCCCChhhhhcchh
Confidence              11223568899999988764 5789999999999999999999987532211   1111111100000          


Q ss_pred             ------ceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          769 ------KVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       769 ------~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                            .................+.++.+++.+||+.||++|||+.+|++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                  00000000011111224567789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.8e-34  Score=308.93  Aligned_cols=263  Identities=28%  Similarity=0.414  Sum_probs=205.4

Q ss_pred             ccccccceeeccccEEEEEeEec-----CCcEEEEEEeccCCcc-chHHHHHHHHHHHhcccCCceEEEEEEEe--CCce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVE--MDEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~  613 (862)
                      +.|+..+.||+|+||.||+++..     .++.+|||++...... ..+.|.+|+++++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35677789999999999999864     2678999999765443 56789999999999999999999999887  5678


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++++||+++++|.+++....  ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            99999999999999996433  25899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCcc-cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcch--------hHHHHHHHH
Q 002969          694 FGGDQTE-QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL--------NLLGHVWRL  764 (862)
Q Consensus       694 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~--------~l~~~~~~~  764 (862)
                      ....... .......++..|+|||.+.+..++.++||||||++++||++|+.|+.........        .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            6532221 1111223456799999999889999999999999999999999886432111100        011111111


Q ss_pred             HhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       765 ~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ...+..        ...+...+.++.+++.+||+.+|++||+|.||+++|+++
T Consensus       239 ~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEGER--------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcCCc--------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111110        111223446788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.6e-34  Score=311.13  Aligned_cols=249  Identities=24%  Similarity=0.399  Sum_probs=202.8

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      .+|+..+.||+|+||.||+|+.. +++.|++|.+........+.+.+|+.+++.++|+||+++++.+......++|+||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            47888899999999999999864 58899999997766556678999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++..    ..+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++........ 
T Consensus       100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            99999998843    24788999999999999999999998   99999999999999999999999999876532221 


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                       ......+++.|+|||.+.+..++.++|||||||++|||++|+.|+......      .........+.      +. ..
T Consensus       172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~------~~~~~~~~~~~------~~-~~  237 (296)
T cd06654         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGT------PE-LQ  237 (296)
T ss_pred             -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH------HhHHHHhcCCC------CC-CC
Confidence             112246788999999999888999999999999999999999997432211      11111111100      00 11


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .+......+.+++.+||+.+|++||++.||++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            12334566889999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.3e-34  Score=306.00  Aligned_cols=250  Identities=23%  Similarity=0.331  Sum_probs=202.3

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      +|+..++||+|+||.||+++.. .++.+|+|.++.. .....+.+.+|+.+++.++|+||+++++.+...+..++++||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4677899999999999999875 4889999998643 3345678889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++... ....+++.....++.||+.||.|||+.+   ++|+||||+||++++++.++|+|||++..+..... 
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            999999988543 2345788999999999999999999998   99999999999999999999999999986643221 


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                       ......++..|+|||++.+..++.++|+||||+++|+|++|+.|+...   +......    ....+..        ..
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~---~~~~~~~----~~~~~~~--------~~  219 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN---SWKNLIL----KVCQGSY--------KP  219 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC---CHHHHHH----HHhcCCC--------CC
Confidence             122356888999999999889999999999999999999999997421   1111111    1111111        11


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .+...+..+.+++.+||+.+|++||++.||+..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            223344567899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.3e-34  Score=303.39  Aligned_cols=249  Identities=31%  Similarity=0.438  Sum_probs=200.4

Q ss_pred             ceeeccccEEEEEeEecC--C--cEEEEEEeccCCc-cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLLE--G--QEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      ++||+|++|.||+|.+.+  +  ..||+|.+..... ...+++.+|+.++++++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            478999999999998744  2  3689999977655 567789999999999999999999999988 889999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc-c
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE-Q  701 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~  701 (862)
                      ++|.+++.+... ..+++.....++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999866433 46899999999999999999999998   999999999999999999999999999876442221 1


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      ......++..|+|||.+.+..++.++||||||++++||++ |+.|+...   ..........   ....        ...
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~~~~~---~~~~--------~~~  221 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL---SGSQILKKID---KEGE--------RLE  221 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHH---hcCC--------cCC
Confidence            1122456789999999999999999999999999999998 99986422   1111211111   1110        011


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      .+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            12334567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.2e-34  Score=314.17  Aligned_cols=263  Identities=24%  Similarity=0.314  Sum_probs=199.4

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ++|++.++||+|+||.||+++... +..+|+|.+.... ....+++.+|++++++++||||+++++++...+..++|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            368888999999999999998764 7788999886542 23456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|.+++...   ..+++..+..++.||++||+|||+..  +++|+||||+|||++.++.+||+|||++......  
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  153 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  153 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence            9999999998543   34889999999999999999999742  3999999999999999999999999998755322  


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce---------
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV---------  770 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---------  770 (862)
                        ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........................         
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence              122356789999999998888999999999999999999999996432211100000000000000000         


Q ss_pred             --------eeee----cccCCCC-ChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          771 --------LEMV----DSSVDNY-PANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       771 --------~~~i----d~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                              .+..    ....... ......++.+++.+||+.+|++||++.||++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    0000    0000000 11234568899999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-34  Score=320.18  Aligned_cols=238  Identities=21%  Similarity=0.259  Sum_probs=188.5

Q ss_pred             ceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHH-HHHhcccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVR-LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~-~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      ++||+|+||.||+++.. +++.+|+|++...   ......++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            47999999999999865 4889999998654   2233445555654 46778999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      ++|..++...   ..+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~  152 (325)
T cd05604          81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT  152 (325)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence            9998887543   35889999999999999999999998   999999999999999999999999998753211  122


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP  782 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~  782 (862)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.|+...   +....    .+......         ....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~---~~~~~----~~~~~~~~---------~~~~  216 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR---DVAEM----YDNILHKP---------LVLR  216 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC---CHHHH----HHHHHcCC---------ccCC
Confidence            23457899999999999999999999999999999999999997432   11111    11111111         0112


Q ss_pred             hHHHHHHHHHHHhccccCCCCCCCHHH
Q 002969          783 ANEVLRCIHVGLLCVQENAEERPTMAS  809 (862)
Q Consensus       783 ~~~~~~l~~li~~cl~~dP~~RPt~~e  809 (862)
                      +.....+.+++.+|++.+|++||++.+
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            234567789999999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.8e-34  Score=307.43  Aligned_cols=252  Identities=23%  Similarity=0.365  Sum_probs=200.2

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      ++|+..++||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46778889999999999999875 47889999987665555667889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++...   ..+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+....  
T Consensus        89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--  160 (267)
T cd06645          89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--  160 (267)
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence            999999988543   34889999999999999999999998   9999999999999999999999999997664221  


Q ss_pred             cccccccccccccChhhhc---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          701 QNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      .......|+..|+|||++.   ...++.++|||||||++|||++|..|+.......      ...........    .+.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~------~~~~~~~~~~~----~~~  230 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR------ALFLMTKSNFQ----PPK  230 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh------hHHhhhccCCC----CCc
Confidence            1223356899999999874   4568899999999999999999999864322111      01111111000    000


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .. .....+..+.+++.+|++.+|++||++++|++
T Consensus       231 ~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         231 LK-DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cc-ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            00 01123456789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.9e-34  Score=342.22  Aligned_cols=261  Identities=20%  Similarity=0.282  Sum_probs=202.9

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|++.++||+|+||.||+|+... ++.||+|+++...   ....++|.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            478889999999999999998754 8899999997542   223567999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccC--------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccc
Q 002969          618 EYMENRSLDSVIFDKAR--------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  689 (862)
                      ||+++++|.+++.....        ...+++..+++++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999854211        123567788999999999999999998   9999999999999999999999999


Q ss_pred             ceeecCCCCcc----------------cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc
Q 002969          690 MARIFGGDQTE----------------QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN  753 (862)
Q Consensus       690 la~~~~~~~~~----------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~  753 (862)
                      +++........                .......||+.|+|||++.+..++.++|||||||++|||++|+.|+...... 
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence            99876221100                0112346899999999999999999999999999999999999997432111 


Q ss_pred             chhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhccCc
Q 002969          754 ELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERP-TMASVVLMLSSET  818 (862)
Q Consensus       754 ~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~  818 (862)
                        ...   ..    ...   ..+.........+..+.+++.+|++.+|++|| +++++++.|+...
T Consensus       238 --ki~---~~----~~i---~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        238 --KIS---YR----DVI---LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             --hhh---hh----hhc---cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence              000   00    000   00000001123445678999999999999996 6777777776653

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-34  Score=303.41  Aligned_cols=248  Identities=29%  Similarity=0.400  Sum_probs=198.9

Q ss_pred             ceeeccccEEEEEeEecCCcEEEEEEeccCCcc-chHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCChh
Q 002969          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLD  626 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~  626 (862)
                      ++||+|+||.||++...+++.||+|++...... ..+.+.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999877999999998765433 5678999999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccccccc
Q 002969          627 SVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV  706 (862)
Q Consensus       627 ~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  706 (862)
                      +++....  ..+++..++.++.+++.+|+|||+.+   ++||||||+|||++.++.+||+|||++...............
T Consensus        81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            9985432  34788999999999999999999998   999999999999999999999999999865422221111222


Q ss_pred             cccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHH
Q 002969          707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE  785 (862)
Q Consensus       707 ~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~  785 (862)
                      ..+..|+|||.+.+..++.++|+||||+++|||++ |..|+......   ...    .......       . ...+...
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~----~~~~~~~-------~-~~~~~~~  220 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTR----ERIESGY-------R-MPAPQLC  220 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHH----HHHhcCC-------C-CCCCccC
Confidence            34667999999998899999999999999999999 67765332211   111    1111110       0 1122334


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          786 VLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       786 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      +..+.+++.+|++.+|++||++.||++.|+
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-35  Score=321.54  Aligned_cols=246  Identities=28%  Similarity=0.439  Sum_probs=203.5

Q ss_pred             eeeccccEEEEEeEecCCc-EEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCChhh
Q 002969          549 KLGQGGFGIVYKGRLLEGQ-EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDS  627 (862)
Q Consensus       549 ~LG~G~fg~Vy~~~~~~~~-~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~  627 (862)
                      +||+|.||+||.|+..+.+ .+|||-+.....+..+-+.+|+.+.++|+|.|||+++|.+.+.+..-+.||.++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            7999999999999987754 699999988777778889999999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec-CCCCeeEecccceeecCCCCcccccccc
Q 002969          628 VIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-KEMTPKISDFGMARIFGGDQTEQNTKRV  706 (862)
Q Consensus       628 ~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~  706 (862)
                      +|..+=..-.=++...-.+..||++||.|||++.   |||||||-+||||. -.|.+||+|||.++.+..  ...-+...
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence            9965432222266777778899999999999998   99999999999996 578999999999987743  23344557


Q ss_pred             cccccccChhhhcCC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChH
Q 002969          707 VGTYGYMSPEYAMDG--LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPAN  784 (862)
Q Consensus       707 ~gt~~y~APE~l~~~--~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~  784 (862)
                      .||..|||||++..+  .|..++|||||||++.||.||++||........     .   +++-|- .    +.-...|.+
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-----A---MFkVGm-y----KvHP~iPee  803 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-----A---MFKVGM-Y----KVHPPIPEE  803 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-----h---hhhhcc-e----ecCCCCcHH
Confidence            899999999999876  489999999999999999999999754333221     1   111110 0    111456777


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          785 EVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       785 ~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .+.++..++++|+..+|.+||++.++++
T Consensus       804 lsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            8889999999999999999999999985

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.6e-34  Score=307.39  Aligned_cols=253  Identities=27%  Similarity=0.416  Sum_probs=198.6

Q ss_pred             HHcccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEeC------
Q 002969          539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM------  610 (862)
Q Consensus       539 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~------  610 (862)
                      .+++.|+..+.||+|+||.||+|...+ ++.||+|++.... .....+..|+.++.++ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            356678888999999999999998754 7789999986543 3456788999999999 699999999998753      


Q ss_pred             CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccc
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  690 (862)
                      ...+++|||+++++|.+++... ....+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            4578999999999999998643 2345889999999999999999999987   99999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhc-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAM-----DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW  765 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~  765 (862)
                      +.......  .......|+..|+|||++.     +..++.++|||||||++|||++|+.|+.......      ......
T Consensus       158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~------~~~~~~  229 (272)
T cd06637         158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ALFLIP  229 (272)
T ss_pred             ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH------HHHHHh
Confidence            98653221  1223356889999999986     3457889999999999999999999874322111      111111


Q ss_pred             hcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          766 KEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       766 ~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .. .     ..  .......+..+.+++.+||+.+|.+||++.|+++
T Consensus       230 ~~-~-----~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 RN-P-----AP--RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             cC-C-----CC--CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            10 0     00  1111223457889999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.5e-33  Score=305.26  Aligned_cols=250  Identities=26%  Similarity=0.354  Sum_probs=199.2

Q ss_pred             ccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          544 FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      |+..++||+|+||+||+++.. +++.+|+|.+....   ....+.+.+|++++++++|+|++++.+++..++..++++||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999875 47899999986542   22345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            99999998886433 235899999999999999999999988   9999999999999999999999999987653221 


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                        ......|+..|+|||++.+..++.++|+||||+++|||++|..|+......   .....+.....+..         .
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~---~~~~~~~~~~~~~~---------~  222 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK---VKREEVDRRVLETE---------E  222 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhhhccc---------c
Confidence              112346899999999999999999999999999999999999997532211   11111111111110         1


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPT-----MASVVL  812 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  812 (862)
                      .++......+.+|+..|++.+|++||+     +.+++.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            122334556789999999999999999     677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1e-34  Score=320.60  Aligned_cols=240  Identities=23%  Similarity=0.253  Sum_probs=188.2

Q ss_pred             ceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHH-HHHHhcccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEV-RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      +.||+|+||.||+++... ++.||+|++....   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            479999999999998764 6789999986532   22233444444 456778999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      ++|.+++...   ..+.+.....++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~  152 (325)
T cd05602          81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT  152 (325)
T ss_pred             CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence            9999988543   34777888889999999999999998   999999999999999999999999998754221  122


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP  782 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~  782 (862)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.|+...   ........+    ....         ...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i----~~~~---------~~~~  216 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNI----LNKP---------LQLK  216 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC---CHHHHHHHH----HhCC---------cCCC
Confidence            33457899999999999999999999999999999999999997421   111121111    1111         1122


Q ss_pred             hHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 002969          783 ANEVLRCIHVGLLCVQENAEERPTMASVV  811 (862)
Q Consensus       783 ~~~~~~l~~li~~cl~~dP~~RPt~~evl  811 (862)
                      ...+..+.+++.+|++.+|.+||++.+.+
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            34456788999999999999999887433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.1e-34  Score=305.32  Aligned_cols=248  Identities=28%  Similarity=0.449  Sum_probs=199.6

Q ss_pred             ccccceeeccccEEEEEeEec-CCcEEEEEEeccCCcc---------chHHHHHHHHHHHhcccCCceEEEEEEEeCCce
Q 002969          544 FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQ---------GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  613 (862)
                      |...+.||+|+||.||+|... +++.+|+|.+......         ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            667789999999999999865 4788999988654321         235788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++++||+++++|.+++...   ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.+||+|||+++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             EEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            9999999999999998543   34788899999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCcc----cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc
Q 002969          694 FGGDQTE----QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK  769 (862)
Q Consensus       694 ~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  769 (862)
                      +......    .......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.....      ...+.. ...  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~--  226 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ------LQAIFK-IGE--  226 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH------HHHHHH-Hhc--
Confidence            6432111    111224578899999999998899999999999999999999999753211      111111 111  


Q ss_pred             eeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          770 VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       770 ~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                            ......+...+..+.+++.+||+.+|++||++.||++
T Consensus       227 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 ------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                  1112223345567889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=324.79  Aligned_cols=250  Identities=29%  Similarity=0.435  Sum_probs=204.8

Q ss_pred             cccceeeccccEEEEEeEecC--Cc--EEEEEEeccCCcc-chHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          545 TDYNKLGQGGFGIVYKGRLLE--GQ--EIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       545 ~~~~~LG~G~fg~Vy~~~~~~--~~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ...++||+|.||.|++|.+..  |+  .||||.++..... ...+|++|+.+|.+|+|||+++|+|+..+ ...++|+|.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            445799999999999998754  44  5899999776443 77899999999999999999999999988 788999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      ++.|+|.+.|++ .....+-......++.|||.||.||..+.   +|||||.++|+||-....+||+||||.+.+.....
T Consensus       192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            999999999977 45566888999999999999999999987   99999999999999999999999999998865433


Q ss_pred             ccc-cccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          700 EQN-TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       700 ~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      ... .....-...|.|||.+....|+.++|||+|||+||||+| |..||-.   -....    +.+.+.++.        
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G---~~g~q----IL~~iD~~e--------  332 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG---CRGIQ----ILKNIDAGE--------  332 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC---CCHHH----HHHhccccc--------
Confidence            322 222344678999999999999999999999999999999 5556432   11111    112222211        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML  814 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  814 (862)
                      ...-+..++.+++++++.||..+|++|||+..|.+.+
T Consensus       333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            1234677899999999999999999999999998433

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-34  Score=303.88  Aligned_cols=248  Identities=32%  Similarity=0.458  Sum_probs=197.6

Q ss_pred             ceeeccccEEEEEeEecC----CcEEEEEEeccCCc-cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      ++||+|+||.||+|+...    +..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999997533    26899999876543 34568999999999999999999999875 5678999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc-
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ-  701 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-  701 (862)
                      ++|.+++....   .+++..+..++.|++.||+|||..+   ++|+||||+|||++.++.+||+|||+++.+....... 
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999996543   5899999999999999999999987   9999999999999999999999999998764332211 


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      ......++..|+|||.+.+..++.++||||||+++||+++ |..|+....   .....    ........        ..
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~---~~~~~----~~~~~~~~--------~~  218 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK---GAEVI----AMLESGER--------LP  218 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC---HHHHH----HHHHcCCc--------CC
Confidence            1111223568999999998999999999999999999998 888864322   11122    12222211        11


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .+...+..+.+++.+|++.+|++||++.+|++.|++.
T Consensus       219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            2333456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.2e-34  Score=304.39  Aligned_cols=254  Identities=28%  Similarity=0.455  Sum_probs=204.2

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      .++|+..++||+|+||.||++...++..+|+|.+... ....+.+.+|++++++++|+||+++++++.+ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            3578888999999999999999877888999988653 2345688999999999999999999999887 7789999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++.... ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+......
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            9999999986532 345888999999999999999999987   999999999999999999999999999876432211


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                       ......++..|+|||++....++.++|+||||+++||+++ |+.|+...   ......    .....+...        
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~---~~~~~~----~~~~~~~~~--------  222 (260)
T cd05073         159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM---SNPEVI----RALERGYRM--------  222 (260)
T ss_pred             -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC---CHHHHH----HHHhCCCCC--------
Confidence             1122345678999999998889999999999999999999 88886421   111111    111221111        


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      ..+...+..+.+++.+|++.+|++||++.+++++|+.
T Consensus       223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1123345678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.5e-34  Score=308.07  Aligned_cols=250  Identities=32%  Similarity=0.498  Sum_probs=198.4

Q ss_pred             ceeeccccEEEEEeEecC-------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          548 NKLGQGGFGIVYKGRLLE-------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +.||+|+||.||+|+..+       ++.+|+|.+.... .....++.+|+.+++.++||||+++++++...+..++|+||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998643       2578999886543 34567889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcc----CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC-----CeeEecccc
Q 002969          620 MENRSLDSVIFDKA----RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-----TPKISDFGM  690 (862)
Q Consensus       620 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-----~~kL~DFGl  690 (862)
                      +++++|.+++....    ....+++.+++.++.|+++||+|||+.+   ++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996532    2234789999999999999999999987   99999999999999877     899999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCc
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGK  769 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  769 (862)
                      +..+.............++..|+|||++.+..++.++||||||+++|||++ |+.|+...   .......    ....+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~---~~~~~~~----~~~~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL---NNQEVLQ----HVTAGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc---CHHHHHH----HHhcCC
Confidence            976543322222222345678999999999999999999999999999998 88886422   1111111    111111


Q ss_pred             eeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          770 VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       770 ~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                              ....+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       231 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 --------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             --------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                    11122334567889999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.2e-34  Score=304.47  Aligned_cols=251  Identities=26%  Similarity=0.414  Sum_probs=201.0

Q ss_pred             cccccceeeccccEEEEEeEecCCcEEEEEEeccCC------ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS------GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      +|+..+.||+|+||.||+|...+++.+|+|.+....      ....+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            367788999999999999988889999999886432      12345688999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      +||+++++|.+++...   ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            9999999999998543   24788999999999999999999987   99999999999999999999999999876532


Q ss_pred             CC----cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          697 DQ----TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       697 ~~----~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      ..    .........++..|+|||++.+..++.++||||||++++||++|+.|+......      .........     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~-----  223 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL------AAMFYIGAH-----  223 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH------HHHHHhhhc-----
Confidence            11    111122346889999999999888999999999999999999999997432111      111110000     


Q ss_pred             eecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        .......+.....++.+++.+||+.+|++||++.|+++
T Consensus       224 --~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         224 --RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             --cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              00112223345667889999999999999999999975

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.6e-34  Score=302.73  Aligned_cols=249  Identities=26%  Similarity=0.418  Sum_probs=203.2

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      ++|+..++||+|+||.||+|+..+ ++.+++|.+.....  .+++.+|++++++++||||+++++++......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578888999999999999998876 78999999865433  678999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++...  ...+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++..+..... 
T Consensus        81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            999999998543  245899999999999999999999988   99999999999999999999999999987643221 


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                       ......++..|+|||++.+..++.++||||||+++|||++|+.|+........      .. ....     .. .....
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~------~~-~~~~-----~~-~~~~~  220 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA------IF-MIPN-----KP-PPTLS  220 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh------hh-hhcc-----CC-CCCCC
Confidence             22234578899999999999999999999999999999999999753221110      00 0000     00 00011


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .+......+.+++.+|++.+|++||++.||++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            22334467889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-34  Score=308.92  Aligned_cols=255  Identities=28%  Similarity=0.448  Sum_probs=203.5

Q ss_pred             ccccccceeeccccEEEEEeEecC-Cc----EEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ----EIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      .+|+..++||+|+||.||+|...+ ++    .+|+|.+.... ....+++.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            467888999999999999998643 32    58999886654 3345788999999999999999999999987 78899


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      |+||+++|+|.+++....  ..+++..++.++.||++||+|||+.+   ++||||||+||++++++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            999999999999986532  34899999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ............++..|+|||.+....++.++||||||++++|+++ |+.|+.....   .+    .......+.     
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~----~~~~~~~~~-----  228 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VE----IPDLLEKGE-----  228 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HH----HHHHHhCCC-----
Confidence            3322221112234568999999988899999999999999999998 9998643221   11    111222111     


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                         ....+......+.+++.+||..+|++||++.++++.|+..
T Consensus       229 ---~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         229 ---RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence               1112233445788999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=7.7e-34  Score=307.62  Aligned_cols=259  Identities=25%  Similarity=0.351  Sum_probs=194.2

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhc---ccCCceEEEEEEEe-----CC
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKL---QHRNLVRLLGCCVE-----MD  611 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~HpnIv~l~g~~~~-----~~  611 (862)
                      +|+..+.||+|+||.||+|+..+ ++.||+|.++...  ......+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            47788999999999999998764 7889999986542  22234566788777766   69999999998864     24


Q ss_pred             ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccce
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  691 (862)
                      ..++++||+++ +|.+++.... ...+++..+..++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999984 8888875432 234899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce-
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV-  770 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-  770 (862)
                      +.+....   ......++..|+|||++.+..++.++|||||||++|||++|++|+....   .......+......... 
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~---~~~~~~~~~~~~~~~~~~  229 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS---EADQLGKIFDLIGLPPED  229 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC---HHHHHHHHHHHhCCCChh
Confidence            8764221   1223467899999999999999999999999999999999999864322   22222222222111000 


Q ss_pred             --ee-------eeccc----CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          771 --LE-------MVDSS----VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       771 --~~-------~id~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        ..       ...+.    .....+.....+.+++.+||+.||++||++.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              00       00000    01111234556789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5e-34  Score=303.63  Aligned_cols=249  Identities=28%  Similarity=0.407  Sum_probs=199.4

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEE-eCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV-EMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-~~~~~~lV~E~~  620 (862)
                      ++|+..+.||+|+||.||++.. .+..+|+|.++...  ..+.+.+|+.++++++|+|++++++++. ..+..++++||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            4678889999999999999976 47889999986432  3567899999999999999999999765 456789999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++.... ...+++..+++++.||+.||+|||+.+   ++||||||+||++++++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            9999999986533 335889999999999999999999988   9999999999999999999999999987653221  


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                         ....++..|+|||++.+..++.++||||||+++|||++ |+.|+...   ......    .....+..        .
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~---~~~~~~----~~~~~~~~--------~  218 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVV----PRVEKGYK--------M  218 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC---CHHHHH----HHHhcCCC--------C
Confidence               12234568999999998899999999999999999998 88875421   111111    11111110        1


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ..+...+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            12234456788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-34  Score=306.95  Aligned_cols=249  Identities=30%  Similarity=0.438  Sum_probs=195.4

Q ss_pred             ceeeccccEEEEEeEecC-Cc--EEEEEEeccC-CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLLE-GQ--EIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      +.||+|+||.||+|+..+ +.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998755 33  4788888643 234556889999999999 799999999999999999999999999


Q ss_pred             CChhhhhhhcc-------------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccc
Q 002969          623 RSLDSVIFDKA-------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (862)
Q Consensus       623 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  689 (862)
                      ++|.+++....             ....+++.++..++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999986432             1234789999999999999999999987   9999999999999999999999999


Q ss_pred             ceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcC
Q 002969          690 MARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEG  768 (862)
Q Consensus       690 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~  768 (862)
                      ++.....   .........+..|+|||++....++.++||||||++++||++ |..|+....   ....    .+....+
T Consensus       158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~---~~~~----~~~~~~~  227 (270)
T cd05047         158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAEL----YEKLPQG  227 (270)
T ss_pred             Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC---HHHH----HHHHhCC
Confidence            9863211   111111233567999999988899999999999999999997 888863211   1111    1112111


Q ss_pred             ceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          769 KVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       769 ~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ..        ...+.....++.+++.+|++.+|.+||++.++++.|+.+
T Consensus       228 ~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         228 YR--------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             CC--------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            11        111223445788999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4e-34  Score=328.23  Aligned_cols=258  Identities=19%  Similarity=0.280  Sum_probs=191.9

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeC--------C
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--------D  611 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--------~  611 (862)
                      .++|+..++||+|+||.||+|+.. .++.||||++....    ....+|+.+++.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999875 47899999885432    2345799999999999999999886432        2


Q ss_pred             ceEEEEEeccCCChhhhhhhc-cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC-CeeEeccc
Q 002969          612 EKMLVYEYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFG  689 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFG  689 (862)
                      ..++||||+++ +|.+++... .....+++..+..++.||++||+|||+.+   |+||||||+||||+.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence            35789999985 676666432 23346899999999999999999999998   99999999999998665 79999999


Q ss_pred             ceeecCCCCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcC
Q 002969          690 MARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG  768 (862)
Q Consensus       690 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  768 (862)
                      +++.+.....   .....||+.|+|||++.+. .++.++|||||||++|||++|.+||....   ....+..+.+.....
T Consensus       217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~p  290 (440)
T PTZ00036        217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS---SVDQLVRIIQVLGTP  290 (440)
T ss_pred             cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCC
Confidence            9987643221   2234679999999998764 68999999999999999999999864321   112222222221110


Q ss_pred             ce----------eeeeccc-----C-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          769 KV----------LEMVDSS-----V-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       769 ~~----------~~~id~~-----~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..          .+..-+.     + ..++...+.++.+|+.+||+.+|.+|||+.|+++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            00          0000000     0 1122234567889999999999999999999984

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.2e-34  Score=302.66  Aligned_cols=251  Identities=26%  Similarity=0.380  Sum_probs=204.4

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +|+..+.||.|+||.||.++... ++.+++|++...  .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            47788999999999999987654 788999988654  344567789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|.+++.... ...+++.++..++.|++++|+|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999986543 345899999999999999999999987   99999999999999999999999999987643332


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                        ......+++.|+|||.+.+..++.++||||||++++||++|..|+...   ........    ...+.        ..
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~----~~~~~--------~~  219 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT---NPLNLVVK----IVQGN--------YT  219 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC---CHHHHHHH----HHcCC--------CC
Confidence              223356889999999998888999999999999999999999986431   11111111    11111        11


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVLML  814 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  814 (862)
                      ..+...+.++.+++.+||+.+|++||++.++++.+
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            12234456788999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.5e-34  Score=318.64  Aligned_cols=237  Identities=22%  Similarity=0.267  Sum_probs=187.4

Q ss_pred             ceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHH-HHHhcccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVR-LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      ++||+|+||.||+|+... ++.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999998754 7889999986532   222344555554 67888999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      ++|...+...   ..+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (321)
T cd05603          81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET  152 (321)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence            9998887542   34788888899999999999999988   999999999999999999999999998753221  122


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP  782 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~  782 (862)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.|+...   +......    .....         ....+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~----~i~~~---------~~~~~  216 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR---DVSQMYD----NILHK---------PLQLP  216 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC---CHHHHHH----HHhcC---------CCCCC
Confidence            23457899999999999999999999999999999999999997432   1111111    11111         11223


Q ss_pred             hHHHHHHHHHHHhccccCCCCCCCHH
Q 002969          783 ANEVLRCIHVGLLCVQENAEERPTMA  808 (862)
Q Consensus       783 ~~~~~~l~~li~~cl~~dP~~RPt~~  808 (862)
                      ......+.+++.+||+.+|++||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            34556788999999999999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.3e-34  Score=307.50  Aligned_cols=251  Identities=26%  Similarity=0.386  Sum_probs=199.6

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      .|+..++||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++|||++++++++...+..++|+||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            35677899999999999998765 67789999876665667789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +++|..++...  ...+++..+..++.|+++||+|||+.+   ++||||||+|||++.++.+||+|||++.......  .
T Consensus        86 ~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~  158 (282)
T cd06643          86 GGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  158 (282)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence            99999887542  235899999999999999999999988   9999999999999999999999999987653221  1


Q ss_pred             ccccccccccccChhhhc-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          702 NTKRVVGTYGYMSPEYAM-----DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ......++..|+|||++.     +..++.++|||||||++|||++|+.|+.....      ............      .
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~~------~  226 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEP------P  226 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHhhcCC------C
Confidence            222346889999999984     34578899999999999999999998643211      111111111100      0


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .. ..+...+.++.+++.+||+.+|++||++.++++.
T Consensus       227 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         227 TL-AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             CC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00 1122345678899999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6e-34  Score=320.02  Aligned_cols=259  Identities=20%  Similarity=0.229  Sum_probs=200.6

Q ss_pred             HHHHHcccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCC
Q 002969          536 TIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD  611 (862)
Q Consensus       536 ~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  611 (862)
                      ++....++|+..+.||+|+||.||+++... ++.+|+|++...   .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            334455789999999999999999998765 778999998642   2233456789999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccce
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  691 (862)
                      ..++||||+++|+|.+++...    .++...+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            999999999999999988532    3788888899999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcCC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhc
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDG----LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE  767 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  767 (862)
                      +.+..... .......||+.|+|||++...    .++.++|||||||++|||++|+.|+...   +.......+   ...
T Consensus       190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i---~~~  262 (371)
T cd05622         190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD---SLVGTYSKI---MNH  262 (371)
T ss_pred             eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC---CHHHHHHHH---HcC
Confidence            87643221 122345799999999998754    3789999999999999999999997432   111111111   111


Q ss_pred             CceeeeecccCCCCChHHHHHHHHHHHhccccCCCC--CCCHHHHHHHh
Q 002969          768 GKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEE--RPTMASVVLML  814 (862)
Q Consensus       768 ~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L  814 (862)
                      ......      ......+..+.+++.+|++.++.+  ||++.|+++..
T Consensus       263 ~~~~~~------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         263 KNSLTF------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CCcccC------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            111110      111234567788999999854443  78999998753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-34  Score=306.09  Aligned_cols=246  Identities=25%  Similarity=0.383  Sum_probs=201.8

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      +|+..+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+++++.++|+||+++++++.+....++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            5778899999999999999876 47899999987543 445567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++...    .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.+....  
T Consensus        82 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--  152 (274)
T cd06609          82 GGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--  152 (274)
T ss_pred             CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence            999999998543    5899999999999999999999987   9999999999999999999999999998775332  


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      .......++..|+|||++.+..++.++||||||+++|||++|+.|+......   ....    ......     .   ..
T Consensus       153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~~~----~~~~~~-----~---~~  217 (274)
T cd06609         153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---RVLF----LIPKNN-----P---PS  217 (274)
T ss_pred             cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---HHHH----HhhhcC-----C---CC
Confidence            1222346788999999999988999999999999999999999997532211   1111    111110     0   11


Q ss_pred             CChH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          781 YPAN-EVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       781 ~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .... .+..+.+++.+||+.+|++||+++++++
T Consensus       218 ~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            1111 4557889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=329.77  Aligned_cols=252  Identities=29%  Similarity=0.414  Sum_probs=211.5

Q ss_pred             cccceeeccccEEEEEeEecC-Cc----EEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          545 TDYNKLGQGGFGIVYKGRLLE-GQ----EIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       545 ~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ...++||+|+||+||+|.+.. ++    +||+|++... ..+..+++.+|+-+|.+++|||++||+|+|.... ..||.+
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            345799999999999997643 43    5899998665 3456789999999999999999999999998766 889999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      ||+.|+|.++++.+  +..+..+..+.+..|||+||.|||++.   +|||||.++||||.+-..+||.|||+++.+..+.
T Consensus       778 ~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             hcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            99999999999653  345889999999999999999999987   9999999999999999999999999999987776


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      .........-.+.|||-|.+....|+.++|||||||++||++| |..|+.....+       ++-..++.+..       
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-------eI~dlle~geR-------  918 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-------EIPDLLEKGER-------  918 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-------HhhHHHhcccc-------
Confidence            6666555556789999999999999999999999999999998 77775433322       23333333322       


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                       -..|+.+..++..++.+||..|++.||+++++...+.+-
T Consensus       919 -LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  919 -LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             -CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence             234677889999999999999999999999999888765

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.3e-34  Score=303.42  Aligned_cols=238  Identities=25%  Similarity=0.439  Sum_probs=189.2

Q ss_pred             ceeeccccEEEEEeEecCCc-----------EEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          548 NKLGQGGFGIVYKGRLLEGQ-----------EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      +.||+|+||.||+|...+..           .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            47999999999999886533           5788877654433 6789999999999999999999999988 788999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC-------CeeEeccc
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-------TPKISDFG  689 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-------~~kL~DFG  689 (862)
                      +||+++++|.+++.....  .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999999865432  5889999999999999999999987   99999999999999887       79999999


Q ss_pred             ceeecCCCCcccccccccccccccChhhhcCC--CCCccccchhHHHHHHHHHhC-CCCCCCCCCCcchhHHHHHHHHHh
Q 002969          690 MARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG--LFSVKSDVFSFGVLLLETVSG-KKNRGFYHSNNELNLLGHVWRLWK  766 (862)
Q Consensus       690 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDVwSlGvil~elltG-~~p~~~~~~~~~~~l~~~~~~~~~  766 (862)
                      ++.....      .....++..|+|||++...  .++.++||||||+++|||++| ..|+......+.   .    ..+.
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~----~~~~  220 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---E----RFYQ  220 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---H----HHHh
Confidence            9986532      1123466789999999876  789999999999999999995 555433221111   0    0111


Q ss_pred             cCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          767 EGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       767 ~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      ...          ..+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus       221 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQH----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCC----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            000          011111267889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8.4e-34  Score=317.81  Aligned_cols=258  Identities=25%  Similarity=0.302  Sum_probs=194.9

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCC------
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD------  611 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~------  611 (862)
                      .++|+..+.||+|+||.||+++... ++.||||++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            4689999999999999999998754 889999999654  2334567889999999999999999999986543      


Q ss_pred             ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccce
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  691 (862)
                      ..++||||+++ +|...+..     .+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence            46999999975 45555521     3788888999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH------
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW------  765 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~------  765 (862)
                      +.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ........+..      
T Consensus       171 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~---~~~~~~~~~~~~~~~~~  244 (359)
T cd07876         171 RTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH---IDQWNKVIEQLGTPSAE  244 (359)
T ss_pred             cccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCcHH
Confidence            764322   122235689999999999999999999999999999999999999753221   11111111110      


Q ss_pred             ------------hcC-cee------eeec----ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          766 ------------KEG-KVL------EMVD----SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       766 ------------~~~-~~~------~~id----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                                  ... ...      +...    +............+.+|+.+||+.||++|||+.|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                        000 000      0000    00001111234567899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-34  Score=302.60  Aligned_cols=253  Identities=23%  Similarity=0.372  Sum_probs=204.5

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      ++|+..++||+|+||.||+++... ++.+++|.+........+.+.+|++++++++||||+++++++......+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            578888999999999999998754 7789999998766566788999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++...  ...+++.++..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++..+....  
T Consensus        83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--  155 (262)
T cd06613          83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--  155 (262)
T ss_pred             CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence            999999988543  235889999999999999999999987   9999999999999999999999999987654321  


Q ss_pred             cccccccccccccChhhhcCC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          701 QNTKRVVGTYGYMSPEYAMDG---LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~---~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      .......++..|+|||.+.+.   .++.++||||||+++|||++|+.|+.......      .........     ....
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~------~~~~~~~~~-----~~~~  224 (262)
T cd06613         156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR------ALFLISKSN-----FPPP  224 (262)
T ss_pred             hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcc-----CCCc
Confidence            112234678899999999777   88999999999999999999999974322111      111111110     0111


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ........+.++.+++.+||+.+|++||++.+|+.
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11123345667899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.9e-34  Score=305.34  Aligned_cols=250  Identities=28%  Similarity=0.409  Sum_probs=193.0

Q ss_pred             ceeeccccEEEEEeEecC----CcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEE-eCCceEEEEEecc
Q 002969          548 NKLGQGGFGIVYKGRLLE----GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV-EMDEKMLVYEYME  621 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-~~~~~~lV~E~~~  621 (862)
                      +.||+|+||.||+|...+    ...+|+|++... .....+.+.+|+.+++.++||||+++++++. .....++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998643    357999998543 3345678899999999999999999999876 4556799999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc--
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT--  699 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~--  699 (862)
                      +++|.+++....  ..+++..++.++.||++||+|||+.+   ++||||||+|||+++++.+||+|||+++.+.....  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            999999985432  33677888999999999999999987   99999999999999999999999999976533211  


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCC-CCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKN-RGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                      ........++..|+|||.+.+..++.++||||||+++|||++|..| +..   .....+...    ...+..        
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~---~~~~~~~~~----~~~~~~--------  220 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VDSFDITVY----LLQGRR--------  220 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHH----HhcCCC--------
Confidence            1111223457789999999988999999999999999999996554 321   111122111    111110        


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ...+...+..+.+++.+||+.+|++||++.||++.|+++
T Consensus       221 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            111222345788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1e-33  Score=307.59  Aligned_cols=251  Identities=25%  Similarity=0.381  Sum_probs=201.5

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      +.|++.++||+|+||.||+|+... ++.+++|.+........+.+.+|+.++++++||||+++++.+......++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            568888999999999999998765 7899999998776667788999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|..++....  ..+++..+..++.|++++|+|||+.+   ++||||||+||+++.++.+||+|||++......  .
T Consensus        92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~  164 (292)
T cd06644          92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--L  164 (292)
T ss_pred             CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--c
Confidence            9999988875432  34899999999999999999999987   999999999999999999999999998754221  1


Q ss_pred             cccccccccccccChhhhc-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          701 QNTKRVVGTYGYMSPEYAM-----DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      .......++..|+|||++.     ...++.++|||||||++|||++|+.|+.....      .....+ ......     
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~-~~~~~~-----  232 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLK-IAKSEP-----  232 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHH-HhcCCC-----
Confidence            1222346788999999884     34578899999999999999999998643221      111111 111100     


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      +. ...+.....++.+++.+||+.+|++||++.|+++
T Consensus       233 ~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         233 PT-LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             cc-CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00 0112234457889999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-34  Score=307.73  Aligned_cols=240  Identities=25%  Similarity=0.400  Sum_probs=190.2

Q ss_pred             ceeeccccEEEEEeEecC--------CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          548 NKLGQGGFGIVYKGRLLE--------GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +.||+|+||.||+|....        ...+++|.+........+++.+|+.+++.++|||++++++++......++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            479999999999997643        234888888665555667889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC--------eeEecccce
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT--------PKISDFGMA  691 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~--------~kL~DFGla  691 (862)
                      +++|+|.+++....  ..+++..+++++.||+.||+|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999986443  25889999999999999999999988   999999999999987765        589999988


Q ss_pred             eecCCCCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCC-CCCCCCCCcchhHHHHHHHHHhcCc
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKK-NRGFYHSNNELNLLGHVWRLWKEGK  769 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~  769 (862)
                      .....      .....++..|+|||++.+. .++.++||||||+++|||++|.. |+....   .....    .....  
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~---~~~~~----~~~~~--  220 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD---SQKKL----QFYED--  220 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc---HHHHH----HHHHc--
Confidence            65432      1224578899999999874 57999999999999999999964 432111   11100    01111  


Q ss_pred             eeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          770 VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       770 ~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                              ....+.....++.+++.+||+.+|++||+++++++.|+
T Consensus       221 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 --------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             --------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                    01223334467889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.7e-34  Score=302.43  Aligned_cols=251  Identities=29%  Similarity=0.475  Sum_probs=201.1

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      .+|+..+.||+|+||.||++...++..+|+|++.... ....+|.+|++++++++|||++++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            3577789999999999999988778899999986442 234678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +++|.+++....  ..+++..+..++.|++.+|+|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-  156 (256)
T cd05112          83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-  156 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence            999999885432  34789999999999999999999988   999999999999999999999999999865332211 


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..|+....   ......    ...++.  ..      .
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~----~~~~~~--~~------~  221 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS---NSEVVE----TINAGF--RL------Y  221 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC---HHHHHH----HHhCCC--CC------C
Confidence            1112234678999999998899999999999999999998 888864211   111221    111111  00      1


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLML  814 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  814 (862)
                      .+...+..+.+++.+||+.+|++||++.|+++.|
T Consensus       222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            1122346788999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-33  Score=316.16  Aligned_cols=193  Identities=23%  Similarity=0.282  Sum_probs=164.7

Q ss_pred             HHcccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       539 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ....+|++.+.||+|+||.||+|+... ++.||+|+....      ....|+.++++++||||+++++++......++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            344679999999999999999998765 678999975432      2356999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      |++. ++|.+++...  ...+++..+..|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       137 e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            9995 6888877543  345899999999999999999999998   999999999999999999999999999753221


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCC
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNR  746 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~  746 (862)
                         .......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence               1222356899999999999999999999999999999999976654

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-34  Score=301.38  Aligned_cols=258  Identities=21%  Similarity=0.225  Sum_probs=207.0

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+.++.||.|.-|+||++++.+ +..+|+|++.+..   .....+...|-+||+.++||.++.|++.+...+..+|+|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            457777899999999999999876 4789999997653   445667888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      |||+||+|..+++.+ ..+.+++..+.-++.+|+-||+|||..|   ||.|||||+||||.++|++-|+||.|+......
T Consensus       157 eyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            999999999988544 4566899988899999999999999998   999999999999999999999999997543110


Q ss_pred             --------------------------------C-c---------------------ccccccccccccccChhhhcCCCC
Q 002969          698 --------------------------------Q-T---------------------EQNTKRVVGTYGYMSPEYAMDGLF  723 (862)
Q Consensus       698 --------------------------------~-~---------------------~~~~~~~~gt~~y~APE~l~~~~~  723 (862)
                                                      . .                     .......+||..|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                     011224689999999999999999


Q ss_pred             CccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCC
Q 002969          724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEE  803 (862)
Q Consensus       724 s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~  803 (862)
                      +.++|.|+|||+||||+.|..||-..  +.+..+..-    +.+.       ...... +..+..+.+||++.|.+||.+
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~--~~~~Tl~NI----v~~~-------l~Fp~~-~~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGS--NNKETLRNI----VGQP-------LKFPEE-PEVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCC--CchhhHHHH----hcCC-------CcCCCC-CcchhHHHHHHHHHhccChhh
Confidence            99999999999999999999996432  222222211    1110       011111 255678899999999999999


Q ss_pred             CCC----HHHHHH--HhccC
Q 002969          804 RPT----MASVVL--MLSSE  817 (862)
Q Consensus       804 RPt----~~evl~--~L~~~  817 (862)
                      |..    +.||-+  +++++
T Consensus       379 Rlg~~rGA~eIK~HpFF~gV  398 (459)
T KOG0610|consen  379 RLGSKRGAAEIKRHPFFEGV  398 (459)
T ss_pred             hhccccchHHhhcCccccCC
Confidence            998    888875  34554

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.8e-34  Score=307.36  Aligned_cols=252  Identities=24%  Similarity=0.381  Sum_probs=201.2

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      +|+..+.||+|+||.||+++.. .++.||+|.++.. .....+++.+|+.++++++||||+++++.+...+..++|+||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5778899999999999999876 5889999988654 3334578899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|..++........+++..+..++.||+.||.|||+..  +++|+||||+||+++.++.+||+|||++..+....  
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  157 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--  157 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence            99999998865433346899999999999999999999742  39999999999999999999999999987653221  


Q ss_pred             cccccccccccccChhhhcCC------CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          701 QNTKRVVGTYGYMSPEYAMDG------LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~------~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                        .....++..|+|||.+.+.      .++.++|+|||||++|||++|+.|+.....   ........ ..        .
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~-~~--------~  223 (286)
T cd06622         158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQLS-AI--------V  223 (286)
T ss_pred             --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHHHH-HH--------h
Confidence              1224578899999998554      357899999999999999999999743211   11111111 11        1


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .......+.....++.+++.+||+.+|++||++.+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         224 DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            11112334446678889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.4e-33  Score=307.20  Aligned_cols=260  Identities=25%  Similarity=0.373  Sum_probs=199.1

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCCcc-----chHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQ-----GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      +|+..+.||+|+||.||+|... +++.||||+++.....     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            3677789999999999999875 5889999999755322     345677899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+ +++|.+++....  ..+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999985433  35899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcC-------
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG-------  768 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-------  768 (862)
                      ...  ......++..|+|||.+.+ ..++.++||||||++++||++|.+++...   ..........+.....       
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD---SDIDQLGKIFEALGTPTEENWPG  229 (298)
T ss_pred             CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC---ccHHHHHHHHHHcCCCchhhhhh
Confidence            221  1122345788999998865 46789999999999999999997665322   2222222222111100       


Q ss_pred             --ceeeeecc------cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          769 --KVLEMVDS------SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       769 --~~~~~id~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                        ........      ............+.+++.+||+.+|++||++.||++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence              00000000      0011122345678899999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.5e-33  Score=307.19  Aligned_cols=248  Identities=25%  Similarity=0.402  Sum_probs=203.0

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      .+|+..++||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            57888899999999999999864 58999999997665556678899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++..    ..+++.++..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++.........
T Consensus        99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            99999998843    24788999999999999999999987   999999999999999999999999998765432211


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc-CC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS-VD  779 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~-~~  779 (862)
                        .....+++.|+|||.+.+..++.++||||||+++|++++|+.|+........  .    .        ....... ..
T Consensus       172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~----~--------~~~~~~~~~~  235 (297)
T cd06656         172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--L----Y--------LIATNGTPEL  235 (297)
T ss_pred             --cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--e----e--------eeccCCCCCC
Confidence              2234678899999999998899999999999999999999999743221110  0    0        0000000 01


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..+......+.+++.+||+.+|++||++.+|++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            122334556789999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.1e-34  Score=308.12  Aligned_cols=247  Identities=26%  Similarity=0.401  Sum_probs=200.3

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      .|+..+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|++++++++||||+++++++......++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            46667889999999999998654 7789999986443 345567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++..    ..+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++..+....  
T Consensus        85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06642          85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--  155 (277)
T ss_pred             CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence            99999998843    34889999999999999999999987   9999999999999999999999999997654322  


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      .......++..|+|||.+.+..++.++||||||++++||++|+.|+.......   ..    ......        ....
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~----~~~~~~--------~~~~  220 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VL----FLIPKN--------SPPT  220 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HH----hhhhcC--------CCCC
Confidence            11223457889999999999899999999999999999999999864322111   00    001111        1112


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .....+..+.+++.+||+.+|++||++.+|++.
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            233455678899999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.4e-34  Score=321.16  Aligned_cols=253  Identities=21%  Similarity=0.272  Sum_probs=196.6

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..+.||+|+||.||+++... ++.||+|+++..   .....+.+.+|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            368888999999999999998764 789999999643   2334567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            999999999998543   34889999999999999999999998   999999999999999999999999998754321


Q ss_pred             Ccc---------------------------------cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCC
Q 002969          698 QTE---------------------------------QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKK  744 (862)
Q Consensus       698 ~~~---------------------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~  744 (862)
                      ...                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 00113479999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 002969          745 NRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPT---MASVVLM  813 (862)
Q Consensus       745 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~  813 (862)
                      ||.....   ......    .........+.+     ......++.+++.+++. +|++|++   +.|+++.
T Consensus       235 Pf~~~~~---~~~~~~----i~~~~~~~~~p~-----~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         235 PFCSETP---QETYRK----VMNWKETLVFPP-----EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCH---HHHHHH----HHcCCCceecCC-----CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            9753221   111111    111110000000     11234567788888764 9999985   6777653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=6.7e-34  Score=305.18  Aligned_cols=255  Identities=24%  Similarity=0.334  Sum_probs=202.5

Q ss_pred             ccccccceeeccccEEEEEeEecCC----cEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEG----QEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ++|...++||+|+||.||+|...+.    ..|+||+..... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4577789999999999999986442    468999886654 4456789999999999999999999998875 567899


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++++|.+++....  ..+++..++.++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            99999999999995432  34899999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ..... .....++..|+|||.+....++.++||||||++++|+++ |..|+.....   ......    ...+..     
T Consensus       160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~----~~~~~~-----  226 (270)
T cd05056         160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---NDVIGR----IENGER-----  226 (270)
T ss_pred             cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHH----HHcCCc-----
Confidence            32211 112234568999999988889999999999999999986 9988643221   111111    111111     


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                         ...+...+..+.+++.+|+..+|++||++.+++..|+++.
T Consensus       227 ---~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         227 ---LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               1123344567889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=8.8e-34  Score=303.98  Aligned_cols=254  Identities=28%  Similarity=0.416  Sum_probs=200.6

Q ss_pred             cccccceeeccccEEEEEeEecC--CcEEEEEEeccC----------CccchHHHHHHHHHHHh-cccCCceEEEEEEEe
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRN----------SGQGIEEFKNEVRLIAK-LQHRNLVRLLGCCVE  609 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~HpnIv~l~g~~~~  609 (862)
                      +|+..+.||+|+||.||+|....  ++.+|+|.+...          ......++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            36778899999999999998765  678999987532          22234567788888875 699999999999999


Q ss_pred             CCceEEEEEeccCCChhhhhhhc-cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecc
Q 002969          610 MDEKMLVYEYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDF  688 (862)
Q Consensus       610 ~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF  688 (862)
                      .+..+++|||+++++|.+++... .....+++..+++++.|++.||.|||+..  +++|+||+|+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999988542 23446899999999999999999999632  3999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcC
Q 002969          689 GMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG  768 (862)
Q Consensus       689 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  768 (862)
                      |++.......   ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...   ......    ....++
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~---~~~~~~----~~~~~~  228 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST---NMLSLA----TKIVEA  228 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc---CHHHHH----HHHhhc
Confidence            9998754332   223456889999999999988999999999999999999999986422   111111    111111


Q ss_pred             ceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          769 KVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       769 ~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      ...    +   .........+.+++.+||+.||++||++.||..+++
T Consensus       229 ~~~----~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 VYE----P---LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cCC----c---CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            110    0   011123467889999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-33  Score=305.54  Aligned_cols=255  Identities=25%  Similarity=0.384  Sum_probs=202.9

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ++|+..++||+|+||+||++.... ++.||+|++.... ....+++.+|+++++.++||||+++++++......++|+||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            467788999999999999998754 7889999886543 34467899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|.+++...   ..+++..+..++.+++.+|.|||+..  +++||||||+||++++++.++|+|||++......  
T Consensus        85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--  157 (284)
T cd06620          85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--  157 (284)
T ss_pred             CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence            9999999988543   34889999999999999999999742  3999999999999999999999999998754221  


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc-----chhHHHHHHHHHhcCceeeee
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN-----ELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~-----~~~l~~~~~~~~~~~~~~~~i  774 (862)
                        ......|+..|+|||.+.+..++.++|||||||++|||++|+.|+.......     .............+       
T Consensus       158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  228 (284)
T cd06620         158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-------  228 (284)
T ss_pred             --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-------
Confidence              1223568999999999988899999999999999999999999976433211     11111111111111       


Q ss_pred             cccCCCCC-hHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 002969          775 DSSVDNYP-ANEVLRCIHVGLLCVQENAEERPTMASVVLML  814 (862)
Q Consensus       775 d~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  814 (862)
                        .....+ ...+..+.+++.+|++.+|++||++.||+++.
T Consensus       229 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         229 --PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             --cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence              011111 12456788999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.3e-33  Score=310.52  Aligned_cols=260  Identities=21%  Similarity=0.328  Sum_probs=187.7

Q ss_pred             cceeeccccEEEEEeEec---CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEe--CCceEEEEEecc
Q 002969          547 YNKLGQGGFGIVYKGRLL---EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE--MDEKMLVYEYME  621 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~  621 (862)
                      .++||+|+||.||+|+..   .++.+|+|++....  ....+.+|+.++++++||||+++++++..  ....++++||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            368999999999999865   35789999986432  23457889999999999999999998864  345789999986


Q ss_pred             CCChhhhhhhcc------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe----cCCCCeeEecccce
Q 002969          622 NRSLDSVIFDKA------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL----DKEMTPKISDFGMA  691 (862)
Q Consensus       622 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kL~DFGla  691 (862)
                      + +|.+++....      +...+++..+..++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            4 7877764321      1234888999999999999999999998   9999999999999    45679999999999


Q ss_pred             eecCCCCc-ccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcc------hhHHHHHHH
Q 002969          692 RIFGGDQT-EQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE------LNLLGHVWR  763 (862)
Q Consensus       692 ~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~------~~l~~~~~~  763 (862)
                      +.+..... ........+|+.|+|||++.+. .++.++||||+||++|||++|++|+.....+..      ...+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            87643322 1222345789999999999774 589999999999999999999999753222110      111111111


Q ss_pred             HHhcCc---------------eeeeecc----------cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          764 LWKEGK---------------VLEMVDS----------SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       764 ~~~~~~---------------~~~~id~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ......               ..+....          ............+.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence            110000               0000000          000000112245779999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.7e-33  Score=315.89  Aligned_cols=259  Identities=23%  Similarity=0.301  Sum_probs=195.7

Q ss_pred             HcccccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeC------
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM------  610 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~------  610 (862)
                      ..++|+..++||+|+||.||++... .++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3468999999999999999999865 4788999999754  233456788999999999999999999987543      


Q ss_pred             CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccc
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  690 (862)
                      ...++||||+++ +|...+..     .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999975 66666532     3788889999999999999999998   99999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHh----
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK----  766 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~----  766 (862)
                      ++......   ......+|..|+|||++.+..++.++|||||||++|||++|+.||.....   ......+.+...    
T Consensus       173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~  246 (364)
T cd07875         173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTPCP  246 (364)
T ss_pred             ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence            98653221   22234689999999999999999999999999999999999999753221   111111111000    


Q ss_pred             --------------cCce-e------eeecccC----CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          767 --------------EGKV-L------EMVDSSV----DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       767 --------------~~~~-~------~~id~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                                    +.+. .      +......    ..........+.+++.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                          0000 0      0000000    01111223567899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.3e-33  Score=310.85  Aligned_cols=255  Identities=19%  Similarity=0.235  Sum_probs=196.3

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..++||+|+||.||+++... ++.+|+|++.+.   .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            368888999999999999998765 678999998642   2233456889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++|+|.+++....  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999999996432  34888899999999999999999988   999999999999999999999999999765332


Q ss_pred             CcccccccccccccccChhhhc-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAM-----DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      .. .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...   +......   ......... 
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~---~~~~~~~---~i~~~~~~~-  227 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYG---KIMNHKERF-  227 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC---CHHHHHH---HHhCCCccc-
Confidence            21 1222357899999999986     346889999999999999999999997432   1111111   111111000 


Q ss_pred             eecccCCCCChHHHHHHHHHHHhccccCCC--CCCCHHHHHHH
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQENAE--ERPTMASVVLM  813 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPt~~evl~~  813 (862)
                          .........+.++.+++.+|+..+++  .||++.|+++.
T Consensus       228 ----~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 ----QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ----cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                01111223456778888888865444  47899999875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-33  Score=308.09  Aligned_cols=249  Identities=24%  Similarity=0.398  Sum_probs=203.0

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      .+|+..++||.|++|.||+|... +++.|++|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46888899999999999999764 58899999997665556678899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++..    ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++..+..... 
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence            99999998843    24899999999999999999999998   99999999999999999999999999876543222 


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                       ......++..|+|||.+.+..++.++|||||||++|||++|+.|+.......      ........ ...      ...
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~~~-~~~------~~~  236 (296)
T cd06655         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATN-GTP------ELQ  236 (296)
T ss_pred             -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhc-CCc------ccC
Confidence             1223467889999999998889999999999999999999999964322111      11111111 000      011


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .+...+..+.+++.+||+.+|++||++.+|++
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            22334556889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.4e-34  Score=310.15  Aligned_cols=260  Identities=22%  Similarity=0.331  Sum_probs=198.0

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ++|+..++||+|+||.||+|+.. .++.||+|.++... ......+.+|+.++++++||||+++++++...+..++|+||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888899999999999999875 47889999986543 33345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      ++ ++|.+++...  ...+++..+..++.||++||+|||+.+   ++|+||||+|||+++++.+||+|||++........
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 5888887543  234788999999999999999999988   99999999999999999999999999976432211


Q ss_pred             ccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhc-----------
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE-----------  767 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-----------  767 (862)
                        ......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+.....   ......+...+..           
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV---EEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCChhhchhhhc
Confidence              11223568899999988764 578899999999999999999998753322   1222222111110           


Q ss_pred             Cceeeeec-cc-----CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          768 GKVLEMVD-SS-----VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       768 ~~~~~~id-~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .......+ +.     ........+..+.+|+.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000000 00     00111233456789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.3e-34  Score=304.81  Aligned_cols=257  Identities=26%  Similarity=0.405  Sum_probs=203.4

Q ss_pred             ccccccceeeccccEEEEEeEecC------CcEEEEEEeccCCcc-chHHHHHHHHHHHhcccCCceEEEEEEEeCCceE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  614 (862)
                      ++|+..+.||+|+||.||+|+...      .+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            468888999999999999998642      457999988654433 4678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhccCC------CCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecc
Q 002969          615 LVYEYMENRSLDSVIFDKARS------SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDF  688 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF  688 (862)
                      +||||+++++|.+++......      ..+++..+..++.||++||+|||+.+   |+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999654322      25899999999999999999999998   999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhc
Q 002969          689 GMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKE  767 (862)
Q Consensus       689 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  767 (862)
                      |++....... ........++..|+|||.+.+...+.++||||||++++||++ |..|+....   ....+    .....
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~---~~~~~----~~~~~  233 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS---DEEVL----NRLQA  233 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc---hHHHH----HHHHc
Confidence            9987543221 112223356778999999988889999999999999999999 666753211   11111    11111


Q ss_pred             CceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          768 GKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       768 ~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      +...       ...+...+..+.+++.+||+.+|++||++.|++..|.+
T Consensus       234 ~~~~-------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         234 GKLE-------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             CCcC-------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            1111       11122345678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=311.88  Aligned_cols=255  Identities=21%  Similarity=0.249  Sum_probs=196.1

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|++.+.||+|+||.||+++... ++.||+|++.+.   .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            468889999999999999998764 889999998642   2334567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            999999999998542  234888999999999999999999998   999999999999999999999999999765432


Q ss_pred             CcccccccccccccccChhhhcC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMD-----GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      ... ......||+.|+|||++..     ..++.++|||||||++|||++|+.|+...   ........+   ........
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~---~~~~~~~~i---~~~~~~~~  228 (331)
T cd05597         156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKI---MNHKEHFQ  228 (331)
T ss_pred             CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC---CHHHHHHHH---HcCCCccc
Confidence            221 1222468999999999863     45788999999999999999999997432   111111111   11111000


Q ss_pred             eecccCCCCChHHHHHHHHHHHhcccc--CCCCCCCHHHHHHH
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQE--NAEERPTMASVVLM  813 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPt~~evl~~  813 (862)
                           ........+..+.+++.+|+..  ++..||++.++++.
T Consensus       229 -----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         229 -----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             -----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                 1111122455677888887754  44448899999875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.6e-33  Score=303.65  Aligned_cols=247  Identities=24%  Similarity=0.389  Sum_probs=202.6

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      .|+..++||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            56777899999999999998754 7889999987543 345678999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++..    ..+++.+...++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||++..+..... 
T Consensus        85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06640          85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence            99999998843    24788899999999999999999987   99999999999999999999999999987643221 


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                       ......++..|+|||++.+..++.++||||||+++|||++|+.|+.......   ..    .....        .....
T Consensus       157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~----~~~~~--------~~~~~  220 (277)
T cd06640         157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VL----FLIPK--------NNPPT  220 (277)
T ss_pred             -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hh----hhhhc--------CCCCC
Confidence             2223467889999999998889999999999999999999999865322111   00    00000        11123


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .....+..+.+++.+||+.+|++||++.++++.
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            344567788899999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.6e-34  Score=301.22  Aligned_cols=250  Identities=25%  Similarity=0.385  Sum_probs=202.4

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +|+..++||+|+||.+|+++.. +++.||+|++...  .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4778899999999999999765 4789999998643  233456889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|.+++.... ...+++.++++++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            99999999885432 234788999999999999999999987   99999999999999999999999999987643221


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                        ......|++.|+|||++.+..++.++||||||++++||++|+.|+...   +.......   . ..+        ...
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~---~-~~~--------~~~  219 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLVLK---I-IRG--------SYP  219 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC---CHHHHHHH---H-hcC--------CCC
Confidence              122345788999999999999999999999999999999999986421   11111111   1 111        111


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ..+.....++.+++.+||+.+|++||++.+|++.
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            2233456678899999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-33  Score=300.84  Aligned_cols=250  Identities=24%  Similarity=0.358  Sum_probs=200.9

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEe-CCceEEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE-MDEKMLVYE  618 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~lV~E  618 (862)
                      +|+..+.||+|++|.||+++... ++.+|+|++....  ....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            47788999999999999998754 6889999986542  3445678999999999999999999988764 345789999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++++|.+++.... ...+++.++..++.+++.||++||+.+   ++||||||+||+++.++.++|+|||++..+....
T Consensus        81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            999999999986532 345899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                      .  ......+++.|+|||++.+..++.++||||||++++||++|+.|+....   ...   .... ...+.        +
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~---~~~---~~~~-~~~~~--------~  219 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD---MNS---LVYR-IIEGK--------L  219 (257)
T ss_pred             C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHH---HHHH-HHhcC--------C
Confidence            1  2233567899999999999999999999999999999999999864211   111   1111 11111        1


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ...+......+.+++.+|++.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            12234455678899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.9e-33  Score=301.65  Aligned_cols=254  Identities=24%  Similarity=0.363  Sum_probs=189.6

Q ss_pred             ceeeccccEEEEEeEecCCc---EEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCC
Q 002969          548 NKLGQGGFGIVYKGRLLEGQ---EIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR  623 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~~~---~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g  623 (862)
                      ++||+|+||.||+|+..++.   .+++|.+.... ....+.|.+|+.+++.++||||+++++.+......++||||++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            36999999999999765433   46677765443 334678999999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccC-CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          624 SLDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       624 sL~~~l~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      +|.+++..... ...+++..+..++.||++||+|||+.+   ++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999965322 234667778899999999999999987   99999999999999999999999999864322211122


Q ss_pred             cccccccccccChhhhcC-------CCCCccccchhHHHHHHHHHhC-CCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          703 TKRVVGTYGYMSPEYAMD-------GLFSVKSDVFSFGVLLLETVSG-KKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~-------~~~s~ksDVwSlGvil~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      .....++..|+|||++..       ..++.++||||||+++|||+++ ..|+..   ......+..+   ..+ ......
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~---~~~~~~~~~~---~~~-~~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH---LSDREVLNHV---IKD-QQVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHH---Hhh-cccccC
Confidence            223567889999998753       2457899999999999999985 445422   1222222222   111 112222


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      ++.+   .......+.+++..|| .+|++||+++||++.|.
T Consensus       231 ~~~~---~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQL---ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCcc---CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2222   2224456778889999 57999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=9.3e-34  Score=306.63  Aligned_cols=261  Identities=25%  Similarity=0.347  Sum_probs=201.1

Q ss_pred             hHHHHHHcccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEE---
Q 002969          534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCV---  608 (862)
Q Consensus       534 ~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~---  608 (862)
                      ++.+..+.++|+..+.||+|+||.||+++... ++.+|+|++.... ...+++.+|+.+++++ +||||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            34455577899999999999999999998754 7889999875432 2346788999999999 6999999999884   


Q ss_pred             --eCCceEEEEEeccCCChhhhhhhc-cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeE
Q 002969          609 --EMDEKMLVYEYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (862)
Q Consensus       609 --~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL  685 (862)
                        .++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence              345689999999999999987543 23345888999999999999999999987   999999999999999999999


Q ss_pred             ecccceeecCCCCcccccccccccccccChhhhcC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHH
Q 002969          686 SDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD-----GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGH  760 (862)
Q Consensus       686 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~  760 (862)
                      +|||+++.+.....  ......|+..|+|||++..     ..++.++|||||||++|||++|+.|+......      ..
T Consensus       166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~------~~  237 (286)
T cd06638         166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM------RA  237 (286)
T ss_pred             ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh------HH
Confidence            99999987643221  2223468999999998753     45788999999999999999999997532211      11


Q ss_pred             HHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          761 VWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       761 ~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ... .....     .... ..+......+.+++.+||+.+|++||++.||++.
T Consensus       238 ~~~-~~~~~-----~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         238 LFK-IPRNP-----PPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             Hhh-ccccC-----CCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            100 00000     0000 1112234568899999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.1e-33  Score=305.85  Aligned_cols=260  Identities=23%  Similarity=0.355  Sum_probs=199.3

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ++|+..++||+|+||.||+|+... ++.||+|++....  ....+.+.+|+.++++++|+|++++++++......++|+|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            368888999999999999998764 8899999986542  2234568899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++++|..++...   ..+++..+..++.||++||+|||+.+   ++||||||+||+++.++.+||+|||++..+....
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            99999888876432   34899999999999999999999987   9999999999999999999999999998764332


Q ss_pred             cccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhc----------
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE----------  767 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----------  767 (862)
                      .  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+......+.   .........+          
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQIFS  229 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChHHhhhcc
Confidence            1  1223457889999999876 5678999999999999999999998753322111   1111111000          


Q ss_pred             -Ccee-eeecccCC------CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          768 -GKVL-EMVDSSVD------NYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       768 -~~~~-~~id~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       .... ....+...      ......+..+.+++.+||+.+|++||++.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence             0000 00000000      001123567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-34  Score=306.15  Aligned_cols=253  Identities=25%  Similarity=0.378  Sum_probs=203.2

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      .++|++.++||.|+||.||+++.. +++.+|+|++........+.|.+|++++++++||||+++++.+......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            456888899999999999999875 4789999999776666677899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|.+++....  ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (280)
T cd06611          84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-  157 (280)
T ss_pred             cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence            99999999985432  35899999999999999999999998   9999999999999999999999999987653221 


Q ss_pred             ccccccccccccccChhhhc-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          700 EQNTKRVVGTYGYMSPEYAM-----DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                       .......++..|+|||.+.     ...++.++||||||+++|||++|+.|+.....      ..... .......    
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~------~~~~~-~~~~~~~----  225 (280)
T cd06611         158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP------MRVLL-KILKSEP----  225 (280)
T ss_pred             -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH------HHHHH-HHhcCCC----
Confidence             1222356889999999975     34577899999999999999999999643211      11111 1111110    


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                       +. ...+...+.++.+++.+||+.+|++||++.+|++.
T Consensus       226 -~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 -PT-LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -CC-cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence             00 11122345578899999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.9e-34  Score=304.47  Aligned_cols=256  Identities=25%  Similarity=0.379  Sum_probs=199.3

Q ss_pred             ccccceeeccccEEEEEeEec----CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCC------
Q 002969          544 FTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD------  611 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~------  611 (862)
                      |++.+.||+|+||.||+|.+.    .++.||||++...  .....+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456789999999999999753    2678999998654  2345678899999999999999999999886543      


Q ss_pred             ceEEEEEeccCCChhhhhhhcc---CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecc
Q 002969          612 EKMLVYEYMENRSLDSVIFDKA---RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDF  688 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF  688 (862)
                      ..++++||+++++|..++....   ....+++....+++.||+.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2478999999999998875321   2234788999999999999999999987   999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhc
Q 002969          689 GMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKE  767 (862)
Q Consensus       689 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  767 (862)
                      |+++...............+++.|++||.+....++.++||||||+++|||++ |+.|+...   ....+...    ...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~---~~~~~~~~----~~~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV---ENSEIYNY----LIK  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC---CHHHHHHH----HHc
Confidence            99987643322222222345678999999999999999999999999999999 77775422   11122221    111


Q ss_pred             CceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          768 GKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       768 ~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ...        ...+...+..+.+++.+|++.+|++||++.|+++.|+++
T Consensus       231 ~~~--------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNR--------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111        111233456888999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.4e-33  Score=315.65  Aligned_cols=259  Identities=24%  Similarity=0.291  Sum_probs=195.6

Q ss_pred             HcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeC------
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM------  610 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~------  610 (862)
                      ..++|+..+.||+|+||.||++... .++.||||++....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3468999999999999999999765 47889999997542  33456788999999999999999999988643      


Q ss_pred             CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccc
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  690 (862)
                      ...++||||+++ +|...+..     .+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence            346999999975 56555522     3788889999999999999999998   99999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH-----
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW-----  765 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~-----  765 (862)
                      ++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||....   .........+..     
T Consensus       166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~~  239 (355)
T cd07874         166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD---YIDQWNKVIEQLGTPCP  239 (355)
T ss_pred             cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCH
Confidence            98653221   1223568999999999999999999999999999999999999975322   111111111100     


Q ss_pred             -------------hcCc-e-e-----eeecccC----CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          766 -------------KEGK-V-L-----EMVDSSV----DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       766 -------------~~~~-~-~-----~~id~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                                   .+.. . .     +......    ..........+.+++.+||+.||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                         0000 0 0     0000000    01112234567899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=9.8e-34  Score=309.62  Aligned_cols=255  Identities=30%  Similarity=0.472  Sum_probs=200.3

Q ss_pred             ccccccceeeccccEEEEEeEecC-Cc----EEEEEEeccCCc-cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ----EIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ++|+..+.||+|+||.||+|+... ++    .||+|++..... ....++.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCcee
Confidence            467788999999999999998643 43    478898865432 334578899999999999999999999875 45679


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ++||+++|+|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            99999999999998543  234788999999999999999999987   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....   ..    .......+..    
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~----~~~~~~~~~~----  229 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---RE----IPDLLEKGER----  229 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HH----HHHHHHCCCC----
Confidence            3332222223345778999999999999999999999999999997 8888643211   11    1111211111    


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                          ...+......+.+++..||..+|++||++.++++.|+.+
T Consensus       230 ----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         230 ----LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                011223456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=311.00  Aligned_cols=252  Identities=26%  Similarity=0.331  Sum_probs=211.4

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCc---cchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCceE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~  614 (862)
                      ..+.|+..+.||+|.||.||+++... |+.+|+|.+.+...   ...+.+.+|+.+|+++. |||||.+.+.+......+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34578888999999999999998876 89999999976533   34578999999999998 999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC----CCeeEecccc
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE----MTPKISDFGM  690 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kL~DFGl  690 (862)
                      +|||++.||.|.+.+...   . +++.....++.||++++.|||+.+   |+||||||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999999765   2 899999999999999999999988   9999999999999533    5799999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV  770 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  770 (862)
                      +.....   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.......  ...     .+..+..
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--~~~-----~i~~~~~  255 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE--IFL-----AILRGDF  255 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH--HHH-----HHHcCCC
Confidence            998754   344556899999999999999999999999999999999999999964322211  111     1222221


Q ss_pred             eeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          771 LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       771 ~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                           .............+.+++..|+..||..|+++.++++.
T Consensus       256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                 11134455567788899999999999999999999984

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2e-33  Score=311.11  Aligned_cols=255  Identities=19%  Similarity=0.230  Sum_probs=197.0

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..++||+|+||.||+++... ++.||+|++.+.   .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            468889999999999999998764 778999998642   2233456888999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++|+|.+++....  ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999996432  35888899999999999999999988   999999999999999999999999999876433


Q ss_pred             CcccccccccccccccChhhhcC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMD-----GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      ... ......|++.|+|||++.+     ..++.++||||||+++|||++|+.|+....   .......   ........ 
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~---i~~~~~~~-  227 (331)
T cd05624         156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGK---IMNHEERF-  227 (331)
T ss_pred             Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC---HHHHHHH---HHcCCCcc-
Confidence            221 1223568999999999876     467889999999999999999999974321   1111111   11111100 


Q ss_pred             eecccCCCCChHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQENAEE--RPTMASVVLM  813 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  813 (862)
                          .........+.++.+++.+|+..++++  |++++++++.
T Consensus       228 ----~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         228 ----QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ----cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence                011111234567888999988865544  5688888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.5e-33  Score=299.51  Aligned_cols=256  Identities=26%  Similarity=0.411  Sum_probs=205.6

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ++|+..+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+++++.++|+|++++++.+...+..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888899999999999999865 47889999986543 33567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|.+++........+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999966544456899999999999999999999988   99999999999999999999999999877644322


Q ss_pred             cc--ccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          700 EQ--NTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       700 ~~--~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ..  ......++..|+|||++... .++.++|+||||++++||++|+.|+.......   .   ..+.....      ..
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~---~~~~~~~~------~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---V---LMLTLQND------PP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---h---HHHHhcCC------CC
Confidence            21  22334688999999999877 78999999999999999999999975322211   1   11111110      11


Q ss_pred             cCCCC--ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          777 SVDNY--PANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       777 ~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .....  ....+..+.+++.+||+.+|++||++.+|++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            11111  1234567889999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.7e-33  Score=297.65  Aligned_cols=247  Identities=28%  Similarity=0.422  Sum_probs=201.2

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-----ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-----GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      +|+..+.||+|+||.||+|... +++.|++|.+....     .+..+.+.+|+.+++.++|+||+++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3667789999999999999876 68899999886543     23456899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      +||+++++|.+++...   ..+++..+..++.||++||+|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999998543   34889999999999999999999998   99999999999999999999999999887543


Q ss_pred             CCcccccccccccccccChhhhcCCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ..   ......++..|+|||.+.... ++.++|+||||+++|||++|+.|+.....      ...........       
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~-------  218 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSK-------  218 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcc-------
Confidence            32   223356788999999988776 89999999999999999999999753221      11111111100       


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       .....+......+.+++.+||+.+|++||++.+++.
T Consensus       219 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         219 -ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence             112223344567889999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2e-33  Score=298.41  Aligned_cols=251  Identities=38%  Similarity=0.546  Sum_probs=201.2

Q ss_pred             ccccceeeccccEEEEEeEecC-----CcEEEEEEeccCCcc-chHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          544 FTDYNKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      |++.+.||.|+||.||+++..+     +..||+|++...... ..+.+..|+++++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3456899999999999998765     378999999765433 5778999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++..... ..+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999865332 12899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ...... ...+++.|+|||.+.+..++.++||||||++++||++ |..|+..   ........    ....+..      
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~---~~~~~~~~----~~~~~~~------  222 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG---MSNEEVLE----YLKKGYR------  222 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC---CCHHHHHH----HHhcCCC------
Confidence            222111 2236789999999988889999999999999999998 6666532   11111111    1121111      


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML  814 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  814 (862)
                        ...+...+.++.+++.+|+..+|++||++.|+++.|
T Consensus       223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              111223566788999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.7e-34  Score=308.00  Aligned_cols=248  Identities=24%  Similarity=0.374  Sum_probs=199.0

Q ss_pred             ccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          544 FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      |.....||+|+||.||++... .++.||||++........+.+.+|+.++++++|+||+++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            344468999999999999875 4789999998765555667899999999999999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      ++|.+++..    ..+++.++..++.||+.||+|||+.+   |+||||||+||++++++.+||+|||++..+.....  .
T Consensus       104 ~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~  174 (292)
T cd06658         104 GALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K  174 (292)
T ss_pred             CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence            999998743    24789999999999999999999997   99999999999999999999999999876533221  1


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP  782 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~  782 (862)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...   ........    ...     ....... ..
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~---~~~~~~~~----~~~-----~~~~~~~-~~  241 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE---PPLQAMRR----IRD-----NLPPRVK-DS  241 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHH----HHh-----cCCCccc-cc
Confidence            22356889999999999889999999999999999999999996421   11111111    111     0111111 11


Q ss_pred             hHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          783 ANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       783 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ......+.+++.+|++.+|++||+++|+++.
T Consensus       242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1234567789999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-33  Score=336.29  Aligned_cols=254  Identities=24%  Similarity=0.325  Sum_probs=197.6

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeC--CceEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKML  615 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~l  615 (862)
                      .++|++.++||+|+||.||+++... ++.+|+|.+...  .......|..|+.++++++||||+++++++...  ...++
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            4579999999999999999998765 667899988643  233456789999999999999999999988653  56899


Q ss_pred             EEEeccCCChhhhhhhcc-CCCCCCHhhHHHHHHHHHHHhHHhhhcCC----CcEEecccCCcceEecC-----------
Q 002969          616 VYEYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSR----FRIIHRDLKASNILLDK-----------  679 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~----~~ivHrDlkp~NILl~~-----------  679 (862)
                      ||||+++++|.++|.... ....+++..++.|+.||+.||+|||+.+.    .+||||||||+||||+.           
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            999999999999986532 23468999999999999999999998542    24999999999999964           


Q ss_pred             ------CCCeeEecccceeecCCCCcccccccccccccccChhhhcC--CCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 002969          680 ------EMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD--GLFSVKSDVFSFGVLLLETVSGKKNRGFYHS  751 (862)
Q Consensus       680 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~  751 (862)
                            ...+||+|||++..+....   ......||+.|+|||++.+  ..++.++||||||||||||++|+.||.... 
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~-  247 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN-  247 (1021)
T ss_pred             ccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC-
Confidence                  2358999999998653322   1223578999999999864  458899999999999999999999974321 


Q ss_pred             CcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          752 NNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       752 ~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       .    ...+...+....         .......+.++.+|+..||+.+|++||++.|++.
T Consensus       248 -~----~~qli~~lk~~p---------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 -N----FSQLISELKRGP---------DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             -c----HHHHHHHHhcCC---------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence             1    111222222111         0011223567889999999999999999999984

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.6e-34  Score=328.73  Aligned_cols=265  Identities=20%  Similarity=0.236  Sum_probs=192.1

Q ss_pred             HHHHHHcccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccC------CceEEEEEE
Q 002969          535 ETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR------NLVRLLGCC  607 (862)
Q Consensus       535 ~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hp------nIv~l~g~~  607 (862)
                      +++...+++|++.++||+|+||.||+|.... ++.||||+++... ...+.+..|+.+++.++|.      +++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            4444566889999999999999999998754 7789999996432 2344567788888887654      588898888


Q ss_pred             EeC-CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc-CCCcEEecccCCcceEecCCC----
Q 002969          608 VEM-DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEM----  681 (862)
Q Consensus       608 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivHrDlkp~NILl~~~~----  681 (862)
                      ... .+.++|||++ +++|.+++...   ..+++..+..|+.||+.||+|||++ +   |+||||||+|||++.++    
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence            754 4678899988 67888887543   3489999999999999999999974 6   99999999999998765    


Q ss_pred             ------------CeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 002969          682 ------------TPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFY  749 (862)
Q Consensus       682 ------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~  749 (862)
                                  .+||+|||++....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                        49999999875421     1223467899999999999999999999999999999999999997543


Q ss_pred             CCCcchhHHHHHH-----------------HHHhcC-ceeeeeccc----C-C---CCChHHHHHHHHHHHhccccCCCC
Q 002969          750 HSNNELNLLGHVW-----------------RLWKEG-KVLEMVDSS----V-D---NYPANEVLRCIHVGLLCVQENAEE  803 (862)
Q Consensus       750 ~~~~~~~l~~~~~-----------------~~~~~~-~~~~~id~~----~-~---~~~~~~~~~l~~li~~cl~~dP~~  803 (862)
                      ...+....+....                 ..+... ......++.    + .   .........+.+|+.+||+.||++
T Consensus       349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence            2211111111100                 000000 000000000    0 0   000012345779999999999999


Q ss_pred             CCCHHHHHH
Q 002969          804 RPTMASVVL  812 (862)
Q Consensus       804 RPt~~evl~  812 (862)
                      |||++|+++
T Consensus       429 R~ta~e~L~  437 (467)
T PTZ00284        429 RLNARQMTT  437 (467)
T ss_pred             CCCHHHHhc
Confidence            999999996

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-35  Score=287.80  Aligned_cols=249  Identities=26%  Similarity=0.357  Sum_probs=201.7

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++.|+..++||+|.|+.||+.... .|+.+|+|++...  +....+++.+|+++-+.|+||||++|.....+....|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            356777789999999999998654 4888999887533  3446788999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC---CCCeeEecccceeec
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---EMTPKISDFGMARIF  694 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DFGla~~~  694 (862)
                      |+|+|++|..-+..+   ...++...-..+.||+++|.|.|.++   |||||+||+|+||.+   ..-+||+|||+|..+
T Consensus        90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999999997766443   34777888889999999999999998   999999999999953   346899999999987


Q ss_pred             CCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          695 GGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       695 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      .   .........|||+|||||++...+|+..+|||+-|||||-|+.|.+||..   ++...+++.+    ..+..    
T Consensus       164 ~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rlye~I----~~g~y----  229 (355)
T KOG0033|consen  164 N---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYEQI----KAGAY----  229 (355)
T ss_pred             C---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHH----hcccc----
Confidence            6   23333456899999999999999999999999999999999999999642   1222233322    22211    


Q ss_pred             cccC-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 002969          775 DSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVV  811 (862)
Q Consensus       775 d~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  811 (862)
                        .+ ........++..+|+.+||..||.+|.|+.|.+
T Consensus       230 --d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL  265 (355)
T KOG0033|consen  230 --DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL  265 (355)
T ss_pred             --CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence              11 123345567888999999999999999999876

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.1e-33  Score=307.38  Aligned_cols=259  Identities=21%  Similarity=0.328  Sum_probs=186.9

Q ss_pred             ceeeccccEEEEEeEecC---CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEe--CCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLLE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE--MDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~~  622 (862)
                      ++||+|+||.||+|+..+   +..||+|++....  ....+.+|+.++++++||||+++++++..  ....++|+||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            689999999999998654   4689999986542  23467899999999999999999999854  4567899999875


Q ss_pred             CChhhhhhhc------cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe----cCCCCeeEeccccee
Q 002969          623 RSLDSVIFDK------ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL----DKEMTPKISDFGMAR  692 (862)
Q Consensus       623 gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kL~DFGla~  692 (862)
                       +|.+++...      .....+++..+..++.||++||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             676666321      12235888899999999999999999998   9999999999999    566799999999998


Q ss_pred             ecCCCCcc-cccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcc------hhHHHHHHHH
Q 002969          693 IFGGDQTE-QNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE------LNLLGHVWRL  764 (862)
Q Consensus       693 ~~~~~~~~-~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~------~~l~~~~~~~  764 (862)
                      .+...... .......+|+.|+|||++.+. .++.++|||||||++|||++|++|+.....+..      ..........
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            76433221 222345789999999998764 589999999999999999999999753221110      0111111111


Q ss_pred             Hh-----------cCc-eeeee---c----------ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          765 WK-----------EGK-VLEMV---D----------SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       765 ~~-----------~~~-~~~~i---d----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      +.           ... .....   .          .............+.+|+.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence            00           000 00000   0          0000111122345778999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.6e-33  Score=299.38  Aligned_cols=247  Identities=28%  Similarity=0.424  Sum_probs=198.4

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      ++|+..+.||+|+||.||++.. .++.||+|+++...  ..+.+.+|+.++++++|||++++++++.. +..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence            4578889999999999999975 67889999986432  34678999999999999999999999865 45799999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +++|.+++.... ...+++..++.++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++.......   
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            999999986543 335889999999999999999999987   9999999999999999999999999987643211   


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                        .....+..|+|||.+.+..++.++|+||||+++|||++ |+.|+.....   ...    ......+..        ..
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~----~~~~~~~~~--------~~  217 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---KEV----KECVEKGYR--------ME  217 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---HHH----HHHHhCCCC--------CC
Confidence              11234568999999998899999999999999999998 8888643211   111    112221111        11


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      .+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            123345678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.4e-33  Score=299.09  Aligned_cols=250  Identities=26%  Similarity=0.412  Sum_probs=194.6

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC-----ccchHHHHHHHHHHHhcccCCceEEEEEEEeC--Cce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-----GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~  613 (862)
                      .+|+..+.||+|+||.||+|.... +..|++|++....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            368888999999999999998754 8899999886432     22345788999999999999999999998753  567


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++++||+++++|.+++...   ..+++.....++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            8999999999999998543   24788999999999999999999987   99999999999999999999999999986


Q ss_pred             cCCCCc-ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          694 FGGDQT-EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       694 ~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      +..... ........++..|+|||++.+..++.++||||||+++|||++|+.|+.....      ...+.......    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~----  225 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQP----  225 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCC----
Confidence            533211 1112234578899999999998899999999999999999999999753211      11111111110    


Q ss_pred             eecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                          .....+......+..++ .||..+|++||+++||++
T Consensus       226 ----~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 ----TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ----CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                01122333344555666 688889999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.4e-33  Score=299.92  Aligned_cols=255  Identities=24%  Similarity=0.370  Sum_probs=198.9

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc----------cchHHHHHHHHHHHhcccCCceEEEEEEEeCC
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG----------QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD  611 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  611 (862)
                      +|...+.||+|+||.||+|... +++.+|+|.++....          ...+.+.+|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4667789999999999999764 588999998853211          12356888999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccce
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  691 (862)
                      ..++|+||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998554   35888999999999999999999987   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcCCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL--FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK  769 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  769 (862)
                      +...............++..|+|||.+....  ++.++||||||++++|+++|..|+....      .............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~  229 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE------AIAAMFKLGNKRS  229 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc------hHHHHHHhhcccc
Confidence            7654322222223356788999999987654  8899999999999999999999963211      1111111111110


Q ss_pred             eeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          770 VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       770 ~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                       ...+   ........+..+.+++.+||+.+|++||++.+|++.
T Consensus       230 -~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 -APPI---PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             -CCcC---CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence             0001   111223345688899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.8e-33  Score=295.15  Aligned_cols=251  Identities=27%  Similarity=0.406  Sum_probs=207.0

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCCc-cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      +|+..+.||+|++|.||+++... ++.|+||++..... ...+.+.+|+..+.+++|+|++++++++...+..++|+||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            57888999999999999998875 89999999876543 45678999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhh-cCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ-DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      ++++|.+++...   ..+++..+..++.|+++||+|||+ .+   ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        82 ~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          82 DGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            999999999654   458999999999999999999999 87   99999999999999999999999999987643322


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                      .  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..............+    ...        ...
T Consensus       156 ~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~----~~~--------~~~  221 (264)
T cd06623         156 Q--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI----CDG--------PPP  221 (264)
T ss_pred             c--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH----hcC--------CCC
Confidence            2  12346788999999999999999999999999999999999997543321222222111    111        111


Q ss_pred             CCChH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          780 NYPAN-EVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       780 ~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ..+.. .+..+.+++.+|++.+|++||++.|+++.
T Consensus       222 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            22233 56788899999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.9e-33  Score=309.34  Aligned_cols=256  Identities=21%  Similarity=0.291  Sum_probs=193.1

Q ss_pred             ccceeecc--ccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          546 DYNKLGQG--GFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       546 ~~~~LG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      ..++||+|  +|++||+++.. +++.||+|++....  ....+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            34789999  78999999775 48899999997542  234456788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++..... ..+++..+.+++.|+++||+|||+.+   |+||||||+|||++.++.++++||+...........
T Consensus        82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            99999999864332 24889999999999999999999988   999999999999999999999999875443211110


Q ss_pred             -----cccccccccccccChhhhcC--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeee
Q 002969          701 -----QNTKRVVGTYGYMSPEYAMD--GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       701 -----~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  773 (862)
                           .......++..|+|||++.+  ..++.++|||||||++|||++|+.|+.......  ......     .+.....
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~-----~~~~~~~  230 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKL-----NGTVPCL  230 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHh-----cCCcccc
Confidence                 01122356778999999976  468999999999999999999999975322111  000000     0000000


Q ss_pred             ec-------------------c------------------cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          774 VD-------------------S------------------SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       774 id-------------------~------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ++                   .                  ............+.+++.+||+.||++|||++||++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            00                   0                  000112233457889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.5e-33  Score=304.30  Aligned_cols=263  Identities=26%  Similarity=0.352  Sum_probs=203.3

Q ss_pred             cChHHHHHHcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEe
Q 002969          532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVE  609 (862)
Q Consensus       532 ~~~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~  609 (862)
                      +...++..++++|+..+.||+|+||.||++... +++.+|+|++.... ...+++.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            444556667889999999999999999999875 47889999986432 2346778899999999 79999999999875


Q ss_pred             C-----CceEEEEEeccCCChhhhhhhc-cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCe
Q 002969          610 M-----DEKMLVYEYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (862)
Q Consensus       610 ~-----~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  683 (862)
                      .     +..++|+||+++++|.+++... .....+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence            4     3579999999999999988542 23346899999999999999999999987   9999999999999999999


Q ss_pred             eEecccceeecCCCCcccccccccccccccChhhhcCC-----CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHH
Q 002969          684 KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG-----LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL  758 (862)
Q Consensus       684 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~  758 (862)
                      ||+|||++..+......  .....++..|+|||.+...     .++.++|||||||++|||++|+.|+.....      .
T Consensus       168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~------~  239 (291)
T cd06639         168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP------V  239 (291)
T ss_pred             EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH------H
Confidence            99999998865432211  1224678899999998643     368899999999999999999998643211      1


Q ss_pred             HHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          759 GHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       759 ~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ....+.. ......     + ..+......+.+++.+||+.+|++||++.|+++.
T Consensus       240 ~~~~~~~-~~~~~~-----~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         240 KTLFKIP-RNPPPT-----L-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHHHHHh-cCCCCC-----C-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            1111111 111100     1 1122334568899999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.5e-33  Score=296.61  Aligned_cols=249  Identities=26%  Similarity=0.391  Sum_probs=200.7

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +|+..+.||+|+||.||++... .++.+|+|++...  .....+.+.+|++++++++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4777899999999999999775 4788999998654  234567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC-CeeEecccceeecCCCC
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFGGDQ  698 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~  698 (862)
                      +++++|.+++.... ...+++..+.+++.+++++|+|||+.+   ++|+||+|+||++++++ .+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999996533 345889999999999999999999987   99999999999998654 68999999998764322


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                         ......++..|+|||.+.+..++.++||||||+++++|++|+.|+.....   .......   . ..        ..
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~---~-~~--------~~  218 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKI---M-SG--------TF  218 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHH---H-hc--------CC
Confidence               12234678899999999988899999999999999999999998643211   1111111   1 11        11


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ...+......+.+++.+||+.+|++||++.|+++.
T Consensus       219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            11223345678899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.6e-33  Score=297.30  Aligned_cols=253  Identities=26%  Similarity=0.453  Sum_probs=201.5

Q ss_pred             cccccceeeccccEEEEEeEe-cCCcEEEEEEeccCC------ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNS------GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      +|+..+.||+|++|.||+++. .+++.+|+|++....      ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            467788999999999999986 458899999986532      1235688999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC-CeeEecccceeec
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIF  694 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~  694 (862)
                      |+||+++++|.+++...   ..+++..+..++.||+.||+|||+.+   ++|+||+|+||+++.++ .+||+|||++..+
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            99999999999998543   34789999999999999999999998   99999999999998776 5999999999876


Q ss_pred             CCCCcc--cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          695 GGDQTE--QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       695 ~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      ......  .......++..|+|||.+.+..++.++||||||++++||++|+.|+.......   ......+....     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~-----  226 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIFKIASA-----  226 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHHHhcc-----
Confidence            433211  11223467889999999988889999999999999999999999975322211   11111111100     


Q ss_pred             eecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                         ......+.....++.+++.+|++.+|++||++.|+++
T Consensus       227 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         227 ---TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ---CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence               0112334445677889999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.3e-33  Score=298.03  Aligned_cols=250  Identities=25%  Similarity=0.375  Sum_probs=197.1

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC-----ccchHHHHHHHHHHHhcccCCceEEEEEEEeC--Cce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-----GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~  613 (862)
                      ++|+..++||+|+||.||+|...+ ++.||+|.+....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            468888999999999999998754 8899999885321     22356788999999999999999999998764  457


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++++||+++++|.+++...   ..+++....+++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            8999999999999988543   24788889999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCc-ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          694 FGGDQT-EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       694 ~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      +..... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+.....      .....+....     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~-----  224 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQ-----  224 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch------HHHHHHHhcC-----
Confidence            543211 1122334688899999999888899999999999999999999999743211      1111111111     


Q ss_pred             eecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                         ......+......+.+++.+|+. +|++||+++||++
T Consensus       225 ---~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         225 ---PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ---CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence               11122344455677889999985 8999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.4e-33  Score=303.06  Aligned_cols=260  Identities=22%  Similarity=0.307  Sum_probs=196.5

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +|+..++||+|+||.||+|+.. .|+.+|+|+++...  ....+.+.+|++++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777889999999999999875 48899999986542  22345678899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      ++ ++|.+++...  ...+++..+..++.||++||.|||+.+   ++||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            97 4777776432  234899999999999999999999998   99999999999999999999999999986533211


Q ss_pred             ccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc---------
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK---------  769 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---------  769 (862)
                        ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+..  ..+....+..+.+......         
T Consensus       155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC--CCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence              11224568899999998775 478999999999999999999988532  2222222222222111000         


Q ss_pred             --eeeeecccC-----CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          770 --VLEMVDSSV-----DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       770 --~~~~id~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        .........     .........++.+++.+||+.||.+|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence              000000000     0111234567789999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-33  Score=313.06  Aligned_cols=258  Identities=24%  Similarity=0.348  Sum_probs=194.6

Q ss_pred             HHcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeC-----
Q 002969          539 RATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-----  610 (862)
Q Consensus       539 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----  610 (862)
                      ...++|+..+.||+|+||.||+|... .++.||||++....  ....+.+.+|++++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34578999999999999999999865 47889999986542  22345678999999999999999999887543     


Q ss_pred             -CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccc
Q 002969          611 -DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (862)
Q Consensus       611 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  689 (862)
                       ...++++|++ +++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3468999988 7888887732    34899999999999999999999998   9999999999999999999999999


Q ss_pred             ceeecCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcC
Q 002969          690 MARIFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG  768 (862)
Q Consensus       690 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  768 (862)
                      +++.....     .....|++.|+|||++.+ ..++.++|||||||++|||++|+.|+....   ....+..+.......
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~~~~~~~~~  235 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND---YIDQLKRIMEVVGTP  235 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHHHhCCC
Confidence            99865322     223468999999999877 568999999999999999999999874321   111111111111000


Q ss_pred             c-----------eeeeecccCCCCC--------hHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          769 K-----------VLEMVDSSVDNYP--------ANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       769 ~-----------~~~~id~~~~~~~--------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .           ....+ ..+...+        ......+.+++.+||+.||++|||+.|++..
T Consensus       236 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         236 SPEVLKKISSEHARKYI-QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CHHHHHhcchhhHHHHh-hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0           00000 0000001        1123356799999999999999999999963

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=295.11  Aligned_cols=246  Identities=26%  Similarity=0.395  Sum_probs=208.8

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      -|.++.+||+|+||.||++.+.+ |+.+|||++.-.  ...++...|+.+|++.+.|++|+++|.+.....+++|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            36677899999999999998765 899999998654  356888999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      .|++.+.++.  +++.|.+.++..|+...++||+|||...   -+|||||+.||||..+|.+||+|||.|..+.....  
T Consensus       112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--  184 (502)
T KOG0574|consen  112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--  184 (502)
T ss_pred             CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH--
Confidence            9999999853  4567999999999999999999999986   79999999999999999999999999987743332  


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC---
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV---  778 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~---  778 (862)
                      ....+.||+-|||||++..-.|..++||||||++..||..|++|+..-++...                .-++....   
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------------IFMIPT~PPPT  248 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------------IFMIPTKPPPT  248 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------------eEeccCCCCCC
Confidence            23347899999999999999999999999999999999999999765443321                11111111   


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      -..|..-+.++-+++++||-++|++|-|+.++++.
T Consensus       249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            22345567788899999999999999999998864

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.2e-33  Score=297.92  Aligned_cols=254  Identities=27%  Similarity=0.399  Sum_probs=201.8

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEe--CCceEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE--MDEKMLVY  617 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~lV~  617 (862)
                      +|+..+.||.|+||.||++... +++.+|+|++...  .....+++..|++++++++||||+++++++..  ....++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4777899999999999999765 4788999998654  23345678899999999999999999998764  44578999


Q ss_pred             EeccCCChhhhhhhc-cCCCCCCHhhHHHHHHHHHHHhHHhhhcC--CCcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          618 EYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDS--RFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       618 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      ||+++++|.+++... .....+++..++.++.||++||+|||..+  ..+++|+||||+||+++.++.+||+|||++..+
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653 22356899999999999999999999332  234999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          695 GGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       695 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ......  .....++..|+|||.+.+..++.++||||||+++++|++|+.|+....   .....    +....+      
T Consensus       161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~----~~~~~~------  225 (265)
T cd08217         161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLA----SKIKEG------  225 (265)
T ss_pred             cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHH----HHHhcC------
Confidence            433221  223468899999999999889999999999999999999999975322   11111    111111      


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                        .....+...+..+.+++.+|++.+|++||++.+|+++
T Consensus       226 --~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         226 --KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence              1123344556788899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.2e-33  Score=301.93  Aligned_cols=259  Identities=25%  Similarity=0.399  Sum_probs=200.3

Q ss_pred             ChHHHHHHcccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEe-
Q 002969          533 DFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVE-  609 (862)
Q Consensus       533 ~~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~-  609 (862)
                      ++.++..+.+.|+..+.||+|+||.||+|+... ++.+|+|++.... ....++..|+.+++++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            334444556788999999999999999998754 7889999885543 3446788999999999 69999999999853 


Q ss_pred             -----CCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCee
Q 002969          610 -----MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK  684 (862)
Q Consensus       610 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k  684 (862)
                           ....+++|||+++++|.+++.... ...+++..+..++.||++||+|||+.+   ++|+||||+||++++++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 456799999999999999885433 345788889999999999999999998   99999999999999999999


Q ss_pred             EecccceeecCCCCcccccccccccccccChhhhc-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHH
Q 002969          685 ISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM-----DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLG  759 (862)
Q Consensus       685 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~  759 (862)
                      |+|||++.......  .......|+..|+|||.+.     +..++.++||||||+++|||++|+.|+.......      
T Consensus       162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~------  233 (282)
T cd06636         162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR------  233 (282)
T ss_pred             EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh------
Confidence            99999987653211  1222356889999999875     3467889999999999999999999974322111      


Q ss_pred             HHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          760 HVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       760 ~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ........ .     ..  .......+..+.+++.+||+.+|.+||++.||++
T Consensus       234 ~~~~~~~~-~-----~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         234 ALFLIPRN-P-----PP--KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hhhhHhhC-C-----CC--CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            11100000 0     00  1111234567889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-34  Score=314.66  Aligned_cols=240  Identities=24%  Similarity=0.277  Sum_probs=186.9

Q ss_pred             eeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhc---ccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKL---QHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       550 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      ||+|+||.||+|+... ++.||||++....   ......+..|..++...   +||||+++++.+.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            7999999999998754 8899999986432   22334556677777665   699999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      ++|..++...   ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            9999888543   34889999999999999999999998   9999999999999999999999999987542221  12


Q ss_pred             cccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY  781 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~  781 (862)
                      .....||+.|+|||++.+. .++.++|||||||++|||++|+.|+...   +..    ...+....+..      .+  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~---~~~----~~~~~i~~~~~------~~--~  217 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE---DTQ----QMYRNIAFGKV------RF--P  217 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC---CHH----HHHHHHHcCCC------CC--C
Confidence            2345789999999998765 4899999999999999999999996421   111    11222221110      01  1


Q ss_pred             ChHHHHHHHHHHHhccccCCCCCC----CHHHHHH
Q 002969          782 PANEVLRCIHVGLLCVQENAEERP----TMASVVL  812 (862)
Q Consensus       782 ~~~~~~~l~~li~~cl~~dP~~RP----t~~evl~  812 (862)
                      ......++.+++.+||+.+|++||    ++.++++
T Consensus       218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            112355678999999999999998    5677665

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-32  Score=297.73  Aligned_cols=258  Identities=26%  Similarity=0.329  Sum_probs=201.1

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeC--CceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~lV~  617 (862)
                      ++|+..++||.|++|.||++...+ ++.+|+|.+.... ....+++.+|++++++++||||+++++++...  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            357888999999999999998854 7889999987543 24567799999999999999999999998654  4689999


Q ss_pred             EeccCCChhhhhhhc-cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          618 EYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       618 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      ||+++++|.+++... .....+++..+..++.||++||+|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999987542 23445888999999999999999999988   99999999999999999999999999876532


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCC--CcchhHHHHHHHHHhcCceeeee
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHS--NNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ...    ....++..|+|||.+.+..++.++||||||+++|||++|+.|+.....  ....+...+    ..........
T Consensus       158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~  229 (287)
T cd06621         158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY----IVNMPNPELK  229 (287)
T ss_pred             ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH----HhcCCchhhc
Confidence            211    134568899999999999999999999999999999999999764322  111122111    1111111111


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      +. . ......+..+.+++.+||+.+|++|||+.||++
T Consensus       230 ~~-~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         230 DE-P-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             cC-C-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            11 0 001123567889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=301.99  Aligned_cols=247  Identities=23%  Similarity=0.374  Sum_probs=207.1

Q ss_pred             ccccccceeeccccEEEEEeEe-cCCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      +-|...+.||+|.|..|-++++ -.|..||||++.+..  .....++.+|++.|+.++|||||+|+.+...+..+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4466668999999999999975 359999999997653  3345678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe-cCCCCeeEecccceeecCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL-DKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl-~~~~~~kL~DFGla~~~~~~  697 (862)
                      .-.+|+|.++|.++..+  +.+....+++.||+.|+.|.|+..   +|||||||+||.+ ..-|.+||.|||++..+...
T Consensus        98 LGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             ecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            99999999999776543  888999999999999999999987   9999999999876 56789999999999776432


Q ss_pred             CcccccccccccccccChhhhcCCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFS-VKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                         ......+|...|-|||++.+..|+ +++||||||||||-|++|++||+.....+..               ..++|-
T Consensus       173 ---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDC  234 (864)
T KOG4717|consen  173 ---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDC  234 (864)
T ss_pred             ---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhcc
Confidence               233446899999999999999986 6889999999999999999998653332221               112222


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      . ...|.-...+|.+||..||..||.+|.+.+||+.
T Consensus       235 K-YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  235 K-YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             c-ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            2 3456677889999999999999999999999985

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.9e-33  Score=298.02  Aligned_cols=251  Identities=25%  Similarity=0.372  Sum_probs=202.2

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      +|+..+.||+|+||.||++... +++.+|+|++.... ....+++.+|++++++++||||+++++.+......++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5777789999999999999886 48899999987653 345567899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhh-cCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ-DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      ++++|.+++....  ..+++..+..++.|+++||+|||+ .+   ++|+||||+||++++++.++|+|||++..+.....
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            9999999986532  458889999999999999999999 76   99999999999999999999999999876532211


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                          ....++..|+|||.+.+..++.++||||||+++++|++|+.|+....... ....... +......        ..
T Consensus       157 ----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~-~~~~~~~--------~~  222 (265)
T cd06605         157 ----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELL-QYIVNEP--------PP  222 (265)
T ss_pred             ----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHH-HHHhcCC--------CC
Confidence                11567889999999999999999999999999999999999975432111 1111111 1111111        11


Q ss_pred             CCChH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          780 NYPAN-EVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       780 ~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..+.. ....+.+++.+||..+|++||++.+++.
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            11222 5567889999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.6e-33  Score=300.26  Aligned_cols=261  Identities=23%  Similarity=0.357  Sum_probs=201.5

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +|+..+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+.++++++||||+++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4777899999999999999875 58899999987653  33457899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      + +++|.+++....  ..+++.++..++.||++||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999985433  45899999999999999999999998   99999999999999999999999999987643321


Q ss_pred             ccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce--------
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV--------  770 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--------  770 (862)
                       .......++..|+|||.+.+. .++.++||||||++++||++|.+++..   .............+.....        
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG---ENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC---CCHHHHHHHHHHHcCCCChHHHhhccC
Confidence             112234688899999988654 468999999999999999999766532   2222222222221111000        


Q ss_pred             ----eeeeccc-----CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          771 ----LEMVDSS-----VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       771 ----~~~id~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                          .....+.     +.....+....+.+++.+||+.+|++||+++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                0000000     011112345778899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.6e-33  Score=311.29  Aligned_cols=256  Identities=23%  Similarity=0.320  Sum_probs=200.9

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcc-c-----CCceEEEEEEEeCCceEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-H-----RNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----pnIv~l~g~~~~~~~~~l  615 (862)
                      +|++.+.||+|.||.|-++.... ++.||||+++.. .....+...|+.+|..|+ |     -|+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            78899999999999999997654 889999999654 344567788999999997 5     389999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC--CCeeEecccceee
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE--MTPKISDFGMARI  693 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kL~DFGla~~  693 (862)
                      |+|.++ .+|.++|..+.- ..++...+..|+.||+.||..||+.+   |||+||||+||||.+.  ..+||+|||.+..
T Consensus       266 VfELL~-~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELLS-TNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhhh-hhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            999995 589999965543 34899999999999999999999998   9999999999999654  4799999999986


Q ss_pred             cCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhc------
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE------  767 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------  767 (862)
                      .....     ....-+.-|+|||++.+.+|+.+.|+||||||+.||++|.+-   ++++++.+.+..+.+.+..      
T Consensus       341 ~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PL---fpG~ne~DQl~~I~e~lG~Pp~~mL  412 (586)
T KOG0667|consen  341 ESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPL---FPGDNEYDQLARIIEVLGLPPPKML  412 (586)
T ss_pred             cCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccc---cCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            53221     134567889999999999999999999999999999999654   4455555555554433211      


Q ss_pred             -------------Ccee------e-----------------eecccCC--------CCChHHHHHHHHHHHhccccCCCC
Q 002969          768 -------------GKVL------E-----------------MVDSSVD--------NYPANEVLRCIHVGLLCVQENAEE  803 (862)
Q Consensus       768 -------------~~~~------~-----------------~id~~~~--------~~~~~~~~~l~~li~~cl~~dP~~  803 (862)
                                   ....      +                 ..+....        ......-..+++++++||+.||.+
T Consensus       413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~  492 (586)
T KOG0667|consen  413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE  492 (586)
T ss_pred             HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence                         0000      0                 0000000        011133456789999999999999


Q ss_pred             CCCHHHHHH
Q 002969          804 RPTMASVVL  812 (862)
Q Consensus       804 RPt~~evl~  812 (862)
                      |+|..|.++
T Consensus       493 R~tp~qal~  501 (586)
T KOG0667|consen  493 RITPAQALN  501 (586)
T ss_pred             cCCHHHHhc
Confidence            999999996

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.1e-33  Score=305.81  Aligned_cols=260  Identities=23%  Similarity=0.392  Sum_probs=199.1

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCc--cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ++|+..++||+|+||.||+|...+ ++.||+|++.....  ...+.+.+|+++++.++||||+++++++......++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            367888999999999999998864 78999999865422  235678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++++|..+....   ..+++.++..++.||++||+|||+.+   ++|+||+|+||++++++.++|+|||++..+....
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            99999998876432   23899999999999999999999987   9999999999999999999999999998764332


Q ss_pred             cccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhc----------
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE----------  767 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----------  767 (862)
                      .  ......++..|+|||++.+ ..++.++||||||+++|||++|++|+....   ..............          
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS---DIDQLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc---hHHHHHHHHHHhCCCchhhHHHhc
Confidence            1  1223457889999999876 457889999999999999999998864322   11111111111000          


Q ss_pred             -Ccee-eeecccC------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          768 -GKVL-EMVDSSV------DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       768 -~~~~-~~id~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       .... ....+..      ....+..+..+.+++.+||+.+|++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             0000 0000000      0011234567889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.4e-33  Score=304.52  Aligned_cols=247  Identities=24%  Similarity=0.362  Sum_probs=198.8

Q ss_pred             cccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCC
Q 002969          545 TDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR  623 (862)
Q Consensus       545 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g  623 (862)
                      ....+||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||++++
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            33458999999999999875 58899999997655555678899999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccccc
Q 002969          624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT  703 (862)
Q Consensus       624 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  703 (862)
                      +|.+++..    ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++..+.....  ..
T Consensus       104 ~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~  174 (297)
T cd06659         104 ALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KR  174 (297)
T ss_pred             CHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cc
Confidence            99987733    34889999999999999999999998   99999999999999999999999999876533221  12


Q ss_pred             ccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCCh
Q 002969          704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA  783 (862)
Q Consensus       704 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~  783 (862)
                      ....++..|+|||++.+..++.++||||||++++||++|+.|+....   ......    .+.....     .. .....
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~---~~~~~~----~~~~~~~-----~~-~~~~~  241 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS---PVQAMK----RLRDSPP-----PK-LKNAH  241 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHH----HHhccCC-----CC-ccccC
Confidence            23568899999999998899999999999999999999999974321   111111    1111100     00 11112


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          784 NEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       784 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .....+.+++.+||+.+|++||++.+|++.
T Consensus       242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         242 KISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            234567899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-33  Score=305.47  Aligned_cols=252  Identities=27%  Similarity=0.369  Sum_probs=202.7

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEecc--CCccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCceEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSR--NSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ...|+++++||+||-+.||++...+.+.+|+|++..  .+.+...-|.+|+..|.+|+ |.+||+|++|-..++.+|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            456888999999999999999988888899998754  35667889999999999995 999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||-+ .+|..+|..+.. ....| .+..+..|++.++.++|+++   |||.||||.|+|+- .|.+||+|||+|..+..+
T Consensus       440 E~Gd-~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  440 ECGD-IDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             eccc-ccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence            9874 689999865433 23344 67779999999999999998   99999999999984 579999999999998877


Q ss_pred             CcccccccccccccccChhhhcCCC-----------CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHh
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGL-----------FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK  766 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~-----------~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~  766 (862)
                      ...-.....+||+.||+||.+....           .+.++||||||||||+|+.|+.||+.+.     +.+..      
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~aK------  581 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIAK------  581 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHHH------
Confidence            7776667789999999999985432           5578999999999999999999975321     11111      


Q ss_pred             cCceeeeecccC-CCCC-hHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          767 EGKVLEMVDSSV-DNYP-ANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       767 ~~~~~~~id~~~-~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                         ...+.++.. -+++ .....+++++|+.||+.||++||++.|||+.
T Consensus       582 ---l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  582 ---LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ---HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence               122333322 1111 1122238999999999999999999999974

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-33  Score=297.16  Aligned_cols=246  Identities=23%  Similarity=0.422  Sum_probs=198.3

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccC-CccchHHHHHHHHHHHhcc---cCCceEEEEEEEeCCceEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQ---HRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      .|+..++||+|+||.||+|... +++.+|+|.+... .....+++.+|+.++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4677789999999999999864 5889999998654 3345677889999999997   999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++...    .+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+...
T Consensus        82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            999999999988432    5889999999999999999999998   999999999999999999999999999876443


Q ss_pred             CcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ..  ......|+..|+|||.+.++ .++.++||||||+++|||++|+.|+.......      ... ....        .
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~-~~~~--------~  217 (277)
T cd06917         155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMM-LIPK--------S  217 (277)
T ss_pred             cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhh-cccc--------C
Confidence            21  12234688899999998754 57899999999999999999999975321111      100 0000        0


Q ss_pred             cCCCCCh-HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          777 SVDNYPA-NEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       777 ~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .....+. ..+.++.+++.+||+.+|++||++.|++.
T Consensus       218 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         218 KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            1111111 14567889999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3e-33  Score=302.66  Aligned_cols=260  Identities=23%  Similarity=0.346  Sum_probs=200.6

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +|+..++||+|+||.||+|...+ ++.||+|+++..  .....+.+.+|++++++++|+||+++++++...+..++++||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            68888999999999999998764 789999998653  233457889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      ++++.+..++..   ...+++.++..++.||++||+|||+.+   ++|+||+|+||++++++.+||+|||++..+.....
T Consensus        82 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          82 VERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            998777665532   234889999999999999999999998   99999999999999999999999999987654332


Q ss_pred             ccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHh-----------c
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK-----------E  767 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~-----------~  767 (862)
                       .......++..|+|||++.+. .++.++||||||+++|||++|+.|+......   +.+......+.           .
T Consensus       156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI---DQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHhhhccc
Confidence             122235678899999999888 8899999999999999999999887532211   11111111100           0


Q ss_pred             Cceee---eecccC-----CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          768 GKVLE---MVDSSV-----DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       768 ~~~~~---~id~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .....   ..+...     ..++...+.++.+++.+||+.+|++||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00000   000000     0122233677899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-33  Score=298.19  Aligned_cols=254  Identities=27%  Similarity=0.420  Sum_probs=200.0

Q ss_pred             HcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCC------
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD------  611 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~------  611 (862)
                      ++++|+..+.||+|++|.||+|+.. +++.+++|++..... ..+++.+|+.+++++ +|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            5678999999999999999999875 477899999865433 356799999999999 6999999999997655      


Q ss_pred             ceEEEEEeccCCChhhhhhhcc-CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccc
Q 002969          612 EKMLVYEYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  690 (862)
                      ..++||||+++++|.+++.... ....+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            4899999999999999886432 2456899999999999999999999988   99999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMD-----GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW  765 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~  765 (862)
                      +.......  .......++..|+|||++..     ..++.++||||||++++||++|+.|+......   ..   ..+. 
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~---~~~~-  230 (275)
T cd06608         160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RA---LFKI-  230 (275)
T ss_pred             ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HH---HHHh-
Confidence            87654322  11223468889999998753     34678999999999999999999997422111   11   1111 


Q ss_pred             hcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          766 KEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       766 ~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ....     .+.. ..+.....++.+++.+||+.||++||++.||++
T Consensus       231 ~~~~-----~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 PRNP-----PPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hccC-----CCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1110     0111 112234567889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2e-32  Score=290.21  Aligned_cols=251  Identities=27%  Similarity=0.434  Sum_probs=206.5

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc--cchHHHHHHHHHHHhcccCCceEEEEEEEeC--CceEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKMLVY  617 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~lV~  617 (862)
                      +|+..+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|+.++++++|+||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3677789999999999999886 588999999866542  4577899999999999999999999999988  8899999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++....   .+++..+..++.|++++|+|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999986543   6899999999999999999999987   999999999999999999999999999877544


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      ..........++..|+|||.+.+...+.++||||||+++++|++|..|+....     +.....++...        ...
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~--------~~~  221 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGS--------SGE  221 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccc--------cCC
Confidence            32212233567889999999998889999999999999999999999975433     11111111110        011


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ....+......+.+++.+|++.+|++||++.|+++
T Consensus       222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            12334444678899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=6.3e-33  Score=299.83  Aligned_cols=260  Identities=23%  Similarity=0.354  Sum_probs=196.5

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +|+..+.||.|++|.||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778899999999999999875 48899999986542  22346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +. ++|.+++.... ...+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++..+.....
T Consensus        81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 68888875433 345899999999999999999999987   99999999999999999999999999876532211


Q ss_pred             ccccccccccccccChhhhcCCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc---------
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK---------  769 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---------  769 (862)
                        ......++..|+|||.+.+.. ++.++||||||+++|||++|+.|+....   ..+......+......         
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS---EIDQLFRIFRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHHHhCCCChhhhhhhhH
Confidence              112234678899999887654 6889999999999999999999864321   1111111111111000         


Q ss_pred             -------eeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          770 -------VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       770 -------~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                             ..................++.+++.+|++.||++||+++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                   0000000011111223456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-33  Score=303.42  Aligned_cols=266  Identities=21%  Similarity=0.331  Sum_probs=197.6

Q ss_pred             cccccceeeccccEEEEEeEecC---CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeC--CceE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE---GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKM  614 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~  614 (862)
                      +|+..++||+|+||.||+|+...   ++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47778899999999999998754   6899999997633   34456788999999999999999999999988  7899


Q ss_pred             EEEEeccCCChhhhhhhccC--CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC----CCCeeEecc
Q 002969          615 LVYEYMENRSLDSVIFDKAR--SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK----EMTPKISDF  688 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~----~~~~kL~DF  688 (862)
                      +|+||+++ +|.+++.....  ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 66666643222  235889999999999999999999998   999999999999999    999999999


Q ss_pred             cceeecCCCCc-ccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcc------hhHHHH
Q 002969          689 GMARIFGGDQT-EQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE------LNLLGH  760 (862)
Q Consensus       689 Gla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~------~~l~~~  760 (862)
                      |++..+..... ........++..|+|||.+.+. .++.++||||||++++||++|+.|+........      ...+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322 1222334678899999988764 578999999999999999999999764332220      001111


Q ss_pred             HHHHHhcC------------ceeeeecc-cCCCCC-----------hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          761 VWRLWKEG------------KVLEMVDS-SVDNYP-----------ANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       761 ~~~~~~~~------------~~~~~id~-~~~~~~-----------~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      +...+...            ......+. .....+           .....++.+++.+||+.+|++||++.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11111000            00000000 000011           033456889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.1e-32  Score=296.96  Aligned_cols=247  Identities=25%  Similarity=0.407  Sum_probs=200.6

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      -|+..++||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++|+||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3667789999999999999764 57899999886442 334567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++..    ..+++..+..++.|++.++.|||+.+   ++|+||+|+||+++.++.++|+|||++..+..... 
T Consensus        85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            99999998843    34889999999999999999999987   99999999999999999999999999876643221 


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                       ......++..|+|||.+.+..++.++||||||++++||++|..|+.....   ....    ......        ....
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~----~~~~~~--------~~~~  220 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVL----FLIPKN--------NPPT  220 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHH----HHHhcC--------CCCC
Confidence             12234678899999999988899999999999999999999998643211   1111    111111        1112


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .+...+..+.+++.+||+.+|++||++.++++.
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            233455678899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-33  Score=300.12  Aligned_cols=261  Identities=24%  Similarity=0.348  Sum_probs=196.1

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc-cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ++|+..++||+|++|.||+|+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888899999999999999876 478999999865432 2334577899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++ +|.+++....  ..+++.....++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 8988885433  25889999999999999999999988   99999999999999999999999999875432111


Q ss_pred             ccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee-------
Q 002969          700 EQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL-------  771 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-------  771 (862)
                        ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.....  ....+..+++........       
T Consensus       159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhhh
Confidence              1112346788999999876 4588999999999999999999998743221  111222222111110000       


Q ss_pred             --eeec--------ccCCCC--ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 --EMVD--------SSVDNY--PANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 --~~id--------~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        +...        ..+...  .......+.+++.+||+.+|++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence              0000        000000  0111256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-34  Score=308.80  Aligned_cols=244  Identities=30%  Similarity=0.435  Sum_probs=198.0

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc---cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .|..++.||.|+||.||-++.. +.+.||||++.....   ..+.++..|++.|++++|||+|.+.||+......+||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            4777789999999999999865 467899999976543   456788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      ||- ||-.+++.-.  .+.+-+.++..|..+.+.||+|||+.+   .||||||+.||||++.|.|||+|||.|....   
T Consensus       107 YCl-GSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---  177 (948)
T KOG0577|consen  107 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA---  177 (948)
T ss_pred             HHh-ccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC---
Confidence            995 5777777433  345888999999999999999999998   9999999999999999999999999987653   


Q ss_pred             cccccccccccccccChhhhc---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          699 TEQNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                         ....++|||.|||||++.   .+.|+-|+||||||++..||.-.++|.-   ..+.+..+-++.   ..+       
T Consensus       178 ---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF---nMNAMSALYHIA---QNe-------  241 (948)
T KOG0577|consen  178 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIA---QNE-------  241 (948)
T ss_pred             ---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc---CchHHHHHHHHH---hcC-------
Confidence               233578999999999985   4789999999999999999999998842   222222222221   110       


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       ...-...+-+..+.+++..||++-|.+|||.+++++
T Consensus       242 -sPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  242 -SPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -CCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence             111113455677889999999999999999998763

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.7e-32  Score=297.80  Aligned_cols=244  Identities=27%  Similarity=0.341  Sum_probs=200.7

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..+.||+|+||.||++.... ++.+|+|++....   ....+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            367888999999999999998764 7899999986532   234567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++...   ..+++..+..++.||++||+|||+.+   ++|+||+|+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999998554   35889999999999999999999987   999999999999999999999999999876432


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                           .....+++.|+|||.+.+...+.++||||||+++|||++|+.|+....   ..    ...+....+.        
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~----~~~~~~~~~~--------  214 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PI----QIYEKILEGK--------  214 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HH----HHHHHHhcCC--------
Confidence                 223468899999999988889999999999999999999999964322   11    1111111111        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERP-----TMASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  812 (862)
                       ...+......+.+++.+||+.+|.+||     +++|++.
T Consensus       215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence             112333456788999999999999999     7788774

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6.8e-33  Score=299.43  Aligned_cols=261  Identities=25%  Similarity=0.388  Sum_probs=199.7

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc-cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      +|+..++||.|++|.||+|+.. +++.||||+++.... ...+.+.+|++++++++|+||+++++++.+.+..++|+||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4778899999999999999986 478899999876532 33567788999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++ +|.+++........+++..+..++.||++||+|||+.+   ++||||||+||++++++.++|+|||++..+..... 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 88888865554456899999999999999999999988   99999999999999999999999999976532211 


Q ss_pred             cccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcC--------cee
Q 002969          701 QNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG--------KVL  771 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------~~~  771 (862)
                       ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+.....   ........+.....        ...
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN---EDQLLKIFRIMGTPTESTWPGISQL  231 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCChhhHHHHhcC
Confidence             11223568899999988664 578899999999999999999998653221   11222211111000        000


Q ss_pred             eeecccC--------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 EMVDSSV--------DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 ~~id~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .......        ....+..+..+.+++.+|++.+|++||++.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000000        0111223456789999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.8e-33  Score=296.51  Aligned_cols=250  Identities=25%  Similarity=0.378  Sum_probs=200.6

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +|+..+.||+|+||.||++.... ++.+|+|.+....  ....+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            47778999999999999998764 7889999986542  23456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC-CeeEecccceeecCCCC
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFGGDQ  698 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~  698 (862)
                      +++++|.+++.... ...+++..+..++.|+++||+|||+.+   ++|+||||+||++++++ .+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999999885432 235789999999999999999999988   99999999999999886 46999999998764322


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                      .  ......|++.|+|||++.+..++.++||||||++++||++|+.|+....      ........ ..+        ..
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~-~~~--------~~  219 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKI-CQG--------YF  219 (257)
T ss_pred             c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHH-hcc--------cC
Confidence            1  1222457889999999998889999999999999999999999864211      11111111 111        11


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ..........+.+++.+|++.+|++||++.||++.
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            12223345678899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8.4e-33  Score=302.48  Aligned_cols=257  Identities=21%  Similarity=0.250  Sum_probs=200.8

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..+.||+|+||.||+++... ++.|++|.+....   ....+.+.+|+++++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            367888999999999999998765 7889999986543   234567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++...   ..+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            999999999999543   34889999999999999999999987   999999999999999999999999998642111


Q ss_pred             Cc-------------ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHH
Q 002969          698 QT-------------EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL  764 (862)
Q Consensus       698 ~~-------------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~  764 (862)
                      ..             ........++..|+|||.+.+..++.++|+||||+++|||++|..|+...   ....+..    .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~---~~~~~~~----~  227 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD---TPEELFG----Q  227 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHH----H
Confidence            00             00111245788999999999889999999999999999999999996421   1111111    1


Q ss_pred             HhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       765 ~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ...+..   ..   .......+..+.+++.+||+.+|++||++.++.+.|+..
T Consensus       228 ~~~~~~---~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         228 VISDDI---EW---PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             HHhccc---CC---CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            111110   00   011113455678999999999999999977776666653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.1e-32  Score=294.27  Aligned_cols=252  Identities=27%  Similarity=0.461  Sum_probs=200.8

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc--cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +|...+.||+|+||.||+|... +++.|++|.++....  ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4677899999999999999865 588999999876544  3677899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|.+++...   ..+++..+..++.++++||+|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            9999999998543   34788899999999999999999988   99999999999999999999999999987643322


Q ss_pred             ccc--cccccccccccChhhhcCCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          700 EQN--TKRVVGTYGYMSPEYAMDGL---FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       700 ~~~--~~~~~gt~~y~APE~l~~~~---~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ...  .....++..|+|||++.+..   ++.++||||||++++|+++|+.|+....  ...   ..... ...+.     
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~--~~~---~~~~~-~~~~~-----  223 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD--NEF---QIMFH-VGAGH-----  223 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc--chH---HHHHH-HhcCC-----
Confidence            111  12346788999999998766   8899999999999999999999975322  111   11111 01110     


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .+.... .......+.+++.+||+.+|++||++.|++.
T Consensus       224 ~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         224 KPPIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            011111 1122566779999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=302.84  Aligned_cols=253  Identities=21%  Similarity=0.251  Sum_probs=201.4

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCc---cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..+.||+|+||.||++...+ ++.+|+|.+.....   ...+.+.+|+++++.++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            368888999999999999998765 88999999976532   24567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++... ....+++..+..++.||++||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999988543 3346899999999999999999999988   999999999999999999999999998754321


Q ss_pred             Ccc---------------------------cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 002969          698 QTE---------------------------QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYH  750 (862)
Q Consensus       698 ~~~---------------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~  750 (862)
                      ...                           .......|+..|+|||++.+..++.++||||||+++|||++|+.|+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           01112467889999999999889999999999999999999999964322


Q ss_pred             CCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 002969          751 SNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPT----MASVVL  812 (862)
Q Consensus       751 ~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~  812 (862)
                      ..   ...   .+.. ....      ... .....+..+.+++.+||+.+|++||+    +.|++.
T Consensus       237 ~~---~~~---~~~~-~~~~------~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RD---ETF---SNIL-KKEV------TFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hH---HHH---HHHh-cCCc------cCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            11   111   1111 1000      000 11114677889999999999999999    777776

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.5e-32  Score=290.02  Aligned_cols=250  Identities=29%  Similarity=0.457  Sum_probs=203.6

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      +|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3667789999999999999886 588999999977655567889999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +++|.+++....  ..+++..+..++.|++++|+|||+.+   ++||||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999985532  45899999999999999999999987   99999999999999999999999999887643322  


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY  781 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~  781 (862)
                       .....++..|+|||.+.+..++.++||||||+++++|++|+.|+.......      ..... .......      ...
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~~~~~~------~~~  219 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK------ALFKI-ATNGPPG------LRN  219 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH------HHHHH-HhcCCCC------cCc
Confidence             234567889999999998889999999999999999999999864322111      11111 1000000      011


Q ss_pred             ChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          782 PANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       782 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .......+.+++.+||+.+|++||++.|+++.
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11125678899999999999999999999863

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.4e-32  Score=298.94  Aligned_cols=250  Identities=25%  Similarity=0.405  Sum_probs=202.4

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      ++|...+.||+|+||.||++... +++.|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57888899999999999999764 57889999987655555678899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++..    ..+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+..... 
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-  170 (293)
T cd06647          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (293)
T ss_pred             CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence            99999999853    24788999999999999999999998   99999999999999999999999999876543222 


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                       ......+++.|+|||.+.+..++.++||||||+++||+++|+.|+........      .......+       .....
T Consensus       171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~------~~~~~~~~-------~~~~~  236 (293)
T cd06647         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNG-------TPELQ  236 (293)
T ss_pred             -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh------eeehhcCC-------CCCCC
Confidence             12234678899999999888899999999999999999999999743221110      00000000       00011


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .+......+.+++.+||+.+|++||++.+++.+
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            122345568899999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.7e-32  Score=297.19  Aligned_cols=247  Identities=24%  Similarity=0.371  Sum_probs=199.6

Q ss_pred             ccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          544 FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      |...++||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            455579999999999999864 5788999998765555567789999999999999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      ++|.+++..    ..+++.++..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++........  .
T Consensus       101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~  171 (285)
T cd06648         101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R  171 (285)
T ss_pred             CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence            999998854    24889999999999999999999998   99999999999999999999999998876533221  1


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP  782 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~  782 (862)
                      .....|+..|+|||.+.+..++.++||||||++++||++|+.|+...   +......    ......     .+.. ..+
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~---~~~~~~~----~~~~~~-----~~~~-~~~  238 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE---PPLQAMK----RIRDNL-----PPKL-KNL  238 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC---CHHHHHH----HHHhcC-----CCCC-ccc
Confidence            22346889999999999888999999999999999999999986421   1111111    111111     0111 112


Q ss_pred             hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          783 ANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       783 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ...+..+.+++.+||+.+|++||++.++++
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            224567889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=9.7e-33  Score=298.07  Aligned_cols=251  Identities=24%  Similarity=0.378  Sum_probs=193.1

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHH-HHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRL-IAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ++|++.+.||+|+||.||+++.. +++.||+|+++... .....++..|+.+ ++.++||||+++++++...+..++++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36788899999999999999876 48899999987543 2233455566665 566689999999999999999999999


Q ss_pred             eccCCChhhhhhhc-cCCCCCCHhhHHHHHHHHHHHhHHhhhc-CCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          619 YMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       619 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |++ ++|.+++... .....+++..+..++.||+.||+|||++ +   ++||||||+||+++.++.+||+|||++..+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 6888887542 2335689999999999999999999986 5   99999999999999999999999999986532


Q ss_pred             CCcccccccccccccccChhhhcC----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMD----GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      ..   ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.|+.....  .   .......... .   
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~---~~~~~~~~~~-~---  224 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--P---FQQLKQVVEE-P---  224 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--C---HHHHHHHHhc-C---
Confidence            21   1122457889999998865    4568899999999999999999999643211  1   1111111111 0   


Q ss_pred             eecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        ....  .....+.++.+++.+||+.+|++||++.+|++
T Consensus       225 --~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         225 --SPQL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             --CCCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0111  11123567889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2e-32  Score=296.42  Aligned_cols=252  Identities=26%  Similarity=0.408  Sum_probs=203.9

Q ss_pred             HcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .++.|+..+.||+|++|.||+|... +++.+++|++..... ..+.+.+|++++++++|+|++++++++...+..++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888899999999999999886 588999999976544 56788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++++|.+++....  ..+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            999999999996543  36899999999999999999999987   9999999999999999999999999987553221


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                      .  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.......      ..... ......     . 
T Consensus       171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~~~~-~~~~~~-----~-  235 (286)
T cd06614         171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALFLI-TTKGIP-----P-  235 (286)
T ss_pred             h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-HhcCCC-----C-
Confidence            1  1223457889999999998889999999999999999999999964322111      11111 111000     0 


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .......+..+.+++.+|++.+|.+||++.+|+.
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0111224567889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-33  Score=280.84  Aligned_cols=250  Identities=26%  Similarity=0.326  Sum_probs=202.4

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC-----c---cchHHHHHHHHHHHhc-ccCCceEEEEEEEeCC
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-----G---QGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD  611 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-----~---~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~  611 (862)
                      .+|...+.||.|..+.|-+..+.. ++++|+|++....     +   .-.++-.+|+.+|+++ -||+|+++.+++....
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            467777899999999998887654 7899999885331     1   1234567799999999 5999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccce
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  691 (862)
                      ..++|+|.|+.|.|.++|....   .+++++..+|+.|+.+|++|||..+   ||||||||+|||++++.++||+|||.+
T Consensus        97 F~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence            9999999999999999996544   4899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhc------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAM------DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW  765 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~  765 (862)
                      ..+...   ......+|||+|+|||.+.      ...|+..+|.|+.|||||-|+.|.+||-  +..     ..-..+++
T Consensus       171 ~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw--HRk-----QmlMLR~I  240 (411)
T KOG0599|consen  171 CQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW--HRK-----QMLMLRMI  240 (411)
T ss_pred             eccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh--HHH-----HHHHHHHH
Confidence            887432   3344579999999999873      2458889999999999999999999952  211     11223344


Q ss_pred             hcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          766 KEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       766 ~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .+|+..-.     .....+.+....+|+.+||+.||.+|.|++|++.
T Consensus       241 meGkyqF~-----speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  241 MEGKYQFR-----SPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HhcccccC-----CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            44432111     1223456667889999999999999999999985

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.8e-32  Score=297.90  Aligned_cols=260  Identities=25%  Similarity=0.356  Sum_probs=198.1

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeC--CceEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~lV  616 (862)
                      ++|+..+.||+|+||.||+|+... ++.+++|.++...  ......+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            468888999999999999998764 7889999996543  22334677899999999999999999999877  889999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      +||+++ +|.+++....  ..+++.++..++.||++||+|||+.+   ++|+||||+||+++.++.+||+|||++..+..
T Consensus        85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999974 8988885433  35899999999999999999999998   99999999999999999999999999987644


Q ss_pred             CCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHh---------
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK---------  766 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~---------  766 (862)
                      ...  ......+++.|+|||.+.+. .++.++|+||||++++||++|+.|+......   .....+...+.         
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~  233 (293)
T cd07843         159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI---DQLNKIFKLLGTPTEKIWPG  233 (293)
T ss_pred             Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchHHHHH
Confidence            321  12234568899999998764 4689999999999999999999987543221   11111111110         


Q ss_pred             --c------CceeeeecccC-CCCChH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          767 --E------GKVLEMVDSSV-DNYPAN-EVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       767 --~------~~~~~~id~~~-~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        +      ..........+ ..++.. ....+.+++.+||+.+|++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence              0      00000000011 112222 3566789999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-33  Score=310.76  Aligned_cols=248  Identities=26%  Similarity=0.373  Sum_probs=201.2

Q ss_pred             ccceeeccccEEEEEeEecC-CcEEEEEEecc----CCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCc--eEEEEE
Q 002969          546 DYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSR----NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE--KMLVYE  618 (862)
Q Consensus       546 ~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~--~~lV~E  618 (862)
                      ...+||+|+|-+||+|.... |.+||=-.++.    ......++|..|+++|+.|+|||||+++....+...  ..+|.|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            34689999999999997654 66665333321    244566899999999999999999999999887655  678999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC-CCCeeEecccceeecCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-EMTPKISDFGMARIFGGD  697 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~  697 (862)
                      .|..|+|..++.+..+   ++.+.+.+++.||++||.|||++. |||||||||-+||+|+. -|.|||+|+|||......
T Consensus       124 L~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             cccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            9999999999966554   788999999999999999999986 79999999999999975 589999999999876432


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                          ....+.|||.|||||... ..|.+.+||||||+.++||+|+..||..      ..-...+++.+..|...+.+.. 
T Consensus       200 ----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE------C~n~AQIYKKV~SGiKP~sl~k-  267 (632)
T KOG0584|consen  200 ----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE------CTNPAQIYKKVTSGIKPAALSK-  267 (632)
T ss_pred             ----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh------hCCHHHHHHHHHcCCCHHHhhc-
Confidence                223478999999999776 8899999999999999999999999743      3334567777766654333221 


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH--Hhcc
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL--MLSS  816 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~  816 (862)
                            -...++.++|.+||.. ..+||++.|+|.  +|..
T Consensus       268 ------V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  268 ------VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             ------cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence                  2245678999999999 999999999996  4444

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.6e-32  Score=296.27  Aligned_cols=263  Identities=22%  Similarity=0.315  Sum_probs=196.8

Q ss_pred             HcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc-cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++++|...+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++|+||+++++++...+..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999765 588999999865432 33346789999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+. ++|.+++...  ...+.+.++..++.||++||+|||+.+   |+|+||||+|||++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 6777666432  234778888899999999999999997   999999999999999999999999998764322


Q ss_pred             CcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc-------
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK-------  769 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-------  769 (862)
                      ..  ......++..|+|||++.+. .++.++||||||+++|||++|+.|+.....  ....+...+..+....       
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07870         157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGV  232 (291)
T ss_pred             CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhhhh
Confidence            11  11223568899999998764 578899999999999999999999753221  1122222222111000       


Q ss_pred             --eeeeeccc--------CCCC--ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          770 --VLEMVDSS--------VDNY--PANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       770 --~~~~id~~--------~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        ........        ....  .......+.+++.+|++.+|++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence              00000000        0000  0112456778999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.3e-32  Score=297.16  Aligned_cols=262  Identities=23%  Similarity=0.325  Sum_probs=195.5

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCc-----
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDE-----  612 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~-----  612 (862)
                      ++|+..+.||+|+||.||+|... +++.||+|+++...  ......+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888899999999999999875 48899999886542  223467889999999995 6999999999987666     


Q ss_pred             eEEEEEeccCCChhhhhhhccC--CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC-CCCeeEeccc
Q 002969          613 KMLVYEYMENRSLDSVIFDKAR--SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-EMTPKISDFG  689 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DFG  689 (862)
                      .++||||+++ +|.+++.....  ...+++..+..++.||++||+|||+.+   ++||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 78888754332  346899999999999999999999988   999999999999998 8899999999


Q ss_pred             ceeecCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcC
Q 002969          690 MARIFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG  768 (862)
Q Consensus       690 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  768 (862)
                      +++.+......  .....+++.|+|||++.+ ..++.++||||||+++|||++|..|+...   +.......+.+.....
T Consensus       157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~---~~~~~~~~~~~~~~~~  231 (295)
T cd07837         157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD---SELQQLLHIFKLLGTP  231 (295)
T ss_pred             cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHHHhCCC
Confidence            99865332111  112346788999998865 45789999999999999999999886432   1111111111111100


Q ss_pred             cee------eeec---------ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          769 KVL------EMVD---------SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       769 ~~~------~~id---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ...      +..+         ..+....+....++.+++.+||+.+|++||++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000      0000         0000111234566889999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.1e-32  Score=293.72  Aligned_cols=247  Identities=26%  Similarity=0.327  Sum_probs=202.1

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      +|+..++||.|+||.||+++... ++.||+|.+....   ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            47788999999999999998764 8899999997542   2456789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++++|.+++...   ..+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999998543   35889999999999999999999988   9999999999999999999999999988764322


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                         ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+.......    ..........         ..
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~---------~~  218 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET---------AD  218 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc---------cc
Confidence               2223467889999999998889999999999999999999999975433221    1111111110         11


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTM--ASVV  811 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl  811 (862)
                      ...+...+..+.+++.+||+.+|.+||++  +|++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            22233445788899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-33  Score=307.34  Aligned_cols=269  Identities=22%  Similarity=0.325  Sum_probs=199.1

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeC-----Cce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-----DEK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~  613 (862)
                      +++|+..++||+|+||.||+|+.. +++.||+|++... .......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999865 4889999998643 233456788999999999999999999887654     357


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++++||+++ +|..++..    ..+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999975 77766632    35899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc-cccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce-
Q 002969          694 FGGDQTE-QNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV-  770 (862)
Q Consensus       694 ~~~~~~~-~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-  770 (862)
                      ....... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+.....   ................ 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~---~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY---LHQLNLILGVLGTPSQE  232 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCCHH
Confidence            6432211 11223467899999998755 5688999999999999999999998743211   1111111111110000 


Q ss_pred             ----------eee---ecccC----CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hccCcCC
Q 002969          771 ----------LEM---VDSSV----DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM--LSSETAT  820 (862)
Q Consensus       771 ----------~~~---id~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~~  820 (862)
                                .+.   .....    ....+....++.+++.+||+.+|++||++.|+++.  ++.....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence                      000   00000    00011234568899999999999999999999986  6555433

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-32  Score=295.43  Aligned_cols=259  Identities=23%  Similarity=0.360  Sum_probs=196.2

Q ss_pred             ccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          544 FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      |+..++||.|++|.||+|... +++.||+|++....  ....+.+.+|++++++++|||++++++++.+.+..++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            566789999999999999875 58899999987543  233467889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      + ++|.+++..... ..+++..+++++.|+++||+|||+.+   ++||||+|+||+++.++.++|+|||+++.+..... 
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  154 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-  154 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence            5 689988854332 35899999999999999999999987   99999999999999999999999999976532211 


Q ss_pred             cccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc----------
Q 002969          701 QNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK----------  769 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----------  769 (862)
                       ......++..|+|||++.+. .++.++||||||+++|||++|+.|+.....   ......+.+......          
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE---IDQLFRIFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHHhhhhhhc
Confidence             11223467899999988664 578999999999999999999998643211   111111111100000          


Q ss_pred             ------eeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          770 ------VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       770 ------~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                            ...................+.+++.+|++.+|++||+++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                  0000000111122334467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.5e-32  Score=290.73  Aligned_cols=242  Identities=24%  Similarity=0.291  Sum_probs=188.2

Q ss_pred             eeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHh---cccCCceEEEEEEEeCCceEEEEEecc
Q 002969          549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAK---LQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       549 ~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~---l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      .||+|+||.||+++..+ ++.+|+|.+....   ......+.+|..+++.   .+||||+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999998754 7899999886542   1222334455544444   369999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +++|.+++...   ..+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            99999988543   34899999999999999999999998   9999999999999999999999999987653221   


Q ss_pred             ccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                       .....|+..|+|||.+.+ ..++.++|||||||+++||++|+.|+.........    ...+....         ....
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~---------~~~~  217 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT---------VNVE  217 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhhc---------CCcC
Confidence             122468999999999864 56889999999999999999999997543322211    11111100         0012


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERP-----TMASVVLM  813 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  813 (862)
                      .+...+.++.+++.+||+.||++||     +++|++++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            2344566788999999999999999     69999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-32  Score=294.89  Aligned_cols=259  Identities=24%  Similarity=0.356  Sum_probs=197.6

Q ss_pred             ccccceeeccccEEEEEeEecC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeC--CceEEEEE
Q 002969          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKMLVYE  618 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~lV~E  618 (862)
                      |+..++||+|+||.||+|+..+ ++.+|+|++....  ....+.+.+|++++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            5667899999999999998765 7899999997653  33456788999999999999999999999988  88999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++ +|.+++....  ..+++..++.++.||++||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9985 8888875432  35899999999999999999999987   9999999999999999999999999998764432


Q ss_pred             cccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc------ee
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK------VL  771 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~  771 (862)
                      . .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.....   ......+.+......      ..
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE---LEQLEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCchhhccccc
Confidence            2 11222356788999998765 4678999999999999999999998643222   122222222111000      00


Q ss_pred             e-----------eecccC-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 E-----------MVDSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 ~-----------~id~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      +           .....+ ......++..+.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0           000000 0011112567889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.2e-32  Score=297.95  Aligned_cols=266  Identities=23%  Similarity=0.344  Sum_probs=193.7

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCc-----
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE-----  612 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-----  612 (862)
                      .++|+..++||+|+||.||+|+.. +++.||||++....  ......+.+|++++++++||||+++++++.....     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            347889999999999999999875 48899999986542  2233456789999999999999999999876543     


Q ss_pred             ---eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccc
Q 002969          613 ---KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (862)
Q Consensus       613 ---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  689 (862)
                         .++|+||+.+ +|.+++...  ...+++.++..++.||++||+|||+.+   ++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence               4999999974 777777432  235899999999999999999999997   9999999999999999999999999


Q ss_pred             ceeecCCCCcc--cccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHh
Q 002969          690 MARIFGGDQTE--QNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK  766 (862)
Q Consensus       690 la~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~  766 (862)
                      ++..+......  .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...........+..+.....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99876432221  112234568899999988764 478899999999999999999988653322211111111110000


Q ss_pred             cC-----ceeeee------cccCCC-----CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          767 EG-----KVLEMV------DSSVDN-----YPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       767 ~~-----~~~~~i------d~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..     ...+..      ......     .+......+.+++.+||+.+|++||+++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00     000000      000000     01112345678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.4e-32  Score=291.93  Aligned_cols=256  Identities=21%  Similarity=0.306  Sum_probs=192.4

Q ss_pred             ccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcc-cCCceEEEEEEEeC--CceEEEEE
Q 002969          544 FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEM--DEKMLVYE  618 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~--~~~~lV~E  618 (862)
                      |+..++||+|+||.||+|+.. +++.||+|+++... ........+|+.++.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            556789999999999999865 47899999987542 222234457888999885 99999999999987  88999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |++ ++|.+.+....  ..+++.++..++.||+.||+|||+.+   ++||||+|+||+++. +.+||+|||+++.+....
T Consensus        81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 57777775432  45899999999999999999999998   999999999999999 999999999998764322


Q ss_pred             cccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHh-----------
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK-----------  766 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~-----------  766 (862)
                      ..   ....++..|+|||++.. ..++.++|||||||++|||++|..|+....   ..+.+........           
T Consensus       154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07831         154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN---ELDQIAKIHDVLGTPDAEVLKKFR  227 (282)
T ss_pred             Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC---HHHHHHHHHHHcCCCCHHHHHhhc
Confidence            21   22457889999997654 567889999999999999999999874322   1222222211111           


Q ss_pred             cCceeeeecc-----cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          767 EGKVLEMVDS-----SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       767 ~~~~~~~id~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .........+     .+.......+..+.+++.+||+.+|++||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000000000     001112234678899999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-33  Score=295.72  Aligned_cols=250  Identities=27%  Similarity=0.353  Sum_probs=205.3

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ..+.|+..++||+||||.||-++... |+.+|.|++.+.   .........+|-.+|.+++.+.||.+-..++..+.++|
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            34678889999999999999997655 889999988543   24455667899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      |+..|.||+|.-+|.+... .-+++..+.-++.+|+-||++||...   ||.||+||+|||||+.|+++|+|+|||..+.
T Consensus       263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence            9999999999999977655 45999999999999999999999997   9999999999999999999999999999874


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ...   .....+||.+|||||+++++.|+...|.|||||+||||+.|+.||-........   +++.+         .+-
T Consensus       339 ~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---eEvdr---------r~~  403 (591)
T KOG0986|consen  339 EGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---EEVDR---------RTL  403 (591)
T ss_pred             CCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---HHHHH---------HHh
Confidence            332   223348999999999999999999999999999999999999997432222111   01111         111


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMA  808 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  808 (862)
                      .....++...+.++..+....|++||++|....
T Consensus       404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            112345666777888999999999999996433

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-32  Score=322.90  Aligned_cols=259  Identities=29%  Similarity=0.435  Sum_probs=208.9

Q ss_pred             ccccccceeeccccEEEEEeEecC--------CcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCC
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE--------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD  611 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~  611 (862)
                      ++..+.+.||+|.||.|++|....        ...||||.++... ....+.+..|+++|+.+ +|+||+.++|+|...+
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            444555699999999999997531        3469999997653 34678899999999999 6999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhcc-------C----C--CCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec
Q 002969          612 EKMLVYEYMENRSLDSVIFDKA-------R----S--SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~-------~----~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~  678 (862)
                      ..++|.||++.|+|.++|....       .    .  ..++..+.+.++.|||.|++||++..   +|||||.++|||+.
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence            9999999999999999997654       0    0  23889999999999999999999987   99999999999999


Q ss_pred             CCCCeeEecccceeecCCCCcccccc-cccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchh
Q 002969          679 KEMTPKISDFGMARIFGGDQTEQNTK-RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELN  756 (862)
Q Consensus       679 ~~~~~kL~DFGla~~~~~~~~~~~~~-~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~  756 (862)
                      ++..+||+|||+|+............ ...-+..|||||.+....|+.|+|||||||+||||+| |..|+....      
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~------  526 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP------  526 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC------
Confidence            99999999999999764433322111 1013567999999999999999999999999999999 556643211      


Q ss_pred             HHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       757 l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ....+++.+++|..++.        |..+..++.++|+.||+.+|++||++.|+++.++..
T Consensus       527 ~~~~l~~~l~~G~r~~~--------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  527 PTEELLEFLKEGNRMEQ--------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             cHHHHHHHHhcCCCCCC--------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            11222445555554433        455677889999999999999999999999999884

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.7e-32  Score=296.18  Aligned_cols=246  Identities=28%  Similarity=0.429  Sum_probs=194.4

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      +.|...++||+|+||.||+|+.. +++.||+|++....   ....+++.+|+++++.++||||+++++++...+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45788899999999999999875 48899999986442   233457889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||++ |+|.+++....  ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++......
T Consensus        95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9997 56766664322  34899999999999999999999988   999999999999999999999999998764321


Q ss_pred             CcccccccccccccccChhhhc---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                            ....++..|+|||++.   ...++.++||||||+++|||++|+.|+...   +..   ......... .     
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~---~~~---~~~~~~~~~-~-----  230 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAM---SALYHIAQN-D-----  230 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc---cHH---HHHHHHhcC-C-----
Confidence                  1245788999999874   456889999999999999999999986321   111   111111110 0     


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                        .........+..+.+++.+||+.+|++||++.+|+..
T Consensus       231 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         231 --SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             --CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence              0011122345678899999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-32  Score=287.11  Aligned_cols=247  Identities=28%  Similarity=0.450  Sum_probs=202.8

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc--cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +|+..++||+|++|.||+++.. .++.|++|.+.....  ...+.+.+|++++++++|+|++++++++...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4677899999999999999876 478999999976543  4567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999998544   45899999999999999999999988   99999999999999999999999999987643322


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                      .  .....++..|+|||.+.+..++.++|||+||+++++|++|+.|+....   .   ....+....         ....
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~---~---~~~~~~~~~---------~~~~  217 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN---P---MAALFRIVQ---------DDHP  217 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc---H---HHHHHHHhc---------cCCC
Confidence            1  223467889999999988888999999999999999999999864322   1   111111111         0111


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..+...+..+.+++.+||+.+|++||++.+++.
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            223344567889999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.3e-32  Score=294.01  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=194.6

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCceEEEEEe
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +|+..++||+|+||.||+++... ++.+|+|++.... ......+.+|+.++.++. |+||+++++++......++++||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            45566899999999999998754 7899999987543 334567889999999996 99999999999999999999999


Q ss_pred             ccCCChhhhhhh--ccCCCCCCHhhHHHHHHHHHHHhHHhhhc-CCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          620 MENRSLDSVIFD--KARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       620 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      ++. +|.++...  ......+++..+.+++.|+++||+|||+. +   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            864 55554321  11234589999999999999999999975 5   99999999999999999999999999976533


Q ss_pred             CCcccccccccccccccChhhhcCC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeee
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDG---LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~---~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  773 (862)
                      ...   .....|+..|+|||.+.+.   .++.++||||||+++|||++|+.|+....     .......+... +.    
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~----  227 (288)
T cd06616         161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GD----  227 (288)
T ss_pred             CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CC----
Confidence            221   1223578899999998776   68999999999999999999999975332     11122211111 10    


Q ss_pred             ecccC-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          774 VDSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       774 id~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                       .+.+ ...+...+.++.+++.+||+.+|++||++.+|++.
T Consensus       228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0111 11223456678999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=307.19  Aligned_cols=251  Identities=25%  Similarity=0.402  Sum_probs=205.4

Q ss_pred             ccccccceeeccccEEEEEeEecCCc-EEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQ-EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~-~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      +.|.++..||.|+||.||+++..+.. ..|.|++........+.|.-|++||...+||+||+|++.|...+.+.++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            34666778999999999999876644 45778887778888999999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      .||-++.++..-.  ..|.+.++.-+++|++.||.|||++.   |||||||+.|||+.-+|.++|+|||.+...  ....
T Consensus       112 ~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn--~~t~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN--KSTR  184 (1187)
T ss_pred             CCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc--hhHH
Confidence            9999999886544  35899999999999999999999998   999999999999999999999999987643  2233


Q ss_pred             cccccccccccccChhhh-----cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          701 QNTKRVVGTYGYMSPEYA-----MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l-----~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      .....+.|||.|||||+.     ...+|+.++||||||++|.||..+.+|...      .+....+.+.-+... ..+  
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMRVllKiaKSeP-PTL--  255 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLLKIAKSEP-PTL--  255 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHHHHHHHhhcCC-Ccc--
Confidence            444568999999999986     457899999999999999999999998432      222223332222211 111  


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                          .-|.--...+.+++.+||.+||+.||++.++++
T Consensus       256 ----lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  256 ----LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ----cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                113334567889999999999999999999885

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.7e-32  Score=292.17  Aligned_cols=244  Identities=27%  Similarity=0.367  Sum_probs=193.9

Q ss_pred             eeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCCh
Q 002969          550 LGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (862)
Q Consensus       550 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL  625 (862)
                      ||+|+||+||++... +++.+|+|.+....   ....+.+..|++++++++||||+++++.+...+..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999765 48899999986532   23345678899999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccccccc
Q 002969          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR  705 (862)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  705 (862)
                      .+++..... ..+++.++..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++......   .....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~  153 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG  153 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence            999865432 35899999999999999999999998   999999999999999999999999998765321   11223


Q ss_pred             ccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHH
Q 002969          706 VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE  785 (862)
Q Consensus       706 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~  785 (862)
                      ..++..|+|||.+.+..++.++||||||++++||++|+.|+..........   .+.    ..     ........+...
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~----~~-----~~~~~~~~~~~~  221 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELK----RR-----TLEMAVEYPDKF  221 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHH----hc-----cccccccCCccC
Confidence            457789999999988889999999999999999999999975432211111   111    00     001111223344


Q ss_pred             HHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 002969          786 VLRCIHVGLLCVQENAEERP-----TMASVVL  812 (862)
Q Consensus       786 ~~~l~~li~~cl~~dP~~RP-----t~~evl~  812 (862)
                      ...+.+++.+||+.+|++||     ++.+++.
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            66788999999999999999     7777764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.2e-31  Score=293.89  Aligned_cols=262  Identities=26%  Similarity=0.372  Sum_probs=196.2

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeC--CceEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKML  615 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~l  615 (862)
                      .++|+..++||+|+||.||+|.... ++.||+|+++...  ......+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            3578899999999999999998754 8899999986542  22234567899999999999999999998765  46799


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      |+||+++ +|.+++....  ..+++.++..++.||++||+|||+.+   ++||||||+||+++.++.+||+|||++..+.
T Consensus        86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999974 7888875432  45899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc-----
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK-----  769 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-----  769 (862)
                      ....  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...   +....+..+........     
T Consensus       160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~---~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK---SEIEQLDLIIQLLGTPNESIWP  234 (309)
T ss_pred             CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHhcCCCChhhch
Confidence            3221  1122345788999999876 45789999999999999999999987532   22222222222111100     


Q ss_pred             ------eeeeec--cc-CCC---CChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          770 ------VLEMVD--SS-VDN---YPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       770 ------~~~~id--~~-~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                            ......  .. ...   ........+.+++.+||+.||++||++.|++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                  000000  00 000   001135567889999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1e-31  Score=300.23  Aligned_cols=259  Identities=24%  Similarity=0.320  Sum_probs=196.5

Q ss_pred             HcccccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeC------
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM------  610 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~------  610 (862)
                      ..++|+..+.||+|+||.||+++.. .++.||+|++...  .....+++.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3468999999999999999999875 5889999998643  233456778899999999999999999988643      


Q ss_pred             CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccc
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  690 (862)
                      ...++|+||+. ++|.+.+..     .++...+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            35799999996 477777632     1788899999999999999999998   99999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH-----
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW-----  765 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~-----  765 (862)
                      ++.......   .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+.....   ......+...+     
T Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~  238 (353)
T cd07850         165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH---IDQWNKIIEQLGTPSD  238 (353)
T ss_pred             ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence            987543221   2234578899999999999999999999999999999999998753221   11111111100     


Q ss_pred             -------------hcCce-------eeeecccC-----CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          766 -------------KEGKV-------LEMVDSSV-----DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       766 -------------~~~~~-------~~~id~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                                   ...+.       .+......     ...+...+..+.+++.+||+.||++||++.|++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                         00000       00000000     00122345667899999999999999999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.6e-32  Score=289.49  Aligned_cols=242  Identities=24%  Similarity=0.344  Sum_probs=195.7

Q ss_pred             eeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCCh
Q 002969          550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (862)
Q Consensus       550 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL  625 (862)
                      ||.|+||.||+++... ++.+|+|++....   ....+.+.+|+.++++++||||+++++.+.+....++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6899999999998865 8899999986542   23456799999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccccccc
Q 002969          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR  705 (862)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  705 (862)
                      .+++...   ..+++..+..++.||++||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            9998543   24889999999999999999999987   9999999999999999999999999998764332   1223


Q ss_pred             ccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHH
Q 002969          706 VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE  785 (862)
Q Consensus       706 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~  785 (862)
                      ..++..|+|||.+.+..++.++|+||||+++|||++|..|+.....+ .....    +....+       ......+...
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~----~~~~~~-------~~~~~~~~~~  219 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEIY----NDILKG-------NGKLEFPNYI  219 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHHH----HHHhcc-------CCCCCCCccc
Confidence            46788999999998888999999999999999999999997543221 11111    111100       0111223333


Q ss_pred             HHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 002969          786 VLRCIHVGLLCVQENAEERPT-----MASVVL  812 (862)
Q Consensus       786 ~~~l~~li~~cl~~dP~~RPt-----~~evl~  812 (862)
                      ...+.+++.+||+.+|++||+     +.|+++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            668899999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.7e-32  Score=299.74  Aligned_cols=262  Identities=26%  Similarity=0.377  Sum_probs=197.2

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeC--CceE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM--DEKM  614 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~--~~~~  614 (862)
                      .++|+..+.||+|+||.||+|... .++.+|+|++...  .......+.+|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            467888899999999999999876 4788999988543  233445678899999999 999999999998654  3579


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      +|+||++ ++|.+++...    .+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++..+
T Consensus        86 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            9999997 5888887432    5788999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCcc---cccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH-----
Q 002969          695 GGDQTE---QNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW-----  765 (862)
Q Consensus       695 ~~~~~~---~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~-----  765 (862)
                      ......   .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+......+   .........     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~  234 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN---QLEKIIEVIGPPSA  234 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCH
Confidence            433221   22233568899999998765 457899999999999999999999875322211   111110000     


Q ss_pred             ------hcC---ceeeeec----ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          766 ------KEG---KVLEMVD----SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       766 ------~~~---~~~~~id----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                            ...   ...+.+.    ..........+.++.+++.+||+.+|++||++.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                  000   0000000    00111112245678899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.8e-32  Score=286.25  Aligned_cols=251  Identities=26%  Similarity=0.399  Sum_probs=205.5

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc--cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +|+..+.||.|+||.||++... +++.+++|++.....  ...+++.+|+++++.++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777889999999999999876 488999999976532  4567889999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcc-CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          620 MENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       620 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      +++++|.+++.... ....+++..+..++.++++||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999986532 2356899999999999999999999997   9999999999999999999999999998764332


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                        .......+++.|+|||.+.+..++.++||||+|+++++|++|+.|+....   ..    ..........        .
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~----~~~~~~~~~~--------~  220 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LL----ELALKILKGQ--------Y  220 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HH----HHHHHHhcCC--------C
Confidence              12223468889999999999899999999999999999999999864322   11    1111111111        1


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ...+......+.+++.+||..+|++||++.|+++.
T Consensus       221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            22233455678899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.98  E-value=5.8e-32  Score=295.00  Aligned_cols=263  Identities=24%  Similarity=0.339  Sum_probs=197.4

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCC-----
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-----  611 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-----  611 (862)
                      ..++|++.++||+|+||.||+|.... ++.||+|+++...  ......+.+|++++++++||||+++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            45688999999999999999998864 7899999986542  233456788999999999999999999987654     


Q ss_pred             -----ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEe
Q 002969          612 -----EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS  686 (862)
Q Consensus       612 -----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~  686 (862)
                           ..++|+||+++ +|...+...  ...+++..+..++.||+.||+|||+.+   |+|+||||+||++++++.+||+
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence                 78999999986 666666433  335899999999999999999999998   9999999999999999999999


Q ss_pred             cccceeecCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH
Q 002969          687 DFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW  765 (862)
Q Consensus       687 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~  765 (862)
                      |||++..+...... ......++..|+|||.+.+ ..++.++|||||||+++||++|+.|+...   +....+..+.+..
T Consensus       159 dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~---~~~~~~~~~~~~~  234 (302)
T cd07864         159 DFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN---QELAQLELISRLC  234 (302)
T ss_pred             cccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHh
Confidence            99999876433221 1112345778999998865 45789999999999999999999886432   2222222222221


Q ss_pred             hcCcee---ee--------ec------ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          766 KEGKVL---EM--------VD------SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       766 ~~~~~~---~~--------id------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ......   ..        .+      ..........+..+.+++.+||+.+|++||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111000   00        00      0000111123567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=3e-32  Score=317.49  Aligned_cols=266  Identities=19%  Similarity=0.243  Sum_probs=186.5

Q ss_pred             cccccccceeeccccEEEEEeEecC--CcEEEEE------------------EeccCCccchHHHHHHHHHHHhcccCCc
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE--GQEIAVK------------------RLSRNSGQGIEEFKNEVRLIAKLQHRNL  600 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~HpnI  600 (862)
                      .++|++.++||+|+||+||++....  +...++|                  ++. .......++.+|+.++++++||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence            4689999999999999999986532  1112222                  111 122335578899999999999999


Q ss_pred             eEEEEEEEeCCceEEEEEeccCCChhhhhhhccC--CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec
Q 002969          601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR--SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (862)
Q Consensus       601 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~  678 (862)
                      +++++++...+..++|+|++. ++|.+++.....  .......+...|+.||+.||+|||+.+   |+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence            999999999999999999985 466666643221  122345667789999999999999998   99999999999999


Q ss_pred             CCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHH
Q 002969          679 KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL  758 (862)
Q Consensus       679 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~  758 (862)
                      .++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|..++...........+
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            9999999999999876432221 122357899999999999999999999999999999999987643222221111111


Q ss_pred             HHHHHHHhc--Cce-------eeee-----cccCCCCC-----hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          759 GHVWRLWKE--GKV-------LEMV-----DSSVDNYP-----ANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       759 ~~~~~~~~~--~~~-------~~~i-----d~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..+...+..  ...       .+.+     .......+     .....++.+++.+||+.||++||++.|++.
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            111111000  000       0000     00000000     012234667899999999999999999986

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.98  E-value=9.3e-32  Score=292.40  Aligned_cols=261  Identities=25%  Similarity=0.358  Sum_probs=195.0

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ++|+..++||+|++|.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++......++|+|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999876 57899999986542  2334678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC-CCCeeEecccceeecCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-EMTPKISDFGMARIFGGD  697 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~  697 (862)
                      |++ ++|.+++.... ...+++.....++.||+.||+|||+.+   ++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 57777764332 233678888899999999999999987   999999999999985 557999999999765322


Q ss_pred             CcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee-----
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL-----  771 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-----  771 (862)
                      .  .......+++.|+|||++.+ ..++.++||||||+++|||++|+.|+.....   .+...............     
T Consensus       157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE---IDELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChhhcccc
Confidence            1  11122356889999998866 4578999999999999999999998753211   11111111111110000     


Q ss_pred             -eeec----------ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 -EMVD----------SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 -~~id----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       ...+          ............++.+++.+|++.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0000          0000111234556889999999999999999999986

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.98  E-value=2.1e-32  Score=291.65  Aligned_cols=244  Identities=25%  Similarity=0.355  Sum_probs=196.2

Q ss_pred             eeccccEEEEEeEecC-CcEEEEEEeccCCc---cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCCh
Q 002969          550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (862)
Q Consensus       550 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL  625 (862)
                      ||+|+||.||+++... ++.+++|++.....   ...+.+.+|++++++++||||+++++.+......++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999875 89999999865432   4567889999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc------
Q 002969          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT------  699 (862)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~------  699 (862)
                      .+++....   .+++..+..++.||++||+|||+.+   ++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99986533   5899999999999999999999988   99999999999999999999999999876433211      


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                      ........++..|+|||.+.+...+.++||||||++++||++|+.|+....   .....    .....+..         
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~----~~~~~~~~---------  218 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET---PEEIF----QNILNGKI---------  218 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHH----HHHhcCCc---------
Confidence            112233567889999999988889999999999999999999999964322   11111    11111110         


Q ss_pred             CCChH--HHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          780 NYPAN--EVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       780 ~~~~~--~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      ..+..  .+..+.+++.+|++.+|++||++.++.+.|+
T Consensus       219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            11111  2567889999999999999999966666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.98  E-value=3.2e-32  Score=289.07  Aligned_cols=249  Identities=28%  Similarity=0.391  Sum_probs=203.4

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +|+..++||+|+||.||+++.. +++.+++|++....  .....++.+|++++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4777899999999999999765 47889999986542  33456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhcc-CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          620 MENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       620 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      +++++|.+++.... ....+++..++.++.|+++||+|||+.+   ++|+||+|.||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999986532 2345899999999999999999999998   999999999999999999999999999876443 


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                         ......++..|+|||.+.+..++.++|+||||++++||++|+.|+.....   ..+    ......+        ..
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~----~~~~~~~--------~~  218 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDL----RYKVQRG--------KY  218 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHH----HHHHhcC--------CC
Confidence               12224578899999999999999999999999999999999999743221   111    1111111        11


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ...+.....++.+++.+|++.+|++||++.|+++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            22334556778999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.98  E-value=7.5e-32  Score=293.15  Aligned_cols=244  Identities=25%  Similarity=0.369  Sum_probs=196.7

Q ss_pred             cceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCCh
Q 002969          547 YNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL  625 (862)
                      ..+||+|+||.||++... +++.||||++........+.+.+|+.++++++|+|++++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            368999999999999875 5889999998665555667799999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccccccc
Q 002969          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR  705 (862)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  705 (862)
                      .+++..    ..+++.....++.|++.+|+|||+.+   ++|+||+|+||++++++.++|+|||++..+....  .....
T Consensus       105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~  175 (292)
T cd06657         105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS  175 (292)
T ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence            998743    24788999999999999999999987   9999999999999999999999999987654322  11233


Q ss_pred             ccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHH
Q 002969          706 VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE  785 (862)
Q Consensus       706 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~  785 (862)
                      ..++..|+|||.+.+..++.++||||||+++|||++|..|+.....   .....    ......     ...... ....
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~----~~~~~~-----~~~~~~-~~~~  242 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMK----MIRDNL-----PPKLKN-LHKV  242 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH----HHHhhC-----CcccCC-cccC
Confidence            5678999999999888899999999999999999999999643211   11111    111110     111111 1223


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          786 VLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       786 ~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ...+.+++.+||+.+|.+||++.++++
T Consensus       243 ~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         243 SPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            456788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.98  E-value=3.2e-32  Score=302.31  Aligned_cols=265  Identities=23%  Similarity=0.324  Sum_probs=199.2

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeC-----Cc
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-----DE  612 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~~  612 (862)
                      .++|...+.||+|+||.||+++.. .++.||||++...  ......++.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            357889999999999999999865 4789999998653  233455778899999999999999999987654     35


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      .++|+||+. ++|.+++...   ..+++..+..++.||++||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 6888877433   35899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhc----
Q 002969          693 IFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE----  767 (862)
Q Consensus       693 ~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----  767 (862)
                      ......  .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+......   .....+......    
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~  231 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV---HQLKLITELLGSPSEE  231 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCChH
Confidence            654322  11223457889999998865 46889999999999999999999997532211   111111111100    


Q ss_pred             -------Cce-------eeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hccC
Q 002969          768 -------GKV-------LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM--LSSE  817 (862)
Q Consensus       768 -------~~~-------~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~  817 (862)
                             ...       ....+..........+.++.+++.+||+.+|++||+++|+++.  +...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                   000       0000000111122345678899999999999999999999976  5443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.98  E-value=1.8e-32  Score=285.00  Aligned_cols=265  Identities=25%  Similarity=0.305  Sum_probs=215.4

Q ss_pred             HHHHHHcccccccceeeccccEEEEEeEec------CCcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEE
Q 002969          535 ETIVRATDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCC  607 (862)
Q Consensus       535 ~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~  607 (862)
                      .++.....+++....+-+|.||.||.|.+.      +.+.|.||.++.. +.-....+..|.-.+.-+.|||+..+.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            344455566777788999999999999553      3456888888765 344677899999999999999999999998


Q ss_pred             EeC-CceEEEEEeccCCChhhhhh-----hccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC
Q 002969          608 VEM-DEKMLVYEYMENRSLDSVIF-----DKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM  681 (862)
Q Consensus       608 ~~~-~~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~  681 (862)
                      .+. +..+++|.++.-|+|..+|.     +......++..+...++.|++.|++|||.++   +||.||.++|++||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence            764 56788999999999999997     3333456888899999999999999999998   99999999999999999


Q ss_pred             CeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHH
Q 002969          682 TPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGH  760 (862)
Q Consensus       682 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~  760 (862)
                      ++||+|=.+++.+-..+..........+..||+||.+.+..|+.++|||||||+||||+| |+.|+..-++.       +
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf-------E  506 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF-------E  506 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-------H
Confidence            999999999997755544443333445789999999999999999999999999999998 77776432222       2


Q ss_pred             HHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          761 VWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       761 ~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ....+++|....        -|.+++.++..+|.-||...|++||+++|++.-|.+-
T Consensus       507 m~~ylkdGyRla--------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  507 MEHYLKDGYRLA--------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             HHHHHhccceec--------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            233344444333        2677889999999999999999999999999988763

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.98  E-value=1.4e-31  Score=291.24  Aligned_cols=255  Identities=19%  Similarity=0.227  Sum_probs=182.7

Q ss_pred             ccccccceeeccccEEEEEeEecCC----cEEEEEEeccCCccch-----------HHHHHHHHHHHhcccCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEG----QEIAVKRLSRNSGQGI-----------EEFKNEVRLIAKLQHRNLVRLLGC  606 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~HpnIv~l~g~  606 (862)
                      ++|.+.++||+|+||.||+|+..++    ..+|+|+.........           .....+...+..++|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5789999999999999999987654    3556665432221110           112233344556689999999998


Q ss_pred             EEeCC----ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC
Q 002969          607 CVEMD----EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT  682 (862)
Q Consensus       607 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~  682 (862)
                      +....    ..++++|++. .++.+.+...   ...++..+..|+.|+++||+|||+.+   |+||||||+|||++.++.
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence            76543    3466777664 3555555322   22567788899999999999999987   999999999999999999


Q ss_pred             eeEecccceeecCCCCcc-----cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhH
Q 002969          683 PKISDFGMARIFGGDQTE-----QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNL  757 (862)
Q Consensus       683 ~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l  757 (862)
                      ++|+|||+++.+......     .......||+.|+|||++.+..++.++|||||||+++||++|+.||.......  ..
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~~  242 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--NL  242 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--HH
Confidence            999999999876432211     11223468999999999999999999999999999999999999986442221  11


Q ss_pred             HHHH----HHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          758 LGHV----WRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       758 ~~~~----~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      ....    .+....+..          .....+..+.+++..|++.+|++||++.++++.|+
T Consensus       243 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        243 IHAAKCDFIKRLHEGKI----------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHhHHHHHHHhhhhhh----------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            1111    111111110          01223567889999999999999999999998764

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.98  E-value=5.9e-32  Score=291.64  Aligned_cols=258  Identities=24%  Similarity=0.381  Sum_probs=199.2

Q ss_pred             ccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc--cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          544 FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      |+..+.||+|++|.||++... +++.+++|++.....  .....+..|++++++++|+||+++++++...+..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456689999999999999875 588899999875532  24567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++ +|.+++....  ..+++..+..++.||++||.|||+.+   ++|+||||+||+++.++.+||+|||.+.......  
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            75 8888775432  45899999999999999999999998   9999999999999999999999999998765433  


Q ss_pred             cccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc---eeeeec-
Q 002969          701 QNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK---VLEMVD-  775 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~id-  775 (862)
                      .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.|+....   ..+.+....+......   .....+ 
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS---EIDQLFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHcCCCchHhcccchhh
Confidence            112224577889999998876 78999999999999999999998864322   1222222211111100   000000 


Q ss_pred             -------------ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          776 -------------SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       776 -------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                                   ..........+.++.+++.+||+.+|.+||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                         0001112234667889999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.98  E-value=1.9e-31  Score=293.57  Aligned_cols=249  Identities=28%  Similarity=0.418  Sum_probs=195.9

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .|...+.||+|+||.||+++.. +++.+|+|++....   ....+++.+|++++++++|||++++++++.+....++|+|
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3677789999999999999865 47899999986442   2334578899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++ +|.+++...  ...+++.++..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++.....  
T Consensus       106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            9974 777766432  234899999999999999999999998   99999999999999999999999999875432  


Q ss_pred             cccccccccccccccChhhhc---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          699 TEQNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                          .....++..|+|||++.   .+.++.++||||||+++|||++|+.|+...   ......   ........      
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~---~~~~~~---~~~~~~~~------  241 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSAL---YHIAQNES------  241 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc---cHHHHH---HHHHhccC------
Confidence                12245788999999974   456889999999999999999999986432   111111   11111110      


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                        ...........+.+++.+||+.+|++||++.+|++.+-..
T Consensus       242 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         242 --PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             --CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence              0111223445688999999999999999999999865443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=3.4e-32  Score=300.27  Aligned_cols=244  Identities=25%  Similarity=0.364  Sum_probs=205.5

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ....|.+.+.||+|.|+.|.+|++.. +..||||.+.+..  ....+.+.+|+++|+.++|||||+++.+......+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            34578888999999999999998765 8899999997763  23345689999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||..+|.+.+++.++.+   ..+.....++.|+.+|++|||+++   |+|||||++||||+.+.++||+|||++..+. 
T Consensus       134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD-  206 (596)
T ss_pred             EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec-
Confidence            999999999999976654   455778889999999999999998   9999999999999999999999999998875 


Q ss_pred             CCcccccccccccccccChhhhcCCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLF-SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                        ........+|++.|.|||++.+..| .+++|+||+|++||-|+.|..||+..                    ..+.++
T Consensus       207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~--------------------~lk~Lr  264 (596)
T KOG0586|consen  207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ--------------------NLKELR  264 (596)
T ss_pred             --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc--------------------cccccc
Confidence              2333445789999999999999876 58999999999999999999997521                    111111


Q ss_pred             ccC----CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          776 SSV----DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       776 ~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ++.    -..+.....++.++++++|-.+|.+|++++++.+
T Consensus       265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            111    1234445667889999999999999999999975

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.7e-31  Score=285.56  Aligned_cols=250  Identities=25%  Similarity=0.380  Sum_probs=198.0

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccC-----CccchHHHHHHHHHHHhcccCCceEEEEEEEeC--Cce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-----SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~  613 (862)
                      .+|+..+.||+|+||.||+|+... ++.||+|++...     .....+.+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            468888999999999999998754 889999987532     233456889999999999999999999998764  457


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++++||+++++|.+++...   ..+++....+++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            8999999999999988543   23788899999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCc-ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          694 FGGDQT-EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       694 ~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      ...... ........++..|+|||++.+..++.++|+||||++++||++|+.|+....   .   ...+.+.....    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~---~~~~~~~~~~~----  225 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE---A---MAAIFKIATQP----  225 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC---H---HHHHHHHHcCC----
Confidence            543211 111223568899999999998889999999999999999999999974321   1   11111111110    


Q ss_pred             eecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                          .....+......+.+++.+|++ +|..||+..+++.
T Consensus       226 ----~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         226 ----TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ----CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                1122344556778899999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.98  E-value=3.8e-31  Score=285.89  Aligned_cols=258  Identities=24%  Similarity=0.356  Sum_probs=195.0

Q ss_pred             ccccceeeccccEEEEEeEecC-CcEEEEEEeccCCc--cchHHHHHHHHHHHhc---ccCCceEEEEEEEeCCc-----
Q 002969          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG--QGIEEFKNEVRLIAKL---QHRNLVRLLGCCVEMDE-----  612 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~l~g~~~~~~~-----  612 (862)
                      |++.++||+|+||.||+|+... ++.+|+|+++....  .....+.+|+.+++++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5667899999999999999865 88999999974422  2234567788887776   59999999999988776     


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      .+++|||+.+ +|.+++..... ..+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999974 78888754332 35899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee-
Q 002969          693 IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL-  771 (862)
Q Consensus       693 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-  771 (862)
                      .+.....   .....++..|+|||++.+..++.++||||||+++|||++|++|+...   ........+.......... 
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGT---SEADQLDKIFDVIGLPSEEE  229 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCC---ChHHHHHHHHHHcCCCChHh
Confidence            7643321   12234688999999999999999999999999999999998876432   2222222222211110000 


Q ss_pred             ---------eeecccC----CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 ---------EMVDSSV----DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 ---------~~id~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                               .......    ..........+.+++.+||+.+|++||++.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                     0000000    1111233466789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.98  E-value=2.2e-31  Score=292.33  Aligned_cols=259  Identities=20%  Similarity=0.204  Sum_probs=192.2

Q ss_pred             cceeeccccEEEEEeEecCCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCC
Q 002969          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRS  624 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs  624 (862)
                      .+.+|.|+++.||+++. +++.||||++...  .....+.+.+|+++++.++|+||+++++++.+.+..+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455556666666655 6899999998754  34456789999999999999999999999999999999999999999


Q ss_pred             hhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc-----
Q 002969          625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT-----  699 (862)
Q Consensus       625 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~-----  699 (862)
                      |.+++..... ..+++.....++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||.+..+.....     
T Consensus        86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            9999865432 34788899999999999999999998   99999999999999999999999999876532211     


Q ss_pred             ccccccccccccccChhhhcC--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH----h-------
Q 002969          700 EQNTKRVVGTYGYMSPEYAMD--GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW----K-------  766 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~----~-------  766 (862)
                      ........++..|+|||++..  ..++.++||||||+++|||++|+.||.....  .....+......    .       
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA--TQMLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCccccccCchhhh
Confidence            111123456788999999876  3588999999999999999999999753221  111111110000    0       


Q ss_pred             cCceee----eecc-----cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          767 EGKVLE----MVDS-----SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       767 ~~~~~~----~id~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ......    ..+.     ...........++.+++.+||+.+|++||++.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            000000    0000     001122334567889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=5.1e-31  Score=282.75  Aligned_cols=248  Identities=22%  Similarity=0.280  Sum_probs=190.6

Q ss_pred             HHHHHccccccccee--eccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCC
Q 002969          536 TIVRATDNFTDYNKL--GQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD  611 (862)
Q Consensus       536 ~i~~~~~~f~~~~~L--G~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~  611 (862)
                      ++....++|++.+.+  |+|+||.||+++.. .++.+|+|.+........     |+.....+ +||||+++++.+...+
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence            334445667777776  99999999999865 477899998865422111     22222223 7999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC-CeeEecccc
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGM  690 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGl  690 (862)
                      ..++||||+++++|.+++....   .+++.++..++.||++||.|||+.+   ++||||||+||+++.++ .++|+|||+
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            9999999999999999985432   6899999999999999999999998   99999999999999998 999999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV  770 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  770 (862)
                      ++......      ...++..|+|||++.+..++.++||||||++++||++|+.|+..... +.... ....... .   
T Consensus       157 ~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~-~~~~~~~-~---  224 (267)
T PHA03390        157 CKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDL-ESLLKRQ-Q---  224 (267)
T ss_pred             ceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhH-HHHHHhh-c---
Confidence            87653221      23578899999999999999999999999999999999999763221 11111 1111111 0   


Q ss_pred             eeeecccCCCCChHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 002969          771 LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPT-MASVVL  812 (862)
Q Consensus       771 ~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~  812 (862)
                           . ........+..+.+++.+||+.+|.+||+ ++|+++
T Consensus       225 -----~-~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        225 -----K-KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -----c-cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                 0 11122245667889999999999999996 688874

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=1.8e-32  Score=319.98  Aligned_cols=256  Identities=30%  Similarity=0.462  Sum_probs=192.4

Q ss_pred             HHHcccccccceeeccccEEEEEeEec-CCcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEe------
Q 002969          538 VRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE------  609 (862)
Q Consensus       538 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------  609 (862)
                      .+...+|++++.||+||||.||+++.+ ||+.+|||++... +........+|+..+++|+|||||+++....+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            456678999999999999999999864 7999999999765 34456678899999999999999999842100      


Q ss_pred             -----------------------------------------------------------C--------------------
Q 002969          610 -----------------------------------------------------------M--------------------  610 (862)
Q Consensus       610 -----------------------------------------------------------~--------------------  610 (862)
                                                                                 .                    
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                       0                    


Q ss_pred             ----------------------------------CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHH
Q 002969          611 ----------------------------------DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY  656 (862)
Q Consensus       611 ----------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~y  656 (862)
                                                        ..+|+-||||+...|.+++..+....  .....++++.+|++||+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence                                              11367889999888888885443221  356778999999999999


Q ss_pred             hhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC----C------------CCcccccccccccccccChhhhcC
Q 002969          657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG----G------------DQTEQNTKRVVGTYGYMSPEYAMD  720 (862)
Q Consensus       657 LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~APE~l~~  720 (862)
                      +|+++   ||||||||.||+|+++..+||+|||+|....    .            .......+..+||.-|+|||++.+
T Consensus       713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99998   9999999999999999999999999998721    0            001113345789999999999976


Q ss_pred             C---CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhcc
Q 002969          721 G---LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCV  797 (862)
Q Consensus       721 ~---~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl  797 (862)
                      .   +|+.|+|+|||||||+||+.-   |+  ...+....+    ..++.+.+..-     ..+.......-..++.+|+
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~yP---F~--TsMERa~iL----~~LR~g~iP~~-----~~f~~~~~~~e~slI~~Ll  855 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLYP---FG--TSMERASIL----TNLRKGSIPEP-----ADFFDPEHPEEASLIRWLL  855 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhcc---CC--chHHHHHHH----HhcccCCCCCC-----cccccccchHHHHHHHHHh
Confidence            5   499999999999999999873   21  112221111    11222221111     2234445556678999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 002969          798 QENAEERPTMASVVL  812 (862)
Q Consensus       798 ~~dP~~RPt~~evl~  812 (862)
                      +.||.+|||+.|+|.
T Consensus       856 ~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  856 SHDPSKRPTATELLN  870 (1351)
T ss_pred             cCCCccCCCHHHHhh
Confidence            999999999999985

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=1e-31  Score=292.53  Aligned_cols=251  Identities=23%  Similarity=0.379  Sum_probs=193.2

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ++|+..++||+|+||.||+|+... ++.||||+++... .....++..|+.++.+.. ||||+++++++.+....+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            567888999999999999999876 8899999997543 234456677887777775 9999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc-CCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      |++ ++|.+++....  ..+++..+.+++.||++||+|||+. +   |+||||+|+||++++++.+||+|||++..+...
T Consensus        95 ~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          95 LMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             ccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            986 46777664422  3689999999999999999999974 5   999999999999999999999999998765332


Q ss_pred             CcccccccccccccccChhhhcCCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeee
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGL----FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~----~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  773 (862)
                      ...   ....++..|+|||.+.+..    ++.++||||||+++|||++|+.|+......     .+...+..... .   
T Consensus       169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~---  236 (296)
T cd06618         169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-P---  236 (296)
T ss_pred             Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-C---
Confidence            211   2235678999999987554    788999999999999999999997432111     11111111111 0   


Q ss_pred             ecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       774 id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                        ... ........++.+++.+||+.+|++||++.++++.
T Consensus       237 --~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 --PSL-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             --CCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              001 0111245678899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.6e-31  Score=283.31  Aligned_cols=243  Identities=22%  Similarity=0.244  Sum_probs=188.2

Q ss_pred             ceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHH-HhcccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLI-AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l-~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      +.||+|+||.||+|... .++.||+|+++...   ......+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999875 47899999986542   12233445555544 345899999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      ++|.+++...   ..+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.+||+|||+++....      
T Consensus        82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            9999998543   34889999999999999999999987   99999999999999999999999999876432      


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP  782 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~  782 (862)
                      .....++..|+|||.+.+..++.++||||||+++|||++|..|+...   .....    +.........     ......
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~---~~~~~----~~~~~~~~~~-----~~~~~~  217 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE---TPDAV----FDNILSRRIN-----WPEEVK  217 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC---CHHHH----HHHHHhcccC-----CCCccc
Confidence            22345788999999998888999999999999999999999997422   11111    1111111100     001112


Q ss_pred             hHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 002969          783 ANEVLRCIHVGLLCVQENAEERPTMASVVLML  814 (862)
Q Consensus       783 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  814 (862)
                      ...+..+.+++.+||+.+|++||++.++.+.|
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            23456788999999999999999776555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=3.5e-31  Score=287.34  Aligned_cols=251  Identities=24%  Similarity=0.307  Sum_probs=196.3

Q ss_pred             cccccceeeccccEEEEEeEe----cCCcEEEEEEeccCC----ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCce
Q 002969          543 NFTDYNKLGQGGFGIVYKGRL----LEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~  613 (862)
                      +|+..+.||+|+||.||+++.    .+++.||+|++....    ....+++.+|+.+++++ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            367788999999999999976    357899999987532    22346788999999999 599999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++|+||+++++|.+++...   ..+++..+..++.||++||.|||+.+   ++||||+|+|||++.++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            9999999999999998543   34788899999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccccChhhhcCC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMDG--LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      +...... ......|+..|+|||.+...  .++.++||||||+++|||++|+.|+.......  .. ....+....    
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~-~~~~~~~~~----  226 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQ-AEISRRILK----  226 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cH-HHHHHHhhc----
Confidence            6432221 12235688999999998753  46789999999999999999999975321111  11 111111110    


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERP-----TMASVVL  812 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  812 (862)
                           ....++......+.+++.+||+.+|++||     ++.+++.
T Consensus       227 -----~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         227 -----SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -----cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                 01122334456778999999999999997     7777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.2e-31  Score=296.28  Aligned_cols=260  Identities=23%  Similarity=0.359  Sum_probs=194.2

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCC------
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD------  611 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~------  611 (862)
                      .++|...+.||+|+||.||+|+.. .++.||||++...  .......+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            368888999999999999999865 5889999998653  2233456889999999999999999999987543      


Q ss_pred             ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccce
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  691 (862)
                      ..++|+||+.. +|..++     ...+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            45899999964 666554     224889999999999999999999998   999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHh----
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK----  766 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~----  766 (862)
                      +.....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....   ....+..+.....    
T Consensus       165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~~  236 (342)
T cd07879         165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD---YLDQLTQILKVTGVPGP  236 (342)
T ss_pred             cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCCH
Confidence            764221     123457889999999876 468899999999999999999999975321   1111211111100    


Q ss_pred             -------cCceeeeec-------ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hccC
Q 002969          767 -------EGKVLEMVD-------SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM--LSSE  817 (862)
Q Consensus       767 -------~~~~~~~id-------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~  817 (862)
                             .......+.       .......+.....+.+++.+||+.||++||++.|++..  ++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence                   000000000       00000011234567899999999999999999999954  6555

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=9.8e-32  Score=298.03  Aligned_cols=262  Identities=21%  Similarity=0.346  Sum_probs=197.5

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEe----CCceE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE----MDEKM  614 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----~~~~~  614 (862)
                      ++|+..+.||+|+||.||+|+... ++.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            678888999999999999998654 8899999987542  2345678889999999999999999988753    34679


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      +|+||+. ++|.+++...   ..+++..+..++.||++||+|||+.+   ++||||||+||++++++.+||+|||++...
T Consensus        85 lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          85 VVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence            9999996 5888887432   34899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCcc--cccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH------
Q 002969          695 GGDQTE--QNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW------  765 (862)
Q Consensus       695 ~~~~~~--~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~------  765 (862)
                      ......  .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.....   ...+..+....      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~---~~~~~~~~~~~g~~~~~  234 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY---VHQLKLILSVLGSPSEE  234 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh---HHHHHHHHHHhCCChhH
Confidence            433221  11123468889999999866 4588999999999999999999999743211   11111111110      


Q ss_pred             -----hcCceeeeeccc--CCC-----CChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          766 -----KEGKVLEMVDSS--VDN-----YPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       766 -----~~~~~~~~id~~--~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                           ......+..+..  ...     .....+.++.+++.+||+.+|++||++.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                 000000000000  001     112346678999999999999999999999873

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=1.8e-31  Score=292.10  Aligned_cols=263  Identities=24%  Similarity=0.357  Sum_probs=193.6

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCC------
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD------  611 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~------  611 (862)
                      .++|+..++||+|+||.||+|+.. +++.+|||++....  ......+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999875 47899999986542  222346788999999999999999999875543      


Q ss_pred             --ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccc
Q 002969          612 --EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (862)
Q Consensus       612 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  689 (862)
                        ..++|+||+.+ +|...+...  ...+++.++..++.||++||+|||+.+   ++|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              45999999975 566666432  335899999999999999999999998   9999999999999999999999999


Q ss_pred             ceeecCCCCccc---------ccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHH
Q 002969          690 MARIFGGDQTEQ---------NTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLG  759 (862)
Q Consensus       690 la~~~~~~~~~~---------~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~  759 (862)
                      +++.........         ......+++.|+|||.+.+. .++.++||||||+++|||++|++|+.....   .....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~---~~~~~  237 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD---IDQLH  237 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH---HHHHH
Confidence            998654322111         11234568889999988654 588999999999999999999988643221   22222


Q ss_pred             HHHHHHhcCc---------eeeee----c----ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          760 HVWRLWKEGK---------VLEMV----D----SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       760 ~~~~~~~~~~---------~~~~i----d----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .+........         .....    .    +.+..........+.+++.+||+.+|++||++.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            2222111000         00000    0    0000001122356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=2.8e-31  Score=287.81  Aligned_cols=256  Identities=23%  Similarity=0.302  Sum_probs=200.2

Q ss_pred             cccccceeeccccEEEEEeEec----CCcEEEEEEeccCC----ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCce
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~  613 (862)
                      +|+..+.||+|++|.||+++..    +++.||||.++...    ....+.+.+|+.++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3677789999999999998743    46789999986432    23346788999999999 599999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++||||+++++|.+++...   ..+++..+..++.|++++|+|||+.+   ++||||+|+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            9999999999999988543   34888999999999999999999987   99999999999999999999999999887


Q ss_pred             cCCCCcccccccccccccccChhhhcCCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGL--FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      +...... ......|+..|+|||.+.+..  .+.++||||||++++||++|..|+.......   ......+.....   
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~---  227 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSEISRRILKS---  227 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHHHHHHHHcc---
Confidence            5433221 122346788999999987765  7889999999999999999999975322111   111111111110   


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                            ....+......+.+++.+||+.+|++|||+.++.+.|+-.
T Consensus       228 ------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         228 ------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             ------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence                  1122333456778999999999999999999888777553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=2.8e-31  Score=294.44  Aligned_cols=261  Identities=25%  Similarity=0.312  Sum_probs=195.5

Q ss_pred             ccccc-cceeeccccEEEEEeEec-CCcEEEEEEeccCCccc--------------hHHHHHHHHHHHhcccCCceEEEE
Q 002969          542 DNFTD-YNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQG--------------IEEFKNEVRLIAKLQHRNLVRLLG  605 (862)
Q Consensus       542 ~~f~~-~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~g  605 (862)
                      ++|.. .+.||+|+||.||+|... .++.||||+++......              ...+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            34543 467999999999999865 58899999986542211              125778999999999999999999


Q ss_pred             EEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeE
Q 002969          606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (862)
Q Consensus       606 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL  685 (862)
                      ++...+..++||||++ ++|.+++...   ..+++.....++.|+++||+|||+.+   ++|+||+|+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999997 6888888432   34889999999999999999999988   999999999999999999999


Q ss_pred             ecccceeecCCCCc------------ccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 002969          686 SDFGMARIFGGDQT------------EQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSN  752 (862)
Q Consensus       686 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~  752 (862)
                      +|||+++.......            ........++..|+|||.+.+. .++.++||||||+++|||++|+.|+....  
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~--  238 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN--  238 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--
Confidence            99999987642110            1111123467889999998764 46899999999999999999999865322  


Q ss_pred             cchhHHHHHHHHHhcCcee---e--------eec----ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          753 NELNLLGHVWRLWKEGKVL---E--------MVD----SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       753 ~~~~l~~~~~~~~~~~~~~---~--------~id----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       .......+..........   +        ...    ............++.+++.+||+.+|++||++.|++.
T Consensus       239 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        239 -EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             -HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence             222233332222111100   0        000    0000111223566889999999999999999999986

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=5.7e-31  Score=284.08  Aligned_cols=241  Identities=24%  Similarity=0.303  Sum_probs=187.5

Q ss_pred             eeeccccEEEEEeEecC-CcEEEEEEeccCCc---cchHHHHHHHHHHH---hcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIA---KLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       549 ~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~---~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      .||+|+||.||+++... ++.||+|.+.....   .....+..|..+++   ...||||+++++++...+..++|+||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999998754 78999999865421   22223445544443   4479999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +++|..++...   ..+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++..+....   
T Consensus        81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            99999888533   35899999999999999999999987   9999999999999999999999999987653221   


Q ss_pred             ccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                       .....|+..|+|||.+.++ .++.++||||+|+++|||++|+.|+..........    ..+....         ....
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~---------~~~~  217 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT---------MAVE  217 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhc---------cCCC
Confidence             1234689999999998754 68999999999999999999999975432222111    1111100         0112


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERP-----TMASVVL  812 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  812 (862)
                      .+...+.++.+++.+|++.+|++||     ++.++++
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            2333467888999999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.9e-33  Score=326.04  Aligned_cols=256  Identities=26%  Similarity=0.358  Sum_probs=205.2

Q ss_pred             HHcccccccceeeccccEEEEEeEecC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       539 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ..+-++....+||.|.||.||.+...+ |...|+|-++..  .........+|+.++..++|||+|+++|+-.+.+..++
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            344566777899999999999997654 778899977543  23456678899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      .||||++|+|.+++...   ...++.....+..|++.|++|||+++   ||||||||.||+|+.+|.+|++|||.|..+.
T Consensus      1312 FMEyC~~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHhccCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence            99999999999998543   23566666678899999999999999   9999999999999999999999999999886


Q ss_pred             CCC--cccccccccccccccChhhhcCCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce
Q 002969          696 GDQ--TEQNTKRVVGTYGYMSPEYAMDGL---FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV  770 (862)
Q Consensus       696 ~~~--~~~~~~~~~gt~~y~APE~l~~~~---~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  770 (862)
                      +..  .........||+.|||||++.+..   ..-++||||+||++.||+||++||..++.+=     . +.-.+.-+. 
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-----a-IMy~V~~gh- 1458 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-----A-IMYHVAAGH- 1458 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-----H-HHhHHhccC-
Confidence            542  123334578999999999997643   4568999999999999999999986543321     0 111122222 


Q ss_pred             eeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 002969          771 LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML  814 (862)
Q Consensus       771 ~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  814 (862)
                             .+..|...+.+-.+++..||+.||+.|.++.|+++.-
T Consensus      1459 -------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1459 -------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             -------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence                   1344555667778999999999999999999888753

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=5.4e-32  Score=302.22  Aligned_cols=203  Identities=30%  Similarity=0.465  Sum_probs=175.5

Q ss_pred             ccccceeeccccEEEEEeEec-CCcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeC------CceEE
Q 002969          544 FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM------DEKML  615 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~------~~~~l  615 (862)
                      +...+.||+|+||.||+|+.. .|+.||||.++.. .....+...+|+++|++++|+|||++++.-.+.      ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            344578999999999999954 5999999999764 345667889999999999999999999986554      35789


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe--cCCC--CeeEecccce
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL--DKEM--TPKISDFGMA  691 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl--~~~~--~~kL~DFGla  691 (862)
                      |||||.+|||+..|.+.++..-|++.+.+.++.+++.||.|||+++   |+||||||.||++  .++|  ..||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999988777777999999999999999999999988   9999999999998  3444  4799999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSN  752 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~  752 (862)
                      +.+..+.   ....++||..|++||+... +.|+..+|.|||||++||++||..||......
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            9875433   5566899999999999985 88999999999999999999999998654433

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=4.2e-31  Score=289.55  Aligned_cols=247  Identities=28%  Similarity=0.414  Sum_probs=194.4

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .|+..+.||+|+||.||+|+... ++.+|+|.+...   .....+++.+|+++++.++|+|++++++++......++|+|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            46667899999999999998754 788999998643   22345678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+. ++|.+++....  ..+++.++..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++...... 
T Consensus        96 ~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          96 YCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             ccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            997 57777764332  34789999999999999999999987   999999999999999999999999998765321 


Q ss_pred             cccccccccccccccChhhhc---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          699 TEQNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                           ....++..|+|||.+.   ...++.++||||||+++|||++|+.|+......   ..   ... ...+..     
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~---~~~-~~~~~~-----  231 (308)
T cd06634         169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SA---LYH-IAQNES-----  231 (308)
T ss_pred             -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH---HH---HHH-HhhcCC-----
Confidence                 2245788999999974   356788999999999999999999986432111   11   111 111110     


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                        ...........+.+++.+||+.+|++||++.+|++..-
T Consensus       232 --~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         232 --PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             --CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence              01112234567889999999999999999999997643

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=6.8e-31  Score=290.53  Aligned_cols=259  Identities=22%  Similarity=0.283  Sum_probs=190.7

Q ss_pred             ceeecc--ccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQG--GFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      ..||+|  +||+||+++.. .++.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  99999999875 58999999986542  23457889999999999999999999999999999999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc-
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ-  701 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-  701 (862)
                      ++|.+++..... ..+++..+..++.||+.||+|||+.+   ++||||||+|||++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            999998865432 34888999999999999999999987   9999999999999999999999998654332111100 


Q ss_pred             ----ccccccccccccChhhhcCC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHH------------
Q 002969          702 ----NTKRVVGTYGYMSPEYAMDG--LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR------------  763 (862)
Q Consensus       702 ----~~~~~~gt~~y~APE~l~~~--~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~------------  763 (862)
                          ......++..|+|||++.+.  .++.++|||||||++|||++|+.|+.......  ........            
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccc
Confidence                01112345679999999764  47899999999999999999999975322110  11000000            


Q ss_pred             ----HHh-----------cCc-----eeeeecccC-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          764 ----LWK-----------EGK-----VLEMVDSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       764 ----~~~-----------~~~-----~~~~id~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                          .+.           +..     ........+ ..........+.+|+.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                000           000     000000111 1112345667899999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-31  Score=287.96  Aligned_cols=259  Identities=25%  Similarity=0.321  Sum_probs=195.0

Q ss_pred             ccccceeeccccEEEEEeEecC-CcEEEEEEeccCCc-cchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCceEEEEEec
Q 002969          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      |++.+.||+|+||.||+|+..+ ++.|+||++..... .......+|+..+++++ |+|++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            5667899999999999998864 78899999865432 22334567999999999 999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                       +++|.+++.... ...+++.++..++.|++++|.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             889988885543 245899999999999999999999988   99999999999999999999999999986543221 


Q ss_pred             cccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHh-------------
Q 002969          701 QNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK-------------  766 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~-------------  766 (862)
                        .....++..|+|||++.. ..++.++|+||||++++||++|+.|+......+   .+......+.             
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID---QLYKICSVLGTPTKQDWPEGYKL  229 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH---HHHHHHHhcCCCChhhhhhHhhh
Confidence              122457889999998754 457899999999999999999998864332211   1111110000             


Q ss_pred             cCceeeeeccc----CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          767 EGKVLEMVDSS----VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       767 ~~~~~~~id~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .......+...    +.........++.+++.+||+.+|++||+++|++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000000    011111224678899999999999999999999753

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=9.2e-32  Score=289.50  Aligned_cols=249  Identities=25%  Similarity=0.348  Sum_probs=202.2

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCceEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ++|...+.||+|+||.||+++.. +++.||+|++...   .....+.+.+|+.++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36788899999999999999876 5889999998653   2334567889999999998 99999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999985432   5999999999999999999999988   99999999999999999999999999987643


Q ss_pred             CCcc------------------cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHH
Q 002969          697 DQTE------------------QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL  758 (862)
Q Consensus       697 ~~~~------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~  758 (862)
                      ....                  .......++..|+|||.+....++.++||||||++++|+++|+.|+....   .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~  231 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN---EYLTF  231 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc---HHHHH
Confidence            3221                  12223467889999999998889999999999999999999999965322   11111


Q ss_pred             HHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCH----HHHHH
Q 002969          759 GHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTM----ASVVL  812 (862)
Q Consensus       759 ~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~  812 (862)
                      ...    ..         .....+...+..+.+++.+||+.+|++||++    +++++
T Consensus       232 ~~~----~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         232 QKI----LK---------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHH----Hh---------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            111    10         1112233446678899999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=4.1e-31  Score=284.91  Aligned_cols=258  Identities=26%  Similarity=0.389  Sum_probs=197.9

Q ss_pred             ccccceeeccccEEEEEeEecC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      |+..+.||+|++|.||+|+... ++.+|+|++....  ....+.+..|+.++++++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            4556889999999999998865 8899999997653  334567889999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      + ++|.+++....  ..+++..+..++.|+++||+|||+.+   ++||||+|+||++++++.+||+|||++........ 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            8 58999986542  35899999999999999999999998   99999999999999999999999999987643221 


Q ss_pred             cccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcC--------cee
Q 002969          701 QNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG--------KVL  771 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------~~~  771 (862)
                       ......++..|+|||.+.+. .++.++||||||++++||++|+.|+....   ....+..+.+.....        ...
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS---EIDQLFKIFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHHHhCCCcHHHHHhhccc
Confidence             11223457789999998776 78999999999999999999988864321   112222221111100        000


Q ss_pred             eeecccCC--------CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 EMVDSSVD--------NYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 ~~id~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ...+....        ...+.....+.+++.+||+.+|++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000000        111122567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.4e-31  Score=294.24  Aligned_cols=265  Identities=25%  Similarity=0.329  Sum_probs=202.3

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCC-----ceE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-----EKM  614 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~  614 (862)
                      +|++.++||+|+||.||+|+... ++.||+|++....  ....+.+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            47788999999999999998765 8899999987643  345578999999999999999999999988775     789


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      +++||++ ++|.+++...   ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999998 4788887443   26899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcc-cccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc---
Q 002969          695 GGDQTE-QNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK---  769 (862)
Q Consensus       695 ~~~~~~-~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---  769 (862)
                      ...... .......++..|+|||.+.+. .++.++|+||||+++++|++|+.|+.....   ......+........   
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~  230 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY---IDQLNLIVEVLGTPSEED  230 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHhcCCCChhH
Confidence            443210 112234578899999999887 789999999999999999999998743221   111111111110000   


Q ss_pred             --------eeeeecc-------cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hccC
Q 002969          770 --------VLEMVDS-------SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM--LSSE  817 (862)
Q Consensus       770 --------~~~~id~-------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~  817 (862)
                              ..+.+..       .........+..+.+++.+||+.+|++||++.+++..  +++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence                    0000000       0011112245678899999999999999999999974  5443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=6.9e-31  Score=292.32  Aligned_cols=259  Identities=24%  Similarity=0.349  Sum_probs=195.1

Q ss_pred             HHHcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCC---
Q 002969          538 VRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD---  611 (862)
Q Consensus       538 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~---  611 (862)
                      ....++|+..+.||+|+||.||++... +++.||||++....  ....+.+.+|+.++++++||||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            334678999999999999999999764 58899999986432  233457889999999999999999999987543   


Q ss_pred             ---ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecc
Q 002969          612 ---EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDF  688 (862)
Q Consensus       612 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF  688 (862)
                         ..++|+||+ +++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence               358999999 6788887742    34889999999999999999999988   999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHH---
Q 002969          689 GMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL---  764 (862)
Q Consensus       689 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~---  764 (862)
                      |++......     .....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.|+.....   ........+.   
T Consensus       163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~---~~~~~~~~~~~~~  234 (343)
T cd07880         163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH---LDQLMEIMKVTGT  234 (343)
T ss_pred             ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCC
Confidence            999765321     123456889999999876 4588999999999999999999999753211   1111111100   


Q ss_pred             --------HhcCce-------eeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          765 --------WKEGKV-------LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       765 --------~~~~~~-------~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                              +.....       .......+..........+.+++.+|++.+|++||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                    000000       000000001111234456889999999999999999999994

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=1.9e-31  Score=284.33  Aligned_cols=249  Identities=28%  Similarity=0.389  Sum_probs=194.8

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccC-----CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-----SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      +|.+.++||+|+||.||+++... +..+++|.++..     ......++..|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47778999999999999997654 344555555432     222344677899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhc-cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          617 YEYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      +||+++++|.+++... .....+++.+++.++.|+++||.|||+.+   ++|+||+|+||+++. +.+||+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988642 23356899999999999999999999987   999999999999975 569999999998764


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ....  ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+...   .   ....... ...+       
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~---~---~~~~~~~-~~~~-------  220 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ---N---FLSVVLR-IVEG-------  220 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc---c---HHHHHHH-HHcC-------
Confidence            3222  122345788999999998888999999999999999999999986321   1   1111111 1111       


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       .....+...+.++.+++.+||+.+|++||++.|+++
T Consensus       221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         221 -PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence             112223455668889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=5.2e-31  Score=291.43  Aligned_cols=263  Identities=26%  Similarity=0.395  Sum_probs=196.5

Q ss_pred             HHHcccccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEe-CCce
Q 002969          538 VRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE-MDEK  613 (862)
Q Consensus       538 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~  613 (862)
                      ...+++|+..++||.|+||.||+++.. +++.||||++...  .....+.+.+|++++++++||||+++++++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            346788999999999999999999865 5889999988643  23345678899999999999999999999875 5678


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++++||+ +++|.+++..    ..+++.....++.|+++||+|||+.+   ++||||+|+||++++++.+||+|||++..
T Consensus        86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence            9999998 5688887742    24778888899999999999999998   99999999999999999999999999875


Q ss_pred             cCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHH--------HHHHHH
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL--------GHVWRL  764 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~--------~~~~~~  764 (862)
                      ....     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...........+        ....+.
T Consensus       158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            4221     122456888999998766 56899999999999999999999987533221110000        000110


Q ss_pred             HhcCceeeeecccC--CCCC-----hHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          765 WKEGKVLEMVDSSV--DNYP-----ANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       765 ~~~~~~~~~id~~~--~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ...+...+.+....  ...+     ......+.+++.+||+.+|++||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00111111100000  0111     1234678899999999999999999999764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=9.2e-31  Score=290.00  Aligned_cols=286  Identities=23%  Similarity=0.311  Sum_probs=201.2

Q ss_pred             cccccceeeccccEEEEEeEecC---CcEEEEEEeccCC--ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeC----Cc
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE---GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM----DE  612 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~----~~  612 (862)
                      +|+..+.||+|+||.||+++...   ++.||+|++....  ....+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            46778899999999999998653   6789999986532  22356788999999999 599999999876433    45


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      .++++||+. ++|.+++..   ...+++..+..++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678888886 688888743   235889999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCcc--cccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHh---
Q 002969          693 IFGGDQTE--QNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK---  766 (862)
Q Consensus       693 ~~~~~~~~--~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~---  766 (862)
                      .+......  .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.|+.....   ............   
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~  230 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY---VDQLNQILQVLGTPD  230 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH---HHHHHHHHHHhCCCC
Confidence            76432211  11223568999999998766 4689999999999999999999988653221   111111111110   


Q ss_pred             --------cCcee------eeec-ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCCCCCCCCcccc
Q 002969          767 --------EGKVL------EMVD-SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGFCL  831 (862)
Q Consensus       767 --------~~~~~------~~id-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~~  831 (862)
                              .....      .... .............+.+++.+|++.+|++||++.|++..  .-......|...+.|.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~--~~~~~~~~~~~~~~~~  308 (332)
T cd07857         231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH--PYLAIWHDPDDEPVCQ  308 (332)
T ss_pred             HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC--hhhhhhcCcccccccc
Confidence                    00000      0000 00011112235678899999999999999999998742  1112223344444454


Q ss_pred             CCCCCCCCC
Q 002969          832 GRNPIETDS  840 (862)
Q Consensus       832 ~~~~~~~~~  840 (862)
                      ...+....+
T Consensus       309 ~~~~~~~~~  317 (332)
T cd07857         309 KPFDFSFES  317 (332)
T ss_pred             ccccCCccc
Confidence            444444333

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=1.5e-30  Score=285.92  Aligned_cols=244  Identities=27%  Similarity=0.406  Sum_probs=191.2

Q ss_pred             ccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc---cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          544 FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      |...++||+|+||.||+|+.. .++.|++|++.....   ...+.+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            566678999999999999875 478899999865422   3345788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +. ++|.+++...  ...+++.++..++.||+.+|+|||+.+   ++|+||+|+||+++.++.+||+|||++.....   
T Consensus       103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            96 5777766432  235899999999999999999999998   99999999999999999999999999864321   


Q ss_pred             ccccccccccccccChhhhc---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          700 EQNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                         .....|+..|+|||++.   ...++.++||||||+++|||++|..|+.....   ..   ......... .      
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~---~~---~~~~~~~~~-~------  237 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MS---ALYHIAQND-S------  237 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HH---HHHHHHhcC-C------
Confidence               12346788999999984   45688899999999999999999998633211   11   111111111 0      


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                       ...........+.+++.+||+.+|++||++.+++..
T Consensus       238 -~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         238 -PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             011112233467889999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1e-30  Score=291.24  Aligned_cols=264  Identities=25%  Similarity=0.345  Sum_probs=197.8

Q ss_pred             hHHHHHHcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeC
Q 002969          534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM  610 (862)
Q Consensus       534 ~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~  610 (862)
                      .+++...+++|+..+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            3556677899999999999999999999764 58899999997542  22356788999999999999999999988643


Q ss_pred             ------CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCee
Q 002969          611 ------DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK  684 (862)
Q Consensus       611 ------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~k  684 (862)
                            ...+++++++ +++|.+++..    ..+++..+..++.||++||+|||+.+   ++||||||+||++++++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence                  3467788776 7889887743    24889999999999999999999998   99999999999999999999


Q ss_pred             EecccceeecCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHH
Q 002969          685 ISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR  763 (862)
Q Consensus       685 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~  763 (862)
                      |+|||+++....     ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.....   ......+.+
T Consensus       161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~---~~~~~~~~~  232 (345)
T cd07877         161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILR  232 (345)
T ss_pred             Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHH
Confidence            999999876422     1223467889999999876 5688999999999999999999998643211   111111111


Q ss_pred             HHh-----------cCce---eeeecc----cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          764 LWK-----------EGKV---LEMVDS----SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       764 ~~~-----------~~~~---~~~id~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ...           ....   ...+..    ...........++.+++.+|++.+|.+||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            100           0000   000000    0001111235568899999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=5.8e-31  Score=292.83  Aligned_cols=260  Identities=22%  Similarity=0.331  Sum_probs=192.9

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeC----------
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM----------  610 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----------  610 (862)
                      .+|...+.||.|+||.||+|.... ++.||+|++........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            578899999999999999998754 789999999776666677899999999999999999999776543          


Q ss_pred             ----CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC-CCCeeE
Q 002969          611 ----DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-EMTPKI  685 (862)
Q Consensus       611 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL  685 (862)
                          ...++|+||++ ++|.+++..    ..+++..+..++.||++||.|||+.+   ++||||||+||+++. ++.+||
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                35789999997 588877732    24889999999999999999999998   999999999999974 567899


Q ss_pred             ecccceeecCCCCcc-cccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHH
Q 002969          686 SDFGMARIFGGDQTE-QNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR  763 (862)
Q Consensus       686 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~  763 (862)
                      +|||+++.+...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.|+.......   .......
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~~~~~~~  233 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE---QMQLILE  233 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHH
Confidence            999999876432111 11122357889999998754 567889999999999999999999975322111   1111000


Q ss_pred             HHhcC----------ceee-------eecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          764 LWKEG----------KVLE-------MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       764 ~~~~~----------~~~~-------~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .....          ....       ...............++.+++.+||+.+|++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            00000          0000       0000000111223456889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.9e-32  Score=275.50  Aligned_cols=248  Identities=24%  Similarity=0.298  Sum_probs=202.5

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .++|..+++||+|.||.|.+++-+. ++.+|+|++++.   .......-..|-++|+..+||.+..|...|...+++++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            4678899999999999999998654 888999999876   344556677899999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||..||.|.-+|..   ...+++....-+-..|+.||.|||+.+   ||.||||.+|+|||.+|++||+||||++.-. 
T Consensus       247 MeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-  319 (516)
T ss_pred             EEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence            999999999888843   345777777778899999999999988   9999999999999999999999999997531 


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                       .....+...+|||.|+|||++....|..++|.|.+||++|||++|+.||..  .+.+ .+.+-+             -.
T Consensus       320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn--~dh~-kLFeLI-------------l~  382 (516)
T KOG0690|consen  320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN--KDHE-KLFELI-------------LM  382 (516)
T ss_pred             -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc--cchh-HHHHHH-------------Hh
Confidence             233445668999999999999999999999999999999999999999642  2221 111111             11


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERP-----TMASVVL  812 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  812 (862)
                      .--.+|.....+...|+...|.+||.+|.     .+.||.+
T Consensus       383 ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  383 EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence            11234555666778888999999999995     4566653

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=1.8e-31  Score=270.41  Aligned_cols=268  Identities=21%  Similarity=0.305  Sum_probs=199.9

Q ss_pred             HcccccccceeeccccEEEEEeEecC-----CcEEEEEEeccCCc--cchHHHHHHHHHHHhcccCCceEEEEEEEe-CC
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVE-MD  611 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~  611 (862)
                      ....|+...+||+|.||.||+|...+     .+.+|+|+++....  ..-....+|+.+++.++||||+.|..++.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            34568888999999999999995433     34689999975522  223467899999999999999999999877 77


Q ss_pred             ceEEEEEeccCCChhhhhhh--ccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC----CCeeE
Q 002969          612 EKMLVYEYMENRSLDSVIFD--KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE----MTPKI  685 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kL  685 (862)
                      ..+|++||.+. +|..+++-  ..+...++-..+..|+.||+.|+.|||++=   |+||||||.||||..+    |.+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence            78999999985 77777743  233456888999999999999999999986   9999999999999777    89999


Q ss_pred             ecccceeecCCCCccc-ccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCC---c---chhH
Q 002969          686 SDFGMARIFGGDQTEQ-NTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSN---N---ELNL  757 (862)
Q Consensus       686 ~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~---~---~~~l  757 (862)
                      +|||+++.+.+.-... ....++-|.-|.|||++.+. .|+.+.|||+.|||+.||++-++-|......   .   -.+.
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            9999999987653332 44557789999999999885 6999999999999999999987765321111   0   0122


Q ss_pred             HHHHHHHHhcCceeeeecccCCCCC---------------h-----------HHHHHHHHHHHhccccCCCCCCCHHHHH
Q 002969          758 LGHVWRLWKEGKVLEMVDSSVDNYP---------------A-----------NEVLRCIHVGLLCVQENAEERPTMASVV  811 (862)
Q Consensus       758 ~~~~~~~~~~~~~~~~id~~~~~~~---------------~-----------~~~~~l~~li~~cl~~dP~~RPt~~evl  811 (862)
                      +..+++.+......+  -+.+..+|               .           .......+|+.++|+.||-+|.|+++.+
T Consensus       258 l~rIf~vLG~Pt~~~--Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl  335 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKD--WPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL  335 (438)
T ss_pred             HHHHHHHcCCCcccc--chhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence            333433332211100  00000000               0           1122367899999999999999999988


Q ss_pred             HH
Q 002969          812 LM  813 (862)
Q Consensus       812 ~~  813 (862)
                      +.
T Consensus       336 eh  337 (438)
T KOG0666|consen  336 EH  337 (438)
T ss_pred             cc
Confidence            64

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=4.3e-31  Score=293.99  Aligned_cols=257  Identities=25%  Similarity=0.366  Sum_probs=195.3

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCc----
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE----  612 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~----  612 (862)
                      ..++|+..+.||+|++|.||+|+... ++.||||++...  .....+.+.+|+.++++++|||++++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            35689999999999999999998864 788999998653  22344667889999999999999999988766554    


Q ss_pred             --eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccc
Q 002969          613 --KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (862)
Q Consensus       613 --~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  690 (862)
                        .++|+||+ +++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 5689888743    34899999999999999999999988   99999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHh---
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK---  766 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~---  766 (862)
                      +......     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.....   ...+..+.....   
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~~~~  236 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH---IDQLKRIMNLVGTPD  236 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCC
Confidence            9865322     223457889999999865 4678999999999999999999998743221   111111111100   


Q ss_pred             --------cCceeeeec-------ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          767 --------EGKVLEMVD-------SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       767 --------~~~~~~~id-------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                              .......+.       ..........+.++.+++.+||+.+|++|||+.||++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                    000000000       0000111123567889999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=4e-30  Score=272.04  Aligned_cols=236  Identities=26%  Similarity=0.329  Sum_probs=192.4

Q ss_pred             eeccccEEEEEeEecC-CcEEEEEEeccCCc---cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCCh
Q 002969          550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (862)
Q Consensus       550 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL  625 (862)
                      ||.|+||.||++.... ++.+|+|++.....   ...+.+..|+.++++++||||+++++.+......++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6899999999998764 88999999876432   2456889999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccccccc
Q 002969          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR  705 (862)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  705 (862)
                      .+++....   .+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            99985432   4899999999999999999999987   9999999999999999999999999998764322  12233


Q ss_pred             ccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHH
Q 002969          706 VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE  785 (862)
Q Consensus       706 ~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~  785 (862)
                      ..++..|+|||...+...+.++|+||||+++||+++|+.|+....   .......    ..+.         ....+...
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~---~~~~~~~----~~~~---------~~~~~~~~  216 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED---RKEIYEK----ILKD---------PLRFPEFL  216 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHH----HhcC---------CCCCCCCC
Confidence            567889999999998889999999999999999999999964321   1111111    1111         01223333


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHH
Q 002969          786 VLRCIHVGLLCVQENAEERPTMAS  809 (862)
Q Consensus       786 ~~~l~~li~~cl~~dP~~RPt~~e  809 (862)
                      +..+.+++.+||+.+|++||++.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            567889999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=265.36  Aligned_cols=263  Identities=25%  Similarity=0.323  Sum_probs=203.9

Q ss_pred             hHHHHHHcccccccceeeccccEEEEEeE-ecCCcEEEEEEeccCCccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCC
Q 002969          534 FETIVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMD  611 (862)
Q Consensus       534 ~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~  611 (862)
                      ++++.+.|+     +.||+|+++.|--++ +..+.++|||++.+.......+..+|++++.+.+ |+||++|+.+|++..
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            455555454     689999999998875 4569999999998887777889999999999995 999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC---CeeEecc
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM---TPKISDF  688 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kL~DF  688 (862)
                      ..|||||-|.||+|...|.++   ..+++.++.++..+||.||.+||..+   |.||||||+|||..+..   -+||+||
T Consensus       150 ~FYLVfEKm~GGplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf  223 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF  223 (463)
T ss_pred             eEEEEEecccCchHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence            999999999999999998654   34899999999999999999999998   99999999999996554   4799999


Q ss_pred             cceeecCCCC-----cccccccccccccccChhhhc-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCC-------
Q 002969          689 GMARIFGGDQ-----TEQNTKRVVGTYGYMSPEYAM-----DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHS-------  751 (862)
Q Consensus       689 Gla~~~~~~~-----~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~-------  751 (862)
                      .|..-+....     ........+|+..|||||+..     ...|+.+.|.||||||||-|++|.+||...-.       
T Consensus       224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr  303 (463)
T KOG0607|consen  224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR  303 (463)
T ss_pred             ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence            9876442211     122223468999999999863     23588999999999999999999999864211       


Q ss_pred             Ccc-hhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          752 NNE-LNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       752 ~~~-~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .+. ..-....++.+.+|+. +..    +.-....+.+..+++...+-.++.+|.++.+++.
T Consensus       304 Ge~Cr~CQ~~LFesIQEGkY-eFP----dkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  304 GEVCRVCQNKLFESIQEGKY-EFP----DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCccHHHHHHHHHHHhccCC-cCC----hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            111 1222333333344331 111    1112334556778888999999999999999886

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=265.36  Aligned_cols=249  Identities=22%  Similarity=0.363  Sum_probs=192.8

Q ss_pred             ccccceeeccccEEEEEeEecC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCceEEEEEec
Q 002969          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      .+.+..||.|.-|.|++.+... |..+|||.+.+.. .+..++.+..+.++.+-+ .|.||+.+|+|.......+.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            4455689999999999998876 7889999998764 445677888888877765 899999999999999999999998


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      .- .++.++..-  .+.+++.-+-++...+.+||.||.++.  .|+|||+||+|||+|+.|++||+|||++..+....  
T Consensus       174 s~-C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--  246 (391)
T KOG0983|consen  174 ST-CAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--  246 (391)
T ss_pred             HH-HHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc--
Confidence            53 345555332  234888888899999999999998875  69999999999999999999999999997764322  


Q ss_pred             cccccccccccccChhhhcC---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          701 QNTKRVVGTYGYMSPEYAMD---GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                       ...+..|-+.|||||.+..   ..|+.++||||||+.|+||.||+.|+.....+  .+.+..+   ..+.      .+.
T Consensus       247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkv---ln~e------PP~  314 (391)
T KOG0983|consen  247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKV---LNEE------PPL  314 (391)
T ss_pred             -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHH---HhcC------CCC
Confidence             2234568899999999864   36889999999999999999999997542221  1122111   1111      111


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      +. .....+..+.+++..||++|+.+||...++++
T Consensus       315 L~-~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  315 LP-GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CC-cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            21 11225677889999999999999999999986

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.2e-31  Score=303.47  Aligned_cols=273  Identities=22%  Similarity=0.255  Sum_probs=212.4

Q ss_pred             HHHHHcccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCC
Q 002969          536 TIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD  611 (862)
Q Consensus       536 ~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  611 (862)
                      ++.-..++|+++++||+|+||.|..+++.. ++.+|+|++.+.   .......|+.|-.+|..-+.+-|++++..|.+..
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            444456789999999999999999999876 678899999763   2445567999999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccce
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  691 (862)
                      ++|+|||||+||+|-.++.+..   .+++..+.-++..|.-||.-||+.|   +|||||||+|||||..|++||+|||.+
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence            9999999999999999996544   4888888889999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHh
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMD-----GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK  766 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~  766 (862)
                      ..+..+.. ......+|||.|++||++..     +.|...+|.||+||++|||+.|..||..   +.-...+..+...  
T Consensus       223 lkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa---dslveTY~KIm~h--  296 (1317)
T KOG0612|consen  223 LKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA---DSLVETYGKIMNH--  296 (1317)
T ss_pred             HhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH---HHHHHHHHHHhch--
Confidence            87764433 33445789999999999853     5689999999999999999999999742   1111112222111  


Q ss_pred             cCceeeeecccCCCCC--hHHHHHHHHHHHhccccCCCCCCC---HHHHHHH--hccCc----CCCCCCCCCccc
Q 002969          767 EGKVLEMVDSSVDNYP--ANEVLRCIHVGLLCVQENAEERPT---MASVVLM--LSSET----ATMPQPKTPGFC  830 (862)
Q Consensus       767 ~~~~~~~id~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~--L~~~~----~~~~~p~~p~~~  830 (862)
                       ..        .-.+|  ...+.+..+||.+.+. +|+.|..   ++++-.+  ++++.    ...++|-.|.+.
T Consensus       297 -k~--------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevs  361 (1317)
T KOG0612|consen  297 -KE--------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVS  361 (1317)
T ss_pred             -hh--------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCC
Confidence             00        11222  3356777888887765 7888887   8888753  33332    234555555543

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1.5e-29  Score=303.81  Aligned_cols=145  Identities=28%  Similarity=0.428  Sum_probs=130.3

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|.+.++||+|+||.||+|... .++.||||+++...   ....+.+..|+.+++.++||||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999876 48899999996542   233467889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      ||+++++|.+++...   ..+++..++.|+.||+.||+|||..+   |+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999998543   34788899999999999999999987   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=9.7e-32  Score=267.35  Aligned_cols=254  Identities=24%  Similarity=0.346  Sum_probs=195.3

Q ss_pred             cccceeeccccEEEEEeEecC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEEecc
Q 002969          545 TDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       545 ~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      +.+..||.|+||+|+|-.++. |+..|||+++... ....++++.|.+...+- +.||||+++|.+..++.-++.||.|.
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd  146 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD  146 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence            445689999999999998765 8999999997653 45677889998876665 68999999999999999999999995


Q ss_pred             CCChhhhhhh--ccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          622 NRSLDSVIFD--KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       622 ~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                       .||+.+-..  ..+...+++.-+-.|+....+||.||...-  .||||||||+||||+..|.+||+|||++..+...  
T Consensus       147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--  221 (361)
T KOG1006|consen  147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--  221 (361)
T ss_pred             -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH--
Confidence             566655421  123345888888889999999999998764  6999999999999999999999999998765322  


Q ss_pred             ccccccccccccccChhhhcC--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          700 EQNTKRVVGTYGYMSPEYAMD--GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                       ...+.-.|-..|||||.+..  ..|+.+|||||||++|+|+.||+.|+..+..     .++++...+..+. ..+. . 
T Consensus       222 -iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gdp-p~l~-~-  292 (361)
T KOG1006|consen  222 -IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGDP-PILL-F-  292 (361)
T ss_pred             -HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCCC-Ceec-C-
Confidence             11223467789999999864  3589999999999999999999999754332     3444443333221 1111 1 


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                       ..........+.+++-.|+.+|..+||...++.++
T Consensus       293 -~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  293 -DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             -cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence             11123356788899999999999999999998753

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-30  Score=278.71  Aligned_cols=242  Identities=25%  Similarity=0.361  Sum_probs=194.0

Q ss_pred             ceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCC
Q 002969          548 NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRS  624 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs  624 (862)
                      ++||+|.||+||-|++. .|+.||||++.+.  ......++++|+.+|++++||.||.+.-.|+..+..++|||-+.| +
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-D  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-D  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-h
Confidence            78999999999999875 4999999999764  344568899999999999999999999999999999999999965 5


Q ss_pred             hhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC---CCeeEecccceeecCCCCccc
Q 002969          625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       625 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kL~DFGla~~~~~~~~~~  701 (862)
                      ..+.+...++ ..|++....-++.||+.||.|||.++   |+|+||||+||||.+.   -++||+|||.|+++.....  
T Consensus       649 MLEMILSsEk-gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--  722 (888)
T KOG4236|consen  649 MLEMILSSEK-GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--  722 (888)
T ss_pred             HHHHHHHhhc-ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence            5555544433 34888888889999999999999998   9999999999999654   3799999999999864433  


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY  781 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~  781 (862)
                       ...++||+.|+|||++.+..|...-|+||.|||+|--++|..||...     .++-+.+..       ...  ......
T Consensus       723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-----EdIndQIQN-------AaF--MyPp~P  787 (888)
T KOG4236|consen  723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-----EDINDQIQN-------AAF--MYPPNP  787 (888)
T ss_pred             -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-----cchhHHhhc-------ccc--ccCCCc
Confidence             33578999999999999999999999999999999999999997431     122111100       000  001233


Q ss_pred             ChHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 002969          782 PANEVLRCIHVGLLCVQENAEERPTMASVV  811 (862)
Q Consensus       782 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl  811 (862)
                      ..+.....++||...||..-++|-+.+.-+
T Consensus       788 W~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  788 WSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            445667788999999999999998877654

>PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation

Probab=99.96  E-value=2.7e-30  Score=236.85  Aligned_cols=110  Identities=53%  Similarity=1.174  Sum_probs=106.8

Q ss_pred             eecCCCCceeecCcCCCccccccceEEEEeCCCceEEEEeecCCCceeEEEECcCCceEEEEeeccCCceeEEEccCCcc
Q 002969          237 YRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQ  316 (862)
Q Consensus       237 ~rsg~w~g~~~~g~p~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~rl~l~~~G~l~~~~w~~~~~~W~~~~~~p~~~  316 (862)
                      ||+|||||..|+|+|+|..+..+.+.|+ ++++|+|++|.+.+.+.++|++||.+|++|+|.|++.++.|.+.|.+|.|+
T Consensus         1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv-~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~   79 (110)
T PF00954_consen    1 WRSGPWNGQRFSGIPEMSSNSLYNYSFV-SNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQ   79 (110)
T ss_pred             CCccccCCeEECCcccccccceeEEEEE-ECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccC
Confidence            8999999999999999998889999999 999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCCCCCCCccccCCCCCccCCCCCccccC
Q 002969          317 CDNYGECGPFGICDTNASPVCQCMRGFEPKD  347 (862)
Q Consensus       317 Cd~yg~CG~~g~C~~~~~~~C~Cl~Gf~~~~  347 (862)
                      ||+|+.||+||+|+.+..|.|+||+||+|++
T Consensus        80 Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n  110 (110)
T PF00954_consen   80 CDVYGFCGPNGICNSNNSPKCSCLPGFEPKN  110 (110)
T ss_pred             CCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence            9999999999999998899999999999985

This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=1.2e-29  Score=267.02  Aligned_cols=219  Identities=23%  Similarity=0.142  Sum_probs=175.9

Q ss_pred             cccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCChhhhhhh
Q 002969          553 GGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD  631 (862)
Q Consensus       553 G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  631 (862)
                      |.||.||+++... ++.+|+|+++...     .+..|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            8899999998754 7899999996543     234556666667899999999999999999999999999999999854


Q ss_pred             ccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccccccccccccc
Q 002969          632 KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG  711 (862)
Q Consensus       632 ~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~  711 (862)
                      ..   .+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.++++|||++..+...     .....++..
T Consensus        79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~  147 (237)
T cd05576          79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM  147 (237)
T ss_pred             hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence            32   3889999999999999999999988   999999999999999999999999987655321     112345678


Q ss_pred             ccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHH
Q 002969          712 YMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIH  791 (862)
Q Consensus       712 y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~  791 (862)
                      |+|||.+....++.++||||+|+++|||++|+.|+.......            ..        ......+......+.+
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~--------~~~~~~~~~~~~~~~~  207 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT--------HTTLNIPEWVSEEARS  207 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc--------ccccCCcccCCHHHHH
Confidence            999999988889999999999999999999998743211100            00        0001123334567889


Q ss_pred             HHHhccccCCCCCCCH
Q 002969          792 VGLLCVQENAEERPTM  807 (862)
Q Consensus       792 li~~cl~~dP~~RPt~  807 (862)
                      ++.+|++.||++||++
T Consensus       208 li~~~l~~dp~~R~~~  223 (237)
T cd05576         208 LLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHccCCHHHhcCC
Confidence            9999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-30  Score=272.04  Aligned_cols=255  Identities=29%  Similarity=0.389  Sum_probs=197.6

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-------ccchHHHHHHHHHHHhcccCCceEEEEEEE-eCCce
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-------GQGIEEFKNEVRLIAKLQHRNLVRLLGCCV-EMDEK  613 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-~~~~~  613 (862)
                      +|-.++.||+|||+.||++... +.+.||||+-..+.       ....+...+|.++.+.|+||.||++++++. +.+..
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            4666678999999999999654 46778999864321       223456788999999999999999999986 55678


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec---CCCCeeEecccc
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGM  690 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kL~DFGl  690 (862)
                      +-|+||++|.+|+-+|..+   +.++++++..|+.||+.||.||.+.. ++|||-||||.||||.   .-|.+||.||||
T Consensus       544 CTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             eeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecch
Confidence            8999999999999999543   45899999999999999999999874 7999999999999994   347899999999


Q ss_pred             eeecCCCCcc-----cccccccccccccChhhhcCC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHH
Q 002969          691 ARIFGGDQTE-----QNTKRVVGTYGYMSPEYAMDG----LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV  761 (862)
Q Consensus       691 a~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~  761 (862)
                      ++++..+...     ..+....||..|++||.+.-+    .++.|+||||.|||+|..+.|++||+......+       
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-------  692 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-------  692 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-------
Confidence            9998655433     223446799999999987533    478899999999999999999999875433321       


Q ss_pred             HHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 002969          762 WRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV  811 (862)
Q Consensus       762 ~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  811 (862)
                        .+.+..+.+.-.-.. ...+....+...+|++||+..-++|....++.
T Consensus       693 --ILqeNTIlkAtEVqF-P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  693 --ILQENTILKATEVQF-PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             --HHhhhchhcceeccC-CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence              222333332222211 12234456778899999999999998777664

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.96  E-value=4e-30  Score=259.78  Aligned_cols=253  Identities=23%  Similarity=0.238  Sum_probs=195.0

Q ss_pred             Hccccccc-ceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEe----CCc
Q 002969          540 ATDNFTDY-NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVE----MDE  612 (862)
Q Consensus       540 ~~~~f~~~-~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~----~~~  612 (862)
                      .+++|.+. ++||-|-.|.|-.+..+. ++.+|+|++...     ...++|+++.-+. .|||||.+++++..    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            34556543 689999999999987654 788999998543     3457888876665 59999999998754    456


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec---CCCCeeEeccc
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFG  689 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kL~DFG  689 (862)
                      +++|||.|+||.|.+.+.++. ...+++.++-.|..||+.|+.|||+.+   |.||||||+|+|..   .|..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            788999999999999986654 345999999999999999999999998   99999999999995   45679999999


Q ss_pred             ceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc
Q 002969          690 MARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK  769 (862)
Q Consensus       690 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  769 (862)
                      +|+.-.   ........+-|+.|.|||++...+|+...|+||+||++|-|++|.+||...+.   ..+..-..+.+..+.
T Consensus       210 FAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gq  283 (400)
T KOG0604|consen  210 FAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQ  283 (400)
T ss_pred             cccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccC
Confidence            998643   23333446779999999999999999999999999999999999999754332   111111111121111


Q ss_pred             eeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          770 VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       770 ~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      . +    .........++...++|+.+|..+|.+|.|+.|++.
T Consensus       284 y-~----FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  284 Y-E----FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             c-c----CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            0 0    001122345667788999999999999999999975

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=3e-29  Score=262.74  Aligned_cols=238  Identities=29%  Similarity=0.374  Sum_probs=193.3

Q ss_pred             ccEEEEEeEecC-CcEEEEEEeccCCccc-hHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCChhhhhhh
Q 002969          554 GFGIVYKGRLLE-GQEIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD  631 (862)
Q Consensus       554 ~fg~Vy~~~~~~-~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  631 (862)
                      +||.||+|+..+ ++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999998875 8899999997665444 78999999999999999999999999999999999999999999999854


Q ss_pred             ccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccccccccccccc
Q 002969          632 KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG  711 (862)
Q Consensus       632 ~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~  711 (862)
                      ...   +++..+..++.++++++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......   ......++..
T Consensus        81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            332   889999999999999999999997   9999999999999999999999999998764332   2233567889


Q ss_pred             ccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHH
Q 002969          712 YMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIH  791 (862)
Q Consensus       712 y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~  791 (862)
                      |+|||.+.+..++.++|||+||+++++|++|..|+...  .+..    ...+.........      .........++.+
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~--~~~~----~~~~~~~~~~~~~------~~~~~~~~~~~~~  219 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD--DQLL----ELFKKIGKPKPPF------PPPEWKISPEAKD  219 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcHH----HHHHHHhccCCCC------ccccccCCHHHHH
Confidence            99999999888999999999999999999999886432  1111    1111222111100      0001114567889


Q ss_pred             HHHhccccCCCCCCCHHHHHH
Q 002969          792 VGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       792 li~~cl~~dP~~RPt~~evl~  812 (862)
                      ++.+|+..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=237.94  Aligned_cols=260  Identities=25%  Similarity=0.383  Sum_probs=199.9

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +|...++||+|.||+||+|+..+ ++.||+|+++..  .+.......+|+-+++.++|.|||+++++...+..+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            45566899999999999998765 778999998754  333456788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +. .+|..+.-.  -+..++......++.|+++||.+.|+++   +.|||+||+|.||..+|++|++|||+++.++-...
T Consensus        83 cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            95 466666532  2345888889999999999999999998   99999999999999999999999999998753321


Q ss_pred             ccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc------eee
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK------VLE  772 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~  772 (862)
                      -  ....+-|..|.+|.++.+. -|+...|+||-|||+.|+.....|  .++..+..+.+..+++.+....      +.+
T Consensus       157 c--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp--lfpg~dvddqlkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             e--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC--CCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence            1  1223568899999999886 488999999999999999986666  3445555566666666554322      122


Q ss_pred             eecccC-CCCCh-----HHHH----HHHHHHHhccccCCCCCCCHHHHHH
Q 002969          773 MVDSSV-DNYPA-----NEVL----RCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       773 ~id~~~-~~~~~-----~~~~----~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      +.|... ..++.     +...    .-.+++.+.+.-+|..|.++++.++
T Consensus       233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            223222 22222     1122    2357888888899999999998775

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9.5e-30  Score=282.50  Aligned_cols=239  Identities=21%  Similarity=0.262  Sum_probs=193.4

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ++.|.....+|.|+|+.|-.+.... ++..+||++.+..    .+-.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            5677888889999999998887654 7889999997652    2234577666666 79999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe-cCCCCeeEecccceeecCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL-DKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl-~~~~~~kL~DFGla~~~~~~  697 (862)
                      .+.++-|.+.+.....   .. .++..|+.+|+.|+.|||+++   +|||||||+|||+ ++.++++|+|||.++.....
T Consensus       397 ~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            9999888777644332   22 677789999999999999998   9999999999999 68999999999999876443


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                           ....+-|..|.|||++....|++++|+||||++||+|++|+.|+...+.+      ..+...+..          
T Consensus       470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~----------  528 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQM----------  528 (612)
T ss_pred             -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcC----------
Confidence                 22345688999999999999999999999999999999999997643333      112222221          


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       ..+....+....+|+.+||+.+|.+||+|.++..
T Consensus       529 -~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  529 -PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             -CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence             1223556778889999999999999999999975

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-30  Score=271.49  Aligned_cols=240  Identities=28%  Similarity=0.364  Sum_probs=197.6

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .+|..+.+||+|+||.|.++.... .+.+|||+++++-   ....+--+.|-++|+.. +-|.++++..++...+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            468888999999999999997655 5679999998762   33445556788888777 468899999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+.||+|--.+.+-.+   +.+..+.-+|..||-||-+||+++   |+.||||..|||||.+|++||+|||+++.-  
T Consensus       429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn--  500 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN--  500 (683)
T ss_pred             EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc--
Confidence            999999999888865443   777888889999999999999998   999999999999999999999999999752  


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      -.....+...+||+.|+|||++...+|...+|.|||||+||||+.|++||+.   +++.++...+    .+.        
T Consensus       501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG---eDE~elF~aI----~eh--------  565 (683)
T KOG0696|consen  501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG---EDEDELFQAI----MEH--------  565 (683)
T ss_pred             ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHH----HHc--------
Confidence            1234455668999999999999999999999999999999999999999643   3333343333    221        


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCC
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERP  805 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP  805 (862)
                       --.+|...+.+...+....+.++|.+|.
T Consensus       566 -nvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  566 -NVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence             1245666777888899999999999994

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=6.7e-29  Score=282.27  Aligned_cols=257  Identities=25%  Similarity=0.396  Sum_probs=207.3

Q ss_pred             hHHHHHHcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEe--
Q 002969          534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVE--  609 (862)
Q Consensus       534 ~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~--  609 (862)
                      ++.+...++.|++.++||.|.+|.||+++.. +++.+|+|++..... ..++...|.++++.+ +|||++.++|++..  
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            3334445677899999999999999999864 488899999865533 345677889999988 69999999999864  


Q ss_pred             ---CCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEe
Q 002969          610 ---MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS  686 (862)
Q Consensus       610 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~  686 (862)
                         ++.++||||||.+||.-+++..-. ...+.|..+..|++.++.||.+||...   ++|||||-.|||+..++.+||.
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence               567899999999999999986544 667999999999999999999999987   9999999999999999999999


Q ss_pred             cccceeecCCCCcccccccccccccccChhhhcC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHH
Q 002969          687 DFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD-----GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV  761 (862)
Q Consensus       687 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~  761 (862)
                      |||.+..+..  +........||+.|||||++.-     ..|+..+|+||||++..||.-|.+|....++.....     
T Consensus       166 DFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF-----  238 (953)
T KOG0587|consen  166 DFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----  238 (953)
T ss_pred             eeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc-----
Confidence            9999987743  3334445689999999999853     347789999999999999999999975444432211     


Q ss_pred             HHHHhcCceeeeec-ccC-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          762 WRLWKEGKVLEMVD-SSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       762 ~~~~~~~~~~~~id-~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                                .+.. +.. ..-+..-..++.++|..||.+|-++||++.++++
T Consensus       239 ----------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  239 ----------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ----------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                      1111 111 1224556778899999999999999999999885

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=286.68  Aligned_cols=245  Identities=25%  Similarity=0.379  Sum_probs=187.4

Q ss_pred             ccccceeeccccEE-EEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEEecc
Q 002969          544 FTDYNKLGQGGFGI-VYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       544 f~~~~~LG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      |...+.+|.|+-|+ ||+|.. +++.||||++-..   ..+...+|+..|+.- +||||||+++.-.++...|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            45557889998876 799987 7889999998543   234567899999998 59999999999999999999999995


Q ss_pred             CCChhhhhhhc-cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC---C--CCeeEecccceeecC
Q 002969          622 NRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---E--MTPKISDFGMARIFG  695 (862)
Q Consensus       622 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~--~~~kL~DFGla~~~~  695 (862)
                       .+|.+++... ...........+.+..|+++||++||+.+   ||||||||+||||+.   +  .+++|+|||+++.+.
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             6999999663 11111222445678899999999999987   999999999999965   3  479999999999886


Q ss_pred             CCCcc-cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCcchhHHHHHHHHHhcCceeee
Q 002969          696 GDQTE-QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG-KKNRGFYHSNNELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       696 ~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  773 (862)
                      ..... .......||.+|+|||++....-+.++|||||||++|+.++| .+||+.....+        ...+........
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~~  734 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLVH  734 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCccceee
Confidence            65432 234456899999999999999888899999999999999997 78875321111        111111111111


Q ss_pred             ecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 002969          774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV  811 (862)
Q Consensus       774 id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  811 (862)
                      +.+     ..++  +..+||.+|+..+|..||++.+|+
T Consensus       735 L~~-----~~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  735 LEP-----LPDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             ecc-----CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            111     1111  778999999999999999999998

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=1.6e-28  Score=281.02  Aligned_cols=263  Identities=21%  Similarity=0.258  Sum_probs=181.5

Q ss_pred             HcccccccceeeccccEEEEEeEe-----------------cCCcEEEEEEeccCCccchHH--------------HHHH
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRL-----------------LEGQEIAVKRLSRNSGQGIEE--------------FKNE  588 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~E  588 (862)
                      ..++|++.++||+|+||.||+|..                 ..++.||||++........++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            356899999999999999999964                 234679999986543322233              3447


Q ss_pred             HHHHHhcccCCc-----eEEEEEEEe--------CCceEEEEEeccCCChhhhhhhccC---------------------
Q 002969          589 VRLIAKLQHRNL-----VRLLGCCVE--------MDEKMLVYEYMENRSLDSVIFDKAR---------------------  634 (862)
Q Consensus       589 ~~~l~~l~HpnI-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~---------------------  634 (862)
                      +.++.+++|.++     ++++++|..        .+..+|||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777888876654     677787753        3568999999999999999864211                     


Q ss_pred             CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccccccccccccccC
Q 002969          635 SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS  714 (862)
Q Consensus       635 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~A  714 (862)
                      ...+++..+..++.|++++|.|||+.+   |+||||||+|||++.++.+||+|||++..+..... .......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence            123467788899999999999999987   99999999999999999999999999976533211 11112234789999


Q ss_pred             hhhhcCCCC----------------------CccccchhHHHHHHHHHhCCC-CCCCCCCCc-chh---HHHHHHHHHhc
Q 002969          715 PEYAMDGLF----------------------SVKSDVFSFGVLLLETVSGKK-NRGFYHSNN-ELN---LLGHVWRLWKE  767 (862)
Q Consensus       715 PE~l~~~~~----------------------s~ksDVwSlGvil~elltG~~-p~~~~~~~~-~~~---l~~~~~~~~~~  767 (862)
                      ||.+.....                      ..+.||||+||+++||++|.. |+....... ...   .....|+....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            998754321                      235799999999999999875 432111000 000   00111111111


Q ss_pred             CceeeeecccCCCCChHHHHHHHHHHHhccccCC---CCCCCHHHHHHH
Q 002969          768 GKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENA---EERPTMASVVLM  813 (862)
Q Consensus       768 ~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~~  813 (862)
                      ..      ... ...........+|+.++|..+|   .+|++++|++++
T Consensus       459 ~~------~~~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        459 QK------YDF-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             cC------CCc-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            11      001 1122345667889999999765   689999999863

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=265.26  Aligned_cols=261  Identities=19%  Similarity=0.242  Sum_probs=198.1

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcc-c-CC----ceEEEEEEEeCCce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-H-RN----LVRLLGCCVEMDEK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-pn----Iv~l~g~~~~~~~~  613 (862)
                      +++|.+...+|+|.||.|-...... +..||||+++. -....+..+-|+++|+++. + |+    +|++.++|...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            6789999999999999999986544 67899999954 3345567788999999994 3 32    77888899999999


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC--------------
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK--------------  679 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~--------------  679 (862)
                      ++|+|.+ |-|+.++|..+ +...++...+..|+.|+++++++||+..   ++|-||||+|||+.+              
T Consensus       167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence            9999999 56899999543 3345888999999999999999999998   999999999999821              


Q ss_pred             ------CCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc
Q 002969          680 ------EMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN  753 (862)
Q Consensus       680 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~  753 (862)
                            +..+||+|||.|..-...     ...++.|..|.|||++.+-.++..+||||+||||.||.+|..-|+..+..+
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                  235899999999864322     245788999999999999999999999999999999999998765443222


Q ss_pred             chhHHHHHH--------------HHHhcCcee----------ee-eccc-----CCCCChHHHHHHHHHHHhccccCCCC
Q 002969          754 ELNLLGHVW--------------RLWKEGKVL----------EM-VDSS-----VDNYPANEVLRCIHVGLLCVQENAEE  803 (862)
Q Consensus       754 ~~~l~~~~~--------------~~~~~~~~~----------~~-id~~-----~~~~~~~~~~~l~~li~~cl~~dP~~  803 (862)
                      .....+.+.              +.+..+++.          .. .+..     .......+..++.+|+..||..||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            211111111              011111000          00 0000     01123456667999999999999999


Q ss_pred             CCCHHHHHH
Q 002969          804 RPTMASVVL  812 (862)
Q Consensus       804 RPt~~evl~  812 (862)
                      |+|+.|+++
T Consensus       397 RiTl~EAL~  405 (415)
T KOG0671|consen  397 RITLREALS  405 (415)
T ss_pred             cccHHHHhc
Confidence            999999986

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=1.2e-28  Score=289.06  Aligned_cols=258  Identities=21%  Similarity=0.232  Sum_probs=166.9

Q ss_pred             HcccccccceeeccccEEEEEeEecC-----CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEE------EE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC------CV  608 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~------~~  608 (862)
                      ..++|+..++||+|+||.||+|++.+     +..||||++.....  .+.+..|  .+....+.++..++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            45689999999999999999998754     57899999864321  1111111  1122222222222211      24


Q ss_pred             eCCceEEEEEeccCCChhhhhhhccCC-----------------CCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccC
Q 002969          609 EMDEKMLVYEYMENRSLDSVIFDKARS-----------------SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK  671 (862)
Q Consensus       609 ~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlk  671 (862)
                      .....++|+||+++++|.+++......                 .......+..++.||++||+|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            566789999999999999988643210                 01122345679999999999999987   9999999


Q ss_pred             CcceEecC-CCCeeEecccceeecCCCCcccccccccccccccChhhhcCC----------------------CCCcccc
Q 002969          672 ASNILLDK-EMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG----------------------LFSVKSD  728 (862)
Q Consensus       672 p~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~----------------------~~s~ksD  728 (862)
                      |+|||++. ++.+||+|||+++.+..... .......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 57999999999986543221 122345789999999965322                      2345679


Q ss_pred             chhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce-----eeeecccC-------CCCChHHHHHHHHHHHhc
Q 002969          729 VFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV-----LEMVDSSV-------DNYPANEVLRCIHVGLLC  796 (862)
Q Consensus       729 VwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-----~~~id~~~-------~~~~~~~~~~l~~li~~c  796 (862)
                      ||||||+||||+++..+..     +....+   .+.+.....     ...+....       ............+|+.+|
T Consensus       362 VwSlGviL~el~~~~~~~~-----~~~~~~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m  433 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSD-----SNLIQF---NRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM  433 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCc-----hHHHHH---HHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence            9999999999999765522     111111   111110000     00000000       000011123456899999


Q ss_pred             cccCCCCCCCHHHHHHH
Q 002969          797 VQENAEERPTMASVVLM  813 (862)
Q Consensus       797 l~~dP~~RPt~~evl~~  813 (862)
                      |+.||++|||+.|+++.
T Consensus       434 L~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        434 MRFKGRQRISAKAALAH  450 (566)
T ss_pred             ccCCcccCCCHHHHhCC
Confidence            99999999999999973

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.8e-30  Score=254.74  Aligned_cols=261  Identities=22%  Similarity=0.384  Sum_probs=191.6

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEe--------C
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE--------M  610 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--------~  610 (862)
                      ..|+...+||+|.||+||+|+..+ ++.||+|++-.+  .+..-....+|+++|..+.|+|++.++..|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            345666899999999999998765 778899876443  22234566899999999999999999988743        3


Q ss_pred             CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccc
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  690 (862)
                      ...|+|+.+++. +|.-+|.+.  ...++..++.++..++..||.|+|...   |+|||+||.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            347999999974 777777433  234888899999999999999999987   99999999999999999999999999


Q ss_pred             eeecCCCCc--ccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhc
Q 002969          691 ARIFGGDQT--EQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE  767 (862)
Q Consensus       691 a~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  767 (862)
                      ++.+.....  .......+.|..|++||.+.+. .|+++.|||..|||+.||.++.+-+.   .+.+...+..+..+...
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq---gnteqqql~~Is~LcGs  247 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ---GNTEQQQLHLISQLCGS  247 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc---CChHHHHHHHHHHHhcc
Confidence            987743322  2223334569999999998874 69999999999999999999987643   22222222222211111


Q ss_pred             -----------Cceeeee-------------cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          768 -----------GKVLEMV-------------DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       768 -----------~~~~~~i-------------d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                                 -.+.+.+             ...+.  +.....+.++|+.+++..||.+||.+++++..
T Consensus       248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~k--p~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLK--PYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcc--cccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence                       0000111             00000  11112367789999999999999999998753

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.3e-30  Score=274.83  Aligned_cols=265  Identities=22%  Similarity=0.306  Sum_probs=211.6

Q ss_pred             cccccceeeccccEEEEEeEecCCc-EEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLEGQ-EIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~~~-~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      +++.+..||-||||.|-+++..... .+|+|++++.   .....+....|-.+|...+.|.||+++..|.+....|++||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            3455568999999999999876544 3888888664   34556788899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      -|-||.|...|.++.   .++.....-++..+.+|++|||.++   ||.|||||+|.+|+.+|-+||.|||+|+.+... 
T Consensus       501 aClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-  573 (732)
T KOG0614|consen  501 ACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-  573 (732)
T ss_pred             hhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence            999999999996654   4788888889999999999999998   999999999999999999999999999987543 


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                        ..+-..+||+.|.|||++.+...+.++|.||||+++|||++|.+||...++....+++-.-..+              
T Consensus       574 --~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~--------------  637 (732)
T KOG0614|consen  574 --RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK--------------  637 (732)
T ss_pred             --CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh--------------
Confidence              3344589999999999999999999999999999999999999998654443332322111111              


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH--hcc-----C-cCCCCCCCCCccc
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPT-----MASVVLM--LSS-----E-TATMPQPKTPGFC  830 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~--L~~-----~-~~~~~~p~~p~~~  830 (862)
                      -.+|........+|+++....+|.+|..     +.+|-++  +++     + ...+|+|-.|+..
T Consensus       638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va  702 (732)
T KOG0614|consen  638 IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVA  702 (732)
T ss_pred             hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCC
Confidence            1234455667789999999999999976     6666543  222     2 1355666666654

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.9e-28  Score=245.88  Aligned_cols=248  Identities=24%  Similarity=0.339  Sum_probs=199.9

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ..+|..+++||+|+|..|..+++.. .+.+|+|++++.   ..+.++=.+.|-.+..+- +||.+|.+..+|.....+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            3568888999999999999998876 678999999764   344555567788877776 79999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      |.||+++|+|--++..+   ..+++..+.-+...|.-||.|||+.+   ||.||||..|||+|.+|.+||.|+|+++.- 
T Consensus       329 vieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~-  401 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-  401 (593)
T ss_pred             EEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC-
Confidence            99999999997666433   34788877778889999999999998   999999999999999999999999998753 


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCC-CcchhHHHHHHHHHhcCceeeee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHS-NNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~-~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                       -.....+...+||+.|+|||++.+..|...+|.|+|||+++||+.|+.||+.... +.+.+.-++.++.+.+..+    
T Consensus       402 -l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi----  476 (593)
T KOG0695|consen  402 -LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI----  476 (593)
T ss_pred             -CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc----
Confidence             2233445568999999999999999999999999999999999999999976433 2333444445544444321    


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCC
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERP  805 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  805 (862)
                           ..|...+.....+++.-|.+||.+|.
T Consensus       477 -----riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  477 -----RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -----cccceeehhhHHHHHHhhcCCcHHhc
Confidence                 22334445566788889999999984

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=5e-28  Score=264.32  Aligned_cols=205  Identities=24%  Similarity=0.359  Sum_probs=172.9

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      -|..++.||-|+||+|.+++..+ ...+|+|.+++.+   .......+.|-.||..-+.+-||+|+..|.+.+.+|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            47778899999999999997655 4568999997653   4456778899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC-
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD-  697 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-  697 (862)
                      |++||++-++|.+.   ..+.+..+.-++.++..|+++.|..|   +|||||||+|||||.+|++||.||||+.-+.-. 
T Consensus       710 YIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             ccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence            99999999998543   35777777778889999999999998   999999999999999999999999998644110 


Q ss_pred             ---------Ccc------------------------------cccccccccccccChhhhcCCCCCccccchhHHHHHHH
Q 002969          698 ---------QTE------------------------------QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE  738 (862)
Q Consensus       698 ---------~~~------------------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~e  738 (862)
                               ...                              ......+||+.|+|||++....|+..+|.||.||||||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence                     000                              00113579999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCCc
Q 002969          739 TVSGKKNRGFYHSNN  753 (862)
Q Consensus       739 lltG~~p~~~~~~~~  753 (862)
                      |+.|+.||....+.+
T Consensus       864 m~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGE  878 (1034)
T ss_pred             HhhCCCCccCCCCCc
Confidence            999999986544433

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=2.9e-26  Score=233.80  Aligned_cols=210  Identities=36%  Similarity=0.606  Sum_probs=183.4

Q ss_pred             eeccccEEEEEeEecC-CcEEEEEEeccCCcc-chHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCChhh
Q 002969          550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDS  627 (862)
Q Consensus       550 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~  627 (862)
                      ||+|.+|.||+++..+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998865 889999999765432 45789999999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC-CCCeeEecccceeecCCCCcccccccc
Q 002969          628 VIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-EMTPKISDFGMARIFGGDQTEQNTKRV  706 (862)
Q Consensus       628 ~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~  706 (862)
                      ++....  ..+++..+..++.++++++++||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            985432  35889999999999999999999997   999999999999999 89999999999987643321  12234


Q ss_pred             cccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHH
Q 002969          707 VGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE  785 (862)
Q Consensus       707 ~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~  785 (862)
                      .+...|++||.+... .++.+.|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            567899999999887 888999999999999998                                              


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          786 VLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       786 ~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                       ..+.+++..|++.+|++||++.++++.
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence             467789999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-27  Score=229.17  Aligned_cols=202  Identities=27%  Similarity=0.402  Sum_probs=165.6

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC-CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      +....+..||+|++|.|-+-++. +|+..|+|+++.. ..+..++..+|+.+..+- ..|.+|.++|.........+.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            34445578999999999888775 5888999999754 345667788888876665 69999999999999999999999


Q ss_pred             eccCCChhhhhhh-ccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          619 YMENRSLDSVIFD-KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       619 ~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      .|. .||+.+-.+ -.++..+++.-+=+|+..+.+||.|||++-  .++|||+||+|||++.+|++||+|||++..+.+.
T Consensus       126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            995 577776533 234566889999999999999999999864  6999999999999999999999999999876432


Q ss_pred             CcccccccccccccccChhhhcC----CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMD----GLFSVKSDVFSFGVLLLETVSGKKNRGFY  749 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~----~~~s~ksDVwSlGvil~elltG~~p~~~~  749 (862)
                      ..   .+.-.|-..|||||.+..    ..|+.|+||||||+++.||.+++.|++.+
T Consensus       203 iA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  203 IA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             hH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            22   122357788999998854    36899999999999999999999997543

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=99.94  E-value=7.5e-28  Score=221.18  Aligned_cols=108  Identities=48%  Similarity=0.771  Sum_probs=79.2

Q ss_pred             CceeEEeeCCCCCCCCC--CceEEEEcc-eeEEEcCCCCeEEcc-CCCCC--CccEEEEecCCCeEEEecCCCceeeeec
Q 002969          103 QRTYVWVANRDDPLANS--SGVLRIINQ-RIGLFDGSQNLVWSS-NQTKA--TNPVAQLQDSGNFVLKEAGSDEILWQSF  176 (862)
Q Consensus       103 ~~t~vWvAnr~~p~~~~--~~~l~~~~~-~~~l~~~~~~~vWst-~~~~~--~~~~a~l~d~GNlVl~~~~~~~~lWqSF  176 (862)
                      ++||||+|||++|+..+  ..+|.+..| +|+|+|+.++++|++ ++.+.  .+..|+|+|+|||||++. .+.++||||
T Consensus         1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~-~~~~lW~Sf   79 (114)
T PF01453_consen    1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS-SGNVLWQSF   79 (114)
T ss_dssp             ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET-TSEEEEEST
T ss_pred             CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee-cceEEEeec
Confidence            47999999999999653  478999977 578899999999999 55543  478999999999999995 789999999


Q ss_pred             CCCCCccCCcCcccceeecCCeeEEEecCCCCCCC
Q 002969          177 DYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPS  211 (862)
Q Consensus       177 d~PtDTlLpg~klg~~~~tg~~~~L~Sw~s~~dps  211 (862)
                      ||||||+||+|+|+.+..+|.+..++||++.+|||
T Consensus        80 ~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps  114 (114)
T PF01453_consen   80 DYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS  114 (114)
T ss_dssp             TSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred             CCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence            99999999999999988887777899999999997

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=7.5e-28  Score=239.80  Aligned_cols=264  Identities=22%  Similarity=0.328  Sum_probs=190.0

Q ss_pred             cccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeC-----CceEEE
Q 002969          545 TDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-----DEKMLV  616 (862)
Q Consensus       545 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~~lV  616 (862)
                      +..+.||.|+||.||..+.. +|+.||+|++..-.  -...+.+.+|+++|..++|.|++..++...-.     .+.|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            44578999999999998765 58999999986532  23456889999999999999999988775432     346788


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      .|.|. .+|..++..   ...++...+.-+.+||++||.|||+.+   |.||||||.|.|++++..+||+|||+++....
T Consensus       136 TELmQ-SDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHH-hhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            88884 466666633   334777777788999999999999998   99999999999999999999999999998654


Q ss_pred             CCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHH--------HHHHHhc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGH--------VWRLWKE  767 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~  767 (862)
                      ++....+. .+-|..|.|||++++. .|+.+.||||.|||+.||+..+--|....+-+-.+++-.        ..+.--|
T Consensus       209 d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  209 RDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            44443333 4568899999999985 699999999999999999987765543222111111111        1111112


Q ss_pred             CceeeeecccCC----------CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          768 GKVLEMVDSSVD----------NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       768 ~~~~~~id~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      |...-++.....          ..+.....+..++..+++..+|+.|.+.++.+..+..
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            211111111110          1112233355678889999999999999998876544

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=4.8e-27  Score=229.09  Aligned_cols=255  Identities=20%  Similarity=0.356  Sum_probs=195.6

Q ss_pred             cccccccceeeccccEEEEEeEe-cCCcEEEEEEeccCCccchHHHHHHHHHHHhcc-cCCceEEEEEEEeC--CceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEM--DEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~--~~~~lV  616 (862)
                      .++|++.+++|+|-+++||.|.. .+.++++||+++.-.   .+...+|+.+|..|. ||||+++++...+.  ....||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            46788889999999999999974 457899999997543   456789999999997 99999999998765  456799


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC-CCeeEecccceeecC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFG  695 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~~~~  695 (862)
                      +||+.+.+...+.      ..++...+...+.++++||.|+|+.|   |.|||+||.|+++|.. -.++|+|+|||..+.
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999998876654      24777788889999999999999998   9999999999999865 579999999999876


Q ss_pred             CCCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeee-
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM-  773 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~-  773 (862)
                      .....   ...+.+..|.-||++..- .|+..-|+|||||+|.+|+..+.||  +++.+..+.+..+.+.+........ 
T Consensus       185 p~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF--FhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  185 PGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF--FHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             CCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc--cCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            54322   223446678899998764 5788999999999999999999995  4444444555555444432211110 


Q ss_pred             ------ecccCC-----------------CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          774 ------VDSSVD-----------------NYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       774 ------id~~~~-----------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                            +++...                 +-..-...+.++++.+.|..|-.+|||++|.+.
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                  111110                 001122357889999999999999999999874

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=2.6e-26  Score=249.63  Aligned_cols=196  Identities=26%  Similarity=0.367  Sum_probs=167.3

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC--------ccchHHHHHHHHHHHhcc---cCCceEEEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--------GQGIEEFKNEVRLIAKLQ---HRNLVRLLGCCV  608 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---HpnIv~l~g~~~  608 (862)
                      ...|..++.+|+|+||.|+.+.++. ..+|+||.+.+..        ....-..-.|+++|..++   |+||++++.+|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3458888999999999999998865 5679999886542        122234567999999997   999999999999


Q ss_pred             eCCceEEEEEec-cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEec
Q 002969          609 EMDEKMLVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISD  687 (862)
Q Consensus       609 ~~~~~~lV~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  687 (862)
                      +.+.+||++|-. ++.+|.+++.-+   +.+++.+..-|+.||+.|+++||+++   |||||||-+||.++.+|-+||+|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence            999999999975 577888888443   34899999999999999999999999   99999999999999999999999


Q ss_pred             ccceeecCCCCcccccccccccccccChhhhcCCCCC-ccccchhHHHHHHHHHhCCCCC
Q 002969          688 FGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS-VKSDVFSFGVLLLETVSGKKNR  746 (862)
Q Consensus       688 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwSlGvil~elltG~~p~  746 (862)
                      ||.|....    .......+||..|.|||++.+.+|- ..-|||++|++||-++.-..|+
T Consensus       714 fgsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  714 FGSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             ccchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            99987653    2334457899999999999998874 5679999999999999888875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=6.5e-25  Score=227.63  Aligned_cols=197  Identities=36%  Similarity=0.490  Sum_probs=171.3

Q ss_pred             ccccceeeccccEEEEEeEecC-CcEEEEEEeccCCcc-chHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      |+..+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4556899999999999999876 889999999766544 67889999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +++|.+++.....  .+++.....++.++++++.+||+.+   ++|+||+|.||+++.++.++|+|||++..+..... .
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~  154 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A  154 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence            9999999854332  1788999999999999999999987   99999999999999999999999999987654321 1


Q ss_pred             ccccccccccccChhhh-cCCCCCccccchhHHHHHHHHHhCCCCC
Q 002969          702 NTKRVVGTYGYMSPEYA-MDGLFSVKSDVFSFGVLLLETVSGKKNR  746 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l-~~~~~s~ksDVwSlGvil~elltG~~p~  746 (862)
                      ......++..|++||.+ ....++.++|||+||++++||++|+.||
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf  200 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPF  200 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCc
Confidence            22334677889999998 6677888999999999999999999996

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.8e-25  Score=238.07  Aligned_cols=132  Identities=26%  Similarity=0.346  Sum_probs=109.6

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcc-----c---CCceEEEEEEEe--
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-----H---RNLVRLLGCCVE--  609 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H---pnIv~l~g~~~~--  609 (862)
                      ..+|.+.++||.|.|++||++-... .+.||+|+.+ ......+....|+++|++++     |   .+||+|++.|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK-SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK-SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEe-hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            3578899999999999999997654 5679999985 33445567789999999994     3   369999999965  


Q ss_pred             --CCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe
Q 002969          610 --MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (862)
Q Consensus       610 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl  677 (862)
                        +.+.++|+|++ |.+|..+|....- .-++...+.+|+.||+.||.|||.+.  +|||-||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence              56889999999 5677777754332 33888999999999999999999987  69999999999998

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=2.4e-26  Score=253.97  Aligned_cols=253  Identities=25%  Similarity=0.351  Sum_probs=202.5

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      .++|+..+++|.|.+|.|||++... ++..|+|.++........-..+|+-+++..+|||||.++|-+...+...+.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            3567888999999999999998764 888999999888777788888999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +.+|+|.+.-+--   ..+++.++..+.+..++||+|||+.+   -+|||||-.|||+.+.|.+|++|||.+..+..  .
T Consensus        94 cgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita--t  165 (829)
T KOG0576|consen   94 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA--T  165 (829)
T ss_pred             cCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--h
Confidence            9999999876432   35889999999999999999999998   79999999999999999999999999876643  2


Q ss_pred             ccccccccccccccChhhh---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          700 EQNTKRVVGTYGYMSPEYA---MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l---~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      -...+...||+.|||||+.   ..+.|..++|||++|+...|+---++|....++..      ..+-+-+.+.     ++
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr------~l~LmTkS~~-----qp  234 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR------ALFLMTKSGF-----QP  234 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH------HHHHhhccCC-----CC
Confidence            2334457899999999987   45679999999999999999988777743222221      1111111111     11


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .-.+-+..-...+.++++.|+.++|++||+++.+++
T Consensus       235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            111112233456778999999999999999988763

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=2.4e-25  Score=227.96  Aligned_cols=256  Identities=25%  Similarity=0.324  Sum_probs=189.1

Q ss_pred             ccccccceeeccccEEEEEeEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeC------Cc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM------DE  612 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~------~~  612 (862)
                      .+|..++.+|.|.- .|-.+-. -.++.||+|++...  .....++..+|..++..++|+||++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46777788999988 5555532 34889999998654  234556788999999999999999999998643      35


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      .|+|||+|. .+|...+.     ..++-.....|..|++.|+.|||+.+   |+||||||+||++..+..+||.|||+|+
T Consensus        96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            699999995 57887775     23677788899999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHH-----------
Q 002969          693 IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV-----------  761 (862)
Q Consensus       693 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~-----------  761 (862)
                      .-...   -..+..+.|..|.|||++.+..+.+.+||||+||++.||++|+--+..   .+..+....+           
T Consensus       167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g---~d~idQ~~ki~~~lgtpd~~F  240 (369)
T KOG0665|consen  167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG---KDHIDQWNKIIEQLGTPDPSF  240 (369)
T ss_pred             ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC---chHHHHHHHHHHHhcCCCHHH
Confidence            64322   234456789999999999998899999999999999999999875431   1111111111           


Q ss_pred             -------HHHHhcCce-------eeeecccC----CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          762 -------WRLWKEGKV-------LEMVDSSV----DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       762 -------~~~~~~~~~-------~~~id~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                             .+.+.+...       .+.+....    .+.+......+.+++.+||-.+|++|-+++++|+.
T Consensus       241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                   111111000       00000000    01112334456789999999999999999999974

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=9.9e-26  Score=242.17  Aligned_cols=199  Identities=23%  Similarity=0.278  Sum_probs=168.5

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcc------cCCceEEEEEEEeCCce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ------HRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~g~~~~~~~~  613 (862)
                      -.+|.+....|+|-|++|..|+... |+.||||++..+. .-.+.=+.|+++|++|+      --|.++|+..|.+.+++
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL  509 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL  509 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence            4578888889999999999998754 8899999996542 23344568999999996      34899999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC-CCeeEeccccee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMAR  692 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~  692 (862)
                      |||+|-+. -+|.++|...++.--|....+..++.|+.-||..|...+   |+|.||||.||||.+. ..+||+|||.|.
T Consensus       510 ClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  510 CLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             EEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcccc
Confidence            99999884 689999988777777889999999999999999999988   9999999999999865 578999999998


Q ss_pred             ecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 002969          693 IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGF  748 (862)
Q Consensus       693 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~  748 (862)
                      ......    .+....+.-|.|||++.+.+|+...|+||.||+||||.||+-.|..
T Consensus       586 ~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG  637 (752)
T KOG0670|consen  586 FASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG  637 (752)
T ss_pred             cccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence            754322    2223446689999999999999999999999999999999987643

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.8e-25  Score=221.92  Aligned_cols=260  Identities=20%  Similarity=0.308  Sum_probs=190.7

Q ss_pred             CCCCccChHHHHHHcccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEE
Q 002969          527 LELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLL  604 (862)
Q Consensus       527 ~~~~~~~~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~  604 (862)
                      .+++..++++      .|.+.+.||+|.||.+-++++.. ...+++|.+++.. ...++|.+|...--.| .|.||+.-+
T Consensus        15 ~el~kv~l~d------~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY   87 (378)
T KOG1345|consen   15 EELKKVDLED------VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTY   87 (378)
T ss_pred             ccccccchhh------hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHH
Confidence            3455555544      58888999999999999999876 5679999886543 3467899998776666 589999877


Q ss_pred             EE-EEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe-c-CCC
Q 002969          605 GC-CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL-D-KEM  681 (862)
Q Consensus       605 g~-~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl-~-~~~  681 (862)
                      +. |+..+.+++++||++.|+|.+-+..    .-+.+....+++.|++.|+.|+|+.+   +||||||.+|||| + +..
T Consensus        88 ~vaFqt~d~YvF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~  160 (378)
T KOG1345|consen   88 EVAFQTSDAYVFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFY  160 (378)
T ss_pred             HHHhhcCceEEEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCcc
Confidence            54 5667778899999999999887744    23778888899999999999999998   9999999999999 3 345


Q ss_pred             CeeEecccceeecCCCCcccccccccccccccChhhhcCC-----CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchh
Q 002969          682 TPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG-----LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELN  756 (862)
Q Consensus       682 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~  756 (862)
                      ++||+|||+.+..+..     .....-+..|.|||+....     ...+.+|||.||++++.+++|+.||......+ ..
T Consensus       161 rvKlcDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~  234 (378)
T KOG1345|consen  161 RVKLCDFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KP  234 (378)
T ss_pred             EEEeeecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-ch
Confidence            8999999998764322     2223346679999987543     24678999999999999999999987432222 22


Q ss_pred             HHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       757 l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .  +-|..+..+...     .++..-......+.++.++-+..+|++|=...++-++
T Consensus       235 Y--~~~~~w~~rk~~-----~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  235 Y--WEWEQWLKRKNP-----ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             H--HHHHHHhcccCc-----cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            2  223334333322     2222222345567788889999999999555555443

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=99.92  E-value=2.7e-24  Score=199.43  Aligned_cols=113  Identities=49%  Similarity=0.785  Sum_probs=99.5

Q ss_pred             CccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc-eeEEEcCCCCeEEc
Q 002969           64 QNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDGSQNLVWS  142 (862)
Q Consensus        64 ~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~-~~~l~~~~~~~vWs  142 (862)
                      ++|+.|++|+|+++.|++|||++......+.+|||.+++ +++||.||++.| ....+.|.+.++ +|+|.|.+|.+||+
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~   79 (116)
T cd00028           2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWS   79 (116)
T ss_pred             cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEE
Confidence            578899999999999999999987654599999999887 899999999999 445678888876 57888999999999


Q ss_pred             cCCCC-CCccEEEEecCCCeEEEecCCCceeeeecCCC
Q 002969          143 SNQTK-ATNPVAQLQDSGNFVLKEAGSDEILWQSFDYP  179 (862)
Q Consensus       143 t~~~~-~~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~P  179 (862)
                      |++++ ....+|+|+|+|||||++. .++++|||||||
T Consensus        80 S~~~~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~~P  116 (116)
T cd00028          80 SNTTRVNGNYVLVLLDDGNLVLYDS-DGNFLWQSFDYP  116 (116)
T ss_pred             ecccCCCCceEEEEeCCCCEEEECC-CCCEEEcCCCCC
Confidence            99886 5667899999999999987 478999999999

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=3e-24  Score=228.04  Aligned_cols=263  Identities=24%  Similarity=0.380  Sum_probs=196.6

Q ss_pred             HHHcccccccceeeccccEEEEEeEecC----CcEEEEEEeccCCccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCc
Q 002969          538 VRATDNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDE  612 (862)
Q Consensus       538 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~  612 (862)
                      ....+.|...++||+|.|++||++.+..    .+.||+|.+...+  ...+..+|+++|..+. +.||+++.+++...+.
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            3345678888999999999999997644    5679999986543  3456889999999995 9999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC-CCeeEecccce
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMA  691 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFGla  691 (862)
                      ..+|+||++.....+++..      ++..++...+..+..||+++|..|   ||||||||.|+|.+.. +.-.|.|||||
T Consensus       110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence            9999999999998888743      678888899999999999999999   9999999999999754 67899999999


Q ss_pred             eecCCCC-------------cc-----------------------------cccccccccccccChhhhcCC-CCCcccc
Q 002969          692 RIFGGDQ-------------TE-----------------------------QNTKRVVGTYGYMSPEYAMDG-LFSVKSD  728 (862)
Q Consensus       692 ~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~APE~l~~~-~~s~ksD  728 (862)
                      .......             ..                             .......||++|.|||++... ..++++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            7321100             00                             001124699999999999875 4688999


Q ss_pred             chhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHh----------cCc--eee---------------eec-ccC--
Q 002969          729 VFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK----------EGK--VLE---------------MVD-SSV--  778 (862)
Q Consensus       729 VwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~----------~~~--~~~---------------~id-~~~--  778 (862)
                      |||-|||++-+++++.||-.  ..++.+.+.++...+.          .++  +.+               .++ ..+  
T Consensus       261 iws~GVI~Lslls~~~PFf~--a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFK--AKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             eeeccceeehhhcccccccc--CccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            99999999999999999633  2222222222222111          122  111               010 000  


Q ss_pred             --------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          779 --------DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       779 --------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                              .......+..+++++.+|++.||.+|.|++|.|+.
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence                    01112223468899999999999999999999863

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.89  E-value=3.4e-24  Score=263.75  Aligned_cols=196  Identities=18%  Similarity=0.202  Sum_probs=138.7

Q ss_pred             hccc-CCceEEEEEE-------EeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcE
Q 002969          594 KLQH-RNLVRLLGCC-------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI  665 (862)
Q Consensus       594 ~l~H-pnIv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i  665 (862)
                      .++| +||.++++.|       .+....++++|++ +++|.++|...  ...+++.+++.++.||++||+|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            4556 5777888877       3334567888987 56999999543  345899999999999999999999998   9


Q ss_pred             EecccCCcceEecC-------------------CCCeeEecccceeecCCCCc--------------ccccccccccccc
Q 002969          666 IHRDLKASNILLDK-------------------EMTPKISDFGMARIFGGDQT--------------EQNTKRVVGTYGY  712 (862)
Q Consensus       666 vHrDlkp~NILl~~-------------------~~~~kL~DFGla~~~~~~~~--------------~~~~~~~~gt~~y  712 (862)
                      +||||||+||||+.                   ++.+||+|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   44566777777654211000              0001123578899


Q ss_pred             cChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHH
Q 002969          713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHV  792 (862)
Q Consensus       713 ~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~l  792 (862)
                      ||||++.+..++.++|||||||+||||++|.+|+..     ........    ...    ...+.    ..........+
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~-----~~~~~~~~----~~~----~~~~~----~~~~~~~~~~~  244 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE-----KSRTMSSL----RHR----VLPPQ----ILLNWPKEASF  244 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh-----HHHHHHHH----HHh----hcChh----hhhcCHHHHHH
Confidence            999999999999999999999999999998876321     01111111    100    00110    11123345688


Q ss_pred             HHhccccCCCCCCCHHHHHH
Q 002969          793 GLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       793 i~~cl~~dP~~RPt~~evl~  812 (862)
                      +.+||+.+|.+||+|.||++
T Consensus       245 ~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHhCCCChhhCcChHHHhh
Confidence            89999999999999999986

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=99.89  E-value=1.1e-22  Score=188.00  Aligned_cols=111  Identities=46%  Similarity=0.770  Sum_probs=96.9

Q ss_pred             CccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc-eeEEEcCCCCeEEc
Q 002969           64 QNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDGSQNLVWS  142 (862)
Q Consensus        64 ~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~-~~~l~~~~~~~vWs  142 (862)
                      +.|..|++|+|+++.|++|||.+... ..+.+|||++.+ +++||+|||+.|+.++ ..|.+.++ +|+|+|.+|.+||+
T Consensus         2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~~-~~l~l~~dGnLvl~~~~g~~vW~   78 (114)
T smart00108        2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDGRVVWS   78 (114)
T ss_pred             cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCCC-EEEEEeCCCCEEEEeCCCCEEEE
Confidence            56888999999999999999988543 789999999987 8999999999998764 77888776 57778999999999


Q ss_pred             cCCC-CCCccEEEEecCCCeEEEecCCCceeeeecCC
Q 002969          143 SNQT-KATNPVAQLQDSGNFVLKEAGSDEILWQSFDY  178 (862)
Q Consensus       143 t~~~-~~~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~  178 (862)
                      |++. +....+|+|+|+|||||++. .++++||||||
T Consensus        79 S~t~~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~~  114 (114)
T smart00108       79 SNTTGANGNYVLVLLDDGNLVIYDS-DGNFLWQSFDY  114 (114)
T ss_pred             ecccCCCCceEEEEeCCCCEEEECC-CCCEEeCCCCC
Confidence            9987 45667899999999999987 46799999997

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.88  E-value=1.3e-22  Score=203.15  Aligned_cols=167  Identities=17%  Similarity=0.149  Sum_probs=124.8

Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      |+|.+++...  ...+++.++..|+.||++||+|||+.+         ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            6888988543  335999999999999999999999875         999999999999999  99998753321    


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP  782 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~  782 (862)
                         ..|++.|+|||++.+..++.++|||||||++|||++|+.|+.....  ....+..........      ++.....+
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~------~~~~~~~~  132 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--LSAILEILLNGMPAD------DPRDRSNL  132 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--hcHHHHHHHHHhccC------CccccccH
Confidence               2578999999999999999999999999999999999999643211  111111111111110      00000111


Q ss_pred             hHHHH--HHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          783 ANEVL--RCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       783 ~~~~~--~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .....  ++.+++.+||+.+|++||++.|+++.+...
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            22222  688999999999999999999999987654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=3.8e-21  Score=211.75  Aligned_cols=260  Identities=21%  Similarity=0.247  Sum_probs=195.6

Q ss_pred             cccccceeeccccEEEEEeEecCC--cEEEEEEeccCCccchHHHHHHHHHHHhccc----CCceEEEEEE-EeCCceEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLEG--QEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH----RNLVRLLGCC-VEMDEKML  615 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----pnIv~l~g~~-~~~~~~~l  615 (862)
                      +|.+.++||+|+||.||++.....  ..+|+|............+..|..++..+.+    +++.+++... ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            789999999999999999987664  4788888766544433378899999999973    6899999998 47778899


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC-----CCeeEecccc
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-----MTPKISDFGM  690 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-----~~~kL~DFGl  690 (862)
                      ||+.+ |.+|.++..... ...++....++|+.|++.+|++||+.+   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99887 789999875544 566999999999999999999999998   9999999999999754     4689999999


Q ss_pred             ee--ecCCCCc----cc-c-cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHH
Q 002969          691 AR--IFGGDQT----EQ-N-TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVW  762 (862)
Q Consensus       691 a~--~~~~~~~----~~-~-~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~  762 (862)
                      ++  .+.....    .. . .....||..|.+++...+...+.+.|+||++.++.|++.|..||...........+... 
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~-  252 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD-  252 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH-
Confidence            99  4322211    11 1 22356999999999999999999999999999999999999998543332221111111 


Q ss_pred             HHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       763 ~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                        ...    .....    .....+..+.++...+-..+..++|....+...|....
T Consensus       253 --~~~----~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~  298 (322)
T KOG1164|consen  253 --PRK----LLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF  298 (322)
T ss_pred             --hhh----hcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence              111    11000    11222334455555555689999999999999887653

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=6.4e-22  Score=217.71  Aligned_cols=166  Identities=20%  Similarity=0.243  Sum_probs=130.3

Q ss_pred             HHcccccccceeeccccEEEEEeEec--CCcEEEEEEeccC-----CccchHHHHHHHHHHHhcccCCceE-EEEEEEeC
Q 002969          539 RATDNFTDYNKLGQGGFGIVYKGRLL--EGQEIAVKRLSRN-----SGQGIEEFKNEVRLIAKLQHRNLVR-LLGCCVEM  610 (862)
Q Consensus       539 ~~~~~f~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~-l~g~~~~~  610 (862)
                      ...++|...++||+|+||.||+|+..  +++.+|||++...     .....+.|.+|+++|++++|+|+++ ++.    .
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----T   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----c
Confidence            34568999999999999999999865  4677899987533     1223567999999999999999985 443    2


Q ss_pred             CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEeccc-CCcceEecCCCCeeEeccc
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDL-KASNILLDKEMTPKISDFG  689 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDl-kp~NILl~~~~~~kL~DFG  689 (862)
                      +..++||||+++++|....    .   ..   ...++.+++++|+|||+.+   |+|||| ||+|||++.++.+||+|||
T Consensus        91 ~~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             CCcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence            5689999999999996321    1   01   1467889999999999998   999999 9999999999999999999


Q ss_pred             ceeecCCCCcccc------cccccccccccChhhhcCC
Q 002969          690 MARIFGGDQTEQN------TKRVVGTYGYMSPEYAMDG  721 (862)
Q Consensus       690 la~~~~~~~~~~~------~~~~~gt~~y~APE~l~~~  721 (862)
                      +++.+........      .....+++.|+|||.+...
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9998754332211      1346788899999998654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.85  E-value=3.7e-22  Score=199.29  Aligned_cols=244  Identities=21%  Similarity=0.336  Sum_probs=189.6

Q ss_pred             cceeeccccEEEEEeEecCCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCC
Q 002969          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRS  624 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs  624 (862)
                      ..+|.+...|+.|+|++. |..+++|++.-.  .....++|.+|.-.|+.+.||||..++|.|.....+.++..||+.|+
T Consensus       195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            357888899999999994 556777777533  33345689999999999999999999999999999999999999999


Q ss_pred             hhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEe--cccceeecCCCCcccc
Q 002969          625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS--DFGMARIFGGDQTEQN  702 (862)
Q Consensus       625 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~--DFGla~~~~~~~~~~~  702 (862)
                      |..+|+... .-..+-.+..+++.+||+|++|||+..+ -|.---|.++.|++|++.+++|+  |--++..        .
T Consensus       274 lynvlhe~t-~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfq--------e  343 (448)
T KOG0195|consen  274 LYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--------E  343 (448)
T ss_pred             HHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeee--------c
Confidence            999997643 3457888999999999999999999873 23334689999999999988874  3222111        1


Q ss_pred             cccccccccccChhhhcCCCC---CccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC-
Q 002969          703 TKRVVGTYGYMSPEYAMDGLF---SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV-  778 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~---s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~-  778 (862)
                      . ...-.+.||+||.++..+-   -.++|+|||.+++|||.|...||....+.+-      -         +++.-+.+ 
T Consensus       344 ~-gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec------g---------mkialeglr  407 (448)
T KOG0195|consen  344 V-GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC------G---------MKIALEGLR  407 (448)
T ss_pred             c-ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh------h---------hhhhhcccc
Confidence            1 1223678999999987654   3578999999999999999999865443321      1         11111122 


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ...|+..+..+.+|+..|+..||.+||.+..|+-.|++.
T Consensus       408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            345777788899999999999999999999999998874

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=1.1e-19  Score=197.64  Aligned_cols=262  Identities=27%  Similarity=0.401  Sum_probs=197.9

Q ss_pred             ccccceeeccccEEEEEeEecCCcEEEEEEeccCCcc---chHHHHHHHHHHHhcccC-CceEEEEEEEeCCceEEEEEe
Q 002969          544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ---GIEEFKNEVRLIAKLQHR-NLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~Hp-nIv~l~g~~~~~~~~~lV~E~  619 (862)
                      |...+.||.|+|+.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++...+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566789999999999999886  88999999765333   477899999999999988 799999999777778999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC-CeeEecccceeecCCCC
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFGGDQ  698 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~  698 (862)
                      +.++++.+++........+.......++.|++.++.|+|..+   ++|||+||+||+++..+ .+++.|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966643321125888999999999999999999998   99999999999999998 79999999998664433


Q ss_pred             ccc----ccccccccccccChhhhcC---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          699 TEQ----NTKRVVGTYGYMSPEYAMD---GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       699 ~~~----~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      ...    ......|+..|+|||.+.+   ..+....|+|++|++++++++|..|+......   .........+......
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence            221    2355789999999999988   57889999999999999999999995433221   0111122222211111


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .................+.+++..++..+|..|.++.+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            000000000012223567789999999999999999987764

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=3.6e-20  Score=190.50  Aligned_cols=205  Identities=22%  Similarity=0.340  Sum_probs=174.5

Q ss_pred             ccccccceeeccccEEEEEeE-ecCCcEEEEEEeccCCccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      -+|.+.++||+|.||..+.|+ +.+++.||||.-.+.+  ..-+++.|.+..+.|. .++|...+.+..++.+-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            479999999999999999996 4579999999876544  3457788999999985 69999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC-----CCeeEecccceeec
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-----MTPKISDFGMARIF  694 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-----~~~kL~DFGla~~~  694 (862)
                      + |-||+++..-.  ...++.+.+..||.|++.-++|+|++.   +|.|||||+|+||...     ..+.|+|||+|+.+
T Consensus       106 L-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8 78999887322  234899999999999999999999998   9999999999999643     35889999999987


Q ss_pred             CCCCcc-----cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcc
Q 002969          695 GGDQTE-----QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE  754 (862)
Q Consensus       695 ~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~  754 (862)
                      ....+.     ...+...||.+||+-.-..+.+-+.+.|+-|||-++++.+.|..||.....+..
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn  244 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN  244 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch
Confidence            654332     344567899999999999999999999999999999999999999987655543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=2.7e-20  Score=183.50  Aligned_cols=258  Identities=20%  Similarity=0.262  Sum_probs=196.7

Q ss_pred             cccccccceeeccccEEEEEeEe-cCCcEEEEEEeccCCccchHHHHHHHHHHHhccc-CCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH-RNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .++|..+++||.|+||.+|.|.. .+|++||||.-+...  ...++..|.++...|+| ..|+.+..+..+..+-.+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            45799999999999999999975 469999999875443  33567889999999986 788889999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC---CCeeEecccceeecC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGMARIFG  695 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kL~DFGla~~~~  695 (862)
                      .+ |.||+++..-..  ..++.+..+-++-|++.-++|+|..+   ++||||||+|+|..-+   ..+.|+|||||+.+.
T Consensus        92 LL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            98 789999874333  34888999999999999999999998   9999999999999643   468999999999875


Q ss_pred             CCCc-----ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce
Q 002969          696 GDQT-----EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV  770 (862)
Q Consensus       696 ~~~~-----~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  770 (862)
                      ...+     ........||.+|.+-....+...+.+.|+-|+|.+|.+...|..||............+.+.    |.+.
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~----EkK~  241 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS----EKKM  241 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH----Hhhc
Confidence            4322     223345789999999888888888999999999999999999999998766555544444433    2222


Q ss_pred             eeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 002969          771 LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML  814 (862)
Q Consensus       771 ~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  814 (862)
                      ...+......+|    .++...+.-|-..--++-|...-+.+.+
T Consensus       242 s~~ie~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlF  281 (341)
T KOG1163|consen  242 STPIEVLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLF  281 (341)
T ss_pred             CCCHHHHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence            222222223333    3444555566666667777766555443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=9.1e-21  Score=221.97  Aligned_cols=253  Identities=20%  Similarity=0.248  Sum_probs=186.5

Q ss_pred             ccceeeccccEEEEEeEec-CCcEEEEEEec-----cCCccc-hHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          546 DYNKLGQGGFGIVYKGRLL-EGQEIAVKRLS-----RNSGQG-IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       546 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~-----~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ..+.+|.|++|.|+..... ..+..+.|..+     ...... ...+..|+.+-..+.|+|++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4478999999977776543 23334444332     111111 1125567777888899999888777777666666699


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++ +|..++...   ..+...++..++.|+++|++|||+.+   |.|||+|++|+++..++.+||+|||.+..+....
T Consensus       402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            9999 999988544   34778888899999999999999998   9999999999999999999999999998876544


Q ss_pred             cc--cccccccccccccChhhhcCCCCCc-cccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          699 TE--QNTKRVVGTYGYMSPEYAMDGLFSV-KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       699 ~~--~~~~~~~gt~~y~APE~l~~~~~s~-ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ..  ......+|...|+|||.+.+..|.+ ..||||.|+++..|++|+.||-.....+.....       ........+.
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-------~~~~~~~~~~  547 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-------NNYSDQRNIF  547 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-------hccccccccc
Confidence            43  4455678999999999999999876 579999999999999999998654443322100       0000001111


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..........+.+...++.+||+.+|.+|-|+++|++
T Consensus       548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            1112233445567788999999999999999999985

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=1.4e-19  Score=185.57  Aligned_cols=170  Identities=14%  Similarity=0.183  Sum_probs=133.2

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchH---H------HHHHHHHHHhcccCCceEEEEEEEeC-
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIE---E------FKNEVRLIAKLQHRNLVRLLGCCVEM-  610 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~---~------~~~E~~~l~~l~HpnIv~l~g~~~~~-  610 (862)
                      .++|+..++||.|+||.||+... ++..+|||.++........   .      +.+|++.+.+++|++|..+..++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            57899999999999999999755 5778999999755322222   2      68999999999999999998886543 


Q ss_pred             -------CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCe
Q 002969          611 -------DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (862)
Q Consensus       611 -------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  683 (862)
                             ...+++|||++|.+|.++..       ++.    ....+++.+|..+|..+   ++|||+||.||++++++ +
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence                   35789999999999987631       222    24569999999999998   99999999999999988 9


Q ss_pred             eEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHH
Q 002969          684 KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETV  740 (862)
Q Consensus       684 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ell  740 (862)
                      +|+|||.......+...              ..+.....+..++|+|+||+++.-+.
T Consensus       174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999988654211111              11445556778999999999987553

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.79  E-value=6.1e-19  Score=178.54  Aligned_cols=139  Identities=17%  Similarity=0.185  Sum_probs=108.5

Q ss_pred             cceeeccccEEEEEeEecCCcEEEEEEeccCCcc--c-------hHHH-----------------HHHHHHHHhcccCCc
Q 002969          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ--G-------IEEF-----------------KNEVRLIAKLQHRNL  600 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~-------~~~~-----------------~~E~~~l~~l~HpnI  600 (862)
                      ...||+|+||.||+|...+|+.||||+++.....  .       ...|                 ..|++++.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3689999999999999888999999999754211  1       1122                 349999999988876


Q ss_pred             eEEEEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHh-hhcCCCcEEecccCCcceEecC
Q 002969          601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL-HQDSRFRIIHRDLKASNILLDK  679 (862)
Q Consensus       601 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivHrDlkp~NILl~~  679 (862)
                      .....+.  ....++||||++++++...+..   ...++.....+++.|++.+|.|| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEE--ecCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            4433322  2234899999999877654322   23478899999999999999999 6777   99999999999998 


Q ss_pred             CCCeeEecccceeec
Q 002969          680 EMTPKISDFGMARIF  694 (862)
Q Consensus       680 ~~~~kL~DFGla~~~  694 (862)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=3.4e-18  Score=173.56  Aligned_cols=140  Identities=20%  Similarity=0.214  Sum_probs=111.0

Q ss_pred             cceeeccccEEEEEeEecCCcEEEEEEeccCCccc--------------------------hHHHHHHHHHHHhcccCCc
Q 002969          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG--------------------------IEEFKNEVRLIAKLQHRNL  600 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~--------------------------~~~~~~E~~~l~~l~HpnI  600 (862)
                      ...||+|+||.||+|+..+|+.||||+++......                          ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46899999999999998789999999997642110                          1224578999999999987


Q ss_pred             eEEEEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhh-cCCCcEEecccCCcceEecC
Q 002969          601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ-DSRFRIIHRDLKASNILLDK  679 (862)
Q Consensus       601 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~  679 (862)
                      .....+...  ..++||||++++++......   ...++..+..+++.|++.++.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544433322  35899999998865443222   1246778889999999999999999 87   99999999999999 


Q ss_pred             CCCeeEecccceeecC
Q 002969          680 EMTPKISDFGMARIFG  695 (862)
Q Consensus       680 ~~~~kL~DFGla~~~~  695 (862)
                      ++.++|+|||++..+.
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8899999999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.77  E-value=1.4e-18  Score=194.38  Aligned_cols=216  Identities=22%  Similarity=0.366  Sum_probs=163.0

Q ss_pred             HHhcccCCceEEEEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccC
Q 002969          592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK  671 (862)
Q Consensus       592 l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlk  671 (862)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+...  ...+++.-...+..+|++||+|||...  -..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            35689999999999999999999999999999999999663  345899999999999999999999875  23999999


Q ss_pred             CcceEecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCC-------CCccccchhHHHHHHHHHhCCC
Q 002969          672 ASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL-------FSVKSDVFSFGVLLLETVSGKK  744 (862)
Q Consensus       672 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-------~s~ksDVwSlGvil~elltG~~  744 (862)
                      +.|++++..+.+||+|||+.................-...|.|||.+....       .+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            999999999999999999987763211111111122356799999987641       4678999999999999999999


Q ss_pred             CCCCCCCCcc-hhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          745 NRGFYHSNNE-LNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       745 p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ||........ .+++..+    .. ...+.+.+.+.... +...++..++..||..+|++||++++|-..++..
T Consensus       157 ~~~~~~~~~~~~eii~~~----~~-~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRV----KK-GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             ccccccccCChHHHHHHH----Hh-cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            9875433332 2222222    22 11112222222111 3334688999999999999999999999888776

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.76  E-value=2.4e-19  Score=208.46  Aligned_cols=252  Identities=18%  Similarity=0.216  Sum_probs=180.0

Q ss_pred             cccccceeeccccEEEEEeEecCCcEEEEEEeccCC-ccchHHHHHHHHHH--HhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS-GQGIEEFKNEVRLI--AKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l--~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      .+...+.||++.|=.|.++++.+|. |+||++-+.. ....+.|.++++-+  ..++|||.+++.-+-......|||.+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            4666689999999999999998887 8999886553 44555565555444  445899999988777777778899999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC-C
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD-Q  698 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~-~  698 (862)
                      ..+ +|.+.|   ..++.+...+...|+.|++.||...|..+   |+|||||.+||||..-.-+.|+||...+...-. +
T Consensus       103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            864 677766   33456888899999999999999999998   999999999999999999999999876543211 1


Q ss_pred             ccccc----ccccccccccChhhhcCC----------C-CCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHH
Q 002969          699 TEQNT----KRVVGTYGYMSPEYAMDG----------L-FSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVW  762 (862)
Q Consensus       699 ~~~~~----~~~~gt~~y~APE~l~~~----------~-~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~  762 (862)
                      .....    ..-..-.+|+|||.+...          . .+++.||||+||++.||++ |+++|..      ..++.+  
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aY--  247 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAY--  247 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhH--
Confidence            11111    112234589999987431          2 5678999999999999998 4666532      111110  


Q ss_pred             HHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       763 ~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                         +.+. .......+...   +...+.++++.|++.||++|.++++.++.-.+.
T Consensus       248 ---r~~~-~~~~e~~Le~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  248 ---RSGN-ADDPEQLLEKI---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             ---hccC-ccCHHHHHHhC---cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence               0110 00000000110   122577999999999999999999999886654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.75  E-value=8.1e-18  Score=177.63  Aligned_cols=233  Identities=21%  Similarity=0.285  Sum_probs=152.6

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcc----------cCCceEEEEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQ----------HRNLVRLLGCCV  608 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~----------HpnIv~l~g~~~  608 (862)
                      .+...+.||.|+++.||.+++.+ ++++|||++...   .....+++++|.-.+..+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            34556789999999999999876 889999988543   3445678888876665532          223333333221


Q ss_pred             ---------eCC--------ceEEEEEeccCCChhhhhh---hccC-CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEe
Q 002969          609 ---------EMD--------EKMLVYEYMENRSLDSVIF---DKAR-SSILNWQRRFNIICGIARGLLYLHQDSRFRIIH  667 (862)
Q Consensus       609 ---------~~~--------~~~lV~E~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH  667 (862)
                               ...        ..+++|+-+ .++|.+++.   .... ...+....++.+..|+++.+++||..+   ++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence                     111        235677777 568877753   2221 233556777888899999999999998   999


Q ss_pred             cccCCcceEecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcC--------CCCCccccchhHHHHHHHH
Q 002969          668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD--------GLFSVKSDVFSFGVLLLET  739 (862)
Q Consensus       668 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~s~ksDVwSlGvil~el  739 (862)
                      +||+|+|++++.+|.++|+||+.....+.....     ...+..|.+||....        -.++.+.|.|+||+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            999999999999999999999988764321111     233577999997643        2478899999999999999


Q ss_pred             HhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCC
Q 002969          740 VSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEER  804 (862)
Q Consensus       740 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~R  804 (862)
                      .+|..|++..........                   ....+. +.+..+..||..+|+.+|++|
T Consensus       244 WC~~lPf~~~~~~~~~~~-------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW-------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG-------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc-------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999865433221111                   223444 667788899999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=2.5e-17  Score=165.31  Aligned_cols=183  Identities=17%  Similarity=0.124  Sum_probs=138.4

Q ss_pred             ccceeeccccEEEEEeEecCCcEEEEEEeccCCcc----chHHHHHHHHHHHhcc-cCCceEEEEEEEeCCceEEEEEec
Q 002969          546 DYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ----GIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       546 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      +...|++|+||+||.+.. ++.+++.+.+.....-    ....|.+|+++|++++ |+++++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            447899999999997765 6788887777554321    1235889999999995 5889999886    4579999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEeccc-CCcceEecCCCCeeEecccceeecCCCCc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDL-KASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDl-kp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +|.+|...+..          ....++.|++++|.++|..+   |+|||| ||.|||++.++.++|+|||++........
T Consensus        81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            99998654311          11357789999999999998   999999 79999999999999999999986543321


Q ss_pred             c----c--c-----cccccccccccChhhhcCC--CCCccccchhHHHHHHHHHhCCCCC
Q 002969          700 E----Q--N-----TKRVVGTYGYMSPEYAMDG--LFSVKSDVFSFGVLLLETVSGKKNR  746 (862)
Q Consensus       700 ~----~--~-----~~~~~gt~~y~APE~l~~~--~~s~ksDVwSlGvil~elltG~~p~  746 (862)
                      .    .  .     ......++.|++|+...-.  .--...+.++.|.-+|.++|++.+.
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            0    0  0     0112357788888854322  2235679999999999999998873

>PRK10345 hypothetical protein; Provisional

Probab=99.71  E-value=1e-16  Score=164.04  Aligned_cols=136  Identities=19%  Similarity=0.259  Sum_probs=106.1

Q ss_pred             cccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhc-----ccCCceEEEEEEEeCC---ceE-E
Q 002969          545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-----QHRNLVRLLGCCVEMD---EKM-L  615 (862)
Q Consensus       545 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~g~~~~~~---~~~-l  615 (862)
                      ...+.||+|+||.||.  +.+....+||++........+.+.+|+.+++.+     +||||++++|++....   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            4457999999999996  444333479988765555567899999999999     5799999999998864   323 7


Q ss_pred             EEEe--ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHh-HHhhhcCCCcEEecccCCcceEecC----CCCeeEecc
Q 002969          616 VYEY--MENRSLDSVIFDKARSSILNWQRRFNIICGIARGL-LYLHQDSRFRIIHRDLKASNILLDK----EMTPKISDF  688 (862)
Q Consensus       616 V~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL-~yLH~~~~~~ivHrDlkp~NILl~~----~~~~kL~DF  688 (862)
                      |+||  +++++|.+++.+.    .+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    +..++|+||
T Consensus        83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  6689999999442    24444  35677888777 9999998   999999999999974    348999995


Q ss_pred             cce
Q 002969          689 GMA  691 (862)
Q Consensus       689 Gla  691 (862)
                      +-+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            433

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.70  E-value=2.3e-18  Score=192.29  Aligned_cols=225  Identities=24%  Similarity=0.264  Sum_probs=176.6

Q ss_pred             eeeccccEEEEEeEe----cCCcEEEEEEeccCCcc--chHHHHHHHHHHHhcc-cCCceEEEEEEEeCCceEEEEEecc
Q 002969          549 KLGQGGFGIVYKGRL----LEGQEIAVKRLSRNSGQ--GIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       549 ~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      .+|+|.||.|++.+-    +.+..+|+|.+++....  .......|..++...+ ||.++++...+......+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            378999999998643    34677899988765321  1225667888899997 9999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +|.|...+...   ...++.........++-+++++|+.+   ++|||+|++||+++.+|.+++.|||+++..-....  
T Consensus        81 gg~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            99998777432   33566666667788999999999998   99999999999999999999999999986532221  


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY  781 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~  781 (862)
                          .+||..|||||++.  ....++|-||||++++||++|..|+..       +...             .+-..-...
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~-------------~Il~~~~~~  206 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMK-------------RILKAELEM  206 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHH-------------HHhhhccCC
Confidence                28999999999998  667789999999999999999999643       1111             111111244


Q ss_pred             ChHHHHHHHHHHHhccccCCCCCCCH
Q 002969          782 PANEVLRCIHVGLLCVQENAEERPTM  807 (862)
Q Consensus       782 ~~~~~~~l~~li~~cl~~dP~~RPt~  807 (862)
                      +.+....+.+++..++..+|.+|--.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            56667777788899999999999755

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=1.1e-16  Score=190.97  Aligned_cols=200  Identities=21%  Similarity=0.239  Sum_probs=162.1

Q ss_pred             HHHHcccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcc---cCCceEEEEEEEeCCce
Q 002969          537 IVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ---HRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       537 i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~g~~~~~~~~  613 (862)
                      ++...+.|.+.+.||+|+||.||+|...+++.||+|+-+....-   +|.-=.+++.+|+   -+-|+.+..++.-.+.-
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            34456778899999999999999999988999999998665322   1222223344443   34555666666777888


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec-------CCCCeeEe
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-------KEMTPKIS  686 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~-------~~~~~kL~  686 (862)
                      +||+||.+.|+|.+++.   ..+.++|...+.++.|+++.+++||..+   |||+||||+|.||.       +...++|+
T Consensus       770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence            99999999999999995   4556999999999999999999999998   99999999999993       23468999


Q ss_pred             cccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCC
Q 002969          687 DFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKN  745 (862)
Q Consensus       687 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p  745 (862)
                      |||-+..+..-.........++|-.+--+|...+++.+...|.|.|.-+++-|+.|+.-
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99998766544444455567889999999999999999999999999999999999763

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.66  E-value=6.3e-16  Score=159.61  Aligned_cols=134  Identities=23%  Similarity=0.341  Sum_probs=113.7

Q ss_pred             ceeeccccEEEEEeEecCCcEEEEEEeccCCcc--------chHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ--------GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +.||+|++|.||+|+. .+..+++|+.......        ....+.+|++++..++|++++....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            6799999999999987 6778999986543211        124678899999999999998877777778889999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      +++++|.+++....      . .+..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999884321      2 77889999999999999998   99999999999999 78999999998864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.65  E-value=9.5e-16  Score=156.76  Aligned_cols=145  Identities=20%  Similarity=0.197  Sum_probs=114.3

Q ss_pred             HHHHHHcccccccceeeccccEEEEEeEecCCcEEEEEEeccCCcc----------------------chHHHHHHHHHH
Q 002969          535 ETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ----------------------GIEEFKNEVRLI  592 (862)
Q Consensus       535 ~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~E~~~l  592 (862)
                      .++......|...+.||+|+||.||++...+++.||||+++.....                      ....+..|..++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            4455555557888999999999999999888999999987643210                      112367789999


Q ss_pred             HhcccC--CceEEEEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEeccc
Q 002969          593 AKLQHR--NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDL  670 (862)
Q Consensus       593 ~~l~Hp--nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDl  670 (862)
                      .++.|+  .+++.++.    ...++||||+++++|..+..         ......++.++++++.++|+.+   ++||||
T Consensus        88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl  151 (198)
T cd05144          88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDL  151 (198)
T ss_pred             HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence            999887  44555442    45689999999999876542         0234578899999999999987   999999


Q ss_pred             CCcceEecCCCCeeEecccceeecC
Q 002969          671 KASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       671 kp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||.||++++++.++|+|||++..+.
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>smart00090 RIO RIO-like kinase

Probab=99.65  E-value=1.1e-15  Score=160.14  Aligned_cols=146  Identities=18%  Similarity=0.148  Sum_probs=113.4

Q ss_pred             HHcccccccceeeccccEEEEEeE--ecCCcEEEEEEeccCCcc------------------------chHHHHHHHHHH
Q 002969          539 RATDNFTDYNKLGQGGFGIVYKGR--LLEGQEIAVKRLSRNSGQ------------------------GIEEFKNEVRLI  592 (862)
Q Consensus       539 ~~~~~f~~~~~LG~G~fg~Vy~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~l  592 (862)
                      .-...|.+.+.||+|+||.||+|.  ..+|+.||||+++.....                        ....+..|++++
T Consensus        25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L  104 (237)
T smart00090       25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL  104 (237)
T ss_pred             hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence            333458888999999999999998  567999999998754210                        012356899999


Q ss_pred             HhcccC--CceEEEEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEeccc
Q 002969          593 AKLQHR--NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDL  670 (862)
Q Consensus       593 ~~l~Hp--nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDl  670 (862)
                      .++.+.  .++++++.    ...++||||+++.+|.......   ..+...+...++.||+.++.+||+.+  .++||||
T Consensus       105 ~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Di  175 (237)
T smart00090      105 QRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDL  175 (237)
T ss_pred             HHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCC
Confidence            999763  34555543    2358999999998887654222   23555667889999999999999986  4999999


Q ss_pred             CCcceEecCCCCeeEecccceeec
Q 002969          671 KASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       671 kp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      ||+||+++ ++.++|+|||.+...
T Consensus       176 kp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      176 SEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             ChhhEEEE-CCCEEEEEChhhhcc
Confidence            99999999 889999999998754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.64  E-value=5.3e-17  Score=178.19  Aligned_cols=176  Identities=23%  Similarity=0.305  Sum_probs=132.3

Q ss_pred             CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccc
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  690 (862)
                      ..+++.|++++..+|.++|.........++...+.++.|++.|++|   ++   .+|+|+||.||+...+..+||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence            3578999999999999999877666778899999999999999999   55   99999999999999999999999999


Q ss_pred             eeecCCCC----cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCcchhHHHHHHHHH
Q 002969          691 ARIFGGDQ----TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG-KKNRGFYHSNNELNLLGHVWRLW  765 (862)
Q Consensus       691 a~~~~~~~----~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG-~~p~~~~~~~~~~~l~~~~~~~~  765 (862)
                      ........    .........||..||+||.+.+..|+.|+||||||+||+||+.- ..+++      ..    ....-+
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------r~----~t~~d~  472 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------RI----ATLTDI  472 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------HH----Hhhhhh
Confidence            87764433    22334456899999999999999999999999999999999982 22210      00    000111


Q ss_pred             hcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHH
Q 002969          766 KEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASV  810 (862)
Q Consensus       766 ~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev  810 (862)
                      ..        ..++......-+.-..|+.+++...|.+||++.++
T Consensus       473 r~--------g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  473 RD--------GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hc--------CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence            11        11111111111223478999999999999955544

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.63  E-value=1.7e-15  Score=154.83  Aligned_cols=130  Identities=28%  Similarity=0.426  Sum_probs=107.0

Q ss_pred             eeeccccEEEEEeEecCCcEEEEEEeccCCc--------cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG--------QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       549 ~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      .||+|+||.||+|.. ++..+++|+......        ...+++.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 678899998654311        12356788999999999987665555666677789999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++++|.+++.....          .++.+++++|.+||+.+   ++|+|++|.||+++ ++.+++.|||++..
T Consensus        80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999988743210          78999999999999998   99999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.63  E-value=1.5e-15  Score=178.70  Aligned_cols=137  Identities=21%  Similarity=0.341  Sum_probs=111.9

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEE-eccCC-------ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKR-LSRNS-------GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~-l~~~~-------~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  613 (862)
                      ..|...++||+|+||.||+|...... +++|+ +.+..       ....+++.+|++++++++|++++....++......
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34456789999999999999875543 44443 32211       11235688999999999999999888888887888


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++||||+++++|.+++.           ....++.+++++|.|||+.+   ++||||||+|||+ .++.++|+|||+++.
T Consensus       412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999998873           34678999999999999998   9999999999999 678999999999975


Q ss_pred             c
Q 002969          694 F  694 (862)
Q Consensus       694 ~  694 (862)
                      .
T Consensus       477 ~  477 (535)
T PRK09605        477 S  477 (535)
T ss_pred             C
Confidence            3

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=99.62  E-value=2.1e-16  Score=130.09  Aligned_cols=64  Identities=55%  Similarity=1.061  Sum_probs=58.5

Q ss_pred             cccceeeeecccCCCCcccccccccCHHHHHHHHhhcCccccccccccCCCcceeeccCcccch
Q 002969          369 SEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDI  432 (862)
Q Consensus       369 ~~d~f~~~~~~~~p~~~~~~~~~~~sl~~C~~~Cl~~CsC~a~~~~~~~gg~~C~~w~g~l~~~  432 (862)
                      ++|+|+++++|++|+++...++.+.++++|++.|++||||+||+|.++.++++|++|+++|+|+
T Consensus         3 ~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~   66 (66)
T PF08276_consen    3 SGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL   66 (66)
T ss_pred             CCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence            5799999999999999887777779999999999999999999998766788999999999874

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.59  E-value=4.4e-15  Score=156.37  Aligned_cols=197  Identities=20%  Similarity=0.264  Sum_probs=137.2

Q ss_pred             ccCCceEEEEEEEe---------------------------CCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHH
Q 002969          596 QHRNLVRLLGCCVE---------------------------MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC  648 (862)
Q Consensus       596 ~HpnIv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  648 (862)
                      +|||||+++++|.+                           ....|+||...+ .+|..++..+.    .+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence            59999999987753                           223588888775 58888885432    45566667899


Q ss_pred             HHHHHhHHhhhcCCCcEEecccCCcceEe--cCCC--CeeEecccceeecCCCCc----ccccccccccccccChhhhcC
Q 002969          649 GIARGLLYLHQDSRFRIIHRDLKASNILL--DKEM--TPKISDFGMARIFGGDQT----EQNTKRVVGTYGYMSPEYAMD  720 (862)
Q Consensus       649 qia~gL~yLH~~~~~~ivHrDlkp~NILl--~~~~--~~kL~DFGla~~~~~~~~----~~~~~~~~gt~~y~APE~l~~  720 (862)
                      |+++|+.|||.++   |.|||+|++||||  |+|+  .+.|+|||.+---.....    ....-...|...-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999998   9999999999999  4444  578899998753222111    111112356778999999865


Q ss_pred             CC------CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHH
Q 002969          721 GL------FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGL  794 (862)
Q Consensus       721 ~~------~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~  794 (862)
                      .+      .-.|+|.|+.|-+.||+++...||..  . .+..+-..           ..-+..+...+...+..+.+++.
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~--r-Gem~L~~r-----------~Yqe~qLPalp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK--R-GEMLLDTR-----------TYQESQLPALPSRVPPVARQLVF  491 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccc--c-chheechh-----------hhhhhhCCCCcccCChHHHHHHH
Confidence            43      23589999999999999999999643  1 11111000           01112234455666778889999


Q ss_pred             hccccCCCCCCCHHHHHHHh
Q 002969          795 LCVQENAEERPTMASVVLML  814 (862)
Q Consensus       795 ~cl~~dP~~RPt~~evl~~L  814 (862)
                      ..|+.||.+||+..=....|
T Consensus       492 ~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHhcCCccccCCccHHHhHH
Confidence            99999999999866444433

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.55  E-value=3.9e-14  Score=136.85  Aligned_cols=135  Identities=23%  Similarity=0.227  Sum_probs=115.2

Q ss_pred             ccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhccc--CCceEEEEEEEeCCceEEEEEeccCC
Q 002969          546 DYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH--RNLVRLLGCCVEMDEKMLVYEYMENR  623 (862)
Q Consensus       546 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~g~~~~~~~~~lV~E~~~~g  623 (862)
                      +.+.||+|.++.||+++..+ ..+++|.......  ...+.+|+.++..++|  .++++++++....+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            34789999999999998754 7899999865433  5678999999999987  59999999988888899999999988


Q ss_pred             ChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       624 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      .+..+          +......++.+++++|++||......++|+|++|+||++++.+.+++.|||++..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77643          4456677899999999999987555699999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.55  E-value=3e-14  Score=144.08  Aligned_cols=137  Identities=20%  Similarity=0.235  Sum_probs=100.6

Q ss_pred             cceeeccccEEEEEeEecCCcEEEEEEeccCCcc--chHH----------------------HHHHHHHHHhcccCC--c
Q 002969          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ--GIEE----------------------FKNEVRLIAKLQHRN--L  600 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~Hpn--I  600 (862)
                      .+.||+|+||.||+|...+++.||||++......  ....                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4689999999999999888999999998653211  1111                      135666777775443  5


Q ss_pred             eEEEEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhh-cCCCcEEecccCCcceEecC
Q 002969          601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ-DSRFRIIHRDLKASNILLDK  679 (862)
Q Consensus       601 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~  679 (862)
                      .+.+++    ...++||||++++.+.........   .. .+...++.+++.++.++|. .+   |+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            555554    346899999999654322111110   11 5677899999999999999 76   99999999999999 


Q ss_pred             CCCeeEecccceeecC
Q 002969          680 EMTPKISDFGMARIFG  695 (862)
Q Consensus       680 ~~~~kL~DFGla~~~~  695 (862)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8999999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.54  E-value=5.7e-15  Score=172.63  Aligned_cols=209  Identities=23%  Similarity=0.264  Sum_probs=141.0

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      .+|..++.|..|++|.||..++.. .+.+|+|+-+... .    +++   ++.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-i----lRn---ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-I----LRN---ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcccccch-h----hhc---cccccCCccee-------------------
Confidence            568888999999999999998865 5678884332110 0    000   11111222222                   


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc-
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT-  699 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~-  699 (862)
                        |+=...+..-   +.++.        +++.+++|||+.+   |+|||+||+|.+|..-|++|+.|||+.+....... 
T Consensus       136 --gDc~tllk~~---g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 --GDCATLLKNI---GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             --chhhhhcccC---CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence              3333333221   11222        2267899999998   99999999999999999999999999875421111 


Q ss_pred             ------------ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhc
Q 002969          700 ------------EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE  767 (862)
Q Consensus       700 ------------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  767 (862)
                                  ....+.++||+.|+|||++....|...+|.|++|+|+||.+-|..||..   +....++..+.....+
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG---dtpeelfg~visd~i~  276 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG---DTPEELFGQVISDDIE  276 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC---CCHHHHHhhhhhhhcc
Confidence                        1122346899999999999999999999999999999999999999643   3333444444321111


Q ss_pred             CceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCC
Q 002969          768 GKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPT  806 (862)
Q Consensus       768 ~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt  806 (862)
                        .        .+-......++.+++.+.|+.+|..|--
T Consensus       277 --w--------pE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  277 --W--------PEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             --c--------cccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence              0        1112334557788999999999999963

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.48  E-value=2.8e-13  Score=142.26  Aligned_cols=135  Identities=24%  Similarity=0.289  Sum_probs=105.7

Q ss_pred             ceee-ccccEEEEEeEecCCcEEEEEEeccCC-------------ccchHHHHHHHHHHHhcccCCc--eEEEEEEEeCC
Q 002969          548 NKLG-QGGFGIVYKGRLLEGQEIAVKRLSRNS-------------GQGIEEFKNEVRLIAKLQHRNL--VRLLGCCVEMD  611 (862)
Q Consensus       548 ~~LG-~G~fg~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~HpnI--v~l~g~~~~~~  611 (862)
                      ..|| .||.|+||.+... +..++||++.+..             ......+.+|++++.+++|+++  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5788 8999999999874 7789999885421             1223567889999999998875  77777754432


Q ss_pred             c----eEEEEEeccC-CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEe
Q 002969          612 E----KMLVYEYMEN-RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS  686 (862)
Q Consensus       612 ~----~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~  686 (862)
                      .    .++|+|++++ .+|.+++...    .++..    .+.+|+++|.+||+.+   |+||||||.|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence            2    2599999997 6898887431    23332    4678999999999998   9999999999999999999999


Q ss_pred             cccceeec
Q 002969          687 DFGMARIF  694 (862)
Q Consensus       687 DFGla~~~  694 (862)
                      |||.+...
T Consensus       185 Dfg~~~~~  192 (239)
T PRK01723        185 DFDRGELR  192 (239)
T ss_pred             ECCCcccC
Confidence            99988753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.45  E-value=1.3e-14  Score=170.42  Aligned_cols=254  Identities=23%  Similarity=0.297  Sum_probs=190.0

Q ss_pred             cccccceeeccccEEEEEeEecC--CcEEEEEEeccCC--ccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCceEEEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      .|...+.||+|.|+.|-......  ...+|+|.+....  ....++...|..+-+.+. |+|++++++...+.+..+++.
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            45666789999999998876533  4457777775543  333444555777777776 999999999999999999999


Q ss_pred             EeccCCChhhhhh-hccCCCCCCHhhHHHHHHHHHHHhHHhh-hcCCCcEEecccCCcceEecCCC-CeeEecccceeec
Q 002969          618 EYMENRSLDSVIF-DKARSSILNWQRRFNIICGIARGLLYLH-QDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIF  694 (862)
Q Consensus       618 E~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~  694 (862)
                      ||..++++.+.+. ...  ...+....-..+.|+..++.|+| ..+   +.|+||||+|.+++..+ ..+++|||+|..+
T Consensus       101 ~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             CcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence            9999999988873 221  12455566678999999999999 777   99999999999999999 9999999999988


Q ss_pred             CC-CCcccccccccc-cccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          695 GG-DQTEQNTKRVVG-TYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       695 ~~-~~~~~~~~~~~g-t~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      .. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ ...     .+.+.+  
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~-----~~~~~~--  247 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYS-----SWKSNK--  247 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cce-----eecccc--
Confidence            76 555555556778 9999999999885 456789999999999999999999865443321 000     011111  


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                         +...............++..+++..+|..|.+.+++..
T Consensus       248 ---~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 ---GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ---cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence               00011222333445667888899999999999888753

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=99.42  E-value=1.9e-13  Score=116.17  Aligned_cols=70  Identities=26%  Similarity=0.377  Sum_probs=61.8

Q ss_pred             cccceeeeecccCCCCcccccccccCHHHHHHHHhh---cCccccccccccCCCcceeeccCcc-cchhcccCCCcceEE
Q 002969          369 SEDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSR---NCSCTAYANTNITGGTGCVTWTGEL-KDIRKYAEGGQDLYV  444 (862)
Q Consensus       369 ~~d~f~~~~~~~~p~~~~~~~~~~~sl~~C~~~Cl~---~CsC~a~~~~~~~gg~~C~~w~g~l-~~~~~~~~~~~~l~~  444 (862)
                      ++++|+++.+||+|++..      .+++||+++|++   ||||+||+|.+.  +.||.+|.+++ .|++.+..+|++||+
T Consensus         7 ~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~--~~gC~~W~~~l~~d~~~~~~~g~~Ly~   78 (80)
T cd00129           7 SAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA--RKQCLWFPFNSMSGVRKEFSHGFDLYE   78 (80)
T ss_pred             cCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC--CCCeEEecCcchhhHHhccCCCceeEe
Confidence            357899999999999864      689999999999   999999999753  35899999999 999988888999999


Q ss_pred             Ee
Q 002969          445 RL  446 (862)
Q Consensus       445 r~  446 (862)
                      |.
T Consensus        79 r~   80 (80)
T cd00129          79 NK   80 (80)
T ss_pred             EC
Confidence            83

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.38  E-value=2e-12  Score=147.46  Aligned_cols=140  Identities=24%  Similarity=0.312  Sum_probs=102.9

Q ss_pred             ceeeccccEEEEEeEecCCcEEEEEEeccCCccch----------------------------------------HHHHH
Q 002969          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGI----------------------------------------EEFKN  587 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~----------------------------------------~~~~~  587 (862)
                      +.||.|++|.||+|++.+|+.||||+.+.......                                        -.|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            67999999999999999999999999865421110                                        13566


Q ss_pred             HHHHHHhcc----cCCceEEEEEE-EeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHH-HhHHhhhcC
Q 002969          588 EVRLIAKLQ----HRNLVRLLGCC-VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR-GLLYLHQDS  661 (862)
Q Consensus       588 E~~~l~~l~----HpnIv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-gL~yLH~~~  661 (862)
                      |++.+.++.    |.+-+.+-..+ ...+..+|||||++|++|.++.......  .   .+.+++..+++ .+..+|..+
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhCC
Confidence            777777663    33333332232 2345679999999999999876432111  1   34457777766 467889887


Q ss_pred             CCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       662 ~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                         ++|+|+||.||+++.++++++.|||++..+.
T Consensus       278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence               9999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=4.9e-12  Score=130.90  Aligned_cols=207  Identities=18%  Similarity=0.209  Sum_probs=141.0

Q ss_pred             HHHHHHhcccCCceEEEEEEEeC-----CceEEEEEeccCCChhhhhhhcc-CCCCCCHhhHHHHHHHHHHHhHHhhhcC
Q 002969          588 EVRLIAKLQHRNLVRLLGCCVEM-----DEKMLVYEYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDS  661 (862)
Q Consensus       588 E~~~l~~l~HpnIv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~  661 (862)
                      -...|-++.|.|||+++.|..+.     ....++.|||+.|+|..+|.+-. ....+......+++.||..||.|||+..
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            33455666799999999887543     45689999999999999996532 3345777778899999999999999975


Q ss_pred             CCcEEecccCCcceEecCCCCeeEeccc--ceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHH
Q 002969          662 RFRIIHRDLKASNILLDKEMTPKISDFG--MARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLET  739 (862)
Q Consensus       662 ~~~ivHrDlkp~NILl~~~~~~kL~DFG--la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~el  739 (862)
                       ++|+|+++.-+.|++..++-+||.--.  .....-..........-.+-++|.|||.-..-..+.++|||+||+..+||
T Consensus       197 -PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 -PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             -CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence             789999999999999999988875311  11100000011112223467899999987777788899999999999999


Q ss_pred             HhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          740 VSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       740 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .-+.-.....  ......-..+.      .+...+...          .-+.++.+|++.+|..||+|.+++..
T Consensus       276 ailEiq~tns--eS~~~~ee~ia------~~i~~len~----------lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  276 AILEIQSTNS--ESKVEVEENIA------NVIIGLENG----------LQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HHheeccCCC--cceeehhhhhh------hheeeccCc----------cccCcCcccccCCCCCCcchhhhhcC
Confidence            8876532111  11000000000      001111111          12357889999999999999998754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.23  E-value=5.1e-11  Score=118.28  Aligned_cols=131  Identities=19%  Similarity=0.153  Sum_probs=99.1

Q ss_pred             cceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCce-EEEEEEEeCCceEEEEEeccCCCh
Q 002969          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV-RLLGCCVEMDEKMLVYEYMENRSL  625 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~g~~~~~~~~~lV~E~~~~gsL  625 (862)
                      .+.|+.|.++.||+++.. ++.+++|+...... ....+..|+.+++.+.+.+++ +++.+.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            367899999999999864 78899998755432 234568899999999765544 455443  3346899999999887


Q ss_pred             hhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcC--CCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS--RFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ....           .....++.+++++|+.||..+  ...++|+|++|.||+++ ++.+++.|||.+..
T Consensus        79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            6430           111245678999999999986  23469999999999999 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=99.19  E-value=2.1e-11  Score=106.08  Aligned_cols=73  Identities=48%  Similarity=1.002  Sum_probs=61.1

Q ss_pred             cceeeeecccCCCCcccccccccCHHHHHHHHhhcCccccccccccCCCcceeeccCcccchhcccCCCcceEEEee
Q 002969          371 DKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLA  447 (862)
Q Consensus       371 d~f~~~~~~~~p~~~~~~~~~~~sl~~C~~~Cl~~CsC~a~~~~~~~gg~~C~~w~g~l~~~~~~~~~~~~l~~r~~  447 (862)
                      ++|..+.++++|+.....  .+.++++|++.|++||+|+||+|.+  ++++|.+|.+.+.+.+.....+.++|||++
T Consensus        12 ~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~--~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~   84 (84)
T cd01098          12 DGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN--GSGGCLLWNGLLNNLRSLSSGGGTLYLRLA   84 (84)
T ss_pred             CEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC--CCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence            689999999999876543  6789999999999999999999874  356899999999887765555678999874

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.17  E-value=3.3e-11  Score=135.56  Aligned_cols=248  Identities=23%  Similarity=0.258  Sum_probs=177.5

Q ss_pred             cccccceeec--cccEEEEEeEe---cCCcEEEEEEeccCCc--cchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceE
Q 002969          543 NFTDYNKLGQ--GGFGIVYKGRL---LEGQEIAVKRLSRNSG--QGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       543 ~f~~~~~LG~--G~fg~Vy~~~~---~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~  614 (862)
                      .|...+.+|.  |.+|.||.++.   .++..+|+|+-+....  .....=.+|+....++ .|+|.++........+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3556688999  99999999976   3477899998544322  3333335677666777 4999999888888999999


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHH----HhHHhhhcCCCcEEecccCCcceEecCC-CCeeEeccc
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR----GLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFG  689 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFG  689 (862)
                      +-.|++. .+|.++.+.  ....++....+.+..+..+    ||.++|...   ++|-|+||.||+...+ ...++.|||
T Consensus       195 iqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence            9999886 677666533  3344677777888888888    999999998   9999999999999999 889999999


Q ss_pred             ceeecCCCCcccc---cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHh
Q 002969          690 MARIFGGDQTEQN---TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK  766 (862)
Q Consensus       690 la~~~~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~  766 (862)
                      +...+........   ..+..|...|++||.+ ++.++.++|+|++|.++.|..++......-....        |   .
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------W---~  336 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------W---S  336 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC--------c---c
Confidence            9998865442211   1233678899999965 4667889999999999999999876532210000        0   0


Q ss_pred             cCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          767 EGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       767 ~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      +.+-..+-    .++-.....++..++..|++.+|..|++.+.+..
T Consensus       337 ~~r~~~ip----~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  337 QLRQGYIP----LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccccccCc----hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            00000000    1112222334555888999999999998887653

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.17  E-value=1.4e-10  Score=133.97  Aligned_cols=145  Identities=18%  Similarity=0.229  Sum_probs=96.0

Q ss_pred             cccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccc------------------------------h---------
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG------------------------------I---------  582 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~------------------------------~---------  582 (862)
                      .|+. +.||+|++|.||+|++.+ |+.||||++++.....                              .         
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4665 789999999999999988 9999999997542110                              0         


Q ss_pred             -HHHHHHHHHHHhcc----cCCceEEEEEEEe-CCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHH-hH
Q 002969          583 -EEFKNEVRLIAKLQ----HRNLVRLLGCCVE-MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG-LL  655 (862)
Q Consensus       583 -~~~~~E~~~l~~l~----HpnIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~g-L~  655 (862)
                       -+|.+|+..+.+++    +.+.+.+-.++.+ ....+|||||++|+.+.++-.-...+  .+..   .++...++. +.
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~---~la~~~v~~~~~  274 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMK---LLAERGVEVFFT  274 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHH---HHHHHHHHHHHH
Confidence             12555666666663    4444443334332 56789999999999998753111111  1111   122222211 22


Q ss_pred             HhhhcCCCcEEecccCCcceEecCCC----CeeEecccceeecCC
Q 002969          656 YLHQDSRFRIIHRDLKASNILLDKEM----TPKISDFGMARIFGG  696 (862)
Q Consensus       656 yLH~~~~~~ivHrDlkp~NILl~~~~----~~kL~DFGla~~~~~  696 (862)
                      -++..+   ++|+|+||.||+++.++    ++++.|||++..+..
T Consensus       275 Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            233455   99999999999999888    999999999987744

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.11  E-value=5.2e-10  Score=126.96  Aligned_cols=167  Identities=20%  Similarity=0.270  Sum_probs=128.4

Q ss_pred             ecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhh
Q 002969          563 LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR  642 (862)
Q Consensus       563 ~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~  642 (862)
                      ..++.+|.|...+.......+...+-++.|+.++||||++++......+..|||.|-+.  .|..++..      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence            44678888888877665445667788899999999999999999999999999999874  56666633      23455


Q ss_pred             HHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCC
Q 002969          643 RFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL  722 (862)
Q Consensus       643 ~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~  722 (862)
                      ....+.||+.||.+||+.+  .++|++|.-..|+|++.|..||++|.++........  ......--..|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence            6668899999999999776  599999999999999999999999998865432221  111122233566777553322


Q ss_pred             CCccccchhHHHHHHHHHhCC
Q 002969          723 FSVKSDVFSFGVLLLETVSGK  743 (862)
Q Consensus       723 ~s~ksDVwSlGvil~elltG~  743 (862)
                        -..|.|.||++++|++.|.
T Consensus       182 --~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcc
Confidence              3469999999999999993

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.04  E-value=1.6e-09  Score=112.31  Aligned_cols=142  Identities=19%  Similarity=0.302  Sum_probs=111.2

Q ss_pred             ceeeccccEEEEEeEecCCcEEEEEEeccCCc-cchHHHHHHHHHHHhccc--CCceEEEEEEEeCC---ceEEEEEecc
Q 002969          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQH--RNLVRLLGCCVEMD---EKMLVYEYME  621 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H--pnIv~l~g~~~~~~---~~~lV~E~~~  621 (862)
                      +.|+.|..+.||+++..+|+.+++|+...... ....++..|+++++.+.+  .++++++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            67899999999999887778999998765432 245678999999999976  44677888776543   5689999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcC----------------------------------------
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS----------------------------------------  661 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~----------------------------------------  661 (862)
                      +.++.+.+..    ..++..++..++.+++++|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988776521    23667777788888888888888531                                        


Q ss_pred             -------------CCcEEecccCCcceEecC--CCCeeEecccceee
Q 002969          662 -------------RFRIIHRDLKASNILLDK--EMTPKISDFGMARI  693 (862)
Q Consensus       662 -------------~~~ivHrDlkp~NILl~~--~~~~kL~DFGla~~  693 (862)
                                   ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         245899999999999998  56789999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.00  E-value=6.5e-09  Score=104.75  Aligned_cols=136  Identities=14%  Similarity=0.141  Sum_probs=100.0

Q ss_pred             ceeeccccEEEEEeEecC-------CcEEEEEEeccCC------------c----------cchHHHH----HHHHHHHh
Q 002969          548 NKLGQGGFGIVYKGRLLE-------GQEIAVKRLSRNS------------G----------QGIEEFK----NEVRLIAK  594 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~------------~----------~~~~~~~----~E~~~l~~  594 (862)
                      ..||.|--+.||.|.-.+       +..+|||+.+...            +          ...+.+.    +|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            478999999999997543       4789999875321            0          0122333    79999999


Q ss_pred             ccc--CCceEEEEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHh-hhcCCCcEEecccC
Q 002969          595 LQH--RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL-HQDSRFRIIHRDLK  671 (862)
Q Consensus       595 l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivHrDlk  671 (862)
                      +..  -++++++++    ...++||||+.+..+......   ...++..+...+..+++.+|..| |..+   +||+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            963  577777765    577899999987544322111   12244556677889999999999 7777   9999999


Q ss_pred             CcceEecCCCCeeEecccceeec
Q 002969          672 ASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       672 p~NILl~~~~~~kL~DFGla~~~  694 (862)
                      +.|||++ ++.+.|+|||.+...
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeC
Confidence            9999997 468999999988764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.99  E-value=3e-10  Score=127.92  Aligned_cols=249  Identities=21%  Similarity=0.204  Sum_probs=176.4

Q ss_pred             HHcccccccceeeccccEEEEEeEec--CCcEEEEEEeccCCccchH--HHHHHHHHHHhc-ccCCceEEEEEEEeCCce
Q 002969          539 RATDNFTDYNKLGQGGFGIVYKGRLL--EGQEIAVKRLSRNSGQGIE--EFKNEVRLIAKL-QHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       539 ~~~~~f~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~~~~~--~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~  613 (862)
                      ..+.+|..+..||.|.|+.|++....  ++..+++|.+.+.......  .-..|+.+...+ .|.+++++......-...
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34567888899999999999987543  4778999988665322222  224566666666 589999988777777788


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC-CCeeEeccccee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMAR  692 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~  692 (862)
                      ++--||++++++...+.   -...++...++++..|++.++.++|+..   ++|+|+||+||++..+ +..++.|||.+.
T Consensus       342 ~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence            89999999999877662   2334788889999999999999999887   9999999999999886 788999999986


Q ss_pred             ecCCCCcccccccccccccc-cChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          693 IFGGDQTEQNTKRVVGTYGY-MSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       693 ~~~~~~~~~~~~~~~gt~~y-~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      .+.....    .....+..| .+++......+-.+.|+||||.-+.|.+++..-...   .               ....
T Consensus       416 ~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~---~---------------~~~~  473 (524)
T KOG0601|consen  416 RLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES---G---------------VQSL  473 (524)
T ss_pred             ccceecc----cccccccccccchhhccccccccccccccccccccccccCcccCcc---c---------------ccce
Confidence            4321111    111122333 355555667788999999999999999998764210   0               0011


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      .+........+... ..+..+...++..++..||.+.++..+.+-
T Consensus       474 ~i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  474 TIRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             eeecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            11111122222222 566678888999999999999888765543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.91  E-value=1.2e-08  Score=99.38  Aligned_cols=131  Identities=26%  Similarity=0.389  Sum_probs=100.9

Q ss_pred             ceeeccccEEEEEeEecCCcEEEEEE-eccCC-------ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          548 NKLGQGGFGIVYKGRLLEGQEIAVKR-LSRNS-------GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~~~~vavK~-l~~~~-------~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ..+++|+-+.+|.+.+.+ ..+++|. +++.-       .-..++-.+|++++.+++--.|.-..=+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            367899999999996643 3455553 33221       11234677899999999766665555566677888999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      +++..|.+.+...          ...++..+-+-+.-||..+   |+|+||.++||++..+. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888443          2467788888899999998   99999999999998765 99999999874

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.88  E-value=2.7e-08  Score=109.62  Aligned_cols=168  Identities=23%  Similarity=0.339  Sum_probs=127.9

Q ss_pred             EEEEEeEe-cCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEE----eCCceEEEEEeccC-CChhhhh
Q 002969          556 GIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV----EMDEKMLVYEYMEN-RSLDSVI  629 (862)
Q Consensus       556 g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~l  629 (862)
                      .+.|++.. .+|..|++|+++....+....-..-++..+++.|.|+|++..++.    ....+++||+|.++ ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            56788864 468999999995544333333445678899999999999998876    34567999999984 6777765


Q ss_pred             hhcc------------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          630 FDKA------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       630 ~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      +...            .+..+++..++.++.|+..||.++|+.|   +..+-|.+++||++.+.+++|+.-|+...+..+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            4321            2234778899999999999999999998   888999999999999999999888877665433


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCC
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKN  745 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p  745 (862)
                      ....                +.   -..+-|.=.||.+++.|.+|...
T Consensus       447 ~~~~----------------le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  447 PTEP----------------LE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCcc----------------hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            3110                11   12366888999999999999764

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.86  E-value=2.6e-08  Score=96.34  Aligned_cols=143  Identities=23%  Similarity=0.342  Sum_probs=107.6

Q ss_pred             ccceeeccccEEEEEeEecCCcEEEEEE-eccC-------CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          546 DYNKLGQGGFGIVYKGRLLEGQEIAVKR-LSRN-------SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       546 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~-l~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      .+..|-+|+-+.|+++.. .|+...||. +.+.       ..-...+..+|++.|.+++--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            457899999999999987 566666663 3322       1123457788999999998666665555677777888999


Q ss_pred             EeccC-CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC---CeeEecccceee
Q 002969          618 EYMEN-RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM---TPKISDFGMARI  693 (862)
Q Consensus       618 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kL~DFGla~~  693 (862)
                      ||+++ .++.+++.........+ .....++..|-+.+.-||..+   |+|+||..+||+|..++   .+.+.|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 57888886554433222 233678888999999999998   99999999999996654   458999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.75  E-value=2.3e-09  Score=126.47  Aligned_cols=248  Identities=19%  Similarity=0.216  Sum_probs=166.4

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      .-+.+.+.+-+-+|.++.++.++-.. +...+.|.....   .....+....+-.++-..+||-+++...-+......+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            34567777888899999998875433 323333333221   11222333333333333445666665555666788999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      +++|+.+++|...|+...   ..+.......+..+..+++|||...   +.|+|++|.|+|...++..+++|||+.....
T Consensus       882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence            999999999999886544   2333333445566788999999876   8999999999999999999999998543321


Q ss_pred             CC-------------------------Ccc----cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCC
Q 002969          696 GD-------------------------QTE----QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNR  746 (862)
Q Consensus       696 ~~-------------------------~~~----~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~  746 (862)
                      .-                         ...    .......+|+.|.+||.+.+......+|.|++|++++|.++|..|+
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            00                         000    1122357899999999999999999999999999999999999996


Q ss_pred             CCCCCCcchhHHHHHHHHHhcCceeeeecc--cCCCCChHHHHHHHHHHHhccccCCCCCCCHH
Q 002969          747 GFYHSNNELNLLGHVWRLWKEGKVLEMVDS--SVDNYPANEVLRCIHVGLLCVQENAEERPTMA  808 (862)
Q Consensus       747 ~~~~~~~~~~l~~~~~~~~~~~~~~~~id~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  808 (862)
                      .......       +++        .++..  .....+.....+..+++...+..+|.+|-.|.
T Consensus      1036 na~tpq~-------~f~--------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQ-------IFE--------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCcchhh-------hhh--------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            4322211       111        11111  11333455566677888888899999998776

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.74  E-value=2e-07  Score=100.43  Aligned_cols=262  Identities=15%  Similarity=0.110  Sum_probs=158.1

Q ss_pred             cccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEE------EeC-CceEEE
Q 002969          545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCC------VEM-DEKMLV  616 (862)
Q Consensus       545 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~------~~~-~~~~lV  616 (862)
                      ...+.||+|+-+.+|-.  .+-...+.|+.+........+.   +..|... .||-+-.-+.+=      -+. ...-+.
T Consensus        14 ~~gr~LgqGgea~ly~l--~e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTL--GEVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeec--chhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            34478999999999964  2223345677765543332222   2223333 465443312111      111 224566


Q ss_pred             EEeccCCC-hhhhhh---hccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          617 YEYMENRS-LDSVIF---DKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       617 ~E~~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      |..+++.- ...++.   ........+|.-.++++..+|.+.+-||..|   .+-+|+.++|+|+++++.+.|.|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence            66665542 222221   2233456889999999999999999999998   8999999999999999999999855443


Q ss_pred             ecCCCCcccccccccccccccChhhhc-----CCCCCccccchhHHHHHHHHHhC-CCCCCCCCCC-cchhHHHHHHHHH
Q 002969          693 IFGGDQTEQNTKRVVGTYGYMSPEYAM-----DGLFSVKSDVFSFGVLLLETVSG-KKNRGFYHSN-NELNLLGHVWRLW  765 (862)
Q Consensus       693 ~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~elltG-~~p~~~~~~~-~~~~l~~~~~~~~  765 (862)
                      .-   .........+|...|.+||.-.     +..-+...|.|.||+++++++.| ++||..-... ......+..   +
T Consensus       166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~---I  239 (637)
T COG4248         166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD---I  239 (637)
T ss_pred             ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh---h
Confidence            32   1222233457889999999754     23456789999999999999887 8887642211 111111100   0


Q ss_pred             hcCceeeeeccc------CCCCChH-HHHHHHHHHHhcccc--CCCCCCCHHHHHHHhccCcCC
Q 002969          766 KEGKVLEMVDSS------VDNYPAN-EVLRCIHVGLLCVQE--NAEERPTMASVVLMLSSETAT  820 (862)
Q Consensus       766 ~~~~~~~~id~~------~~~~~~~-~~~~l~~li~~cl~~--dP~~RPt~~evl~~L~~~~~~  820 (862)
                      ..+......+..      ....+.. .+..+..+..+|+..  ++.-||+++..+..|..+.++
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            111111111111      1122222 234455677788775  367899999999888776443

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.72  E-value=1.4e-07  Score=94.85  Aligned_cols=125  Identities=26%  Similarity=0.301  Sum_probs=84.5

Q ss_pred             EEEEeEecCCcEEEEEEeccCC--------------c-------c-----chHHHHHHHHHHHhcccC--CceEEEEEEE
Q 002969          557 IVYKGRLLEGQEIAVKRLSRNS--------------G-------Q-----GIEEFKNEVRLIAKLQHR--NLVRLLGCCV  608 (862)
Q Consensus       557 ~Vy~~~~~~~~~vavK~l~~~~--------------~-------~-----~~~~~~~E~~~l~~l~Hp--nIv~l~g~~~  608 (862)
                      .||.|...++..+|||+.+...              .       .     ......+|.+.|.++..-  ++++++.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            4899998899999999875321              0       0     113467899999999755  57777755  


Q ss_pred             eCCceEEEEEecc--CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHH-hhhcCCCcEEecccCCcceEecCCCCeeE
Q 002969          609 EMDEKMLVYEYME--NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY-LHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (862)
Q Consensus       609 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~y-LH~~~~~~ivHrDlkp~NILl~~~~~~kL  685 (862)
                        ....|||||++  +..+..+....     ++......++.++++.+.. +|..+   |+|+||.+.|||++++ .+.|
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence              35689999999  65555443211     2234456678888886665 56777   9999999999999888 9999


Q ss_pred             ecccceeec
Q 002969          686 SDFGMARIF  694 (862)
Q Consensus       686 ~DFGla~~~  694 (862)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999988764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.69  E-value=2.9e-07  Score=98.01  Aligned_cols=141  Identities=17%  Similarity=0.121  Sum_probs=101.5

Q ss_pred             ceeeccccEEEEEeEecCCcEEEEEEeccCCc-----------cchHHHHHHHHHHHhcccCC--ceEEEEEEEe-----
Q 002969          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG-----------QGIEEFKNEVRLIAKLQHRN--LVRLLGCCVE-----  609 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~Hpn--Iv~l~g~~~~-----  609 (862)
                      +.+-.-....|++..+ +|+.+.||+......           .....+.+|.+.+.++...+  .++++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444455667655 678899997743221           11124789999999995433  4455666543     


Q ss_pred             CCceEEEEEeccCC-ChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC-------CC
Q 002969          610 MDEKMLVYEYMENR-SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-------EM  681 (862)
Q Consensus       610 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-------~~  681 (862)
                      ....+||+|++++. +|.+++.... ....+...+..++.++++.+.-||..+   |+|+|++++|||++.       +.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence            23468999999986 8988874322 123455677789999999999999998   999999999999975       46


Q ss_pred             CeeEecccceee
Q 002969          682 TPKISDFGMARI  693 (862)
Q Consensus       682 ~~kL~DFGla~~  693 (862)
                      .+.|+||+.++.
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            899999998854

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.50  E-value=6.3e-07  Score=92.50  Aligned_cols=133  Identities=21%  Similarity=0.215  Sum_probs=98.1

Q ss_pred             cccceeeccccEEEEEeEecCCcEEEEEEeccCCc----------------------cchHHHHHHHHHHHhcccC--Cc
Q 002969          545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG----------------------QGIEEFKNEVRLIAKLQHR--NL  600 (862)
Q Consensus       545 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~Hp--nI  600 (862)
                      .+..+||.|--+.||.|...+|.++|||.-+....                      .......+|.++|.+|.-.  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            45579999999999999999999999997542210                      0123467899999999654  77


Q ss_pred             eEEEEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC
Q 002969          601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE  680 (862)
Q Consensus       601 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~  680 (862)
                      ++.+++    +...+||||+++-.|...-        ++....-.|+..|++-+..+-..|   |||+|+.+-||++++|
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d  238 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED  238 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence            777755    6678999999997775543        122333344555555555554555   9999999999999999


Q ss_pred             CCeeEeccccee
Q 002969          681 MTPKISDFGMAR  692 (862)
Q Consensus       681 ~~~kL~DFGla~  692 (862)
                      |.+.++||--+.
T Consensus       239 g~~~vIDwPQ~v  250 (304)
T COG0478         239 GDIVVIDWPQAV  250 (304)
T ss_pred             CCEEEEeCcccc
Confidence            999999996554

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.44  E-value=9e-07  Score=101.88  Aligned_cols=141  Identities=18%  Similarity=0.255  Sum_probs=95.7

Q ss_pred             ceeeccccEEEEEeEecCCcEEEEEEeccCCccch----------------------------------------HHHHH
Q 002969          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGI----------------------------------------EEFKN  587 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~----------------------------------------~~~~~  587 (862)
                      +.|+.++-|.||+|++.+|+.||||+.++.-....                                        =.+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            57899999999999999999999999875421110                                        12455


Q ss_pred             HHHHHHhcc----cCCceEEEEEE-EeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHH-hHHhhhcC
Q 002969          588 EVRLIAKLQ----HRNLVRLLGCC-VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG-LLYLHQDS  661 (862)
Q Consensus       588 E~~~l~~l~----HpnIv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~g-L~yLH~~~  661 (862)
                      |+..+.+++    +..-+++=.++ ...+...|+|||++|..+.+...-+..  .++.+   .++..++++ +..+=..+
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k---~ia~~~~~~f~~q~~~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRK---ELAELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHH---HHHHHHHHHHHHHHHhcC
Confidence            666666663    12222222233 335778999999999999988533221  23422   333333333 22222234


Q ss_pred             CCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       662 ~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                         ++|.|.+|.||+++.++++.+.|||+...+..
T Consensus       286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence               99999999999999999999999999987643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.44  E-value=5.4e-08  Score=111.29  Aligned_cols=152  Identities=18%  Similarity=0.275  Sum_probs=105.6

Q ss_pred             HHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc-------ccccccccccccccChhhhc
Q 002969          647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT-------EQNTKRVVGTYGYMSPEYAM  719 (862)
Q Consensus       647 ~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~-------~~~~~~~~gt~~y~APE~l~  719 (862)
                      +.+++.||.|+|...  .+||++|.|++|.++..+..||+.|+.+........       ........-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            445668999999875  699999999999999999999999998765433111       00011123356899999999


Q ss_pred             CCCCCccccchhHHHHHHHHHhCCCCCC-CCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccc
Q 002969          720 DGLFSVKSDVFSFGVLLLETVSGKKNRG-FYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQ  798 (862)
Q Consensus       720 ~~~~s~ksDVwSlGvil~elltG~~p~~-~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~  798 (862)
                      +...+.++|+||+|+++|-+..|..+.- .......    ...        .....+.....+..+.+.++.+=+.+++.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~----~~~--------~~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS----YSF--------SRNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcch----hhh--------hhcccccccccccccCcHHHHHHHHHHhc
Confidence            9888999999999999999996655521 1111110    000        01111222233445667778888889999


Q ss_pred             cCCCCCCCHHHHHH
Q 002969          799 ENAEERPTMASVVL  812 (862)
Q Consensus       799 ~dP~~RPt~~evl~  812 (862)
                      .++.-||++.++..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999998887764

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.41  E-value=2.2e-06  Score=88.12  Aligned_cols=123  Identities=23%  Similarity=0.241  Sum_probs=92.7

Q ss_pred             CcEEEEEEeccCC-------ccchHHHHHHHHHHHhccc--CCceEEEEEEEeCC----ceEEEEEeccCC-Chhhhhhh
Q 002969          566 GQEIAVKRLSRNS-------GQGIEEFKNEVRLIAKLQH--RNLVRLLGCCVEMD----EKMLVYEYMENR-SLDSVIFD  631 (862)
Q Consensus       566 ~~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~H--pnIv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~  631 (862)
                      ++.+.+|......       .-......+|...+..+..  -..++.+++.....    ..++|+|++++. +|.+++..
T Consensus        32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~  111 (206)
T PF06293_consen   32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ  111 (206)
T ss_pred             ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence            5566666543211       1234568889999988864  44567777776533    348999999974 79998854


Q ss_pred             ccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC---CeeEecccceeec
Q 002969          632 KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM---TPKISDFGMARIF  694 (862)
Q Consensus       632 ~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kL~DFGla~~~  694 (862)
                      ...   ++......++.++++.++-||..+   |+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       112 ~~~---~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  112 WEQ---LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hcc---cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            322   556677889999999999999998   99999999999998887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.33  E-value=7.9e-06  Score=82.71  Aligned_cols=139  Identities=19%  Similarity=0.129  Sum_probs=103.6

Q ss_pred             eeccccEEEEEeEecCCcEEEEEEeccC------CccchHHHHHHHHHHHhccc--CCceEEEEEEEeC----CceEEEE
Q 002969          550 LGQGGFGIVYKGRLLEGQEIAVKRLSRN------SGQGIEEFKNEVRLIAKLQH--RNLVRLLGCCVEM----DEKMLVY  617 (862)
Q Consensus       550 LG~G~fg~Vy~~~~~~~~~vavK~l~~~------~~~~~~~~~~E~~~l~~l~H--pnIv~l~g~~~~~----~~~~lV~  617 (862)
                      -|+||-+-|+.-.+ +|+.+-+|+-...      .+.....|.+|...|.++..  -.+++.+.+....    -.-+||+
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            46688889999776 4457889987421      13466789999999999963  3355555332222    2357999


Q ss_pred             Eecc-CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC--eeEecccceee
Q 002969          618 EYME-NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT--PKISDFGMARI  693 (862)
Q Consensus       618 E~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kL~DFGla~~  693 (862)
                      |-++ ..+|.+++.+... ...+...+..++.++++.++-||+.+   +.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9775 4688888744322 24577778899999999999999998   999999999999987677  99999986654

>smart00473 PAN_AP divergent subfamily of APPLE domains

Probab=98.27  E-value=1.2e-06  Score=74.56  Aligned_cols=73  Identities=38%  Similarity=0.810  Sum_probs=55.5

Q ss_pred             ccceeeeecccCCCCcccccccccCHHHHHHHHhh-cCccccccccccCCCcceeecc-CcccchhcccCCCcceEEE
Q 002969          370 EDKFLQLKNMKLPDTTTSFVDYNMTLKECEAFCSR-NCSCTAYANTNITGGTGCVTWT-GELKDIRKYAEGGQDLYVR  445 (862)
Q Consensus       370 ~d~f~~~~~~~~p~~~~~~~~~~~sl~~C~~~Cl~-~CsC~a~~~~~~~gg~~C~~w~-g~l~~~~~~~~~~~~l~~r  445 (862)
                      ...|..++++++++..... ....++++|++.|++ +|+|.||.|..  ++.+|.+|. +.+.+....+..+.++|.+
T Consensus         3 ~~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~--~~~~C~l~~~~~~~~~~~~~~~~~~~y~~   77 (78)
T smart00473        3 DDCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN--GTKGCLLWSESSLGDARLFPSGGVDLYEK   77 (78)
T ss_pred             CceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC--CCCEEEEeeCCccccceecccCCceeEEe
Confidence            4569999999999654432 345799999999999 99999999975  557899999 7776665444455556654

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.17  E-value=2.3e-05  Score=81.73  Aligned_cols=139  Identities=15%  Similarity=0.181  Sum_probs=86.4

Q ss_pred             ceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCC--ceEEEEEEEeCCceEEEEEeccCCC-
Q 002969          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN--LVRLLGCCVEMDEKMLVYEYMENRS-  624 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gs-  624 (862)
                      ..||+|..+.||+.   .+..+++|..+...  ......+|.++++.+..-.  +++.+++....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57999999999984   35567788876432  3355788999999997543  4778888877778889999999963 


Q ss_pred             hhhhhh--------------h-----cc-CCCCCCHhhHH-HHHHH----------HHH-HhHHhhh-cCCCcEEecccC
Q 002969          625 LDSVIF--------------D-----KA-RSSILNWQRRF-NIICG----------IAR-GLLYLHQ-DSRFRIIHRDLK  671 (862)
Q Consensus       625 L~~~l~--------------~-----~~-~~~~l~~~~~~-~i~~q----------ia~-gL~yLH~-~~~~~ivHrDlk  671 (862)
                      +...+.              .     +. ........... ++..+          +.+ ...+|.. .....++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            221110              0     00 00001111000 00000          011 1122221 123457999999


Q ss_pred             CcceEecCCCCeeEeccccee
Q 002969          672 ASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       672 p~NILl~~~~~~kL~DFGla~  692 (862)
                      |.||++++++ +.|.||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.17  E-value=1.2e-05  Score=92.28  Aligned_cols=139  Identities=17%  Similarity=0.234  Sum_probs=92.6

Q ss_pred             ceeeccccEEEEEeEecCCcEEEEEEeccCCccc-------------------------------------hHHHHHHHH
Q 002969          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG-------------------------------------IEEFKNEVR  590 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-------------------------------------~~~~~~E~~  590 (862)
                      +.||..+.|.||+|++.+|+.||||+.++.-...                                     .=+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6899999999999999999999999986542111                                     012566666


Q ss_pred             HHHhc----ccCC------ceEEEEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc
Q 002969          591 LIAKL----QHRN------LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD  660 (862)
Q Consensus       591 ~l~~l----~Hpn------Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~  660 (862)
                      ...+.    .|-+      |++++-  .....+.|+||||+|..+.++..-...  .++...   |+..+.++...  ..
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~---i~~~l~~~~~~--qI  317 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHD---ILNKLVEAYLE--QI  317 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc--CCCHHH---HHHHHHHHHHH--HH
Confidence            65555    3444      222221  223578999999999999887532222  244443   33333333222  11


Q ss_pred             CCCcEEecccCCcceEecC----CCCeeEecccceeecC
Q 002969          661 SRFRIIHRDLKASNILLDK----EMTPKISDFGMARIFG  695 (862)
Q Consensus       661 ~~~~ivHrDlkp~NILl~~----~~~~kL~DFGla~~~~  695 (862)
                      -..+++|+|=+|.||++..    ++.+.+.|||+...+.
T Consensus       318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            1123999999999999984    6789999999987653

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.07  E-value=4.3e-05  Score=79.57  Aligned_cols=144  Identities=22%  Similarity=0.189  Sum_probs=86.8

Q ss_pred             cceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccC--CceEEEEEEEe---CCceEEEEEecc
Q 002969          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR--NLVRLLGCCVE---MDEKMLVYEYME  621 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~g~~~~---~~~~~lV~E~~~  621 (862)
                      ++.|+.|..+.||+....+ ..+++|.....  .....+.+|+.+++.+...  .+++++.+...   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3689999999999998877 69999997544  4556788999999998643  35677775533   234689999999


Q ss_pred             CCChhh----------------hhh---hcc-CCCCCCHhh---------HHHH------------HHHHHH-HhHHhhh
Q 002969          622 NRSLDS----------------VIF---DKA-RSSILNWQR---------RFNI------------ICGIAR-GLLYLHQ  659 (862)
Q Consensus       622 ~gsL~~----------------~l~---~~~-~~~~l~~~~---------~~~i------------~~qia~-gL~yLH~  659 (862)
                      +..+..                .+.   ... .........         ....            ...+.+ .++.++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            998877                111   110 000011100         0000            111222 2333332


Q ss_pred             ----cCCCcEEecccCCcceEec-CCCCeeEecccceee
Q 002969          660 ----DSRFRIIHRDLKASNILLD-KEMTPKISDFGMARI  693 (862)
Q Consensus       660 ----~~~~~ivHrDlkp~NILl~-~~~~~kL~DFGla~~  693 (862)
                          .....++|+|+.|.|||++ +++.+.|.||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                2345699999999999999 666668999988754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.05  E-value=7.5e-07  Score=100.78  Aligned_cols=190  Identities=19%  Similarity=0.150  Sum_probs=138.3

Q ss_pred             HcccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCC-ceEEEEEEEeCCceEEEEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN-LVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~g~~~~~~~~~lV~E  618 (862)
                      .+..+...+.+++++++.++|.+....+....+.+...     ....-++++|.+++||| .++.++-+..++...++++
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR  314 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence            34445555678999999999998655665556666432     34456889999999999 7777777777888899999


Q ss_pred             eccCC-ChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          619 YMENR-SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       619 ~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ++..+ +-.....  .....+...+...+...-++++++||+..   =+|+|    ||+..+ +..|..||+....+...
T Consensus       315 i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  315 ICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             hhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence            99877 2221110  01111333444456666778999999864   48888    777765 68899999998776543


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCC
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRG  747 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~  747 (862)
                      .   ......+++.++|||+..+..+..+.|+|++|+-..++.-|.+|..
T Consensus       385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            3   2334678999999999999999999999999997777777777643

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.04  E-value=5.2e-05  Score=80.11  Aligned_cols=140  Identities=13%  Similarity=0.112  Sum_probs=87.1

Q ss_pred             eeecccc-EEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCceEEEEEeccCCChh
Q 002969          549 KLGQGGF-GIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYMENRSLD  626 (862)
Q Consensus       549 ~LG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~  626 (862)
                      .|..|.. ..||+.... +..+.||+.....   ..+..+|+++++.+. +--+++++++....+..++|||+++|.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            4555555 788998764 4678888875432   345778999999884 455678888877767789999999998876


Q ss_pred             hhhh-------------------hccC-CCCCC--HhhHHHHHH--------------------HHHHHhHHhhh----c
Q 002969          627 SVIF-------------------DKAR-SSILN--WQRRFNIIC--------------------GIARGLLYLHQ----D  660 (862)
Q Consensus       627 ~~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------qia~gL~yLH~----~  660 (862)
                      ....                   .... .....  ....+....                    .+.+.+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            4421                   0000 00000  000000000                    01111222211    1


Q ss_pred             CCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          661 SRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       661 ~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      ..+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            23569999999999999998778899999774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=98.03  E-value=5e-06  Score=62.82  Aligned_cols=45  Identities=71%  Similarity=1.033  Sum_probs=39.9

Q ss_pred             cCCCCCCCCCccccCCCCCCCCCCCCCC-CCcceecceeeecccCC
Q 002969          818 TATMPQPKTPGFCLGRNPIETDSSSSKH-DETFTVNQVTVTMLNAR  862 (862)
Q Consensus       818 ~~~~~~p~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  862 (862)
                      ...+|.||.|+|+.+|.+....+++++. ++.+++|+||+|+|+||
T Consensus         3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R   48 (48)
T PF11883_consen    3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR   48 (48)
T ss_pred             cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence            4689999999999999999888876644 58999999999999998

; GO: 0004674 protein serine/threonine kinase activity

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.99  E-value=3.3e-05  Score=78.49  Aligned_cols=137  Identities=15%  Similarity=0.197  Sum_probs=91.0

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHH---------HHHHHHHHHhcccC---CceEEEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEE---------FKNEVRLIAKLQHR---NLVRLLGCCV  608 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~Hp---nIv~l~g~~~  608 (862)
                      ..+|...+++-......|.+... +++.+++|..+.......+.         ..+++..+.+++..   ....++.+..
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            35677777777777777777655 67889999876554332222         23344445555322   2233232222


Q ss_pred             -----eCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCe
Q 002969          609 -----EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (862)
Q Consensus       609 -----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  683 (862)
                           .....+++|||++|..|.++..       ++.    .++..|++++.-||+.|   ++|+|.+|.|++++++ .+
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i  173 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GI  173 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cE
Confidence                 2234578999999988876541       222    25566788899999998   9999999999999865 49


Q ss_pred             eEecccceee
Q 002969          684 KISDFGMARI  693 (862)
Q Consensus       684 kL~DFGla~~  693 (862)
                      ++.||+..+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.98  E-value=2.6e-05  Score=78.66  Aligned_cols=105  Identities=22%  Similarity=0.238  Sum_probs=83.5

Q ss_pred             HHHHHHHHhccc-CCceEEEEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCc
Q 002969          586 KNEVRLIAKLQH-RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR  664 (862)
Q Consensus       586 ~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~  664 (862)
                      ..|.-+++.+++ +++++++|.|    ..++|.||...+++...-..-.+--..+|..|.+||.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458889999986 6999999999    44779999987766432100001123689999999999999999999865556


Q ss_pred             EEecccCCcceEecCCCCeeEecccceeec
Q 002969          665 IIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       665 ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      +.-.|++++|+-+++++++|+.|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            999999999999999999999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.88  E-value=0.00013  Score=74.90  Aligned_cols=153  Identities=18%  Similarity=0.196  Sum_probs=101.4

Q ss_pred             cChHHHHHHcccccccce---eeccccEEEEEeEecCCcEEEEEEeccCCccc-------------------hH-----H
Q 002969          532 FDFETIVRATDNFTDYNK---LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG-------------------IE-----E  584 (862)
Q Consensus       532 ~~~~~i~~~~~~f~~~~~---LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-------------------~~-----~  584 (862)
                      .+.+.+.....+..+...   |..|--+.||+|...++..+|||+++......                   .+     =
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            445555555555544444   55666778999988889999999986432110                   01     1


Q ss_pred             HHHHHHHHHhcc--cCCceEEEEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCC
Q 002969          585 FKNEVRLIAKLQ--HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR  662 (862)
Q Consensus       585 ~~~E~~~l~~l~--HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~  662 (862)
                      ..+|+..|.++.  +-.+++.+++.    .-.|||||+....+..-.   .+...+...+...+..++++.+.-|-... 
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~---LkDv~~e~~e~~~~~~~~v~~~~~l~~~a-  186 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPR---LKDVPLELEEAEGLYEDVVEYMRRLYKEA-  186 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCC---cccCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence            245778888874  55666666664    458999999754211111   11111223356667788888888877633 


Q ss_pred             CcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          663 FRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       663 ~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                       .+||+||+.-|||+. ++.+.|+||+-|...
T Consensus       187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             -CcccccchhhheEEE-CCeEEEEECcccccc
Confidence             399999999999999 889999999988654

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=97.79  E-value=0.00012  Score=67.64  Aligned_cols=78  Identities=23%  Similarity=0.382  Sum_probs=52.6

Q ss_pred             eeEEEcCC-CCeEEccCCCCC--CccEEEEecCCCeEEEecCCCceeeeecCCCCCccCCcCcccceeecCCeeEEEecC
Q 002969          129 RIGLFDGS-QNLVWSSNQTKA--TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWK  205 (862)
Q Consensus       129 ~~~l~~~~-~~~vWst~~~~~--~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtDTlLpg~klg~~~~tg~~~~L~Sw~  205 (862)
                      ++|+++.. +.+||++|+...  ....+.|.++|||||++. .+.++|+|     +|                       
T Consensus        31 nlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~S-----~t-----------------------   81 (114)
T smart00108       31 NLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDG-DGRVVWSS-----NT-----------------------   81 (114)
T ss_pred             EEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeC-CCCEEEEe-----cc-----------------------
Confidence            45566554 589999997632  336789999999999986 46789998     11                       


Q ss_pred             CCCCCCCCCcEEEeccCCCcceEeecCCcceeec
Q 002969          206 STDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRS  239 (862)
Q Consensus       206 s~~dps~G~~s~~l~~~g~~~~~~~~~~~~~~rs  239 (862)
                         ....|.+.+.|+.+|...++-- ...+.|.|
T Consensus        82 ---~~~~~~~~~~L~ddGnlvl~~~-~~~~~W~S  111 (114)
T smart00108       82 ---TGANGNYVLVLLDDGNLVIYDS-DGNFLWQS  111 (114)
T ss_pred             ---cCCCCceEEEEeCCCCEEEECC-CCCEEeCC
Confidence               0123567888999997543322 23567754

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.78  E-value=0.0003  Score=71.41  Aligned_cols=131  Identities=19%  Similarity=0.254  Sum_probs=92.7

Q ss_pred             cceeeccccEEEEEeEecCCcEEEEEEeccCC----------------ccchHHHHHHHHHHHhcc------cCCceEEE
Q 002969          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS----------------GQGIEEFKNEVRLIAKLQ------HRNLVRLL  604 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------HpnIv~l~  604 (862)
                      ...||+|+.-.||.  +++.....||+.....                ....++..+|+.-...+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46899999999997  4566778888886554                223567777887777776      78999999


Q ss_pred             EEEEeCCceEEEEEeccC--C----ChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec
Q 002969          605 GCCVEMDEKMLVYEYMEN--R----SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (862)
Q Consensus       605 g~~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~  678 (862)
                      |+....-..-+|+|.+.+  |    +|.+++.+    ..++. +.   ...+-+-..||-+..   |+.+|++|.||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~---~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-EL---RQALDEFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HH---HHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence            999999999999998653  2    35566522    23444 33   333344456666665   99999999999995


Q ss_pred             CC--C--CeeEec-ccc
Q 002969          679 KE--M--TPKISD-FGM  690 (862)
Q Consensus       679 ~~--~--~~kL~D-FGl  690 (862)
                      ..  +  .+.|+| ||-
T Consensus       153 ~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             ecCCCceEEEEEeCCCC
Confidence            33  2  467777 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=97.75  E-value=0.00015  Score=67.24  Aligned_cols=80  Identities=23%  Similarity=0.336  Sum_probs=54.5

Q ss_pred             eeEEEcCC-CCeEEccCCCC--CCccEEEEecCCCeEEEecCCCceeeeecCCCCCccCCcCcccceeecCCeeEEEecC
Q 002969          129 RIGLFDGS-QNLVWSSNQTK--ATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWK  205 (862)
Q Consensus       129 ~~~l~~~~-~~~vWst~~~~--~~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtDTlLpg~klg~~~~tg~~~~L~Sw~  205 (862)
                      ++++++.. +.+||++|+..  .....+.|.++|||||.+. ++.++|+|=-.                           
T Consensus        32 nlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~S~~~---------------------------   83 (116)
T cd00028          32 NLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDG-SGTVVWSSNTT---------------------------   83 (116)
T ss_pred             EEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcC-CCcEEEEeccc---------------------------
Confidence            45666544 58999999864  3456789999999999986 46789998210                           


Q ss_pred             CCCCCCCCCcEEEeccCCCcceEeecCCcceeecCC
Q 002969          206 STDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGP  241 (862)
Q Consensus       206 s~~dps~G~~s~~l~~~g~~~~~~~~~~~~~~rsg~  241 (862)
                          .+.+.+.+.|+.+|...++-- ...+.|.|..
T Consensus        84 ----~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~  114 (116)
T cd00028          84 ----RVNGNYVLVLLDDGNLVLYDS-DGNFLWQSFD  114 (116)
T ss_pred             ----CCCCceEEEEeCCCCEEEECC-CCCEEEcCCC
Confidence                124567888999997543322 3456776543

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>PLN02876 acyl-CoA dehydrogenase

Probab=97.71  E-value=0.00035  Score=86.80  Aligned_cols=79  Identities=15%  Similarity=0.348  Sum_probs=59.0

Q ss_pred             cceeeccccEEEEEeEecCC---cEEEEEEeccCC-ccchHHHHHHHHHHHhcc-cCCc--eEEEEEEEeC---CceEEE
Q 002969          547 YNKLGQGGFGIVYKGRLLEG---QEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQ-HRNL--VRLLGCCVEM---DEKMLV  616 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-HpnI--v~l~g~~~~~---~~~~lV  616 (862)
                      .+.++.|.+..+|+....++   ..+++|+..... ......+.+|+++++.+. |.++  ++++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999876554   467888765432 123457889999999995 6665  7888888764   457899


Q ss_pred             EEeccCCCh
Q 002969          617 YEYMENRSL  625 (862)
Q Consensus       617 ~E~~~~gsL  625 (862)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998754

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.70  E-value=0.00026  Score=74.31  Aligned_cols=73  Identities=18%  Similarity=0.287  Sum_probs=47.9

Q ss_pred             ceeeccccE-EEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccC---CceEEEEEEEeCC---ceEEEEEec
Q 002969          548 NKLGQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR---NLVRLLGCCVEMD---EKMLVYEYM  620 (862)
Q Consensus       548 ~~LG~G~fg-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~g~~~~~~---~~~lV~E~~  620 (862)
                      +.|+.|+.. .||+.    +..+++|..+.  ......+.+|++++..+...   .+.+.++.....+   ..+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            567777776 48875    23577776543  22345788999999988532   3555555443322   347899999


Q ss_pred             cCCChh
Q 002969          621 ENRSLD  626 (862)
Q Consensus       621 ~~gsL~  626 (862)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            998874

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.68  E-value=0.00076  Score=73.41  Aligned_cols=79  Identities=9%  Similarity=0.072  Sum_probs=59.0

Q ss_pred             ccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhccc---CCceEEEEEEEeC---CceEEEE
Q 002969          544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH---RNLVRLLGCCVEM---DEKMLVY  617 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~g~~~~~---~~~~lV~  617 (862)
                      ....+.||.|..+.||+....++ .+.+|..+..  .....|..|++.|+.+.-   ..++++++++...   +..++||
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            34456899999999999876555 4666765331  123578999999999953   4688999888643   5689999


Q ss_pred             EeccCCCh
Q 002969          618 EYMENRSL  625 (862)
Q Consensus       618 E~~~~gsL  625 (862)
                      |++++.++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.52  E-value=0.00091  Score=70.07  Aligned_cols=74  Identities=18%  Similarity=0.238  Sum_probs=49.9

Q ss_pred             ceeeccccEEEEEeEecC--CcEEEEEEeccCCccchHHHHHHHHHHHhcccCC-ceEEEEEEEeCCceEEEEEeccCCC
Q 002969          548 NKLGQGGFGIVYKGRLLE--GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN-LVRLLGCCVEMDEKMLVYEYMENRS  624 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~g~~~~~~~~~lV~E~~~~gs  624 (862)
                      +.|..|-...+|+....+  ++.+++|+........ ....+|+.+++.+...+ .+++++.+.    ..++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            567778888999987664  6788899775433221 23357899999985433 445554432    247999999987


Q ss_pred             hh
Q 002969          625 LD  626 (862)
Q Consensus       625 L~  626 (862)
                      +.
T Consensus        79 l~   80 (235)
T cd05157          79 LE   80 (235)
T ss_pred             CC
Confidence            63

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.47  E-value=0.0017  Score=65.46  Aligned_cols=125  Identities=25%  Similarity=0.392  Sum_probs=90.4

Q ss_pred             ccccccceeecccc-EEEEEeEecCCcEEEEEEecc---CC--------c----------cchHHHHHHHHHHHhcc---
Q 002969          542 DNFTDYNKLGQGGF-GIVYKGRLLEGQEIAVKRLSR---NS--------G----------QGIEEFKNEVRLIAKLQ---  596 (862)
Q Consensus       542 ~~f~~~~~LG~G~f-g~Vy~~~~~~~~~vavK~l~~---~~--------~----------~~~~~~~~E~~~l~~l~---  596 (862)
                      .+++.++.||.|.- |.||++++ +|+.+|+|.++.   ..        .          ...+-|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            68889999999999 99999988 678999999421   10        0          12345888999988885   


Q ss_pred             cCCc--eEEEEEEEeCC------------------ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHH
Q 002969          597 HRNL--VRLLGCCVEMD------------------EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY  656 (862)
Q Consensus       597 HpnI--v~l~g~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~y  656 (862)
                      +.++  |+.+|+..-..                  ...+|.||.+...                ....+-+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQIRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccchhHHHHHHHHHHH
Confidence            4566  89999874221                  1246777765432                1122345677788889


Q ss_pred             hhhcCCCcEEecccCCcceEecCCCCeeEecccce
Q 002969          657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (862)
Q Consensus       657 LH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  691 (862)
                      +|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99988   999999999986     4489999864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.47  E-value=0.00065  Score=66.25  Aligned_cols=129  Identities=20%  Similarity=0.279  Sum_probs=88.8

Q ss_pred             cccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceE-EEEEEEeCCceEEEEEeccCC
Q 002969          545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR-LLGCCVEMDEKMLVYEYMENR  623 (862)
Q Consensus       545 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~-l~g~~~~~~~~~lV~E~~~~g  623 (862)
                      ...+.|++|.+|.||+|.+. +..+|+|+-+.++  ....+..|+++|..++-.++-+ ++.+-.    -.+.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence            34478999999999999874 5588898875543  4567889999999998776644 444432    23449999998


Q ss_pred             ChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccC-CcceEecCCCCeeEecccceee
Q 002969          624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK-ASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       624 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlk-p~NILl~~~~~~kL~DFGla~~  693 (862)
                      .|.++-...      +-+    -...+++.---|...+   |-|+.|. |...+|-.+..+.|+||.-|..
T Consensus        98 ~L~~~~~~~------~rk----~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIGG------DRK----HLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhcc------cHH----HHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            887765211      112    2334455544455445   8888886 5555555666999999998874

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.45  E-value=0.0045  Score=69.63  Aligned_cols=75  Identities=15%  Similarity=0.239  Sum_probs=56.1

Q ss_pred             ceeeccccEEEEEeEecCC-cEEEEEEeccC------C-ccchHHHHHHHHHHHhcc-c--CCceEEEEEEEeCCceEEE
Q 002969          548 NKLGQGGFGIVYKGRLLEG-QEIAVKRLSRN------S-GQGIEEFKNEVRLIAKLQ-H--RNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~~-~~vavK~l~~~------~-~~~~~~~~~E~~~l~~l~-H--pnIv~l~g~~~~~~~~~lV  616 (862)
                      +.||.|.+..||++...+| +.++||.-...      . ....+++..|.+.|+.+. +  .++++++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5799999999999998776 58999985321      1 234567888999988873 2  457778777  44567899


Q ss_pred             EEeccCCC
Q 002969          617 YEYMENRS  624 (862)
Q Consensus       617 ~E~~~~gs  624 (862)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.35  E-value=0.0013  Score=70.02  Aligned_cols=139  Identities=14%  Similarity=0.106  Sum_probs=80.1

Q ss_pred             eeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCc-eEEEEEEEeCCceEEEEEeccCCChhh
Q 002969          549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL-VRLLGCCVEMDEKMLVYEYMENRSLDS  627 (862)
Q Consensus       549 ~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~g~~~~~~~~~lV~E~~~~gsL~~  627 (862)
                      .+..|-...+|+.. .+++.+++|+.........-...+|.++++.+....+ +++++...    ..+|+||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            35567778899887 3567888887654332221235789999999964433 44554432    368999999877642


Q ss_pred             h-----------------hhhcc-CCCCCCHhhHH-HHHHH---------HHHHhHHhhhc-----CCCcEEecccCCcc
Q 002969          628 V-----------------IFDKA-RSSILNWQRRF-NIICG---------IARGLLYLHQD-----SRFRIIHRDLKASN  674 (862)
Q Consensus       628 ~-----------------l~~~~-~~~~l~~~~~~-~i~~q---------ia~gL~yLH~~-----~~~~ivHrDlkp~N  674 (862)
                      .                 |+... ....++....+ ....+         +.+.+..+...     .+..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11110 01111211111 11111         11112222111     12458999999999


Q ss_pred             eEecCCCCeeEecccceee
Q 002969          675 ILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       675 ILl~~~~~~kL~DFGla~~  693 (862)
                      |++++++ +.|.||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999998753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.22  E-value=0.0019  Score=70.31  Aligned_cols=142  Identities=19%  Similarity=0.182  Sum_probs=87.0

Q ss_pred             cceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCC--ceEEEEE------EEeCCceEEEEE
Q 002969          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN--LVRLLGC------CVEMDEKMLVYE  618 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~g~------~~~~~~~~lV~E  618 (862)
                      .+.|..|....+|+.... +..+++|+...   ...++...|++++..+.+.+  +++++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            466777877899998664 45788888754   23456777888888885433  4555442      223455689999


Q ss_pred             eccCCChhh----hh----------hhccCC--------CCCCHhhHH----------HHHHHHHHHhHHhhhc----CC
Q 002969          619 YMENRSLDS----VI----------FDKARS--------SILNWQRRF----------NIICGIARGLLYLHQD----SR  662 (862)
Q Consensus       619 ~~~~gsL~~----~l----------~~~~~~--------~~l~~~~~~----------~i~~qia~gL~yLH~~----~~  662 (862)
                      +++|..+..    ..          +.....        ....|....          .....+.+++.++...    -+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999887643    10          110000        111221111          0111233445555431    12


Q ss_pred             CcEEecccCCcceEecCCCCeeEeccccee
Q 002969          663 FRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       663 ~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      ..++|+|+.|.|||++++..+.|.||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            359999999999999998777899998775

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.05  E-value=0.0039  Score=68.10  Aligned_cols=140  Identities=22%  Similarity=0.287  Sum_probs=84.0

Q ss_pred             ceeeccccEEEEEeEecC-------CcEEEEEEeccCCccchHHHHHHHHHHHhcccCC-ceEEEEEEEeCCceEEEEEe
Q 002969          548 NKLGQGGFGIVYKGRLLE-------GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN-LVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~g~~~~~~~~~lV~E~  619 (862)
                      +.|..|--..+|+....+       ++.+++|+..... .......+|.+++..+...+ .+++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            456666667899987655       4788999875543 23345578998998885433 3455665532    358999


Q ss_pred             ccCCChhhhh-----------------hhccCCC------CCC--HhhHHH--------------------------HHH
Q 002969          620 MENRSLDSVI-----------------FDKARSS------ILN--WQRRFN--------------------------IIC  648 (862)
Q Consensus       620 ~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~  648 (862)
                      ++|..+....                 +......      ...  +....+                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            9988764311                 1100000      000  101000                          111


Q ss_pred             HHHHHhHHhhh------cCCCcEEecccCCcceEecCC----CCeeEeccccee
Q 002969          649 GIARGLLYLHQ------DSRFRIIHRDLKASNILLDKE----MTPKISDFGMAR  692 (862)
Q Consensus       649 qia~gL~yLH~------~~~~~ivHrDlkp~NILl~~~----~~~kL~DFGla~  692 (862)
                      .+.+.+..|..      .....++|+|+.+.|||++++    +.++++||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            22223334432      234579999999999999885    889999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.03  E-value=0.0017  Score=79.23  Aligned_cols=198  Identities=20%  Similarity=0.164  Sum_probs=134.4

Q ss_pred             HHHHHHHHHHhcccCCceEEEEEEEeCCce----EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhh
Q 002969          584 EFKNEVRLIAKLQHRNLVRLLGCCVEMDEK----MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ  659 (862)
Q Consensus       584 ~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~  659 (862)
                      ....|...+.++.|+|+++++.+..+....    .+..|++..-++...+...   ..++......+..++.+||+|+|+
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v---~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV---GSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc---cccCHHHHHHHHHHHhhhHHHHHH
Confidence            344577788888999999999987665433    3455778777777777443   346777777888999999999999


Q ss_pred             cCCCcEEecccCCc---ceEecCCCCeeEe--cccceeecCCCCcccccccccccccccChhhhcCCCCCc--cccchhH
Q 002969          660 DSRFRIIHRDLKAS---NILLDKEMTPKIS--DFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV--KSDVFSF  732 (862)
Q Consensus       660 ~~~~~ivHrDlkp~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~--ksDVwSl  732 (862)
                      ..   ..|.-+..+   +-..+.++...++  ||+..+.+.......   ...-+..+.|||......+..  ..|+|.+
T Consensus       305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHH
Confidence            85   555555444   4455667777777  888887654322211   122355678888877666554  4799999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          733 GVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       733 Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      |..+..+..|..+.......                      ...+.   ............+|+..++++|+.+.+++.
T Consensus       379 gll~~~~~~~~~i~~~~~~~----------------------~~~l~---~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~  433 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSAVP----------------------VSLLD---VLSTSELLDALPKCLDEDSEERLSALELLT  433 (1351)
T ss_pred             HHHHhhhhhcCcccccccch----------------------hhhhc---cccchhhhhhhhhhcchhhhhccchhhhhh
Confidence            99999999987763211100                      00000   011114567788999999999999999997


Q ss_pred             Hhc
Q 002969          813 MLS  815 (862)
Q Consensus       813 ~L~  815 (862)
                      ..-
T Consensus       434 ~~f  436 (1351)
T KOG1035|consen  434 HPF  436 (1351)
T ss_pred             chh
Confidence            653

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=97.02  E-value=0.0083  Score=55.25  Aligned_cols=99  Identities=23%  Similarity=0.374  Sum_probs=62.0

Q ss_pred             CEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeC-CCCCCCCCCceEEEEcc-eeEEEcCCCCeEEccCCCC
Q 002969           70 KTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVAN-RDDPLANSSGVLRIINQ-RIGLFDGSQNLVWSSNQTK  147 (862)
Q Consensus        70 ~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAn-r~~p~~~~~~~l~~~~~-~~~l~~~~~~~vWst~~~~  147 (862)
                      +.+.+.+|.|.|-|-..|+     |-|..   ...++||..+ ...... ....+.+.++ +++|+|..+.++|++. ..
T Consensus        12 ~p~~~~s~~~~L~l~~dGn-----Lvl~~---~~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf-~~   81 (114)
T PF01453_consen   12 SPLTSSSGNYTLILQSDGN-----LVLYD---SNGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSF-DY   81 (114)
T ss_dssp             EEEEECETTEEEEEETTSE-----EEEEE---TTTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEEST-TS
T ss_pred             cccccccccccceECCCCe-----EEEEc---CCCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeec-CC
Confidence            3565655888887776655     55543   2257799993 333332 3567888876 5778899999999993 33


Q ss_pred             CCccEEEEec--CCCeEEEecCCCceeeeecCCCC
Q 002969          148 ATNPVAQLQD--SGNFVLKEAGSDEILWQSFDYPT  180 (862)
Q Consensus       148 ~~~~~a~l~d--~GNlVl~~~~~~~~lWqSFd~Pt  180 (862)
                      ...+.+..++  .||++ ... ...+.|.|=+.|+
T Consensus        82 ptdt~L~~q~l~~~~~~-~~~-~~~~sw~s~~dps  114 (114)
T PF01453_consen   82 PTDTLLPGQKLGDGNVT-GKN-DSLTSWSSNTDPS  114 (114)
T ss_dssp             SS-EEEEEET--TSEEE-EES-TSSEEEESS----
T ss_pred             CccEEEeccCcccCCCc-ccc-ceEEeECCCCCCC
Confidence            3456777777  89998 543 3578899877663

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>PLN02236 choline kinase

Probab=96.80  E-value=0.011  Score=65.70  Aligned_cols=141  Identities=21%  Similarity=0.295  Sum_probs=83.0

Q ss_pred             ceeeccccEEEEEeEecC-----CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCc-eEEEEEEEeCCceEEEEEecc
Q 002969          548 NKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL-VRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~g~~~~~~~~~lV~E~~~  621 (862)
                      +.|-.|-.-.+|+....+     ++.+++|+........+++ .+|..+++.+...++ +++++.+..+    .|.||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            455557777889886533     3678999886655444443 779999999965444 3556665332    5899998


Q ss_pred             CCChhhh-----------------hhhcc-CC-C-CCCHhhHHHHHHH-----------------HHHHhHHh----hh-
Q 002969          622 NRSLDSV-----------------IFDKA-RS-S-ILNWQRRFNIICG-----------------IARGLLYL----HQ-  659 (862)
Q Consensus       622 ~gsL~~~-----------------l~~~~-~~-~-~l~~~~~~~i~~q-----------------ia~gL~yL----H~-  659 (862)
                      +.+|...                 ++... .. . ...+.+..++..+                 +...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            8776421                 01100 00 0 1112222222211                 11112222    21 


Q ss_pred             cCCCcEEecccCCcceEecC-CCCeeEecccceee
Q 002969          660 DSRFRIIHRDLKASNILLDK-EMTPKISDFGMARI  693 (862)
Q Consensus       660 ~~~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~  693 (862)
                      .....++|+|+++.|||+++ ++.+.++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22346899999999999986 47899999988753

>PRK05231 homoserine kinase; Provisional

Probab=96.73  E-value=0.018  Score=63.39  Aligned_cols=142  Identities=17%  Similarity=0.216  Sum_probs=79.0

Q ss_pred             cceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccC--CceEEEE------EEEeCCceEEEEE
Q 002969          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR--NLVRLLG------CCVEMDEKMLVYE  618 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~g------~~~~~~~~~lV~E  618 (862)
                      .+.|+.|....+|+....++ .+++|+....   ..+....|+.++..|...  .+++.+.      +....+..++++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            35677777788999876555 6888987521   233444566667666422  2344442      1223456789999


Q ss_pred             eccCCChhh-----------hh---hhccCC--------CCCCH-hhHHH------------HH-HHHHHHhHHhhhc--
Q 002969          619 YMENRSLDS-----------VI---FDKARS--------SILNW-QRRFN------------II-CGIARGLLYLHQD--  660 (862)
Q Consensus       619 ~~~~gsL~~-----------~l---~~~~~~--------~~l~~-~~~~~------------i~-~qia~gL~yLH~~--  660 (862)
                      |++|..+..           .|   +.....        ..+.| .....            .. ..+...++.+...  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            999876421           11   111100        01111 11111            11 1111122333211  


Q ss_pred             --CCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          661 --SRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       661 --~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                        -+..++|+|++|.|||++.+...-|.||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              13469999999999999976556899999875

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.67  E-value=0.014  Score=62.78  Aligned_cols=31  Identities=26%  Similarity=0.536  Sum_probs=25.9

Q ss_pred             CcEEecccCCcceEecCCCC-eeEecccceee
Q 002969          663 FRIIHRDLKASNILLDKEMT-PKISDFGMARI  693 (862)
Q Consensus       663 ~~ivHrDlkp~NILl~~~~~-~kL~DFGla~~  693 (862)
                      +.++|+|++|.|||++++++ .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997565 46999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.55  E-value=0.021  Score=61.68  Aligned_cols=75  Identities=20%  Similarity=0.276  Sum_probs=50.9

Q ss_pred             cccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcc---cCCceEEEEEEEeCCceEEEEEecc
Q 002969          545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ---HRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       545 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      +..+.++.|....+|+.+ .+++.+.||.-.   ......|..|++-|+.|.   --.+++.+++....+..+||+||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            444678989999999987 578889999875   334467889999999994   3558889999888888899999998


Q ss_pred             CC
Q 002969          622 NR  623 (862)
Q Consensus       622 ~g  623 (862)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            77

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.53  E-value=0.038  Score=60.44  Aligned_cols=143  Identities=17%  Similarity=0.207  Sum_probs=83.5

Q ss_pred             cceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccC--CceEEEEEE------EeCCceEEEEE
Q 002969          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR--NLVRLLGCC------VEMDEKMLVYE  618 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~g~~------~~~~~~~lV~E  618 (862)
                      .+.++.|....+|+.+..++ .+++|+.....  ..+....|++++..|...  .+++++...      ...+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45677777789999876444 67788775421  234556677888887432  244554421      22355689999


Q ss_pred             eccCCChhhh--------------hhhccCC---------CCCCHhhHH------------HHHHHHHHHhHHhhh----
Q 002969          619 YMENRSLDSV--------------IFDKARS---------SILNWQRRF------------NIICGIARGLLYLHQ----  659 (862)
Q Consensus       619 ~~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~qia~gL~yLH~----  659 (862)
                      |++|..+...              ++.....         ..-.|....            .....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9998664311              1111000         001111110            011123344555543    


Q ss_pred             cCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       660 ~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      .-+..++|+|+++.||++++++.+.|.||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            123569999999999999988777899999774

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.31  E-value=0.033  Score=60.53  Aligned_cols=119  Identities=21%  Similarity=0.309  Sum_probs=75.1

Q ss_pred             CcEEEEEEecc--CCccchHHHHHHHHHHHhccc--CCceEEEEEEEeCC--ceEEEEEeccCCChhhhhhhccCCCCCC
Q 002969          566 GQEIAVKRLSR--NSGQGIEEFKNEVRLIAKLQH--RNLVRLLGCCVEMD--EKMLVYEYMENRSLDSVIFDKARSSILN  639 (862)
Q Consensus       566 ~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H--pnIv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~  639 (862)
                      ++++++. ...  ..........+|.++|+.+.-  .-+.+.+++|.++.  ..+.||+|.+|..+.+.+.....    .
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~----~  122 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESL----G  122 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccc----h
Confidence            7778777 332  123345566778888888743  34556677787766  66999999998544332211000    0


Q ss_pred             HhhHHHHH-HHHHHHh--------------------------------------------------HHhhhc-----CCC
Q 002969          640 WQRRFNII-CGIARGL--------------------------------------------------LYLHQD-----SRF  663 (862)
Q Consensus       640 ~~~~~~i~-~qia~gL--------------------------------------------------~yLH~~-----~~~  663 (862)
                          -+++ ..+++.|                                                  .+|+..     ++.
T Consensus       123 ----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~  198 (321)
T COG3173         123 ----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPP  198 (321)
T ss_pred             ----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCc
Confidence                0111 1333333                                                  333332     235


Q ss_pred             cEEecccCCcceEecCCCCeeEecccceee
Q 002969          664 RIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       664 ~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      .++|+|+++.||+++.+.-+-+.||+++..
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            699999999999999988899999999875

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.13  E-value=0.0079  Score=64.07  Aligned_cols=133  Identities=16%  Similarity=0.167  Sum_probs=93.8

Q ss_pred             cccccceeeccccEEEEEeEecCCcEEEEEEeccCC-----------------c-c----chHHHHHHHHHHHhccc--C
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS-----------------G-Q----GIEEFKNEVRLIAKLQH--R  598 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----------------~-~----~~~~~~~E~~~l~~l~H--p  598 (862)
                      -+...++||-|--+.||.+-..+|++.++|.-+...                 . .    ..-...+|...|+.|.-  =
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            467789999999999999999889999988543210                 0 0    01234668888888853  2


Q ss_pred             CceEEEEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec
Q 002969          599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (862)
Q Consensus       599 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~  678 (862)
                      -+++.+++    +..++|||++.+-.|...-+      ..+...   +...+..-+.-|..+|   +||+|..-=||+++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~  236 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeee------cCChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence            34555544    56689999999888765431      122233   3344444456666777   99999999999999


Q ss_pred             CCCCeeEecccce
Q 002969          679 KEMTPKISDFGMA  691 (862)
Q Consensus       679 ~~~~~kL~DFGla  691 (862)
                      +++.++++||--.
T Consensus       237 dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  237 DDDKIVVIDFPQM  249 (465)
T ss_pred             cCCCEEEeechHh
Confidence            9999999999643

>cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins

Probab=95.91  E-value=0.0067  Score=50.98  Aligned_cols=49  Identities=22%  Similarity=0.481  Sum_probs=34.4

Q ss_pred             ecccCCCCcccccccccCHHHHHHHHhhcCccccccccccCCCcceeeccCc
Q 002969          377 KNMKLPDTTTSFVDYNMTLKECEAFCSRNCSCTAYANTNITGGTGCVTWTGE  428 (862)
Q Consensus       377 ~~~~~p~~~~~~~~~~~sl~~C~~~Cl~~CsC~a~~~~~~~gg~~C~~w~g~  428 (862)
                      +++.++..+.... ...+.++|++.|+.+|+|.||.|.  .+...|+++.+.
T Consensus        10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~--~~~~~C~lk~~~   58 (73)
T cd01100          10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYN--TKSKKCFLKSSE   58 (73)
T ss_pred             CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEE--CCCCeEEcccCC
Confidence            4455554433322 245899999999999999999986  334579887764

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.89  E-value=0.06  Score=59.56  Aligned_cols=141  Identities=18%  Similarity=0.285  Sum_probs=80.4

Q ss_pred             ceeeccccEEEEEeEecC----CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCc-eEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL-VRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      +.|..|=.-.+|+....+    +..|++|+........+ .-.+|..+++.+..-++ +++++++..  .  +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~~--G--~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFGN--G--MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeCC--c--EeehhhcC
Confidence            455556667788876543    23788898765544332 33679999999976555 456666532  2  58999987


Q ss_pred             CChhhh-------h----------hhcc-C-CCCC-CHhhHHHHHHH----------------------HHHHhHH----
Q 002969          623 RSLDSV-------I----------FDKA-R-SSIL-NWQRRFNIICG----------------------IARGLLY----  656 (862)
Q Consensus       623 gsL~~~-------l----------~~~~-~-~~~l-~~~~~~~i~~q----------------------ia~gL~y----  656 (862)
                      ..|..-       +          +... . .... -|....++..+                      +.+-+..    
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            766321       1          1100 0 0001 12222111111                      1111111    


Q ss_pred             hhh-cCCCcEEecccCCcceEecC-CCCeeEecccceee
Q 002969          657 LHQ-DSRFRIIHRDLKASNILLDK-EMTPKISDFGMARI  693 (862)
Q Consensus       657 LH~-~~~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~  693 (862)
                      +.. ..+.-+.|+|+.+.|||+++ ++.++++||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            111 12245899999999999975 57899999998754

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.69  E-value=0.0019  Score=80.32  Aligned_cols=161  Identities=14%  Similarity=-0.016  Sum_probs=111.8

Q ss_pred             HHHHHHHHHHhcccCCceEEEEEEE--eCCceEEEEEeccCCChhhhhhhccC-CCCCCHhhHHHHHHHHHHHhHHhhhc
Q 002969          584 EFKNEVRLIAKLQHRNLVRLLGCCV--EMDEKMLVYEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQD  660 (862)
Q Consensus       584 ~~~~E~~~l~~l~HpnIv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~  660 (862)
                      ....|...++...|+++.....=..  +..+.+.+++|+..|.+.+.|.+... ...++..-+...-.+...+..-.|..
T Consensus      1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence            3444555556668888776554332  34456889999999999998865433 23333333332223324444454443


Q ss_pred             C--CCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHH
Q 002969          661 S--RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE  738 (862)
Q Consensus       661 ~--~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~e  738 (862)
                      .  ....+|+++|+-|.+|..+.++|++++|+.++...  .........+++-|++|++.....++.++|+|..|+-+|+
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred             ccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence            2  23479999999999999999999999999984321  1222233567888999999999999999999999999999


Q ss_pred             HHhCCCCC
Q 002969          739 TVSGKKNR  746 (862)
Q Consensus       739 lltG~~p~  746 (862)
                      +.-|..++
T Consensus      1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred             HhcccHHH
Confidence            98887763

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.66  E-value=0.041  Score=56.58  Aligned_cols=123  Identities=21%  Similarity=0.259  Sum_probs=60.8

Q ss_pred             CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCc-eEEEEEEEeCCceEEEEEeccCCChhhh-------h--------
Q 002969          566 GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL-VRLLGCCVEMDEKMLVYEYMENRSLDSV-------I--------  629 (862)
Q Consensus       566 ~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~g~~~~~~~~~lV~E~~~~gsL~~~-------l--------  629 (862)
                      .+.|+||+....... .-.-..|..+++.+...++ +++++++..    ..|+||+++..|..-       +        
T Consensus         2 ~~~~~~Ri~g~~t~~-~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEGTEN-FIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESCGCS-HHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCccc-ccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence            467888887665433 3455689999999865444 556666433    257799877665331       0        


Q ss_pred             --hhccC----CCCCCHhhHHHH----------------------HHHHHHHhHHhhh----c-CCCcEEecccCCcceE
Q 002969          630 --FDKAR----SSILNWQRRFNI----------------------ICGIARGLLYLHQ----D-SRFRIIHRDLKASNIL  676 (862)
Q Consensus       630 --~~~~~----~~~l~~~~~~~i----------------------~~qia~gL~yLH~----~-~~~~ivHrDlkp~NIL  676 (862)
                        +....    ...--|....++                      ...+.+-+..+..    . ....+.|+|+.|.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence              00000    000011111111                      0111122222221    1 1235899999999999


Q ss_pred             e-cCCCCeeEecccceee
Q 002969          677 L-DKEMTPKISDFGMARI  693 (862)
Q Consensus       677 l-~~~~~~kL~DFGla~~  693 (862)
                      + +.++.++++||..+..
T Consensus       157 ~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             ETSSSSCEEE--GTT-EE
T ss_pred             eccCCCeEEEecHHHHhh
Confidence            9 8899999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.59  E-value=0.11  Score=57.51  Aligned_cols=73  Identities=15%  Similarity=0.221  Sum_probs=49.5

Q ss_pred             eeeccccEEEEEeEecCC-cEEEEEEecc-------CCccchHHHHHHHHHHHhcc--cC-CceEEEEEEEeCCceEEEE
Q 002969          549 KLGQGGFGIVYKGRLLEG-QEIAVKRLSR-------NSGQGIEEFKNEVRLIAKLQ--HR-NLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       549 ~LG~G~fg~Vy~~~~~~~-~~vavK~l~~-------~~~~~~~~~~~E~~~l~~l~--Hp-nIv~l~g~~~~~~~~~lV~  617 (862)
                      .||.|....||++...++ +.|+||.-..       .-+-..++..-|.+.|+...  -| .+++++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            579999999999997654 5899996431       11334566677888887763  24 35555544  455667999


Q ss_pred             EeccCC
Q 002969          618 EYMENR  623 (862)
Q Consensus       618 E~~~~g  623 (862)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998643

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=94.99  E-value=0.25  Score=55.57  Aligned_cols=73  Identities=12%  Similarity=0.122  Sum_probs=52.0

Q ss_pred             cceeeccccEEEEEeEecCCcEEEEEEeccCC----c---cchHHHHHHHHHHHhcc---cCCceEEEEEEEeCCceEEE
Q 002969          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS----G---QGIEEFKNEVRLIAKLQ---HRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~---~~~~~~~~E~~~l~~l~---HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .+.||.|....||+... +++.++||+-....    .   ...++-..|++.|+.+.   ..++++++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            36889999999999876 45679999765211    1   23445556677777664   257888998887  456888


Q ss_pred             EEeccC
Q 002969          617 YEYMEN  622 (862)
Q Consensus       617 ~E~~~~  622 (862)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	862
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-55
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-54
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-40
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		7e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-38
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-38
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-38
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-36
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-25
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-25
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-25
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-23
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-23
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-23
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-23
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-22
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-22
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-22
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-22
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-22
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-22
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-22
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-22
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-22
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-22
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-22
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-22
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-22
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-21
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-21
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-21
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-21
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-21
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-21
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-20
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-20
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-20
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-20
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-20
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		7e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-20
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		8e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		9e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-19
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-19
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-19
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-19
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-19
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-19
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-19
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-19
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-19
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-19
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-19
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-19
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-19
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-19
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-19
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-19
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-18
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-18
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-18
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-18
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-18
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-18
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-18
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-18
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-18
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-18
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-18
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-18
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-18
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-18
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-18
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-18
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-18
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-18
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-18
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-18
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-18
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-18
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-18
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-18
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-18
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-18
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-18
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-18
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-18
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-18
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-18
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-18
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-18
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-18
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-18
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-18
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-18
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-18
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-18
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-18
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-18
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-18
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-18
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-18
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-18
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-18
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		8e-18
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-18
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-18
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-18
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-17
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-17
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-17
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-17
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-17
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-17
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-17
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-17
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-17
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-17
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-17
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-17
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-17
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		5e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-17
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		6e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-17
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-17
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-17
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-16
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-16
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-16
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-16
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-16
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-16
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-16
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-16
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-16
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-16
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-15
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-15
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-15
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-15
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-15
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-15
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-15
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-15
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-15
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-15
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-14
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-14
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-14
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-14
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-14
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-14
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		9e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-13
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-13
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-13
3soa_A	444	Full-Length Human Camkii Length = 444		2e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-13
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-13
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-13
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-13
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-12
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-12
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-12
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-12
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-12
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-12
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-12
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		7e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-12
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-12
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		8e-12
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-12
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		9e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-11
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-11
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-11
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-11
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-11
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-10
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-10
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		8e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		9e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-09
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		7e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-08
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		5e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		5e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		5e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		5e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		8e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-07
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-06
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-06
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		9e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-05
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-05
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-05
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-04
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  214 bits (545), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 126/296 (42%), Positives = 181/296 (61%), Gaps = 8/296 (2%)
Query: 528 ELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIE-EFK 586
           +L  F    +  A+DNF++ N LG+GGFG VYKGRL +G  +AVKRL     QG E +F+
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQ 83
Query: 587 NEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFN 645
            EV +I+   HRNL+RL G C+   E++LVY YM N S+ S + ++  S   L+W +R  
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           I  G ARGL YLH     +IIHRD+KA+NILLD+E    + DFG+A++   D  + +   
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDXHVXX 201
Query: 706 VV-GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKK--NRGFYHSNNELNLLGHVW 762
            V GT G+++PEY   G  S K+DVF +GV+LLE ++G++  +     +++++ LL  V 
Sbjct: 202 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 261
Query: 763 RLWKEGKVLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE 817
            L KE K+  +VD  +  NY   EV + I V LLC Q +  ERP M+ VV ML  +
Sbjct: 262 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  211 bits (537), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 125/296 (42%), Positives = 179/296 (60%), Gaps = 8/296 (2%)
Query: 528 ELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIE-EFK 586
           +L  F    +  A+DNF + N LG+GGFG VYKGRL +G  +AVKRL     QG E +F+
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQ 75
Query: 587 NEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFN 645
            EV +I+   HRNL+RL G C+   E++LVY YM N S+ S + ++  S   L+W +R  
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           I  G ARGL YLH     +IIHRD+KA+NILLD+E    + DFG+A++   D  + +   
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDXHVXX 193
Query: 706 VV-GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKK--NRGFYHSNNELNLLGHVW 762
            V G  G+++PEY   G  S K+DVF +GV+LLE ++G++  +     +++++ LL  V 
Sbjct: 194 AVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 763 RLWKEGKVLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE 817
            L KE K+  +VD  +  NY   EV + I V LLC Q +  ERP M+ VV ML  +
Sbjct: 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  162 bits (411), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 107/287 (37%), Positives = 167/287 (58%), Gaps = 12/287 (4%)
Query: 529 LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNE 588
           +PL D E    AT+NF     +G G FG VYKG L +G ++A+KR +  S QGIEEF+ E
Sbjct: 29  VPLVDLE---EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNII 647
           +  ++  +H +LV L+G C E +E +L+Y+YMEN +L   ++     ++ ++W++R  I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
            G ARGL YLH  +   IIHRD+K+ NILLD+   PKI+DFG+++   G + +Q     V
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELDQTHLXXV 200
Query: 708 --GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW 765
             GT GY+ PEY + G  + KSDV+SFGV+L E +  +           +NL        
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 766 KEGKVLEMVDSSVDNYPANEVLRCI-HVGLLCVQENAEERPTMASVV 811
             G++ ++VD ++ +    E LR      + C+  ++E+RP+M  V+
Sbjct: 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  162 bits (410), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 107/286 (37%), Positives = 168/286 (58%), Gaps = 10/286 (3%)
Query: 529 LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNE 588
           +PL D E    AT+NF     +G G FG VYKG L +G ++A+KR +  S QGIEEF+ E
Sbjct: 29  VPLVDLE---EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNII 647
           +  ++  +H +LV L+G C E +E +L+Y+YMEN +L   ++     ++ ++W++R  I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
            G ARGL YLH  +   IIHRD+K+ NILLD+   PKI+DFG+++  G +  + +   VV
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK-GTELGQTHLXXVV 201
Query: 708 -GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK 766
            GT GY+ PEY + G  + KSDV+SFGV+L E +  +           +NL         
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 767 EGKVLEMVDSSVDNYPANEVLRCI-HVGLLCVQENAEERPTMASVV 811
            G++ ++VD ++ +    E LR      + C+  ++E+RP+M  V+
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  158 bits (400), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 107/299 (35%), Positives = 158/299 (52%), Gaps = 16/299 (5%)
Query: 532 FDFETIVRATDNFTDY------NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEF 585
           F F  +   T+NF +       NK+G+GGFG+VYKG  +    +AVK+L+       EE 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 67
Query: 586 KN----EVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ 641
           K     E++++AK QH NLV LLG   + D+  LVY YM N SL   +     +  L+W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
            R  I  G A G+ +LH++     IHRD+K++NILLD+  T KISDFG+AR         
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
              R+VGT  YM+PE A+ G  + KSD++SFGV+LLE ++G       H   +L L    
Sbjct: 185 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD-EHREPQLLLDIKE 242
Query: 762 WRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
               +E  + + +D  +++  +  V     V   C+ E   +RP +  V  +L   TA+
Sbjct: 243 EIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 301

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  158 bits (400), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 107/299 (35%), Positives = 158/299 (52%), Gaps = 16/299 (5%)
Query: 532 FDFETIVRATDNFTDY------NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEF 585
           F F  +   T+NF +       NK+G+GGFG+VYKG  +    +AVK+L+       EE 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 586 KN----EVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ 641
           K     E++++AK QH NLV LLG   + D+  LVY YM N SL   +     +  L+W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
            R  I  G A G+ +LH++     IHRD+K++NILLD+  T KISDFG+AR         
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
              R+VGT  YM+PE A+ G  + KSD++SFGV+LLE ++G       H   +L L    
Sbjct: 191 MXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD-EHREPQLLLDIKE 248
Query: 762 WRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
               +E  + + +D  +++  +  V     V   C+ E   +RP +  V  +L   TA+
Sbjct: 249 EIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  158 bits (399), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 107/299 (35%), Positives = 158/299 (52%), Gaps = 16/299 (5%)
Query: 532 FDFETIVRATDNFTDY------NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEF 585
           F F  +   T+NF +       NK+G+GGFG+VYKG  +    +AVK+L+       EE 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 586 KN----EVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ 641
           K     E++++AK QH NLV LLG   + D+  LVY YM N SL   +     +  L+W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
            R  I  G A G+ +LH++     IHRD+K++NILLD+  T KISDFG+AR         
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
              R+VGT  YM+PE A+ G  + KSD++SFGV+LLE ++G       H   +L L    
Sbjct: 191 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD-EHREPQLLLDIKE 248
Query: 762 WRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
               +E  + + +D  +++  +  V     V   C+ E   +RP +  V  +L   TA+
Sbjct: 249 EIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  152 bits (383), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 153/299 (51%), Gaps = 16/299 (5%)
Query: 532 FDFETIVRATDNFTDY------NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEE- 584
           F F  +   T+NF +       NK G+GGFG+VYKG  +    +AVK+L+       EE 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 64
Query: 585 ---FKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ 641
              F  E+++ AK QH NLV LLG   + D+  LVY Y  N SL   +     +  L+W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
            R  I  G A G+ +LH++     IHRD+K++NILLD+  T KISDFG+AR         
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
              R+VGT  Y +PE A+ G  + KSD++SFGV+LLE ++G       H   +L L    
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD-EHREPQLLLDIKE 239
Query: 762 WRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
               +E  + + +D   ++  +  V     V   C+ E   +RP +  V  +L   TA+
Sbjct: 240 EIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQEXTAS 298

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  114 bits (286), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 120/225 (53%), Gaps = 16/225 (7%)
Query: 525 DDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGI 582
           DD+++P  D               K+G G FG V++     G ++AVK L       + +
Sbjct: 30  DDMDIPWCDLNI----------KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERV 78
Query: 583 EEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
            EF  EV ++ +L+H N+V  +G   +     +V EY+   SL  ++        L+ +R
Sbjct: 79  NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 643 RFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN 702
           R ++   +A+G+ YLH  +   I+HR+LK+ N+L+DK+ T K+ DFG++R+     T  +
Sbjct: 139 RLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLS 195
Query: 703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRG 747
           +K   GT  +M+PE   D   + KSDV+SFGV+L E  + ++  G
Sbjct: 196 SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  114 bits (284), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 118/225 (52%), Gaps = 16/225 (7%)
Query: 525 DDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGI 582
           DD+++P  D               K+G G FG V++     G ++AVK L       + +
Sbjct: 30  DDMDIPWCDLNI----------KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERV 78
Query: 583 EEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
            EF  EV ++ +L+H N+V  +G   +     +V EY+   SL  ++        L+ +R
Sbjct: 79  NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 643 RFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN 702
           R ++   +A+G+ YLH +    I+HRDLK+ N+L+DK+ T K+ DFG++R+         
Sbjct: 139 RLSMAYDVAKGMNYLH-NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLX-- 195
Query: 703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRG 747
           +K   GT  +M+PE   D   + KSDV+SFGV+L E  + ++  G
Sbjct: 196 SKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  114 bits (284), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 76/209 (36%), Positives = 114/209 (54%), Gaps = 27/209 (12%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           +G GGFG VY+   + G E+AVK    +      Q IE  + E +L A L+H N++ L G
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDK--ARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
            C++     LV E+     L+ V+  K      ++NW  +      IARG+ YLH ++  
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IARGMNYLHDEAIV 127
Query: 664 RIIHRDLKASNILLDKEM--------TPKISDFGMARIFGGDQTEQNTK-RVVGTYGYMS 714
            IIHRDLK+SNIL+ +++          KI+DFG+AR     +  + TK    G Y +M+
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWMA 182
Query: 715 PEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           PE     +FS  SDV+S+GVLL E ++G+
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  106 bits (264), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 147/285 (51%), Gaps = 32/285 (11%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 27  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLY-AV 84
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 85  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 139
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFS 724
           HRDL+A+NIL+   ++ KI+DFG+AR+    +  + T R    +   + +PE    G F+
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFT 196
Query: 725 VKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPAN 784
           +KSDV+SFG+LL E V+    R  Y       ++ ++ R ++      MV    DN P  
Sbjct: 197 IKSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYR------MVRP--DNCP-E 245
Query: 785 EVLRCIHVGLLCVQENAEERPT---MASVV--LMLSSETATMPQP 824
           E+ + +    LC +E  E+RPT   + SV+     ++E    PQP
Sbjct: 246 ELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP 287

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  106 bits (264), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 132/284 (46%), Gaps = 33/284 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
             T   ++G G FG+V+ G  L   ++A+K + R      E+F  E  ++ KL H  LV+
Sbjct: 8   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C+E     LV+E+ME+  L   +  + +  +   +    +   +  G+ YL + S 
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT---YGYMSPEYAM 719
             +IHRDL A N L+ +    K+SDFGM R    DQ   +T    GT     + SPE   
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFS 177
Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD 779
              +S KSDV+SFGVL+ E  S  K      SN+E               V+E + +   
Sbjct: 178 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------------VVEDISTGFR 222
Query: 780 NYPANEVLRCIHVGLL---CVQENAEERPTMASVVLMLSSETAT 820
            Y     L   HV  +   C +E  E+RP  + ++  L++  A+
Sbjct: 223 LYKPR--LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAIAAS 264

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  105 bits (263), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 147/285 (51%), Gaps = 32/285 (11%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLY-AV 82
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 83  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 137
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFS 724
           HRDL+A+NIL+   ++ KI+DFG+AR+    +  + T R    +   + +PE    G F+
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFT 194
Query: 725 VKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPAN 784
           +KSDV+SFG+LL E V+    R  Y       ++ ++ R ++      MV    DN P  
Sbjct: 195 IKSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYR------MVRP--DNCP-E 243
Query: 785 EVLRCIHVGLLCVQENAEERPT---MASVV--LMLSSETATMPQP 824
           E+ + +    LC +E  E+RPT   + SV+     ++E    PQP
Sbjct: 244 ELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP 285

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 147/285 (51%), Gaps = 32/285 (11%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLY-AV 76
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 77  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFS 724
           HRDL+A+NIL+   ++ KI+DFG+AR+    +  + T R    +   + +PE    G F+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 725 VKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPAN 784
           +KSDV+SFG+LL E V+    R  Y       ++ ++ R ++      MV    DN P  
Sbjct: 189 IKSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYR------MVRP--DNCP-E 237
Query: 785 EVLRCIHVGLLCVQENAEERPT---MASVV--LMLSSETATMPQP 824
           E+ + +    LC +E  E+RPT   + SV+     ++E    PQP
Sbjct: 238 ELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP 279

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 147/285 (51%), Gaps = 32/285 (11%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 29  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLY-AV 86
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 87  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 141
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFS 724
           HRDL+A+NIL+   ++ KI+DFG+AR+    +  + T R    +   + +PE    G F+
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFT 198
Query: 725 VKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPAN 784
           +KSDV+SFG+LL E V+    R  Y       ++ ++ R ++      MV    DN P  
Sbjct: 199 IKSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYR------MVRP--DNCP-E 247
Query: 785 EVLRCIHVGLLCVQENAEERPT---MASVV--LMLSSETATMPQP 824
           E+ + +    LC +E  E+RPT   + SV+     ++E    PQP
Sbjct: 248 ELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP 289

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 94/285 (32%), Positives = 147/285 (51%), Gaps = 32/285 (11%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 28  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLY-AV 85
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 86  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 140
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFS 724
           HRDL+A+NIL+   ++ KI+DFG+AR+    +  + T R    +   + +PE    G F+
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFT 197
Query: 725 VKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPAN 784
           +KSDV+SFG+LL E V+    R  Y       ++ ++ R ++      MV    DN P  
Sbjct: 198 IKSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYR------MVRP--DNCP-E 246
Query: 785 EVLRCIHVGLLCVQENAEERPT---MASVV--LMLSSETATMPQP 824
           E+ + +    LC +E  E+RPT   + SV+     ++E    PQP
Sbjct: 247 ELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATEGQFQPQP 288

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 88/261 (33%), Positives = 137/261 (52%), Gaps = 27/261 (10%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    V
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 79
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
             +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    IH
Sbjct: 80  TQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 134
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFSV 725
           RDL+A+NIL+   ++ KI+DFG+AR+    +  + T R    +   + +PE    G F++
Sbjct: 135 RDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFTI 191
Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           KSDV+SFG+LL E V+    R  Y       ++ ++ R ++      MV    DN P  E
Sbjct: 192 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYR------MVRP--DNCP-EE 240
Query: 786 VLRCIHVGLLCVQENAEERPT 806
           + + +    LC +E  E+RPT
Sbjct: 241 LYQLMR---LCWKERPEDRPT 258

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 88/261 (33%), Positives = 137/261 (52%), Gaps = 27/261 (10%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    V
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
             +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    IH
Sbjct: 78  TQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFSV 725
           RDL+A+NIL+   ++ KI+DFG+AR+    +  + T R    +   + +PE    G F++
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           KSDV+SFG+LL E V+    R  Y       ++ ++ R ++      MV    DN P  E
Sbjct: 190 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYR------MVRP--DNCP-EE 238
Query: 786 VLRCIHVGLLCVQENAEERPT 806
           + + +    LC +E  E+RPT
Sbjct: 239 LYQLMR---LCWKERPEDRPT 256

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 88/261 (33%), Positives = 137/261 (52%), Gaps = 27/261 (10%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    V
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 78
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
             +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    IH
Sbjct: 79  TQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 133
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFSV 725
           RDL+A+NIL+   ++ KI+DFG+AR+    +  + T R    +   + +PE    G F++
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFTI 190
Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           KSDV+SFG+LL E V+    R  Y       ++ ++ R ++      MV    DN P  E
Sbjct: 191 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYR------MVRP--DNCP-EE 239
Query: 786 VLRCIHVGLLCVQENAEERPT 806
           + + +    LC +E  E+RPT
Sbjct: 240 LYQLMR---LCWKERPEDRPT 257

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  103 bits (257), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 128/279 (45%), Gaps = 33/279 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
             T   ++G G FG+V+ G  L   ++A+K + R      E+F  E  ++ KL H  LV+
Sbjct: 11  ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 69
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C+E     LV+E+ME+  L   +  + +  +   +    +   +  G+ YL +   
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 126
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT---YGYMSPEYAM 719
             +IHRDL A N L+ +    K+SDFGM R    DQ   +T    GT     + SPE   
Sbjct: 127 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFS 180
Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD 779
              +S KSDV+SFGVL+ E  S  K      SN+E               V+E + +   
Sbjct: 181 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------------VVEDISTGFR 225
Query: 780 NYPANEVLRCIHVGLL---CVQENAEERPTMASVVLMLS 815
            Y     L   HV  +   C +E  E+RP  + ++  L+
Sbjct: 226 LYKPR--LASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 262

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 88/262 (33%), Positives = 137/262 (52%), Gaps = 27/262 (10%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 24  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV- 81
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 82  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 136
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFS 724
           HRDL+A+NIL+   ++ KI+DFG+AR+    +  + T R    +   + +PE    G F+
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFT 193
Query: 725 VKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPAN 784
           +KSDV+SFG+LL E V+    R  Y       ++ ++ R ++      MV    DN P  
Sbjct: 194 IKSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYR------MVRP--DNCP-E 242
Query: 785 EVLRCIHVGLLCVQENAEERPT 806
           E+ + +    LC +E  E+RPT
Sbjct: 243 ELYQLMR---LCWKERPEDRPT 261

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 88/262 (33%), Positives = 137/262 (52%), Gaps = 27/262 (10%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV- 82
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 83  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 137
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFS 724
           HRDL+A+NIL+   ++ KI+DFG+AR+    +  + T R    +   + +PE    G F+
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFT 194
Query: 725 VKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPAN 784
           +KSDV+SFG+LL E V+    R  Y       ++ ++ R ++      MV    DN P  
Sbjct: 195 IKSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYR------MVRP--DNCP-E 243
Query: 785 EVLRCIHVGLLCVQENAEERPT 806
           E+ + +    LC +E  E+RPT
Sbjct: 244 ELYQLMR---LCWKERPEDRPT 262

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 107/216 (49%), Gaps = 13/216 (6%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
             T   ++G G FG+V+ G  L   ++A+K + R      E+F  E  ++ KL H  LV+
Sbjct: 8   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C+E     LV+E+ME+  L   +  + +  +   +    +   +  G+ YL +   
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT---YGYMSPEYAM 719
             +IHRDL A N L+ +    K+SDFGM R    DQ   +T    GT     + SPE   
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFS 177
Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
              +S KSDV+SFGVL+ E  S  K      SN+E+
Sbjct: 178 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 213

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 130/263 (49%), Gaps = 28/263 (10%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L   +   ++ F  E  L+  LQH  LVRL    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 608 VEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
              +   ++ EYM   SL D +  D+    +L   +  +    IA G+ Y+    R   I
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYI 132
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFS 724
           HRDL+A+N+L+ + +  KI+DFG+AR+    +  + T R    +   + +PE    G F+
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGCFT 189
Query: 725 VKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +KSDV+SFG+LL E V+ GK       + + +  L   +R+             V+N P 
Sbjct: 190 IKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRM-----------PRVENCP- 237
Query: 784 NEVLRCIHVGLLCVQENAEERPT 806
           +E+   +    +C +E AEERPT
Sbjct: 238 DELYDIMK---MCWKEKAEERPT 257

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 107/216 (49%), Gaps = 13/216 (6%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
             T   ++G G FG+V+ G  L   ++A+K + R      E+F  E  ++ KL H  LV+
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C+E     LV+E+ME+  L   +  + +  +   +    +   +  G+ YL +   
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT---YGYMSPEYAM 719
             +IHRDL A N L+ +    K+SDFGM R    DQ   +T    GT     + SPE   
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFS 175
Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
              +S KSDV+SFGVL+ E  S  K      SN+E+
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 211

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 88/261 (33%), Positives = 137/261 (52%), Gaps = 27/261 (10%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    V
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
             +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    IH
Sbjct: 78  TQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFSV 725
           RDL+A+NIL+   ++ KI+DFG+AR+    +  + T R    +   + +PE    G F++
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           KSDV+SFG+LL E V+    R  Y       ++ ++ R ++      MV    DN P  E
Sbjct: 190 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYR------MVRP--DNCP-EE 238
Query: 786 VLRCIHVGLLCVQENAEERPT 806
           + + +    LC +E  E+RPT
Sbjct: 239 LYQLMR---LCWKERPEDRPT 256

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  102 bits (255), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 93/285 (32%), Positives = 146/285 (51%), Gaps = 32/285 (11%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G  G V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLY-AV 76
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    I
Sbjct: 77  VTQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFS 724
           HRDL+A+NIL+   ++ KI+DFG+AR+    +  + T R    +   + +PE    G F+
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLI---EDAEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 725 VKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPAN 784
           +KSDV+SFG+LL E V+    R  Y       ++ ++ R ++      MV    DN P  
Sbjct: 189 IKSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYR------MVRP--DNCP-E 237
Query: 785 EVLRCIHVGLLCVQENAEERPT---MASVV--LMLSSETATMPQP 824
           E+ + +    LC +E  E+RPT   + SV+     ++E    PQP
Sbjct: 238 ELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP 279

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  102 bits (254), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 88/261 (33%), Positives = 137/261 (52%), Gaps = 27/261 (10%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    V
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 72
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
             +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    IH
Sbjct: 73  TQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 127
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFSV 725
           RDL+A+NIL+   ++ KI+DFG+AR+    +  + T R    +   + +PE    G F++
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTI 184
Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           KSDV+SFG+LL E V+    R  Y       ++ ++ R ++      MV    DN P  E
Sbjct: 185 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYR------MVRP--DNCP-EE 233
Query: 786 VLRCIHVGLLCVQENAEERPT 806
           + + +    LC +E  E+RPT
Sbjct: 234 LYQLMR---LCWKERPEDRPT 251

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 91/284 (32%), Positives = 139/284 (48%), Gaps = 29/284 (10%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           E +   +V EYM   SL  + F K  +   L   +  ++   IA G+ Y+    R   +H
Sbjct: 333 E-EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 386
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           RDL+A+NIL+ + +  K++DFG+AR+   ++    Q  K  +    + +PE A+ G F++
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGRFTI 443
Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           KSDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D      
Sbjct: 444 KSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------ 495
Query: 786 VLRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQPKTPG 828
            L C      C ++  EERPT   +   L    T+T PQ + PG
Sbjct: 496 -LMC-----QCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQ-PG 532

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 127/279 (45%), Gaps = 33/279 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
             T   ++G G FG+V+ G  L   ++A+K + R      E+F  E  ++ KL H  LV+
Sbjct: 9   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C+E     LV E+ME+  L   +  + +  +   +    +   +  G+ YL +   
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 124
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT---YGYMSPEYAM 719
             +IHRDL A N L+ +    K+SDFGM R    DQ   +T    GT     + SPE   
Sbjct: 125 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFS 178
Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD 779
              +S KSDV+SFGVL+ E  S  K      SN+E               V+E + +   
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------------VVEDISTGFR 223
Query: 780 NYPANEVLRCIHVGLL---CVQENAEERPTMASVVLMLS 815
            Y     L   HV  +   C +E  E+RP  + ++  L+
Sbjct: 224 LYKPR--LASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 134/279 (48%), Gaps = 26/279 (9%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++A+K L   +    E F  E +++ KL+H  LV+L    
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            E +   +V EYM   SL   + D      L      ++   +A G+ Y+    R   IH
Sbjct: 74  SE-EPIYIVTEYMNKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 128
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFSV 725
           RDL+++NIL+   +  KI+DFG+AR+    +  + T R    +   + +PE A+ G F++
Sbjct: 129 RDLRSANILVGNGLICKIADFGLARLI---EDNEXTARQGAKFPIKWTAPEAALYGRFTI 185
Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           KSDV+SFG+LL E V+  K R  Y   N   +L  V R ++               P + 
Sbjct: 186 KSDVWSFGILLTELVT--KGRVPYPGMNNREVLEQVERGYRM------------PCPQDC 231
Query: 786 VLRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQ 823
            +    + + C +++ EERPT   +   L    TAT PQ
Sbjct: 232 PISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEPQ 270

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 91/284 (32%), Positives = 139/284 (48%), Gaps = 29/284 (10%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           E +   +V EYM   SL  + F K  +   L   +  ++   IA G+ Y+    R   +H
Sbjct: 250 E-EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           RDL+A+NIL+ + +  K++DFG+AR+   ++    Q  K  +    + +PE A+ G F++
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGRFTI 360
Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           KSDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D      
Sbjct: 361 KSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------ 412
Query: 786 VLRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQPKTPG 828
            L C      C ++  EERPT   +   L    T+T PQ + PG
Sbjct: 413 -LMC-----QCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQ-PG 449

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 89/279 (31%), Positives = 136/279 (48%), Gaps = 28/279 (10%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           E +   +V EYM   SL  + F K  +   L   +  ++   IA G+ Y+    R   +H
Sbjct: 250 E-EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           RDL+A+NIL+ + +  K++DFG+AR+   ++    Q  K  +    + +PE A+ G F++
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGRFTI 360
Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           KSDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D      
Sbjct: 361 KSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------ 412
Query: 786 VLRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQ 823
            L C      C ++  EERPT   +   L    T+T PQ
Sbjct: 413 -LMC-----QCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 137/261 (52%), Gaps = 27/261 (10%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LVRL    V
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 73
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
             +   ++ EYMEN SL  V F K  S I L   +  ++   IA G+ ++ + +    IH
Sbjct: 74  TQEPIYIITEYMENGSL--VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 128
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFSV 725
           R+L+A+NIL+   ++ KI+DFG+AR+    +  + T R    +   + +PE    G F++
Sbjct: 129 RNLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTI 185
Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           KSDV+SFG+LL E V+    R  Y       ++ ++ R ++      MV    DN P  E
Sbjct: 186 KSDVWSFGILLTEIVT--HGRIPYPGMTNPEVIQNLERGYR------MVRP--DNCP-EE 234
Query: 786 VLRCIHVGLLCVQENAEERPT 806
           + + +    LC +E  E+RPT
Sbjct: 235 LYQLMR---LCWKERPEDRPT 252

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 91/284 (32%), Positives = 139/284 (48%), Gaps = 29/284 (10%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           E +   +V EYM   SL  + F K  +   L   +  ++   IA G+ Y+    R   +H
Sbjct: 250 E-EPIYIVGEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           RDL+A+NIL+ + +  K++DFG+AR+   ++    Q  K  +    + +PE A+ G F++
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGRFTI 360
Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           KSDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D      
Sbjct: 361 KSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------ 412
Query: 786 VLRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQPKTPG 828
            L C      C ++  EERPT   +   L    T+T PQ + PG
Sbjct: 413 -LMC-----QCWRKEPEERPTFEYLQAFLEDYFTSTEPQXQ-PG 449

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 146/299 (48%), Gaps = 37/299 (12%)
Query: 520 SADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG 579
           S D +DD E+P              T   ++G G FG VYKG+      + +  ++  + 
Sbjct: 12  SRDSSDDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTP 61
Query: 580 QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILN 639
           Q ++ FKNEV ++ K +H N++  +G   +  +  +V ++ E  SL   +   A  +   
Sbjct: 62  QQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLH--ASETKFE 118
Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA----RIFG 695
            ++  +I    ARG+ YLH  S   IIHRDLK++NI L ++ T KI DFG+A    R  G
Sbjct: 119 MKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175
Query: 696 GDQTEQNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSN 752
             Q EQ    + G+  +M+PE         +S +SDV++FG++L E ++G+    + + N
Sbjct: 176 SHQFEQ----LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNIN 229
Query: 753 NELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
           N   ++  V R    G +   +     N P     R   +   C+++  +ERP+   ++
Sbjct: 230 NRDQIIEMVGR----GSLSPDLSKVRSNCPK----RMKRLMAECLKKKRDERPSFPRIL 280

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 89/279 (31%), Positives = 136/279 (48%), Gaps = 28/279 (10%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           E +   +V EYM   SL  + F K  +   L   +  ++   IA G+ Y+    R   +H
Sbjct: 74  E-EPIXIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 127
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           RDL+A+NIL+ + +  K++DFG+AR+   ++    Q  K  +    + +PE A+ G F++
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPI---KWTAPEAALYGRFTI 184
Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           KSDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D      
Sbjct: 185 KSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------ 236
Query: 786 VLRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQ 823
            L C      C ++  EERPT   +   L    T+T PQ
Sbjct: 237 -LMC-----QCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 269

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 135/278 (48%), Gaps = 26/278 (9%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 73  E-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSVK 726
           DL+A+NIL+ + +  K++DFG+AR+   ++    Q  K  +    + +PE A+ G F++K
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGRFTIK 184
Query: 727 SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEV 786
           SDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D       
Sbjct: 185 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------- 235
Query: 787 LRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQ 823
           L C      C +++ EERPT   +   L    T+T PQ
Sbjct: 236 LMC-----QCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 268

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 135/278 (48%), Gaps = 26/278 (9%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 75  E-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSVK 726
           DL+A+NIL+ + +  K++DFG+AR+   ++    Q  K  +    + +PE A+ G F++K
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGRFTIK 186
Query: 727 SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEV 786
           SDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D       
Sbjct: 187 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------- 237
Query: 787 LRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQ 823
           L C      C +++ EERPT   +   L    T+T PQ
Sbjct: 238 LMC-----QCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 270

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 107/216 (49%), Gaps = 13/216 (6%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
             T   ++G G FG+V+ G  L   ++A+K +   S    ++F  E  ++ KL H  LV+
Sbjct: 28  ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQ 86
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C+E     LV+E+ME+  L   +  + +  +   +    +   +  G+ YL +   
Sbjct: 87  LYGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 143
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT---YGYMSPEYAM 719
             +IHRDL A N L+ +    K+SDFGM R    DQ   +T    GT     + SPE   
Sbjct: 144 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFS 197
Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
              +S KSDV+SFGVL+ E  S  K      SN+E+
Sbjct: 198 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 233

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 137/283 (48%), Gaps = 27/283 (9%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L +      E F  E +++ KL+H  LV+L     
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 251 E-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSVK 726
           DL+A+NIL+ + +  K++DFG+ R+   ++    Q  K  +    + +PE A+ G F++K
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPI---KWTAPEAALYGRFTIK 362
Query: 727 SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEV 786
           SDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D       
Sbjct: 363 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------- 413
Query: 787 LRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQPKTPG 828
           L C      C +++ EERPT   +   L    T+T PQ + PG
Sbjct: 414 LMC-----QCWRKDPEERPTFEYLQAFLEDYFTSTEPQXQ-PG 450

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 135/278 (48%), Gaps = 26/278 (9%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 84  E-EPIYIVIEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSVK 726
           DL+A+NIL+ + +  K++DFG+AR+   ++    Q  K  +    + +PE A+ G F++K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGRFTIK 195
Query: 727 SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEV 786
           SDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D       
Sbjct: 196 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------- 246
Query: 787 LRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQ 823
           L C      C +++ EERPT   +   L    T+T PQ
Sbjct: 247 LMC-----QCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 89/279 (31%), Positives = 136/279 (48%), Gaps = 28/279 (10%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           E +   +V EYM   SL  + F K  +   L   +  ++   IA G+ Y+    R   +H
Sbjct: 77  E-EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 130
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           RDL+A+NIL+ + +  K++DFG+AR+   ++    Q  K  +    + +PE A+ G F++
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGRFTI 187
Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           KSDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D      
Sbjct: 188 KSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------ 239
Query: 786 VLRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQ 823
            L C      C ++  EERPT   +   L    T+T PQ
Sbjct: 240 -LMC-----QCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 272

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 135/278 (48%), Gaps = 26/278 (9%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSVK 726
           DL+A+NIL+ + +  K++DFG+AR+   ++    Q  K  +    + +PE A+ G F++K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGRFTIK 195
Query: 727 SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEV 786
           SDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D       
Sbjct: 196 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------- 246
Query: 787 LRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQ 823
           L C      C +++ EERPT   +   L    T+T PQ
Sbjct: 247 LMC-----QCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 135/278 (48%), Gaps = 26/278 (9%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 84  E-EPIYIVIEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSVK 726
           DL+A+NIL+ + +  K++DFG+AR+   ++    Q  K  +    + +PE A+ G F++K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPI---KWTAPEAALYGRFTIK 195
Query: 727 SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEV 786
           SDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D       
Sbjct: 196 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------- 246
Query: 787 LRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQ 823
           L C      C +++ EERPT   +   L    T+T PQ
Sbjct: 247 LMC-----QCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 89/279 (31%), Positives = 136/279 (48%), Gaps = 28/279 (10%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           E +   +V EYM   SL  + F K  +   L   +  ++   IA G+ Y+    R   +H
Sbjct: 81  E-EPIYIVTEYMNKGSL--LDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           RDL+A+NIL+ + +  K++DFG+AR+   ++    Q  K  +    + +PE A+ G F++
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPI---KWTAPEAALYGRFTI 191
Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           KSDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D      
Sbjct: 192 KSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------ 243
Query: 786 VLRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQ 823
            L C      C ++  EERPT   +   L    T+T PQ
Sbjct: 244 -LMC-----QCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 276

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 132/263 (50%), Gaps = 28/263 (10%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            KLG G FG V+ G      ++AVK L   +   ++ F  E  L+  LQH  LVRL    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 608 VEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
            + +   ++ E+M   SL D +  D+    +L   +  +    IA G+ Y+    R   I
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYI 131
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFS 724
           HRDL+A+N+L+ + +  KI+DFG+AR+    +  + T R    +   + +PE    G F+
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGCFT 188
Query: 725 VKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +KS+V+SFG+LL E V+ GK       + + ++ L   +R+             ++N P 
Sbjct: 189 IKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRM-----------PRMENCP- 236
Query: 784 NEVLRCIHVGLLCVQENAEERPT 806
           +E+   +    +C +E AEERPT
Sbjct: 237 DELYDIMK---MCWKEKAEERPT 256

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 135/278 (48%), Gaps = 26/278 (9%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 84  E-EPIYIVCEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSVK 726
           DL+A+NIL+ + +  K++DFG+AR+   ++    Q  K  +    + +PE A+ G F++K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGRFTIK 195
Query: 727 SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEV 786
           SDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D       
Sbjct: 196 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------- 246
Query: 787 LRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQ 823
           L C      C +++ EERPT   +   L    T+T PQ
Sbjct: 247 LMC-----QCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 145/297 (48%), Gaps = 37/297 (12%)
Query: 522 DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG 581
           D +DD E+P              T   ++G G FG VYKG+      + +  ++  + Q 
Sbjct: 2   DSSDDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ 51
Query: 582 IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ 641
           ++ FKNEV ++ K +H N++  +G   +  +  +V ++ E  SL   +   A  +    +
Sbjct: 52  LQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLH--ASETKFEMK 108
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA----RIFGGD 697
           +  +I    ARG+ YLH  S   IIHRDLK++NI L ++ T KI DFG+A    R  G  
Sbjct: 109 KLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSH 165
Query: 698 QTEQNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
           Q EQ    + G+  +M+PE         +S +SDV++FG++L E ++G+    + + NN 
Sbjct: 166 QFEQ----LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNR 219
Query: 755 LNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
             ++  V R    G +   +     N P     R   +   C+++  +ERP+   ++
Sbjct: 220 DQIIEMVGR----GSLSPDLSKVRSNCPK----RMKRLMAECLKKKRDERPSFPRIL 268

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 89/279 (31%), Positives = 136/279 (48%), Gaps = 28/279 (10%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           E +   +V EYM   SL  + F K  +   L   +  ++   IA G+ Y+    R   +H
Sbjct: 81  E-EPIYIVTEYMNKGSL--LDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           RDL+A+NIL+ + +  K++DFG+AR+   ++    Q  K  +    + +PE A+ G F++
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGRFTI 191
Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           KSDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D      
Sbjct: 192 KSDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------ 243
Query: 786 VLRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQ 823
            L C      C ++  EERPT   +   L    T+T PQ
Sbjct: 244 -LMC-----QCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 276

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 144/299 (48%), Gaps = 37/299 (12%)
Query: 520 SADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG 579
           S D  DD E+P              T   ++G G FG VYKG+      + +  ++  + 
Sbjct: 12  SRDAADDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTP 61
Query: 580 QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILN 639
           Q ++ FKNEV ++ K +H N++  +G      +  +V ++ E  SL   +   A  +   
Sbjct: 62  QQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLH--ASETKFE 118
Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA----RIFG 695
            ++  +I    ARG+ YLH  S   IIHRDLK++NI L ++ T KI DFG+A    R  G
Sbjct: 119 MKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175
Query: 696 GDQTEQNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSN 752
             Q EQ    + G+  +M+PE         +S +SDV++FG++L E ++G+    + + N
Sbjct: 176 SHQFEQ----LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNIN 229
Query: 753 NELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
           N   ++  V R    G +   +     N P     R   +   C+++  +ERP+   ++
Sbjct: 230 NRDQIIEMVGR----GSLSPDLSKVRSNCPK----RMKRLMAECLKKKRDERPSFPRIL 280

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 86/278 (30%), Positives = 135/278 (48%), Gaps = 26/278 (9%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ K++H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSVK 726
           DL+A+NIL+ + +  K++DFG+AR+   ++    Q  K  +    + +PE A+ G F++K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGRFTIK 195
Query: 727 SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEV 786
           SDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D       
Sbjct: 196 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------- 246
Query: 787 LRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQ 823
           L C      C +++ EERPT   +   L    T+T PQ
Sbjct: 247 LMC-----QCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 87/278 (31%), Positives = 134/278 (48%), Gaps = 26/278 (9%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 84  E-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSVK 726
           DL A+NIL+ + +  K++DFG+AR+   ++    Q  K  +    + +PE A+ G F++K
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGRFTIK 195
Query: 727 SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEV 786
           SDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D       
Sbjct: 196 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------- 246
Query: 787 LRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQ 823
           L C      C +++ EERPT   +   L    T+T PQ
Sbjct: 247 LMC-----QCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/278 (30%), Positives = 134/278 (48%), Gaps = 26/278 (9%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM    L   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 84  E-EPIYIVMEYMSKGCLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSVK 726
           DL+A+NIL+ + +  K++DFG+AR+   ++    Q  K  +    + +PE A+ G F++K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGRFTIK 195
Query: 727 SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEV 786
           SDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D       
Sbjct: 196 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------- 246
Query: 787 LRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQ 823
           L C      C +++ EERPT   +   L    T+T PQ
Sbjct: 247 LMC-----QCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/278 (30%), Positives = 134/278 (48%), Gaps = 26/278 (9%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E +   +V EYM    L   +  +     L   +  ++   IA G+ Y+    R   +HR
Sbjct: 84  E-EPIYIVTEYMSKGCLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSVK 726
           DL+A+NIL+ + +  K++DFG+AR+   ++    Q  K  +    + +PE A+ G F++K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI---KWTAPEAALYGRFTIK 195
Query: 727 SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEV 786
           SDV+SFG+LL E  +  K R  Y       +L  V R ++     E  +S  D       
Sbjct: 196 SDVWSFGILLTELTT--KGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD------- 246
Query: 787 LRCIHVGLLCVQENAEERPTMASVVLMLSSE-TATMPQ 823
           L C      C +++ EERPT   +   L    T+T PQ
Sbjct: 247 LMC-----QCWRKDPEERPTFEYLQAFLEDYFTSTEPQ 279

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 128/272 (47%), Gaps = 27/272 (9%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-YGYMSPEYAMDGLF 723
            +HRDL A NIL++  +  K+SDFG+AR+   D     T R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +  SDV+S+G++L E +S    R ++  +N+               V++ VD      P 
Sbjct: 228 TSASDVWSYGIVLWEVMS-YGERPYWEMSNQ--------------DVIKAVDEGYRLPPP 272
Query: 784 NEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
            +    ++  +L C Q++   RP    +V +L
Sbjct: 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 113/233 (48%), Gaps = 27/233 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGR---LLEGQE---IAVKRLSRNSGQGIEEFKNEVRLIAKLQ 596
           N     +LG+G FG V+      L   Q+   +AVK L   S    ++F  E  L+  LQ
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 73
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ----------RRFNI 646
           H ++V+  G CVE D  ++V+EYM++  L+  +      ++L  +          +  +I
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHI 133
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              IA G++YL   +    +HRDL   N L+ + +  KI DFGM+R    D    +  RV
Sbjct: 134 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRV 186
Query: 707 VG----TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
            G       +M PE  M   F+ +SDV+S GV+L E  +  K   +  SNNE+
Sbjct: 187 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 239

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 121/219 (55%), Gaps = 26/219 (11%)
Query: 541 TDNFTDYNK-LGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQG-------IEEFKNEVRL 591
            DN  +Y K +G+GGFG+V+KGRL++ +  +A+K L     +G        +EF+ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIA 651
           ++ L H N+V+L G     +   +V E++    L   + DKA    + W  +  ++  IA
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDK--EMTP---KISDFGMARIFGGDQTEQNTKRV 706
            G+ Y+ Q+    I+HRDL++ NI L    E  P   K++DFG+++     Q+  +   +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGL 186
Query: 707 VGTYGYMSPEY--AMDGLFSVKSDVFSFGVLLLETVSGK 743
           +G + +M+PE   A +  ++ K+D +SF ++L   ++G+
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 145/307 (47%), Gaps = 44/307 (14%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK 704
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R I+  D   +  K
Sbjct: 143 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELNLLGHVW 762
            ++    +MSPE   DG+F+  SDV+SFGV+L E  T++ +  +G    +NE      V 
Sbjct: 200 GLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNE-----QVL 250
Query: 763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMP 822
           R   EG +L+  D+  D     E++R      +C Q N + RP+   ++  +  E     
Sbjct: 251 RFVMEGGLLDKPDNCPDML--FELMR------MCWQYNPKMRPSFLEIISSIKEEM---- 298
Query: 823 QPKTPGF 829
               PGF
Sbjct: 299 ---EPGF 302

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 128/272 (47%), Gaps = 27/272 (9%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-YGYMSPEYAMDGLF 723
            +HRDL A NIL++  +  K+SDFG++R+   D     T R       + SPE      F
Sbjct: 168 FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +  SDV+S+G++L E +S    R ++  +N+               V++ VD      P 
Sbjct: 228 TSASDVWSYGIVLWEVMS-YGERPYWEMSNQ--------------DVIKAVDEGYRLPPP 272
Query: 784 NEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
            +    ++  +L C Q++   RP    +V +L
Sbjct: 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 108/207 (52%), Gaps = 14/207 (6%)
Query: 550 LGQGGFGIVYKGRLL-EGQ----EIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRNLVRL 603
           LG G FG VYKG  + EG+     +A+K L+  +G     EF +E  ++A + H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           LG C+      LV + M +  L   + +   +  +  Q   N    IA+G++YL +    
Sbjct: 106 LGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER--- 159
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           R++HRDL A N+L+      KI+DFG+AR+  GD+ E N         +M+ E      F
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 219
Query: 724 SVKSDVFSFGVLLLE--TVSGKKNRGF 748
           + +SDV+S+GV + E  T  GK   G 
Sbjct: 220 THQSDVWSYGVTIWELMTFGGKPYDGI 246

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 145/305 (47%), Gaps = 40/305 (13%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK 704
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R I+  D   +  K
Sbjct: 133 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 189
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            ++    +MSPE   DG+F+  SDV+SFGV+L E ++    + +   +NE      V R 
Sbjct: 190 GLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNE-----QVLRF 242
Query: 765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQP 824
             EG +L+  D+  D     E++R      +C Q N + RP+   ++       +++ + 
Sbjct: 243 VMEGGLLDKPDNCPDML--FELMR------MCWQYNPKMRPSFLEII-------SSIKEE 287
Query: 825 KTPGF 829
             PGF
Sbjct: 288 MEPGF 292

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 141/285 (49%), Gaps = 33/285 (11%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           ++G G FG VYKG+      + + ++   + +  + F+NEV ++ K +H N++  +G   
Sbjct: 43  RIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           + D   +V ++ E  SL   +    + +     +  +I    A+G+ YLH  +   IIHR
Sbjct: 103 K-DNLAIVTQWCEGSSLYKHL--HVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHR 156
Query: 669 DLKASNILLDKEMTPKISDFGMA----RIFGGDQTEQNTKRVVGTYGYMSPEYAM---DG 721
           D+K++NI L + +T KI DFG+A    R  G  Q EQ T    G+  +M+PE      + 
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT----GSVLWMAPEVIRMQDNN 212
Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE---GKVLEMVDSSV 778
            FS +SDV+S+G++L E ++G+    + H NN   ++  V R +      K+ +    ++
Sbjct: 213 PFSFQSDVYSYGIVLYELMTGE--LPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAM 270
Query: 779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQ 823
               A+           CV++  EERP    ++  +     ++P+
Sbjct: 271 KRLVAD-----------CVKKVKEERPLFPQILSSIELLQHSLPK 304

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 120/219 (54%), Gaps = 26/219 (11%)
Query: 541 TDNFTDYNK-LGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQG-------IEEFKNEVRL 591
            DN  +Y K +G+GGFG+V+KGRL++ +  +A+K L     +G        +EF+ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIA 651
           ++ L H N+V+L G     +   +V E++    L   + DKA    + W  +  ++  IA
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDK--EMTP---KISDFGMARIFGGDQTEQNTKRV 706
            G+ Y+ Q+    I+HRDL++ NI L    E  P   K++DFG ++     Q+  +   +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGL 186
Query: 707 VGTYGYMSPEY--AMDGLFSVKSDVFSFGVLLLETVSGK 743
           +G + +M+PE   A +  ++ K+D +SF ++L   ++G+
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 550 LGQGGFGIVYKGRLL-EGQ----EIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRNLVRL 603
           LG G FG VYKG  + EG+     +A+K L+  +G     EF +E  ++A + H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           LG C+    + LV + M +  L   + +   +  +  Q   N    IA+G++YL +    
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER--- 136
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           R++HRDL A N+L+      KI+DFG+AR+  GD+ E N         +M+ E      F
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 724 SVKSDVFSFGVLLLE--TVSGKKNRGF 748
           + +SDV+S+GV + E  T  GK   G 
Sbjct: 197 THQSDVWSYGVTIWELMTFGGKPYDGI 223

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 128/272 (47%), Gaps = 27/272 (9%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-YGYMSPEYAMDGLF 723
            +HRDL A NIL++  +  K+SDFG++R+   D     T R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +  SDV+S+G++L E +S    R ++  +N+               V++ VD      P 
Sbjct: 228 TSASDVWSYGIVLWEVMS-YGERPYWEMSNQ--------------DVIKAVDEGYRLPPP 272
Query: 784 NEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
            +    ++  +L C Q++   RP    +V +L
Sbjct: 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 128/272 (47%), Gaps = 27/272 (9%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 110
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 111 GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 165
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-YGYMSPEYAMDGLF 723
            +HRDL A NIL++  +  K+SDFG++R+   D     T R       + SPE      F
Sbjct: 166 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 225
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +  SDV+S+G++L E +S    R ++  +N+               V++ VD      P 
Sbjct: 226 TSASDVWSYGIVLWEVMS-YGERPYWEMSNQ--------------DVIKAVDEGYRLPPP 270
Query: 784 NEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
            +    ++  +L C Q++   RP    +V +L
Sbjct: 271 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 128/272 (47%), Gaps = 27/272 (9%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-YGYMSPEYAMDGLF 723
            +HRDL A NIL++  +  K+SDFG++R+   D     T R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +  SDV+S+G++L E +S    R ++  +N+               V++ VD      P 
Sbjct: 228 TSASDVWSYGIVLWEVMS-YGERPYWEMSNQ--------------DVIKAVDEGYRLPPP 272
Query: 784 NEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
            +    ++  +L C Q++   RP    +V +L
Sbjct: 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 128/272 (47%), Gaps = 27/272 (9%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-YGYMSPEYAMDGLF 723
            +HRDL A NIL++  +  K+SDFG++R+   D     T R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +  SDV+S+G++L E +S    R ++  +N+               V++ VD      P 
Sbjct: 228 TSASDVWSYGIVLWEVMS-YGERPYWEMSNQ--------------DVIKAVDEGYRLPPP 272
Query: 784 NEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
            +    ++  +L C Q++   RP    +V +L
Sbjct: 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 128/272 (47%), Gaps = 27/272 (9%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 84  GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 138
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-YGYMSPEYAMDGLF 723
            +HRDL A NIL++  +  K+SDFG++R+   D     T R       + SPE      F
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 198
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +  SDV+S+G++L E +S    R ++  +N+               V++ VD      P 
Sbjct: 199 TSASDVWSYGIVLWEVMS-YGERPYWEMSNQ--------------DVIKAVDEGYRLPPP 243
Query: 784 NEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
            +    ++  +L C Q++   RP    +V +L
Sbjct: 244 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 128/272 (47%), Gaps = 27/272 (9%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-YGYMSPEYAMDGLF 723
            +HRDL A NIL++  +  K+SDFG++R+   D     T R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +  SDV+S+G++L E +S    R ++  +N+               V++ VD      P 
Sbjct: 228 TSASDVWSYGIVLWEVMS-YGERPYWEMSNQ--------------DVIKAVDEGYRLPPP 272
Query: 784 NEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
            +    ++  +L C Q++   RP    +V +L
Sbjct: 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 127/272 (46%), Gaps = 27/272 (9%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-YGYMSPEYAMDGLF 723
            +HRDL A NIL++  +  K+SDFG+ R+   D     T R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +  SDV+S+G++L E +S    R ++  +N+               V++ VD      P 
Sbjct: 228 TSASDVWSYGIVLWEVMS-YGERPYWEMSNQ--------------DVIKAVDEGYRLPPP 272
Query: 784 NEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
            +    ++  +L C Q++   RP    +V +L
Sbjct: 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 128/272 (47%), Gaps = 27/272 (9%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 100
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 101 GVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 155
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-YGYMSPEYAMDGLF 723
            +HRDL A NIL++  +  K+SDFG++R+   D     T R       + SPE      F
Sbjct: 156 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 215
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +  SDV+S+G++L E +S    R ++  +N+               V++ VD      P 
Sbjct: 216 TSASDVWSYGIVLWEVMS-YGERPYWEMSNQ--------------DVIKAVDEGYRLPPP 260
Query: 784 NEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
            +    ++  +L C Q++   RP    +V +L
Sbjct: 261 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 120/219 (54%), Gaps = 26/219 (11%)
Query: 541 TDNFTDYNK-LGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQG-------IEEFKNEVRL 591
            DN  +Y K +G+GGFG+V+KGRL++ +  +A+K L     +G        +EF+ EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIA 651
           ++ L H N+V+L G     +   +V E++    L   + DKA    + W  +  ++  IA
Sbjct: 77  MSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIA 132
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDK--EMTP---KISDFGMARIFGGDQTEQNTKRV 706
            G+ Y+ Q+    I+HRDL++ NI L    E  P   K++DF +++     Q+  +   +
Sbjct: 133 LGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGL 186
Query: 707 VGTYGYMSPEY--AMDGLFSVKSDVFSFGVLLLETVSGK 743
           +G + +M+PE   A +  ++ K+D +SF ++L   ++G+
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 145/307 (47%), Gaps = 44/307 (14%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 142
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK 704
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R I+  D   +  K
Sbjct: 143 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELNLLGHVW 762
            ++    +MSPE   DG+F+  SDV+SFGV+L E  T++ +  +G    +NE      V 
Sbjct: 200 GLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNE-----QVL 250
Query: 763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMP 822
           R   EG +L+  D+  D     E++R      +C Q N + RP+   ++  +  E     
Sbjct: 251 RFVMEGGLLDKPDNCPDML--FELMR------MCWQYNPKMRPSFLEIISSIKEEM---- 298
Query: 823 QPKTPGF 829
               PGF
Sbjct: 299 ---EPGF 302

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 147/307 (47%), Gaps = 44/307 (14%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK 704
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R I+  D   +  K
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 193
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELNLLGHVW 762
            ++    +MSPE   DG+F+  SDV+SFGV+L E  T++ +  +G    +NE      V 
Sbjct: 194 GLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNE-----QVL 244
Query: 763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMP 822
           R   EG +L+  D+  D     E++R      +C Q N + RP+   ++       +++ 
Sbjct: 245 RFVMEGGLLDKPDNCPDML--FELMR------MCWQYNPKMRPSFLEII-------SSIK 289
Query: 823 QPKTPGF 829
           +   PGF
Sbjct: 290 EEMEPGF 296

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 549 KLGQGGFGIVYKGR---LLEGQE---IAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           +LG+G FG V+      LL  Q+   +AVK L   S    ++F+ E  L+  LQH+++VR
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIF------------DKARSSILNWQRRFNIICGI 650
             G C E    ++V+EYM +  L+  +             +      L   +   +   +
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A G++YL   +    +HRDL   N L+ + +  KI DFGM+R        +   R +   
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
            +M PE  +   F+ +SDV+SFGV+L E  +  K   +  SN E
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 245

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 145/305 (47%), Gaps = 40/305 (13%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK 704
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R I+  D   +  K
Sbjct: 136 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            ++    +MSPE   DG+F+  SDV+SFGV+L E ++    + +   +NE      V R 
Sbjct: 193 GLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNE-----QVLRF 245
Query: 765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQP 824
             EG +L+  D+  D     E++R      +C Q N + RP+   ++       +++ + 
Sbjct: 246 VMEGGLLDKPDNCPDML--FELMR------MCWQYNPKMRPSFLEII-------SSIKEE 290
Query: 825 KTPGF 829
             PGF
Sbjct: 291 MEPGF 295

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 145/305 (47%), Gaps = 40/305 (13%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK 704
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R I+  D   +  K
Sbjct: 130 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            ++    +MSPE   DG+F+  SDV+SFGV+L E ++    + +   +NE      V R 
Sbjct: 187 GLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNE-----QVLRF 239
Query: 765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQP 824
             EG +L+  D+  D     E++R      +C Q N + RP+   ++       +++ + 
Sbjct: 240 VMEGGLLDKPDNCPDML--FELMR------MCWQYNPKMRPSFLEII-------SSIKEE 284
Query: 825 KTPGF 829
             PGF
Sbjct: 285 MEPGF 289

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 549 KLGQGGFGIVYKGR---LLEGQE---IAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           +LG+G FG V+      LL  Q+   +AVK L   S    ++F+ E  L+  LQH+++VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIF------------DKARSSILNWQRRFNIICGI 650
             G C E    ++V+EYM +  L+  +             +      L   +   +   +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A G++YL   +    +HRDL   N L+ + +  KI DFGM+R        +   R +   
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
            +M PE  +   F+ +SDV+SFGV+L E  +  K   +  SN E
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 145/305 (47%), Gaps = 40/305 (13%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK 704
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R I+  D   +  K
Sbjct: 136 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            ++    +MSPE   DG+F+  SDV+SFGV+L E ++    + +   +NE      V R 
Sbjct: 193 GLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNE-----QVLRF 245
Query: 765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQP 824
             EG +L+  D+  D     E++R      +C Q N + RP+   ++       +++ + 
Sbjct: 246 VMEGGLLDKPDNCPDML--FELMR------MCWQYNPKMRPSFLEII-------SSIKEE 290
Query: 825 KTPGF 829
             PGF
Sbjct: 291 MEPGF 295

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 549 KLGQGGFGIVYKGR---LLEGQE---IAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           +LG+G FG V+      LL  Q+   +AVK L   S    ++F+ E  L+  LQH+++VR
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIF------------DKARSSILNWQRRFNIICGI 650
             G C E    ++V+EYM +  L+  +             +      L   +   +   +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A G++YL   +    +HRDL   N L+ + +  KI DFGM+R        +   R +   
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
            +M PE  +   F+ +SDV+SFGV+L E  +  K   +  SN E
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 239

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 117/226 (51%), Gaps = 19/226 (8%)
Query: 521 ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ 580
           +D +DD E+P              T   ++G G FG VYKG+      + +  ++  + Q
Sbjct: 2   SDSSDDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQ 51
Query: 581 GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNW 640
            ++ FKNEV ++ K +H N++  +G   +  +  +V ++ E  SL   +      +    
Sbjct: 52  QLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEM 108
Query: 641 QRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
            +  +I    A+G+ YLH  S   IIHRDLK++NI L +++T KI DFG+A +       
Sbjct: 109 IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 165
Query: 701 QNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGK 743
              +++ G+  +M+PE         +S +SDV++FG++L E ++G+
Sbjct: 166 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 145/305 (47%), Gaps = 40/305 (13%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 133
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK 704
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R I+  D   +  K
Sbjct: 134 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 190
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            ++    +MSPE   DG+F+  SDV+SFGV+L E ++    + +   +NE      V R 
Sbjct: 191 GLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNE-----QVLRF 243
Query: 765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQP 824
             EG +L+  D+  D     E++R      +C Q N + RP+   ++       +++ + 
Sbjct: 244 VMEGGLLDKPDNCPDML--FELMR------MCWQYNPKMRPSFLEII-------SSIKEE 288
Query: 825 KTPGF 829
             PGF
Sbjct: 289 MEPGF 293

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 117/226 (51%), Gaps = 19/226 (8%)
Query: 521 ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ 580
           +D +DD E+P              T   ++G G FG VYKG+      + +  ++  + Q
Sbjct: 2   SDSSDDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQ 51
Query: 581 GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNW 640
            ++ FKNEV ++ K +H N++  +G   +  +  +V ++ E  SL   +      +    
Sbjct: 52  QLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEM 108
Query: 641 QRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
            +  +I    A+G+ YLH  S   IIHRDLK++NI L +++T KI DFG+A +       
Sbjct: 109 IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 165
Query: 701 QNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGK 743
              +++ G+  +M+PE         +S +SDV++FG++L E ++G+
Sbjct: 166 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 147/307 (47%), Gaps = 44/307 (14%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 164
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK 704
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R I+  D   +  K
Sbjct: 165 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 221
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELNLLGHVW 762
            ++    +MSPE   DG+F+  SDV+SFGV+L E  T++ +  +G    +NE      V 
Sbjct: 222 GLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNE-----QVL 272
Query: 763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMP 822
           R   EG +L+  D+  D     E++R      +C Q N + RP+   ++       +++ 
Sbjct: 273 RFVMEGGLLDKPDNCPDML--FELMR------MCWQYNPKMRPSFLEII-------SSIK 317
Query: 823 QPKTPGF 829
           +   PGF
Sbjct: 318 EEMEPGF 324

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 144/305 (47%), Gaps = 40/305 (13%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK 704
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R I   D   +  K
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 193
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            ++    +MSPE   DG+F+  SDV+SFGV+L E ++    + +   +NE      V R 
Sbjct: 194 GLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNE-----QVLRF 246
Query: 765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQP 824
             EG +L+  D+  D     E++R      +C Q N + RP+   ++       +++ + 
Sbjct: 247 VMEGGLLDKPDNCPDML--FELMR------MCWQYNPKMRPSFLEII-------SSIKEE 291
Query: 825 KTPGF 829
             PGF
Sbjct: 292 MEPGF 296

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 139/292 (47%), Gaps = 35/292 (11%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR---LLEGQ---EIAVKRLSRNSG-QGIEEFKNEVRLIAK 594
           +  T   +LGQG FG+VY+G    +++G+    +AVK ++ ++  +   EF NE  ++  
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 76
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFNII 647
               ++VRLLG   +    ++V E M +       RSL     +         Q    + 
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRV 706
             IA G+ YL+     + +HRDL A N ++  + T KI DFGM R I+  D   +  K +
Sbjct: 137 AEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 193
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK 766
           +    +M+PE   DG+F+  SD++SFGV+L E ++    + +   +NE            
Sbjct: 194 LPVR-WMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNE------------ 239
Query: 767 EGKVLEMV-DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE 817
             +VL+ V D    + P N   R   +  +C Q N + RPT   +V +L  +
Sbjct: 240 --QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 142/305 (46%), Gaps = 40/305 (13%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK 704
           +   IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R I   D   +  K
Sbjct: 128 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 184
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            ++    +MSPE   DG+F+  SDV+SFGV+L E ++    + +   +NE      V R 
Sbjct: 185 GLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNE-----QVLRF 237
Query: 765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQP 824
             EG +L+  D+  D          + +  +C Q N + RP+   ++       +++ + 
Sbjct: 238 VMEGGLLDKPDNCPD--------MLLELMRMCWQYNPKMRPSFLEII-------SSIKEE 282
Query: 825 KTPGF 829
             PGF
Sbjct: 283 MEPGF 287

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 25/215 (11%)
Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNL 600
            +LG+  FG VYKG L       + Q +A+K L  +  G   EEF++E  L A+LQH N+
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIF-------------DKARSSILNWQRRFNII 647
           V LLG   +     +++ Y  +  L   +              D+   S L      +++
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRV 706
             IA G+ YL   S   ++H+DL   N+L+  ++  KISD G+ R ++  D  +     +
Sbjct: 152 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
           +    +M+PE  M G FS+ SD++S+GV+L E  S
Sbjct: 209 LPI-RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 118/229 (51%), Gaps = 27/229 (11%)
Query: 522 DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG 581
           D +DD E+P              T   ++G G FG VYKG+      + +  ++  + Q 
Sbjct: 18  DSSDDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ 67
Query: 582 IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ 641
           ++ FKNEV ++ K +H N++  +G   +  +  +V ++ E  SL   +      +     
Sbjct: 68  LQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMI 124
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA----RIFGGD 697
           +  +I    A+G+ YLH  S   IIHRDLK++NI L +++T KI DFG+A    R  G  
Sbjct: 125 KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSH 181
Query: 698 QTEQNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGK 743
           Q EQ    + G+  +M+PE         +S +SDV++FG++L E ++G+
Sbjct: 182 QFEQ----LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 142/305 (46%), Gaps = 40/305 (13%)
Query: 540 ATDNFTDYNKLGQGGFGIVY----KGRLLEGQEIAVKRLSRNSGQGIEE---FKNEVRLI 592
           A +  T   +LGQG FG+VY    KG + +  E  V   + N    + E   F NE  ++
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFN 645
            +    ++VRLLG   +    +++ E M         RSL   + +    +  +  +   
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK 704
           +   IA G+ YL+ +   + +HRDL A N  + ++ T KI DFGM R I+  D   +  K
Sbjct: 130 MAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            ++    +MSPE   DG+F+  SDV+SFGV+L E ++    + +   +NE      V R 
Sbjct: 187 GLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWE-IATLAEQPYQGLSNE-----QVLRF 239
Query: 765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQP 824
             EG +L+  D+  D          + +  +C Q N + RP+   ++       +++ + 
Sbjct: 240 VMEGGLLDKPDNCPD--------MLLELMRMCWQYNPKMRPSFLEII-------SSIKEE 284
Query: 825 KTPGF 829
             PGF
Sbjct: 285 MEPGF 289

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 25/215 (11%)
Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNL 600
            +LG+  FG VYKG L       + Q +A+K L  +  G   EEF++E  L A+LQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIF-------------DKARSSILNWQRRFNII 647
           V LLG   +     +++ Y  +  L   +              D+   S L      +++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRV 706
             IA G+ YL   S   ++H+DL   N+L+  ++  KISD G+ R ++  D  +     +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
           +    +M+PE  M G FS+ SD++S+GV+L E  S
Sbjct: 192 LPI-RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 118/229 (51%), Gaps = 27/229 (11%)
Query: 522 DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG 581
           D +DD E+P              T   ++G G FG VYKG+      + +  ++  + Q 
Sbjct: 26  DSSDDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ 75
Query: 582 IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ 641
           ++ FKNEV ++ K +H N++  +G   +  +  +V ++ E  SL   +      +     
Sbjct: 76  LQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLH--IIETKFEMI 132
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA----RIFGGD 697
           +  +I    A+G+ YLH  S   IIHRDLK++NI L +++T KI DFG+A    R  G  
Sbjct: 133 KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 189
Query: 698 QTEQNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGK 743
           Q EQ    + G+  +M+PE         +S +SDV++FG++L E ++G+
Sbjct: 190 QFEQ----LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 118/229 (51%), Gaps = 27/229 (11%)
Query: 522 DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG 581
           D +DD E+P              T   ++G G FG VYKG+      + +  ++  + Q 
Sbjct: 26  DSSDDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ 75
Query: 582 IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ 641
           ++ FKNEV ++ K +H N++  +G   +  +  +V ++ E  SL   +      +     
Sbjct: 76  LQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMI 132
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA----RIFGGD 697
           +  +I    A+G+ YLH  S   IIHRDLK++NI L +++T KI DFG+A    R  G  
Sbjct: 133 KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSH 189
Query: 698 QTEQNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGK 743
           Q EQ    + G+  +M+PE         +S +SDV++FG++L E ++G+
Sbjct: 190 QFEQ----LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 118/229 (51%), Gaps = 27/229 (11%)
Query: 522 DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG 581
           D +DD E+P              T   ++G G FG VYKG+      + +  ++  + Q 
Sbjct: 25  DSSDDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ 74
Query: 582 IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ 641
           ++ FKNEV ++ K +H N++  +G   +  +  +V ++ E  SL   +      +     
Sbjct: 75  LQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMI 131
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA----RIFGGD 697
           +  +I    A+G+ YLH  S   IIHRDLK++NI L +++T KI DFG+A    R  G  
Sbjct: 132 KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 188
Query: 698 QTEQNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGK 743
           Q EQ    + G+  +M+PE         +S +SDV++FG++L E ++G+
Sbjct: 189 QFEQ----LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 127/272 (46%), Gaps = 27/272 (9%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V E MEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 84  GVVTKSKPVMIVTEXMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 138
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-YGYMSPEYAMDGLF 723
            +HRDL A NIL++  +  K+SDFG++R+   D     T R       + SPE      F
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 198
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +  SDV+S+G++L E +S    R ++  +N+               V++ VD      P 
Sbjct: 199 TSASDVWSYGIVLWEVMS-YGERPYWEMSNQ--------------DVIKAVDEGYRLPPP 243
Query: 784 NEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
            +    ++  +L C Q++   RP    +V +L
Sbjct: 244 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 127/272 (46%), Gaps = 27/272 (9%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V E MEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-YGYMSPEYAMDGLF 723
            +HRDL A NIL++  +  K+SDFG++R+   D     T R       + SPE      F
Sbjct: 168 AVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +  SDV+S+G++L E +S    R ++  +N+               V++ VD      P 
Sbjct: 228 TSASDVWSYGIVLWEVMS-YGERPYWEMSNQ--------------DVIKAVDEGYRLPPP 272
Query: 784 NEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
            +    ++  +L C Q++   RP    +V +L
Sbjct: 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 127/272 (46%), Gaps = 27/272 (9%)
Query: 550 LGQGGFGIVYKGRLL--EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL     +EI+V   +   G   +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V E MEN SLDS  F +   +     +   ++ GIA G+ YL   S   
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMG 167
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-YGYMSPEYAMDGLF 723
            +HRDL A NIL++  +  K+SDFG++R+   D     T R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +  SDV+S+G++L E +S    R ++  +N+               V++ VD      P 
Sbjct: 228 TSASDVWSYGIVLWEVMS-YGERPYWEMSNQ--------------DVIKAVDEGYRLPPP 272
Query: 784 NEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
            +    ++  +L C Q++   RP    +V +L
Sbjct: 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 137/292 (46%), Gaps = 35/292 (11%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR---LLEGQ---EIAVKRLSRNSG-QGIEEFKNEVRLIAK 594
           +  T   +LGQG FG+VY+G    +++G+    +AVK ++ ++  +   EF NE  ++  
Sbjct: 16  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 75
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILN-------WQRRFNII 647
               ++VRLLG   +    ++V E M +  L S +      +  N        Q    + 
Sbjct: 76  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 135
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRV 706
             IA G+ YL+     + +HRDL A N ++  + T KI DFGM R I+  D   +  K +
Sbjct: 136 AEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 192
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK 766
           +    +M+PE   DG+F+  SD++SFGV+L E  S               L    ++   
Sbjct: 193 LPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLS 236
Query: 767 EGKVLEMV-DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE 817
             +VL+ V D    + P N   R   +  +C Q N + RPT   +V +L  +
Sbjct: 237 NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 288

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 135/290 (46%), Gaps = 31/290 (10%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR---LLEGQ---EIAVKRLSRNSG-QGIEEFKNEVRLIAK 594
           +  T   +LGQG FG+VY+G    +++G+    +AVK ++ ++  +   EF NE  ++  
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 76
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFNII 647
               ++VRLLG   +    ++V E M +       RSL     +         Q    + 
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             IA G+ YL+     + +HRDL A N ++  + T KI DFGM R        +   + +
Sbjct: 137 AEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGL 193
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE 767
               +M+PE   DG+F+  SD++SFGV+L E ++    + +   +NE      V +   +
Sbjct: 194 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNE-----QVLKFVMD 247
Query: 768 GKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE 817
           G  L+      DN P     R   +  +C Q N + RPT   +V +L  +
Sbjct: 248 GGYLD----QPDNCPE----RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 114/205 (55%), Gaps = 11/205 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHRN 599
           + +    K+G+G +G+VYK +  +G+ +A+KR+  ++  +GI      E+ L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V L+          LV+E+ME + L  V+ D+ ++ + + Q +  +   + RG+ + HQ
Sbjct: 81  IVSLIDVIHSERCLTLVFEFME-KDLKKVL-DENKTGLQDSQIKIYLY-QLLRGVAHCHQ 137
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
               RI+HRDLK  N+L++ +   K++DFG+AR F G      T  VV T  Y +P+  M
Sbjct: 138 ---HRILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLM 192
Query: 720 -DGLFSVKSDVFSFGVLLLETVSGK 743
               +S   D++S G +  E ++GK
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 114/205 (55%), Gaps = 11/205 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHRN 599
           + +    K+G+G +G+VYK +  +G+ +A+KR+  ++  +GI      E+ L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V L+          LV+E+ME + L  V+ D+ ++ + + Q +  +   + RG+ + HQ
Sbjct: 81  IVSLIDVIHSERCLTLVFEFME-KDLKKVL-DENKTGLQDSQIKIYLY-QLLRGVAHCHQ 137
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
               RI+HRDLK  N+L++ +   K++DFG+AR F G      T  VV T  Y +P+  M
Sbjct: 138 ---HRILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLM 192
Query: 720 -DGLFSVKSDVFSFGVLLLETVSGK 743
               +S   D++S G +  E ++GK
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 135/290 (46%), Gaps = 31/290 (10%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR---LLEGQ---EIAVKRLSRNSG-QGIEEFKNEVRLIAK 594
           +  T   +LGQG FG+VY+G    +++G+    +AVK ++ ++  +   EF NE  ++  
Sbjct: 14  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 73
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFNII 647
               ++VRLLG   +    ++V E M +       RSL     +         Q    + 
Sbjct: 74  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 133
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             IA G+ YL+     + +HRDL A N ++  + T KI DFGM R        +   + +
Sbjct: 134 AEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGL 190
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE 767
               +M+PE   DG+F+  SD++SFGV+L E ++    + +   +NE      V +   +
Sbjct: 191 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNE-----QVLKFVMD 244
Query: 768 GKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE 817
           G  L+      DN P     R   +  +C Q N + RPT   +V +L  +
Sbjct: 245 GGYLD----QPDNCPE----RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 286

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 31/290 (10%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR---LLEGQ---EIAVKRLSRNSG-QGIEEFKNEVRLIAK 594
           +  T   +LGQG FG+VY+G    +++G+    +AVK ++ ++  +   EF NE  ++  
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 76
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFNII 647
               ++VRLLG   +    ++V E M +       RSL     +         Q    + 
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             IA G+ YL+     + +HRDL A N ++  + T KI DFGM R        +   + +
Sbjct: 137 AEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGL 193
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE 767
               +M+PE   DG+F+  SD++SFGV+L E ++    + +   +NE      V +   +
Sbjct: 194 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNE-----QVLKFVMD 247
Query: 768 GKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE 817
           G  L+      DN P     R   +  +C Q N   RPT   +V +L  +
Sbjct: 248 GGYLD----QPDNCPE----RVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 289

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN---EVRLIAKLQHRN 599
           F+D  ++G G FG VY  R +   E+ A+K++S +  Q  E++++   EVR + KL+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
            ++  GC +      LV EY    + D +   +     L       +  G  +GL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE--Y 717
            +   +IHRD+KA NILL +    K+ DFG A I             VGT  +M+PE   
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAPEVIL 223
Query: 718 AMD-GLFSVKSDVFSFGVLLLETVSGK 743
           AMD G +  K DV+S G+  +E    K
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERK 250

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 126/239 (52%), Gaps = 23/239 (9%)
Query: 530 PLFDFETIVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK- 586
           PL D E       NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+     
Sbjct: 2   PLVDME-------NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI 54
Query: 587 NEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFN 645
            E+ L+ +L H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + + 
Sbjct: 55  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY- 112
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            +  + +GL + H     R++HRDLK  N+L++ E   K++DFG+AR FG       T  
Sbjct: 113 -LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHE 167
Query: 706 VVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           VV T  Y +PE  +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 168 VV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 222

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 115/223 (51%), Gaps = 19/223 (8%)
Query: 524 TDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIE 583
           +DD E+P              T   ++G G FG VYKG+      + +  ++  + Q ++
Sbjct: 2   SDDWEIP----------DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQ 51
Query: 584 EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRR 643
            FKNEV ++ K +H N++  +G   +  +  +V ++ E  SL   +      +     + 
Sbjct: 52  AFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMIKL 108
Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
            +I    A+G+ YLH  S   IIHRDLK++NI L +++T KI DFG+A +          
Sbjct: 109 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 165
Query: 704 KRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGK 743
           +++ G+  +M+PE         +S +SDV++FG++L E ++G+
Sbjct: 166 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 144/283 (50%), Gaps = 35/283 (12%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ YL   +  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 151
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEY 717
           + +HRDL A N +LD++ T K++DFG+AR    D  ++    V    G      +M+ E 
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                F+ KSDV+SFGVLL E ++  +    Y   N  ++  ++     +G+ L   +  
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL----QGRRLLQPEYC 261
Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
            D  P  EV+      L C    AE RP+ + +V  +S+  +T
Sbjct: 262 PD--PLYEVM------LKCWHPKAEMRPSFSELVSRISAIFST 296

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN---EVRLIAKLQHRN 599
           F+D  ++G G FG VY  R +   E+ A+K++S +  Q  E++++   EVR + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
            ++  GC +      LV EY    + D +   +     L       +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE--Y 717
            +   +IHRD+KA NILL +    K+ DFG A I             VGT  +M+PE   
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVIL 184
Query: 718 AMD-GLFSVKSDVFSFGVLLLETVSGK 743
           AMD G +  K DV+S G+  +E    K
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 108/199 (54%), Gaps = 9/199 (4%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            ++G G FG VYKG+      + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            +  +  +V ++ E  SL   +      +     +  +I    A+G+ YLH  S   IIH
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM---DGLFS 724
           RDLK++NI L +++T KI DFG+A +          +++ G+  +M+PE         +S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 725 VKSDVFSFGVLLLETVSGK 743
            +SDV++FG++L E ++G+
Sbjct: 188 FQSDVYAFGIVLYELMTGQ 206

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 124/229 (54%), Gaps = 16/229 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 118
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG       T  VV T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAP 173
Query: 716 EYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           E  +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 219

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 123/227 (54%), Gaps = 16/227 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 126
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     R++HRDLK  N+L++ E   K++DFG+AR FG       T  VV T  Y +PE 
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 181
Query: 718 AMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
            +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 182 LLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 225

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 123/227 (54%), Gaps = 16/227 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 126
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     R++HRDLK  N+L++ E   K++DFG+AR FG       T  VV T  Y +PE 
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 181
Query: 718 AM-DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
            +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 182 LLGXKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 225

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 119/228 (52%), Gaps = 14/228 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H N+V+LL      ++  LV+E++     D    D +  + +      + +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKD--FMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
            H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPE 173
Query: 717 YAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
             +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 110/203 (54%), Gaps = 17/203 (8%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            ++G G FG VYKG+      + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            +  +  +V ++ E  SL   +      +     +  +I    A+G+ YLH  S   IIH
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 668 RDLKASNILLDKEMTPKISDFGMA----RIFGGDQTEQNTKRVVGTYGYMSPEYAM---D 720
           RDLK++NI L +++T KI DFG+A    R  G  Q EQ    + G+  +M+PE       
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ----LSGSILWMAPEVIRMQDK 183
Query: 721 GLFSVKSDVFSFGVLLLETVSGK 743
             +S +SDV++FG++L E ++G+
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 123/227 (54%), Gaps = 16/227 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 118
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     R++HRDLK  N+L++ E   K++DFG+AR FG       T  VV T  Y +PE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 173
Query: 718 AMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
            +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 217

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 116/252 (46%), Gaps = 44/252 (17%)
Query: 548 NKLGQGGFGIVY----------KGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
            +LG+G FG V+          K ++L    +AVK L   +    ++F+ E  L+  LQH
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKML----VAVKALKDPTLAARKDFQREAELLTNLQH 76
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-------------LNWQRRF 644
            ++V+  G C + D  ++V+EYM++  L+  +      ++             L   +  
Sbjct: 77  EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           +I   IA G++YL        +HRDL   N L+   +  KI DFGM+R    D    +  
Sbjct: 137 HIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYY 189
Query: 705 RVVG----TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGH 760
           RV G       +M PE  M   F+ +SDV+SFGV+L E  +  K   F  SN E      
Sbjct: 190 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------ 243
Query: 761 VWRLWKEGKVLE 772
           V     +G+VLE
Sbjct: 244 VIECITQGRVLE 255

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 143/283 (50%), Gaps = 35/283 (12%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ YL      
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLASK--- 144
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEY 717
           + +HRDL A N +LD++ T K++DFG+AR    D  ++    V    G      +M+ E 
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                F+ KSDV+SFGVLL E ++  +    Y   N  ++  ++     +G+ L   +  
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL----QGRRLLQPEYC 254
Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
            D  P  EV+      L C    AE RP+ + +V  +S+  +T
Sbjct: 255 PD--PLYEVM------LKCWHPKAEMRPSFSELVSRISAIFST 289

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 123/227 (54%), Gaps = 16/227 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 119
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     R++HRDLK  N+L++ E   K++DFG+AR FG       T  VV T  Y +PE 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 174
Query: 718 AMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
            +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 123/227 (54%), Gaps = 16/227 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 118
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     R++HRDLK  N+L++ E   K++DFG+AR FG       T  VV T  Y +PE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 173
Query: 718 AMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
            +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 217

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 123/227 (54%), Gaps = 16/227 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 119
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     R++HRDLK  N+L++ E   K++DFG+AR FG       T  VV T  Y +PE 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 174
Query: 718 AM-DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
            +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 175 LLGXKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 144/283 (50%), Gaps = 35/283 (12%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ YL   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 152
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEY 717
           + +HRDL A N +LD++ T K++DFG+AR    D  ++    V    G      +M+ E 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                F+ KSDV+SFGVLL E ++  +    Y   N  ++  ++     +G+ L   +  
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL----QGRRLLQPEYC 262
Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
            D  P  EV+      L C    AE RP+ + +V  +S+  +T
Sbjct: 263 PD--PLYEVM------LKCWHPKAEMRPSFSELVSRISAIFST 297

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 123/227 (54%), Gaps = 16/227 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 119
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     R++HRDLK  N+L++ E   K++DFG+AR FG       T  VV T  Y +PE 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 174
Query: 718 AMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
            +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 144/283 (50%), Gaps = 35/283 (12%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ YL   +  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 147
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEY 717
           + +HRDL A N +LD++ T K++DFG+AR    D  ++    V    G      +M+ E 
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                F+ KSDV+SFGVLL E ++  +    Y   N  ++  ++     +G+ L   +  
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL----QGRRLLQPEYC 257
Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
            D  P  EV+      L C    AE RP+ + +V  +S+  +T
Sbjct: 258 PD--PLYEVM------LKCWHPKAEMRPSFSELVSRISAIFST 292

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 124/227 (54%), Gaps = 16/227 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L + +   A + I L   + +  +  + +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSY--LFQLLQGLAFC 118
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     R++HRDLK  N+L++ E   K++DFG+AR FG       T  VV T  Y +PE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 173
Query: 718 AMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
            +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 217

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 144/283 (50%), Gaps = 35/283 (12%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ YL   +  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 170
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEY 717
           + +HRDL A N +LD++ T K++DFG+AR    D  ++    V    G      +M+ E 
Sbjct: 171 KFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                F+ KSDV+SFGVLL E ++  +    Y   N  ++  ++     +G+ L   +  
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL----QGRRLLQPEYC 280
Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
            D  P  EV+      L C    AE RP+ + +V  +S+  +T
Sbjct: 281 PD--PLYEVM------LKCWHPKAEMRPSFSELVSRISAIFST 315

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 144/283 (50%), Gaps = 35/283 (12%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ YL   +  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 150
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEY 717
           + +HRDL A N +LD++ T K++DFG+AR    D  ++    V    G      +M+ E 
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                F+ KSDV+SFGVLL E ++  +    Y   N  ++  ++     +G+ L   +  
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL----QGRRLLQPEYC 260
Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
            D  P  EV+      L C    AE RP+ + +V  +S+  +T
Sbjct: 261 PD--PLYEVM------LKCWHPKAEMRPSFSELVSRISAIFST 295

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 124/229 (54%), Gaps = 16/229 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L + +   A + I L   + +  +  + +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSY--LFQLLQGLA 120
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAP 175
Query: 716 EYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           E  +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 221

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 143/283 (50%), Gaps = 35/283 (12%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ YL      
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLASK--- 171
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEY 717
           + +HRDL A N +LD++ T K++DFG+AR    D  ++    V    G      +M+ E 
Sbjct: 172 KFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                F+ KSDV+SFGVLL E ++  +    Y   N  ++  ++     +G+ L   +  
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL----QGRRLLQPEYC 281
Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
            D  P  EV+      L C    AE RP+ + +V  +S+  +T
Sbjct: 282 PD--PLYEVM------LKCWHPKAEMRPSFSELVSRISAIFST 316

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 135/292 (46%), Gaps = 35/292 (11%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR---LLEGQ---EIAVKRLSRNSG-QGIEEFKNEVRLIAK 594
           +  T   +LGQG FG+VY+G    +++G+    +AVK ++ ++  +   EF NE  ++  
Sbjct: 18  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 77
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFNII 647
               ++VRLLG   +    ++V E M +       RSL     +         Q    + 
Sbjct: 78  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 137
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRV 706
             IA G+ YL+     + +HR+L A N ++  + T KI DFGM R I+  D   +  K +
Sbjct: 138 AEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 194
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK 766
           +    +M+PE   DG+F+  SD++SFGV+L E  S               L    ++   
Sbjct: 195 LPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLS 238
Query: 767 EGKVLEMV-DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE 817
             +VL+ V D    + P N   R   +  +C Q N   RPT   +V +L  +
Sbjct: 239 NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 290

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 144/283 (50%), Gaps = 35/283 (12%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ YL   +  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 149
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEY 717
           + +HRDL A N +LD++ T K++DFG+AR    D  ++    V    G      +M+ E 
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                F+ KSDV+SFGVLL E ++  +    Y   N  ++  ++     +G+ L   +  
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL----QGRRLLQPEYC 259
Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
            D  P  EV+      L C    AE RP+ + +V  +S+  +T
Sbjct: 260 PD--PLYEVM------LKCWHPKAEMRPSFSELVSRISAIFST 294

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 107/199 (53%), Gaps = 9/199 (4%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            ++G G FG VYKG+      + +  ++  + Q ++ FKNEV ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
               +  +V ++ E  SL   +      +     +  +I    A+G+ YLH  S   IIH
Sbjct: 74  TA-PQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM---DGLFS 724
           RDLK++NI L +++T KI DFG+A +          +++ G+  +M+PE         +S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 725 VKSDVFSFGVLLLETVSGK 743
            +SDV++FG++L E ++G+
Sbjct: 188 FQSDVYAFGIVLYELMTGQ 206

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 144/283 (50%), Gaps = 35/283 (12%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ YL   +  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 151
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEY 717
           + +HRDL A N +LD++ T K++DFG+AR    D  ++    V    G      +M+ E 
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                F+ KSDV+SFGVLL E ++  +    Y   N  ++  ++     +G+ L   +  
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL----QGRRLLQPEYC 261
Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
            D  P  EV+      L C    AE RP+ + +V  +S+  +T
Sbjct: 262 PD--PLYEVM------LKCWHPKAEMRPSFSELVSRISAIFST 296

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 144/283 (50%), Gaps = 35/283 (12%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ YL   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYL---ASK 152
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEY 717
           + +HRDL A N +LD++ T K++DFG+AR    D  ++    V    G      +M+ E 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                F+ KSDV+SFGVLL E ++  +    Y   N  ++  ++     +G+ L   +  
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL----QGRRLLQPEYC 262
Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
            D  P  EV+      L C    AE RP+ + +V  +S+  +T
Sbjct: 263 PD--PLYEVM------LKCWHPKAEMRPSFSELVSRISAIFST 297

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 135/292 (46%), Gaps = 35/292 (11%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR---LLEGQ---EIAVKRLSRNSG-QGIEEFKNEVRLIAK 594
           +  T   +LGQG FG+VY+G    +++G+    +AVK ++ ++  +   EF NE  ++  
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 76
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIFDKARSSILNWQRRFNII 647
               ++VRLLG   +    ++V E M +       RSL     +         Q    + 
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRV 706
             IA G+ YL+     + +HR+L A N ++  + T KI DFGM R I+  D   +  K +
Sbjct: 137 AEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL 193
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK 766
           +    +M+PE   DG+F+  SD++SFGV+L E  S               L    ++   
Sbjct: 194 LPVR-WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLS 237
Query: 767 EGKVLEMV-DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE 817
             +VL+ V D    + P N   R   +  +C Q N   RPT   +V +L  +
Sbjct: 238 NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 289

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 122/229 (53%), Gaps = 16/229 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIF-DKARSSILNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++   S+D   F D +  + +      + +  + +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAP 175
Query: 716 EYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           E  +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 221

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 129/271 (47%), Gaps = 29/271 (10%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            KLG G FG V+     +  ++AVK +   S   +E F  E  ++  LQH  LV+L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAV 251
Query: 608 VEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ E+M   SL D +  D+     L   +  +    IA G+ ++ Q +    I
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 306
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFS 724
           HRDL+A+NIL+   +  KI+DFG+AR+    +  + T R    +   + +PE    G F+
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 725 VKSDVFSFGVLLLETVSGKKNRGFYHSNNE-LNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +KSDV+SFG+LL+E V+  +      SN E +  L   +R+ +               P 
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR---------------PE 408
Query: 784 NEVLRCIHVGLLCVQENAEERPTMASVVLML 814
           N      ++ + C +   EERPT   +  +L
Sbjct: 409 NCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 123/227 (54%), Gaps = 16/227 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLSFC 119
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     R++HRDLK  N+L++ E   K++DFG+AR FG       T  VV T  Y +PE 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 174
Query: 718 AMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
            +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 136/291 (46%), Gaps = 33/291 (11%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR---LLEGQ---EIAVKRLSRNSG-QGIEEFKNEVRLIAK 594
           +  T   +LGQG FG+VY+G    +++G+    +AVK ++ ++  +   EF NE  ++  
Sbjct: 17  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 76
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILN-------WQRRFNII 647
               ++VRLLG   +    ++V E M +  L S +      +  N        Q    + 
Sbjct: 77  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             IA G+ YL+     + +HRDL A N ++  + T KI DFGM R        +   + +
Sbjct: 137 AEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGL 193
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE 767
               +M+PE   DG+F+  SD++SFGV+L E ++    + +   +NE             
Sbjct: 194 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNE------------- 239
Query: 768 GKVLEMV-DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE 817
            +VL+ V D    + P N   R   +  +C Q N + RPT   +V +L  +
Sbjct: 240 -QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 113/213 (53%), Gaps = 14/213 (6%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFK-NEVRLIAKL 595
           + ++  F    KLG G +  VYKG     G  +A+K +  +S +G       E+ L+ +L
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDS-VIFDKARSSILNWQRRFNIICGIA 651
           +H N+VRL       ++  LV+E+M+N   + +DS  + +  R   LN  + F     + 
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ--WQLL 118
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG 711
           +GL + H++   +I+HRDLK  N+L++K    K+ DFG+AR FG      +++ V  T  
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLW 173
Query: 712 YMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGK 743
           Y +P+  M    +S   D++S G +L E ++GK
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 123/229 (53%), Gaps = 16/229 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 117
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +P
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAP 172
Query: 716 EYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           E  +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 604 LGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            G C     +   L+ EY+   SL   +  +A +  ++  +       I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEYLGTK- 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV-VGTYGYMSPEYAMD 720
             R IHRDL   NIL++ E   KI DFG+ ++   D+     K        + +PE   +
Sbjct: 137 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 721 GLFSVKSDVFSFGVLLLE 738
             FSV SDV+SFGV+L E
Sbjct: 195 SKFSVASDVWSFGVVLYE 212

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 128/272 (47%), Gaps = 27/272 (9%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL + G+    +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M++ EYMEN SLD+  F +         +   ++ GI  G+ YL   S   
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDA--FLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDMS 151
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-YGYMSPEYAMDGLF 723
            +HRDL A NIL++  +  K+SDFGM+R+   D     T R       + +PE      F
Sbjct: 152 AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 211
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +  SDV+S+G+++ E +S    R ++  +N+               V++ ++      P 
Sbjct: 212 TSASDVWSYGIVMWEVMS-YGERPYWDMSNQ--------------DVIKAIEEGYRLPPP 256
Query: 784 NEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
            +    +H  +L C Q+   +RP    +V ML
Sbjct: 257 MDCPIALHQLMLDCWQKERSDRPKFGQIVNML 288

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 123/229 (53%), Gaps = 16/229 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 120
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAP 175
Query: 716 EYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           E  +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 221

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 123/229 (53%), Gaps = 16/229 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 120
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAP 175
Query: 716 EYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           E  +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 221

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 123/229 (53%), Gaps = 16/229 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 119
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAP 174
Query: 716 EYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           E  +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 220

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 123/229 (53%), Gaps = 16/229 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 117
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +P
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAP 172
Query: 716 EYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           E  +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 123/229 (53%), Gaps = 16/229 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 117
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +P
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAP 172
Query: 716 EYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           E  +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 122/229 (53%), Gaps = 16/229 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIF-DKARSSILNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++   S+D   F D +  + +      + +  + +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAP 173
Query: 716 EYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           E  +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 219

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 119/228 (52%), Gaps = 14/228 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H N+V+LL      ++  LV+E++     D    D +  + +      + +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKD--FMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
            H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPE 176
Query: 717 YAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
             +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 221

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 127/267 (47%), Gaps = 29/267 (10%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            KLG G FG V+     +  ++AVK +   S   +E F  E  ++  LQH  LV+L    
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAV 78
Query: 608 VEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ E+M   SL D +  D+     L   +  +    IA G+ ++ Q +    I
Sbjct: 79  VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 133
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGLFS 724
           HRDL+A+NIL+   +  KI+DFG+AR+    +  + T R    +   + +PE    G F+
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFT 190
Query: 725 VKSDVFSFGVLLLETVSGKKNRGFYHSNNE-LNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +KSDV+SFG+LL+E V+  +      SN E +  L   +R+ +               P 
Sbjct: 191 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR---------------PE 235
Query: 784 NEVLRCIHVGLLCVQENAEERPTMASV 810
           N      ++ + C +   EERPT   +
Sbjct: 236 NCPEELYNIMMRCWKNRPEERPTFEYI 262

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 123/229 (53%), Gaps = 16/229 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 119
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAP 174
Query: 716 EYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           E  +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 220

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 123/229 (53%), Gaps = 16/229 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 119
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +P
Sbjct: 120 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAP 174
Query: 716 EYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           E  +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 220

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 123/229 (53%), Gaps = 16/229 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 118
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAP 173
Query: 716 EYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           E  +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 219

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 123/229 (53%), Gaps = 16/229 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 118
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAP 173
Query: 716 EYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           E  +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 219

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 123/229 (53%), Gaps = 16/229 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 121
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +P
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAP 176
Query: 716 EYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           E  +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 222

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQ-----EIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRNLVRL 603
           +G G FG VYKG L          +A+K L     +    +F  E  ++ +  H N++RL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSR 662
            G   +    M++ EYMEN +LD  + +K    S+L       ++ GIA G+ YL   + 
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL---VGMLRGIAAGMKYL---AN 165
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD-QTEQNTKRVVGTYGYMSPEYAMDG 721
              +HRDL A NIL++  +  K+SDFG++R+   D +    T        + +PE     
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
            F+  SDV+SFG+++ E ++  +   +  SN+E+
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 259

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 119/228 (52%), Gaps = 14/228 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H N+V+LL      ++  LV+E++     D    D +  + +      + +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKD--FMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
            H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPE 175
Query: 717 YAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
             +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 220

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 123/229 (53%), Gaps = 16/229 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 117
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +P
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAP 172
Query: 716 EYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           E  +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 128/272 (47%), Gaps = 27/272 (9%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL + G+    +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M++ EYMEN SLD+  F +         +   ++ GI  G+ YL   S   
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDA--FLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDMS 130
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-YGYMSPEYAMDGLF 723
            +HRDL A NIL++  +  K+SDFGM+R+   D     T R       + +PE      F
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +  SDV+S+G+++ E +S    R ++  +N+               V++ ++      P 
Sbjct: 191 TSASDVWSYGIVMWEVMS-YGERPYWDMSNQ--------------DVIKAIEEGYRLPPP 235
Query: 784 NEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
            +    +H  +L C Q+   +RP    +V ML
Sbjct: 236 MDCPIALHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 122/227 (53%), Gaps = 16/227 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 118
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +PE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEI 173
Query: 718 AMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
            +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 217

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 122/227 (53%), Gaps = 16/227 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 118
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +PE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEI 173
Query: 718 AMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
            +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 217

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 144/283 (50%), Gaps = 35/283 (12%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ +L   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 152
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEY 717
           + +HRDL A N +LD++ T K++DFG+AR    D  ++    V    G      +M+ E 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                F+ KSDV+SFGVLL E ++  +    Y   N  ++  ++     +G+ L   +  
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL----QGRRLLQPEYC 262
Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
            D  P  EV+      L C    AE RP+ + +V  +S+  +T
Sbjct: 263 PD--PLYEVM------LKCWHPKAEMRPSFSELVSRISAIFST 297

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 122/227 (53%), Gaps = 16/227 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 120
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +PE 
Sbjct: 121 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAPEI 175
Query: 718 AMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
            +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 219

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 102/196 (52%), Gaps = 11/196 (5%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           +G+G FG+V K +    +++A+K++   S +  + F  E+R ++++ H N+V+L G C  
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC-- 71
Query: 610 MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRD 669
           ++   LV EY E  SL +V+               +     ++G+ YLH      +IHRD
Sbjct: 72  LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 131
Query: 670 LKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSD 728
           LK  N+LL    T  KI DFG A      QT     +  G+  +M+PE      +S K D
Sbjct: 132 LKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK--GSAAWMAPEVFEGSNYSEKCD 186
Query: 729 VFSFGVLLLETVSGKK 744
           VFS+G++L E ++ +K
Sbjct: 187 VFSWGIILWEVITRRK 202

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 98/200 (49%), Gaps = 11/200 (5%)
Query: 548 NKLGQGGFGIVYKGR-LLEGQEIAVKRL---SRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +KLG GG   VY     +   ++A+K +    R   + ++ F+ EV   ++L H+N+V +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +    E D   LV EY+E  +L   I        L+     N    I  G+ + H     
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHD---M 130
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           RI+HRD+K  NIL+D   T KI DFG+A+        Q T  V+GT  Y SPE A     
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEAT 189
Query: 724 SVKSDVFSFGVLLLETVSGK 743
              +D++S G++L E + G+
Sbjct: 190 DECTDIYSIGIVLYEMLVGE 209

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 144/283 (50%), Gaps = 35/283 (12%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ +L   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 152
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEY 717
           + +HRDL A N +LD++ T K++DFG+AR    D  ++    V    G      +M+ E 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                F+ KSDV+SFGVLL E ++  +    Y   N  ++  ++     +G+ L   +  
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL----QGRRLLQPEYC 262
Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
            D  P  EV+      L C    AE RP+ + +V  +S+  +T
Sbjct: 263 PD--PLYEVM------LKCWHPKAEMRPSFSELVSRISAIFST 297

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 115/227 (50%), Gaps = 15/227 (6%)
Query: 528 ELPLFDFETIVRATDNFTD-YNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEF 585
           +L   D +++ +  +   D   KLG+G +G VYK    E GQ +A+K++   S   ++E 
Sbjct: 14  QLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEI 71
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
             E+ ++ +    ++V+  G   +  +  +V EY    S+  +I  + R+  L       
Sbjct: 72  IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIAT 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           I+    +GL YLH     R IHRD+KA NILL+ E   K++DFG+A    G  T+   KR
Sbjct: 130 ILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVA----GQLTDXMAKR 182
Query: 706 --VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYH 750
             V+GT  +M+PE   +  ++  +D++S G+  +E   GK      H
Sbjct: 183 NXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 131/273 (47%), Gaps = 29/273 (10%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL + G+    +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIF-DKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   +    M++ EYMEN SLD+ +  +  R +++       ++ GI  G+ YL   S  
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLRGIGSGMKYL---SDM 135
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-YGYMSPEYAMDGL 722
             +HRDL A NIL++  +  K+SDFGM+R+   D     T R       + +PE      
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 723 FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP 782
           F+  SDV+S+G+++ E +S    R ++  +N+               V++ ++      P
Sbjct: 196 FTSASDVWSYGIVMWEVMS-YGERPYWDMSNQ--------------DVIKAIEEGYRLPP 240
Query: 783 ANEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
             +    +H  +L C Q+   +RP    +V ML
Sbjct: 241 PMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 102/196 (52%), Gaps = 11/196 (5%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           +G+G FG+V K +    +++A+K++   S +  + F  E+R ++++ H N+V+L G C  
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC-- 70
Query: 610 MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRD 669
           ++   LV EY E  SL +V+               +     ++G+ YLH      +IHRD
Sbjct: 71  LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 670 LKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSD 728
           LK  N+LL    T  KI DFG A      QT     +  G+  +M+PE      +S K D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTA---CDIQTHMTNNK--GSAAWMAPEVFEGSNYSEKCD 185
Query: 729 VFSFGVLLLETVSGKK 744
           VFS+G++L E ++ +K
Sbjct: 186 VFSWGIILWEVITRRK 201

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 143/283 (50%), Gaps = 35/283 (12%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ +L      
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFLASK--- 211
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEY 717
           + +HRDL A N +LD++ T K++DFG+AR    D  ++    V    G      +M+ E 
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                F+ KSDV+SFGVLL E ++  +    Y   N  ++  ++     +G+ L   +  
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL----QGRRLLQPEYC 321
Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
            D  P  EV+      L C    AE RP+ + +V  +S+  +T
Sbjct: 322 PD--PLYEVM------LKCWHPKAEMRPSFSELVSRISAIFST 356

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 123/229 (53%), Gaps = 16/229 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQ 596
           + +NF    K+G+G +G+VYK R  L G+ +A+K++  ++  +G+      E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLL 655
           H N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLA 120
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           + H     R++HRDLK  N+L++ E   K++DFG+AR FG     +     V T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYXHEVVTLWYRAP 175
Query: 716 EYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           E  +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 221

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 144/283 (50%), Gaps = 35/283 (12%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ +L   +  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 150
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEY 717
           + +HRDL A N +LD++ T K++DFG+AR    D  ++    V    G      +M+ E 
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                F+ KSDV+SFGVLL E ++  +    Y   N  ++  ++     +G+ L   +  
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL----QGRRLLQPEYC 260
Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
            D  P  EV+      L C    AE RP+ + +V  +S+  +T
Sbjct: 261 PD--PLYEVM------LKCWHPKAEMRPSFSELVSRISAIFST 295

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 144/283 (50%), Gaps = 35/283 (12%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ +L   +  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 157
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEY 717
           + +HRDL A N +LD++ T K++DFG+AR    D  ++    V    G      +M+ E 
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                F+ KSDV+SFGVLL E ++  +    Y   N  ++  ++     +G+ L   +  
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL----QGRRLLQPEYC 267
Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
            D  P  EV+      L C    AE RP+ + +V  +S+  +T
Sbjct: 268 PD--PLYEVM------LKCWHPKAEMRPSFSELVSRISAIFST 302

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQH 597
           ++F   N LG+G F  VY+   +  G E+A+K + + +      ++  +NEV++  +L+H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            +++ L     + +   LV E   N  ++  + ++ +    N  R F  +  I  G+LYL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIITGMLYL 128
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      I+HRDL  SN+LL + M  KI+DFG+A        +  T  + GT  Y+SPE 
Sbjct: 129 HSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEI 183
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGK 743
           A      ++SDV+S G +    + G+
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 144/283 (50%), Gaps = 35/283 (12%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ +L   +  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 153
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEY 717
           + +HRDL A N +LD++ T K++DFG+AR    D  ++    V    G      +M+ E 
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLAR----DMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                F+ KSDV+SFGVLL E ++  +    Y   N  ++  ++     +G+ L   +  
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL----QGRRLLQPEYC 263
Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
            D  P  EV+      L C    AE RP+ + +V  +S+  +T
Sbjct: 264 PD--PLYEVM------LKCWHPKAEMRPSFSELVSRISAIFST 298

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 192
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 123/284 (43%), Gaps = 33/284 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L     +  E +F  E  +I+KL
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 105
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            G  YL ++     IHRD+ A N LL         KI DFGMAR        +     + 
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG 768
              +M PE  M+G+F+ K+D +SFGVLL E  S         SN E              
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------------- 268
Query: 769 KVLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            VLE V S    + P N       +   C Q   E+RP  A ++
Sbjct: 269 -VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 311

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 144/283 (50%), Gaps = 35/283 (12%)
Query: 550 LGQGGFGIVYKGRLLE--GQEI--AVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG VY G LL+  G++I  AVK L+R +  G + +F  E  ++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 605 GCCVEMD-EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G C+  +   ++V  YM++  L + I ++  +  +     F +   +A+G+ +L   +  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFL---ASK 153
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEY 717
           + +HRDL A N +LD++ T K++DFG+AR    D  ++    V    G      +M+ E 
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                F+ KSDV+SFGVLL E ++  +    Y   N  ++  ++     +G+ L   +  
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYLL----QGRRLLQPEYC 263
Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT 820
            D  P  EV+      L C    AE RP+ + +V  +S+  +T
Sbjct: 264 PD--PLYEVM------LKCWHPKAEMRPSFSELVSRISAIFST 298

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 114/218 (52%), Gaps = 15/218 (6%)
Query: 531 LFDFETIVRATD---NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFK 586
           L    +IV   D    +T + K+GQG  G VY    +  GQE+A+++++       E   
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 587 NEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
           NE+ ++ + ++ N+V  L   +  DE  +V EY+   SL  V+ +         + +   
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAA 120
Query: 647 IC-GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +C    + L +LH +   ++IHRD+K+ NILL  + + K++DFG       +Q++++T  
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-- 175
Query: 706 VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           +VGT  +M+PE      +  K D++S G++ +E + G+
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 122/227 (53%), Gaps = 16/227 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+ ++  ++  +G+      E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 119
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     R++HRDLK  N+L++ E   K++DFG+AR FG       T  VV T  Y +PE 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 174
Query: 718 AMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
            +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 218

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 122/227 (53%), Gaps = 16/227 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNS-GQGIEEFK-NEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R  L G+ +A+ ++  ++  +G+      E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLYL 657
           N+V+LL      ++  LV+E++ ++ L   +   A + I L   + +  +  + +GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY--LFQLLQGLAFC 118
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     R++HRDLK  N+L++ E   K++DFG+AR FG       T  VV T  Y +PE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEI 173
Query: 718 AMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
            +    +S   D++S G +  E V+    R  +  ++E++ L  ++R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT---RRALFPGDSEIDQLFRIFR 217

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 123/284 (43%), Gaps = 33/284 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L     +  E +F  E  +I+KL
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 91
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            G  YL ++     IHRD+ A N LL         KI DFGMAR        +     + 
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG 768
              +M PE  M+G+F+ K+D +SFGVLL E  S         SN E              
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------------- 254
Query: 769 KVLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            VLE V S    + P N       +   C Q   E+RP  A ++
Sbjct: 255 -VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 297

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 127/271 (46%), Gaps = 25/271 (9%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL L G+    +A+K L    + +   +F  E  ++ +  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M+V EYMEN SLD+  F K         +   ++ GI+ G+ YL   S   
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDT--FLKKNDGQFTVIQLVGMLRGISAGMKYL---SDMG 144
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT-YGYMSPEYAMDGLF 723
            +HRDL A NIL++  +  K+SDFG++R+   D     T R       + +PE      F
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKF 204
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           +  SDV+S+G+++ E VS    R ++   N+      V +  +EG  L     S  + PA
Sbjct: 205 TSASDVWSYGIVMWEVVS-YGERPYWEMTNQ-----DVIKAVEEGYRL----PSPMDCPA 254
Query: 784 NEVLRCIHVGLLCVQENAEERPTMASVVLML 814
                   + L C Q+    RP    +V ML
Sbjct: 255 A----LYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 73
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 74  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 132
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 133 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 188
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 189 KFSIKSDVWAFGVLLWEIAT 208

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 135
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 136 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 191
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 192 KFSIKSDVWAFGVLLWEIAT 211

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           LG+G FG   K    E G+ + +K L R   +    F  EV+++  L+H N+++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           +      + EY++  +L  +I  K+  S   W +R +    IA G+ YLH      IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR------------VVGTYGYMSPE 716
           DL + N L+ +     ++DFG+AR+   ++T+    R            VVG   +M+PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 717 YAMDGLFSVKSDVFSFGVLLLETV 740
                 +  K DVFSFG++L E +
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII 216

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 131
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 109/219 (49%), Gaps = 23/219 (10%)
Query: 537 IVRATDNFTDY--------NKLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIE 583
           + R + N T +         +LG+G FG V   R   L+   G+ +AVK+L  ++ + + 
Sbjct: 15  VPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 74
Query: 584 EFKNEVRLIAKLQHRNLVRLLGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNW 640
           +F+ E+ ++  LQH N+V+  G C     +   L+ EY+   SL D +   K R   +  
Sbjct: 75  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 134
Query: 641 QRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
            +  + IC   +G+ YL      R IHRDL   NIL++ E   KI DFG+ ++   D+  
Sbjct: 135 LQYTSQIC---KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 188
Query: 701 QNTKRV-VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
              K        + +PE   +  FSV SDV+SFGV+L E
Sbjct: 189 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 227

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 131
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRL-SRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  G L L G+    +A+K L S  + +   +F +E  ++ +  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M++ E+MEN SLDS  F +         +   ++ GIA G+ YL   +   
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDS--FLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 155
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG---TYGYMSPEYAMDG 721
            +HRDL A NIL++  +  K+SDFG++R    D ++      +G      + +PE     
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE--LNLLGHVWRLWKEGKVLEMVDSSVD 779
            F+  SDV+S+G+++ E +S    R ++   N+  +N +   +RL               
Sbjct: 216 KFTSASDVWSYGIVMWEVMS-YGERPYWDMTNQDVINAIEQDYRL--------------- 259
Query: 780 NYPANEVLRCIHVGLL-CVQENAEERPTMASVV 811
             P  +    +H  +L C Q++   RP    +V
Sbjct: 260 -PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 291

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 109/219 (49%), Gaps = 23/219 (10%)
Query: 537 IVRATDNFTDY--------NKLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIE 583
           + R + N T +         +LG+G FG V   R   L+   G+ +AVK+L  ++ + + 
Sbjct: 15  VPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 74
Query: 584 EFKNEVRLIAKLQHRNLVRLLGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNW 640
           +F+ E+ ++  LQH N+V+  G C     +   L+ EY+   SL D +   K R   +  
Sbjct: 75  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 134
Query: 641 QRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
            +  + IC   +G+ YL      R IHRDL   NIL++ E   KI DFG+ ++   D+  
Sbjct: 135 LQYTSQIC---KGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 188
Query: 701 QNTKRV-VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
              K        + +PE   +  FSV SDV+SFGV+L E
Sbjct: 189 XKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 227

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 548 NKLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
            +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 603 LLGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
             G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL  
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGT 163
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV-VGTYGYMSPEYA 718
               R IHRDL   NIL++ E   KI DFG+ ++   D+     K        + +PE  
Sbjct: 164 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 719 MDGLFSVKSDVFSFGVLLLE 738
            +  FSV SDV+SFGV+L E
Sbjct: 221 TESKFSVASDVWSFGVVLYE 240

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 103/200 (51%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 91
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       +V EYM   +L   + +  R  +      + +   I+  + YL + +
Sbjct: 92  QLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLY-MATQISSAMEYLEKKN 150
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 151 ---FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 206
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 207 TFSIKSDVWAFGVLLWEIAT 226

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 129/281 (45%), Gaps = 41/281 (14%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G  G V  GRL + GQ    +A+K L    + +   +F +E  ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G        M+V EYMEN SLD+  F +         +   ++ G+  G+ YL   S   
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG-----YMSPEYAM 719
            +HRDL A N+L+D  +  K+SDFG++R+   D     T     T G     + +PE   
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT----TGGKIPIRWTAPEAIA 227
Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD 779
              FS  SDV+SFGV++ E ++    R +++  N                  +++ S  +
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA-YGERPYWNMTNR-----------------DVISSVEE 269
Query: 780 NYPANEVLRCIH----VGLLCVQENAEERPTMASVVLMLSS 816
            Y     + C H    + L C  ++  +RP  + +V +L +
Sbjct: 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 133
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 134 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 189
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT 209

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 73
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 74  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 132
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD T            + +PE     
Sbjct: 133 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIKWTAPESLAYN 188
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 189 KFSIKSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 133
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD T            + +PE     
Sbjct: 134 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIKWTAPESLAYN 189
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT 209

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 140
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV-VGTYGYMSPEYAM 719
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K        + +PE   
Sbjct: 141 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 720 DGLFSVKSDVFSFGVLLLE 738
           +  FSV SDV+SFGV+L E
Sbjct: 198 ESKFSVASDVWSFGVVLYE 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 133
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV-VGTYGYMSPEYAM 719
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K        + +PE   
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 720 DGLFSVKSDVFSFGVLLLE 738
           +  FSV SDV+SFGV+L E
Sbjct: 191 ESKFSVASDVWSFGVVLYE 209

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 548 NKLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
            +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 603 LLGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
             G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL  
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGT 130
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV-VGTYGYMSPEYA 718
               R IHRDL   NIL++ E   KI DFG+ ++   D+     K        + +PE  
Sbjct: 131 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 719 MDGLFSVKSDVFSFGVLLLE 738
            +  FSV SDV+SFGV+L E
Sbjct: 188 TESKFSVASDVWSFGVVLYE 207

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 138
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV-VGTYGYMSPEYAM 719
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K        + +PE   
Sbjct: 139 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 720 DGLFSVKSDVFSFGVLLLE 738
           +  FSV SDV+SFGV+L E
Sbjct: 196 ESKFSVASDVWSFGVVLYE 214

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 74
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 133
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 134 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 189
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 190 KFSIKSDVWAFGVLLWEIAT 209

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 131/284 (46%), Gaps = 40/284 (14%)
Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            KLG G FG V+     +  ++AVK +   S   +E F  E  ++  LQH  LV+L    
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAV 245
Query: 608 VEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
           V  +   ++ E+M   SL D +  D+     L   +  +    IA G+ ++ Q +    I
Sbjct: 246 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 300
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVK 726
           HRDL+A+NIL+   +  KI+DFG+AR+      +           + +PE    G F++K
Sbjct: 301 HRDLRAANILVSASLVCKIADFGLARVGAKFPIK-----------WTAPEAINFGSFTIK 349
Query: 727 SDVFSFGVLLLETVSGKKNRGFYHSNNE-LNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           SDV+SFG+LL+E V+  +      SN E +  L   +R+ +               P N 
Sbjct: 350 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR---------------PENC 394
Query: 786 VLRCIHVGLLCVQENAEERPTMASVVLML-----SSETATMPQP 824
                ++ + C +   EERPT   +  +L     ++E+    QP
Sbjct: 395 PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQXQQQP 438

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 126/294 (42%), Gaps = 35/294 (11%)
Query: 533 DFETIVRATDNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EF 585
           D + + R   N T    LG G FG VY+G++          ++AVK L     +  E +F
Sbjct: 15  DLKEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 72
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQ 641
             E  +I+K  H+N+VR +G  ++   + ++ E M    L S + +     ++ S L   
Sbjct: 73  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 132
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQ 698
              ++   IA G  YL ++     IHRD+ A N LL         KI DFGMAR      
Sbjct: 133 DLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 189
Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
             +     +    +M PE  M+G+F+ K+D +SFGVLL E  S         SN E    
Sbjct: 190 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---- 245
Query: 759 GHVWRLWKEGKVLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
                      VLE V S    + P N       +   C Q   E+RP  A ++
Sbjct: 246 -----------VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 288

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 132
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV-VGTYGYMSPEYAM 719
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K        + +PE   
Sbjct: 133 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 720 DGLFSVKSDVFSFGVLLLE 738
           +  FSV SDV+SFGV+L E
Sbjct: 190 ESKFSVASDVWSFGVVLYE 208

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 136
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV-VGTYGYMSPEYAM 719
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K        + +PE   
Sbjct: 137 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 720 DGLFSVKSDVFSFGVLLLE 738
           +  FSV SDV+SFGV+L E
Sbjct: 194 ESKFSVASDVWSFGVVLYE 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 137
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV-VGTYGYMSPEYAM 719
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K        + +PE   
Sbjct: 138 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 720 DGLFSVKSDVFSFGVLLLE 738
           +  FSV SDV+SFGV+L E
Sbjct: 195 ESKFSVASDVWSFGVVLYE 213

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 85
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 86  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 144
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 145 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 200
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 201 KFSIKSDVWAFGVLLWEIAT 220

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 129/281 (45%), Gaps = 41/281 (14%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G  G V  GRL + GQ    +A+K L    + +   +F +E  ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G        M+V EYMEN SLD+  F +         +   ++ G+  G+ YL   S   
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG-----YMSPEYAM 719
            +HRDL A N+L+D  +  K+SDFG++R+   D     T     T G     + +PE   
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT----TGGKIPIRWTAPEAIA 227
Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD 779
              FS  SDV+SFGV++ E ++    R +++  N                  +++ S  +
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA-YGERPYWNMTNR-----------------DVISSVEE 269
Query: 780 NYPANEVLRCIH----VGLLCVQENAEERPTMASVVLMLSS 816
            Y     + C H    + L C  ++  +RP  + +V +L +
Sbjct: 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 113/220 (51%), Gaps = 19/220 (8%)
Query: 531 LFDFETIVRATD---NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFK 586
           L    +IV   D    +T + K+GQG  G VY    +  GQE+A+++++       E   
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 587 NEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
           NE+ ++ + ++ N+V  L   +  DE  +V EY+   SL  V+ +         + +   
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAA 120
Query: 647 IC-GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +C    + L +LH +   ++IHRD+K+ NILL  + + K++DFG    F    T + +KR
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKR 173
Query: 706 --VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
             +VGT  +M+PE      +  K D++S G++ +E + G+
Sbjct: 174 SXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 141/284 (49%), Gaps = 26/284 (9%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRN 599
           D++     +G G   +V        +E +A+KR++    Q  ++E   E++ +++  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD-----KARSSILNWQRRFNIICGIARGL 654
           +V      V  DE  LV + +   S+  +I       + +S +L+      I+  +  GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRV-VGTYG 711
            YLH++ +   IHRD+KA NILL ++ + +I+DFG++     GGD T    ++  VGT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 712 YMSPEYAMDGL--FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK 769
           +M+PE  M+ +  +  K+D++SFG+  +E  +G      YH    + +L  +  L  +  
Sbjct: 187 WMAPE-VMEQVRGYDFKADIWSFGITAIELATGAAP---YHKYPPMKVL--MLTLQNDPP 240
Query: 770 VLE--MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            LE  + D  +         + I    LC+Q++ E+RPT A ++
Sbjct: 241 SLETGVQDKEMLKKYGKSFRKMIS---LCLQKDPEKRPTAAELL 281

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 113/220 (51%), Gaps = 19/220 (8%)
Query: 531 LFDFETIVRATD---NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFK 586
           L    +IV   D    +T + K+GQG  G VY    +  GQE+A+++++       E   
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65
Query: 587 NEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
           NE+ ++ + ++ N+V  L   +  DE  +V EY+   SL  V+ +         + +   
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAA 120
Query: 647 IC-GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +C    + L +LH +   ++IHRD+K+ NILL  + + K++DFG    F    T + +KR
Sbjct: 121 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKR 173
Query: 706 --VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
             +VGT  +M+PE      +  K D++S G++ +E + G+
Sbjct: 174 SEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 139
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV-VGTYGYMSPEYAM 719
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K        + +PE   
Sbjct: 140 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 720 DGLFSVKSDVFSFGVLLLE 738
           +  FSV SDV+SFGV+L E
Sbjct: 197 ESKFSVASDVWSFGVVLYE 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 113/220 (51%), Gaps = 19/220 (8%)
Query: 531 LFDFETIVRATD---NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFK 586
           L    +IV   D    +T + K+GQG  G VY    +  GQE+A+++++       E   
Sbjct: 7   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 66
Query: 587 NEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
           NE+ ++ + ++ N+V  L   +  DE  +V EY+   SL  V+ +         + +   
Sbjct: 67  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAA 121
Query: 647 IC-GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +C    + L +LH +   ++IHRD+K+ NILL  + + K++DFG    F    T + +KR
Sbjct: 122 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKR 174
Query: 706 --VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
             +VGT  +M+PE      +  K D++S G++ +E + G+
Sbjct: 175 SXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 133
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV-VGTYGYMSPEYAM 719
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K        + +PE   
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 720 DGLFSVKSDVFSFGVLLLE 738
           +  FSV SDV+SFGV+L E
Sbjct: 191 ESKFSVASDVWSFGVVLYE 209

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 122/284 (42%), Gaps = 33/284 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L     +  E +F  E  +I+K 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            G  YL ++     IHRD+ A N LL         KI DFGMAR        +     + 
Sbjct: 151 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG 768
              +M PE  M+G+F+ K+D +SFGVLL E  S         SN E              
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------------- 253
Query: 769 KVLEMVDSSVDNYPANEVLRCIH-VGLLCVQENAEERPTMASVV 811
            VLE V S     P       ++ +   C Q   E+RP  A ++
Sbjct: 254 -VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 296

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 122/284 (42%), Gaps = 33/284 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L     +  E +F  E  +I+K 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            G  YL ++     IHRD+ A N LL         KI DFGMAR        +     + 
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG 768
              +M PE  M+G+F+ K+D +SFGVLL E  S         SN E              
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------------- 254
Query: 769 KVLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            VLE V S    + P N       +   C Q   E+RP  A ++
Sbjct: 255 -VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 297

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 122/284 (42%), Gaps = 33/284 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L     +  E +F  E  +I+K 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 105
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            G  YL ++     IHRD+ A N LL         KI DFGMAR        +     + 
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG 768
              +M PE  M+G+F+ K+D +SFGVLL E  S         SN E              
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------------- 268
Query: 769 KVLEMVDSSVDNYPANEVLRCIH-VGLLCVQENAEERPTMASVV 811
            VLE V S     P       ++ +   C Q   E+RP  A ++
Sbjct: 269 -VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 311

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 122/284 (42%), Gaps = 33/284 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L     +  E +F  E  +I+K 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            G  YL ++     IHRD+ A N LL         KI DFGMAR        +     + 
Sbjct: 151 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG 768
              +M PE  M+G+F+ K+D +SFGVLL E  S         SN E              
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------------- 253
Query: 769 KVLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            VLE V S    + P N       +   C Q   E+RP  A ++
Sbjct: 254 -VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 296

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 141/284 (49%), Gaps = 26/284 (9%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRN 599
           D++     +G G   +V        +E +A+KR++    Q  ++E   E++ +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD-----KARSSILNWQRRFNIICGIARGL 654
           +V      V  DE  LV + +   S+  +I       + +S +L+      I+  +  GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRV-VGTYG 711
            YLH++ +   IHRD+KA NILL ++ + +I+DFG++     GGD T    ++  VGT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 712 YMSPEYAMDGL--FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK 769
           +M+PE  M+ +  +  K+D++SFG+  +E  +G      YH    + +L  +  L  +  
Sbjct: 192 WMAPE-VMEQVRGYDFKADIWSFGITAIELATGA---APYHKYPPMKVL--MLTLQNDPP 245
Query: 770 VLE--MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            LE  + D  +         + I    LC+Q++ E+RPT A ++
Sbjct: 246 SLETGVQDKEMLKKYGKSFRKMIS---LCLQKDPEKRPTAAELL 286

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 13/219 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           +  T   +LG G FG+V  G+     ++AVK +   S    +EF  E + + KL H  LV
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLV 66
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +  G C +     +V EY+ N  L + +  ++    L   +   +   +  G+ +L    
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESH- 123
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT---YGYMSPEYA 718
             + IHRDL A N L+D+++  K+SDFGM R    DQ   +    VGT     + +PE  
Sbjct: 124 --QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVF 177
Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNL 757
               +S KSDV++FG+L+ E  S  K     ++N+E+ L
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL 216

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G FG VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + +      +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN 129
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD T            + +PE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TXTAHAGAKFPIKWTAPESLAYN 185
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 186 KFSIKSDVWAFGVLLWEIAT 205

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 122/284 (42%), Gaps = 33/284 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L     +  E +F  E  +I+K 
Sbjct: 38  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 97
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 98  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 157
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            G  YL ++     IHRD+ A N LL         KI DFGMAR        +     + 
Sbjct: 158 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 214
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG 768
              +M PE  M+G+F+ K+D +SFGVLL E  S         SN E              
Sbjct: 215 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------------- 260
Query: 769 KVLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            VLE V S    + P N       +   C Q   E+RP  A ++
Sbjct: 261 -VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 303

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 122/284 (42%), Gaps = 33/284 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSR-NSGQGIEEFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L    S Q   +F  E  +I+K 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKF 105
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            G  YL ++     IHRD+ A N LL         KI DFGMAR        +     + 
Sbjct: 166 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 222
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG 768
              +M PE  M+G+F+ K+D +SFGVLL E  S         SN E              
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------------- 268
Query: 769 KVLEMVDSSVDNYPANEVLRCIH-VGLLCVQENAEERPTMASVV 811
            VLE V S     P       ++ +   C Q   E+RP  A ++
Sbjct: 269 -VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 311

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 126/294 (42%), Gaps = 35/294 (11%)
Query: 533 DFETIVRATDNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EF 585
           D + + R   N T    LG G FG VY+G++          ++AVK L     +  E +F
Sbjct: 40  DLKEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 97
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQ 641
             E  +I+K  H+N+VR +G  ++   + ++ E M    L S + +     ++ S L   
Sbjct: 98  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 157
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQ 698
              ++   IA G  YL ++     IHRD+ A N LL         KI DFGMAR      
Sbjct: 158 DLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 214
Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
             +     +    +M PE  M+G+F+ K+D +SFGVLL E  S         SN E    
Sbjct: 215 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---- 270
Query: 759 GHVWRLWKEGKVLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
                      VLE V S    + P N       +   C Q   E+RP  A ++
Sbjct: 271 -----------VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 313

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 121/265 (45%), Gaps = 23/265 (8%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           + T   +LG G FG+V  G+     ++A+K +   S    +EF  E +++  L H  LV+
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C +     ++ EYM N  L + +  +        Q+   +   +   + YL     
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK-- 139
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
            + +HRDL A N L++ +   K+SDFG++R +  D  E ++        +  PE  M   
Sbjct: 140 -QFLHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEETSSVGSKFPVRWSPPEVLMYSK 197
Query: 723 FSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY 781
           FS KSD+++FGVL+ E  S GK     + ++     +    RL++              +
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP-------------H 244
Query: 782 PANEVLRCIHVGLLCVQENAEERPT 806
            A+E +  I     C  E A+ERPT
Sbjct: 245 LASEKVYTIMYS--CWHEKADERPT 267

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + +      +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN 129
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYN 185
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 186 KFSIKSDVWAFGVLLWEIAT 205

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 129/295 (43%), Gaps = 37/295 (12%)
Query: 533 DFETIVRATDNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EF 585
           D + + R   N T    LG G FG VY+G++          ++AVK L     +  E +F
Sbjct: 64  DLKEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 121
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQ 641
             E  +I+K  H+N+VR +G  ++   + ++ E M    L S + +     ++ S L   
Sbjct: 122 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 181
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQ 698
              ++   IA G  YL ++     IHRD+ A N LL         KI DFGMAR      
Sbjct: 182 DLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG 238
Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
             +     +    +M PE  M+G+F+ K+D +SFGVLL E  S                L
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----------------L 282
Query: 759 GHVWRLWKEGK-VLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
           G++    K  + VLE V S    + P N       +   C Q   E+RP  A ++
Sbjct: 283 GYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 337

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 126/294 (42%), Gaps = 35/294 (11%)
Query: 533 DFETIVRATDNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EF 585
           D + + R   N T    LG G FG VY+G++          ++AVK L     +  E +F
Sbjct: 41  DLKEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 98
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQ 641
             E  +I+K  H+N+VR +G  ++   + ++ E M    L S + +     ++ S L   
Sbjct: 99  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 158
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQ 698
              ++   IA G  YL ++     IHRD+ A N LL         KI DFGMAR      
Sbjct: 159 DLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG 215
Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
             +     +    +M PE  M+G+F+ K+D +SFGVLL E  S         SN E    
Sbjct: 216 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---- 271
Query: 759 GHVWRLWKEGKVLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
                      VLE V S    + P N       +   C Q   E+RP  A ++
Sbjct: 272 -----------VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 314

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 126/294 (42%), Gaps = 35/294 (11%)
Query: 533 DFETIVRATDNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EF 585
           D + + R   N T    LG G FG VY+G++          ++AVK L     +  E +F
Sbjct: 50  DLKEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 107
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQ 641
             E  +I+K  H+N+VR +G  ++   + ++ E M    L S + +     ++ S L   
Sbjct: 108 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 167
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQ 698
              ++   IA G  YL ++     IHRD+ A N LL         KI DFGMAR      
Sbjct: 168 DLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 224
Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
             +     +    +M PE  M+G+F+ K+D +SFGVLL E  S         SN E    
Sbjct: 225 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---- 280
Query: 759 GHVWRLWKEGKVLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
                      VLE V S    + P N       +   C Q   E+RP  A ++
Sbjct: 281 -----------VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 323

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 122/268 (45%), Gaps = 29/268 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           + T   +LG G FG+V  G+     ++A+K +   S    +EF  E +++  L H  LV+
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C +     ++ EYM N  L + +  +        Q+   +   +   + YL     
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK-- 139
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT---YGYMSPEYAM 719
            + +HRDL A N L++ +   K+SDFG++R    D+   +    VG+     +  PE  M
Sbjct: 140 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLM 194
Query: 720 DGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
              FS KSD+++FGVL+ E  S GK     + ++     +    RL++            
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP----------- 243
Query: 779 DNYPANEVLRCIHVGLLCVQENAEERPT 806
             + A+E +  I     C  E A+ERPT
Sbjct: 244 --HLASEKVYTIMYS--CWHEKADERPT 267

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 109/202 (53%), Gaps = 12/202 (5%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           +T + K+GQG  G VY    +  GQE+A+++++       E   NE+ ++ + ++ N+V 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLHQDS 661
            L   +  DE  +V EY+   SL  V+ +         + +   +C    + L +LH + 
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHSN- 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
             ++IHR++K+ NILL  + + K++DFG       +Q++++T  +VGT  +M+PE     
Sbjct: 137 --QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRK 192
Query: 722 LFSVKSDVFSFGVLLLETVSGK 743
            +  K D++S G++ +E + G+
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 15/197 (7%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAV-KRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           +LG G FG VYK +  E   +A  K +   S + +E++  E+ ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG-IARGLLYLHQDSRFRII 666
              +   ++ E+    ++D+V+ +  R      + +  ++C      L YLH +   +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHDN---KII 157
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM-----DG 721
           HRDLKA NIL   +   K++DFG++      +T Q     +GT  +M+PE  M     D 
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 722 LFSVKSDVFSFGVLLLE 738
            +  K+DV+S G+ L+E
Sbjct: 216 PYDYKADVWSLGITLIE 232

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 131/274 (47%), Gaps = 29/274 (10%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V +GRL   G++   +A+K L    + +   EF +E  ++ + +H N++RL 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G        M++ E+MEN +LDS  F +         +   ++ GIA G+ YL + S   
Sbjct: 82  GVVTNSMPVMILTEFMENGALDS--FLRLNDGQFTVIQLVGMLRGIASGMRYLAEMS--- 136
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG---TYGYMSPEYAMDG 721
            +HRDL A NIL++  +  K+SDFG++R    + ++      +G      + +PE     
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY 781
            F+  SD +S+G+++ E +S  + R ++  +N+               V+  ++      
Sbjct: 197 KFTSASDAWSYGIVMWEVMSFGE-RPYWDMSNQ--------------DVINAIEQDYRLP 241
Query: 782 PANEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
           P  +    +H  +L C Q++   RP    VV  L
Sbjct: 242 PPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL 275

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 77
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + +      +   I+  + YL + +
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 137 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 192
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 193 KFSIKSDVWAFGVLLWEIAT 212

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 318
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + N      +   I+  + YL + +
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLLYMATQISSAMEYLEKKN 377
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHR+L A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 378 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 433
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 434 KFSIKSDVWAFGVLLWEIAT 453

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + +      +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN 131
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 604 LGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            G C     +   L+ E++   SL   +  +     ++  +       I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYLGTK- 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV-VGTYGYMSPEYAMD 720
             R IHRDL   NIL++ E   KI DFG+ ++   D+     K        + +PE   +
Sbjct: 137 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 721 GLFSVKSDVFSFGVLLLE 738
             FSV SDV+SFGV+L E
Sbjct: 195 SKFSVASDVWSFGVVLYE 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + +      +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN 131
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + +      +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN 131
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + +      +   I+  + YL + +
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN 131
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 132 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 187
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 131/275 (47%), Gaps = 31/275 (11%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V +GRL   G++   +A+K L    + +   EF +E  ++ + +H N++RL 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G        M++ E+MEN +LDS  F +         +   ++ GIA G+ YL + S   
Sbjct: 84  GVVTNSMPVMILTEFMENGALDS--FLRLNDGQFTVIQLVGMLRGIASGMRYLAEMS--- 138
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIF---GGDQTEQNTKRVVGTYGYMSPEYAMDG 721
            +HRDL A NIL++  +  K+SDFG++R       D TE ++        + +PE     
Sbjct: 139 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE-LNLLGHVWRLWKEGKVLEMVDSSVDN 780
            F+  SD +S+G+++ E +S  +   +  SN + +N +   +RL                
Sbjct: 199 KFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRL---------------- 242
Query: 781 YPANEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
            P  +    +H  +L C Q++   RP    VV  L
Sbjct: 243 PPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSAL 277

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 106/198 (53%), Gaps = 10/198 (5%)
Query: 547 YNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           Y K+G+G  GIV   R    G+++AVK +     Q  E   NEV ++   QH N+V +  
Sbjct: 50  YVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
             +  +E  ++ E+++  +L  ++  + R   LN ++   +   + + L YLH      +
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIV-SQVR---LNEEQIATVCEAVLQALAYLHAQG---V 162
Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           IHRD+K+ +ILL  +   K+SDFG       D  ++  K +VGT  +M+PE     L++ 
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KXLVGTPYWMAPEVISRSLYAT 220
Query: 726 KSDVFSFGVLLLETVSGK 743
           + D++S G++++E V G+
Sbjct: 221 EVDIWSLGIMVIEMVDGE 238

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 122/268 (45%), Gaps = 29/268 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           + T   +LG G FG+V  G+     ++A+K +   S    +EF  E +++  L H  LV+
Sbjct: 9   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 67
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C +     ++ EYM N  L + +  +        Q+   +   +   + YL     
Sbjct: 68  LYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK-- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT---YGYMSPEYAM 719
            + +HRDL A N L++ +   K+SDFG++R    D+   +    VG+     +  PE  M
Sbjct: 124 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLM 178
Query: 720 DGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
              FS KSD+++FGVL+ E  S GK     + ++     +    RL++            
Sbjct: 179 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP----------- 227
Query: 779 DNYPANEVLRCIHVGLLCVQENAEERPT 806
             + A+E +  I     C  E A+ERPT
Sbjct: 228 --HLASEKVYTIMYS--CWHEKADERPT 251

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 123/267 (46%), Gaps = 27/267 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           + T   +LG G FG+V  G+     ++A+K +   S    +EF  E +++  L H  LV+
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C +     ++ EYM N  L + +  +        Q+   +   +   + YL     
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK-- 124
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMD 720
            + +HRDL A N L++ +   K+SDFG++R    D+  + + +K  V    +  PE  M 
Sbjct: 125 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPV---RWSPPEVLMY 180
Query: 721 GLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD 779
             FS KSD+++FGVL+ E  S GK     + ++     +    RL++             
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP------------ 228
Query: 780 NYPANEVLRCIHVGLLCVQENAEERPT 806
            + A+E +  I     C  E A+ERPT
Sbjct: 229 -HLASEKVYTIMYS--CWHEKADERPT 252

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 122/284 (42%), Gaps = 33/284 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           N T    LG G FG VY+G++          ++AVK L     +  E +F  E  +I+K 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIA 651
            H+N+VR +G  ++   + ++ E M    L S + +     ++ S L      ++   IA
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            G  YL ++     IHRD+ A N LL         KI DFGMA+        +     + 
Sbjct: 152 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAML 208
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG 768
              +M PE  M+G+F+ K+D +SFGVLL E  S         SN E              
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------------- 254
Query: 769 KVLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            VLE V S    + P N       +   C Q   E+RP  A ++
Sbjct: 255 -VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 297

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 122/268 (45%), Gaps = 29/268 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           + T   +LG G FG+V  G+     ++A+K +   S    +EF  E +++  L H  LV+
Sbjct: 16  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 74
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C +     ++ EYM N  L + +  +        Q+   +   +   + YL     
Sbjct: 75  LYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK-- 130
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT---YGYMSPEYAM 719
            + +HRDL A N L++ +   K+SDFG++R    D+   +    VG+     +  PE  M
Sbjct: 131 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLM 185
Query: 720 DGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
              FS KSD+++FGVL+ E  S GK     + ++     +    RL++            
Sbjct: 186 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP----------- 234
Query: 779 DNYPANEVLRCIHVGLLCVQENAEERPT 806
             + A+E +  I     C  E A+ERPT
Sbjct: 235 --HLASEKVYTIMYS--CWHEKADERPT 258

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 110/217 (50%), Gaps = 18/217 (8%)
Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           +LG G FG VYK +  E G   A K +   S + +E++  E+ ++A   H  +V+LLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLHQDSRFRII 666
               +  ++ E+    ++D+++ +  R      + +  ++C  +   L +LH     RII
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHSK---RII 131
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM-----DG 721
           HRDLKA N+L+  E   +++DFG++      +T Q     +GT  +M+PE  M     D 
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
            +  K+D++S G+ L+E    +     +H  N + +L
Sbjct: 190 PYDYKADIWSLGITLIEMAQIEPP---HHELNPMRVL 223

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 133
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV-VGTYGYMSPEYAM 719
              R IHRDL   NIL++ E   KI DFG+ ++   D+     K        + +PE   
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 720 DGLFSVKSDVFSFGVLLLE 738
           +  FSV SDV+SFGV+L E
Sbjct: 191 ESKFSVASDVWSFGVVLYE 209

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 122/268 (45%), Gaps = 29/268 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           + T   +LG G FG+V  G+     ++A+K +   S    +EF  E +++  L H  LV+
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C +     ++ EYM N  L + +  +        Q+   +   +   + YL     
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK-- 119
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT---YGYMSPEYAM 719
            + +HRDL A N L++ +   K+SDFG++R    D+   +    VG+     +  PE  M
Sbjct: 120 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLM 174
Query: 720 DGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
              FS KSD+++FGVL+ E  S GK     + ++     +    RL++            
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP----------- 223
Query: 779 DNYPANEVLRCIHVGLLCVQENAEERPT 806
             + A+E +  I     C  E A+ERPT
Sbjct: 224 --HLASEKVYTIMYS--CWHEKADERPT 247

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 122/268 (45%), Gaps = 29/268 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           + T   +LG G FG+V  G+     ++A+K +   S    +EF  E +++  L H  LV+
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G C +     ++ EYM N  L + +  +        Q+   +   +   + YL     
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK-- 124
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT---YGYMSPEYAM 719
            + +HRDL A N L++ +   K+SDFG++R    D+   +    VG+     +  PE  M
Sbjct: 125 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLM 179
Query: 720 DGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
              FS KSD+++FGVL+ E  S GK     + ++     +    RL++            
Sbjct: 180 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP----------- 228
Query: 779 DNYPANEVLRCIHVGLLCVQENAEERPT 806
             + A+E +  I     C  E A+ERPT
Sbjct: 229 --HLASEKVYTIMYS--CWHEKADERPT 252

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 135/273 (49%), Gaps = 22/273 (8%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS---RNSGQGIEEFKNEVRLIAKLQHR 598
           NF    K+G+G F  VY+   LL+G  +A+K++        +   +   E+ L+ +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD-KARSSILNWQRRFNIICGIARGLLYL 657
           N+++     +E +E  +V E  +   L  +I   K +  ++  +  +     +   L ++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H  SR R++HRD+K +N+ +      K+ D G+ R F    T  ++  +VGT  YMSPE 
Sbjct: 153 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 207
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
             +  ++ KSD++S G LL E  + +    FY   +++NL    + L K+ +  +     
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQS--PFY--GDKMNL----YSLCKKIEQCDYPPLP 259
Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASV 810
            D+Y  +E LR   +  +C+  + E+RP +  V
Sbjct: 260 SDHY--SEELR--QLVNMCINPDPEKRPDVTYV 288

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  + +      +   I+  + YL + +
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN 129
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 130 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI-KWTAPESLAYN 185
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 186 KFSIKSDVWAFGVLLWEIAT 205

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 549 KLGQGGFGIVYKGRL--LE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG+G FG V   R   L+   G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+ 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 604 LGCCVEMDEK--MLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
            G C     +   L+ EY+   SL D +   K R   +   +  + IC   +G+ YL   
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC---KGMEYLGTK 134
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV-VGTYGYMSPEYAM 719
              R IHR+L   NIL++ E   KI DFG+ ++   D+     K        + +PE   
Sbjct: 135 ---RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 720 DGLFSVKSDVFSFGVLLLE 738
           +  FSV SDV+SFGV+L E
Sbjct: 192 ESKFSVASDVWSFGVVLYE 210

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 110/217 (50%), Gaps = 18/217 (8%)
Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           +LG G FG VYK +  E G   A K +   S + +E++  E+ ++A   H  +V+LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLHQDSRFRII 666
               +  ++ E+    ++D+++ +  R      + +  ++C  +   L +LH     RII
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHSK---RII 139
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM-----DG 721
           HRDLKA N+L+  E   +++DFG++      +T Q     +GT  +M+PE  M     D 
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
            +  K+D++S G+ L+E    +     +H  N + +L
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPP---HHELNPMRVL 231

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 125/271 (46%), Gaps = 29/271 (10%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRL-SRNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  G L L G+    +A+K L S  + +   +F +E  ++ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G   +    M++ E+MEN SLDS  F +         +   ++ GIA G+ YL   +   
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDS--FLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 129
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG---TYGYMSPEYAMDG 721
            +HR L A NIL++  +  K+SDFG++R    D ++      +G      + +PE     
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY 781
            F+  SDV+S+G+++ E +S    R ++   N+               V+  ++      
Sbjct: 190 KFTSASDVWSYGIVMWEVMS-YGERPYWDMTNQ--------------DVINAIEQDYRLP 234
Query: 782 PANEVLRCIHVGLL-CVQENAEERPTMASVV 811
           P  +    +H  +L C Q++   RP    +V
Sbjct: 235 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 265

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 114/234 (48%), Gaps = 18/234 (7%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQ-GIE-EFKNEVRLIAKLQ 596
           AT  +    ++G G +G VYK R    G  +A+K +   +G+ G+      EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 597 ---HRNLVRLLGCCV--EMDEKMLVYEYMENRSLD-SVIFDKARSSILNWQRRFNIICGI 650
              H N+VRL+  C     D ++ V    E+   D     DKA    L  +   +++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
            RGL +LH +    I+HRDLK  NIL+    T K++DFG+ARI+     +     VV T 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALAPVVVTL 175
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            Y +PE  +   ++   D++S G +  E     + +  +  N+E + LG ++ L
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMF---RRKPLFCGNSEADQLGKIFDL 226

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCV 608
           +G G +G VYKGR ++  ++A  ++   +G   EE K E+ ++ K   HRN+    G  +
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 609 E-----MDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           +     MD+++ LV E+    S+  +I +  + + L  +    I   I RGL +LHQ   
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQ--- 147
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM--- 719
            ++IHRD+K  N+LL +    K+ DFG++     D+T       +GT  +M+PE      
Sbjct: 148 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 205
Query: 720 --DGLFSVKSDVFSFGVLLLETVSG 742
             D  +  KSD++S G+  +E   G
Sbjct: 206 NPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           + T  +KLG G +G VY+G   +    +AVK L  ++ + +EEF  E  ++ +++H NLV
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 279
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +LLG C       ++ E+M   +L   + +  R  +      + +   I+  + YL + +
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-MATQISSAMEYLEKKN 338
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHR+L A N L+ +    K++DFG++R+  GD    +         + +PE     
Sbjct: 339 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYN 394
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            FS+KSDV++FGVLL E  +
Sbjct: 395 KFSIKSDVWAFGVLLWEIAT 414

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 111/211 (52%), Gaps = 13/211 (6%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    ++++        LD V   +     +  Q   N    I
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYV---REHKDNIGSQYLLNWCVQI 127
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      
Sbjct: 128 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 118/236 (50%), Gaps = 19/236 (8%)
Query: 518 DYSADKTDDL------ELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI- 569
           DY    T++L      E P      I++ T+ F     LG G FG VYKG  + EG+++ 
Sbjct: 11  DYDIPTTENLYFQGSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVK 69
Query: 570 ---AVKRLSR-NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL 625
              A+K L    S +  +E  +E  ++A + + ++ RLLG C+    +++         L
Sbjct: 70  IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLL 129
Query: 626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI 685
           D V   +     +  Q   N    IA+G+ YL      R++HRDL A N+L+      KI
Sbjct: 130 DYV---REHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKI 183
Query: 686 SDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
           +DFG+A++ G ++ E + +       +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 184 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 114/234 (48%), Gaps = 18/234 (7%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQ-GIE-EFKNEVRLIAKLQ 596
           AT  +    ++G G +G VYK R    G  +A+K +   +G+ G+      EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 597 ---HRNLVRLLGCCV--EMDEKMLVYEYMENRSLD-SVIFDKARSSILNWQRRFNIICGI 650
              H N+VRL+  C     D ++ V    E+   D     DKA    L  +   +++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
            RGL +LH +    I+HRDLK  NIL+    T K++DFG+ARI+     +     VV T 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALDPVVVTL 175
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            Y +PE  +   ++   D++S G +  E     + +  +  N+E + LG ++ L
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMF---RRKPLFCGNSEADQLGKIFDL 226

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 111/208 (53%), Gaps = 21/208 (10%)
Query: 550 LGQGGFGIVYKGRLLE----GQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+G FG V +G L +      ++AVK  +L  +S + IEEF +E   +    H N++RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 604 LGCCVEMDEK-----MLVYEYMENRSLDS-VIFDKARS--SILNWQRRFNIICGIARGLL 655
           LG C+EM  +     M++  +M+   L + +++ +  +    +  Q     +  IA G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA-RIFGGDQTEQNTKRVVGT-YGYM 713
           YL   S    +HRDL A N +L  +MT  ++DFG++ +I+ GD   Q   R+      ++
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG--RIAKMPVKWI 216
Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVS 741
           + E   D +++ KSDV++FGV + E  +
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 110/211 (52%), Gaps = 13/211 (6%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYV---REHKDNIGSQYLLNWCVQI 126
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 15/197 (7%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAV-KRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           +LG G FG VYK +  E   +A  K +   S + +E++  E+ ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG-IARGLLYLHQDSRFRII 666
              +   ++ E+    ++D+V+ +  R      + +  ++C      L YLH +   +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHDN---KII 157
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM-----DG 721
           HRDLKA NIL   +   K++DFG++      +  Q     +GT  +M+PE  M     D 
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDXFIGTPYWMAPEVVMCETSKDR 215
Query: 722 LFSVKSDVFSFGVLLLE 738
            +  K+DV+S G+ L+E
Sbjct: 216 PYDYKADVWSLGITLIE 232

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 101/197 (51%), Gaps = 15/197 (7%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAV-KRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           +LG G FG VYK +  E   +A  K +   S + +E++  E+ ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG-IARGLLYLHQDSRFRII 666
              +   ++ E+    ++D+V+ +  R      + +  ++C      L YLH +   +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHDN---KII 157
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM-----DG 721
           HRDLKA NIL   +   K++DFG++      +  Q     +GT  +M+PE  M     D 
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 722 LFSVKSDVFSFGVLLLE 738
            +  K+DV+S G+ L+E
Sbjct: 216 PYDYKADVWSLGITLIE 232

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 550 LGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+G FG V   R        G+++AVK L   SG   I + K E+ ++  L H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 604 LGCCVE--MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            G C E   +   L+ E++ + SL   +  K ++ I N +++      I +G+ YL   S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKI-NLKQQLKYAVQICKGMDYL--GS 144
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK--RVVGTYGYMSPEYAM 719
           R + +HRDL A N+L++ E   KI DFG+ +    D+     K  R    + Y +PE  M
Sbjct: 145 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 202
Query: 720 DGLFSVKSDVFSFGVLLLETVS 741
              F + SDV+SFGV L E ++
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 111/211 (52%), Gaps = 13/211 (6%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    ++++        LD V   +     +  Q   N    I
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 128
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 111/211 (52%), Gaps = 13/211 (6%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 15  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    ++++        LD V   +     +  Q   N    I
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 130
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      
Sbjct: 131 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 187
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 550 LGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRL 603
           LG+G FG V   R        G+++AVK L   SG   I + K E+ ++  L H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 604 LGCCVE--MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            G C E   +   L+ E++ + SL   +  K ++ I N +++      I +G+ YL   S
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKI-NLKQQLKYAVQICKGMDYL--GS 132
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK--RVVGTYGYMSPEYAM 719
           R + +HRDL A N+L++ E   KI DFG+ +    D+     K  R    + Y +PE  M
Sbjct: 133 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 190
Query: 720 DGLFSVKSDVFSFGVLLLETVS 741
              F + SDV+SFGV L E ++
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 111/211 (52%), Gaps = 13/211 (6%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    ++++        LD V   +     +  Q   N    I
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 127
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      
Sbjct: 128 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 548 NKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRNLVRLLG 605
            ++G+G FG V+ GRL  +   +AVK         ++ +F  E R++ +  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
            C +     +V E ++    D + F +   + L  +    ++   A G+ YL        
Sbjct: 180 VCTQKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFG-GDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IHRDL A N L+ ++   KISDFGM+R    G        R V    + +PE    G +S
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPV-KWTAPEALNYGRYS 293
Query: 725 VKSDVFSFGVLLLETVS 741
            +SDV+SFG+LL ET S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 111/211 (52%), Gaps = 13/211 (6%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    ++++        LD V   +     +  Q   N    I
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 126
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 111/211 (52%), Gaps = 13/211 (6%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    ++++        LD V   +     +  Q   N    I
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 129
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 9/198 (4%)
Query: 550 LGQGGFGIVYKGRLLEGQ-EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           LG+G +GIVY GR L  Q  IA+K +     +  +    E+ L   L+H+N+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E     +  E +   SL +++  K      N Q        I  GL YLH +   +I+HR
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 669 DLKASNILLDK-EMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL--FSV 725
           D+K  N+L++      KISDFG ++   G      T+   GT  YM+PE    G   +  
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRGYGK 204
Query: 726 KSDVFSFGVLLLETVSGK 743
            +D++S G  ++E  +GK
Sbjct: 205 AADIWSLGCTIIEMATGK 222

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 114/234 (48%), Gaps = 18/234 (7%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQ-GIE-EFKNEVRLIAKLQ 596
           AT  +    ++G G +G VYK R    G  +A+K +   +G+ G+      EV L+ +L+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 597 ---HRNLVRLLGCCV--EMDEKMLVYEYMENRSLD-SVIFDKARSSILNWQRRFNIICGI 650
              H N+VRL+  C     D ++ V    E+   D     DKA    L  +   +++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
            RGL +LH +    I+HRDLK  NIL+    T K++DFG+ARI+     +     VV T 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALFPVVVTL 175
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            Y +PE  +   ++   D++S G +  E     + +  +  N+E + LG ++ L
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMF---RRKPLFCGNSEADQLGKIFDL 226

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 110/211 (52%), Gaps = 13/211 (6%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 126
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 110/211 (52%), Gaps = 13/211 (6%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 17  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 76  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 132
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      
Sbjct: 133 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 189
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 190 KWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 110/211 (52%), Gaps = 13/211 (6%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 128
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 110/211 (52%), Gaps = 13/211 (6%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 129
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 548 NKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRNLVRLLG 605
            ++G+G FG V+ GRL  +   +AVK         ++ +F  E R++ +  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
            C +     +V E ++    D + F +   + L  +    ++   A G+ YL        
Sbjct: 180 VCTQKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFG-GDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IHRDL A N L+ ++   KISDFGM+R    G        R V    + +PE    G +S
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV-KWTAPEALNYGRYS 293
Query: 725 VKSDVFSFGVLLLETVS 741
            +SDV+SFG+LL ET S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 111/214 (51%), Gaps = 19/214 (8%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    +++         LD V   K       +LNW       
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 123
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             IA+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +   
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 13/193 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           +G+G FG V  G    G ++AVK +  ++    + F  E  ++ +L+H NLV+LLG  VE
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 610 MDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
               + +V EYM   SL   +  + RS +L           +   + YL  ++    +HR
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 132
Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSD 728
           DL A N+L+ ++   K+SDFG+ +      + Q+T ++     + +PE   +  FS KSD
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREAAFSTKSD 187
Query: 729 VFSFGVLLLETVS 741
           V+SFG+LL E  S
Sbjct: 188 VWSFGILLWEIYS 200

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 110/211 (52%), Gaps = 13/211 (6%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 5   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 120
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      
Sbjct: 121 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 110/211 (52%), Gaps = 13/211 (6%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 129
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 111/214 (51%), Gaps = 19/214 (8%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 21  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    +++         LD V   K       +LNW       
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 133
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             IA+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +   
Sbjct: 134 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 190
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 191 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 9/198 (4%)
Query: 550 LGQGGFGIVYKGRLLEGQ-EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           LG+G +GIVY GR L  Q  IA+K +     +  +    E+ L   L+H+N+V+ LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E     +  E +   SL +++  K      N Q        I  GL YLH +   +I+HR
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 132
Query: 669 DLKASNILLDK-EMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL--FSV 725
           D+K  N+L++      KISDFG ++   G      T+   GT  YM+PE    G   +  
Sbjct: 133 DIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRGYGK 190
Query: 726 KSDVFSFGVLLLETVSGK 743
            +D++S G  ++E  +GK
Sbjct: 191 AADIWSLGCTIIEMATGK 208

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 111/214 (51%), Gaps = 19/214 (8%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    +++         LD V   K       +LNW       
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 126
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             IA+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +   
Sbjct: 127 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 110/211 (52%), Gaps = 13/211 (6%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 133
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      
Sbjct: 134 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 133/277 (48%), Gaps = 37/277 (13%)
Query: 550 LGQGGFGIVYKGRL-LEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           +G G FG V  GRL L G+    +A+K L    + +   +F  E  ++ +  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G        M+V E+MEN +LD+  F +         +   ++ GIA G+ YL   +   
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDA--FLRKHDGQFTVIQLVGMLRGIAAGMRYL---ADMG 165
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEYA 718
            +HRDL A NIL++  +  K+SDFG++R+      E + + V  T G      + +PE  
Sbjct: 166 YVHRDLAARNILVNSNLVCKVSDFGLSRVI-----EDDPEAVYTTTGGKIPVRWTAPEAI 220
Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
               F+  SDV+S+G+++ E +S    R ++  +N+      V +  +EG  L     + 
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMS-YGERPYWDMSNQ-----DVIKAIEEGYRL----PAP 270
Query: 779 DNYPANEVLRCIHVGLL-CVQENAEERPTMASVVLML 814
            + PA      +H  +L C Q+   ERP    +V +L
Sbjct: 271 MDCPAG-----LHQLMLDCWQKERAERPKFEQIVGIL 302

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 113/233 (48%), Gaps = 39/233 (16%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ 596
           +R   +F +   LGQG FG V K R  L+ +  A+K++ R++ + +    +EV L+A L 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLN 60
Query: 597 HRNLVRLLGCCVE----------MDEKMLVY---EYMENRSLDSVIFDKARSSILNWQR- 642
           H+ +VR     +E          + +K  ++   EY ENR+L    +D   S  LN QR 
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTL----YDLIHSENLNQQRD 116
Query: 643 -RFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-------IF 694
             + +   I   L Y+H      IIHRDLK  NI +D+    KI DFG+A+       I 
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 695 GGDQ-----TEQNTKRVVGTYGYMSPEYAMDGL--FSVKSDVFSFGVLLLETV 740
             D      +  N    +GT  Y++ E  +DG   ++ K D++S G++  E +
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 13/193 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           +G+G FG V  G    G ++AVK +  ++    + F  E  ++ +L+H NLV+LLG  VE
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 610 MDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
               + +V EYM   SL   +  + RS +L           +   + YL  ++    +HR
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSD 728
           DL A N+L+ ++   K+SDFG+ +      + Q+T ++     + +PE   +  FS KSD
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFSTKSD 368
Query: 729 VFSFGVLLLETVS 741
           V+SFG+LL E  S
Sbjct: 369 VWSFGILLWEIYS 381

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 109/211 (51%), Gaps = 13/211 (6%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 8   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      
Sbjct: 124 AEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 180
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 181 KWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 111/220 (50%), Gaps = 23/220 (10%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQG--IEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G FG V K +  +  QE AVK +++ S +         EV L+ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
             +     +V E      L   I  + R S  +  R   II  +  G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 667 HRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRV--VGTYGYMSPEYAMDG 721
           HRDLK  NILL   +K+   KI DFG++  F     +QNTK    +GT  Y++PE  + G
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTKMKDRIGTAYYIAPE-VLRG 197
Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
            +  K DV+S GV+L   +SG      ++  NE ++L  V
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPP---FYGKNEYDILKRV 234

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 111/214 (51%), Gaps = 19/214 (8%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    ++++        LD V   K       +LNW       
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------C 125
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             IA+G+ YL      R++HRDL A N+L+      KI+DFG A++ G ++ E + +   
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 105/203 (51%), Gaps = 14/203 (6%)
Query: 544 FTDYNKLGQGGFGIV-YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
             ++ K+G+G  GIV        G+++AVK++     Q  E   NEV ++    H N+V 
Sbjct: 47  LANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVD 106
Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           +    +  DE  +V E++E  +L  ++      + +N ++   +   + R L YLH    
Sbjct: 107 MYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQG- 161
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSPEYAMD 720
             +IHRD+K+ +ILL  +   K+SDFG    F    +++  KR  +VGT  +M+PE    
Sbjct: 162 --VIHRDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKXLVGTPYWMAPEVISR 215
Query: 721 GLFSVKSDVFSFGVLLLETVSGK 743
             +  + D++S G++++E + G+
Sbjct: 216 LPYGTEVDIWSLGIMVIEMIDGE 238

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQE-----IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRL 603
           LG G FG VYKG  +   E     +A+K L  N S +  +E  +E  ++A +    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           LG C+    +++         LD V  ++ R   L  Q   N    IA+G+ YL      
Sbjct: 85  LGICLTSTVQLVTQLMPYGCLLDHVRENRGR---LGSQDLLNWCMQIAKGMSYLED---V 138
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           R++HRDL A N+L+      KI+DFG+AR+   D+TE +         +M+ E  +   F
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRF 198
Query: 724 SVKSDVFSFGVLLLETVS 741
           + +SDV+S+GV + E ++
Sbjct: 199 THQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 110/211 (52%), Gaps = 13/211 (6%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 15  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    ++++        LD V   +     +  Q   N    I
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 130
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ YL      R++HRDL A N+L+      KI+DFG A++ G ++ E + +      
Sbjct: 131 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 187
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 112/220 (50%), Gaps = 23/220 (10%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEE--FKNEVRLIAKLQHRNLVRLLGC 606
           LG+G FG V K +  +  QE AVK +++ S +  +      EV L+ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
             +     +V E      L   I  + R S  +  R   II  +  G+ Y+H+ +   I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMHKHN---IV 143
Query: 667 HRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRV--VGTYGYMSPEYAMDG 721
           HRDLK  NILL   +K+   KI DFG++  F     +QNTK    +GT  Y++PE  + G
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTKMKDRIGTAYYIAPE-VLRG 197
Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
            +  K DV+S GV+L   +SG      ++  NE ++L  V
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPP---FYGKNEYDILKRV 234

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 550 LGQGGFGIVYKGRLLEG---QEIAVKRLSR-NSGQGIEEFKNEVRLIAKL-QHRNLVRLL 604
           +G+G FG V K R+ +     + A+KR+    S     +F  E+ ++ KL  H N++ LL
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 605 GCCVEMDEKMLVYEYMENRSL-------------DSVIFDKARSSILNWQRRFNIICGIA 651
           G C       L  EY  + +L              +     + +S L+ Q+  +    +A
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG 711
           RG+ YL Q    + IHRDL A NIL+ +    KI+DFG++R       E   K+ +G   
Sbjct: 143 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLP 194
Query: 712 --YMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
             +M+ E     +++  SDV+S+GVLL E VS
Sbjct: 195 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 111/214 (51%), Gaps = 19/214 (8%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    ++++        LD V   K       +LNW       
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------C 125
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             IA+G+ YL      R++HRDL A N+L+      KI+DFG A++ G ++ E + +   
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 550 LGQGGFGIVYKGRLLEG---QEIAVKRLSR-NSGQGIEEFKNEVRLIAKL-QHRNLVRLL 604
           +G+G FG V K R+ +     + A+KR+    S     +F  E+ ++ KL  H N++ LL
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 605 GCCVEMDEKMLVYEYMENRSL-------------DSVIFDKARSSILNWQRRFNIICGIA 651
           G C       L  EY  + +L              +     + +S L+ Q+  +    +A
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG 711
           RG+ YL Q    + IHRDL A NIL+ +    KI+DFG++R       E   K+ +G   
Sbjct: 153 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLP 204
Query: 712 --YMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
             +M+ E     +++  SDV+S+GVLL E VS
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELN 756
             +NT        +M+PE   D +++ +SDV+SFGVL+ E  T+ G    G         
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-------- 263
Query: 757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            +  +++L KEG  +        + PAN       +   C      +RPT   +V
Sbjct: 264 PVEELFKLLKEGHRM--------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 110/214 (51%), Gaps = 19/214 (8%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    +++         LD V   K       +LNW       
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 125
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             IA+G+ YL      R++HRDL A N+L+      KI+DFG A++ G ++ E + +   
Sbjct: 126 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 26/209 (12%)
Query: 551 GQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC---- 606
            +G FG V+K +LL  + +AVK       Q  +  + EV  +  ++H N+++ +G     
Sbjct: 33  ARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRG 90
Query: 607 -CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD----- 660
             V++D   L+  + E  SL     D  ++++++W    +I   +ARGL YLH+D     
Sbjct: 91  TSVDVD-LWLITAFHEKGSLS----DFLKANVVSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 661 --SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
              +  I HRD+K+ N+LL   +T  I+DFG+A  F   ++  +T   VGT  YM+PE  
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE-V 204
Query: 719 MDGLFSVKSDVF------SFGVLLLETVS 741
           ++G  + + D F      + G++L E  S
Sbjct: 205 LEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 110/214 (51%), Gaps = 19/214 (8%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    +++         LD V   K       +LNW       
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 123
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             IA+G+ YL      R++HRDL A N+L+      KI+DFG A++ G ++ E + +   
Sbjct: 124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 180
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 133/298 (44%), Gaps = 47/298 (15%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR---LLEGQE---IAVKRLSRNSGQGIE-EFKNEVRLIAK 594
           +N      +G+G FG V++ R   LL  +    +AVK L   +   ++ +F+ E  L+A+
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLD----------------SVIFDKARSS-- 636
             + N+V+LLG C       L++EYM    L+                S +  +AR S  
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 637 ---ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR- 692
               L+   +  I   +A G+ YL   S  + +HRDL   N L+ + M  KI+DFG++R 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 693 IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSN 752
           I+  D  + +    +    +M PE      ++ +SDV+++GV+L E  S           
Sbjct: 224 IYSADYYKADGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG--------- 273
Query: 753 NELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASV 810
                L   + +  E  +  + D ++   P N  L   ++  LC  +   +RP+  S+
Sbjct: 274 -----LQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 326

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 110/214 (51%), Gaps = 19/214 (8%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    +++         LD V   K       +LNW       
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 130
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             IA+G+ YL      R++HRDL A N+L+      KI+DFG A++ G ++ E + +   
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGK 187
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 112/233 (48%), Gaps = 39/233 (16%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ 596
           +R   +F +   LGQG FG V K R  L+ +  A+K++ R++ + +    +EV L+A L 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLN 60
Query: 597 HRNLVRLLGCCVE----------MDEKMLVY---EYMENRSLDSVIFDKARSSILNWQR- 642
           H+ +VR     +E          + +K  ++   EY ENR+L    +D   S  LN QR 
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTL----YDLIHSENLNQQRD 116
Query: 643 -RFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-------IF 694
             + +   I   L Y+H      IIHR+LK  NI +D+    KI DFG+A+       I 
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 695 GGDQ-----TEQNTKRVVGTYGYMSPEYAMDGL--FSVKSDVFSFGVLLLETV 740
             D      +  N    +GT  Y++ E  +DG   ++ K D +S G++  E +
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAXYVATE-VLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 110/215 (51%), Gaps = 23/215 (10%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRL--SRNSGQGIEEFKNEVRLIAKL 595
           ++ + +    K+G+G FG     +  E G++  +K +  SR S +  EE + EV ++A +
Sbjct: 21  QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM 80
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSL-------DSVIFDKARSSILNWQRRFNIIC 648
           +H N+V+      E     +V +Y E   L         V+F +    IL+W   F  IC
Sbjct: 81  KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE--DQILDW---FVQIC 135
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
                L   H   R +I+HRD+K+ NI L K+ T ++ DFG+AR+   + T +  +  +G
Sbjct: 136 -----LALKHVHDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIG 187
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           T  Y+SPE   +  ++ KSD+++ G +L E  + K
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 13/193 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           +G+G FG V  G    G ++AVK +  ++    + F  E  ++ +L+H NLV+LLG  VE
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 610 MDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
               + +V EYM   SL   +  + RS +L           +   + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSD 728
           DL A N+L+ ++   K+SDFG+ +      + Q+T ++     + +PE   +  FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFSTKSD 181
Query: 729 VFSFGVLLLETVS 741
           V+SFG+LL E  S
Sbjct: 182 VWSFGILLWEIYS 194

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 101/193 (52%), Gaps = 13/193 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           +G+G FG V  G    G ++AVK +  ++    + F  E  ++ +L+H NLV+LLG  VE
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 610 MDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
               + +V EYM   SL   +  + RS +L           +   + YL  ++    +HR
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSD 728
           DL A N+L+ ++   K+SDFG+ +      + Q+T ++     + +PE   +  FS KSD
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFSTKSD 196
Query: 729 VFSFGVLLLETVS 741
           V+SFG+LL E  S
Sbjct: 197 VWSFGILLWEIYS 209

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 119/238 (50%), Gaps = 25/238 (10%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRNSGQ------GIEEFKNE 588
           + RA   +    ++G+G +G V+K R L+  G+ +A+KR+   +G+       I E    
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV- 64
Query: 589 VRLIAKLQHRNLVRLLGCCV----EMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRR 643
           +R +   +H N+VRL   C     + + K+ LV+E+++     +   DK     +  +  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL--TTYLDKVPEPGVPTETI 122
Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
            +++  + RGL +LH     R++HRDLK  NIL+      K++DFG+ARI+     +   
Sbjct: 123 KDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMAL 176
Query: 704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
             VV T  Y +PE  +   ++   D++S G +  E     + +  +  +++++ LG +
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSDVDQLGKI 231

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 109/211 (51%), Gaps = 13/211 (6%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     L  G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 11  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    +++         LD V   +     +  Q   N    I
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 126
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 110/211 (52%), Gaps = 13/211 (6%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     L  G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+    ++++        LD V   +     +  Q   N    I
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQI 133
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      
Sbjct: 134 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 111/220 (50%), Gaps = 23/220 (10%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEE--FKNEVRLIAKLQHRNLVRLLGC 606
           LG+G FG V K +  +  QE AVK +++ S +  +      EV L+ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
             +     +V E      L   I  + R S  +  R   II  +  G+ Y+H   +  I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMH---KHNIV 143
Query: 667 HRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRV--VGTYGYMSPEYAMDG 721
           HRDLK  NILL   +K+   KI DFG++  F     +QNTK    +GT  Y++PE  + G
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCF-----QQNTKMKDRIGTAYYIAPE-VLRG 197
Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
            +  K DV+S GV+L   +SG      ++  NE ++L  V
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPP---FYGKNEYDILKRV 234

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 110/214 (51%), Gaps = 19/214 (8%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI----AVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     L  G FG VYKG  + EG+++    A+K L    S +  +E  +E  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNII 647
           ++A + + ++ RLLG C+    +++         LD V   K       +LNW       
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 130
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             IA+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +   
Sbjct: 131 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 119/238 (50%), Gaps = 25/238 (10%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRNSGQ------GIEEFKNE 588
           + RA   +    ++G+G +G V+K R L+  G+ +A+KR+   +G+       I E    
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV- 64
Query: 589 VRLIAKLQHRNLVRLLGCCV----EMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRR 643
           +R +   +H N+VRL   C     + + K+ LV+E+++     +   DK     +  +  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL--TTYLDKVPEPGVPTETI 122
Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
            +++  + RGL +LH     R++HRDLK  NIL+      K++DFG+ARI+     +   
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMAL 176
Query: 704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
             VV T  Y +PE  +   ++   D++S G +  E     + +  +  +++++ LG +
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSDVDQLGKI 231

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG +       + + T  + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPP 201
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 119/238 (50%), Gaps = 25/238 (10%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRNSGQ------GIEEFKNE 588
           + RA   +    ++G+G +G V+K R L+  G+ +A+KR+   +G+       I E    
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV- 64
Query: 589 VRLIAKLQHRNLVRLLGCCV----EMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRR 643
           +R +   +H N+VRL   C     + + K+ LV+E+++     +   DK     +  +  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL--TTYLDKVPEPGVPTETI 122
Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
            +++  + RGL +LH     R++HRDLK  NIL+      K++DFG+ARI+     +   
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMAL 176
Query: 704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
             VV T  Y +PE  +   ++   D++S G +  E     + +  +  +++++ LG +
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSDVDQLGKI 231

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            F  +      +ARG+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELN 756
             + T        +M+PE   D +++ +SDV+SFGVL+ E  T+ G    G         
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------- 264
Query: 757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            +  +++L KEG  +        + PAN       +   C      +RPT   +V
Sbjct: 265 -VEELFKLLKEGHRM--------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 112/237 (47%), Gaps = 21/237 (8%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKL- 595
           AT  +    ++G G +G VYK R    G  +A+K  R+    G G     + VR +A L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 596 -----QHRNLVRLLGCCV--EMDEKMLVYEYMENRSLD-SVIFDKARSSILNWQRRFNII 647
                +H N+VRL+  C     D ++ V    E+   D     DKA    L  +   +++
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
               RGL +LH +    I+HRDLK  NIL+    T K++DFG+ARI+     +     VV
Sbjct: 127 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALTPVV 180
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            T  Y +PE  +   ++   D++S G +  E     + +  +  N+E + LG ++ L
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF---RRKPLFCGNSEADQLGKIFDL 234

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 19/236 (8%)
Query: 515 SKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEI---- 569
            +R+     T   E P      I++ T+ F     LG G FG VYKG  + EG+++    
Sbjct: 23  QERELVEPLTPSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV 81
Query: 570 AVKRLSR-NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSV 628
           A+  L    S +  +E  +E  ++A + + ++ RLLG C+    +++         LD V
Sbjct: 82  AIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV 141
Query: 629 IFDK---ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI 685
              K       +LNW         IA+G+ YL      R++HRDL A N+L+      KI
Sbjct: 142 REHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKI 192
Query: 686 SDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
           +DFG+A++ G ++ E + +       +M+ E  +  +++ +SDV+S+GV + E ++
Sbjct: 193 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 106/226 (46%), Gaps = 27/226 (11%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQ 596
           R   +F     LG+GGFG+V++ +  ++    A+KR+   N     E+   EV+ +AKL+
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 597 HRNLVRLLGCCVEMD--EKML-----VYEYMEN---RSLDSVIFDKARSSILNWQRR--F 644
           H  +VR     +E +  EK+      VY Y++    R  +   +   R +I   +R    
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           +I   IA  + +LH      ++HRDLK SNI    +   K+ DFG+      D+ EQ   
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 705 RV----------VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETV 740
                       VGT  YMSPE      +S K D+FS G++L E +
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG +       + ++T  + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDT--LCGTLDYLPP 176
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 550 LGQGGFGIVYKGRLLE-GQE-----IAVKRL-SRNSGQGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +      G+E     +AVK L S       E   +E+++++ L QH N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-------LNWQRRFNIICGIARGL 654
            LLG C      +++ EY     L + +  KA + +       L  +   +    +A+G+
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
            +L   +    IHRD+ A N+LL      KI DFG+AR    D              +M+
Sbjct: 166 AFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 222
Query: 715 PEYAMDGLFSVKSDVFSFGVLLLETVS 741
           PE   D +++V+SDV+S+G+LL E  S
Sbjct: 223 PESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 550 LGQGGFGIVYKGRLLEG---QEIAVKRLSR-NSGQGIEEFKNEVRLIAKL-QHRNLVRLL 604
           +G+G FG V K R+ +     + A+KR+    S     +F  E+ ++ KL  H N++ LL
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 605 GCCVEMDEKMLVYEYMENRSL-------------DSVIFDKARSSILNWQRRFNIICGIA 651
           G C       L  EY  + +L              +     + +S L+ Q+  +    +A
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG 711
           RG+ YL Q    + IHR+L A NIL+ +    KI+DFG++R       E   K+ +G   
Sbjct: 150 RGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLP 201
Query: 712 --YMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
             +M+ E     +++  SDV+S+GVLL E VS
Sbjct: 202 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG +       + + T  + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPP 175
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLS-RNSGQGIEEFK-NEVRLIAKLQHRN 599
           + +    K+G+G +G+VYK +   G+  A+K++      +GI      E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 600 LVRLLGCCVEMDEKMLVYEYMEN---RSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           +V+L          +LV+E+++    + LD  + +    S+        ++ GIA    Y
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIA----Y 115
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
            H     R++HRDLK  N+L+++E   KI+DFG+AR F G    + T  VV T  Y +P+
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVV-TLWYRAPD 170
Query: 717 YAM-DGLFSVKSDVFSFGVLLLETVSG 742
             M    +S   D++S G +  E V+G
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 17/205 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           DNF    K+G+G  GIV    +   G+ +AVK++     Q  E   NEV ++   QH N+
Sbjct: 154 DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 210
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V +    +  DE  +V E++E  +L  ++      + +N ++   +   + + L  LH  
Sbjct: 211 VEMYNSYLVGDELWVVMEFLEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQ 266
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSPEYA 718
               +IHRD+K+ +ILL  +   K+SDFG    F    +++  +R  +VGT  +M+PE  
Sbjct: 267 G---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELI 319
Query: 719 MDGLFSVKSDVFSFGVLLLETVSGK 743
               +  + D++S G++++E V G+
Sbjct: 320 SRLPYGPEVDIWSLGIMVIEMVDGE 344

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLS-RNSGQGIEEFK-NEVRLIAKLQHRN 599
           + +    K+G+G +G+VYK +   G+  A+K++      +GI      E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 600 LVRLLGCCVEMDEKMLVYEYMEN---RSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           +V+L          +LV+E+++    + LD  + +    S+        ++ GIA    Y
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIA----Y 115
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
            H     R++HRDLK  N+L+++E   KI+DFG+AR F G    + T  VV T  Y +P+
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVV-TLWYRAPD 170
Query: 717 YAM-DGLFSVKSDVFSFGVLLLETVSG 742
             M    +S   D++S G +  E V+G
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG +       + + T  + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPP 178
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG +       + + T  + GT  Y+ P
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPP 192
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG +       + + T  + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPP 180
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 550 LGQGGFGIVYKGRLLE-GQE-----IAVKRL-SRNSGQGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +      G+E     +AVK L S       E   +E+++++ L QH N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR-----------SSILNWQRRFNIICGI 650
            LLG C      +++ EY     L + +  K+R           +S L+ +   +    +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ +L   +    IHRD+ A N+LL      KI DFG+AR    D             
Sbjct: 174 AQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+PE   D +++V+SDV+S+G+LL E  S
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 129/295 (43%), Gaps = 44/295 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELN 756
             + T        +M+PE   D +++ +SDV+SFGVL+ E  T+ G    G         
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-------- 263
Query: 757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            +  +++L KEG  +        + PAN       +   C      +RPT   +V
Sbjct: 264 PVEELFKLLKEGHRM--------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 15/219 (6%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLV 601
           FT  +++G+G FG VYKG     +E+ A+K +    +   IE+ + E+ ++++     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           R  G  ++  +  ++ EY+   S      D  +   L       I+  I +GL YLH + 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 135
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSPEYAM 719
             R IHRD+KA+N+LL ++   K++DFG+A    G  T+   KR   VGT  +M+PE   
Sbjct: 136 --RKIHRDIKAANVLLSEQGDVKLADFGVA----GQLTDTQIKRNXFVGTPFWMAPEVIK 189
Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
              +  K+D++S G+  +E   G+      H    L L+
Sbjct: 190 QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 228

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 550 LGQGGFGIVYKGRLLE-GQE-----IAVKRL-SRNSGQGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +      G+E     +AVK L S       E   +E+++++ L QH N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-------LNWQRRFNIICGIARGL 654
            LLG C      +++ EY     L + +  KA + +       L  +   +    +A+G+
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
            +L   +    IHRD+ A N+LL      KI DFG+AR    D              +M+
Sbjct: 174 AFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 230
Query: 715 PEYAMDGLFSVKSDVFSFGVLLLETVS 741
           PE   D +++V+SDV+S+G+LL E  S
Sbjct: 231 PESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 128/261 (49%), Gaps = 30/261 (11%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLV 601
           FT   ++G+G FG V+KG     Q++ A+K +    +   IE+ + E+ ++++     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +  G  ++  +  ++ EY+   S      D  R+   +  +   ++  I +GL YLH + 
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 140
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
           +   IHRD+KA+N+LL ++   K++DFG+A      Q ++NT   VGT  +M+PE     
Sbjct: 141 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 195
Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYH---------SNNELNLLGHVWRLWKEGKVLE 772
            +  K+D++S G+  +E   G+      H          NN   L+G   + +K     E
Sbjct: 196 AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFK-----E 250
Query: 773 MVDSSVDNYP-----ANEVLR 788
            +D+ ++  P     A E+L+
Sbjct: 251 FIDACLNKDPSFRPTAKELLK 271

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 17/205 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           DNF    K+G+G  GIV    +   G+ +AVK++     Q  E   NEV ++   QH N+
Sbjct: 23  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V +    +  DE  +V E++E  +L  ++      + +N ++   +   + + L  LH  
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ 135
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSPEYA 718
               +IHRD+K+ +ILL  +   K+SDFG    F    +++  +R  +VGT  +M+PE  
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELI 188
Query: 719 MDGLFSVKSDVFSFGVLLLETVSGK 743
               +  + D++S G++++E V G+
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGE 213

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG +       + + T  + GT  Y+ P
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPP 174
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 17/205 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           DNF    K+G+G  GIV    +   G+ +AVK++     Q  E   NEV ++   QH N+
Sbjct: 32  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V +    +  DE  +V E++E  +L  ++      + +N ++   +   + + L  LH  
Sbjct: 89  VEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ 144
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSPEYA 718
               +IHRD+K+ +ILL  +   K+SDFG    F    +++  +R  +VGT  +M+PE  
Sbjct: 145 G---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELI 197
Query: 719 MDGLFSVKSDVFSFGVLLLETVSGK 743
               +  + D++S G++++E V G+
Sbjct: 198 SRLPYGPEVDIWSLGIMVIEMVDGE 222

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 17/205 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           DNF    K+G+G  GIV    +   G+ +AVK++     Q  E   NEV ++   QH N+
Sbjct: 34  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V +    +  DE  +V E++E  +L  ++      + +N ++   +   + + L  LH  
Sbjct: 91  VEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ 146
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSPEYA 718
               +IHRD+K+ +ILL  +   K+SDFG    F    +++  +R  +VGT  +M+PE  
Sbjct: 147 G---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELI 199
Query: 719 MDGLFSVKSDVFSFGVLLLETVSGK 743
               +  + D++S G++++E V G+
Sbjct: 200 SRLPYGPEVDIWSLGIMVIEMVDGE 224

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 144/298 (48%), Gaps = 24/298 (8%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKR-LSRNSGQGIEEFK-NEVRLIAKL 595
           ++ + + +   +G+G +G+V K R  + G+ +A+K+ L  +  + +++    E++L+ +L
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGL 654
           +H NLV LL  C +     LV+E++++  LD + +F       +  +  F II GI  G 
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI--GF 139
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
            + H      IIHRD+K  NIL+ +    K+ DFG AR         + +  V T  Y +
Sbjct: 140 CHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VATRWYRA 192
Query: 715 PEYAM-DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM 773
           PE  + D  +    DV++ G L+ E   G+     +  +++++ L H+           +
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGEP---LFPGDSDIDQLYHIMMCLG-----NL 244
Query: 774 VDSSVDNYPANEVLRCIHVGLLCVQENAEER-PTMASVVLMLSSETATMPQPKTPGFC 830
           +    + +  N V   + +  +  +E  E R P ++ VV+ L+ +   +   K P FC
Sbjct: 245 IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP-FC 301

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 129/295 (43%), Gaps = 44/295 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELN 756
             + T        +M+PE   D +++ +SDV+SFGVL+ E  T+ G    G         
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-------- 263
Query: 757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            +  +++L KEG  +        + PAN       +   C      +RPT   +V
Sbjct: 264 PVEELFKLLKEGHRM--------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPP 175
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 17/205 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           DNF    K+G+G  GIV    +   G+ +AVK++     Q  E   NEV ++   QH N+
Sbjct: 27  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V +    +  DE  +V E++E  +L  ++      + +N ++   +   + + L  LH  
Sbjct: 84  VEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ 139
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSPEYA 718
               +IHRD+K+ +ILL  +   K+SDFG    F    +++  +R  +VGT  +M+PE  
Sbjct: 140 G---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELI 192
Query: 719 MDGLFSVKSDVFSFGVLLLETVSGK 743
               +  + D++S G++++E V G+
Sbjct: 193 SRLPYGPEVDIWSLGIMVIEMVDGE 217

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLS-RNSGQGIEEFK-NEVRLIAKLQHRN 599
           + +    K+G+G +G+VYK +   G+  A+K++      +GI      E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 600 LVRLLGCCVEMDEKMLVYEYMEN---RSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           +V+L          +LV+E+++    + LD  + +    S+        ++ GIA    Y
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIA----Y 115
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
            H     R++HRDLK  N+L+++E   KI+DFG+AR F G    + T  +V T  Y +P+
Sbjct: 116 CHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPD 170
Query: 717 YAM-DGLFSVKSDVFSFGVLLLETVSG 742
             M    +S   D++S G +  E V+G
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG +      + +     + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD----LCGTLDYLPP 201
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG +       + + T  + GT  Y+ P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPP 179
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLVRLLG 605
           LG GG   V+  R L + +++AVK L  +  +       F+ E +  A L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 606 CC-VEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
               E     L Y   EY++  +L  ++  +     +  +R   +I    + L + HQ+ 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFG--GDQTEQNTKRVVGTYGYMSPEYAM 719
              IIHRD+K +NIL+      K+ DFG+AR     G+   Q T  V+GT  Y+SPE A 
Sbjct: 137 ---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQ-TAAVIGTAQYLSPEQAR 192
Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
                 +SDV+S G +L E ++G+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 129/295 (43%), Gaps = 44/295 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELN 756
             + T        +M+PE   D +++ +SDV+SFGVL+ E  T+ G    G         
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-------- 263
Query: 757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            +  +++L KEG  +        + PAN       +   C      +RPT   +V
Sbjct: 264 PVEELFKLLKEGHRM--------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 113/233 (48%), Gaps = 18/233 (7%)
Query: 517 RDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQE----IAVK 572
           RD  +    +++  L   E +V  +D       +G+G FG+VY G  ++  +     A+K
Sbjct: 1   RDLDSALLAEVKDVLIPHERVVTHSDRV-----IGKGHFGVVYHGEYIDQAQNRIQCAIK 55
Query: 573 RLSR-NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE-KMLVYEYMENRSLDSVIF 630
            LSR    Q +E F  E  L+  L H N++ L+G  +  +    ++  YM +  L   I 
Sbjct: 56  SLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR 115
Query: 631 DKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM 690
              R+  +     F +   +ARG+ YL +    + +HRDL A N +LD+  T K++DFG+
Sbjct: 116 SPQRNPTVKDLISFGL--QVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGL 170
Query: 691 ARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
           AR     +  + Q  +       + + E      F+ KSDV+SFGVLL E ++
Sbjct: 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 177
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 112/233 (48%), Gaps = 39/233 (16%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ 596
           +R   +F +   LGQG FG V K R  L+ +  A+K++ R++ + +    +EV L+A L 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLN 60
Query: 597 HRNLVRLLGCCVE----------MDEKMLVY---EYMENRSLDSVIFDKARSSILNWQR- 642
           H+ +VR     +E          + +K  ++   EY EN +L    +D   S  LN QR 
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRD 116
Query: 643 -RFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-------IF 694
             + +   I   L Y+H      IIHRDLK  NI +D+    KI DFG+A+       I 
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 695 GGDQ-----TEQNTKRVVGTYGYMSPEYAMDGL--FSVKSDVFSFGVLLLETV 740
             D      +  N    +GT  Y++ E  +DG   ++ K D++S G++  E +
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG +       + + T  + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPP 178
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 129/295 (43%), Gaps = 44/295 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 593 AKL-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI-------------FDKARSSIL 638
             + +H+N++ LLG C +     ++ EY    +L   +              ++     +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 639 NWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            ++   +    +ARG+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELN 756
             + T        +M+PE   D +++ +SDV+SFGVL+ E  T+ G    G         
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------- 264
Query: 757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            +  +++L KEG  +        + PAN       +   C      +RPT   +V
Sbjct: 265 -VEELFKLLKEGHRM--------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 17/205 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           DNF    K+G+G  GIV    +   G+ +AVK++     Q  E   NEV ++   QH N+
Sbjct: 77  DNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V +    +  DE  +V E++E  +L  ++      + +N ++   +   + + L  LH  
Sbjct: 134 VEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLQALSVLHAQ 189
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSPEYA 718
               +IHRD+K+ +ILL  +   K+SDFG    F    +++  +R  +VGT  +M+PE  
Sbjct: 190 G---VIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELI 242
Query: 719 MDGLFSVKSDVFSFGVLLLETVSGK 743
               +  + D++S G++++E V G+
Sbjct: 243 SRLPYGPEVDIWSLGIMVIEMVDGE 267

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 178
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 129/295 (43%), Gaps = 44/295 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQG-IEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR      
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELN 756
             + T        +M+PE   D +++ +SDV+SFGVL+ E  T+ G    G         
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------- 310
Query: 757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            +  +++L KEG  +        + PAN       +   C      +RPT   +V
Sbjct: 311 -VEELFKLLKEGHRM--------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 17/209 (8%)
Query: 541 TDNFTDYNKLGQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQ---GIEEFKNEVRLIAKLQ 596
           +D +     LG+G FG ++     + GQE AVK +S+   +     E    EV+L+ +L 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H N+++L     +     LV E      L   I  + R S ++  R   II  +  G+ Y
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITY 147
Query: 657 LHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
           +H++   +I+HRDLK  N+LL+   K+   +I DFG++  F   +  +  K  +GT  Y+
Sbjct: 148 MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYI 201
Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           +PE  + G +  K DV+S GV+L   +SG
Sbjct: 202 APE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPP 175
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 11/207 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +     
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL +
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 125
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
             + +I+HRD+K SNIL++     K+ DFG++    G   ++     VGT  YMSPE   
Sbjct: 126 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDEMANEFVGTRSYMSPERLQ 179
Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNR 746
              +SV+SD++S G+ L+E   G+  R
Sbjct: 180 GTHYSVQSDIWSMGLSLVEMAVGRYPR 206

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 175
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG +       + + T  + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPP 180
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E         K D++S GVL  E + GK
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLVRLLG 605
           LG GG   V+  R L + +++AVK L  +  +       F+ E +  A L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 606 CC-VEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
               E     L Y   EY++  +L  ++  +     +  +R   +I    + L + HQ+ 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFG--GDQTEQNTKRVVGTYGYMSPEYAM 719
              IIHRD+K +NI++      K+ DFG+AR     G+   Q T  V+GT  Y+SPE A 
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYLSPEQAR 192
Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
                 +SDV+S G +L E ++G+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 541 TDNFTDYNKLGQGGFG--IVYKGRLLEGQEIAVKRLSRNSGQ---GIEEFKNEVRLIAKL 595
           +D +     LG+G FG  I+ K ++  GQE AVK +S+   +     E    EV+L+ +L
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
            H N+++L     +     LV E      L   I  + R S ++  R   II  +  G+ 
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 164
Query: 656 YLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           Y+H++   +I+HRDLK  N+LL+   K+   +I DFG++  F   +  +  K  +GT  Y
Sbjct: 165 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYY 218
Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           ++PE  + G +  K DV+S GV+L   +SG
Sbjct: 219 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 180
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPP 176
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 541 TDNFTDYNKLGQGGFG--IVYKGRLLEGQEIAVKRLSRNSGQ---GIEEFKNEVRLIAKL 595
           +D +     LG+G FG  I+ K ++  GQE AVK +S+   +     E    EV+L+ +L
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
            H N+++L     +     LV E      L   I  + R S ++  R   II  +  G+ 
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 163
Query: 656 YLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           Y+H++   +I+HRDLK  N+LL+   K+   +I DFG++  F   +  +  K  +GT  Y
Sbjct: 164 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYY 217
Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           ++PE  + G +  K DV+S GV+L   +SG
Sbjct: 218 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 129/295 (43%), Gaps = 44/295 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR      
Sbjct: 147 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELN 756
             + T        +M+PE   D +++ +SDV+SFGVL+ E  T+ G    G         
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-------- 255
Query: 757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            +  +++L KEG  +        + PAN       +   C      +RPT   +V
Sbjct: 256 PVEELFKLLKEGHRM--------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 302

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 176
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLVRLLG 605
           LG GG   V+  R L + +++AVK L  +  +       F+ E +  A L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 606 CC-VEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
               E     L Y   EY++  +L  ++  +     +  +R   +I    + L + HQ+ 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFG--GDQTEQNTKRVVGTYGYMSPEYAM 719
              IIHRD+K +NI++      K+ DFG+AR     G+   Q T  V+GT  Y+SPE A 
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYLSPEQAR 192
Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
                 +SDV+S G +L E ++G+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 109/210 (51%), Gaps = 19/210 (9%)
Query: 541 TDNFTDYNKLGQGGFG--IVYKGRLLEGQEIAVKRLSRNSGQ---GIEEFKNEVRLIAKL 595
           +D +     LG+G FG  I+ K ++  GQE AVK +S+   +     E    EV+L+ +L
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
            H N+++L     +     LV E      L   I  + R S ++  R   II  +  G+ 
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 140
Query: 656 YLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           Y+H++   +I+HRDLK  N+LL+   K+   +I DFG++  F   +  +  K  +GT  Y
Sbjct: 141 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYY 194
Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           ++PE  + G +  K DV+S GV+L   +SG
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 129/295 (43%), Gaps = 44/295 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR      
Sbjct: 144 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELN 756
             + T        +M+PE   D +++ +SDV+SFGVL+ E  T+ G    G         
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-------- 252
Query: 757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            +  +++L KEG  +        + PAN       +   C      +RPT   +V
Sbjct: 253 PVEELFKLLKEGHRM--------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 299

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 129/295 (43%), Gaps = 44/295 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR      
Sbjct: 142 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELN 756
             + T        +M+PE   D +++ +SDV+SFGVL+ E  T+ G    G         
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-------- 250
Query: 757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            +  +++L KEG  +        + PAN       +   C      +RPT   +V
Sbjct: 251 PVEELFKLLKEGHRM--------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 297

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 129/295 (43%), Gaps = 44/295 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         VE   K  + EY+  R    + +    + +   Q 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            F  +      +ARG+ YL      + IHRDL A N+L+ +    +I+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELN 756
             + T        +M+PE   D +++ +SDV+SFGVL+ E  T+ G    G         
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-------- 263
Query: 757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            +  +++L KEG  +        + PAN       +   C      +RPT   +V
Sbjct: 264 PVEELFKLLKEGHRM--------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 178
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 178
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQ--GIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L +   +  G+E + + EV + + L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG +       + + T  + GT  Y+ P
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPP 172
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPP 175
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           +F +   +G GGFG V+K +  ++G+   +KR+  N+    E+ + EV+ +AKL H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIV 67
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIF---------------DKARSSILNWQRRFNI 646
              GC    D          +RS    +F               +K R   L+      +
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              I +G+ Y+H     ++I+RDLK SNI L      KI DFG+      D     +K  
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK-- 182
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
            GT  YMSPE      +  + D+++ G++L E
Sbjct: 183 -GTLRYMSPEQISSQDYGKEVDLYALGLILAE 213

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 550 LGQGGFGIVYKGRLLE-GQE-----IAVKRL-SRNSGQGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +      G+E     +AVK L S       E   +E+++++ L QH N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            LLG C      +++ EY     L  + F + +S +L     F I    A     LH  S
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDL--LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 662 RF----------RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG 711
           +             IHRD+ A N+LL      KI DFG+AR    D              
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231
Query: 712 YMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
           +M+PE   D +++V+SDV+S+G+LL E  S
Sbjct: 232 WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI++FG +       + + T  + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT--LCGTLDYLPP 177
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLVRLLG 605
           LG GG   V+  R L   +++AVK L  +  +       F+ E +  A L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 606 CC-VEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
               E     L Y   EY++  +L  ++  +     +  +R   +I    + L + HQ+ 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFG--GDQTEQNTKRVVGTYGYMSPEYAM 719
              IIHRD+K +NI++      K+ DFG+AR     G+   Q T  V+GT  Y+SPE A 
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYLSPEQAR 192
Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
                 +SDV+S G +L E ++G+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +     
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL +
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 184
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
             + +I+HRD+K SNIL++     K+ DFG++    G   +      VGT  YMSPE   
Sbjct: 185 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 238
Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
              +SV+SD++S G+ L+E   G+
Sbjct: 239 GTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 11/217 (5%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLV 601
           FT   K+G+G FG V+KG     Q++ A+K +    +   IE+ + E+ ++++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +  G  ++  +  ++ EY+   S      D      L+  +   I+  I +GL YLH + 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
           +   IHRD+KA+N+LL +    K++DFG+A      Q ++NT   VGT  +M+PE     
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 179
Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
            +  K+D++S G+  +E   G+      H    L L+
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 216

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 99/208 (47%), Gaps = 11/208 (5%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAV-KRLSRNSGQGIEE--FKNEVRLIAKL 595
           RA D    Y  +G G +G   K R     +I V K L   S    E+    +EV L+ +L
Sbjct: 4   RAEDYEVLYT-IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 596 QHRNLVRLLGCCVEMDEKML--VYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIAR 652
           +H N+VR     ++     L  V EY E   L SVI    +    L+ +    ++  +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 653 GLLYLHQ--DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
            L   H+  D    ++HRDLK +N+ LD +   K+ DFG+ARI   D  E   K  VGT 
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--EDFAKEFVGTP 180
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
            YMSPE      ++ KSD++S G LL E
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI++FG +       + + T  + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT--LCGTLDYLPP 178
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
             + +I+HRD+K SNIL++     K+ DFG++    G   +      VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
              +SV+SD++S G+ L+E   G+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 11/217 (5%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLV 601
           FT   K+G+G FG V+KG     Q++ A+K +    +   IE+ + E+ ++++     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +  G  ++  +  ++ EY+   S      D      L+  +   I+  I +GL YLH + 
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 144
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
           +   IHRD+KA+N+LL +    K++DFG+A      Q ++NT   VGT  +M+PE     
Sbjct: 145 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 199
Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
            +  K+D++S G+  +E   G+      H    L L+
Sbjct: 200 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 236

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 107/210 (50%), Gaps = 19/210 (9%)
Query: 541 TDNFTDYNKLGQGGFG--IVYKGRLLEGQEIAVKRLSRNSGQ---GIEEFKNEVRLIAKL 595
           +D +     LG+G FG  I+ K ++  GQE AVK +S+   +     E    EV+L+ +L
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
            H N+ +L     +     LV E      L   I  + R S ++  R   II  +  G+ 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 140
Query: 656 YLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           Y H++   +I+HRDLK  N+LL+   K+   +I DFG++  F   +  +  K  +GT  Y
Sbjct: 141 YXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKXKDKIGTAYY 194
Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           ++PE  + G +  K DV+S GV+L   +SG
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
             + +I+HRD+K SNIL++     K+ DFG++    G   +      VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
              +SV+SD++S G+ L+E   G+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 593 AKL-QHRNLVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR 642
             + +H+N++ LLG C         V    K  + EY+  R    + +    + +   Q 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 643 RFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
            F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNELN 756
             + T        +M+PE   D +++ +SDV+SFGVL+ E  T+ G    G         
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-------- 263
Query: 757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
            +  +++L KEG  +        + PAN       +   C      +RPT   +V
Sbjct: 264 PVEELFKLLKEGHRM--------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
             + +I+HRD+K SNIL++     K+ DFG++    G   +      VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
              +SV+SD++S G+ L+E   G+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLVRLLG 605
           LG GG   V+  R L   +++AVK L  +  +       F+ E +  A L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 606 CC-VEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
               E     L Y   EY++  +L  ++  +     +  +R   +I    + L + HQ+ 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 136
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFG--GDQTEQNTKRVVGTYGYMSPEYAM 719
              IIHRD+K +NI++      K+ DFG+AR     G+   Q T  V+GT  Y+SPE A 
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYLSPEQAR 192
Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
                 +SDV+S G +L E ++G+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY        V  +  + S  + QR    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPR---GEVYKELQKLSKFDEQRTATYITELANALS 127
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG +       + + T  + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPP 180
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 86/325 (26%), Positives = 143/325 (44%), Gaps = 62/325 (19%)
Query: 520 SADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRL--LEGQE----IAVKR 573
           S D    LE P ++F        N      LG+G FG V K     L+G+     +AVK 
Sbjct: 6   SVDAFKILEDPKWEF-----PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM 60
Query: 574 LSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI--- 629
           L  N S   + +  +E  ++ ++ H ++++L G C +    +L+ EY +  SL   +   
Sbjct: 61  LKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRES 120
Query: 630 ------------------FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK 671
                              D      L      +    I++G+ YL   +  +++HRDL 
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLA 177
Query: 672 ASNILLDKEMTPKISDFGMARIFGGDQTEQNT--KRVVG--TYGYMSPEYAMDGLFSVKS 727
           A NIL+ +    KISDFG++R    D  E+++  KR  G     +M+ E   D +++ +S
Sbjct: 178 ARNILVAEGRKMKISDFGLSR----DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQS 233
Query: 728 DVFSFGVLLLE--TVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           DV+SFGVLL E  T+ G    G             ++ L K G  +E  D+      + E
Sbjct: 234 DVWSFGVLLWEIVTLGGNPYPGIPPER--------LFNLLKTGHRMERPDNC-----SEE 280
Query: 786 VLRCIHVGLLCVQENAEERPTMASV 810
           + R +   L C ++  ++RP  A +
Sbjct: 281 MYRLM---LQCWKQEPDKRPVFADI 302

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 86/325 (26%), Positives = 143/325 (44%), Gaps = 62/325 (19%)
Query: 520 SADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRL--LEGQE----IAVKR 573
           S D    LE P ++F        N      LG+G FG V K     L+G+     +AVK 
Sbjct: 6   SVDAFKILEDPKWEF-----PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM 60
Query: 574 LSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI--- 629
           L  N S   + +  +E  ++ ++ H ++++L G C +    +L+ EY +  SL   +   
Sbjct: 61  LKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRES 120
Query: 630 ------------------FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK 671
                              D      L      +    I++G+ YL   +  +++HRDL 
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLA 177
Query: 672 ASNILLDKEMTPKISDFGMARIFGGDQTEQNT--KRVVG--TYGYMSPEYAMDGLFSVKS 727
           A NIL+ +    KISDFG++R    D  E+++  KR  G     +M+ E   D +++ +S
Sbjct: 178 ARNILVAEGRKMKISDFGLSR----DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQS 233
Query: 728 DVFSFGVLLLE--TVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           DV+SFGVLL E  T+ G    G             ++ L K G  +E  D+      + E
Sbjct: 234 DVWSFGVLLWEIVTLGGNPYPGIPPER--------LFNLLKTGHRMERPDNC-----SEE 280
Query: 786 VLRCIHVGLLCVQENAEERPTMASV 810
           + R +   L C ++  ++RP  A +
Sbjct: 281 MYRLM---LQCWKQEPDKRPVFADI 302

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
             + +I+HRD+K SNIL++     K+ DFG++    G   +      VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
              +SV+SD++S G+ L+E   G+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 122
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
             + +I+HRD+K SNIL++     K+ DFG++    G   +      VGT  YMSPE   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 176
Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
              +SV+SD++S G+ L+E   G+
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 135/285 (47%), Gaps = 33/285 (11%)
Query: 521 ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKR-LSRNS 578
           A + D +E P  D          +    K+GQG FG V+K R  + GQ++A+K+ L  N 
Sbjct: 3   AKQYDSVECPFCD------EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE 56
Query: 579 GQGIE-EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM--------LVYEYMENRSLDSVI 629
            +G       E++++  L+H N+V L+  C               LV+++ E+  L  ++
Sbjct: 57  KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL 115
Query: 630 FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
            +      L+  +R  ++  +  GL Y+H   R +I+HRD+KA+N+L+ ++   K++DFG
Sbjct: 116 SNVLVKFTLSEIKR--VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 170
Query: 690 MARIFGGDQTEQNTK---RVVGTYGYMSPEYAM-DGLFSVKSDVFSFGVLLLETVSGKKN 745
           +AR F   +  Q  +   RVV T  Y  PE  + +  +    D++  G ++ E  +    
Sbjct: 171 LARAFSLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT---R 226
Query: 746 RGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCI 790
                 N E + L  + +L   G +   V  +VDNY   E L  +
Sbjct: 227 SPIMQGNTEQHQLALISQLC--GSITPEVWPNVDNYELYEKLELV 269

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 14/223 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL 595
             DNF     LG+G FG V   R+ E G   AVK L ++       +E    E R+++  
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           ++   +  L CC +  +++     ME  +   ++F   +S   +  R       I   L+
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFV--MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           +LH      II+RDLK  N+LLD E   K++DFGM +   G      T    GT  Y++P
Sbjct: 139 FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAP 193
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
           E   + L+    D ++ GVLL E + G      + + NE +L 
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAP---FEAENEDDLF 233

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 116/240 (48%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + +   + +G G +G V     +  G +IAVK+LSR     I   +   E+RL
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 158
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 159 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 210
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + +++  D++S G ++ E ++G   R  +   + +N L  + RL
Sbjct: 211 YVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG---RTLFPGTDHINQLQQIMRL 267

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 129/296 (43%), Gaps = 46/296 (15%)
Query: 542 DNFTDYNKLGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLI 592
           D  T    LG+G FG V         K +  E   +AVK L  ++ +  + +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 593 AKL-QHRNLVRLLGCCVEMDEKMLVY----------EYMENRSLDSVIFDKARSSILNWQ 641
             + +H+N++ LLG C + D  + V           EY+  R    + +    + +   Q
Sbjct: 95  KMIGKHKNIINLLGACTQ-DGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 642 RRFNIICG----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
             F  +      +ARG+ YL      + IHRDL A N+L+ +    KI+DFG+AR     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE--TVSGKKNRGFYHSNNEL 755
              + T        +M+PE   D +++ +SDV+SFGVL+ E  T+ G    G        
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------- 263
Query: 756 NLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
             +  +++L KEG  +        + PAN       +   C      +RPT   +V
Sbjct: 264 -PVEELFKLLKEGHRM--------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 101/205 (49%), Gaps = 14/205 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQ--GIE-EFKNEVRLIAKLQH 597
           ++F     LG+G FG VY  R  + + I A+K L +   +  G+E + + EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     R+IHRD+K  N+LL      KI+DFG +       + ++T  + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDT--LCGTLDYLPPEM 181
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
               +   K D++S GVL  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL +
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 149
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
             + +I+HRD+K SNIL++     K+ DFG++    G   +      VGT  YMSPE   
Sbjct: 150 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 203
Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
              +SV+SD++S G+ L+E   G+
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ + A L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH 73
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 87/325 (26%), Positives = 143/325 (44%), Gaps = 62/325 (19%)
Query: 520 SADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRL--LEGQE----IAVKR 573
           S D    LE P ++F        N      LG+G FG V K     L+G+     +AVK 
Sbjct: 6   SVDAFKILEDPKWEF-----PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM 60
Query: 574 LSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI--- 629
           L  N S   + +  +E  ++ ++ H ++++L G C +    +L+ EY +  SL   +   
Sbjct: 61  LKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRES 120
Query: 630 ------------------FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK 671
                              D      L      +    I++G+ YL + S   ++HRDL 
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLA 177
Query: 672 ASNILLDKEMTPKISDFGMARIFGGDQTEQNT--KRVVG--TYGYMSPEYAMDGLFSVKS 727
           A NIL+ +    KISDFG++R    D  E+++  KR  G     +M+ E   D +++ +S
Sbjct: 178 ARNILVAEGRKMKISDFGLSR----DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQS 233
Query: 728 DVFSFGVLLLE--TVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           DV+SFGVLL E  T+ G    G             ++ L K G  +E  D+      + E
Sbjct: 234 DVWSFGVLLWEIVTLGGNPYPGIPPER--------LFNLLKTGHRMERPDNC-----SEE 280
Query: 786 VLRCIHVGLLCVQENAEERPTMASV 810
           + R +   L C ++  ++RP  A +
Sbjct: 281 MYRLM---LQCWKQEPDKRPVFADI 302

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R  + + I A+K L  ++    G+E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY        V  +  + S  + QR    I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPR---GEVYKELQKLSKFDEQRTATYITELANALS 127
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     R+IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLPP 180
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKL 595
           A ++F     LG+G FG VY  R    + I A+K L  ++    G+E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYA---PLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           Y H     ++IHRD+K  N+LL      KI+DFG    +           + GT  Y+ P
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPP 175
Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +   K D++S GVL  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 99/208 (47%), Gaps = 11/208 (5%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAV-KRLSRNSGQGIEE--FKNEVRLIAKL 595
           RA D    Y  +G G +G   K R     +I V K L   S    E+    +EV L+ +L
Sbjct: 4   RAEDYEVLYT-IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 596 QHRNLVRLLGCCVEMDEKML--VYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIAR 652
           +H N+VR     ++     L  V EY E   L SVI    +    L+ +    ++  +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 653 GLLYLHQ--DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
            L   H+  D    ++HRDLK +N+ LD +   K+ DFG+ARI   D +   T   VGT 
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTP 180
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
            YMSPE      ++ KSD++S G LL E
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 109/219 (49%), Gaps = 15/219 (6%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLV 601
           FT   K+G+G FG V+KG     Q++ A+K +    +   IE+ + E+ ++++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +  G  ++  +  ++ EY+   S      D      L+  +   I+  I +GL YLH + 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSPEYAM 719
           +   IHRD+KA+N+LL +    K++DFG+A    G  T+   KR   VGT  +M+PE   
Sbjct: 140 K---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNXFVGTPFWMAPEVIK 192
Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
              +  K+D++S G+  +E   G+      H    L L+
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 231

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQ--GIE-EFKNEVRLIAKLQH 597
           ++F     LG+G FG VY  R  + + I A+K L +   +  G+E + + EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N++RL G   +     L+ EY     L +V  +  + S  + QR    I  +A  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYA---PLGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     R+IHRD+K  N+LL      KI+DFG +       + + T  + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTT--LCGTLDYLPPEM 181
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
               +   K D++S GVL  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 99/208 (47%), Gaps = 11/208 (5%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAV-KRLSRNSGQGIEE--FKNEVRLIAKL 595
           RA D    Y  +G G +G   K R     +I V K L   S    E+    +EV L+ +L
Sbjct: 4   RAEDYEVLYT-IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 596 QHRNLVRLLGCCVEMDEKML--VYEYMENRSLDSVIFDKARS-SILNWQRRFNIICGIAR 652
           +H N+VR     ++     L  V EY E   L SVI    +    L+ +    ++  +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 653 GLLYLHQ--DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
            L   H+  D    ++HRDLK +N+ LD +   K+ DFG+ARI   D +    K  VGT 
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTP 180
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
            YMSPE      ++ KSD++S G LL E
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 110/258 (42%), Gaps = 33/258 (12%)
Query: 512 VISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQE-- 568
           +I S    S    D  +LP  +     R  +N      LG G FG V +      G+E  
Sbjct: 3   IIESYEGNSYTFIDPTQLPYNEKWEFPR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDA 60
Query: 569 ---IAVKRL-SRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEY---- 619
              +AVK L S       E   +E+++++ L QH N+V LLG C      +++ EY    
Sbjct: 61  VLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 120
Query: 620 ------------MENRSL----DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
                       M   SL    D    DK     L  +   +    +A+G+ +L   +  
Sbjct: 121 DLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN-- 178
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
             IHRD+ A N+LL      KI DFG+AR    D              +M+PE   D ++
Sbjct: 179 -CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 237
Query: 724 SVKSDVFSFGVLLLETVS 741
           +V+SDV+S+G+LL E  S
Sbjct: 238 TVQSDVWSYGILLWEIFS 255

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 122/263 (46%), Gaps = 27/263 (10%)
Query: 499 HPERSQDLL-LNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYN--------- 548
           HP+R  D L  +       R  S DK   + +    FE+     +   D           
Sbjct: 279 HPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLL 338
Query: 549 ----KLGQGGFGIVYKG--RLLEGQ-EIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNL 600
               +LG G FG V +G  R+ + Q ++A+K L + + +   EE   E +++ +L +  +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           VRL+G C + +  MLV E      L   +  K     ++      ++  ++ G+ YL + 
Sbjct: 399 VRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEEK 455
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYA 718
           +    +HR+L A N+LL      KISDFG+++  G D +   T R  G +   + +PE  
Sbjct: 456 N---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECI 511
Query: 719 MDGLFSVKSDVFSFGVLLLETVS 741
               FS +SDV+S+GV + E +S
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLVRLLG 605
           LG GG   V+  R L   +++AVK L  +  +       F+ E +  A L H  +V +  
Sbjct: 37  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 96
Query: 606 CC-VEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
               E     L Y   EY++  +L  ++  +     +  +R   +I    + L + HQ+ 
Sbjct: 97  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG 153
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFG--GDQTEQNTKRVVGTYGYMSPEYAM 719
              IIHRD+K +NI++      K+ DFG+AR     G+   Q T  V+GT  Y+SPE A 
Sbjct: 154 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYLSPEQAR 209
Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
                 +SDV+S G +L E ++G+
Sbjct: 210 GDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 26/227 (11%)
Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQ----EIAVKRLSRN--SGQGIEEFKN 587
            E ++     FT    LG+G FG V + +L +      ++AVK L  +  +   IEEF  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 588 EVRLIAKLQHRNLVRLLGCCVEMDEK------MLVYEYMENRSLDSVIFDKARSSI---- 637
           E   + +  H ++ +L+G  +    K      M++  +M++  L + +     S I    
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENP 131
Query: 638 --LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IF 694
             L  Q     +  IA G+ YL   S    IHRDL A N +L ++MT  ++DFG++R I+
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188
Query: 695 GGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            GD   Q     +    +++ E   D L++V SDV++FGV + E ++
Sbjct: 189 SGDYYRQGCASKLPV-KWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 13/199 (6%)
Query: 549 KLGQGGFGIVYKG--RLLEGQ-EIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLL 604
           +LG G FG V +G  R+ + Q ++A+K L + + +   EE   E +++ +L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G C + +  MLV E      L   +  K     ++      ++  ++ G+ YL + +   
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEEKN--- 130
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDGL 722
            +HRDL A N+LL      KISDFG+++  G D +   T R  G +   + +PE      
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK 189
Query: 723 FSVKSDVFSFGVLLLETVS 741
           FS +SDV+S+GV + E +S
Sbjct: 190 FSSRSDVWSYGVTMWEALS 208

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 548 NKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           ++LG+G FG V   R        G  +AVK+L  +      +F+ E++++  L    +V+
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 603 LLGCCVE--MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             G        E  LV EY+ +  L    F +   + L+  R       I +G+ YL   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYL--G 128
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV-VGTYGYMSPEYAM 719
           SR R +HRDL A NIL++ E   KI+DFG+A++   D+     +        + +PE   
Sbjct: 129 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLS 187
Query: 720 DGLFSVKSDVFSFGVLLLE 738
           D +FS +SDV+SFGV+L E
Sbjct: 188 DNIFSRQSDVWSFGVVLYE 206

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+     +G+G F  V   R +L G+E+AVK + +   +   +++   EVR++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L           LV EY     +   +    R      + +F  I    +   Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQ 131
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG-GDQTEQNTKRVVGTYGYMSPEYA 718
             +F I+HRDLKA N+LLD +M  KI+DFG +  F  G++ +             SP YA
Sbjct: 132 --KF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYA 179
Query: 719 MDGLFSVKS------DVFSFGVLLLETVSG 742
              LF  K       DV+S GV+L   VSG
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRL--- 603
           +LG GGFG V +    + G+++A+K+  +  S +  E +  E++++ KL H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 604 ---LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
              L      D  +L  EY E   L   +        L       ++  I+  L YLH++
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 661 SRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
              RIIHRDLK  NI+L    + +  KI D G A+    DQ E  T+  VGT  Y++PE 
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTE-FVGTLQYLAPEL 194
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
                ++V  D +SFG L  E ++G
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLS----RNSGQGIEEFK-NEVRLIAKLQHRNLVRL 603
           LG+G F  VYK R     Q +A+K++       +  GI      E++L+ +L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           L          LV+++ME    D  +  K  S +L        +    +GL YLHQ    
Sbjct: 78  LDAFGHKSNISLVFDFMET---DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 132
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG-L 722
            I+HRDLK +N+LLD+    K++DFG+A+ FG        + V  T  Y +PE      +
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAPELLFGARM 189
Query: 723 FSVKSDVFSFGVLLLETV 740
           + V  D+++ G +L E +
Sbjct: 190 YGVGVDMWAVGCILAELL 207

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 109/219 (49%), Gaps = 15/219 (6%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLV 601
           FT   K+G+G FG V+KG     Q++ A+K +    +   IE+ + E+ ++++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +  G  ++  +  ++ EY+   S      D      L+  +   I+  I +GL YLH + 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSPEYAM 719
           +   IHRD+KA+N+LL +    K++DFG+A    G  T+   KR   VGT  +M+PE   
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNXFVGTPFWMAPEVIK 177
Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
              +  K+D++S G+  +E   G+      H    L L+
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 216

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRL--- 603
           +LG GGFG V +    + G+++A+K+  +  S +  E +  E++++ KL H N+V     
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 604 ---LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
              L      D  +L  EY E   L   +        L       ++  I+  L YLH++
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 661 SRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
              RIIHRDLK  NI+L    + +  KI D G A+    DQ E  T+  VGT  Y++PE 
Sbjct: 142 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTE-FVGTLQYLAPEL 195
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
                ++V  D +SFG L  E ++G
Sbjct: 196 LEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 135/285 (47%), Gaps = 33/285 (11%)
Query: 521 ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKR-LSRNS 578
           A + D +E P  D          +    K+GQG FG V+K R  + GQ++A+K+ L  N 
Sbjct: 3   AKQYDSVECPFCD------EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE 56
Query: 579 GQGIE-EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM--------LVYEYMENRSLDSVI 629
            +G       E++++  L+H N+V L+  C               LV+++ E+  L  ++
Sbjct: 57  KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL 115
Query: 630 FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
            +      L+  +R  ++  +  GL Y+H   R +I+HRD+KA+N+L+ ++   K++DFG
Sbjct: 116 SNVLVKFTLSEIKR--VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 170
Query: 690 MARIFGGDQTEQNTK---RVVGTYGYMSPEYAM-DGLFSVKSDVFSFGVLLLETVSGKKN 745
           +AR F   +  Q  +   RVV T  Y  PE  + +  +    D++  G ++ E  +    
Sbjct: 171 LARAFSLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT---R 226
Query: 746 RGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCI 790
                 N E + L  + +L   G +   V  +VDNY   E L  +
Sbjct: 227 SPIMQGNTEQHQLALISQLC--GSITPEVWPNVDNYELYEKLELV 269

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 135/285 (47%), Gaps = 33/285 (11%)
Query: 521 ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKR-LSRNS 578
           A + D +E P  D          +    K+GQG FG V+K R  + GQ++A+K+ L  N 
Sbjct: 3   AKQYDSVECPFCD------EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE 56
Query: 579 GQGIE-EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM--------LVYEYMENRSLDSVI 629
            +G       E++++  L+H N+V L+  C               LV+++ E+  L  ++
Sbjct: 57  KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLL 115
Query: 630 FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
            +      L+  +R  ++  +  GL Y+H   R +I+HRD+KA+N+L+ ++   K++DFG
Sbjct: 116 SNVLVKFTLSEIKR--VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 170
Query: 690 MARIFGGDQTEQNTK---RVVGTYGYMSPEYAM-DGLFSVKSDVFSFGVLLLETVSGKKN 745
           +AR F   +  Q  +   RVV T  Y  PE  + +  +    D++  G ++ E  +    
Sbjct: 171 LARAFSLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT---R 226
Query: 746 RGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCI 790
                 N E + L  + +L   G +   V  +VDNY   E L  +
Sbjct: 227 SPIMQGNTEQHQLALISQLC--GSITPEVWPNVDNYELYEKLELV 269

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+     +G+G F  V   R +L G+E+AV+ + +   +   +++   EVR++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L           LV EY     +   +    R      + +F  I    +   Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQ 131
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG-GDQTEQNTKRVVGTYGYMSPEYA 718
             +F I+HRDLKA N+LLD +M  KI+DFG +  F  G++ ++            SP YA
Sbjct: 132 --KF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCG---------SPPYA 179
Query: 719 MDGLFSVKS------DVFSFGVLLLETVSG 742
              LF  K       DV+S GV+L   VSG
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+     +G+G F  V   R +L G+E+AVK + +   +   +++   EVR++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L           LV EY     +   +    R      + +F  I    +   Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQ 131
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG-GDQTEQNTKRVVGTYGYMSPEYA 718
             +F I+HRDLKA N+LLD +M  KI+DFG +  F  G++ +             SP YA
Sbjct: 132 --KF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYA 179
Query: 719 MDGLFSVKS------DVFSFGVLLLETVSG 742
              LF  K       DV+S GV+L   VSG
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 27/211 (12%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+     +G+G F  V   R +L G+E+A+K + +   +   +++   EVR++  L H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L           L+ EY     +   +    R      + +F  I    +   Y HQ
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQ 129
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRVVGTYGYMSPEY 717
               RI+HRDLKA N+LLD +M  KI+DFG +  F  GG          + T+   SP Y
Sbjct: 130 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---------LDTFC-GSPPY 176
Query: 718 AMDGLFSVKS------DVFSFGVLLLETVSG 742
           A   LF  K       DV+S GV+L   VSG
Sbjct: 177 AAPELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIE-EFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +     
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL +
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE 141
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
             + +I+HRD+K SNIL++     K+ DFG++    G   +      VGT  YMSPE   
Sbjct: 142 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 195
Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
              +SV+SD++S G+ L+E   G+
Sbjct: 196 GTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 135/285 (47%), Gaps = 33/285 (11%)
Query: 521 ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKR-LSRNS 578
           A + D +E P  D          +    K+GQG FG V+K R  + GQ++A+K+ L  N 
Sbjct: 2   AKQYDSVECPFCD------EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE 55
Query: 579 GQGIE-EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM--------LVYEYMENRSLDSVI 629
            +G       E++++  L+H N+V L+  C               LV+++ E+  L  ++
Sbjct: 56  KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL 114
Query: 630 FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
            +      L+  +R  ++  +  GL Y+H   R +I+HRD+KA+N+L+ ++   K++DFG
Sbjct: 115 SNVLVKFTLSEIKR--VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG 169
Query: 690 MARIFGGDQTEQNTK---RVVGTYGYMSPEYAM-DGLFSVKSDVFSFGVLLLETVSGKKN 745
           +AR F   +  Q  +   RVV T  Y  PE  + +  +    D++  G ++ E  +    
Sbjct: 170 LARAFSLAKNSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT---R 225
Query: 746 RGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCI 790
                 N E + L  + +L   G +   V  +VDNY   E L  +
Sbjct: 226 SPIMQGNTEQHQLALISQLC--GSITPEVWPNVDNYELYEKLELV 268

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 13/223 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI----AVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           D F D+  LG+GGFG V+  ++    ++     + +      +G +    E +++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLY 656
           R +V L        +  LV   M    +   I++    +      R       I  GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           LHQ +   II+RDLK  N+LLD +   +ISD G+A      QT+  TK   GT G+M+PE
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359
Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGK---KNRGFYHSNNELN 756
             +   +    D F+ GV L E ++ +   + RG    N EL 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 13/223 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI----AVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           D F D+  LG+GGFG V+  ++    ++     + +      +G +    E +++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLY 656
           R +V L        +  LV   M    +   I++    +      R       I  GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           LHQ +   II+RDLK  N+LLD +   +ISD G+A      QT+  TK   GT G+M+PE
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359
Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGK---KNRGFYHSNNELN 756
             +   +    D F+ GV L E ++ +   + RG    N EL 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 602 RLLGCCVEMDEKMLVY----------EYMENRSLDSVIFDKARSSILNWQRRFNIIC--- 648
            LLG C +    ++V            Y+ ++  + V +        ++    ++IC   
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    D           
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
              +M+PE   D +++++SDV+SFGVLL E  S
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 13/223 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI----AVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           D F D+  LG+GGFG V+  ++    ++     + +      +G +    E +++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLY 656
           R +V L        +  LV   M    +   I++    +      R       I  GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           LHQ +   II+RDLK  N+LLD +   +ISD G+A      QT+  TK   GT G+M+PE
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359
Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGK---KNRGFYHSNNELN 756
             +   +    D F+ GV L E ++ +   + RG    N EL 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 13/223 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI----AVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           D F D+  LG+GGFG V+  ++    ++     + +      +G +    E +++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARGLLY 656
           R +V L        +  LV   M    +   I++    +      R       I  GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           LHQ +   II+RDLK  N+LLD +   +ISD G+A      QT+  TK   GT G+M+PE
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359
Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGK---KNRGFYHSNNELN 756
             +   +    D F+ GV L E ++ +   + RG    N EL 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 602 RLLGCCVEMDEKMLVY----------EYMENRSLDSVIFDKARSSILNWQRRFNIICGIA 651
            LLG C +    ++V            Y+ ++  + V +       L  +        +A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG 711
           +G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    D              
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 712 YMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
           +M+PE   D +++++SDV+SFGVLL E  S
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L  ++ +  + +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVI-----------FDKARSSILNWQRRFNIIC 648
           ++ LLG C +     ++ EY    +L   +           F+ + +       +  + C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 649 G--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR        + T   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
                +M+PE   D +++ +SDV+SFGVLL E
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 244

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 602 RLLGCCVEMDEK-MLVYEYMENRSLDSVIFDKARSSILNWQRRF-------NIIC---GI 650
            LLG C +     M++ E+ +  +L + +  K R+  + ++  +       ++IC    +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPYKDLYKDFLTLEHLICYSFQV 153
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    D             
Sbjct: 154 AKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 210
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            +M+PE   D +++++SDV+SFGVLL E  S
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 27/211 (12%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+     +G+G F  V   R +L G+E+A+K + +   +   +++   EVR++  L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L           L+ EY     +   +    R      + +F  I    +   Y HQ
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQ 132
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRVVGTYGYMSPEY 717
               RI+HRDLKA N+LLD +M  KI+DFG +  F  GG        ++    G  +P Y
Sbjct: 133 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--------KLDAFCG--APPY 179
Query: 718 AMDGLFSVKS------DVFSFGVLLLETVSG 742
           A   LF  K       DV+S GV+L   VSG
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLS--RNSGQGIEEFKNEVRLIAKLQH 597
           TD +  Y  +G+G F +V +  +L  G E A K ++  + S +  ++ + E R+   L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N+VRL     E     LV++ +    L   I  +   S  +     + I  I   +L+ 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAVLHC 119
Query: 658 HQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
           HQ     ++HRDLK  N+LL    K    K++DFG+A    GDQ  Q      GT GY+S
Sbjct: 120 HQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ--QAWFGFAGTPGYLS 174
Query: 715 PEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           PE      +    D+++ GV+L   + G
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 101/223 (45%), Gaps = 31/223 (13%)
Query: 536 TIVRATD------NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFK 586
           +I  ATD      N+     +G+G F  V   R +L G+E+AVK + +   +   +++  
Sbjct: 3   SITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 587 NEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
            EVR++  L H N+V+L           LV EY     +   +    R      + +F  
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 122
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG-GDQTEQNTKR 705
           I    +   Y HQ     I+HRDLKA N+LLD +M  KI+DFG +  F  G++ +     
Sbjct: 123 IVSAVQ---YCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCG- 175
Query: 706 VVGTYGYMSPEYAMDGLFSVKS------DVFSFGVLLLETVSG 742
                   SP YA   LF  K       DV+S GV+L   VSG
Sbjct: 176 --------SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 116/257 (45%), Gaps = 15/257 (5%)
Query: 566 GQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQHRNLVRLLGCCVEMDEK--MLVYEYMEN 622
           G+ +AVK L    G  +   ++ E+ ++  L H ++V+  GCC +  EK   LV EY+  
Sbjct: 38  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 97
Query: 623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT 682
            SL     D      +   +       I  G+ YLH       IHR L A N+LLD +  
Sbjct: 98  GSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRL 150
Query: 683 PKISDFGMAR-IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            KI DFG+A+ +  G +  +  +       + +PE   +  F   SDV+SFGV L E ++
Sbjct: 151 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210
Query: 742 GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRC--IHVGLLCVQE 799
              +    H+     L+GH        ++ E+++   +  P  +   C   H+   C + 
Sbjct: 211 YCDSNQSPHTKFT-ELIGHTQGQMTVLRLTELLERG-ERLPRPDRCPCEIYHLMKNCWET 268
Query: 800 NAEERPTMASVVLMLSS 816
            A  RPT  ++V +L +
Sbjct: 269 EASFRPTFQNLVPILQT 285

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+     +G+G F  V   R +L G+E+AVK + +   +   +++   EVR++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L           LV EY     +   +    R      + +F  I    +   Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQ 131
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG-GDQTEQNTKRVVGTYGYMSPEYA 718
             +F I+HRDLKA N+LLD +M  KI+DFG +  F  G++ +             +P YA
Sbjct: 132 --KF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCG---------APPYA 179
Query: 719 MDGLFSVKS------DVFSFGVLLLETVSG 742
              LF  K       DV+S GV+L   VSG
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 116/257 (45%), Gaps = 15/257 (5%)
Query: 566 GQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQHRNLVRLLGCCVEMDEK--MLVYEYMEN 622
           G+ +AVK L    G  +   ++ E+ ++  L H ++V+  GCC +  EK   LV EY+  
Sbjct: 37  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 96
Query: 623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT 682
            SL     D      +   +       I  G+ YLH       IHR L A N+LLD +  
Sbjct: 97  GSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRL 149
Query: 683 PKISDFGMAR-IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            KI DFG+A+ +  G +  +  +       + +PE   +  F   SDV+SFGV L E ++
Sbjct: 150 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209
Query: 742 GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRC--IHVGLLCVQE 799
              +    H+     L+GH        ++ E+++   +  P  +   C   H+   C + 
Sbjct: 210 YCDSNQSPHTKFT-ELIGHTQGQMTVLRLTELLERG-ERLPRPDRCPCEIYHLMKNCWET 267
Query: 800 NAEERPTMASVVLMLSS 816
            A  RPT  ++V +L +
Sbjct: 268 EASFRPTFQNLVPILQT 284

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 13  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 72  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 121
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGE 203

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+     +G+G F  V   R +L G+E+AV+ + +   +   +++   EVR++  L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L           LV EY     +   +    R      + +F  I    +   Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQ 131
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG-GDQTEQNTKRVVGTYGYMSPEYA 718
             +F I+HRDLKA N+LLD +M  KI+DFG +  F  G++ +             SP YA
Sbjct: 132 --KF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYA 179
Query: 719 MDGLFSVKS------DVFSFGVLLLETVSG 742
              LF  K       DV+S GV+L   VSG
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 548 NKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           ++LG+G FG V   R        G  +AVK+L  +      +F+ E++++  L    +V+
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 603 LLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             G       +   LV EY+ +  L    F +   + L+  R       I +G+ YL   
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYL--G 131
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG--YMSPEYA 718
           SR R +HRDL A NIL++ E   KI+DFG+A++   D+ +    R  G     + +PE  
Sbjct: 132 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DYYVVREPGQSPIFWYAPESL 189
Query: 719 MDGLFSVKSDVFSFGVLLLE 738
            D +FS +SDV+SFGV+L E
Sbjct: 190 SDNIFSRQSDVWSFGVVLYE 209

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 548 NKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           ++LG+G FG V   R        G  +AVK+L  +      +F+ E++++  L    +V+
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 603 LLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             G       +   LV EY+ +  L    F +   + L+  R       I +G+ YL   
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYL--G 132
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG--YMSPEYA 718
           SR R +HRDL A NIL++ E   KI+DFG+A++   D+ +    R  G     + +PE  
Sbjct: 133 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DYYVVREPGQSPIFWYAPESL 190
Query: 719 MDGLFSVKSDVFSFGVLLLE 738
            D +FS +SDV+SFGV+L E
Sbjct: 191 SDNIFSRQSDVWSFGVVLYE 210

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 31/220 (14%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG G FG V         +     ++AVK L   +     E   +E++++ +L  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 602 RLLGCCVEMDEKMLVYEYM-------------ENRSLDSVIFDKARS-------SILNWQ 641
            LLG C       L++EY              E  S D + ++  +        ++L ++
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
                   +A+G+ +L   S    +HRDL A N+L+      KI DFG+AR    D    
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
                     +M+PE   +G++++KSDV+S+G+LL E  S
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           +G+G FG VY GR      I +  + R++   ++ FK EV    + +H N+V  +G C+ 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 610 MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRD 669
                ++    + R+L SV+ D     +L+  +   I   I +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 670 LKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY-----------MSPEYA 718
           LK+ N+  D      I+DFG+  I G  Q  +   ++    G+           +SP+  
Sbjct: 156 LKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 719 MDGL-FSVKSDVFSFGVLLLE 738
            D L FS  SDVF+ G +  E
Sbjct: 215 EDKLPFSKHSDVFALGTIWYE 235

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 123
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 39/225 (17%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           +F +   +G GGFG V+K +  ++G+   ++R+  N+    E+ + EV+ +AKL H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIV 68
Query: 602 RLLGC-------CVEMDEKMLVYEY------MENRSLDSVIF---------------DKA 633
              GC           D+ +   +Y        +RS    +F               +K 
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 634 RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
           R   L+      +   I +G+ Y+H     ++IHRDLK SNI L      KI DFG+   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
              D     +K   GT  YMSPE      +  + D+++ G++L E
Sbjct: 186 LKNDGKRTRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAE 227

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 548 NKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           ++LG+G FG V   R        G  +AVK+L  +      +F+ E++++  L    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 603 LLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             G       +   LV EY+ +  L    F +   + L+  R       I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYL--G 144
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG--YMSPEYA 718
           SR R +HRDL A NIL++ E   KI+DFG+A++   D+ +    R  G     + +PE  
Sbjct: 145 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DYYVVREPGQSPIFWYAPESL 202
Query: 719 MDGLFSVKSDVFSFGVLLLE 738
            D +FS +SDV+SFGV+L E
Sbjct: 203 SDNIFSRQSDVWSFGVVLYE 222

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G +G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKG-RLLEGQEIAVK-----RLSRNSGQGIEEFKNEVRLIAKLQ 596
           N+     LG+G FG V        GQ++A+K      L+++  QG    + E+  +  L+
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 71
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H ++++L       DE ++V EY  N   D ++     S      RRF     I   + Y
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE--QEARRF--FQQIISAVEY 127
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSP 715
            H   R +I+HRDLK  N+LLD+ +  KI+DFG++ I     T+ N  K   G+  Y +P
Sbjct: 128 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAP 180
Query: 716 EYAMDGLFS-VKSDVFSFGVLL 736
           E     L++  + DV+S GV+L
Sbjct: 181 EVISGKLYAGPEVDVWSCGVIL 202

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKG-RLLEGQEIAVK-----RLSRNSGQGIEEFKNEVRLIAKLQ 596
           N+     LG+G FG V        GQ++A+K      L+++  QG    + E+  +  L+
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 66
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H ++++L       DE ++V EY  N   D ++     S      RRF     I   + Y
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE--QEARRF--FQQIISAVEY 122
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSP 715
            H   R +I+HRDLK  N+LLD+ +  KI+DFG++ I     T+ N  K   G+  Y +P
Sbjct: 123 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAP 175
Query: 716 EYAMDGLFS-VKSDVFSFGVLL 736
           E     L++  + DV+S GV+L
Sbjct: 176 EVISGKLYAGPEVDVWSCGVIL 197

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 27/210 (12%)
Query: 551 GQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLL-----G 605
            +G FG V+K +L+    +AVK       Q  +  + E+     ++H NL++ +     G
Sbjct: 24  ARGRFGCVWKAQLM-NDFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRG 81
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD----- 660
             +E+ E  L+  + +  SL     D  + +I+ W    ++   ++RGL YLH+D     
Sbjct: 82  SNLEV-ELWLITAFHDKGSLT----DYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCR 136
Query: 661 ---SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
               +  I HRD K+ N+LL  ++T  ++DFG+A  F   +   +T   VGT  YM+PE 
Sbjct: 137 GEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE- 195
Query: 718 AMDGLFSVKSDVF------SFGVLLLETVS 741
            ++G  + + D F      + G++L E VS
Sbjct: 196 VLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKG-RLLEGQEIAVK-----RLSRNSGQGIEEFKNEVRLIAKLQ 596
           N+     LG+G FG V        GQ++A+K      L+++  QG    + E+  +  L+
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 72
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H ++++L       DE ++V EY  N   D ++     S      RRF     I   + Y
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE--QEARRF--FQQIISAVEY 128
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSP 715
            H   R +I+HRDLK  N+LLD+ +  KI+DFG++ I     T+ N  K   G+  Y +P
Sbjct: 129 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAP 181
Query: 716 EYAMDGLFS-VKSDVFSFGVLL 736
           E     L++  + DV+S GV+L
Sbjct: 182 EVISGKLYAGPEVDVWSCGVIL 203

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 12/205 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKR-LSRNSGQGIEEFK-NEVRLIAKLQHR 598
           + +    K+G+G +G+V+K R  + GQ +A+K+ L       I++    E+R++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           NLV LL          LV+EY ++  L  +  D+ +  +     + +I     + + + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHEL--DRYQRGVPEHLVK-SITWQTLQAVNFCH 119
Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
           + +    IHRD+K  NIL+ K    K+ DFG AR+  G     + +  V T  Y SPE  
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSPELL 174
Query: 719 M-DGLFSVKSDVFSFGVLLLETVSG 742
           + D  +    DV++ G +  E +SG
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 536 TIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAV-----KRLSRNSGQGIEEFKNEV 589
           T  R T+ +  + +LG+G F +V +  ++L GQE A      K+LS    Q +E    E 
Sbjct: 5   TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REA 61
Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG 649
           R+   L+H N+VRL     E     L+++ +    L   I  +   S  +     + I  
Sbjct: 62  RICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---HCIQQ 118
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEM---TPKISDFGMARIFGGDQTEQNTKRV 706
           I   +L+ HQ     ++HR+LK  N+LL  ++     K++DFG+A    G+Q  Q     
Sbjct: 119 ILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGF 173
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            GT GY+SPE      +    D+++ GV+L   + G
Sbjct: 174 AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKG-RLLEGQEIAVK-----RLSRNSGQGIEEFKNEVRLIAKLQ 596
           N+     LG+G FG V        GQ++A+K      L+++  QG    + E+  +  L+
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 62
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H ++++L       DE ++V EY  N   D ++     S      RRF     I   + Y
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSE--QEARRF--FQQIISAVEY 118
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSP 715
            H   R +I+HRDLK  N+LLD+ +  KI+DFG++ I     T+ N  K   G+  Y +P
Sbjct: 119 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAP 171
Query: 716 EYAMDGLFS-VKSDVFSFGVLL 736
           E     L++  + DV+S GV+L
Sbjct: 172 EVISGKLYAGPEVDVWSCGVIL 193

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQ 596
           D F    KLG G FG V+   L+E    G E  +K ++++  Q  +E+ + E+ ++  L 
Sbjct: 22  DLFIFKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYME-NRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           H N++++     +     +V E  E    L+ ++  +AR   L+      ++  +   L 
Sbjct: 79  HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQTEQNTKRVVGTYG 711
           Y H      ++H+DLK  NIL  ++ +P    KI DFG+A +F  D+   N     GT  
Sbjct: 139 YFHSQ---HVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNA---AGTAL 191
Query: 712 YMSPE-YAMDGLFSVKSDVFSFGVLLLETVSG 742
           YM+PE +  D  F  K D++S GV++   ++G
Sbjct: 192 YMAPEVFKRDVTF--KCDIWSAGVVMYFLLTG 221

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 602 RLLGCCVEMDEKMLVY----------EYMENRSLDSVIFDKARSSIL-NWQRRFNIIC-- 648
            LLG C +    ++V            Y+ ++  + V + +A   +  ++    ++IC  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    D          
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+PE   D +++++SDV+SFGVLL E  S
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 602 RLLGCCVEMDEKMLVY----------EYMENRSLDSVIFDKARSSIL-NWQRRFNIIC-- 648
            LLG C +    ++V            Y+ ++  + V +  A   +  ++    ++IC  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    D          
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+PE   D +++++SDV+SFGVLL E  S
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L  ++ +  + +  +E+ ++  + +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 600 LVRLLGCC---------VEMDEKMLVYEYMENRSLDSV--IFDKARSSILNWQRRFNIIC 648
           ++ LLG C         VE   K  + EY++ R    +   ++ + +       +  + C
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 649 G--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR        + T   
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
                +M+PE   D +++ +SDV+SFGVLL E
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 229

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 103
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
            C + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 104 FCFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 157
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 158 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 217
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 218 KSSDLWALGCIIYQLVAG 235

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 550 LGQGGFGIVYKGRLLE-GQE-----IAVKRL-SRNSGQGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +      G+E     +AVK L S       E   +E+++++ L QH N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-------------LNWQRRFNIIC 648
            LLG C      +++ EY     L + +  K    +             L+ +   +   
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            +A+G+ +L   +    IHRD+ A N+LL      KI DFG+AR    D           
Sbjct: 174 QVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 230
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
              +M+PE   D +++V+SDV+S+G+LL E  S
Sbjct: 231 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 114/274 (41%), Gaps = 33/274 (12%)
Query: 548 NKLGQGGFGIVYKGR--LLEGQ--EIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNL 600
            KLG G FG+V +G      G+   +AVK L  +     + +++F  EV  +  L HRNL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +RL G  +    KM V E     SL   +       +L    R+ +   +A G+ YL   
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRVVGTYGYMSPEYA 718
              R IHRDL A N+LL      KI DFG+ R      D       R V  + + +PE  
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 190
Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
               FS  SD + FGV L E  +       Y     + L G         ++L  +D   
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNG--------SQILHKIDKEG 235
Query: 779 DNYPANE--VLRCIHVGLLCVQENAEERPTMASV 810
           +  P  E       +V + C     E+RPT  ++
Sbjct: 236 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 269

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 114/274 (41%), Gaps = 33/274 (12%)
Query: 548 NKLGQGGFGIVYKGR--LLEGQ--EIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNL 600
            KLG G FG+V +G      G+   +AVK L  +     + +++F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +RL G  +    KM V E     SL   +       +L    R+ +   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRVVGTYGYMSPEYA 718
              R IHRDL A N+LL      KI DFG+ R      D       R V  + + +PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESL 186
Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
               FS  SD + FGV L E  +       Y     + L G         ++L  +D   
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNG--------SQILHKIDKEG 231
Query: 779 DNYPANE--VLRCIHVGLLCVQENAEERPTMASV 810
           +  P  E       +V + C     E+RPT  ++
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 30/214 (14%)
Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L  ++ +  + +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 600 LVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN----I 646
           ++ LLG C         VE   K  + EY++ R    + +    S   N + + +    +
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSH--NPEEQLSSKDLV 153
Query: 647 ICG--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
            C   +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR        + T 
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
                  +M+PE   D +++ +SDV+SFGVLL E
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 244

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L  ++ +  + +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 600 LVRLLGCC---------VEMDEKMLVYEYMENRSLDSV--IFDKARSSILNWQRRFNIIC 648
           ++ LLG C         VE   K  + EY++ R    +   ++ + +       +  + C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 649 G--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR        + T   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
                +M+PE   D +++ +SDV+SFGVLL E
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 244

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 114/274 (41%), Gaps = 33/274 (12%)
Query: 548 NKLGQGGFGIVYKGR--LLEGQ--EIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNL 600
            KLG G FG+V +G      G+   +AVK L  +     + +++F  EV  +  L HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +RL G  +    KM V E     SL   +       +L    R+ +   +A G+ YL   
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRVVGTYGYMSPEYA 718
              R IHRDL A N+LL      KI DFG+ R      D       R V  + + +PE  
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESL 196
Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
               FS  SD + FGV L E  +       Y     + L G         ++L  +D   
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNG--------SQILHKIDKEG 241
Query: 779 DNYPANE--VLRCIHVGLLCVQENAEERPTMASV 810
           +  P  E       +V + C     E+RPT  ++
Sbjct: 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 275

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 25/205 (12%)
Query: 550 LGQGGFGIV---YKGRLLEGQEIAVKRLSRNSGQGIEEFKN--EVRLIAKLQHRNLVRLL 604
           +G G +G V   Y  RL   Q++AVK+LSR     I   +   E+RL+  L+H N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 605 -----GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
                   +E   ++ +   +    L++++    +S  L+ +    ++  + RGL Y+H 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIV----KSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
                IIHRDLK SN+ ++++   +I DFG+AR     Q ++     V T  Y +PE  +
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIML 201
Query: 720 DGL-FSVKSDVFSFGVLLLETVSGK 743
           + + ++   D++S G ++ E + GK
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 602 RLLGCCVEMDEKMLVYE----------YMENRSLDSVIFDKARSSIL-NWQRRFNIIC-- 648
            LLG C +    ++V            Y+ ++  + V +  A   +  ++    ++IC  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    D          
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+PE   D +++++SDV+SFGVLL E  S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 602 RLLGCCVEMDEKMLVY----------EYMENRSLDSVIFDKARSSIL-NWQRRFNIIC-- 648
            LLG C +    ++V            Y+ ++  + V +  A   +  ++    ++IC  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    D          
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+PE   D +++++SDV+SFGVLL E  S
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 30/214 (14%)
Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L  ++ +  + +  +E+ ++  + +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 600 LVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN----I 646
           ++ LLG C         VE   K  + EY++ R    + +    S   N + + +    +
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH--NPEEQLSSKDLV 146
Query: 647 ICG--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
            C   +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR        + T 
Sbjct: 147 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 203
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
                  +M+PE   D +++ +SDV+SFGVLL E
Sbjct: 204 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 237

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 30/214 (14%)
Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L  ++ +  + +  +E+ ++  + +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 600 LVRLLGCC---------VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN----I 646
           ++ LLG C         VE   K  + EY++ R    + +    S   N + + +    +
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH--NPEEQLSSKDLV 142
Query: 647 ICG--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
            C   +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR        + T 
Sbjct: 143 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 199
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
                  +M+PE   D +++ +SDV+SFGVLL E
Sbjct: 200 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 233

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 550 LGQGGFGIVYKGR-LLEGQEI----AVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRL 603
           LG G FG V+KG  + EG+ I     +K +   SG Q  +   + +  I  L H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARS--SILNWQRRFNIICGIARGLLYLHQDS 661
           LG C       LV +Y+   SL     D  R     L  Q   N    IA+G+ YL +  
Sbjct: 99  LGLC-PGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 153
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
              ++HR+L A N+LL      +++DFG+A +   D  +           +M+ E    G
Sbjct: 154 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 210
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            ++ +SDV+S+GV + E ++
Sbjct: 211 KYTHQSDVWSYGVTVWELMT 230

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 602 RLLGCCVEMDEKMLVY----------EYMENRSLDSVIFDKARSSIL-NWQRRFNIIC-- 648
            LLG C +    ++V            Y+ ++  + V +  A   +  ++    ++IC  
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    D          
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+PE   D +++++SDV+SFGVLL E  S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGI--EEFKNEVRLIAKLQHRN 599
           D+F   ++LG G  G+V K +      I  ++L     +     +   E++++ +     
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR--SSILNWQRRFNIICGIARGLLYL 657
           +V   G      E  +  E+M+  SLD V+ +  R    IL       +   + RGL YL
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYL 130
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
            +  + +I+HRD+K SNIL++     K+ DFG++    G   +      VGT  YM+PE 
Sbjct: 131 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMAPER 184
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGK 743
                +SV+SD++S G+ L+E   G+
Sbjct: 185 LQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 91/189 (48%), Gaps = 19/189 (10%)
Query: 559 YKGRLLEGQEIAVKRLSRNSGQGI----EEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM 614
           Y+  LLE +    K  S N    I    ++FKNE+++I  +++   +   G     DE  
Sbjct: 62  YEKSLLEKKRDFTK--SNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVY 119
Query: 615 LVYEYMENRSL---DSVIF--DKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRD 669
           ++YEYMEN S+   D   F  DK  +  +  Q    II  +     Y+H +    I HRD
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHRD 177
Query: 670 LKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD--GLFSVKS 727
           +K SNIL+DK    K+SDFG +        ++  K   GTY +M PE+  +       K 
Sbjct: 178 VKPSNILMDKNGRVKLSDFGESEY----MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKV 233
Query: 728 DVFSFGVLL 736
           D++S G+ L
Sbjct: 234 DIWSLGICL 242

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 550 LGQGGFGIVYKGRLL-EGQEI----AVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRL 603
           LG G FG V+KG  + EG+ I     +K +   SG Q  +   + +  I  L H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARS--SILNWQRRFNIICGIARGLLYLHQDS 661
           LG C       LV +Y+   SL     D  R     L  Q   N    IA+G+ YL +  
Sbjct: 81  LGLC-PGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
              ++HR+L A N+LL      +++DFG+A +   D  +           +M+ E    G
Sbjct: 136 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 722 LFSVKSDVFSFGVLLLETVS 741
            ++ +SDV+S+GV + E ++
Sbjct: 193 KYTHQSDVWSYGVTVWELMT 212

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L  ++ +  + +  +E+ ++  + +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVI-----------FDKARSSILNWQRRFNIIC 648
           ++ LLG C +     ++ EY    +L   +           ++ + +       +  + C
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 649 G--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR        + T   
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
                +M+PE   D +++ +SDV+SFGVLL E
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 236

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQG-IEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L  ++ +  + +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVI-----------FDKARSSILNWQRRFNIIC 648
           ++ LLG C +     ++ EY    +L   +           ++ + +       +  + C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 649 G--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR        + T   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
                +M+PE   D +++ +SDV+SFGVLL E
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 244

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 550 LGQGGFGIVY--------KGRLLEGQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKL-QHRN 599
           LG+G FG V         K +     ++AVK L  ++ +  + +  +E+ ++  + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVI-----------FDKARSSILNWQRRFNIIC 648
           ++ LLG C +     ++ EY    +L   +           ++ + +       +  + C
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 649 G--IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR        + T   
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
                +M+PE   D +++ +SDV+SFGVLL E  +
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 114/274 (41%), Gaps = 33/274 (12%)
Query: 548 NKLGQGGFGIVYKGR--LLEGQ--EIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNL 600
            KLG G FG+V +G      G+   +AVK L  +     + +++F  EV  +  L HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +RL G  +    KM V E     SL   +       +L    R+ +   +A G+ YL   
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRVVGTYGYMSPEYA 718
              R IHRDL A N+LL      KI DFG+ R      D       R V  + + +PE  
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 196
Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
               FS  SD + FGV L E  +       Y     + L G         ++L  +D   
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNG--------SQILHKIDKEG 241
Query: 779 DNYPANE--VLRCIHVGLLCVQENAEERPTMASV 810
           +  P  E       +V + C     E+RPT  ++
Sbjct: 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 275

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 114/274 (41%), Gaps = 33/274 (12%)
Query: 548 NKLGQGGFGIVYKGR--LLEGQ--EIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNL 600
            KLG G FG+V +G      G+   +AVK L  +     + +++F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +RL G  +    KM V E     SL   +       +L    R+ +   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRVVGTYGYMSPEYA 718
              R IHRDL A N+LL      KI DFG+ R      D       R V  + + +PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 186
Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
               FS  SD + FGV L E  +       Y     + L G         ++L  +D   
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNG--------SQILHKIDKEG 231
Query: 779 DNYPANE--VLRCIHVGLLCVQENAEERPTMASV 810
           +  P  E       +V + C     E+RPT  ++
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 115/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    + + L       
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCAKLTDDHVQF 125
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 177
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 234

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 114/274 (41%), Gaps = 33/274 (12%)
Query: 548 NKLGQGGFGIVYKGR--LLEGQ--EIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNL 600
            KLG G FG+V +G      G+   +AVK L  +     + +++F  EV  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +RL G  +    KM V E     SL   +       +L    R+ +   +A G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRVVGTYGYMSPEYA 718
              R IHRDL A N+LL      KI DFG+ R      D       R V  + + +PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 186
Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
               FS  SD + FGV L E  +       Y     + L G         ++L  +D   
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNG--------SQILHKIDKEG 231
Query: 779 DNYPANE--VLRCIHVGLLCVQENAEERPTMASV 810
           +  P  E       +V + C     E+RPT  ++
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 602 RLLGCCVEMDEKMLVY----------EYMENRSLDSVIFDKARSSIL-NWQRRFNIIC-- 648
            LLG C +    ++V            Y+ ++  + V +  A   +  ++    ++IC  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    D          
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+PE   D +++++SDV+SFGVLL E  S
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 550 LGQGGFGIVYKG--RLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           LG+G  G V     R+ E + +AVK +  + +    E  K E+ +   L H N+V+  G 
Sbjct: 14  LGEGAAGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSI----LNWQRRFNIICGIARGLLYLHQDSR 662
             E + + L  EY     L    FD+    I     + QR F+ +     G++YLH    
Sbjct: 73  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG--- 122
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 723 FSVKS-DVFSFGVLLLETVSGK 743
           F  +  DV+S G++L   ++G+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 114/274 (41%), Gaps = 33/274 (12%)
Query: 548 NKLGQGGFGIVYKGR--LLEGQ--EIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNL 600
            KLG G FG+V +G      G+   +AVK L  +     + +++F  EV  +  L HRNL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +RL G  +    KM V E     SL   +       +L    R+ +   +A G+ YL   
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRVVGTYGYMSPEYA 718
              R IHRDL A N+LL      KI DFG+ R      D       R V  + + +PE  
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 190
Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
               FS  SD + FGV L E  +       Y     + L G         ++L  +D   
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFT-------YGQEPWIGLNG--------SQILHKIDKEG 235
Query: 779 DNYPANE--VLRCIHVGLLCVQENAEERPTMASV 810
           +  P  E       +V + C     E+RPT  ++
Sbjct: 236 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 269

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 89/180 (49%), Gaps = 11/180 (6%)
Query: 566 GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK--MLVYEYMEN 622
           G+ +AVK L  + G Q    +K E+ ++  L H ++++  GCC +  EK   LV EY+  
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT 682
            SL   +    R SI    +       I  G+ YLH       IHR+L A N+LLD +  
Sbjct: 103 GSLRDYL---PRHSI-GLAQLLLFAQQICEGMAYLHSQ---HYIHRNLAARNVLLDNDRL 155
Query: 683 PKISDFGMAR-IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            KI DFG+A+ +  G +  +  +       + +PE   +  F   SDV+SFGV L E ++
Sbjct: 156 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 89/180 (49%), Gaps = 11/180 (6%)
Query: 566 GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK--MLVYEYMEN 622
           G+ +AVK L  + G Q    +K E+ ++  L H ++++  GCC +  EK   LV EY+  
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT 682
            SL   +    R SI    +       I  G+ YLH       IHR+L A N+LLD +  
Sbjct: 103 GSLRDYL---PRHSI-GLAQLLLFAQQICEGMAYLHAQ---HYIHRNLAARNVLLDNDRL 155
Query: 683 PKISDFGMAR-IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            KI DFG+A+ +  G +  +  +       + +PE   +  F   SDV+SFGV L E ++
Sbjct: 156 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 542 DNFTDYNKLGQGGFGIV------YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL 595
           + F  Y  LG+GGFG V        G++   +++  KR+ +  G+ +    NE +++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKV 241
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF---NIICGIAR 652
             R +V L       D   LV   M    L   I+   ++     +  F    I CG+  
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
               LH++   RI++RDLK  NILLD     +ISD G+A      QT    K  VGT GY
Sbjct: 302 ----LHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGY 351
Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           M+PE   +  ++   D ++ G LL E ++G+
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 602 RLLGCCVEMDEK-MLVYEYMENRSLDSVIFDKARSSI-----------LNWQRRFNIICG 649
            LLG C +     M++ E+ +  +L + +  K    +           L  +        
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    D            
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
             +M+PE   D +++++SDV+SFGVLL E  S
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 602 RLLGCCVEMDEKMLVYE----------YMENRSLDSVIFDKARSSIL-NWQRRFNIIC-- 648
            LLG C +    ++V            Y+ ++  + V +  A   +  ++    ++IC  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    D          
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+PE   D +++++SDV+SFGVLL E  S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 542 DNFTDYNKLGQGGFGIV------YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL 595
           + F  Y  LG+GGFG V        G++   +++  KR+ +  G+ +    NE +++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKV 241
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF---NIICGIAR 652
             R +V L       D   LV   M    L   I+   ++     +  F    I CG+  
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
               LH++   RI++RDLK  NILLD     +ISD G+A      QT    K  VGT GY
Sbjct: 302 ----LHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGY 351
Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           M+PE   +  ++   D ++ G LL E ++G+
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 548 NKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLVRL 603
           + LG G FG V  G+  L G ++AVK L+R   + ++   + + E++ +   +H ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
                   +  +V EY+    L   I    R      +R F  I     G+ Y H   R 
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS---GVDYCH---RH 135
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
            ++HRDLK  N+LLD  M  KI+DFG++ +    +  + +    G+  Y +PE     L+
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGSPNYAAPEVISGRLY 192
Query: 724 S-VKSDVFSFGVLLLETVSG 742
           +  + D++S GV+L   + G
Sbjct: 193 AGPEVDIWSSGVILYALLCG 212

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 125
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 177
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 178 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 234

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 602 RLLGCCVEMDEKMLVY----------EYMENRSLDSVIFDKARSSIL-NWQRRFNIIC-- 648
            LLG C +    ++V            Y+ ++  + V +  A   +  ++    ++IC  
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    D          
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+PE   D +++++SDV+SFGVLL E  S
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 550 LGQGGFGIVYKG------RLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKL-QHRNLV 601
           LG+G FG V +       +    + +AVK L   +         +E++++  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 602 RLLGCCVEMDEKMLVYE----------YMENRSLDSVIFDKARSSIL-NWQRRFNIIC-- 648
            LLG C +    ++V            Y+ ++  + V +  A   +  ++    ++IC  
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 649 -GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    D          
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+PE   D +++++SDV+SFGVLL E  S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 125
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 177
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 234

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 YVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 550 LGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           LG G FG V+K      G ++A K +     +  EE KNE+ ++ +L H NL++L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
             ++ +LV EY++   L   I D++ +  L        +  I  G+ ++HQ     I+H 
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIRHMHQ---MYILHL 211
Query: 669 DLKASNIL-LDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVK 726
           DLK  NIL ++++    KI DFG+AR +   +  +  K   GT  +++PE       S  
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVNFGTPEFLAPEVVNYDFVSFP 268
Query: 727 SDVFSFGVLLLETVSG 742
           +D++S GV+    +SG
Sbjct: 269 TDMWSVGVIAYMLLSG 284

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 107/205 (52%), Gaps = 25/205 (12%)
Query: 550 LGQGGFGIV---YKGRLLEGQEIAVKRLSRNSGQGIEEFKN--EVRLIAKLQHRNLVRLL 604
           +G G +G V   Y  RL   Q++AVK+LSR     I   +   E+RL+  L+H N++ LL
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 605 -----GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
                   +E   ++ +   +    L++++  +A S   +   +F ++  + RGL Y+H 
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALS---DEHVQF-LVYQLLRGLKYIHS 141
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
                IIHRDLK SN+ ++++   +I DFG+AR     Q ++     V T  Y +PE  +
Sbjct: 142 AG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVATRWYRAPEIML 193
Query: 720 DGL-FSVKSDVFSFGVLLLETVSGK 743
           + + ++   D++S G ++ E + GK
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 36/222 (16%)
Query: 549 KLGQGGFGIVYKG-RLLEGQEIAVKRLS---RNSGQGIEEFKNEVRLIAKLQ-HRNLVRL 603
           KLG+G +GIV+K      G+ +AVK++    +NS      F+ E+ ++ +L  H N+V L
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNL 74
Query: 604 LGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           L      +++   LV++YME   L +VI    R++IL    +  ++  + + + YLH   
Sbjct: 75  LNVLRADNDRDVYLVFDYMET-DLHAVI----RANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ---------TEQNTKRV------ 706
              ++HRD+K SNILL+ E   K++DFG++R F   +           +NT+        
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 707 ----VGTYGYMSPEYAMDGLFSVKS-DVFSFGVLLLETVSGK 743
               V T  Y +PE  +      K  D++S G +L E + GK
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+     +G+G F  V   R +L G+E+AVK + +   +   +++   EVR++  L H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L           LV EY     +   +           + +F  I    +   Y HQ
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ---YCHQ 124
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG-GDQTEQNTKRVVGTYGYMSPEYA 718
             +F I+HRDLKA N+LLD +M  KI+DFG +  F  G++ +             SP YA
Sbjct: 125 --KF-IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYA 172
Query: 719 MDGLFSVKS------DVFSFGVLLLETVSG 742
              LF  K       DV+S GV+L   VSG
Sbjct: 173 APELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 86/310 (27%), Positives = 136/310 (43%), Gaps = 47/310 (15%)
Query: 524 TDDLELPLFDFETIVRATDNFTDYN-------KLGQGGFGIVYKG--RLLEGQEIAVKRL 574
           T+  E P  D E I R  + + D         +LG G FG V KG  ++ +  +    ++
Sbjct: 345 TEVFESPFADPEEI-RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKI 403
Query: 575 SRNSGQGI---EEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD 631
            +N        +E   E  ++ +L +  +VR++G C E +  MLV E  E   L+  +  
Sbjct: 404 LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 462
Query: 632 KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
                  N      ++  ++ G+ YL ++S F  +HRDL A N+LL  +   KISDFG++
Sbjct: 463 NRHVKDKNI---IELVHQVSMGMKYL-EESNF--VHRDLAARNVLLVTQHYAKISDFGLS 516
Query: 692 RIFGGDQTEQNTKRVVGTYG-----YMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKN 745
           +    D+     +    T+G     + +PE      FS KSDV+SFGVL+ E  S G+K 
Sbjct: 517 KALRADENYYKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK- 571
Query: 746 RGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEER 804
                           +R  K  +V  M++       PA        +  LC   + E R
Sbjct: 572 ---------------PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 616
Query: 805 PTMASVVLML 814
           P  A+V L L
Sbjct: 617 PGFAAVELRL 626

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 149
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 201
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 258

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 149
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXG 201
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 202 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 258

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRN 599
           N+     +G+G F  V   R +L G+E+AVK + +   +   +++   EVR+   L H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L           LV EY     +   +    R      + +F  I    +   Y HQ
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ---YCHQ 131
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM------ 713
             +F I+HRDLKA N+LLD +   KI+DFG +  F              T+G        
Sbjct: 132 --KF-IVHRDLKAENLLLDADXNIKIADFGFSNEF--------------TFGNKLDAFCG 174
Query: 714 SPEYAMDGLFSVKS------DVFSFGVLLLETVSG 742
           +P YA   LF  K       DV+S GV+L   VSG
Sbjct: 175 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 148
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 149 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 200
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 257

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 547 YNKLGQGGFGIVYKG-RLLEGQEIAVKRLS--RNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           + +LG+G F +V +  ++L GQE A K ++  + S +  ++ + E R+   L+H N+VRL
Sbjct: 27  FEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL 86
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
                E     L+++ +    L   I  +   S  +     + I  I   +L+ HQ    
Sbjct: 87  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAVLHCHQ---M 140
Query: 664 RIIHRDLKASNILLDKEM---TPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD 720
            ++HRDLK  N+LL  ++     K++DFG+A    G+Q  Q      GT GY+SPE    
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRK 198
Query: 721 GLFSVKSDVFSFGVLLLETVSG 742
             +    D+++ GV+L   + G
Sbjct: 199 DPYGKPVDLWACGVILYILLVG 220

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++       + +   +F 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV---KXQKLTDDHVQF- 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 135
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 187
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 244

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 107/205 (52%), Gaps = 25/205 (12%)
Query: 550 LGQGGFGIV---YKGRLLEGQEIAVKRLSRNSGQGIEEFKN--EVRLIAKLQHRNLVRLL 604
           +G G +G V   Y  RL   Q++AVK+LSR     I   +   E+RL+  L+H N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 605 -----GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
                   +E   ++ +   +    L++++  +A S   +   +F ++  + RGL Y+H 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALS---DEHVQF-LVYQLLRGLKYIHS 149
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
                IIHRDLK SN+ ++++   +I DFG+AR     Q ++     V T  Y +PE  +
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIML 201
Query: 720 DGL-FSVKSDVFSFGVLLLETVSGK 743
           + + ++   D++S G ++ E + GK
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 99  FTFQDDEKLYFGLSYAKNGCLLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 152
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +   S
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAS 212
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 149 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 244

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 205
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 244

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 149
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 150 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 206
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 245

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 149
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 150 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 206
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 245

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 150
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 151 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 207
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 208 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 246

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 141
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 142 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 198
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 199 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 237

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 244

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 88/180 (48%), Gaps = 11/180 (6%)
Query: 566 GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK--MLVYEYMEN 622
           G+ +AVK L  ++G Q    +K E+ ++  L H ++++  GCC +       LV EY+  
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT 682
            SL   +    R SI    +       I  G+ YLH       IHRDL A N+LLD +  
Sbjct: 120 GSLRDYL---PRHSI-GLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRL 172
Query: 683 PKISDFGMAR-IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
            KI DFG+A+ +  G +  +  +       + +PE   +  F   SDV+SFGV L E ++
Sbjct: 173 VKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFK-NEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 149 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 244

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 548 NKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLVRL 603
           + LG G FG V  G   L G ++AVK L+R   + ++   + K E++ +   +H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
                   +  +V EY+    L   I    R   +  +R F     I   + Y H   R 
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSAVDYCH---RH 130
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
            ++HRDLK  N+LLD  M  KI+DFG++ +    +  +++    G+  Y +PE     L+
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPEVISGRLY 187
Query: 724 S-VKSDVFSFGVLLLETVSG 742
           +  + D++S GV+L   + G
Sbjct: 188 AGPEVDIWSCGVILYALLCG 207

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 142
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 143 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 238

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 134
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTG 186
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 243

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 113/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + +   +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 84
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 85  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 139
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 140 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 191
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 192 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 248

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 536 TIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLS--RNSGQGIEEFKNEVRLI 592
           T  R TD++  + +LG+G F +V +  +    QE A K ++  + S +  ++ + E R+ 
Sbjct: 25  TCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARIC 84
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR 652
             L+H N+VRL     E     LV++ +    L   I  +   S  +     + I  I  
Sbjct: 85  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIHQILE 141
Query: 653 GLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
            + ++HQ     I+HRDLK  N+LL    K    K++DFG+A    G+Q  Q      GT
Sbjct: 142 SVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ--QAWFGFAGT 196
Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            GY+SPE      +    D+++ GV+L   + G
Sbjct: 197 PGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 17/214 (7%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHR 598
           +F     LG G FG V+  R    G+  A+K L +      + +E   +E  +++ + H 
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
            ++R+ G   +  +  ++ +Y+E   L S++    R    N   +F     +   L YLH
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP--NPVAKF-YAAEVCLALEYLH 123
Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
                 II+RDLK  NILLDK    KI+DFG A+          T  + GT  Y++PE  
Sbjct: 124 SKD---IIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTPDYIAPEVV 175
Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSN 752
               ++   D +SFG+L+ E ++G     FY SN
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAGYT--PFYDSN 207

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 116/240 (48%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++       + +   +F 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV---KXQKLTDDHVQF- 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 142
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 143 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 238

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 134
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTG 186
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 243

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 72
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 73  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 127
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 128 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 179
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 236

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 126
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 178
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 235

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 125
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 177
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 234

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 131
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 183
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 240

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 86/310 (27%), Positives = 136/310 (43%), Gaps = 47/310 (15%)
Query: 524 TDDLELPLFDFETIVRATDNFTDYN-------KLGQGGFGIVYKG--RLLEGQEIAVKRL 574
           T+  E P  D E I R  + + D         +LG G FG V KG  ++ +  +    ++
Sbjct: 346 TEVYESPYADPEEI-RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKI 404
Query: 575 SRNSGQGI---EEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD 631
            +N        +E   E  ++ +L +  +VR++G C E +  MLV E  E   L+  +  
Sbjct: 405 LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 463
Query: 632 KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
                  N      ++  ++ G+ YL ++S F  +HRDL A N+LL  +   KISDFG++
Sbjct: 464 NRHVKDKNI---IELVHQVSMGMKYL-EESNF--VHRDLAARNVLLVTQHYAKISDFGLS 517
Query: 692 RIFGGDQTEQNTKRVVGTYG-----YMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKN 745
           +    D+     +    T+G     + +PE      FS KSDV+SFGVL+ E  S G+K 
Sbjct: 518 KALRADENYYKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK- 572
Query: 746 RGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEER 804
                           +R  K  +V  M++       PA        +  LC   + E R
Sbjct: 573 ---------------PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 617
Query: 805 PTMASVVLML 814
           P  A+V L L
Sbjct: 618 PGFAAVELRL 627

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 548 NKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLVRL 603
           + LG G FG V  G   L G ++AVK L+R   + ++   + K E++ +   +H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
                   +  +V EY+    L   I    R   +  +R F     I   + Y H   R 
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSAVDYCH---RH 130
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
            ++HRDLK  N+LLD  M  KI+DFG++ +    +  + +    G+  Y +PE     L+
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVISGRLY 187
Query: 724 S-VKSDVFSFGVLLLETVSG 742
           +  + D++S GV+L   + G
Sbjct: 188 AGPEVDIWSCGVILYALLCG 207

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 140
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 141 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTG 192
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 249

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 136
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 188
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 245

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 126
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 178
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 235

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 148
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 149 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 200
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 257

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 131
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 183
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 240

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 131
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 183
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 240

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 107/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   +   L+       +  I RGL Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 244

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 134
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 186
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 243

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 134
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 186
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 243

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 73
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 74  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 128
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 129 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 180
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 181 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 237

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +S  L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KSQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+ R      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 131
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTG 183
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 240

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 141
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 193
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 250

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 140
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 141 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 192
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 249

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 141
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 193
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 250

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 135
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 187
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 244

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 152
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 153 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXG 204
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 261

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 149
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 150 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 201
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 258

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 152
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 153 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 204
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 261

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNH 82
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M+  +L  VI    D  R S L +Q    ++C
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHERMSYLLYQ----MLC 137
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV 
Sbjct: 138 GIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVT 188
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y Y +PE  +   +    D++S G ++ E V  K
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 135
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 187
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 244

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHR 598
           + +   +KLG+G +  VYKG+  L    +A+K  RL    G      + EV L+  L+H 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHA 60
Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           N+V L           LV+EY+ ++ L   + D    +I+N       +  + RGL Y H
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCH 117
Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
              R +++HRDLK  N+L+++    K++DFG+AR      T+     VV T  Y  P+  
Sbjct: 118 ---RQKVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYDNEVV-TLWYRPPDIL 172
Query: 719 MDGL-FSVKSDVFSFGVLLLETVSGK 743
           +    +S + D++  G +  E  +G+
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 108/224 (48%), Gaps = 14/224 (6%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T    +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   +S  L+       +  I RGL Y+H  +
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN 164
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT---KRVVGTYGYMSPEYA 718
              ++HRDLK SN+L++     KI DFG+ARI   D    +T      V T  Y +PE  
Sbjct: 165 ---VLHRDLKPSNLLINTTCDLKICDFGLARI--ADPEHDHTGFLTEXVATRWYRAPEIM 219
Query: 719 MDGLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
           ++     KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 260

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 240

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   Y+   ++ +E+   ++   S        E+   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+ +   I +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           IHRDLK  N+ L+ +M  KI DFG+A     D   + T  + GT  Y++PE       S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKGHSF 221
Query: 726 KSDVFSFGVLLLETVSGK 743
           + D++S G +L   + GK
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 135
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTG 187
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 244

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      L    +A++++S    Q   +    E++++ + +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 244

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 29/212 (13%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ----MLCGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV  Y
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRY 190
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            Y +PE  +   +    D++S G ++ E + G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 145 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 240

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 242

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 76
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 77  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 130
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 131 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 190
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 191 KSSDLWALGCIIYQLVAG 208

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 240

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 240

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 152
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 153 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 209
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 210 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 248

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 145 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 240

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   Y+   ++ +E+   ++   S        E+   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+ +   I +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           IHRDLK  N+ L+ +M  KI DFG+A     D   +  K + GT  Y++PE       S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERKKXLCGTPNYIAPEVLCKKGHSF 221
Query: 726 KSDVFSFGVLLLETVSGK 743
           + D++S G +L   + GK
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 108/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 165 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 260

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 113/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 136
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T      
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTG 188
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 245

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 540 ATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLS-RNSGQGIEEFK-NEVRLIAKLQ 596
           + D +    KLG+G +G VYK    +  + +A+KR+   +  +G+      EV L+ +LQ
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           HRN++ L           L++EY EN  L   + DK     +   + F  +  +  G+ +
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSF--LYQLINGVNF 147
Query: 657 LHQDSRFRIIHRDLKASNILL---DKEMTP--KISDFGMARIFGGDQTEQNTKRVVGTYG 711
            H  SR R +HRDLK  N+LL   D   TP  KI DFG+AR F G    Q T  ++ T  
Sbjct: 148 CH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII-TLW 202
Query: 712 YMSPEYAMDGL-FSVKSDVFSFGVLLLETV 740
           Y  PE  +    +S   D++S   +  E +
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 75
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 76  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 129
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 130 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 189
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 190 KSSDLWALGCIIYQLVAG 207

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 99
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 153
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 213
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 214 KSSDLWALGCIIYQLVAG 231

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 113/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 136
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T      
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTG 188
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 245

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 107/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++ + +H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    + + ++   ++  L+       +  I RGL Y+H  +
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 165 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 260

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   ++    + +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+  +  I  G  YLH++   R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 142
Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           IHRDLK  N+ L++++  KI DFG+A     D   + T  + GT  Y++PE       S 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 200
Query: 726 KSDVFSFGVLLLETVSGK 743
           + DV+S G ++   + GK
Sbjct: 201 EVDVWSIGCIMYTLLVGK 218

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 113/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 136
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T      
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTG 188
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 245

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 99
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 153
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 213
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 214 KSSDLWALGCIIYQLVAG 231

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   ++    + +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+  +  I  G  YLH++   R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 138
Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           IHRDLK  N+ L++++  KI DFG+A     D   + T  + GT  Y++PE       S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 726 KSDVFSFGVLLLETVSGK 743
           + DV+S G ++   + GK
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   ++    + +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+  +  I  G  YLH++   R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 138
Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           IHRDLK  N+ L++++  KI DFG+A     D   + T  + GT  Y++PE       S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 726 KSDVFSFGVLLLETVSGK 743
           + DV+S G ++   + GK
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 114/235 (48%), Gaps = 29/235 (12%)
Query: 524 TDDLELPLFDFETIVRATDNFTDYN-------KLGQGGFGIVYKG--RLLEGQEIAVKRL 574
           T+  E P  D E I R  + + D         +LG G FG V KG  ++ +  +    ++
Sbjct: 3   TEVYESPYADPEEI-RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKI 61
Query: 575 SRNSGQGI---EEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD 631
            +N        +E   E  ++ +L +  +VR++G C E +  MLV E  E   L+  +  
Sbjct: 62  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-- 118
Query: 632 KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
             ++  +  +    ++  ++ G+ YL ++S F  +HRDL A N+LL  +   KISDFG++
Sbjct: 119 -QQNRHVKDKNIIELVHQVSMGMKYL-EESNF--VHRDLAARNVLLVTQHYAKISDFGLS 174
Query: 692 RIFGGDQTEQNTKRVVGTYG-----YMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
           +    D+     +    T+G     + +PE      FS KSDV+SFGVL+ E  S
Sbjct: 175 KALRADENYYKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 114/235 (48%), Gaps = 29/235 (12%)
Query: 524 TDDLELPLFDFETIVRATDNFTDYN-------KLGQGGFGIVYKG--RLLEGQEIAVKRL 574
           T+  E P  D E I R  + + D         +LG G FG V KG  ++ +  +    ++
Sbjct: 3   TEVYESPYADPEEI-RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKI 61
Query: 575 SRNSGQGI---EEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD 631
            +N        +E   E  ++ +L +  +VR++G C E +  MLV E  E   L+  +  
Sbjct: 62  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL-- 118
Query: 632 KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
             ++  +  +    ++  ++ G+ YL ++S F  +HRDL A N+LL  +   KISDFG++
Sbjct: 119 -QQNRHVKDKNIIELVHQVSMGMKYL-EESNF--VHRDLAARNVLLVTQHYAKISDFGLS 174
Query: 692 RIFGGDQTEQNTKRVVGTYG-----YMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
           +    D+     +    T+G     + +PE      FS KSDV+SFGVL+ E  S
Sbjct: 175 KALRADENYYKAQ----THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 152
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 152
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 29/212 (13%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++ GI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ----MLVGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV  Y
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRY 190
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            Y +PE  +   +    D++S GV++ E + G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 101
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 102 FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 155
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 156 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 215
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 216 KSSDLWALGCIIYQLVAG 233

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 73
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 74  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 127
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 128 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 187
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 188 KSSDLWALGCIIYQLVAG 205

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 29/212 (13%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ----MLCGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV  Y
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRY 190
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            Y +PE  +   +    D++S G ++ E + G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 150
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 211 KSSDLWALGCIIYQLVAG 228

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 150
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 211 KSSDLWALGCIIYQLVAG 228

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 150
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSAC 210
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 211 KSSDLWALGCIIYQLVAG 228

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 152
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 152
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLS--RNSGQGIEEFKNEVRLIAKLQH 597
           TD +  + +LG+G F +V +  ++  GQE A K ++  + S +  ++ + E R+   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N+VRL     E     LV++ +    L   I  +   S  +     + I  I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILESVNHC 119
Query: 658 HQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
           H +    I+HRDLK  N+LL    K    K++DFG+A    GDQ  Q      GT GY+S
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ--QAWFGFAGTPGYLS 174
Query: 715 PEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           PE      +    D+++ GV+L   + G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   Y+   ++ +E+   ++   S        E+   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+ +   I +G+ YLH +   R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           IHRDLK  N+ L+ +M  KI DFG+A     D   +  K + GT  Y++PE       S 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERKKDLCGTPNYIAPEVLCKKGHSF 221
Query: 726 KSDVFSFGVLLLETVSGK 743
           + D++S G +L   + GK
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 549 KLGQGGFGIVYKG--RLLEGQEIAVKRLSRNSGQG---IEEFKNEVRLIAKLQHRNLVRL 603
           +LG G FG V KG  ++ +  +    ++ +N        +E   E  ++ +L +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G C E +  MLV E  E   L+  +    ++  +  +    ++  ++ G+ YL ++S F
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL-EESNF 132
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG-----YMSPEYA 718
             +HRDL A N+LL  +   KISDFG+++    D+     +    T+G     + +PE  
Sbjct: 133 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQ----THGKWPVKWYAPECI 186
Query: 719 MDGLFSVKSDVFSFGVLLLETVS 741
               FS KSDV+SFGVL+ E  S
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 74
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 75  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 128
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 188
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 189 KSSDLWALGCIIYQLVAG 206

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 152
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAX 212
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 213 KSSDLWALGCIIYQLVAG 230

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 29/212 (13%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ----MLCGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV  Y
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY 190
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            Y +PE  +   +    D++S G ++ E + G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 80
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 81  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 134
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 194
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 195 KSSDLWALGCIIYQLVAG 212

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 108/232 (46%), Gaps = 32/232 (13%)
Query: 529 LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRL-SRNSGQGIEEFKN 587
           LPL    TI +         ++G+G +G V+ G+   G+++AVK   +        E   
Sbjct: 27  LPLLVQRTIAKQIQMV---KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRE--T 80
Query: 588 EVRLIAKLQHRNLVRLLGCCVE----MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRR 643
           E+     ++H N++  +   ++      +  L+ +Y EN SL    +D  +S+ L+ +  
Sbjct: 81  EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSM 136
Query: 644 FNIICGIARGLLYLHQD-----SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
             +      GL +LH +      +  I HRDLK+ NIL+ K  T  I+D G+A  F  D 
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196
Query: 699 TE----QNTKRVVGTYGYMSPEYAMDGL------FSVKSDVFSFGVLLLETV 740
            E     NT+  VGT  YM PE   + L        + +D++SFG++L E  
Sbjct: 197 NEVDIPPNTR--VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 549 KLGQGGFGIVYKG--RLLEGQEIAVKRLSRNSGQGI---EEFKNEVRLIAKLQHRNLVRL 603
           +LG G FG V KG  ++ +  +    ++ +N        +E   E  ++ +L +  +VR+
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G C E +  MLV E  E   L+  +    ++  +  +    ++  ++ G+ YL ++S F
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL-EESNF 146
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG-----YMSPEYA 718
             +HRDL A N+LL  +   KISDFG+++    D+     +    T+G     + +PE  
Sbjct: 147 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPECI 200
Query: 719 MDGLFSVKSDVFSFGVLLLETVS 741
               FS KSDV+SFGVL+ E  S
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 29/212 (13%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV  Y
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPEVVTRY 190
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            Y +PE  +   +    D++S G ++ E + G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLS--RNSGQGIEEFKNEVRLIAKLQH 597
           TD +  + +LG+G F +V +  ++  GQE A K ++  + S +  ++ + E R+   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N+VRL     E     LV++ +    L   I  +   S  +     + I  I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILESVNHC 119
Query: 658 HQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
           H +    I+HRDLK  N+LL    K    K++DFG+A    GDQ  Q      GT GY+S
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ--QAWFGFAGTPGYLS 174
Query: 715 PEYAMDGLFSVKSDVFSFGVLL 736
           PE      +    D+++ GV+L
Sbjct: 175 PEVLRKDPYGKPVDMWACGVIL 196

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 550 LGQGGFGIVYKGRLL------EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +              +AVK L  ++     E   +E+++++ L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 602 RLLGCCVEMDEKMLVYEY--------MENRSLDSVIFDKARSSILNWQRRF-------NI 646
            LLG C      +++ EY           R  DS I  K   +I+             + 
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D         
Sbjct: 174 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
                +M+PE   + +++ +SDV+S+G+ L E  S
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   Y+   ++ +E+   ++   S        E+   E+ +   L + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+ +   I +G+ YLH +   R+
Sbjct: 94  FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 147
Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           IHRDLK  N+ L+ +M  KI DFG+A     D   +  K + GT  Y++PE       S 
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDG--ERKKDLCGTPNYIAPEVLCKKGHSF 205
Query: 726 KSDVFSFGVLLLETVSGK 743
           + D++S G +L   + GK
Sbjct: 206 EVDIWSLGCILYTLLVGK 223

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI D+G+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 95
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 96  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 149
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 209
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 210 KSSDLWALGCIIYQLVAG 227

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNH 82
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M+  +L  VI    D  R S L +Q    ++C
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQ----MLC 137
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV 
Sbjct: 138 GIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVT 188
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y Y +PE  +   +    D++S G ++ E V  K
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 95
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 96  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 149
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 209
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 210 KSSDLWALGCIIYQLVAG 227

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LS+     I   +   E+RL
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRL 86
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 141
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR      T+     
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 193
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 250

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 113
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 172
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 173 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-Y 226
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 227 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKLQH 597
           D+F     LG+G FG VY  R  +   I A+K L  S+   +G+E + + E+ + A L H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N++RL     +     L+ EY     L   +    +S   + QR   I+  +A  L+Y 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELADALMYC 139
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     ++IHRD+K  N+LL  +   KI+DFG    +         K + GT  Y+ PE 
Sbjct: 140 HGK---KVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCGTLDYLPPEM 192
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
               + + K D++  GVL  E + G
Sbjct: 193 IEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 168
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 169 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-Y 222
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 550 LGQGGFGIVYKGRLL------EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +              +AVK L  ++     E   +E+++++ L  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 602 RLLGCCVEMDEKMLVYEY--------MENRSLDSVIFDKARSSILNWQRRF-------NI 646
            LLG C      +++ EY           R  DS I  K   +I+             + 
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D         
Sbjct: 167 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
                +M+PE   + +++ +SDV+S+G+ L E  S
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 107/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++   +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 242

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 103
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 162
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 163 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-Y 216
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 217 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 109
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 168
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 169 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-Y 222
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 550 LGQGGFGIVYKGRLL------EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +              +AVK L  ++     E   +E+++++ L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 602 RLLGCCVEMDEKMLVYEY--------MENRSLDSVIFDKARSSILNWQRRF-------NI 646
            LLG C      +++ EY           R  DS I  K   +I+             + 
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D         
Sbjct: 174 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
                +M+PE   + +++ +SDV+S+G+ L E  S
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   ++    + +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+  +  I  G  YLH++   R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 162
Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           IHRDLK  N+ L++++  KI DFG+A     D   +  K + GT  Y++PE       S 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 726 KSDVFSFGVLLLETVSGK 743
           + DV+S G ++   + GK
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 550 LGQGGFGIVYKGRLL------EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +              +AVK L  ++     E   +E+++++ L  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 602 RLLGCCVEMDEKMLVYEY--------MENRSLDSVIFDKARSSILNWQRRF-------NI 646
            LLG C      +++ EY           R  DS I  K   +I+             + 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D         
Sbjct: 151 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
                +M+PE   + +++ +SDV+S+G+ L E  S
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 111
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 170
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 171 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-Y 224
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 225 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 544 FTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHRN 599
           +     +G G  GIV      + G  +AVK+LSR   N       ++ E+ L+  + H+N
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKN 84
Query: 600 LVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           ++ LL          E  +  LV E M + +L  VI    D  R S L +Q    ++CGI
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQ----MLCGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
                +LH      IIHRDLK SNI++  + T KI DFG+AR    +     T  VV  Y
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVVTRY 190
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            Y +PE  +   ++   D++S G ++ E V G
Sbjct: 191 -YRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 601 VRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIA-----RGL 654
           VRL        EK  +VY  +    +   ++  AR      Q    I   +      R L
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
            Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YR 189
Query: 714 SPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
           +PE       ++   DV+S G +L E + G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   ++    + +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+  +  I  G  YLH++   R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 160
Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           IHRDLK  N+ L++++  KI DFG+A     D   +  K + GT  Y++PE       S 
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSF 218
Query: 726 KSDVFSFGVLLLETVSGK 743
           + DV+S G ++   + GK
Sbjct: 219 EVDVWSIGCIMYTLLVGK 236

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 107/222 (48%), Gaps = 10/222 (4%)
Query: 544 FTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLV 601
           +T+ + +G+G +G+V      +    +A+K++S    Q   +    E++++   +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            +         + +   Y+    +++ ++   ++  L+       +  I RGL Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYAMD 720
              ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE  ++
Sbjct: 147 ---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 721 GLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                KS D++S G +L E +S   NR  +   + L+ L H+
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLS---NRPIFPGKHYLDQLNHI 242

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 117/229 (51%), Gaps = 22/229 (9%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLS-RNSGQGIEEFK-NEVRLIAKLQHRNL 600
           +    K+G+G +G V+K +  E  EI A+KR+   +  +G+      E+ L+ +L+H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 601 VRLLGCCVEMDEKM-LVYEYMEN---RSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           VRL    +  D+K+ LV+E+ +    +  DS   D      L+ +   + +  + +GL +
Sbjct: 64  VRLHDV-LHSDKKLTLVFEFCDQDLKKYFDSCNGD------LDPEIVKSFLFQLLKGLGF 116
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
            H  +   ++HRDLK  N+L+++    K++DFG+AR FG      + +  V T  Y  P+
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE--VVTLWYRPPD 171
Query: 717 YAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
                 L+S   D++S G +  E  +    R  +  N+  + L  ++RL
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAA--RPLFPGNDVDDQLKRIFRL 218

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 549 KLGQGGFGIVYKG--RLLEGQEIAVKRLSRNSGQG---IEEFKNEVRLIAKLQHRNLVRL 603
           +LG G FG V KG  ++ +  +    ++ +N        +E   E  ++ +L +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G C E +  MLV E  E   L+  +    ++  +  +    ++  ++ G+ YL ++S F
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL-EESNF 132
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG-----YMSPEYA 718
             +HRDL A N+LL  +   KISDFG+++    D+     +    T+G     + +PE  
Sbjct: 133 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPECI 186
Query: 719 MDGLFSVKSDVFSFGVLLLETVS 741
               FS KSDV+SFGVL+ E  S
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 29/206 (14%)
Query: 550 LGQGGFGIV-----YKGRLLEGQEIAVKRLSRNSGQGIE---EFKNEVRLIAKLQHRNLV 601
           LG+G FG V     YK +    Q++A+K +SR   +  +     + E+  +  L+H +++
Sbjct: 17  LGEGSFGKVKLATHYKTQ----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF--NIICGIARGLLYLHQ 659
           +L        + ++V EY      D ++  K  +   +  RRF   IIC I     Y H 
Sbjct: 73  KLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTE--DEGRRFFQQIICAIE----YCH- 125
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN-TKRVVGTYGYMSPEYA 718
             R +I+HRDLK  N+LLD  +  KI+DFG++ I     T+ N  K   G+  Y +PE  
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAPEVI 179
Query: 719 MDGLFS-VKSDVFSFGVLLLETVSGK 743
              L++  + DV+S G++L   + G+
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 549 KLGQGGFGIVYKG--RLLEGQEIAVKRLSRNSGQG---IEEFKNEVRLIAKLQHRNLVRL 603
           +LG G FG V KG  ++ +  +    ++ +N        +E   E  ++ +L +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G C E +  MLV E  E   L+  +    ++  +  +    ++  ++ G+ YL ++S F
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL-EESNF 128
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG-----YMSPEYA 718
             +HRDL A N+LL  +   KISDFG+++    D+     +    T+G     + +PE  
Sbjct: 129 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPECI 182
Query: 719 MDGLFSVKSDVFSFGVLLLETVS 741
               FS KSDV+SFGVL+ E  S
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 27/211 (12%)
Query: 549 KLGQGGFGIVYKGRLLEGQ-EIAVKRLSR---------NSGQGIEEFK----NEVRLIAK 594
           KLG G +G V   +   G  E A+K + +         +  + IE+F     NE+ L+  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           L H N+++L     +     LV E+ E   L   I ++ +    +     NI+  I  G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA---NIMKQILSGI 159
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGMARIFGGDQTEQNTKRVVGTYG 711
            YLH+ +   I+HRD+K  NILL+ +   +  KI DFG++  F  D   ++    +GT  
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---LGTAY 213
Query: 712 YMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           Y++PE  +   ++ K DV+S GV++   + G
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 29/212 (13%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++ GI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ----MLVGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV  Y
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRY 190
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            Y +PE  +   +    D++S GV++ E + G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 549 KLGQGGFGIVYKG--RLLEGQEIAVKRLSRNSGQG---IEEFKNEVRLIAKLQHRNLVRL 603
           +LG G FG V KG  ++ +  +    ++ +N        +E   E  ++ +L +  +VR+
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G C E +  MLV E  E   L+  +    ++  +  +    ++  ++ G+ YL ++S F
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL-EESNF 126
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG-----YMSPEYA 718
             +HRDL A N+LL  +   KISDFG+++    D+     +    T+G     + +PE  
Sbjct: 127 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPECI 180
Query: 719 MDGLFSVKSDVFSFGVLLLETVS 741
               FS KSDV+SFGVL+ E  S
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 550 LGQGGFGIVYKGRLL------EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKL-QHRNLV 601
           LG G FG V +              +AVK L  ++     E   +E+++++ L  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 602 RLLGCCVEMDEKMLVYEY--------MENRSLDSVIFDKARSSILNWQRRF-------NI 646
            LLG C      +++ EY           R  DS I  K   +I+             + 
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              +A+G+ +L   +    IHRDL A NILL      KI DFG+AR    D         
Sbjct: 169 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
                +M+PE   + +++ +SDV+S+G+ L E  S
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 120
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M+  +L  VI    D  R S L +Q    ++C
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSYLLYQ----MLC 175
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV 
Sbjct: 176 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVT 226
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y Y +PE  +   +    D++S G ++ E V  K
Sbjct: 227 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 80
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 139
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 140 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-Y 193
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 194 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 154
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 213
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 214 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-Y 267
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 268 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 83
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 142
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 143 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-Y 196
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 197 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 94
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 153
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 154 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-Y 207
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 208 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 549 KLGQGGFGIVYKG--RLLEGQEIAVKRLSRNSGQG---IEEFKNEVRLIAKLQHRNLVRL 603
           +LG G FG V KG  ++ +  +    ++ +N        +E   E  ++ +L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G C E +  MLV E  E   L+  +    ++  +  +    ++  ++ G+ YL ++S F
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL-EESNF 138
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG-----YMSPEYA 718
             +HRDL A N+LL  +   KISDFG+++    D+     +    T+G     + +PE  
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKWPVKWYAPECI 192
Query: 719 MDGLFSVKSDVFSFGVLLLETVS 741
               FS KSDV+SFGVL+ E  S
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLS--RNSGQGIEEFKNEVRLIAKLQH 597
           +DN+    +LG+G F +V +      G E A K ++  + S +  ++ + E R+  KLQH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N+VRL     E     LV++ +    L   I  +   S  +     + I  I   + Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAYC 120
Query: 658 HQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
           H +    I+HR+LK  N+LL    K    K++DFG+A      +         GT GY+S
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 174
Query: 715 PEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           PE      +S   D+++ GV+L   + G
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 146
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 147 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-Y 200
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLS--RNSGQGIEEFKNEVRLIAKLQH 597
           +DN+    +LG+G F +V +      G E A K ++  + S +  ++ + E R+  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N+VRL     E     LV++ +    L   I  +   S  +     + I  I   + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAYC 121
Query: 658 HQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
           H +    I+HR+LK  N+LL    K    K++DFG+A      +         GT GY+S
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 175
Query: 715 PEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           PE      +S   D+++ GV+L   + G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 146
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 147 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-Y 200
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   ++    + +E+   ++   S        E+   E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              + D   +V E    RSL  +   K R ++   + R+  +  I  G  YLH++   R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN---RV 136
Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           IHRDLK  N+ L++++  KI DFG+A     D   +  K + GT  Y++PE       S 
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 726 KSDVFSFGVLLLETVSGK 743
           + DV+S G ++   + GK
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 29/212 (13%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV  Y
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY 190
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            Y +PE  +   +    D++S G ++ E + G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 83
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M+  +L  VI    D  R S L +Q    ++C
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQ----MLC 138
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV 
Sbjct: 139 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVT 189
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y Y +PE  +   +    D++S G ++ E V  K
Sbjct: 190 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLS--RNSGQGIEEFKNEVRLIAKLQH 597
           +DN+    +LG+G F +V +      G E A K ++  + S +  ++ + E R+  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N+VRL     E     LV++ +    L   I  +   S  +     + I  I   + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAYC 121
Query: 658 HQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
           H +    I+HR+LK  N+LL    K    K++DFG+A      +         GT GY+S
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 175
Query: 715 PEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           PE      +S   D+++ GV+L   + G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 113/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DF +AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 134
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-Y 188
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M+  +L  VI    D  R S L +Q    ++C
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQ----MLC 137
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV 
Sbjct: 138 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVT 188
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y Y +PE  +   +    D++S G ++ E V  K
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 29/212 (13%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 84
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 140
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV  Y
Sbjct: 141 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY 191
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            Y +PE  +   +    D++S G ++ E + G
Sbjct: 192 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 134
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-Y 188
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 112/233 (48%), Gaps = 26/233 (11%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           + D   LG GG G+V+     +  + +A+K++     Q ++    E+++I +L H N+V+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 603 L--------------LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC 648
           +              +G   E++   +V EYME   L +V+    +  +L    R   + 
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL---EQGPLLEEHARL-FMY 127
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTEQ-NTKRV 706
            + RGL Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+ARI     + + +    
Sbjct: 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 707 VGTYGYMSPEYAMDGLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
           + T  Y SP   +      K+ D+++ G +  E ++GK      H   ++ L+
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 76
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 135
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 136 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-Y 189
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 190 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M + +L  VI    D  R S L +Q    ++C
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ----MLC 137
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV 
Sbjct: 138 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVT 188
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y Y +PE  +   +    D++S G ++ E V  K
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 79
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 138
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 139 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-Y 192
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 193 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 76
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M+  +L  VI    D  R S L +Q    ++C
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQ----MLC 131
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV 
Sbjct: 132 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVT 182
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y Y +PE  +   +    D++S G ++ E V  K
Sbjct: 183 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 81
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M+  +L  VI    D  R S L +Q    ++C
Sbjct: 82  KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQ----MLC 136
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV 
Sbjct: 137 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVT 187
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y Y +PE  +   +    D++S G ++ E V  K
Sbjct: 188 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 83
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M + +L  VI    D  R S L +Q    ++C
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ----MLC 138
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV 
Sbjct: 139 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVT 189
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y Y +PE  +   +    D++S G ++ E V  K
Sbjct: 190 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 88
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 147
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 148 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-Y 201
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 202 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 29/212 (13%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV  Y
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY 190
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            Y +PE  +   +    D++S G ++ E + G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 76
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M + +L  VI    D  R S L +Q    ++C
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ----MLC 131
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV 
Sbjct: 132 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVT 182
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y Y +PE  +   +    D++S G ++ E V  K
Sbjct: 183 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 134
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-Y 188
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 104/214 (48%), Gaps = 31/214 (14%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 120
Query: 598 RNLVRLLGCCVE---MDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICG 649
           +N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CG
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ----MLCG 176
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           I     +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV  
Sbjct: 177 IK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTR 227
Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           Y Y +PE  +   +    D++S G ++ E V  K
Sbjct: 228 Y-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M + +L  VI    D  R S L +Q    ++C
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQ----MLC 130
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
           GI     +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV 
Sbjct: 131 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVT 181
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y Y +PE  +   +    D++S G ++ E V  K
Sbjct: 182 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 99/212 (46%), Gaps = 29/212 (13%)
Query: 544 FTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHRN 599
           +     +G G  GIV      + G  +AVK+LSR   N       ++ E+ L+  + H+N
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKN 82
Query: 600 LVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           ++ LL          E  +  LV E M + +L  VI    D  R S L +Q    ++CGI
Sbjct: 83  IISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQ----MLCGI 137
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
                +LH      IIHRDLK SNI++  + T KI DFG+AR          T  VV  Y
Sbjct: 138 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TASTNFMMTPYVVTRY 188
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            Y +PE  +   +    D++S G ++ E V G
Sbjct: 189 -YRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F      R L   +E A+K L +        +     E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 606 CCVEMDEKMLV-YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
              + DEK+     Y +N  L   I  +   S      RF     I   L YLH      
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRF-YTAEIVSALEYLHGKG--- 150
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE   +    
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 725 VKSDVFSFGVLLLETVSG 742
             SD+++ G ++ + V+G
Sbjct: 211 KSSDLWALGCIIYQLVAG 228

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 35/218 (16%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ +        FKN E++++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNI 75
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN-------------II 647
           VRL        EK       ++    +++ D   +++    R ++              +
Sbjct: 76  VRLRYFFYSSGEK-------KDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRV 706
             + R L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +
Sbjct: 129 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXI 183
Query: 707 VGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
              Y Y +PE       ++   DV+S G +L E + G+
Sbjct: 184 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 15/211 (7%)
Query: 532 FDFETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLS--RNSGQGIEEFKNE 588
           F      + +DN+    +LG+G F +V +      G E A K ++  + S +  ++ + E
Sbjct: 19  FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC 648
            R+  KLQH N+VRL     E     LV++ +    L   I  +   S  +     + I 
Sbjct: 79  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQ 135
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKR 705
            I   + Y H +    I+HR+LK  N+LL    K    K++DFG+A      +       
Sbjct: 136 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--- 189
Query: 706 VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
             GT GY+SPE      +S   D+++ GV+L
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           DN      +G+G +G VYKG L E + +AVK  S  + Q     KN  R +  ++H N+ 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSLDE-RPVAVKVFSFANRQNFINEKNIYR-VPLMEHDNIA 70
Query: 602 RLL--GCCVEMDEKM---LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           R +     V  D +M   LV EY  N SL   +         +W     +   + RGL Y
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGLAY 126
Query: 657 LHQD------SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT----EQNTKRV 706
           LH +       +  I HRDL + N+L+  + T  ISDFG++    G++     E++   +
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 707 --VGTYGYMSPEYAMDGLFSVKS--------DVFSFGVLLLE 738
             VGT  YM+PE  ++G  +++         D+++ G++  E
Sbjct: 187 SEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWE 227

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 33/215 (15%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNH 82
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M + +L  VI    D  R S L +Q       
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQ------- 134
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            +  G+ +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV 
Sbjct: 135 -MLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVT 188
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y Y +PE  +   +    D++S G ++ E V  K
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 113/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI  FG+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ +        FKN E++++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNI 75
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 134
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-Y 188
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 113/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI D G+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 23/212 (10%)
Query: 543 NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNL 600
           ++TD   +G G FG+VY+ +L + G+ +A+K++ +        FKN E++++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNI 75
Query: 601 VRLLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           VRL        EK       LV +Y+ E     +  + +A+ ++     +  +   + R 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY-QLFRS 134
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y Y
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-Y 188
Query: 713 MSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +PE       ++   DV+S G +L E + G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 96/204 (47%), Gaps = 11/204 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           D++  + +LG G FG+V++      G   A K +        E  + E++ ++ L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V L     + +E +++YE+M    L   + D+     ++       +  + +GL ++H++
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHEN 274
Query: 661 SRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
           +    +H DLK  NI+   + +   K+ DFG+         +Q+ K   GT  + +PE A
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 328
Query: 719 MDGLFSVKSDVFSFGVLLLETVSG 742
                   +D++S GVL    +SG
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 85
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 141
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G   T       V T 
Sbjct: 142 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMVPFVVTR 191
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            Y +PE  +   +    D++S G ++ E + G
Sbjct: 192 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 30/237 (12%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLI 592
           I    ++F  +  LG+G FG V+     +  Q  A+K L ++       +E    E R++
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 72
Query: 593 AKLQHRNLVRLLGCCVEMDEKML-VYEYMENRSLDSVI-----FDKARSSILNWQRRFNI 646
           +       +  + C  +  E +  V EY+    L   I     FD +R++    +     
Sbjct: 73  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE----- 127
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTK 704
              I  GL +LH      I++RDLK  NILLDK+   KI+DFGM +  + G  +T +   
Sbjct: 128 ---IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNE--- 178
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
              GT  Y++PE  +   ++   D +SFGVLL E + G+     +H  +E  L   +
Sbjct: 179 -FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP---FHGQDEEELFHSI 231

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 107/237 (45%), Gaps = 30/237 (12%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLI 592
           I    ++F  +  LG+G FG V+     +  Q  A+K L ++       +E    E R++
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 593 AKLQHRNLVRLLGCCVEMDEKML-VYEYMENRSLDSVI-----FDKARSSILNWQRRFNI 646
           +       +  + C  +  E +  V EY+    L   I     FD +R++    +     
Sbjct: 72  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE----- 126
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTK 704
              I  GL +LH      I++RDLK  NILLDK+   KI+DFGM +  + G    +  T 
Sbjct: 127 ---IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG----DAKTN 176
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
              GT  Y++PE  +   ++   D +SFGVLL E + G+     +H  +E  L   +
Sbjct: 177 XFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP---FHGQDEEELFHSI 230

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 117/229 (51%), Gaps = 22/229 (9%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLS-RNSGQGIEEFK-NEVRLIAKLQHRNL 600
           +    K+G+G +G V+K +  E  EI A+KR+   +  +G+      E+ L+ +L+H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 601 VRLLGCCVEMDEKM-LVYEYMEN---RSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           VRL    +  D+K+ LV+E+ +    +  DS   D      L+ +   + +  + +GL +
Sbjct: 64  VRLHDV-LHSDKKLTLVFEFCDQDLKKYFDSCNGD------LDPEIVKSFLFQLLKGLGF 116
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
            H  +   ++HRDLK  N+L+++    K+++FG+AR FG      + +  V T  Y  P+
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE--VVTLWYRPPD 171
Query: 717 YAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
                 L+S   D++S G +  E  +    R  +  N+  + L  ++RL
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANA--GRPLFPGNDVDDQLKRIFRL 218

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 77
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 133
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV  Y
Sbjct: 134 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY 184
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y +PE  +   +    D++S G ++ E V  K
Sbjct: 185 -YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 104/213 (48%), Gaps = 29/213 (13%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G   T    +  V T 
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMEPEVVTR 189
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y +PE  +   +    D++S G ++ E V  K
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 88
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 144
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV  Y
Sbjct: 145 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY 195
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y +PE  +   +    D++S G ++ E V  K
Sbjct: 196 -YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 113/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI D G+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 96/204 (47%), Gaps = 11/204 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYK-GRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           D++  + +LG G FG+V++      G   A K +        E  + E++ ++ L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V L     + +E +++YE+M    L   + D+     ++       +  + +GL ++H++
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHEN 168
Query: 661 SRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
           +    +H DLK  NI+   + +   K+ DFG+         +Q+ K   GT  + +PE A
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 222
Query: 719 MDGLFSVKSDVFSFGVLLLETVSG 742
                   +D++S GVL    +SG
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q        +
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ--------M 135
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
             G+ +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV  Y
Sbjct: 136 LVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRY 190
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            Y +PE  +   +    D++S G ++ E + G
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 33/215 (15%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 82
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M + +L  VI    D  R S L +Q       
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQ------- 134
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            +  G+ +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV 
Sbjct: 135 -MLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVT 188
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y Y +PE  +   +    D++S G ++ E V  K
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 113/240 (47%), Gaps = 26/240 (10%)
Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN--EVRL 591
           +TI    + + + + +G G +G V        G  +AVK+LSR     I   +   E+RL
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  ++H N++ LL          E ++  LV   M    L++++    +   L       
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQF 129
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           +I  I RGL Y+H      IIHRDLK SN+ ++++   KI D G+AR      T+     
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR-----HTDDEMTG 181
Query: 706 VVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            V T  Y +PE  ++ + ++   D++S G ++ E ++G   R  +   + ++ L  + RL
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG---RTLFPGTDHIDQLKLILRL 238

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 33/215 (15%)
Query: 544 FTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           + +   +G G  GIV   Y   L   + +A+K+LSR   N       ++ E+ L+  + H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNH 75
Query: 598 RNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVI---FDKARSSILNWQRRFNIIC 648
           +N++ LL          E  +  LV E M+  +L  VI    D  R S L +Q       
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHERMSYLLYQ------- 127
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            +  G+ +LH      IIHRDLK SNI++  + T KI DFG+AR  G   +   T  VV 
Sbjct: 128 -MLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT--SFMMTPYVVT 181
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y Y +PE  +   +    D++S G ++ E V  K
Sbjct: 182 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 17/222 (7%)
Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKN---EV 589
           F+      D +     +G G +G+V   R  L GQ++A+K++  N+   +   K    E+
Sbjct: 47  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP-NAFDVVTNAKRTLREL 105
Query: 590 RLIAKLQHRNLVRL---LGCCVEMDEKMLVYEYMENRSLD-SVIFDKARSSILNWQRRFN 645
           +++   +H N++ +   L   V   E   VY  ++    D   I   ++   L   R F 
Sbjct: 106 KILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYF- 164
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN--T 703
            +  + RGL Y+H     ++IHRDLK SN+L+++    KI DFGMAR       E     
Sbjct: 165 -LYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 220
Query: 704 KRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKK 744
              V T  Y +PE  +    ++   D++S G +  E ++ ++
Sbjct: 221 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 105/271 (38%), Gaps = 72/271 (26%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQ 596
           R   +F     +G+GGFG+V++ +  ++    A+KR+   N     E+   EV+ +AKL+
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 597 HRNLVRLLGCCV---------EMDEKMLVYEY----------MENRSLDSVIFDK----- 632
           H  +VR     +         EMDE  L  E           M+  S+     D      
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 633 ---------------------ARSSILNWQRR------------FNIICGIARGLLYLHQ 659
                                 + ++ +W  R             +I   IA  + +LH 
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV----------VGT 709
                ++HRDLK SNI    +   K+ DFG+      D+ EQ               VGT
Sbjct: 183 KG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGT 239
Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLETV 740
             YMSPE      +S K D+FS G++L E +
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIEE-FKNEVRLIAK 594
           I+  +D +     +G G FG+    R  +  E +AVK + R  G+ I+E  K E+     
Sbjct: 14  IMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIER--GEKIDENVKREIINHRS 71
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           L+H N+VR     +      +V EY     L   I +  R S    + RF     +  G+
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARF-FFQQLISGV 128
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
            Y H     ++ HRDLK  N LLD    P  KI+DFG ++           K  VGT  Y
Sbjct: 129 SYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTPAY 182
Query: 713 MSPEYAMDGLFSVK-SDVFSFGVLLLETVSG 742
           ++PE  +   +  K +DV+S GV L   + G
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 104/213 (48%), Gaps = 29/213 (13%)
Query: 544 FTDYNKLGQGGFGIVYKG--RLLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHR 598
           + +   +G G  GIV      +LE + +A+K+LSR   N       ++ E+ L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 599 NLVRLLGCCV---EMDEKMLVYEYME--NRSLDSVI---FDKARSSILNWQRRFNIICGI 650
           N++ LL        ++E   VY  ME  + +L  VI    D  R S L +Q    ++CGI
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----MLCGI 139
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
                +LH      IIHRDLK SNI++  + T KI DFG+AR  G   T    +  V T 
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMEPEVVTR 189
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            Y +PE  +   +    D++S G ++ E V  K
Sbjct: 190 YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 16/192 (8%)
Query: 550 LGQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQHRNLVRLLGCC 607
           LG G F  +V       G+  AVK + + + +G E   +NE+ ++ K++H N+V L    
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIY 89
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
              +   LV + +    L   I +K        +    +I  +   + YLH   R  I+H
Sbjct: 90  ESPNHLYLVMQLVSGGELFDRIVEKG---FYTEKDASTLIRQVLDAVYYLH---RMGIVH 143
Query: 668 RDLKASNILL---DKEMTPKISDFGMARIFG-GDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           RDLK  N+L    D+E    ISDFG++++ G GD          GT GY++PE      +
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMST----ACGTPGYVAPEVLAQKPY 199
Query: 724 SVKSDVFSFGVL 735
           S   D +S GV+
Sbjct: 200 SKAVDCWSIGVI 211

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 17/222 (7%)
Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKN---EV 589
           F+      D +     +G G +G+V   R  L GQ++A+K++  N+   +   K    E+
Sbjct: 46  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP-NAFDVVTNAKRTLREL 104
Query: 590 RLIAKLQHRNLVRL---LGCCVEMDEKMLVYEYMENRSLD-SVIFDKARSSILNWQRRFN 645
           +++   +H N++ +   L   V   E   VY  ++    D   I   ++   L   R F 
Sbjct: 105 KILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYF- 163
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN--T 703
            +  + RGL Y+H     ++IHRDLK SN+L+++    KI DFGMAR       E     
Sbjct: 164 -LYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 219
Query: 704 KRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKK 744
              V T  Y +PE  +    ++   D++S G +  E ++ ++
Sbjct: 220 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 113/235 (48%), Gaps = 24/235 (10%)
Query: 538 VRATDNFTDYNKLGQGGFGIV---YKGRLLEGQEIAVKRLSR--NSGQGIEEFKNEVRLI 592
           VRA   + D   +G G +G V     GR   G ++A+K+L R   S    +    E+RL+
Sbjct: 23  VRAV--YRDLQPVGSGAYGAVCSAVDGR--TGAKVAIKKLYRPFQSELFAKRAYRELRLL 78
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYE--YMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
             ++H N++ LL      DE +  +   Y+    + + +    +   L   R   ++  +
Sbjct: 79  KHMRHENVIGLLDVFTP-DETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 137
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
            +GL Y+H      IIHRDLK  N+ ++++   KI DFG+AR     Q +      V T 
Sbjct: 138 LKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTR 189
Query: 711 GYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            Y +PE  ++ + ++   D++S G ++ E ++GK     +  ++ L+ L  + ++
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT---LFKGSDHLDQLKEIMKV 241

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 92/174 (52%), Gaps = 28/174 (16%)
Query: 582 IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML--VYEY------MENRSLDSVIFDKA 633
           IE+   E+ ++ KL H N+V+L+    + +E  L  V+E       ME  +L  +  D+A
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 634 RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
           R    +          + +G+ YLH     +IIHRD+K SN+L+ ++   KI+DFG++  
Sbjct: 140 RFYFQD----------LIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 694 F-GGDQTEQNTKRVVGTYGYMSPEYAMD--GLFSVKS-DVFSFGVLLLETVSGK 743
           F G D    NT   VGT  +M+PE   +   +FS K+ DV++ GV L   V G+
Sbjct: 187 FKGSDALLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIEE-FKNEVRLIAK 594
           I+  +D +     +G G FG+    R  +  E +AVK + R  G+ I+E  K E+     
Sbjct: 13  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER--GEKIDENVKREIINHRS 70
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           L+H N+VR     +      +V EY     L   I +  R S    + RF     +  G+
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARF-FFQQLISGV 127
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
            Y H     ++ HRDLK  N LLD    P  KI DFG ++           K  VGT  Y
Sbjct: 128 SYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAY 181
Query: 713 MSPEYAMDGLFSVK-SDVFSFGVLLLETVSG 742
           ++PE  +   +  K +DV+S GV L   + G
Sbjct: 182 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK----ISDFGMARI--FGGDQTEQNTK 704
             G+ YLH     +I H DLK  NI+L     PK    I DFG+A    FG +      K
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FK 175
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            + GT  +++PE        +++D++S GV+    +SG
Sbjct: 176 NIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 122
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK----ISDFGMARI--FGGDQTEQNTK 704
             G+ YLH     +I H DLK  NI+L     PK    I DFG+A    FG +      K
Sbjct: 123 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FK 174
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            + GT  +++PE        +++D++S GV+    +SG
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 122
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK----ISDFGMARI--FGGDQTEQNTK 704
             G+ YLH     +I H DLK  NI+L     PK    I DFG+A    FG +      K
Sbjct: 123 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FK 174
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            + GT  +++PE        +++D++S GV+    +SG
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK----ISDFGMARI--FGGDQTEQNTK 704
             G+ YLH     +I H DLK  NI+L     PK    I DFG+A    FG +      K
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FK 175
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            + GT  +++PE        +++D++S GV+    +SG
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK----ISDFGMARI--FGGDQTEQNTK 704
             G+ YLH     +I H DLK  NI+L     PK    I DFG+A    FG +      K
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FK 175
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            + GT  +++PE        +++D++S GV+    +SG
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 543 NFTDYN---KLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIAKL 595
             TD+N    LG+G FG V        +E+ A+K L ++       +E    E R++A L
Sbjct: 17  KLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALL 76
Query: 596 QHRNLVRLLGCCVE-MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
                +  L  C + +D    V EY+    L   ++   +       +       I+ GL
Sbjct: 77  DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISIGL 133
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
            +LH+     II+RDLK  N++LD E   KI+DFGM +    D     T+   GT  Y++
Sbjct: 134 FFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV--TTREFCGTPDYIA 188
Query: 715 PEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           PE      +    D +++GVLL E ++G+
Sbjct: 189 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFK--NEVRLIAKLQH 597
           ++ +    KLG G +G V   R  +   E A+K + + S       K   EV ++  L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 598 RNLVRLLGCCVEMDEKMLVYE-YMENRSLDSVI----FDKARSSILNWQRRFNIICGIAR 652
            N+++L     +     LV E Y      D +I    F++  +++        II  +  
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV--------IIKQVLS 147
Query: 653 GLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           G+ YLH   +  I+HRDLK  N+LL   +K+   KI DFG++ +F   + ++  K  +GT
Sbjct: 148 GVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGT 201
Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
             Y++PE  +   +  K DV+S GV+L   ++G
Sbjct: 202 AYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 128/288 (44%), Gaps = 55/288 (19%)
Query: 541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL--QH 597
            D+     +LG+G +G+V K R +  GQ +AVKR+           + + RL+  L    
Sbjct: 50  ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-----QEQKRLLMDLDISM 104
Query: 598 RNL-----VRLLGCCVEMDEKMLVYEYMENRSLDSV---IFDKARS---SILNWQRRFNI 646
           R +     V   G      +  +  E M+  SLD     + DK ++    IL       I
Sbjct: 105 RTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILG-----KI 158
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              I + L +LH  S+  +IHRD+K SN+L++     K+ DFG++    G   +   K +
Sbjct: 159 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS----GYLVDSVAKTI 212
Query: 707 -VGTYGYMSPEYAMDGL----FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
             G   YM+PE     L    +SVKSD++S G+ ++                EL +L   
Sbjct: 213 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMI----------------ELAILRFP 256
Query: 762 WRLWKEG--KVLEMVDSSVDNYPANEV-LRCIHVGLLCVQENAEERPT 806
           +  W     ++ ++V+      PA++     +     C+++N++ERPT
Sbjct: 257 YDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPT 304

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKLQH 597
           D+F     LG+G FG VY  R  + + I A+K L  S+   +G+E + + E+ + + L+H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N++R+     +     L+ E+     L   +    R    + QR    +  +A  L Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYC 130
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H+    ++IHRD+K  N+L+  +   KI+DFG    +         + + GT  Y+ PE 
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEM 183
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
                   K D++  GVL  E + G
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK----ISDFGMARI--FGGDQTEQNTK 704
             G+ YLH     +I H DLK  NI+L     PK    I DFG+A    FG +      K
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FK 175
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            + GT  +++PE        +++D++S GV+    +SG
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK----ISDFGMARI--FGGDQTEQNTK 704
             G+ YLH     +I H DLK  NI+L     PK    I DFG+A    FG +      K
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FK 175
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            + GT  +++PE        +++D++S GV+    +SG
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 21/202 (10%)
Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN 599
           +D F   ++LG+G   IVY+ +    Q+  A+K L +   + I   + E+ ++ +L H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPN 109
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +++L        E  LV E +    L   I +K   S    +   + +  I   + YLH+
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYS---ERDAADAVKQILEAVAYLHE 166
Query: 660 DSRFRIIHRDLKASNILLDKEMTP------KISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
           +    I+HRDLK  N+L     TP      KI+DFG+++I    + +   K V GT GY 
Sbjct: 167 NG---IVHRDLKPENLLY---ATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYC 217
Query: 714 SPEYAMDGLFSVKSDVFSFGVL 735
           +PE      +  + D++S G++
Sbjct: 218 APEILRGCAYGPEVDMWSVGII 239

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 14/224 (6%)
Query: 536 TIVRATDNFTDYNKL-GQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN---EVR 590
            + R T N  +Y KL G+G FG ++       G+  A+K L +      +E  +   E R
Sbjct: 2   AMARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 61
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++   +H  L  L       D    V EY     L    F  +R  + +  R       I
Sbjct: 62  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEI 118
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
              L YLH +    +++RDLK  N++LDK+   KI+DFG+ +   G +     K   GT 
Sbjct: 119 VSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTP 174
Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
            Y++PE   D  +    D +  GV++ E + G+    FY+ ++E
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK----ISDFGMARI--FGGDQTEQNTK 704
             G+ YLH     +I H DLK  NI+L     PK    I DFG+A    FG +      K
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FK 175
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            + GT  +++PE        +++D++S GV+    +SG
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/127 (33%), Positives = 70/127 (55%), Gaps = 7/127 (5%)
Query: 619 YMENRSLDSVIFDKARSSIL-NWQRRFNIIC---GIARGLLYLHQDSRFRIIHRDLKASN 674
           ++E +SL  V  ++A   +  ++    ++IC    +A+G+ +L   +  + IHRDL A N
Sbjct: 172 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARN 228
Query: 675 ILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGV 734
           ILL ++   KI DFG+AR    D              +M+PE   D +++++SDV+SFGV
Sbjct: 229 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 288
Query: 735 LLLETVS 741
           LL E  S
Sbjct: 289 LLWEIFS 295

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK----ISDFGMARI--FGGDQTEQNTK 704
             G+ YLH     +I H DLK  NI+L     PK    I DFG+A    FG +      K
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FK 175
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            + GT  +++PE        +++D++S GV+    +SG
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK----ISDFGMARI--FGGDQTEQNTK 704
             G+ YLH     +I H DLK  NI+L     PK    I DFG+A    FG +      K
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FK 175
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            + GT  +++PE        +++D++S GV+    +SG
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNLVR 602
           +T+   +G G FG+V++ +L+E  E+A+K++ ++     + FKN E++++  ++H N+V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVD 96
Query: 603 LLGCCVEMDEKM------LVYEYM-ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           L        +K       LV EY+ E     S  + K + ++     +   +  + R L 
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL-YMYQLLRSLA 155
Query: 656 YLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
           Y+H      I HRD+K  N+LLD      K+ DFG A+I      E N   +   Y Y +
Sbjct: 156 YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVSXICSRY-YRA 209
Query: 715 PEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
           PE       ++   D++S G ++ E + G+
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/127 (33%), Positives = 70/127 (55%), Gaps = 7/127 (5%)
Query: 619 YMENRSLDSVIFDKARSSIL-NWQRRFNIIC---GIARGLLYLHQDSRFRIIHRDLKASN 674
           ++E +SL  V  ++A   +  ++    ++IC    +A+G+ +L   +  + IHRDL A N
Sbjct: 174 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARN 230
Query: 675 ILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGV 734
           ILL ++   KI DFG+AR    D              +M+PE   D +++++SDV+SFGV
Sbjct: 231 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 290
Query: 735 LLLETVS 741
           LL E  S
Sbjct: 291 LLWEIFS 297

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/127 (33%), Positives = 70/127 (55%), Gaps = 7/127 (5%)
Query: 619 YMENRSLDSVIFDKARSSIL-NWQRRFNIIC---GIARGLLYLHQDSRFRIIHRDLKASN 674
           ++E +SL  V  ++A   +  ++    ++IC    +A+G+ +L   +  + IHRDL A N
Sbjct: 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARN 223
Query: 675 ILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGV 734
           ILL ++   KI DFG+AR    D              +M+PE   D +++++SDV+SFGV
Sbjct: 224 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 283
Query: 735 LLLETVS 741
           LL E  S
Sbjct: 284 LLWEIFS 290

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 111/252 (44%), Gaps = 34/252 (13%)
Query: 518 DYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLS-R 576
           D+S        LP     T+ R     T    +G+G +G V++G   +G+ +AVK  S R
Sbjct: 16  DHSCTSGSGSGLPFLVQRTVAR---QITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR 71
Query: 577 NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM------LVYEYMENRSLDSVIF 630
           +      E   E+     L+H N++  +    +M  +       L+  Y E  SL    +
Sbjct: 72  DEKSWFRE--TELYNTVMLRHENILGFIAS--DMTSRHSSTQLWLITHYHEMGSL----Y 123
Query: 631 DKARSSILNWQRRFNIICGIARGLLYLHQD-----SRFRIIHRDLKASNILLDKEMTPKI 685
           D  + + L+      I+  IA GL +LH +      +  I HRDLK+ NIL+ K     I
Sbjct: 124 DYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 183
Query: 686 SDFGMARIF--GGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV-------KSDVFSFGVLL 736
           +D G+A +     +Q +      VGT  YM+PE  +D    V       + D+++FG++L
Sbjct: 184 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVL 242
Query: 737 LETVSGKKNRGF 748
            E      + G 
Sbjct: 243 WEVARRMVSNGI 254

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/127 (33%), Positives = 70/127 (55%), Gaps = 7/127 (5%)
Query: 619 YMENRSLDSVIFDKARSSIL-NWQRRFNIIC---GIARGLLYLHQDSRFRIIHRDLKASN 674
           ++E +SL  V  ++A   +  ++    ++IC    +A+G+ +L   +  + IHRDL A N
Sbjct: 165 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARN 221
Query: 675 ILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGV 734
           ILL ++   KI DFG+AR    D              +M+PE   D +++++SDV+SFGV
Sbjct: 222 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 281
Query: 735 LLLETVS 741
           LL E  S
Sbjct: 282 LLWEIFS 288

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK----ISDFGMARI--FGGDQTEQNTK 704
             G+ YLH     +I H DLK  NI+L     PK    I DFG+A    FG +      K
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FK 175
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            + GT  +++PE        +++D++S GV+    +SG
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 14/221 (6%)
Query: 539 RATDNFTDYNKL-GQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           R T N  +Y KL G+G FG ++       G+  A+K L +      +E  +   E R++ 
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  + +  R       I   
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSA 260
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
           L YLH +    +++RDLK  N++LDK+   KI+DFG+ +   G +     K   GT  Y+
Sbjct: 261 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYL 316
Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
           +PE   D  +    D +  GV++ E + G+    FY+ ++E
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 355

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 550 LGQGGFGIVYKGRLLE-GQEIAVK-----RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +G+G F +V +    E GQ+ AVK     + + + G   E+ K E  +   L+H ++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR-RFNIICGIARGLLYLHQDSR 662
           L          +V+E+M+   L   I  +A +  +  +    + +  I   L Y H ++ 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 150
Query: 663 FRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
             IIHRD+K  N+LL   +     K+ DFG+A   G        +  VGT  +M+PE   
Sbjct: 151 --IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR--VGTPHFMAPEVVK 206
Query: 720 DGLFSVKSDVFSFGVLLLETVSG 742
              +    DV+  GV+L   +SG
Sbjct: 207 REPYGKPVDVWGCGVILFILLSG 229

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK----ISDFGMARI--FGGDQTEQNTK 704
             G+ YLH     +I H DLK  NI+L     PK    I DFG+A    FG +      K
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FK 175
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            + GT  +++PE        +++D++S GV+    +SG
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK----ISDFGMARI--FGGDQTEQNTK 704
             G+ YLH     +I H DLK  NI+L     PK    I DFG+A    FG +      K
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FK 175
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            + GT  +++PE        +++D++S GV+    +SG
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 28/218 (12%)
Query: 542 DNFTDY----NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +N  DY     +LG G F +V K R     L    +   KR +++S +G+  E+ + EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++ ++QH N++ L        + +L+ E +    L   + +K     L  +     +  I
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK----ISDFGMARI--FGGDQTEQNTK 704
             G+ YLH     +I H DLK  NI+L     PK    I DFG+A    FG +      K
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-----FK 175
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            + GT  +++PE        +++D++S GV+    +SG
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 14/221 (6%)
Query: 539 RATDNFTDYNKL-GQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           R T N  +Y KL G+G FG ++       G+  A+K L +      +E  +   E R++ 
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 206
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  + +  R       I   
Sbjct: 207 NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSA 263
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
           L YLH +    +++RDLK  N++LDK+   KI+DFG+ +   G +     K   GT  Y+
Sbjct: 264 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYL 319
Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
           +PE   D  +    D +  GV++ E + G+    FY+ ++E
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 358

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 14/221 (6%)
Query: 539 RATDNFTDYNKL-GQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           R T N  +Y KL G+G FG ++       G+  A+K L +      +E  +   E R++ 
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  + +  R       I   
Sbjct: 66  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSA 122
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
           L YLH +    +++RDLK  N++LDK+   KI+DFG+ +   G +     K   GT  Y+
Sbjct: 123 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYL 178
Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
           +PE   D  +    D +  GV++ E + G+    FY+ ++E
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 217

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL--SRNSGQGIE-EFKNEVRLIAKLQH 597
           D+F     LG+G FG VY  R  + + I A+K L  S+   +G+E + + E+ + + L+H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N++R+     +     L+ E+     L   +    R    + QR    +  +A  L Y 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYC 131
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H+    ++IHRD+K  N+L+  +   KI+DFG    +         + + GT  Y+ PE 
Sbjct: 132 HER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEM 184
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
                   K D++  GVL  E + G
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 550 LGQGGFGIVYKGRLL----EGQEIAVKRLSRNSGQGIEEFKNEVR--LIAKLQHRNLVRL 603
           LGQG FG V+  R +     G   A+K L + + +  +  + ++   ++A + H  +V+L
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI-ICGIARGLLYLHQDSR 662
                   +  L+ +++    L    F +    ++  +      +  +A GL +LH    
Sbjct: 96  HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALGLDHLHS--- 148
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             II+RDLK  NILLD+E   K++DFG+++       E+      GT  YM+PE      
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGTVEYMAPEVVNRQG 206
Query: 723 FSVKSDVFSFGVLLLETVSG 742
            S  +D +S+GVL+ E ++G
Sbjct: 207 HSHSADWWSYGVLMFEMLTG 226

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 100/230 (43%), Gaps = 22/230 (9%)
Query: 518 DYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSR 576
           D +   T  L++P      I+  +D +     +G G FG+    R  L  + +AVK + R
Sbjct: 2   DRAPVTTGPLDMP------IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER 55
Query: 577 NSGQGIEE-FKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARS 635
             G  I+E  + E+     L+H N+VR     +      ++ EY     L   I +  R 
Sbjct: 56  --GAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRF 113
Query: 636 SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP--KISDFGMARI 693
           S    + RF     +  G+ Y H     +I HRDLK  N LLD    P  KI DFG ++ 
Sbjct: 114 S--EDEARF-FFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSK- 166
Query: 694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVK-SDVFSFGVLLLETVSG 742
                     K  VGT  Y++PE  +   +  K +DV+S GV L   + G
Sbjct: 167 --SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 14/221 (6%)
Query: 539 RATDNFTDYNKL-GQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           R T N  +Y KL G+G FG ++       G+  A+K L +      +E  +   E R++ 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  + +  R       I   
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSA 120
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
           L YLH +    +++RDLK  N++LDK+   KI+DFG+ +   G +     K   GT  Y+
Sbjct: 121 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYL 176
Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
           +PE   D  +    D +  GV++ E + G+    FY+ ++E
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 215

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 126/287 (43%), Gaps = 53/287 (18%)
Query: 541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL--QH 597
            D+     +LG+G +G+V K R +  GQ +AVKR+           + + RL+  L    
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-----QEQKRLLMDLDISM 60
Query: 598 RNL-----VRLLGCCVEMDEKMLVYEYMENRSLDSV---IFDKARS---SILNWQRRFNI 646
           R +     V   G      +  +  E M+  SLD     + DK ++    IL       I
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILG-----KI 114
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              I + L +LH  S+  +IHRD+K SN+L++     K+ DFG++     D  +      
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--- 169
Query: 707 VGTYGYMSPEYAMDGL----FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVW 762
            G   YM+PE     L    +SVKSD++S G+ ++                EL +L   +
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMI----------------ELAILRFPY 213
Query: 763 RLWKEG--KVLEMVDSSVDNYPANEV-LRCIHVGLLCVQENAEERPT 806
             W     ++ ++V+      PA++     +     C+++N++ERPT
Sbjct: 214 DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPT 260

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 17/170 (10%)
Query: 581 GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME------NRSLDSVIFDKAR 634
           G    K E++L+ +L+H+N+++L+      +EK  +Y  ME         LDSV   + R
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYN-EEKQKMYMVMEYCVCGMQEMLDSV--PEKR 105
Query: 635 SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
             +      F   C +  GL YLH      I+H+D+K  N+LL    T KIS  G+A   
Sbjct: 106 FPVCQAHGYF---CQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
Query: 695 GGDQTEQNTKRVVGTYGYMSPEYA--MDGLFSVKSDVFSFGVLLLETVSG 742
                +   +   G+  +  PE A  +D     K D++S GV L    +G
Sbjct: 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 113/245 (46%), Gaps = 29/245 (11%)
Query: 529 LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN- 587
           LPL    TI R          +G+G FG V++G+   G+E+AVK  S  S +    F+  
Sbjct: 32  LPLLVQRTIAR---TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREA 85
Query: 588 EVRLIAKLQHRNLVRLLGCCVEMD----EKMLVYEYMENRSLDSVIFDKARSSILNWQRR 643
           E+     L+H N++  +    + +    +  LV +Y E+ SL    FD      +  +  
Sbjct: 86  EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGM 141
Query: 644 FNIICGIARGLLYLHQD-----SRFRIIHRDLKASNILLDKEMTPKISDFGMA--RIFGG 696
             +    A GL +LH +      +  I HRDLK+ NIL+ K  T  I+D G+A       
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 201
Query: 697 DQTEQNTKRVVGTYGYMSPEYAMDGL----FSV--KSDVFSFGVLLLETVSGKKNRGFYH 750
           D  +      VGT  YM+PE   D +    F    ++D+++ G++  E ++ + + G  H
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIH 260
Query: 751 SNNEL 755
            + +L
Sbjct: 261 EDYQL 265

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 543 NFTDYN---KLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIA-K 594
             TD+N    LG+G FG V         E+ AVK L ++       +E    E R++A  
Sbjct: 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 398
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
            +   L +L  C   MD    V EY+    L   I    R               IA GL
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGL 455
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGTYGY 712
            +L       II+RDLK  N++LD E   KI+DFGM +  I+ G      TK   GT  Y
Sbjct: 456 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFCGTPDY 508
Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           ++PE      +    D ++FGVLL E ++G+
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/94 (43%), Positives = 56/94 (59%), Gaps = 7/94 (7%)
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGG-DQTEQNTKRVV 707
           +ARG+ +L   S  + IHRDL A NILL +    KI DFG+AR I+   D   +   R+ 
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL- 263
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
               +M+PE   D ++S KSDV+S+GVLL E  S
Sbjct: 264 -PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 26/209 (12%)
Query: 536 TIVRATDNFTDYNKLGQGGFGIVY--KGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIA 593
           T +R T  F +   LG G F  V+  K RL  G+  A+K + ++        +NE+ ++ 
Sbjct: 5   TNIRKTFIFMEV--LGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLK 61
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYME-----NRSLDSVIFDKARSSILNWQRRFNIIC 648
           K++H N+V L           LV + +      +R L+  ++ +  +S+        +I 
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL--------VIQ 113
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN--TKRV 706
            +   + YLH++    I+HRDLK  N+L    +TP+ +   M   FG  + EQN      
Sbjct: 114 QVLSAVKYLHENG---IVHRDLKPENLLY---LTPEENSKIMITDFGLSKMEQNGIMSTA 167
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVL 735
            GT GY++PE      +S   D +S GV+
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVI 196

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 112/249 (44%), Gaps = 37/249 (14%)
Query: 529 LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN- 587
           LPL    TI R          +G+G FG V++G+   G+E+AVK  S  S +    F+  
Sbjct: 19  LPLLVQRTIAR---TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREA 72
Query: 588 EVRLIAKLQHRNLVRLLGCCVEMDEK--------MLVYEYMENRSLDSVIFDKARSSILN 639
           E+     L+H N++  +      D K         LV +Y E+ SL    FD      + 
Sbjct: 73  EIYQTVMLRHENILGFIAA----DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVT 124
Query: 640 WQRRFNIICGIARGLLYLHQD-----SRFRIIHRDLKASNILLDKEMTPKISDFGMA--R 692
            +    +    A GL +LH +      +  I HRDLK+ NIL+ K  T  I+D G+A   
Sbjct: 125 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 184
Query: 693 IFGGDQTEQNTKRVVGTYGYMSPEYAMDGL----FSV--KSDVFSFGVLLLETVSGKKNR 746
               D  +      VGT  YM+PE   D +    F    ++D+++ G++  E ++ + + 
Sbjct: 185 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSI 243
Query: 747 GFYHSNNEL 755
           G  H + +L
Sbjct: 244 GGIHEDYQL 252

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSR-------NSGQGIEEFKNEVRLI 592
           +D +    KLG G +G V   +  L G E A+K + +       NSG  +    +EV ++
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL----DEVAVL 75
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYE-YMENRSLDSVIFDKARSSILNWQRRFNIICGIA 651
            +L H N+++L     +     LV E Y      D +I  +  S +        I+  + 
Sbjct: 76  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV----DAAVIMKQVL 131
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIF--GGDQTEQNTKRV 706
            G  YLH+ +   I+HRDLK  N+LL+   ++   KI DFG++  F  GG   E+     
Sbjct: 132 SGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER----- 183
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           +GT  Y++PE  +   +  K DV+S GV+L   + G
Sbjct: 184 LGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 104/234 (44%), Gaps = 31/234 (13%)
Query: 532 FDFETIVRATDNFTDYNKLGQGGFGIV--YKGRLLEGQEIAVKRLSRNSGQGIEEFKNEV 589
           F    ++    ++    KLG+GGF  V   +G L +G   A+KR+  +  Q  EE + E 
Sbjct: 19  FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREA 77
Query: 590 RLIAKLQHRNLVRLLGCCVE----MDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRF 644
            +     H N++RL+  C+       E  L+  + +  +L + +   K + + L   +  
Sbjct: 78  DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG-----MARIFGGDQ- 698
            ++ GI RGL  +H        HRDLK +NILL  E  P + D G        + G  Q 
Sbjct: 138 WLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 699 -TEQNTKRVVGTYGYMSPEYAMDGLFSVKS--------DVFSFGVLLLETVSGK 743
            T Q+      T  Y +PE     LFSV+S        DV+S G +L   + G+
Sbjct: 195 LTLQDWAAQRCTISYRAPE-----LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     +G G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EYM    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 15/221 (6%)
Query: 539 RATDNFTDYNKL-GQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           + T N  DY KL G+G FG V   R    G+  A+K L +      +E  +   E R++ 
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  +   +R       I   
Sbjct: 66  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 122
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
           L YLH      +++RD+K  N++LDK+   KI+DFG+ +   G       K   GT  Y+
Sbjct: 123 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYL 177
Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
           +PE   D  +    D +  GV++ E + G+    FY+ ++E
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 216

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     +G G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EYM    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSR----NSGQGIEEFKNEVRLIAKLQHRNLV 601
           LG+GG+G V++ R + G       A+K L +     + +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            L+       +  L+ EY+    L        R  I         +  I+  L +LHQ  
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
              II+RDLK  NI+L+ +   K++DFG+ +    D T  +T    GT  YM+PE  M  
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMRS 196
Query: 722 LFSVKSDVFSFGVLLLETVSG 742
             +   D +S G L+ + ++G
Sbjct: 197 GHNRAVDWWSLGALMYDMLTG 217

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 52/282 (18%)
Query: 549 KLGQGGFGIVYKGRLLEGQ------EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           ++G+G F  VYKG   E        E+  ++L+++  Q    FK E   +  LQH N+VR
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIVR 89
Query: 603 LLGC---------CVEMDEKMLVYEYMENRSLDSVI--FDKARSSIL-NWQRRFNIICGI 650
                        C+     +LV E   + +L + +  F   +  +L +W R+      I
Sbjct: 90  FYDSWESTVKGKKCI-----VLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------I 138
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFGGDQTEQNTKRVVGT 709
            +GL +LH  +   IIHRDLK  NI +     + KI D G+A +    +     K V+GT
Sbjct: 139 LKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGT 193
Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK 769
             + +PE   +  +    DV++FG   LE  + +      +  +E      ++R    G 
Sbjct: 194 PEFXAPE-XYEEKYDESVDVYAFGXCXLEXATSE------YPYSECQNAAQIYRRVTSG- 245
Query: 770 VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
              +  +S D     EV   I     C+++N +ER ++  ++
Sbjct: 246 ---VKPASFDKVAIPEVKEIIEG---CIRQNKDERYSIKDLL 281

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 15/221 (6%)
Query: 539 RATDNFTDYNKL-GQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           + T N  DY KL G+G FG V   R    G+  A+K L +      +E  +   E R++ 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  +   +R       I   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
           L YLH      +++RD+K  N++LDK+   KI+DFG+ +   G       K   GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYL 172
Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
           +PE   D  +    D +  GV++ E + G+    FY+ ++E
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 211

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIEE-FKNEVRLIAK 594
           I+  +D +     +G G FG+    R  +  E +AVK + R  G+ I+E  K E+     
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER--GEKIDENVKREIINHRS 71
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           L+H N+VR     +      +V EY     L   I +  R S    + RF     +  G+
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARF-FFQQLISGV 128
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
            Y H     ++ HRDLK  N LLD    P  KI  FG ++           K  VGT  Y
Sbjct: 129 SYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKSTVGTPAY 182
Query: 713 MSPEYAMDGLFSVK-SDVFSFGVLLLETVSG 742
           ++PE  +   +  K +DV+S GV L   + G
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 15/221 (6%)
Query: 539 RATDNFTDYNKL-GQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           + T N  DY KL G+G FG V   R    G+  A+K L +      +E  +   E R++ 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  +   +R       I   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
           L YLH      +++RD+K  N++LDK+   KI+DFG+ +   G       K   GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 172
Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
           +PE   D  +    D +  GV++ E + G+    FY+ ++E
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHE 211

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 92/211 (43%), Gaps = 16/211 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGI-EEFKNEVRLIAK 594
           I+  +D +     +G G FG+    R  +  E +AVK + R  G+ I    K E+     
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER--GEKIAANVKREIINHRS 71
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           L+H N+VR     +      +V EY     L   I +  R S    + RF     +  G+
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARF-FFQQLISGV 128
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
            Y H     ++ HRDLK  N LLD    P  KI DFG ++           K  VGT  Y
Sbjct: 129 SYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAY 182
Query: 713 MSPEYAMDGLFSVK-SDVFSFGVLLLETVSG 742
           ++PE  +   +  K +DV+S GV L   + G
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 12/208 (5%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           ++  +  ++G G  G V+K R  + G  IAVK++ R SG   E  +  + L   L+  + 
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDC 83
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             ++ C         V+  ME     +    K     +  +    +   I + L YL + 
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE- 142
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY--- 717
            +  +IHRD+K SNILLD+    K+ DFG++     D+ +    R  G   YM+PE    
Sbjct: 143 -KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD---RSAGCAAYMAPERIDP 198
Query: 718 --AMDGLFSVKSDVFSFGVLLLETVSGK 743
                  + +++DV+S G+ L+E  +G+
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 15/221 (6%)
Query: 539 RATDNFTDYNKL-GQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           + T N  DY KL G+G FG V   R    G+  A+K L +      +E  +   E R++ 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  +   +R       I   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
           L YLH      +++RD+K  N++LDK+   KI+DFG+ +   G       K   GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYL 172
Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
           +PE   D  +    D +  GV++ E + G+    FY+ ++E
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHE 211

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 31/210 (14%)
Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSR-------NSGQGIEEFKNEVRLI 592
           +D +    KLG G +G V   +  L G E A+K + +       NSG  +    +EV ++
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL----DEVAVL 58
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYE-YMENRSLDSVIFDKARSSILNWQRRFNIICGIA 651
            +L H N+++L     +     LV E Y      D +I  +  S +        I+  + 
Sbjct: 59  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV----DAAVIMKQVL 114
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIF--GGDQTEQNTKRV 706
            G  YLH   +  I+HRDLK  N+LL+   ++   KI DFG++  F  GG   E+     
Sbjct: 115 SGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER----- 166
Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
           +GT  Y++PE  +   +  K DV+S GV+L
Sbjct: 167 LGTAYYIAPE-VLRKKYDEKCDVWSCGVIL 195

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 15/221 (6%)
Query: 539 RATDNFTDYNKL-GQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           + T N  DY KL G+G FG V   R    G+  A+K L +      +E  +   E R++ 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  +   +R       I   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
           L YLH      +++RD+K  N++LDK+   KI+DFG+ +   G       K   GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYL 172
Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
           +PE   D  +    D +  GV++ E + G+    FY+ ++E
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHE 211

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIEE-FKNEVRLIAK 594
           I+  +D +     +G G FG+    R  +  E +AVK + R  G+ I+E  K E+     
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIER--GEKIDENVKREIINHRS 71
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           L+H N+VR     +      +V EY     L   I +  R S    + RF     +  G+
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS--EDEARF-FFQQLISGV 128
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
            Y H     ++ HRDLK  N LLD    P  KI  FG ++           K  VGT  Y
Sbjct: 129 SYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPAY 182
Query: 713 MSPEYAMDGLFSVK-SDVFSFGVLLLETVSG 742
           ++PE  +   +  K +DV+S GV L   + G
Sbjct: 183 IAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 543 NFTDYN---KLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIA-K 594
             TD+N    LG+G FG V         E+ AVK L ++       +E    E R++A  
Sbjct: 18  KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
            +   L +L  C   MD    V EY+    L   I    R               IA GL
Sbjct: 78  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGL 134
Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGTYGY 712
            +L       II+RDLK  N++LD E   KI+DFGM +  I+ G      TK   GT  Y
Sbjct: 135 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFCGTPDY 187
Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           ++PE      +    D ++FGVLL E ++G+
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 15/221 (6%)
Query: 539 RATDNFTDYNKL-GQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLIA 593
           + T N  DY KL G+G FG V   R    G+  A+K L +      +E  +   E R++ 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             +H  L  L       D    V EY     L    F  +R  +   +R       I   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSA 117
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
           L YLH      +++RD+K  N++LDK+   KI+DFG+ +   G       K   GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 172
Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
           +PE   D  +    D +  GV++ E + G+    FY+ ++E
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 211

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 15/222 (6%)
Query: 538 VRATDNFTDYNKL-GQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---EVRLI 592
            + T N  DY KL G+G FG V   R    G+  A+K L +      +E  +   E R++
Sbjct: 3   AKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 62
Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR 652
              +H  L  L       D    V EY     L    F  +R  +   +R       I  
Sbjct: 63  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVS 119
Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
            L YLH      +++RD+K  N++LDK+   KI+DFG+ +   G       K   GT  Y
Sbjct: 120 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEY 174
Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
           ++PE   D  +    D +  GV++ E + G+    FY+ ++E
Sbjct: 175 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 214

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSR----NSGQGIEEFKNEVRLIAKLQHRNLV 601
           LG+GG+G V++ R + G       A+K L +     + +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            L+       +  L+ EY+    L        R  I         +  I+  L +LHQ  
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
              II+RDLK  NI+L+ +   K++DFG+ +    D T   T    GT  YM+PE  M  
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCGTIEYMAPEILMRS 196
Query: 722 LFSVKSDVFSFGVLLLETVSG 742
             +   D +S G L+ + ++G
Sbjct: 197 GHNRAVDWWSLGALMYDMLTG 217

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI--AVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           +T  N +G+G +G V K  + +G  I  A K++ +   + ++ FK E+ ++  L H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           RL     +  +  LV E      L   +  K    +        I+  +   + Y H   
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCH--- 123
Query: 662 RFRIIHRDLKASNILL--DKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
           +  + HRDLK  N L   D   +P K+ DFG+A  F   +  +     VGT  Y+SP+  
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQ-V 179
Query: 719 MDGLFSVKSDVFSFGVLLLETVSG 742
           ++GL+  + D +S GV++   + G
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSR----NSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           +G+G +  V   RL +   I   R+ +    N  + I+  + E  +  +  +   +  L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 606 CCVEMDEKML-VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
            C + + ++  V EY+    L   +F   R   L  +        I+  L YLH+     
Sbjct: 120 SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 173
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           II+RDLK  N+LLD E   K++D+GM +   G +    T    GT  Y++PE      + 
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 231
Query: 725 VKSDVFSFGVLLLETVSGK 743
              D ++ GVL+ E ++G+
Sbjct: 232 FSVDWWALGVLMFEMMAGR 250

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEI----AVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           +G+G +  V   RL +   I     VK+   N  + I+  + E  +  +  +   +  L 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 606 CCVEMDEKML-VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
            C + + ++  V EY+    L   +F   R   L  +        I+  L YLH+     
Sbjct: 73  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 126
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           II+RDLK  N+LLD E   K++D+GM +   G +    T    GT  Y++PE      + 
Sbjct: 127 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG 184
Query: 725 VKSDVFSFGVLLLETVSGK 743
              D ++ GVL+ E ++G+
Sbjct: 185 FSVDWWALGVLMFEMMAGR 203

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFK---NEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +     ++E +   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY     + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+++D++   K++DFG+A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           +G+G +G V++G   +G+ +AVK  S R+      E   E+     L+H N++  +    
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIAS-- 70
Query: 609 EMDEKM------LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-- 660
           +M  +       L+  Y E  SL    +D  + + L+      I+  IA GL +LH +  
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 661 ---SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRVVGTYGYMSP 715
               +  I HRDLK+ NIL+ K     I+D G+A +     +Q +      VGT  YM+P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 716 EYAMDGLFSV-------KSDVFSFGVLLLETVSGKKNRGF 748
           E  +D    V       + D+++FG++L E      + G 
Sbjct: 187 E-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEI--AVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           +T  N +G+G +G V K  + +G  I  A K++ +   + ++ FK E+ ++  L H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           RL     +  +  LV E      L   +  K    +        I+  +   + Y H   
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCH--- 140
Query: 662 RFRIIHRDLKASNILL--DKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
           +  + HRDLK  N L   D   +P K+ DFG+A  F   +  +     VGT  Y+SP+  
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQ-V 196
Query: 719 MDGLFSVKSDVFSFGVLLLETVSG 742
           ++GL+  + D +S GV++   + G
Sbjct: 197 LEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           +G+G +G V++G   +G+ +AVK  S R+      E   E+     L+H N++  +    
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIAS-- 70
Query: 609 EMDEKM------LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-- 660
           +M  +       L+  Y E  SL    +D  + + L+      I+  IA GL +LH +  
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 661 ---SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRVVGTYGYMSP 715
               +  I HRDLK+ NIL+ K     I+D G+A +     +Q +      VGT  YM+P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 716 EYAMDGLFSV-------KSDVFSFGVLLLETVSGKKNRGF 748
           E  +D    V       + D+++FG++L E      + G 
Sbjct: 187 E-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEI----AVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           +G+G +  V   RL +   I     VK+   N  + I+  + E  +  +  +   +  L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 606 CCVEMDEKML-VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
            C + + ++  V EY+    L   +F   R   L  +        I+  L YLH+     
Sbjct: 77  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 130
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           II+RDLK  N+LLD E   K++D+GM +   G +    T    GT  Y++PE      + 
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG 188
Query: 725 VKSDVFSFGVLLLETVSGK 743
              D ++ GVL+ E ++G+
Sbjct: 189 FSVDWWALGVLMFEMMAGR 207

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 33/214 (15%)
Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCC 607
           LG+G    V     L+  QE AVK + +  G        EV ++ + Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN------IICGIARGLLYLHQDS 661
            E D   LV+E M   S+ S I  +         R FN      ++  +A  L +LH   
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKR---------RHFNELEASVVVQDVASALDFLHNKG 131
Query: 662 RFRIIHRDLKASNILLDK--EMTP-KISDFGMAR--IFGGDQTEQNTKRVV---GTYGYM 713
              I HRDLK  NIL +   +++P KI DFG+       GD +  +T  ++   G+  YM
Sbjct: 132 ---IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 714 SPEYA-----MDGLFSVKSDVFSFGVLLLETVSG 742
           +PE          ++  + D++S GV+L   +SG
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVK-----RLSRNSGQGI--EEFKNEVRLIA 593
           D++    +LG G F IV K R    G+E A K     RLS +S +G+  EE + EV ++ 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREVNILR 70
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           +++H N++ L        + +L+ E +    L   + +K     L        +  I  G
Sbjct: 71  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDG 127
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMA-RIFGGDQTEQNTKRVVG 708
           + YLH     RI H DLK  NI+L  +  P    K+ DFG+A +I  G++     K + G
Sbjct: 128 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIFG 180
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           T  +++PE        +++D++S GV+    +SG
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 550 LGQGGFGIVYKGRLLEGQEI----AVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           +G+G +  V   RL +   I     VK+   N  + I+  + E  +  +  +   +  L 
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 606 CCVEMDEKML-VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
            C + + ++  V EY+    L   +F   R   L  +        I+  L YLH+     
Sbjct: 88  SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 141
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           II+RDLK  N+LLD E   K++D+GM +   G +    T    GT  Y++PE      + 
Sbjct: 142 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG 199
Query: 725 VKSDVFSFGVLLLETVSGK 743
              D ++ GVL+ E ++G+
Sbjct: 200 FSVDWWALGVLMFEMMAGR 218

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     +G G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 27/219 (12%)
Query: 539 RATDNFTDY-NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +  ++F D   +LG G F IV K R     L    +   KR SR S +G+  EE + EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD-KARSSILNWQRRFNIICG 649
           ++ ++ H N++ L        + +L+ E +    L    FD  A+   L+ +   + I  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQ 123
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQTEQNT-- 703
           I  G+ YLH     +I H DLK  NI+L  +  P    K+ DFG+A      + E     
Sbjct: 124 ILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-----EIEDGVEF 175
Query: 704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           K + GT  +++PE        +++D++S GV+    +SG
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 550 LGQGGFGIVYKGRLLEG----QEIAVKRLSRNSGQGIEEFKNEVR--LIAKLQHRNLVRL 603
           LGQG FG V+  + + G    Q  A+K L + + +  +  + ++   ++ ++ H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI-ICGIARGLLYLHQDSR 662
                   +  L+ +++    L    F +    ++  +      +  +A  L +LH    
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS--- 144
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             II+RDLK  NILLD+E   K++DFG+++       E+      GT  YM+PE      
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 723 FSVKSDVFSFGVLLLETVSG 742
            +  +D +SFGVL+ E ++G
Sbjct: 203 HTQSADWWSFGVLMFEMLTG 222

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVK-----RLSRNSGQGI--EEFKNEVRLIA 593
           D++    +LG G F IV K R    G+E A K     RLS +S +G+  EE + EV ++ 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREVNILR 63
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           +++H N++ L        + +L+ E +    L   + +K     L        +  I  G
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDG 120
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMA-RIFGGDQTEQNTKRVVG 708
           + YLH     RI H DLK  NI+L  +  P    K+ DFG+A +I  G++     K + G
Sbjct: 121 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIFG 173
Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           T  +++PE        +++D++S GV+    +SG
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 108/221 (48%), Gaps = 24/221 (10%)
Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSR----NSGQGI--EEFK 586
           F+++V   D++    +LG G F IV K R    G+E A K + +    +S +G+  EE +
Sbjct: 20  FQSMVE--DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIE 77
Query: 587 NEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
            EV ++ +++H N++ L        + +L+ E +    L   + +K     L        
Sbjct: 78  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQF 134
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMA-RIFGGDQTEQ 701
           +  I  G+ YLH     RI H DLK  NI+L  +  P    K+ DFG+A +I  G++   
Sbjct: 135 LKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--- 188
Query: 702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
             K + GT  +++PE        +++D++S GV+    +SG
Sbjct: 189 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 539 RATDNFTDY-NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +  ++F D   +LG G F IV K R     L    +   KR SR S +G+  EE + EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD-KARSSILNWQRRFNIICG 649
           ++ ++ H N++ L        + +L+ E +    L    FD  A+   L+ +   + I  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQ 123
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQTEQNTKR 705
           I  G+ YLH     +I H DLK  NI+L  +  P    K+ DFG+A     D  E   K 
Sbjct: 124 ILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVE--FKN 177
Query: 706 VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           + GT  +++PE        +++D++S GV+    +SG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 539 RATDNFTDY-NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +  ++F D   +LG G F IV K R     L    +   KR SR S +G+  EE + EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD-KARSSILNWQRRFNIICG 649
           ++ ++ H N++ L        + +L+ E +    L    FD  A+   L+ +   + I  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQ 123
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQTEQNTKR 705
           I  G+ YLH     +I H DLK  NI+L  +  P    K+ DFG+A     D  E   K 
Sbjct: 124 ILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVE--FKN 177
Query: 706 VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           + GT  +++PE        +++D++S GV+    +SG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 143
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 144 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPEI 195
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPEI 210
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 542 DNFTDYNKLGQGGFGIVYK------GRLLEGQEIAVKRLSRNSGQGIEEF--KNEVRLIA 593
           D +    +LG G FG+V++      GR+   + I       N+   ++++  KNE+ ++ 
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI-------NTPYPLDKYTVKNEISIMN 103
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI----FDKARSSILNWQRRFNIICG 649
           +L H  L+ L     +  E +L+ E++    L   I    +  + + ++N+ R+      
Sbjct: 104 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ------ 157
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLD--KEMTPKISDFGMARIFGGDQTEQNTKRVV 707
              GL ++H+ S   I+H D+K  NI+ +  K  + KI DFG+A     D+     K   
Sbjct: 158 ACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTT 211
Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
            T  + +PE          +D+++ GVL    +SG
Sbjct: 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 539 RATDNFTDY-NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +  ++F D   +LG G F IV K R     L    +   KR SR S +G+  EE + EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD-KARSSILNWQRRFNIICG 649
           ++ ++ H N++ L        + +L+ E +    L    FD  A+   L+ +   + I  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQ 123
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQTEQNTKR 705
           I  G+ YLH     +I H DLK  NI+L  +  P    K+ DFG+A     D  E   K 
Sbjct: 124 ILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVE--FKN 177
Query: 706 VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           + GT  +++PE        +++D++S GV+    +SG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 34/217 (15%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQH 597
           ++F+ +  +G+GGFG VY  R  + G+  A+K L +      QG     NE R++  L  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVS 247
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ-----------RRFNI 646
                 + C        + Y +     L S I D      L++             RF  
Sbjct: 248 TGDCPFIVC--------MSYAFHTPDKL-SFILDLMNGGDLHYHLSQHGVFSEADMRF-Y 297
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              I  GL ++H  +RF +++RDLK +NILLD+    +ISD G+A     D +++     
Sbjct: 298 AAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHAS 350
Query: 707 VGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSG 742
           VGT+GYM+PE    G+ +   +D FS G +L + + G
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 34/217 (15%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQH 597
           ++F+ +  +G+GGFG VY  R  + G+  A+K L +      QG     NE R++  L  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVS 247
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ-----------RRFNI 646
                 + C        + Y +     L S I D      L++             RF  
Sbjct: 248 TGDCPFIVC--------MSYAFHTPDKL-SFILDLMNGGDLHYHLSQHGVFSEADMRF-Y 297
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              I  GL ++H  +RF +++RDLK +NILLD+    +ISD G+A     D +++     
Sbjct: 298 AAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHAS 350
Query: 707 VGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSG 742
           VGT+GYM+PE    G+ +   +D FS G +L + + G
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY     + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+++D++   K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 539 RATDNFTDY-NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +  ++F D   +LG G F IV K R     L    +   KR SR S +G+  EE + EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD-KARSSILNWQRRFNIICG 649
           ++ ++ H N++ L        + +L+ E +    L    FD  A+   L+ +   + I  
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQ 123
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQTEQNTKR 705
           I  G+ YLH     +I H DLK  NI+L  +  P    K+ DFG+A     D  E   K 
Sbjct: 124 ILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVE--FKN 177
Query: 706 VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           + GT  +++PE        +++D++S GV+    +SG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGI--EEFKNEVRLIAKLQHRNLVRLLGC 606
           +G G +G V        G+++A+K+LSR     I  +    E+ L+  +QH N++ LL  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
                     Y++            K      + ++   ++  + +GL Y+H      ++
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VV 166
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL-FSV 725
           HRDLK  N+ ++++   KI DFG+AR    + T       V T  Y +PE  +  + ++ 
Sbjct: 167 HRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----GYVVTRWYRAPEVILSWMHYNQ 221
Query: 726 KSDVFSFGVLLLETVSGK 743
             D++S G ++ E ++GK
Sbjct: 222 TVDIWSVGCIMAEMLTGK 239

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           +R   +F D   LG G F  V        Q+ +A+K +++ + +G E   +NE+ ++ K+
Sbjct: 16  IRDIYDFRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI 73
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N+V L           L+ + +    L   I +K   +  +  R   +I  +   + 
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVK 130
Query: 656 YLHQDSRFRIIHRDLKASNIL---LDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           YLH      I+HRDLK  N+L   LD++    ISDFG++++   +          GT GY
Sbjct: 131 YLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGY 184
Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN 753
           ++PE      +S   D +S GV+    + G     FY  N+
Sbjct: 185 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--FYDEND 223

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFK---NEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +     ++E +   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY     + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+++D++   +++DFG+A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGI--EEFKNEVRLIAKLQHRNLVRLLGC 606
           +G G +G V        G+++A+K+LSR     I  +    E+ L+  +QH N++ LL  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
                     Y++            K      + ++   ++  + +GL Y+H      ++
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VV 148
Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL-FSV 725
           HRDLK  N+ ++++   KI DFG+AR    + T       V T  Y +PE  +  + ++ 
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----GYVVTRWYRAPEVILSWMHYNQ 203
Query: 726 KSDVFSFGVLLLETVSGK 743
             D++S G ++ E ++GK
Sbjct: 204 TVDIWSVGCIMAEMLTGK 221

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 34/217 (15%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQH 597
           ++F+ +  +G+GGFG VY  R  + G+  A+K L +      QG     NE R++  L  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVS 247
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ-----------RRFNI 646
                 + C        + Y +     L S I D      L++             RF  
Sbjct: 248 TGDCPFIVC--------MSYAFHTPDKL-SFILDLMNGGDLHYHLSQHGVFSEADMRF-Y 297
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              I  GL ++H  +RF +++RDLK +NILLD+    +ISD G+A     D +++     
Sbjct: 298 AAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHAS 350
Query: 707 VGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSG 742
           VGT+GYM+PE    G+ +   +D FS G +L + + G
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 34/217 (15%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQH 597
           ++F+ +  +G+GGFG VY  R  + G+  A+K L +      QG     NE R++  L  
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVS 246
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ-----------RRFNI 646
                 + C        + Y +     L S I D      L++             RF  
Sbjct: 247 TGDCPFIVC--------MSYAFHTPDKL-SFILDLMNGGDLHYHLSQHGVFSEADMRF-Y 296
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              I  GL ++H  +RF +++RDLK +NILLD+    +ISD G+A     D +++     
Sbjct: 297 AAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHAS 349
Query: 707 VGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSG 742
           VGT+GYM+PE    G+ +   +D FS G +L + + G
Sbjct: 350 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 34/228 (14%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNLVRLLGCCV 608
           +G+G FG V++G+   G+E+AVK  S  S +    F+  E+     L+H N++  +    
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAA-- 66
Query: 609 EMDEK--------MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             D K         LV +Y E+ SL    FD      +  +    +    A GL +LH +
Sbjct: 67  --DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 120
Query: 661 -----SRFRIIHRDLKASNILLDKEMTPKISDFGMA--RIFGGDQTEQNTKRVVGTYGYM 713
                 +  I HRDLK+ NIL+ K  T  I+D G+A       D  +      VGT  YM
Sbjct: 121 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 180
Query: 714 SPEYAMDGL----FSV--KSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
           +PE   D +    F    ++D+++ G++  E ++ + + G  H + +L
Sbjct: 181 APEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQL 227

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI----AVKRLSRNS----GQGIEEFKNEVRLIA 593
           +NF     LG G +G V+  R + G +     A+K L + +     +  E  + E +++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 594 KLQHRNLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG-IA 651
            ++    +  L    + + K+ L+ +Y+    L + +  + R +    +    I  G I 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT----EHEVQIYVGEIV 169
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG 711
             L +LH   +  II+RD+K  NILLD      ++DFG+++ F  D+TE+      GT  
Sbjct: 170 LALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIE 225
Query: 712 YMSPEYAM--DGLFSVKSDVFSFGVLLLETVSG 742
           YM+P+     D       D +S GVL+ E ++G
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 539 RATDNFTDY-NKLGQGGFGIVYKGR-----LLEGQEIAVKRLSRNSGQGI--EEFKNEVR 590
           +  ++F D   +LG G F IV K R     L    +   KR SR S +G+  EE + EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD-KARSSILNWQRRFNIICG 649
           ++ ++ H N++ L        + +L+ E +    L    FD  A+   L+ +   + I  
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQ 123
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQTEQNTKR 705
           I  G+ YLH     +I H DLK  NI+L  +  P    K+ DFG+A     D  E   K 
Sbjct: 124 ILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVE--FKN 177
Query: 706 VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           + GT  +++PE        +++D++S GV+    +SG
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 14/212 (6%)
Query: 550 LGQGGFGIVYKGRLL----EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           LG+G FG VY+G       E   +AVK   ++ +    E+F +E  ++  L H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G  +E +   ++ E      L   +     S  +     +++   I + + YL       
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 129
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
            +HRD+   NIL+      K+ DFG++R I   D  + +  R+     +MSPE      F
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 187
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
           +  SDV+ F V + E +S  K   F+  N ++
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQPFFWLENKDV 219

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 34/228 (14%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNLVRLLGCCV 608
           +G+G FG V++G+   G+E+AVK  S  S +    F+  E+     L+H N++  +    
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAA-- 68
Query: 609 EMDEK--------MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             D K         LV +Y E+ SL    FD      +  +    +    A GL +LH +
Sbjct: 69  --DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 122
Query: 661 -----SRFRIIHRDLKASNILLDKEMTPKISDFGMA--RIFGGDQTEQNTKRVVGTYGYM 713
                 +  I HRDLK+ NIL+ K  T  I+D G+A       D  +      VGT  YM
Sbjct: 123 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 182
Query: 714 SPEYAMDGL----FSV--KSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
           +PE   D +    F    ++D+++ G++  E ++ + + G  H + +L
Sbjct: 183 APEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQL 229

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 34/228 (14%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNLVRLLGCCV 608
           +G+G FG V++G+   G+E+AVK  S  S +    F+  E+     L+H N++  +    
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAA-- 71
Query: 609 EMDEK--------MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             D K         LV +Y E+ SL    FD      +  +    +    A GL +LH +
Sbjct: 72  --DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 125
Query: 661 -----SRFRIIHRDLKASNILLDKEMTPKISDFGMA--RIFGGDQTEQNTKRVVGTYGYM 713
                 +  I HRDLK+ NIL+ K  T  I+D G+A       D  +      VGT  YM
Sbjct: 126 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 185
Query: 714 SPEYAMDGL----FSV--KSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
           +PE   D +    F    ++D+++ G++  E ++ + + G  H + +L
Sbjct: 186 APEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQL 232

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 34/228 (14%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHRNLVRLLGCCV 608
           +G+G FG V++G+   G+E+AVK  S  S +    F+  E+     L+H N++  +    
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFS--SREERSWFREAEIYQTVMLRHENILGFIAA-- 65
Query: 609 EMDEK--------MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             D K         LV +Y E+ SL    FD      +  +    +    A GL +LH +
Sbjct: 66  --DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 119
Query: 661 -----SRFRIIHRDLKASNILLDKEMTPKISDFGMA--RIFGGDQTEQNTKRVVGTYGYM 713
                 +  I HRDLK+ NIL+ K  T  I+D G+A       D  +      VGT  YM
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 714 SPEYAMDGL----FSV--KSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
           +PE   D +    F    ++D+++ G++  E ++ + + G  H + +L
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQL 226

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           +R   +F D   LG G F  V        Q+ +A+K +++ + +G E   +NE+ ++ K+
Sbjct: 16  IRDIYDFRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI 73
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N+V L           L+ + +    L   I +K   +  +  R   +I  +   + 
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVK 130
Query: 656 YLHQDSRFRIIHRDLKASNIL---LDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           YLH      I+HRDLK  N+L   LD++    ISDFG++++   +          GT GY
Sbjct: 131 YLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGY 184
Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN 753
           ++PE      +S   D +S GV+    + G     FY  N+
Sbjct: 185 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--FYDEND 223

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           +R   +F D   LG G F  V        Q+ +A+K +++ + +G E   +NE+ ++ K+
Sbjct: 16  IRDIYDFRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI 73
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N+V L           L+ + +    L   I +K   +  +  R   +I  +   + 
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVK 130
Query: 656 YLHQDSRFRIIHRDLKASNIL---LDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           YLH      I+HRDLK  N+L   LD++    ISDFG++++   +          GT GY
Sbjct: 131 YLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGY 184
Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN 753
           ++PE      +S   D +S GV+    + G     FY  N+
Sbjct: 185 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--FYDEND 223

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 550 LGQGGFGIVYKGRLLEG----QEIAVKRLSRNSGQGIEEFKNEVR--LIAKLQHRNLVRL 603
           LGQG FG V+  + + G    Q  A+K L + + +  +  + ++   ++ ++ H  +V+L
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI-ICGIARGLLYLHQDSR 662
                   +  L+ +++    L    F +    ++  +      +  +A  L +LH    
Sbjct: 93  HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS--- 145
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             II+RDLK  NILLD+E   K++DFG+++       E+      GT  YM+PE      
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRG 203
Query: 723 FSVKSDVFSFGVLLLETVSG 742
            +  +D +SFGVL+ E ++G
Sbjct: 204 HTQSADWWSFGVLMFEMLTG 223

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 14/212 (6%)
Query: 550 LGQGGFGIVYKGRLL----EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           LG+G FG VY+G       E   +AVK   ++ +    E+F +E  ++  L H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G  +E +   ++ E      L   +     S  +     +++   I + + YL       
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 133
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
            +HRD+   NIL+      K+ DFG++R I   D  + +  R+     +MSPE      F
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 191
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
           +  SDV+ F V + E +S  K   F+  N ++
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPFFWLENKDV 223

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 16/198 (8%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE 609
           LG+G FGIV++      ++  + +  +  G      K E+ ++   +HRN++ L      
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 610 MDEKMLVYEYMENRSLDSVIFDKARSSI--LNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           M+E ++++E++    LD  IF++  +S   LN +   + +  +   L +LH  +   I H
Sbjct: 73  MEELVMIFEFISG--LD--IFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGH 125
Query: 668 RDLKASNILLD--KEMTPKISDFGMARIFG-GDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
            D++  NI+    +  T KI +FG AR    GD    N + +     Y +PE     + S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAPEVHQHDVVS 181
Query: 725 VKSDVFSFGVLLLETVSG 742
             +D++S G L+   +SG
Sbjct: 182 TATDMWSLGTLVYVLLSG 199

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 14/212 (6%)
Query: 550 LGQGGFGIVYKGRLL----EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           LG+G FG VY+G       E   +AVK   ++ +    E+F +E  ++  L H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G  +E +   ++ E      L   +     S  +     +++   I + + YL       
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 145
Query: 665 IIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
            +HRD+   NIL+      K+ DFG++R I   D  + +  R+     +MSPE      F
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 203
Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
           +  SDV+ F V + E +S  K   F+  N ++
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQPFFWLENKDV 235

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 550 LGQGGFGIVYKGRLLEG----QEIAVKRLSRNSGQGIEEFKNEVR--LIAKLQHRNLVRL 603
           LGQG FG V+  + + G    Q  A+K L + + +  +  + ++   ++ ++ H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI-ICGIARGLLYLHQDSR 662
                   +  L+ +++    L    F +    ++  +      +  +A  L +LH    
Sbjct: 92  HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS--- 144
Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
             II+RDLK  NILLD+E   K++DFG+++       E+      GT  YM+PE      
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 723 FSVKSDVFSFGVLLLETVSG 742
            +  +D +SFGVL+ E ++G
Sbjct: 203 HTQSADWWSFGVLMFEMLTG 222

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R        RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIE-EFKNEVRLIAKL 595
           +R   +F D   LG G F  V        Q+ +A+K +++ + +G E   +NE+ ++ K+
Sbjct: 16  IRDIYDFRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI 73
Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
           +H N+V L           L+ + +    L   I +K   +  +  R   +I  +   + 
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVK 130
Query: 656 YLHQDSRFRIIHRDLKASNIL---LDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           YLH      I+HRDLK  N+L   LD++    ISDFG++++   +          GT GY
Sbjct: 131 YLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGY 184
Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN 753
           ++PE      +S   D +S GV+    + G     FY  N+
Sbjct: 185 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--FYDEND 223

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCC 607
           LG+G    V     L+  QE AVK + +  G        EV ++ + Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN------IICGIARGLLYLHQDS 661
            E D   LV+E M   S+ S I  +         R FN      ++  +A  L +LH   
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKR---------RHFNELEASVVVQDVASALDFLHNKG 131
Query: 662 RFRIIHRDLKASNILLDK--EMTP-KISDF--GMARIFGGDQTEQNTKRVV---GTYGYM 713
              I HRDLK  NIL +   +++P KI DF  G      GD +  +T  ++   G+  YM
Sbjct: 132 ---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 714 SPEYA-----MDGLFSVKSDVFSFGVLLLETVSG 742
           +PE          ++  + D++S GV+L   +SG
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R        RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY     + S +    R        RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+++D++   K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN 599
            ++  D  ++G+G +G V K      GQ +AVKR+ R++    E+ +  + L   ++  +
Sbjct: 21  AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSD 79
Query: 600 ---LVRLLGCCVEMDEKMLVYEYMEN------RSLDSVIFDKARSSILNWQRRFNIICGI 650
              +V+  G      +  +  E M        + + SV+ D     IL       I    
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-----KITLAT 134
Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK-RVVGT 709
            + L +L ++   +IIHRD+K SNILLD+    K+ DFG++    G   +   K R  G 
Sbjct: 135 VKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGIS----GQLVDSIAKTRDAGC 188
Query: 710 YGYMSPEY----AMDGLFSVKSDVFSFGVLLLETVSGK 743
             YM+PE     A    + V+SDV+S G+ L E  +G+
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R        RF     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 17/209 (8%)
Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFK-NEVRLIAKLQHRNLVRLLGCC 607
           K+G+G +G VYK +  +G++     L +  G GI      E+ L+ +L+H N++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 608 V-EMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY-----LHQD 660
           +   D K+ L+++Y E+     + F +A  +    ++   +  G+ + LLY     +H  
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 661 SRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGD-QTEQNTKRVVGTYGYMSP 715
               ++HRDLK +NIL+  E       KI+D G AR+F    +   +   VV T+ Y +P
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 716 EYAMDGLFSVKS-DVFSFGVLLLETVSGK 743
           E  +      K+ D+++ G +  E ++ +
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLAGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY     + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+++D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 150
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 151 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 202
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             L +L     +     +V EY     + S +    R S      RF     I     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+++D++   K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 14/197 (7%)
Query: 550 LGQGGFGIVYKGRLLE----GQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +        +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 78  GVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK--- 130
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           R +HRD+ A N+L+      K+ DFG++R +  D T     +      +M+PE      F
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 724 SVKSDVFSFGVLLLETV 740
           +  SDV+ FGV + E +
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             L +L     +     +V EY     + S +    R S      RF     I     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+++D++   K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLXGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 121/274 (44%), Gaps = 66/274 (24%)
Query: 534 FETIVRATDNFTDYNKLGQGGFGIVY--KGRLLEGQE--IAVKRLSRNSGQGIEEFKNEV 589
           +E + + ++ F   +K+G+G F  VY    +L  G E  IA+K L   S        + +
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--------HPI 64
Query: 590 RLIAKLQ-------HRNLVRLLGCCVEMDEKMLVYEYMENRS----LDSVIFDKARSSIL 638
           R+ A+LQ         N++ +  C  + D  ++   Y+E+ S    L+S+ F + R  +L
Sbjct: 65  RIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYML 124
Query: 639 NWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMAR----- 692
           N          + + L  +HQ   F I+HRD+K SN L ++ +    + DFG+A+     
Sbjct: 125 N----------LFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171
Query: 693 ---IFGGDQTEQNTKRV------------------VGTYGYMSPEYAMDGLFSVKS-DVF 730
              +    Q+E   +R                    GT G+ +PE          + D++
Sbjct: 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMW 231
Query: 731 SFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
           S GV+ L  +SG+    FY ++++L  L  +  +
Sbjct: 232 SAGVIFLSLLSGR--YPFYKASDDLTALAQIMTI 263

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 128/294 (43%), Gaps = 36/294 (12%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN-- 599
           ++   ++G GG   V++    + Q  A+K   L     Q ++ ++NE+  + KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++RL    +       +Y  ME  ++D   + K + SI  W+R+ +    +   +  +HQ
Sbjct: 118 IIRLYDYEIT---DQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 173
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
                I+H DLK +N L+   M  K+ DFG+A     D T       VGT  YM PE   
Sbjct: 174 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 720 DGLFSVKS-----------DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG 768
           D   S ++           DV+S G +L     GK    F    N+++ L  +     E 
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKLHAIIDPNHEI 287
Query: 769 KVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMP 822
           +  ++ +  +      +VL+C      C++ + ++R ++  ++     +  T P
Sbjct: 288 EFPDIPEKDL-----QDVLKC------CLKRDPKQRISIPELLAHPYVQIQTHP 330

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 178
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 230
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 144
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 145 HS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 196
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 197 ILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY     + S +    R S      RF     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+++D++   K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN-- 599
           ++   ++G GG   V++    + Q  A+K   L     Q ++ ++NE+  + KLQ  +  
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 73
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++RL     E+ ++  +Y  ME  ++D   + K + SI  W+R+          L  +H 
Sbjct: 74  IIRLYD--YEITDQ-YIYMVMECGNIDLNSWLKKKKSIDPWERK----SYWKNMLEAVHT 126
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
             +  I+H DLK +N L+   M  K+ DFG+A     D T       VGT  YM PE   
Sbjct: 127 IHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 185
Query: 720 DGLFSVKS-----------DVFSFGVLLLETVSGK 743
           D   S ++           DV+S G +L     GK
Sbjct: 186 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN-- 599
           ++   ++G GG   V++    + Q  A+K   L     Q ++ ++NE+  + KLQ  +  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++RL    +       +Y  ME  ++D   + K + SI  W+R+ +    +   +  +HQ
Sbjct: 90  IIRLYDYEIT---DQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 145
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
                I+H DLK +N L+   M  K+ DFG+A     D T       VGT  YM PE   
Sbjct: 146 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 720 DGLFSVKS-----------DVFSFGVLLLETVSGK 743
           D   S ++           DV+S G +L     GK
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 14/197 (7%)
Query: 550 LGQGGFGIVYKGRLLE----GQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +        +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 78  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 130
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           R +HRD+ A N+L+      K+ DFG++R +  D T     +      +M+PE      F
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 724 SVKSDVFSFGVLLLETV 740
           +  SDV+ FGV + E +
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +  +     +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 106 GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 158
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           R +HRD+ A N+L+      K+ DFG++R +  D T     +      +M+PE      F
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 217
Query: 724 SVKSDVFSFGVLLLETV 740
           +  SDV+ FGV + E +
Sbjct: 218 TSASDVWMFGVCMWEIL 234

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV- 608
           +G+G +G V++G L  G+ +AVK  S    Q     + E+     L+H N++  +   + 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIASDMT 73
Query: 609 ---EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD----- 660
                 +  L+  Y E+ SL    +D  +   L       +    A GL +LH +     
Sbjct: 74  SRNSSTQLWLITHYHEHGSL----YDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRVVGTYGYMSPEYA 718
            +  I HRD K+ N+L+   +   I+D G+A +   G D  +      VGT  YM+PE  
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 719 -----MDGLFSVK-SDVFSFGVLLLE 738
                 D   S K +D+++FG++L E
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWE 215

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +  +     +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 78  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 130
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           R +HRD+ A N+L+      K+ DFG++R +  D T     +      +M+PE      F
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 724 SVKSDVFSFGVLLLETV 740
           +  SDV+ FGV + E +
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +  +     +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 80  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 132
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           R +HRD+ A N+L+      K+ DFG++R +  D T     +      +M+PE      F
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 191
Query: 724 SVKSDVFSFGVLLLETV 740
           +  SDV+ FGV + E +
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +  +     +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 81  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 133
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           R +HRD+ A N+L+      K+ DFG++R +  D T     +      +M+PE      F
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 192
Query: 724 SVKSDVFSFGVLLLETV 740
           +  SDV+ FGV + E +
Sbjct: 193 TSASDVWMFGVCMWEIL 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +  +     +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 75  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 127
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           R +HRD+ A N+L+      K+ DFG++R +  D T     +      +M+PE      F
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 724 SVKSDVFSFGVLLLETV 740
           +  SDV+ FGV + E +
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 178
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----ATWTLCGTPEYLAPEI 230
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +  +     +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 83  GVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--- 135
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           R +HRD+ A N+L+      K+ DFG++R +  D T     +      +M+PE      F
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 724 SVKSDVFSFGVLLLETV 740
           +  SDV+ FGV + E +
Sbjct: 195 TSASDVWMFGVCMWEIL 211

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 26/209 (12%)
Query: 550 LGQGGFGIVYKGRLLE----GQ----EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           LGQG F  ++KG   E    GQ    E+ +K L +      E F     +++KL H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
              G CV  DE +LV E+++  SLD+ +  K   + +N   +  +   +A  + +L +++
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFLEENT 133
Query: 662 RFRIIHRDLKASNILLDKEM-----TP---KISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
              +IH ++ A NILL +E       P   K+SD G++         Q     V      
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIE 190
Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           +P+       ++ +D +SFG  L E  SG
Sbjct: 191 NPKN-----LNLATDKWSFGTTLWEICSG 214

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 122/287 (42%), Gaps = 53/287 (18%)
Query: 541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL--QH 597
            D+     +LG+G +G+V K R +  GQ  AVKR+           + + RL+  L    
Sbjct: 33  ADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNS-----QEQKRLLXDLDISX 87
Query: 598 RNL-----VRLLGCCVEMDEKMLVYEYMENRSLDSV---IFDKARS---SILNWQRRFNI 646
           R +     V   G      +  +  E + + SLD     + DK ++    IL       I
Sbjct: 88  RTVDCPFTVTFYGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILG-----KI 141
Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              I + L +LH  S+  +IHRD+K SN+L++     K  DFG++     D  +      
Sbjct: 142 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID--- 196
Query: 707 VGTYGYMSPEYAMDGL----FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVW 762
            G   Y +PE     L    +SVKSD++S G+  +                EL +L   +
Sbjct: 197 AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXI----------------ELAILRFPY 240
Query: 763 RLWKEG--KVLEMVDSSVDNYPANEV-LRCIHVGLLCVQENAEERPT 806
             W     ++ ++V+      PA++     +     C+++N++ERPT
Sbjct: 241 DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPT 287

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 14/197 (7%)
Query: 550 LGQGGFGIVYKGRLLE----GQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +        +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 78  GVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK--- 130
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           R +HRD+ A N+L+      K+ DFG++R +  D T     +      +M+PE      F
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 724 SVKSDVFSFGVLLLETV 740
           +  SDV+ FGV + E +
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R        RF     I     YL
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 150
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 151 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 202
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN-- 599
           ++   ++G GG   V++    + Q  A+K   L     Q ++ ++NE+  + KLQ  +  
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 69
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++RL     E+ ++  +Y  ME  ++D   + K + SI  W+R+ +    +   +  +HQ
Sbjct: 70  IIRLYD--YEITDQ-YIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 125
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
                I+H DLK +N L+   M  K+ DFG+A     D T       VGT  YM PE   
Sbjct: 126 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 181
Query: 720 DGLFSVKS-----------DVFSFGVLLLETVSGK 743
           D   S ++           DV+S G +L     GK
Sbjct: 182 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R        RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN-- 599
           ++   ++G GG   V++    + Q  A+K   L     Q ++ ++NE+  + KLQ  +  
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++RL    +       +Y  ME  ++D   + K + SI  W+R+ +    +   +  +HQ
Sbjct: 71  IIRLYDYEIT---DQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 126
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
                I+H DLK +N L+   M  K+ DFG+A     D T       VGT  YM PE   
Sbjct: 127 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 720 DGLFSVKS-----------DVFSFGVLLLETVSGK 743
           D   S ++           DV+S G +L     GK
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   + +E G   A+K L +      + IE   NE R++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             L +L     +     +V EY     + S +    R        RF     I     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+++D++   K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+++D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 IISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN-- 599
           ++   ++G GG   V++    + Q  A+K   L     Q ++ ++NE+  + KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++RL    +       +Y  ME  ++D   + K + SI  W+R+ +    +   +  +HQ
Sbjct: 118 IIRLYDYEIT---DQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 173
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
                I+H DLK +N L+   M  K+ DFG+A     D T       VGT  YM PE   
Sbjct: 174 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 720 DGLFSVKS-----------DVFSFGVLLLETVSGK 743
           D   S ++           DV+S G +L     GK
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R +      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFA--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R        RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R+   +  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY     + S +    R S      RF     I     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 158
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R        RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R        RF     I     YL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 178
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 230
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R        RF     I     YL
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FXEPHARF-YAAQIVLTFEYL 152
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 153 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 204
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 205 ILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ +  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 15/203 (7%)
Query: 550 LGQGGFGIVYKGRLLE-GQEIAVK-----RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +G+G F +V +    E GQ+ AVK     + + + G   E+ K E  +   L+H ++V L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR-RFNIICGIARGLLYLHQDSR 662
           L          +V+E+M+   L   I  +A +  +  +    + +  I   L Y H ++ 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 150
Query: 663 FRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
             IIHRD+K   +LL   +     K+  FG+A   G        +  VGT  +M+PE   
Sbjct: 151 --IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPEVVK 206
Query: 720 DGLFSVKSDVFSFGVLLLETVSG 742
              +    DV+  GV+L   +SG
Sbjct: 207 REPYGKPVDVWGCGVILFILLSG 229

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 31/219 (14%)
Query: 566 GQEIAVKRLS----RNSGQGIEEFKNEVR-----LIAKLQHRNLVRLLGCCVEMDEKMLV 616
           G E AVK +     R S + +EE +   R     L     H +++ L+          LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNIL 676
           ++ M    L   + +K     L+ +   +I+  +   + +LH ++   I+HRDLK  NIL
Sbjct: 179 FDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENIL 232
Query: 677 LDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY---AMDGL---FSVKSDVF 730
           LD  M  ++SDFG +      +  +  + + GT GY++PE    +MD     +  + D++
Sbjct: 233 LDDNMQIRLSDFGFSCHL---EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLW 289
Query: 731 SFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK 769
           + GV+L   ++G     F+H    L L     R+  EG+
Sbjct: 290 ACGVILFTLLAGSP--PFWHRRQILML-----RMIMEGQ 321

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 36/225 (16%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLI---AK 594
           R T  F +  K+G G FG V+K  + L+G   A+KR  +     ++E +N +R +   A 
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDE-QNALREVYAHAV 64
Query: 595 L-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIAR 652
           L QH ++VR      E D  ++  EY    SL   I +  R  S        +++  + R
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTP-------------------KISDFGMARI 693
           GL Y+H  S   ++H D+K SNI + +   P                   KI D G    
Sbjct: 125 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 181
Query: 694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV-KSDVFSFGVLLL 737
               Q E+   R      +++ E   +    + K+D+F+  + ++
Sbjct: 182 ISSPQVEEGDSR------FLANEVLQENYTHLPKADIFALALTVV 220

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 36/231 (15%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLI---AK 594
           R T  F +  K+G G FG V+K  + L+G   A+KR  +     ++E +N +R +   A 
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDE-QNALREVYAHAV 62
Query: 595 L-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIAR 652
           L QH ++VR      E D  ++  EY    SL   I +  R  S        +++  + R
Sbjct: 63  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 122
Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTP-------------------KISDFGMARI 693
           GL Y+H  S   ++H D+K SNI + +   P                   KI D G    
Sbjct: 123 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 179
Query: 694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV-KSDVFSFGVLLLETVSGK 743
               Q E+   R      +++ E   +    + K+D+F+  + ++     +
Sbjct: 180 ISSPQVEEGDSR------FLANEVLQENYTHLPKADIFALALTVVXAAGAE 224

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 36/225 (16%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLI---AK 594
           R T  F +  K+G G FG V+K  + L+G   A+KR  +     ++E +N +R +   A 
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDE-QNALREVYAHAV 64
Query: 595 L-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIAR 652
           L QH ++VR      E D  ++  EY    SL   I +  R  S        +++  + R
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTP-------------------KISDFGMARI 693
           GL Y+H  S   ++H D+K SNI + +   P                   KI D G    
Sbjct: 125 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 181
Query: 694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV-KSDVFSFGVLLL 737
               Q E+   R      +++ E   +    + K+D+F+  + ++
Sbjct: 182 ISSPQVEEGDSR------FLANEVLQENYTHLPKADIFALALTVV 220

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 36/225 (16%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLI---AK 594
           R T  F +  K+G G FG V+K  + L+G   A+KR  +     ++E +N +R +   A 
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDE-QNALREVYAHAV 66
Query: 595 L-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIAR 652
           L QH ++VR      E D  ++  EY    SL   I +  R  S        +++  + R
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTP-------------------KISDFGMARI 693
           GL Y+H  S   ++H D+K SNI + +   P                   KI D G    
Sbjct: 127 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV-KSDVFSFGVLLL 737
               Q E+   R      +++ E   +    + K+D+F+  + ++
Sbjct: 184 ISSPQVEEGDSR------FLANEVLQENYTHLPKADIFALALTVV 222

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 15/203 (7%)
Query: 550 LGQGGFGIVYKGRLLE-GQEIAVK-----RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +G+G F +V +    E GQ+ AVK     + + + G   E+ K E  +   L+H ++V L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQR-RFNIICGIARGLLYLHQDSR 662
           L          +V+E+M+   L   I  +A +  +  +    + +  I   L Y H ++ 
Sbjct: 94  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN- 152
Query: 663 FRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
             IIHRD+K   +LL   +     K+  FG+A   G        +  VGT  +M+PE   
Sbjct: 153 --IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPEVVK 208
Query: 720 DGLFSVKSDVFSFGVLLLETVSG 742
              +    DV+  GV+L   +SG
Sbjct: 209 REPYGKPVDVWGCGVILFILLSG 231

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQE----IAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +  +     +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 458 GVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           R +HRD+ A N+L+      K+ DFG++R +  D T     +      +M+PE      F
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 724 SVKSDVFSFGVLLLETV 740
           +  SDV+ FGV + E +
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 14/197 (7%)
Query: 550 LGQGGFGIVYKGRLLE----GQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQHRNLVRLL 604
           +G+G FG V++G  +        +A+K     +   + E+F  E   + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 605 GCCVEMDEKMLVYEYMENRSLDSV-IFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           G   E      V+  ME  +L  +  F + R   L+          ++  L YL      
Sbjct: 458 GVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           R +HRD+ A N+L+      K+ DFG++R +  D T     +      +M+PE      F
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 724 SVKSDVFSFGVLLLETV 740
           +  SDV+ FGV + E +
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 132/288 (45%), Gaps = 47/288 (16%)
Query: 539 RATDNFTDY-----NKLGQGGFGIVYKG-RLLEGQEIAVKRLS-RNSGQGIE-EFKNEVR 590
           ++ +NF ++      +LG+G F +V +      GQE A K L  R  GQ    E  +E+ 
Sbjct: 21  QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA 80
Query: 591 LI--AKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC 648
           ++  AK   R ++ L        E +L+ EY     + S+   +  + +++      +I 
Sbjct: 81  VLELAKSCPR-VINLHEVYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIK 138
Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQTEQNTK 704
            I  G+ YLHQ++   I+H DLK  NILL   + P    KI DFGM+R  G        +
Sbjct: 139 QILEGVYYLHQNN---IVHLDLKPQNILLSS-IYPLGDIKIVDFGMSRKIGH---ACELR 191
Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGV---LLLETVS---GKKNRGFYHSNNELNLL 758
            ++GT  Y++PE       +  +D+++ G+   +LL   S   G+ N+  Y + +++N  
Sbjct: 192 EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN-- 249
Query: 759 GHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPT 806
                          VD S + + +   L    +  L V+ N E+RPT
Sbjct: 250 ---------------VDYSEETFSSVSQLATDFIQSLLVK-NPEKRPT 281

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 103/227 (45%), Gaps = 27/227 (11%)
Query: 530 PLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN- 587
           P+FD    V   D+F     +G+G FG V   +  + +++ A+K +++       E +N 
Sbjct: 4   PVFDENEDVNF-DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV 62
Query: 588 --EVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-----DSVIFDKARSSILNW 640
             E++++  L+H  LV L     + ++  +V + +    L      +V F +    +   
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF-- 120
Query: 641 QRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
                 IC +   L YL      RIIHRD+K  NILLD+     I+DF +A +      E
Sbjct: 121 ------ICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RE 168
Query: 701 QNTKRVVGTYGYMSPEY--AMDGL-FSVKSDVFSFGVLLLETVSGKK 744
                + GT  YM+PE   +  G  +S   D +S GV   E + G++
Sbjct: 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT  Y++P  
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPAI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 23/215 (10%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN-- 599
           ++   ++G GG   V++    + Q  A+K   L     Q ++ ++NE+  + KLQ  +  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++RL    +       +Y  ME  ++D   + K + SI  W+R+ +    +   +  +HQ
Sbjct: 90  IIRLYDYEIT---DQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 145
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
                I+H DLK +N L+   M  K+ DFG+A     D         VGT  YM PE   
Sbjct: 146 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIK 201
Query: 720 DGLFSVKS-----------DVFSFGVLLLETVSGK 743
           D   S ++           DV+S G +L     GK
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 81/165 (49%), Gaps = 7/165 (4%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKGRLLEG-QEIAVKRLSRNSGQGIE--EFKNEVRLIAK 594
           V+  DN+   + +G+G +G VY        + +A+K+++R     I+      E+ ++ +
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNR 83
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARG 653
           L+   ++RL    +  D       Y+     DS +    ++ I L  Q    I+  +  G
Sbjct: 84  LKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLG 143
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
             ++H+     IIHRDLK +N LL+++ + KI DFG+AR    D+
Sbjct: 144 EKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDK 185

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 23/215 (10%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN-- 599
           ++   ++G GG   V++    + Q  A+K   L     Q ++ ++NE+  + KLQ  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++RL    +       +Y  ME  ++D   + K + SI  W+R+ +    +   +  +HQ
Sbjct: 118 IIRLYDYEIT---DQYIYMVMECGNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQ 173
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
                I+H DLK +N L+   M  K+ DFG+A     D T       VG   YM PE   
Sbjct: 174 HG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 720 DGLFSVKS-----------DVFSFGVLLLETVSGK 743
           D   S ++           DV+S G +L     GK
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 103/257 (40%), Gaps = 32/257 (12%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG-----------IEEFKNEVRLIAKLQHR 598
           +  G +G V  G   EG  +A+KR+      G            +    E+RL+    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 599 NLVRLLGCCVEMDEKM-----LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           N++ L    V  +E       LV E M    L  VI D+    +++ Q     +  I  G
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ--RIVISPQHIQYFMYHILLG 146
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
           L  LH+     ++HRDL   NILL       I DF +AR    D  + N    V    Y 
Sbjct: 147 LHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYR 200
Query: 714 SPEYAMDGL-FSVKSDVFSFGVLLLETVSGK---KNRGFYHSNNELNLLGHVWRLWKEGK 769
           +PE  M    F+   D++S G ++ E  + K   +   FY   N+LN +  V    K   
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---NQLNKIVEVVGTPKIED 257
Query: 770 VLEMVDSSVDNYPANEV 786
           V+     S  +Y  N +
Sbjct: 258 VVMFSSPSARDYLRNSL 274

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 103/257 (40%), Gaps = 32/257 (12%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQG-----------IEEFKNEVRLIAKLQHR 598
           +  G +G V  G   EG  +A+KR+      G            +    E+RL+    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 599 NLVRLLGCCVEMDEKM-----LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           N++ L    V  +E       LV E M    L  VI D+    +++ Q     +  I  G
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQ--RIVISPQHIQYFMYHILLG 146
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
           L  LH+     ++HRDL   NILL       I DF +AR    D  + N    V    Y 
Sbjct: 147 LHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYR 200
Query: 714 SPEYAMDGL-FSVKSDVFSFGVLLLETVSGK---KNRGFYHSNNELNLLGHVWRLWKEGK 769
           +PE  M    F+   D++S G ++ E  + K   +   FY   N+LN +  V    K   
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---NQLNKIVEVVGTPKIED 257
Query: 770 VLEMVDSSVDNYPANEV 786
           V+     S  +Y  N +
Sbjct: 258 VVMFSSPSARDYLRNSL 274

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 550 LGQGGFGIVYKGRLLE----GQ----EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           LGQG F  ++KG   E    GQ    E+ +K L +      E F     +++KL H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
              G C   DE +LV E+++  SLD+ +  K   + +N   +  +   +A  + +L +++
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAWAMHFLEENT 133
Query: 662 RFRIIHRDLKASNILLDKEM-----TP---KISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
              +IH ++ A NILL +E       P   K+SD G++         Q     V      
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIE 190
Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           +P+       ++ +D +SFG  L E  SG
Sbjct: 191 NPKN-----LNLATDKWSFGTTLWEICSG 214

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 36/265 (13%)
Query: 484 KTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDN 543
           KT   R  R  EP    E ++ +LL + +     +Y               E +  AT  
Sbjct: 34  KTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYR--------------EEVHWATHQ 79
Query: 544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFK-NEVRLIAKLQHRNLV 601
                +LG+G FG V++    + G + AVK++       +E F+  E+   A L    +V
Sbjct: 80  L----RLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIV 129
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            L G   E     +  E +E  SL  ++ ++     L   R    +     GL YLH  S
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSLGQLVKEQG---CLPEDRALYYLGQALEGLEYLH--S 184
Query: 662 RFRIIHRDLKASNILLDKEMT-PKISDFGMARIFGGDQTEQNT---KRVVGTYGYMSPEY 717
           R RI+H D+KA N+LL  + +   + DFG A     D   ++      + GT  +M+PE 
Sbjct: 185 R-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEV 243
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +      K DV+S   ++L  ++G
Sbjct: 244 VLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQH 597
           D F     LG G FG V   +  E G   A+K L +      + IE   NE R++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             LV+L     +     +V EY+    + S +    R S      RF     I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPHARF-YAAQIVLTFEYL 157
Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT   ++PE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEALAPEI 209
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +   ++   D ++ GVL+ E  +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFK-NEVRLIAKLQHRNLV 601
            T   +LG+G FG V++ +  + G + AVK++       +E F+  E+   A L    +V
Sbjct: 74  MTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 127
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            L G   E     +  E +E  SL  +I    +   L   R    +     GL YLH   
Sbjct: 128 PLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR- 183
Query: 662 RFRIIHRDLKASNILLDKEMT-PKISDFGMARIFGGD---QTEQNTKRVVGTYGYMSPEY 717
             RI+H D+KA N+LL  + +   + DFG A     D   ++      + GT  +M+PE 
Sbjct: 184 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 241
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            M      K D++S   ++L  ++G
Sbjct: 242 VMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 26/232 (11%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
            +F   ++LG G +G V+K R  E G+  AVKR S +  +G    K+  R +A++     
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGP---KDRARKLAEVGSHEK 112
Query: 601 VRLLGCCVEMD----EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           V    CCV ++    E  ++Y   E          +A  + L   + +  +      L +
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           LH      ++H D+K +NI L      K+ DFG+    G   T    +   G   YM+PE
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPE 226
Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG 768
             + G +   +DVFS G+ +LE             N EL   G  W+  ++G
Sbjct: 227 L-LQGSYGTAADVFSLGLTILEVA----------CNMELPHGGEGWQQLRQG 267

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 36/265 (13%)
Query: 484 KTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDN 543
           KT   R  R  EP    E ++ +LL + +     +Y               E +  AT  
Sbjct: 53  KTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYR--------------EEVHWATHQ 98
Query: 544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFK-NEVRLIAKLQHRNLV 601
                +LG+G FG V++    + G + AVK++       +E F+  E+   A L    +V
Sbjct: 99  L----RLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIV 148
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            L G   E     +  E +E  SL  ++ ++     L   R    +     GL YLH  S
Sbjct: 149 PLYGAVREGPWVNIFMELLEGGSLGQLVKEQG---CLPEDRALYYLGQALEGLEYLH--S 203
Query: 662 RFRIIHRDLKASNILLDKEMT-PKISDFGMARIFGGD---QTEQNTKRVVGTYGYMSPEY 717
           R RI+H D+KA N+LL  + +   + DFG A     D   ++      + GT  +M+PE 
Sbjct: 204 R-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEV 262
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            +      K DV+S   ++L  ++G
Sbjct: 263 VLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFK-NEVRLIAKLQHRNLV 601
            T   ++G+G FG V++ +  + G + AVK++       +E F+  E+   A L    +V
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 113
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            L G   E     +  E +E  SL  +I    +   L   R    +     GL YLH   
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR- 169
Query: 662 RFRIIHRDLKASNILLDKEMT-PKISDFGMARIFGGDQTEQNT---KRVVGTYGYMSPEY 717
             RI+H D+KA N+LL  + +   + DFG A     D   ++      + GT  +M+PE 
Sbjct: 170 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            M      K D++S   ++L  ++G
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           +G+G FG V   R    Q++ A+K LS+     +    F  E R I    +   V  L C
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 142
Query: 607 CVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
             + D+ + +V EYM    L +++ +        W + +      A  +L L       +
Sbjct: 143 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--KWAKFYT-----AEVVLALDAIHSMGL 195
Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ-NTKRVVGTYGYMSPEY----AMD 720
           IHRD+K  N+LLDK    K++DFG       D+T   +    VGT  Y+SPE       D
Sbjct: 196 IHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVHCDTAVGTPDYISPEVLKSQGGD 253
Query: 721 GLFSVKSDVFSFGVLLLETVSG 742
           G +  + D +S GV L E + G
Sbjct: 254 GYYGRECDWWSVGVFLFEMLVG 275

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 544 FTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFK-NEVRLIAKLQHRNLV 601
            T   ++G+G FG V++ +  + G + AVK++       +E F+  E+   A L    +V
Sbjct: 76  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 129
Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            L G   E     +  E +E  SL  +I    +   L   R    +     GL YLH   
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR- 185
Query: 662 RFRIIHRDLKASNILLDKEMT-PKISDFGMARIFGGD---QTEQNTKRVVGTYGYMSPEY 717
             RI+H D+KA N+LL  + +   + DFG A     D   ++      + GT  +M+PE 
Sbjct: 186 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 243
Query: 718 AMDGLFSVKSDVFSFGVLLLETVSG 742
            M      K D++S   ++L  ++G
Sbjct: 244 VMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 87/201 (43%), Gaps = 19/201 (9%)
Query: 550 LGQGGFGIVYKGRLLEGQEI--AVKRLSRNSGQGIEEFKNEVR----LIAKLQHRNLVRL 603
           +G+G FG V   R  + +E+  AVK L + +    +E K+ +     L+  ++H  LV L
Sbjct: 46  IGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
                  D+   V +Y+    L    +   R       R       IA  L YLH     
Sbjct: 105 HFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAEIASALGYLHS---L 158
Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN--TKRVVGTYGYMSPEYAMDG 721
            I++RDLK  NILLD +    ++DFG+ +    +  E N  T    GT  Y++PE     
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNSTTSTFCGTPEYLAPEVLHKQ 214
Query: 722 LFSVKSDVFSFGVLLLETVSG 742
            +    D +  G +L E + G
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYG 235

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 18/164 (10%)
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRF 644
           + E+ ++ KL H  ++++     + ++  +V E ME   L D V+ +K           +
Sbjct: 188 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQ 701
            ++  +     YLH++    IIHRDLK  N+LL   +++   KI+DFG ++I G      
Sbjct: 247 QMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 297
Query: 702 NTKRVVGTYGYMSPEYAMD---GLFSVKSDVFSFGVLLLETVSG 742
             + + GT  Y++PE  +      ++   D +S GV+L   +SG
Sbjct: 298 -MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 18/164 (10%)
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRF 644
           + E+ ++ KL H  ++++     + ++  +V E ME   L D V+ +K           +
Sbjct: 202 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 260
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQ 701
            ++  +     YLH++    IIHRDLK  N+LL   +++   KI+DFG ++I G      
Sbjct: 261 QMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 311
Query: 702 NTKRVVGTYGYMSPEYAMD---GLFSVKSDVFSFGVLLLETVSG 742
             + + GT  Y++PE  +      ++   D +S GV+L   +SG
Sbjct: 312 -MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 18/164 (10%)
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRF 644
           + E+ ++ KL H  ++++     + ++  +V E ME   L D V+ +K           +
Sbjct: 69  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQ 701
            ++  +     YLH++    IIHRDLK  N+LL   +++   KI+DFG ++I G      
Sbjct: 128 QMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 178
Query: 702 NTKRVVGTYGYMSPEYAMD---GLFSVKSDVFSFGVLLLETVSG 742
             + + GT  Y++PE  +      ++   D +S GV+L   +SG
Sbjct: 179 -MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN------EVRLIAKLQ----HR 598
           LG+GGFG V+ G RL +  ++A+K + RN   G     +      EV L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 599 NLVRLLGCCVEMDEKMLVYEY-MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            ++RLL      +  MLV E  +  + L   I +K        +  F  +    +     
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ----- 153
Query: 658 HQDSRFRIIHRDLKASNILLD-KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           H  SR  ++HRD+K  NIL+D +    K+ DFG   +      ++      GT  Y  PE
Sbjct: 154 HCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALL----HDEPYTDFDGTRVYSPPE 208
Query: 717 Y-AMDGLFSVKSDVFSFGVLLLETVSG 742
           + +     ++ + V+S G+LL + V G
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 128/310 (41%), Gaps = 60/310 (19%)
Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCC 607
           L +GGF  VY+ + +  G+E A+KRL  N  +       EV  + KL  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 608 V----EMD----EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
                E D    E +L+ E  + + ++ +   ++R   L+      I     R + ++H+
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHMHR 154
Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMA---------------RIFGGDQTEQNTK 704
             +  IIHRDLK  N+LL  + T K+ DFG A               R    ++  +NT 
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT- 212
Query: 705 RVVGTYGYMSPEYAMDGLFS-----VKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLG 759
               T  Y +PE  +  L+S      K D+++ G +L                    LL 
Sbjct: 213 ----TPMYRTPE--IIDLYSNFPIGEKQDIWALGCILY-------------------LLC 247
Query: 760 HVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLC-VQENAEERPTMASVVLMLSSET 818
                +++G  L +V+      P +      H  +   +Q N EER ++A VV  L    
Sbjct: 248 FRQHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307
Query: 819 ATM-PQPKTP 827
           A     PK+P
Sbjct: 308 AARNVNPKSP 317

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 40/222 (18%)
Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
           + +F   + LG+G +G+V        G+ +A+K+        IE F           E++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 591 LIAKLQHRNLVRLLGC-----CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           ++   +H N++ +            +E  ++ E M+   L  VI     + +L+      
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI----STQMLSDDHIQY 116
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF---GGDQTEQN 702
            I    R +  LH  +   +IHRDLK SN+L++     K+ DFG+ARI      D +E  
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 703 TKR-----VVGTYGYMSPEYAM-DGLFSVKSDVFSFGVLLLE 738
            ++      V T  Y +PE  +    +S   DV+S G +L E
Sbjct: 174 GQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 18/164 (10%)
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRF 644
           + E+ ++ KL H  ++++     + ++  +V E ME   L D V+ +K           +
Sbjct: 62  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQ 701
            ++  +     YLH++    IIHRDLK  N+LL   +++   KI+DFG ++I G      
Sbjct: 121 QMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 171
Query: 702 NTKRVVGTYGYMSPEYAMD---GLFSVKSDVFSFGVLLLETVSG 742
             + + GT  Y++PE  +      ++   D +S GV+L   +SG
Sbjct: 172 -MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 40/222 (18%)
Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
           + +F   + LG+G +G+V        G+ +A+K+        IE F           E++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 591 LIAKLQHRNLVRLLGC-----CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           ++   +H N++ +            +E  ++ E M+   L  VI     + +L+      
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI----STQMLSDDHIQY 116
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF---GGDQTEQN 702
            I    R +  LH  +   +IHRDLK SN+L++     K+ DFG+ARI      D +E  
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 703 TKR-----VVGTYGYMSPEYAM-DGLFSVKSDVFSFGVLLLE 738
            ++      V T  Y +PE  +    +S   DV+S G +L E
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 18/164 (10%)
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRF 644
           + E+ ++ KL H  ++++     + ++  +V E ME   L D V+ +K           +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQ 701
            ++  +     YLH++    IIHRDLK  N+LL   +++   KI+DFG ++I G      
Sbjct: 122 QMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 172
Query: 702 NTKRVVGTYGYMSPEYAMD---GLFSVKSDVFSFGVLLLETVSG 742
             + + GT  Y++PE  +      ++   D +S GV+L   +SG
Sbjct: 173 -MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 18/164 (10%)
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRF 644
           + E+ ++ KL H  ++++     + ++  +V E ME   L D V+ +K           +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQ 701
            ++  +     YLH++    IIHRDLK  N+LL   +++   KI+DFG ++I G      
Sbjct: 122 QMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 172
Query: 702 NTKRVVGTYGYMSPEYAMD---GLFSVKSDVFSFGVLLLETVSG 742
             + + GT  Y++PE  +      ++   D +S GV+L   +SG
Sbjct: 173 -MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 18/164 (10%)
Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRF 644
           + E+ ++ KL H  ++++     + ++  +V E ME   L D V+ +K           +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQ 701
            ++  +     YLH++    IIHRDLK  N+LL   +++   KI+DFG ++I G      
Sbjct: 122 QMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 172
Query: 702 NTKRVVGTYGYMSPEYAMD---GLFSVKSDVFSFGVLLLETVSG 742
             + + GT  Y++PE  +      ++   D +S GV+L   +SG
Sbjct: 173 -MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 40/222 (18%)
Query: 541 TDNFTDYNKLGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
           + +F   + LG+G +G+V        G+ +A+K+        IE F           E++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 591 LIAKLQHRNLVRLLGC-----CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           ++   +H N++ +            +E  ++ E M+   L  VI     + +L+      
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI----STQMLSDDHIQY 116
Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF---GGDQTEQN 702
            I    R +  LH  +   +IHRDLK SN+L++     K+ DFG+ARI      D +E  
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 703 TKR-----VVGTYGYMSPEYAM-DGLFSVKSDVFSFGVLLLE 738
            ++      V T  Y +PE  +    +S   DV+S G +L E
Sbjct: 174 GQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 16/202 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN------LVRL 603
           +G+G FG V K      QE    ++ +N    + + + EVRL+  +   +      +V L
Sbjct: 43  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 102
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
               +  +   LV+E +     D +     R   LN  R+F     +   LL+L      
Sbjct: 103 KRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKF--AQQMCTALLFL-ATPEL 159
Query: 664 RIIHRDLKASNILL--DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
            IIH DLK  NILL   K    KI DFG +   G     Q   + + +  Y SPE  +  
Sbjct: 160 SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG-----QRIYQXIQSRFYRSPEVLLGM 214
Query: 722 LFSVKSDVFSFGVLLLETVSGK 743
            + +  D++S G +L+E  +G+
Sbjct: 215 PYDLAIDMWSLGCILVEMHTGE 236

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 26/224 (11%)
Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLI 592
           FE + + T        LG+G +  V     L+ G+E AVK + + +G        EV  +
Sbjct: 10  FEDMYKLTSEL-----LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETL 64
Query: 593 AKLQ-HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIA 651
            + Q ++N++ L+    +     LV+E ++  S+ + I    +    N +    ++  +A
Sbjct: 65  YQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHI---QKQKHFNEREASRVVRDVA 121
Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLD--KEMTP-KISDF--GMARIFGGDQTEQNTKRV 706
             L +LH      I HRDLK  NIL +  ++++P KI DF  G         T   T  +
Sbjct: 122 AALDFLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPEL 178
Query: 707 V---GTYGYMSPEYA-----MDGLFSVKSDVFSFGVLLLETVSG 742
               G+  YM+PE           +  + D++S GV+L   +SG
Sbjct: 179 TTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 16/202 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN------LVRL 603
           +G+G FG V K      QE    ++ +N    + + + EVRL+  +   +      +V L
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
               +  +   LV+E +     D +     R   LN  R+F     +   LL+L      
Sbjct: 122 KRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKF--AQQMCTALLFL-ATPEL 178
Query: 664 RIIHRDLKASNILL--DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
            IIH DLK  NILL   K    KI DFG +   G     Q   + + +  Y SPE  +  
Sbjct: 179 SIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLG-----QRIYQXIQSRFYRSPEVLLGM 233
Query: 722 LFSVKSDVFSFGVLLLETVSGK 743
            + +  D++S G +L+E  +G+
Sbjct: 234 PYDLAIDMWSLGCILVEMHTGE 255

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/267 (23%), Positives = 117/267 (43%), Gaps = 37/267 (13%)
Query: 516 KRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRL 574
           K+ +S+  T  +  P  D++      D +   + +G G +G V +    LE + +A+K++
Sbjct: 31  KQHHSSKPTASMPRPHSDWQI----PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI 86
Query: 575 SRNSGQGIE--EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK 632
            R     I+      E+ ++ +L H ++V++L   +  D +     Y+     DS     
Sbjct: 87  LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKL 146
Query: 633 ARSSI-LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
            R+ + L       ++  +  G+ Y+H      I+HRDLK +N L++++ + K+ DFG+A
Sbjct: 147 FRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203
Query: 692 RIF-----GGDQTE----------------QNTKRV----VGTYGYMSPEYA-MDGLFSV 725
           R       G  Q                  +N KR     V T  Y +PE   +   ++ 
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE 263
Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSN 752
             DV+S G +  E ++  K    YH++
Sbjct: 264 AIDVWSIGCIFAELLNMIKENVAYHAD 290

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 81/165 (49%), Gaps = 7/165 (4%)
Query: 538 VRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-IAVKRLSRNSGQGIE--EFKNEVRLIAK 594
           V   DN+   + +G+G +G VY       ++ +A+K+++R     I+      E+ ++ +
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNR 81
Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGIARG 653
           L+   ++RL    +  D       Y+     DS +    ++ I L  +    I+  +  G
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
             ++H+     IIHRDLK +N LL+++ + K+ DFG+AR    ++
Sbjct: 142 ENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 16/202 (7%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN------LVRL 603
           +G+G FG V K      QE    ++ +N    + + + EVRL+  +   +      +V L
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
               +  +   LV+E +     D +     R   LN  R+F     +   LL+L      
Sbjct: 122 KRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKF--AQQMCTALLFL-ATPEL 178
Query: 664 RIIHRDLKASNILL--DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
            IIH DLK  NILL   K    KI DFG +   G     Q   + + +  Y SPE  +  
Sbjct: 179 SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG-----QRIYQXIQSRFYRSPEVLLGM 233
Query: 722 LFSVKSDVFSFGVLLLETVSGK 743
            + +  D++S G +L+E  +G+
Sbjct: 234 PYDLAIDMWSLGCILVEMHTGE 255

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           LGQG    V++GR  + G   A+K  +  S  + ++    E  ++ KL H+N+V+L    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 608 VEMD--EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
            E     K+L+ E+    SL +V+ + + +  L       ++  +  G+ +L ++    I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 666 IHRDLKASNILL----DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
           +HR++K  NI+     D +   K++DFG AR     + ++    + GT  Y+ P+     
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVXLYGTEEYLHPDMYERA 190
Query: 722 L--------FSVKSDVFSFGVLLLETVSG 742
           +        +    D++S GV      +G
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 93/192 (48%), Gaps = 24/192 (12%)
Query: 578 SGQGIEEFK----NEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK 632
           S + ++E +     EV ++ K+  H N+++L           LV++ M+   L   + +K
Sbjct: 46  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK 105
Query: 633 ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA- 691
                L+ +    I+  +   +  LH   +  I+HRDLK  NILLD +M  K++DFG + 
Sbjct: 106 V---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 159
Query: 692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL------FSVKSDVFSFGVLLLETVSGKKN 745
           ++  G++     + V GT  Y++PE     +      +  + D++S GV++   ++G  +
Sbjct: 160 QLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG--S 213
Query: 746 RGFYHSNNELNL 757
             F+H    L L
Sbjct: 214 PPFWHRKQMLML 225

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           LGQG    V++GR  + G   A+K  +  S  + ++    E  ++ KL H+N+V+L    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 608 VEMD--EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
            E     K+L+ E+    SL +V+ + + +  L       ++  +  G+ +L ++    I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 666 IHRDLKASNILL----DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
           +HR++K  NI+     D +   K++DFG AR    D   +    + GT  Y+ P+     
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPDMYERA 190
Query: 722 L--------FSVKSDVFSFGVLLLETVSG 742
           +        +    D++S GV      +G
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 93/192 (48%), Gaps = 24/192 (12%)
Query: 578 SGQGIEEFK----NEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK 632
           S + ++E +     EV ++ K+  H N+++L           LV++ M+   L   + +K
Sbjct: 59  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK 118
Query: 633 ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA- 691
                L+ +    I+  +   +  LH   +  I+HRDLK  NILLD +M  K++DFG + 
Sbjct: 119 V---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172
Query: 692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL------FSVKSDVFSFGVLLLETVSGKKN 745
           ++  G++     + V GT  Y++PE     +      +  + D++S GV++   ++G  +
Sbjct: 173 QLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG--S 226
Query: 746 RGFYHSNNELNL 757
             F+H    L L
Sbjct: 227 PPFWHRKQMLML 238

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 99/238 (41%), Gaps = 56/238 (23%)
Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRN-----SGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +GQG +G+V      + + I A+K +++N     + + +E  K EVRL+ KL H N+ RL
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 604 LGCCVEMDEKMLVYEYMENRSL---------DSV---IFDKARSSI-------------- 637
                +     LV E      L         DS      D  ++ I              
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 638 -------LNWQRRFNIICGIAR----GLLYLHQDSRFRIIHRDLKASNILL--DKEMTPK 684
                  L++ +R  +I  I R     L YLH      I HRD+K  N L   +K    K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 685 ISDFGMARIF----GGDQTEQNTKRVVGTYGYMSPEY--AMDGLFSVKSDVFSFGVLL 736
           + DFG+++ F     G+     TK   GT  +++PE     +  +  K D +S GVLL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTK--AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 93/192 (48%), Gaps = 24/192 (12%)
Query: 578 SGQGIEEFK----NEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK 632
           S + ++E +     EV ++ K+  H N+++L           LV++ M+   L   + +K
Sbjct: 59  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK 118
Query: 633 ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA- 691
                L+ +    I+  +   +  LH   +  I+HRDLK  NILLD +M  K++DFG + 
Sbjct: 119 V---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172
Query: 692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL------FSVKSDVFSFGVLLLETVSGKKN 745
           ++  G++     + V GT  Y++PE     +      +  + D++S GV++   ++G  +
Sbjct: 173 QLDPGEK----LRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG--S 226
Query: 746 RGFYHSNNELNL 757
             F+H    L L
Sbjct: 227 PPFWHRKQMLML 238

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 82/198 (41%), Gaps = 14/198 (7%)
Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           LG+G F I  K       Q  AVK +S+      ++    ++L     H N+V+L     
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLHEVFH 76
Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           +     LV E +    L   I  K   S         I+  +   + ++H      ++HR
Sbjct: 77  DQLHTFLVMELLNGGELFERIKKKKHFSETEASY---IMRKLVSAVSHMHD---VGVVHR 130
Query: 669 DLKASNILLDKE---MTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           DLK  N+L   E   +  KI DFG AR+   D   Q  K    T  Y +PE      +  
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDE 188
Query: 726 KSDVFSFGVLLLETVSGK 743
             D++S GV+L   +SG+
Sbjct: 189 SCDLWSLGVILYTMLSGQ 206

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 41/227 (18%)
Query: 536 TIVRATDNFTDYNKLGQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAK 594
            ++    +F   + LG G  G IVY+G + + +++AVKR+        +    EV+L+ +
Sbjct: 18  VVIVGKISFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECFSFAD---REVQLLRE 73
Query: 595 L-QHRNLVRLLGCCVEMDEKM----------LVYEYMENRSLDSVIFDKARSSILNWQRR 643
             +H N++R    C E D +            + EY+E +    +  +            
Sbjct: 74  SDEHPNVIRYF--CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP----------- 120
Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-----EMTPKISDFGMARIFG-GD 697
             ++     GL +LH      I+HRDLK  NIL+       ++   ISDFG+ +    G 
Sbjct: 121 ITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177
Query: 698 QTEQNTKRVVGTYGYMSPEYAMDGLF---SVKSDVFSFGVLLLETVS 741
            +      V GT G+++PE   +      +   D+FS G +    +S
Sbjct: 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 22/213 (10%)
Query: 538 VRATDNFTDYNKLGQGGFGI----VYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIA 593
           ++ TD +     +G G + +    ++K       E AVK + ++     EE +  +R   
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSKRDPTEEIEILLRY-- 72
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             QH N++ L     +     +V E M+   L   I    R    + +    ++  I + 
Sbjct: 73  -GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSEREASAVLFTITKT 128
Query: 654 LLYLHQDSRFRIIHRDLKASNIL-LDKEMTP---KISDFGMARIFGGDQTEQNTKRVVGT 709
           + YLH      ++HRDLK SNIL +D+   P   +I DFG A+    +     T     T
Sbjct: 129 VEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP--CYT 183
Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
             +++PE      +    D++S GVLL   ++G
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 538 VRATDNFTDYNKLGQGGFGI----VYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIA 593
           ++ TD +     +G G + +    ++K       E AVK + ++     EE +  +R   
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKA---TNXEFAVKIIDKSKRDPTEEIEILLRY-- 72
Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
             QH N++ L       D+   VY   E      ++    R    + +    ++  I + 
Sbjct: 73  -GQHPNIITLKDV---YDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 654 LLYLHQDSRFRIIHRDLKASNIL-LDKEMTP---KISDFGMARIFGGDQTEQNTKRVVGT 709
           + YLH      ++HRDLK SNIL +D+   P   +I DFG A+    +     T     T
Sbjct: 129 VEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTP--CYT 183
Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
             +++PE      +    D++S GVLL   ++G
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 40/224 (17%)
Query: 550 LGQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN----EVRLIAKLQ-HRNLVRL 603
           LG G  G +V++G   +G+ +AVKR+       + +F +    E++L+ +   H N++R 
Sbjct: 41  LGYGSSGTVVFQGSF-QGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRY 92
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIIC---GIARGLLYLHQ 659
             C    D  + +   + N +L  ++  K  S   L  Q+ +N I     IA G+ +LH 
Sbjct: 93  Y-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 660 DSRFRIIHRDLKASNILLD-------------KEMTPKISDFGMARIFGGDQT--EQNTK 704
               +IIHRDLK  NIL+              + +   ISDFG+ +     Q     N  
Sbjct: 152 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 705 RVVGTYGYMSPEYAMDGL---FSVKSDVFSFGVLLLETVSGKKN 745
              GT G+ +PE   +      +   D+FS G +    +S  K+
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 40/224 (17%)
Query: 550 LGQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN----EVRLIAKLQ-HRNLVRL 603
           LG G  G +V++G   +G+ +AVKR+       + +F +    E++L+ +   H N++R 
Sbjct: 41  LGYGSSGTVVFQGSF-QGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRY 92
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIIC---GIARGLLYLHQ 659
             C    D  + +   + N +L  ++  K  S   L  Q+ +N I     IA G+ +LH 
Sbjct: 93  Y-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 660 DSRFRIIHRDLKASNILLD-------------KEMTPKISDFGMARIFGGDQT--EQNTK 704
               +IIHRDLK  NIL+              + +   ISDFG+ +     Q     N  
Sbjct: 152 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 705 RVVGTYGYMSPEYAMDGL---FSVKSDVFSFGVLLLETVSGKKN 745
              GT G+ +PE   +      +   D+FS G +    +S  K+
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR------NLVRL 603
           +G+G FG V K    +  +    ++ RN  +   +   E+R++  L+ +      N++ +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           L      +   + +E +     + +  +K +   L   R+F     I + L  LH++   
Sbjct: 165 LENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKF--AHSILQCLDALHKN--- 219
Query: 664 RIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
           RIIH DLK  NILL ++     K+ DFG +         Q     + +  Y +PE  +  
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-----EHQRVYTXIQSRFYRAPEVILGA 274
Query: 722 LFSVKSDVFSFGVLLLETVSG 742
            + +  D++S G +L E ++G
Sbjct: 275 RYGMPIDMWSLGCILAELLTG 295

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR------NLVRL 603
           +G+G FG V K    +  +    ++ RN  +   +   E+R++  L+ +      N++ +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           L      +   + +E +     + +  +K +   L   R+F     I + L  LH++   
Sbjct: 165 LENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKF--AHSILQCLDALHKN--- 219
Query: 664 RIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
           RIIH DLK  NILL ++     K+ DFG +         Q     + +  Y +PE  +  
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-----EHQRVYTXIQSRFYRAPEVILGA 274
Query: 722 LFSVKSDVFSFGVLLLETVSG 742
            + +  D++S G +L E ++G
Sbjct: 275 RYGMPIDMWSLGCILAELLTG 295

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/240 (22%), Positives = 113/240 (47%), Gaps = 21/240 (8%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH-RNL 600
           D++    KLG+G +  V++   +   E  V ++ +   +   + K E++++  L+   N+
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKN--KIKREIKILENLRGGPNI 94
Query: 601 VRLLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           + L     +   +   LV+E++ N       F +   ++ ++  RF  +  I + L Y H
Sbjct: 95  ITLADIVKDPVSRTPALVFEHVNNTD-----FKQLYQTLTDYDIRF-YMYEILKALDYCH 148
Query: 659 QDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
                 I+HRD+K  N+++D E    ++ D+G+A  +   Q E N  RV   Y +  PE 
Sbjct: 149 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVASRY-FKGPEL 202
Query: 718 AMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS 776
            +D  ++    D++S G +L   +  K+   F+H ++  + L  + ++     + + +D 
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKE--PFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 260

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 550 LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR------NLVRL 603
           +G+G FG V K    +  +    ++ RN  +   +   E+R++  L+ +      N++ +
Sbjct: 105 IGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           L      +   + +E +     + +  +K +   L   R+F     I + L  LH++   
Sbjct: 165 LENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKF--AHSILQCLDALHKN--- 219
Query: 664 RIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
           RIIH DLK  NILL ++     K+ DFG +         Q     + +  Y +PE  +  
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-----EHQRVYXXIQSRFYRAPEVILGA 274
Query: 722 LFSVKSDVFSFGVLLLETVSG 742
            + +  D++S G +L E ++G
Sbjct: 275 RYGMPIDMWSLGCILAELLTG 295

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 44/228 (19%)
Query: 550 LGQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN----EVRLIAKLQ-HRNLVRL 603
           LG G  G +V++G   +G+ +AVKR+       + +F +    E++L+ +   H N++R 
Sbjct: 23  LGYGSSGTVVFQGSF-QGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIIC---GIARGLLYLHQ 659
             C    D  + +   + N +L  ++  K  S   L  Q+ +N I     IA G+ +LH 
Sbjct: 75  Y-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 660 DSRFRIIHRDLKASNILLD-------------KEMTPKISDFGMARIFGGDQT--EQNTK 704
               +IIHRDLK  NIL+              + +   ISDFG+ +     Q+    N  
Sbjct: 134 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 705 RVVGTYGYMSPEYAMDG-------LFSVKSDVFSFGVLLLETVSGKKN 745
              GT G+ +PE   +          +   D+FS G +    +S  K+
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 44/228 (19%)
Query: 550 LGQGGFG-IVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN----EVRLIAKLQ-HRNLVRL 603
           LG G  G +V++G   +G+ +AVKR+       + +F +    E++L+ +   H N++R 
Sbjct: 23  LGYGSSGTVVFQGSF-QGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIIC---GIARGLLYLHQ 659
             C    D  + +   + N +L  ++  K  S   L  Q+ +N I     IA G+ +LH 
Sbjct: 75  Y-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 660 DSRFRIIHRDLKASNILLD-------------KEMTPKISDFGMARIFGGDQT--EQNTK 704
               +IIHRDLK  NIL+              + +   ISDFG+ +     Q     N  
Sbjct: 134 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 190
Query: 705 RVVGTYGYMSPEYAMDG-------LFSVKSDVFSFGVLLLETVSGKKN 745
              GT G+ +PE   +          +   D+FS G +    +S  K+
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 568 EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDS 627
           E AVK + ++     EE +    L+   QH N++ L     +     LV E M    L  
Sbjct: 54  EYAVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLD 110
Query: 628 VIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNIL-LDKEMTP--- 683
            I    R    + +    ++  I + + YLH      ++HRDLK SNIL +D+   P   
Sbjct: 111 KIL---RQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECL 164
Query: 684 KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           +I DFG A+    +     T     T  +++PE      +    D++S G+LL   ++G
Sbjct: 165 RICDFGFAKQLRAENGLLMTP--CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 96/231 (41%), Gaps = 26/231 (11%)
Query: 520 SADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNS 578
           + +K  DL +   D+E +            +G+G FG V   R    +++ A+K LS+  
Sbjct: 57  TINKIRDLRMKAEDYEVV----------KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE 106
Query: 579 --GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARS 635
              +    F  E R I    +   V  L    + D  + +V EYM    L +++ +    
Sbjct: 107 MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP 166
Query: 636 SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
               W R +      A  +L L        IHRD+K  N+LLDK    K++DFG      
Sbjct: 167 E--KWARFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219
Query: 696 GDQTEQNTKRVVGTYGYMSPEYAM----DGLFSVKSDVFSFGVLLLETVSG 742
            +   +     VGT  Y+SPE       DG +  + D +S GV L E + G
Sbjct: 220 KEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 15/179 (8%)
Query: 568 EIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDS 627
           E AVK + ++     EE +  +R     QH N++ L     +     LV E M    L  
Sbjct: 54  EYAVKVIDKSKRDPSEEIEILLRYG---QHPNIITLKDVYDDGKHVYLVTELMRGGELLD 110
Query: 628 VIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNIL-LDKEMTP--- 683
            I    R    + +    ++  I + + YLH      ++HRDLK SNIL +D+   P   
Sbjct: 111 KIL---RQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECL 164
Query: 684 KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           +I DFG A+    +     T     T  +++PE      +    D++S G+LL   ++G
Sbjct: 165 RICDFGFAKQLRAENGLLMTP--CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 96/231 (41%), Gaps = 26/231 (11%)
Query: 520 SADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNS 578
           + +K  DL +   D+E +            +G+G FG V   R    +++ A+K LS+  
Sbjct: 62  TINKIRDLRMKAEDYEVV----------KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE 111
Query: 579 --GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARS 635
              +    F  E R I    +   V  L    + D  + +V EYM    L +++ +    
Sbjct: 112 MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP 171
Query: 636 SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
               W R +      A  +L L        IHRD+K  N+LLDK    K++DFG      
Sbjct: 172 E--KWARFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 224
Query: 696 GDQTEQNTKRVVGTYGYMSPEYAM----DGLFSVKSDVFSFGVLLLETVSG 742
            +   +     VGT  Y+SPE       DG +  + D +S GV L E + G
Sbjct: 225 KEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           I   +L +    +   +HRD+K  N+LLD     +++DFG       D T Q++   VGT
Sbjct: 181 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV-AVGT 239
Query: 710 YGYMSPEY--AMD---GLFSVKSDVFSFGVLLLETVSGK 743
             Y+SPE   AM+   G +  + D +S GV + E + G+
Sbjct: 240 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 96/231 (41%), Gaps = 26/231 (11%)
Query: 520 SADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNS 578
           + +K  DL +   D+E +            +G+G FG V   R    +++ A+K LS+  
Sbjct: 62  TINKIRDLRMKAEDYEVV----------KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE 111
Query: 579 --GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARS 635
              +    F  E R I    +   V  L    + D  + +V EYM    L +++ +    
Sbjct: 112 MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP 171
Query: 636 SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
               W R +      A  +L L        IHRD+K  N+LLDK    K++DFG      
Sbjct: 172 E--KWARFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 224
Query: 696 GDQTEQNTKRVVGTYGYMSPEYAM----DGLFSVKSDVFSFGVLLLETVSG 742
            +   +     VGT  Y+SPE       DG +  + D +S GV L E + G
Sbjct: 225 KEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           I   +L +    +   +HRD+K  N+LLD     +++DFG       D T Q++   VGT
Sbjct: 197 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV-AVGT 255
Query: 710 YGYMSPEY--AMD---GLFSVKSDVFSFGVLLLETVSGK 743
             Y+SPE   AM+   G +  + D +S GV + E + G+
Sbjct: 256 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           +A  ++ +    +   +HRD+K  NIL+D     +++DFG       D T Q++   VGT
Sbjct: 181 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGT 239
Query: 710 YGYMSPEY--AMD---GLFSVKSDVFSFGVLLLETVSGK 743
             Y+SPE   AM+   G +  + D +S GV + E + G+
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN------EVRLIAKLQH--RNL 600
           LG GGFG VY G R+ +   +A+K + ++      E  N      EV L+ K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +RLL      D  +L+ E ME    D   F   R ++     R +    +   + + H  
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQ-DLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 133
Query: 661 SRFRIIHRDLKASNILLD-KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
               ++HRD+K  NIL+D      K+ DFG   +      +       GT  Y  PE+  
Sbjct: 134 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 186
Query: 720 DGLFSVKS-DVFSFGVLLLETVSG 742
              +  +S  V+S G+LL + V G
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 80/164 (48%), Gaps = 16/164 (9%)
Query: 615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASN 674
           LV+E++ N       F + R ++ ++  RF  +  I + L Y H      I+HRD+K  N
Sbjct: 111 LVFEHVNNTD-----FKQLRQTLTDYDIRF-YMYEILKALDYCHS---MGIMHRDVKPHN 161
Query: 675 ILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSF 732
           +++D E    ++ D+G+A  +   Q E N  RV   Y +  PE  +D  ++    D++S 
Sbjct: 162 VMIDHEHRKLRLIDWGLAEFYHPGQ-EYNV-RVASRY-FKGPELLVDYQMYDYSLDMWSL 218
Query: 733 GVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS 776
           G +L   +  K+   F+H ++  + L  + ++     + + +D 
Sbjct: 219 GCMLASMIFRKE--PFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 260

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 49/232 (21%)
Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRL---IA 593
           +  D F      GQG FG V  G+    G  +A+K++ ++       F+N E+++   +A
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLA 74
Query: 594 KLQHRNLVRLLGCCVEMDEK-------MLVYEYMENRSLDSVIFDKARSSILNWQRR--- 643
            L H N+V+L      + E+        +V EY+          D       N+ RR   
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---------DTLHRCCRNYYRRQVA 125
Query: 644 ----------FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-EMTPKISDFGMAR 692
                     F +I  I  G L+L       + HRD+K  N+L+++ + T K+ DFG A+
Sbjct: 126 PPPILIKVFLFQLIRSI--GCLHL---PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180
Query: 693 IFGGDQTEQNTKRVVGTYGYMSPEYAM-DGLFSVKSDVFSFGVLLLETVSGK 743
                 +E N   +   Y Y +PE    +  ++   D++S G +  E + G+
Sbjct: 181 KLS--PSEPNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 115/271 (42%), Gaps = 28/271 (10%)
Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSR----NSGQGIEEFKNEVRLIAKLQ 596
           D+F     +G+G F  V   ++ + GQ  A+K +++      G+ +  F+ E  ++    
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE-VSCFREERDVLVNGD 119
Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
            R + +L     + +   LV EY     L +++  K    I     RF +    A  ++ 
Sbjct: 120 RRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL-SKFGERIPAEMARFYL----AEIVMA 174
Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           +    R   +HRD+K  NILLD+    +++DFG       D T ++    VGT  Y+SPE
Sbjct: 175 IDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPE 233
Query: 717 Y-------AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK 769
                      G +  + D ++ GV   E   G+     +++++     G +   +KE  
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP---FYADSTAETYGKIVH-YKEHL 289
Query: 770 VLEMVDSSVDNYPANEVLRCIHVGLLCVQEN 800
            L +VD  V     + + R     LLC  E 
Sbjct: 290 SLPLVDEGVPEEARDFIQR-----LLCPPET 315

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN------EVRLIAKLQ--HRNL 600
           LG GGFG VY G R+ +   +A+K + ++      E  N      EV L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +RLL      D  +L+ E  E    D   F   R ++     R +    +   + + H  
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELAR-SFFWQVLEAVRHCHNX 129
Query: 661 SRFRIIHRDLKASNILLD-KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
               ++HRD+K  NIL+D      K+ DFG   +      +       GT  Y  PE+  
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 182
Query: 720 DGLFSVKS-DVFSFGVLLLETVSG 742
              +  +S  V+S G+LL + V G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 20/204 (9%)
Query: 550 LGQGGFGIVYKG-RLLEGQEIAVKRLSRNSGQGIEEFKN------EVRLIAKLQH--RNL 600
           LG GGFG VY G R+ +   +A+K + ++      E  N      EV L+ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +RLL      D  +L+ E  E    D   F   R ++     R +    +   + + H  
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 148
Query: 661 SRFRIIHRDLKASNILLD-KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
               ++HRD+K  NIL+D      K+ DFG   +      +       GT  Y  PE+  
Sbjct: 149 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 201
Query: 720 DGLFSVKS-DVFSFGVLLLETVSG 742
              +  +S  V+S G+LL + V G
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCG 225
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	862
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-149
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-144
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-124
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-96
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-79
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-64
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-60
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-60
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-59
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-58
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-56
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-52
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-50
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-49
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-48
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-48
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	7e-48
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-47
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-46
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-46
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-45
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-45
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-45
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-45
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-45
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-45
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-45
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-44
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-44
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-44
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-44
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-44
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-44
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-44
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-44
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-44
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-44
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-44
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-43
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-43
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-43
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-43
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-43
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-43
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-43
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-43
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-42
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-42
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-42
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-42
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-42
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-42
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-42
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-42
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-42
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-42
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-42
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-42
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-42
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-41
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-41
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-41
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-41
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-40
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-40
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-40
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-40
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-40
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-40
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-40
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-39
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-39
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-39
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-37
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-37
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-36
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-36
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-36
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-35
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-34
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-34
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-34
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-33
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-33
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-32
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-32
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-32
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-31
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-31
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-31
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-31
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-31
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-31
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-31
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-30
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-30
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-30
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-30
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-30
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-29
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-29
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-29
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-29
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-29
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-29
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-29
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-28
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-28
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-28
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-28
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-28
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-28
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-28
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-27
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-27
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-27
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-27
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-27
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-27
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-27
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-26
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-26
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-26
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-26
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-26
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-25
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-24
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-24
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-24
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-24
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-23
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-22
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-22
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-22
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-21
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-21
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-21
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-21
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-20
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-20
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-20
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-20
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-19
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-16
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-13
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-13
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-09
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	2e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-09
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	4e-08
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	7e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-06
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-06
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	1e-05
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	3e-05
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	2e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  440 bits (1134), Expect = e-149
 Identities = 107/306 (34%), Positives = 159/306 (51%), Gaps = 18/306 (5%)

Query: 526 DLELPLFDFETIVRATDNF------TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLS---- 575
           D     F F  +   T+NF         NK+G+GGFG+VYKG +     +AVK+L+    
Sbjct: 9   DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVD 67

Query: 576 RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARS 635
             + +  ++F  E++++AK QH NLV LLG   + D+  LVY YM N SL   +     +
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT 127

Query: 636 SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
             L+W  R  I  G A G+ +LH++     IHRD+K++NILLD+  T KISDFG+AR   
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASE 184

Query: 696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
                  T R+VGT  YM+PE  + G  + KSD++SFGV+LLE ++G             
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPA--VDEHREPQ 241

Query: 756 NLLGHVWRLWKEGKVLE-MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
            LL     +  E K +E  +D  +++  +  V     V   C+ E   +RP +  V  +L
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

Query: 815 SSETAT 820
              TA+
Sbjct: 302 QEMTAS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  427 bits (1099), Expect = e-144
 Identities = 127/291 (43%), Positives = 175/291 (60%), Gaps = 6/291 (2%)

Query: 532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIE-EFKNEVR 590
           F    +  A+DNF++ N LG+GGFG VYKGRL +G  +AVKRL     QG E +F+ EV 
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICG 649
           +I+   HRNL+RL G C+   E++LVY YM N S+ S + ++  S   L+W +R  I  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
            ARGL YLH     +IIHRD+KA+NILLD+E    + DFG+A++     T   T  V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198

Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE--LNLLGHVWRLWKE 767
            G+++PEY   G  S K+DVF +GV+LLE ++G++        N+  + LL  V  L KE
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258

Query: 768 GKVLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE 817
            K+  +VD  +  NY   EV + I V LLC Q +  ERP M+ VV ML  +
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  376 bits (967), Expect = e-124
 Identities = 104/286 (36%), Positives = 163/286 (56%), Gaps = 7/286 (2%)

Query: 532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRL 591
                +  AT+NF     +G G FG VYKG L +G ++A+KR +  S QGIEEF+ E+  
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI-LNWQRRFNIICGI 650
           ++  +H +LV L+G C E +E +L+Y+YMEN +L   ++     ++ ++W++R  I  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF-GGDQTEQNTKRVVGT 709
           ARGL YLH  +   IIHRD+K+ NILLD+   PKI+DFG+++     DQT  +T  V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGT 204

Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK 769
            GY+ PEY + G  + KSDV+SFGV+L E +  +           +NL          G+
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264

Query: 770 VLEMVDSS-VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
           + ++VD +  D      + +     + C+  ++E+RP+M  V+  L
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  304 bits (780), Expect = 1e-96
 Identities = 67/308 (21%), Positives = 127/308 (41%), Gaps = 29/308 (9%)

Query: 532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRL 591
              E +   +          +G FG V+K +L   + +AVK       Q   + + EV  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71

Query: 592 IAKLQHRNLVRLLGCCVE----MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNII 647
           +  ++H N+++ +G          +  L+  + E  SL   +    ++++++W    +I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127

Query: 648 CGIARGLLYLHQD-------SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE 700
             +ARGL YLH+D        +  I HRD+K+ N+LL   +T  I+DFG+A  F   ++ 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 701 QNTKRVVGTYGYMSPEYAMDGL-----FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL 755
            +T   VGT  YM+PE     +       ++ D+++ G++L E  S             L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 756 NLLGHVWRLWKEGKVLEMVDSSV------DNYPANEVLRCI-HVGLLCVQENAEERPTMA 808
                + +      + E+V          D +  +  +  +      C   +AE R +  
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

Query: 809 SVVLMLSS 816
            V   ++ 
Sbjct: 308 CVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  259 bits (663), Expect = 2e-79
 Identities = 70/333 (21%), Positives = 121/333 (36%), Gaps = 46/333 (13%)

Query: 532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNE--V 589
                     DN      +G+G +G VYKG L + + +AVK  S  + Q    F NE  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 590 RLIAKLQHRNLVRLLGCCVEMD-----EKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
             +  ++H N+ R +     +      E +LV EY  N SL   +         +W    
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114

Query: 645 NIICGIARGLLYLHQD------SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG-- 696
            +   + RGL YLH +       +  I HRDL + N+L+  + T  ISDFG++    G  
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 697 ----DQTEQNTKRVVGTYGYMSPEYAMDGL-------FSVKSDVFSFGVLLLETVSGKKN 745
                + +      VGT  YM+PE     +          + D+++ G++  E      +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 746 RGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV---------DNYPANEVLRCIHVGLL- 795
                S  E  +      +       +M              + +  N +        + 
Sbjct: 235 LFPGESVPEYQMAFQ-TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 796 -CVQENAEERPTMASVVLMLSSETATMPQPKTP 827
            C  ++AE R T       ++       + K+ 
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  216 bits (552), Expect = 6e-64
 Identities = 80/280 (28%), Positives = 141/280 (50%), Gaps = 21/280 (7%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRL--SRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
            K+G G FG V++     G ++AVK L       + + EF  EV ++ +L+H N+V  +G
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
              +     +V EY+   SL  ++        L+ +RR ++   +A+G+ YLH      I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160

Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           +HR+LK+ N+L+DK+ T K+ DFG++R+     T  ++K   GT  +M+PE   D   + 
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218

Query: 726 KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           KSDV+SFGV+L E  + ++    +     LN    V  +  + K LE +  +++   A  
Sbjct: 219 KSDVYSFGVILWELATLQQ---PWG---NLNPAQVVAAVGFKCKRLE-IPRNLNPQVAAI 271

Query: 786 VLRCIHVGLLCVQENAEERPTMASVVLMLSS-ETATMPQP 824
           +  C             +RP+ A+++ +L     + +P P
Sbjct: 272 IEGCWT-------NEPWKRPSFATIMDLLRPLIKSAVPPP 304

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  210 bits (537), Expect = 7e-62
 Identities = 69/280 (24%), Positives = 113/280 (40%), Gaps = 31/280 (11%)

Query: 548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
             LG+G FG   K    E G+ + +K L R   +    F  EV+++  L+H N+++ +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
             +      + EY++  +L  +I          W +R +    IA G+ YLH      II
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS---MNII 130

Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR------------VVGTYGYMS 714
           HRDL + N L+ +     ++DFG+AR+   ++T+    R            VVG   +M+
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 715 PEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV 774
           PE      +  K DVFSFG++L E +        Y        L       +        
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-----RGFLDRYC- 244

Query: 775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
                N P           + C   + E+RP+   +   L
Sbjct: 245 ---PPNCPP-SFFPIT---VRCCDLDPEKRPSFVKLEHWL 277

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  206 bits (527), Expect = 2e-60
 Identities = 72/292 (24%), Positives = 128/292 (43%), Gaps = 34/292 (11%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
                   +G+G FG+V K +    +++A+K++   S    + F  E+R ++++ H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +L G C  ++   LV EY E  SL +V+               +     ++G+ YLH   
Sbjct: 65  KLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 662 RFRIIHRDLKASNILLDKEMT-PKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD 720
              +IHRDLK  N+LL    T  KI DFG A        + +     G+  +M+PE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEG 177

Query: 721 GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV-- 778
             +S K DVFS+G++L E ++ +K    +       + G  +R      ++  V +    
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PFD-----EIGGPAFR------IMWAVHNGTRP 223

Query: 779 ---DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTP 827
               N P   +   +     C  ++  +RP+M  +V +++      P    P
Sbjct: 224 PLIKNLPK-PIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  201 bits (514), Expect = 7e-59
 Identities = 69/284 (24%), Positives = 136/284 (47%), Gaps = 37/284 (13%)

Query: 548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG-------IEEFKNEVRLIAKLQHRN 599
            ++G+GGFG+V+KGRL++    +A+K L     +G        +EF+ EV +++ L H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L G     +   +V E++    L   + DKA    + W  +  ++  IA G+ Y+  
Sbjct: 85  IVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQN 140

Query: 660 DSRFRIIHRDLKASNILLDK-----EMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
                I+HRDL++ NI L        +  K++DFG+++      +  +   ++G + +M+
Sbjct: 141 -QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMA 194

Query: 715 PE--YAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE 772
           PE   A +  ++ K+D +SF ++L   ++G+     +        +  +  + +EG    
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEG---PF-DEYSYGKIKFINMIREEGLRPT 250

Query: 773 MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS 816
           + +           LR +    LC   + ++RP  + +V  LS 
Sbjct: 251 IPED------CPPRLRNV--IELCWSGDPKKRPHFSYIVKELSE 286

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  200 bits (511), Expect = 1e-58
 Identities = 72/208 (34%), Positives = 106/208 (50%), Gaps = 21/208 (10%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRL----SRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
             +G GGFG VY+   + G E+AVK        +  Q IE  + E +L A L+H N++ L
Sbjct: 13  EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
            G C++     LV E+     L+ V+        +      N    IARG+ YLH ++  
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 664 RIIHRDLKASNILLDKEMTP--------KISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
            IIHRDLK+SNIL+ +++          KI+DFG+AR               G Y +M+P
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWMAP 183

Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E     +FS  SDV+S+GVLL E ++G+
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  197 bits (504), Expect = 2e-57
 Identities = 81/309 (26%), Positives = 143/309 (46%), Gaps = 35/309 (11%)

Query: 514 SSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKR 573
                 S D  DD E+P                  ++G G FG VYKG+     ++AVK 
Sbjct: 6   HHHHHGSRDAADDWEIPDGQITVG----------QRIGSGSFGTVYKGKWH--GDVAVKM 53

Query: 574 L--SRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIF 630
           L  +  + Q ++ FKNEV ++ K +H N++  +G       ++ +V ++ E  SL   + 
Sbjct: 54  LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS--TAPQLAIVTQWCEGSSLYHHL- 110

Query: 631 DKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM 690
             A  +    ++  +I    ARG+ YLH  S   IIHRDLK++NI L ++ T KI DFG+
Sbjct: 111 -HASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGL 166

Query: 691 ARIFGGDQTEQNTKRVVGTYGYMSPE---YAMDGLFSVKSDVFSFGVLLLETVSGKKNRG 747
           A            +++ G+  +M+PE         +S +SDV++FG++L E ++G+    
Sbjct: 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LP 224

Query: 748 FYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTM 807
           + + NN   ++  V R      + + V S+        +  C+        +  +ERP+ 
Sbjct: 225 YSNINNRDQIIEMVGRGSLSPDLSK-VRSNCPKRMKRLMAECLK-------KKRDERPSF 276

Query: 808 ASVVLMLSS 816
             ++  +  
Sbjct: 277 PRILAEIEE 285

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  193 bits (494), Expect = 3e-56
 Identities = 48/204 (23%), Positives = 92/204 (45%), Gaps = 19/204 (9%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRL--SRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
            KL +   G ++KGR  +G +I VK L     S +   +F  E   +    H N++ +LG
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 606 CCVE--MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
            C         L+  +M   SL +V+ +   + +++  +       +ARG+ +LH     
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHT-LEP 132

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG-- 721
            I    L + ++++D++MT +IS   +   F        +   +    +++PE A+    
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE-ALQKKP 184

Query: 722 --LFSVKSDVFSFGVLLLETVSGK 743
                  +D++SF VLL E V+ +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  192 bits (491), Expect = 3e-55
 Identities = 66/281 (23%), Positives = 119/281 (42%), Gaps = 36/281 (12%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRL--SRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
             +G+G FG VY GR     E+A++ +   R++   ++ FK EV    + +H N+V  +G
Sbjct: 39  ELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRI 665
            C+      ++    + R+L SV+  +    +L+  +   I   I +G+ YLH      I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---I 151

Query: 666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR---VVGTYGYMSPE------ 716
           +H+DLK+ N+  D      I+DFG+  I G  Q  +   +     G   +++PE      
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 717 ---YAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM 773
                    FS  SDVF+ G +  E  + +     + +     ++  +      G    +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWP---FKTQPAEAIIWQMGT----GMKPNL 263

Query: 774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
               +    ++ +L C            EERPT   ++ ML
Sbjct: 264 SQIGMGKEISDILLFCWA-------FEQEERPTFTKLMDML 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  183 bits (467), Expect = 8e-52
 Identities = 72/318 (22%), Positives = 127/318 (39%), Gaps = 46/318 (14%)

Query: 529 LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNE 588
           LPL    TI +         ++G+G +G V+ G+   G+++AVK            +  E
Sbjct: 27  LPLLVQRTIAK---QIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRE 79

Query: 589 --VRLIAKLQHRNLVRLLGCCVEMDEK----MLVYEYMENRSLDSVIFDKARSSILNWQR 642
             +     ++H N++  +   ++         L+ +Y EN SL   +    +S+ L+ + 
Sbjct: 80  TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKS 135

Query: 643 RFNIICGIARGLLYLHQDSRFR-----IIHRDLKASNILLDKEMTPKISDFGMARIF--G 695
              +      GL +LH +         I HRDLK+ NIL+ K  T  I+D G+A  F   
Sbjct: 136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD 195

Query: 696 GDQTEQNTKRVVGTYGYMSPE------YAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFY 749
            ++ +      VGT  YM PE              + +D++SFG++L E      + G  
Sbjct: 196 TNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG-- 253

Query: 750 HSNNELNLLGHVWRLWKEGKVLEMVDSSV---------DNYPANEVLRCIHVGLL--CVQ 798
               E   L +   +  +    +M +            + + ++E LR +   L+  C  
Sbjct: 254 --IVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQM-GKLMTECWA 310

Query: 799 ENAEERPTMASVVLMLSS 816
            N   R T   V   L+ 
Sbjct: 311 HNPASRLTALRVKKTLAK 328

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  181 bits (461), Expect = 5e-51
 Identities = 75/319 (23%), Positives = 126/319 (39%), Gaps = 48/319 (15%)

Query: 529 LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNE 588
           LPL    TI R          +G+G FG V++G+   G+E+AVK  S    +    +  E
Sbjct: 32  LPLLVQRTIAR---TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFRE 84

Query: 589 --VRLIAKLQHRNLVRLLGCCVEMDEK----MLVYEYMENRSLDSVIFDKARSSILNWQR 642
             +     L+H N++  +    + +       LV +Y E+ SL    FD      +  + 
Sbjct: 85  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEG 140

Query: 643 RFNIICGIARGLLYLHQDSRFR-----IIHRDLKASNILLDKEMTPKISDFGMARIF--G 695
              +    A GL +LH +         I HRDLK+ NIL+ K  T  I+D G+A      
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200

Query: 696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSV-------KSDVFSFGVLLLETVSGKKNRGF 748
            D  +      VGT  YM+PE  +D   ++       ++D+++ G++  E        G 
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259

Query: 749 YHSNNELNLLGHVWRLWKEGKVLEMV---------DSSVDNYPANEVLRCIHVGLL--CV 797
            H + +L     V       ++ ++V          +   +  A  V+      ++  C 
Sbjct: 260 -HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA----KIMRECW 314

Query: 798 QENAEERPTMASVVLMLSS 816
             N   R T   +   LS 
Sbjct: 315 YANGAARLTALRIKKTLSQ 333

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  179 bits (456), Expect = 1e-50
 Identities = 64/305 (20%), Positives = 112/305 (36%), Gaps = 55/305 (18%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNE--VRLIAKLQHRNLVRLLG 605
             +G+G +G V++G   +G+ +AVK  S    +  + +  E  +     L+H N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 606 CCVEMDEK----MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
             +          L+  Y E  SL    +D  + + L+      I+  IA GL +LH + 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 662 RFR-----IIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRVVGTYGYMS 714
                   I HRDLK+ NIL+ K     I+D G+A +     +Q +      VGT  YM+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 715 PE------YAMDGLFSVKSDVFSFGVLLLETVSGKKNRGF-------YHSNNELNLLGHV 761
           PE               + D+++FG++L E      + G        ++     +     
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP---- 241

Query: 762 WRLWKEGKVLEMVDSSVDN-----YPANEVLRCIHVGLL-----CVQENAEERPTMASVV 811
                     +M      +      P           L      C  +N   R T   + 
Sbjct: 242 -------SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294

Query: 812 LMLSS 816
             L+ 
Sbjct: 295 KTLTK 299

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  177 bits (450), Expect = 5e-49
 Identities = 73/288 (25%), Positives = 118/288 (40%), Gaps = 43/288 (14%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRL-SRNSGQGIEEFKNEVRLIAKLQHRN 599
           ++     ++G+G FG V+ GRL  +   +AVK            +F  E R++ +  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +VRL+G C +     +V E ++     +  F +   + L  +    ++   A G+ YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLT--FLRTEGARLRVKTLLQMVGDAAAGMEYLES 231

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
                 IHRDL A N L+ ++   KISDFGM+R         +         + +PE   
Sbjct: 232 K---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288

Query: 720 DGLFSVKSDVFSFGVLLLETVS-GKKNRGFY--HSNNELNLLGHVWRLWKEGKVLEMVDS 776
            G +S +SDV+SFG+LL ET S G      Y   SN +                 E V+ 
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASP---YPNLSNQQ---------------TREFVE- 329

Query: 777 SVDNY----PANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
                    P      C   +  +   C      +RP+ +++   L S
Sbjct: 330 --KGGRLPCPEL----CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  172 bits (438), Expect = 6e-48
 Identities = 74/340 (21%), Positives = 133/340 (39%), Gaps = 46/340 (13%)

Query: 497 RGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFG 556
             H           +        + +  D  +              +     +LG+G FG
Sbjct: 6   HHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFE----------ERHLKFLQQLGKGNFG 55

Query: 557 IVYKGRLL-----EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD 611
            V   R        G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+  G C    
Sbjct: 56  SVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115

Query: 612 EK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRD 669
            +   L+ EY+   SL    + +     ++  +       I +G+ YL   ++ R IHRD
Sbjct: 116 RRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLG--TK-RYIHRD 170

Query: 670 LKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG-----YMSPEYAMDGLFS 724
           L   NIL++ E   KI DFG+ ++   D+        V   G     + +PE   +  FS
Sbjct: 171 LATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAPESLTESKFS 226

Query: 725 VKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY--- 781
           V SDV+SFGV+L E  +  +      +     +            ++E++    +N    
Sbjct: 227 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK---NNGRLP 283

Query: 782 -PANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
            P      C   I+ +   C   N  +RP+   + L +  
Sbjct: 284 RPDG----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  172 bits (437), Expect = 7e-48
 Identities = 74/294 (25%), Positives = 120/294 (40%), Gaps = 48/294 (16%)

Query: 548 NKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLV 601
             LG+G FG V            G+ +AVK L  ++G Q    +K E+ ++  L H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 602 RLLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +  GCC +       LV EY+   SL   +        +   +       I  G+ YLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH- 151

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG-----YMS 714
            ++   IHRDL A N+LLD +   KI DFG+A+              V   G     + +
Sbjct: 152 -AQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYA 205

Query: 715 PEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLL-------GHVWRLWK 766
           PE   +  F   SDV+SFGV L E ++    ++       EL  +         +  L +
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265

Query: 767 EGKVLEMVDSSVDNYPANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
            G+ L          P      C   ++ +   C +  A  RPT  +++ +L +
Sbjct: 266 RGERLPR--------PDK----CPAEVYHLMKNCWETEASFRPTFENLIPILKT 307

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  171 bits (435), Expect = 7e-48
 Identities = 70/291 (24%), Positives = 127/291 (43%), Gaps = 40/291 (13%)

Query: 548 NKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
            +LG+G FG V   R        G+ +AVK+L  ++ + + +F+ E+ ++  LQH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 603 LLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             G C     +   L+ EY+   SL    + +     ++  +       I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLG-- 131

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ----TEQNTK---RVVGTYGYM 713
           ++ R IHRDL   NIL++ E   KI DFG+ ++   D+     ++  +          + 
Sbjct: 132 TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF------WY 184

Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM 773
           +PE   +  FSV SDV+SFGV+L E  +  +      +     +            ++E+
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244

Query: 774 VDSSVDNY----PANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
           +    +N     P      C   I+ +   C   N  +RP+   + L +  
Sbjct: 245 LK---NNGRLPRPDG----CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  170 bits (433), Expect = 3e-47
 Identities = 76/297 (25%), Positives = 126/297 (42%), Gaps = 57/297 (19%)

Query: 548 NKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR 602
           ++LG+G FG V   R        G  +AVK+L  +      +F+ E++++  L    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 603 LLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
             G       +   LV EY+ +  L    F +   + L+  R       I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYLG-- 144

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG-----YMSP 715
           SR R +HRDL A NIL++ E   KI+DFG+A++   D+       VV   G     + +P
Sbjct: 145 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAP 199

Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV 774
           E   D +FS +SDV+SFGV+L E  +   K+                       + L M+
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC------------------SPSAEFLRMM 241

Query: 775 DSSVDNYPANEVLRCIHVG-----------------LLCVQENAEERPTMASVVLML 814
               D    + +L  +  G                  LC   + ++RP+ +++   L
Sbjct: 242 GCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  167 bits (425), Expect = 4e-46
 Identities = 79/298 (26%), Positives = 128/298 (42%), Gaps = 61/298 (20%)

Query: 548 NKLGQGGFGIVYKGR---LLEGQE---IAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
            +LG+G FG V+      LL  Q+   +AVK L   S    ++F+ E  L+  LQH+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDS------------VIFDKARSSILNWQRRFNIICG 649
           R  G C E    ++V+EYM +  L+                +      L   +   +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK---- 704
           +A G++YL   +    +HRDL   N L+ + +  KI DFGM+R I+  D      +    
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223

Query: 705 -RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFY--HSNNELNLLGH 760
            R      +M PE  +   F+ +SDV+SFGV+L E  + GK+    +   SN E      
Sbjct: 224 IR------WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP---WYQLSNTE------ 268

Query: 761 VWRLWKEGKVLEMVDSSVDNYPANEVLRC---IH-VGLLCVQENAEERPTMASVVLML 814
                 +G+ LE         P      C   ++ +   C Q   ++R ++  V   L
Sbjct: 269 AIDCITQGRELER--------PRA----CPPEVYAIMRGCWQREPQQRHSIKDVHARL 314

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  165 bits (420), Expect = 8e-46
 Identities = 81/310 (26%), Positives = 136/310 (43%), Gaps = 52/310 (16%)

Query: 526 DLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEG----QEIAVKRLSRN-SGQ 580
           +L   +     I  ++        +G+G FG VY G LL+        AVK L+R     
Sbjct: 10  ELVQAVQHVV-IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 68

Query: 581 GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK-MLVYEYMENRSLDSVIFDKARSSILN 639
            + +F  E  ++    H N++ LLG C+  +   ++V  YM++  L +  F +  +    
Sbjct: 69  EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPT 126

Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
            +        +A+G+ YL   +  + +HRDL A N +LD++ T K++DFG+AR    D  
Sbjct: 127 VKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMY 179

Query: 700 EQNTKRVVGTYG------YMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGF--Y-- 749
           ++    V    G      +M+ E      F+ KSDV+SFGVLL E ++    RG   Y  
Sbjct: 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPD 235

Query: 750 HSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRC---IH-VGLLCVQENAEERP 805
            +  +      +     +G+ L          P      C   ++ V L C    AE RP
Sbjct: 236 VNTFD------ITVYLLQGRRLLQ--------PEY----CPDPLYEVMLKCWHPKAEMRP 277

Query: 806 TMASVVLMLS 815
           + + +V  +S
Sbjct: 278 SFSELVSRIS 287

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  164 bits (418), Expect = 1e-45
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 62/299 (20%)

Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
            +LG+G FG V+           +   +AVK L   +    ++F+ E  L+  LQH ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDS-------------VIFDKARSSILNWQRRFNIIC 648
           +  G C + D  ++V+EYM++  L+                  +     L   +  +I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK--- 704
            IA G++YL   +    +HRDL   N L+   +  KI DFGM+R ++  D          
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197

Query: 705 --RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFY--HSNNELNLLG 759
             R      +M PE  M   F+ +SDV+SFGV+L E  + GK+    +   SN E     
Sbjct: 198 PIR------WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP---WFQLSNTE----- 243

Query: 760 HVWRLWKEGKVLEMVDSSVDNYPANEVLRC---IH-VGLLCVQENAEERPTMASVVLML 814
            V     +G+VLE         P      C   ++ V L C Q   ++R  +  +  +L
Sbjct: 244 -VIECITQGRVLER--------PRV----CPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  164 bits (418), Expect = 1e-45
 Identities = 70/296 (23%), Positives = 121/296 (40%), Gaps = 50/296 (16%)

Query: 548 NKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLV 601
             LG+G FG V   R        G+++AVK L   SG   I + K E+ ++  L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 602 RLLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +  G C E       L+ E++ + SL    +     + +N +++      I +G+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKE--YLPKNKNKINLKQQLKYAVQICKGMDYLGS 144

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ----TEQNTK---RVVGTYGY 712
               + +HRDL A N+L++ E   KI DFG+ +    D+     + +            +
Sbjct: 145 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF------W 195

Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLL-------GHVWRL 764
            +PE  M   F + SDV+SFGV L E ++    +        ++            +   
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255

Query: 765 WKEGKVLEMVDSSVDNYPANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
            KEGK L          P N    C   ++ +   C +     R +  +++    +
Sbjct: 256 LKEGKRLPC--------PPN----CPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  164 bits (418), Expect = 2e-45
 Identities = 81/339 (23%), Positives = 147/339 (43%), Gaps = 69/339 (20%)

Query: 512 VISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL----EGQ 567
           ++    +   +K +D+ +         R  +       LG+G FG V +G L        
Sbjct: 14  LVPRGSEELQNKLEDVVID--------R--NLLILGKILGEGEFGSVMEGNLKQEDGTSL 63

Query: 568 EIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-----EKMLVYEYM 620
           ++AVK +  +  S + IEEF +E   +    H N++RLLG C+EM      + M++  +M
Sbjct: 64  KVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123

Query: 621 ENRSLDSVI---FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL 677
           +   L + +     +     +  Q     +  IA G+ YL   S    +HRDL A N +L
Sbjct: 124 KYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCML 180

Query: 678 DKEMTPKISDFGMAR-IFGGDQTEQNTK-----RVVGTYGYMSPEYAMDGLFSVKSDVFS 731
             +MT  ++DFG+++ I+ GD   Q        +      +++ E   D +++ KSDV++
Sbjct: 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK------WIAIESLADRVYTSKSDVWA 234

Query: 732 FGVLLLETVSGKKNRGF--Y--HSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVL 787
           FGV + E  +    RG   Y    N+E      ++     G  L+         P +   
Sbjct: 235 FGVTMWEIAT----RGMTPYPGVQNHE------MYDYLLHGHRLKQ--------PED--- 273

Query: 788 RC---IH-VGLLCVQENAEERPTMASVVLMLSSETATMP 822
            C   ++ +   C + +  +RPT + + L L     ++P
Sbjct: 274 -CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  164 bits (416), Expect = 5e-45
 Identities = 84/317 (26%), Positives = 136/317 (42%), Gaps = 61/317 (19%)

Query: 525 DDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN- 577
           D+ E+            +  T   +LGQG FG+VY+G             +A+K ++   
Sbjct: 18  DEWEVAR----------EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 67

Query: 578 SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN-------RSLDSVIF 630
           S +   EF NE  ++ +    ++VRLLG   +    +++ E M         RSL   + 
Sbjct: 68  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 127

Query: 631 DKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM 690
           +    +  +  +   +   IA G+ YL   +  + +HRDL A N ++ ++ T KI DFGM
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGM 184

Query: 691 AR-IFGGDQTEQNTK-----RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKK 744
            R I+  D   +  K     R      +MSPE   DG+F+  SDV+SFGV+L E  +   
Sbjct: 185 TRDIYETDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT--- 235

Query: 745 NRGF--Y--HSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQEN 800
                 Y   SN +      V R   EG +L+         P N       +  +C Q N
Sbjct: 236 -LAEQPYQGLSNEQ------VLRFVMEGGLLDK--------PDNCPDMLFELMRMCWQYN 280

Query: 801 AEERPTMASVVLMLSSE 817
            + RP+   ++  +  E
Sbjct: 281 PKMRPSFLEIISSIKEE 297

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  165 bits (419), Expect = 6e-45
 Identities = 90/357 (25%), Positives = 143/357 (40%), Gaps = 61/357 (17%)

Query: 482 RRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRAT 541
             +  +G +++  E +    R+  ++ +          ++  +D  E+P           
Sbjct: 21  YFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPR---------- 70

Query: 542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAK 594
            N T    LG G FG VY+G++          ++AVK L    S Q   +F  E  +I+K
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI----FDKARSSILNWQRRFNIICGI 650
             H+N+VR +G  ++   + ++ E M    L S +       ++ S L      ++   I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGMAR-IFGGDQTEQNTK-- 704
           A G  YL        IHRD+ A N LL         KI DFGMAR I+      +     
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247

Query: 705 ---RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGF--Y--HSNNELNL 757
              +      +M PE  M+G+F+ K+D +SFGVLL E  S     G+  Y   SN E   
Sbjct: 248 LPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQE--- 294

Query: 758 LGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
              V      G  ++         P N       +   C Q   E+RP  A ++  +
Sbjct: 295 ---VLEFVTSGGRMDP--------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  162 bits (412), Expect = 7e-45
 Identities = 81/302 (26%), Positives = 131/302 (43%), Gaps = 63/302 (20%)

Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNL 600
            +LG+  FG VYKG L       + Q +A+K L     G   EEF++E  L A+LQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDS-------------VIFDKARSSILNWQRRFNII 647
           V LLG   +     +++ Y  +  L                  D+   S L      +++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK-- 704
             IA G+ YL   S   ++H+DL   N+L+  ++  KISD G+ R ++  D  +      
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191

Query: 705 ---RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFY--HSNNELNLL 758
              R      +M+PE  M G FS+ SD++S+GV+L E  S G +    Y  +SN +    
Sbjct: 192 LPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP---YCGYSNQD---- 238

Query: 759 GHVWRLWKEGKVLEMVDSSVDNYPANEVLRC---IH-VGLLCVQENAEERPTMASVVLML 814
             V  + +  +VL          P +    C   ++ + + C  E    RP    +   L
Sbjct: 239 --VVEMIRNRQVLPC--------PDD----CPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

Query: 815 SS 816
            +
Sbjct: 285 RA 286

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  163 bits (415), Expect = 9e-45
 Identities = 83/306 (27%), Positives = 123/306 (40%), Gaps = 56/306 (18%)

Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNL 600
             LG G FG VY+G++          ++AVK L    S Q   +F  E  +I+K  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVI----FDKARSSILNWQRRFNIICGIARGLLY 656
           VR +G  ++   + ++ E M    L S +       ++ S L      ++   IA G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 657 LHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGMAR-IFGGDQTEQNTK-----RVV 707
           L        IHRD+ A N LL         KI DFGMAR I+      +        +  
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK-- 210

Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGF--Y--HSNNELNLLGHVWR 763
               +M PE  M+G+F+ K+D +SFGVLL E  S     G+  Y   SN E      V  
Sbjct: 211 ----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----LGYMPYPSKSNQE------VLE 256

Query: 764 LWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML-----SSET 818
               G  ++         P N       +   C Q   E+RP  A ++  +       + 
Sbjct: 257 FVTSGGRMDP--------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308

Query: 819 ATMPQP 824
                P
Sbjct: 309 INTALP 314

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  161 bits (410), Expect = 1e-44
 Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 53/285 (18%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG+V  G+     ++A+K + +      +EF  E +++  L H  LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            +     ++ EYM N  L +  + +        Q+   +   +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLH 143

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTK---RVVGTYGYMSPEYAMDGL 722
           RDL A N L++ +   K+SDFG++R    D+  +   +K   R      +  PE  M   
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLMYSK 197

Query: 723 FSVKSDVFSFGVLLLETVS-GKKNRGFYH--SNNELNLLGHVWRLWKEGKVLEMVDSSVD 779
           FS KSD+++FGVL+ E  S GK     Y   +N+E                 E +     
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMP---YERFTNSE---------------TAEHIA---Q 236

Query: 780 NY----PANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
                 P          ++ +   C  E A+ERPT   ++  +  
Sbjct: 237 GLRLYRPHL----ASEKVYTIMYSCWHEKADERPTFKILLSNILD 277

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  160 bits (408), Expect = 1e-44
 Identities = 75/284 (26%), Positives = 123/284 (43%), Gaps = 53/284 (18%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           +LG G FG+V  G+     ++AVK + +      +EF  E + + KL H  LV+  G C 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           +     +V EY+ N  L +  + ++    L   +   +   +  G+ +L      + IHR
Sbjct: 74  KEYPIYIVTEYISNGCLLN--YLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128

Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTK---RVVGTYGYMSPEYAMDGLF 723
           DL A N L+D+++  K+SDFGM R    DQ  +   TK   +      + +PE      +
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK------WSAPEVFHYFKY 182

Query: 724 SVKSDVFSFGVLLLETVS-GKKNRGFYH--SNNELNLLGHVWRLWKEGKVLEMVDSSVDN 780
           S KSDV++FG+L+ E  S GK     Y   +N+E               V+  V      
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMP---YDLYTNSE---------------VVLKVS---QG 221

Query: 781 Y----PANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
           +    P          I+ +   C  E  E+RPT   ++  +  
Sbjct: 222 HRLYRPHL----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEP 261

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  161 bits (410), Expect = 2e-44
 Identities = 76/314 (24%), Positives = 127/314 (40%), Gaps = 52/314 (16%)

Query: 522 DKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQE----IAVKRLSRN 577
           D    L   + D   I            +G+G FG+VY G  ++  +     A+K LSR 
Sbjct: 2   DLDSALLAEVKDVL-IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI 60

Query: 578 SGQG-IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE-KMLVYEYMENRSLDSVIFDKARS 635
           +    +E F  E  L+  L H N++ L+G  +  +    ++  YM +  L    F ++  
Sbjct: 61  TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ--FIRSPQ 118

Query: 636 SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IF 694
                +   +    +ARG+ YL   +  + +HRDL A N +LD+  T K++DFG+AR I 
Sbjct: 119 RNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175

Query: 695 GGDQTEQNTKRVVGTYG-----YMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGF- 748
             +            +      + + E      F+ KSDV+SFGVLL E ++    RG  
Sbjct: 176 DREYYSVQQ----HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT----RGAP 227

Query: 749 -Y--HSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRC---IH-VGLLCVQENA 801
            Y      +      +     +G+ L          P      C   ++ V   C + + 
Sbjct: 228 PYRHIDPFD------LTHFLAQGRRLPQ--------PEY----CPDSLYQVMQQCWEADP 269

Query: 802 EERPTMASVVLMLS 815
             RPT   +V  + 
Sbjct: 270 AVRPTFRVLVGEVE 283

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  163 bits (415), Expect = 2e-44
 Identities = 79/288 (27%), Positives = 132/288 (45%), Gaps = 51/288 (17%)

Query: 548 NKLGQGGFGIVYKGRLLEG----QEIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVR 602
             +G+G FG VY G LL+        AVK L+R +  G + +F  E  ++    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 603 LLGCCVEMDEK-MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           LLG C+  +   ++V  YM++  L +  F +  +     +        +A+G+ +L   +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL---A 209

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSP 715
             + +HRDL A N +LD++ T K++DFG+AR    D  ++    V    G      +M+ 
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVKWMAL 265

Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGF--Y--HSNNELNLLGHVWRLWKEGKVL 771
           E      F+ KSDV+SFGVLL E ++    RG   Y   +  +      +     +G+ L
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFD------ITVYLLQGRRL 315

Query: 772 EMVDSSVDNYPANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLS 815
                     P      C   ++ V L C    AE RP+ + +V  +S
Sbjct: 316 LQ--------PEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  160 bits (407), Expect = 2e-44
 Identities = 78/282 (27%), Positives = 125/282 (44%), Gaps = 47/282 (16%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            ++G G FG+V+ G  L   ++A+K + R      E+F  E  ++ KL H  LV+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
           +E     LV E+ME+  L    + + +  +   +    +   +  G+ YL       +IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIH 127

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTK---RVVGTYGYMSPEYAMDGL 722
           RDL A N L+ +    K+SDFGM R    DQ  +   TK   +      + SPE      
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK------WASPEVFSFSR 181

Query: 723 FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY- 781
           +S KSDV+SFGVL+ E  S  K      SN+E               V+E + +    + 
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------------VVEDIST---GFR 223

Query: 782 ---PANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
              P          ++ +   C +E  E+RP  + ++  L+ 
Sbjct: 224 LYKPRL----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  169 bits (430), Expect = 2e-44
 Identities = 85/391 (21%), Positives = 145/391 (37%), Gaps = 55/391 (14%)

Query: 451 IGDGANATPIIIGV-----TVGSAILILGLVAC------FLWRRKTLLGRQIRKTEPRGH 499
           +       P+ +           A LI G              R    G +   + P+  
Sbjct: 288 LKIAGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLA 347

Query: 500 PERSQDLLLNQVVISSKRDYS--ADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGI 557
               Q +  + V +S   DY+   D+ D   +P      I R  +       +G+G FG 
Sbjct: 348 NNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQR--ERIELGRCIGEGQFGD 405

Query: 558 VYKGRLL--EGQEI--AVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE 612
           V++G  +  E   +  A+K      S    E+F  E   + +  H ++V+L+G   E + 
Sbjct: 406 VHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP 464

Query: 613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKA 672
             ++ E      L S  F + R   L+          ++  L YL      R +HRD+ A
Sbjct: 465 VWIIMELCTLGELRS--FLQVRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAA 519

Query: 673 SNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSF 732
            N+L+      K+ DFG++R        + +K  +    +M+PE      F+  SDV+ F
Sbjct: 520 RNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMF 578

Query: 733 GVLLLETVS-GKKNRGFY--HSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRC 789
           GV + E +  G K    +    NN+      V    + G+ L M        P N    C
Sbjct: 579 GVCMWEILMHGVKP---FQGVKNND------VIGRIENGERLPM--------PPN----C 617

Query: 790 ---IH-VGLLCVQENAEERPTMASVVLMLSS 816
              ++ +   C   +   RP    +   LS+
Sbjct: 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  160 bits (408), Expect = 2e-44
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 28/217 (12%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           R   +F +   +G GGFG V+K +  ++G+   +KR+  N+    E+ + EV+ +AKL H
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDH 63

Query: 598 RNLVRLLGCCVEMDEKM----------------LVYEYMENRSLDSVIFDKARSSILNWQ 641
            N+V   GC    D                   +  E+ +  +L+  I +K R   L+  
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKV 122

Query: 642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ 701
               +   I +G+ Y+H     ++I+RDLK SNI L      KI DFG+      D    
Sbjct: 123 LALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---G 176

Query: 702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
              R  GT  YMSPE      +  + D+++ G++L E
Sbjct: 177 KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  162 bits (411), Expect = 3e-44
 Identities = 65/289 (22%), Positives = 123/289 (42%), Gaps = 54/289 (18%)

Query: 548 NKLGQGGFGIVYKGRLLEGQE-----IAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLV 601
             LG G FG VYKG  +   E     +A+K L   +     +E  +E  ++A + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           RLLG C+      L+ + M    L    + +     +  Q   N    IA+G+ YL    
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG-----YMSPE 716
             R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      G     +M+ E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV-WRLWKEGKVLEMVD 775
             +  +++ +SDV+S+GV + E ++                 G   +      ++  +++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT----------------FGSKPYDGIPASEISSILE 233

Query: 776 SSVDNY----PANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
                     P      C   ++ +   C   +A+ RP    +++  S 
Sbjct: 234 K---GERLPQPPI----CTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 275

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  161 bits (410), Expect = 4e-44
 Identities = 85/313 (27%), Positives = 138/313 (44%), Gaps = 50/313 (15%)

Query: 549 KLGQGGFGIVYKGRLLEGQE-----IAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVR 602
            +G G FG VYKG L          +A+K L    + +   +F  E  ++ +  H N++R
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G   +    M++ EYMEN +LD   F + +    +  +   ++ GIA G+ YL   + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKYL---AN 165

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPE 716
              +HRDL A NIL++  +  K+SDFG++R+   D     T       G      + +PE
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIRWTAPE 220

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYH--SNNELNLLGHVWRLWKEGKVLEM 773
                 F+  SDV+SFG+++ E ++ G++    Y   SN+E      V +   +G  L  
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERP---YWELSNHE------VMKAINDGFRLPT 271

Query: 774 VDSSVDNYPANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGF 829
                   P +    C   I+ + + C Q+    RP  A +V +L          KT   
Sbjct: 272 --------PMD----CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 319

Query: 830 CLGRNPIETDSSS 842
              R  I   S+S
Sbjct: 320 FDPRVSIRLPSTS 332

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  161 bits (409), Expect = 5e-44
 Identities = 87/368 (23%), Positives = 151/368 (41%), Gaps = 74/368 (20%)

Query: 507 LLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL-- 564
           +L+ + IS +     +K +D+ +P             FT    LG+G FG V + +L   
Sbjct: 1   MLDSLGISDE---LKEKLEDVLIP--------E--QQFTLGRMLGKGEFGSVREAQLKQE 47

Query: 565 --EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK------M 614
                ++AVK L  +  +   IEEF  E   + +  H ++ +L+G  +    K      M
Sbjct: 48  DGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPM 107

Query: 615 LVYEYMENRSLDSVIFD---KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK 671
           ++  +M++  L + +           L  Q     +  IA G+ YL   S    IHRDL 
Sbjct: 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLA 164

Query: 672 ASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK-----RVVGTYGYMSPEYAMDGLFSV 725
           A N +L ++MT  ++DFG++R I+ GD   Q        +      +++ E   D L++V
Sbjct: 165 ARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK------WLALESLADNLYTV 218

Query: 726 KSDVFSFGVLLLETVSGKKNRGF--Y--HSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY 781
            SDV++FGV + E ++    RG   Y    N E      ++     G  L+         
Sbjct: 219 HSDVWAFGVTMWEIMT----RGQTPYAGIENAE------IYNYLIGGNRLKQ-------- 260

Query: 782 PANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGFCLGRNPIE 837
           P      C   ++ +   C   + ++RP+   + + L +    +    T    L  N IE
Sbjct: 261 PPE----CMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYIN-IE 315

Query: 838 TDSSSSKH 845
                  H
Sbjct: 316 RAHHHHHH 323

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  160 bits (407), Expect = 8e-44
 Identities = 76/290 (26%), Positives = 123/290 (42%), Gaps = 55/290 (18%)

Query: 548 NKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVR 602
             +G G  G V  GRL         +A+K L      +   +F +E  ++ +  H N++R
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G        M+V EYMEN SLD+  F +         +   ++ G+  G+ YL   S 
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYL---SD 169

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ----TEQNTK---RVVGTYGYMSP 715
              +HRDL A N+L+D  +  K+SDFG++R+   D     T    K   R      + +P
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR------WTAP 223

Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV-WRLWKEGKVLEMV 774
           E      FS  SDV+SFGV++ E ++                 G   +       V+  V
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLA----------------YGERPYWNMTNRDVISSV 267

Query: 775 DSSVDNY----PANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
           +   + Y    P      C   +H + L C  ++  +RP  + +V +L +
Sbjct: 268 E---EGYRLPAPMG----CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  164 bits (416), Expect = 2e-43
 Identities = 70/274 (25%), Positives = 123/274 (44%), Gaps = 29/274 (10%)

Query: 548 NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           +KLG G +G VY+G        +AVK L +     +EEF  E  ++ +++H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
           C       ++ E+M   +L   + +  R   ++      +   I+  + YL    +   I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL---EKKNFI 340

Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVK 726
           HR+L A N L+ +    K++DFG++R+  GD    +         + +PE      FS+K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 399

Query: 727 SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEV 786
           SDV++FGVLL E  +   +       ++      V+ L ++   +E         P    
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDYRMER--------PEG-- 443

Query: 787 LRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
             C   ++ +   C Q N  +RP+ A +     +
Sbjct: 444 --CPEKVYELMRACWQWNPSDRPSFAEIHQAFET 475

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  157 bits (400), Expect = 2e-43
 Identities = 86/295 (29%), Positives = 139/295 (47%), Gaps = 52/295 (17%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            +LG G FG V+ G      ++AVK L +      + F  E  L+ +LQH+ LVRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            + +   ++ EYMEN SL   +   +    L   +  ++   IA G+ ++        IH
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFI---EERNYIH 132

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY--MSPEYAMDGLFSV 725
           RDL+A+NIL+   ++ KI+DFG+AR+   ++    T R    +     +PE    G F++
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTI 189

Query: 726 KSDVFSFGVLLLETVS-GKKNRGFYH--SNNELNLLGHVWRLWKEGKVLEMVDSSVDNY- 781
           KSDV+SFG+LL E V+ G+     Y   +N E               V++ ++     Y 
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP---YPGMTNPE---------------VIQNLE---RGYR 228

Query: 782 ---PANEVLRC---IH-VGLLCVQENAEERPTMASVVLML-----SSETATMPQP 824
              P N    C   ++ +  LC +E  E+RPT   +  +L     ++E    PQP
Sbjct: 229 MVRPDN----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP 279

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  159 bits (405), Expect = 2e-43
 Identities = 75/308 (24%), Positives = 124/308 (40%), Gaps = 71/308 (23%)

Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNL 600
             +G+G FG V++ R            +AVK L    S     +F+ E  L+A+  + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDS---------------------VIFDKARSSILN 639
           V+LLG C       L++EYM    L+                                L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQ 698
              +  I   +A G+ YL   S  + +HRDL   N L+ + M  KI+DFG++R I+  D 
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 699 TEQNTK-----RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGF--Y-- 749
            + +       R      +M PE      ++ +SDV+++GV+L E  S     G   Y  
Sbjct: 230 YKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS----YGLQPYYG 279

Query: 750 HSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPAN---EVLRCIHVGLLCVQENAEERPT 806
            ++ E      V    ++G +L          P N   E+   +    LC  +   +RP+
Sbjct: 280 MAHEE------VIYYVRDGNILAC--------PENCPLELYNLM---RLCWSKLPADRPS 322

Query: 807 MASVVLML 814
             S+  +L
Sbjct: 323 FCSIHRIL 330

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  157 bits (399), Expect = 5e-43
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 27/224 (12%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQ 596
           R   +F     LG+GGFG+V++ +  ++    A+KR+   N     E+   EV+ +AKL+
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 597 HRNLVRLLGCCVEMDEKM------------LVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           H  +VR     +E +               +  +     +L   +  +            
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           +I   IA  + +LH      ++HRDLK SNI    +   K+ DFG+      D+ EQ   
Sbjct: 122 HIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 705 RV----------VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
                       VGT  YMSPE      +S K D+FS G++L E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  158 bits (401), Expect = 6e-43
 Identities = 74/321 (23%), Positives = 123/321 (38%), Gaps = 44/321 (13%)

Query: 548 NKLGQGGFGIVYKGRLL---EGQEI--AVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLV 601
             LG G FG V+KG  +   E  +I   +K +   SG Q  +   + +  I  L H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           RLLG C       LV +Y+   SL      +     L  Q   N    IA+G+ YL    
Sbjct: 79  RLLGLCPG-SSLQLVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMYYL---E 132

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG-----YMSPE 716
              ++HR+L A N+LL      +++DFG+A +   D  +                +M+ E
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMALE 187

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFY--HSNNELNLLGHVWRLWKEGKVLEM 773
               G ++ +SDV+S+GV + E ++ G +    Y      E      V  L ++G+ L  
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEP---YAGLRLAE------VPDLLEKGERLAQ 238

Query: 774 -VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGFCLG 832
               ++D Y          V + C   +   RPT   +    +      P+        G
Sbjct: 239 PQICTIDVY---------MVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESG 289

Query: 833 RNPIETDSSSSKHDETFTVNQ 853
                        ++     +
Sbjct: 290 PGIAPGPEPHGLTNKKLEEVE 310

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  157 bits (398), Expect = 6e-43
 Identities = 67/292 (22%), Positives = 118/292 (40%), Gaps = 58/292 (19%)

Query: 549 KLGQGGFGIVYKGRL--------LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
            LGQG F  ++KG          L   E+ +K L +      E F     +++KL H++L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V   G CV  DE +LV E+++  SLD+  + K   + +N   +  +   +A  + +L   
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDT--YLKKNKNCINILWKLEVAKQLAAAMHFL--- 129

Query: 661 SRFRIIHRDLKASNILLDKEMTP--------KISDFGMARIFGGDQTEQNTKRVVGTYGY 712
               +IH ++ A NILL +E           K+SD G++         Q  +R+     +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ--ERI----PW 183

Query: 713 MSPEYAMDG-LFSVKSDVFSFGVLLLETVS-GKKNRGFY--HSNNELNLLGHVWRLWKEG 768
           + PE   +    ++ +D +SFG  L E  S G K         +                
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP---LSALDSQR-------------- 226

Query: 769 KVLEMVDSSVDNY----PANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS 816
             L+  +   D +    P    L  +     C+    + RP+  +++  L+S
Sbjct: 227 -KLQFYE---DRHQLPAPKAAELANLI--NNCMDYEPDHRPSFRAIIRDLNS 272

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  156 bits (397), Expect = 7e-43
 Identities = 73/282 (25%), Positives = 125/282 (44%), Gaps = 45/282 (15%)

Query: 548 NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           +KLG G +G VY+G        +AVK L +     +EEF  E  ++ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
           C       ++ E+M   +L   + +  R   ++      +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYL---EKKNFI 133

Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK-----RVVGTYGYMSPEYAMDG 721
           HRDL A N L+ +    K++DFG++R+  GD    +       +      + +PE     
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAYN 187

Query: 722 LFSVKSDVFSFGVLLLETVS-GKKNRGFYH--SNNELNLLGHVWRLWKEGKVLEMVDSSV 778
            FS+KSDV++FGVLL E  + G      Y     ++      V+ L ++   +E      
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSP---YPGIDLSQ------VYELLEKDYRMER----- 233

Query: 779 DNYPANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
              P      C   ++ +   C Q N  +RP+ A +     +
Sbjct: 234 ---PEG----CPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  161 bits (409), Expect = 8e-43
 Identities = 75/278 (26%), Positives = 117/278 (42%), Gaps = 43/278 (15%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
             +G+G FG V  G    G ++AVK +  ++    + F  E  ++ +L+H NLV+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 608 VEMDEK-MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
           VE      +V EYM   SL   +  + RS  L           +   + YL        +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL---EGNNFV 311

Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY--MSPEYAMDGLFS 724
           HRDL A N+L+ ++   K+SDFG+ +       E ++ +  G       +PE   +  FS
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 364

Query: 725 VKSDVFSFGVLLLETVSGKKNRGFYH--SNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP 782
            KSDV+SFG+LL E  S    R  Y      +      V    ++G  ++         P
Sbjct: 365 TKSDVWSFGILLWEIYS--FGRVPYPRIPLKD------VVPRVEKGYKMDA--------P 408

Query: 783 ANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
                 C   ++ V   C   +A  RPT   +   L  
Sbjct: 409 DG----CPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  158 bits (401), Expect = 2e-42
 Identities = 89/377 (23%), Positives = 155/377 (41%), Gaps = 76/377 (20%)

Query: 479 FLWRRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADK-----TDDLELPLFD 533
               ++  L RQ+           S +     V I+++   +AD        + ELP   
Sbjct: 18  HKLTKRIPLRRQV---TVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDP 74

Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLL--------EGQEIAVKRLSRN-SGQGIEE 584
                R  D  T    LG+G FG V     +        E   +AVK L  + + + + +
Sbjct: 75  KWEFPR--DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD 132

Query: 585 FKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMENRSL-------------DSVIF 630
             +E+ ++  + +H+N++ LLG C +     ++ EY    +L              S   
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192

Query: 631 DKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM 690
           ++     + ++   +    +ARG+ YL   +  + IHRDL A N+L+ +    KI+DFG+
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGL 249

Query: 691 AR-IFGGDQTEQNTK-----RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKK 744
           AR I   D  ++ T      +      +M+PE   D +++ +SDV+SFGVL+ E  +   
Sbjct: 250 ARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT--- 300

Query: 745 NRGF--Y--HSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPAN---EVLRCIHVGLLCV 797
             G   Y      E      +++L KEG  ++         PAN   E+   +     C 
Sbjct: 301 -LGGSPYPGIPVEE------LFKLLKEGHRMDK--------PANCTNELYMMM---RDCW 342

Query: 798 QENAEERPTMASVVLML 814
                +RPT   +V  L
Sbjct: 343 HAVPSQRPTFKQLVEDL 359

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  158 bits (401), Expect = 2e-42
 Identities = 80/286 (27%), Positives = 127/286 (44%), Gaps = 49/286 (17%)

Query: 548 NKLGQGGFGIVYKGRLLEGQE----IAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVR 602
             +G G FG V  GRL    +    +A+K L      +   +F  E  ++ +  H N++R
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           L G   +    M+V EYMEN SLDS  F +   +     +   ++ GIA G+ YL   S 
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SD 165

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ----TEQNTKRVVGTYGYMSPEYA 718
              +HRDL A NIL++  +  K+SDFG+ R+   D     T +  K  +    + SPE  
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI---RWTSPEAI 222

Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV-WRLWKEGKVLEMVDSS 777
               F+  SDV+S+G++L E +S                 G   +       V++ VD  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMS----------------YGERPYWEMSNQDVIKAVD-- 264

Query: 778 VDNY----PANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLS 815
            + Y    P +    C   ++ + L C Q++   RP    +V +L 
Sbjct: 265 -EGYRLPPPMD----CPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  157 bits (398), Expect = 2e-42
 Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 11/214 (5%)

Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHR 598
           + +    K+G+G FG     +   +G++  +K   +SR S +  EE + EV ++A ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           N+V+      E     +V +Y E   L   I +  +  +    +  +    I   L ++H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
                +I+HRD+K+ NI L K+ T ++ DFG+AR+             +GT  Y+SPE  
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197

Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSN 752
            +  ++ KSD+++ G +L E  + K    F   +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK--HAFEAGS 229

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  155 bits (393), Expect = 3e-42
 Identities = 61/287 (21%), Positives = 112/287 (39%), Gaps = 54/287 (18%)

Query: 549 KLGQGGFGIVYKGRLL--EGQEI--AVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRL 603
            LG+G FG VY+G     +G++I  AVK   ++ +    E+F +E  ++  L H ++V+L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G   E +   ++ E      L    + +   + L           I + + YL      
Sbjct: 79  IGIIEE-EPTWIIMELYPYGELGH--YLERNKNSLKVLTLVLYSLQICKAMAYL---ESI 132

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK-----RVVGTYGYMSPEYA 718
             +HRD+   NIL+      K+ DFG++R    +   + +      +      +MSPE  
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK------WMSPESI 186

Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV-WRLWKEGKVLEMVDSS 777
               F+  SDV+ F V + E +S                 G   +   +   V+ +++  
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILS----------------FGKQPFFWLENKDVIGVLE-- 228

Query: 778 VDNY----PANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
                   P      C   ++ +   C   +  +RP    +V  LS 
Sbjct: 229 -KGDRLPKPDL----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  155 bits (393), Expect = 3e-42
 Identities = 73/287 (25%), Positives = 108/287 (37%), Gaps = 49/287 (17%)

Query: 549 KLGQGGFGIVYKGRLL--EGQEI--AVKRL---SRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           KLG G FG+V +G      G+ +  AVK L     +  + +++F  EV  +  L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           RL G  +      +V E     SL      +                 +A G+ YL    
Sbjct: 85  RLYGVVLT-PPMKMVTELAPLGSLLD--RLRKHQGHFLLGTLSRYAVQVAEGMGYL---E 138

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT---YGYMSPEYA 718
             R IHRDL A N+LL      KI DFG+ R    +      +        + + +PE  
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESL 196

Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV-WRLWKEGKVLEMVDSS 777
               FS  SD + FGV L E  +                 G   W      ++L  +D  
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT----------------YGQEPWIGLNGSQILHKIDK- 239

Query: 778 VDNY----PANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
            +      P +    C   I+ V + C     E+RPT  ++   L  
Sbjct: 240 -EGERLPRPED----CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 281

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  154 bits (392), Expect = 3e-42
 Identities = 62/197 (31%), Positives = 94/197 (47%), Gaps = 17/197 (8%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
             +G+G FG V  G    G ++AVK +   +    + F  E  ++ +L+H NLV+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 608 VEMDEK-MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRII 666
           VE      +V EYM   SL   +  + RS  L           +   + YL        +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL---EGNNFV 139

Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY--MSPEYAMDGLFS 724
           HRDL A N+L+ ++   K+SDFG+ +       E ++ +  G       +PE   +  FS
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 192

Query: 725 VKSDVFSFGVLLLETVS 741
            KSDV+SFG+LL E  S
Sbjct: 193 TKSDVWSFGILLWEIYS 209

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  159 bits (404), Expect = 4e-42
 Identities = 76/281 (27%), Positives = 127/281 (45%), Gaps = 45/281 (16%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            KLG G FG V+     +  ++AVK + +     +E F  E  ++  LQH  LV+L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            + +   ++ E+M   SL   +     S      +  +    IA G+ ++    +   IH
Sbjct: 253 TK-EPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFI---EQRNYIH 307

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDGLFSV 725
           RDL+A+NIL+   +  KI+DFG+AR+   ++    +  K  +    + +PE    G F++
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAINFGSFTI 364

Query: 726 KSDVFSFGVLLLETVSGKKNRGFYH--SNNELNLLGHVWRLWKEGKVLEMVDSSVDNY-- 781
           KSDV+SFG+LL+E V+    R  Y   SN E               V+  ++     Y  
Sbjct: 365 KSDVWSFGILLMEIVT--YGRIPYPGMSNPE---------------VIRALER---GYRM 404

Query: 782 --PANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
             P N    C   ++ + + C +   EERPT   +  +L  
Sbjct: 405 PRPEN----CPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 441

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  155 bits (393), Expect = 5e-42
 Identities = 54/213 (25%), Positives = 100/213 (46%), Gaps = 22/213 (10%)

Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRL---SRNSGQGIEEFKNEVRLIAKLQH 597
            NF    K+G+G F  VY+   LL+G  +A+K++        +   +   E+ L+ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKAR-------SSILNWQRRFNIICGI 650
            N+++     +E +E  +V E  +   L  +I    +        ++  +         +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY------FVQL 145

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
              L ++H     R++HRD+K +N+ +      K+ D G+ R F    T  ++  +VGT 
Sbjct: 146 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 200

Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            YMSPE   +  ++ KSD++S G LL E  + +
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  155 bits (394), Expect = 7e-42
 Identities = 86/354 (24%), Positives = 145/354 (40%), Gaps = 79/354 (22%)

Query: 496 PRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGF 555
              H   SQD +L  V      +Y   +    E P           D  T    LG+G F
Sbjct: 4   SHHHHHHSQDPMLAGVS-----EYELPEDPKWEFPR----------DKLTLGKPLGEGAF 48

Query: 556 GIVYKGRLL--------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLG 605
           G V     +        E   +AVK L  + + + + +  +E+ ++  + +H+N++ LLG
Sbjct: 49  GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 108

Query: 606 CCVEMDEKMLVYEYMENRSL-------------DSVIFDKARSSILNWQRRFNIICGIAR 652
            C +     ++ EY    +L              S   ++     + ++   +    +AR
Sbjct: 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 168

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK-----RV 706
           G+ YL   +  + IHRDL A N+L+ +    KI+DFG+AR I   D  ++ T      + 
Sbjct: 169 GMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK- 224

Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGF--Y--HSNNELNLLGHVW 762
                +M+PE   D +++ +SDV+SFGVL+ E  +     G   Y      E      ++
Sbjct: 225 -----WMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEE------LF 269

Query: 763 RLWKEGKVLEMVDSSVDNYPAN--EVLRCIHVGLLCVQENAEERPTMASVVLML 814
           +L KEG  ++         PAN    L  +     C      +RPT   +V  L
Sbjct: 270 KLLKEGHRMDK--------PANCTNELYMMM--RDCWHAVPSQRPTFKQLVEDL 313

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  153 bits (390), Expect = 7e-42
 Identities = 67/285 (23%), Positives = 116/285 (40%), Gaps = 49/285 (17%)

Query: 549 KLGQGGFGIVYKGRLLEGQE---IAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLL 604
           +LG G FG V +G     ++   +A+K L + +     EE   E +++ +L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
           G C   +  MLV E      L    F   +   +       ++  ++ G+ YL       
Sbjct: 77  GVCQA-EALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGD----QTEQNTKRVVGTYGYMSPEYAMD 720
            +HRDL A N+LL      KISDFG+++  G D          K  +    + +PE    
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPECINF 187

Query: 721 GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV-WRLWKEGKVLEMVDSSVD 779
             FS +SDV+S+GV + E +S                 G   ++  K  +V+  ++    
Sbjct: 188 RKFSSRSDVWSYGVTMWEALS----------------YGQKPYKKMKGPEVMAFIEQ--- 228

Query: 780 NY----PANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
                 P      C   ++ +   C     E+RP   +V   + +
Sbjct: 229 GKRMECPPE----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  155 bits (393), Expect = 8e-42
 Identities = 81/298 (27%), Positives = 131/298 (43%), Gaps = 64/298 (21%)

Query: 548 NKLGQGGFGIVYKGRLLEGQE---IAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVR 602
           + +G+G FG V K R+ +       A+KR+    S     +F  E+ ++ KL  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDS-------------VIFDKARSSILNWQRRFNIICG 649
           LLG C       L  EY  + +L                    + +S L+ Q+  +    
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK----- 704
           +ARG+ YL   S+ + IHRDL A NIL+ +    KI+DFG++R  G +   + T      
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 205

Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGF--Y--HSNNELNLLGH 760
           R      +M+ E     +++  SDV+S+GVLL E VS     G   Y   +  E      
Sbjct: 206 R------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS----LGGTPYCGMTCAE------ 249

Query: 761 VWRLWKEGKVLEMVDSSVDNYPANEVLRC---IH-VGLLCVQENAEERPTMASVVLML 814
           ++    +G  LE         P N    C   ++ +   C +E   ERP+ A +++ L
Sbjct: 250 LYEKLPQGYRLEK--------PLN----CDDEVYDLMRQCWREKPYERPSFAQILVSL 295

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  158 bits (401), Expect = 9e-42
 Identities = 79/277 (28%), Positives = 123/277 (44%), Gaps = 37/277 (13%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            KLGQG FG V+ G       +A+K L +      E F  E +++ KL+H  LV+L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            E +   +V EYM   SL            L   +  ++   IA G+ Y+    R   +H
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 303

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKS 727
           RDL+A+NIL+ + +  K++DFG+AR+   ++             + +PE A+ G F++KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 362

Query: 728 DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY----PA 783
           DV+SFG+LL E  +  +       N E               VL+ V+     Y    P 
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQVER---GYRMPCPP 404

Query: 784 NEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
                C   +H +   C ++  EERPT   +   L  
Sbjct: 405 E----CPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  154 bits (392), Expect = 9e-42
 Identities = 70/284 (24%), Positives = 129/284 (45%), Gaps = 44/284 (15%)

Query: 548 NKLGQGGFGIVYKGRLLEGQE-----IAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLV 601
             LG G FG VYKG  +   E     +A+K L   +     +E  +E  ++A + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           RLLG C+      L+ + M    L    + +     +  Q   N    IA+G+ YL    
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG-----YMSPE 716
             R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      G     +M+ E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYH--SNNELNLLGHVWRLWKEGKVLEM 773
             +  +++ +SDV+S+GV + E ++ G K    Y     +E      +  + ++G+ L  
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP---YDGIPASE------ISSILEKGERLPQ 240

Query: 774 -VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS 816
               ++D Y          + + C   +A+ RP    +++  S 
Sbjct: 241 PPICTIDVY---------MIMVKCWMIDADSRPKFRELIIEFSK 275

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  159 bits (403), Expect = 2e-41
 Identities = 79/277 (28%), Positives = 123/277 (44%), Gaps = 37/277 (13%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
            KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            E +   +V EYM   SL            L   +  ++   IA G+ Y+    R   +H
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386

Query: 668 RDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKS 727
           RDL+A+NIL+ + +  K++DFG+AR+   ++             + +PE A+ G F++KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 445

Query: 728 DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY----PA 783
           DV+SFG+LL E  +  +       N E               VL+ V+     Y    P 
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQVER---GYRMPCPP 487

Query: 784 NEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
                C   +H +   C ++  EERPT   +   L  
Sbjct: 488 E----CPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  152 bits (386), Expect = 2e-41
 Identities = 66/294 (22%), Positives = 112/294 (38%), Gaps = 53/294 (18%)

Query: 549 KLGQGGFGIVYKGRLL--EGQEI--AVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRL 603
            +G+G FG V++G  +  E   +  A+K      S    E+F  E   + +  H ++V+L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G   E +   ++ E      L S  F + R   L+          ++  L YL      
Sbjct: 82  IGVITE-NPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYL---ESK 135

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY--GYMSPEYAMDG 721
           R +HRD+ A N+L+      K+ DFG++R           K   G     +M+PE     
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY---YKASKGKLPIKWMAPESINFR 192

Query: 722 LFSVKSDVFSFGVLLLETVS-GKKNRGFYH--SNNELNLLGHVWRLWKEGKVLEMVDSSV 778
            F+  SDV+ FGV + E +  G K    +    NN+               V+  ++   
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKP---FQGVKNND---------------VIGRIE--- 231

Query: 779 DNY----PANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSSE-TATMPQ 823
           +      P N    C   ++ +   C   +   RP    +   LS+       Q
Sbjct: 232 NGERLPMPPN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 281

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  152 bits (387), Expect = 3e-41
 Identities = 72/314 (22%), Positives = 126/314 (40%), Gaps = 83/314 (26%)

Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNL 600
             LG+G FG V K              +AVK L  N S   + +  +E  ++ ++ H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSL---------------------DSVIFDKARSSILN 639
           ++L G C +    +L+ EY +  SL                     +S   D      L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQ 698
                +    I++G+ YL   +  +++HRDL A NIL+ +    KISDFG++R ++  D 
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

Query: 699 TEQNTK-----RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-------GKKNR 746
             + ++     +      +M+ E   D +++ +SDV+SFGVLL E V+       G    
Sbjct: 206 YVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--- 256

Query: 747 GFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPAN------EVLRCIHVGLLCVQEN 800
                         ++ L K G  +E         P N       ++        C ++ 
Sbjct: 257 ----PPER------LFNLLKTGHRMER--------PDNCSEEMYRLMLQ------CWKQE 292

Query: 801 AEERPTMASVVLML 814
            ++RP  A +   L
Sbjct: 293 PDKRPVFADISKDL 306

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  150 bits (382), Expect = 8e-41
 Identities = 75/288 (26%), Positives = 119/288 (41%), Gaps = 55/288 (19%)

Query: 549 KLGQGGFGIVYKGRL-LEGQEI--AVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRL 603
           +LG G FG V KG   ++      AVK L          +E   E  ++ +L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           +G C   +  MLV E  E   L+   + +     +  +    ++  ++ G+ YL      
Sbjct: 84  IGICEA-ESWMLVMEMAELGPLNK--YLQQNRH-VKDKNIIELVHQVSMGMKYL---EES 136

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYG------YMSPEY 717
             +HRDL A N+LL  +   KISDFG+++    D+     +             + +PE 
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPEC 191

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV-WRLWKEGKVLEMVDS 776
                FS KSDV+SFGVL+ E  S                 G   +R  K  +V  M++ 
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS----------------YGQKPYRGMKGSEVTAMLEK 235

Query: 777 SVDNY----PANEVLRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
                    PA     C   ++ +  LC   + E RP  A+V L L +
Sbjct: 236 ---GERMGCPAG----CPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  150 bits (381), Expect = 2e-40
 Identities = 73/300 (24%), Positives = 120/300 (40%), Gaps = 60/300 (20%)

Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRN 599
             LG+G FG V +            + +AVK L    +        +E++++  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 600 LVRLLGCCVEMDE-KMLVYEYMENRSL-------------DSVIFDKARSSILNWQRRFN 645
           +V LLG C +     M++ E+ +  +L               V  +      L  +    
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK 704
               +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR I+      +   
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209

Query: 705 -----RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLL 758
                +      +M+PE   D +++++SDV+SFGVLL E  S G         + E    
Sbjct: 210 ARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 259

Query: 759 GHVWRLWKEGKVLEMVDSSVDNYPANEVLRC---IH-VGLLCVQENAEERPTMASVVLML 814
               R  KEG  +          P          ++   L C      +RPT + +V  L
Sbjct: 260 --FCRRLKEGTRMRA--------PDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  150 bits (381), Expect = 2e-40
 Identities = 65/291 (22%), Positives = 118/291 (40%), Gaps = 38/291 (13%)

Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRL 591
           F+++      ++   ++G GG   V++    + Q  A+K ++      Q ++ ++NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79

Query: 592 IAKLQHRNL--VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG 649
           + KLQ  +   +RL    +      +V E   N  L+S +  K     ++   R +    
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKN 135

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           +   +  +HQ     I+H DLK +N L+   M  K+ DFG+A     D T       VGT
Sbjct: 136 MLEAVHTIHQ---HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 191

Query: 710 YGYMSPE-----------YAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
             YM PE                  S KSDV+S G +L     GK    F    N+++ L
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKL 249

Query: 759 GHVWRLWKEGKVLEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMA 808
                         ++D + +  +P         V   C++ + ++R ++ 
Sbjct: 250 ------------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 288

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  152 bits (385), Expect = 3e-40
 Identities = 70/339 (20%), Positives = 123/339 (36%), Gaps = 46/339 (13%)

Query: 489 RQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDY- 547
                  PRG   +       +       D   D  D       +  ++         Y 
Sbjct: 5   HHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISV-----KGRIYS 59

Query: 548 --NKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNL--V 601
              ++G GG   V++    + Q  A+K ++      Q ++ ++NE+  + KLQ  +   +
Sbjct: 60  ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           RL    +      +V E   N  L+S +  K     ++   R +    +   +  +HQ  
Sbjct: 120 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ-- 173

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE----- 716
              I+H DLK +N L+   M  K+ DFG+A     D T       VG   YM PE     
Sbjct: 174 -HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 717 ------YAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV 770
                        S KSDV+S G +L     GK    F    N+++ L            
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKL------------ 277

Query: 771 LEMVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMA 808
             ++D + +  +P         V   C++ + ++R ++ 
Sbjct: 278 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 316

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  148 bits (376), Expect = 4e-40
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 22/216 (10%)

Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHR 598
           +++     +G G +G   K R   +G+ +  K       +    +   +EV L+ +L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 599 NLVRLLGCCVEMDEKML--VYEYMENRSLDSVIFDKARSS-------ILNWQRRFNIICG 649
           N+VR     ++     L  V EY E   L SVI    +         +L        +  
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV------MTQ 119

Query: 650 IARGLLYLHQ--DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
           +   L   H+  D    ++HRDLK +N+ LD +   K+ DFG+ARI   +      K  V
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFV 177

Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           GT  YMSPE      ++ KSD++S G LL E  +  
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  156 bits (395), Expect = 5e-40
 Identities = 73/334 (21%), Positives = 130/334 (38%), Gaps = 49/334 (14%)

Query: 499 HPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIV 558
            P R       + +      + +  +D  EL       + R      D  +LG G FG V
Sbjct: 295 EPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLF-LKRDNLLIAD-IELGCGNFGSV 352

Query: 559 YKGRL-LEGQEI--AVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM 614
            +G   +  ++I  A+K L + +     EE   E +++ +L +  +VRL+G C   +  M
Sbjct: 353 RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411

Query: 615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASN 674
           LV E      L    F   +   +       ++  ++ G+ YL        +HR+L A N
Sbjct: 412 LVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARN 466

Query: 675 ILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT---YGYMSPEYAMDGLFSVKSDVFS 731
           +LL      KISDFG+++  G D +    +          + +PE      FS +SDV+S
Sbjct: 467 VLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFRKFSSRSDVWS 524

Query: 732 FGVLLLETVSGKKNRGFYHSNNELNLLGHV-WRLWKEGKVLEMVDSSVDNY----PANEV 786
           +GV + E +S                 G   ++  K  +V+  ++          P    
Sbjct: 525 YGVTMWEALS----------------YGQKPYKKMKGPEVMAFIEQ---GKRMECPPE-- 563

Query: 787 LRC---IH-VGLLCVQENAEERPTMASVVLMLSS 816
             C   ++ +   C     E+RP   +V   + +
Sbjct: 564 --CPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  150 bits (380), Expect = 6e-40
 Identities = 67/277 (24%), Positives = 115/277 (41%), Gaps = 38/277 (13%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNL--VRL 603
            ++G GG   V++    + Q  A+K ++      Q ++ ++NE+  + KLQ  +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
               +      +V E   N  L+S +  K + SI  W+R+      +   +  +HQ    
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKS-YWKNMLEAVHTIHQ---H 127

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE------- 716
            I+H DLK +N L+   M  K+ DFG+A     D T       VGT  YM PE       
Sbjct: 128 GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 717 ----YAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE 772
                      S KSDV+S G +L     GK    F    N+++ L              
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQIINQISKL------------HA 232

Query: 773 MVDSSVD-NYPANEVLRCIHVGLLCVQENAEERPTMA 808
           ++D + +  +P         V   C++ + ++R ++ 
Sbjct: 233 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 269

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  147 bits (374), Expect = 8e-40
 Identities = 72/302 (23%), Positives = 127/302 (42%), Gaps = 38/302 (12%)

Query: 517 RDYSADKTDDLELPLFDFETIVRATDNFTDYNK----LGQGGFGIVYKGR-LLEGQEIAV 571
           ++    + DD+E    + ET      N   + K    +G+G F  VYKG       E+A 
Sbjct: 1   QEERNQQQDDIE----ELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAW 56

Query: 572 K--RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM----LVYEYMENRSL 625
              +  + +    + FK E  ++  LQH N+VR         +      LV E M + +L
Sbjct: 57  CELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL 116

Query: 626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-KEMTPK 684
            + +    R  ++  +   +    I +GL +LH  +   IIHRDLK  NI +     + K
Sbjct: 117 KTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVK 172

Query: 685 ISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKK 744
           I D G+A +    +     K V+GT  +M+PE   +  +    DV++FG+ +LE  + + 
Sbjct: 173 IGDLGLATL----KRASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE- 226

Query: 745 NRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEER 804
                +  +E      ++R    G      D         E++        C+++N +ER
Sbjct: 227 -----YPYSECQNAAQIYRRVTSGVKPASFDKVAIP-EVKEIIE------GCIRQNKDER 274

Query: 805 PT 806
            +
Sbjct: 275 YS 276

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  147 bits (373), Expect = 4e-39
 Identities = 80/333 (24%), Positives = 130/333 (39%), Gaps = 59/333 (17%)

Query: 512 VISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL------E 565
           +I S    S    D  +LP  +     R  +N      LG G FG V +           
Sbjct: 18  IIESYEGNSYTFIDPTQLPYNEKWEFPR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDA 75

Query: 566 GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMEN- 622
             ++AVK L         E   +E+++++ L QH N+V LLG C      +++ EY    
Sbjct: 76  VLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135

Query: 623 ----------RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKA 672
                     R L++       +S  + +   +    +A+G+ +L   +    IHRD+ A
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAA 192

Query: 673 SNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK-----RVVGTYGYMSPEYAMDGLFSVK 726
            N+LL      KI DFG+AR I                +      +M+PE   D +++V+
Sbjct: 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK------WMAPESIFDCVYTVQ 246

Query: 727 SDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANE 785
           SDV+S+G+LL E  S G         N++       ++L K+G  +          PA  
Sbjct: 247 SDVWSYGILLWEIFSLGLNPYPGILVNSK------FYKLVKDGYQMAQ--------PAF- 291

Query: 786 VLRC---IH-VGLLCVQENAEERPTMASVVLML 814
                  I+ +   C       RPT   +   L
Sbjct: 292 ---APKNIYSIMQACWALEPTHRPTFQQICSFL 321

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  146 bits (370), Expect = 5e-39
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 33/227 (14%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
           R   +F +   LGQG FG V K R  L+ +  A+K++     + +    +EV L+A L H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNH 61

Query: 598 RNLVRLLGCCVEMDEKM-------------LVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           + +VR     +E    +             +  EY EN +L  +I   + +        +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYW 119

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF---------- 694
            +   I   L Y+H      IIHRDLK  NI +D+    KI DFG+A+            
Sbjct: 120 RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 695 --GGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLE 738
                 +  N    +GT  Y++ E     G ++ K D++S G++  E
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  148 bits (375), Expect = 5e-39
 Identities = 75/302 (24%), Positives = 130/302 (43%), Gaps = 64/302 (21%)

Query: 548 NKLGQGGFGIVYKGRLL--------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QH 597
             LG+G FG V     +           ++AVK L  + + + + +  +E+ ++  + +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSL-------------DSVIFDKARSSILNWQRRF 644
           +N++ LLG C +     ++ EY    +L              S          L+ +   
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNT 703
           +    +ARG+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR I   D  ++ T
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251

Query: 704 K-----RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGF--Y--HSNNE 754
                 +      +M+PE   D +++ +SDV+SFGVLL E  +     G   Y      E
Sbjct: 252 NGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVEE 301

Query: 755 LNLLGHVWRLWKEGKVLEMVDSSVDNYPAN--EVLRCIHVGLLCVQENAEERPTMASVVL 812
                 +++L KEG  ++         P+N    L  +     C      +RPT   +V 
Sbjct: 302 ------LFKLLKEGHRMDK--------PSNCTNELYMMM--RDCWHAVPSQRPTFKQLVE 345

Query: 813 ML 814
            L
Sbjct: 346 DL 347

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  146 bits (370), Expect = 7e-39
 Identities = 68/301 (22%), Positives = 118/301 (39%), Gaps = 61/301 (20%)

Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRN 599
             LG G FG V +              +AVK L  +      E   +E+++++ L  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG---------- 649
           +V LLG C      +++ EY     L + +  K  S I +      +             
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 650 -----IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNT 703
                +A+G+ +L   +    IHRDL A NILL      KI DFG+AR I          
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 704 K-----RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNL 757
                 +      +M+PE   + +++ +SDV+S+G+ L E  S G         +++   
Sbjct: 206 NARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256

Query: 758 LGHVWRLWKEGKVLEMVDSSVDNYPANEVLRC---IH-VGLLCVQENAEERPTMASVVLM 813
               +++ KEG  +          P +        ++ +   C   +  +RPT   +V +
Sbjct: 257 ---FYKMIKEGFRMLS--------PEH----APAEMYDIMKTCWDADPLKRPTFKQIVQL 301

Query: 814 L 814
           +
Sbjct: 302 I 302

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  143 bits (362), Expect = 1e-37
 Identities = 78/355 (21%), Positives = 129/355 (36%), Gaps = 66/355 (18%)

Query: 497 RGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFG 556
           +        L + QV  SS  +Y     D  E          R  +N      LG G FG
Sbjct: 4   KKQFRYESQLQMVQVTGSSDNEYFY--VDFREYEYDLKWEFPR--ENLEFGKVLGSGAFG 59

Query: 557 IVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCV 608
            V               ++AVK L         E   +E++++ +L  H N+V LLG C 
Sbjct: 60  KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119

Query: 609 EMDEKMLVYEYMENRSL-----------DSVIFDKARSSILNWQRRFNIICG-------- 649
                 L++EY     L                +      L  +   N++          
Sbjct: 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179

Query: 650 -IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTK--- 704
            +A+G+ +L        +HRDL A N+L+      KI DFG+AR I              
Sbjct: 180 QVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL 236

Query: 705 --RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHV 761
             +      +M+PE   +G++++KSDV+S+G+LL E  S G         +         
Sbjct: 237 PVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN------F 284

Query: 762 WRLWKEGKVLEMVDSSVDNYPAN--EVLRCIHVGLLCVQENAEERPTMASVVLML 814
           ++L + G  ++         P    E +  I     C   ++ +RP+  ++   L
Sbjct: 285 YKLIQNGFKMDQ--------PFYATEEIYIIM--QSCWAFDSRKRPSFPNLTSFL 329

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  141 bits (358), Expect = 2e-37
 Identities = 61/256 (23%), Positives = 98/256 (38%), Gaps = 17/256 (6%)

Query: 496 PRGHPERSQDLLLNQVVISSKRDYS--ADKTDDLELPLFD-FETIVRATDNFTDYNKLGQ 552
             G    +++L    +     R  S   + ++ L+ P +D          +F   ++LG 
Sbjct: 8   SSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGH 67

Query: 553 GGFGIVYKGR-LLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCV 608
           G +G V+K R   +G+  AVK         +       EV    K+ QH   VRL     
Sbjct: 68  GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E     L  E     SL      +A  + L   + +  +      L +LH      ++H 
Sbjct: 128 EGGILYLQTELCG-PSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHL 181

Query: 669 DLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSD 728
           D+K +NI L      K+ DFG+    G   T    +   G   YM+PE      +   +D
Sbjct: 182 DVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPELLQGS-YGTAAD 237

Query: 729 VFSFGVLLLETVSGKK 744
           VFS G+ +LE     +
Sbjct: 238 VFSLGLTILEVACNME 253

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  139 bits (352), Expect = 1e-36
 Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 11/199 (5%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
           LG+G +GIVY GR L     IA+K +     +  +    E+ L   L+H+N+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHR 668
           E     +  E +   SL +++  K      N Q        I  GL YLH +   +I+HR
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146

Query: 669 DLKASNILLD-KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE---YAMDGLFS 724
           D+K  N+L++      KISDFG ++   G      T    GT  YM+PE       G + 
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRG-YG 203

Query: 725 VKSDVFSFGVLLLETVSGK 743
             +D++S G  ++E  +GK
Sbjct: 204 KAADIWSLGCTIIEMATGK 222

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  139 bits (352), Expect = 2e-36
 Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 19/216 (8%)

Query: 535 ETIVRATD---NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVR 590
             +V   D       Y K+G+G  GIV   R    G+++AVK +     Q  E   NEV 
Sbjct: 35  RMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVV 94

Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-G 649
           ++   QH N+V +    +  +E  ++ E+++  +L  ++        LN + +   +C  
Sbjct: 95  IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQVRLN-EEQIATVCEA 149

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VV 707
           + + L YLH      +IHRD+K+ +ILL  +   K+SDFG    F    ++   KR  +V
Sbjct: 150 VLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLV 202

Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           GT  +M+PE     L++ + D++S G++++E V G+
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  138 bits (349), Expect = 2e-36
 Identities = 59/207 (28%), Positives = 110/207 (53%), Gaps = 16/207 (7%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN 599
              +T + K+GQG  G VY    +  GQE+A+++++       E   NE+ ++ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLH 658
           +V  L   +  DE  +V EY+   SL  V+      + ++ + +   +C    + L +LH
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMD-EGQIAAVCRECLQALEFLH 133

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSPE 716
            +   ++IHRD+K+ NILL  + + K++DFG    F    T + +KR  +VGT  +M+PE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGK 743
                 +  K D++S G++ +E + G+
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  138 bits (350), Expect = 3e-36
 Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 25/220 (11%)

Query: 543 NFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           ++    KLG+GGF  V     L +G   A+KR+  +  Q  EE + E  +     H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 602 RLLGCCVEMDEKM----LVYEYMENRSLDSVIFD-KARSSILNWQRRFNIICGIARGLLY 656
           RL+  C+          L+  + +  +L + I   K + + L   +   ++ GI RGL  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD-------QTEQNTKRVVGT 709
           +H        HRDLK +NILL  E  P + D G                T Q+      T
Sbjct: 150 IHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 710 YGYMSPE------YAMDGLFSVKSDVFSFGVLLLETVSGK 743
             Y +PE      + +      ++DV+S G +L   + G+
Sbjct: 207 ISYRAPELFSVQSHCVID---ERTDVWSLGCVLYAMMFGE 243

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  138 bits (349), Expect = 5e-36
 Identities = 59/274 (21%), Positives = 102/274 (37%), Gaps = 48/274 (17%)

Query: 482 RRKTLLGRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRAT 541
             KT      +        E ++ +LL + +     +Y  +                   
Sbjct: 16  LAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREE------------------V 57

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFK-NEVRLIAKLQHRN 599
              T   ++G+G FG V++ +  + G + AVK++       +E F+  E+   A L    
Sbjct: 58  HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPR 111

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF--NIICGIAR----G 653
           +V L G   E     +  E +E  SL           ++        +           G
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSL---------GQLIKQMGCLPEDRALYYLGQALEG 162

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQ---TEQNTKRVVGT 709
           L YLH     RI+H D+KA N+LL  + +   + DFG A     D    +      + GT
Sbjct: 163 LEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219

Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
             +M+PE  M      K D++S   ++L  ++G 
Sbjct: 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  136 bits (346), Expect = 7e-36
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 11/199 (5%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLS---RNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           KLG GG   VY     +   ++A+K +    R   + ++ F+ EV   ++L H+N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 605 GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFR 664
               E D   LV EY+E  +L   I        L+     N    I  G+ + H     R
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS 724
           I+HRD+K  NIL+D   T KI DFG+A+    + +   T  V+GT  Y SPE A      
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 725 VKSDVFSFGVLLLETVSGK 743
             +D++S G++L E + G+
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  134 bits (339), Expect = 6e-35
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 22/222 (9%)

Query: 534 FETIVRATD---NFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEV 589
           +E + R  D    +    +LG G FG VYK +  E G   A K +   S + +E++  E+
Sbjct: 8   YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI 67

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC- 648
            ++A   H  +V+LLG      +  ++ E+    ++D+++        L  + +  ++C 
Sbjct: 68  EILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLT-EPQIQVVCR 124

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--V 706
            +   L +LH     RIIHRDLKA N+L+  E   +++DFG++        +   KR   
Sbjct: 125 QMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSF 177

Query: 707 VGTYGYMSPE-----YAMDGLFSVKSDVFSFGVLLLETVSGK 743
           +GT  +M+PE        D  +  K+D++S G+ L+E    +
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  133 bits (336), Expect = 1e-34
 Identities = 64/299 (21%), Positives = 109/299 (36%), Gaps = 64/299 (21%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKR--LSRNSGQGIEEFKNEVRLIAKL 595
           R T  F +  K+G G FG V+K    L+G   A+KR           +    EV   A L
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 596 -QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF------NIIC 648
            QH ++VR      E D  ++  EY    SL   I +  R         F      +++ 
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRI-----MSYFKEAELKDLLL 122

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKE-------------------MTPKISDFG 689
            + RGL Y+H      ++H D+K SNI + +                    +  KI D G
Sbjct: 123 QVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179

Query: 690 MARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGF 748
                   Q E       G   +++ E   +      K+D+F+  + ++     +     
Sbjct: 180 HVTRISSPQVE------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE----- 228

Query: 749 YHSNNELNLLGHVWRLWKEGKVLEMVDS-SVDNYPANEVLRCIHVGLLCVQENAEERPT 806
                 L   G  W   ++G++  +    S +     E+L+      + +  + E RP+
Sbjct: 229 -----PLPRNGDQWHEIRQGRLPRIPQVLSQE---FTELLK------VMIHPDPERRPS 273

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  133 bits (337), Expect = 3e-34
 Identities = 65/251 (25%), Positives = 110/251 (43%), Gaps = 33/251 (13%)

Query: 501 ERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYK 560
           ++ ++L L++        +   K    EL   DFE I          ++LG G  G+V+K
Sbjct: 2   KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKI----------SELGAGNGGVVFK 51

Query: 561 GRLLE-GQEIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE 618
                 G  +A K +          +   E++++ +     +V   G      E  +  E
Sbjct: 52  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111

Query: 619 YMENRSLDSVIFDKARSSILNWQRRFN--IICGIAR----GLLYLHQDSRFRIIHRDLKA 672
           +M+  SLD          +L    R    I+  ++     GL YL    + +I+HRD+K 
Sbjct: 112 HMDGGSLDQ---------VLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKP 160

Query: 673 SNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSF 732
           SNIL++     K+ DFG++       +  N+   VGT  YMSPE      +SV+SD++S 
Sbjct: 161 SNILVNSRGEIKLCDFGVSGQL--IDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSM 216

Query: 733 GVLLLETVSGK 743
           G+ L+E   G+
Sbjct: 217 GLSLVEMAVGR 227

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  132 bits (334), Expect = 3e-34
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 16/207 (7%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN 599
            + F    KLG+G +G VYK    E GQ +A+K++       ++E   E+ ++ +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYLH 658
           +V+  G   +  +  +V EY    S+  +I  + R+  L  +     I     +GL YLH
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLT-EDEIATILQSTLKGLEYLH 142

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSPE 716
                R IHRD+KA NILL+ E   K++DFG      G  T+   KR  V+GT  +M+PE
Sbjct: 143 FM---RKIHRDIKAGNILLNTEGHAKLADFG----VAGQLTDTMAKRNTVIGTPFWMAPE 195

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGK 743
              +  ++  +D++S G+  +E   GK
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGK 222

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  130 bits (330), Expect = 9e-34
 Identities = 57/208 (27%), Positives = 106/208 (50%), Gaps = 17/208 (8%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHR 598
            + FT   K+G+G FG V+KG      + +A+K +     +  IE+ + E+ ++++    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLLYL 657
            + +  G  ++  +  ++ EY+   S   ++        L+ + +   I   I +GL YL
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLD-ETQIATILREILKGLDYL 135

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSP 715
           H +   + IHRD+KA+N+LL +    K++DFG+A    G  T+   KR   VGT  +M+P
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTFVGTPFWMAP 188

Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E      +  K+D++S G+  +E   G+
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGE 216

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  130 bits (329), Expect = 2e-33
 Identities = 59/269 (21%), Positives = 94/269 (34%), Gaps = 72/269 (26%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQ 596
           R   +F     +G+GGFG+V++ +  ++    A+KR+   N     E+   EV+ +AKL+
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 597 HRNLVRLLGC------------------------CVEMDEKMLVYEYMENRSLDSVIFDK 632
           H  +VR                                    +    ++ R +D      
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 633 ARSSILNWQRRF---------------------------------NIICGIARGLLYLHQ 659
               +     +                                  +I   IA  + +LH 
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK----------RVVGT 709
                ++HRDLK SNI    +   K+ DFG+      D+ EQ               VGT
Sbjct: 183 K---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239

Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLE 738
             YMSPE      +S K D+FS G++L E
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  130 bits (328), Expect = 2e-33
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVK----RLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
            LG GG   V+  R L + +++AVK     L+R+       F+ E +  A L H  +V +
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP-SFYLRFRREAQNAAALNHPAIVAV 77

Query: 604 L--GCCVEMDEKM--LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
              G        +  +V EY++  +L  ++  +     +  +R   +I    + L + H 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH- 133

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMAR-IFGGDQTEQNTKRVVGTYGYMSPEYA 718
             +  IIHRD+K +NI++      K+ DFG+AR I     +   T  V+GT  Y+SPE A
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191

Query: 719 MDGLFSVKSDVFSFGVLLLETVSGK 743
                  +SDV+S G +L E ++G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  130 bits (328), Expect = 2e-33
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 17/202 (8%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQG---IEEFKNEVRLIAKLQHRNLVRL- 603
            +G+GG G VY+    +  + +A+K +S             + E R   +LQ  ++V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 604 -LGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
             G   E+D ++ +    +    L +++  +     L   R   I+  I   L   H   
Sbjct: 101 DFG---EIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA- 153

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
                HRD+K  NIL+  +    + DFG+A     D+        VGT  YM+PE   + 
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGTLYYMAPERFSES 210

Query: 722 LFSVKSDVFSFGVLLLETVSGK 743
             + ++D+++   +L E ++G 
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  130 bits (328), Expect = 2e-33
 Identities = 50/218 (22%), Positives = 95/218 (43%), Gaps = 22/218 (10%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRN 599
             +   + LGQG    V++GR  + G   A+K  +  S  + ++    E  ++ KL H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 600 LVRLLGCCVEMDEKM--LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
           +V+L     E   +   L+ E+    SL +V+ + + +  L       ++  +  G+ +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 658 HQDSRFRIIHRDLKASNILL----DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
            ++    I+HR++K  NI+     D +   K++DFG AR    D+       + GT  Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYL 182

Query: 714 SPE--------YAMDGLFSVKSDVFSFGVLLLETVSGK 743
            P+              +    D++S GV      +G 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  136 bits (343), Expect = 3e-33
 Identities = 46/204 (22%), Positives = 80/204 (39%), Gaps = 26/204 (12%)

Query: 549 KLGQGGFGIVYKGR--LLEGQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLL 604
            +  GG G +Y      + G+ + +K L  +SG  +       E + +A++ H ++V++ 
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 605 GCCVEMDEKM-----LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
                 D        +V EY+  +SL      K     L        +  I   L YLH 
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH- 199

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
                +++ DLK  NI+L +E   K+ D G                + GT G+ +PE   
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVR 250

Query: 720 DGLFSVKSDVFSFGVLLLETVSGK 743
            G  +V +D+++ G  L       
Sbjct: 251 TGP-TVATDIYTVGRTLAALTLDL 273

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  131 bits (331), Expect = 7e-33
 Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 23/212 (10%)

Query: 543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLV 601
           +F   + LG G  G +    + + +++AVKR+     +       EV+L+ +  +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81

Query: 602 RLLGCCVEMDEKM--LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           R    C E D +   +  E     +L   +  + +           ++     GL +LH 
Sbjct: 82  RYF--CTEKDRQFQYIAIELCAA-TLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS 136

Query: 660 DSRFRIIHRDLKASNILL-----DKEMTPKISDFGMARIFGGDQTE-QNTKRVVGTYGYM 713
                I+HRDLK  NIL+       ++   ISDFG+ +     +        V GT G++
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 714 SPEY---AMDGLFSVKSDVFSFGVLLLETVSG 742
           +PE          +   D+FS G +    +S 
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  129 bits (327), Expect = 1e-32
 Identities = 49/219 (22%), Positives = 92/219 (42%), Gaps = 24/219 (10%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRN 599
             +   + LGQG    V++GR  + G   A+K  +  S  + ++    E  ++ KL H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 600 LVRLLGCCVEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           +V+L     E           E+    SL +V+ + + +  L       ++  +  G+ +
Sbjct: 69  IVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 657 LHQDSRFRIIHRDLKASNILL----DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
           L ++    I+HR++K  NI+     D +   K++DFG AR    D+       + GT  Y
Sbjct: 128 LREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEY 181

Query: 713 MSPE--------YAMDGLFSVKSDVFSFGVLLLETVSGK 743
           + P+              +    D++S GV      +G 
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  126 bits (319), Expect = 5e-32
 Identities = 55/237 (23%), Positives = 97/237 (40%), Gaps = 25/237 (10%)

Query: 520 SADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS 578
           S + +  L++            ++  D  ++G+G +G V K      GQ +AVKR+    
Sbjct: 2   SIESSGKLKISPEQHWDF--TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV 59

Query: 579 G-QGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSS 636
             +  ++   ++ ++ +      +V+  G      +  +  E M + S D       +  
Sbjct: 60  DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY----KYV 114

Query: 637 ILNWQRRF--NIICGIAR----GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM 690
                      I+  I       L +L      +IIHRD+K SNILLD+    K+ DFG+
Sbjct: 115 YSVLDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGI 172

Query: 691 ARIFGGDQTEQNTKRVVGTYGYMSPE----YAMDGLFSVKSDVFSFGVLLLETVSGK 743
           +        +       G   YM+PE     A    + V+SDV+S G+ L E  +G+
Sbjct: 173 SGQLVDSIAKTRD---AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  132 bits (332), Expect = 6e-32
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 17/216 (7%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQ 596
           +    +    +LG GGFG V +      G+++A+K+  +       E +  E++++ KL 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70

Query: 597 HRNLVRLLGCCVEM------DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           H N+V        +      D  +L  EY E   L   +        L       ++  I
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFGGDQTEQNTKRVV 707
           +  L YLH+    RIIHRDLK  NI+L    + +  KI D G A+        +     V
Sbjct: 131 SSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFV 184

Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           GT  Y++PE      ++V  D +SFG L  E ++G 
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  125 bits (315), Expect = 7e-32
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 24/215 (11%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-QGIEEFKNEVR-LIAKLQHR 598
           D+     +LG+G +G+V K R +  GQ +AVKR+      Q  +    ++   +  +   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF--NIICGIAR---- 652
             V   G      +  +  E M + SLD          +++  +    +I+  IA     
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
            L +LH  S+  +IHRD+K SN+L++     K+ DFG++     D   ++     G   Y
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDI--DAGCKPY 175

Query: 713 MSPE----YAMDGLFSVKSDVFSFGVLLLETVSGK 743
           M+PE          +SVKSD++S G+ ++E    +
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  125 bits (316), Expect = 8e-32
 Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 16/214 (7%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQ-GIEEFKNEVRLIAKLQHRN 599
           D++     +G G   +V         +++A+KR++    Q  ++E   E++ +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN-----IIC-GIARG 653
           +V      V  DE  LV + +   S+  +I     +   +     +      I   +  G
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDII-KHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM-ARIFGGDQTEQNTKR--VVGTY 710
           L YLH++     IHRD+KA NILL ++ + +I+DFG+ A +  G    +N  R   VGT 
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190

Query: 711 GYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            +M+PE       +  K+D++SFG+  +E  +G 
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  126 bits (318), Expect = 1e-31
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 25/213 (11%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLS---RNSGQGIEEFKNEVRLIAKLQ 596
              F+D  ++G G FG VY  R +   + +A+K++S   + S +  ++   EVR + KL+
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC-GIARGLL 655
           H N ++  GC +      LV EY    + D +   +     L  +     +  G  +GL 
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQ-EVEIAAVTHGALQGLA 168

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYM 713
           YLH      +IHRD+KA NILL +    K+ DFG A                 VGT  +M
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWM 217

Query: 714 SPE---YAMDGLFSVKSDVFSFGVLLLETVSGK 743
           +PE      +G +  K DV+S G+  +E    K
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  125 bits (317), Expect = 2e-31
 Identities = 66/260 (25%), Positives = 108/260 (41%), Gaps = 21/260 (8%)

Query: 488 GRQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDY 547
            +  R          S   L  ++ + SKR  +           FD   +         +
Sbjct: 29  DQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSF 88

Query: 548 ------NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
                   LG G FG V+K      G ++A K +     +  EE KNE+ ++ +L H NL
Sbjct: 89  YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL 148

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK--ARSSILNWQRRFNIICGIARGLLYLH 658
           ++L       ++ +LV EY++   L    FD+    S  L        +  I  G+ ++H
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMH 204

Query: 659 QDSRFRIIHRDLKASNILL-DKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           Q     I+H DLK  NIL  +++    KI DFG+AR +      +  K   GT  +++PE
Sbjct: 205 QM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR---EKLKVNFGTPEFLAPE 258

Query: 717 YAMDGLFSVKSDVFSFGVLL 736
                  S  +D++S GV+ 
Sbjct: 259 VVNYDFVSFPTDMWSVGVIA 278

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  124 bits (314), Expect = 2e-31
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 18/201 (8%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG---IEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+GGF   ++    +  +  A K + ++        E+   E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 606 CCVEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
                ++   V+   E    RSL  +   K R ++   + R+  +  I  G  YLH++  
Sbjct: 109 F---FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARY-YLRQIVLGCQYLHRN-- 160

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL 722
            R+IHRDLK  N+ L++++  KI DFG+A     D   +    + GT  Y++PE      
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 217

Query: 723 FSVKSDVFSFGVLLLETVSGK 743
            S + DV+S G ++   + GK
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGK 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  123 bits (310), Expect = 4e-31
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 21/217 (9%)

Query: 537 IVRATDNFTDYNK---LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG---IEEFKNEV 589
           ++    +   Y +   LG+GGF   ++    +  +  A K + ++        E+   E+
Sbjct: 7   VLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEI 66

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFNI 646
            +   L H+++V   G     ++   V+   E    RSL  +   K R ++   + R+  
Sbjct: 67  SIHRSLAHQHVVGFHGF---FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARY-Y 120

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
           +  I  G  YLH++   R+IHRDLK  N+ L++++  KI DFG+A     D   +    +
Sbjct: 121 LRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--L 175

Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            GT  Y++PE       S + DV+S G ++   + GK
Sbjct: 176 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  121 bits (307), Expect = 7e-31
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 29/207 (14%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEE-FKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  VY+   +  G E+A+K + + +    G+ +  +NEV++  +L+H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 606 CCVEMDEKMLVY---EYMENRSLDSVIFDKARSSILNWQRRFN------IICGIARGLLY 656
                ++   VY   E   N  +        ++      + F+       +  I  G+LY
Sbjct: 79  Y---FEDSNYVYLVLEMCHNGEM----NRYLKNR----VKPFSENEARHFMHQIITGMLY 127

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           LH      I+HRDL  SN+LL + M  KI+DFG+A        +  T  + GT  Y+SPE
Sbjct: 128 LH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPE 182

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGK 743
            A      ++SDV+S G +    + G+
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGR 209

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  126 bits (318), Expect = 9e-31
 Identities = 64/234 (27%), Positives = 106/234 (45%), Gaps = 34/234 (14%)

Query: 537 IVRATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEV 589
           I     + ++      KLG G +G V   R      E A+K + +   S     +   EV
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN---- 645
            ++  L H N+++L     +     LV E  +   L    FD+    I++ + +FN    
Sbjct: 88  AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDE----IIH-RMKFNEVDA 138

Query: 646 --IICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTE 700
             II  +  G+ YLH+     I+HRDLK  N+LL   +K+   KI DFG++ +F   +  
Sbjct: 139 AVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK- 194

Query: 701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
              K  +GT  Y++PE  +   +  K DV+S GV+L   ++G     F    ++
Sbjct: 195 --MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY--PPFGGQTDQ 243

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  120 bits (304), Expect = 3e-30
 Identities = 55/242 (22%), Positives = 102/242 (42%), Gaps = 35/242 (14%)

Query: 518 DYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSR 576
             S  +T  L +    ++      ++  +  ++G G  G V+K R  + G  IAVK++ R
Sbjct: 4   GSSGKQTGYLTIGGQRYQA---EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60

Query: 577 NSGQGIEEFKNEVR----LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK 632
           +  +  EE K  +     ++       +V+  G  +   +  +  E M     + +    
Sbjct: 61  SGNK--EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLK--- 114

Query: 633 ARSSILNWQRRF--NIICGIAR----GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS 686
                   Q      I+  +       L YL    +  +IHRD+K SNILLD+    K+ 
Sbjct: 115 -----KRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLC 167

Query: 687 DFGMARIFGGDQTEQNTKRVVGTYGYMSPE-----YAMDGLFSVKSDVFSFGVLLLETVS 741
           DFG++     D+ +  +    G   YM+PE           + +++DV+S G+ L+E  +
Sbjct: 168 DFGISGRLVDDKAKDRS---AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT 224

Query: 742 GK 743
           G+
Sbjct: 225 GQ 226

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  121 bits (305), Expect = 3e-30
 Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 24/227 (10%)

Query: 532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVR 590
            D   +      F     +G G +G VYKGR ++ GQ  A+K +   +G   EE K E+ 
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEIN 72

Query: 591 LIAKL-QHRNLVRLLGC-----CVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRR 643
           ++ K   HRN+    G         MD+++ LV E+    S+  +I +   +++      
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
           + I   I RGL +LHQ    ++IHRD+K  N+LL +    K+ DFG++            
Sbjct: 133 Y-ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVG 184

Query: 704 KR--VVGTYGYMSPE-----YAMDGLFSVKSDVFSFGVLLLETVSGK 743
           +R   +GT  +M+PE        D  +  KSD++S G+  +E   G 
Sbjct: 185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (305), Expect = 4e-30
 Identities = 54/226 (23%), Positives = 89/226 (39%), Gaps = 41/226 (18%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGC 606
            L +GGF  VY+ + +  G+E A+KRL  N  +       EV  + KL  H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 607 CVEMDEK--------MLVYEYMENRSLDSVIFDKARSSILNWQRRF------NIICGIAR 652
                E+        +L+ E  + + ++     K  S     +          I     R
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVE--FLKKMES-----RGPLSCDTVLKIFYQTCR 147

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF----------GGDQTEQN 702
            + ++H+  +  IIHRDLK  N+LL  + T K+ DFG A                   + 
Sbjct: 148 AVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 703 TKRVVGTYGYMSPEYAMDGLFS-----VKSDVFSFGVLLLETVSGK 743
                 T  Y +PE  +  L+S      K D+++ G +L      +
Sbjct: 207 EITRNTTPMYRTPE--IIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  122 bits (307), Expect = 5e-30
 Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 19/224 (8%)

Query: 522 DKTDDLELPLFDFETIVRATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSR 576
           DK  +     +  + +     +  DY     +LG G FG+V++      G+    K ++ 
Sbjct: 27  DKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 86

Query: 577 NSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK--AR 634
                    KNE+ ++ +L H  L+ L     +  E +L+ E++    L    FD+  A 
Sbjct: 87  PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL----FDRIAAE 142

Query: 635 SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL-DKEMTP-KISDFGMAR 692
              ++     N +     GL ++H+     I+H D+K  NI+   K+ +  KI DFG+A 
Sbjct: 143 DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLAT 199

Query: 693 IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
               D   +  K    T  + +PE          +D+++ GVL 
Sbjct: 200 KLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  122 bits (307), Expect = 7e-30
 Identities = 45/326 (13%), Positives = 84/326 (25%), Gaps = 72/326 (22%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLS---RNSGQGIEEFKNEVRLIAKLQH-------- 597
           LGQ       +      G+   V       R     I++ K EV  +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 598 --------RNLVRLLGCCVEMDEK-----------MLVYEYMENRSLD--SVIFDKARSS 636
                    +LV+       +  +             +Y  M++       V+   + + 
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 637 -ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
             L    R  +   + R L  LH    + ++H  L+  +I+LD+     ++ F      G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 696 GDQTEQNTKRVVGTYGYMSPE-----YAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYH 750
                    R        +            L +   D ++ G+ +              
Sbjct: 263 ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD--LPNTD 319

Query: 751 SNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASV 810
                                E +  S  N P   V   +  G L  +   E+R      
Sbjct: 320 DA--------------ALGGSEWIFRSCKNIPQ-PVRALLE-GFL--RYPKEDRLLPLQA 361

Query: 811 VL---------MLSSETATMPQPKTP 827
           +           LS+          P
Sbjct: 362 METPEYEQLRTELSAALPLYQTDGEP 387

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  123 bits (310), Expect = 8e-30
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 33/217 (15%)

Query: 537 IVRATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNE 588
           +  +T  F+D       LG+G FG V   +    GQE AVK +S+         E    E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN--- 645
           V+L+ +L H N+++L     +     LV E      L    FD+    I++ ++RF+   
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDE----IIS-RKRFSEVD 127

Query: 646 ---IICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQT 699
              II  +  G+ Y+H+    +I+HRDLK  N+LL    K+   +I DFG++  F   + 
Sbjct: 128 AARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184

Query: 700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
               K  +GT  Y++PE  + G +  K DV+S GV+L
Sbjct: 185 ---MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  121 bits (304), Expect = 8e-30
 Identities = 25/230 (10%), Positives = 54/230 (23%), Gaps = 45/230 (19%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRL---SRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           L  G   +V+  R +E  ++ A+K     + NS   +E         A+L   +      
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 606 CCVEM--------------------------DEKMLVYEYMENRSLDSVI----FDKARS 635
               +                             +L+        L+ +     F     
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188

Query: 636 SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
                     +   + R    L       ++H      N+ +  +    + D       G
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

Query: 696 GDQTEQNTKRVVGTYGYMSPEYAMDG--LFSVKSDVFSFGVLLLETVSGK 743
                           Y   E+       F+   + +  G+ +       
Sbjct: 246 -----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  119 bits (301), Expect = 9e-30
 Identities = 63/244 (25%), Positives = 112/244 (45%), Gaps = 44/244 (18%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN--------EVR 590
              + +    K+G+G +G+VYK +  +G+ +A+KR+       ++            E+ 
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREIS 71

Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDS--VIFDKARSSILNWQRRFN 645
           L+ +L H N+V L+          LV+E+ME    + LD        ++  I  +Q    
Sbjct: 72  LLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ---- 127

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
               + RG+ + HQ    RI+HRDLK  N+L++ +   K++DFG+AR F G      T  
Sbjct: 128 ----LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHE 179

Query: 706 VVGTYGYMSPEYAMDGLFSVKS-----DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGH 760
           VV T  Y +P+     L   K      D++S G +  E ++GK     +    + + L  
Sbjct: 180 VV-TLWYRAPDV----LMGSKKYSTSVDIWSIGCIFAEMITGKP---LFPGVTDDDQLPK 231

Query: 761 VWRL 764
           ++ +
Sbjct: 232 IFSI 235

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  121 bits (304), Expect = 1e-29
 Identities = 46/221 (20%), Positives = 81/221 (36%), Gaps = 28/221 (12%)

Query: 541 TDNFTDYNKLGQG--GFGIVYKGRLLE-GQEIAVKR--LSRNSGQGIEEFKNEVRLIAKL 595
              +     +G+G      V   R    G+ + V+R  L   S + +   + E+ +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN-----IIC-G 649
            H N+V      +  +E  +V  +M   S   +I         ++    N      I  G
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI-------CTHFMDGMNELAIAYILQG 136

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT-----K 704
           + + L Y+H       +HR +KAS+IL+  +    +S              Q       K
Sbjct: 137 VLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193

Query: 705 RVVGTYGYMSPEYAMDGL--FSVKSDVFSFGVLLLETVSGK 743
             V    ++SPE     L  +  KSD++S G+   E  +G 
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  122 bits (308), Expect = 2e-29
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 32/212 (15%)

Query: 541 TDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIA 593
              F +       LG+G FG V K +     QE AVK +++     +       EV L+ 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN------II 647
           KL H N+++L     +     +V E      L    FD+    I+  ++RF+      II
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDE----IIK-RKRFSEHDAARII 127

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTK 704
             +  G+ Y+H+     I+HRDLK  NILL   +K+   KI DFG++  F  +      K
Sbjct: 128 KQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MK 181

Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
             +GT  Y++PE  + G +  K DV+S GV+L
Sbjct: 182 DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  117 bits (296), Expect = 3e-29
 Identities = 58/242 (23%), Positives = 107/242 (44%), Gaps = 44/242 (18%)

Query: 542 DNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN--------EVRLI 592
             +    K+G+G +G V+K +     + +A+KR+       +++           E+ L+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55

Query: 593 AKLQHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDS--VIFDKARSSILNWQRRFNII 647
            +L+H+N+VRL        +  LV+E+ +    +  DS     D        +Q      
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ------ 109

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             + +GL + H      ++HRDLK  N+L+++    K+++FG+AR F G      +  VV
Sbjct: 110 --LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163

Query: 708 GTYGYMSPEYAMDGLFSVKS-----DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVW 762
            T  Y  P+     LF  K      D++S G +  E  +    R  +  N+  + L  ++
Sbjct: 164 -TLWYRPPDV----LFGAKLYSTSIDMWSAGCIFAELAN--AGRPLFPGNDVDDQLKRIF 216

Query: 763 RL 764
           RL
Sbjct: 217 RL 218

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  120 bits (303), Expect = 3e-29
 Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 38/218 (17%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGC 606
             LG G  G V      +G+ +AVKR+  +     +    E++L+ +   H N++R    
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYY-- 75

Query: 607 CVEMDEKM--LVYEYMENRSLDSVIFDKARSS----ILNWQRRFNIICGIARGLLYLHQD 660
           C E  ++   +  E     +L  ++  K  S     +       +++  IA G+ +LH  
Sbjct: 76  CSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134

Query: 661 SRFRIIHRDLKASNILLDKEMTP-------------KISDFGMARIFGGDQT--EQNTKR 705
              +IIHRDLK  NIL+                    ISDFG+ +     Q+    N   
Sbjct: 135 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191

Query: 706 VVGTYGYMSPEYAMDGLFSV-------KSDVFSFGVLL 736
             GT G+ +PE   +              D+FS G + 
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  122 bits (308), Expect = 4e-29
 Identities = 54/257 (21%), Positives = 107/257 (41%), Gaps = 21/257 (8%)

Query: 491 IRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLE--LPLFDFETIVRATDNFTDY- 547
           +          R  D+     ++  K   S++  + +      +  + +    D+  D+ 
Sbjct: 100 VLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHY 159

Query: 548 ---NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRL 603
               +LG G FG+V++      G   A K +        E  + E++ ++ L+H  LV L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDK--ARSSILNWQRRFNIICGIARGLLYLHQDS 661
                + +E +++YE+M    L    F+K     + ++       +  + +GL ++H+++
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275

Query: 662 RFRIIHRDLKASNILL--DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
               +H DLK  NI+    +    K+ DFG+          Q+ K   GT  + +PE A 
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVAE 329

Query: 720 DGLFSVKSDVFSFGVLL 736
                  +D++S GVL 
Sbjct: 330 GKPVGYYTDMWSVGVLS 346

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  116 bits (292), Expect = 7e-29
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 30/212 (14%)

Query: 539 RATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIA 593
               +   Y    N +G+G +G V            A K++ +   + ++ FK E+ ++ 
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61

Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN------II 647
            L H N++RL     +  +  LV E      L    F++    +++ +R F       I+
Sbjct: 62  SLDHPNIIRLYETFEDNTDIYLVMELCTGGEL----FER----VVH-KRVFRESDAARIM 112

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTK 704
             +   + Y H+     + HRDLK  N L      +   K+ DFG+A  F   +     +
Sbjct: 113 KDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MR 166

Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
             VGT  Y+SP+  ++GL+  + D +S GV++
Sbjct: 167 TKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  117 bits (295), Expect = 9e-29
 Identities = 64/245 (26%), Positives = 107/245 (43%), Gaps = 42/245 (17%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN--------EV 589
                +   + LG+G F  VYK R     Q +A+K++         E K+        E+
Sbjct: 7   SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREI 63

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDS--VIFDKARSSILNWQRRF 644
           +L+ +L H N++ LL          LV+++ME      +    ++   +           
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM--- 120

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
                  +GL YLHQ     I+HRDLK +N+LLD+    K++DFG+A+ F G      T 
Sbjct: 121 -----TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTH 171

Query: 705 RVVGTYGYMSPEYAMDGLF-----SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLG 759
           +VV T  Y +PE     LF      V  D+++ G +L E +       F   +++L+ L 
Sbjct: 172 QVV-TRWYRAPEL----LFGARMYGVGVDMWAVGCILAELLLRVP---FLPGDSDLDQLT 223

Query: 760 HVWRL 764
            ++  
Sbjct: 224 RIFET 228

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  115 bits (291), Expect = 1e-28
 Identities = 60/241 (24%), Positives = 112/241 (46%), Gaps = 44/241 (18%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN--------EVRLIA 593
           + +    K+G+G +G+VYK +   G+  A+K++       +E+           E+ ++ 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55

Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDS--VIFDKARSSILNWQRRFNIIC 648
           +L+H N+V+L          +LV+E+++    + LD      +   +     Q       
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ------- 108

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            +  G+ Y H     R++HRDLK  N+L+++E   KI+DFG+AR F G    + T  +V 
Sbjct: 109 -LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV- 162

Query: 709 TYGYMSPEYAMDGLFSVKS-----DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
           T  Y +P+     L   K      D++S G +  E V+G      +   +E + L  ++R
Sbjct: 163 TLWYRAPDV----LMGSKKYSTTIDIWSVGCIFAEMVNGTP---LFPGVSEADQLMRIFR 215

Query: 764 L 764
           +
Sbjct: 216 I 216

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  115 bits (291), Expect = 1e-28
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 32/212 (15%)

Query: 541 TDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIA 593
              F +       LG+G FG V K +     QE AVK +++     +       EV L+ 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN------II 647
           KL H N+++L     +     +V E      L    FD+    I+  ++RF+      II
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDE----IIK-RKRFSEHDAARII 127

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTK 704
             +  G+ Y+H+ +   I+HRDLK  NILL   +K+   KI DFG++  F  +      K
Sbjct: 128 KQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MK 181

Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
             +GT  Y++PE  + G +  K DV+S GV+L
Sbjct: 182 DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  117 bits (294), Expect = 1e-28
 Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 33/217 (15%)

Query: 541 TDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVK-----RLSRNSGQGIEEFKNEVR 590
              F D       +G+G F +V +    E GQ+ AVK     + + + G   E+ K E  
Sbjct: 19  DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78

Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK--ARSSILNWQRRF---- 644
           +   L+H ++V LL          +V+E+M+   L      +   R+        +    
Sbjct: 79  ICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGF---VYSEAV 131

Query: 645 --NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQT 699
             + +  I   L Y H +    IIHRD+K   +LL   +     K+  FG+A   G    
Sbjct: 132 ASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 188

Query: 700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
                  VGT  +M+PE      +    DV+  GV+L
Sbjct: 189 VAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  116 bits (293), Expect = 2e-28
 Identities = 61/245 (24%), Positives = 108/245 (44%), Gaps = 45/245 (18%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVK--RLSRNSGQGIEEFKN----EVRL 591
           ++ + + +   +G+G +G+V K R  + G+ +A+K    S +     +  K     E++L
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKL 77

Query: 592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDS--VIFDKARSSILNWQRRFNI 646
           + +L+H NLV LL  C +     LV+E++++     L+      D        +Q     
Sbjct: 78  LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ----- 132

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRV 706
              I  G+ + H      IIHRD+K  NIL+ +    K+ DFG AR       E     V
Sbjct: 133 ---IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEV 185

Query: 707 VGTYGYMSPE-------YAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLG 759
             T  Y +PE       Y      +V  DV++ G L+ E   G+     +  +++++ L 
Sbjct: 186 A-TRWYRAPELLVGDVKYGK----AV--DVWAIGCLVTEMFMGEP---LFPGDSDIDQLY 235

Query: 760 HVWRL 764
           H+   
Sbjct: 236 HIMMC 240

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  116 bits (293), Expect = 2e-28
 Identities = 37/272 (13%), Positives = 78/272 (28%), Gaps = 28/272 (10%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR------LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAK 594
           +     ++ LG+G F  VY+            Q+  +K     +          +  +  
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI--FDKARSSILNWQRRFNIICGIAR 652
                 ++     +  +  +LV E     +L + I  +      ++      +    +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTP-----------KISDFGMARIFGGDQTEQ 701
            +  +H      IIH D+K  N +L                  + D G +          
Sbjct: 184 MIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
                  T G+   E   +  ++ + D F     +   + G   +   +   E    G  
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK-VKNEGGECKPEGLF 299

Query: 762 WRLWKEGKVLEMVDS-----SVDNYPANEVLR 788
            RL       E            + P+ ++LR
Sbjct: 300 RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  119 bits (300), Expect = 2e-28
 Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 43/227 (18%)

Query: 537 IVRATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-------------S 578
           + +      +      KLG G +G V   +      E A+K + ++              
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 579 GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSIL 638
            +  EE  NE+ L+  L H N+++L     +     LV E+ E   L    F++    I+
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQ----II 138

Query: 639 NWQRRFN------IICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFG 689
           N + +F+      I+  I  G+ YLH+     I+HRD+K  NILL   +  +  KI DFG
Sbjct: 139 N-RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFG 194

Query: 690 MARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
           ++  F  D      +  +GT  Y++PE  +   ++ K DV+S GV++
Sbjct: 195 LSSFFSKDYK---LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  114 bits (288), Expect = 2e-28
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 17/206 (8%)

Query: 541 TDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLS-RNSGQGIEEFKNEVRLIAK 594
                D      KLG G FG V+       G E  +K ++   S   +E+ + E+ ++  
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKS 76

Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSL-DSVIFDKARSSILNWQRRFNIICGIARG 653
           L H N++++     +     +V E  E   L + ++  +AR   L+      ++  +   
Sbjct: 77  LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136

Query: 654 LLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           L Y H      ++H+DLK  NIL          KI DFG+A +F  D+    +    GT 
Sbjct: 137 LAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTA 190

Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLL 736
            YM+PE       + K D++S GV++
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVVM 215

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  115 bits (290), Expect = 2e-28
 Identities = 54/188 (28%), Positives = 92/188 (48%), Gaps = 19/188 (10%)

Query: 538 VRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN-----EVRL 591
           + ++  F    KLG G +  VYKG     G  +A+K +  +S +G           E+ L
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISL 56

Query: 592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDSVIFDKARSSILNWQRRFNIIC 648
           + +L+H N+VRL       ++  LV+E+M+N   + +DS         +     +     
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK-YFQW 115

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            + +GL + H++   +I+HRDLK  N+L++K    K+ DFG+AR F G      +  VV 
Sbjct: 116 QLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV- 170

Query: 709 TYGYMSPE 716
           T  Y +P+
Sbjct: 171 TLWYRAPD 178

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  113 bits (286), Expect = 4e-28
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 32/215 (14%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQH 597
           ++F     LG+G FG VY  R  +    +A+K L +          + + EV + + L+H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 598 RNLVRLLGCCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFN------IICG 649
            N++RL G     D     L+ EY    ++    + + +        +F+       I  
Sbjct: 69  PNILRLYG--YFHDATRVYLILEYAPLGTV----YRELQK-----LSKFDEQRTATYITE 117

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV-G 708
           +A  L Y H     R+IHRD+K  N+LL      KI+DFG +          + +  + G
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-----HAPSSRRTDLCG 169

Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           T  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  116 bits (291), Expect = 5e-28
 Identities = 44/307 (14%), Positives = 84/307 (27%), Gaps = 74/307 (24%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLS---RNSGQGIEEFKNEVRLIAKLQ--------- 596
           LGQ       +    E G+   V       R     I++ K EV  +  L+         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 597 ----------------HRNLVRLLGCCVEMDEKMLVYEYM----ENRSLDSVIFDKARSS 636
                            + ++R+     +M      + Y       ++   V+   + + 
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 637 -ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG 695
             L    R  +   + R L  LH    + ++H  L+  +I+LD+     ++ F      G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 696 GDQTEQNTKRVVGTYGYMSPEY-----------AMDGLFSVKSDVFSFGVLLLETVSGKK 744
                        + G+  PE                L +   D ++ G+++        
Sbjct: 258 ARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD- 310

Query: 745 NRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEER 804
                                      E +  S  N P   V   +  G L      E+R
Sbjct: 311 -LPITKDA--------------ALGGSEWIFRSCKNIPQ-PVRALLE-GFLRY--PKEDR 351

Query: 805 PTMASVV 811
                 +
Sbjct: 352 LLPLQAM 358

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  114 bits (288), Expect = 5e-28
 Identities = 43/203 (21%), Positives = 86/203 (42%), Gaps = 20/203 (9%)

Query: 543 NFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH 597
              +       LG+G FGIV++       +    K +    G      K E+ ++   +H
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK--ARSSILNWQRRFNIICGIARGLL 655
           RN++ L      M+E ++++E++    +    F++    +  LN +   + +  +   L 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 656 YLHQDSRFRIIHRDLKASNILL-DKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
           +LH  +   I H D++  NI+   +  +  KI +FG AR           + +     Y 
Sbjct: 117 FLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYY 170

Query: 714 SPEYAMDGLFSVKSDVFSFGVLL 736
           +PE     + S  +D++S G L+
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLV 193

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  114 bits (288), Expect = 7e-28
 Identities = 57/239 (23%), Positives = 97/239 (40%), Gaps = 43/239 (17%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRN-----------------SGQGIEEFKNEVRL 591
            L QG F  +      + +  A+K+  ++                      ++FKNE+++
Sbjct: 38  TLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 592 IAKLQHRNLVRLLGCCVEMDEKM--LVYEYMENRSLDSVI-----FDKARSSILNWQRRF 644
           I  +++   +   G  +  +     ++YEYMEN S+          DK  +  +  Q   
Sbjct: 97  ITDIKNEYCLTCEG--IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
            II  +     Y+H  +   I HRD+K SNIL+DK    K+SDFG +        ++  K
Sbjct: 155 CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM----VDKKIK 208

Query: 705 RVVGTYGYMSPE-----YAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
              GTY +M PE      + +G    K D++S G+ L           F    + + L 
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYNVVP--FSLKISLVELF 262

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  114 bits (287), Expect = 7e-28
 Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 28/186 (15%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-----EVRLIAKL 595
           + +   +KLG+G +  VYKG+       +A+K +     +G           EV L+  L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDL 57

Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDS--VIFDKARSSILNWQRRFNIICGI 650
           +H N+V L           LV+EY++    + LD    I +     +  +Q        +
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ--------L 109

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
            RGL Y H+    +++HRDLK  N+L+++    K++DFG+AR      T+     VV T 
Sbjct: 110 LRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TL 164

Query: 711 GYMSPE 716
            Y  P+
Sbjct: 165 WYRPPD 170

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  115 bits (291), Expect = 7e-28
 Identities = 61/232 (26%), Positives = 106/232 (45%), Gaps = 44/232 (18%)

Query: 533 DFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN-EVRL 591
           D +T  +    +T+   +G G FG+V++ +L+E  E+A+K++ ++     + FKN E+++
Sbjct: 31  DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQI 85

Query: 592 IAKLQHRNLVRLLGCCVEMDEKM------LVYEYME---NRSLDSVIFDKARSSILN--- 639
           +  ++H N+V L        +K       LV EY+     R+       K    +L    
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL 145

Query: 640 --WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGG 696
             +Q        + R L Y+H      I HRD+K  N+LLD      K+ DFG A+I   
Sbjct: 146 YMYQ--------LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-- 192

Query: 697 DQTEQNTKRVVGTYGYMSPEYAMDGLF-----SVKSDVFSFGVLLLETVSGK 743
              E N   +   Y Y +PE     +F     +   D++S G ++ E + G+
Sbjct: 193 IAGEPNVSYICSRY-YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  113 bits (285), Expect = 1e-27
 Identities = 52/187 (27%), Positives = 83/187 (44%), Gaps = 29/187 (15%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVK--RLSRNSGQGIEEFKN----EVRLIAK 594
           + +    K+G+G +G+V+K R  + GQ +A+K    S +        K     E+R++ +
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD----PVIKKIALREIRMLKQ 58

Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDS--VIFDKARSSILNWQRRFNIICG 649
           L+H NLV LL          LV+EY ++     LD       +     + WQ        
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ-------- 110

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
             + + + H+      IHRD+K  NIL+ K    K+ DFG AR+     ++     V  T
Sbjct: 111 TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-T 165

Query: 710 YGYMSPE 716
             Y SPE
Sbjct: 166 RWYRSPE 172

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  112 bits (282), Expect = 2e-27
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 33/213 (15%)

Query: 541 TDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIA 593
           +  F+D      +LG+G F +V +      G E A K ++    S +  ++ + E R+  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF-------NI 646
           KLQH N+VRL     E     LV++ +    L    F+     I+   R F       + 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FED----IV--AREFYSEADASHC 110

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNT 703
           I  I   + Y H +    I+HR+LK  N+LL    K    K++DFG+A      +     
Sbjct: 111 IQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---W 164

Query: 704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
               GT GY+SPE      +S   D+++ GV+L
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  113 bits (286), Expect = 2e-27
 Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 35/220 (15%)

Query: 535 ETIVRATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKN 587
           E ++ A+  F+D      +LG+G F +V +      G E A K ++    S +  ++ + 
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77

Query: 588 EVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK--ARSSILNWQRRF- 644
           E R+  KLQH N+VRL     E     LV++ +    L    F+   AR         + 
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREF-------YS 126

Query: 645 -----NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGG 696
                + I  I   + Y H +    I+HR+LK  N+LL    K    K++DFG+A     
Sbjct: 127 EADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183

Query: 697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
            +         GT GY+SPE      +S   D+++ GV+L
Sbjct: 184 SEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  113 bits (284), Expect = 2e-27
 Identities = 61/249 (24%), Positives = 102/249 (40%), Gaps = 49/249 (19%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN--------EV 589
            + D +    KLG+G +G VYK    +  + +A+KR+       +E  +         EV
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREV 84

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN---RSLDS-VIFDKARSSILNWQRRFN 645
            L+ +LQHRN++ L           L++EY EN   + +D              +Q    
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQ---- 140

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP-----KISDFGMARIFGGDQTE 700
               +  G+ + H     R +HRDLK  N+LL           KI DFG+AR F G    
Sbjct: 141 ----LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIR 192

Query: 701 QNTKRVVGTYGYMSPEYAMDGLFSVKS-----DVFSFGVLLLETVSGKKNRGFYHSNNEL 755
           Q T  ++ T  Y  PE     L   +      D++S   +  E +        +  ++E+
Sbjct: 193 QFTHEII-TLWYRPPEI----LLGSRHYSTSVDIWSIACIWAEMLMKTP---LFPGDSEI 244

Query: 756 NLLGHVWRL 764
           + L  ++ +
Sbjct: 245 DQLFKIFEV 253

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  113 bits (284), Expect = 2e-27
 Identities = 55/251 (21%), Positives = 85/251 (33%), Gaps = 56/251 (22%)

Query: 539 RATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVK-----RLSRNSGQGIEEFKNE 588
            +             +GQG +G+V      +     A+K     ++ + + + +E  K E
Sbjct: 19  GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTE 78

Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF---- 644
           VRL+ KL H N+ RL     +     LV E      L   +      S            
Sbjct: 79  VRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138

Query: 645 ---------------------------------NIICGIARGLLYLHQDSRFRIIHRDLK 671
                                            NI+  I   L YLH      I HRD+K
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIK 195

Query: 672 ASNILL--DKEMTPKISDFGMARIFGGDQTEQNT--KRVVGTYGYMSPE--YAMDGLFSV 725
             N L   +K    K+ DFG+++ F      +        GT  +++PE     +  +  
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255

Query: 726 KSDVFSFGVLL 736
           K D +S GVLL
Sbjct: 256 KCDAWSAGVLL 266

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  111 bits (281), Expect = 3e-27
 Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 37/246 (15%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLS-RNSGQGIEEFKN----EVRLI 592
            AT  +    ++G G +G VYK R    G  +A+K +   N G G          EV L+
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 593 AKLQ---HRNLVRLLGCCVEMDEK-----MLVYEYMEN------RSLDSVIFDKARSSIL 638
            +L+   H N+VRL+  C            LV+E+++                      L
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125

Query: 639 NWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
             Q          RGL +LH +    I+HRDLK  NIL+    T K++DFG+ARI+    
Sbjct: 126 MRQ--------FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174

Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
               T  VV T  Y +PE  +   ++   D++S G +  E    K     +  N+E + L
Sbjct: 175 A--LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP---LFCGNSEADQL 228

Query: 759 GHVWRL 764
           G ++ L
Sbjct: 229 GKIFDL 234

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  112 bits (283), Expect = 4e-27
 Identities = 62/258 (24%), Positives = 109/258 (42%), Gaps = 59/258 (22%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKN--------EV 589
                +    K+GQG FG V+K R  +  +  A+K++       +E  K         E+
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREI 67

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKM--------LVYEYMEN---RSLDS--VIFDKARSS 636
           +++  L+H N+V L+  C               LV+++ E+     L +  V F  +   
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 127

Query: 637 ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG 696
            +           +  GL Y+H++   +I+HRD+KA+N+L+ ++   K++DFG+AR F  
Sbjct: 128 RVMQM--------LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSL 176

Query: 697 DQTEQN---TKRVVGTYGYMSPE-------YAMDGLFSVKSDVFSFGVLLLETVSGKKNR 746
            +  Q    T RVV T  Y  PE       Y          D++  G ++ E  +     
Sbjct: 177 AKNSQPNRYTNRVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS--- 226

Query: 747 GFYHSNNELNLLGHVWRL 764
                N E + L  + +L
Sbjct: 227 PIMQGNTEQHQLALISQL 244

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  111 bits (280), Expect = 5e-27
 Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 32/213 (15%)

Query: 539 RATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIA 593
             T N          LG G F  V+  +    G+  A+K + ++        +NE+ ++ 
Sbjct: 2   MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK 61

Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF-------NI 646
           K++H N+V L           LV + +    L    FD+    IL  +R          +
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGEL----FDR----IL--ERGVYTEKDASLV 111

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNT 703
           I  +   + YLH++    I+HRDLK  N+L    ++     I+DFG++++          
Sbjct: 112 IQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIM 164

Query: 704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
               GT GY++PE      +S   D +S GV+ 
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  112 bits (281), Expect = 9e-27
 Identities = 56/274 (20%), Positives = 106/274 (38%), Gaps = 41/274 (14%)

Query: 489 RQIRKTEPRGHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDY- 547
           R+      R  P +S +LL     ++  +    +      +   D      A   F    
Sbjct: 37  RRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKY 96

Query: 548 ---NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG--------IEEFKNEVRLIAKL 595
              + +G+G   +V +      G E AVK +   + +          E  + E  ++ ++
Sbjct: 97  DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156

Query: 596 -QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF------NIIC 648
             H +++ L+          LV++ M    L    FD     +   +         +I+ 
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDY----LTE-KVALSEKETRSIMR 207

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            +   + +LH +    I+HRDLK  NILLD  M  ++SDFG +      +     + + G
Sbjct: 208 SLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCG 261

Query: 709 TYGYMSPE------YAMDGLFSVKSDVFSFGVLL 736
           T GY++PE            +  + D+++ GV+L
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  110 bits (278), Expect = 1e-26
 Identities = 61/250 (24%), Positives = 110/250 (44%), Gaps = 47/250 (18%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRNSGQGIEEFKN--------E 588
           RA   +    ++G+G +G V+K R L+  G+ +A+KR+       ++  +         E
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIRE 61

Query: 589 VRLIAKLQ---HRNLVRLLGCCVEMDEK-----MLVYEYMEN------RSLDSVIFDKAR 634
           V ++  L+   H N+VRL   C            LV+E+++         +         
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 121

Query: 635 SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
              + +Q        + RGL +LH     R++HRDLK  NIL+      K++DFG+ARI+
Sbjct: 122 IKDMMFQ--------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170

Query: 695 GGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
                   T  VV T  Y +PE  +   ++   D++S G +  E    K     +  +++
Sbjct: 171 SFQMAL--TSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSD 224

Query: 755 LNLLGHVWRL 764
           ++ LG +  +
Sbjct: 225 VDQLGKILDV 234

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  112 bits (283), Expect = 1e-26
 Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 37/221 (16%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRLIAKLQHR 598
             ++TD   +G G FG+VY+ +L + G+ +A+K++ ++     + FKN E++++ KL H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107

Query: 599 NLVRLLGCCVEMDEKM------LVYEYMENRSLDSVI--FDKARSSILNWQRRFNIICGI 650
           N+VRL        EK       LV +Y+   ++  V   + +A+ ++     +   +  +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKL-YMYQL 165

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGT 709
            R L Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSR 220

Query: 710 YGYMSPE-------YAMDGLFSVKSDVFSFGVLLLETVSGK 743
           Y Y +PE       Y      +   DV+S G +L E + G+
Sbjct: 221 Y-YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  110 bits (276), Expect = 2e-26
 Identities = 61/222 (27%), Positives = 92/222 (41%), Gaps = 38/222 (17%)

Query: 541 TDNFTDY-----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAK 594
           +  F D      + LG+G    V     L   QE AVK + +  G        EV ++ +
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66

Query: 595 LQ-HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN------II 647
            Q HRN++ L+    E D   LV+E M   S+           I   +R FN      ++
Sbjct: 67  CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----LSH----IHK-RRHFNELEASVVV 117

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIF--GGDQTEQN 702
             +A  L +LH      I HRDLK  NIL    ++    KI DF +       GD +  +
Sbjct: 118 QDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174

Query: 703 TKR---VVGTYGYMSPE-----YAMDGLFSVKSDVFSFGVLL 736
           T       G+  YM+PE          ++  + D++S GV+L
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  110 bits (276), Expect = 2e-26
 Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 27/217 (12%)

Query: 536 TIVRATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRL------SRNSGQGIEE 584
           T+ R  +N  DY     +LG G F +V K R    G + A K +      S   G   E+
Sbjct: 2   TVFR-QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 60

Query: 585 FKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK-ARSSILNWQRR 643
            + EV ++ ++QH N++ L        + +L+ E +    L    FD  A    L  +  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEA 116

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQT 699
              +  I  G+ YLH      I H DLK  NI+L     P    KI DFG+A        
Sbjct: 117 TEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173

Query: 700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
               K + GT  +++PE        +++D++S GV+ 
Sbjct: 174 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  110 bits (278), Expect = 2e-26
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 28/213 (13%)

Query: 541 TDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVK------RLSRNSGQGIEEFKNEV 589
                D+     +LG G F IV K R    G E A K        +   G   EE + EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK--ARSSILNWQRRFNII 647
            ++ ++ H N++ L        + +L+ E +    L    FD    + S L+ +   + I
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKES-LSEEEATSFI 121

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQTEQNT 703
             I  G+ YLH      I H DLK  NI+L  +  P    K+ DFG+A            
Sbjct: 122 KQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---F 175

Query: 704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
           K + GT  +++PE        +++D++S GV+ 
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  108 bits (273), Expect = 3e-26
 Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 42/225 (18%)

Query: 539 RATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGI---------EE 584
            +T  F +       LG+G   +V +       +E AVK +    G            E 
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 585 FKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRR 643
              EV ++ K+  H N+++L           LV++ M+   L    FD     +   +  
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDY----LTE-KVT 120

Query: 644 F------NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
                   I+  +   +  LH+     I+HRDLK  NILLD +M  K++DFG +      
Sbjct: 121 LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177

Query: 698 QTEQNTKRVVGTYGYMSPE------YAMDGLFSVKSDVFSFGVLL 736
           +     + V GT  Y++PE            +  + D++S GV++
Sbjct: 178 EK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  109 bits (274), Expect = 3e-26
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 26/212 (12%)

Query: 541 TDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVK------RLSRNSGQGIEEFKNEV 589
                D+     +LG G F IV K R    G E A K        +   G   EE + EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK-ARSSILNWQRRFNIIC 648
            ++ ++ H N++ L        + +L+ E +    L    FD  A+   L+ +   + I 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIK 122

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQTEQNTK 704
            I  G+ YLH      I H DLK  NI+L  +  P    K+ DFG+A            K
Sbjct: 123 QILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FK 176

Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
            + GT  +++PE        +++D++S GV+ 
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  109 bits (275), Expect = 5e-26
 Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 45/235 (19%)

Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN----E 588
            E   +  D F      GQG FG V  G+    G  +A+K++ ++       F+N     
Sbjct: 15  DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQI 69

Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEK-------MLVYEYMENRSLDSVIFDKARSSILNWQ 641
           ++ +A L H N+V+L      + E+        +V EY+ + +L        R+      
Sbjct: 70  MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC----RNYYRRQV 124

Query: 642 RRFNIICG-----IARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFG 695
               I+       + R +  LH  S   + HRD+K  N+L+++   T K+ DFG A+   
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL- 182

Query: 696 GDQTEQNTKRVVGTYGYMSPE-------YAMDGLFSVKSDVFSFGVLLLETVSGK 743
              +E N   +   Y Y +PE       Y      +   D++S G +  E + G+
Sbjct: 183 -SPSEPNVAYICSRY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  107 bits (270), Expect = 5e-26
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 30/206 (14%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G FG VY  R  +    +A+K L ++         + + E+ + + L+H N++R+  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 606 CCVEMDEKM--LVYEYMENRSLDSVIFDKARSSILNWQRRFN------IICGIARGLLYL 657
                D K   L+ E+     L    + + +        RF+       +  +A  L Y 
Sbjct: 82  --YFHDRKRIYLMLEFAPRGEL----YKELQK-----HGRFDEQRSATFMEELADALHYC 130

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     ++IHRD+K  N+L+  +   KI+DFG +         + T  + GT  Y+ PE 
Sbjct: 131 H---ERKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRT--MCGTLDYLPPEM 183

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGK 743
                   K D++  GVL  E + G 
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGM 209

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  110 bits (278), Expect = 6e-26
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 32/213 (15%)

Query: 541 TDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIA 593
              FT+      +LG+G F +V +   +  GQE A   ++    S +  ++ + E R+  
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65

Query: 594 KLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF-------NI 646
            L+H N+VRL     E     L+++ +    L    F+     I+   R +       + 
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FED----IV--AREYYSEADASHC 115

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNT 703
           I  I   +L+ HQ     ++HR+LK  N+LL    K    K++DFG+A    G+Q  Q  
Sbjct: 116 IQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAW 170

Query: 704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
               GT GY+SPE      +    D+++ GV+L
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  109 bits (275), Expect = 9e-26
 Identities = 49/184 (26%), Positives = 91/184 (49%), Gaps = 22/184 (11%)

Query: 549 KLGQGGFGIVYKGRLLE---GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           K+G+G +G VYK +  +    ++ A+K++   +G  +   + E+ L+ +L+H N++ L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85

Query: 606 CCVEMDEK--MLVYEYMENRSLDSVIFDKARSSILNWQRRFN------IICGIARGLLYL 657
             +   ++   L+++Y E+  L  +I     S       +        ++  I  G+ YL
Sbjct: 86  VFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGG-DQTEQNTKRVVGTYGY 712
           H +    ++HRDLK +NIL+  E       KI+D G AR+F    +   +   VV T+ Y
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201

Query: 713 MSPE 716
            +PE
Sbjct: 202 RAPE 205

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  106 bits (267), Expect = 1e-25
 Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 38/216 (17%)

Query: 543 NFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVK------RLSRNSGQGIEEFKNEVRL 591
              D+     +LG G F IV K R    G+E A K        S   G   EE + EV +
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF------- 644
           + +++H N++ L        + +L+ E +    L    FD     +   ++         
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDF----LA--EKESLTEDEAT 111

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQTE 700
             +  I  G+ YLH     RI H DLK  NI+L  +  P    K+ DFG+A         
Sbjct: 112 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE- 167

Query: 701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
              K + GT  +++PE        +++D++S GV+ 
Sbjct: 168 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  105 bits (265), Expect = 3e-25
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 28/210 (13%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSR----NSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
           LG+G +G V +          AVK L +        G    K E++L+ +L+H+N+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 605 G-CCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILN-WQ-RRF--NIICGIARGLLYLH 658
                E  +KM +V EY      +  + D          Q   +   +I G+     YLH
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
                 I+H+D+K  N+LL    T KIS  G+A        +   +   G+  +  PE A
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183

Query: 719 M-----DGLFSVKSDVFSFGVLLLETVSGK 743
                  G    K D++S GV L    +G 
Sbjct: 184 NGLDTFSGF---KVDIWSAGVTLYNITTGL 210

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  106 bits (266), Expect = 6e-25
 Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 34/219 (15%)

Query: 534 FETIVRATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNE 588
            + + R +  FTD       +G G + +  +        E AVK + ++      +   E
Sbjct: 10  VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEE 65

Query: 589 VRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN-- 645
           + ++ +  QH N++ L     +     +V E M+   L     DK    IL  Q+ F+  
Sbjct: 66  IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDK----ILR-QKFFSER 116

Query: 646 ----IICGIARGLLYLHQDSRFRIIHRDLKASNILL-DKEMTP---KISDFGMARIFGGD 697
               ++  I + + YLH      ++HRDLK SNIL  D+   P   +I DFG A+    +
Sbjct: 117 EASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173

Query: 698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
                T     T  +++PE      +    D++S GVLL
Sbjct: 174 NGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  105 bits (263), Expect = 1e-24
 Identities = 59/253 (23%), Positives = 106/253 (41%), Gaps = 31/253 (12%)

Query: 498 GHPERSQDLLLNQVVISSKRDYSADKTDDLELPLFDFETIVRATDNFTDY----NKLGQG 553
            H     DL    +   S    +A         + D+       D  +D+    ++LG+G
Sbjct: 5   HHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRG 64

Query: 554 GFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE 612
              IVY+ +     +  A+K L +      +  + E+ ++ +L H N+++L        E
Sbjct: 65  ATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE 122

Query: 613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRF------NIICGIARGLLYLHQDSRFRII 666
             LV E +    L    FD+    I+  +  +      + +  I   + YLH++    I+
Sbjct: 123 ISLVLELVTGGEL----FDR----IVE-KGYYSERDAADAVKQILEAVAYLHEN---GIV 170

Query: 667 HRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
           HRDLK  N+L      +   KI+DFG+++I          K V GT GY +PE      +
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAY 227

Query: 724 SVKSDVFSFGVLL 736
             + D++S G++ 
Sbjct: 228 GPEVDMWSVGIIT 240

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  103 bits (259), Expect = 1e-24
 Identities = 57/196 (29%), Positives = 89/196 (45%), Gaps = 21/196 (10%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQHRNLVRLLGCC 607
           LG+G +G V      +  + +AVK +         E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN-IICGIARGLLYLHQDSRFRII 666
            E + + L  EY     L   I         + QR F+ ++ G+     YLH      I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---GIGIT 127

Query: 667 HRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE------YAMD 720
           HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE      +   
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF--H 185

Query: 721 GLFSVKSDVFSFGVLL 736
                  DV+S G++L
Sbjct: 186 AE---PVDVWSCGIVL 198

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  104 bits (262), Expect = 1e-24
 Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 37/221 (16%)

Query: 537 IVRATDNFTDY-----NKLGQGGFGIVYKGRLLE-GQEIAVK--RLSRNSGQGIEEFKNE 588
             ++ +NF ++      +LG+G F +V +      GQE A K  +  R       E  +E
Sbjct: 19  YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78

Query: 589 VRLIAKLQHR-NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF--- 644
           + ++   +    ++ L        E +L+ EY     +    F       L         
Sbjct: 79  IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSL----CL--PELAEMV 128

Query: 645 ------NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFG 695
                  +I  I  G+ YLHQ+    I+H DLK  NILL         KI DFGM+R  G
Sbjct: 129 SENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185

Query: 696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
                   + ++GT  Y++PE       +  +D+++ G++ 
Sbjct: 186 HACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  103 bits (260), Expect = 2e-24
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 27/205 (13%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGC 606
           +G+G F  V   R +L G+E+A+K + +   +   +++   EVR++  L H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 607 CVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFN-IICGIARGLLYLHQDSRFR 664
            +E ++ + L+ EY     +   +    R      + +F  I+  +     Y H   + R
Sbjct: 83  -IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH---QKR 134

Query: 665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE------YA 718
           I+HRDLKA N+LLD +M  KI+DFG +  F             G   Y +PE      Y 
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPELFQGKKY- 190

Query: 719 MDGLFSVKSDVFSFGVLLLETVSGK 743
            DG    + DV+S GV+L   VSG 
Sbjct: 191 -DGP---EVDVWSLGVILYTLVSGS 211

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  103 bits (259), Expect = 3e-24
 Identities = 51/214 (23%), Positives = 85/214 (39%), Gaps = 35/214 (16%)

Query: 541 TDNFTDY-------NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLI 592
              F  +         LG+G F I  K    +  Q  AVK +S+         + E+  +
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITAL 59

Query: 593 AKLQ-HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN------ 645
              + H N+V+L     +     LV E +    L    F++    I   ++ F+      
Sbjct: 60  KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL----FER----IKK-KKHFSETEASY 110

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQN 702
           I+  +   + ++H      ++HRDLK  N+L    +  +  KI DFG AR+   D     
Sbjct: 111 IMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167

Query: 703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
           T     T  Y +PE      +    D++S GV+L
Sbjct: 168 T--PCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  103 bits (258), Expect = 5e-24
 Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 37/204 (18%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQHRNLVRLLGCC 607
           LG+G +G V      +  + +AVK +         E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ-------RRF--NIICGIARGLLYLH 658
            E + + L  EY     L    FD+    I           +RF   ++ G+     YLH
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDR----IEPDIGMPEPDAQRFFHQLMAGVV----YLH 122

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE-- 716
                 I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE  
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 717 ----YAMDGLFSVKSDVFSFGVLL 736
               +          DV+S G++L
Sbjct: 180 KRREF--HAE---PVDVWSCGIVL 198

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  102 bits (257), Expect = 6e-24
 Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 37/217 (17%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEE--------FKNEVRL 591
            D +     LG G  G V      +  +++A+K +S+                 + E+ +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 592 IAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF------N 645
           + KL H  ++++     + ++  +V E ME   L    FDK    ++   +R        
Sbjct: 69  LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDK----VVG-NKRLKEATCKL 118

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQN 702
               +   + YLH++    IIHRDLK  N+LL   +++   KI+DFG ++I G       
Sbjct: 119 YFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--- 172

Query: 703 TKRVVGTYGYMSPE---YAMDGLFSVKSDVFSFGVLL 736
            + + GT  Y++PE         ++   D +S GV+L
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  105 bits (264), Expect = 9e-24
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 28/216 (12%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIAKLQH 597
           D F D+  LG+GGFG V+  ++    ++ A K+L++      +G +    E +++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 598 RNLVRLLGCCVEMDEKM-LVYEYM---------ENRSLDSVIFDKARSSILNWQRRFNII 647
           R +V L     E    + LV   M          N   D+  F + R+        F   
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA-------IFYTA 296

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             I  GL +LHQ     II+RDLK  N+LLD +   +ISD G+A      QT+  TK   
Sbjct: 297 Q-IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYA 350

Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           GT G+M+PE  +   +    D F+ GV L E ++ +
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  104 bits (260), Expect = 1e-23
 Identities = 48/222 (21%), Positives = 94/222 (42%), Gaps = 39/222 (17%)

Query: 539 RATDNFTDY----NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--------SGQGIEEF 585
                  D       LG G  G V      +  +++A++ +S+                 
Sbjct: 128 VYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNV 187

Query: 586 KNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME-----NRSLDSVIFDKARSSILNW 640
           + E+ ++ KL H  ++++     + ++  +V E ME     ++ + +    +A   +  +
Sbjct: 188 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246

Query: 641 QRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGD 697
           Q        +   + YLH++    IIHRDLK  N+LL   +++   KI+DFG ++I G  
Sbjct: 247 Q--------MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-- 293

Query: 698 QTEQNTKRVVGTYGYMSPE---YAMDGLFSVKSDVFSFGVLL 736
                 + + GT  Y++PE         ++   D +S GV+L
Sbjct: 294 -ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  101 bits (254), Expect = 1e-23
 Identities = 61/234 (26%), Positives = 100/234 (42%), Gaps = 57/234 (24%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSR--------------------------NSGQGI 582
           +G+G +G+V       +    A+K LS+                               I
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 583 EEFKNEVRLIAKLQHRNLVRLLGCCVEM------DEKMLVYEYMENRSLDSVIFDKARSS 636
           E+   E+ ++ KL H N+V+L    VE+      D   +V+E +    +     +     
Sbjct: 81  EQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK 132

Query: 637 ILNWQ--RRF--NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
            L+    R +  ++I GI     YLH     +IIHRD+K SN+L+ ++   KI+DFG++ 
Sbjct: 133 PLSEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185

Query: 693 IFGGDQTEQNTKRVVGTYGYMSPE--YAMDGLFS-VKSDVFSFGVLLLETVSGK 743
            F G     +    VGT  +M+PE       +FS    DV++ GV L   V G+
Sbjct: 186 EFKGSDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  104 bits (261), Expect = 2e-23
 Identities = 67/213 (31%), Positives = 96/213 (45%), Gaps = 25/213 (11%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIAKLQH 597
           + F  Y  LG+GGFG V   ++    ++ A K+L +      +G     NE +++ K+  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSL-------DSVIFDKARSSILNWQRRFNIICGI 650
           R +V L       D   LV   M    L           F +AR+        F     I
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA-------VFYAAE-I 295

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
             GL  LH   R RI++RDLK  NILLD     +ISD G+A      QT    K  VGT 
Sbjct: 296 CCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTV 349

Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           GYM+PE   +  ++   D ++ G LL E ++G+
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 98.9 bits (247), Expect = 2e-22
 Identities = 57/227 (25%), Positives = 86/227 (37%), Gaps = 26/227 (11%)

Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEE--FKN---- 587
              +      +T    +  G +G V  G   EG  +A+KR+      G       +    
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 588 -----EVRLIAKLQHRNLVRLLGCCV-----EMDEKMLVYEYMENRSLDSVIFDKARSSI 637
                E+RL+    H N++ L    V      M +  LV E M    L  VI    +  +
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIV 130

Query: 638 LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
           ++ Q     +  I  GL  LH+     ++HRDL   NILL       I DF +AR     
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR--EDT 185

Query: 698 QTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGK 743
                T  V     Y +PE  M    F+   D++S G ++ E  + K
Sbjct: 186 ADANKTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 97.3 bits (243), Expect = 3e-22
 Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 26/206 (12%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G F  V   R L      A+K L +        +     E  ++++L H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 606 CCVEMDEKML--VYEYMENRSLDSVIFDKARSSILNWQRRFNIICG------IARGLLYL 657
                D++ L     Y +N  L            +     F+  C       I   L YL
Sbjct: 98  TF--QDDEKLYFGLSYAKNGEL----L-----KYIRKIGSFDETCTRFYTAEIVSALEYL 146

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+SPE 
Sbjct: 147 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGK 743
             +      SD+++ G ++ + V+G 
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGL 229

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 97.9 bits (244), Expect = 3e-22
 Identities = 46/213 (21%), Positives = 84/213 (39%), Gaps = 38/213 (17%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRN--------SGQGIEEFKNEVRLIAKLQHRNL 600
           LG G FG V+      + +E+ VK + +             + +   E+ ++++++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK-ARSSILNWQ--RRF--NIICGIARGLL 655
           +++L      + +      ME       +F    R   L+          ++  +     
Sbjct: 92  IKVLDI---FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG---- 144

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
           YL       IIHRD+K  NI++ ++ T K+ DFG A      +         GT  Y +P
Sbjct: 145 YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAP 198

Query: 716 E------YAMDGLFSVKSDVFSFGVLLLETVSG 742
           E      Y   G    + +++S GV L   V  
Sbjct: 199 EVLMGNPY--RGP---ELEMWSLGVTLYTLVFE 226

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  101 bits (252), Expect = 4e-22
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 34/218 (15%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIAKL-- 595
           ++F+ +  +G+GGFG VY  R  +  ++ A+K L +      QG     NE  +++ +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 596 -QHRNLVRLLGCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIIC 648
                +V +        +K+  + + M    L        +F +A         RF    
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-------RFYAAE 300

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            I  GL ++H      +++RDLK +NILLD+    +ISD G+A  F   +        VG
Sbjct: 301 -IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVG 352

Query: 709 TYGYMSPEYAMDGL---FSVKSDVFSFGVLLLETVSGK 743
           T+GYM+PE    G+    S   D FS G +L + + G 
Sbjct: 353 THGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 97.4 bits (243), Expect = 5e-22
 Identities = 51/220 (23%), Positives = 98/220 (44%), Gaps = 38/220 (17%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN---------EVR 590
              +     +G G +G V        G+++A+K+LSR        F++         E+ 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-------PFQSEIFAKRAYRELL 75

Query: 591 LIAKLQHRNLVRLL------GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           L+  +QH N++ LL             +  LV  +M+   L  ++           + ++
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM----GLKFSEEKIQY 130

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
            ++  + +GL Y+H      ++HRDLK  N+ ++++   KI DFG+AR    + T     
Sbjct: 131 -LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY--- 183

Query: 705 RVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGK 743
             V T  Y +PE  +    ++   D++S G ++ E ++GK
Sbjct: 184 --VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 97.9 bits (244), Expect = 8e-22
 Identities = 46/219 (21%), Positives = 82/219 (37%), Gaps = 39/219 (17%)

Query: 538 VRATDNFTDYN----KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLI 592
           ++      DY      LG G  G V +       ++ A+K L         + + EV L 
Sbjct: 54  IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELH 108

Query: 593 AKLQ-HRNLVRLLGCCVEMDEKM----LVYEYMENRSLDSVIFDKARSSILN-WQRRF-- 644
            +     ++VR++     +        +V E ++   L    F +    I +   + F  
Sbjct: 109 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSR----IQDRGDQAFTE 160

Query: 645 ----NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGD 697
                I+  I   + YLH  +   I HRD+K  N+L          K++DFG A+     
Sbjct: 161 REASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217

Query: 698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
            +         T  Y++PE      +    D++S GV++
Sbjct: 218 NS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 97.5 bits (243), Expect = 8e-22
 Identities = 53/260 (20%), Positives = 103/260 (39%), Gaps = 72/260 (27%)

Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN-EVRL 591
            ET    +  ++    LG G FGIV +   +E G+  A+K++ ++       +KN E+ +
Sbjct: 2   LETS---SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDI 53

Query: 592 IAKLQHRNLVRLLGCCVEMDEKM------------------------------------- 614
           +  L H N+++L+       ++                                      
Sbjct: 54  MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113

Query: 615 -LVYEYMENRSLDSVI--FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK 671
            ++ EY+ + +L  V+  F ++  SI         I  + R + ++H      I HRD+K
Sbjct: 114 NVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIHS---LGICHRDIK 168

Query: 672 ASNILLDKEMTP-KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE-------YAMDGLF 723
             N+L++ +    K+ DFG A+      +E +   +   + Y +PE       Y      
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEY------ 219

Query: 724 SVKSDVFSFGVLLLETVSGK 743
           +   D++S G +  E + GK
Sbjct: 220 TPSIDLWSIGCVFGELILGK 239

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 96.3 bits (240), Expect = 1e-21
 Identities = 50/217 (23%), Positives = 84/217 (38%), Gaps = 41/217 (18%)

Query: 541 TDNFTD-YN----KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAK 594
               TD Y      LG G  G V +      GQ+ A+K L  +      + + EV    +
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQ 77

Query: 595 LQ-HRNLVRLLGCCVEMDEKM----LVYEYMENRSLDSVIFDKARSSILNWQRRF----- 644
                ++V +L     M        ++ E ME   L    F +    I     +      
Sbjct: 78  ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FSR----IQERGDQAFTERE 129

Query: 645 --NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQT 699
              I+  I   + +LH  +   I HRD+K  N+L    +K+   K++DFG A+      T
Sbjct: 130 AAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----T 182

Query: 700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
           +   +    T  Y++PE      +    D++S GV++
Sbjct: 183 QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 28/206 (13%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG G FG V  G   L G ++AVK L+R    S   + + K E++ +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 606 CCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFN-IICGIARGLLYLHQDSRF 663
             +       +V EY+    L   I    R   +  +R F  I+  +     Y H   R 
Sbjct: 79  V-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCH---RH 130

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE------Y 717
            ++HRDLK  N+LLD  M  KI+DFG++ +    +  + +    G+  Y +PE      Y
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVISGRLY 187

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGK 743
              G    + D++S GV+L   + G 
Sbjct: 188 --AGP---EVDIWSCGVILYALLCGT 208

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 57/216 (26%), Positives = 88/216 (40%), Gaps = 42/216 (19%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN------EVRLIAKLQHR--NL 600
           LG GGFG VY G  + +   +A+K + ++      E  N      EV L+ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK-----------ARSSILNWQRRFNIICG 649
           +RLL      D  +L+ E  E    D  +FD            ARS    WQ    ++  
Sbjct: 111 IRLLDWFERPDSFVLILERPEP-VQD--LFDFITERGALQEELARS--FFWQ----VLEA 161

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTEQNTKRVVG 708
           +     + H      ++HRD+K  NIL+D      K+ DFG   +      +       G
Sbjct: 162 VR----HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDG 210

Query: 709 TYGYMSPEYAMDGLFS-VKSDVFSFGVLLLETVSGK 743
           T  Y  PE+     +    + V+S G+LL + V G 
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 96.3 bits (240), Expect = 2e-21
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 39/221 (17%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
              + +   +G G  GIV      +  + +A+K+LSR        F+N         E+ 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-------PFQNQTHAKRAYRELV 76

Query: 591 LIAKLQHRNLVRLL------GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           L+  + H+N++ LL          E  +  +V E M+  +L  VI    +  + + +  +
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDHERMSY 131

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQN 702
            ++  +  G+ +LH      IIHRDLK SNI++  + T KI DFG+AR  G     T   
Sbjct: 132 -LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY- 186

Query: 703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
               V T  Y +PE  +   +    D++S G ++ E + G 
Sbjct: 187 ----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 96.8 bits (241), Expect = 3e-21
 Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 39/221 (17%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
              + +   +G G  GIV      +  + +A+K+LSR        F+N         E+ 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAKRAYRELV 113

Query: 591 LIAKLQHRNLVRLL------GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           L+  + H+N++ LL          E  +  LV E M+  +L  VI    +  + + +  +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI----QMELDHERMSY 168

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ--TEQN 702
            ++  +  G+ +LH  S   IIHRDLK SNI++  + T KI DFG+AR  G     T   
Sbjct: 169 -LLYQMLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY- 223

Query: 703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
               V T  Y +PE  +   +    D++S G ++ E V  K
Sbjct: 224 ----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 95.5 bits (238), Expect = 3e-21
 Identities = 56/227 (24%), Positives = 101/227 (44%), Gaps = 37/227 (16%)

Query: 534 FETIVRATDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN----- 587
            +T       + D   +G G +G V        G ++A+K+L R        F++     
Sbjct: 17  TKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-------PFQSELFAK 69

Query: 588 ----EVRLIAKLQHRNLVRLL------GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI 637
               E+RL+  ++H N++ LL          +  +  LV  +M    L  ++    +   
Sbjct: 70  RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM----KHEK 124

Query: 638 LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
           L   R   ++  + +GL Y+H      IIHRDLK  N+ ++++   KI DFG+AR    +
Sbjct: 125 LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181

Query: 698 QTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGK 743
            T       V T  Y +PE  ++   ++   D++S G ++ E ++GK
Sbjct: 182 MTGY-----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 94.3 bits (235), Expect = 7e-21
 Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 37/220 (16%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN---------EVR 590
            + + + + +G G +G V      + G  +AVK+LSR        F++         E+R
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80

Query: 591 LIAKLQHRNLVRLL------GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           L+  ++H N++ LL          E ++  LV   M    L++++    +   L      
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV----KCQKLTDDHVQ 135

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
            +I  I RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR    + T     
Sbjct: 136 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY--- 189

Query: 705 RVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGK 743
             V T  Y +PE  ++   ++   D++S G ++ E ++G+
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 92.5 bits (230), Expect = 8e-21
 Identities = 31/286 (10%), Positives = 76/286 (26%), Gaps = 53/286 (18%)

Query: 549 KLGQGGFGIVYKGR--LLEGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRL 603
             G       ++     L  +++A+  +          ++E  +    ++++    + R+
Sbjct: 38  FHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 604 LGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
           L         ++V E++   SL  V       +  +       +  +A      H   R 
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RA 148

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF 723
            +       S +         +S  G                V+     M          
Sbjct: 149 GVALSIDHPSRVR--------VSIDGDV--------------VLAYPATMPDA------- 179

Query: 724 SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPA 783
           + + D+   G  L   +  +       +     L         +      +D  +    +
Sbjct: 180 NPQDDIRGIGASLYALLVNR--WPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237

Query: 784 NEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGF 829
               R        VQ +   R     ++ ++   TA   + +  G 
Sbjct: 238 AVAAR-------SVQGDGGIRSAST-LLNLMQQATAVADRTEVLGP 275

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 95.3 bits (237), Expect = 1e-20
 Identities = 39/195 (20%), Positives = 84/195 (43%), Gaps = 29/195 (14%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
            D +   + +G G +G V +    LE + +A+K++ R        F++         E+ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104

Query: 591 LIAKLQHRNLVRLL-----GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           ++ +L H ++V++L         + DE  +V E  +      +   +    +     +  
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLF--RTPVYLTELHIKT- 160

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           ++  +  G+ Y+H  S   I+HRDLK +N L++++ + K+ DFG+AR     +   +   
Sbjct: 161 LLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217

Query: 706 VVGTYGYMSPEYAMD 720
           +      M+      
Sbjct: 218 ISPREDDMNLVTFPH 232

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 93.9 bits (234), Expect = 1e-20
 Identities = 56/225 (24%), Positives = 104/225 (46%), Gaps = 43/225 (19%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
              +T+ + +G+G +G+V      L    +A+K++S         F++         E++
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77

Query: 591 LIAKLQHRNLVRLL-----GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           ++ + +H N++ +          +M +  +V + ME   L  ++    ++  L+      
Sbjct: 78  ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICY 132

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN--T 703
            +  I RGL Y+H  S   ++HRDLK SN+LL+     KI DFG+AR+   D       T
Sbjct: 133 FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189

Query: 704 KRVVGTYGYMSPEYAMDGLFSVKS-----DVFSFGVLLLETVSGK 743
           + V  T  Y +PE     + + K      D++S G +L E +S +
Sbjct: 190 EYVA-TRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 44/217 (20%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN------EVRLIAKL----QHR 598
           LG+GGFG V+ G  L +  ++A+K + RN   G     +      EV L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK-----------ARSSILNWQRRFNII 647
            ++RLL      +  MLV E     + D  +FD            +R      Q    ++
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLP-AQD--LFDYITEKGPLGEGPSRC--FFGQ----VV 149

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFGGDQTEQNTKRV 706
             I     + H      ++HRD+K  NIL+D      K+ DFG   +      ++     
Sbjct: 150 AAIQ----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL----HDEPYTDF 198

Query: 707 VGTYGYMSPEYAMDGLFS-VKSDVFSFGVLLLETVSG 742
            GT  Y  PE+     +  + + V+S G+LL + V G
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 55/231 (23%), Positives = 103/231 (44%), Gaps = 46/231 (19%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
              + D   LG GG G+V+        + +A+K++            +         E++
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60

Query: 591 LIAKLQHRNLVRLL--------------GCCVEMDEKMLVYEYMENRSLDSVIFDKARSS 636
           +I +L H N+V++               G   E++   +V EYME   L +V+       
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL----EQG 115

Query: 637 ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFG 695
            L  +     +  + RGL Y+H  +   ++HRDLK +N+ ++ E +  KI DFG+ARI  
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 696 GDQTEQN--TKRVVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
              + +   ++ +V T  Y SP   +    ++   D+++ G +  E ++GK
Sbjct: 173 PHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 93.2 bits (232), Expect = 2e-20
 Identities = 61/206 (29%), Positives = 88/206 (42%), Gaps = 44/206 (21%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQHRNLVRLLGCC 607
           +G G FG+    R  L  + +AVK + R  G  I+E  + E+     L+H N+VR     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQ-------RRF--NIICGIARGLLYLH 658
           +      ++ EY     L    +++    I N         R F   ++ G++    Y H
Sbjct: 86  LTPTHLAIIMEYASGGEL----YER----ICNAGRFSEDEARFFFQQLLSGVS----YCH 133

Query: 659 QDSRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
                +I HRDLK  N LLD    P  KI DFG ++           K  VGT  Y++PE
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPE 187

Query: 717 ------YAMDGLFSVKSDVFSFGVLL 736
                 Y  DG     +DV+S GV L
Sbjct: 188 VLLRQEY--DGK---IADVWSCGVTL 208

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 94.1 bits (234), Expect = 3e-20
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 28/206 (13%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG G FG V  G+  L G ++AVK L+R    S   + + + E++ +   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 606 CCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFN-IICGIARGLLYLHQDSRF 663
             +     + +V EY+    L   I    R      +R F  I+ G+     Y H   R 
Sbjct: 84  V-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YCH---RH 135

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE------Y 717
            ++HRDLK  N+LLD  M  KI+DFG++ +    +  + +    G+  Y +PE      Y
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVISGRLY 192

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGK 743
              G    + D++S GV+L   + G 
Sbjct: 193 --AGP---EVDIWSSGVILYALLCGT 213

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 51/217 (23%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQHRNLVRLLG 605
           LG+G FG V         Q++A+K +SR            + E+  +  L+H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74

Query: 606 CCVEMDEKMLVYEYMENRS-----LDSV---IFDK-ARSSILNWQ--RRF--NIICGIAR 652
                      Y+ +   +     ++     +FD       +     RRF   IIC I  
Sbjct: 75  -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE- 122

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
              Y H   R +I+HRDLK  N+LLD  +  KI+DFG++ I       + +    G+  Y
Sbjct: 123 ---YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPNY 173

Query: 713 MSPE------YAMDGLFSVKSDVFSFGVLLLETVSGK 743
            +PE      Y   G    + DV+S G++L   + G+
Sbjct: 174 AAPEVINGKLY--AGP---EVDVWSCGIVLYVMLVGR 205

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 90.0 bits (224), Expect = 2e-19
 Identities = 46/192 (23%), Positives = 83/192 (43%), Gaps = 34/192 (17%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKN---------EVR 590
           + +F   + LG+G +G+V        G+ +A+K+        IE F           E++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61

Query: 591 LIAKLQHRNLVRLL-----GCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           ++   +H N++ +            +E  ++ E M+   L  VI     + +L+      
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI----STQMLSDDHIQY 116

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
            I    R +  LH  +   +IHRDLK SN+L++     K+ DFG+ARI   D++  +   
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSE 171

Query: 706 VVGTYGYMSPEY 717
             G    M  E+
Sbjct: 172 PTGQQSGMV-EF 182

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 52/232 (22%), Positives = 106/232 (45%), Gaps = 27/232 (11%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HR 598
            D++    KLG+G +  V++   +   +++ VK L     +   + K E++++  L+   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91

Query: 599 NLVRLLGCCVEMDEKM----LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           N++ L    +  D       LV+E++ N     +       ++ ++  RF  +  I + L
Sbjct: 92  NIITLA--DIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF-YMYEILKAL 143

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
            Y H  S   I+HRD+K  N+++D E    ++ D+G+A        ++   RV   Y + 
Sbjct: 144 DYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FK 197

Query: 714 SPEYAMDGLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            PE  +D      S D++S G +L   +  K    F+H ++  + L  + ++
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRK--EPFFHGHDNYDQLVRIAKV 247

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 90.6 bits (225), Expect = 3e-19
 Identities = 40/196 (20%), Positives = 82/196 (41%), Gaps = 29/196 (14%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
            DN+   + +G+G +G VY        + +A+K+++R        F++         E+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77

Query: 591 LIAKLQHRNLVRLLGCCV-----EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           ++ +L+   ++RL    +     + DE  +V E  +   L  +   K    +     +  
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLF--KTPIFLTEEHIKT- 133

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           I+  +  G  ++H      IIHRDLK +N LL+++ + K+ DFG+AR    ++       
Sbjct: 134 ILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190

Query: 706 VVGTYGYMSPEYAMDG 721
           +            +  
Sbjct: 191 LEENEEPGPHNKNLKK 206

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 88.8 bits (220), Expect = 5e-19
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 3/92 (3%)

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
           +A+G+ +L   +  + IHRDL A NILL ++   KI DFG+AR    D            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258

Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS 741
             +M+PE   D +++++SDV+SFGVLL E  S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 29/154 (18%), Positives = 56/154 (36%), Gaps = 19/154 (12%)

Query: 548 NKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNSGQG-IEEFKNEVRLIAKL-QHRN 599
             LG+G FG V +            + +AVK L   +         +E++++  +  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 600 LVRLLGCCVEMDEK-MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           +V LLG C +     M++ E+ +  +L + +            +R   +    +G  +  
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR 692
                  I  DLK     +    +   S F   +
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 88.2 bits (219), Expect = 1e-18
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 28/195 (14%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKN---------EVR 590
              +    KLG+G +GIV+K      G+ +AVK++          F+N         E+ 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-------AFQNSTDAQRTFREIM 60

Query: 591 LIAKLQ-HRNLVRLLGCCV--EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNII 647
           ++ +L  H N+V LL         +  LV++YME   L +VI    R++IL    +  ++
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVI----RANILEPVHKQYVV 115

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             + + + YLH  S   ++HRD+K SNILL+ E   K++DFG++R F   +   N   + 
Sbjct: 116 YQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 708 GTYGYMSPEYAMDGL 722
                 + +     L
Sbjct: 173 INENTENFDDDQPIL 187

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 87.8 bits (218), Expect = 1e-18
 Identities = 63/245 (25%), Positives = 109/245 (44%), Gaps = 50/245 (20%)

Query: 528 ELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLS------RNSGQ 580
           ++    FE I+RA         +G+G FG V   +  + +++ A+K ++      RN   
Sbjct: 11  DVNFDHFE-ILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE-- 58

Query: 581 GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM-LVYEYM---ENRSL--DSVIFDKAR 634
            +     E++++  L+H  LV L     + +E M +V + +   + R     +V F +  
Sbjct: 59  -VRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET 116

Query: 635 SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF 694
                   +   IC +   L YL      RIIHRD+K  NILLD+     I+DF +A + 
Sbjct: 117 V-------KL-FICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165

Query: 695 GGDQTEQNTKRVVGTYGYMSPE--YAMDGL---FSVKSDVFSFGVLLLETVSGKKNRGFY 749
             +        + GT  YM+PE   +  G    F+V  D +S GV   E + G+  R ++
Sbjct: 166 PRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGR--RPYH 218

Query: 750 HSNNE 754
             ++ 
Sbjct: 219 IRSST 223

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 80.9 bits (200), Expect = 3e-16
 Identities = 50/238 (21%), Positives = 92/238 (38%), Gaps = 41/238 (17%)

Query: 523 KTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---S 578
           +  ++ L   DFE +            +G+G F  V   ++ +  ++ A+K +++     
Sbjct: 52  RLKEVRLQRDDFEIL----------KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLK 101

Query: 579 GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM-LVYEYMENRSL------DSVIFD 631
              +  F+ E  ++     R + +L     + +  + LV EY     L            
Sbjct: 102 RGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP 160

Query: 632 KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
              +       RF  +  I   +  +H+      +HRD+K  NILLD+    +++DFG  
Sbjct: 161 AEMA-------RF-YLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSC 209

Query: 692 RIFGGDQTEQNTKRVVGTYGYMSPE-------YAMDGLFSVKSDVFSFGVLLLETVSG 742
                D T + +   VGT  Y+SPE           G +  + D ++ GV   E   G
Sbjct: 210 LKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 80.6 bits (199), Expect = 5e-16
 Identities = 50/217 (23%), Positives = 87/217 (40%), Gaps = 29/217 (13%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVRLIAKLQH 597
           ++F     +G+G FG V   +L    ++ A+K L++           F+ E  ++     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 598 RNLVRLLGCCVEMDEKM-LVYEYMENRSL------DSVIFDKARSSILNWQRRFNIICGI 650
           + +  L     + D  + LV +Y     L            +  +       RF  +  +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-------RF-YLAEM 184

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
              +  +HQ      +HRD+K  NIL+D     +++DFG       D T Q +   VGT 
Sbjct: 185 VIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTP 240

Query: 711 GYMSPE-----YAMDGLFSVKSDVFSFGVLLLETVSG 742
            Y+SPE         G +  + D +S GV + E + G
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 79.7 bits (197), Expect = 7e-16
 Identities = 61/246 (24%), Positives = 96/246 (39%), Gaps = 42/246 (17%)

Query: 513 ISSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEI-AV 571
             S+   + +K  DL +   D+E +            +G+G FG V   R    +++ A+
Sbjct: 50  FLSRYKDTINKIRDLRMKAEDYEVV----------KVIGRGAFGEVQLVRHKSTRKVYAM 99

Query: 572 KRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSV 628
           K LS+           F  E  ++A      +V+L     +     +V EYM    L   
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL--- 156

Query: 629 IFDKARSSILNWQRRFNIICGIAR--------GLLYLHQDSRFRIIHRDLKASNILLDKE 680
                    +N    +++    AR         L  +H       IHRD+K  N+LLDK 
Sbjct: 157 ---------VNLMSNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKS 204

Query: 681 MTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE----YAMDGLFSVKSDVFSFGVLL 736
              K++DFG       +   +     VGT  Y+SPE       DG +  + D +S GV L
Sbjct: 205 GHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263

Query: 737 LETVSG 742
            E + G
Sbjct: 264 YEMLVG 269

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 38/174 (21%), Positives = 65/174 (37%), Gaps = 36/174 (20%)

Query: 538 VRATDNFTDYN----KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLI 592
           ++      DY      LG G  G V +       ++ A+K L         + + EV L 
Sbjct: 10  IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELH 64

Query: 593 AKL-QHRNLVRLLGCCVEMDEKM----LVYEYMENRSLDSVIFDKARSSILNWQRRF--- 644
            +  Q  ++VR++     +        +V E ++   L    F +    I +   +    
Sbjct: 65  WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSR----IQDRGDQAFTE 116

Query: 645 ----NIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMA 691
                I+  I   + YLH  +   I HRD+K  N+L          K++DFG A
Sbjct: 117 REASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 31/222 (13%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSR----NSGQGIEEFKNEVRLIAKLQ 596
           D F     LG G FG V   +  E     A+K L +       Q IE   NE R++  + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN------IICGI 650
              LV+L     +     +V EY+    +    F     S L    RF+          I
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEM----F-----SHLRRIGRFSEPHARFYAAQI 150

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
                YLH      +I+RDLK  N+L+D++   +++DFG A+   G      T  + GT 
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTP 202

Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSN 752
             ++PE  +   ++   D ++ GVL+ E  +G     F+   
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP--FFADQ 242

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 77.5 bits (191), Expect = 5e-15
 Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 35/228 (15%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL------SRNSGQGIEEFKNEVRLIAK 594
           + F     LG+G FG V   +        A+K L      +++    +     E R++  
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE---VAHTLTENRVLQN 204

Query: 595 LQHRNLVRLLGCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIIC 648
            +H  L  L     +  +++  V EY     L        +F + R+       RF    
Sbjct: 205 SRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-------RFYGAE 256

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRV 706
            I   L YLH  S   +++RDLK  N++LDK+   KI+DFG+ +  I  G      T   
Sbjct: 257 -IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KT--F 309

Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
            GT  Y++PE   D  +    D +  GV++ E + G+    FY+ ++E
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHE 355

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 77.8 bits (191), Expect = 7e-15
 Identities = 65/214 (30%), Positives = 91/214 (42%), Gaps = 27/214 (12%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRN---SGQGIEEFKNEVR-LIAKLQ 596
            +F     LG+G FG V         E+ AVK L ++       +E    E R L    +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIA 651
              L +L  C   MD    V EY+    L         F +  +        F     IA
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAE-IA 452

Query: 652 RGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGT 709
            GL +L       II+RDLK  N++LD E   KI+DFGM +  I+ G  T   T    GT
Sbjct: 453 IGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KT--FCGT 505

Query: 710 YGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
             Y++PE      +    D ++FGVLL E ++G+
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 75.3 bits (186), Expect = 9e-15
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 34/217 (15%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRL------SRNSGQGIEEFKNEVRLIAK 594
           ++F     LG+G FG V   R        A+K L      +++    +     E R++  
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE---VAHTVTESRVLQN 61

Query: 595 LQHRNLVRLLGCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIIC 648
            +H  L  L     +  +++  V EY     L        +F + R+       RF    
Sbjct: 62  TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-------RFYGAE 113

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRV 706
            I   L YLH      +++RD+K  N++LDK+   KI+DFG+ +  I  G      T   
Sbjct: 114 -IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KT--F 165

Query: 707 VGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
            GT  Y++PE   D  +    D +  GV++ E + G+
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 75.3 bits (184), Expect = 1e-14
 Identities = 29/203 (14%), Positives = 58/203 (28%), Gaps = 54/203 (26%)

Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS--------GQGIEEFKNEVRL 591
            T+      K+G+G FG V++    +   +A+K ++            +  EE   E+ +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 592 IAKLQ---------HRNLVRLLGCCV--------------EMDEKM-------------- 614
             +L              + L                     +                 
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 615 --LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKA 672
             +V E+           ++ R+ + +     +I+  +   L         R  HRDL  
Sbjct: 137 LFIVLEFEFGGID----LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190

Query: 673 SNILLDKEMTPKISDFGMARIFG 695
            N+LL K    K+      +   
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSST 213

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 50/263 (19%), Positives = 102/263 (38%), Gaps = 68/263 (25%)

Query: 537 IVRATDNFTDY-----NKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVR 590
                + + D       KLG G F  V+  + ++    +A+K + R      E  ++E++
Sbjct: 9   PAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIK 67

Query: 591 LIAKLQ-----------HRNLVRLLGC-----------CVEMDEKMLVYEYMENRSLDSV 628
           L+ ++              ++++LL                     +V+E +   +L ++
Sbjct: 68  LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVV-------MVFEVL-GENLLAL 119

Query: 629 IFDKARSSILNWQRRFNI--ICGIAR----GLLYLHQDSRFRIIHRDLKASNILLDKEMT 682
           I            R   +  +  I++    GL Y+H   R  IIH D+K  N+L++   +
Sbjct: 120 IKK-------YEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDS 170

Query: 683 P------KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLL 736
           P      KI+D G A        +++    + T  Y SPE  +   +   +D++S   L+
Sbjct: 171 PENLIQIKIADLGNAC-----WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLI 225

Query: 737 LETVSGK-----KNRGFYHSNNE 754
            E ++G           Y  +++
Sbjct: 226 FELITGDFLFEPDEGHSYTKDDD 248

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 73.8 bits (182), Expect = 4e-14
 Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 37/211 (17%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKNEVR--------LIAKLQHRNL 600
           LG+G FG V         E+ AVK L ++    + +  ++V         L    +   L
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDV---VIQ-DDDVECTMVEKRVLALPGKPPFL 83

Query: 601 VRLLGCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGL 654
            +L   C +  +++  V EY+    L         F +  +        F     IA GL
Sbjct: 84  TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-------VFYAAE-IAIGL 134

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGTYGY 712
            +L       II+RDLK  N++LD E   KI+DFGM +  I+ G  T   T    GT  Y
Sbjct: 135 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KT--FCGTPDY 187

Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           ++PE      +    D ++FGVLL E ++G+
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 73.0 bits (180), Expect = 6e-14
 Identities = 67/210 (31%), Positives = 94/210 (44%), Gaps = 35/210 (16%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKNEVR--------LIAKLQHRNL 600
           LG+G FG V   R+ E  ++ AVK L ++    I +  ++V         L     H  L
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDV---ILQ-DDDVECTMTEKRILSLARNHPFL 86

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGLL 655
            +L  C    D    V E++    L      S  FD+AR+       RF     I   L+
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-------RFYAAE-IISALM 138

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA--RIFGGDQTEQNTKRVVGTYGYM 713
           +LH      II+RDLK  N+LLD E   K++DFGM    I  G  T   T    GT  Y+
Sbjct: 139 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--AT--FCGTPDYI 191

Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           +PE   + L+    D ++ GVLL E + G 
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 72.6 bits (179), Expect = 8e-14
 Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 35/209 (16%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKNEVR--------LIAKLQHRNL 600
           LG+G FG V+     +  +  A+K L ++    +    ++V         L    +H  L
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDV---VLM-DDDVECTMVEKRVLSLAWEHPFL 80

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGLL 655
             +       +    V EY+    L         FD +R+        F     I  GL 
Sbjct: 81  THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-------TFYAAE-IILGLQ 132

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGTYGYM 713
           +LH      I++RDLK  NILLDK+   KI+DFGM +  + G  +T  NT    GT  Y+
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NT--FCGTPDYI 185

Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSG 742
           +PE  +   ++   D +SFGVLL E + G
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 72.2 bits (178), Expect = 1e-13
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 32/210 (15%)

Query: 550 LGQGGFGIVYKGRLLEG---QEI-AVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLV 601
           LG+GG+G V++ R + G    +I A+K L +       +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 602 RLLGCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGLL 655
            L+    +   K+ L+ EY+    L        IF +  +        F +   I+  L 
Sbjct: 85  DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-------CFYLAE-ISMALG 135

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGTYGYM 713
           +LHQ     II+RDLK  NI+L+ +   K++DFG+ +  I  G  T  +T    GT  YM
Sbjct: 136 HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT--HT--FCGTIEYM 188

Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           +PE  M    +   D +S G L+ + ++G 
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 72.2 bits (178), Expect = 1e-13
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 41/218 (18%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEI-AVKRLSRNS----GQGIEEFKNEVRLIAKLQ 596
            +F     LG G FG V+  R        A+K L +       Q +E   +E  +++ + 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVT 64

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI------ICGI 650
           H  ++R+ G   +  +  ++ +Y+E   L    F     S+L   +RF           +
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGEL----F-----SLLRKSQRFPNPVAKFYAAEV 115

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
              L YLH      II+RDLK  NILLDK    KI+DFG A+          T  + GT 
Sbjct: 116 CLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTP 167

Query: 711 GYMSPE------YAMDGLFSVKSDVFSFGVLLLETVSG 742
            Y++PE      Y      S+  D +SFG+L+ E ++G
Sbjct: 168 DYIAPEVVSTKPYNK----SI--DWWSFGILIYEMLAG 199

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 37/211 (17%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSRNSGQGIEEFKNEVR--------LIAKLQHRNL 600
           +G+G FG V   R    +   AVK L + +   I + K E +        L+  ++H  L
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKA---ILK-KKEEKHIMSERNVLLKNVKHPFL 101

Query: 601 VRLLGCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGL 654
           V L     +  +K+  V +Y+    L         F + R+       RF     IA  L
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-------RFYAAE-IASAL 152

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGTYGY 712
            YLH      I++RDLK  NILLD +    ++DFG+ +  I     T  +T    GT  Y
Sbjct: 153 GYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--ST--FCGTPEY 205

Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           ++PE      +    D +  G +L E + G 
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 29/207 (14%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSR---NSGQGIEEFKNEVR-LIAKLQHRNLVRLL 604
           +G+G +  V   RL +   I A+K + +   N  + I+  + E         H  LV L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 605 GCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
             C + + ++  V EY+    L           +  +       RF     I+  L YLH
Sbjct: 77  -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAE-ISLALNYLH 127

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGTYGYMSPE 716
           +     II+RDLK  N+LLD E   K++D+GM +  +  GD T  +T    GT  Y++PE
Sbjct: 128 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--ST--FCGTPNYIAPE 180

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGK 743
                 +    D ++ GVL+ E ++G+
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGR 207

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 71.4 bits (176), Expect = 2e-13
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 30/208 (14%)

Query: 550 LGQGGFGIVYKGRLLEG---QEI-AVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRL 603
           LGQG FG V+  + + G   +++ A+K L + +   +     K E  ++ ++ H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 604 LGCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
                + + K+ L+ +++    L       V+F +          +F +   +A  L +L
Sbjct: 92  H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-------KFYLAE-LALALDHL 142

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGTYGYMSP 715
           H      II+RDLK  NILLD+E   K++DFG+++  I    +    +    GT  YM+P
Sbjct: 143 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA--YS--FCGTVEYMAP 195

Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           E       +  +D +SFGVL+ E ++G 
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 72.4 bits (178), Expect = 2e-13
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 29/207 (14%)

Query: 550 LGQGGFGIVYKGRLLEGQEI-AVKRLSR---NSGQGIEEFKNEVR-LIAKLQHRNLVRLL 604
           +G+G +  V   RL +   I A++ + +   N  + I+  + E         H  LV L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 605 GCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
             C + + ++  V EY+    L           +  +       RF     I+  L YLH
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-------RFYSAE-ISLALNYLH 170

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR--IFGGDQTEQNTKRVVGTYGYMSPE 716
           +     II+RDLK  N+LLD E   K++D+GM +  +  GD T  +T    GT  Y++PE
Sbjct: 171 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--ST--FCGTPNYIAPE 223

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGK 743
                 +    D ++ GVL+ E ++G+
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGR 250

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 69.7 bits (170), Expect = 2e-12
 Identities = 43/182 (23%), Positives = 78/182 (42%), Gaps = 30/182 (16%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV-RLLGC 606
           K+G G FG +Y G  +   +E+A+K  +  +     +   E ++   LQ    +  +   
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWF 71

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI--ICGIARGLL----YLHQD 660
            VE D  +LV + +   SL+  +F+          R+ ++  +  +A  ++    ++H  
Sbjct: 72  GVEGDYNVLVMDLL-GPSLED-LFNFCS-------RKLSLKTVLMLADQMINRVEFVHSK 122

Query: 661 SRFRIIHRDLKASNILLDKEMTPK---ISDFGMARIFGGDQTEQ-----NTKRVVGTYGY 712
           S    +HRD+K  N L+          I DFG+A+ +    T Q       K + GT  Y
Sbjct: 123 S---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

Query: 713 MS 714
            S
Sbjct: 180 AS 181

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 45/182 (24%), Positives = 79/182 (43%), Gaps = 30/182 (16%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH-RNLVRLLGC 606
           K+G G FG +Y G  +  G+E+A+K     +         E ++   +Q    +  +  C
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI--ICGIARGLL----YLHQD 660
             E D  ++V E +   SL+  +F+          R+F++  +  +A  ++    Y+H  
Sbjct: 74  GAEGDYNVMVMELL-GPSLED-LFNFCS-------RKFSLKTVLLLADQMISRIEYIHSK 124

Query: 661 SRFRIIHRDLKASNILLDKEMTPK---ISDFGMARIFGGDQTEQ-----NTKRVVGTYGY 712
           +    IHRD+K  N L+          I DFG+A+ +   +T Q       K + GT  Y
Sbjct: 125 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181

Query: 713 MS 714
            S
Sbjct: 182 AS 183

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 44/184 (23%), Positives = 83/184 (45%), Gaps = 32/184 (17%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH-RNLVRLLGC 606
           ++G+G FG++++G  LL  Q++A+K   R S       ++E R    L     +  +   
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGIPNVYYF 74

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI--ICGIARGLL----YLHQD 660
             E    +LV + +   SL+  + D          R+F++  +   A+ +L     +H+ 
Sbjct: 75  GQEGLHNVLVIDLL-GPSLED-LLDLCG-------RKFSVKTVAMAAKQMLARVQSIHEK 125

Query: 661 SRFRIIHRDLKASNILLDKEMTPK-----ISDFGMARIFGGDQTEQ-----NTKRVVGTY 710
           S   +++RD+K  N L+ +  +       + DFGM + +    T+Q       K + GT 
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182

Query: 711 GYMS 714
            YMS
Sbjct: 183 RYMS 186

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 66.6 bits (163), Expect = 7e-12
 Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 32/184 (17%)

Query: 549 KLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH-RNLVRLLGC 606
           K+G G FG +  G+ L   + +A+K     S     +   E R   +L     + ++   
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYF 73

Query: 607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI--ICGIARGLL----YLHQD 660
                   +V E +   SL+  +FD          R F++  +  IA  L+    Y+H  
Sbjct: 74  GPCGKYNAMVLELL-GPSLED-LFDLCD-------RTFSLKTVLMIAIQLISRMEYVHSK 124

Query: 661 SRFRIIHRDLKASNILLDKEMTPK-----ISDFGMARIFGGDQTEQ-----NTKRVVGTY 710
           +   +I+RD+K  N L+ +          I DF +A+ +   +T++       K + GT 
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181

Query: 711 GYMS 714
            YMS
Sbjct: 182 RYMS 185

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 66.5 bits (163), Expect = 8e-12
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 34/213 (15%)

Query: 550 LGQGGFGIVYKGRLLEG---QEI-AVKRLSRNS----GQGIEEFKNEVRLIAKLQHRN-L 600
           LG G +G V+  R + G    ++ A+K L + +     +  E  + E +++  ++    L
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 601 VRLLGCCVEMDEKM-LVYEYMENRSL-----DSVIFDKARSSILNWQRRFNIICGIARGL 654
           V L     + + K+ L+ +Y+    L         F +          +   +  I   L
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-------QI-YVGEIVLAL 172

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
            +LH+     II+RD+K  NILLD      ++DFG+++ F  D+TE+      GT  YM+
Sbjct: 173 EHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMA 228

Query: 715 PEYAMDGL----FSVKSDVFSFGVLLLETVSGK 743
           P+    G      +V  D +S GVL+ E ++G 
Sbjct: 229 PDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 41/198 (20%), Positives = 74/198 (37%), Gaps = 45/198 (22%)

Query: 549 KLGQGGFGIVYKG-RLLEGQEIA---VKRLSRNSGQGIEEFKNEVRL-----IAKLQHRN 599
           K+G GGFG++Y      + ++ A   VK   + +G    E K   R+     I K   R 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 600 LVRLLG----------CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI--I 647
            +  LG                 + +V E +    L           I      F    +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK---------ISGQNGTFKKSTV 153

Query: 648 CGIARGLL----YLHQDSRFRIIHRDLKASNILLDKEMTPKI--SDFGMARIFGGDQT-- 699
             +   +L    Y+H++     +H D+KA+N+LL  +   ++  +D+G++  +  +    
Sbjct: 154 LQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210

Query: 700 ---EQNTKRVVGTYGYMS 714
              E   K   GT  + S
Sbjct: 211 QYQENPRKGHNGTIEFTS 228

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 38/200 (19%), Positives = 75/200 (37%), Gaps = 46/200 (23%)

Query: 549 KLGQGGFGIVYKGRLLEGQEI------AVKRLSRNSGQGIEEFKNEVRL-----IAKLQH 597
            +GQGGFG +Y   +   + +       VK    ++G    E K   R      I K   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 598 RNLVRLLG----------CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI- 646
              ++ LG                 + ++ +      L   I++          +RF+  
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANA-------KRFSRK 152

Query: 647 -ICGIARGLL----YLHQDSRFRIIHRDLKASNILLDKEMTPKI--SDFGMARIFGGDQT 699
            +  ++  +L    Y+H+      +H D+KASN+LL+ +   ++   D+G+A  +  +  
Sbjct: 153 TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209

Query: 700 EQ-----NTKRVVGTYGYMS 714
            +       +   GT  + S
Sbjct: 210 HKAYAADPKRCHDGTIEFTS 229

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 33/201 (16%), Positives = 69/201 (34%), Gaps = 46/201 (22%)

Query: 548 NKLGQGGFGIVYKGR---------LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR 598
           +   +   GI+Y+             + Q+ ++K  +++ G+   E     R    LQ  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVN 106

Query: 599 NLVRLLGC------------CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
              +L                 +   + LV   +  RSL S +    +          + 
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-------HVLSE 158

Query: 647 --ICGIARGLL----YLHQDSRFRIIHRDLKASNILLDKEMTPKI--SDFGMARIFGGDQ 698
             +  +A  LL    +LH++     +H ++ A NI +D E   ++  + +G A  +    
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215

Query: 699 T-----EQNTKRVVGTYGYMS 714
                 E +     G   ++S
Sbjct: 216 KHVAYVEGSRSPHEGDLEFIS 236

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 61.1 bits (148), Expect = 7e-10
 Identities = 56/291 (19%), Positives = 97/291 (33%), Gaps = 112/291 (38%)

Query: 537 IVRATDNFTD----YNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRL 591
           +V+  D F        KLG G F  V+    +   + +A+K + +++    E   +E+RL
Sbjct: 28  LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRL 86

Query: 592 IAKLQ--------HRNLVRLLGC-----------CVEMDEKMLVYEYMENRSLDSVIFDK 632
           +  ++           +V+LL             C       +V+E +            
Sbjct: 87  LKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC-------MVFEVL------------ 127

Query: 633 ARSSILNWQRRFN-----------IICGIARGLLYLHQDSRFRIIHRDLKASNILL---- 677
               +L W  + N           II  + +GL YLH  ++ RIIH D+K  NILL    
Sbjct: 128 -GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNE 184

Query: 678 ---------------------------------------------DKEMTPKISDFGMAR 692
                                                         +++  KI+D G A 
Sbjct: 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC 244

Query: 693 IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
                 TE      + T  Y S E  +   ++  +D++S   +  E  +G 
Sbjct: 245 WVHKHFTE-----DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 36/215 (16%)

Query: 547 YNKLGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR------N 599
            + +G+G FG V K    +E + +A+K + +N    + + + EVRL+  +          
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYY 117

Query: 600 LVRLLG--------CCV-EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           +V L          C V EM    L Y+ + N +   V  +  R               +
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSYNL-YDLLRNTNFRGVSLNLTRK----------FAQQM 166

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVG 708
              LL+L       IIH DLK  NILL        KI DFG +   G     Q   + + 
Sbjct: 167 CTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG-----QRIYQYIQ 220

Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           +  Y SPE  +   + +  D++S G +L+E  +G+
Sbjct: 221 SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 58.5 bits (140), Expect = 2e-09
 Identities = 40/282 (14%), Positives = 71/282 (25%), Gaps = 29/282 (10%)

Query: 49  LFPTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIG--IWYKNIAQRTY 106
             P   +    L A Q L+ G+ L+S +  F+L     G+      G  +W  N  Q   
Sbjct: 6   RIPFNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFS 65

Query: 107 VWVANRDDP---LANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVL 163
             +  R+              + +        + N  ++SN          LQD GN V 
Sbjct: 66  STIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQ-WNRTHLVLQDDGNIV- 123

Query: 164 KEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHG 223
                        D                           +       G  + KL F G
Sbjct: 124 -----------LVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQG 172

Query: 224 FPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLF 283
                 +        +    G    G          N   +    + V +          
Sbjct: 173 DGNLVAYGPNGAATWNAGTQG---KGAVRAVFQGDGNLVVY-GAGNAVLWHSHTGGHASA 228

Query: 284 SRLIVSPDGFL----QRFTWIEANKIWNPFWYAPKDQCDNYG 321
             L +  +G +    ++  W  A   + P +   +    +  
Sbjct: 229 -VLRLQANGSIAILDEKPVW--ARFGFQPTYRHIRKINPDQK 267

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 50/219 (22%), Positives = 91/219 (41%), Gaps = 52/219 (23%)

Query: 550 LGQGGFGIVYKGR-LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR------NLVR 602
           +G+G FG V K       Q +A+K + RN  +   +   E+R++  L+ +      N++ 
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163

Query: 603 LLGC-------CVEMDEKML---VYEYMENRSLDSVIFDKARSSILNWQRRFNI--ICGI 650
           +L         C+  +  +L   +YE ++                    + F++  +   
Sbjct: 164 MLENFTFRNHICMTFE--LLSMNLYELIKKNKF----------------QGFSLPLVRKF 205

Query: 651 AR----GLLYLHQDSRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTK 704
           A      L  LH   + RIIH DLK  NILL ++     K+ DFG +         Q   
Sbjct: 206 AHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-----EHQRVY 257

Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
             + +  Y +PE  +   + +  D++S G +L E ++G 
Sbjct: 258 TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110

 Score = 51.3 bits (123), Expect = 4e-08
 Identities = 21/120 (17%), Positives = 44/120 (36%), Gaps = 16/120 (13%)

Query: 57  VDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPL 116
           V++L++  +L  G +L      + L      +       + Y +      VW +N     
Sbjct: 1   VNSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS---GKPVWASNTGGLG 50

Query: 117 ANSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNP-VAQLQDSGNFVLKEAGSDEILWQS 175
           +     L   N  + ++D S  ++W +      +  V  LQ   N V+       ++W +
Sbjct: 51  SGCRLTLHN-NGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVI----YGPVVWAT 105

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 50.6 bits (121), Expect = 7e-08
 Identities = 20/125 (16%), Positives = 44/125 (35%), Gaps = 22/125 (17%)

Query: 58  DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLA 117
           + LT  + L  G++L      +        +     + ++  + +     W +N      
Sbjct: 2   NLLTNGEGLYAGQSLDVEP--YHFIMQEDCN-----LVLYDHSTSV----WASNTGIL-- 48

Query: 118 NSSGVLRIINQRIG---LFDGSQNLVWSSNQTKATNP-VAQLQDSGNFVLKEAGSDEILW 173
                 + + Q  G   ++D     +W+S+  +     V  LQ+ GN V+        +W
Sbjct: 49  -GKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVI----YGSDIW 103

Query: 174 QSFDY 178
            +  Y
Sbjct: 104 STGTY 108

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 50.8 bits (122), Expect = 1e-06
 Identities = 61/280 (21%), Positives = 97/280 (34%), Gaps = 81/280 (28%)

Query: 514 SSKRDYSADKTDDLELPLFDFETIVRATDNFTD----YNKLGQGGFGIVYKGR-LLEGQE 568
           SS R+    + DD       F    +      +      K+G G FG V   + +   + 
Sbjct: 8   SSGRENLYFQGDDEI---VHF--SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKY 62

Query: 569 IAVKRLSRNSGQGIEEFKN----EVRLIAKLQHR-----NLVRLLGC-------CVEMDE 612
            AVK + RN    I+++      E  ++ K+Q+      N+V+  G        C+  + 
Sbjct: 63  YAVKVV-RN----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE- 116

Query: 613 KML---VYEYMENRSLDSVIFDKARSSILNWQRRFNI--ICGIARGLL----YLHQDSRF 663
             L   +YE +                  N    F+I  I      +L    YL    + 
Sbjct: 117 -PLGPSLYEIITR----------------NNYNGFHIEDIKLYCIEILKALNYLR---KM 156

Query: 664 RIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR------------------ 705
            + H DLK  NILLD     K          G       TK                   
Sbjct: 157 SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH 216

Query: 706 --VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
             ++ T  Y +PE  ++  + V SD++SFG +L E  +G 
Sbjct: 217 GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115

 Score = 46.4 bits (110), Expect = 2e-06
 Identities = 23/119 (19%), Positives = 42/119 (35%), Gaps = 17/119 (14%)

Query: 58  DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLA 117
           + L + Q L    +L +    + L   +  +       + Y+N      +W +N D   +
Sbjct: 3   NVLLSGQTLHADHSLQAGA--YTLTIQNKCNL------VKYQN---GRQIWASNTDRRGS 51

Query: 118 NSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNP-VAQLQDSGNFVLKEAGSDEILWQS 175
                L   +  + ++D + N VW S            LQ  G FV+       +LW  
Sbjct: 52  GCRLTLLS-DGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVI----YGPVLWSL 105

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.9 bits (118), Expect = 4e-06
 Identities = 90/632 (14%), Positives = 175/632 (27%), Gaps = 191/632 (30%)

Query: 152 VAQLQDSGNFVLKEAGSDEIL-------------WQSFDYPTDTLLPQMKIGWDLKTGFE 198
              +QD    +L +   D I+             W       + +  Q  +   L+  ++
Sbjct: 35  CKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMV--QKFVEEVLRINYK 92

Query: 199 WYLTSWKSTD-DPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVR-FS--GVPEMK 254
           + ++  K+    PS     +                  + R   +N  + F+   V  ++
Sbjct: 93  FLMSPIKTEQRQPSMMTRMYI-----------------EQRDRLYNDNQVFAKYNVSRLQ 135

Query: 255 PIEGINFEFFIDQDHDVYYSFFIENKNLF---------SRL---IVSPDGFLQRFTWIEA 302
           P   +       +            KN+          + +   +        +      
Sbjct: 136 PYLKLRQALLELRPA----------KNVLIDGVLGSGKTWVALDVCLSYKVQCKM----D 181

Query: 303 NKIWNPFWYAPKDQCDNYGECGPFGICDTNASPVCQCMRGFEPKDPQAWSLRDGSGGC-V 361
            KI   FW                  C++  + +    +     DP   S  D S    +
Sbjct: 182 FKI---FWLN-------------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL 225

Query: 362 RKTELQCSEDKFLQLKNMKLPDTTTSFVDYNMTL---------KECEAFCSRNCSCTAYA 412
           R   +Q    + L+ K             Y   L         K   AF   N SC    
Sbjct: 226 RIHSIQAELRRLLKSK------------PYENCLLVLLNVQNAKAWNAF---NLSCK--- 267

Query: 413 NTNITGGTGCVTWTGELKDIRKYAEGGQDLYVRLAASDIGDGANATPIII-----GVTVG 467
              +T     VT                         D    A  T I +      +T  
Sbjct: 268 -ILLTTRFKQVT-------------------------DFLSAATTTHISLDHHSMTLTPD 301

Query: 468 SAILILGLVACFLWRRKTLLGRQIRKTEP----------RGHPERSQDLL-LNQVVISSK 516
                  L+  +L  R   L R++  T P          R       +   +N   +++ 
Sbjct: 302 EV---KSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTI 358

Query: 517 RDYSADKTDDLEL-PLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLS 575
            + S +  +  E   +FD  ++      F     +      +++   +     + V +L 
Sbjct: 359 IESSLNVLEPAEYRKMFDRLSV------FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLH 412

Query: 576 RNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARS 635
           + S            L+ K    + + +    +E+  K+     +    +D     K   
Sbjct: 413 KYS------------LVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFD 460

Query: 636 S---ILNWQRRFNIICGIARGLLYLHQDSR---FRIIHRDLKASNILLDKEMTPKISDFG 689
           S   I  +  ++     I   L  +    R   FR++  D +     L++    KI    
Sbjct: 461 SDDLIPPYLDQY-FYSHIGHHLKNIEHPERMTLFRMVFLDFR----FLEQ----KIRHDS 511

Query: 690 MARIFGGDQTEQNTKRVVGTY-GYMS---PEY 717
            A    G     NT + +  Y  Y+    P+Y
Sbjct: 512 TAWNASGSIL--NTLQQLKFYKPYICDNDPKY 541

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.7 bits (102), Expect = 3e-04
 Identities = 49/328 (14%), Positives = 84/328 (25%), Gaps = 102/328 (31%)

Query: 19  ERRETSAK--NMIMNDITSHPCYTNLFLIIFI---------------------LFPTIAI 55
           E +    K  +    D+      TN   +  I                     L   I  
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES 361

Query: 56  SVDTLTATQNLTYGKTLVSSDDVFE-LGFFSPGSSGKWYIGIWYKNIAQRTY--VWVA-N 111
           S++ L   +              F+ L  F P +           +I       +W    
Sbjct: 362 SLNVLEPAEYRKM----------FDRLSVFPPSA-----------HIPTILLSLIWFDVI 400

Query: 112 RDDP------LANSSGVLRIINQ-RIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLK 164
           + D       L   S V +   +  I +      L        A +    + D  N    
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH--RSIVDHYNIPKT 458

Query: 165 EAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFK---LDF 221
                        + +D L+P     +     F  ++       +       F+   LDF
Sbjct: 459 -------------FDSDDLIPPYLDQY-----FYSHIGHHLKNIEHPERMTLFRMVFLDF 500

Query: 222 HGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKN 281
                 FL  K            +R            +N      Q    Y  +  +N  
Sbjct: 501 R-----FLEQK------------IRHDSTAWNASGSILN----TLQQLKFYKPYICDNDP 539

Query: 282 LFSRLIVSPDGFLQRFTWIEANKIWNPF 309
            + RL+ +   FL +   IE N I + +
Sbjct: 540 KYERLVNAILDFLPK---IEENLICSKY 564

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 48.8 bits (117), Expect = 4e-06
 Identities = 52/259 (20%), Positives = 98/259 (37%), Gaps = 84/259 (32%)

Query: 537 IVRATDNFTD----YNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRNSGQGIEEFKN--- 587
           I ++ D  +      + LG+G FG V +    +  G+ +AVK + +N    ++ +     
Sbjct: 5   ICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KN----VDRYCEAAR 59

Query: 588 -EVRLIAKLQHR------NLVRLLGC-------CVEMDEKML---VYEYMENRSLDSVIF 630
            E++++  L           V++L         C+  +  +L    Y++++         
Sbjct: 60  SEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKE-------- 109

Query: 631 DKARSSILNWQRRFNI--ICGIARGLL----YLHQDSRFRIIHRDLKASNILLDKEMTP- 683
                   N    F +  I  +A  +     +LH     ++ H DLK  NIL  +     
Sbjct: 110 --------NGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTE 158

Query: 684 ------------------KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL-FS 724
                             K+ DFG A  +     +++   +V T  Y +PE  +  L +S
Sbjct: 159 AYNPKIKRDERTLINPDIKVVDFGSA-TY----DDEHHSTLVSTRHYRAPEVIL-ALGWS 212

Query: 725 VKSDVFSFGVLLLETVSGK 743
              DV+S G +L+E   G 
Sbjct: 213 QPCDVWSIGCILIEYYLGF 231

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 48.5 bits (116), Expect = 5e-06
 Identities = 48/252 (19%), Positives = 92/252 (36%), Gaps = 70/252 (27%)

Query: 537 IVRATDNFTD----YNKLGQGGFGIVYKGR-LLEGQEI-AVKRLSRNSGQGIEEFKN--- 587
           + R  D   +       LG+G FG V +      G+   A+K + RN    + +++    
Sbjct: 10  VCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RN----VGKYREAAR 64

Query: 588 -EVRLIAKLQHR------NLVRLLGC-------CVEMDEKML---VYEYMENRSLDSVIF 630
            E+ ++ K++ +        V +          C+  +  +L    +E+++  +      
Sbjct: 65  LEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENNFQPYPL 122

Query: 631 DKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP------- 683
              R   + +Q        +   L +LH     ++ H DLK  NIL              
Sbjct: 123 PHVRH--MAYQ--------LCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHK 169

Query: 684 ------------KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFS 731
                       +++DFG A  F      ++   +V T  Y  PE  ++  ++   DV+S
Sbjct: 170 SCEEKSVKNTSIRVADFGSA-TF----DHEHHTTIVATRHYRPPEVILELGWAQPCDVWS 224

Query: 732 FGVLLLETVSGK 743
            G +L E   G 
Sbjct: 225 IGCILFEYYRGF 236

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 44.1 bits (104), Expect = 1e-05
 Identities = 18/118 (15%), Positives = 44/118 (37%), Gaps = 13/118 (11%)

Query: 58  DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLA 117
           D L +   L  G +L      +     +  +     + ++  N A     W +  +   +
Sbjct: 2   DRLNSGHQLDTGGSLAEGG--YLFIIQNDCN-----LVLYDNNRAV----WASGTNGKAS 50

Query: 118 NSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQS 175
                ++  +  + ++ GS+ +  S+   +  N    LQ   N V+ +  S+  +W +
Sbjct: 51  GCVLKMQN-DGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDN-SNNAIWAT 106

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109

 Score = 42.9 bits (101), Expect = 3e-05
 Identities = 18/119 (15%), Positives = 39/119 (32%), Gaps = 17/119 (14%)

Query: 58  DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLA 117
           + L + + L+ G+ L +    +        +       + Y        +W  N      
Sbjct: 2   NILYSGETLSPGEFLNNGR--YVFIMQEDCNL------VLYDV---DKPIWATNTGGLDR 50

Query: 118 NSSGVLRIINQRIGLFDGSQNLVWSSN-QTKATNPVAQLQDSGNFVLKEAGSDEILWQS 175
                ++  +  + ++    N +W+SN   +  N V  LQ   N V+         W +
Sbjct: 51  RCHLSMQS-DGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIY----GTARWAT 104

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 29/158 (18%), Positives = 55/158 (34%), Gaps = 28/158 (17%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEE--------FKNEVRLIAKLQH 597
             +G+G    V+     +  E  VK  ++   S + ++E        F       A+ + 
Sbjct: 96  KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 155

Query: 598 RNLVRLLGCCV----EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           R L +L G  V      +   ++ E ++ + L  V  +             ++I      
Sbjct: 156 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEV-------LDMILEEVAK 208

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA 691
                      I+H DL   N+L+ +E    I DF  +
Sbjct: 209 F------YHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS 239

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	862
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.98
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.79
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.77
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	99.76
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.75
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.74
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.73
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	99.66
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	99.57
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.56
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	99.53
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	99.46
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	99.46
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	99.39
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	99.39
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	99.27
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.25
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	99.24
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	99.09
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.08
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	98.99
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.9
3mez_A	111	Mannose-specific lectin 3 chain 1; heterotetramer,	98.84
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.81
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	98.62
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	98.61
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	98.59
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.5
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	98.46
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.41
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.41
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.3
4h3o_A	105	Lectin; cadmium, plant protein; 2.17A {Allium sati	98.21
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.21
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.2
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.9
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.75
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.72
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.71
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.45
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.24
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.19
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.16
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.05
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.03
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.92
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.9
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.73
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.33
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.13
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.96
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.5
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.96
3no2_A	276	Uncharacterized protein; six-bladed beta-propeller	86.83
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	85.04
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	81.73
3no2_A	276	Uncharacterized protein; six-bladed beta-propeller	80.24

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.6e-52  Score=449.47  Aligned_cols=259  Identities=28%  Similarity=0.442  Sum_probs=216.9

Q ss_pred             ccccccceeeccccEEEEEeEec------CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ++|...++||+|+||.||+|++.      ++..||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46788899999999999999864      367899999987776777899999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcc----------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeE
Q 002969          616 VYEYMENRSLDSVIFDKA----------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL  685 (862)
                      |||||++|+|.++|....          ....++|.++++|+.|||+||+|||+++   |+||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999996532          2346999999999999999999999987   999999999999999999999


Q ss_pred             ecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHH
Q 002969          686 SDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRL  764 (862)
Q Consensus       686 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~  764 (862)
                      +|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...   ....    +...
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~---~~~~----~~~~  242 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL---SNNE----VIEC  242 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS---CHHH----HHHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---CHHH----HHHH
Confidence            99999987654433333444679999999999999999999999999999999999 89997432   2222    2222


Q ss_pred             HhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       765 ~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      +..+..        ...+...+.++.+|+.+||+.||++||||+||++.|+++.
T Consensus       243 i~~~~~--------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          243 ITQGRV--------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HHHTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcCCC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            333322        2234556678899999999999999999999999998874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2e-51  Score=450.52  Aligned_cols=260  Identities=26%  Similarity=0.406  Sum_probs=209.8

Q ss_pred             ccccccceeeccccEEEEEeEec------CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ++|...++||+|+||.||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45777789999999999999864      367899999987777777899999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccC------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCe
Q 002969          616 VYEYMENRSLDSVIFDKAR------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  683 (862)
                      |||||++|+|.+++.....            ...++|.++++|+.|||+||+|||+.+   ||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999965432            245999999999999999999999987   9999999999999999999


Q ss_pred             eEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHH
Q 002969          684 KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVW  762 (862)
Q Consensus       684 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~  762 (862)
                      ||+|||+++.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||...   .....    .
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~---~~~~~----~  270 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL---SNTEA----I  270 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS---CHHHH----H
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC---CHHHH----H
Confidence            9999999997754444444445679999999999999999999999999999999999 89997432   22222    2


Q ss_pred             HHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       763 ~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                      ..+..+..        ...+...+.++.+|+.+||+.||++||||+||++.|+.+..
T Consensus       271 ~~i~~g~~--------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          271 DCITQGRE--------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHHHTCC--------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHcCCC--------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            22223221        12344566788999999999999999999999999998743

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.2e-51  Score=443.85  Aligned_cols=257  Identities=28%  Similarity=0.435  Sum_probs=213.5

Q ss_pred             cccccceeeccccEEEEEeEec------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      .++..++||+|+||+||+|++.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4566789999999999999863      46789999997553 3456789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccC-------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC
Q 002969          616 VYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT  682 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~  682 (862)
                      |||||++|+|.++|.....             ...++|.++++|+.|||+||+|||+.+   ||||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence            9999999999999965321             235899999999999999999999998   999999999999999999


Q ss_pred             eeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHH
Q 002969          683 PKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHV  761 (862)
Q Consensus       683 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~  761 (862)
                      +||+|||+++.+.............||+.|||||++.++.|+.++|||||||+||||+| |+.||...   ...+    +
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~---~~~~----~  256 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY---SNQD----V  256 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC---CHHH----H
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC---CHHH----H
Confidence            99999999987654443334445689999999999999999999999999999999998 88886432   2222    2


Q ss_pred             HHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          762 WRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       762 ~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ...+..+..        ...+...+..+.+|+.+||+.||++||+|+||++.|+..
T Consensus       257 ~~~i~~~~~--------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          257 VEMIRNRQV--------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHcCCC--------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            223333322        223455677889999999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-50  Score=437.89  Aligned_cols=263  Identities=27%  Similarity=0.444  Sum_probs=207.9

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ++++..++||+|+||+||+|++.+  .||||+++..  .....++|.+|++++++++|||||+++|++.+ +..+|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            467778999999999999998743  6999998654  34456789999999999999999999999865 568999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++|+|.++|...  ...+++.++++|+.|||+||+|||+.+   ||||||||+||||++++.+||+|||+|+.......
T Consensus       113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            9999999999643  235999999999999999999999987   99999999999999999999999999987654443


Q ss_pred             ccccccccccccccChhhhcC---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          700 EQNTKRVVGTYGYMSPEYAMD---GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      .......+||+.|||||++.+   ..|+.++|||||||+||||+||+.||......      ..+......+.    ..+
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~----~~p  257 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGY----ASP  257 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTC----CCC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCC----CCC
Confidence            444455789999999999964   46899999999999999999999997532211      11222222221    122


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCCC
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMP  822 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~  822 (862)
                      .+...+...+..+.+|+.+||+.||++||||.||++.|+.+..++|
T Consensus       258 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          258 DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence            2334455667789999999999999999999999999988744443

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.2e-48  Score=426.99  Aligned_cols=264  Identities=23%  Similarity=0.260  Sum_probs=212.5

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      +.|+..++||+|+||.||+|+... |+.||||+++...     ...+|+.++++++|||||++++++.+.+..+|||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            568888999999999999998754 8999999997542     2247999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC-CeeEecccceeecCCCCc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFGGDQT  699 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~  699 (862)
                      ++|+|.++|....   .+++.++..++.||+.||+|||+++   ||||||||+||||+.++ .+||+|||+|+.+.....
T Consensus       133 ~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          133 EGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             TTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            9999999996543   4999999999999999999999998   99999999999999988 699999999998754322


Q ss_pred             cc---ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          700 EQ---NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       700 ~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ..   .....+||+.|||||++.+..|+.++|||||||+||||++|+.||......   .+...+.   .+.       .
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~---~~~-------~  273 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG---PLCLKIA---SEP-------P  273 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS---CCHHHHH---HSC-------C
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHH---cCC-------C
Confidence            21   223467999999999999999999999999999999999999997543222   2222221   111       1


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCCCCCCCCcc
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGF  829 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~  829 (862)
                      .....+...+..+.+++.+||+.||++|||+.||++.|..........+.|-+
T Consensus       274 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~  326 (336)
T 4g3f_A          274 PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWK  326 (336)
T ss_dssp             GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSS
T ss_pred             CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCc
Confidence            11233455667889999999999999999999999988776544444444443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.8e-49  Score=432.23  Aligned_cols=250  Identities=24%  Similarity=0.396  Sum_probs=204.0

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ++|+.+++||+|+||.||+|+.. +++.||||++...  .....+++.+|+++|++++|||||++++++.+.+..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999875 4899999999754  33456789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++|+|.++|... +...+++.++..|+.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+..  
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--  177 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--  177 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH--
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC--
Confidence            99999999999643 2345789999999999999999999998   99999999999999999999999999987632  


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                      ........+||+.|||||++.+..|+.++|||||||+||||++|+.||..   .+...++..+    ..+.        .
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~---~~~~~~~~~i----~~~~--------~  242 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA---GSMKNLVLKI----ISGS--------F  242 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHH----HHTC--------C
T ss_pred             CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC---cCHHHHHHHH----HcCC--------C
Confidence            12223446899999999999999999999999999999999999999743   2222222222    1111        1


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1233445677899999999999999999999985

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.3e-48  Score=424.01  Aligned_cols=249  Identities=24%  Similarity=0.348  Sum_probs=210.4

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      +.|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..||||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46899999999999999999876 48999999998766666788999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++|+|.+++..    ..+++.++..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+....  
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--  224 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  224 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence            99999999854    24899999999999999999999998   9999999999999999999999999999874332  


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|+.||..   .+....+..    +..+.     .+. ..
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~---~~~~~~~~~----i~~~~-----~~~-~~  291 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN---EPPLKAMKM----IRDNL-----PPR-LK  291 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT---SCHHHHHHH----HHHSS-----CCC-CS
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC---cCHHHHHHH----HHcCC-----CCC-CC
Confidence            223447899999999999999999999999999999999999999742   222222222    22111     011 11


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .....+.++.+|+.+||+.||++|||+.|+++
T Consensus       292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            23345678899999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1e-48  Score=432.54  Aligned_cols=269  Identities=28%  Similarity=0.409  Sum_probs=220.2

Q ss_pred             cChHHHHHHcccccccceeeccccEEEEEeEecC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhccc-CCceEE
Q 002969          532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQH-RNLVRL  603 (862)
Q Consensus       532 ~~~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H-pnIv~l  603 (862)
                      ++..+.+...++|+..++||+|+||.||+|+...      ++.||||+++... ....++|.+|+++|.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4444444556789999999999999999998643      3579999997654 3346789999999999965 899999


Q ss_pred             EEEEEeC-CceEEEEEeccCCChhhhhhhccC-------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecc
Q 002969          604 LGCCVEM-DEKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRD  669 (862)
Q Consensus       604 ~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrD  669 (862)
                      +|+|.+. +..++|||||++|+|.++|.....             ...+++.+++.++.|||+||+|||+++   |||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            9999764 568999999999999999975432             345899999999999999999999998   99999


Q ss_pred             cCCcceEecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 002969          670 LKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGF  748 (862)
Q Consensus       670 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~  748 (862)
                      |||+||||++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999998765544444455789999999999999999999999999999999998 8999754


Q ss_pred             CCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          749 YHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       749 ~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ....      ..+.+.+.++...        ..+...+.++.+++.+||+.||++||||.||+++|+.+
T Consensus       291 ~~~~------~~~~~~i~~g~~~--------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          291 VKID------EEFCRRLKEGTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             CCCS------HHHHHHHHHTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCHH------HHHHHHHHcCCCC--------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            3222      1222333333221        23444567889999999999999999999999999876

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.7e-48  Score=420.91  Aligned_cols=248  Identities=24%  Similarity=0.340  Sum_probs=211.4

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..++||+|+||+||+|+.. +++.||||++.+.   .....+.+.+|+++|++++|||||++++++.+.+..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999875 4889999999753   2345678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++|+|.+++....   .+++.++..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999996543   4899999999999999999999998   999999999999999999999999999987655


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      .........+||+.|||||++.+..|+.++|||||||++|||++|+.||..   .+...+...+    ..+.        
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~---~~~~~~~~~i----~~~~--------  250 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEGLIFAKI----IKLE--------  250 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHH----HHTC--------
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHH----HcCC--------
Confidence            444455567899999999999999999999999999999999999999742   2222232222    2211        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVV  811 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  811 (862)
                       ..++...+.++.+|+.+||+.||++|||++|++
T Consensus       251 -~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          251 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence             122344566788999999999999999999863

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.5e-47  Score=416.43  Aligned_cols=267  Identities=24%  Similarity=0.301  Sum_probs=201.2

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCC----ceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD----EKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~----~~~lV~  617 (862)
                      ++|...++||+|+||+||+|++ .|+.||||+++.... ....+..|+..+.+++|||||+++++|.+.+    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3577778999999999999988 689999999965422 1222344666667889999999999998764    579999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc-----CCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-----SRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-----~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      ||+++|+|.++|...    .++|..+++++.|+|+||+|||++     ..++|+||||||+||||+.++++||+|||+|+
T Consensus        81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            999999999999643    489999999999999999999987     13459999999999999999999999999998


Q ss_pred             ecCCCCcc--cccccccccccccChhhhcCC------CCCccccchhHHHHHHHHHhCCCCCCCCCCCc--------chh
Q 002969          693 IFGGDQTE--QNTKRVVGTYGYMSPEYAMDG------LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN--------ELN  756 (862)
Q Consensus       693 ~~~~~~~~--~~~~~~~gt~~y~APE~l~~~------~~s~ksDVwSlGvil~elltG~~p~~~~~~~~--------~~~  756 (862)
                      ........  ......+||+.|||||++.+.      .++.++|||||||+||||+||++|+.......        ...
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            77543322  222346799999999999764      36789999999999999999988764321110        011


Q ss_pred             HHHHHHHHHhcCceeeeecccCCC--CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          757 LLGHVWRLWKEGKVLEMVDSSVDN--YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       757 l~~~~~~~~~~~~~~~~id~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      ......+...+..    .++.+..  ...+.+..+.+|+.+||+.||++||||.||++.|+++.
T Consensus       237 ~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            1222333222222    1222211  12345667889999999999999999999999998763

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.5e-47  Score=425.26  Aligned_cols=249  Identities=24%  Similarity=0.352  Sum_probs=210.4

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      +.|+..++||+|+||.||+|+... |+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            569999999999999999998754 8999999998776667788999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++|+|.+++...    .+++.++..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+.+....  
T Consensus       231 ~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--  301 (423)
T 4fie_A          231 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  301 (423)
T ss_dssp             TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred             CCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence            999999998532    3899999999999999999999998   9999999999999999999999999999874332  


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|+.||..   ......+..    +..+..     +.+ .
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~---~~~~~~~~~----i~~~~~-----~~~-~  368 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN---EPPLKAMKM----IRDNLP-----PRL-K  368 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT---SCHHHHHHH----HHHSCC-----CCC-S
T ss_pred             ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC---cCHHHHHHH----HHcCCC-----CCC-c
Confidence            223457899999999999999999999999999999999999999742   222222222    222110     111 1


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .....+.++.+|+.+||+.||++|||+.|+++
T Consensus       369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            22334567889999999999999999999987

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.1e-47  Score=410.30  Aligned_cols=246  Identities=26%  Similarity=0.386  Sum_probs=197.7

Q ss_pred             cccceeeccccEEEEEeEecC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEe----CCceEEEE
Q 002969          545 TDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE----MDEKMLVY  617 (862)
Q Consensus       545 ~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----~~~~~lV~  617 (862)
                      +..++||+|+||.||+|+... ++.||+|++...  .....++|.+|++++++++|||||++++++..    ....++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            555789999999999998764 889999999654  33456789999999999999999999999865    34579999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC-CCCeeEecccceeecCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-EMTPKISDFGMARIFGG  696 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~  696 (862)
                      ||+++|+|.+++...   ..+++..+..++.||++||+|||+++ ++|+||||||+||||+. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            999999999999654   35899999999999999999999975 46999999999999974 79999999999976432


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                          ......+||+.|||||++.+ .|+.++|||||||+||||++|+.||....  ..    ..+.+.+..+...     
T Consensus       185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~--~~----~~~~~~i~~~~~~-----  248 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NA----AQIYRRVTSGVKP-----  248 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SH----HHHHHHHTTTCCC-----
T ss_pred             ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC--cH----HHHHHHHHcCCCC-----
Confidence                22334689999999998865 69999999999999999999999974221  11    1222222222111     


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        ...+...+.++.+|+.+||+.||++|||++|+++
T Consensus       249 --~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          249 --ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             --GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              1112223457889999999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.2e-47  Score=403.14  Aligned_cols=245  Identities=24%  Similarity=0.354  Sum_probs=192.3

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..+.||+|+||+||+|+.. +++.||||++.+..   ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999875 48999999997542   334568999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+ +|+|.+++...   ..+++.++..++.||+.||+|||+++   |+||||||+||||++++.+||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 67999988653   34999999999999999999999998   999999999999999999999999999875432


Q ss_pred             CcccccccccccccccChhhhcCCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLF-SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      .   .....+||+.|||||++.+..+ +.++|||||||++|||++|+.||..   .....+.    +....+.       
T Consensus       166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~---~~~~~~~----~~i~~~~-------  228 (275)
T 3hyh_A          166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD---ESIPVLF----KNISNGV-------  228 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHH----HHHHHTC-------
T ss_pred             C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC---CCHHHHH----HHHHcCC-------
Confidence            2   2234689999999999998876 5799999999999999999999742   2222222    2222221       


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        ...+...+.++.+|+.+||+.||++|||++|+++
T Consensus       229 --~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 --YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              1223345667889999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3e-47  Score=411.11  Aligned_cols=247  Identities=23%  Similarity=0.291  Sum_probs=198.6

Q ss_pred             ccccccceeeccccEEEEEeEec----CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ++|+..++||+|+||.||+|+..    .++.||||++++..  .....++.+|+++|++++|||||++++++.+.+..++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            47999999999999999999763    36789999997542  2344578899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||+++|+|.+++....   .+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999999996543   4899999999999999999999998   9999999999999999999999999998653


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ...  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||..   .+...+...+    ..+.      
T Consensus       178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~---~~~~~~~~~i----~~~~------  242 (304)
T 3ubd_A          178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG---KDRKETMTMI----LKAK------  242 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHH----HHCC------
T ss_pred             CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC---cCHHHHHHHH----HcCC------
Confidence            322  223346899999999999999999999999999999999999999742   2222222222    1111      


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPT-----MASVVL  812 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  812 (862)
                         ...+...+.++.+|+.+||+.||++|||     ++|+++
T Consensus       243 ---~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          243 ---LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             ---CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence               1234445678899999999999999998     577774

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.4e-45  Score=399.21  Aligned_cols=251  Identities=25%  Similarity=0.374  Sum_probs=190.0

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCc-------
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE-------  612 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-------  612 (862)
                      ++|+..+.||+|+||.||+|+.. +++.||||+++... ....+++.+|+++|++++|||||++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46899999999999999999875 58899999997554 3345789999999999999999999999876543       


Q ss_pred             -----eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEec
Q 002969          613 -----KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISD  687 (862)
Q Consensus       613 -----~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  687 (862)
                           .++||||+++|+|.+++.........++..++.|+.||++||+|||+++   |+||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                 6899999999999999976554445666778899999999999999998   99999999999999999999999


Q ss_pred             ccceeecCCCCccc----------ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhH
Q 002969          688 FGMARIFGGDQTEQ----------NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNL  757 (862)
Q Consensus       688 FGla~~~~~~~~~~----------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l  757 (862)
                      ||+|+.+.......          .....+||+.|||||++.+..|+.++|||||||++|||++   |+..     ..+.
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-----~~~~  233 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-----QMER  233 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS-----HHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC-----ccHH
Confidence            99998875432211          1233579999999999999999999999999999999996   4321     1111


Q ss_pred             HHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          758 LGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       758 ~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ...+ .......        ...........+.+|+.+||+.||++|||+.|+++
T Consensus       234 ~~~~-~~~~~~~--------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 VRTL-TDVRNLK--------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHH-HHHHTTC--------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHH-HHHhcCC--------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111 1111111        11111233345678999999999999999999987

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=100.00  E-value=1.1e-44  Score=384.63  Aligned_cols=235  Identities=20%  Similarity=0.265  Sum_probs=185.9

Q ss_pred             hhhhhhccccCCCCccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCC----CceEEEE
Q 002969           51 PTIAISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANS----SGVLRII  126 (862)
Q Consensus        51 ~~~~~~~~~~~~~~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~----~~~l~~~  126 (862)
                      |.++++.|+|++||+|++|++|||++|+|+||||.++   ++||   |+  +++ |||||||++|+.++    +++|+|+
T Consensus         8 ~~~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~   78 (276)
T 3m7h_A            8 PFNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLA   78 (276)
T ss_dssp             ECCCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSE
T ss_pred             eeccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEe
Confidence            4457788999999999999999999999999999543   6788   77  788 99999999999885    7889998


Q ss_pred             cc-eeEE--EcCCCCeEEccCCCC------CCccEEEEecCCCeEEEecCCCceeeeecCCCCCccCCcCcccceeecCC
Q 002969          127 NQ-RIGL--FDGSQNLVWSSNQTK------ATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGF  197 (862)
Q Consensus       127 ~~-~~~l--~~~~~~~vWst~~~~------~~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtDTlLpg~klg~~~~tg~  197 (862)
                      .+ +|+|  .|++|.+||||+++.      ..+.+|+|+|+|||||++   +.+||||  |||||+|||||+|+++++|.
T Consensus        79 ~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~---~~~lWqS--~ptdtlLpg~~~~~~l~~g~  153 (276)
T 3m7h_A           79 FYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD---SLALWNG--TPAIPLVPGAIDSLLLAPGS  153 (276)
T ss_dssp             EEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE---EEEEEES--CTTSCCCCSCTTCEEECSSE
T ss_pred             CCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC---CceeeCc--ccccccccccccccccccCc
Confidence            76 4777  688899999999764      345789999999999997   5799999  99999999999999999987


Q ss_pred             eeEEEecCCCCCCCCCCcEEEeccCCCcceEee-cCCcceeecCCCCceeecCcCCCccccccceEEEEeCCCceEEEEe
Q 002969          198 EWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLW-NKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFF  276 (862)
Q Consensus       198 ~~~L~Sw~s~~dps~G~~s~~l~~~g~~~~~~~-~~~~~~~rsg~w~g~~~~g~p~~~~~~~~~~~~~~~~~~e~~~~~~  276 (862)
                      .  |   ++.+||++|.|+++++++|.  +++| +++.+||++|+|++..    ..+......++.+. +++. ..+-++
T Consensus       154 ~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~----~~l~l~~dGnLvl~-d~~~-~~vWsS  220 (276)
T 3m7h_A          154 E--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGA----VRAVFQGDGNLVVY-GAGN-AVLWHS  220 (276)
T ss_dssp             E--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTC----CEEEECTTSCEEEE-CTTS-CEEEEC
T ss_pred             c--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCcc----EEEEEcCCCeEEEE-eCCC-cEEEEe
Confidence            5  5   67899999999999999995  4555 4569999999997532    11121222333333 4333 222233


Q ss_pred             ecCCCceeEEEECcCCceEEEEeeccCCceeEEEccCCc
Q 002969          277 IENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKD  315 (862)
Q Consensus       277 ~~~~~~~~rl~l~~~G~l~~~~w~~~~~~W~~~~~~p~~  315 (862)
                      .......+|++|+.||+|++|.|   ...|..++.+|+.
T Consensus       221 ~t~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~~  256 (276)
T 3m7h_A          221 HTGGHASAVLRLQANGSIAILDE---KPVWARFGFQPTY  256 (276)
T ss_dssp             SCTTCTTCEEEECTTSCEEEEEE---EEEEESSSCCTTS
T ss_pred             cCCCCCCEEEEEcCCccEEEEcC---CCeEEccCccCCc
Confidence            33333458999999999999999   3578888877764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3e-43  Score=386.14  Aligned_cols=283  Identities=35%  Similarity=0.616  Sum_probs=241.2

Q ss_pred             cChHHHHHHcccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCC
Q 002969          532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD  611 (862)
Q Consensus       532 ~~~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  611 (862)
                      +.+.++..++++|+..+.||+|+||.||+|+..+++.||||++........+.+.+|++++++++||||+++++++.+.+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            33444556788999999999999999999998889999999998776677889999999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhccC-CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccc
Q 002969          612 EKMLVYEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  690 (862)
                      ..++||||+++++|.+++..... ...+++.+++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999999865432 235899999999999999999999998   99999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV  770 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  770 (862)
                      ++...............||+.|+|||++.+..++.++||||||+++|||++|+.|+......+......+.......+..
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL  265 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence            98764433333334456899999999999999999999999999999999999998765555555555555555555555


Q ss_pred             eeeecccC-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          771 LEMVDSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       771 ~~~id~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .+.+++.. ...+...+..+.+++.+||+.||++||++.||++.|+.+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            56666555 456778888999999999999999999999999999876

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-43  Score=393.65  Aligned_cols=262  Identities=21%  Similarity=0.315  Sum_probs=203.3

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEe------CC
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE------MD  611 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------~~  611 (862)
                      .++|++.++||+|+||.||+|+.. .|+.||||+++...  ....+.+.+|+++|++++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            357999999999999999999875 48999999997543  3345678899999999999999999999764      35


Q ss_pred             ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccce
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  691 (862)
                      ..|+||||++ |+|.+++...   ..+++.++..++.||+.||+|||+.+   ||||||||+|||++.++.+||+|||+|
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            7899999996 6799888543   45999999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCC--cccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcC
Q 002969          692 RIFGGDQ--TEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG  768 (862)
Q Consensus       692 ~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  768 (862)
                      +.+....  ........+||+.|||||++.+. .++.++||||+||++|||++|+.||..   .+..+.+..+.......
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g---~~~~~~l~~I~~~~g~p  282 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG---KNYVHQLQLIMMVLGTP  282 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC---SSHHHHHHHHHHHHCCC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC---CCHHHHHHHHHHhcCCC
Confidence            8764332  12233457899999999998875 569999999999999999999999742   33334444443322211


Q ss_pred             ceee-----------eecccC--CCC-----ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          769 KVLE-----------MVDSSV--DNY-----PANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       769 ~~~~-----------~id~~~--~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ....           .+....  ...     ....+.++.+|+.+||+.||++|||+.|+++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1000           000000  000     1123457889999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.1e-42  Score=384.34  Aligned_cols=261  Identities=22%  Similarity=0.304  Sum_probs=200.8

Q ss_pred             HHcccccccceeeccccEEEEEeEec----CCcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCce
Q 002969          539 RATDNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       539 ~~~~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~  613 (862)
                      ...++|++.++||+|+||+||+|+..    .++.||||++....  ...++.+|+++|+.+ +||||+++++++.+.++.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            34578999999999999999999753    36789999986543  345688999999998 699999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC-CCeeEeccccee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMAR  692 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~  692 (862)
                      ++||||+++|+|.+++.      .+++.++..++.||+.||+|||+++   |+||||||+|||++.+ +.+||+|||+|+
T Consensus        96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            99999999999999882      3889999999999999999999998   9999999999999877 799999999998


Q ss_pred             ecCCCCcc--------------------------cccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCC
Q 002969          693 IFGGDQTE--------------------------QNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKN  745 (862)
Q Consensus       693 ~~~~~~~~--------------------------~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p  745 (862)
                      ........                          ......+||+.|+|||++.+. .++.++||||+||++|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            76432211                          112235799999999999876 589999999999999999999999


Q ss_pred             CCCCCCCcchhHHHHHHHHHhc----------Ccee--------------------------e---eecccC--CCCChH
Q 002969          746 RGFYHSNNELNLLGHVWRLWKE----------GKVL--------------------------E---MVDSSV--DNYPAN  784 (862)
Q Consensus       746 ~~~~~~~~~~~l~~~~~~~~~~----------~~~~--------------------------~---~id~~~--~~~~~~  784 (862)
                      |.  ...++.+.+..+.+....          ....                          .   .+....  ......
T Consensus       247 f~--~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  324 (361)
T 4f9c_A          247 FY--KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE  324 (361)
T ss_dssp             SS--CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred             CC--CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence            63  333333333333221110          0000                          0   000000  011123


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          785 EVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       785 ~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .+.++.+|+.+||+.||++|||++|+++
T Consensus       325 is~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          325 VPDEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            4567889999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.4e-42  Score=379.51  Aligned_cols=289  Identities=43%  Similarity=0.711  Sum_probs=238.3

Q ss_pred             CCCccChHHHHHHcccccccceeeccccEEEEEeEecCCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEE
Q 002969          528 ELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGC  606 (862)
Q Consensus       528 ~~~~~~~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~  606 (862)
                      .+..++..++....++|+..++||+|+||.||+|+..+++.||||++.... ......+.+|++++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            345688999999999999999999999999999998889999999997653 2234478999999999999999999999


Q ss_pred             EEeCCceEEEEEeccCCChhhhhhhcc-CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeE
Q 002969          607 CVEMDEKMLVYEYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (862)
Q Consensus       607 ~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL  685 (862)
                      +...+..++||||+++++|.+++.... ....+++..+..++.||+.||+|||+....+|+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999996543 2345999999999999999999999992223999999999999999999999


Q ss_pred             ecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCC--CCCcchhHHHHHHH
Q 002969          686 SDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFY--HSNNELNLLGHVWR  763 (862)
Q Consensus       686 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~--~~~~~~~l~~~~~~  763 (862)
                      +|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+...  ..........+...
T Consensus       176 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          176 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             CCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             ccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            99999987643322 2233356899999999999999999999999999999999999998531  12222334444444


Q ss_pred             HHhcCceeeeecccC-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          764 LWKEGKVLEMVDSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       764 ~~~~~~~~~~id~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ...........+... ...+...+..+.+++.+||+.+|++|||+.||+++|++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            444444444445444 456778889999999999999999999999999999886

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.7e-41  Score=363.74  Aligned_cols=283  Identities=35%  Similarity=0.560  Sum_probs=234.5

Q ss_pred             CCCccChHHHHHHccccccc------ceeeccccEEEEEeEecCCcEEEEEEeccC----CccchHHHHHHHHHHHhccc
Q 002969          528 ELPLFDFETIVRATDNFTDY------NKLGQGGFGIVYKGRLLEGQEIAVKRLSRN----SGQGIEEFKNEVRLIAKLQH  597 (862)
Q Consensus       528 ~~~~~~~~~i~~~~~~f~~~------~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H  597 (862)
                      ..+.|++.++..++++|...      ++||+|+||.||+|+. +++.||||++...    .....+.+.+|+.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            45679999999999999887      8999999999999987 6889999998653    23346789999999999999


Q ss_pred             CCceEEEEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe
Q 002969          598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (862)
Q Consensus       598 pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl  677 (862)
                      |||+++++++.+.+..++||||+++++|.+++........+++..++.++.||++||+|||+.+   |+||||||+|||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            9999999999999999999999999999999976555567999999999999999999999998   9999999999999


Q ss_pred             cCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhH
Q 002969          678 DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNL  757 (862)
Q Consensus       678 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l  757 (862)
                      +.++.+||+|||+++...............|++.|+|||.+.+ .++.++||||||+++|||++|+.|+.........  
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--  243 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL--  243 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT--
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH--
Confidence            9999999999999987654333333344678999999998865 5789999999999999999999997654333221  


Q ss_pred             HHHHHHHHhc--CceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          758 LGHVWRLWKE--GKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       758 ~~~~~~~~~~--~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                       ..+.+....  ....+.++..+...+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus       244 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          244 -LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             -THHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             -HHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence             111111111  122334445555667778889999999999999999999999999998863

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.5e-41  Score=399.94  Aligned_cols=251  Identities=23%  Similarity=0.318  Sum_probs=208.7

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      ++|++.++||+|+||.||+|+.. .|+.||||++........+.+.+|+++|++++|||||++++++.+.+..++|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            57999999999999999999875 48999999998766666778999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC--CCeeEecccceeecCCCC
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE--MTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kL~DFGla~~~~~~~  698 (862)
                      ++|+|.++|...  ...+++.++..++.||++||+|||+++   |+||||||+|||++.+  +.+||+|||+|+.+....
T Consensus       237 ~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          237 SGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             CCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            999999988543  335899999999999999999999998   9999999999999854  899999999999874332


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                         .....+||+.|||||++.+..|+.++|||||||++|||++|+.||..   ......+..    +..... ...    
T Consensus       312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~---~~~~~~~~~----i~~~~~-~~~----  376 (573)
T 3uto_A          312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG---ENDDETLRN----VKSCDW-NMD----  376 (573)
T ss_dssp             ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC---SSHHHHHHH----HHTTCC-CCC----
T ss_pred             ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC---cCHHHHHHH----HHhCCC-CCC----
Confidence               23346899999999999999999999999999999999999999742   222222222    221111 000    


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .......+.++.+|+.+||+.||++||++.|+++
T Consensus       377 ~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1112234567889999999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.4e-41  Score=397.84  Aligned_cols=249  Identities=24%  Similarity=0.301  Sum_probs=201.6

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHH---HHHHHhcccCCceEEEEEEEeCCce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNE---VRLIAKLQHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E---~~~l~~l~HpnIv~l~g~~~~~~~~  613 (862)
                      .++|++.++||+|+||.||+|+... |+.||||++.+..   ......+.+|   +.+++.++|||||++++++.+.+..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            3679999999999999999998765 8999999996531   2223334444   5566677899999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      |+||||++||+|.++|....   .+++..+..++.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence            99999999999999996543   4899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      +....    ....+||+.|||||++.+ ..|+.++|+|||||+||||++|+.||......+...    +.+......   
T Consensus       342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~----i~~~i~~~~---  410 (689)
T 3v5w_A          342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTMA---  410 (689)
T ss_dssp             CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH----HHHHHHHCC---
T ss_pred             cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH----HHHhhcCCC---
Confidence            64322    234689999999999975 579999999999999999999999985432222211    111111111   


Q ss_pred             eecccCCCCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPT-----MASVVL  812 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  812 (862)
                            ..++...+.++.+|+.+||+.||++|++     ++||++
T Consensus       411 ------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          411 ------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                  1234455678899999999999999998     788874

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.8e-41  Score=370.17  Aligned_cols=265  Identities=28%  Similarity=0.441  Sum_probs=207.2

Q ss_pred             HHcccccccceeeccccEEEEEeEecCCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       539 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ...++|++.++||+|+||.||+|+. .++.||||++....  ....+++.+|++++++++||||+++++++.+.+..++|
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV  112 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence            3456789999999999999999987 68899999997553  33456899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++++|.+++........+++..++.++.||++||+|||+.+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            999999999999965443345899999999999999999999985 3599999999999999999999999999976432


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ..  .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....   .......   ....        
T Consensus       192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~---~~~~--------  255 (309)
T 3p86_A          192 TF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAV---GFKC--------  255 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHH---HHSC--------
T ss_pred             cc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH---HhcC--------
Confidence            21  222345789999999999999999999999999999999999999753221   1111111   1111        


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCC
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATM  821 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  821 (862)
                      .....+...+..+.+++.+||+.+|++||++.||++.|+.+....
T Consensus       256 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          256 KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            112234455667889999999999999999999999999885543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.4e-40  Score=372.63  Aligned_cols=260  Identities=28%  Similarity=0.423  Sum_probs=214.7

Q ss_pred             cccccccceeeccccEEEEEeEec--------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeC
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL--------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM  610 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~  610 (862)
                      .++|+..+.||+|+||.||+|+..        .+..||||+++... ....+++.+|+.+++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            367889999999999999999753        34579999997653 34567899999999999 899999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhccC-------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl  677 (862)
                      +..++||||+++|+|.+++.....             ...+++.+++.++.||++||+|||+.+   |+||||||+||||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999975432             235889999999999999999999998   9999999999999


Q ss_pred             cCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchh
Q 002969          678 DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELN  756 (862)
Q Consensus       678 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~  756 (862)
                      +.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+.....   ..
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---~~  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GG
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---HH
Confidence            9999999999999997754443333444567889999999999999999999999999999999 8888754322   11


Q ss_pred             HHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       757 l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      +.    .....+..        ...+...+..+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus       314 ~~----~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          314 LF----KLLKEGHR--------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             HH----HHHHTTCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HH----HHHhcCCC--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            21    22222211        1234455678899999999999999999999999998863

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=362.36  Aligned_cols=259  Identities=27%  Similarity=0.436  Sum_probs=212.3

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      ++|...++||+|+||.||+|+... ++.||+|++........+.|.+|++++++++||||+++++++.+.+..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            578889999999999999998754 8899999997766677789999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++...  ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+......
T Consensus        90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            999999999653  335899999999999999999999998   999999999999999999999999999876433221


Q ss_pred             c------------ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcC
Q 002969          701 Q------------NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG  768 (862)
Q Consensus       701 ~------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  768 (862)
                      .            ......||+.|+|||++.+..++.++||||||+++|||++|..|+............. .....   
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~~~---  240 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRGFL---  240 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HHHHH---
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hhccc---
Confidence            1            1113578999999999999999999999999999999999999876433322110000 00000   


Q ss_pred             ceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          769 KVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       769 ~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                            +   ...+...+..+.+++.+||+.||++||++.||++.|+.+.
T Consensus       241 ------~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          241 ------D---RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             ------H---HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------c---ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                  0   0112334456889999999999999999999999998874

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.1e-40  Score=355.02  Aligned_cols=250  Identities=24%  Similarity=0.395  Sum_probs=208.9

Q ss_pred             cccccccceeeccccEEEEEeEe-cCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      .++|+..++||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            35799999999999999999986 45889999999776666678899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|.+++...    .+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            9999999998543    4889999999999999999999998   99999999999999999999999999987643322


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                        ......||+.|+|||++.+..++.++||||||+++|||++|+.||....   ..   ............       ..
T Consensus       172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~---~~~~~~~~~~~~-------~~  236 (297)
T 3fxz_A          172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN---PL---RALYLIATNGTP-------EL  236 (297)
T ss_dssp             --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HH---HHHHHHHHHCSC-------CC
T ss_pred             --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HH---HHHHHHHhCCCC-------CC
Confidence              2234579999999999999999999999999999999999999974321   11   111111111110       01


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..+...+..+.+++.+||+.||++||++.|+++
T Consensus       237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            223445667889999999999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.8e-39  Score=356.35  Aligned_cols=262  Identities=24%  Similarity=0.355  Sum_probs=216.0

Q ss_pred             CccChHHHHHHccc----------ccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccC
Q 002969          530 PLFDFETIVRATDN----------FTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR  598 (862)
Q Consensus       530 ~~~~~~~i~~~~~~----------f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hp  598 (862)
                      +.++++++..+++.          |+..++||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45788888877764          677789999999999999876 5899999999877666778899999999999999


Q ss_pred             CceEEEEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec
Q 002969          599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (862)
Q Consensus       599 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~  678 (862)
                      ||+++++++...+..++||||+++++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+|||++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence            999999999999999999999999999998843    34899999999999999999999998   99999999999999


Q ss_pred             CCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHH
Q 002969          679 KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL  758 (862)
Q Consensus       679 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~  758 (862)
                      .++.+||+|||++..+.....  ......||+.|+|||++.+..++.++||||||+++|||++|+.|+...   ......
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~---~~~~~~  250 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD---SPVQAM  250 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHH
T ss_pred             CCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHH
Confidence            999999999999987643322  223457999999999999999999999999999999999999997432   111111


Q ss_pred             HHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          759 GHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       759 ~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .    .......     +.. ......+..+.+++.+||+.||++||++.|+++.
T Consensus       251 ~----~~~~~~~-----~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          251 K----RLRDSPP-----PKL-KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             H----HHHHSSC-----CCC-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             H----HHhcCCC-----CCc-CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1    1111111     011 1123345678899999999999999999999873

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.9e-40  Score=362.71  Aligned_cols=266  Identities=24%  Similarity=0.340  Sum_probs=208.2

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCc----eEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE----KMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~----~~lV  616 (862)
                      .++|+..++||+|+||.||+|+.. ++.||||++.... .....+..|+.++++++||||+++++++.+...    .++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            468999999999999999999875 7899999996543 334456679999999999999999999987554    6999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc----------CCCcEEecccCCcceEecCCCCeeEe
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD----------SRFRIIHRDLKASNILLDKEMTPKIS  686 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~----------~~~~ivHrDlkp~NILl~~~~~~kL~  686 (862)
                      |||+++|+|.+++...    .+++..+..++.||++||+|||+.          +   |+||||||+|||++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence            9999999999999542    389999999999999999999998          6   9999999999999999999999


Q ss_pred             cccceeecCCCCcccccccccccccccChhhhcCC-----CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhH----
Q 002969          687 DFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG-----LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNL----  757 (862)
Q Consensus       687 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l----  757 (862)
                      |||+++.+.............||+.|+|||++.+.     .++.++|||||||++|||++|+.|+...........    
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999887654444444446799999999999873     456788999999999999999999764322211111    


Q ss_pred             -----HHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          758 -----LGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       758 -----~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                           ................+...  ......+.++.+++.+||+.||++|||+.||++.|+.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDY--WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGG--GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCcccc--ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                 11111111111111111110  01234566789999999999999999999999999876

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.3e-40  Score=368.70  Aligned_cols=269  Identities=28%  Similarity=0.403  Sum_probs=217.3

Q ss_pred             cChHHHHHHcccccccceeeccccEEEEEeEe------cCCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEE
Q 002969          532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRL  603 (862)
Q Consensus       532 ~~~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l  603 (862)
                      ++..+.....++|+..++||+|+||.||+|++      .+++.||||+++... ....+.+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            55566666778999999999999999999973      235789999997643 33456799999999999 79999999


Q ss_pred             EEEEEeCCc-eEEEEEeccCCChhhhhhhccC------------------------------------------------
Q 002969          604 LGCCVEMDE-KMLVYEYMENRSLDSVIFDKAR------------------------------------------------  634 (862)
Q Consensus       604 ~g~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------  634 (862)
                      ++++.+.+. .++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999987654 8999999999999999965432                                                


Q ss_pred             ---------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          635 ---------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       635 ---------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                                     ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           122889999999999999999999998   99999999999999999999999999987654443


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                      ........||+.|+|||++.+..++.++||||||+++|||++ |+.|+.......      ........+..        
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~--------  314 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTR--------  314 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCC--------
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCC--------
Confidence            334445678999999999999999999999999999999998 999975432221      11122222211        


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ...+...+.++.+++.+||+.+|++||++.||+++|+.+
T Consensus       315 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            122334556788999999999999999999999999876

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.3e-40  Score=361.96  Aligned_cols=259  Identities=27%  Similarity=0.404  Sum_probs=209.7

Q ss_pred             cccccccceeeccccEEEEEeEec----CCcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      .++|++.++||+|+||.||+|+..    .+..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            357888899999999999999874    3456999999765 34456789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||+++++|.+++...  ...+++.+++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            99999999999999543  235899999999999999999999998   9999999999999999999999999998775


Q ss_pred             CCCcc-cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeee
Q 002969          696 GDQTE-QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       696 ~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  773 (862)
                      ..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....   ....    ......+.    
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~---~~~~----~~~~~~~~----  271 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT---NRDV----ISSVEEGY----  271 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHH----HHHHHTTC----
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC---HHHH----HHHHHcCC----
Confidence            43221 12223456788999999999999999999999999999999 999864321   1111    12222221    


Q ss_pred             ecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       774 id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                          ....+...+..+.+++.+||+.||++||++.||++.|+.+..
T Consensus       272 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          272 ----RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                112234456788899999999999999999999999998743

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.7e-40  Score=371.26  Aligned_cols=257  Identities=26%  Similarity=0.377  Sum_probs=210.4

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .++|...++||+|+||.||+|+.. +++.||||+++... ....++|.+|++++++++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            457888999999999999999986 58899999987543 3345678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++|+|.+++....  ..+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            999999999996532  34889999999999999999999998   9999999999999999999999999998754322


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      .........++..|+|||.+.+..++.++||||||+++|||++ |..|+.....   .    ........+..       
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~----~~~~~~~~~~~-------  333 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---Q----QTREFVEKGGR-------  333 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---H----HHHHHHHTTCC-------
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---H----HHHHHHHcCCC-------
Confidence            2221222345778999999999999999999999999999998 8888643221   1    11222222211       


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                       ...+...+..+.+++.+||+.||++||++.+|++.|+.+
T Consensus       334 -~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          334 -LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence             122344566788999999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.6e-40  Score=359.87  Aligned_cols=248  Identities=27%  Similarity=0.374  Sum_probs=207.0

Q ss_pred             cccccccceeeccccEEEEEeEe-cCCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      .++|+..+.||+|+||.||+|+. .+++.||||++...  .....+.+.+|++++++++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            45799999999999999999987 46899999999654  3345677899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++....   .+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            9999999999996543   4899999999999999999999998   999999999999999999999999999866432


Q ss_pred             CcccccccccccccccChhhhcCCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFS-VKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      .   ......||+.|+|||++.+..+. .++|||||||++|||++|+.||...   ....+.    .....+.       
T Consensus       168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~----~~i~~~~-------  230 (328)
T 3fe3_A          168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ---NLKELR----ERVLRGK-------  230 (328)
T ss_dssp             C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHH----HHHHHCC-------
T ss_pred             C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC---CHHHHH----HHHHhCC-------
Confidence            2   23346799999999999988875 7999999999999999999997432   211221    1122211       


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                        ...+...+.++.+++.+||+.||++|||++|+++.
T Consensus       231 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          231 --YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             --CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             --CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              12233456678899999999999999999999863

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.7e-39  Score=346.39  Aligned_cols=256  Identities=28%  Similarity=0.417  Sum_probs=211.4

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      .++|+..+.||+|+||.||+|+..++..||||++.... ...+++.+|++++++++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            46789999999999999999999888899999996543 34567999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++....  ..+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            9999999996542  34899999999999999999999998   999999999999999999999999999876443222


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                       ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+......   ...    .....+.        ..
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~----~~~~~~~--------~~  224 (268)
T 3sxs_A          161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS---EVV----LKVSQGH--------RL  224 (268)
T ss_dssp             -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHH----HHHHTTC--------CC
T ss_pred             -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH---HHH----HHHHcCC--------CC
Confidence             2223456778999999999899999999999999999999 99886432211   111    1111111        11


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      ..+...+..+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            122334567889999999999999999999999999873

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=349.05  Aligned_cols=271  Identities=20%  Similarity=0.272  Sum_probs=216.3

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCC--ceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD--EKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--~~~lV~  617 (862)
                      ++|...++||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            578999999999999999998765 8899999997543 344677889999999999999999999998765  679999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe----cCCCCeeEecccceee
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL----DKEMTPKISDFGMARI  693 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kL~DFGla~~  693 (862)
                      ||+++++|.+++........+++.+++.++.||++||+|||+.+   |+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999977655555999999999999999999999998   9999999999999    7888899999999987


Q ss_pred             cCCCCcccccccccccccccChhhhc--------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc-chhHHHHHHHH
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAM--------DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN-ELNLLGHVWRL  764 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~--------~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~-~~~l~~~~~~~  764 (862)
                      +.....   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||....... .......+...
T Consensus       166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            644322   22356899999999986        5778999999999999999999999975433222 22222222221


Q ss_pred             HhcCceeeee----------cc--cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          765 WKEGKVLEMV----------DS--SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       765 ~~~~~~~~~i----------d~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      ..........          ..  ............+.+++.+||+.||++||+++|+++...+..
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            1111111110          00  112345667788899999999999999999999999998763

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=9.8e-40  Score=353.50  Aligned_cols=265  Identities=26%  Similarity=0.406  Sum_probs=208.6

Q ss_pred             ccccccceeeccccEEEEEeEe-----cCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeC--CceE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRL-----LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKM  614 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~  614 (862)
                      ++|+..++||+|+||.||+++.     .+++.||||++........+.+.+|++++++++||||+++++++...  ...+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            5789999999999999999984     24789999999877666778899999999999999999999998654  5589


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      +||||+++++|.+++....  ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        90 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             EEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            9999999999999996543  34899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcc-cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCC---------CcchhHHHHHHHH
Q 002969          695 GGDQTE-QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHS---------NNELNLLGHVWRL  764 (862)
Q Consensus       695 ~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~---------~~~~~l~~~~~~~  764 (862)
                      ...... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....         .............
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  244 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence            433221 122234577889999999999999999999999999999999988643210         0001111122222


Q ss_pred             HhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       765 ~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                      ...+.        ....+...+.++.+++.+||+.||++||++.||++.|+.+..
T Consensus       245 ~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          245 LKNNG--------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHTTC--------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhccC--------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            22211        122344556788999999999999999999999999988643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.9e-40  Score=349.32  Aligned_cols=254  Identities=29%  Similarity=0.446  Sum_probs=210.3

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      ++|+..+.||+|+||.||+|+..+++.||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            5788899999999999999999889999999997543 345779999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +++|.+++...  ...+++..++.++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++....... .
T Consensus        89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  162 (269)
T 4hcu_A           89 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  162 (269)
T ss_dssp             TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred             CCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence            99999999543  345899999999999999999999998   99999999999999999999999999986543221 1


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      ......+++.|+|||++.+..++.++||||||+++|||++ |+.|+...   ......    .....+.        ...
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~---~~~~~~----~~~~~~~--------~~~  227 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVV----EDISTGF--------RLY  227 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHH----HHHHTTC--------CCC
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC---CHHHHH----HHHhcCc--------cCC
Confidence            2223456788999999999999999999999999999999 88886432   111121    1222211        112


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence            2333456788999999999999999999999999876

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-39  Score=358.95  Aligned_cols=256  Identities=26%  Similarity=0.452  Sum_probs=203.2

Q ss_pred             ccccccceeeccccEEEEEeEecC-Cc----EEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ----EIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ++|+..++||+|+||.||+|+... ++    +||+|++... .....++|.+|+.++++++||||+++++++.+. ..++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence            578899999999999999998643 43    3688888644 334567899999999999999999999999875 4789


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      |+||+++|+|.+++....  ..+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        94 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            999999999999996533  35899999999999999999999998   9999999999999999999999999998875


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.......   ..    .....+.     
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~----~~~~~~~-----  236 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKGE-----  236 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTC-----
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HH----HHHHcCC-----
Confidence            5444444444567889999999999999999999999999999999 999975432221   11    1111111     


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                         ....+...+..+.+++.+||+.+|++||++.||++.|+.+.
T Consensus       237 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~  277 (327)
T 3poz_A          237 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             ---CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence               11223445668889999999999999999999999997753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-40  Score=362.10  Aligned_cols=263  Identities=26%  Similarity=0.414  Sum_probs=214.9

Q ss_pred             HHcccccccceeeccccEEEEEeEecC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCC
Q 002969          539 RATDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD  611 (862)
Q Consensus       539 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  611 (862)
                      ...++|+..+.||+|+||.||+|+...      ++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            345789999999999999999998753      4789999997653 334678999999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhccC---------------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEeccc
Q 002969          612 EKMLVYEYMENRSLDSVIFDKAR---------------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDL  670 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDl  670 (862)
                      ..++||||+++++|.+++.....                     ...+++.+++.++.||++||+|||+.+   |+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            99999999999999999965321                     146899999999999999999999998   999999


Q ss_pred             CCcceEecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 002969          671 KASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFY  749 (862)
Q Consensus       671 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~  749 (862)
                      ||+|||++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999987643333233334567899999999999999999999999999999999 88886432


Q ss_pred             CCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          750 HSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       750 ~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                         ...    ........+..        ...+...+.++.+++.+||+.+|++||++.||++.|+++..
T Consensus       281 ---~~~----~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          281 ---AHE----EVIYYVRDGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             ---CHH----HHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ---ChH----HHHHHHhCCCc--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence               111    12222222221        12334456688999999999999999999999999998743

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=366.09  Aligned_cols=265  Identities=27%  Similarity=0.405  Sum_probs=217.3

Q ss_pred             cccccccceeeccccEEEEEeEec--------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeC
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL--------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM  610 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~  610 (862)
                      .++|...++||+|+||.||+|+..        .+..||||+++... ....+++.+|+++++++ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            468899999999999999999853        23579999997653 34557899999999999 899999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhccC-------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl  677 (862)
                      +..++||||+++++|.+++.....             ...+++.+++.++.||++||+|||+.+   |+||||||+||||
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence            999999999999999999975432             235899999999999999999999998   9999999999999


Q ss_pred             cCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchh
Q 002969          678 DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELN  756 (862)
Q Consensus       678 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~  756 (862)
                      +.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....   .  
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~---~--  299 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---V--  299 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---H--
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---H--
Confidence            9999999999999987654433333444567899999999999999999999999999999999 888864321   1  


Q ss_pred             HHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCCCC
Q 002969          757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQ  823 (862)
Q Consensus       757 l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  823 (862)
                        ....+.+..+..        ...+...+.++.+++.+||+.+|++||++.||++.|+.+.+..+.
T Consensus       300 --~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  356 (382)
T 3tt0_A          300 --EELFKLLKEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN  356 (382)
T ss_dssp             --HHHHHHHHTTCC--------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred             --HHHHHHHHcCCC--------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence              122223333221        122334556788999999999999999999999999998544433

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.7e-39  Score=353.00  Aligned_cols=260  Identities=17%  Similarity=0.193  Sum_probs=209.8

Q ss_pred             cccccccceeeccccEEEEEeEe-cCCcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .++|+..++||+|+||.||+|+. .+++.||||++....  ..+++.+|+++++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            35789999999999999999986 458899999986543  235688999999999 99999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC-----eeEecccceee
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT-----PKISDFGMARI  693 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~-----~kL~DFGla~~  693 (862)
                      |+ +++|.+++...  ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999998653  345999999999999999999999998   999999999999998887     99999999997


Q ss_pred             cCCCCccc-----ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcC
Q 002969          694 FGGDQTEQ-----NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG  768 (862)
Q Consensus       694 ~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  768 (862)
                      +.......     ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.......+.......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            64432211     1234679999999999999999999999999999999999999986554443333332221111110


Q ss_pred             ceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          769 KVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       769 ~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .    ..    ......+ ++.+++..||+.+|.+||++.+|++.|+.+
T Consensus       240 ~----~~----~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          240 P----IE----VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             C----HH----HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             C----HH----HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            0    00    0011123 788999999999999999999999998765

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.9e-39  Score=352.57  Aligned_cols=253  Identities=26%  Similarity=0.319  Sum_probs=204.3

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ++|+..++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            57999999999999999999876 58899999986543 23356789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|.+++...   ..+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus        87 ~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           87 CSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             CTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            9999999998533   34899999999999999999999998   99999999999999999999999999987644333


Q ss_pred             ccccccccccccccChhhhcCCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLF-SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                      ........||+.|+|||++.+..+ +.++||||||+++|||++|+.||........  ..    ..+....       ..
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~----~~~~~~~-------~~  227 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EY----SDWKEKK-------TY  227 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HH----HHHHTTC-------TT
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HH----HHHhccc-------cc
Confidence            333445689999999999988775 7899999999999999999999754322211  11    1111110       00


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            11123445678899999999999999999999863

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-39  Score=358.66  Aligned_cols=266  Identities=26%  Similarity=0.419  Sum_probs=212.0

Q ss_pred             HcccccccceeeccccEEEEEeEec------CCcEEEEEEeccC-CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCC
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD  611 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~  611 (862)
                      ..++|+..+.||+|+||.||+|+..      .+..||||++... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            3468999999999999999999862      3567999999754 334567899999999999 8999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhccCC--------------------CCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccC
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARS--------------------SILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK  671 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlk  671 (862)
                      ..++||||+++|+|.+++......                    ..+++..++.++.||++||+|||+.+   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            999999999999999999654321                    34789999999999999999999998   9999999


Q ss_pred             CcceEecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 002969          672 ASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYH  750 (862)
Q Consensus       672 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~  750 (862)
                      |+|||++.++.+||+|||++..+.............+|+.|+|||++.+..++.++||||||+++|||++ |..|+....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987654433333344567889999999999999999999999999999998 998875432


Q ss_pred             CCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCCC
Q 002969          751 SNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMP  822 (862)
Q Consensus       751 ~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~  822 (862)
                      ...      ........+..        ...+...+.++.+++.+||+.||++||++.||++.|+......+
T Consensus       280 ~~~------~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          280 VDA------NFYKLIQNGFK--------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             CSH------HHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             cHH------HHHHHHhcCCC--------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence            221      11122222211        12233456678899999999999999999999999998754433

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.5e-40  Score=368.06  Aligned_cols=258  Identities=29%  Similarity=0.450  Sum_probs=199.5

Q ss_pred             cccccccceeeccccEEEEEeEec----CCcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      .++|+..++||+|+||.||+|+..    .+..||||+++.. .....++|.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357899999999999999999875    4677999999765 33456789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||+++++|.+++...  ...+++.+++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999999643  345899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcc-cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeee
Q 002969          696 GDQTE-QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       696 ~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  773 (862)
                      ..... .......++..|+|||++.+..++.++||||||+++|||++ |+.|+....   ...    .......+..   
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~---~~~----~~~~i~~~~~---  268 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS---NQD----VIKAVDEGYR---  268 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC---HHH----HHHHHHTTEE---
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC---HHH----HHHHHHcCCC---
Confidence            33221 11222345778999999999999999999999999999998 999864321   111    1222222211   


Q ss_pred             ecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       774 id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                           ...+...+..+.+++.+||+.+|++||++.||++.|+.+.
T Consensus       269 -----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~  308 (373)
T 2qol_A          269 -----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI  308 (373)
T ss_dssp             -----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence                 1223345678899999999999999999999999998864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.7e-39  Score=354.39  Aligned_cols=260  Identities=27%  Similarity=0.419  Sum_probs=214.2

Q ss_pred             cccccccceeeccccEEEEEeEec------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  613 (862)
                      .++|...+.||+|+||.||+|+..      +++.||||++.... ....+++.+|++++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            467899999999999999999762      35789999997643 34567899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccC---------------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCC
Q 002969          614 MLVYEYMENRSLDSVIFDKAR---------------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKA  672 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp  672 (862)
                      ++||||+++++|.+++.....                     ...+++.+++.++.||++||+|||+.+   |+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            999999999999999975432                     234889999999999999999999998   99999999


Q ss_pred             cceEecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCC
Q 002969          673 SNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHS  751 (862)
Q Consensus       673 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~  751 (862)
                      +|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987754443333334567889999999999999999999999999999999 9988753322


Q ss_pred             CcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          752 NNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       752 ~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      .   ...    .....+..        ...+...+..+.+++.+||+.||++||++.||++.|+++.
T Consensus       259 ~---~~~----~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          259 E---RLF----NLLKTGHR--------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             G---GHH----HHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H---HHH----HHhhcCCc--------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1   111    22222211        1223445678889999999999999999999999998763

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.5e-39  Score=355.90  Aligned_cols=271  Identities=25%  Similarity=0.359  Sum_probs=213.0

Q ss_pred             ccccccceeeccccEEEEEeEe-----cCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEE--eCCceE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRL-----LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV--EMDEKM  614 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~--~~~~~~  614 (862)
                      ++|+..++||+|+||.||+++.     ..++.||||++........+.+.+|++++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5788999999999999999984     357889999998776666788999999999999999999999987  455689


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      +||||+++++|.+++....  ..+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            9999999999999996532  24899999999999999999999998   999999999999999999999999999877


Q ss_pred             CCCCcc-cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCC--------cchhHHHHHHHHH
Q 002969          695 GGDQTE-QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSN--------NELNLLGHVWRLW  765 (862)
Q Consensus       695 ~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~--------~~~~l~~~~~~~~  765 (862)
                      ...... .......+|..|+|||++.+..++.++||||||+++|||++|+.|+......        .............
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL  257 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence            543322 1223346788899999999999999999999999999999999986421110        0001111222222


Q ss_pred             hcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCCCCCC
Q 002969          766 KEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPK  825 (862)
Q Consensus       766 ~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~  825 (862)
                      ..+.        ....+...+..+.+++.+||+.||++||++.||++.|+.+........
T Consensus       258 ~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~  309 (327)
T 3lxl_A          258 EEGQ--------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE  309 (327)
T ss_dssp             HTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred             hccc--------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence            2211        122344566788999999999999999999999999999865444333

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.2e-39  Score=349.20  Aligned_cols=265  Identities=26%  Similarity=0.414  Sum_probs=206.2

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      ++|+..++||+|+||.||+|+. .++.||||++...  ...+.|.+|++++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            5688889999999999999987 4788999998643  34578999999999999999999999876  45899999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC-eeEecccceeecCCCCcc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT-PKISDFGMARIFGGDQTE  700 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~-~kL~DFGla~~~~~~~~~  700 (862)
                      +++|.+++........+++..++.++.||++||+|||+.+..+|+||||||+|||++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999976554445788999999999999999999943234999999999999998887 799999999765322   


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                        .....||+.|+|||++.+..++.++||||||+++|||++|+.|+.......    ....+ ....+..        ..
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~-~~~~~~~--------~~  224 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMW-AVHNGTR--------PP  224 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHH-HHHTTCC--------CC
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHH-HHhcCCC--------CC
Confidence              123468999999999999999999999999999999999999975432221    11111 1111111        11


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCCCCCCCCcc
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGF  829 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~  829 (862)
                      .+...+..+.+++.+||+.+|++||++.|+++.|+.+....+.+..|..
T Consensus       225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~  273 (307)
T 2eva_A          225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ  273 (307)
T ss_dssp             CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCC
T ss_pred             cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccc
Confidence            2233456788999999999999999999999999987665555554443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.1e-38  Score=350.52  Aligned_cols=252  Identities=24%  Similarity=0.355  Sum_probs=201.4

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCc------
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE------  612 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~------  612 (862)
                      .++|+..++||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+...      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            357899999999999999999886 68999999997543 3456789999999999999999999999876542      


Q ss_pred             ---------------------------------------------------eEEEEEeccCCChhhhhhhccCCCCCCHh
Q 002969          613 ---------------------------------------------------KMLVYEYMENRSLDSVIFDKARSSILNWQ  641 (862)
Q Consensus       613 ---------------------------------------------------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~  641 (862)
                                                                         .++||||+++++|.+++..........+.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                               79999999999999999776655556777


Q ss_pred             hHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc----------ccccccccccc
Q 002969          642 RRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE----------QNTKRVVGTYG  711 (862)
Q Consensus       642 ~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~----------~~~~~~~gt~~  711 (862)
                      .++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+......          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            88999999999999999998   999999999999999999999999999887543221          11233578999


Q ss_pred             ccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHH
Q 002969          712 YMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIH  791 (862)
Q Consensus       712 y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~  791 (862)
                      |+|||++.+..++.++||||||+++|||++|..|..        .. ...........        ...........+.+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~-~~~~~~~~~~~--------~~~~~~~~~~~~~~  304 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ER-VRIITDVRNLK--------FPLLFTQKYPQEHM  304 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HH-HHHHHHHHTTC--------CCHHHHHHCHHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HH-HHHHHHhhccC--------CCcccccCChhHHH
Confidence            999999999999999999999999999999876621        11 11111111111        11112334456789


Q ss_pred             HHHhccccCCCCCCCHHHHHH
Q 002969          792 VGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       792 li~~cl~~dP~~RPt~~evl~  812 (862)
                      ++.+||+.||++||++.|+++
T Consensus       305 li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          305 MVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCCCCcCCCHHHHhh
Confidence            999999999999999999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.6e-39  Score=356.47  Aligned_cols=261  Identities=25%  Similarity=0.401  Sum_probs=196.8

Q ss_pred             cccccccceeeccccEEEEEeEecCCc----EEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCce-
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQ----EIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK-  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~----~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~-  613 (862)
                      .++|+..+.||+|+||.||+|+.....    .||||+++..  .....+++.+|++++++++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            467999999999999999999876533    7999999764  344578899999999999999999999999877665 


Q ss_pred             -----EEEEEeccCCChhhhhhhccC---CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeE
Q 002969          614 -----MLVYEYMENRSLDSVIFDKAR---SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (862)
Q Consensus       614 -----~lV~E~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL  685 (862)
                           ++|+||+++++|.+++.....   ...+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence                 999999999999999865432   225899999999999999999999998   999999999999999999999


Q ss_pred             ecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHH
Q 002969          686 SDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRL  764 (862)
Q Consensus       686 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~  764 (862)
                      +|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......   .....    
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~----  251 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYNY----  251 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHHH----
Confidence            99999987654433333334456889999999999999999999999999999999 88886532221   22211    


Q ss_pred             HhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       765 ~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                      ...+.        ....+...+..+.+++.+||+.||++||++.|+++.|+++..
T Consensus       252 ~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          252 LIGGN--------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             HHTTC--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhcCC--------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            11111        112234455678999999999999999999999999998743

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.2e-39  Score=355.55  Aligned_cols=248  Identities=23%  Similarity=0.288  Sum_probs=206.7

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..+.||+|+||.||+++.. +++.||+|++++.   .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57899999999999999999876 4889999999754   2345678899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++|+|..++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        85 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            999999999998643   34899999999999999999999998   999999999999999999999999999864322


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                        ........||+.|+|||++.+..++.++||||||+++|||++|+.|+..   .+.......    .....        
T Consensus       159 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~---~~~~~~~~~----i~~~~--------  221 (337)
T 1o6l_A          159 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFEL----ILMEE--------  221 (337)
T ss_dssp             --TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHH----HHHCC--------
T ss_pred             --CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC---CCHHHHHHH----HHcCC--------
Confidence              1223346799999999999999999999999999999999999999742   122222221    11111        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERP-----TMASVVLM  813 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  813 (862)
                       ..++...+.++.+++.+||+.||++||     ++.||++.
T Consensus       222 -~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          222 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence             122344566788999999999999999     89999863

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.2e-38  Score=348.10  Aligned_cols=261  Identities=23%  Similarity=0.361  Sum_probs=203.3

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .++|+..++||+|+||.||+|+..+++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            36899999999999999999999889999999996542  2335678999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++ +|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            9985 787777543  234899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee------
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL------  771 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------  771 (862)
                        .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......   .....+..........      
T Consensus       174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD---DQLPKIFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT---THHHHHHHHHCCCCTTTSGGGT
T ss_pred             --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHHCCCChHHhhhhh
Confidence              22233568999999999876 56899999999999999999999997543332   2233333222211100      


Q ss_pred             ----------eeecccC-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 ----------EMVDSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 ----------~~id~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                                ....... .........++.+|+.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                      0000000 0011223457889999999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.4e-39  Score=372.21  Aligned_cols=261  Identities=28%  Similarity=0.422  Sum_probs=208.4

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      .++|+..++||+|+||.||+|+..++..||||+++... ...++|.+|++++++++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            46788889999999999999999888889999997643 345789999999999999999999999876 7789999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++|+|.+++.... ...+++.+++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus       261 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-  335 (452)
T 1fmk_A          261 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  335 (452)
T ss_dssp             TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             cCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce-
Confidence            9999999996432 234899999999999999999999998   99999999999999999999999999987643221 


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....   ...    ....+..+..        .
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~---~~~----~~~~i~~~~~--------~  400 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NRE----VLDQVERGYR--------M  400 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHH----HHHHHHTTCC--------C
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC---HHH----HHHHHHcCCC--------C
Confidence            11223456789999999999999999999999999999999 888864321   111    1222222211        1


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCCCC
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQ  823 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~  823 (862)
                      ..+...+..+.+++.+||+.+|++||++.+|++.|+......+.
T Consensus       401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~  444 (452)
T 1fmk_A          401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  444 (452)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence            22345567888999999999999999999999999998554433

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.9e-39  Score=373.51  Aligned_cols=258  Identities=28%  Similarity=0.432  Sum_probs=211.6

Q ss_pred             HcccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ..++|+..++||+|+||.||+|+..++..||||+++... ...++|.+|+.++++++||||+++++++. .+..++||||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            456788899999999999999999888999999997643 45788999999999999999999999986 6778999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++|+|.+++.... ...+++..++.++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       264 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~  339 (454)
T 1qcf_A          264 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  339 (454)
T ss_dssp             CTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred             cCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence            99999999996432 224788999999999999999999998   99999999999999999999999999987643211


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                       .......++..|+|||++....++.++||||||+++|||++ |+.|+....   .....    ..+..+..        
T Consensus       340 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~---~~~~~----~~i~~~~~--------  403 (454)
T 1qcf_A          340 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVI----RALERGYR--------  403 (454)
T ss_dssp             -HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHH----HHHHHTCC--------
T ss_pred             -eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC---HHHHH----HHHHcCCC--------
Confidence             11122346788999999999999999999999999999999 998864321   11222    22222211        


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                      ...+...+.++.+++.+||+.||++||++.+|++.|+....
T Consensus       404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            11234456788999999999999999999999999998743

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.7e-39  Score=346.34  Aligned_cols=260  Identities=27%  Similarity=0.359  Sum_probs=206.5

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .++|+..++||+|+||.||+++.. .++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            357999999999999999999865 48899999986542   33457899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++++|.+++....   .+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus        90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999996543   4899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....      .....+.... .....   
T Consensus       164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~-~~~~~---  232 (294)
T 4eqm_A          164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQD-SVPNV---  232 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSS-CCCCH---
T ss_pred             ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhc-cCCCc---
Confidence            221 222345789999999999999999999999999999999999999743211      1111111111 11110   


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhccCc
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERP-TMASVVLMLSSET  818 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~  818 (862)
                       ........+..+.+++.+||+.||++|| +++++.+.|+...
T Consensus       233 -~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          233 -TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             -HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             -chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence             0112233456788999999999999999 9999999998873

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.8e-38  Score=343.62  Aligned_cols=263  Identities=17%  Similarity=0.209  Sum_probs=213.5

Q ss_pred             cccccccceeeccccEEEEEeEe-cCCcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .++|+..+.||+|+||.||+|+. .+++.||||++....  ..+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            35799999999999999999986 458899999986543  345688999999999 79999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC-----eeEecccceee
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT-----PKISDFGMARI  693 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~-----~kL~DFGla~~  693 (862)
                      |+ +++|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 99999999653  234899999999999999999999998   999999999999987776     99999999987


Q ss_pred             cCCCCcc-----cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcC
Q 002969          694 FGGDQTE-----QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG  768 (862)
Q Consensus       694 ~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  768 (862)
                      +......     .......||+.|+|||++.+..++.++||||||+++|||++|+.|+..............+.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            7543222     12334679999999999999999999999999999999999999987644443333333332221111


Q ss_pred             ceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          769 KVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       769 ~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                      ..        .......+..+.+++.+||+.+|++||++.+|++.|+++..
T Consensus       241 ~~--------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          241 PL--------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             CH--------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cH--------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            11        01112345678899999999999999999999999988743

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.7e-39  Score=357.06  Aligned_cols=257  Identities=25%  Similarity=0.375  Sum_probs=205.8

Q ss_pred             ccccccceeeccccEEEEEeEecC-Cc----EEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ----EIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ++|+..++||+|+||.||+|+... ++    .||+|.+... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            468888999999999999998654 43    3888887544 2445567889999999999999999999986 567899


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      |+||+++|+|.+++...  ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999998643  235899999999999999999999998   9999999999999999999999999998875


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ............++..|+|||++.+..++.++||||||+++|||++ |+.|+.......   .    ......+..    
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~~~~----  235 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---V----PDLLEKGER----  235 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---H----HHHHHTTCB----
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---H----HHHHHcCCC----
Confidence            5444444445678889999999999999999999999999999999 999975432221   1    112222211    


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                          ...+...+..+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus       236 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          236 ----LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             ----CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             ----CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                11222344467789999999999999999999999988643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=364.85  Aligned_cols=261  Identities=30%  Similarity=0.415  Sum_probs=211.2

Q ss_pred             cccccccceeeccccEEEEEeEec------CCcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  613 (862)
                      .++|+..++||+|+||.||+|+..      .++.||||+++.. ......++.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            357888999999999999999853      3568999999654 344556789999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcc----CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC---CeeEe
Q 002969          614 MLVYEYMENRSLDSVIFDKA----RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM---TPKIS  686 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kL~  686 (862)
                      ++||||+++|+|.+++....    ....+++.+++.++.||++||+|||+.+   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999996543    2245899999999999999999999998   99999999999999555   59999


Q ss_pred             cccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHH
Q 002969          687 DFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLW  765 (862)
Q Consensus       687 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  765 (862)
                      |||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |..|+...   .....    ....
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~---~~~~~----~~~i  299 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEV----LEFV  299 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHH----HHHH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---CHHHH----HHHH
Confidence            9999986533333233334567899999999999999999999999999999998 88886432   21122    2222


Q ss_pred             hcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          766 KEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       766 ~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                      ..+..        ...+...+..+.+++.+||+.+|++||++.||++.|+....
T Consensus       300 ~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          300 TSGGR--------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             HTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HcCCC--------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            22211        12234455678899999999999999999999999987643

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.4e-38  Score=345.04  Aligned_cols=262  Identities=24%  Similarity=0.321  Sum_probs=202.1

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHh--cccCCceEEEEEEEeC----CceE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAK--LQHRNLVRLLGCCVEM----DEKM  614 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~g~~~~~----~~~~  614 (862)
                      .++|+..++||+|+||.||+|+. +++.||||++...   ..+.+..|.+++..  ++||||+++++++...    ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46799999999999999999987 6899999998643   34566777777777  7899999999997653    4578


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhh--------hcCCCcEEecccCCcceEecCCCCeeEe
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH--------QDSRFRIIHRDLKASNILLDKEMTPKIS  686 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~ivHrDlkp~NILl~~~~~~kL~  686 (862)
                      +||||+++|+|.+++..    ..+++..+++++.||++||+|||        +.+   |+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence            99999999999999943    35899999999999999999999        665   9999999999999999999999


Q ss_pred             cccceeecCCCCccc--ccccccccccccChhhhcCC------CCCccccchhHHHHHHHHHhC----------CCCCCC
Q 002969          687 DFGMARIFGGDQTEQ--NTKRVVGTYGYMSPEYAMDG------LFSVKSDVFSFGVLLLETVSG----------KKNRGF  748 (862)
Q Consensus       687 DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~------~~s~ksDVwSlGvil~elltG----------~~p~~~  748 (862)
                      |||+++.........  ......||+.|+|||++.+.      .++.++||||||+++|||++|          +.|+..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            999998764432221  12234789999999999876      455799999999999999999          666543


Q ss_pred             CCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          749 YHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       749 ~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ......  .................+..  ...+...+..+.+++.+||+.||++|||+.||++.|+++
T Consensus       236 ~~~~~~--~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          236 VVPNDP--SFEDMRKVVCVDQQRPNIPN--RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TSCSSC--CHHHHHHHHTTSCCCCCCCG--GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCc--chhhhhHHHhccCCCCCCCh--hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            222221  11222222211111100000  112334677899999999999999999999999999864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.8e-39  Score=373.89  Aligned_cols=257  Identities=26%  Similarity=0.403  Sum_probs=213.1

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      .++|+..++||+|+||.||+|+... +..||||+++... ...++|.+|+.+|++++||||++++++|.+.+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            4568888999999999999999876 7899999997543 3467899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++|+|.+++.... ...+++..++.++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.......
T Consensus       298 ~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             cCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            99999999996533 345899999999999999999999998   99999999999999999999999999987643322


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                       .......++..|+|||++....++.++||||||++||||++ |+.|+......   ...    +.+..+..        
T Consensus       374 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~----~~~~~~~~--------  437 (495)
T 1opk_A          374 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVY----ELLEKDYR--------  437 (495)
T ss_dssp             -ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHH----HHHHTTCC--------
T ss_pred             -eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCC--------
Confidence             12223456789999999999999999999999999999999 88886532221   111    12222111        


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      ...+...+..+.+|+.+||+.+|++||++.||++.|+.+.
T Consensus       438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            1224455678889999999999999999999999999874

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.8e-39  Score=346.59  Aligned_cols=255  Identities=27%  Similarity=0.412  Sum_probs=207.4

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      .++|+..++||+|+||.||+++..++..||||++.... ...+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            46789999999999999999999888899999997543 33577999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++....  ..+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus       102 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  175 (283)
T 3gen_A          102 ANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-  175 (283)
T ss_dssp             TTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence            9999999996532  34899999999999999999999998   99999999999999999999999999986543221 


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                      .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.....   ....    .....+.        ..
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---~~~~----~~~~~~~--------~~  240 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETA----EHIAQGL--------RL  240 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHH----HHHHTTC--------CC
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---hHHH----HHHhccc--------CC
Confidence            11223456788999999999999999999999999999998 9998653221   1111    1112211        11


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ..+...+..+.+++.+||+.+|++||++.|+++.|..+
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            12233456788999999999999999999999999875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.2e-38  Score=366.15  Aligned_cols=250  Identities=28%  Similarity=0.402  Sum_probs=207.4

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCC-ceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD-EKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~lV~E~  619 (862)
                      .++|+..++||+|+||.||+|+.. ++.||||+++...  ..+.|.+|++++++++||||+++++++.+.+ ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            457888899999999999999874 7899999997543  5678999999999999999999999988765 78999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++|+|.+++.... ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus       269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            99999999996543 334789999999999999999999998   999999999999999999999999999864321  


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                         .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+   ..    ..+..+..        
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~----~~i~~~~~--------  404 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKGYK--------  404 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HH----HHHHTTCC--------
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCC--------
Confidence               112356889999999999999999999999999999998 999875433222   11    12222211        


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ...+...+..+.+++.+||+.||++||++.+|++.|+.+
T Consensus       405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            123445567889999999999999999999999999876

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.8e-39  Score=350.70  Aligned_cols=261  Identities=26%  Similarity=0.400  Sum_probs=213.4

Q ss_pred             cccccccceeeccccEEEEEeEe------cCCcEEEEEEeccCCc-cchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCc
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDE  612 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~  612 (862)
                      .++|+..+.||+|+||.||+|+.      ..++.||||+++.... ...+.+.+|+.+++++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46789999999999999999974      2367899999976533 3457899999999999 99999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhccC---------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe
Q 002969          613 KMLVYEYMENRSLDSVIFDKAR---------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl  677 (862)
                      .++||||+++++|.+++.....               ...+++.+++.++.||++||+|||+.+   |+||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            9999999999999999965432               124899999999999999999999998   9999999999999


Q ss_pred             cCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchh
Q 002969          678 DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELN  756 (862)
Q Consensus       678 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~  756 (862)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.......  .
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~  256 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K  256 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--H
Confidence            9999999999999987754433333334567889999999999999999999999999999999 888865432221  1


Q ss_pred             HHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       757 l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                          ......+...        ...+...+..+.+++.+||+.||++||++.||++.|++..
T Consensus       257 ----~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          257 ----FYKMIKEGFR--------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             ----HHHHHHHTCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHHHhccCCC--------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence                1112222110        1122344567889999999999999999999999998864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.9e-38  Score=355.70  Aligned_cols=255  Identities=23%  Similarity=0.319  Sum_probs=205.1

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~l  615 (862)
                      .++|+..++||+|+||.||+++... ++.||||++++.   .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            3579999999999999999998765 778999999764   233456788999999887 89999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||+++|+|..++....   .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            999999999999986543   4899999999999999999999998   9999999999999999999999999998532


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc--chhHHHHHHHHHhcCceeee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN--ELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~  773 (862)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+  .........+......    
T Consensus       205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----  278 (396)
T 4dc2_A          205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----  278 (396)
T ss_dssp             CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC----
T ss_pred             cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc----
Confidence            21  223344689999999999999999999999999999999999999985432211  1111122222222221    


Q ss_pred             ecccCCCCChHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 002969          774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTM------ASVVL  812 (862)
Q Consensus       774 id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~  812 (862)
                           ..++...+.++.+|+.+||+.||++||++      .||++
T Consensus       279 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          279 -----IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             -----cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence                 12344456778899999999999999985      67764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.7e-38  Score=341.81  Aligned_cols=261  Identities=22%  Similarity=0.322  Sum_probs=204.6

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ++|+..++||+|+||+||+|+... ++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            478899999999999999998764 8899999997543  3345788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++ +|.+.+...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 ~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9986 555554332  245899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccccccccccccccChhhhcCCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceee-----
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE-----  772 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-----  772 (862)
                        .......||+.|+|||++.+.. ++.++||||||+++|||++|..|+.  ...+.......+.+.........     
T Consensus       156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~--~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF--PGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC--CCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc--CCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence              2223357899999999998765 8999999999999999999998852  23333334444433322111000     


Q ss_pred             -e----------ecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          773 -M----------VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       773 -~----------id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       .          ............+..+.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence             0          000111223345667889999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.9e-39  Score=342.07  Aligned_cols=253  Identities=31%  Similarity=0.476  Sum_probs=197.4

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCC----ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..++||+|+||.||+|+.. ++.||||+++...    ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            57888899999999999999874 8899999986542    234578999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC--------CCCeeEeccc
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK--------EMTPKISDFG  689 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~--------~~~~kL~DFG  689 (862)
                      ||+++++|.+++.    ...+++..+..++.|+++||+|||+.+..+|+||||||+|||++.        ++.+||+|||
T Consensus        86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999999999884    235899999999999999999999987666999999999999986        7789999999


Q ss_pred             ceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc
Q 002969          690 MARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK  769 (862)
Q Consensus       690 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  769 (862)
                      ++.......    .....|++.|+|||.+.+..++.++||||||+++|||++|+.|+....   ...   ......... 
T Consensus       162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~---~~~~~~~~~-  230 (271)
T 3dtc_A          162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID---GLA---VAYGVAMNK-  230 (271)
T ss_dssp             C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC---HHH---HHHHHHTSC-
T ss_pred             ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHH---HHHhhhcCC-
Confidence            998654322    123568999999999999999999999999999999999999974321   111   111111111 


Q ss_pred             eeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          770 VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       770 ~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                             .....+...+..+.+++.+||+.+|++||++.|+++.|+.+
T Consensus       231 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          231 -------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                   11223344566788999999999999999999999999753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.6e-39  Score=354.58  Aligned_cols=264  Identities=28%  Similarity=0.414  Sum_probs=214.3

Q ss_pred             HHHcccccccceeeccccEEEEEeEec------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeC
Q 002969          538 VRATDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM  610 (862)
Q Consensus       538 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~  610 (862)
                      ....++|+..+.||+|+||.||+|+..      .++.||||++.... .....++.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG  100 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence            345678999999999999999999764      36789999997543 33456789999999999999999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhccC-------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCe
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKAR-------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  683 (862)
                      +..++||||+++++|.+++.....       ...+++..+++++.||++||+|||+.+   |+||||||+|||++.++.+
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence            999999999999999999865321       245789999999999999999999998   9999999999999999999


Q ss_pred             eEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHH
Q 002969          684 KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVW  762 (862)
Q Consensus       684 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~  762 (862)
                      ||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.|+...   ...    ...
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~----~~~  250 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNE----QVL  250 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHH----HHH
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC---CHH----HHH
Confidence            9999999987643333233334467889999999999999999999999999999999 77876432   111    112


Q ss_pred             HHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       763 ~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                      .....+..        ...+...+..+.+++.+||+.+|++||++.|+++.|++...
T Consensus       251 ~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          251 RFVMEGGL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHcCCc--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            22222221        12234456678899999999999999999999999988743

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.2e-38  Score=344.14  Aligned_cols=260  Identities=28%  Similarity=0.470  Sum_probs=198.4

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .++|+..++||+|+||.||+|+..  ..||||+++...  ....+.|.+|+.++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            357899999999999999999864  369999986543  34567899999999999999999999965 5567899999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++++|.+++...  ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence            99999999998543  345899999999999999999999998   9999999999999999999999999998664433


Q ss_pred             cccccccccccccccChhhhc---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          699 TEQNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      .........||+.|+|||++.   +..++.++||||||+++|||++|+.|+......      .........+...    
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~----  244 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGRGSLS----  244 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHHTSCC----
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhcccccC----
Confidence            333344467899999999986   567889999999999999999999997532221      1122222222221    


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      +.........+..+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus       245 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            1222333455678899999999999999999999999999874

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.5e-38  Score=351.49  Aligned_cols=251  Identities=24%  Similarity=0.306  Sum_probs=204.9

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCcc------chHHHHHHHHHHHhcccCCceEEEEEEEeCCce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQ------GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  613 (862)
                      .+.|+..+.||+|+||.||+++... ++.||+|++......      ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            4578999999999999999998764 889999999764321      357899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC----CeeEeccc
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM----TPKISDFG  689 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kL~DFG  689 (862)
                      ++||||+++|+|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            9999999999999999543   35899999999999999999999998   99999999999998877    79999999


Q ss_pred             ceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc
Q 002969          690 MARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK  769 (862)
Q Consensus       690 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  769 (862)
                      ++..+....   ......||+.|+|||++.+..++.++|||||||++|||++|..||...   ........    +....
T Consensus       165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~---~~~~~~~~----i~~~~  234 (361)
T 2yab_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLAN----ITAVS  234 (361)
T ss_dssp             SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHH----HHTTC
T ss_pred             CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHH----HHhcC
Confidence            998764322   223457999999999999999999999999999999999999997432   22222221    11111


Q ss_pred             eeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          770 VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       770 ~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      . .. +   .......+..+.+|+.+||+.||++|||+.|+++
T Consensus       235 ~-~~-~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          235 Y-DF-D---EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             C-CC-C---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             C-CC-C---chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0 00 0   0001223457889999999999999999999985

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.9e-39  Score=352.66  Aligned_cols=261  Identities=27%  Similarity=0.423  Sum_probs=213.0

Q ss_pred             cccccccceeeccccEEEEEeEec--------CCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeC
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL--------EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM  610 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~  610 (862)
                      .++|+..+.||+|+||.||+|+..        +++.||||++.... ....+++.+|+++++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            468999999999999999999863        46789999997653 34567899999999999 899999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhccC-------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl  677 (862)
                      +..++||||+++++|.+++.....             ...+++..++.++.||++||+|||+.+   |+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            999999999999999999965432             234889999999999999999999998   9999999999999


Q ss_pred             cCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchh
Q 002969          678 DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELN  756 (862)
Q Consensus       678 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~  756 (862)
                      +.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.|+....   ...
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VEE  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC---HHH
Confidence            9999999999999987754433333334567889999999999899999999999999999999 888864321   111


Q ss_pred             HHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       757 l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                          .......+..        ...+...+..+.+++.+||+.+|++||++.||++.|+.+..
T Consensus       268 ----~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          268 ----LFKLLKEGHR--------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             ----HHHHHHHTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHHhcCCC--------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                2222222211        12234455678899999999999999999999999988743

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.2e-38  Score=341.87  Aligned_cols=260  Identities=23%  Similarity=0.363  Sum_probs=201.9

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ++|+..++||+|+||.||+|+...++.||+|++....  ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4788999999999999999998779999999996543  23457788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++ +|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (288)
T ss_dssp             CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence            986 888888543  235889999999999999999999998   9999999999999999999999999998764321 


Q ss_pred             ccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee-------
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL-------  771 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-------  771 (862)
                       .......||+.|+|||++.+. .++.++||||||+++|||++|+.|+...   ........+.+........       
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV---SEADQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHHCCCChhhchhhhc
Confidence             122234689999999999764 5899999999999999999999997432   2223333333322111000       


Q ss_pred             -eeecccC--------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 -EMVDSSV--------DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 -~~id~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       ...++..        .......+.++.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             0001100        0112234567889999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.8e-38  Score=342.94  Aligned_cols=263  Identities=25%  Similarity=0.390  Sum_probs=208.8

Q ss_pred             ccccccceeeccccEEEEEeEe-----cCCcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeC--Cce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRL-----LEGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~  613 (862)
                      +.|+..++||+|+||.||+++.     ..++.||||++... .....+.+.+|++++++++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588889999999999999983     35789999999754 334567899999999999999999999999876  668


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++||||+++++|.+++....  ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            99999999999999995433  34899999999999999999999998   99999999999999999999999999988


Q ss_pred             cCCCCcc-cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCC--------CCcchhHHHHHHHH
Q 002969          694 FGGDQTE-QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYH--------SNNELNLLGHVWRL  764 (862)
Q Consensus       694 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~--------~~~~~~l~~~~~~~  764 (862)
                      +...... .......+|..|+|||.+.+..++.++||||||+++|||++|..|+....        ..............
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            7544322 22233567888999999999999999999999999999999998743210        01111111222222


Q ss_pred             HhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       765 ~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ...+.        ....+...+..+.+++.+||+.||++||++.|+++.|+.+
T Consensus       256 ~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          256 LKEGK--------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHTTC--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhccC--------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            22221        1223445567889999999999999999999999999865

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=353.24  Aligned_cols=248  Identities=28%  Similarity=0.369  Sum_probs=201.9

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~l  615 (862)
                      .++|+..++||+|+||.||+++... ++.||||+++..   .....+.+.+|..+++.+ +||||+++++++.+.+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            4689999999999999999998764 889999999754   234556788999999998 79999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||+++|+|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       102 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            999999999999986543   4899999999999999999999998   9999999999999999999999999998542


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..   .........+    ..+.      
T Consensus       176 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~---~~~~~~~~~i----~~~~------  240 (353)
T 3txo_A          176 CN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA---ENEDDLFEAI----LNDE------  240 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHH----HHCC------
T ss_pred             cC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC---CCHHHHHHHH----HcCC------
Confidence            22  2233346899999999999999999999999999999999999999743   2222222222    1111      


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTM------ASVVL  812 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~  812 (862)
                         ..++......+.+++.+||+.||++||++      .|+++
T Consensus       241 ---~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 ---VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence               12234455678899999999999999998      77774

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.4e-38  Score=351.20  Aligned_cols=246  Identities=24%  Similarity=0.341  Sum_probs=204.6

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .++|...+.||+|+||.||+|+.. .++.||||++...   .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            357999999999999999999874 5889999998653   223356789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+ +|+|.+++....   .+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 688888886543   4899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCcccccccccccccccChhhhcCCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLF-SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ..   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......                ..+.+.
T Consensus       161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----------------~~~~i~  221 (336)
T 3h4j_B          161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN----------------LFKKVN  221 (336)
T ss_dssp             SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT----------------CBCCCC
T ss_pred             Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH----------------HHHHHH
Confidence            22   2234579999999999988776 789999999999999999999975322211                112222


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ......+...+..+.+++.+||+.||++|||+.|+++
T Consensus       222 ~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          222 SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            2223344556678889999999999999999999986

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.3e-38  Score=346.15  Aligned_cols=250  Identities=24%  Similarity=0.325  Sum_probs=204.1

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCc------cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG------QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  614 (862)
                      ++|+..+.||+|+||.||+++... ++.||+|++.....      ...+.+.+|+.++++++||||+++++++.+....+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            568999999999999999998764 88999999975432      23578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC----CeeEecccc
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM----TPKISDFGM  690 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kL~DFGl  690 (862)
                      +||||+++++|.+++...   ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++    .+||+|||+
T Consensus        91 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            999999999999998543   35899999999999999999999998   99999999999998887    899999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV  770 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  770 (862)
                      ++.+....   ......||+.|+|||++.+..++.++||||||+++|||++|+.|+...   ........+    .....
T Consensus       165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~~----~~~~~  234 (326)
T 2y0a_A          165 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANV----SAVNY  234 (326)
T ss_dssp             CEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHH----HHTCC
T ss_pred             CeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC---CHHHHHHHH----HhcCC
Confidence            98764322   223357899999999999999999999999999999999999997432   211222111    11110


Q ss_pred             eeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          771 LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       771 ~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       ...    .......+..+.+++.+||+.||++|||+.|+++
T Consensus       235 -~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          235 -EFE----DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             -CCC----HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -CcC----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             000    0011223456889999999999999999999997

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.3e-38  Score=348.11  Aligned_cols=254  Identities=24%  Similarity=0.317  Sum_probs=205.4

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ++|+..+.||+|+||.||+++... ++.||||++....   ....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            578899999999999999998765 7889999997542   33456788999999998 899999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            99999999999986543   4899999999999999999999998   99999999999999999999999999986422


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcc--hhHHHHHHHHHhcCceeeee
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE--LNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~i  774 (862)
                      .  ........||+.|+|||++.+..++.++|||||||++|||++|+.||........  ........+......     
T Consensus       163 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-----  235 (345)
T 3a8x_A          163 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----  235 (345)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-----
T ss_pred             C--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-----
Confidence            2  1223346899999999999999999999999999999999999999854222111  111122222222221     


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTM------ASVVL  812 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~  812 (862)
                          ...+...+.++.+++.+||+.||++||++      .|+++
T Consensus       236 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          236 ----IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             ----CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence                12334456678899999999999999995      67764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-38  Score=345.36  Aligned_cols=251  Identities=20%  Similarity=0.296  Sum_probs=204.9

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      .++|+..+.||+|+||.||+++... ++.+|+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            3678999999999999999998765 788999998644 33456789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC--CCCeeEecccceeecCCC
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK--EMTPKISDFGMARIFGGD  697 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kL~DFGla~~~~~~  697 (862)
                      +++++|.+++...  ...+++.++..++.||++||+|||+.+   |+||||||+|||++.  ++.+||+|||+++.+...
T Consensus        83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            9999999998542  235899999999999999999999998   999999999999987  789999999999876432


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      .   ......||+.|+|||++.+..++.++||||||+++|||++|..|+...   ........+    ..+... . +  
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i----~~~~~~-~-~--  223 (321)
T 1tki_A          158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENI----MNAEYT-F-D--  223 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHH----HHTCCC-C-C--
T ss_pred             C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC---CHHHHHHHH----HcCCCC-C-C--
Confidence            2   223457899999999999988999999999999999999999997432   222222221    111100 0 0  


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       .......+.++.+++.+||+.||++|||+.|+++
T Consensus       224 -~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          224 -EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             0001123567889999999999999999999997

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.2e-38  Score=353.16  Aligned_cols=249  Identities=23%  Similarity=0.364  Sum_probs=206.6

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..+.||+|+||.||+++... ++.||+|++...   .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            578999999999999999998765 788999998653   2345678899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++|+|..++...   ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+...
T Consensus        95 e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            999999999998543   34899999999999999999999998   999999999999999999999999999876432


Q ss_pred             CcccccccccccccccChhhhcC---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMD---GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                         .......||+.|+|||++..   ..++.++|||||||++|||++|+.||..............    ...       
T Consensus       169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----~~~-------  234 (384)
T 4fr4_A          169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT----FET-------  234 (384)
T ss_dssp             ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH----HHH-------
T ss_pred             ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH----Hhh-------
Confidence               22334679999999999974   4589999999999999999999999864433332222221    111       


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPT-MASVVL  812 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~  812 (862)
                        ....++...+..+.+|+.+||+.||++||+ +++|++
T Consensus       235 --~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          235 --TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence              112334455678899999999999999998 777764

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.1e-38  Score=342.24  Aligned_cols=257  Identities=30%  Similarity=0.450  Sum_probs=209.4

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      .++|+..+.||+|+||.||+|+..+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            35788999999999999999998888899999996543 34678999999999999999999999986 45689999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++++|.+++.... ...+++.+++.++.||++||+|||+.+   |+||||||+|||+++++.+||+|||++........ 
T Consensus        90 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  164 (279)
T 1qpc_A           90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (279)
T ss_dssp             TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence            9999999985432 124899999999999999999999998   99999999999999999999999999987653322 


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...   .....    ......+..        .
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~~~----~~~~~~~~~--------~  229 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEV----IQNLERGYR--------M  229 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHH----HHHHHTTCC--------C
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc---CHHHH----HHHHhcccC--------C
Confidence            12223456789999999998899999999999999999999 88886432   11111    122222211        1


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                      ..+...+..+.+++.+||+.+|++||++.++++.|+....
T Consensus       230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence            1233455678899999999999999999999999988743

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.9e-39  Score=351.06  Aligned_cols=266  Identities=25%  Similarity=0.413  Sum_probs=201.4

Q ss_pred             HHHcccccccceeeccccEEEEEeEecC----CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCC
Q 002969          538 VRATDNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD  611 (862)
Q Consensus       538 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  611 (862)
                      ....++|...+.||+|+||.||+|+...    ++.||||+++..  .....+.+.+|+.++++++||||+++++++.+.+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            3345789999999999999999997643    457999998754  2334578999999999999999999999998765


Q ss_pred             c-----eEEEEEeccCCChhhhhhhc---cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCe
Q 002969          612 E-----KMLVYEYMENRSLDSVIFDK---ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (862)
Q Consensus       612 ~-----~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  683 (862)
                      .     .++|+||+++++|.+++...   .....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence            3     49999999999999998542   23356999999999999999999999998   9999999999999999999


Q ss_pred             eEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHH
Q 002969          684 KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVW  762 (862)
Q Consensus       684 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~  762 (862)
                      ||+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |..|+.....   ......  
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~--  261 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN---HEMYDY--  261 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHH--
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHH--
Confidence            9999999987644333233334567889999999999999999999999999999999 7777643222   122211  


Q ss_pred             HHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCC
Q 002969          763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATM  821 (862)
Q Consensus       763 ~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  821 (862)
                        ...+.        ....+...+..+.+++.+||+.+|++||++.+|++.|+.+....
T Consensus       262 --~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          262 --LLHGH--------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             --HHTTC--------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --HHcCC--------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence              11111        11223445567889999999999999999999999998875433

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.7e-39  Score=339.99  Aligned_cols=254  Identities=29%  Similarity=0.427  Sum_probs=209.9

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      ++|+..+.||+|+||.||+++..+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            57888899999999999999998889999999976533 34789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +++|.+++...  ...+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++....... ..
T Consensus        87 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~  160 (267)
T 3t9t_A           87 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT  160 (267)
T ss_dssp             TCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred             CCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence            99999999643  235899999999999999999999998   9999999999999999999999999998654321 11


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.|+...   .....    ......+..        ..
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~~~~~----~~~i~~~~~--------~~  225 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEV----VEDISTGFR--------LY  225 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHH----HHHHHTTCC--------CC
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC---CHHHH----HHHHhcCCc--------CC
Confidence            1223456789999999999999999999999999999999 88886432   11111    112222111        11


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .+...+..+.+++.+||+.+|++||++.|+++.|+.+
T Consensus       226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            2333456788999999999999999999999999876

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1e-38  Score=348.59  Aligned_cols=269  Identities=28%  Similarity=0.404  Sum_probs=216.4

Q ss_pred             cChHHHHHHcccccccceeeccccEEEEEeEe------cCCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEE
Q 002969          532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRL  603 (862)
Q Consensus       532 ~~~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l  603 (862)
                      ++........++|+..+.||+|+||.||+|+.      .+++.||||+++... ....+.+.+|+.+++++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            44455555668899999999999999999974      246789999997653 33456899999999999 79999999


Q ss_pred             EEEEEeCC-ceEEEEEeccCCChhhhhhhccC-------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecc
Q 002969          604 LGCCVEMD-EKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRD  669 (862)
Q Consensus       604 ~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrD  669 (862)
                      ++++...+ ..++||||+++++|.+++.....             ...+++..+..++.||++||.|||+.+   |+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            99988755 48999999999999999965432             223889999999999999999999998   99999


Q ss_pred             cCCcceEecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 002969          670 LKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGF  748 (862)
Q Consensus       670 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~  748 (862)
                      |||+|||++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987654433333444567899999999999999999999999999999998 9888754


Q ss_pred             CCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          749 YHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       749 ~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .....      ........+..        ...+...+..+.+++.+||+.+|++||++.||++.|+.+
T Consensus       254 ~~~~~------~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          254 VKIDE------EFCRRLKEGTR--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CCCSH------HHHHHHHHTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhH------HHHHHhccCcc--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            32221      11122222211        112333456788999999999999999999999999876

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.2e-38  Score=354.10  Aligned_cols=267  Identities=20%  Similarity=0.257  Sum_probs=204.5

Q ss_pred             cccccccceeecc--ccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          541 TDNFTDYNKLGQG--GFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       541 ~~~f~~~~~LG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      .++|+..++||+|  +||.||+|+.. +++.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4689999999999  99999999886 48999999997543  3445778899999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||+++++|.+++.... ...+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||++....
T Consensus       104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999996542 234899999999999999999999998   9999999999999999999999999987543


Q ss_pred             CCCc-----ccccccccccccccChhhhcC--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHh--
Q 002969          696 GDQT-----EQNTKRVVGTYGYMSPEYAMD--GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK--  766 (862)
Q Consensus       696 ~~~~-----~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~--  766 (862)
                      ....     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||........  ..........  
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~  257 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCL  257 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC--------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCcc
Confidence            2211     111223478999999999987  6789999999999999999999999754322211  1000000000  


Q ss_pred             -c-------------------Cceeee----------ecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          767 -E-------------------GKVLEM----------VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       767 -~-------------------~~~~~~----------id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                       .                   ....+.          .+......+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence             0                   000000          0000011233345678899999999999999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.1e-38  Score=350.01  Aligned_cols=253  Identities=24%  Similarity=0.288  Sum_probs=203.9

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC-----CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN-----SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ++|+..+.||+|+||.||+++.. +++.||||++...     .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            57899999999999999999875 4899999998642     12246789999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhcc-CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC---eeEecccce
Q 002969          616 VYEYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT---PKISDFGMA  691 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kL~DFGla  691 (862)
                      ||||+++++|.+.+.... ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            999999999998876543 3345899999999999999999999998   999999999999987654   999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      +.+.....  ......||+.|+|||++.+..++.++|||||||++|||++|+.|+...    ....    ......+...
T Consensus       181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~----~~~i~~~~~~  250 (351)
T 3c0i_A          181 IQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----KERL----FEGIIKGKYK  250 (351)
T ss_dssp             EECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----HHHH----HHHHHHTCCC
T ss_pred             eEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----HHHH----HHHHHcCCCC
Confidence            87654322  223357999999999999999999999999999999999999997431    1111    1122221110


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .  .+   ......+.++.+++.+||+.||++||++.|+++
T Consensus       251 ~--~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          251 M--NP---RQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             C--CH---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C--Cc---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0  00   000123467889999999999999999999985

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-38  Score=342.82  Aligned_cols=255  Identities=22%  Similarity=0.311  Sum_probs=197.1

Q ss_pred             cccccccceeeccccEEEEEeEecC----CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      .++|+..+.||+|+||.||+|+...    +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            3578899999999999999998743    4569999987643 344678999999999999999999999984 567899


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||+++++|.+++...  ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence            99999999999999643  235899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ..... ......+++.|+|||++.+..++.++||||||+++|||++ |..|+.....   ......    ...+.     
T Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~---~~~~~~----i~~~~-----  234 (281)
T 1mp8_A          168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGR----IENGE-----  234 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHH----HHTTC-----
T ss_pred             ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH---HHHHHH----HHcCC-----
Confidence            32221 1223456789999999999999999999999999999997 8888653322   122221    11111     


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                         ....+...+..+.+++.+||+.||++||++.||++.|+.+
T Consensus       235 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          235 ---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence               1123344567888999999999999999999999999875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.7e-38  Score=339.70  Aligned_cols=249  Identities=25%  Similarity=0.318  Sum_probs=196.1

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc--------------------------cchHHHHHHHHHHH
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG--------------------------QGIEEFKNEVRLIA  593 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~  593 (862)
                      .++|+..++||+|+||.||+|+.. +++.||||++.....                          ...+++.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            357899999999999999999875 478899999865421                          12467899999999


Q ss_pred             hcccCCceEEEEEEEe--CCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccC
Q 002969          594 KLQHRNLVRLLGCCVE--MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK  671 (862)
Q Consensus       594 ~l~HpnIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlk  671 (862)
                      +++||||+++++++.+  .+..++||||+++++|.+++.    ...+++.++..++.||++||+|||+.+   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999987  567899999999999988652    235899999999999999999999998   9999999


Q ss_pred             CcceEecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCC---CCccccchhHHHHHHHHHhCCCCCCC
Q 002969          672 ASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL---FSVKSDVFSFGVLLLETVSGKKNRGF  748 (862)
Q Consensus       672 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~s~ksDVwSlGvil~elltG~~p~~~  748 (862)
                      |+|||++.++.+||+|||+++.+.....  ......||+.|+|||++.+..   ++.++||||||+++|||++|+.|+..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999987643322  223357899999999998765   37889999999999999999999743


Q ss_pred             CCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          749 YHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       749 ~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .   ......    ........ .      .......+..+.+++.+||+.||++||++.|+++
T Consensus       243 ~---~~~~~~----~~~~~~~~-~------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 E---RIMCLH----SKIKSQAL-E------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             S---SHHHHH----HHHHHCCC-C------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             c---cHHHHH----HHHhcccC-C------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            2   111111    11111111 0      0111234567889999999999999999999975

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8.7e-39  Score=352.26  Aligned_cols=261  Identities=28%  Similarity=0.421  Sum_probs=211.5

Q ss_pred             HcccccccceeeccccEEEEEeEecC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCC
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMD  611 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~  611 (862)
                      ..++|+..+.||+|+||.||+|+...      .+.||+|++.... ....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            45688999999999999999998643      2479999997653 33567899999999999 8999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhccC-----------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC
Q 002969          612 EKMLVYEYMENRSLDSVIFDKAR-----------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE  680 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~  680 (862)
                      ..++||||+++|+|.+++.....           ...+++..++.++.||++||+|||+.+   |+||||||+|||++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence            99999999999999999965421           335799999999999999999999998   9999999999999999


Q ss_pred             CCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHH
Q 002969          681 MTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLG  759 (862)
Q Consensus       681 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~  759 (862)
                      +.+||+|||+++.+.............+|+.|+|||.+.+..++.++||||||+++|||++ |..|+.......      
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------  274 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------  274 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH------
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH------
Confidence            9999999999987644333223334567889999999999999999999999999999999 888865332221      


Q ss_pred             HHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          760 HVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       760 ~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ........+..        ...+...+..+.+++.+||+.+|++||++.||++.|+..
T Consensus       275 ~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          275 KFYKLVKDGYQ--------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             HHHHHHHHTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHhcCCC--------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence            11112222111        112233456788999999999999999999999999875

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1e-38  Score=344.12  Aligned_cols=251  Identities=25%  Similarity=0.383  Sum_probs=204.5

Q ss_pred             ccccccceeeccccEEEEEeEecC-C-------cEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-G-------QEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  613 (862)
                      ++|...+.||+|+||.||+|+... +       ..||+|++........+.+.+|+.++++++||||+++++++.+.+..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            578889999999999999997654 3       47999999777667778899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC--------eeE
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT--------PKI  685 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~--------~kL  685 (862)
                      ++||||+++++|.+++....  ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.        +||
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             EEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence            99999999999999996532  34899999999999999999999998   999999999999998887        999


Q ss_pred             ecccceeecCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHH
Q 002969          686 SDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL  764 (862)
Q Consensus       686 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~  764 (862)
                      +|||++.....      .....+++.|+|||++.+ ..++.++||||||+++|||++|..|+...  ......    ...
T Consensus       163 ~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~--~~~~~~----~~~  230 (289)
T 4fvq_A          163 SDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA--LDSQRK----LQF  230 (289)
T ss_dssp             CCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT--SCHHHH----HHH
T ss_pred             ccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc--cchHHH----HHH
Confidence            99999865421      123457889999999987 67999999999999999999976553211  111111    111


Q ss_pred             HhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       765 ~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                      ....          ...+...+.++.+++.+||+.||++||++.|+++.|+.+..
T Consensus       231 ~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          231 YEDR----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHTT----------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             hhcc----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            1111          11122224457899999999999999999999999998843

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.5e-38  Score=360.80  Aligned_cols=263  Identities=18%  Similarity=0.220  Sum_probs=210.7

Q ss_pred             ChHHHHHHcccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEE
Q 002969          533 DFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV  608 (862)
Q Consensus       533 ~~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~  608 (862)
                      .+.++....++|+..++||+|+||.||+|+... ++.||||++.+.   .....+.+.+|+.++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            344555667899999999999999999999876 788999999653   2233456899999999999999999999999


Q ss_pred             eCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecc
Q 002969          609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDF  688 (862)
Q Consensus       609 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF  688 (862)
                      +.+..++||||+++|+|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+||
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence            999999999999999999999652  235899999999999999999999998   999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccccChhhhc-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHH
Q 002969          689 GMARIFGGDQTEQNTKRVVGTYGYMSPEYAM-----DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR  763 (862)
Q Consensus       689 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~  763 (862)
                      |+++.+...... .....+||+.|+|||++.     ...++.++|||||||++|||++|+.||..   .+.......+..
T Consensus       220 Gla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~---~~~~~~~~~i~~  295 (437)
T 4aw2_A          220 GSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA---ESLVETYGKIMN  295 (437)
T ss_dssp             TTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC---SSHHHHHHHHHT
T ss_pred             hhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC---CChhHHHHhhhh
Confidence            999876433222 223367999999999997     56789999999999999999999999743   222222222221


Q ss_pred             HHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCC--CCCHHHHHH
Q 002969          764 LWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEE--RPTMASVVL  812 (862)
Q Consensus       764 ~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~  812 (862)
                      ....-        .........+.++.+|+.+||+.+|++  ||+++|+++
T Consensus       296 ~~~~~--------~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          296 HKERF--------QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHHHC--------CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ccccc--------cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            11100        111112234567889999999888888  999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-38  Score=345.35  Aligned_cols=244  Identities=25%  Similarity=0.331  Sum_probs=205.0

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..++||+|+||.||+++.. +++.||+|+++..   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57899999999999999999876 4889999999754   2345677889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.... 
T Consensus        86 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-  158 (318)
T ss_dssp             CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence            999999999999653   34889999999999999999999998   99999999999999999999999999987532 


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.|+...   +.......+    ....        
T Consensus       159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i----~~~~--------  219 (318)
T 1fot_A          159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKI----LNAE--------  219 (318)
T ss_dssp             ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHH----HHCC--------
T ss_pred             ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHH----HhCC--------
Confidence                123457999999999999999999999999999999999999997432   222222211    1111        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERP-----TMASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  812 (862)
                       ..++...+.++.+++.+||+.||++||     +++||++
T Consensus       220 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          220 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence             122334556788999999999999999     8999984

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-37  Score=350.70  Aligned_cols=253  Identities=23%  Similarity=0.286  Sum_probs=207.4

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      .++|+..++||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            357999999999999999999876 4889999999776555567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC--CCCeeEecccceeecCCC
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK--EMTPKISDFGMARIFGGD  697 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kL~DFGla~~~~~~  697 (862)
                      +++++|.+++...  ...+++.++..++.||++||+|||+.+   |+||||||+|||++.  ++.+||+|||+++.+...
T Consensus       130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            9999999988543  235899999999999999999999998   999999999999974  478999999999876433


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      ..   .....||+.|+|||++.+..++.++|||||||++|||++|+.|+...   ........+    ..... . .   
T Consensus       205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~---~~~~~~~~i----~~~~~-~-~---  269 (387)
T 1kob_A          205 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE---DDLETLQNV----KRCDW-E-F---  269 (387)
T ss_dssp             SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHH----HHCCC-C-C---
T ss_pred             cc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC---CHHHHHHHH----HhCCC-C-C---
Confidence            22   22357899999999999999999999999999999999999997432   222222221    11110 0 0   


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ........+.++.+++.+||+.||++||++.|+++.
T Consensus       270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            011223445678899999999999999999999974

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.1e-38  Score=353.12  Aligned_cols=248  Identities=26%  Similarity=0.352  Sum_probs=205.1

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~  614 (862)
                      ..++|+..++||+|+||.||+|+... ++.||||+++...   ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            45789999999999999999998864 8899999997542   34566788999999987 8999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      +||||+++|+|.+++....   .+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        95 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            9999999999999996533   4899999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          695 GGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       695 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ...  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..   .+.......    ...+.     
T Consensus       169 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~---~~~~~~~~~----i~~~~-----  234 (345)
T 1xjd_A          169 MLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEELFHS----IRMDN-----  234 (345)
T ss_dssp             CCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHH----HHHCC-----
T ss_pred             ccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC---CCHHHHHHH----HHhCC-----
Confidence            322  1223446899999999999999999999999999999999999999743   222222222    21111     


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMA-SVV  811 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl  811 (862)
                          ..++...+.++.+++.+||+.||++||++. ||+
T Consensus       235 ----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 ----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                122334556788999999999999999997 665

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=351.80  Aligned_cols=252  Identities=24%  Similarity=0.327  Sum_probs=197.9

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccC--CccchHHHHHHHHHHHhccc--CCceEEEEEEEeCCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQH--RNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H--pnIv~l~g~~~~~~~~~lV  616 (862)
                      .++|++.++||+|+||.||++...+++.||||++...  .....+.+.+|+.++++++|  |||+++++++......++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            4579999999999999999999888999999998754  33445789999999999986  9999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      || +.+++|.+++...   ..+++.++..++.||++||+|||+.+   |+||||||+|||++ ++.+||+|||+++.+..
T Consensus        88 ~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 5688999999653   34899999999999999999999998   99999999999997 67899999999987654


Q ss_pred             CCcccccccccccccccChhhhcC-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMD-----------GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW  765 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~-----------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~  765 (862)
                      ...........||+.|+|||++.+           ..++.++|||||||++|||++|+.|+.....     .........
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~  234 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII  234 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHH
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHh
Confidence            433333445679999999999865           6789999999999999999999999743211     111111111


Q ss_pred             hcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          766 KEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       766 ~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ....        ....+.....++.+++.+||+.||++|||+.|+++.
T Consensus       235 ~~~~--------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          235 DPNH--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             CTTS--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCc--------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            1111        112233344678899999999999999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.6e-38  Score=350.02  Aligned_cols=244  Identities=23%  Similarity=0.283  Sum_probs=206.0

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..+.||+|+||.||+++.. +++.||||++...   .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57899999999999999999876 4889999999654   2345678899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence            9999999999996543   4899999999999999999999998   999999999999999999999999999876432


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.|+...   ......    ..+..+.        
T Consensus       195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~----~~i~~~~--------  254 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIY----EKIVSGK--------  254 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHH----HHHHHCC--------
T ss_pred             -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC---CHHHHH----HHHHcCC--------
Confidence                 23457999999999999999999999999999999999999997432   222222    2222221        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPT-----MASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  812 (862)
                       ..++...+.++.+++.+||+.||++||+     ++||++
T Consensus       255 -~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence             1223445667889999999999999998     898885

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9e-38  Score=357.35  Aligned_cols=253  Identities=24%  Similarity=0.327  Sum_probs=204.7

Q ss_pred             HcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ..++|+..++||+|+||.||++... +++.+|+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            3568999999999999999999765 58899999997543  33456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec---CCCCeeEecccceee
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARI  693 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kL~DFGla~~  693 (862)
                      |||+++|+|.+.+...   ..+++..+..++.||++||+|||+.+   |+||||||+|||++   .++.+||+|||++..
T Consensus        89 ~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            9999999999988654   34899999999999999999999998   99999999999998   467899999999987


Q ss_pred             cCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeee
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  773 (862)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|..||..   .......    .....+.. ..
T Consensus       163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~---~~~~~~~----~~i~~~~~-~~  232 (444)
T 3soa_A          163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD---EDQHRLY----QQIKAGAY-DF  232 (444)
T ss_dssp             CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHH----HHHHHTCC-CC
T ss_pred             ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC---ccHHHHH----HHHHhCCC-CC
Confidence            643322  22345799999999999999999999999999999999999999642   2222222    22222211 00


Q ss_pred             ecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       774 id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .    .......+.++.+++.+||+.||++||++.|+++
T Consensus       233 ~----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          233 P----SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             C----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             C----ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0    1112234567889999999999999999999987

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.5e-38  Score=355.96  Aligned_cols=258  Identities=20%  Similarity=0.202  Sum_probs=208.0

Q ss_pred             HHHHHcccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCC
Q 002969          536 TIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD  611 (862)
Q Consensus       536 ~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  611 (862)
                      ++....++|+..++||+|+||.||+++... ++.||+|++++.   .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            444556789999999999999999998865 789999999653   2334556889999999999999999999999999


Q ss_pred             ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccce
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  691 (862)
                      ..++||||+++|+|.+++...    .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence            999999999999999998542    3889999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcCCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhc
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDGL----FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE  767 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  767 (862)
                      +.+..... ......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||..   .+.......+......
T Consensus       216 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~---~~~~~~~~~i~~~~~~  291 (410)
T 3v8s_A          216 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA---DSLVGTYSKIMNHKNS  291 (410)
T ss_dssp             EECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC---SSHHHHHHHHHTHHHH
T ss_pred             EeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC---CChhhHHHHHHhcccc
Confidence            87643321 2233468999999999998765    78999999999999999999999742   2222222222211100


Q ss_pred             CceeeeecccCCCCChHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 002969          768 GKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEE--RPTMASVVLM  813 (862)
Q Consensus       768 ~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  813 (862)
                      -   .      .......+.++.+|+.+||+.+|++  ||+++||++.
T Consensus       292 ~---~------~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          292 L---T------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             C---C------CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             c---c------CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            0   0      0011234567889999999999988  9999999964

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.4e-38  Score=347.53  Aligned_cols=259  Identities=25%  Similarity=0.346  Sum_probs=196.4

Q ss_pred             cccccccceeeccccEEEEEeEe-cCCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCce---
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK---  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~---  613 (862)
                      .++|+..++||+|+||.||+++. .+++.||||+++...   ....+.+.+|+.++++++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            35799999999999999999986 458899999997642   23356789999999999999999999998776544   


Q ss_pred             -EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          614 -MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       614 -~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                       ++||||+++++|.+++....   .+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence             99999999999999996543   4899999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCcc-cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          693 IFGGDQTE-QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       693 ~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      .+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....   .   ..............
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~---~---~~~~~~~~~~~~~~  238 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---P---VSVAYQHVREDPIP  238 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---H---HHHHHHHHHCCCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC---h---HHHHHHHhcCCCCC
Confidence            76433221 22334578999999999999999999999999999999999999974321   1   11122222221110


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHH-HHhccC
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV-LMLSSE  817 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl-~~L~~~  817 (862)
                      .      .......+.++.+++.+||+.||++||++.+++ ..|...
T Consensus       239 ~------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          239 P------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             H------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             c------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            0      001122456788999999999999999666554 455444

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=373.46  Aligned_cols=258  Identities=28%  Similarity=0.428  Sum_probs=211.1

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      .++|+..++||+|+||.||+|++.++..||||+++... ...++|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            46788889999999999999999888899999997644 345789999999999999999999999876 7789999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++|+|.+++.... ...+++.+++.|+.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.+..... 
T Consensus       344 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-  418 (535)
T 2h8h_A          344 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  418 (535)
T ss_dssp             TTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-
T ss_pred             cCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-
Confidence            9999999996432 234899999999999999999999998   99999999999999999999999999986542211 


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                      .......++..|+|||++....++.++||||||++||||++ |+.|+....   ...    +...+..+..        .
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~---~~~----~~~~i~~~~~--------~  483 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NRE----VLDQVERGYR--------M  483 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC---HHH----HHHHHHTTCC--------C
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHH----HHHHHHcCCC--------C
Confidence            11222356789999999999999999999999999999999 888864321   111    2222222211        1


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCC
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT  820 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  820 (862)
                      ..+...+..+.+|+.+||+.||++||++.+|++.|+.+...
T Consensus       484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            22344566788999999999999999999999999988543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4e-38  Score=344.34  Aligned_cols=269  Identities=22%  Similarity=0.291  Sum_probs=209.4

Q ss_pred             HcccccccceeeccccEEEEEeEe-cCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEe----CCceE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE----MDEKM  614 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----~~~~~  614 (862)
                      ..++|+..++||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++..    ....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            346899999999999999999987 4589999999977666677889999999999999999999999873    34678


Q ss_pred             EEEEeccCCChhhhhhhcc-CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          615 LVYEYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      +|+||+++++|.+++.... ....+++.+++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            9999999999999986532 3456899999999999999999999998   99999999999999999999999999876


Q ss_pred             cCCCCcc-------cccccccccccccChhhhcCCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHH
Q 002969          694 FGGDQTE-------QNTKRVVGTYGYMSPEYAMDGL---FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR  763 (862)
Q Consensus       694 ~~~~~~~-------~~~~~~~gt~~y~APE~l~~~~---~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~  763 (862)
                      .......       .......||+.|+|||++.+..   ++.++||||||+++|||++|+.|+........ .. ..   
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~-~~---  258 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SV-AL---  258 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CH-HH---
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hh-hH---
Confidence            5321111       0112345799999999987654   68999999999999999999999742111110 00 00   


Q ss_pred             HHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCCCCC
Q 002969          764 LWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQP  824 (862)
Q Consensus       764 ~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p  824 (862)
                      .....        .........+..+.+++.+||+.||++||++.||++.|+.+..+.|.+
T Consensus       259 ~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~  311 (317)
T 2buj_A          259 AVQNQ--------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ  311 (317)
T ss_dssp             HHHCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred             Hhhcc--------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence            11110        001112334567889999999999999999999999999885444433

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=8.4e-38  Score=348.87  Aligned_cols=252  Identities=25%  Similarity=0.327  Sum_probs=204.9

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      .++|+..++||+|+||.||+++.. +++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            467999999999999999999875 48899999997543  334578899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC---CCeeEecccceeec
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGMARIF  694 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kL~DFGla~~~  694 (862)
                      ||+++++|.+++...   ..+++..+..++.||++||+|||+.+   |+||||||+|||++.+   +.+||+|||++...
T Consensus       108 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          108 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             CCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            999999999988543   35899999999999999999999998   9999999999999765   45999999999876


Q ss_pred             CCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          695 GGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       695 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...   +...+..    ....+... . 
T Consensus       182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~---~~~~~~~----~i~~~~~~-~-  249 (362)
T 2bdw_A          182 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYA----QIKAGAYD-Y-  249 (362)
T ss_dssp             TTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHH----HHHHTCCC-C-
T ss_pred             cCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC---CHHHHHH----HHHhCCCC-C-
Confidence            4322   223457999999999999999999999999999999999999996422   2222222    22222110 0 


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                         ........+.++.+++.+||+.||++||++.|+++.
T Consensus       250 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          250 ---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ---CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               011112345678899999999999999999998853

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-38  Score=350.22  Aligned_cols=258  Identities=28%  Similarity=0.442  Sum_probs=202.7

Q ss_pred             ccccccceeeccccEEEEEeEecC-----CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-----GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ++|+..+.||+|+||.||+|+...     +..||||+++... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            467778999999999999998653     2359999997653 3345678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||+++++|.+++...  ...+++.+++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            99999999999999643  345899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcc-cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeee
Q 002969          696 GDQTE-QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       696 ~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  773 (862)
                      ..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.|+....   ...    ....+..+..   
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~~----~~~~~~~~~~---  268 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---NHE----VMKAINDGFR---  268 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHH----HHHHHHTTCC---
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC---HHH----HHHHHHCCCc---
Confidence            33221 11222346788999999999999999999999999999999 999864321   111    2222222211   


Q ss_pred             ecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       774 id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                           ...+...+..+.+++.+||+.+|++||++.||++.|+.+..
T Consensus       269 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          269 -----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             -----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                 11233456678899999999999999999999999988643

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.8e-38  Score=346.73  Aligned_cols=248  Identities=25%  Similarity=0.318  Sum_probs=195.5

Q ss_pred             cccccccceeeccccEEEEEeEe----cCCcEEEEEEeccCC----ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCc
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRL----LEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE  612 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  612 (862)
                      .++|+..++||+|+||.||+++.    ..++.||+|+++...    ......+.+|+.++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35799999999999999999987    468899999997642    2345678899999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      .++||||+++++|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            99999999999999998653   34889999999999999999999998   9999999999999999999999999997


Q ss_pred             ecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          693 IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       693 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      ......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||...   ........+.    ...   
T Consensus       170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i~----~~~---  237 (327)
T 3a62_A          170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE---NRKKTIDKIL----KCK---  237 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHH----HTC---
T ss_pred             ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC---CHHHHHHHHH----hCC---
Confidence            643221  1223457899999999999999999999999999999999999997432   2222222221    111   


Q ss_pred             eecccCCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQENAEERP-----TMASVVL  812 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  812 (862)
                            ...+...+.++.+++.+||+.||++||     ++.|+++
T Consensus       238 ------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 ------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                  122344566788999999999999999     7888886

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.6e-38  Score=334.69  Aligned_cols=249  Identities=26%  Similarity=0.426  Sum_probs=185.0

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .++|+..+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            467899999999999999999874 58899999996542   23457899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      +||+++++|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            9999999999998643  245899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ...  ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+........   .            ......
T Consensus       165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~------------~~~~~~  227 (278)
T 3cok_A          165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---L------------NKVVLA  227 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS
T ss_pred             CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---H------------HHHhhc
Confidence            221  12235689999999999999999999999999999999999999754322111   0            000001


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      . ...+...+.++.+++.+||+.||++||++.|+++
T Consensus       228 ~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          228 D-YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             C-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             c-cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            1 1223445667889999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7.5e-38  Score=342.77  Aligned_cols=263  Identities=25%  Similarity=0.352  Sum_probs=191.8

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .++|+..++||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            357889999999999999999875 48899999997553 3345788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccC---CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          619 YMENRSLDSVIFDKAR---SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      |++ ++|.+++.....   ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 599998865321   234889999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce----
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV----  770 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~----  770 (862)
                      ....  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...   ........+.+.......    
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT---NDEEQLKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCSCCTTTCG
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCChhHhh
Confidence            3221  2223578999999999976 46899999999999999999999997532   222333333322211000    


Q ss_pred             ----eeeecccC-------------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          771 ----LEMVDSSV-------------DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       771 ----~~~id~~~-------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                          .....+..             .......+.++.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                00000000             0011123457889999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-38  Score=347.80  Aligned_cols=257  Identities=26%  Similarity=0.445  Sum_probs=201.3

Q ss_pred             ccccccceeeccccEEEEEeEecC-Cc----EEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ----EIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ++|+..++||+|+||.||+|+... ++    +||+|.+... .....+++.+|+.++++++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            578999999999999999998643 43    3688877544 3446678999999999999999999999998754 889


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      |+||+++|+|.+++....  ..+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        94 v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            999999999999986542  35899999999999999999999998   9999999999999999999999999998775


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.......   ..    .....+.     
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~----~~~~~~~-----  236 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKGE-----  236 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTC-----
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCC-----
Confidence            4443333344567889999999999999999999999999999999 999975432221   11    1111111     


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                         ....+...+.++.+++.+||+.+|++||++.|+++.|+.+..
T Consensus       237 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          237 ---RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             ---CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence               112234456678899999999999999999999999998743

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.6e-38  Score=353.31  Aligned_cols=269  Identities=17%  Similarity=0.195  Sum_probs=204.5

Q ss_pred             HcccccccceeeccccEEEEEeEecC------CcEEEEEEeccCCccc-----------hHHHHHHHHHHHhcccCCceE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNSGQG-----------IEEFKNEVRLIAKLQHRNLVR  602 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~HpnIv~  602 (862)
                      ..++|+..++||+|+||.||+|++..      ++.||||++.......           ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34689999999999999999998765      3689999986543211           122344556667778999999


Q ss_pred             EEEEEEeC----CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec
Q 002969          603 LLGCCVEM----DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (862)
Q Consensus       603 l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~  678 (862)
                      +++++...    ...++||||+ +++|.+++...  ...+++..++.|+.||+.||+|||+.+   |+||||||+||||+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99999775    4579999999 99999999653  345999999999999999999999998   99999999999999


Q ss_pred             --CCCCeeEecccceeecCCCCcc-----cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 002969          679 --KEMTPKISDFGMARIFGGDQTE-----QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHS  751 (862)
Q Consensus       679 --~~~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~  751 (862)
                        .++.+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999876433221     111234699999999999999999999999999999999999999764222


Q ss_pred             CcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          752 NNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       752 ~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                      .  ............. ...+.++..+.  ....+.++.+++..||+.+|++||++.+|++.|+.+..
T Consensus       267 ~--~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          267 D--PKYVRDSKIRYRE-NIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             C--HHHHHHHHHHHHH-CHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             C--HHHHHHHHHHhhh-hHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            2  1122111111111 12222222221  12335678899999999999999999999999987643

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.1e-38  Score=340.17  Aligned_cols=257  Identities=27%  Similarity=0.405  Sum_probs=212.5

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ..++|+..++||+|+||.||+|+... ++.||+|++... ....+++.+|++++++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            34678999999999999999998865 788999999654 3456789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++++|.+++.... ...+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             cCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            999999999996533 345899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      . .......+++.|+|||.+.+..++.++||||||+++|||++ |..|+......   ....    ......        
T Consensus       166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~----~~~~~~--------  229 (288)
T 3kfa_A          166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE----LLEKDY--------  229 (288)
T ss_dssp             S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH----HHHTTC--------
T ss_pred             c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHhccC--------
Confidence            2 22233457889999999999999999999999999999999 88886533221   1111    111111        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ....+...+..+.+++.+||+.||++||++.|+++.|+..
T Consensus       230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            1122344566788999999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6.4e-38  Score=343.39  Aligned_cols=260  Identities=26%  Similarity=0.373  Sum_probs=206.9

Q ss_pred             ccccceeeccccEEEEEeEec-----CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeC--CceEE
Q 002969          544 FTDYNKLGQGGFGIVYKGRLL-----EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKML  615 (862)
Q Consensus       544 f~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~l  615 (862)
                      |+..++||+|+||.||+++..     +++.||||+++... ....+.+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488899999999999887542     47889999997653 34467899999999999999999999999884  56799


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||+++++|.+++...    .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            99999999999998543    3899999999999999999999998   9999999999999999999999999998875


Q ss_pred             CCCcc-cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCC--------cchhHHHHHHHHHh
Q 002969          696 GDQTE-QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSN--------NELNLLGHVWRLWK  766 (862)
Q Consensus       696 ~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~--------~~~~l~~~~~~~~~  766 (862)
                      ..... .......++..|+|||++.+..++.++||||||+++|||++|+.|+......        ..............
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            43221 2223356788899999999999999999999999999999999986432110        00000111111111


Q ss_pred             cCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          767 EGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       767 ~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      .+.        ....+...+.++.+++.+||+.||++||++.||++.|+.+.
T Consensus       266 ~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          266 RGE--------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccc--------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            111        12234455678999999999999999999999999998864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.4e-38  Score=347.58  Aligned_cols=261  Identities=22%  Similarity=0.257  Sum_probs=202.3

Q ss_pred             HHHHcccccccceeeccccEEEEEeEecC-CcEEEEEEeccC-----CccchHHHHHHHHHHHhcccCCceEEEEEEEeC
Q 002969          537 IVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-----SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM  610 (862)
Q Consensus       537 i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~  610 (862)
                      +....++|+..++||+|+||.||+|+... ++.||+|++...     .....+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            44556789999999999999999998754 788999998643     345567899999999999999999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhccC-------------------------------------CCCCCHhhHHHHHHHHHHH
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKAR-------------------------------------SSILNWQRRFNIICGIARG  653 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~qia~g  653 (862)
                      +..++||||+++|+|.+++.....                                     ...+++..+..++.||++|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999998842110                                     1224677788999999999


Q ss_pred             hHHhhhcCCCcEEecccCCcceEecCCC--CeeEecccceeecCCCCcc--cccccccccccccChhhhcC--CCCCccc
Q 002969          654 LLYLHQDSRFRIIHRDLKASNILLDKEM--TPKISDFGMARIFGGDQTE--QNTKRVVGTYGYMSPEYAMD--GLFSVKS  727 (862)
Q Consensus       654 L~yLH~~~~~~ivHrDlkp~NILl~~~~--~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~--~~~s~ks  727 (862)
                      |+|||+.+   |+||||||+|||++.++  .+||+|||+++.+......  .......||+.|+|||++.+  ..++.++
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999998   99999999999998776  8999999999876432211  12334578999999999975  6789999


Q ss_pred             cchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCH
Q 002969          728 DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTM  807 (862)
Q Consensus       728 DVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  807 (862)
                      ||||||+++|||++|+.|+....   ......   .........      ........+..+.+++.+||+.+|++||++
T Consensus       258 DiwslG~il~el~~g~~pf~~~~---~~~~~~---~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  325 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVN---DADTIS---QVLNKKLCF------ENPNYNVLSPLARDLLSNLLNRNVDERFDA  325 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSS---HHHHHH---HHHHCCCCT------TSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCC---hHHHHH---HHHhccccc------CCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence            99999999999999999974321   111111   111111000      001112245678899999999999999999


Q ss_pred             HHHHH
Q 002969          808 ASVVL  812 (862)
Q Consensus       808 ~evl~  812 (862)
                      .|+++
T Consensus       326 ~~~l~  330 (345)
T 3hko_A          326 MRALQ  330 (345)
T ss_dssp             HHHHH
T ss_pred             HHHhc
Confidence            99987

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.2e-37  Score=345.91  Aligned_cols=248  Identities=27%  Similarity=0.338  Sum_probs=205.6

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~l  615 (862)
                      .++|+..++||+|+||.||+++... ++.||||+++..   .....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            4679999999999999999998865 788999999754   234567788999999988 79999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||+++|+|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            999999999999996543   4899999999999999999999998   9999999999999999999999999998642


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..   .....+...+    ....      
T Consensus       173 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~---~~~~~~~~~i----~~~~------  237 (353)
T 2i0e_A          173 WD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG---EDEDELFQSI----MEHN------  237 (353)
T ss_dssp             CT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHH----HHCC------
T ss_pred             cC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC---CCHHHHHHHH----HhCC------
Confidence            22  2223446899999999999999999999999999999999999999743   2222222222    1111      


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPT-----MASVVL  812 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  812 (862)
                         ..++...+.++.+++.+||+.||++||+     +.||++
T Consensus       238 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 ---VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence               1233445678889999999999999995     578775

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-38  Score=339.82  Aligned_cols=257  Identities=26%  Similarity=0.408  Sum_probs=209.0

Q ss_pred             ccccccc-eeeccccEEEEEeEec---CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          542 DNFTDYN-KLGQGGFGIVYKGRLL---EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ++|...+ .||+|+||.||+|+..   .++.||||+++... ....+++.+|++++++++||||+++++++ +.+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566655 9999999999999753   47789999997653 34567899999999999999999999999 56679999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++++|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++..+..
T Consensus        88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            9999999999998543  345899999999999999999999998   99999999999999999999999999987754


Q ss_pred             CCcc-cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          697 DQTE-QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       697 ~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      .... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.....   ....    .....+..    
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~----~~i~~~~~----  231 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVM----AFIEQGKR----  231 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHH----HHHHTTCC----
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHH----HHHhcCCc----
Confidence            3322 12223456889999999998899999999999999999998 9999753222   1111    22222211    


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                          ...+...+..+.+++.+||+.+|++||++.||++.|+.+..
T Consensus       232 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          232 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                22344556788999999999999999999999999988643

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.4e-37  Score=334.39  Aligned_cols=263  Identities=19%  Similarity=0.245  Sum_probs=208.9

Q ss_pred             cccccccceeeccccEEEEEeEe-cCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEE-EeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC-VEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-~~~~~~~lV~E  618 (862)
                      .++|+..+.||+|+||.||+|+. .+++.||||++....  ..+++.+|+.+++.++|++++..+..+ .+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999986 468899999986543  235689999999999988866655555 66777899999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe---cCCCCeeEecccceeecC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFG  695 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~~  695 (862)
                      |+ +++|.+++...  ...+++.++..++.||++||+|||+.+   |+||||||+|||+   +.++.+||+|||+++...
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 99999999533  235899999999999999999999998   9999999999999   488999999999998775


Q ss_pred             CCCccc-----ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce
Q 002969          696 GDQTEQ-----NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV  770 (862)
Q Consensus       696 ~~~~~~-----~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  770 (862)
                      ......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+..............+.........
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence            433211     123457899999999999999999999999999999999999998764443333333333221111100


Q ss_pred             eeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          771 LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       771 ~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                              .......+.++.+++.+||+.||++||++.+|++.|+.+..
T Consensus       240 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  280 (296)
T 3uzp_A          240 --------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             --------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             --------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence                    00112234678899999999999999999999999988743

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.5e-37  Score=334.89  Aligned_cols=254  Identities=27%  Similarity=0.497  Sum_probs=202.8

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCcc-------chHHHHHHHHHHHhcccCCceEEEEEEEeCCce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQ-------GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  613 (862)
                      ++|+..+.||+|+||.||+|+.. +++.||||++......       ..+.+.+|++++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            57888999999999999999875 5889999998654322       1267899999999999999999999986544  


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC-----eeEecc
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT-----PKISDF  688 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~-----~kL~DF  688 (862)
                      ++||||+++++|.+++...  ...+++..++.++.|+++||+|||+.+ .+|+||||||+|||++.++.     +||+||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            7999999999999888543  345899999999999999999999985 34999999999999988776     999999


Q ss_pred             cceeecCCCCcccccccccccccccChhhhc--CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHh
Q 002969          689 GMARIFGGDQTEQNTKRVVGTYGYMSPEYAM--DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK  766 (862)
Q Consensus       689 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~  766 (862)
                      |+++....     ......||+.|+|||++.  ...++.++||||||+++|||++|+.|+........ .....   ...
T Consensus       174 g~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~---~~~  244 (287)
T 4f0f_A          174 GLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINM---IRE  244 (287)
T ss_dssp             TTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHHHH---HHH
T ss_pred             Cccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHHHH---Hhc
Confidence            99975422     223357899999999984  45678999999999999999999999754332211 11111   111


Q ss_pred             cCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          767 EGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       767 ~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .+.        ....+...+..+.+++.+||+.||++||++.||++.|+++
T Consensus       245 ~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          245 EGL--------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             SCC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             cCC--------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            111        1223445567889999999999999999999999999763

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.6e-38  Score=354.61  Aligned_cols=252  Identities=23%  Similarity=0.322  Sum_probs=198.4

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccC--CccchHHHHHHHHHHHhcc--cCCceEEEEEEEeCCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQ--HRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .++|++.++||+|+||.||++....++.||||++...  .....+.+.+|+.++++++  ||||+++++++...+..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            3569999999999999999999888999999999654  3345678999999999996  59999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      || +.+++|.+++....   .+++.++..++.||++||+|||+.+   |+||||||+|||++ ++.+||+|||+++.+..
T Consensus       135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 67889999986543   5888899999999999999999998   99999999999995 58999999999987654


Q ss_pred             CCcccccccccccccccChhhhcC-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMD-----------GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW  765 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~-----------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~  765 (862)
                      ...........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....     .........
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~  281 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII  281 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHH
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHh
Confidence            333333344679999999999875           4688999999999999999999999743211     111111111


Q ss_pred             hcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          766 KEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       766 ~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ....        ....+.....++.+|+.+||+.||++||++.||++.
T Consensus       282 ~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          282 DPNH--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             CTTS--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             Cccc--------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            1111        011222335678899999999999999999999863

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.1e-37  Score=334.73  Aligned_cols=264  Identities=19%  Similarity=0.241  Sum_probs=205.7

Q ss_pred             HcccccccceeeccccEEEEEeEe-cCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEE-EeCCceEEEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC-VEMDEKMLVY  617 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-~~~~~~~lV~  617 (862)
                      ..++|+..+.||+|+||.||+|+. .+++.||||++....  ..+++.+|++++++++|++++..+..+ .+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999986 458899999875443  234688999999999988877666555 6677889999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe---cCCCCeeEecccceeec
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIF  694 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~  694 (862)
                      ||+ +++|.+++....  ..+++..+..++.||++||+|||+.+   |+||||||+|||+   +.++.+||+|||+++.+
T Consensus        85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 999999986432  34899999999999999999999998   9999999999999   78899999999999887


Q ss_pred             CCCCcc-----cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc
Q 002969          695 GGDQTE-----QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK  769 (862)
Q Consensus       695 ~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  769 (862)
                      ......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            543321     122346789999999999999999999999999999999999999875444433333333222111110


Q ss_pred             eeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          770 VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       770 ~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                      .        .......+..+.+++.+||+.+|++||++.+|++.|+++..
T Consensus       239 ~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          239 I--------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             H--------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             h--------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            0        00012234578899999999999999999999999988643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-38  Score=354.72  Aligned_cols=261  Identities=20%  Similarity=0.230  Sum_probs=208.0

Q ss_pred             hHHHHHHcccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEe
Q 002969          534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE  609 (862)
Q Consensus       534 ~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~  609 (862)
                      ++++....++|+..++||+|+||.||+++.. +++.||||++++.   .....+.+.+|..++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            4445556788999999999999999999885 5899999999653   22345678999999999999999999999999


Q ss_pred             CCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccc
Q 002969          610 MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (862)
Q Consensus       610 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  689 (862)
                      .+..++||||+++|+|.+++....  ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence            999999999999999999996532  35899999999999999999999998   9999999999999999999999999


Q ss_pred             ceeecCCCCcccccccccccccccChhhhc-------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHH
Q 002969          690 MARIFGGDQTEQNTKRVVGTYGYMSPEYAM-------DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVW  762 (862)
Q Consensus       690 la~~~~~~~~~~~~~~~~gt~~y~APE~l~-------~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~  762 (862)
                      +++.+..... ......+||+.|+|||++.       ...++.++|||||||++|||++|+.||..   .+.......+.
T Consensus       208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~---~~~~~~~~~i~  283 (412)
T 2vd5_A          208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA---DSTAETYGKIV  283 (412)
T ss_dssp             TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC---SSHHHHHHHHH
T ss_pred             hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC---CCHHHHHHHHH
Confidence            9987643322 1223457999999999997       35689999999999999999999999743   22222222222


Q ss_pred             HHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCC---CCHHHHHH
Q 002969          763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEER---PTMASVVL  812 (862)
Q Consensus       763 ~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~  812 (862)
                      ......        .....+...+.++.+|+.+||+ +|++|   |+++||++
T Consensus       284 ~~~~~~--------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          284 HYKEHL--------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             THHHHC--------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             hcccCc--------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            110000        0111123345678899999999 99998   69999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=351.49  Aligned_cols=270  Identities=20%  Similarity=0.275  Sum_probs=213.5

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCC--ceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD--EKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--~~~lV~  617 (862)
                      ++|...++||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++.+.+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            578999999999999999998765 8899999997543 344677889999999999999999999998765  679999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe----cCCCCeeEecccceee
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL----DKEMTPKISDFGMARI  693 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kL~DFGla~~  693 (862)
                      ||+++++|.+++........+++..++.++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            99999999999976555555999999999999999999999998   9999999999999    7778899999999987


Q ss_pred             cCCCCcccccccccccccccChhhhcC--------CCCCccccchhHHHHHHHHHhCCCCCCCCCCC-cchhHHHHHHHH
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMD--------GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSN-NELNLLGHVWRL  764 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~-~~~~l~~~~~~~  764 (862)
                      +....   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||...... ........+...
T Consensus       166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            64322   2223578999999999865        56778999999999999999999998643322 222222222211


Q ss_pred             HhcCceeee----------ecc--cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          765 WKEGKVLEM----------VDS--SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       765 ~~~~~~~~~----------id~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .........          ...  ............+.+++.+||+.||++||++.|+++.++.+
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            111111100          000  11234466778888999999999999999999999888775

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.5e-37  Score=332.99  Aligned_cols=246  Identities=22%  Similarity=0.321  Sum_probs=204.6

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      .++|+..++||+|+||.||+|+... +..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            4579999999999999999998765 678999999876666778999999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe---cCCCCeeEecccceeecCC
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~~~  696 (862)
                      +++++|.+++....   .+++..+..++.|+++||+|||+.+   |+||||||+|||+   +.++.+||+|||++..+..
T Consensus        88 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           88 CTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            99999999886543   4899999999999999999999998   9999999999999   7889999999999987643


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ..   ......||+.|+|||++.+. ++.++||||||+++|||++|+.|+....   .....    .....+..      
T Consensus       162 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~----~~~~~~~~------  224 (277)
T 3f3z_A          162 GK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVM----LKIREGTF------  224 (277)
T ss_dssp             TS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH----HHHHHCCC------
T ss_pred             cc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC---HHHHH----HHHHhCCC------
Confidence            32   22335689999999988654 8999999999999999999999974321   11111    11111111      


Q ss_pred             cCCCCCh----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          777 SVDNYPA----NEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       777 ~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                         ..+.    ..+..+.+++.+||+.||++||++.|+++
T Consensus       225 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          225 ---TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             ---CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               1111    23567889999999999999999999985

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.7e-38  Score=347.46  Aligned_cols=251  Identities=23%  Similarity=0.318  Sum_probs=190.6

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ..++|+..++||+|+||.||+|+... ++.||||+++...  ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            45679999999999999999998865 7889999997543  34678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC---CCCeeEecccceeecC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---EMTPKISDFGMARIFG  695 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DFGla~~~~  695 (862)
                      |+++++|.+++...   ..+++.++..++.||++||+|||+.+   |+||||||+|||++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            99999999998543   34899999999999999999999998   999999999999975   8899999999998753


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ..   .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.....  ....    .+.+..... ..  
T Consensus       203 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~----~~~i~~~~~-~~--  270 (349)
T 2w4o_A          203 HQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG--DQFM----FRRILNCEY-YF--  270 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC--HHHH----HHHHHTTCC-CC--
T ss_pred             cc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc--cHHH----HHHHHhCCC-cc--
Confidence            32   122345789999999999999999999999999999999999999743221  1111    112222111 00  


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        ........+.++.+++.+||+.||++||++.|+++
T Consensus       271 --~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          271 --ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             --CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              11122345567889999999999999999999987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.6e-38  Score=345.76  Aligned_cols=250  Identities=23%  Similarity=0.252  Sum_probs=181.3

Q ss_pred             cceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCceEEEEEeccCCC
Q 002969          547 YNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYMENRS  624 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gs  624 (862)
                      .++||+|+||.||+++... ++.||||++...   ....+.+|+.+++++. ||||+++++++.+....++||||+++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            3789999999999998764 889999999643   3467789999999997 9999999999999999999999999999


Q ss_pred             hhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC---CeeEecccceeecCCCCccc
Q 002969          625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM---TPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       625 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kL~DFGla~~~~~~~~~~  701 (862)
                      |.+++...   ..+++.++..++.||++||+|||+.+   |+||||||+|||++.++   .+||+|||+++......  .
T Consensus        93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~  164 (325)
T 3kn6_A           93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--Q  164 (325)
T ss_dssp             HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--C
Confidence            99999653   35899999999999999999999998   99999999999997765   89999999998754322  2


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY  781 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~  781 (862)
                      ......||+.|+|||++.+..++.++||||||+++|||++|+.|+..................+..+....     ....
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~  239 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF-----EGEA  239 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC-----CSHH
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC-----Cccc
Confidence            22345689999999999999999999999999999999999999864332211111222222232221100     0000


Q ss_pred             ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          782 PANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       782 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ....+.++.+|+.+||+.||++||++.|+++
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            1234567889999999999999999999875

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=348.97  Aligned_cols=248  Identities=25%  Similarity=0.309  Sum_probs=197.6

Q ss_pred             cccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCC
Q 002969          545 TDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENR  623 (862)
Q Consensus       545 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g  623 (862)
                      ...+.||+|+||.||+|+.. +++.||+|+++.......+++.+|++++++++||||+++++++.+.+..++||||++++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            33568999999999999875 48899999998766566788999999999999999999999999999999999999999


Q ss_pred             ChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe--cCCCCeeEecccceeecCCCCccc
Q 002969          624 SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL--DKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       624 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl--~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +|.+++....  ..+++..+..++.||++||+|||+.+   |+||||||+|||+  +.++.+||+|||+++.+.....  
T Consensus       172 ~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--  244 (373)
T 2x4f_A          172 ELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--  244 (373)
T ss_dssp             EEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred             cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence            9999886432  34899999999999999999999998   9999999999999  5678999999999987643322  


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY  781 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~  781 (862)
                       .....||+.|+|||++.+..++.++|||||||++|||++|+.|+...   .....+..+.   .. .. ...    ...
T Consensus       245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~---~~~~~~~~i~---~~-~~-~~~----~~~  311 (373)
T 2x4f_A          245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD---NDAETLNNIL---AC-RW-DLE----DEE  311 (373)
T ss_dssp             -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHH---HT-CC-CSC----SGG
T ss_pred             -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHH---hc-cC-CCC----hhh
Confidence             22346899999999999999999999999999999999999997432   2222222221   11 10 000    011


Q ss_pred             ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          782 PANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       782 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ....+.++.+|+.+||+.||++||++.|+++
T Consensus       312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          312 FQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1234567889999999999999999999996

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.5e-38  Score=336.31  Aligned_cols=248  Identities=25%  Similarity=0.337  Sum_probs=202.2

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      +.++|+..+.||+|+||.||+|+... ++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            34679999999999999999998765 6789999986532   2335678999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||+++++|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            999999999999986543   4899999999999999999999988   9999999999999999999999999986543


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ..    ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+...   .......    .....       
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~----~~~~~-------  222 (279)
T 3fdn_A          161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYK----RISRV-------  222 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHH----HHHHT-------
T ss_pred             cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC---cHHHHHH----HHHhC-------
Confidence            22    223357899999999999999999999999999999999999997432   1111111    11111       


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                        ....+...+..+.+++.+||+.+|++||++.||++.
T Consensus       223 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          223 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             --CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              112233455678899999999999999999999963

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.1e-37  Score=343.35  Aligned_cols=267  Identities=16%  Similarity=0.190  Sum_probs=201.2

Q ss_pred             cccccccceeeccccEEEEEeEec----CCcEEEEEEeccCCcc-----------chHHHHHHHHHHHhcccCCceEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNSGQ-----------GIEEFKNEVRLIAKLQHRNLVRLLG  605 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~HpnIv~l~g  605 (862)
                      .++|+..++||+|+||.||+|+..    .+..+|||++......           ..+.+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            357999999999999999999875    4678999998765321           1234677888999999999999999


Q ss_pred             EEEe----CCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC
Q 002969          606 CCVE----MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM  681 (862)
Q Consensus       606 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~  681 (862)
                      ++..    ....++||||+ +++|.+++....   .+++.+++.++.||++||+|||+.+   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9988    67889999999 999999986543   5899999999999999999999998   99999999999998887


Q ss_pred             --CeeEecccceeecCCCCcc-----cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcc
Q 002969          682 --TPKISDFGMARIFGGDQTE-----QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE  754 (862)
Q Consensus       682 --~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~  754 (862)
                        .+||+|||+++.+......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... 
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-  267 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP-  267 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence              9999999999876432211     11234578999999999999999999999999999999999999975322211 


Q ss_pred             hhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          755 LNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       755 ~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                       .............. ...+.....  ....+.++.+++.+||+.+|++||++.+|++.|+....
T Consensus       268 -~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          268 -VAVQTAKTNLLDEL-PQSVLKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             -HHHHHHHHHHHHTT-THHHHHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             -HHHHHHHHhhcccc-cHHHHhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence             11111111111100 000000000  11345578899999999999999999999999988743

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=9.7e-38  Score=332.60  Aligned_cols=252  Identities=22%  Similarity=0.345  Sum_probs=205.0

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeC--CceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--DEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~lV~  617 (862)
                      ++|+..++||+|+||.||+|+.. ++.||||++....  ....++|.+|+.++++++||||+++++++.+.  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            57888999999999999999984 8899999997643  34456899999999999999999999999887  7789999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++.... ...+++.+++.++.||++||+|||+.+ .+++||||||+|||++.++.++|.|||++..... 
T Consensus        89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-  165 (271)
T ss_dssp             ECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred             cccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence            9999999999996532 235899999999999999999999874 4599999999999999999999999998754321 


Q ss_pred             CcccccccccccccccChhhhcCCCCCc---cccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSV---KSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~---ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                            ....||+.|+|||.+.+..++.   ++||||||+++|||++|+.|+.....   ...   .......+.     
T Consensus       166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~---~~~~~~~~~-----  228 (271)
T 3kmu_A          166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---MEI---GMKVALEGL-----  228 (271)
T ss_dssp             ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---HHH---HHHHHHSCC-----
T ss_pred             ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---HHH---HHHHHhcCC-----
Confidence                  2246789999999998765544   89999999999999999999753211   111   111122211     


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                         ....+...+..+.+++.+||+.||++||++.|+++.|+.+
T Consensus       229 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          229 ---RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence               1123344566788999999999999999999999999876

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.9e-37  Score=345.42  Aligned_cols=270  Identities=24%  Similarity=0.280  Sum_probs=208.2

Q ss_pred             CCccChHHHHHHcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcc-----cCCceE
Q 002969          529 LPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-----HRNLVR  602 (862)
Q Consensus       529 ~~~~~~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----HpnIv~  602 (862)
                      ...+.+.+.....++|+..++||+|+||.||+|+.. +++.||||+++.. ....+.+..|+.++++++     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            334555555556789999999999999999999875 5889999999642 344567788999999997     999999


Q ss_pred             EEEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC---
Q 002969          603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---  679 (862)
Q Consensus       603 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---  679 (862)
                      +++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.   
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence            999999999999999999 9999999965432 34899999999999999999999998   999999999999975   


Q ss_pred             ----------------------CCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHH
Q 002969          680 ----------------------EMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLL  737 (862)
Q Consensus       680 ----------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~  737 (862)
                                            ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  250 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA  250 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence                                  789999999999864322     22357899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCCcchhHHHHHHHHHhcC-----------ceeeeeccc-----C-CC----------------CChH
Q 002969          738 ETVSGKKNRGFYHSNNELNLLGHVWRLWKEG-----------KVLEMVDSS-----V-DN----------------YPAN  784 (862)
Q Consensus       738 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-----------~~~~~id~~-----~-~~----------------~~~~  784 (862)
                      ||++|+.||....   .......+.......           ......+..     . ..                ....
T Consensus       251 ell~g~~pf~~~~---~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  327 (360)
T 3llt_A          251 ELYTGSLLFRTHE---HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKII  327 (360)
T ss_dssp             HHHHSSCSCCCSS---HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHC
T ss_pred             HHHHCCCCCCCCc---HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccc
Confidence            9999999975322   222222221111000           000000000     0 00                0011


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          785 EVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       785 ~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ....+.+|+.+||+.||++|||+.|+++
T Consensus       328 ~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          328 KHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            1256779999999999999999999975

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-37  Score=339.25  Aligned_cols=265  Identities=24%  Similarity=0.322  Sum_probs=201.0

Q ss_pred             HcccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhc--ccCCceEEEEEEEeC----Cce
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL--QHRNLVRLLGCCVEM----DEK  613 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~HpnIv~l~g~~~~~----~~~  613 (862)
                      ..++|+..++||+|+||.||+|+.. ++.||||++...   ....+..|.+++..+  +||||+++++++...    ...
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            4468999999999999999999875 899999998543   234455666666655  899999999999887    678


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcC-----CCcEEecccCCcceEecCCCCeeEecc
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS-----RFRIIHRDLKASNILLDKEMTPKISDF  688 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDlkp~NILl~~~~~~kL~DF  688 (862)
                      ++||||+++|+|.+++...    .+++..++.++.|++.||+|||+..     +.+|+||||||+|||++.++.+||+||
T Consensus       111 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence            9999999999999999543    4899999999999999999999881     113999999999999999999999999


Q ss_pred             cceeecCCCCcccc--cccccccccccChhhhcCCCCCcc------ccchhHHHHHHHHHhC----------CCCCCCCC
Q 002969          689 GMARIFGGDQTEQN--TKRVVGTYGYMSPEYAMDGLFSVK------SDVFSFGVLLLETVSG----------KKNRGFYH  750 (862)
Q Consensus       689 Gla~~~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~s~k------sDVwSlGvil~elltG----------~~p~~~~~  750 (862)
                      |+++.+........  .....||+.|+|||++.+.....+      +|||||||++|||++|          +.|+....
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~  266 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV  266 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence            99987643322211  223578999999999988776665      9999999999999999          55543322


Q ss_pred             CCcchhHHHHHHHHHhcCceeeeecccCC--CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          751 SNNELNLLGHVWRLWKEGKVLEMVDSSVD--NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       751 ~~~~~~l~~~~~~~~~~~~~~~~id~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      ....  .............    ..+...  ......+.++.+++.+||+.||++||++.||++.|+.+.
T Consensus       267 ~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          267 PSDP--SYEDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             CSSC--CHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCC--chhhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence            2111  1111211111111    111111  112356778999999999999999999999999998874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.4e-38  Score=339.12  Aligned_cols=261  Identities=28%  Similarity=0.396  Sum_probs=204.1

Q ss_pred             cccccccceeeccccEEEEEeEecCC----cEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEe-CCceE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEG----QEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE-MDEKM  614 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~  614 (862)
                      ..+|+..++||+|+||.||+|+..+.    ..+|+|++.... ....+++.+|+.++++++||||+++++++.+ .+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            34688889999999999999986432    358999987643 3456789999999999999999999998654 56789


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      +||||+++++|.+++...  ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus       104 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            999999999999999543  345889999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCc--ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCC-CCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          695 GGDQT--EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKN-RGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       695 ~~~~~--~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      .....  ........+|+.|+|||.+.+..++.++||||||+++|||++|..| +...   .........    ..+.  
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~----~~~~--  249 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTFDITVYL----LQGR--  249 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS---CTTTHHHHH----HTTC--
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC---CHHHHHHHH----hcCC--
Confidence            43322  1222334678899999999999999999999999999999995554 3222   111221111    1111  


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCC
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATM  821 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  821 (862)
                            ....+...+..+.+++.+||+.+|++||++.|+++.|+.+....
T Consensus       250 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          250 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             ------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                  11123334567889999999999999999999999998875433

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-38  Score=339.00  Aligned_cols=260  Identities=27%  Similarity=0.355  Sum_probs=206.5

Q ss_pred             cccccceeeccccEEEEEeEecC-C---cEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCce-EEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLE-G---QEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK-MLV  616 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~-~lV  616 (862)
                      .|...++||+|+||.||+|+..+ +   ..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45666899999999999998643 2   369999997643 34567899999999999999999999999876665 999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      +||+.+++|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            9999999999999542  345899999999999999999999998   99999999999999999999999999986643


Q ss_pred             CC--cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          697 DQ--TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       697 ~~--~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ..  .........+++.|+|||.+.+..++.++||||||+++|||++|..|+..  ..+.......    ...+..    
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~--~~~~~~~~~~----~~~~~~----  246 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR--HIDPFDLTHF----LAQGRR----  246 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTT--TSCGGGHHHH----HHTTCC----
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCc--cCCHHHHHHH----hhcCCC----
Confidence            32  11222345678999999999999999999999999999999997666422  1122222211    111111    


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCC
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATM  821 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  821 (862)
                          ...+...+..+.+++.+||+.+|++||++.|+++.|+++....
T Consensus       247 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          247 ----LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ----CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence                1223344567889999999999999999999999998875433

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=342.37  Aligned_cols=264  Identities=26%  Similarity=0.406  Sum_probs=210.3

Q ss_pred             cccccccceeeccccEEEEEeEe-----cCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCC--ce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRL-----LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD--EK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--~~  613 (862)
                      .++|+..++||+|+||.||+++.     .+++.||||++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688899999999999999983     358899999998776667788999999999999999999999987654  68


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++|+||+++++|.+++....  ..+++.+++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            99999999999999996542  35899999999999999999999998   99999999999999999999999999988


Q ss_pred             cCCCCccc-ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCC---------CCcchhHHHHHHH
Q 002969          694 FGGDQTEQ-NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYH---------SNNELNLLGHVWR  763 (862)
Q Consensus       694 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~---------~~~~~~l~~~~~~  763 (862)
                      ........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+....         .............
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            75433211 1223456788999999999889999999999999999999998854210         0000111111222


Q ss_pred             HHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          764 LWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       764 ~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .+..+..        ...+...+.++.+++.+||+.||++||++.||++.|+.+
T Consensus       275 ~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          275 LLKNNGR--------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHTTCC--------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhhcCCC--------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2222111        122344567889999999999999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.9e-37  Score=332.61  Aligned_cols=252  Identities=27%  Similarity=0.390  Sum_probs=201.5

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      .|....+||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            3455569999999999999864 478999999987766667889999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC-CCCeeEecccceeecCCCCcc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-EMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~  700 (862)
                      +++|.+++........+++..+..++.||++||+|||+.+   |+||||||+|||++. ++.+||+|||++.......  
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--  177 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--  177 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence            9999999976544455778899999999999999999998   999999999999987 8999999999998764322  


Q ss_pred             cccccccccccccChhhhcCCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGL--FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~--~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                      .......|++.|+|||++.+..  ++.++||||||+++|||++|+.|+.......  .   ........        ...
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~---~~~~~~~~--------~~~  244 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--A---AMFKVGMF--------KVH  244 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH--H---HHHHHHHH--------CCC
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh--H---HHHhhccc--------ccc
Confidence            1123357899999999997654  8899999999999999999999974321111  1   11111000        011


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ...+...+.++.+++.+||+.||++||++.|+++
T Consensus       245 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          245 PEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            2234445667889999999999999999999985

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.8e-38  Score=362.89  Aligned_cols=248  Identities=23%  Similarity=0.281  Sum_probs=195.5

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .++|+..++||+|+||.||+++.. +++.||||++...   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            367999999999999999999875 4889999999753   334456788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhh-cCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ-DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      |||+++++|.+++...   ..+++..+..++.||++||+|||+ .+   |+||||||+||||+.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            9999999999998553   348999999999999999999998 77   9999999999999999999999999997543


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ..  ........||+.|+|||++.+..++.++|||||||++|||++|+.||...   ....+...+    ....      
T Consensus       301 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i----~~~~------  365 (446)
T 4ejn_A          301 KD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHEKLFELI----LMEE------  365 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH----HHCC------
T ss_pred             CC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC---CHHHHHHHH----HhCC------
Confidence            22  22233467999999999999999999999999999999999999997432   222222211    1111      


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERP-----TMASVVL  812 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  812 (862)
                         ..++...+.++.+|+.+||+.||++||     +++|+++
T Consensus       366 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 ---IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence               122344556788999999999999999     9999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-38  Score=353.26  Aligned_cols=260  Identities=28%  Similarity=0.404  Sum_probs=196.7

Q ss_pred             ccccccceeeccccEEEEEeEecC--C--cEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEe-CCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE--G--QEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE-MDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~--~--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~l  615 (862)
                      ..|+..++||+|+||.||+|+..+  +  ..||||.++.. .....++|.+|+.++++++||||+++++++.+ .+..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            346777899999999999998643  2  35899998654 33456789999999999999999999999765 457899


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||+++++|.+++...  ...+++.+++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       169 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence            99999999999999543  345889999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcc--cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          696 GDQTE--QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       696 ~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      .....  .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+|+......   .....    ...+..  
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~~----~~~~~~--  314 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVY----LLQGRR--  314 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHHH----HHTTCC--
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHHH----HHcCCC--
Confidence            33211  12223457889999999999999999999999999999999 55554332221   12111    112211  


Q ss_pred             eecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCC
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATM  821 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  821 (862)
                            ...+...+..+.+++.+||+.+|++||++.||++.|+.+....
T Consensus       315 ------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          315 ------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence                  1123345567889999999999999999999999999875443

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.7e-37  Score=330.70  Aligned_cols=247  Identities=26%  Similarity=0.407  Sum_probs=205.0

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEe----------
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE----------  609 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----------  609 (862)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++....    +.+.+|++++++++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            457899999999999999999886 58999999997543    467899999999999999999999864          


Q ss_pred             ------CCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCe
Q 002969          610 ------MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (862)
Q Consensus       610 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  683 (862)
                            ....++||||+++++|.+++.... ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence                  345799999999999999996543 345899999999999999999999998   9999999999999999999


Q ss_pred             eEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHH
Q 002969          684 KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR  763 (862)
Q Consensus       684 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~  763 (862)
                      ||+|||++..+.....   .....|++.|+|||++.+..++.++||||||+++|||++|..|+..         ......
T Consensus       162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~~~  229 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKFFT  229 (284)
T ss_dssp             EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHHHH
T ss_pred             EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHHHH
Confidence            9999999987654322   2234689999999999999999999999999999999999987421         111112


Q ss_pred             HHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          764 LWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       764 ~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      ....+.           .+...+..+.+++.+||+.||++||++.|+++.|....
T Consensus       230 ~~~~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          230 DLRDGI-----------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             HHHTTC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             Hhhccc-----------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            222211           12233456789999999999999999999999998874

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.3e-37  Score=335.21  Aligned_cols=260  Identities=24%  Similarity=0.335  Sum_probs=198.8

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCc--cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ++|+..++||+|+||.||+|+... ++.||||++.....  ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            578899999999999999998865 88999999865432  235678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++++|.+++...   ..+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        83 ~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            99999999887543   34899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHh-----------
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWK-----------  766 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~-----------  766 (862)
                      .  ......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+......   .....+.+...           
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (311)
T 4agu_A          157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV---DQLYLIRKTLGDLIPRHQQVFS  231 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHHHHHHHH
T ss_pred             c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhcccccccccccc
Confidence            2  2233578999999999976 67899999999999999999999997543221   22222111111           


Q ss_pred             cCcee---eeecccC-C---CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          767 EGKVL---EMVDSSV-D---NYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       767 ~~~~~---~~id~~~-~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .....   ...++.. .   ......+..+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            10000   0000000 0   001234556889999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6.9e-38  Score=342.10  Aligned_cols=244  Identities=24%  Similarity=0.299  Sum_probs=193.8

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..++||+|+||+||+|+.. +++.||||++....  .....++..|+..+.++ +||||+++++++.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57999999999999999999886 58999999986542  23344556666666666 8999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+ +++|.+++....  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            999 679988886543  35999999999999999999999998   999999999999999999999999999876432


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      .   ......||+.|+|||++.+ .++.++||||||+++|||++|..++..   .   .    .+..+..+....     
T Consensus       211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~---~---~----~~~~~~~~~~~~-----  271 (311)
T 3p1a_A          211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG---G---E----GWQQLRQGYLPP-----  271 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS---H---H----HHHHHTTTCCCH-----
T ss_pred             C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC---c---c----HHHHHhccCCCc-----
Confidence            2   2233568999999998876 789999999999999999999776421   0   1    111122211110     


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        ..+...+.++.+++.+||+.||++||++.|+++
T Consensus       272 --~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          272 --EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             --HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence              111234567889999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8e-38  Score=335.98  Aligned_cols=255  Identities=24%  Similarity=0.339  Sum_probs=203.7

Q ss_pred             cccccccceeeccccEEEEEeEecC----CcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      .++|+..+.||+|+||.||+|+...    +..||+|++... .....+++.+|+.++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4678999999999999999998643    235999999765 33456789999999999999999999999764 56789


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||+++++|.+++....  ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        90 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            999999999999996532  34899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ..... ......+++.|+|||++.+..++.++||||||+++|||++ |+.|+......   .....    ...+..    
T Consensus       165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~----~~~~~~----  232 (281)
T 3cc6_A          165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGV----LEKGDR----  232 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHH----HHHTCC----
T ss_pred             ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHH----HhcCCC----
Confidence            32211 1223456889999999999999999999999999999998 99997533222   22211    111111    


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                          ...+...+..+.+++.+||+.+|++||++.|+++.|+.+
T Consensus       233 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          233 ----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence                112333456788999999999999999999999999875

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.7e-37  Score=331.96  Aligned_cols=253  Identities=26%  Similarity=0.323  Sum_probs=205.9

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            357899999999999999999876 58899999996543 3456789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++++|.+++...   ..+++..+..++.||++||+|||+.+   ++||||||+||+++.++.+||+|||++..+....
T Consensus        86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            99999999988432   35899999999999999999999998   9999999999999999999999999998764333


Q ss_pred             cccccccccccccccChhhhcCCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLF-SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      .........|++.|+|||.+.+..+ +.++||||||+++|||++|+.|+........  ..    ..+....       .
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~~~~~-------~  226 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EY----SDWKEKK-------T  226 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HH----HHHHTTC-------T
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HH----HHhhhcc-------c
Confidence            2233344678999999999987765 7899999999999999999999754322211  11    1111111       0


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ........+..+.+++.+||+.||++||++.|+++
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            01112334567889999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.9e-37  Score=357.18  Aligned_cols=246  Identities=24%  Similarity=0.375  Sum_probs=205.1

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|...+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57888999999999999999876 58999999996542   234567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++...   ..+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        96 E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            999999999998543   35899999999999999999999998   999999999999999999999999999876432


Q ss_pred             CcccccccccccccccChhhhcCCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLF-SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      .   ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....   ...+.    ..+..+.       
T Consensus       170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~----~~i~~~~-------  232 (476)
T 2y94_A          170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH---VPTLF----KKICDGI-------  232 (476)
T ss_dssp             C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS---SHHHH----HHHHTTC-------
T ss_pred             c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC---HHHHH----HHHhcCC-------
Confidence            2   2234579999999999988765 689999999999999999999975322   11222    2222221       


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        ...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       233 --~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          233 --FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence              1123334567889999999999999999999996

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=341.88  Aligned_cols=265  Identities=22%  Similarity=0.323  Sum_probs=198.6

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc-cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ++|...++||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999876 588999999965432 2233566899999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      ++ ++|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--  153 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP--  153 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC--
Confidence            98 5888888543  345899999999999999999999998   999999999999999999999999999865322  


Q ss_pred             ccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee---eeec
Q 002969          700 EQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL---EMVD  775 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~~id  775 (862)
                      ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...   ........+.+........   ....
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS---TVEEQLHFIFRILGTPTEETWPGILS  230 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCChHhchhhhc
Confidence            122233568999999999877 56899999999999999999999997532   2223333333322211000   0000


Q ss_pred             --------------ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH--HhccC
Q 002969          776 --------------SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL--MLSSE  817 (862)
Q Consensus       776 --------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~  817 (862)
                                    ............++.+|+.+||+.||++|||+.|+++  .+.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence                          0000011223457789999999999999999999997  44444

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.5e-37  Score=329.14  Aligned_cols=251  Identities=25%  Similarity=0.338  Sum_probs=204.2

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      .++|+..++||+|+||.||+|.... ++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4679999999999999999998754 889999999654  2334577889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC---eeEecccceeec
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT---PKISDFGMARIF  694 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kL~DFGla~~~  694 (862)
                      ||+++++|.+.+...   ..+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            999999999888654   34899999999999999999999998   999999999999987655   999999999876


Q ss_pred             CCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          695 GGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       695 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      .....   .....||+.|+|||++.+..++.++||||||+++|||++|+.|+...   .......    ....+.. .. 
T Consensus       159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~---~~~~~~~----~~~~~~~-~~-  226 (284)
T 3kk8_A          159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYA----QIKAGAY-DY-  226 (284)
T ss_dssp             CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHH----HHHHTCC-CC-
T ss_pred             ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC---chhHHHH----HHHhccc-cC-
Confidence            43222   23357899999999999999999999999999999999999997432   1111211    1111111 00 


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                         ........+.++.+++.+||+.||++||++.|+++
T Consensus       227 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          227 ---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             ---CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence               01111234567889999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.9e-37  Score=360.75  Aligned_cols=253  Identities=28%  Similarity=0.369  Sum_probs=209.0

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .++|+..++||+|+||.||+++.. +++.||||++...   .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999876 5899999999653   234456789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999986543 234899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ..   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ..+.+.....        
T Consensus       339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~---~~i~~~i~~~--------  404 (576)
T 2acx_A          339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEV--------  404 (576)
T ss_dssp             TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH---HHHHHHHHHC--------
T ss_pred             Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH---HHHHHHhhcc--------
Confidence            22   223357999999999999999999999999999999999999997643322211   1122222211        


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERP-----TMASVVL  812 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  812 (862)
                       ...++...+.++.+|+.+||+.||++||     ++.||++
T Consensus       405 -~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          405 -PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence             1123344567889999999999999999     7899985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.9e-37  Score=344.94  Aligned_cols=252  Identities=14%  Similarity=0.116  Sum_probs=205.8

Q ss_pred             HcccccccceeeccccEEEEEeE------ecCCcEEEEEEeccCCccchHHHHHHHHHHHhcc---cCCceEEEEEEEeC
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGR------LLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ---HRNLVRLLGCCVEM  610 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~g~~~~~  610 (862)
                      ..++|...++||+|+||.||+|.      ...++.||||+++..   ...++..|++++++++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            45789999999999999999994      445889999999654   3456788888888886   99999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhcc--CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC---------
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKA--RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---------  679 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---------  679 (862)
                      +..++||||+++|+|.+++....  ....+++..++.|+.||++||+|||+.+   |+||||||+||||+.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            99999999999999999996532  3456999999999999999999999998   999999999999998         


Q ss_pred             --CCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhH
Q 002969          680 --EMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNL  757 (862)
Q Consensus       680 --~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l  757 (862)
                        ++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.|+......     
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----  291 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG-----  291 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT-----
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC-----
Confidence              8999999999998764333333444567999999999999999999999999999999999999996321111     


Q ss_pred             HHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCC-CCHHHHHHHhccC
Q 002969          758 LGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEER-PTMASVVLMLSSE  817 (862)
Q Consensus       758 ~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~~  817 (862)
                                  . ..+.......+  ....+.+++..|++.+|.+| |+++++.+.|+..
T Consensus       292 ------------~-~~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          292 ------------E-CKPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             ------------E-EEECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             ------------c-eeechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence                        0 11222222222  24566789999999999998 6888888888775

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.4e-37  Score=345.06  Aligned_cols=253  Identities=23%  Similarity=0.262  Sum_probs=194.7

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      .++|+..++||+|+||.||+++.. .++.||||++.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467999999999999999999876 58899999996543 3346788999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC--eeEecccceeecCCC
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT--PKISDFGMARIFGGD  697 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kL~DFGla~~~~~~  697 (862)
                      +++|+|.+++....   .+++..+..++.||++||+|||+.+   |+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            99999999986543   4899999999999999999999998   999999999999987765  999999999753221


Q ss_pred             CcccccccccccccccChhhhcCCCCCcc-ccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVK-SDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~k-sDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                         .......||+.|+|||++.+..+..+ +|||||||++|||++|+.||........  .. ...........      
T Consensus       172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~-~~~~~~~~~~~------  239 (361)
T 3uc3_A          172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YR-KTIQRILSVKY------  239 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HH-HHHHHHHTTCC------
T ss_pred             ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HH-HHHHHHhcCCC------
Confidence               22234579999999999988887665 8999999999999999999754322221  11 11111111110      


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      . .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       240 ~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          240 S-IPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             C-CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             C-CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            0 00111235678899999999999999999999963

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=337.69  Aligned_cols=262  Identities=26%  Similarity=0.364  Sum_probs=201.3

Q ss_pred             HcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-----ccchHHHHHHHHHHHhcc---cCCceEEEEEEEeC
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-----GQGIEEFKNEVRLIAKLQ---HRNLVRLLGCCVEM  610 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~---HpnIv~l~g~~~~~  610 (862)
                      ..++|+..++||+|+||.||+|+.. +++.||||++....     ......+.+|+.++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3568999999999999999999864 58899999986432     222456778888888775   99999999999876


Q ss_pred             C-----ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeE
Q 002969          611 D-----EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKI  685 (862)
Q Consensus       611 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL  685 (862)
                      .     ..++||||++ ++|.+++..... ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     4799999997 599999865432 34899999999999999999999998   999999999999999999999


Q ss_pred             ecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH
Q 002969          686 SDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW  765 (862)
Q Consensus       686 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~  765 (862)
                      +|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.|+..   .........+.+..
T Consensus       162 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~---~~~~~~~~~i~~~~  235 (308)
T 3g33_A          162 ADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG---NSEADQLGKIFDLI  235 (308)
T ss_dssp             CSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC---SSHHHHHHHHHHHH
T ss_pred             eeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHHh
Confidence            999999865322   222346789999999999999999999999999999999999999643   22333333333322


Q ss_pred             hcCceeee------ecccC--------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          766 KEGKVLEM------VDSSV--------DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       766 ~~~~~~~~------id~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ........      .....        ..........+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            11110000      00000        0011234567889999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6e-38  Score=338.88  Aligned_cols=257  Identities=29%  Similarity=0.404  Sum_probs=205.8

Q ss_pred             cccccccc-eeeccccEEEEEeEec---CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceE
Q 002969          541 TDNFTDYN-KLGQGGFGIVYKGRLL---EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       541 ~~~f~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  614 (862)
                      .++|...+ .||+|+||.||+|...   .++.||||+++...  ....+++.+|++++++++||||+++++++ +.+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45677777 9999999999999542   36789999997543  33467899999999999999999999999 667889


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      +||||+++++|.+++...   ..+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++..+
T Consensus        94 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            999999999999999653   34899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcc-cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          695 GGDQTE-QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       695 ~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      ...... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.....   ..    .......+..  
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~----~~~~~~~~~~--  238 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SE----VTAMLEKGER--  238 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HH----HHHHHHTTCC--
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HH----HHHHHHcCCC--
Confidence            543322 11222346789999999998889999999999999999999 9998653221   11    2222222211  


Q ss_pred             eecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                            ...+...+..+.+++.+||+.||++||++.+|++.|+....
T Consensus       239 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          239 ------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                  12334556788999999999999999999999999988643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.3e-37  Score=340.12  Aligned_cols=257  Identities=25%  Similarity=0.314  Sum_probs=199.3

Q ss_pred             cccccc-ceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDY-NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      +.|.+. ++||+|+||.||+|+.. +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            457664 78999999999999864 5889999999876666678899999999995 79999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC---eeEecccceeecC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT---PKISDFGMARIFG  695 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kL~DFGla~~~~  695 (862)
                      |+++++|.+++...   ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.   +||+|||++..+.
T Consensus        92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            99999999999654   34899999999999999999999998   999999999999988776   9999999998654


Q ss_pred             CCCc-----ccccccccccccccChhhhcC-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcc--------hhH
Q 002969          696 GDQT-----EQNTKRVVGTYGYMSPEYAMD-----GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE--------LNL  757 (862)
Q Consensus       696 ~~~~-----~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~--------~~l  757 (862)
                      ....     ........||+.|+|||++.+     ..++.++||||||+++|||++|+.||......+.        ...
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            2211     111223468999999999875     5588999999999999999999999864322210        000


Q ss_pred             HHHHHHHHhcCceeeeecccCCCCCh----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          758 LGHVWRLWKEGKVLEMVDSSVDNYPA----NEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       758 ~~~~~~~~~~~~~~~~id~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ..........+..         ..+.    ..+..+.+++.+||+.||++||++.|+++.
T Consensus       246 ~~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          246 QNMLFESIQEGKY---------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHCCC---------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHhccCc---------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            1112222222211         1111    234578899999999999999999999973

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-37  Score=333.63  Aligned_cols=251  Identities=24%  Similarity=0.334  Sum_probs=198.1

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ++|...++||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            57899999999999999999875 48899999997653 34567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhc-cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe---cCCCCeeEecccceeecC
Q 002969          620 MENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFG  695 (862)
Q Consensus       620 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~~  695 (862)
                      +++++|.+++... .....+++..+..++.||++||+|||+.+   |+||||||+|||+   +.++.+||+|||++..+.
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999988653 23356999999999999999999999998   9999999999999   456789999999998654


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ...   ......|++.|+|||++. ..++.++||||||+++|||++|+.|+....   ........    ....      
T Consensus       179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~---~~~~~~~~----~~~~------  241 (285)
T 3is5_A          179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS---LEEVQQKA----TYKE------  241 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH----HHCC------
T ss_pred             Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC---HHHHHhhh----ccCC------
Confidence            322   223456899999999875 568999999999999999999999975321   11111111    1110      


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..........+..+.+++.+||+.||++||++.||++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          242 PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0011111123457789999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.7e-38  Score=344.92  Aligned_cols=260  Identities=24%  Similarity=0.264  Sum_probs=192.9

Q ss_pred             HcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcc-cCCceEEEEEEEe--------
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVE--------  609 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~--------  609 (862)
                      ...+|+..++||+|+||.||+|+.. +++.||||++........+.+.+|+.+++++. ||||+++++++..        
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            3457999999999999999999875 58899999997766666778999999999996 9999999999953        


Q ss_pred             CCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccc
Q 002969          610 MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (862)
Q Consensus       610 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  689 (862)
                      ....++|+||++ |+|.+++........+++.+++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence            334789999996 799998876555566999999999999999999999875 359999999999999999999999999


Q ss_pred             ceeecCCCCccc----------ccccccccccccChhhh---cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchh
Q 002969          690 MARIFGGDQTEQ----------NTKRVVGTYGYMSPEYA---MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELN  756 (862)
Q Consensus       690 la~~~~~~~~~~----------~~~~~~gt~~y~APE~l---~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~  756 (862)
                      +++.+.......          ......||+.|+|||++   .+..++.++||||||+++|||++|+.|+......    
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----  259 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----  259 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH----
Confidence            998764332211          11134689999999998   5667899999999999999999999997421110    


Q ss_pred             HHHHHHHHHhcCceeeeecccC-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCC
Q 002969          757 LLGHVWRLWKEGKVLEMVDSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT  820 (862)
Q Consensus       757 l~~~~~~~~~~~~~~~~id~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  820 (862)
                                     +.+.... ..........+.+++.+||+.||++||++.|+++.|..+...
T Consensus       260 ---------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          260 ---------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             ---------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                           0011111 111122234577899999999999999999999999887543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.2e-37  Score=337.27  Aligned_cols=251  Identities=24%  Similarity=0.307  Sum_probs=204.5

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCcc------chHHHHHHHHHHHhcccCCceEEEEEEEeCCce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQ------GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  613 (862)
                      .++|+..+.||+|+||.||+++.. +++.||||++......      ..+++.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            357899999999999999999876 4889999999754321      357899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC----CeeEeccc
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM----TPKISDFG  689 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kL~DFG  689 (862)
                      ++||||+++++|.+++...   ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            9999999999999999543   35899999999999999999999998   99999999999999888    79999999


Q ss_pred             ceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc
Q 002969          690 MARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK  769 (862)
Q Consensus       690 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  769 (862)
                      ++.......   ......||+.|+|||++.+..++.++||||||+++|||++|+.|+...   ........    .....
T Consensus       165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~~~~~----i~~~~  234 (321)
T 2a2a_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLAN----ITSVS  234 (321)
T ss_dssp             TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHH----HHTTC
T ss_pred             cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC---CHHHHHHH----HHhcc
Confidence            998764322   223356899999999999999999999999999999999999997432   11122111    11111


Q ss_pred             eeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          770 VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       770 ~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      . .. +.   ......+..+.+++.+||+.||++||++.|+++
T Consensus       235 ~-~~-~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          235 Y-DF-DE---EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             C-CC-CH---HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             c-cc-Ch---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0 00 00   001223456889999999999999999999987

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.2e-37  Score=336.19  Aligned_cols=267  Identities=22%  Similarity=0.355  Sum_probs=202.4

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .++|+..++||+|+||.||+|+.. +++.||||++...   .....+++.+|+.++++++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            357999999999999999999864 5899999999753   233467889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhc-cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          617 YEYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      |||+++++|.+++... .....+++..++.++.||++||+|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999998643 23455899999999999999999999998   9999999999999999999999999998664


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ....  ......|++.|+|||++.+..++.++||||||+++|||++|+.|+......    .. ............    
T Consensus       188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~-~~~~~~~~~~~~----  256 (310)
T 2wqm_A          188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LY-SLCKKIEQCDYP----  256 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HH-HHHHHHHTTCSC----
T ss_pred             CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HH-HHHHHhhcccCC----
Confidence            3221  222356899999999999999999999999999999999999997432111    11 111222221111    


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCCCCC
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQP  824 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p  824 (862)
                         .......+.++.+++.+||+.||++||++.||++.|+++.+..+.|
T Consensus       257 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          257 ---PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             ---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             ---CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence               1112334567889999999999999999999999999885544433

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.9e-37  Score=343.12  Aligned_cols=251  Identities=22%  Similarity=0.303  Sum_probs=202.5

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .++|+..+.||+|+||.||+++... ++.||||++.....    .+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            4679999999999999999998764 88999999975432    345788899888 79999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC----CCeeEecccceeec
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE----MTPKISDFGMARIF  694 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kL~DFGla~~~  694 (862)
                      |+++|+|.+++...   ..+++.++..++.||+.||+|||+.+   |+||||||+|||+.++    +.+||+|||+++.+
T Consensus        97 ~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           97 LMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            99999999998543   35899999999999999999999998   9999999999998543    35999999999876


Q ss_pred             CCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          695 GGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       695 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+.    ..+..+...   
T Consensus       171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~~---  241 (342)
T 2qr7_A          171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKFS---  241 (342)
T ss_dssp             BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCCC---
T ss_pred             cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCcc---
Confidence            43322  223457899999999998888999999999999999999999998643333322222    222222211   


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        .........+.++.+|+.+||+.||++||++.|+++
T Consensus       242 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          242 --LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             --CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              011223345667889999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.3e-38  Score=344.69  Aligned_cols=260  Identities=30%  Similarity=0.417  Sum_probs=206.0

Q ss_pred             cccccccceeeccccEEEEEeEec------CCcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  613 (862)
                      .++|+..+.||+|+||.||+|+..      .++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            367899999999999999999842      3678999999654 334566899999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccC----CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC---CCCeeEe
Q 002969          614 MLVYEYMENRSLDSVIFDKAR----SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---EMTPKIS  686 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kL~  686 (862)
                      ++||||+++++|.+++.....    ...+++.+++.++.||++||.|||+.+   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999975432    245889999999999999999999998   999999999999984   4569999


Q ss_pred             cccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHH
Q 002969          687 DFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLW  765 (862)
Q Consensus       687 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  765 (862)
                      |||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.|+...   .....    ....
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~---~~~~~----~~~~  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEV----LEFV  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHH----HHHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc---CHHHH----HHHH
Confidence            9999986544333333334567899999999999999999999999999999998 88886432   11111    2222


Q ss_pred             hcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          766 KEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       766 ~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      ..+..        ...+...+..+.+++.+||+.+|++||++.||++.|+...
T Consensus       259 ~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          259 TSGGR--------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcCCC--------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            22211        1223345567889999999999999999999999998763

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.5e-37  Score=333.92  Aligned_cols=245  Identities=24%  Similarity=0.379  Sum_probs=200.8

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .++|+..++||+|+||.||+|+.. +++.||||++...  ......++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467999999999999999999876 5899999999764  234566788999999999 999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccC-CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC---------------
Q 002969          617 YEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE---------------  680 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---------------  680 (862)
                      |||+++++|.+++..... ...+++.++..++.||++||+|||+.+   |+||||||+|||++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999965422 245899999999999999999999998   9999999999999844               


Q ss_pred             ----CCeeEecccceeecCCCCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcch
Q 002969          681 ----MTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL  755 (862)
Q Consensus       681 ----~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~  755 (862)
                          ..+||+|||++.......      ...||+.|+|||++.+. .++.++||||||+++|||++|.+++..   .   
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---~---  234 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN---G---  234 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS---S---
T ss_pred             cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc---h---
Confidence                479999999998764322      23589999999999876 567899999999999999999876421   1   


Q ss_pred             hHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          756 NLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       756 ~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..    +.....+.        ....+...+..+.+++.+||+.||++||++.|+++
T Consensus       235 ~~----~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          235 DQ----WHEIRQGR--------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HH----HHHHHTTC--------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hH----HHHHHcCC--------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            11    11122221        12233445667889999999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=343.39  Aligned_cols=243  Identities=22%  Similarity=0.300  Sum_probs=202.6

Q ss_pred             HcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc--------cchHHHHHHHHHHHhcccCCceEEEEEEEeC
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG--------QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM  610 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~  610 (862)
                      ..++|+..++||+|+||.||+|+.. +++.||||++.....        ...+.+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3468999999999999999999864 588899999976421        2345788999999999999999999999999


Q ss_pred             CceEEEEEeccCC-ChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccc
Q 002969          611 DEKMLVYEYMENR-SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (862)
Q Consensus       611 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  689 (862)
                      +..++||||+.+| +|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999776 999988543   34899999999999999999999998   9999999999999999999999999


Q ss_pred             ceeecCCCCcccccccccccccccChhhhcCCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcC
Q 002969          690 MARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF-SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG  768 (862)
Q Consensus       690 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  768 (862)
                      +++.+....   ......||+.|+|||++.+..+ +.++||||||+++|||++|+.|+.....                 
T Consensus       176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------------  235 (335)
T 3dls_A          176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------------  235 (335)
T ss_dssp             TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------
T ss_pred             cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------
Confidence            998764332   2233578999999999988876 8899999999999999999999743110                 


Q ss_pred             ceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          769 KVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       769 ~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                          .... ....+...+.++.+++.+||+.||++||++.|+++.
T Consensus       236 ----~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 ----TVEA-AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----GTTT-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----HHhh-ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0000 011223345678899999999999999999999974

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-37  Score=343.95  Aligned_cols=254  Identities=23%  Similarity=0.301  Sum_probs=204.8

Q ss_pred             ccccccceeeccccEEEEEeEe----cCCcEEEEEEeccCC----ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRL----LEGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDE  612 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~  612 (862)
                      ++|+..++||+|+||.||+++.    ..++.||||+++...    ....+.+.+|+++++++ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5799999999999999999987    368899999986532    23456788899999999 69999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      .++||||+++++|.+++....   .+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            999999999999999996543   4899999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCcccccccccccccccChhhhcC--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce
Q 002969          693 IFGGDQTEQNTKRVVGTYGYMSPEYAMD--GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV  770 (862)
Q Consensus       693 ~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  770 (862)
                      .+..... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.|+.........   ..+.+.....  
T Consensus       208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~--  281 (355)
T 1vzo_A          208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRILKS--  281 (355)
T ss_dssp             ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHHHC--
T ss_pred             ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH---HHHHHHHhcc--
Confidence            7643222 22234579999999999986  34789999999999999999999997643322221   1111111111  


Q ss_pred             eeeecccCCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHh
Q 002969          771 LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERP-----TMASVVLML  814 (862)
Q Consensus       771 ~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L  814 (862)
                             ....+...+..+.+|+.+||+.||++||     ++.|+++..
T Consensus       282 -------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                   1223444566788999999999999999     999998754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.2e-37  Score=333.51  Aligned_cols=248  Identities=24%  Similarity=0.316  Sum_probs=205.6

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .++|...+.||+|+||.||+++..+ ++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            3678999999999999999998865 7889999986542   33457789999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++++|.+++...   ..+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            9999999999988543   34899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ...  ......|++.|+|||++.+..++.++||||||+++|||++|+.|+.....   ...    ........       
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~----~~~~~~~~-------  231 (294)
T 2rku_A          168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---KET----YLRIKKNE-------  231 (294)
T ss_dssp             TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHH----HHHHHTTC-------
T ss_pred             Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHH----HHHHhhcc-------
Confidence            222  22335789999999999999999999999999999999999999743221   111    11111111       


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        ...+......+.+++.+||+.||++||++.|+++
T Consensus       232 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          232 --YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             --CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence              1123344567889999999999999999999996

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.5e-37  Score=340.95  Aligned_cols=268  Identities=26%  Similarity=0.335  Sum_probs=198.0

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHH--HHhcccCCceEEEEEEEe-----CCce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRL--IAKLQHRNLVRLLGCCVE-----MDEK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~--l~~l~HpnIv~l~g~~~~-----~~~~  613 (862)
                      .++|+..++||+|+||.||+|+. +++.||||++....   ...+..|.++  +..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            35789999999999999999977 68999999996432   3344455554  445899999999986643     2256


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc---------CCCcEEecccCCcceEecCCCCee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD---------SRFRIIHRDLKASNILLDKEMTPK  684 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~---------~~~~ivHrDlkp~NILl~~~~~~k  684 (862)
                      ++||||+++|+|.+++....    .++..+.+++.||++||+|||+.         +   |+||||||+||||+.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence            89999999999999995432    58889999999999999999998         6   99999999999999999999


Q ss_pred             EecccceeecCCCCc------ccccccccccccccChhhhcC-------CCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 002969          685 ISDFGMARIFGGDQT------EQNTKRVVGTYGYMSPEYAMD-------GLFSVKSDVFSFGVLLLETVSGKKNRGFYHS  751 (862)
Q Consensus       685 L~DFGla~~~~~~~~------~~~~~~~~gt~~y~APE~l~~-------~~~s~ksDVwSlGvil~elltG~~p~~~~~~  751 (862)
                      |+|||+++.+.....      ........||+.|+|||++.+       ..++.++||||||+++|||++|..|+.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999987653321      112223568999999999987       3566789999999999999999877533222


Q ss_pred             Ccc-hh----------HHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCC
Q 002969          752 NNE-LN----------LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETAT  820 (862)
Q Consensus       752 ~~~-~~----------l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  820 (862)
                      ... ..          .................+... .......+..+.+++.+||+.||++|||+.||++.|+.+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA-WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT-CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc-cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence            111 00          011111111111111111111 112334667899999999999999999999999999887433

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.9e-37  Score=340.83  Aligned_cols=248  Identities=24%  Similarity=0.312  Sum_probs=205.8

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .++|...+.||+|+||.||+++..+ ++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            4679999999999999999998765 7889999986542   33567889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++++|.+++...   ..+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++..+..
T Consensus       120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            9999999999988543   34899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ..  .......|++.|+|||++.+..++.++||||||+++|||++|+.|+....   .....    .......       
T Consensus       194 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~----~~~~~~~-------  257 (335)
T 2owb_A          194 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETY----LRIKKNE-------  257 (335)
T ss_dssp             TT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHH----HHHHHTC-------
T ss_pred             Cc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC---HHHHH----HHHhcCC-------
Confidence            22  22234578999999999999999999999999999999999999974321   11111    1111111       


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        ...+......+.+++.+||+.||++||++.|+++
T Consensus       258 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          258 --YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             --CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              1122334567889999999999999999999996

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=346.78  Aligned_cols=266  Identities=17%  Similarity=0.174  Sum_probs=207.7

Q ss_pred             cccccccceeeccccEEEEEeEecC---------CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceE---------
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE---------GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVR---------  602 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~---------  602 (862)
                      .++|+..+.||+|+||.||+|+...         ++.||||++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999998764         788999998654     46889999999999999887         


Q ss_pred             ------EEEEEEe-CCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcce
Q 002969          603 ------LLGCCVE-MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNI  675 (862)
Q Consensus       603 ------l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NI  675 (862)
                            +++++.. ....++||||+ +++|.+++.... ...+++.+++.++.||++||+|||+.+   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  6778776 67889999999 999999996542 345999999999999999999999998   99999999999


Q ss_pred             EecCCC--CeeEecccceeecCCCCcc-----cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 002969          676 LLDKEM--TPKISDFGMARIFGGDQTE-----QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGF  748 (862)
Q Consensus       676 Ll~~~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~  748 (862)
                      |++.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  9999999999876432211     112335789999999999999999999999999999999999999764


Q ss_pred             CCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCC
Q 002969          749 YHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATM  821 (862)
Q Consensus       749 ~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~  821 (862)
                      .....  ..+......+... .....+...  .....+..+.+++.+||+.||++||++.||++.|+.+....
T Consensus       271 ~~~~~--~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          271 CLPNT--EDIMKQKQKFVDK-PGPFVGPCG--HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             GTTCH--HHHHHHHHHHHHS-CCCEECTTS--CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CCcCH--HHHHHHHHhccCC-hhhhhhhcc--ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence            33221  1111221111111 111111111  01123467889999999999999999999999998875443

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.7e-37  Score=341.27  Aligned_cols=257  Identities=29%  Similarity=0.415  Sum_probs=205.0

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcE--EEEEEeccC-CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQE--IAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~--vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ++|+..+.||+|+||.||+|+... +..  +|+|++... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            578889999999999999998754 554  599998754 344567899999999999 899999999999999999999


Q ss_pred             EEeccCCChhhhhhhcc-------------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCe
Q 002969          617 YEYMENRSLDSVIFDKA-------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  683 (862)
                      |||+++++|.+++....             ....+++.+++.++.||++||+|||+.+   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999996542             2346899999999999999999999998   9999999999999999999


Q ss_pred             eEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHH
Q 002969          684 KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVW  762 (862)
Q Consensus       684 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~  762 (862)
                      ||+|||+++....   ........+++.|+|||++.+..++.++||||||+++|||++ |+.|+....   ..    ...
T Consensus       182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~----~~~  251 (327)
T 1fvr_A          182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CA----ELY  251 (327)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HH----HHH
T ss_pred             EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc---HH----HHH
Confidence            9999999974321   111223456889999999998889999999999999999998 999864321   11    112


Q ss_pred             HHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       763 ~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                      .....+.        ....+...+..+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus       252 ~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  300 (327)
T 1fvr_A          252 EKLPQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  300 (327)
T ss_dssp             HHGGGTC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhhcCC--------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            2222221        112234456778899999999999999999999999988643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=8.4e-38  Score=335.16  Aligned_cols=259  Identities=27%  Similarity=0.358  Sum_probs=206.0

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEe--CCceEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE--MDEKML  615 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~l  615 (862)
                      .++|+..+.||+|+||.||+++.. +++.||+|++....  ....+.+.+|+.++++++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            367899999999999999999876 58899999997543  3446789999999999999999999998864  567899


Q ss_pred             EEEeccCCChhhhhhhcc-CCCCCCHhhHHHHHHHHHHHhHHhhhcC--CCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          616 VYEYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDS--RFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      ||||+++++|.+++.... ....+++..++.++.||++||+|||+.+  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999996543 2345899999999999999999999976  1349999999999999999999999999998


Q ss_pred             ecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          693 IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       693 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      ......  .......|++.|+|||.+.+..++.++||||||+++|||++|+.|+....   ....    ...+..+..  
T Consensus       165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~----~~~i~~~~~--  233 (279)
T 2w5a_A          165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKEL----AGKIREGKF--  233 (279)
T ss_dssp             HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH----HHHHHHTCC--
T ss_pred             eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC---HHHH----HHHHhhccc--
Confidence            754321  11223568999999999999999999999999999999999999975322   1112    222222221  


Q ss_pred             eecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                            ...+...+.++.+++.+||+.+|++||++.||++.+..
T Consensus       234 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          234 ------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence                  12233456678899999999999999999999986644

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=7.7e-37  Score=332.09  Aligned_cols=252  Identities=22%  Similarity=0.281  Sum_probs=200.9

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC----ccchHHHHHHHHHHHhcccCCceEEEEEEE--eCCce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQHRNLVRLLGCCV--EMDEK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~--~~~~~  613 (862)
                      .++|+..+.||+|+||.||++... +++.||+|++....    ....+.+.+|++++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            368999999999999999999875 47899999996542    345678999999999999999999999984  45678


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++||||++++ |.+++... ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999977 66666443 2345899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccccChhhhcCCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGL--FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      ..............|++.|+|||++.+..  ++.++||||||+++|||++|+.|+...   ....    ....+..+.  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~----~~~~i~~~~--  229 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD---NIYK----LFENIGKGS--  229 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS---SHHH----HHHHHHHCC--
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc---hHHH----HHHHHhcCC--
Confidence            65433333334457899999999998654  378999999999999999999997532   1111    122222221  


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                             ...+...+..+.+++.+||+.||++||++.|+++.
T Consensus       230 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 -------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   12233455678899999999999999999999963

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.8e-37  Score=337.22  Aligned_cols=265  Identities=23%  Similarity=0.310  Sum_probs=206.6

Q ss_pred             HHcccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHh--cccCCceEEEEEEEeCC----c
Q 002969          539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAK--LQHRNLVRLLGCCVEMD----E  612 (862)
Q Consensus       539 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~g~~~~~~----~  612 (862)
                      ...++|+..+.||+|+||.||+|+. .++.||||++...   ..+.+.+|++++..  ++||||+++++++....    .
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            3456899999999999999999987 5899999999643   34677889999988  78999999999998876    7


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhh--------hcCCCcEEecccCCcceEecCCCCee
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH--------QDSRFRIIHRDLKASNILLDKEMTPK  684 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~ivHrDlkp~NILl~~~~~~k  684 (862)
                      .++||||+++++|.+++...    .+++.+++.++.||++||+|||        +.+   |+||||||+|||++.++.+|
T Consensus       115 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEE
T ss_pred             eEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEE
Confidence            89999999999999999542    4899999999999999999999        665   99999999999999999999


Q ss_pred             EecccceeecCCCCccc--ccccccccccccChhhhcCCC------CCccccchhHHHHHHHHHhC----------CCCC
Q 002969          685 ISDFGMARIFGGDQTEQ--NTKRVVGTYGYMSPEYAMDGL------FSVKSDVFSFGVLLLETVSG----------KKNR  746 (862)
Q Consensus       685 L~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~------~s~ksDVwSlGvil~elltG----------~~p~  746 (862)
                      |+|||++..........  ......||+.|+|||++.+..      ++.++||||||+++|||++|          ..|+
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            99999998765433221  223457899999999998763      33689999999999999999          5565


Q ss_pred             CCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          747 GFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       747 ~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      .......  .......+...+......+...  .........+.+++.+||+.||++||++.||++.|+.+.
T Consensus       268 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~  335 (342)
T 1b6c_B          268 YDLVPSD--PSVEEMRKVVCEQKLRPNIPNR--WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  335 (342)
T ss_dssp             TTTSCSS--CCHHHHHHHHTTSCCCCCCCGG--GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccCcCc--ccHHHHHHHHHHHHhCCCCccc--ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence            4322211  1112222222222111111100  012356678999999999999999999999999998873

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.9e-37  Score=335.72  Aligned_cols=261  Identities=19%  Similarity=0.207  Sum_probs=200.6

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .++|+..++||+|+||.||+++.. +++.||||++....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            468999999999999999999875 58899999997542   22347889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      +||+++++|.+++...   ..+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            9999999999999654   34899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ... .......|++.|+|||++.+..++.++||||||+++|||++|+.||....   . .   ..........      .
T Consensus       187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~-~---~~~~~~~~~~------~  252 (309)
T 2h34_A          187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ---L-S---VMGAHINQAI------P  252 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH---H-H---HHHHHHHSCC------C
T ss_pred             ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch---H-H---HHHHHhccCC------C
Confidence            221 12223568999999999999999999999999999999999999974311   1 1   1111111111      0


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhccCcCCC
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERP-TMASVVLMLSSETATM  821 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~  821 (862)
                      .....+...+..+.+++.+||+.||++|| +++++++.|+......
T Consensus       253 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          253 RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            01122334455788999999999999999 9999999999874443

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.3e-37  Score=330.83  Aligned_cols=245  Identities=22%  Similarity=0.291  Sum_probs=204.1

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..+.||+|+||.||+|+... ++.||||++...   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            578999999999999999998764 778999998653   2234567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++....   .+++..+..++.||++||+|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            9999999999986543   4899999999999999999999998   999999999999999999999999999765322


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                          ......|++.|+|||++.+..++.++||||||+++|||++|+.|+....   .....    .......        
T Consensus       168 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~----~~~~~~~--------  228 (284)
T 2vgo_A          168 ----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS---HTETH----RRIVNVD--------  228 (284)
T ss_dssp             ----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHH----HHHHTTC--------
T ss_pred             ----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC---HhHHH----HHHhccc--------
Confidence                1233578999999999999999999999999999999999999974321   11111    1111111        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       ...+...+..+.+++.+||+.+|++||++.|+++
T Consensus       229 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          229 -LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence             1223345567889999999999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.8e-37  Score=346.99  Aligned_cols=263  Identities=25%  Similarity=0.368  Sum_probs=193.4

Q ss_pred             HcccccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCC--ce
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMD--EK  613 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~--~~  613 (862)
                      ..++|+..++||+|+||.||+|... .++.||||++...  .....+++.+|+.++.++. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            3568999999999999999999865 4889999998654  3345567889999999997 999999999998654  68


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++||||++ ++|..++..    ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            99999998 589888854    25889999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCC-------------------cccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCc
Q 002969          694 FGGDQ-------------------TEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN  753 (862)
Q Consensus       694 ~~~~~-------------------~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~  753 (862)
                      +....                   ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..   .+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~---~~  235 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG---SS  235 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC---SS
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC---CC
Confidence            63211                   1111233579999999999987 6789999999999999999999999743   22


Q ss_pred             chhHHHHHHHHHhcCceeee---------------------ecccCCC-------------CChHHHHHHHHHHHhcccc
Q 002969          754 ELNLLGHVWRLWKEGKVLEM---------------------VDSSVDN-------------YPANEVLRCIHVGLLCVQE  799 (862)
Q Consensus       754 ~~~l~~~~~~~~~~~~~~~~---------------------id~~~~~-------------~~~~~~~~l~~li~~cl~~  799 (862)
                      ....+..+............                     .......             .....+.++.+|+.+||+.
T Consensus       236 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            22333333222111100000                     0000000             0113355788999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 002969          800 NAEERPTMASVVLM  813 (862)
Q Consensus       800 dP~~RPt~~evl~~  813 (862)
                      ||++|||+.|+++.
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.6e-37  Score=333.85  Aligned_cols=248  Identities=25%  Similarity=0.405  Sum_probs=206.1

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      +.|+..++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            56888999999999999999865 48899999997553 44568899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|.+++..    ..+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++..+.....
T Consensus       102 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          102 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             CTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            999999999843    35899999999999999999999998   99999999999999999999999999987643322


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                        ......|++.|+|||++.+..++.++||||||+++|||++|+.|+.....   .....    ......        ..
T Consensus       175 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~----~~~~~~--------~~  237 (303)
T 3a7i_A          175 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLF----LIPKNN--------PP  237 (303)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH----HHHHSC--------CC
T ss_pred             --ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHH----HhhcCC--------CC
Confidence              22335789999999999999999999999999999999999999743221   11111    111111        11


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ..+...+..+.+++.+||+.+|++||++.|+++.
T Consensus       238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            2233445678899999999999999999999863

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.6e-36  Score=353.61  Aligned_cols=255  Identities=27%  Similarity=0.371  Sum_probs=208.6

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .++|...++||+|+||.||+++.. +++.||||++....   ....+.+.+|++++++++||||+++++++...+..++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367888999999999999999886 48999999996542   34457889999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccC-CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          617 YEYMENRSLDSVIFDKAR-SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      |||+++|+|.+++..... ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999865432 345899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........   ...+.+......      
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~---~~~~~~~i~~~~------  409 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQRVLEQA------  409 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC---HHHHHHHHHHCC------
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh---HHHHHHHHhhcc------
Confidence            3322  22335899999999999999999999999999999999999999754322111   111222221111      


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTM-----ASVVL  812 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~  812 (862)
                         ..++...+..+.+++.+||+.||++||++     .+|++
T Consensus       410 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          410 ---VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ---cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence               12344556788899999999999999965     67764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9.4e-37  Score=335.55  Aligned_cols=262  Identities=22%  Similarity=0.298  Sum_probs=205.4

Q ss_pred             ChHHHHHHccccccc-ceeeccccEEEEEeEecC-CcEEEEEEeccCC--ccchHHHHHHHHHHHhcc-cCCceEEEEEE
Q 002969          533 DFETIVRATDNFTDY-NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQ-HRNLVRLLGCC  607 (862)
Q Consensus       533 ~~~~i~~~~~~f~~~-~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~  607 (862)
                      .+.......+.|... ++||+|+||.||+|+... ++.||||++....  .....++.+|+.+++++. ||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            333444445677776 889999999999998764 8899999997542  334678999999999994 69999999999


Q ss_pred             EeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC---CCCee
Q 002969          608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---EMTPK  684 (862)
Q Consensus       608 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~k  684 (862)
                      .+.+..++||||+++++|.+++... ....+++.++..++.||+.||+|||+.+   |+||||||+|||++.   ++.+|
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence            9999999999999999999998543 2345899999999999999999999998   999999999999987   78999


Q ss_pred             EecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHH
Q 002969          685 ISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL  764 (862)
Q Consensus       685 L~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~  764 (862)
                      |+|||+++.+....   ......||+.|+|||++.+..++.++||||||+++|||++|+.|+....   .......+   
T Consensus       175 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i---  245 (327)
T 3lm5_A          175 IVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETYLNI---  245 (327)
T ss_dssp             ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---
T ss_pred             EeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHH---
Confidence            99999998764322   2233578999999999999999999999999999999999999974321   11111111   


Q ss_pred             HhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       765 ~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                       .....     ..........+..+.+++.+||+.||++||+++|+++.
T Consensus       246 -~~~~~-----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          246 -SQVNV-----DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -HHTCC-----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -Hhccc-----ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence             11100     01112223455678899999999999999999999864

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.7e-37  Score=352.26  Aligned_cols=261  Identities=19%  Similarity=0.245  Sum_probs=209.0

Q ss_pred             cccccccceeeccccEEEEEeEe-cCCcEEEEEEeccCCccchHHHHHHHHHHHhccc-CCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH-RNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .++|++.++||+|+||.||+|+. .+++.||||++.....  .+++..|+++++.++| +++..+..++.+.+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            36799999999999999999986 4588999998865432  3468899999999986 566667777788888999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe---cCCCCeeEecccceeecC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFG  695 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~~  695 (862)
                      |+ +++|.+++...  ...+++..++.|+.||+.||+|||+.+   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999999543  235899999999999999999999998   9999999999999   688999999999998875


Q ss_pred             CCCcc-----cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce
Q 002969          696 GDQTE-----QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV  770 (862)
Q Consensus       696 ~~~~~-----~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  770 (862)
                      .....     .......||+.|+|||++.+..++.++|||||||+||||++|+.||...........+..+........ 
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~-  236 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS-  236 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC-
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc-
Confidence            43322     122246799999999999999999999999999999999999999876544443333333322211111 


Q ss_pred             eeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          771 LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       771 ~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                         +...    ....+.++.+++..||+.+|++||++.+|++.|+.+
T Consensus       237 ---~~~l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          237 ---IEAL----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             ---HHHH----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             ---HHHH----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence               1111    112345788999999999999999999999988775

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=369.19  Aligned_cols=248  Identities=27%  Similarity=0.413  Sum_probs=200.1

Q ss_pred             eeeccccEEEEEeEec---CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccCCC
Q 002969          549 KLGQGGFGIVYKGRLL---EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRS  624 (862)
Q Consensus       549 ~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs  624 (862)
                      +||+|+||.||+|...   ++..||||+++... ....++|.+|+++|++++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999764   35679999997653 3457889999999999999999999999976 66999999999999


Q ss_pred             hhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc-ccc
Q 002969          625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE-QNT  703 (862)
Q Consensus       625 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~  703 (862)
                      |.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.+...... ...
T Consensus       422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  496 (613)
T 2ozo_A          422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  496 (613)
T ss_dssp             HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence            99999543  345899999999999999999999998   999999999999999999999999999876433221 111


Q ss_pred             ccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCC
Q 002969          704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYP  782 (862)
Q Consensus       704 ~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~  782 (862)
                      ....+++.|+|||++.+..++.++|||||||+||||++ |+.||......   .    +...+..+..        ...+
T Consensus       497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~----~~~~i~~~~~--------~~~p  561 (613)
T 2ozo_A          497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---E----VMAFIEQGKR--------MECP  561 (613)
T ss_dssp             -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---H----HHHHHHTTCC--------CCCC
T ss_pred             cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---H----HHHHHHcCCC--------CCCC
Confidence            22345689999999999999999999999999999998 99997543221   1    2222223221        1234


Q ss_pred             hHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          783 ANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       783 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ...+.++.+++.+||+.+|++||++.+|++.|+..
T Consensus       562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            45667889999999999999999999999999885

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.5e-37  Score=341.11  Aligned_cols=246  Identities=28%  Similarity=0.426  Sum_probs=199.7

Q ss_pred             ccccccceeeccccEEEEEeEe-cCCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRL-LEGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      +.|+..+.||+|+||.||+|+. .+++.||||++....   ....+++.+|++++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588889999999999999986 458899999997543   233467899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||++ |+|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            9997 6788777543  235899999999999999999999998   999999999999999999999999999865321


Q ss_pred             CcccccccccccccccChhhhc---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                            ....||+.|+|||++.   +..++.++||||||+++|||++|+.|+...   ..   ............ .   
T Consensus       208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~---~~---~~~~~~~~~~~~-~---  271 (348)
T 1u5q_A          208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NA---MSALYHIAQNES-P---  271 (348)
T ss_dssp             ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CH---HHHHHHHHHSCC-C---
T ss_pred             ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---Ch---HHHHHHHHhcCC-C---
Confidence                  2357899999999985   567899999999999999999999996432   11   111222222111 0   


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                          ...+...+..+.+++.+||+.+|++||++.++++.
T Consensus       272 ----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          272 ----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                11122345668899999999999999999999863

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.6e-37  Score=345.87  Aligned_cols=244  Identities=23%  Similarity=0.259  Sum_probs=192.0

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC---ccchHHHHHHHHH-HHhcccCCceEEEEEEEeCCceEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS---GQGIEEFKNEVRL-IAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      .++|+..++||+|+||.||+++... ++.||||++++..   ....+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            3679999999999999999998765 7889999997643   2334566677776 567899999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||+++|+|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            999999999999986533   4888999999999999999999998   9999999999999999999999999998643


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..   .+.......+    ....      
T Consensus       191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~---~~~~~~~~~i----~~~~------  255 (373)
T 2r5t_A          191 EH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS---RNTAEMYDNI----LNKP------  255 (373)
T ss_dssp             CC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC---SBHHHHHHHH----HHSC------
T ss_pred             cC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC---CCHHHHHHHH----Hhcc------
Confidence            22  2223446899999999999999999999999999999999999999742   2222222222    1111      


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMA  808 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  808 (862)
                         ..++...+..+.+++.+||+.||++||++.
T Consensus       256 ---~~~~~~~~~~~~~li~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          256 ---LQLKPNITNSARHLLEGLLQKDRTKRLGAK  285 (373)
T ss_dssp             ---CCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred             ---cCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence               122334556788999999999999999974

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1e-36  Score=335.19  Aligned_cols=255  Identities=19%  Similarity=0.294  Sum_probs=200.3

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcc-cCCceEEEEEEEe--CCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVE--MDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~--~~~~~lV  616 (862)
                      .++|+..++||+|+||.||+|+.. +++.||||+++..   ..+.+.+|+.++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            367999999999999999999864 5889999999643   3567899999999997 9999999999988  6678999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC-CeeEecccceeecC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFG  695 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~  695 (862)
                      |||+++++|.+++.      .+++.++..++.||++||+|||+.+   |+||||||+|||++.++ .+||+|||+++.+.
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999999873      2788999999999999999999998   99999999999999777 89999999998764


Q ss_pred             CCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee---
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL---  771 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---  771 (862)
                      ....   .....++..|+|||++.+ ..++.++||||||+++|||++|+.|+....  .....+....+........   
T Consensus       183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~--~~~~~l~~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH--DNYDQLVRIAKVLGTEDLYDYI  257 (330)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS--SHHHHHHHHHHHHCHHHHHHHH
T ss_pred             CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC--chHHHHHHHHHhcCCchhhhHH
Confidence            3322   233568999999999987 678999999999999999999999974322  2222222211111100000   


Q ss_pred             --------------------eeecccC-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 --------------------EMVDSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 --------------------~~id~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                                          ....... .......+.++.+|+.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                                0000001 1112234678899999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-37  Score=334.00  Aligned_cols=250  Identities=27%  Similarity=0.400  Sum_probs=198.9

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeC-CceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-DEKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~lV~E~  619 (862)
                      .++|+..+.||+|+||.||+++. .++.||||+++...  ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            36789999999999999999987 48899999986543  457899999999999999999999997654 478999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|.+++.... ...+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.+||+|||++......  
T Consensus        97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            99999999996532 223788999999999999999999998   999999999999999999999999998765322  


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                         .....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......   ....    ....+.        .
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~----~~~~~~--------~  232 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP----RVEKGY--------K  232 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH----HHTTTC--------C
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHhcCC--------C
Confidence               122356889999999999999999999999999999998 99887543221   1111    111111        1


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ...+...+..+.+++.+||+.||++||++.|+++.|+.+
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence            122344567888999999999999999999999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-36  Score=337.99  Aligned_cols=263  Identities=26%  Similarity=0.362  Sum_probs=199.1

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCc-----cchHHHHHHHHHHHhcccCCceEEEEEEEeCCce
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-----QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  613 (862)
                      ..++|+..+.||+|+||.||+|+... ++.||||++.....     ...+.+.+|++++++++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            45689999999999999999998764 88999999965321     1235788999999999999999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++||||+++ +|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            999999986 888887543  345889999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      +....  .......||+.|+|||++.+. .++.++||||||+++|||++|.+|+..   ......+..+...........
T Consensus       162 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~---~~~~~~~~~i~~~~~~~~~~~  236 (346)
T 1ua2_A          162 FGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQ  236 (346)
T ss_dssp             TTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC---CCHHHHHHHHHHHcCCCChhh
Confidence            64322  222335789999999999764 589999999999999999999988543   233333333333222111000


Q ss_pred             ee------cc----cCCCCC-----hHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          773 MV------DS----SVDNYP-----ANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       773 ~i------d~----~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ..      +.    .....+     ...+.++.+|+.+||+.||++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00      00    000111     2335678999999999999999999999974

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.1e-36  Score=327.22  Aligned_cols=250  Identities=24%  Similarity=0.315  Sum_probs=200.9

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc------cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG------QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  614 (862)
                      ++|+..+.||+|+||.||+++.. +++.||+|+++....      ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            57889999999999999999886 488999999875421      23678999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC----CeeEecccc
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM----TPKISDFGM  690 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kL~DFGl  690 (862)
                      +||||+++++|.+++...   ..+++.++..++.||++||+|||+.+   ++||||||+||+++.++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            999999999999999653   34899999999999999999999998   99999999999998877    899999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV  770 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  770 (862)
                      +.......   ......|++.|+|||++.+..++.++||||||+++|||++|+.|+....   .....    ........
T Consensus       159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~----~~~~~~~~  228 (283)
T 3bhy_A          159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET---KQETL----TNISAVNY  228 (283)
T ss_dssp             CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHH----HHHHTTCC
T ss_pred             ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc---hHHHH----HHhHhccc
Confidence            98764322   1233568999999999999999999999999999999999999974321   11111    11111110


Q ss_pred             eeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          771 LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       771 ~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      . . .   .......+..+.+++.+||+.||++||++.|+++
T Consensus       229 ~-~-~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          229 D-F-D---EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             C-C-C---HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C-C-c---chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            0 0 0   0001223456889999999999999999999996

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=9.3e-37  Score=331.69  Aligned_cols=250  Identities=23%  Similarity=0.318  Sum_probs=203.1

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      .++|...+.||+|+||.||+++.. +++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            357899999999999999999875 5889999999866555567789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe---cCCCCeeEecccceeecCC
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~~~  696 (862)
                      +++++|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||+   +.++.+||+|||++.....
T Consensus        88 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           88 VSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            99999999986543   4889999999999999999999998   9999999999999   7889999999999876432


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      .    ......|++.|+|||++.+..++.++||||||+++|||++|+.|+...   .......    .+.++.. .    
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~~~~----~i~~~~~-~----  225 (304)
T 2jam_A          162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE---TESKLFE----KIKEGYY-E----  225 (304)
T ss_dssp             B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHH----HHHHCCC-C----
T ss_pred             C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC---CHHHHHH----HHHcCCC-C----
Confidence            1    223356899999999999999999999999999999999999996432   2222222    2222211 0    


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .........+..+.+++.+||+.||++||++.|+++
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            011222345567889999999999999999999996

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.3e-36  Score=343.82  Aligned_cols=251  Identities=21%  Similarity=0.230  Sum_probs=191.9

Q ss_pred             cccccc-ceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEe----CCceE
Q 002969          542 DNFTDY-NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVE----MDEKM  614 (862)
Q Consensus       542 ~~f~~~-~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~----~~~~~  614 (862)
                      ++|... ++||+|+||.||+++... ++.||||++..     ...+.+|+.++.++ +||||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456655 689999999999998764 88999999963     24677899887554 89999999999875    56789


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC---CCCeeEecccce
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---EMTPKISDFGMA  691 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DFGla  691 (862)
                      +||||+++|+|.+++.... ...+++.++..|+.||+.||+|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            9999999999999996532 245899999999999999999999998   999999999999987   789999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcch-hHHHHHHHHHhcCce
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL-NLLGHVWRLWKEGKV  770 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~  770 (862)
                      +......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....    +..+..
T Consensus       212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~~~~~  284 (400)
T 1nxk_A          212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQY  284 (400)
T ss_dssp             EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HHHTCC
T ss_pred             cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HHcCcc
Confidence            8754221   223457899999999999999999999999999999999999997543322211 11111    111111


Q ss_pred             eeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          771 LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       771 ~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                       ...    .......+.++.+|+.+||+.||++|||+.|+++.
T Consensus       285 -~~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          285 -EFP----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             -CCC----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -cCC----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             000    11112345678899999999999999999999973

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.7e-38  Score=351.25  Aligned_cols=242  Identities=16%  Similarity=0.151  Sum_probs=190.4

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHH---HHHHhcccCCceEEE-------EE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEV---RLIAKLQHRNLVRLL-------GC  606 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~HpnIv~l~-------g~  606 (862)
                      .++|+..++||+|+||.||+|+.. +++.||||++...   .....+.+.+|+   +++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467888999999999999999864 5899999999743   344567899999   455555899999998       66


Q ss_pred             EEeCCc-----------------eEEEEEeccCCChhhhhhhccC----CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcE
Q 002969          607 CVEMDE-----------------KMLVYEYMENRSLDSVIFDKAR----SSILNWQRRFNIICGIARGLLYLHQDSRFRI  665 (862)
Q Consensus       607 ~~~~~~-----------------~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i  665 (862)
                      +...+.                 .++||||+ +|+|.+++.....    ...+++..++.|+.||++||+|||+.+   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            665532                 78999999 6899999965422    123456888899999999999999998   9


Q ss_pred             EecccCCcceEecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCC-----------CCCccccchhHHH
Q 002969          666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG-----------LFSVKSDVFSFGV  734 (862)
Q Consensus       666 vHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----------~~s~ksDVwSlGv  734 (862)
                      +||||||+||||+.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986422     2233567 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          735 LLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       735 il~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ++|||++|+.|+........                .+.+...    ....+.++.+++.+||+.||++||++.|+++
T Consensus       302 il~elltg~~Pf~~~~~~~~----------------~~~~~~~----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGG----------------SEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CC----------------SGGGGSS----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccc----------------hhhhhhh----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999999743221111                0111111    1233467889999999999999999999985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.1e-37  Score=368.32  Aligned_cols=248  Identities=29%  Similarity=0.421  Sum_probs=198.9

Q ss_pred             ceeeccccEEEEEeEec---CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLL---EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      ++||+|+||.||+|.+.   .++.||||+++...  ....+++.+|++++++++||||+++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            57999999999999653   35789999997643  334678999999999999999999999986 4568999999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc-c
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE-Q  701 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~  701 (862)
                      |+|.+++...   ..+++..++.|+.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus       454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            9999999543   35899999999999999999999998   999999999999999999999999999876543221 2


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      ......+|+.|+|||++.+..++.++|||||||++|||++ |+.|+.....   .    .+...+..+..        ..
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~----~~~~~i~~~~~--------~~  592 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---S----EVTAMLEKGER--------MG  592 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---H----HHHHHHHTTCC--------CC
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---H----HHHHHHHcCCC--------CC
Confidence            2223456789999999999999999999999999999998 9999743221   1    12222222221        12


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .+...+.++.+++.+||+.||++||++.+|++.|+..
T Consensus       593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            3445667889999999999999999999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.2e-37  Score=337.87  Aligned_cols=261  Identities=23%  Similarity=0.310  Sum_probs=194.0

Q ss_pred             HcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ..++|+..++||+|+||.||+|+.. +++.||||+++...  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            4568999999999999999999865 58899999996543  23356788999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec-----CCCCeeEecccce
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-----KEMTPKISDFGMA  691 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~-----~~~~~kL~DFGla  691 (862)
                      |||+++ +|.+++....   .+++..+..++.||++||+|||+.+   |+||||||+|||++     .++.+||+|||++
T Consensus       112 ~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            999985 9999885443   4899999999999999999999998   99999999999994     4556999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV  770 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  770 (862)
                      +.+....  .......||+.|+|||++.+. .++.++|||||||++|||++|+.|+..   .........+.........
T Consensus       185 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~---~~~~~~~~~~~~~~~~~~~  259 (329)
T 3gbz_A          185 RAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG---DSEIDQLFKIFEVLGLPDD  259 (329)
T ss_dssp             HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHHHCCCCT
T ss_pred             cccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC---CCHHHHHHHHHHHhCCCch
Confidence            8764321  222335679999999999875 589999999999999999999999643   2222222222222111000


Q ss_pred             eee--e------cccC---CC------CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          771 LEM--V------DSSV---DN------YPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       771 ~~~--i------d~~~---~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ...  .      ....   ..      .......++.+|+.+||+.||++|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            000  0      0000   00      01113467889999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.3e-37  Score=341.37  Aligned_cols=261  Identities=25%  Similarity=0.349  Sum_probs=202.2

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ++|+..++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            57899999999999999999876 48899999997653 33457899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc-CCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      +++++|.+++....   .+++..+..++.|++.||+|||+. +   |+||||||+|||++.++.+||+|||++..+..  
T Consensus       113 ~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--  184 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--  184 (360)
T ss_dssp             CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred             CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc--
Confidence            99999999996543   488999999999999999999986 6   99999999999999999999999999875421  


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHH---------HHHHhcCc
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV---------WRLWKEGK  769 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~---------~~~~~~~~  769 (862)
                        .......||+.|+|||++.+..++.++||||||+++|||++|+.|+......+........         ......+.
T Consensus       185 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          185 --SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             --HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             --ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence              1223357899999999999999999999999999999999999997542211110000000         00000000


Q ss_pred             --------------eeee----ecccC-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          770 --------------VLEM----VDSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       770 --------------~~~~----id~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                                    ..+.    ..... .......+.++.+|+.+||+.||++|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                          0000    00001 1111224567889999999999999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-36  Score=339.78  Aligned_cols=257  Identities=24%  Similarity=0.357  Sum_probs=197.1

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCC------
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD------  611 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~------  611 (862)
                      .++|+..+.||+|+||.||+|+.. +++.||||++...  .....+++.+|++++++++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467999999999999999999875 5899999999654  2334567899999999999999999999997653      


Q ss_pred             ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccce
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  691 (862)
                      ..++||||+ +++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 8899999854    24889999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc-
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK-  769 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-  769 (862)
                      +.....     .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||...   +..+.+..+.+...... 
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~l~~i~~~~g~~~~  247 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS---DHLDQLKEIMKVTGTPPA  247 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCH
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHhcCCCCH
Confidence            875422     223578999999999987 68999999999999999999999997432   22222322222111100 


Q ss_pred             -----------------eeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          770 -----------------VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       770 -----------------~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                                       ..+.............+..+.+|+.+||+.||++|||+.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                             00000011112233446678899999999999999999999973

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.8e-37  Score=353.18  Aligned_cols=258  Identities=24%  Similarity=0.292  Sum_probs=195.0

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeC------C
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM------D  611 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~------~  611 (862)
                      .++|+..++||+|+||.||+|+... ++.||||++...  .....+++.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            4689999999999999999998654 889999999754  334467889999999999999999999999655      3


Q ss_pred             ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccce
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  691 (862)
                      ..++||||++++ |.+.+..     .+++.++..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            569999999865 5555521     3889999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc--
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK--  769 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--  769 (862)
                      +.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||..   .+..+.+..+.+......  
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g---~~~~~~~~~i~~~lg~p~~~  285 (464)
T 3ttj_A          212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG---RDYIDQWNKVIEQLGTPCPE  285 (464)
T ss_dssp             -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHHHCSCCHH
T ss_pred             eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHhcCCCCHH
Confidence            876432   223346789999999999999999999999999999999999999743   222223333322211100  


Q ss_pred             ----ee----eeeccc--CCCC-----------------ChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          770 ----VL----EMVDSS--VDNY-----------------PANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       770 ----~~----~~id~~--~~~~-----------------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                          ..    ..+...  ....                 ......++.+|+.+||+.||++|||++|+++.
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                00    000000  0000                 01125678899999999999999999999963

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.2e-37  Score=328.46  Aligned_cols=247  Identities=23%  Similarity=0.357  Sum_probs=197.0

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|...+.||+|+||.||+|+.. +++.||||++...   .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            57889999999999999999876 5899999998654   2334568899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++....   .+++..+..++.||++||+|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           91 EYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            9999999999996543   4889999999999999999999998   999999999999999999999999999876432


Q ss_pred             CcccccccccccccccChhhhcCCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLF-SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      .   ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.|+...   .....    .+....+.       
T Consensus       165 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~----~~~~~~~~-------  227 (276)
T 2h6d_A          165 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE---HVPTL----FKKIRGGV-------  227 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHH----HHHHHHCC-------
T ss_pred             c---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC---cHHHH----HHHhhcCc-------
Confidence            2   1223468999999999988765 68999999999999999999997432   11111    12222211       


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                        ...+......+.+++.+||+.||++||++.|+++.
T Consensus       228 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 --FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              11233345678899999999999999999999973

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.1e-37  Score=347.74  Aligned_cols=252  Identities=22%  Similarity=0.323  Sum_probs=191.5

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC--------ccchHHHHHHHHHHHhcccCCceEEEEEEEeC
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--------GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM  610 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~  610 (862)
                      ..++|...++||+|+||.||+|.... ++.||||++....        ......+.+|+.++++++||||+++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            45789999999999999999998755 7899999986531        122346889999999999999999999975 4


Q ss_pred             CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC---CCeeEec
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE---MTPKISD  687 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kL~D  687 (862)
                      +..++||||+++++|.+++...   ..+++.++..++.||++||+|||+.+   |+||||||+|||++.+   ..+||+|
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             CceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence            5689999999999999988543   35899999999999999999999998   9999999999999654   4599999


Q ss_pred             ccceeecCCCCcccccccccccccccChhhhcC---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHH
Q 002969          688 FGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD---GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL  764 (862)
Q Consensus       688 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~  764 (862)
                      ||+++.+...   .......||+.|+|||++.+   ..++.++||||||+++|||++|+.||.......  .+...    
T Consensus       286 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~----  356 (419)
T 3i6u_A          286 FGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ----  356 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH----
T ss_pred             cccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH----
Confidence            9999876432   22234679999999999864   578899999999999999999999975432221  11111    


Q ss_pred             HhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       765 ~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ...+... ..    .......+..+.+++.+||+.||++||++.|+++
T Consensus       357 i~~~~~~-~~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          357 ITSGKYN-FI----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHTTCCC-CC----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhcCCCC-CC----chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1111100 00    0001123567889999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.1e-37  Score=332.98  Aligned_cols=252  Identities=24%  Similarity=0.382  Sum_probs=199.7

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      .++|++.+.||+|+||.||+|+... ++.||+|++........+.+.+|++++++++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            4679999999999999999998864 889999999877666778999999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++++|.+++....  ..+++..+..++.||++||+|||+.+   ++||||||+|||++.++.+||+|||++......  
T Consensus        98 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  170 (302)
T 2j7t_A           98 CPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--  170 (302)
T ss_dssp             CTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--
T ss_pred             CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc--
Confidence            99999999886532  34899999999999999999999998   999999999999999999999999987543111  


Q ss_pred             ccccccccccccccChhhh-----cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          700 EQNTKRVVGTYGYMSPEYA-----MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l-----~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ........|++.|+|||++     .+..++.++||||||+++|||++|+.|+.....   ...   ......... .   
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~---~~~~~~~~~-~---  240 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRV---LLKIAKSDP-P---  240 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH---HHHHHHSCC-C---
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---HHH---HHHHhccCC-c---
Confidence            1112235689999999998     366789999999999999999999999753221   111   111111111 0   


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                         ....+...+..+.+++.+||+.||++||++.|+++
T Consensus       241 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          241 ---TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ---CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ---ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence               01123344567889999999999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.3e-37  Score=348.73  Aligned_cols=265  Identities=20%  Similarity=0.305  Sum_probs=197.5

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeC-----Cc
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-----DE  612 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~~  612 (862)
                      .++|+..++||+|+||.||+|+... ++.||||++...  .....+++.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            4689999999999999999998755 788999999754  233457889999999999999999999999776     56


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      .++||||++ ++|.+++...   ..+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999987 5999988542   35899999999999999999999998   9999999999999999999999999999


Q ss_pred             ecCCCCcc--------------------cccccccccccccChhhh-cCCCCCccccchhHHHHHHHHHhCCCCCCCCC-
Q 002969          693 IFGGDQTE--------------------QNTKRVVGTYGYMSPEYA-MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYH-  750 (862)
Q Consensus       693 ~~~~~~~~--------------------~~~~~~~gt~~y~APE~l-~~~~~s~ksDVwSlGvil~elltG~~p~~~~~-  750 (862)
                      ........                    ......+||+.|+|||++ ....++.++|||||||++|||++|..|+.... 
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence            76433211                    122456789999999986 55679999999999999999998765543211 


Q ss_pred             -------CCc-----------------chhHHHHHHHHHhcCce-----------eeeecccC--CC-----CChHHHHH
Q 002969          751 -------SNN-----------------ELNLLGHVWRLWKEGKV-----------LEMVDSSV--DN-----YPANEVLR  788 (862)
Q Consensus       751 -------~~~-----------------~~~l~~~~~~~~~~~~~-----------~~~id~~~--~~-----~~~~~~~~  788 (862)
                             ...                 ..+.+..+...+.....           .+.+....  ..     .....+.+
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  337 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD  337 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence                   100                 01112222221111100           00000000  00     01234567


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHH
Q 002969          789 CIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       789 l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      +.+|+.+||+.||++|||+.|+++
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhc
Confidence            889999999999999999999997

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.1e-36  Score=340.96  Aligned_cols=260  Identities=22%  Similarity=0.236  Sum_probs=201.7

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcc--------cCCceEEEEEEE----
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ--------HRNLVRLLGCCV----  608 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------HpnIv~l~g~~~----  608 (862)
                      ++|+..++||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++        |+||+++++++.    
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            67999999999999999999865 4788999999643 344577899999999996        788999999987    


Q ss_pred             eCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc-CCCcEEecccCCcceEecCCC------
Q 002969          609 EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEM------  681 (862)
Q Consensus       609 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivHrDlkp~NILl~~~~------  681 (862)
                      .....++||||+ +++|.+.+.... ...+++..+..++.||++||+|||++ +   |+||||||+||||+.++      
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhh
Confidence            556789999999 566666664432 24589999999999999999999998 7   99999999999998775      


Q ss_pred             -------------------------------------------CeeEecccceeecCCCCcccccccccccccccChhhh
Q 002969          682 -------------------------------------------TPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA  718 (862)
Q Consensus       682 -------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l  718 (862)
                                                                 .+||+|||++......     .....||+.|+|||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence                                                       8999999999876422     2234789999999999


Q ss_pred             cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcc---hhHHHHHHHHHhcCc--------e-eeeec---------c-
Q 002969          719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE---LNLLGHVWRLWKEGK--------V-LEMVD---------S-  776 (862)
Q Consensus       719 ~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~---~~l~~~~~~~~~~~~--------~-~~~id---------~-  776 (862)
                      .+..++.++|||||||++|||++|+.||........   ...+..+.+......        . .+...         . 
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            999999999999999999999999999865433322   122222222111100        0 00000         0 


Q ss_pred             ----------cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          777 ----------SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       777 ----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                                .....+......+.+|+.+||+.||++|||+.|+++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                      001234566778999999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3e-37  Score=340.01  Aligned_cols=261  Identities=24%  Similarity=0.405  Sum_probs=199.1

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCc--cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      .++|+..++||+|+||.||+|+... ++.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            3579999999999999999998765 88999999865432  23566889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++...   ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       104 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            999999998886432   34899999999999999999999998   999999999999999999999999999865432


Q ss_pred             CcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHH-----------H
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL-----------W  765 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~-----------~  765 (862)
                      .  .......|++.|+|||++.+. .++.++||||||+++|||++|+.|+.....   ......+...           +
T Consensus       178 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~  252 (331)
T 4aaa_A          178 G--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD---IDQLYHIMMCLGNLIPRHQELF  252 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHHHHHH
T ss_pred             c--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCChhhhhHh
Confidence            2  122335689999999999875 789999999999999999999999753221   1222111111           1


Q ss_pred             hcCceee-eecccC-CC-----CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          766 KEGKVLE-MVDSSV-DN-----YPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       766 ~~~~~~~-~id~~~-~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ....... ...+.. ..     .....+..+.+|+.+||+.||++||++.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1110000 000000 00     11234567889999999999999999999885

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.7e-37  Score=352.70  Aligned_cols=197  Identities=24%  Similarity=0.399  Sum_probs=155.2

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeC-----Cc
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-----DE  612 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~~  612 (862)
                      .++|+..++||+|+||.||+|+.. +++.||||++...  .....+++.+|+++|++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            368999999999999999999865 5889999999654  233457899999999999999999999999543     56


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      .++||||+. ++|.+++...   ..+++..+..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            899999985 6888888543   35899999999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCcc-------------------------cccccccccccccChhhh-cCCCCCccccchhHHHHHHHHHhCCC
Q 002969          693 IFGGDQTE-------------------------QNTKRVVGTYGYMSPEYA-MDGLFSVKSDVFSFGVLLLETVSGKK  744 (862)
Q Consensus       693 ~~~~~~~~-------------------------~~~~~~~gt~~y~APE~l-~~~~~s~ksDVwSlGvil~elltG~~  744 (862)
                      .+......                         ......+||+.|+|||++ ....++.++|||||||+||||++|..
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            76432111                         122345789999999986 45679999999999999999999533

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=7.9e-37  Score=340.78  Aligned_cols=267  Identities=24%  Similarity=0.294  Sum_probs=199.8

Q ss_pred             hHHHHHHcccccccceeeccccEEEEEeEecCCcEEEEEEeccCCcc-----------chHHHHHHHHHHHhcccCCceE
Q 002969          534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ-----------GIEEFKNEVRLIAKLQHRNLVR  602 (862)
Q Consensus       534 ~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~HpnIv~  602 (862)
                      ..++....++|+..++||+|+||.||+|+..+++.||||++......           ..+.+.+|++++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            45677788999999999999999999999888999999998653211           1378999999999999999999


Q ss_pred             EEEEEEeC-----CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe
Q 002969          603 LLGCCVEM-----DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (862)
Q Consensus       603 l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl  677 (862)
                      +++++...     ...++||||++ |+|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence            99998653     35799999998 5888877532  345899999999999999999999998   9999999999999


Q ss_pred             cCCCCeeEecccceeecCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchh
Q 002969          678 DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELN  756 (862)
Q Consensus       678 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~  756 (862)
                      +.++.+||+|||+++.....   .......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+...   ....
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~---~~~~  241 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS---TFYN  241 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHH
T ss_pred             cCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC---CHHH
Confidence            99999999999999754322   22233578999999999887 67899999999999999999999997532   2222


Q ss_pred             HHHHHHHHHhcCcee-----------eeecccC--------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          757 LLGHVWRLWKEGKVL-----------EMVDSSV--------DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       757 l~~~~~~~~~~~~~~-----------~~id~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ....+..........           +.+....        ..........+.+|+.+||+.||++|||+.|+++
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            222222221111100           0000000        1112233556889999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.2e-37  Score=334.90  Aligned_cols=260  Identities=26%  Similarity=0.408  Sum_probs=199.8

Q ss_pred             cChHHHHHHcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEe
Q 002969          532 FDFETIVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVE  609 (862)
Q Consensus       532 ~~~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~  609 (862)
                      +++.++....++|+..+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            344444456788999999999999999999875 58899999996543 3457889999999999 79999999999987


Q ss_pred             ------CCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCe
Q 002969          610 ------MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (862)
Q Consensus       610 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  683 (862)
                            .+..++||||+++++|.+++.... ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence                  467899999999999999996542 345889999999999999999999998   9999999999999999999


Q ss_pred             eEecccceeecCCCCcccccccccccccccChhhhc-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHH
Q 002969          684 KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM-----DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL  758 (862)
Q Consensus       684 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~  758 (862)
                      ||+|||++..+....  .......|++.|+|||++.     +..++.++||||||+++|||++|+.|+.....   .   
T Consensus       169 kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---  240 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---M---  240 (326)
T ss_dssp             EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---H---
T ss_pred             EEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---H---
Confidence            999999998654221  1223357899999999987     56789999999999999999999999743211   1   


Q ss_pred             HHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          759 GHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       759 ~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ........ ....       .......+..+.+++.+||+.||++||++.|+++
T Consensus       241 ~~~~~~~~-~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          241 RALFLIPR-NPAP-------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHHHH-SCCC-------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhc-Cccc-------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            11111111 1110       1112234567889999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.6e-36  Score=336.97  Aligned_cols=263  Identities=21%  Similarity=0.324  Sum_probs=200.2

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeC--------
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM--------  610 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--------  610 (862)
                      ++|+..++||+|+||.||+|+.. +++.||||++....  ......+.+|+.++++++||||+++++++...        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            57999999999999999999874 58899999986543  33356788999999999999999999999873        


Q ss_pred             CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccc
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  690 (862)
                      +..++||||+++ +|.+.+....  ..+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence            468999999985 7777664332  34899999999999999999999998   99999999999999999999999999


Q ss_pred             eeecCCCCc--ccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhc
Q 002969          691 ARIFGGDQT--EQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE  767 (862)
Q Consensus       691 a~~~~~~~~--~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  767 (862)
                      ++.+.....  ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+...   ........+......
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~  247 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN---TEQHQLALISQLCGS  247 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCC
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCC
Confidence            987653222  222234578999999999876 45899999999999999999999996532   222223222222111


Q ss_pred             Cce-----------eeeecccC-CCCCh-H------HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          768 GKV-----------LEMVDSSV-DNYPA-N------EVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       768 ~~~-----------~~~id~~~-~~~~~-~------~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ...           .+.+.... ..... .      ....+.+|+.+||+.||++|||+.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            000           00000000 00000 0      13457899999999999999999999873

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.7e-36  Score=329.32  Aligned_cols=251  Identities=26%  Similarity=0.400  Sum_probs=200.7

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ..++|+..+.||+|+||.||+|+... ++.||||++....  ..+++.+|+.++++++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            34679999999999999999998764 8899999997543  45788999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++++|.+++...  ...+++..+..++.||++||.|||+.+   ++|+||||+||+++.++.+||+|||++..+....
T Consensus       105 ~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          105 YCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             CCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            99999999998532  345899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                      .  ......|++.|+|||++.+..++.++||||||+++|||++|+.|+.....      ....... ......      .
T Consensus       180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~-~~~~~~------~  244 (314)
T 3com_A          180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMI-PTNPPP------T  244 (314)
T ss_dssp             S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHH-HHSCCC------C
T ss_pred             c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHH-hcCCCc------c
Confidence            2  22335689999999999999999999999999999999999999753221      1111111 111100      0


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ...+...+..+.+++.+||+.||++||++.++++
T Consensus       245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            1123334567889999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.1e-37  Score=334.50  Aligned_cols=263  Identities=25%  Similarity=0.385  Sum_probs=187.4

Q ss_pred             HcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ..++|+..+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            3468999999999999999999865 58899999986543 344677899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhc-----cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          618 EYMENRSLDSVIFDK-----ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       618 E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      ||+++++|.+++...     .....+++..+..++.||++||+|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            999999999998642     12345899999999999999999999998   9999999999999999999999999997


Q ss_pred             ecCCCCc---ccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcC
Q 002969          693 IFGGDQT---EQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG  768 (862)
Q Consensus       693 ~~~~~~~---~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  768 (862)
                      .+.....   ........||+.|+|||++.+ ..++.++||||||+++|||++|+.|+.......   ...   ......
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~---~~~~~~  243 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLM---LTLQND  243 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH---HHHTSS
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHH---HHhccC
Confidence            6543211   111233578999999999876 568999999999999999999999975433221   111   111111


Q ss_pred             ceeeeecc-cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          769 KVLEMVDS-SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       769 ~~~~~id~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       ....... .........+..+.+++.+||+.||++||++.|+++
T Consensus       244 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          244 -PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             -CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence             1000000 001122334567889999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.9e-37  Score=331.92  Aligned_cols=257  Identities=28%  Similarity=0.392  Sum_probs=198.2

Q ss_pred             cccccccceeeccccEEEEEeEecC--Cc--EEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE--GQ--EIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~--~~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  613 (862)
                      .++|+..++||+|+||.||+|+...  ++  .||||+++..   .....+++.+|++++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            3578999999999999999998532  33  6899998754   2345678999999999999999999999998754 8


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++|+||+++++|.+++....  ..+++..+..++.||++||+|||+.+   ++||||||+|||++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            89999999999999996542  34889999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc-cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          694 FGGDQTE-QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       694 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      +...... .......++..|+|||++.+..++.++||||||+++|||++ |+.|+....   .......   ......  
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~---~~~~~~--  242 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHK---IDKEGE--  242 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHH---HHTSCC--
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC---HHHHHHH---HHccCC--
Confidence            7543322 12233467889999999998889999999999999999999 999864321   1112111   111111  


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                            ....+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       243 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  282 (291)
T 1u46_A          243 ------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  282 (291)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence                  0112334567789999999999999999999999999887

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=8.6e-37  Score=341.94  Aligned_cols=253  Identities=11%  Similarity=0.069  Sum_probs=184.3

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc---cchHHHHHHHHHHHhc--ccCCceEEE-------EEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG---QGIEEFKNEVRLIAKL--QHRNLVRLL-------GCC  607 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l--~HpnIv~l~-------g~~  607 (862)
                      ..+|...++||+|+||.||+|+.. +++.||||++.....   ...+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            346888999999999999999875 588999999977542   3456788887666666  599988855       454


Q ss_pred             EeC-----------------CceEEEEEeccCCChhhhhhhccCCCCCCHhhH------HHHHHHHHHHhHHhhhcCCCc
Q 002969          608 VEM-----------------DEKMLVYEYMENRSLDSVIFDKARSSILNWQRR------FNIICGIARGLLYLHQDSRFR  664 (862)
Q Consensus       608 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~gL~yLH~~~~~~  664 (862)
                      ...                 ...++||||++ ++|.+++.....  .+.+..+      +.++.||++||+|||+.+   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG---  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence            433                 23799999999 899999965432  3455666      788899999999999998   


Q ss_pred             EEecccCCcceEecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcC--CCCCccccchhHHHHHHHHHhC
Q 002969          665 IIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD--GLFSVKSDVFSFGVLLLETVSG  742 (862)
Q Consensus       665 ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvil~elltG  742 (862)
                      |+||||||+||||+.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++|||||||++|||++|
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999999999875321     113456799999999987  6799999999999999999999


Q ss_pred             CCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          743 KKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       743 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      +.|+..........        +............. .......+..+.+|+.+||+.||++||++.|+++
T Consensus       290 ~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          290 FLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99976432221100        00000000000111 1112345678889999999999999999999974

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.6e-36  Score=334.55  Aligned_cols=255  Identities=22%  Similarity=0.343  Sum_probs=204.3

Q ss_pred             HHHHcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc--------cchHHHHHHHHHHHhc-ccCCceEEEEE
Q 002969          537 IVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG--------QGIEEFKNEVRLIAKL-QHRNLVRLLGC  606 (862)
Q Consensus       537 i~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l-~HpnIv~l~g~  606 (862)
                      .....++|+..+.||+|+||.||+|+.. +|+.||||++.....        ...+.+.+|+.+++++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3444568999999999999999999886 589999999865432        1245788999999999 79999999999


Q ss_pred             EEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEe
Q 002969          607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS  686 (862)
Q Consensus       607 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~  686 (862)
                      +...+..++||||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence            99999999999999999999999653   34899999999999999999999998   9999999999999999999999


Q ss_pred             cccceeecCCCCcccccccccccccccChhhhcC------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHH
Q 002969          687 DFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD------GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGH  760 (862)
Q Consensus       687 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~  760 (862)
                      |||++..+....   ......||+.|+|||++.+      ..++.++||||||+++|||++|+.||...   ......  
T Consensus       243 DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~---~~~~~~--  314 (365)
T 2y7j_A          243 DFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR---RQILML--  314 (365)
T ss_dssp             CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHH--
T ss_pred             ecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC---CHHHHH--
Confidence            999998764332   2234678999999999863      35889999999999999999999997432   111111  


Q ss_pred             HHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          761 VWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       761 ~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        .....+... ...+.    ....+..+.+++.+||+.||++||++.|+++
T Consensus       315 --~~i~~~~~~-~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          315 --RMIMEGQYQ-FSSPE----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             --HHHHHTCCC-CCHHH----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --HHHHhCCCC-CCCcc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              111111110 00000    0123456889999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8.8e-37  Score=366.83  Aligned_cols=249  Identities=27%  Similarity=0.331  Sum_probs=207.3

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~  614 (862)
                      ..++|+..++||+|+||.||+|+... ++.||||+++..   .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            34679999999999999999998765 788999999753   234567788999999988 7999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      +||||+++|+|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            9999999999999996543   4899999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          695 GGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       695 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ....  .......||+.|+|||++.+..++.++|||||||+||||++|+.||..   .+...+...    +.+..     
T Consensus       493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~---~~~~~~~~~----i~~~~-----  558 (674)
T 3pfq_A          493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG---EDEDELFQS----IMEHN-----  558 (674)
T ss_dssp             CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHH----HHSSC-----
T ss_pred             ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC---CCHHHHHHH----HHhCC-----
Confidence            3222  223456899999999999999999999999999999999999999743   222222222    22211     


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTM-----ASVVL  812 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~  812 (862)
                          ..++...+.++.+|+.+||+.||++||++     +||++
T Consensus       559 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ----CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                22344566788999999999999999997     77774

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.6e-36  Score=327.36  Aligned_cols=249  Identities=25%  Similarity=0.372  Sum_probs=197.9

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEe----CCceE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE----MDEKM  614 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----~~~~~  614 (862)
                      +.|...++||+|+||.||+|.... +..||+|++...  .....+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            457778899999999999998754 778999998654  33456789999999999999999999999875    35579


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec-CCCCeeEecccceee
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-KEMTPKISDFGMARI  693 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL~DFGla~~  693 (862)
                      +||||+++++|.+++...   ..+++..+..++.||+.||+|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            999999999999999653   34889999999999999999999875 3599999999999997 789999999999975


Q ss_pred             cCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeee
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  773 (862)
                      ....    ......|++.|+|||++. +.++.++||||||+++|||++|+.|+.....  .    .........+...  
T Consensus       182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~----~~~~~~~~~~~~~--  248 (290)
T 1t4h_A          182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--A----AQIYRRVTSGVKP--  248 (290)
T ss_dssp             CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--H----HHHHHHHTTTCCC--
T ss_pred             cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc--H----HHHHHHHhccCCc--
Confidence            4322    223356899999999876 4589999999999999999999999743221  1    1112222221111  


Q ss_pred             ecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       774 id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                           ...+...+.++.+++.+||+.||++||++.|+++
T Consensus       249 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          249 -----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                 1112223457889999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.8e-37  Score=337.82  Aligned_cols=270  Identities=26%  Similarity=0.364  Sum_probs=200.7

Q ss_pred             HcccccccceeeccccEEEEEeEecCCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ..++|+..+.||+|+||.||+|+...  .+|+|+++..  .....+.+.+|+.++++++||||+++++++.+.+..++|+
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            35678999999999999999998754  5999998654  2344567889999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++...  ...+++..+..++.||++||+|||+.+   |+||||||+|||++ ++.+||+|||++......
T Consensus       109 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             BCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             ecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            999999999999543  335899999999999999999999998   99999999999998 679999999998765322


Q ss_pred             C---cccccccccccccccChhhhcC---------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH
Q 002969          698 Q---TEQNTKRVVGTYGYMSPEYAMD---------GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW  765 (862)
Q Consensus       698 ~---~~~~~~~~~gt~~y~APE~l~~---------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~  765 (862)
                      .   .........|++.|+|||++.+         ..++.++||||||+++|||++|+.|+....   ....    ....
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~----~~~~  255 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP---AEAI----IWQM  255 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC---HHHH----HHHH
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHH----HHHh
Confidence            1   1122233468999999999874         457899999999999999999999974321   1111    1112


Q ss_pred             hcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCCCCCCCCcccc
Q 002969          766 KEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGFCL  831 (862)
Q Consensus       766 ~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p~~~~  831 (862)
                      ..+.....       .....+.++.+++.+||+.+|++||++.+|+++|+.+.........|+...
T Consensus       256 ~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~  314 (319)
T 2y4i_B          256 GTGMKPNL-------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW  314 (319)
T ss_dssp             HTTCCCCC-------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred             ccCCCCCC-------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence            22211111       111234467899999999999999999999999999865555545555443

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=9.1e-37  Score=338.10  Aligned_cols=257  Identities=25%  Similarity=0.342  Sum_probs=204.2

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCcc---c--------------hHHHHHHHHHHHhcccCCceEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQ---G--------------IEEFKNEVRLIAKLQHRNLVRL  603 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~--------------~~~~~~E~~~l~~l~HpnIv~l  603 (862)
                      .++|+..+.||+|+||.||+|+. +++.||||++......   .              .+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36799999999999999999998 8999999998654211   1              1789999999999999999999


Q ss_pred             EEEEEeCCceEEEEEeccCCChhhh------hhhccCCCCCCHhhHHHHHHHHHHHhHHhhh-cCCCcEEecccCCcceE
Q 002969          604 LGCCVEMDEKMLVYEYMENRSLDSV------IFDKARSSILNWQRRFNIICGIARGLLYLHQ-DSRFRIIHRDLKASNIL  676 (862)
Q Consensus       604 ~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NIL  676 (862)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..+..++.||++||+|||+ .+   |+||||||+|||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      432 124569999999999999999999999 77   999999999999


Q ss_pred             ecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCC-CCCc-cccchhHHHHHHHHHhCCCCCCCCCCCcc
Q 002969          677 LDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG-LFSV-KSDVFSFGVLLLETVSGKKNRGFYHSNNE  754 (862)
Q Consensus       677 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~-ksDVwSlGvil~elltG~~p~~~~~~~~~  754 (862)
                      ++.++.+||+|||++......    ......|++.|+|||++.+. .++. ++||||||+++|||++|+.|+......  
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--  258 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--  258 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence            999999999999999876432    23345789999999999887 6666 999999999999999999997543221  


Q ss_pred             hhHHHHHHHHHhcCceeeeecc--cC--------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          755 LNLLGHVWRLWKEGKVLEMVDS--SV--------DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       755 ~~l~~~~~~~~~~~~~~~~id~--~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ...    ...+..+......+.  ..        .......+..+.+++.+||+.||++||++.|+++
T Consensus       259 ~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 VEL----FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHH----HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHH----HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            112    222222211100000  00        0011345567889999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.3e-37  Score=334.47  Aligned_cols=258  Identities=24%  Similarity=0.335  Sum_probs=199.6

Q ss_pred             hHHHHHHcccccccceeeccccEEEEEeEecCCcEEEEEEeccC--CccchHHHHHHHHHHHhcc--cCCceEEEEEEEe
Q 002969          534 FETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQ--HRNLVRLLGCCVE  609 (862)
Q Consensus       534 ~~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--HpnIv~l~g~~~~  609 (862)
                      +..+....++|+..+.||+|+||.||+++..+++.||||++...  .....+.+.+|+.++.+++  ||||+++++++..
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred             eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence            33344456789999999999999999999888999999999654  2345678999999999997  4999999999999


Q ss_pred             CCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccc
Q 002969          610 MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (862)
Q Consensus       610 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  689 (862)
                      .+..++||| +.+++|.+++...   ..+++.++..++.||++||.|||+.+   |+||||||+|||++ ++.+||+|||
T Consensus       100 ~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Dfg  171 (313)
T 3cek_A          100 DQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFG  171 (313)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred             CCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeecc
Confidence            999999999 6688999999653   35889999999999999999999998   99999999999996 4899999999


Q ss_pred             ceeecCCCCcccccccccccccccChhhhcC-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHH
Q 002969          690 MARIFGGDQTEQNTKRVVGTYGYMSPEYAMD-----------GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL  758 (862)
Q Consensus       690 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~  758 (862)
                      +++.+.............|++.|+|||++.+           ..++.++||||||+++|||++|+.|+......     .
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~  246 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I  246 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----H
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----H
Confidence            9987654333333334578999999999875           46888999999999999999999997532211     1


Q ss_pred             HHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          759 GHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       759 ~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ...........        ....+...+..+.+++.+||+.||++||++.|+++
T Consensus       247 ~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          247 SKLHAIIDPNH--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHHHHHHCTTS--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHhccc--------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            11111111111        01222333567889999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.2e-36  Score=340.05  Aligned_cols=260  Identities=20%  Similarity=0.296  Sum_probs=198.5

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCc------eE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE------KM  614 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~------~~  614 (862)
                      ..+|+..++||+|+||.||+|+...+..||+|++.....    ...+|+++++.++||||+++++++.....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            357899999999999999999998888899999865432    23479999999999999999999966543      78


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec-CCCCeeEecccceee
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-KEMTPKISDFGMARI  693 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL~DFGla~~  693 (862)
                      +||||++++.+............+++..+..++.||++||+|||+.+   |+||||||+||||+ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999987655554433334456899999999999999999999998   99999999999999 799999999999987


Q ss_pred             cCCCCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce--
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV--  770 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--  770 (862)
                      +.....   .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...   ...+.+..+.+.......  
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~---~~~~~l~~i~~~~g~p~~~~  265 (394)
T 4e7w_A          192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE---SGIDQLVEIIKVLGTPSREQ  265 (394)
T ss_dssp             CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCHHH
T ss_pred             ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCCHHH
Confidence            643322   2235689999999998765 5899999999999999999999997432   222233333222211100  


Q ss_pred             --------eeeecccCC------CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          771 --------LEMVDSSVD------NYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       771 --------~~~id~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                              .+..-+...      .++...+.++.+|+.+||+.||++|||+.|+++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                    000000000      1122345688999999999999999999999974

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=100.00  E-value=3.9e-36  Score=313.84  Aligned_cols=215  Identities=14%  Similarity=0.176  Sum_probs=168.9

Q ss_pred             hhccccCCCCccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc-eeEEE
Q 002969           55 ISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLF  133 (862)
Q Consensus        55 ~~~~~~~~~~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~-~~~l~  133 (862)
                      ++.|+|++||+|++|++|  ++|.|+|||+.+++     +.+ |..   +|+||+|||+.|   +.+.|.+.++ +|||+
T Consensus         6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~l-y~~---~~~vW~an~~~~---~~~~l~l~~dGnLvl~   71 (236)
T 1dlp_A            6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVL-FDS---DVRVWASNTAGA---TGCRAVLQSDGLLVIL   71 (236)
T ss_dssp             CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEE-EES---SSEEECCCCCSC---SCCBCCBCSSSCBCCB
T ss_pred             eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEE-EEC---CEEEEECCCCCC---CCeEEEEcCCCcEEEE
Confidence            455999999999999999  59999999997765     334 443   799999999998   5678888876 57888


Q ss_pred             cCCCCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeeecCCCCCcc-CCcCccccee-ecCC-----eeEEEecC
Q 002969          134 DGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTL-LPQMKIGWDL-KTGF-----EWYLTSWK  205 (862)
Q Consensus       134 ~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtDTl-Lpg~klg~~~-~tg~-----~~~L~Sw~  205 (862)
                      |++|.+||+|++... ....|+|+|+|||||++.    ++||||||||||+ ||+|  |.|. .+|+     +++|+|  
T Consensus        72 d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~----~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~s--  143 (236)
T 1dlp_A           72 TAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP----GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLHA--  143 (236)
T ss_dssp             CTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS----EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEECS--
T ss_pred             cCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC----CEEECCCCCCcccccCCc--cceEEecCCcCCCccceEEc--
Confidence            999999999998743 456899999999999852    8999999999988 7776  6666 6666     678885  


Q ss_pred             CCCCCCCCCcEEEeccCCCcceEeecCCcceeecCCCCceeecCcCCCccccccceEEEEeCCCceEEEEeecCCCceeE
Q 002969          206 STDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGINFEFFIDQDHDVYYSFFIENKNLFSR  285 (862)
Q Consensus       206 s~~dps~G~~s~~l~~~g~~~~~~~~~~~~~~rsg~w~g~~~~g~p~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~r  285 (862)
                       .+||++|.|+++++++|  ++++|+++.+||++|+|++. +.+.++|....  .+...-.++++++.+|+..+. ...|
T Consensus       144 -~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~G--nl~ly~~~~~~vw~s~~~~~~-~~~r  216 (236)
T 1dlp_A          144 -TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNG--RMDVLTNQNIAVWTSGNSRSA-GRYV  216 (236)
T ss_dssp             -SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTT--EEEEEETTTEEEEECCCCCSS-SCCE
T ss_pred             -CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCC--cEEEEeCCCcEEEEeCCCCCC-CCEE
Confidence             78999999999999999  67889888999999999764 56666665332  222221344455555544333 4689


Q ss_pred             EEECcCCceEEEE
Q 002969          286 LIVSPDGFLQRFT  298 (862)
Q Consensus       286 l~l~~~G~l~~~~  298 (862)
                      ++||+||++++|.
T Consensus       217 l~Ld~dG~l~ly~  229 (236)
T 1dlp_A          217 FVLQPDRNLAIYG  229 (236)
T ss_dssp             EEECSSSCEEEEC
T ss_pred             EEEcCCCcEEEeC
Confidence            9999999999994

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.9e-36  Score=338.12  Aligned_cols=260  Identities=19%  Similarity=0.275  Sum_probs=197.4

Q ss_pred             HHcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeC-------
Q 002969          539 RATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-------  610 (862)
Q Consensus       539 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-------  610 (862)
                      ...++|+..++||+|+||.||+|+.. +++.||||++....    ....+|+++++.++||||+++++++...       
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            45678999999999999999999864 58999999986543    2234799999999999999999998543       


Q ss_pred             -------------------------------CceEEEEEeccCCChhhhhhhc-cCCCCCCHhhHHHHHHHHHHHhHHhh
Q 002969          611 -------------------------------DEKMLVYEYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLH  658 (862)
Q Consensus       611 -------------------------------~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH  658 (862)
                                                     ...++||||++ ++|.+.+... .....+++..+..++.||++||+|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                           33789999998 5888777542 23456999999999999999999999


Q ss_pred             hcCCCcEEecccCCcceEec-CCCCeeEecccceeecCCCCcccccccccccccccChhhhcCC-CCCccccchhHHHHH
Q 002969          659 QDSRFRIIHRDLKASNILLD-KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLL  736 (862)
Q Consensus       659 ~~~~~~ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil  736 (862)
                      +.+   |+||||||+|||++ .++.+||+|||+++.+.....   .....+|+.|+|||++.+. .++.++|||||||++
T Consensus       159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            998   99999999999997 688999999999987643322   2235679999999998875 489999999999999


Q ss_pred             HHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee----------eeecccC------CCCChHHHHHHHHHHHhccccC
Q 002969          737 LETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL----------EMVDSSV------DNYPANEVLRCIHVGLLCVQEN  800 (862)
Q Consensus       737 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~----------~~id~~~------~~~~~~~~~~l~~li~~cl~~d  800 (862)
                      |||++|+.||..   ....+.+..+.+........          +..-+..      ...+...+.++.+|+.+||+.|
T Consensus       233 ~ell~g~~pf~~---~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          233 GELILGKPLFSG---ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHSSCSSCC---SSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHhCCCCCCC---CChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            999999999753   22223333333222111100          0000000      0123335567899999999999


Q ss_pred             CCCCCCHHHHHH
Q 002969          801 AEERPTMASVVL  812 (862)
Q Consensus       801 P~~RPt~~evl~  812 (862)
                      |++|||+.|+++
T Consensus       310 P~~R~t~~e~l~  321 (383)
T 3eb0_A          310 PDLRINPYEAMA  321 (383)
T ss_dssp             GGGSCCHHHHHT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999984

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.4e-36  Score=329.22  Aligned_cols=251  Identities=23%  Similarity=0.330  Sum_probs=195.6

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCC--------ccchHHHHHHHHHHHhcccCCceEEEEEEEeCC
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--------GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD  611 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  611 (862)
                      .++|...+.||+|+||.||+|+... ++.||||++....        ......+.+|++++++++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            4679999999999999999998754 7899999986532        123456889999999999999999999987654


Q ss_pred             ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC---eeEecc
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT---PKISDF  688 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kL~DF  688 (862)
                       .++||||+++++|.+++...   ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.   +||+||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             -eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence             89999999999999988543   35899999999999999999999998   999999999999987654   999999


Q ss_pred             cceeecCCCCcccccccccccccccChhhhc---CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH
Q 002969          689 GMARIFGGDQTEQNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW  765 (862)
Q Consensus       689 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~  765 (862)
                      |+++.....   .......||+.|+|||++.   ...++.++||||||+++|||++|+.|+.......  .+...+    
T Consensus       162 g~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~----  232 (322)
T 2ycf_A          162 GHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI----  232 (322)
T ss_dssp             TTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH----
T ss_pred             ccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH----
Confidence            999876432   1223456899999999974   4678999999999999999999999975433221  111111    


Q ss_pred             hcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          766 KEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       766 ~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..+... ..    .......+..+.+++.+||+.||++||++.|+++
T Consensus       233 ~~~~~~-~~----~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          233 TSGKYN-FI----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHTCCC-CC----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhCccc-cC----chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            111110 00    0001223567889999999999999999999984

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2e-36  Score=362.61  Aligned_cols=256  Identities=21%  Similarity=0.311  Sum_probs=204.5

Q ss_pred             HcccccccceeeccccEEEEEeEecC----CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  614 (862)
                      ..++|+..+.||+|+||.||+|+...    +..||||+++... ....+.|.+|+.++++++||||+++++++. .+..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            34678899999999999999998743    4579999987543 334578999999999999999999999985 46789


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      +||||+++|+|.+++...  ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            999999999999999643  235899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeee
Q 002969          695 GGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       695 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  773 (862)
                      ..... .......+|+.|+|||++.+..++.++||||||+++|||++ |..|+...   ........    ...+..   
T Consensus       542 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~---~~~~~~~~----i~~~~~---  610 (656)
T 2j0j_A          542 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNNDVIGR----IENGER---  610 (656)
T ss_dssp             CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHH----HHHTCC---
T ss_pred             CCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC---CHHHHHHH----HHcCCC---
Confidence            43322 12223456789999999999999999999999999999997 88886432   11222221    222111   


Q ss_pred             ecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       774 id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                           ...+...+..+.+++.+||+.||++||++.||++.|+.+
T Consensus       611 -----~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          611 -----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                 123345567888999999999999999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.1e-35  Score=321.87  Aligned_cols=251  Identities=23%  Similarity=0.293  Sum_probs=203.2

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---------ccchHHHHHHHHHHHhcc-cCCceEEEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---------GQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVE  609 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~  609 (862)
                      .++|+..+.||+|+||.||+|+.. +++.||||++....         ....+.+.+|+++++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468999999999999999999876 47899999996543         123467889999999995 9999999999999


Q ss_pred             CCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccc
Q 002969          610 MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (862)
Q Consensus       610 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  689 (862)
                      .+..++||||+++++|.+++...   ..+++..+..++.||++||+|||+.+   ++||||||+||+++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence            99999999999999999999653   34899999999999999999999998   9999999999999999999999999


Q ss_pred             ceeecCCCCcccccccccccccccChhhhc------CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHH
Q 002969          690 MARIFGGDQTEQNTKRVVGTYGYMSPEYAM------DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR  763 (862)
Q Consensus       690 la~~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~  763 (862)
                      ++..+....   ......|++.|+|||++.      ...++.++||||||+++|||++|+.|+...   ......    .
T Consensus       170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~----~  239 (298)
T 1phk_A          170 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR---KQMLML----R  239 (298)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHH----H
T ss_pred             chhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc---cHHHHH----H
Confidence            998764322   223356899999999985      456889999999999999999999997432   111111    1


Q ss_pred             HHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          764 LWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       764 ~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ....+... .    ........+..+.+++.+||+.||++||++.|+++
T Consensus       240 ~~~~~~~~-~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          240 MIMSGNYQ-F----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHTCCC-C----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHhcCCcc-c----CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            12221110 0    01112345667889999999999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.2e-36  Score=351.28  Aligned_cols=251  Identities=27%  Similarity=0.372  Sum_probs=200.6

Q ss_pred             HcccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCc-------------cchHHHHHHHHHHHhcccCCceEEEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-------------QGIEEFKNEVRLIAKLQHRNLVRLLG  605 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~HpnIv~l~g  605 (862)
                      ..++|...++||+|+||.||+|+... ++.||||++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            45789999999999999999998765 78999999865421             34568899999999999999999999


Q ss_pred             EEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC---C
Q 002969          606 CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM---T  682 (862)
Q Consensus       606 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~---~  682 (862)
                      ++.+....++||||+++|+|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999999886543   4899999999999999999999998   99999999999998776   6


Q ss_pred             eeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHH
Q 002969          683 PKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVW  762 (862)
Q Consensus       683 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~  762 (862)
                      +||+|||++..+....   ......||+.|+|||++. ..++.++|||||||++|||++|..||...   ......    
T Consensus       188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~----  256 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ---NDQDII----  256 (504)
T ss_dssp             EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHH----
T ss_pred             EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC---CHHHHH----
Confidence            9999999998764332   223357999999999987 56899999999999999999999997532   222222    


Q ss_pred             HHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          763 RLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       763 ~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..+..+......     ......+.++.+|+.+||+.||.+|||+.|+++
T Consensus       257 ~~i~~~~~~~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          257 KKVEKGKYYFDF-----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHHCCCCCCH-----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHcCCCCCCc-----cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            222222110000     000123467889999999999999999999985

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.4e-36  Score=347.79  Aligned_cols=250  Identities=26%  Similarity=0.362  Sum_probs=198.2

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      .++|+..++||+|+||.||+|+.. .+..||||++....  ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            357999999999999999999876 47899999997643  344678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC---CCeeEecccceeec
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGMARIF  694 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kL~DFGla~~~  694 (862)
                      ||+++|+|.+.+....   .+++..+..++.||++||+|||+.+   |+||||||+|||++..   +.+||+|||+++.+
T Consensus       116 e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            9999999999886543   4899999999999999999999998   9999999999999764   55999999999876


Q ss_pred             CCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          695 GGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       695 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ....   ......||+.|+|||++. ..++.++|||||||++|||++|+.||...   ......    ..+..+... ..
T Consensus       190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~----~~i~~~~~~-~~  257 (494)
T 3lij_A          190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ---TDQEIL----RKVEKGKYT-FD  257 (494)
T ss_dssp             BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHH----HHHHHTCCC-CC
T ss_pred             CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHH----HHHHhCCCC-CC
Confidence            4332   223457999999999886 56899999999999999999999997432   222222    222222111 00


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .+    .....+..+.+++.+||+.+|++|||+.|+++
T Consensus       258 ~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          258 SP----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             SG----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ch----hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            00    11234567889999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.3e-35  Score=338.89  Aligned_cols=258  Identities=20%  Similarity=0.239  Sum_probs=200.5

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhc------ccCCceEEEEEEEeCCce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL------QHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~g~~~~~~~~  613 (862)
                      ..+|+..++||+|+||.||+|+... ++.||||+++.. ....+++.+|+++++.+      +|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            3579999999999999999998765 789999999653 33456788899999888      467999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC--eeEecccce
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT--PKISDFGMA  691 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kL~DFGla  691 (862)
                      ++||||+. ++|.+++.... ...+++..+..++.||++||+|||+.+   |+||||||+||||+.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 68998886543 234899999999999999999999998   999999999999999987  999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc--
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK--  769 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--  769 (862)
                      ......     .....||+.|+|||++.+..++.++|||||||++|||++|+.|+...   .....+..+.+......  
T Consensus       250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~---~~~~~l~~i~~~~~~p~~~  321 (429)
T 3kvw_A          250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE---DEGDQLACMIELLGMPSQK  321 (429)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCHH
T ss_pred             eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHcCCCCHH
Confidence            764322     22357899999999999999999999999999999999999986432   22222322222211000  


Q ss_pred             -------eeeeecc-------------------------------cCCC------CChHHHHHHHHHHHhccccCCCCCC
Q 002969          770 -------VLEMVDS-------------------------------SVDN------YPANEVLRCIHVGLLCVQENAEERP  805 (862)
Q Consensus       770 -------~~~~id~-------------------------------~~~~------~~~~~~~~l~~li~~cl~~dP~~RP  805 (862)
                             ....++.                               ....      .+......+.+|+.+||+.||++||
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp  401 (429)
T 3kvw_A          322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM  401 (429)
T ss_dssp             HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence                   0000000                               0000      0111245688999999999999999


Q ss_pred             CHHHHHH
Q 002969          806 TMASVVL  812 (862)
Q Consensus       806 t~~evl~  812 (862)
                      |+.|+++
T Consensus       402 ta~e~L~  408 (429)
T 3kvw_A          402 TPGQALR  408 (429)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhC
Confidence            9999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.7e-36  Score=327.40  Aligned_cols=262  Identities=24%  Similarity=0.358  Sum_probs=203.4

Q ss_pred             HcccccccceeeccccEEEEEeEe--cCCcEEEEEEeccCC--ccchHHHHHHHHHHHhc---ccCCceEEEEEEE----
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRL--LEGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKL---QHRNLVRLLGCCV----  608 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~HpnIv~l~g~~~----  608 (862)
                      +.++|+..+.||+|+||.||+|+.  .+++.||||+++...  ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999987  357889999986542  22345677888888877   7999999999987    


Q ss_pred             -eCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEec
Q 002969          609 -EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISD  687 (862)
Q Consensus       609 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  687 (862)
                       .....++|+||++ ++|.+++.... ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             4567899999998 69999986543 234899999999999999999999998   99999999999999999999999


Q ss_pred             ccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhc
Q 002969          688 FGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE  767 (862)
Q Consensus       688 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  767 (862)
                      ||+++.....   .......|++.|+|||++.+..++.++||||||+++|||++|+.|+...   ........+......
T Consensus       164 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~~~  237 (326)
T 1blx_A          164 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS---SDVDQLGKILDVIGL  237 (326)
T ss_dssp             CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCC
T ss_pred             CcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHHHcCC
Confidence            9999865322   1223457899999999999999999999999999999999999996432   222333333322211


Q ss_pred             Cceee--------------eecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          768 GKVLE--------------MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       768 ~~~~~--------------~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .....              .............+..+.+++.+||+.||++||++.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000              0000111223345567889999999999999999999995

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.4e-36  Score=325.54  Aligned_cols=252  Identities=24%  Similarity=0.334  Sum_probs=188.0

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc--cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG--QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      .++|+..++||+|+||.||+++.. +++.||||+++....  ...+.+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            467999999999999999999874 588999999975422  22334555566688889999999999999999999999


Q ss_pred             EeccCCChhhhhhhc-cCCCCCCHhhHHHHHHHHHHHhHHhhhc-CCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          618 EYMENRSLDSVIFDK-ARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       618 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||++ ++|.+++... .....+++..+..++.||+.||+|||+. +   |+||||||+|||++.++.+||+|||++....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9998 4888877542 2345699999999999999999999998 7   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccChhhh----cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYA----MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l----~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      ...   ......||+.|+|||++    .+..++.++||||||+++|||++|+.|+......     ............  
T Consensus       162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~--  231 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEPS--  231 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSCC--
T ss_pred             ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccCC--
Confidence            322   12234689999999996    5567899999999999999999999997532211     111222222211  


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                            ........+.++.+++.+||+.||++|||+.|+++
T Consensus       232 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          232 ------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                  11112234567889999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.5e-36  Score=329.69  Aligned_cols=257  Identities=21%  Similarity=0.250  Sum_probs=202.5

Q ss_pred             ccccccceeeccccEEEEEeEe--cCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCC------ceEEEEEEEeCCce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRL--LEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN------LVRLLGCCVEMDEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l~g~~~~~~~~  613 (862)
                      ++|+..++||+|+||.||+|..  .+++.||||+++.. ....+.+.+|+++++.++|+|      ++++++++...+..
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            5799999999999999999986  35789999999643 344577899999999998765      99999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC--------------
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK--------------  679 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~--------------  679 (862)
                      ++||||+ +++|.+++.... ...+++..+..++.||++||+|||+.+   |+||||||+|||++.              
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence            9999999 899999986543 235889999999999999999999998   999999999999987              


Q ss_pred             -----CCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcc
Q 002969          680 -----EMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE  754 (862)
Q Consensus       680 -----~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~  754 (862)
                           ++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.|+......  
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--  240 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK--  240 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH--
T ss_pred             cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH--
Confidence                 678999999999864322     22357899999999999999999999999999999999999997543222  


Q ss_pred             hhHHHHHHHHHhcC--------ceeee---------------------ec--ccCCCCChHHHHHHHHHHHhccccCCCC
Q 002969          755 LNLLGHVWRLWKEG--------KVLEM---------------------VD--SSVDNYPANEVLRCIHVGLLCVQENAEE  803 (862)
Q Consensus       755 ~~l~~~~~~~~~~~--------~~~~~---------------------id--~~~~~~~~~~~~~l~~li~~cl~~dP~~  803 (862)
                       .....+.+.....        .....                     ..  ..........+.++.+++.+||+.||++
T Consensus       241 -~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          241 -EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             -HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             -HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence             1121111111100        00000                     00  0001223455778999999999999999


Q ss_pred             CCCHHHHHH
Q 002969          804 RPTMASVVL  812 (862)
Q Consensus       804 RPt~~evl~  812 (862)
                      |||+.|+++
T Consensus       320 Rpt~~ell~  328 (339)
T 1z57_A          320 RITLREALK  328 (339)
T ss_dssp             SCCHHHHTT
T ss_pred             ccCHHHHhc
Confidence            999999985

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.6e-36  Score=349.11  Aligned_cols=250  Identities=27%  Similarity=0.336  Sum_probs=204.4

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .++|+..++||+|+||.||+++.. .++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            357999999999999999999876 58899999996542   34567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe---cCCCCeeEecccceee
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARI  693 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~  693 (862)
                      +||+++++|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||+   +.++.+||+|||+++.
T Consensus       105 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            9999999999988543   34899999999999999999999998   9999999999999   5678999999999987


Q ss_pred             cCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeee
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  773 (862)
                      +....   ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...   .......    .+..+.....
T Consensus       179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~----~i~~~~~~~~  247 (484)
T 3nyv_A          179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA---NEYDILK----KVEKGKYTFE  247 (484)
T ss_dssp             BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHH----HHHHCCCCCC
T ss_pred             ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC---CHHHHHH----HHHcCCCCCC
Confidence            64322   2334579999999999876 6899999999999999999999997432   2222222    2222211100


Q ss_pred             ecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       774 id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                           .......+..+.+|+.+||+.+|++|||+.|+++
T Consensus       248 -----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          248 -----LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -----SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                 0111234567889999999999999999999985

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.9e-36  Score=347.45  Aligned_cols=251  Identities=27%  Similarity=0.325  Sum_probs=202.4

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      .++|++.++||+|+||.||+++.. +++.||||++...  .....+.+.+|++++++++||||+++++++.+....++|+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            357999999999999999999875 5889999998643  2345678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec---CCCCeeEecccceeec
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIF  694 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kL~DFGla~~~  694 (862)
                      ||+++++|.+.+....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||+++.+
T Consensus       101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            9999999999886543   4899999999999999999999998   99999999999995   4568999999999865


Q ss_pred             CCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          695 GGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       695 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ....   ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...   .....+.    .+..+..... 
T Consensus       175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~----~i~~~~~~~~-  242 (486)
T 3mwu_A          175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK---NEYDILK----RVETGKYAFD-  242 (486)
T ss_dssp             CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHH----HHHHTCCCSC-
T ss_pred             CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHH----HHHhCCCCCC-
Confidence            4322   2233579999999999875 5899999999999999999999997432   2222222    2222211100 


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                          .......+.++.+++.+||+.+|++|||+.|+++.
T Consensus       243 ----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          243 ----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             ----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             ----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                01112345678899999999999999999999973

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.8e-36  Score=332.72  Aligned_cols=268  Identities=21%  Similarity=0.257  Sum_probs=193.2

Q ss_pred             HHHHHHcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCc-
Q 002969          535 ETIVRATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE-  612 (862)
Q Consensus       535 ~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-  612 (862)
                      +......++|+..++||+|+||.||+|+.. +++.||||++.... ...+.+.+|++.++.++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            445667789999999999999999999875 48899999986543 334567788999999999999999999976444 


Q ss_pred             ------eEEEEEeccCCChhhhhhh-ccCCCCCCHhhHHHHHHHHHHHhHHhh--hcCCCcEEecccCCcceEecC-CCC
Q 002969          613 ------KMLVYEYMENRSLDSVIFD-KARSSILNWQRRFNIICGIARGLLYLH--QDSRFRIIHRDLKASNILLDK-EMT  682 (862)
Q Consensus       613 ------~~lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~gL~yLH--~~~~~~ivHrDlkp~NILl~~-~~~  682 (862)
                            .++||||+++ +|...+.. ......+++..+..++.||+.||.|||  +.+   |+||||||+|||++. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence                  7899999986 44444332 234456889999999999999999999  777   999999999999996 899


Q ss_pred             eeEecccceeecCCCCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHH
Q 002969          683 PKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV  761 (862)
Q Consensus       683 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~  761 (862)
                      +||+|||+++.+.....   .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...   .....+..+
T Consensus       171 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~---~~~~~~~~~  244 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD---NSAGQLHEI  244 (360)
T ss_dssp             EEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH
T ss_pred             EEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC---ChHHHHHHH
Confidence            99999999987643322   2235689999999998765 4899999999999999999999997532   222223332


Q ss_pred             HHHHhcCc------------eeeee-------cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          762 WRLWKEGK------------VLEMV-------DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       762 ~~~~~~~~------------~~~~i-------d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .+......            .....       ...........+.++.+|+.+||+.||++|||+.|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            22211100            00000       000112223356789999999999999999999999963

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5e-36  Score=341.30  Aligned_cols=257  Identities=23%  Similarity=0.320  Sum_probs=194.8

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCC------ceE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD------EKM  614 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~------~~~  614 (862)
                      .+|+..++||+|+||.||+|+... ++.||||++....    +.+.+|++++++++||||+++++++....      ..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            468889999999999999999864 8999999986542    23457999999999999999999986422      257


Q ss_pred             EEEEeccCCChhhhhhh-ccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC-CCeeEeccccee
Q 002969          615 LVYEYMENRSLDSVIFD-KARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMAR  692 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~  692 (862)
                      +||||+++ +|.+++.. ......+++..+..++.||++||+|||+.+   |+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999986 56555533 223456899999999999999999999998   9999999999999965 568999999998


Q ss_pred             ecCCCCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc--
Q 002969          693 IFGGDQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK--  769 (862)
Q Consensus       693 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--  769 (862)
                      .+.....   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..   ....+.+..+.+......  
T Consensus       206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~---~~~~~~l~~i~~~lg~p~~~  279 (420)
T 1j1b_A          206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG---DSGVDQLVEIIKVLGTPTRE  279 (420)
T ss_dssp             ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHHHCSCCHH
T ss_pred             hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHHhCCCCHH
Confidence            7643322   2235789999999999765 789999999999999999999999643   222233333332221110  


Q ss_pred             --------eeeeecccCCC------CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          770 --------VLEMVDSSVDN------YPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       770 --------~~~~id~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                              ..+..-+.+..      ++...+.++.+|+.+||+.||++||++.|+++
T Consensus       280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                    00100011111      12234568899999999999999999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6.4e-36  Score=334.87  Aligned_cols=257  Identities=23%  Similarity=0.300  Sum_probs=190.6

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCC------
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD------  611 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~------  611 (862)
                      .++|+..+.||+|+||.||+|+.. .++.||||++...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            367999999999999999999865 4888999999754  2334567889999999999999999999997665      


Q ss_pred             ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccce
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  691 (862)
                      ..++||||+++ +|.+++.     ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            67999999985 6777773     23889999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH------
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW------  765 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~------  765 (862)
                      +.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||...   +.......+.+..      
T Consensus       175 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i~~~~~~~~~~  248 (371)
T 2xrw_A          175 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT---DHIDQWNKVIEQLGTPCPE  248 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHC-CCCCCHH
T ss_pred             cccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCCHH
Confidence            865322   1223357899999999999999999999999999999999999997532   1111111111100      


Q ss_pred             -------------hcCcee------eeecccC-CC---CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          766 -------------KEGKVL------EMVDSSV-DN---YPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       766 -------------~~~~~~------~~id~~~-~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                                   ......      +...... ..   ........+.+|+.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                         000000      0000000 00   01123567889999999999999999999997

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=8e-36  Score=333.18  Aligned_cols=261  Identities=22%  Similarity=0.332  Sum_probs=201.4

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeC-----Cce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-----DEK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~  613 (862)
                      .++|+..++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457999999999999999999875 47889999997543 33457889999999999999999999999765     368


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++|+||++ ++|.+++...    .+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999998 5898888542    4899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc-cccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          694 FGGDQTE-QNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       694 ~~~~~~~-~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      ....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+....   ....+..+..........
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~  254 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH---YLDQLNHILGILGSPSQE  254 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS---GGGHHHHHHHHHCSCCHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC---hHHHHHHHHHHhCCCCHH
Confidence            6433221 11234578999999998765 458999999999999999999999975332   222333332221111000


Q ss_pred             e-----------eeccc--CC-----CCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 E-----------MVDSS--VD-----NYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 ~-----------~id~~--~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .           .....  ..     ......+.++.+|+.+||+.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0           00000  00     011233567889999999999999999999996

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1e-35  Score=330.25  Aligned_cols=261  Identities=22%  Similarity=0.298  Sum_probs=199.1

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeC-----Cce
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-----DEK  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~  613 (862)
                      .++|+..+.||+|+||.||+|+.. +++.||||++.... .....++.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467999999999999999999876 48899999996543 33456788999999999999999999998764     678


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++|+||++ ++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 589888854    24899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCccc--------ccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHH
Q 002969          694 FGGDQTEQ--------NTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL  764 (862)
Q Consensus       694 ~~~~~~~~--------~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~  764 (862)
                      +.......        ......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+....   .......+...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~  238 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD---YRHQLLLIFGI  238 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHH
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHH
Confidence            64322111        1223478999999998765 678999999999999999999999975322   11222222211


Q ss_pred             HhcCcee------------eeecc-------cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          765 WKEGKVL------------EMVDS-------SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       765 ~~~~~~~------------~~id~-------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .......            +.+..       .........+.++.+++.+||+.||++||++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1110000            00000       000011234567889999999999999999999987

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.5e-35  Score=320.86  Aligned_cols=252  Identities=24%  Similarity=0.411  Sum_probs=193.9

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEe----------
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE----------  609 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----------  609 (862)
                      .++|+..+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            457899999999999999999875 5889999999643 3446788999999999999999999999865          


Q ss_pred             ---CCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEe
Q 002969          610 ---MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS  686 (862)
Q Consensus       610 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~  686 (862)
                         .+..++||||+++++|.+++...  ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence               35679999999999999999643  234788899999999999999999998   9999999999999999999999


Q ss_pred             cccceeecCCCCc------------ccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCc
Q 002969          687 DFGMARIFGGDQT------------EQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN  753 (862)
Q Consensus       687 DFGla~~~~~~~~------------~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~  753 (862)
                      |||++........            ........|++.|+|||++.+. .++.++||||||+++|||++   |+.  ...+
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~--~~~~  233 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS--TGME  233 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS--SHHH
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC--Cchh
Confidence            9999987643211            1122345689999999999865 78999999999999999998   321  1111


Q ss_pred             chhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          754 ELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       754 ~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..    .....+.....     ......+...+..+.+++.+||+.||++||++.|+++
T Consensus       234 ~~----~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 RV----NILKKLRSVSI-----EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HH----HHHHHHHSTTC-----CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HH----HHHHhcccccc-----ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            11    11122221110     1112334455667889999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.8e-36  Score=337.07  Aligned_cols=257  Identities=25%  Similarity=0.360  Sum_probs=184.8

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeC------C
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM------D  611 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~------~  611 (862)
                      .++|+..+.||+|+||.||+|+.. +++.||||++...  .....+++.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            468999999999999999999864 4889999999654  233456888999999999999999999998754      5


Q ss_pred             ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccce
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  691 (862)
                      ..++|+|++ +++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 6899988843    34899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV  770 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  770 (862)
                      +.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..   .+....+..+.+.......
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~---~~~~~~l~~i~~~~g~p~~  251 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG---TDHIDQLKLILRLVGTPGA  251 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHHHHCSCCH
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHHHhCCCCH
Confidence            865321     233578999999999987 6789999999999999999999999743   2222333333322211100


Q ss_pred             -----------eeeecc--cCCC-----CChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          771 -----------LEMVDS--SVDN-----YPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       771 -----------~~~id~--~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                                 ...+..  ....     ........+.+|+.+||+.||++|||+.|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                       000000  0000     011234568899999999999999999999863

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.5e-35  Score=329.58  Aligned_cols=260  Identities=20%  Similarity=0.296  Sum_probs=200.5

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcc-----------cCCceEEEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-----------HRNLVRLLGCCVE  609 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~g~~~~  609 (862)
                      ++|+..++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            57999999999999999999874 5889999999643 334567889999999987           8999999999986


Q ss_pred             CC----ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc-CCCcEEecccCCcceEec------
Q 002969          610 MD----EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLD------  678 (862)
Q Consensus       610 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivHrDlkp~NILl~------  678 (862)
                      .+    ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+. +   |+||||||+|||++      
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence            54    689999999 899999986533 23489999999999999999999998 7   99999999999994      


Q ss_pred             CCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc---ch
Q 002969          679 KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN---EL  755 (862)
Q Consensus       679 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~---~~  755 (862)
                      ..+.+||+|||++......     .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......   ..
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence            4448999999999876422     223478999999999999999999999999999999999999986433221   11


Q ss_pred             hHHHHHHHHHhcCc------------------eeeeec-----------ccCCCCChHHHHHHHHHHHhccccCCCCCCC
Q 002969          756 NLLGHVWRLWKEGK------------------VLEMVD-----------SSVDNYPANEVLRCIHVGLLCVQENAEERPT  806 (862)
Q Consensus       756 ~l~~~~~~~~~~~~------------------~~~~id-----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt  806 (862)
                      ..+..+........                  ....+.           ......+.....++.+|+.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            22222222111100                  000000           0011345667888999999999999999999


Q ss_pred             HHHHHH
Q 002969          807 MASVVL  812 (862)
Q Consensus       807 ~~evl~  812 (862)
                      +.||++
T Consensus       328 ~~ell~  333 (373)
T 1q8y_A          328 AGGLVN  333 (373)
T ss_dssp             HHHHHT
T ss_pred             HHHHhh
Confidence            999997

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.6e-36  Score=328.57  Aligned_cols=260  Identities=22%  Similarity=0.364  Sum_probs=194.0

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEE------------
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV------------  608 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~------------  608 (862)
                      ++|+..++||+|+||.||+|+... ++.||||++........+++.+|++++++++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            578999999999999999998865 8899999998776667788999999999999999999999873            


Q ss_pred             --eCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec-CCCCeeE
Q 002969          609 --EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-KEMTPKI  685 (862)
Q Consensus       609 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL  685 (862)
                        +....++||||++ ++|.+++..    ..+++..+..++.||++||+|||+.+   |+||||||+|||++ +++.+||
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence              3467899999998 699998843    34889999999999999999999998   99999999999997 5679999


Q ss_pred             ecccceeecCCCCc-ccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHH
Q 002969          686 SDFGMARIFGGDQT-EQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR  763 (862)
Q Consensus       686 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~  763 (862)
                      +|||+++....... ........++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....   .......+..
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---~~~~~~~~~~  239 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH---ELEQMQLILE  239 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHH
Confidence            99999987643221 122233467899999998876 678999999999999999999999975322   1122222111


Q ss_pred             HHhcC----------ceeeeecccC-------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          764 LWKEG----------KVLEMVDSSV-------DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       764 ~~~~~----------~~~~~id~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .....          .....+....       .......+.++.+++.+||+.||++||++.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            10000          0000000000       0111234567889999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-35  Score=337.32  Aligned_cols=266  Identities=22%  Similarity=0.322  Sum_probs=184.4

Q ss_pred             ccccc-cceeeccccEEEEEeEec---CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEe--CCceEE
Q 002969          542 DNFTD-YNKLGQGGFGIVYKGRLL---EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE--MDEKML  615 (862)
Q Consensus       542 ~~f~~-~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~l  615 (862)
                      +.|+. .++||+|+||.||+|+..   +++.||||++....  ..+.+.+|+.++++++||||+++++++..  ....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34555 468999999999999865   47789999996542  33578899999999999999999999965  667899


Q ss_pred             EEEeccCCChhhhhhhcc------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe----cCCCCeeE
Q 002969          616 VYEYMENRSLDSVIFDKA------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL----DKEMTPKI  685 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kL  685 (862)
                      ||||+++ +|.+++....      ....+++..+..|+.||+.||+|||+.+   |+||||||+||||    +.++.+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999975 7777764321      1224899999999999999999999998   9999999999999    67889999


Q ss_pred             ecccceeecCCCCc-ccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCC------cchhH
Q 002969          686 SDFGMARIFGGDQT-EQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSN------NELNL  757 (862)
Q Consensus       686 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~------~~~~l  757 (862)
                      +|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||......      ...+.
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            99999987643221 1223346789999999999874 5899999999999999999999998533221      11122


Q ss_pred             HHHHHHHHhcCcee--eee--------------cccCCC---------CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          758 LGHVWRLWKEGKVL--EMV--------------DSSVDN---------YPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       758 ~~~~~~~~~~~~~~--~~i--------------d~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      +..+...+......  +.+              ......         ........+.+|+.+||+.||++|||++|+++
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            23332222111000  000              000000         00111446789999999999999999999997


Q ss_pred             H
Q 002969          813 M  813 (862)
Q Consensus       813 ~  813 (862)
                      .
T Consensus       334 h  334 (405)
T 3rgf_A          334 D  334 (405)
T ss_dssp             S
T ss_pred             C
Confidence            3

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.2e-35  Score=332.75  Aligned_cols=256  Identities=21%  Similarity=0.330  Sum_probs=196.6

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCce----
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEK----  613 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~----  613 (862)
                      .++|...++||+|+||.||+|+.. +++.||||++....  ....+++.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467889999999999999999875 48899999997643  33457889999999999999999999999877655    


Q ss_pred             --EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccce
Q 002969          614 --MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (862)
Q Consensus       614 --~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  691 (862)
                        ++||||++ ++|.+++.     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999998 57877762     23899999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV  770 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  770 (862)
                      +.....     .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...   +....+..+.+.......
T Consensus       192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i~~~~~~~~~  263 (371)
T 4exu_A          192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK---DYLDQLTQILKVTGVPGT  263 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCH
T ss_pred             cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCcH
Confidence            865322     223568999999999987 68899999999999999999999997432   222222222221111000


Q ss_pred             --------------eeeeccc----CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          771 --------------LEMVDSS----VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       771 --------------~~~id~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                                    .+.+...    ........+..+.+|+.+||+.||++|||+.|+++.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                          0000000    001112345678899999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.8e-35  Score=327.24  Aligned_cols=254  Identities=21%  Similarity=0.323  Sum_probs=197.5

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCc------
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE------  612 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~------  612 (862)
                      ++|...+.||+|+||.||+|+.. +++.||||++....  ....+++.+|+.++++++||||+++++++...+.      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            57888999999999999999875 48899999996542  2345678999999999999999999999987654      


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      .++||||++ ++|.+++.     ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence            499999998 58887763     23899999999999999999999998   9999999999999999999999999997


Q ss_pred             ecCCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc--
Q 002969          693 IFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK--  769 (862)
Q Consensus       693 ~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--  769 (862)
                      .....     .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.|+...   +....+..+.+......  
T Consensus       175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~---~~~~~~~~i~~~~~~~~~~  246 (353)
T 3coi_A          175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK---DYLDQLTQILKVTGVPGTE  246 (353)
T ss_dssp             C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS---CHHHHHHHHHHHHCBCCHH
T ss_pred             CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCCHH
Confidence            64321     223578999999999887 67899999999999999999999997532   22222222222111000  


Q ss_pred             ----------------eeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          770 ----------------VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       770 ----------------~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                                      ................+..+.+++.+||+.||++||++.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                            0000011112233455678899999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.1e-36  Score=325.39  Aligned_cols=242  Identities=26%  Similarity=0.399  Sum_probs=192.1

Q ss_pred             HHcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc------cchHHHHHHHHHHHhc----ccCCceEEEEEE
Q 002969          539 RATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG------QGIEEFKNEVRLIAKL----QHRNLVRLLGCC  607 (862)
Q Consensus       539 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~HpnIv~l~g~~  607 (862)
                      ...++|+..++||+|+||.||+|+.. +++.||||++.....      .....+.+|+.++.++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            34578999999999999999999864 588999999965432      2344677899999999    899999999999


Q ss_pred             EeCCceEEEEEe-ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec-CCCCeeE
Q 002969          608 VEMDEKMLVYEY-MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-KEMTPKI  685 (862)
Q Consensus       608 ~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL  685 (862)
                      ...+..++|+|+ +++++|.+++....   .+++..+..++.||++||+|||+.+   |+||||||+||+++ .++.+||
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence            999999999999 78999999996543   4899999999999999999999998   99999999999999 8899999


Q ss_pred             ecccceeecCCCCcccccccccccccccChhhhcCCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHH
Q 002969          686 SDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFS-VKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL  764 (862)
Q Consensus       686 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~  764 (862)
                      +|||++.......    .....|+..|+|||++.+..+. .++||||||+++|||++|+.|+...     .    ..   
T Consensus       182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~----~~---  245 (312)
T 2iwi_A          182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----Q----EI---  245 (312)
T ss_dssp             CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----H----HH---
T ss_pred             EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-----H----HH---
Confidence            9999998764322    2235689999999999877664 5899999999999999999996421     0    00   


Q ss_pred             HhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       765 ~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      . ..         ....+......+.+++.+||+.+|++||++.|+++
T Consensus       246 ~-~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          246 L-EA---------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             H-HT---------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             h-hh---------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0 00         01223345567889999999999999999999997

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.6e-35  Score=316.38  Aligned_cols=251  Identities=27%  Similarity=0.327  Sum_probs=201.9

Q ss_pred             HcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ..++|+..++||+|+||.||+|+.. +++.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3468999999999999999999876 58899999986542  34567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC---CCeeEecccceee
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE---MTPKISDFGMARI  693 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kL~DFGla~~  693 (862)
                      +||+++++|.+++....   .+++.++..++.||++||+|||+.+   ++||||||+||+++.+   +.+||+|||++..
T Consensus       100 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            99999999999886543   4899999999999999999999998   9999999999999754   4799999999986


Q ss_pred             cCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeee
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  773 (862)
                      ......   .....+++.|+|||.+.+ .++.++||||||+++|||++|+.|+...   .....    ...+..+.....
T Consensus       174 ~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~----~~~~~~~~~~~~  242 (287)
T 2wei_A          174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK---NEYDI----LKRVETGKYAFD  242 (287)
T ss_dssp             BCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHH----HHHHHHCCCCCC
T ss_pred             ecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC---CHHHH----HHHHHcCCCCCC
Confidence            543221   223458999999998875 4899999999999999999999996432   11122    122222211100


Q ss_pred             ecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       774 id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      . +    .....+.++.+++.+||+.+|++||++.|+++
T Consensus       243 ~-~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          243 L-P----QWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             S-G----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             c-h----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            0 0    01233567889999999999999999999997

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.2e-34  Score=325.95  Aligned_cols=261  Identities=22%  Similarity=0.277  Sum_probs=200.1

Q ss_pred             HcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcc-cC-----CceEEEEEEEeCCc
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HR-----NLVRLLGCCVEMDE  612 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-Hp-----nIv~l~g~~~~~~~  612 (862)
                      ..++|+..++||+|+||.||+|+.. +++.||||+++.. ....+++..|+++++.++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            3568999999999999999999876 4788999999643 334567888999999885 45     49999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec--CCCCeeEecccc
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD--KEMTPKISDFGM  690 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kL~DFGl  690 (862)
                      .++||||++ ++|.+++..... ..+++..+..++.||+.||+|||.+. .+|+||||||+||||+  .++.+||+|||+
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             eEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            999999996 599999865432 34899999999999999999999531 2499999999999995  478899999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc-
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK-  769 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-  769 (862)
                      ++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...   .....+..+.+...... 
T Consensus       208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~---~~~~~~~~i~~~~~~~~~  279 (382)
T 2vx3_A          208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA---NEVDQMNKIVEVLGIPPA  279 (382)
T ss_dssp             CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCSCCH
T ss_pred             ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCCH
Confidence            9876432     22357899999999999999999999999999999999999997532   22223333322211000 


Q ss_pred             -----------eeeee-cc----------c----------------------------CCCCChHHHHHHHHHHHhcccc
Q 002969          770 -----------VLEMV-DS----------S----------------------------VDNYPANEVLRCIHVGLLCVQE  799 (862)
Q Consensus       770 -----------~~~~i-d~----------~----------------------------~~~~~~~~~~~l~~li~~cl~~  799 (862)
                                 ..+.+ +.          .                            .......+...+.+|+.+||+.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence                       00000 00          0                            0001123345789999999999


Q ss_pred             CCCCCCCHHHHHH
Q 002969          800 NAEERPTMASVVL  812 (862)
Q Consensus       800 dP~~RPt~~evl~  812 (862)
                      ||++|||+.|+++
T Consensus       360 dP~~Rpta~e~L~  372 (382)
T 2vx3_A          360 DPKTRIQPYYALQ  372 (382)
T ss_dssp             CTTTSCCHHHHTT
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.3e-35  Score=326.00  Aligned_cols=253  Identities=23%  Similarity=0.353  Sum_probs=178.4

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHH-HHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVR-LIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ++|+..+.||+|+||.||+|+.. +++.||||++.... .....++..|+. +++.++||||+++++++.+.+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            57888899999999999999885 58899999997653 233445666666 6777899999999999999999999999


Q ss_pred             eccCCChhhhhhhc--cCCCCCCHhhHHHHHHHHHHHhHHhhhc-CCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          619 YMENRSLDSVIFDK--ARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       619 ~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      |+++ +|.+++...  .....+++..+..++.|+++||.|||+. +   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            9985 787777431  2245689999999999999999999998 7   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccChhhh----cCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYA----MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l----~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      ...   ......||+.|+|||++    .+..++.++||||||+++|||++|+.|+........     ..    .  ...
T Consensus       178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~----~--~~~  243 (327)
T 3aln_A          178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QL----T--QVV  243 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------C--CCC
T ss_pred             ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HH----H--HHh
Confidence            322   12234689999999998    456789999999999999999999999753221100     00    0  000


Q ss_pred             eeecccC-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 EMVDSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 ~~id~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ....+.+ .......+..+.+++.+||+.||++||++.||++
T Consensus       244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            0000111 1112335667889999999999999999999974

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.9e-34  Score=319.71  Aligned_cols=257  Identities=19%  Similarity=0.249  Sum_probs=199.2

Q ss_pred             ccccccceeeccccEEEEEeEecC-C-cEEEEEEeccCCccchHHHHHHHHHHHhcccCC------ceEEEEEEEeCCce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-G-QEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN------LVRLLGCCVEMDEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l~g~~~~~~~~  613 (862)
                      ++|+..++||+|+||.||+|+... + +.||||+++.. ....+.+.+|+.++++++|++      ++.+++++...+..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            689999999999999999998753 4 68999999643 344577889999999998776      99999999999999


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe----------------
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL----------------  677 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl----------------  677 (862)
                      ++||||+ +++|.+++.... ...+++.++..++.||++||+|||+.+   |+||||||+|||+                
T Consensus        98 ~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence            9999999 567767664432 235899999999999999999999998   9999999999999                


Q ss_pred             ---cCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcc
Q 002969          678 ---DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE  754 (862)
Q Consensus       678 ---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~  754 (862)
                         +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.|+.....   
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---  244 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN---  244 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---
T ss_pred             ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---
Confidence               56789999999999864322     2235789999999999999999999999999999999999999753222   


Q ss_pred             hhHHHHHHHHHhcC--------ceeee-ec----------------------ccCCCCChHHHHHHHHHHHhccccCCCC
Q 002969          755 LNLLGHVWRLWKEG--------KVLEM-VD----------------------SSVDNYPANEVLRCIHVGLLCVQENAEE  803 (862)
Q Consensus       755 ~~l~~~~~~~~~~~--------~~~~~-id----------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~  803 (862)
                      ......+.+.....        ..... ..                      .........+...+.+|+.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            12222221111100        00000 00                      0001122344668889999999999999


Q ss_pred             CCCHHHHHH
Q 002969          804 RPTMASVVL  812 (862)
Q Consensus       804 RPt~~evl~  812 (862)
                      |||+.|+++
T Consensus       325 Rpt~~e~l~  333 (355)
T 2eu9_A          325 RITLAEALL  333 (355)
T ss_dssp             SCCHHHHTT
T ss_pred             CcCHHHHhc
Confidence            999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.3e-35  Score=325.53  Aligned_cols=241  Identities=24%  Similarity=0.362  Sum_probs=198.8

Q ss_pred             HcccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCcc------chHHHHHHHHHHHhcc--cCCceEEEEEEEeC
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQ------GIEEFKNEVRLIAKLQ--HRNLVRLLGCCVEM  610 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--HpnIv~l~g~~~~~  610 (862)
                      ..++|+..++||+|+||.||+|+.. +++.||||++......      ..+.+.+|+.++++++  |+||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            4567999999999999999999864 5889999999754321      2356788999999996  59999999999999


Q ss_pred             CceEEEEEeccC-CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec-CCCCeeEecc
Q 002969          611 DEKMLVYEYMEN-RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-KEMTPKISDF  688 (862)
Q Consensus       611 ~~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL~DF  688 (862)
                      +..++|+|++.+ ++|.+++...   ..+++..+..++.||++||+|||+.+   |+||||||+|||++ +++.+||+||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred             CcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            999999999986 8999998653   34899999999999999999999998   99999999999999 7899999999


Q ss_pred             cceeecCCCCcccccccccccccccChhhhcCCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhc
Q 002969          689 GMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF-SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE  767 (862)
Q Consensus       689 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  767 (862)
                      |+++.+....    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.|+...     .    ..   .. 
T Consensus       195 g~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~-----~----~~---~~-  257 (320)
T 3a99_A          195 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----E----EI---IR-  257 (320)
T ss_dssp             TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----H----HH---HH-
T ss_pred             cccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh-----h----hh---hc-
Confidence            9998764322    223568999999999987765 68899999999999999999996421     0    00   11 


Q ss_pred             CceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          768 GKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       768 ~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..         ...+...+.++.+++.+||+.||++||++.||++
T Consensus       258 ~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          258 GQ---------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             CC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cc---------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            10         1122334567889999999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.9e-35  Score=334.60  Aligned_cols=252  Identities=24%  Similarity=0.297  Sum_probs=187.1

Q ss_pred             cccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEEecc
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      .|...++||+|+||+||.+...+++.||||++...   ..+.+.+|+.+++++ +||||+++++++.+.+..++||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            45556889999999998776678999999998653   245678999999987 89999999999999999999999996


Q ss_pred             CCChhhhhhhccCCC----CCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC-------------CCee
Q 002969          622 NRSLDSVIFDKARSS----ILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-------------MTPK  684 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-------------~~~k  684 (862)
                       |+|.+++.......    ...+..++.++.||+.||+|||+.+   |+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             69999996543221    1244566789999999999999998   9999999999999654             4899


Q ss_pred             EecccceeecCCCCccc--ccccccccccccChhhhcC-------CCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcc
Q 002969          685 ISDFGMARIFGGDQTEQ--NTKRVVGTYGYMSPEYAMD-------GLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNE  754 (862)
Q Consensus       685 L~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~-------~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~  754 (862)
                      |+|||+++.+.......  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.|+....... 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            99999999875432211  2234579999999999976       678999999999999999999 888874322111 


Q ss_pred             hhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          755 LNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       755 ~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                          ..+   .......   ...........+.++.+++.+||+.||++||++.||++
T Consensus       248 ----~~i---~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 ----SNI---IRGIFSL---DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ----HHH---HHTCCCC---CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HHH---hcCCCCc---ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                111   1111000   00011123456778999999999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.8e-35  Score=322.59  Aligned_cols=252  Identities=20%  Similarity=0.206  Sum_probs=173.1

Q ss_pred             cccccccc-eeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEe----CCceE
Q 002969          541 TDNFTDYN-KLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE----MDEKM  614 (862)
Q Consensus       541 ~~~f~~~~-~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----~~~~~  614 (862)
                      .++|...+ +||+|+||.||+|+.. +++.||||++....    ....+....++.++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            45788854 6999999999999876 48999999996431    222233334566799999999999876    44589


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC---CCCeeEecccce
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---EMTPKISDFGMA  691 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DFGla  691 (862)
                      +||||+++|+|.+++.... ...+++.++..++.||++||+|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus       103 lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            9999999999999996543 245899999999999999999999998   999999999999976   456999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      +.....    ......||+.|+|||++.+..++.++||||||+++|||++|+.|+........   ...........   
T Consensus       179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~---  248 (336)
T 3fhr_A          179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI---SPGMKRRIRLG---  248 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh---hhhHHHhhhcc---
Confidence            865322    22235689999999999888899999999999999999999999753222111   00000000000   


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       . ...........+..+.+++.+||+.||++||++.|+++
T Consensus       249 -~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          249 -Q-YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -c-cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             0 00001112345667889999999999999999999997

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.5e-35  Score=331.63  Aligned_cols=250  Identities=21%  Similarity=0.289  Sum_probs=187.6

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ..+|...++||+|+||+|+.....+++.||||++....   .+.+.+|+++++++ +||||+++++++.+....++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            34688889999999999765556679999999996543   23467899999999 799999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC-----CCCeeEecccceeec
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-----EMTPKISDFGMARIF  694 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-----~~~~kL~DFGla~~~  694 (862)
                      ++ |+|.+++....  ..+.+..+..++.||++||+|||+.+   |+||||||+||||+.     ...+||+|||+++.+
T Consensus       100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            97 59999986433  23455667889999999999999998   999999999999943     336889999999876


Q ss_pred             CCCCc-ccccccccccccccChhhhc---CCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCc
Q 002969          695 GGDQT-EQNTKRVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGK  769 (862)
Q Consensus       695 ~~~~~-~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  769 (862)
                      ..... ........||+.|+|||++.   ...++.++|||||||++|||++ |..|+......    .   . .......
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----~---~-~~~~~~~  245 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----Q---A-NILLGAC  245 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----H---H-HHHTTCC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----H---H-HHHhccC
Confidence            43321 12233467999999999997   4567889999999999999999 88886422111    1   1 0111100


Q ss_pred             eeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          770 VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       770 ~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                           ..............+.+|+.+||+.||++||++.||++
T Consensus       246 -----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          246 -----SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             -----CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                 00111123345566789999999999999999999984

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.7e-34  Score=313.75  Aligned_cols=251  Identities=22%  Similarity=0.348  Sum_probs=179.4

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCcc--chHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQ--GIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      .++|+..+.||+|+||.||+|+.. +++.||||++......  ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            357888999999999999999886 5889999999765322  2334555556788889999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc-CCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      ||+ ++.+..+....  ...+++..+..++.||++||+|||+. +   |+||||||+|||++.++.+||+|||++..+..
T Consensus       104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 44555544322  34589999999999999999999985 7   99999999999999999999999999976543


Q ss_pred             CCcccccccccccccccChhhhc-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAM-----DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      ..   ......|++.|+|||++.     ...++.++||||||+++|||++|+.|+.....  .......   ...... .
T Consensus       178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~---~~~~~~-~  248 (318)
T 2dyl_A          178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTK---VLQEEP-P  248 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHH---HHHSCC-C
T ss_pred             Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHH---HhccCC-C
Confidence            22   122356899999999994     45688999999999999999999999753221  1112111   111111 0


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                           .. ......+.++.+++.+||+.||++||++.|+++
T Consensus       249 -----~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          249 -----LL-PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -----CC-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -----CC-CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                 00 111234567889999999999999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7e-35  Score=343.94  Aligned_cols=260  Identities=25%  Similarity=0.315  Sum_probs=198.6

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEe------CCce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE------MDEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------~~~~  613 (862)
                      ++|+..++||+|+||.||+|... +++.||||+++.. .....+.+.+|++++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            67999999999999999999875 4889999998764 34456789999999999999999999999765      6678


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCC---eeEecccc
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMT---PKISDFGM  690 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kL~DFGl  690 (862)
                      ++||||+++++|.+++........+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence            999999999999999976555556899999999999999999999998   999999999999997765   99999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhc-Cc
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE-GK  769 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~  769 (862)
                      +.......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||......  ............. ..
T Consensus       171 a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~--~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          171 AKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP--VQWHGKVREKSNEHIV  245 (676)
T ss_dssp             CCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH--HHSSTTCC------CC
T ss_pred             cccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch--hhhhhhhhcccchhhh
Confidence            98764322   223457899999999999999999999999999999999999997432100  0000000000000 00


Q ss_pred             eeee------ec---ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHH
Q 002969          770 VLEM------VD---SSVDNYPANEVLRCIHVGLLCVQENAEERPTMAS  809 (862)
Q Consensus       770 ~~~~------id---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e  809 (862)
                      ..+.      ..   +.........+..+.+++.+||+.||++||++.|
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            0000      00   1112345567888999999999999999999976

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.1e-33  Score=305.10  Aligned_cols=228  Identities=11%  Similarity=0.042  Sum_probs=183.3

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCc---cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+..++||+|+||.||+|+... ++.||||++.....   ...+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            579999999999999999998865 88999999976532   33578999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++++|.+++...     ....++.+|+.||++||+|||+.+   |+||||||+|||++.++.+||++++        
T Consensus       111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence            999999999998431     345578899999999999999998   9999999999999999999998543        


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                                    |++       .++.++||||||+++|||++|+.||......+....            ....+...
T Consensus       175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~~~  221 (286)
T 3uqc_A          175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDTAGQ  221 (286)
T ss_dssp             --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCTTSC
T ss_pred             --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHhccC
Confidence                          333       368899999999999999999999764322211000            00000000


Q ss_pred             C---CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          778 V---DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       778 ~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                      .   .......+.++.+++.+||+.||++| |+.|+++.|+....
T Consensus       222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            0   01123345678899999999999999 99999999988643

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.3e-33  Score=340.91  Aligned_cols=237  Identities=20%  Similarity=0.285  Sum_probs=191.1

Q ss_pred             ccccccceeeccccEEEEEeEec--CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCc-----e
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL--EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE-----K  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-----~  613 (862)
                      ++|++.++||+|+||.||+|+..  +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            67999999999999999999875  58899999986543 3445678999999999999999999999988766     6


Q ss_pred             EEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          614 MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ++||||+++++|.+++..     .+++.+++.++.||++||.|||+.+   |+||||||+|||++.+ .+||+|||+++.
T Consensus       160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence            999999999999987632     5899999999999999999999998   9999999999999886 999999999987


Q ss_pred             cCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeee
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  773 (862)
                      ....      ....||+.|+|||++.+.. +.++|||||||++|||++|..|+.......                    
T Consensus       231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------------  283 (681)
T 2pzi_A          231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------------  283 (681)
T ss_dssp             TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------------
T ss_pred             cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc--------------------
Confidence            6432      3357899999999987664 899999999999999999988753211000                    


Q ss_pred             ecccCCCCChHHHHHHHHHHHhccccCCCCCCC-HHHHHHHhcc
Q 002969          774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPT-MASVVLMLSS  816 (862)
Q Consensus       774 id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L~~  816 (862)
                      +..  ..........+.+++.+||+.||++||+ ++++...|..
T Consensus       284 ~~~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          284 LPE--DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             CCT--TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ccc--cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            000  0001123356889999999999999995 6666665554

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.1e-32  Score=299.03  Aligned_cols=226  Identities=21%  Similarity=0.254  Sum_probs=178.2

Q ss_pred             cccccc-ceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHH-HhcccCCceEEEEEEEe----CCceE
Q 002969          542 DNFTDY-NKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLI-AKLQHRNLVRLLGCCVE----MDEKM  614 (862)
Q Consensus       542 ~~f~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~HpnIv~l~g~~~~----~~~~~  614 (862)
                      ++|... +.||+|+||.||+++.. +++.||||++..     ...+.+|+.++ +.++||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456666 77999999999999874 588999999954     34677899988 55589999999999987    67789


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC---CCCeeEecccce
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---EMTPKISDFGMA  691 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DFGla  691 (862)
                      +||||+++++|.+++.... ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            9999999999999996543 235899999999999999999999998   999999999999998   789999999998


Q ss_pred             eecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      ....                        +..++.++||||||+++|||++|+.|+........           . ....
T Consensus       168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~-~~~~  211 (299)
T 3m2w_A          168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------S-PGMK  211 (299)
T ss_dssp             EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCSC
T ss_pred             cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------h-HHHH
Confidence            7542                        13457789999999999999999999743221110           0 0001


Q ss_pred             eeecccCCCCC----hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 EMVDSSVDNYP----ANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 ~~id~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..+.......+    ...+.++.+++.+||+.||++||++.|+++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            11111111112    234567889999999999999999999997

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-33  Score=319.43  Aligned_cols=241  Identities=16%  Similarity=0.168  Sum_probs=177.7

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhccc-CCc---------e-----
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQH-RNL---------V-----  601 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H-pnI---------v-----  601 (862)
                      +..|...++||+|+||.||+|+.. +++.||||++....   ....+.+.+|+.+++.++| +|.         +     
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345777889999999999999854 58999999987432   2346789999999999977 221         1     


Q ss_pred             -------EEEEEEEe-----CCceEEEEEeccCCChhhhhhh----ccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcE
Q 002969          602 -------RLLGCCVE-----MDEKMLVYEYMENRSLDSVIFD----KARSSILNWQRRFNIICGIARGLLYLHQDSRFRI  665 (862)
Q Consensus       602 -------~l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~i  665 (862)
                             .+..++..     ....+++|+++ +++|.+++..    ......+++..++.++.||++||+|||+.+   |
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence                   11111111     12345666654 6899988842    122345888999999999999999999998   9


Q ss_pred             EecccCCcceEecCCCCeeEecccceeecCCCCcccccccccccccccChhhh----------cCCCCCccccchhHHHH
Q 002969          666 IHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA----------MDGLFSVKSDVFSFGVL  735 (862)
Q Consensus       666 vHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l----------~~~~~s~ksDVwSlGvi  735 (862)
                      +||||||+||||+.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999999865322     334567 999999999          55568899999999999


Q ss_pred             HHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 002969          736 LLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV  811 (862)
Q Consensus       736 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  811 (862)
                      +|||++|+.|+.........                +.+-....    ..+..+.+|+.+||+.||++||++.|++
T Consensus       307 l~elltg~~Pf~~~~~~~~~----------------~~~~~~~~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGS----------------EWIFRSCK----NIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCS----------------GGGGSSCC----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHCCCCCCCcchhhhH----------------HHHHhhcc----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999997532211110                00000111    2346788999999999999999976664

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.98  E-value=5.4e-32  Score=298.60  Aligned_cols=242  Identities=14%  Similarity=0.121  Sum_probs=186.0

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccCC--------ccchHHHHHHHHHHHhcc---------cCCceEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS--------GQGIEEFKNEVRLIAKLQ---------HRNLVRL  603 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------HpnIv~l  603 (862)
                      .++|+..++||+|+||.||+|+. +++.||||++....        ....+.+.+|+.++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            45789999999999999999987 78999999997642        223478999999999996         8899888


Q ss_pred             EEEEE------------------------------eCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHH
Q 002969          604 LGCCV------------------------------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG  653 (862)
Q Consensus       604 ~g~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~g  653 (862)
                      .+.+.                              ..+..++||||+++|++.+.+.+    ..+++.++..++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            88753                              26789999999999977666632    348999999999999999


Q ss_pred             hHHhh-hcCCCcEEecccCCcceEecCCC--------------------CeeEecccceeecCCCCcccccccccccccc
Q 002969          654 LLYLH-QDSRFRIIHRDLKASNILLDKEM--------------------TPKISDFGMARIFGGDQTEQNTKRVVGTYGY  712 (862)
Q Consensus       654 L~yLH-~~~~~~ivHrDlkp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y  712 (862)
                      |+||| +.+   |+||||||+||||+.++                    .+||+|||+++.....       ...||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence            99999 888   99999999999999887                    8999999999876421       34799999


Q ss_pred             cChhhhcCCCCCccccchhHHHH-HHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHH
Q 002969          713 MSPEYAMDGLFSVKSDVFSFGVL-LLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIH  791 (862)
Q Consensus       713 ~APE~l~~~~~s~ksDVwSlGvi-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~  791 (862)
                      +|||++.+.. +.++|||||+++ .+++++|..|+..      ..................  ...........+.++.+
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~------~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~d  314 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN------VLWLHYLTDKMLKQMTFK--TKCNTPAMKQIKRKIQE  314 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH------HHHHHHHHHHHHHTCCCS--SCCCSHHHHHHHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc------hhhhhHHHHhhhhhhccC--cccchhhhhhcCHHHHH
Confidence            9999998766 899999998777 7778889888521      000011111111110000  00011123456778999


Q ss_pred             HHHhccccCCCCCCCHHHHH
Q 002969          792 VGLLCVQENAEERPTMASVV  811 (862)
Q Consensus       792 li~~cl~~dP~~RPt~~evl  811 (862)
                      |+.+||+.|     |+.|++
T Consensus       315 li~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          315 FHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHGGGSS-----SHHHHH
T ss_pred             HHHHHhccC-----CHHHHH
Confidence            999999966     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.93  E-value=3.2e-27  Score=277.87  Aligned_cols=185  Identities=17%  Similarity=0.153  Sum_probs=130.7

Q ss_pred             eeeccccEEEEEeEe-cCCcEEEEEEeccCC----------ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEE
Q 002969          549 KLGQGGFGIVYKGRL-LEGQEIAVKRLSRNS----------GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       549 ~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ..+.|++|.+..++. --|+.++||++....          ....++|.+|+++|+++ .|+||+++++++.+....|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            466777777766543 348899999996542          22346799999999999 799999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||++|++|.++|....   .++..   +|+.||++||+|||+++   ||||||||+||||++++.+||+|||+|+.+..
T Consensus       321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            99999999999996543   35543   58999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCC
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKN  745 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p  745 (862)
                      ..  ......+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            32  22334689999999999875 466789999999999888766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.90  E-value=1.3e-24  Score=254.15  Aligned_cols=185  Identities=21%  Similarity=0.247  Sum_probs=146.6

Q ss_pred             cccceeeccccEEEEEeEecCCcEEEEEEeccCCc--------cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG--------QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       545 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ...++||+|+||.||+|+. .++.+++|+......        ...+++.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3457899999999999954 578889988643211        1235689999999999999999777777788888999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++++|.+++..           +..++.||++||+|||+.+   |+||||||+|||++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999843           5689999999999999998   999999999999999  999999999998754


Q ss_pred             CCccc-----ccccccccccccChhhhcC--CCCCccccchhHHHHHHHHHhCCCCC
Q 002969          697 DQTEQ-----NTKRVVGTYGYMSPEYAMD--GLFSVKSDVFSFGVLLLETVSGKKNR  746 (862)
Q Consensus       697 ~~~~~-----~~~~~~gt~~y~APE~l~~--~~~s~ksDVwSlGvil~elltG~~p~  746 (862)
                      .....     ......||+.|||||++..  ..|+.++|+|+..+-..+.+.++.++
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            32211     1235689999999999987  56888899999999999988877764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=9e-22  Score=211.16  Aligned_cols=152  Identities=19%  Similarity=0.138  Sum_probs=121.3

Q ss_pred             HHHHHHcccccccceeeccccEEEEEeEecCCcEEEEEEeccCCc------------------cchHHHHHHHHHHHhcc
Q 002969          535 ETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG------------------QGIEEFKNEVRLIAKLQ  596 (862)
Q Consensus       535 ~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~  596 (862)
                      ..+......|...+.||+|+||.||+|+..+++.||||+++....                  .....+.+|+.++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344555566777799999999999999996789999999964321                  13457899999999999


Q ss_pred             cCCceEEEEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceE
Q 002969          597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNIL  676 (862)
Q Consensus       597 HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NIL  676 (862)
                      |   +++.+++. .+..++||||+++++|.+ +.         ......++.||++||.|||+.+   |+||||||+|||
T Consensus       163 ~---~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL  225 (282)
T 1zar_A          163 G---LAVPKVYA-WEGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL  225 (282)
T ss_dssp             T---SSSCCEEE-EETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred             C---CCcCeEEe-ccceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence            5   44444443 356799999999999988 41         1234579999999999999998   999999999999


Q ss_pred             ecCCCCeeEecccceeecCCCCcccccccccccccccChhhhc
Q 002969          677 LDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM  719 (862)
Q Consensus       677 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~  719 (862)
                      ++ ++.+||+|||+++.               +..++|||++.
T Consensus       226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             EE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             EE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence            99 99999999999874               34578899874

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.79  E-value=6.2e-19  Score=162.46  Aligned_cols=106  Identities=17%  Similarity=0.243  Sum_probs=90.5

Q ss_pred             hhccccCCCCccCCCCEEe--cCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc-eeE
Q 002969           55 ISVDTLTATQNLTYGKTLV--SSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIG  131 (862)
Q Consensus        55 ~~~~~~~~~~~l~~~~~lv--S~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~-~~~  131 (862)
                      ++.|+|++||+|.+|++|+  |++|.|+|+|+++|+     + +||++   +++||+||++.|  +..+.+.+.++ +||
T Consensus         6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~---~~~vW~sn~~~~--~~~~~l~l~~dGNLV   74 (119)
T 1b2p_A            6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN---NNPIWATNTGGL--GNGCRAVLQPDGVLV   74 (119)
T ss_dssp             CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--CSSCEEEECTTSCEE
T ss_pred             ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC---CEEEEeCCCccC--CCceEEEEccCCEEE
Confidence            4569999999999999999  999999999998876     3 68876   799999999977  34578888877 578


Q ss_pred             EEcCCCCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeee
Q 002969          132 LFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQS  175 (862)
Q Consensus       132 l~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqS  175 (862)
                      |+|.++.+||+|++... ....++|+|+|||||++    .++|||
T Consensus        75 l~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~----~~~W~S  115 (119)
T 1b2p_A           75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG----DALWAT  115 (119)
T ss_dssp             EECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE----SEEEEC
T ss_pred             EEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC----ccEeCC
Confidence            88999999999987643 45689999999999987    289998

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.77  E-value=1.8e-18  Score=157.34  Aligned_cols=108  Identities=21%  Similarity=0.390  Sum_probs=91.0

Q ss_pred             ccccCCCCccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc-eeEEEcC
Q 002969           57 VDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDG  135 (862)
Q Consensus        57 ~~~~~~~~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~-~~~l~~~  135 (862)
                      +|+|.+||.|..|++|+ ++|.|+|+|+..|+     | |||+   ..++||.||++.|.  ....+.+.++ +|||+|.
T Consensus         1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~---~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~   68 (110)
T 3a0c_A            1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD---SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQ   68 (110)
T ss_dssp             CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred             CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE---CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECC
Confidence            38999999999999999 99999999998776     3 6786   37999999998763  3467888876 5778898


Q ss_pred             CCCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeeecCCCC
Q 002969          136 SQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPT  180 (862)
Q Consensus       136 ~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~Pt  180 (862)
                      ++.+||+|++... ....++|+|+|||||++.    .+||||+||.
T Consensus        69 ~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~----~~W~S~~~~~  110 (110)
T 3a0c_A           69 SNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP----VVWATGSGPA  110 (110)
T ss_dssp             TCCEEEECCCCCSSSCCEEEECTTSCEEEECS----EEEECSCCC-
T ss_pred             CCcEEEecCCCCCCCCEEEEEeCCccEEEECC----CEecCCCcCC
Confidence            9999999997744 456899999999999863    7999999983

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=99.76  E-value=3.7e-18  Score=153.54  Aligned_cols=102  Identities=19%  Similarity=0.360  Sum_probs=87.3

Q ss_pred             cccCCCCccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc-eeEEEcCC
Q 002969           58 DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDGS  136 (862)
Q Consensus        58 ~~~~~~~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~-~~~l~~~~  136 (862)
                      |+|.+||.|..|+.|+|  |.|.|.|...++     |.++..    .++||+|||++|..+ .+.|.+..+ +|+|+|++
T Consensus         2 n~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~~----~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~d~~   69 (105)
T 4h3o_A            2 NILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYDH----STSTWASNTEIGGKS-GCSAVLQSDGNFVVYDSS   69 (105)
T ss_dssp             CEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEET----TEEEEECCCCCTTCC-SCEEEECTTSCEEEECTT
T ss_pred             CCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEEC----CEEEEEecCCCCCCc-cEEEEEeCCccEEEECCC
Confidence            78999999999999998  889999987776     778653    589999999999765 467888877 57889999


Q ss_pred             CCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeee
Q 002969          137 QNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQS  175 (862)
Q Consensus       137 ~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqS  175 (862)
                      +.+||+|+++.. ...+|+|+|+|||||++.    .+|||
T Consensus        70 ~~~vWss~t~~~~~~~~l~L~ddGNlVly~~----~~W~S  105 (105)
T 4h3o_A           70 GRSLWASHSTRGSGNYILILQDDGNVIIYGS----DIWST  105 (105)
T ss_dssp             CCEEEECCCCCCSSCEEEEECTTSCEEEEES----EEEEC
T ss_pred             cEEEEEecCCCCCCCEEEEEeCCCeEEEECC----cEecC
Confidence            999999998743 556899999999999964    69998

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.75  E-value=3.4e-18  Score=156.24  Aligned_cols=110  Identities=18%  Similarity=0.352  Sum_probs=75.2

Q ss_pred             ccccCCCCccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcceeEEEcCC
Q 002969           57 VDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQRIGLFDGS  136 (862)
Q Consensus        57 ~~~~~~~~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~~~~l~~~~  136 (862)
                      +|||.+||+|.+|++|  ++|.|+|+|+.+|+     | +||++   +++||+||++.+  +.                 
T Consensus         1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~---~~~vW~sn~~~~--~~-----------------   50 (112)
T 1xd5_A            1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN---NRAVWASGTNGK--AS-----------------   50 (112)
T ss_dssp             CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET---TEEEEECCCTTS--CS-----------------
T ss_pred             CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC---CEEEEeCCCcCC--CC-----------------
Confidence            4899999999999999  58999999998876     3 35654   578888887532  11                 


Q ss_pred             CCeEEccCCCCCCccEEEEecCCCeEEEecCCCceeeeecCCCCCccCCcCcccceeecCCeeEEEecCCCCCCCCCCcE
Q 002969          137 QNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNS  216 (862)
Q Consensus       137 ~~~vWst~~~~~~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtDTlLpg~klg~~~~tg~~~~L~Sw~s~~dps~G~~s  216 (862)
                                   ..+|+|+|+|||||++  .+.++||||+                               ||++|.|+
T Consensus        51 -------------~~~l~l~~~GNLvl~d--~~~~~W~S~~-------------------------------~~~~g~~~   84 (112)
T 1xd5_A           51 -------------GCVLKMQNDGNLVIYS--GSRAIWASNT-------------------------------NRQNGNYY   84 (112)
T ss_dssp             -------------SEEEEECTTSCEEEEE--TTEEEEECCC-------------------------------CCSCCCCE
T ss_pred             -------------CEEEEEeCCCCEEEEc--CCEEEEECCc-------------------------------cCCCCCEE
Confidence                         2356666777777766  3456677762                               44556666


Q ss_pred             EEeccCCCcceEeec-CCcceeecCCCCc
Q 002969          217 FKLDFHGFPEGFLWN-KQERKYRSGPWNG  244 (862)
Q Consensus       217 ~~l~~~g~~~~~~~~-~~~~~~rsg~w~g  244 (862)
                      +.++++|.  ++++. ++.+||+|++|+|
T Consensus        85 l~l~~dGn--lvl~~~~~~~~W~S~~~~g  111 (112)
T 1xd5_A           85 LILQRDRN--VVIYDNSNNAIWATHTNVG  111 (112)
T ss_dssp             EEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred             EEEeCCCc--EEEECCCCceEEECCCccC
Confidence            77776665  34443 4556777777664

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.74  E-value=7.4e-18  Score=154.69  Aligned_cols=108  Identities=21%  Similarity=0.345  Sum_probs=89.9

Q ss_pred             ccccCCCCccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc-eeEEEcC
Q 002969           57 VDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDG  135 (862)
Q Consensus        57 ~~~~~~~~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~-~~~l~~~  135 (862)
                      .|+|.+||+|.+|++|+  +|.|+|+|+++|+     + ++|+   ..++||+||++.|.  ..+.|.+.++ +|+|+|.
T Consensus         2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----l-vly~---~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~   68 (115)
T 2dpf_A            2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----L-VKYQ---NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDH   68 (115)
T ss_dssp             CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----E-EEEE---TTEEEEECSCTTSC--SSCEEEECTTSCEEEECT
T ss_pred             CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----E-EEEe---CCEEEEeCCCCCCC--CceEEEECCCCcEEEECC
Confidence            48999999999999998  8999999987765     3 2465   47999999999883  4578888876 5778898


Q ss_pred             CCCeEEccCCCC-CCccEEEEecCCCeEEEecCCCceeeeecCCCCC
Q 002969          136 SQNLVWSSNQTK-ATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTD  181 (862)
Q Consensus       136 ~~~~vWst~~~~-~~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtD  181 (862)
                      ++.+||+|++.. ....+|+|+|+|||||++.    ++||||.++..
T Consensus        69 ~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~----~~W~S~~~~~~  111 (115)
T 2dpf_A           69 NNNDVWGSACWGDNGKYALVLQKDGRFVIYGP----VLWSLGPNGCR  111 (115)
T ss_dssp             TCCEEEECCCCCSSSCCEEEECTTSCEEEECS----EEECSSTTCBC
T ss_pred             CceEEEEcCCCCCCCCEEEEEeCCCeEEEECC----CEEECCCCCCc
Confidence            899999998764 3456899999999999853    89999998765

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.73  E-value=1.3e-17  Score=176.29  Aligned_cols=137  Identities=16%  Similarity=0.169  Sum_probs=107.7

Q ss_pred             cccccceeeccccEEEEEeEe-cCCcE--EEEEEeccCCcc------------------------chHHHHHHHHHHHhc
Q 002969          543 NFTDYNKLGQGGFGIVYKGRL-LEGQE--IAVKRLSRNSGQ------------------------GIEEFKNEVRLIAKL  595 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~-~~~~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l  595 (862)
                      -|+..+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|+.++.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            466778999999999999988 67888  999987543111                        113678999999999


Q ss_pred             ccCCc--eEEEEEEEeCCceEEEEEeccC-C----ChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhh-hcCCCcEEe
Q 002969          596 QHRNL--VRLLGCCVEMDEKMLVYEYMEN-R----SLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH-QDSRFRIIH  667 (862)
Q Consensus       596 ~HpnI--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~ivH  667 (862)
                      +|+++  +.++.+    +..+|||||+.+ |    +|.++...      .++.....++.||+++|.||| +.+   |+|
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH  194 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH  194 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence            98864  445543    467899999952 4    55554321      235567889999999999999 887   999


Q ss_pred             cccCCcceEecCCCCeeEecccceeec
Q 002969          668 RDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       668 rDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      |||||+|||++.  .++|+|||+|...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999999764

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=99.66  E-value=3.4e-16  Score=142.08  Aligned_cols=102  Identities=19%  Similarity=0.316  Sum_probs=84.3

Q ss_pred             cccCCCCccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc-eeEEEcCC
Q 002969           58 DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDGS  136 (862)
Q Consensus        58 ~~~~~~~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~-~~~l~~~~  136 (862)
                      +||.+||.|.+|++|+  +|.|+|+|+.+|+     |-+ |+.   .++||+||++.+  ++...+.+.++ +++|+|.+
T Consensus         2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~---~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~   68 (109)
T 3dzw_A            2 NILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV---DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR   68 (109)
T ss_dssp             CEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET---TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred             CCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC---CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence            7899999999999997  7999999988775     433 654   589999999876  34567888876 57888988


Q ss_pred             CCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeeec
Q 002969          137 QNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSF  176 (862)
Q Consensus       137 ~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqSF  176 (862)
                      +.++|+|++... ...+|+|+|+|||||++.    ++|||=
T Consensus        69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~----~~W~s~  105 (109)
T 3dzw_A           69 NNPIWASNTGGENGNYVCVLQKDRNVVIYGT----ARWATG  105 (109)
T ss_dssp             SCEEEECCCCCSSSCEEEEECTTSCEEEEES----CCCCCC
T ss_pred             CCEEEECCCCCCCCCEEEEEeCCCEEEEECC----CEEeCC
Confidence            999999998754 346899999999999973    799983

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.57  E-value=6.6e-15  Score=133.56  Aligned_cols=103  Identities=20%  Similarity=0.283  Sum_probs=82.0

Q ss_pred             hhccccCCCCccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc-eeEEE
Q 002969           55 ISVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLF  133 (862)
Q Consensus        55 ~~~~~~~~~~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~-~~~l~  133 (862)
                      .+.|+|.+||.|..|+.|+|.  .|.|-|...|+     |.+ |..    ++||.+|++..  .....+.+.++ +++|+
T Consensus         4 ~~~dtL~~gq~L~~g~~L~sg--~~~L~~q~dGn-----Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~dGNLvl~   69 (110)
T 3r0e_B            4 FTNNLLFSGQVLYGDGRLTAK--NHQLVMQGDCN-----LVL-YGG----KYGWQSNTHGN--GEHCFLRLNHKGELIIK   69 (110)
T ss_dssp             CBTTEEETTCEEETTEEEECS--SCEEEECTTSC-----EEE-ECS----SSCEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred             cccCEECCCCEecCCCEEEeC--CEEEEEcCCCe-----EEE-ECC----eEEEECCCcCC--CcCEEEEEeCCCcEEEE
Confidence            467999999999999999984  58886655444     655 654    48999999863  33468888876 57888


Q ss_pred             cCCCCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeee
Q 002969          134 DGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQS  175 (862)
Q Consensus       134 ~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqS  175 (862)
                      |.++.++|++++... ...+|+|+|+|||||++    ..+|+|
T Consensus        70 d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~----~~~W~t  108 (110)
T 3r0e_B           70 DDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG----PAIFET  108 (110)
T ss_dssp             CTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC----SEEEES
T ss_pred             eCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec----CCEecC
Confidence            999999999998643 44789999999999997    379997

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.56  E-value=1.7e-15  Score=167.10  Aligned_cols=144  Identities=16%  Similarity=0.180  Sum_probs=105.2

Q ss_pred             HHHHHHcccccccceeeccccEEEEEeEecCCcEEEEEEeccCCc--------------cchH--------HHHHHHHHH
Q 002969          535 ETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG--------------QGIE--------EFKNEVRLI  592 (862)
Q Consensus       535 ~~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------------~~~~--------~~~~E~~~l  592 (862)
                      ..+.....-|++.++||+|+||.||+|...+|+.||||+++....              ....        ....|...|
T Consensus        88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL  167 (397)
T 4gyi_A           88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM  167 (397)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence            344444445889999999999999999998999999998753210              0001        123467777


Q ss_pred             HhcccCCce--EEEEEEEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEeccc
Q 002969          593 AKLQHRNLV--RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDL  670 (862)
Q Consensus       593 ~~l~HpnIv--~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDl  670 (862)
                      .++.+.++.  +.+.+    ...+|||||+++++|..+.         .......++.||+.+|.|||+.+   ||||||
T Consensus       168 ~rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~g---IVHrDL  231 (397)
T 4gyi_A          168 KALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKHG---LIHGDF  231 (397)
T ss_dssp             HHHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred             HHHHhcCCCCCeeeec----cCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCC
Confidence            777655442  23322    2347999999998886653         12234568899999999999998   999999


Q ss_pred             CCcceEecCCC----------CeeEecccceeec
Q 002969          671 KASNILLDKEM----------TPKISDFGMARIF  694 (862)
Q Consensus       671 kp~NILl~~~~----------~~kL~DFGla~~~  694 (862)
                      ||.||||++++          .+.|+||+-+...
T Consensus       232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             STTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            99999998776          3889999977643

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.53  E-value=5.4e-14  Score=128.26  Aligned_cols=105  Identities=17%  Similarity=0.235  Sum_probs=85.4

Q ss_pred             hccccCCCCccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc-eeEEEc
Q 002969           56 SVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFD  134 (862)
Q Consensus        56 ~~~~~~~~~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~-~~~l~~  134 (862)
                      +.|+|.+||.|..|+.|.+  |.|.|-|...|+     |.++..+  ..++||.+|+..+  +....+.+.++ ++||+|
T Consensus         5 ~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~~~--~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~d   73 (113)
T 3mez_B            5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTKGS--KTNIVWESGTSGR--GQHCFMRLGHSGELDITD   73 (113)
T ss_dssp             CSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEETT--TTEEEEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred             cCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEECC--CCEEEEECCcccC--CcCEEEEEeCCCcEEEEC
Confidence            5699999999999999974  889998877665     7775431  4689999999876  23567888876 578889


Q ss_pred             CCCCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeee
Q 002969          135 GSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQS  175 (862)
Q Consensus       135 ~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqS  175 (862)
                      .++.++|+|++... ...+|+|+|+|||||++    ..+|+|
T Consensus        74 ~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~----~~~W~s  111 (113)
T 3mez_B           74 DRLNTVFVSNTVGQEGDYVLILQINGQAVVYG----PAVWST  111 (113)
T ss_dssp             TTSCEEEECSCCCSSSCCEEEECTTSCEEEEC----SEEEES
T ss_pred             CCCCEEEECCCcCCCCCEEEEEcCCceEEEec----CCEecC
Confidence            99999999998643 44789999999999996    489997

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A*

Probab=99.46  E-value=1.4e-13  Score=125.00  Aligned_cols=88  Identities=20%  Similarity=0.333  Sum_probs=71.4

Q ss_pred             CCCceEEEEcc-eeEEEcCCCCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeeecCCCCCccCCcCcccceeec
Q 002969          118 NSSGVLRIINQ-RIGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKT  195 (862)
Q Consensus       118 ~~~~~l~~~~~-~~~l~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtDTlLpg~klg~~~~t  195 (862)
                      +...+|.+..+ +++|+| .+++||++|+... ....|+|+|+|||||++. ++.++||||                   
T Consensus        19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~-~~~~~W~S~-------------------   77 (110)
T 3a0c_A           19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQ-SNRVIWQTK-------------------   77 (110)
T ss_dssp             TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECT-TCCEEEECC-------------------
T ss_pred             CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECC-CCcEEEecC-------------------
Confidence            34567888766 577888 5889999998743 356899999999999986 578999999                   


Q ss_pred             CCeeEEEecCCCCCCCCCCcEEEeccCCCcceEeecCCcceeecCCC
Q 002969          196 GFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPW  242 (862)
Q Consensus       196 g~~~~L~Sw~s~~dps~G~~s~~l~~~g~~~~~~~~~~~~~~rsg~w  242 (862)
                                  .+|++|.|++.++++|.  ++++++  +||+|+++
T Consensus        78 ------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~  108 (110)
T 3a0c_A           78 ------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG  108 (110)
T ss_dssp             ------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred             ------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence                        36778999999999997  566765  79999886

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=99.46  E-value=1.7e-13  Score=124.08  Aligned_cols=106  Identities=18%  Similarity=0.306  Sum_probs=84.9

Q ss_pred             hccccCCCCccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc-eeEEEc
Q 002969           56 SVDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFD  134 (862)
Q Consensus        56 ~~~~~~~~~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~-~~~l~~  134 (862)
                      |.|||.+||.|..|+.|  .+|.|.|.|...|+     |-+ |..      +|.+|+..+  .....|.+.++ +++|+|
T Consensus         2 ~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~------~Wssnt~~~--~~~~~l~l~~dGnLvl~d   65 (109)
T 3r0e_A            2 GTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YNG------NWQSNTANN--GRDCKLTLTDYGELVIKN   65 (109)
T ss_dssp             CCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ETT------TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred             ccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-EeC------eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence            56999999999999999  57999999977665     433 432      699998865  33578888876 577889


Q ss_pred             CCCCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeeecCCCCCccCCc
Q 002969          135 GSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQ  186 (862)
Q Consensus       135 ~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtDTlLpg  186 (862)
                      .++.++|+|++... ...+|+|+|+|||||++    ..+|+|     +|.+||
T Consensus        66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~----~~~W~s-----~t~~~~  109 (109)
T 3r0e_A           66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG----PSVFKI-----DPWVRG  109 (109)
T ss_dssp             TTSCEEEECCCCCSSSCCEEEEETTTEEEEEC----SEEEEE-----CTTSCC
T ss_pred             CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe----cCEECC-----CCccCC
Confidence            99999999998643 45689999999999996    479998     565554

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1

Probab=99.39  E-value=1.1e-12  Score=120.47  Aligned_cols=83  Identities=18%  Similarity=0.290  Sum_probs=67.6

Q ss_pred             eEEEEcc-eeEEEcCCCCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeeecCCCCCccCCcCcccceeecCCee
Q 002969          122 VLRIINQ-RIGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEW  199 (862)
Q Consensus       122 ~l~~~~~-~~~l~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtDTlLpg~klg~~~~tg~~~  199 (862)
                      .|.+..+ ++++++. +++||++|+... ....|+|+|+|||||++. ++.++||||                       
T Consensus        33 ~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~-~~~~lW~S~-----------------------   87 (119)
T 1b2p_A           33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN-ENVTVWQSP-----------------------   87 (119)
T ss_dssp             EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT-TCCEEEECS-----------------------
T ss_pred             EEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeC-CCcEEEcCC-----------------------
Confidence            4666655 5778887 889999998643 357899999999999986 578999999                       


Q ss_pred             EEEecCCCCCCCCCCcEEEeccCCCcceEeecCCcceeecCC
Q 002969          200 YLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGP  241 (862)
Q Consensus       200 ~L~Sw~s~~dps~G~~s~~l~~~g~~~~~~~~~~~~~~rsg~  241 (862)
                              .||++|.|++.++++|.  ++++.  .+||+||+
T Consensus        88 --------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~  117 (119)
T 1b2p_A           88 --------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT  117 (119)
T ss_dssp             --------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred             --------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence                    46788999999999997  56665  38999987

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A*

Probab=99.39  E-value=1.4e-12  Score=119.32  Aligned_cols=89  Identities=19%  Similarity=0.334  Sum_probs=71.2

Q ss_pred             CceEEEEcc-eeEEEcCCCCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeeecCCCCCccCCcCcccceeecCC
Q 002969          120 SGVLRIINQ-RIGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGF  197 (862)
Q Consensus       120 ~~~l~~~~~-~~~l~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtDTlLpg~klg~~~~tg~  197 (862)
                      ...|.+..+ +++|++ .+++||++|+... ....++|+++|||||++. ++.++|||||+                   
T Consensus        21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~-~~~~vW~S~~~-------------------   79 (115)
T 2dpf_A           21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDH-NNNDVWGSACW-------------------   79 (115)
T ss_dssp             TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECT-TCCEEEECCCC-------------------
T ss_pred             CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECC-CceEEEEcCCC-------------------
Confidence            345666655 577777 5789999997643 356899999999999986 47799999997                   


Q ss_pred             eeEEEecCCCCCCCCCCcEEEeccCCCcceEeecCCcceeecCCCCce
Q 002969          198 EWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGV  245 (862)
Q Consensus       198 ~~~L~Sw~s~~dps~G~~s~~l~~~g~~~~~~~~~~~~~~rsg~w~g~  245 (862)
                                  |++|.|++.++++|+  +++++.  .+|+|++|...
T Consensus        80 ------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~  111 (115)
T 2dpf_A           80 ------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR  111 (115)
T ss_dssp             ------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred             ------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence                        456889999999997  566754  89999999753

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A

Probab=99.27  E-value=1.8e-11  Score=111.43  Aligned_cols=99  Identities=18%  Similarity=0.389  Sum_probs=71.7

Q ss_pred             cccCCCCccCCCC--EEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc-eeEEEc
Q 002969           58 DTLTATQNLTYGK--TLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFD  134 (862)
Q Consensus        58 ~~~~~~~~l~~~~--~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~-~~~l~~  134 (862)
                      .+|.+||+|..+.  ..+..+|.+.|  |.. .     -.||-.+...        +..+..     +.+.++ +|||+|
T Consensus         8 q~L~~g~~L~~~~~~L~~~~dgnlvl--~~~-~-----~~vW~sn~~~--------~~~~~~-----l~l~~~GNLvl~d   66 (112)
T 1xd5_A            8 HQLDTGGSLAEGGYLFIIQNDCNLVL--YDN-N-----RAVWASGTNG--------KASGCV-----LKMQNDGNLVIYS   66 (112)
T ss_dssp             EEECTTCEEEETTEEEEECTTSCEEE--EET-T-----EEEEECCCTT--------SCSSEE-----EEECTTSCEEEEE
T ss_pred             CEECCCCEEeCCCEEEEEcCCCcEEE--EEC-C-----EEEEeCCCcC--------CCCCEE-----EEEeCCCCEEEEc
Confidence            6788999997654  45678898887  433 1     3689877432        222222     455555 678889


Q ss_pred             CCCCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeeecCCC
Q 002969          135 GSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYP  179 (862)
Q Consensus       135 ~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~P  179 (862)
                       ++.++|+|++... ....++|+++|||||++. .+.++||||+|.
T Consensus        67 -~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~-~~~~~W~S~~~~  110 (112)
T 1xd5_A           67 -GSRAIWASNTNRQNGNYYLILQRDRNVVIYDN-SNNAIWATHTNV  110 (112)
T ss_dssp             -TTEEEEECCCCCSCCCCEEEECTTSCEEEECT-TSCEEEECCCCC
T ss_pred             -CCEEEEECCccCCCCCEEEEEeCCCcEEEECC-CCceEEECCCcc
Confidence             8889999987643 456899999999999974 467999999985

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.25  E-value=3.1e-11  Score=127.27  Aligned_cols=146  Identities=14%  Similarity=0.057  Sum_probs=115.8

Q ss_pred             HHcccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCceEEEE
Q 002969          539 RATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       539 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ...+.|+....++.|+.+.||+.... ++.+++|+...........+.+|+++++.+. |..++++++++...+..++||
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            34456877788888889999999754 6899999986532233457899999999995 678889999999988999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc-------------------------------------
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-------------------------------------  660 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-------------------------------------  660 (862)
                      ||++|.+|.+.+.        +......++.+++++|+.||+.                                     
T Consensus        90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999999877531        2233457889999999999982                                     


Q ss_pred             -------------------CCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          661 -------------------SRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       661 -------------------~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                                         ....++|+|++|.|||++++..+.|+||+.+..
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                               114599999999999998765667999997753

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=99.24  E-value=2e-11  Score=110.80  Aligned_cols=101  Identities=15%  Similarity=0.250  Sum_probs=79.2

Q ss_pred             ccccCCCCccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc-eeEEEcC
Q 002969           57 VDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDG  135 (862)
Q Consensus        57 ~~~~~~~~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~-~~~l~~~  135 (862)
                      .|+|.+||.|..|+.|  .+|.|.|-|...|+     |.+ |..   .. ||.+|+..+  .....+.+.++ ++||+|.
T Consensus         2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn-----Lvl-~~~---~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~   67 (111)
T 3mez_A            2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN-----LVL-YNE---AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSA   67 (111)
T ss_dssp             TTEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ECS---SC-CEECCCTTS--CSSCEEEECTTSCEEEECS
T ss_pred             cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe-----EEE-ECC---CC-EEECCcccC--CcCEEEEEcCCCcEEEEeC
Confidence            4899999999999999  47899999977665     545 543   23 999999876  23467888876 5778888


Q ss_pred             CCC-eEEccCCC--C-CCccEEEEecCCCeEEEecCCCceeeee
Q 002969          136 SQN-LVWSSNQT--K-ATNPVAQLQDSGNFVLKEAGSDEILWQS  175 (862)
Q Consensus       136 ~~~-~vWst~~~--~-~~~~~a~l~d~GNlVl~~~~~~~~lWqS  175 (862)
                      ++. ++|+|++.  . ....+|+|+|+|||||++    ..+|+|
T Consensus        68 ~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~----~~~W~s  107 (111)
T 3mez_A           68 NSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG----PAIWST  107 (111)
T ss_dssp             SCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC----SEEEEC
T ss_pred             CCCEEEEEeccccCCCCcCEEEEECCCCeEEEec----cCEEcc
Confidence            775 59999864  2 245689999999999996    579998

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A*

Probab=99.09  E-value=2.4e-10  Score=120.82  Aligned_cols=112  Identities=17%  Similarity=0.307  Sum_probs=86.2

Q ss_pred             hhccccCCCCc----cCCCCEEecCCCeEEEEeecCC--CCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc
Q 002969           55 ISVDTLTATQN----LTYGKTLVSSDDVFELGFFSPG--SSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ  128 (862)
Q Consensus        55 ~~~~~~~~~~~----l~~~~~lvS~~g~f~lGFf~~~--~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~  128 (862)
                      ..+||+.|||.    |..|++|+|+ ..++.|+|+..  ...+.+  + |++  ..+++|.+++.++-  . ..+.+..+
T Consensus       134 ~ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGnlv--L-y~~--~~~~yW~Sgt~~~~--~-~~l~l~~d  204 (276)
T 3m7h_A          134 TPAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGNLV--A-YGP--NGAATWNAGTQGKG--A-VRAVFQGD  204 (276)
T ss_dssp             CTTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSCEE--E-ECT--TSSEEEECCCTTTT--C-CEEEECTT
T ss_pred             ccccccccccccccccccCcccccC-CCCCCceEEEeecCCceEE--E-EeC--CCeEEEECCCCCCc--c-EEEEEcCC
Confidence            45699999999    8899999764 57777777542  233444  3 332  25899999998762  2 67888766


Q ss_pred             -eeEEEcCCCCeEEccCCCCCCccEEEEecCCCeEEEecCCCceeeeecCC
Q 002969          129 -RIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDY  178 (862)
Q Consensus       129 -~~~l~~~~~~~vWst~~~~~~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~  178 (862)
                       +++++|.++.++|++++......+|+|+++|||||++.   +++||||||
T Consensus       205 GnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~  252 (276)
T 3m7h_A          205 GNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE---KPVWARFGF  252 (276)
T ss_dssp             SCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE---EEEEESSSC
T ss_pred             CeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC---CCeEEccCc
Confidence             57788988899999998755567999999999999975   589999998

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.08  E-value=2.8e-10  Score=119.40  Aligned_cols=132  Identities=15%  Similarity=0.137  Sum_probs=100.5

Q ss_pred             ceee-ccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCC--ceEEEEEEEeCCceEEEEEeccCCC
Q 002969          548 NKLG-QGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN--LVRLLGCCVEMDEKMLVYEYMENRS  624 (862)
Q Consensus       548 ~~LG-~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gs  624 (862)
                      +.++ .|..+.||+....+|+.+++|+....   ....+.+|+.+++.+.+.+  +++++++....+..++||||++|.+
T Consensus        25 ~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~  101 (264)
T 1nd4_A           25 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD  101 (264)
T ss_dssp             EECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcc
Confidence            3444 55569999998777888999997543   3356889999999996544  5668998888888999999999988


Q ss_pred             hhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcC-------------------------------------------
Q 002969          625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS-------------------------------------------  661 (862)
Q Consensus       625 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-------------------------------------------  661 (862)
                      |.  ...      .   ....++.++++.|+.||+..                                           
T Consensus       102 l~--~~~------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (264)
T 1nd4_A          102 LL--SSH------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  170 (264)
T ss_dssp             TT--TSC------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cC--cCc------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence            84  210      1   12356778888888888643                                           


Q ss_pred             ------------CCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          662 ------------RFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       662 ------------~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                                  +..++|+|++|.|||++++..+.|+||+.+..
T Consensus       171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                        12399999999999998776677999998754

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=98.99  E-value=1.5e-09  Score=98.71  Aligned_cols=93  Identities=18%  Similarity=0.309  Sum_probs=68.5

Q ss_pred             CCCCCCCCceEEEEcc-eeEEEcC-CCCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeeecCCCCCccCCcCcc
Q 002969          113 DDPLANSSGVLRIINQ-RIGLFDG-SQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKI  189 (862)
Q Consensus       113 ~~p~~~~~~~l~~~~~-~~~l~~~-~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtDTlLpg~kl  189 (862)
                      +.|+.+....|.+..| +|||++. .+.++|++++... ....++|+++|||||++. .+.++|||=.+           
T Consensus        18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~-~~~~iW~S~t~-----------   85 (113)
T 3mez_B           18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDD-RLNTVFVSNTV-----------   85 (113)
T ss_dssp             TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECT-TSCEEEECSCC-----------
T ss_pred             CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECC-CCCEEEECCCc-----------
Confidence            4455555677888776 5778887 5899999998743 356899999999999986 46789998211           


Q ss_pred             cceeecCCeeEEEecCCCCCCCCCCcEEEeccCCCcceEeecCCcceeecCC
Q 002969          190 GWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGP  241 (862)
Q Consensus       190 g~~~~tg~~~~L~Sw~s~~dps~G~~s~~l~~~g~~~~~~~~~~~~~~rsg~  241 (862)
                                          -..|.|.+.|+.+|...  ++.  .+.|.|||
T Consensus        86 --------------------~~~~~~~~~L~~dGnlv--ly~--~~~W~s~~  113 (113)
T 3mez_B           86 --------------------GQEGDYVLILQINGQAV--VYG--PAVWSTAA  113 (113)
T ss_dssp             --------------------CSSSCCEEEECTTSCEE--EEC--SEEEESCC
T ss_pred             --------------------CCCCCEEEEEcCCceEE--Eec--CCEecCCC
Confidence                                01245889999999754  444  68898875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.90  E-value=6.8e-09  Score=114.73  Aligned_cols=142  Identities=14%  Similarity=0.227  Sum_probs=107.9

Q ss_pred             ccceeeccccEEEEEeEecCCcEEEEEEec--cCC-ccchHHHHHHHHHHHhcc--cCCceEEEEEEEeC---CceEEEE
Q 002969          546 DYNKLGQGGFGIVYKGRLLEGQEIAVKRLS--RNS-GQGIEEFKNEVRLIAKLQ--HRNLVRLLGCCVEM---DEKMLVY  617 (862)
Q Consensus       546 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--HpnIv~l~g~~~~~---~~~~lV~  617 (862)
                      ..+.|+.|.++.||+.+.. +..+++|+..  ... ......+.+|+.+++.+.  +..+++++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3578999999999998875 4688888875  322 123457889999999997  45688999998776   3479999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcC------------------------------------
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS------------------------------------  661 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------  661 (862)
                      ||++|..+.+..     ...++..++..++.++++.|+.||...                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998875422     123677788889999999999999731                                    


Q ss_pred             -------------------CCcEEecccCCcceEecCCCC--eeEecccceee
Q 002969          662 -------------------RFRIIHRDLKASNILLDKEMT--PKISDFGMARI  693 (862)
Q Consensus       662 -------------------~~~ivHrDlkp~NILl~~~~~--~kL~DFGla~~  693 (862)
                                         ...++|+|+++.|||++.++.  +.|.||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               256999999999999997753  68999999875

>3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0

Probab=98.84  E-value=7.5e-09  Score=93.69  Aligned_cols=92  Identities=13%  Similarity=0.226  Sum_probs=65.8

Q ss_pred             CCCCCCceEEEEcc-eeEEEcCCCCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeeecCCCCCccCCcCcccce
Q 002969          115 PLANSSGVLRIINQ-RIGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWD  192 (862)
Q Consensus       115 p~~~~~~~l~~~~~-~~~l~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtDTlLpg~klg~~  192 (862)
                      ++.+....|.+..+ +|||++.++  +|++++... ....++|+++|||||++.+.+.++|||..+              
T Consensus        16 ~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~--------------   79 (111)
T 3mez_A           16 QLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS--------------   79 (111)
T ss_dssp             EEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS--------------
T ss_pred             EEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc--------------
Confidence            33444567888776 577888776  999998753 347899999999999987434469999621              


Q ss_pred             eecCCeeEEEecCCCCCCCCCCcEEEeccCCCcceEeecCCcceeecCC
Q 002969          193 LKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGP  241 (862)
Q Consensus       193 ~~tg~~~~L~Sw~s~~dps~G~~s~~l~~~g~~~~~~~~~~~~~~rsg~  241 (862)
                                     .....|.|.+.|+.+|...  ++.  .++|.++.
T Consensus        80 ---------------~~~~~~~~~l~Lq~dGNlv--ly~--~~~W~s~t  109 (111)
T 3mez_A           80 ---------------VNTVRGNYAATLGPDQHVT--IYG--PAIWSTPA  109 (111)
T ss_dssp             ---------------CCCCSSCCEEEECTTSCEE--EEC--SEEEECCC
T ss_pred             ---------------cCCCCcCEEEEECCCCeEE--Eec--cCEEccCC
Confidence                           0112468899999999754  444  67888764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.81  E-value=7.1e-09  Score=111.77  Aligned_cols=186  Identities=19%  Similarity=0.242  Sum_probs=123.4

Q ss_pred             cceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcc-cCC--ceEEEEEEEeCC---ceEEEEEec
Q 002969          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRN--LVRLLGCCVEMD---EKMLVYEYM  620 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-Hpn--Iv~l~g~~~~~~---~~~lV~E~~  620 (862)
                      .+.++.|....||+..    ..+++|+....  .....+.+|+++++.+. +..  +++++......+   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            3679999999999873    56888886432  34567899999999983 333  455665544333   347899999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc----------------------------------------
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD----------------------------------------  660 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~----------------------------------------  660 (862)
                      +|.+|.....     ..++..++..++.++++.|+.||..                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9998875432     1256677778888888888888862                                        


Q ss_pred             ---------------CCCcEEecccCCcceEecC--CCCeeEecccceeecCCCCccccc------------cccccccc
Q 002969          661 ---------------SRFRIIHRDLKASNILLDK--EMTPKISDFGMARIFGGDQTEQNT------------KRVVGTYG  711 (862)
Q Consensus       661 ---------------~~~~ivHrDlkp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~------------~~~~gt~~  711 (862)
                                     ..+.++|+|++|.||++++  ...+.|.||+.+..-.....-...            .......+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                           1245899999999999998  456789999998753221000000            00011111


Q ss_pred             ccC-hhhhcCCCCCccccchhHHHHHHHHHhCCCC
Q 002969          712 YMS-PEYAMDGLFSVKSDVFSFGVLLLETVSGKKN  745 (862)
Q Consensus       712 y~A-PE~l~~~~~s~ksDVwSlGvil~elltG~~p  745 (862)
                      ... |+.....  ....+.|+++.++|++.+|..+
T Consensus       254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHH
T ss_pred             CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHH
Confidence            222 3322111  1235899999999999999876

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A*

Probab=98.62  E-value=1.4e-07  Score=85.01  Aligned_cols=85  Identities=16%  Similarity=0.309  Sum_probs=60.5

Q ss_pred             CceEEEEcc-eeEEEcCCCCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeeecCCCCCccCCcCcccceeecCC
Q 002969          120 SGVLRIINQ-RIGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGF  197 (862)
Q Consensus       120 ~~~l~~~~~-~~~l~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtDTlLpg~klg~~~~tg~  197 (862)
                      .-.|.+..+ +++|++. +.+||++|+... ....++|+++|||||++. .+.++|||....                  
T Consensus        20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~-~~~~~W~S~t~~------------------   79 (109)
T 3dzw_A           20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSP-RNNPIWASNTGG------------------   79 (109)
T ss_dssp             TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECT-TSCEEEECCCCC------------------
T ss_pred             CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECC-CCCEEEECCCCC------------------
Confidence            345777666 5777777 789999998743 356899999999999986 467899984211                  


Q ss_pred             eeEEEecCCCCCCCCCCcEEEeccCCCcceEeecCCcceeecCC
Q 002969          198 EWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGP  241 (862)
Q Consensus       198 ~~~L~Sw~s~~dps~G~~s~~l~~~g~~~~~~~~~~~~~~rsg~  241 (862)
                                   ..+.|.+.|+.+|+..  ++..  +.|.||.
T Consensus        80 -------------~~~~~~~~L~ddGNlv--ly~~--~~W~s~t  106 (109)
T 3dzw_A           80 -------------ENGNYVCVLQKDRNVV--IYGT--ARWATGT  106 (109)
T ss_dssp             -------------SSSCEEEEECTTSCEE--EEES--CCCCCCC
T ss_pred             -------------CCCCEEEEEeCCCEEE--EECC--CEEeCCC
Confidence                         1245788899999754  4442  6777654

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=98.61  E-value=1e-07  Score=86.08  Aligned_cols=82  Identities=18%  Similarity=0.402  Sum_probs=59.3

Q ss_pred             ceEEEEcc-eeEEEcCCCCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeeecCCCCCccCCcCcccceeecCCe
Q 002969          121 GVLRIINQ-RIGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFE  198 (862)
Q Consensus       121 ~~l~~~~~-~~~l~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtDTlLpg~klg~~~~tg~~  198 (862)
                      ..|.+..+ +|+|++.  .++|++|+... ....++|+++|||||++. .+.++|||-.+-                   
T Consensus        26 ~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~-~~~~iW~S~t~~-------------------   83 (110)
T 3r0e_B           26 HQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDD-DFKTIWSSRSSS-------------------   83 (110)
T ss_dssp             CEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECT-TCCEEEECCCCC-------------------
T ss_pred             EEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeC-CCCEEEEcCCcC-------------------
Confidence            45777666 5777776  58999998743 346899999999999986 467899983210                   


Q ss_pred             eEEEecCCCCCCCCCCcEEEeccCCCcceEeecCCcceeecC
Q 002969          199 WYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSG  240 (862)
Q Consensus       199 ~~L~Sw~s~~dps~G~~s~~l~~~g~~~~~~~~~~~~~~rsg  240 (862)
                                  ..|.|.+.|+.+|...  ++.  .+.|.+|
T Consensus        84 ------------~~~~~~~~L~~dGNlv--ly~--~~~W~t~  109 (110)
T 3r0e_B           84 ------------KQGEYVLILQDDGFGV--IYG--PAIFETS  109 (110)
T ss_dssp             ------------SSSCCEEEECTTSCEE--EEC--SEEEESC
T ss_pred             ------------CCCCEEEEEcCCccEE--Eec--CCEecCC
Confidence                        1245788999999754  444  4778776

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara}

Probab=98.59  E-value=1e-07  Score=85.87  Aligned_cols=90  Identities=21%  Similarity=0.435  Sum_probs=64.8

Q ss_pred             CCCCCCCCceEEEEcc-eeEEEcCCCCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeeecCCCCCccCCcCccc
Q 002969          113 DDPLANSSGVLRIINQ-RIGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIG  190 (862)
Q Consensus       113 ~~p~~~~~~~l~~~~~-~~~l~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtDTlLpg~klg  190 (862)
                      +.|+.+....|.+..+ +|||+++    +|+|++... ....++|+++|||||++. .+.++|+|-     |        
T Consensus        15 g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~-~~~~vWss~-----t--------   76 (109)
T 3r0e_A           15 EGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNG-DGSTVWKSG-----A--------   76 (109)
T ss_dssp             TCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECT-TSCEEEECC-----C--------
T ss_pred             CCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeC-CCCEEEcCC-----C--------
Confidence            3444445567888776 5777774    799998753 457899999999999986 467899761     1        


Q ss_pred             ceeecCCeeEEEecCCCCCCCCCCcEEEeccCCCcceEeecCCcceeecCCC
Q 002969          191 WDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPW  242 (862)
Q Consensus       191 ~~~~tg~~~~L~Sw~s~~dps~G~~s~~l~~~g~~~~~~~~~~~~~~rsg~w  242 (862)
                                        ....+.|.+.|+.+|+..  ++.  .+.|.+++|
T Consensus        77 ------------------~~~~~~~~~~L~~dGNlv--ly~--~~~W~s~t~  106 (109)
T 3r0e_A           77 ------------------QSVKGNYAAVVHPDGRLV--VFG--PSVFKIDPW  106 (109)
T ss_dssp             ------------------CCSSSCCEEEEETTTEEE--EEC--SEEEEECTT
T ss_pred             ------------------cCCCcCEEEEEcCCCeEE--EEe--cCEECCCCc
Confidence                              001356789999999744  444  689999987

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1

Probab=98.46  E-value=2.9e-07  Score=95.29  Aligned_cols=48  Identities=38%  Similarity=0.493  Sum_probs=39.0

Q ss_pred             eeEEEcCCCCeEEccCCCCCCccEEEEecCCCeEEEecCCCceeeeecCC
Q 002969          129 RIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFDY  178 (862)
Q Consensus       129 ~~~l~~~~~~~vWst~~~~~~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~  178 (862)
                      +++++++ +++||++|+.......++|.++|||||++. ++.++|+|+++
T Consensus        37 nl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~-~~~~vW~s~~~   84 (236)
T 1dlp_A           37 NLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTA-QNTIRWSSGTK   84 (236)
T ss_dssp             CEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCT-TTCCSCCCCCC
T ss_pred             cEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcC-CCcEEEeCCcc
Confidence            4566665 789999997655566889999999999986 57799999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.30  E-value=5.2e-06  Score=89.34  Aligned_cols=136  Identities=21%  Similarity=0.199  Sum_probs=95.5

Q ss_pred             cceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccC---CceEEEEEEE-eCCceEEEEEeccC
Q 002969          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHR---NLVRLLGCCV-EMDEKMLVYEYMEN  622 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~g~~~-~~~~~~lV~E~~~~  622 (862)
                      .+.++.|....||+.    ++.+++|+-.  .......+.+|+++|+.+.+.   .+++.+.++. ..+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            357888888899987    5778888742  223456789999999999752   3667777774 34557899999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc------------------------------------------
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD------------------------------------------  660 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------------------------------------------  660 (862)
                      ..|.+....     .++..++..++.++++.|+.||+.                                          
T Consensus        98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            988763211     133444445555555555555532                                          


Q ss_pred             ---------------CCCcEEecccCCcceEecC---CCCe-eEecccceee
Q 002969          661 ---------------SRFRIIHRDLKASNILLDK---EMTP-KISDFGMARI  693 (862)
Q Consensus       661 ---------------~~~~ivHrDlkp~NILl~~---~~~~-kL~DFGla~~  693 (862)
                                     ..+.++|+|++|.|||++.   ++.+ .|.||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           2335799999999999987   4554 8999998865

>4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D*

Probab=98.21  E-value=4.2e-06  Score=74.63  Aligned_cols=52  Identities=31%  Similarity=0.530  Sum_probs=39.7

Q ss_pred             eEEEEcc-eeEEEcCCCCeEEccCCCC--CCccEEEEecCCCeEEEecCCCceeeee
Q 002969          122 VLRIINQ-RIGLFDGSQNLVWSSNQTK--ATNPVAQLQDSGNFVLKEAGSDEILWQS  175 (862)
Q Consensus       122 ~l~~~~~-~~~l~~~~~~~vWst~~~~--~~~~~a~l~d~GNlVl~~~~~~~~lWqS  175 (862)
                      .|.+..| +|||++. +.+||++|+..  .....+.|.++|||||+|. +++++|.|
T Consensus        22 ~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~-~~~~vWss   76 (105)
T 4h3o_A           22 HFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDS-SGRSLWAS   76 (105)
T ss_dssp             EEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECT-TCCEEEEC
T ss_pred             EEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECC-CcEEEEEe
Confidence            3555565 5667764 57999999763  3456899999999999987 57789987

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.21  E-value=9.2e-06  Score=85.43  Aligned_cols=136  Identities=18%  Similarity=0.136  Sum_probs=98.2

Q ss_pred             ceeeccccE-EEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCceEEEEEeccCCC
Q 002969          548 NKLGQGGFG-IVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYEYMENRS  624 (862)
Q Consensus       548 ~~LG~G~fg-~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gs  624 (862)
                      +.+..|..+ .||+..... +..+++|+-...   ....+.+|+..|+.+. +--+.++++++.+.+..++|||++++.+
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            345556554 689876544 567889986533   3457888999999884 4457889999999999999999999988


Q ss_pred             hhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc--------------------------------------------
Q 002969          625 LDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD--------------------------------------------  660 (862)
Q Consensus       625 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~--------------------------------------------  660 (862)
                      +.+....       .......++.++++.|+-||..                                            
T Consensus       107 ~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          107 AFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             ccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            8765421       1122334556666666666632                                            


Q ss_pred             -----------CCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          661 -----------SRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       661 -----------~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                                 ..+.++|+|+.+.|||+++++.+-|.||+.+..
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       112389999999999999877777999998754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.20  E-value=4.9e-06  Score=91.43  Aligned_cols=81  Identities=7%  Similarity=-0.033  Sum_probs=58.6

Q ss_pred             ccee-eccccEEEEEeEec-------CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcc-c--CCceEEEEEEEeC--
Q 002969          547 YNKL-GQGGFGIVYKGRLL-------EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQ-H--RNLVRLLGCCVEM--  610 (862)
Q Consensus       547 ~~~L-G~G~fg~Vy~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H--pnIv~l~g~~~~~--  610 (862)
                      .+.| +.|....+|+....       +++.+++|+.....   ......+.+|+.+++.+. +  ..+++++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 78888999998764       26678888765432   112356889999999995 3  3578888887665  


Q ss_pred             -CceEEEEEeccCCChhh
Q 002969          611 -DEKMLVYEYMENRSLDS  627 (862)
Q Consensus       611 -~~~~lV~E~~~~gsL~~  627 (862)
                       +..++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             34689999999877654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.90  E-value=4.4e-05  Score=85.17  Aligned_cols=75  Identities=12%  Similarity=0.180  Sum_probs=52.0

Q ss_pred             cceeeccccEEEEEeEec-CCcEEEEEEeccCCc-------cchHHHHHHHHHHHhccc--C-CceEEEEEEEeCCceEE
Q 002969          547 YNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG-------QGIEEFKNEVRLIAKLQH--R-NLVRLLGCCVEMDEKML  615 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H--p-nIv~l~g~~~~~~~~~l  615 (862)
                      .+.||.|..+.||+++.. +++.++||.......       ...+++..|+++++.+..  + .+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            468999999999999764 468899998653211       234567889999998853  3 34566654  4556789


Q ss_pred             EEEeccCC
Q 002969          616 VYEYMENR  623 (862)
Q Consensus       616 V~E~~~~g  623 (862)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.75  E-value=9.2e-05  Score=80.34  Aligned_cols=141  Identities=17%  Similarity=0.222  Sum_probs=82.3

Q ss_pred             ceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhccc--CCceEEEE------EEEeCCceEEEEEe
Q 002969          548 NKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH--RNLVRLLG------CCVEMDEKMLVYEY  619 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~g------~~~~~~~~~lV~E~  619 (862)
                      +.|+.|..+.||+....++ .+++|+....    .+++..|+.+++.+..  -.+++++.      +....+..++++||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677889999877544 5899988652    2344556677766642  22344443      12345677899999


Q ss_pred             ccCCChh-----------hh---hhhccC----C-------CCCCHhhHH------------------------------
Q 002969          620 MENRSLD-----------SV---IFDKAR----S-------SILNWQRRF------------------------------  644 (862)
Q Consensus       620 ~~~gsL~-----------~~---l~~~~~----~-------~~l~~~~~~------------------------------  644 (862)
                      ++|..+.           ..   ++....    .       ..-.|...+                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9987653           01   111111    0       011222110                              


Q ss_pred             -HHHHHHHHHhHHhhh----------cCCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          645 -NIICGIARGLLYLHQ----------DSRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       645 -~i~~qia~gL~yLH~----------~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                       .+...+.+++++|+.          ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             111223445667763          1235699999999999998888999999997753

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.72  E-value=0.00025  Score=76.24  Aligned_cols=139  Identities=18%  Similarity=0.155  Sum_probs=93.9

Q ss_pred             ccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcc---cCCceEEEEEEEeCCceEEEEEeccC
Q 002969          546 DYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ---HRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       546 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      ..+.|+.|....+|+... +++.+++|+....   ....+..|+..|+.|.   ...+++++.++...+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            346799999999999876 5678889987542   3567889999999985   25688999998888889999999998


Q ss_pred             CChhh--------h---hhhccCCC-------------------CCCHhhHH---HHHH----------------HHHHH
Q 002969          623 RSLDS--------V---IFDKARSS-------------------ILNWQRRF---NIIC----------------GIARG  653 (862)
Q Consensus       623 gsL~~--------~---l~~~~~~~-------------------~l~~~~~~---~i~~----------------qia~g  653 (862)
                      ..+..        .   |+......                   .-+|...+   ++..                .+++.
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            87531        1   12211100                   11343221   1111                11111


Q ss_pred             -hHHhhh-cCCCcEEecccCCcceEecCCCCeeEeccc
Q 002969          654 -LLYLHQ-DSRFRIIHRDLKASNILLDKEMTPKISDFG  689 (862)
Q Consensus       654 -L~yLH~-~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  689 (862)
                       ...|.. ..++.++|+|+.+.||+++.++ +.|.|+.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             223432 2356899999999999999887 8899974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.71  E-value=0.00027  Score=75.03  Aligned_cols=81  Identities=19%  Similarity=0.254  Sum_probs=61.7

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcc-c--CCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-H--RNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H--pnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ......+.+|.|..+.||+.++.+|+.++||+-..........|..|+..|+.|. .  --+++.+++    +..++|||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e   90 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME   90 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence            3455667899999999999999999999999876555445567889999999984 2  235566654    24578999


Q ss_pred             eccCCChh
Q 002969          619 YMENRSLD  626 (862)
Q Consensus       619 ~~~~gsL~  626 (862)
                      |++.+...
T Consensus        91 ~l~~~~~~   98 (288)
T 3f7w_A           91 WVDERPPT   98 (288)
T ss_dssp             CCCCCCCC
T ss_pred             eecccCCC
Confidence            99877643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.45  E-value=0.00071  Score=75.97  Aligned_cols=78  Identities=8%  Similarity=0.023  Sum_probs=47.9

Q ss_pred             CCcEEecccCCcceEecCCCCeeEecccceeecCCCCccccccccc--ccccccChhhhcCCC---CCccccchhHHHHH
Q 002969          662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV--GTYGYMSPEYAMDGL---FSVKSDVFSFGVLL  736 (862)
Q Consensus       662 ~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~--gt~~y~APE~l~~~~---~s~ksDVwSlGvil  736 (862)
                      ...++|+|++|.|||++.++ ++|.||+.+..-...   .......  -...|.+|+......   -....++......+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~---~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG---FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH---HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH---HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            45699999999999998876 999999988753110   0000011  123466666543111   11234566778888


Q ss_pred             HHHHhCC
Q 002969          737 LETVSGK  743 (862)
Q Consensus       737 ~elltG~  743 (862)
                      |+.+++.
T Consensus       307 ~~~y~~~  313 (420)
T 2pyw_A          307 WNLFNKR  313 (420)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            8877653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.24  E-value=0.0012  Score=70.94  Aligned_cols=159  Identities=12%  Similarity=0.127  Sum_probs=89.4

Q ss_pred             cChHHHHHHcccccc-----cceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCC--ceEEE
Q 002969          532 FDFETIVRATDNFTD-----YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN--LVRLL  604 (862)
Q Consensus       532 ~~~~~i~~~~~~f~~-----~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~  604 (862)
                      ++.+++......|..     .+.|+.|....+|+....++ .+++|+....  ...+++..|+.++..+...+  +++++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            444555555455543     34567788889999987555 6888988652  12345667888888885322  33333


Q ss_pred             EE------EEeCCceEEEEEeccCCChhh----h----------hhhccCC---C------CCCHhhHHH----------
Q 002969          605 GC------CVEMDEKMLVYEYMENRSLDS----V----------IFDKARS---S------ILNWQRRFN----------  645 (862)
Q Consensus       605 g~------~~~~~~~~lV~E~~~~gsL~~----~----------l~~~~~~---~------~l~~~~~~~----------  645 (862)
                      ..      ....+..+++++|++|..+..    .          ++.....   .      ...|...+.          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      122356789999999876432    0          1111000   0      011222100          


Q ss_pred             --HHHHHHHHhHHhhhc----CCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          646 --IICGIARGLLYLHQD----SRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       646 --i~~qia~gL~yLH~~----~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                        +...+.+.++.|+..    .+..++|+|+++.|||++++..+.|.||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              111244455555532    234699999999999998876668999987753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.19  E-value=0.0011  Score=74.68  Aligned_cols=73  Identities=19%  Similarity=0.283  Sum_probs=51.6

Q ss_pred             cceeeccccEEEEEeEecC--------CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCc-eEEEEEEEeCCceEEEE
Q 002969          547 YNKLGQGGFGIVYKGRLLE--------GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL-VRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~g~~~~~~~~~lV~  617 (862)
                      .+.|+.|-...+|+....+        ++.+++|+....  ...+.+..|..+++.+...++ +++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3578888889999998653        478999987432  112566689999999864444 667776542    3899


Q ss_pred             EeccCCCh
Q 002969          618 EYMENRSL  625 (862)
Q Consensus       618 E~~~~gsL  625 (862)
                      ||+++.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987555

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.16  E-value=0.0015  Score=69.61  Aligned_cols=72  Identities=10%  Similarity=0.166  Sum_probs=48.1

Q ss_pred             cceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCc-eEEEEEEEeCCceEEEEEec-cCCC
Q 002969          547 YNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL-VRLLGCCVEMDEKMLVYEYM-ENRS  624 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~g~~~~~~~~~lV~E~~-~~gs  624 (862)
                      .+.|+.|....+|+.     +.+++|+....... .....+|+.+++.+...++ ++++++  +.+.-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            578999999999998     56888887654222 2234578888888854333 466654  344568899999 6655


Q ss_pred             hh
Q 002969          625 LD  626 (862)
Q Consensus       625 L~  626 (862)
                      |.
T Consensus        95 l~   96 (301)
T 3dxq_A           95 MS   96 (301)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.05  E-value=0.0027  Score=71.89  Aligned_cols=74  Identities=14%  Similarity=0.201  Sum_probs=49.5

Q ss_pred             ceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCc-eEEEEEEEeCCceEEEEEeccCCCh
Q 002969          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL-VRLLGCCVEMDEKMLVYEYMENRSL  625 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~g~~~~~~~~~lV~E~~~~gsL  625 (862)
                      +.|+.|-...+|+....+ ++.+++|+......... .-.+|..+++.|...++ +++++.+.  +  .+|+||+++.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            678888889999998765 47888888754322211 22589999999965444 56777763  2  259999998665


Q ss_pred             h
Q 002969          626 D  626 (862)
Q Consensus       626 ~  626 (862)
                      .
T Consensus       189 ~  189 (458)
T 2qg7_A          189 S  189 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.03  E-value=0.0023  Score=70.61  Aligned_cols=141  Identities=19%  Similarity=0.209  Sum_probs=83.3

Q ss_pred             ceeeccccEEEEEeEec--------CCcEEEEEEeccCCccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCceEEEEE
Q 002969          548 NKLGQGGFGIVYKGRLL--------EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      +.|..|-...+|+....        +++.+++|+.... ......+.+|.++++.+. +.-.+++++++.+    -+|+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            56777778889998764        2478999886332 234566779999999985 3333667776643    29999


Q ss_pred             eccCCChhhh-----------------hhhcc--CCCCCC--HhhHHHHHHHHHH-------------------HhHH--
Q 002969          619 YMENRSLDSV-----------------IFDKA--RSSILN--WQRRFNIICGIAR-------------------GLLY--  656 (862)
Q Consensus       619 ~~~~gsL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~qia~-------------------gL~y--  656 (862)
                      |++|..|..-                 |+...  -.....  +.++.++..++..                   .+..  
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998766421                 01100  011111  3333334333321                   1222  


Q ss_pred             --hhhc-CCCcEEecccCCcceEecCC----CCeeEecccceee
Q 002969          657 --LHQD-SRFRIIHRDLKASNILLDKE----MTPKISDFGMARI  693 (862)
Q Consensus       657 --LH~~-~~~~ivHrDlkp~NILl~~~----~~~kL~DFGla~~  693 (862)
                        |... ....++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              2222 23569999999999999876    7899999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.92  E-value=0.0054  Score=66.20  Aligned_cols=141  Identities=16%  Similarity=0.127  Sum_probs=75.0

Q ss_pred             ceeeccccEE-EEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhccc--CCceEEEEEEEeCCceEEEEEeccCCC
Q 002969          548 NKLGQGGFGI-VYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH--RNLVRLLGCCVEMDEKMLVYEYMENRS  624 (862)
Q Consensus       548 ~~LG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gs  624 (862)
                      +.|+.|+... +|+....+++.+++|......   .+.+..|+.+++.+..  -.+++++.+..+  .-+++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCcc
Confidence            4565554444 667665446778777654322   1445678888888753  235667776433  2378999998766


Q ss_pred             hhhhhhhcc---------------------CC--CCCCHhhHH-------H-------------HHHHHHHHhHHhh---
Q 002969          625 LDSVIFDKA---------------------RS--SILNWQRRF-------N-------------IICGIARGLLYLH---  658 (862)
Q Consensus       625 L~~~l~~~~---------------------~~--~~l~~~~~~-------~-------------i~~qia~gL~yLH---  658 (862)
                      +.+++....                     ..  ..++.....       .             ....+.+.++.|.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654332110                     00  011110000       0             0001112222221   


Q ss_pred             hcCCCcEEecccCCcceEecCC----CCeeEecccceee
Q 002969          659 QDSRFRIIHRDLKASNILLDKE----MTPKISDFGMARI  693 (862)
Q Consensus       659 ~~~~~~ivHrDlkp~NILl~~~----~~~kL~DFGla~~  693 (862)
                      ......++|+|+.+.|||++.+    +.+.|.||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1123569999999999999875    6789999998865

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.90  E-value=0.0089  Score=64.21  Aligned_cols=158  Identities=14%  Similarity=0.134  Sum_probs=90.1

Q ss_pred             cChHHHHHHccccc-----ccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCC--ceEEE
Q 002969          532 FDFETIVRATDNFT-----DYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN--LVRLL  604 (862)
Q Consensus       532 ~~~~~i~~~~~~f~-----~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~  604 (862)
                      .+.+.+....+.|.     ..+.|+ |....||+....+|+.+++|+..... ...+.+..|..++..+....  +++++
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~   88 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV   88 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence            44455544444442     224566 77889999877777789999986332 23456778898888885322  44444


Q ss_pred             EE-----EEeCCceEEEEEeccCCChhh----h----------hhhcc------CCCCCCHhhH----HHH---------
Q 002969          605 GC-----CVEMDEKMLVYEYMENRSLDS----V----------IFDKA------RSSILNWQRR----FNI---------  646 (862)
Q Consensus       605 g~-----~~~~~~~~lV~E~~~~gsL~~----~----------l~~~~------~~~~l~~~~~----~~i---------  646 (862)
                      ..     ....+..++++|+++|..+..    .          ++...      .....++...    ..+         
T Consensus        89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  168 (328)
T 1zyl_A           89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS  168 (328)
T ss_dssp             CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred             ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence            43     122445678999999865431    0          11110      0111222110    000         


Q ss_pred             ------HHHHHHHhHHhhhc----CCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          647 ------ICGIARGLLYLHQD----SRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       647 ------~~qia~gL~yLH~~----~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                            ...+.+.++.+...    .+..++|+|+++.|||++ + .+.|.||+.+..
T Consensus       169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                  11111222333221    234689999999999999 4 899999987754

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.73  E-value=0.0043  Score=68.13  Aligned_cols=73  Identities=11%  Similarity=0.141  Sum_probs=46.2

Q ss_pred             ceeeccccEEEEEeEecC---------CcEEEEEEeccCCccchHHHHHHHHHHHhcccCC-ceEEEEEEEeCCceEEEE
Q 002969          548 NKLGQGGFGIVYKGRLLE---------GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN-LVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~g~~~~~~~~~lV~  617 (862)
                      +.|+.|....+|+....+         ++.+++|+...... .......|.++++.+...+ .+++++..    .-.+|+
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence            567778888999987654         26788887754322 2223468899999886444 45676554    236899


Q ss_pred             EeccCCCh
Q 002969          618 EYMENRSL  625 (862)
Q Consensus       618 E~~~~gsL  625 (862)
                      ||++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99998654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.13  E-value=0.019  Score=62.23  Aligned_cols=64  Identities=9%  Similarity=0.107  Sum_probs=43.3

Q ss_pred             cEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhccc---CCceEEEEE------EEeCCceEEEEEeccCCCh
Q 002969          555 FGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH---RNLVRLLGC------CVEMDEKMLVYEYMENRSL  625 (862)
Q Consensus       555 fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~g~------~~~~~~~~lV~E~~~~gsL  625 (862)
                      ...||+....++ .+++|+......      ..|+.++..|..   |.+++.+..      ....+..+++|+|++|..+
T Consensus        36 ~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~  108 (339)
T 3i1a_A           36 NAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG  108 (339)
T ss_dssp             SCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred             ccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence            578999987667 899998755431      356777777642   224555432      2335667899999998776

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.96  E-value=0.024  Score=56.60  Aligned_cols=103  Identities=11%  Similarity=0.092  Sum_probs=66.3

Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcccc
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQN  702 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  702 (862)
                      -+|.++|...  ..++++.+++.++.|.+++|.-+-.... + ..+=+.|..|+|..+|.+.+.+ ..+.          
T Consensus        33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence            4788888543  4569999999999999999877622110 1 1333457999999999988764 1110          


Q ss_pred             cccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCC
Q 002969          703 TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKN  745 (862)
Q Consensus       703 ~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p  745 (862)
                          .....+.|||... ...+.+.=|||||+++|..+--..|
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                1123466888653 3456788999999999998775544

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.50  E-value=0.038  Score=61.68  Aligned_cols=73  Identities=12%  Similarity=0.204  Sum_probs=49.4

Q ss_pred             ceeeccccEEEEEeEecC--------CcEEEEEEeccCCccchHHHHHHHHHHHhcccCC-ceEEEEEEEeCCceEEEEE
Q 002969          548 NKLGQGGFGIVYKGRLLE--------GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN-LVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~g~~~~~~~~~lV~E  618 (862)
                      +.|..|-...+|+....+        ++.+++|+....... .-.-.+|.++++.+.-.+ .+++++.+    .-.+|+|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEE
Confidence            567777788899987753        578999886543322 223468999999885333 45566543    2378999


Q ss_pred             eccCCCh
Q 002969          619 YMENRSL  625 (862)
Q Consensus       619 ~~~~gsL  625 (862)
                      |++|..|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998765

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.96  E-value=0.93  Score=49.97  Aligned_cols=30  Identities=27%  Similarity=0.393  Sum_probs=25.3

Q ss_pred             cEEecccCCcceEe------cCCCCeeEecccceee
Q 002969          664 RIIHRDLKASNILL------DKEMTPKISDFGMARI  693 (862)
Q Consensus       664 ~ivHrDlkp~NILl------~~~~~~kL~DFGla~~  693 (862)
                      .++|+|+.+.|||+      +++..++++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      4567799999998864

>3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae}

Probab=86.83  E-value=24  Score=36.00  Aligned_cols=72  Identities=13%  Similarity=0.185  Sum_probs=45.2

Q ss_pred             EEEEEEeecCCceeEEeeCCCCC--CC----CCCceEEEEcc-eeEEEcCCCCeEEccCCCC-CCccEEEEecCCCeEEE
Q 002969           93 YIGIWYKNIAQRTYVWVANRDDP--LA----NSSGVLRIINQ-RIGLFDGSQNLVWSSNQTK-ATNPVAQLQDSGNFVLK  164 (862)
Q Consensus        93 y~gIw~~~~~~~t~vWvAnr~~p--~~----~~~~~l~~~~~-~~~l~~~~~~~vWst~~~~-~~~~~a~l~d~GNlVl~  164 (862)
                      .+.||=  ....+++|...+..+  +.    .+.+.+.++.+ ++..+|.+|..+|.-.... .....++.+.+||+++-
T Consensus        16 ~v~~~d--~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~   93 (276)
T 3no2_A           16 KIAIIN--KDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVA   93 (276)
T ss_dssp             EEEEEE--TTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEE
T ss_pred             EEEEEE--CCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEE
Confidence            355662  235678888877542  11    13455666555 4566899999999876542 23345677788888887


Q ss_pred             ec
Q 002969          165 EA  166 (862)
Q Consensus       165 ~~  166 (862)
                      +.
T Consensus        94 ~~   95 (276)
T 3no2_A           94 WC   95 (276)
T ss_dssp             EE
T ss_pred             ec
Confidence            54

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=85.04  E-value=0.14  Score=36.96  Aligned_cols=32  Identities=38%  Similarity=0.456  Sum_probs=14.3

Q ss_pred             CCCCccEEEeeehHHHHHH-HHHHhhheeeecc
Q 002969          454 GANATPIIIGVTVGSAILI-LGLVACFLWRRKT  485 (862)
Q Consensus       454 ~~~~~~iiig~~v~~~ilv-~~~~~~~~~rrk~  485 (862)
                      +++...|+.|++.+.++++ +++++++++|||+
T Consensus         6 ~s~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr   38 (44)
T 2l2t_A            6 HARTPLIAAGVIGGLFILVIVGLTFAVYVRRKS   38 (44)
T ss_dssp             SCSSHHHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CCCcceEEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence            3444444445544444333 3344445555543

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=81.73  E-value=0.29  Score=35.29  Aligned_cols=28  Identities=21%  Similarity=0.356  Sum_probs=12.2

Q ss_pred             ccEEEeeehHHHHHH-HHHHhhheeeecc
Q 002969          458 TPIIIGVTVGSAILI-LGLVACFLWRRKT  485 (862)
Q Consensus       458 ~~iiig~~v~~~ilv-~~~~~~~~~rrk~  485 (862)
                      ..|+.+++.+.++++ +++++++++|||+
T Consensus        11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~   39 (44)
T 2ks1_B           11 PSIATGMVGALLLLLVVALGIGLFMRRRH   39 (44)
T ss_dssp             SSSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             ceEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence            344445544444333 3334444555443

>3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae}

Probab=80.24  E-value=8.1  Score=39.73  Aligned_cols=63  Identities=8%  Similarity=0.027  Sum_probs=38.9

Q ss_pred             CceeEEeeCCCC-CCC---CCCceEEEEc--ce-eEEEcCC-CCeEEccCCC---C---CCccEEEEecCCCeEEEe
Q 002969          103 QRTYVWVANRDD-PLA---NSSGVLRIIN--QR-IGLFDGS-QNLVWSSNQT---K---ATNPVAQLQDSGNFVLKE  165 (862)
Q Consensus       103 ~~t~vWvAnr~~-p~~---~~~~~l~~~~--~~-~~l~~~~-~~~vWst~~~---~---~~~~~a~l~d~GNlVl~~  165 (862)
                      +..++|...+.. |..   ...+.+.+..  ++ ++.+|.+ |.++|+-...   .   .....+.++.+||+++.+
T Consensus       154 ~G~~~w~~~~~~~~~~~~~~~~g~~~v~~~~~~~v~~~d~~tG~~~w~~~~~~~~~~~l~~~~~~~~~~~G~i~v~~  230 (276)
T 3no2_A          154 NGQLLNSVKLSGTPFSSAFLDNGDCLVACGDAHCFVQLNLESNRIVRRVNANDIEGVQLFFVAQLFPLQNGGLYICN  230 (276)
T ss_dssp             TSCEEEEEECSSCCCEEEECTTSCEEEECBTTSEEEEECTTTCCEEEEEEGGGSBSCCCSEEEEEEECTTSCEEEEE
T ss_pred             CCCEEEEEECCCCccceeEcCCCCEEEEeCCCCeEEEEeCcCCcEEEEecCCCCCCccccccccceEcCCCCEEEEe
Confidence            357788877653 321   1234444433  23 5567877 9999986532   1   124567888999999987

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	862
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-77
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-69
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-68
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-67
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-66
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-66
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-64
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-64
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-64
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-64
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-63
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-63
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-63
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-63
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-62
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-62
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-61
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-61
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-61
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-60
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-60
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-60
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-58
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-58
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-57
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-56
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-55
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-52
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-51
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-49
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-48
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-47
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-46
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-46
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-46
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-46
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-45
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-44
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-44
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-44
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-43
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-43
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-43
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-41
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-39
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-38
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-36
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-35
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-33
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-32
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-25
d1kj1a_	109	b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium	2e-17
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	4e-13
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	1e-12
d1jpca_	108	b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan	3e-11
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	1e-09
d1dlpa1	115	b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p	1e-07

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  250 bits (640), Expect = 2e-77
 Identities = 74/302 (24%), Positives = 140/302 (46%), Gaps = 29/302 (9%)

Query: 525 DDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEE 584
           DD E+P              T   ++G G FG VYKG+      + +  ++  + Q ++ 
Sbjct: 1   DDWEIPD----------GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA 50

Query: 585 FKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           FKNEV ++ K +H N++  +G      +  +V ++ E  SL   +            +  
Sbjct: 51  FKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLI 107

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
           +I    A+G+ YLH  S   IIHRDLK++NI L +++T KI DFG+A +          +
Sbjct: 108 DIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164

Query: 705 RVVGTYGYMSPEYAM---DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV 761
           ++ G+  +M+PE         +S +SDV++FG++L E ++G+    + + NN   ++  V
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMV 222

Query: 762 WRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATM 821
            R          +   +    +N       +   C+++  +ERP    ++  +     ++
Sbjct: 223 GR--------GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

Query: 822 PQ 823
           P+
Sbjct: 275 PK 276

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (578), Expect = 8e-69
 Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 23/275 (8%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
              T   ++G G FG+V+ G  L   ++A+K + R      E+F  E  ++ KL H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +L G C+E     LV+E+ME+  L    + + +  +   +    +   +  G+ YL +  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEA- 120

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
              +IHRDL A N L+ +    K+SDFGM R    DQ   ++        + SPE     
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFS 177

Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL-NLLGHVWRLWKEGKVLEMVDSSVDN 780
            +S KSDV+SFGVL+ E  S  K      SN+E+   +   +RL+K              
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-------------- 223

Query: 781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS 815
            P         +   C +E  E+RP  + ++  L+
Sbjct: 224 -PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (578), Expect = 1e-68
 Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 21/273 (7%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           +      +LG G FG V+ G      ++AVK L + S    + F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           RL     + +   ++ EYMEN SL   +        L   +  ++   IA G+ ++ + +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               IHRDL+A+NIL+   ++ KI+DFG+AR+   ++             + +PE    G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185

Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY 781
            F++KSDV+SFG+LL E V+  +      +N E      V +  + G  +          
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGYRMVR-------- 231

Query: 782 PANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
           P N       +  LC +E  E+RPT   +  +L
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (568), Expect = 4e-67
 Identities = 75/287 (26%), Positives = 125/287 (43%), Gaps = 21/287 (7%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
           ++     KLGQG FG V+ G       +A+K L   +    E F  E +++ KL+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +L       +   +V EYM   SL   +  +     L   +  ++   IA G+ Y+ +  
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER-- 131

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
               +HRDL+A+NIL+ + +  K++DFG+AR+   ++             + +PE A+ G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189

Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY 781
            F++KSDV+SFG+LL E  +  +    Y       +L  V R ++               
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV--PYPGMVNREVLDQVERGYRM------------PC 235

Query: 782 PANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPG 828
           P         +   C ++  EERPT   +   L     +      PG
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  219 bits (559), Expect = 7e-66
 Identities = 77/292 (26%), Positives = 133/292 (45%), Gaps = 23/292 (7%)

Query: 526 DLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEE 584
           D   P +D   + R   + T  +KLG G +G VY+G   +    +AVK L  ++ + +EE
Sbjct: 3   DPSSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEE 59

Query: 585 FKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRF 644
           F  E  ++ +++H NLV+LLG C       ++ E+M   +L   + +  R   ++     
Sbjct: 60  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLL 118

Query: 645 NIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK 704
            +   I+  + YL +      IHRDL A N L+ +    K++DFG++R+  GD    +  
Sbjct: 119 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA- 174

Query: 705 RVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
                  + +PE      FS+KSDV++FGVLL E  +   +   Y   +    L  V+ L
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS--PYPGID----LSQVYEL 228

Query: 765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS 816
            ++   +E         P     +   +   C Q N  +RP+ A +     +
Sbjct: 229 LEKDYRME--------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  220 bits (560), Expect = 9e-66
 Identities = 74/320 (23%), Positives = 131/320 (40%), Gaps = 55/320 (17%)

Query: 523 KTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSR 576
           K   LE P  + E +            +G+G FG V++ R            +AVK L  
Sbjct: 4   KLLSLEYPRNNIEYV----------RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE 53

Query: 577 NSGQGIE-EFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARS 635
            +   ++ +F+ E  L+A+  + N+V+LLG C       L++EYM    L+  +   +  
Sbjct: 54  EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 113

Query: 636 SI---------------------LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASN 674
           ++                     L+   +  I   +A G+ YL +    + +HRDL   N
Sbjct: 114 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRN 170

Query: 675 ILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGV 734
            L+ + M  KI+DFG++R        +          +M PE      ++ +SDV+++GV
Sbjct: 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 230

Query: 735 LLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGL 794
           +L E  S      +Y   +E      V    ++G +L          P N  L   ++  
Sbjct: 231 VLWEIFSYGLQP-YYGMAHE-----EVIYYVRDGNILA--------CPENCPLELYNLMR 276

Query: 795 LCVQENAEERPTMASVVLML 814
           LC  +   +RP+  S+  +L
Sbjct: 277 LCWSKLPADRPSFCSIHRIL 296

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 7e-65
 Identities = 74/308 (24%), Positives = 122/308 (39%), Gaps = 37/308 (12%)

Query: 540 ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQH 597
             D+F   ++LG G  G+V+K      G  +A K +       I  +   E++++ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             +V   G      E  +  E+M+  SLD V+    R   +  Q    +   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
               + +I+HRD+K SNIL++     K+ DFG++               VGT  YMSPE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                +SV+SD++S G+ L+E   G+        + +              ++  M    
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR--YPIPPPDAK--------------ELELMFGCQ 218

Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGF-------- 829
           V+   A    R    G        + RP MA   L+        P+  +  F        
Sbjct: 219 VEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 278

Query: 830 --CLGRNP 835
             CL +NP
Sbjct: 279 NKCLIKNP 286

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 8e-65
 Identities = 69/273 (25%), Positives = 115/273 (42%), Gaps = 21/273 (7%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
            + T   +LG G FG+V  G+     ++A+K +   S    +EF  E +++  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           +L G C +     ++ EYM N  L + + +         Q+   +   +   + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDG 721
             + +HRDL A N L++ +   K+SDFG++R    D+   +         +  PE  M  
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYS 176

Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY 781
            FS KSD+++FGVL+ E  S  K   +    N             +G  L          
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK-MPYERFTNS-----ETAEHIAQGLRLYR-------- 222

Query: 782 PANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
           P     +   +   C  E A+ERPT   ++  +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  216 bits (552), Expect = 1e-64
 Identities = 71/300 (23%), Positives = 124/300 (41%), Gaps = 36/300 (12%)

Query: 532 FDFETIVRATDNFTDY---------NKLGQGGFGIVYKGRLL----EGQEIAVKRLSRN- 577
           F FE    A   F              +G G FG V  G L         +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 578 SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI 637
           + +   +F +E  ++ +  H N++ L G   +    M++ E+MEN SLD   F +     
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD--SFLRQNDGQ 124

Query: 638 LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD 697
               +   ++ GIA G+ YL        +HRDL A NIL++  +  K+SDFG++R    D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 698 QTEQNTKRVVG---TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
            ++      +G      + +PE      F+  SDV+S+G+++ E +S  +    Y     
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--PYWDMTN 239

Query: 755 LNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
            +++  + + ++               P +       + L C Q++   RP    +V  L
Sbjct: 240 QDVINAIEQDYRL------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 2e-64
 Identities = 71/274 (25%), Positives = 116/274 (42%), Gaps = 27/274 (9%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV 601
                   +G+G FG V  G    G ++AVK +  ++    + F  E  ++ +L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 602 RLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           +LLG  VE    + +V EYM   SL   +  + RS +L           +   + YL  +
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 661 SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD 720
                +HRDL A N+L+ ++   K+SDFG+ +     Q             + +PE   +
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALRE 174

Query: 721 GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN 780
             FS KSDV+SFG+LL E  S  +    Y      +++  V    ++G  ++  D     
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV--PYPRIPLKDVVPRV----EKGYKMDAPDGCPP- 227

Query: 781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
                      V   C   +A  RP+   +   L
Sbjct: 228 -------AVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 4e-64
 Identities = 68/291 (23%), Positives = 123/291 (42%), Gaps = 26/291 (8%)

Query: 540 ATDNFTDYN-KLGQGGFGIVYKGRLL---EGQEIAVKRLSRNSGQG-IEEFKNEVRLIAK 594
             DN    + +LG G FG V +G      +  ++A+K L + + +   EE   E +++ +
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           L +  +VRL+G C + +  MLV E      L   +  K     +       ++  ++ G+
Sbjct: 66  LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR-VVGTYGYM 713
            YL + +    +HRDL A N+LL      KISDFG+++  G D +    +        + 
Sbjct: 123 KYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM 773
           +PE      FS +SDV+S+GV + E +S  + + +            V    ++GK +E 
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ-KPYKKMKGP-----EVMAFIEQGKRMEC 233

Query: 774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQP 824
                   P         +   C     E+RP   +V   + +   ++   
Sbjct: 234 --------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 4e-64
 Identities = 65/291 (22%), Positives = 118/291 (40%), Gaps = 29/291 (9%)

Query: 549 KLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCV 608
            +G+G FG V++G+   G+E+AVK  S    +     + E+     L+H N++  +    
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67

Query: 609 EMDEK----MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD---- 660
           + +       LV +Y E+ SL   +        +  +    +    A GL +LH +    
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 661 -SRFRIIHRDLKASNILLDKEMTPKISDFGMARIF--GGDQTEQNTKRVVGTYGYMSPEY 717
             +  I HRDLK+ NIL+ K  T  I+D G+A       D  +      VGT  YM+PE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 718 AMDGL------FSVKSDVFSFGVLLLETVSGKKNRGFYHSNN----ELNLLGHVWRLWKE 767
             D +         ++D+++ G++  E        G +        +L          ++
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 768 GKVLEMVDSSV-DNYPANEVLRCIH-VGLLCVQENAEERPTMASVVLMLSS 816
               + +  ++ + + + E LR +  +   C   N   R T   +   LS 
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 2e-63
 Identities = 73/275 (26%), Positives = 119/275 (43%), Gaps = 27/275 (9%)

Query: 548 NKLGQGGFGIVYKGRLLE---GQEIAVKRLSR--NSGQGIEEFKNEVRLIAKLQHRNLVR 602
            +LG G FG V KG        + +AVK L    N     +E   E  ++ +L +  +VR
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 603 LLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSR 662
           ++G C E +  MLV E  E   L+  +        +  +    ++  ++ G+ YL +   
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES-- 126

Query: 663 FRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTK-RVVGTYGYMSPEYAMDG 721
              +HRDL A N+LL  +   KISDFG+++    D+     +        + +PE     
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 722 LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY 781
            FS KSDV+SFGVL+ E  S  + + +            V  + ++G+ +          
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQ-KPYRGMKGS-----EVTAMLEKGERMG--------C 231

Query: 782 PANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS 816
           PA        +  LC   + E RP  A+V L L +
Sbjct: 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 2e-63
 Identities = 72/277 (25%), Positives = 125/277 (45%), Gaps = 27/277 (9%)

Query: 548 NKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHRNLVR 602
             +G+G FG VY G LL+        AVK L+R +  G + +F  E  ++    H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 603 LLGCCVEMDEK-MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
           LLG C+  +   ++V  YM++  L + I ++  +  +     F +          +   +
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLA 147

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR--VVGTYGYMSPEYAM 719
             + +HRDL A N +LD++ T K++DFG+AR     + +    +        +M+ E   
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD 779
              F+ KSDV+SFGVLL E ++       Y   N  ++  ++     +G+ L        
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLL----QGRRLL------- 254

Query: 780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS 816
             P         V L C    AE RP+ + +V  +S+
Sbjct: 255 -QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 8e-63
 Identities = 68/299 (22%), Positives = 118/299 (39%), Gaps = 39/299 (13%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNSGQG-IEEFKNEVRLIAK 594
           +  +    LG G FG V +              +AVK L  ++     E   +E+++++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 595 L-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI---------------L 638
           L  H N+V LLG C      +++ EY     L + +  K  S I               L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 639 NWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ 698
           + +   +    +A+G+ +L        IHRDL A NILL      KI DFG+AR    D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL 758
                        +M+PE   + +++ +SDV+S+G+ L E  S   +       +     
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---- 255

Query: 759 GHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE 817
              +++ KEG  +          P +       +   C   +  +RPT   +V ++  +
Sbjct: 256 -KFYKMIKEGFRML--------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 8e-63
 Identities = 67/304 (22%), Positives = 119/304 (39%), Gaps = 44/304 (14%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNSGQG-IEEFKNEVRLIAK 594
           +N      LG G FG V               ++AVK L   +     E   +E++++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 595 L-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDK--------------------A 633
           L  H N+V LLG C       L++EY     L + +  K                     
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 634 RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARI 693
             ++L ++        +A+G+ +L        +HRDL A N+L+      KI DFG+AR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNN 753
              D              +M+PE   +G++++KSDV+S+G+LL E  S      +     
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPV 272

Query: 754 ELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM 813
           + N     ++L + G  ++         P         +   C   ++ +RP+  ++   
Sbjct: 273 DANF----YKLIQNGFKMD--------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

Query: 814 LSSE 817
           L  +
Sbjct: 321 LGCQ 324

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 3e-62
 Identities = 75/319 (23%), Positives = 136/319 (42%), Gaps = 33/319 (10%)

Query: 537 IVRATDNFTDYNKLGQGGFGIVYKGRLLEGQE-----IAVKRLSR-NSGQGIEEFKNEVR 590
           I++ T+ F     LG G FG VYKG  +   E     +A+K L    S +  +E  +E  
Sbjct: 5   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63

Query: 591 LIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           ++A + + ++ RLLG C+      L+ + M    L   + +   +     Q   N    I
Sbjct: 64  VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQI 120

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
           A+G+ YL      R++HRDL A N+L+      KI+DFG+A++ G ++ E + +      
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV 770
            +M+ E  +  +++ +SDV+S+GV + E ++       Y       +   +    ++G+ 
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISSIL----EKGER 231

Query: 771 LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTPGFC 830
           L          P    +    + + C   +A+ RP    +++  S         + P   
Sbjct: 232 LP--------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA------RDPQRY 277

Query: 831 LGRNPIETDSSSSKHDETF 849
           L     E     S  D  F
Sbjct: 278 LVIQGDERMHLPSPTDSNF 296

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 4e-62
 Identities = 70/286 (24%), Positives = 130/286 (45%), Gaps = 29/286 (10%)

Query: 534 FETIVR---ATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEV 589
           +E + R     D +    +LG G FG VYK +  E     A K +   S + +E++  E+
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 590 RLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICG 649
            ++A   H N+V+LL      +   ++ E+    ++D+V+ +  R   L   +   +   
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQ 118

Query: 650 IARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGT 709
               L YLH     +IIHRDLKA NIL   +   K++DFG++         +++   +GT
Sbjct: 119 TLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGT 173

Query: 710 YGYMSPEYAM-----DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
             +M+PE  M     D  +  K+DV+S G+ L+E    +     +H  N + +L  +   
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP---PHHELNPMRVLLKI--- 227

Query: 765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASV 810
             + +   +   S  +    + L+       C+++N + R T + +
Sbjct: 228 -AKSEPPTLAQPSRWSSNFKDFLKK------CLEKNVDARWTTSQL 266

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 2e-61
 Identities = 77/292 (26%), Positives = 126/292 (43%), Gaps = 26/292 (8%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQE-----IAVKRLSRNSGQG-IEEFKNEVRLIAKL 595
              T    +G G FG VYKG L          +A+K L     +    +F  E  ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 596 QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
            H N++RL G   +    M++ EYMEN +LD   F + +    +  +   ++ GIA G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 656 YLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT-KRVVGTYGYMS 714
           YL        +HRDL A NIL++  +  K+SDFG++R+   D     T         + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 715 PEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV 774
           PE      F+  SDV+SFG+++ E ++  +   +  SN+E      V +   +G  L   
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDGFRLP-- 233

Query: 775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKT 826
                  P +       + + C Q+    RP  A +V +L          KT
Sbjct: 234 ------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKT 279

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  207 bits (529), Expect = 3e-61
 Identities = 75/278 (26%), Positives = 122/278 (43%), Gaps = 33/278 (11%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG---IEEFKNEVRLIAKLQ 596
              F+D  ++G G FG VY  R +   + +A+K++S +  Q     ++   EVR + KL+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H N ++  GC +      LV EY    + D +   K     L       +  G  +GL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           LH      +IHRD+KA NILL +    K+ DFG A I             VGT  +M+PE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181

Query: 717 YAM---DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM 773
             +   +G +  K DV+S G+  +E       +    + N ++ L H+ +     +   +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAER---KPPLFNMNAMSALYHIAQ----NESPAL 234

Query: 774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
                  Y  N V  C+       Q+  ++RPT   ++
Sbjct: 235 QSGHWSEYFRNFVDSCL-------QKIPQDRPTSEVLL 265

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 3e-61
 Identities = 66/272 (24%), Positives = 115/272 (42%), Gaps = 22/272 (8%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLS-RNSGQGIEEFKNEVRLIAKLQHRN 599
           +++     LG+G +G V         + +AVK +  + +    E  K E+ +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+  G   E + + L  EY     L   I        +           +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
                I HRD+K  N+LLD+    KISDFG+A +F  +  E+   ++ GT  Y++PE   
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 720 DGLF-SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
              F +   DV+S G++L   ++G+    +   ++        +  WKE K        +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQE----YSDWKEKKTYLNPWKKI 232

Query: 779 DNYPANEVLRCIHVGLLCVQENAEERPTMASV 810
           D+ P   + + +        EN   R T+  +
Sbjct: 233 DSAPLALLHKIL-------VENPSARITIPDI 257

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (524), Expect = 4e-61
 Identities = 71/278 (25%), Positives = 119/278 (42%), Gaps = 25/278 (8%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHR 598
           +++     +G G +G   K R    G+ +  K L   S      +   +EV L+ +L+H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 599 NLVRLLGCCVEMDEKML--VYEYMENRSLDSVIFDKARSS-ILNWQRRFNIICGIARGLL 655
           N+VR     ++     L  V EY E   L SVI    +    L+ +    ++  +   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 656 YLHQ--DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
             H+  D    ++HRDLK +N+ LD +   K+ DFG+ARI   D +    K  VGT  YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYM 181

Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM 773
           SPE      ++ KSD++S G LL E  +       + + ++  L G +    +EGK   +
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELAGKI----REGKFRRI 234

Query: 774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
                   P         +    +      RP++  ++
Sbjct: 235 --------PYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 3e-60
 Identities = 77/287 (26%), Positives = 116/287 (40%), Gaps = 27/287 (9%)

Query: 536 TIVRATDNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSR---NSGQGIEEFKNE 588
           T +    +     KLG G FG+V +G       +   +AVK L     +  + +++F  E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61

Query: 589 VRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIIC 648
           V  +  L HRNL+RL G  +    KM V E     SL   +       +L    R     
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR--YAV 118

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ-NTKRVV 707
            +A G+ YL      R IHRDL A N+LL      KI DFG+ R    +       +   
Sbjct: 119 QVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175

Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE 767
             + + +PE      FS  SD + FGV L E  +  +    +   N   +L    ++ KE
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQIL---HKIDKE 230

Query: 768 GKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLML 814
           G+ L          P +      +V + C     E+RPT  ++   L
Sbjct: 231 GERLP--------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 7e-60
 Identities = 65/272 (23%), Positives = 117/272 (43%), Gaps = 30/272 (11%)

Query: 548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLS--RNSGQGIEEFKNEVRLIAKLQHRNLVRLL 604
            ++G+G F  VYKG   E   E+A   L   + +    + FK E  ++  LQH N+VR  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 605 GCCVEMDEK----MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
                  +     +LV E M + +L + +    R  ++  +   +    I +GL +LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 661 SRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
           +   IIHRDLK  NI +     + KI D G+A +          K V+GT  +M+PE   
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEM-Y 185

Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD 779
           +  +    DV++FG+ +LE  + +    +    N   +   V    K             
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSE--YPYSECQNAAQIYRRVTSGVKP-----------A 232

Query: 780 NYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
           ++    +     +   C+++N +ER ++  ++
Sbjct: 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 7e-60
 Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 38/292 (13%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEG---QEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-Q 596
           ++    + +G+G FG V K R+ +     + A+KR+    S     +F  E+ ++ KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI-------------FDKARSSILNWQRR 643
           H N++ LLG C       L  EY  + +L   +                + +S L+ Q+ 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 644 FNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT 703
            +    +ARG+ YL Q    + IHRDL A NIL+ +    KI+DFG++R     +     
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183

Query: 704 KRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
                   +M+ E     +++  SDV+S+GVLL E VS         +  EL      + 
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YE 237

Query: 764 LWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS 815
              +G  LE         P N       +   C +E   ERP+ A +++ L+
Sbjct: 238 KLPQGYRLE--------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 2e-58
 Identities = 78/302 (25%), Positives = 135/302 (44%), Gaps = 33/302 (10%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRN-SGQGIEEFKNEVRLIAK 594
           +  T   +LGQG FG+VY+G             +A+K ++   S +   EF NE  ++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIF-------DKARSSILNWQRRFNII 647
               ++VRLLG   +    +++ E M    L S +        +    +  +  +   + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 648 CGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVV 707
             IA G+ YL+ +   + +HRDL A N ++ ++ T KI DFGM R        +   + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE 767
               +MSPE   DG+F+  SDV+SFGV+L E  +  + + +   +NE      V R   E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-QPYQGLSNE-----QVLRFVME 250

Query: 768 GKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTP 827
           G +L+  D+  D            +  +C Q N + RP+   ++  +  E    P  +  
Sbjct: 251 GGLLDKPDNCPD--------MLFELMRMCWQYNPKMRPSFLEIISSIKEEME--PGFREV 300

Query: 828 GF 829
            F
Sbjct: 301 SF 302

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 4e-58
 Identities = 65/271 (23%), Positives = 127/271 (46%), Gaps = 23/271 (8%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN 599
              +T + K+GQG  G VY    +  GQE+A+++++       E   NE+ ++ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V  L   +  DE  +V EY+   SL  V+ +          +   +     + L +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLHS 134

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
               ++IHRD+K+ NILL  + + K++DFG       +Q++++T  +VGT  +M+PE   
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189

Query: 720 DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD 779
              +  K D++S G++ +E + G+     Y + N L  L   + +   G         + 
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRAL---YLIATNGTPELQNPEKLS 243

Query: 780 NYPANEVLRCIHVGLLCVQENAEERPTMASV 810
               + + RC+ +       + E+R +   +
Sbjct: 244 AIFRDFLNRCLDM-------DVEKRGSAKEL 267

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 1e-57
 Identities = 68/274 (24%), Positives = 115/274 (41%), Gaps = 30/274 (10%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQH 597
           ++F     LG+G FG VY  R  +    +A+K L +          + + EV + + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
            N++RL G   +     L+ EY    ++   +    + S  + QR    I  +A  L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H     R+IHRD+K  N+LL      KI+DFG +      +       + GT  Y+ PE 
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
               +   K D++S GVL  E + GK     + +N        + R+  E    + V   
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP---PFEANTYQETYKRISRV--EFTFPDFVTEG 230

Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVV 811
                A +++         ++ N  +RP +  V+
Sbjct: 231 -----ARDLISR------LLKHNPSQRPMLREVL 253

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 2e-56
 Identities = 72/297 (24%), Positives = 116/297 (39%), Gaps = 38/297 (12%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNSGQG-IEEFKNEVRLIAK 594
           D       LG+G FG V +            + +AVK L   +         +E++++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 595 -LQHRNLVRLLGCCVEMDEK-MLVYEYMENRSLDSVIFDK-------------ARSSILN 639
              H N+V LLG C +     M++ E+ +  +L + +  K                  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 640 WQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT 699
            +        +A+G+ +L      + IHRDL A NILL ++   KI DFG+AR    D  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLG 759
                       +M+PE   D +++++SDV+SFGVLL E  S             + +  
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----LGASPYPGVKIDE 244

Query: 760 HVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS 816
              R  KEG  +   D +                L C      +RPT + +V  L +
Sbjct: 245 EFCRRLKEGTRMRAPDYTTP--------EMYQTMLDCWHGEPSQRPTFSELVEHLGN 293

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 4e-56
 Identities = 74/311 (23%), Positives = 131/311 (42%), Gaps = 42/311 (13%)

Query: 528 ELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE--------GQEIAVKRLSRN-S 578
           ELP      + R  D       LG+G FG V     +           ++AVK L  + +
Sbjct: 1   ELPEDPRWELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 58

Query: 579 GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSI 637
            + + +  +E+ ++  + +H+N++ LLG C +     ++ EY    +L   +  +    +
Sbjct: 59  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118

Query: 638 -------------LNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPK 684
                        L+ +   +    +ARG+ YL      + IHRDL A N+L+ ++   K
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMK 175

Query: 685 ISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKK 744
           I+DFG+AR        + T        +M+PE   D +++ +SDV+SFGVLL E  +   
Sbjct: 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235

Query: 745 NRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEER 804
              +     E      +++L KEG  ++         P+N       +   C      +R
Sbjct: 236 -SPYPGVPVE-----ELFKLLKEGHRMD--------KPSNCTNELYMMMRDCWHAVPSQR 281

Query: 805 PTMASVVLMLS 815
           PT   +V  L 
Sbjct: 282 PTFKQLVEDLD 292

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 4e-55
 Identities = 62/280 (22%), Positives = 108/280 (38%), Gaps = 26/280 (9%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNSGQGI-EEFKNEVRLIAKLQ 596
           +       +G+G FG V++G  +        +A+K     +   + E+F  E   + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H ++V+L+G   E +   ++ E      L S +  +  S  L+          ++  L Y
Sbjct: 67  HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           L      R +HRD+ A N+L+      K+ DFG++R    D T     +      +M+PE
Sbjct: 124 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPE 179

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS 776
                 F+  SDV+ FGV + E +           NN+      V    + G+ L M   
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPM--- 230

Query: 777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS 816
                P N       +   C   +   RP    +   LS+
Sbjct: 231 -----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  184 bits (469), Expect = 2e-52
 Identities = 58/272 (21%), Positives = 110/272 (40%), Gaps = 23/272 (8%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           D++  + +LG G FG+V++      G   A K +        E  + E++ ++ L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           V L     + +E +++YE+M    L   + D+     ++       +  + +GL ++H++
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHEN 143

Query: 661 SRFRIIHRDLKASNILL--DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
                +H DLK  NI+    +    K+ DFG+         +Q+ K   GT  + +PE A
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 197

Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
                   +D++S GVL    +SG      +   N+   L +V           M DS+ 
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLS---PFGGENDDETLRNVKS-----CDWNMDDSAF 249

Query: 779 DNYPANEVLRCIHVGLLCVQENAEERPTMASV 810
                +            +  +   R T+   
Sbjct: 250 SGISED----GKDFIRKLLLADPNTRMTIHQA 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 3e-52
 Identities = 60/274 (21%), Positives = 107/274 (39%), Gaps = 26/274 (9%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAK 594
           +  ++F     LG+G F  V   R L   +E A+K L +        +     E  ++++
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           L H   V+L     + ++      Y +N  L   I         +          I   L
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 121

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
            YLH      IIHRDLK  NILL+++M  +I+DFG A++   +  +      VGT  Y+S
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 715 PEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV 774
           PE   +      SD+++ G ++ + V+G                   +R   E  + + +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGL----------------PPFRAGNEYLIFQKI 222

Query: 775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMA 808
                ++P     +   +    +  +A +R    
Sbjct: 223 IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCE 256

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  181 bits (459), Expect = 4e-51
 Identities = 59/272 (21%), Positives = 107/272 (39%), Gaps = 23/272 (8%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           D +    +LG G FG+V++      G+    K ++          KNE+ ++ +L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           + L     +  E +L+ E++    L   I   A    ++     N +     GL ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144

Query: 661 SRFRIIHRDLKASNILLDKEMTP--KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
               I+H D+K  NI+ + +     KI DFG+A     D+     K    T  + +PE  
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200

Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
                   +D+++ GVL    +SG      +   ++L  L +V R   + +  E   SSV
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS---PFAGEDDLETLQNVKR--CDWEFDEDAFSSV 255

Query: 779 DNYPANEVLRCIHVGLLCVQENAEERPTMASV 810
                + +   +            +R T+   
Sbjct: 256 SPEAKDFIKNLLQK-------EPRKRLTVHDA 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  172 bits (436), Expect = 6e-49
 Identities = 63/281 (22%), Positives = 119/281 (42%), Gaps = 27/281 (9%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG---IEEFKNEVRLIAKLQ 596
           +D +     LG GG   V+  R L   +++AVK L  +  +       F+ E +  A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 597 HRNLVRLLGCCVEMDEK----MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR 652
           H  +V +               +V EY++  +L  ++  +     +  +R   +I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ-NTKRVVGTYG 711
            L + H   +  IIHRD+K +NI++      K+ DFG+AR           T  V+GT  
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 712 YMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL 771
           Y+SPE A       +SDV+S G +L E ++G+     +  ++ +++    ++  +E  + 
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSVA---YQHVREDPIP 233

Query: 772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL 812
                   +   + V+         + +N E R   A+ + 
Sbjct: 234 PSARHEGLSADLDAVVLK------ALAKNPENRYQTAAEMR 268

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-48
 Identities = 60/289 (20%), Positives = 120/289 (41%), Gaps = 22/289 (7%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG-IEEFKNEVRLIAKLQHR 598
              +T+ + +G+G +G+V           +A+K++S    Q   +    E++++ + +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           N++ +         + +   Y+    + + ++   ++  L+       +  I RGL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNT-KRVVGTYGYMSPEY 717
                 ++HRDLK SN+LL+     KI DFG+AR+   D          V T  Y +PE 
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 718 AMDGLFSVKS-DVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS 776
            ++     KS D++S G +L E +S +      H  ++LN +  +     +  +  +++ 
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 777 SVDNY----------PANEVLRCIHVGLL-----CVQENAEERPTMASV 810
              NY          P N +        L      +  N  +R  +   
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 2e-47
 Identities = 51/272 (18%), Positives = 103/272 (37%), Gaps = 24/272 (8%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
           + +     LG+G FGIV++       +    K + +  G      K E+ ++   +HRN+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNI 63

Query: 601 VRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD 660
           + L      M+E ++++E++    +   I     +  LN +   + +  +   L +LH  
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120

Query: 661 SRFRIIHRDLKASNILLD--KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
               I H D++  NI+    +  T KI +FG AR         N + +     Y +PE  
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVH 175

Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV 778
              + S  +D++S G L+   +SG     F    N+      +       +     + + 
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGI--NPFLAETNQ-----QIIENIMNAE-YTFDEEAF 227

Query: 779 DNYPANEVLRCIHVGLLCVQENAEERPTMASV 810
                      +      + +  + R T +  
Sbjct: 228 KEISIE----AMDFVDRLLVKERKSRMTASEA 255

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  166 bits (421), Expect = 2e-46
 Identities = 58/275 (21%), Positives = 109/275 (39%), Gaps = 26/275 (9%)

Query: 541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEE-FKNEVRLIAKLQHR 598
            D +   + LG G F  V         + +A+K +++ + +G E   +NE+ ++ K++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           N+V L           L+ + +    L   I +K        +    +I  +   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124

Query: 659 QDSRFRIIHRDLKASNILL---DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSP 715
                 I+HRDLK  N+L    D++    ISDFG++++              GT GY++P
Sbjct: 125 D---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAP 178

Query: 716 EYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD 775
           E      +S   D +S GV+    + G      ++  N+  L   + +        E   
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYP---PFYDENDAKLFEQILK-----AEYEFDS 230

Query: 776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASV 810
              D+   +            ++++ E+R T    
Sbjct: 231 PYWDDISDS----AKDFIRHLMEKDPEKRFTCEQA 261

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  165 bits (418), Expect = 2e-46
 Identities = 58/286 (20%), Positives = 111/286 (38%), Gaps = 38/286 (13%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGI---------EEFKNEVRL 591
           +N+     LG+G   +V +       +E AVK +    G            E    EV +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 592 IAKLQ-HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           + K+  H N+++L           LV++ M+   L   + +K     L+ +    I+  +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRAL 119

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
              +  LH   +  I+HRDLK  NILLD +M  K++DFG +      +     + V GT 
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173

Query: 711 GYMSPEYAMDGL------FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL 764
            Y++PE     +      +  + D++S GV++   ++G      +    ++ +L  +   
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMS- 229

Query: 765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASV 810
                  +      D+Y          +    +    ++R T    
Sbjct: 230 ----GNYQFGSPEWDDYSDT----VKDLVSRFLVVQPQKRYTAEEA 267

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  167 bits (425), Expect = 2e-46
 Identities = 60/276 (21%), Positives = 107/276 (38%), Gaps = 31/276 (11%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSR---NSGQGIEEFKNEVRLIAKLQ- 596
           ++F+ +  +G+GGFG VY  R  + G+  A+K L +      QG     NE  +++ +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 597 --HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
                +V +       D+   + + M    L   +         +          I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGL 120

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMS 714
            ++H      +++RDLK +NILLD+    +ISD G+A  F   +        VGT+GYM+
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMA 173

Query: 715 PEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM 773
           PE    G+ +   +D FS G +L + + G          ++      + R+     V   
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH----SPFRQHKTKDKHEIDRMTLTMAV--- 226

Query: 774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMAS 809
                   P +       +    +Q +   R     
Sbjct: 227 ------ELPDSFSPELRSLLEGLLQRDVNRRLGCLG 256

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (419), Expect = 2e-46
 Identities = 56/289 (19%), Positives = 109/289 (37%), Gaps = 26/289 (8%)

Query: 538 VRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ 596
           +R  + +    K+G G FG +Y G  +  G+E+A+K     +     +   E ++   +Q
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ 60

Query: 597 HRNLVRLLG-CCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLL 655
               +  +  C  E D  ++V E +     D        S   + +    +   +   + 
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLLADQMISRIE 117

Query: 656 YLHQDSRFRIIHRDLKASNIL---LDKEMTPKISDFGMARIFGGDQTEQN-----TKRVV 707
           Y+H       IHRD+K  N L     K     I DFG+A+ +   +T Q+      K + 
Sbjct: 118 YIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174

Query: 708 GTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE 767
           GT  Y S    +    S + D+ S G +L+    G        +  +       +    E
Sbjct: 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR----QKYERISE 230

Query: 768 GKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS 816
            K+   ++     YP +E    ++    C     +++P  + +  +  +
Sbjct: 231 KKMSTPIEVLCKGYP-SEFATYLN---FCRSLRFDDKPDYSYLRQLFRN 275

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 4e-46
 Identities = 66/276 (23%), Positives = 110/276 (39%), Gaps = 29/276 (10%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG---QGIEEFKNEVRLIAK-LQ 596
           ++F  +  LG+G FG V+     +  Q  A+K L ++       +E    E R+++   +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 597 HRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLY 656
           H  L  +       +    V EY+    L   I    +    +  R       I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118

Query: 657 LHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE 716
           LH      I++RDLK  NILLDK+   KI+DFGM +       + NT    GT  Y++PE
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173

Query: 717 YAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS 776
             +   ++   D +SFGVLL E + G+    F+  + E              ++   +  
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDEE--------------ELFHSIRM 217

Query: 777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL 812
               YP         + +       E+R  +   + 
Sbjct: 218 DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  165 bits (418), Expect = 5e-46
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 17/217 (7%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQH 597
            +F     LG G FG V+  R    G+  A+K L +      + +E   +E  +++ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             ++R+ G   +  +  ++ +Y+E   L S++    R      +     +C      L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LAL 117

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
                  II+RDLK  NILLDK    KI+DFG A+             + GT  Y++PE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV 172

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE 754
                ++   D +SFG+L+ E ++G     FY SN  
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTP--FYDSNTM 207

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 5e-45
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 35/304 (11%)

Query: 548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEE-----FKNEVRLIAKLQHRNLV 601
           + LG+G F  VYK R     Q +A+K++        ++        E++L+ +L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 602 RLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS 661
            LL          LV+++ME          K  S +L        +    +GL YLHQ  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 662 RFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD- 720
              I+HRDLK +N+LLD+    K++DFG+A+ FG           V T  Y +PE     
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--HQVVTRWYRAPELLFGA 175

Query: 721 GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL--------WKEGKVLE 772
            ++ V  D+++ G +L E +       F   +++L+ L  ++          W +   L 
Sbjct: 176 RMYGVGVDMWAVGCILAELLLR---VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232

Query: 773 MVDS--SVDNYPANEVLRCIHVGLL-----CVQENAEERPTMASVVLM--LSSETATMPQ 823
              +  S    P + +       LL         N   R T    + M   S+     P 
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292

Query: 824 PKTP 827
            + P
Sbjct: 293 CQLP 296

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 1e-44
 Identities = 66/296 (22%), Positives = 124/296 (41%), Gaps = 33/296 (11%)

Query: 539 RATDNFTDYNKLGQGGFGIVYKGRLLE--GQEIAVKRLSRNSGQG--IEEFKNEVRLIAK 594
           RA   +    ++G+G +G V+K R L+  G+ +A+KR+   +G+         EV ++  
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 595 L---QHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFD---KARSSILNWQRRFNIIC 648
           L   +H N+VRL   C            +    +D  +     K     +  +   +++ 
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 649 GIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVG 708
            + RGL +LH     R++HRDLK  NIL+      K++DFG+ARI+     +     VV 
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVV 177

Query: 709 TYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW--- 765
           T  Y +PE  +   ++   D++S G +  E    K     +  +++++ LG +  +    
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDVIGLP 234

Query: 766 ------KEGKVLEMVDSSVDNYPANEVLRCIHVGLL-----CVQENAEERPTMASV 810
                 ++  +      S    P  + +  I          C+  N  +R +  S 
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  159 bits (403), Expect = 3e-44
 Identities = 65/288 (22%), Positives = 124/288 (43%), Gaps = 30/288 (10%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHRN 599
           + +    K+G+G +G+VYK +   G+  A+K  RL +           E+ ++ +L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           +V+L          +LV+E+++      +   +     L      + +  +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118

Query: 660 DSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAM 719
               R++HRDLK  N+L+++E   KI+DFG+AR FG    +      + T  Y +P+  M
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173

Query: 720 -DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL--------WKEGKV 770
               +S   D++S G +  E V+G      +   +E + L  ++R+        W     
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTP---LFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230

Query: 771 LEMVDSSVDNY---PANEVLRCIHVGLL-----CVQENAEERPTMASV 810
           L   D +   Y   P    L+ +    +      ++ +  +R T    
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 4e-44
 Identities = 66/289 (22%), Positives = 125/289 (43%), Gaps = 30/289 (10%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHR 598
           +NF    K+G+G +G+VYK R    G+ +A+K  RL   +         E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           N+V+LL      ++  LV+E++          D +  + +      + +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPE-Y 717
                R++HRDLK  N+L++ E   K++DFG+AR FG           V T  Y +PE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL--------WKEGK 769
                +S   D++S G +  E V+ +     +  ++E++ L  ++R         W    
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA---LFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231

Query: 770 VLEMVDSSVDNYPANEVLRCIH------VGLL--CVQENAEERPTMASV 810
            +     S   +   +  + +         LL   +  +  +R +  + 
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  158 bits (399), Expect = 1e-43
 Identities = 46/279 (16%), Positives = 103/279 (36%), Gaps = 26/279 (9%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           ++G+G FG++++G  L   Q++A+K   R S     + ++E R    L     +  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 608 VEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIH 667
            +     ++   +   SL+ ++    R    + +        +   +  +H+     +++
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVY 124

Query: 668 RDLKASNILLDKEMTP-----KISDFGMARIFGGDQTEQN-----TKRVVGTYGYMSPEY 717
           RD+K  N L+ +  +       + DFGM + +    T+Q+      K + GT  YMS   
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
            +    S + D+ + G + +  + G        +         +     E K    +   
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI----GEKKQSTPLREL 240

Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS 816
              +P  E  + +H          +  P    +  + S 
Sbjct: 241 CAGFPE-EFYKYMH---YARNLAFDATPDYDYLQGLFSK 275

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 7e-43
 Identities = 62/292 (21%), Positives = 107/292 (36%), Gaps = 34/292 (11%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNL 600
            ++TD   +G G FG+VY+ +L + G+ +A+K++ ++          E++++ KL H N+
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75

Query: 601 VRLLGCCVEMDEKM------LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           VRL        EK       LV +Y+                 L        +  + R L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
            Y+H    F I HRD+K  N+LLD +    K+ DFG A+     + E N   +   Y   
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRA 190

Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE------LNLLGHVWRLWKE 767
                    ++   DV+S G +L E + G+    F   +        + +LG   R    
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ--PIFPGDSGVDQLVEIIKVLGTPTREQIR 248

Query: 768 GKVLEMVDSSVDNYPANEVLRCIHVGL---------LCVQENAEERPTMASV 810
                  +       A+   +                 ++     R T    
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 9e-43
 Identities = 62/280 (22%), Positives = 110/280 (39%), Gaps = 32/280 (11%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSR------NSGQGIEEFKNEVRLIAK 594
           D +    +LG G F +V K R    G + A K + +        G   E+ + EV ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 595 LQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
           +QH N++ L        + +L+ E +    L   + +K     L  +     +  I  G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGV 126

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKEMTP----KISDFGMARIFGGDQTEQNTKRVVGTY 710
            YLH     +I H DLK  NI+L     P    KI DFG+A            K + GT 
Sbjct: 127 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180

Query: 711 GYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV 770
            +++PE        +++D++S GV+    +SG      +  + +   L           V
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---PFLGDTKQETL---------ANV 228

Query: 771 LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASV 810
             +     D Y +N            + ++ ++R T+   
Sbjct: 229 SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-41
 Identities = 65/308 (21%), Positives = 127/308 (41%), Gaps = 46/308 (14%)

Query: 538 VRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQG--IEEFKNEVRLIAK 594
                 +    K+GQG FG V+K R  + GQ++A+K++   + +         E++++  
Sbjct: 6   CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL 65

Query: 595 LQHRNLVRLLGCCVEMDEKM--------LVYEYMENRSLDSVIFDKARSSILNWQRRFNI 646
           L+H N+V L+  C               LV+++ E+     +     + ++   +R   +
Sbjct: 66  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125

Query: 647 ICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR- 705
           +      L  L+   R +I+HRD+KA+N+L+ ++   K++DFG+AR F   +  Q  +  
Sbjct: 126 L------LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179

Query: 706 -VVGTYGYMSPEYAM-DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
             V T  Y  PE  + +  +    D++  G ++ E  +          N E + L  + +
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP---IMQGNTEQHQLALISQ 236

Query: 764 LWKEGKVLEMVDSSVDNYPANEVLRCIH-------------------VGLL--CVQENAE 802
           L   G +   V  +VDNY   E L  +                    + L+   +  +  
Sbjct: 237 L--CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294

Query: 803 ERPTMASV 810
           +R      
Sbjct: 295 QRIDSDDA 302

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 3e-41
 Identities = 53/270 (19%), Positives = 102/270 (37%), Gaps = 29/270 (10%)

Query: 550 LGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCC 607
           LG G  G V +       ++ A+K L         + + EV L  +  Q  ++VR++   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVY 74

Query: 608 VEMDEK----MLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRF 663
             +       ++V E ++   L S I D+   +    +    I+  I   + YLH     
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS---I 130

Query: 664 RIIHRDLKASNILLDKEMTP---KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD 720
            I HRD+K  N+L   +      K++DFG A+      +         T  Y++PE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187

Query: 721 GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN 780
             +    D++S GV++   + G      ++SN+ L +   +    + G+  E  +     
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQ-YEFPNPEWSE 243

Query: 781 YPANEVLRCIHVGLLCVQENAEERPTMASV 810
                      +    ++    +R T+   
Sbjct: 244 VSEE----VKMLIRNLLKTEPTQRMTITEF 269

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (370), Expect = 7e-40
 Identities = 59/288 (20%), Positives = 115/288 (39%), Gaps = 28/288 (9%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVK--RLSRNSGQGIEEFKNEVRLIAKLQHR 598
             +    K+G+G +G V+K +  E  + +A+K  RL  +          E+ L+ +L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 599 NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLH 658
           N+VRL        +  LV+E+ +                 + +   + +  + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH 118

Query: 659 QDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
                 ++HRDLK  N+L+++    K+++FG+AR FG       +  VV  +        
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLF 174

Query: 719 MDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS- 777
              L+S   D++S G +  E  +    R  +  N+  + L  ++RL       +    + 
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAG--RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 778 ------VDNYPANEVLRCIHVGL---------LCVQENAEERPTMASV 810
                    YPA   L  +   L           ++ N  +R +    
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 1e-39
 Identities = 57/273 (20%), Positives = 94/273 (34%), Gaps = 42/273 (15%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEE------FKNEVRLIAKLQ--HRN 599
            LG GGFG VY G  +     +A+K + ++      E         EV L+ K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 600 LVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ 659
           ++RLL      D  +L+ E  E          +  +  L  +   +    +   + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHN 128

Query: 660 DSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYA 718
                ++HRD+K  NIL+D      K+ DFG   +      +       GT  Y  PE+ 
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181

Query: 719 M-DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
                    + V+S G+LL + V G     F H    +       +              
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDEEIIRGQVFFRQRVSS---------- 229

Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASV 810
                      C H+   C+     +RPT   +
Sbjct: 230 ----------ECQHLIRWCLALRPSDRPTFEEI 252

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 6e-39
 Identities = 60/272 (22%), Positives = 108/272 (39%), Gaps = 28/272 (10%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQH 597
           ++F     LG+G FG V   R    G+  A+K L +    +   +     E R++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 598 RNLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
             L  L       D    V EY     L   +   +R  +   +R       I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      +++RD+K  N++LDK+   KI+DFG+ +    D      K   GT  Y++PE 
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV 176

Query: 718 AMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS 777
             D  +    D +  GV++ E + G+    FY+ ++E              ++ E++   
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE--------------RLFELILME 220

Query: 778 VDNYPANEVLRCIHVGLLCVQENAEERPTMAS 809
              +P         +    ++++ ++R     
Sbjct: 221 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGP 252

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  144 bits (364), Expect = 2e-38
 Identities = 56/254 (22%), Positives = 100/254 (39%), Gaps = 18/254 (7%)

Query: 514 SSKRDYSADKTDDLELPLFDFETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVK 572
            S +++ A   +D               D F     LG G FG V   +  E G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72

Query: 573 RLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMENRSLDSVI 629
            L +      + IE   NE R++  +    LV+L     +     +V EY+    + S +
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132

Query: 630 FDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFG 689
               R    +          I     YLH      +I+RDLK  N+L+D++   +++DFG
Sbjct: 133 RRIGR---FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG 186

Query: 690 MARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFY 749
            A+   G         + GT   ++PE  +   ++   D ++ GVL+ E  +G      +
Sbjct: 187 FAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP---PF 238

Query: 750 HSNNELNLLGHVWR 763
            ++  + +   +  
Sbjct: 239 FADQPIQIYEKIVS 252

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-36
 Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 13/207 (6%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSR--NSGQGIEEFKNEVRLIAKLQHR 598
             + D   +G G +G V        G ++A+K+L R   S    +    E+RL+  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 599 NLVRLLGCCVEMDEKMLVYE-YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYL 657
           N++ LL      +      + Y+    + + +    +   L   R   ++  + +GL Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 658 HQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEY 717
           H      IIHRDLK  N+ ++++   KI DFG+AR     Q +      V T  Y +PE 
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189

Query: 718 AMDGL-FSVKSDVFSFGVLLLETVSGK 743
            ++ + ++   D++S G ++ E ++GK
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  133 bits (336), Expect = 7e-35
 Identities = 54/261 (20%), Positives = 111/261 (42%), Gaps = 26/261 (9%)

Query: 513 ISSKRDYSADKTDDLELPLFDFETIVRATDNFTDY---NKLGQGGFGIVYKGRLLE-GQE 568
           + S+     D         +D+E+ V    N  DY    KLG+G +  V++   +   ++
Sbjct: 3   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 62

Query: 569 IAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKM--LVYEYMENRSL 625
           + VK L        ++ K E++++  L+   N++ L     +   +   LV+E++ N   
Sbjct: 63  VVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 119

Query: 626 DSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPK 684
             +         L        +  I + L Y H      I+HRD+K  N+++D E    +
Sbjct: 120 KQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLR 170

Query: 685 ISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGK 743
           + D+G+A  +   Q        V +  +  PE  +D  ++    D++S G +L   +  K
Sbjct: 171 LIDWGLAEFYHPGQEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227

Query: 744 KNRGFYHSNNELNLLGHVWRL 764
           +   F+H ++  + L  + ++
Sbjct: 228 EP--FFHGHDNYDQLVRIAKV 246

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 6e-34
 Identities = 61/278 (21%), Positives = 111/278 (39%), Gaps = 30/278 (10%)

Query: 542 DNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSR----NSGQGIEEFKNEVRLIA 593
           +NF     LG G +G V+  R +     G+  A+K L +       +  E  + E +++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 594 KLQHR-NLVRLLGCCVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIAR 652
            ++    LV L        +  L+ +Y+    L + +  + R            +  I  
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVL 140

Query: 653 GLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGY 712
            L +LH   +  II+RD+K  NILLD      ++DFG+++ F  D+TE+      GT  Y
Sbjct: 141 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEY 196

Query: 713 MSPEYAMDGL--FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV 770
           M+P+    G        D +S GVL+ E ++G      +  + E N    + R   + + 
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS---PFTVDGEKNSQAEISRRILKSEP 253

Query: 771 LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMA 808
                     YP         +    + ++ ++R    
Sbjct: 254 ---------PYPQEMSALAKDLIQRLLMKDPKKRLGCG 282

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 6e-33
 Identities = 56/238 (23%), Positives = 99/238 (41%), Gaps = 24/238 (10%)

Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSR--NSGQGIEEFKNEVRL 591
           ++       + +   +G G  GIV         + +A+K+LSR   +    +    E+ L
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69

Query: 592 IAKLQHRNLVRLLGCCV------EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFN 645
           +  + H+N++ LL          E  +  LV E M+      +  +       + +R   
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSY 123

Query: 646 IICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR 705
           ++  +  G+ +LH      IIHRDLK SNI++  + T KI DFG+AR  G          
Sbjct: 124 LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTP 177

Query: 706 VVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR 763
            V T  Y +PE  +   +    D++S G ++ E V  K     +   + ++    V  
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI---LFPGRDYIDQWNKVIE 232

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 5e-32
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 13/214 (6%)

Query: 535 ETIVRATDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRL 591
           +TI    + + + + +G G +G V      + G  +AVK+LSR   S    +    E+RL
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 592 IAKLQHRNLVRLLGCCVEMDEKM-LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGI 650
           +  ++H N++ LL               Y+    + + + +  +   L       +I  I
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 651 ARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTY 710
            RGL Y+H      IIHRDLK SN+ ++++   KI DFG+AR    + T         T 
Sbjct: 131 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TR 182

Query: 711 GYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGK 743
            Y +PE  ++ + ++   D++S G ++ E ++G+
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  118 bits (295), Expect = 3e-29
 Identities = 39/210 (18%), Positives = 81/210 (38%), Gaps = 18/210 (8%)

Query: 549 KLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCC 607
           KLG G F  V+  + +     +A+K + R      E  ++E++L+ ++   +  +     
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 608 VEMDEKMLVY-------------EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGL 654
                K+L +              +         +  K     +       I   +  GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 655 LYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGMARIFGGDQTEQNTKRVVGTYGYM 713
            Y+H+  R  IIH D+K  N+L++       +    +A +      +++    + T  Y 
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 714 SPEYAMDGLFSVKSDVFSFGVLLLETVSGK 743
           SPE  +   +   +D++S   L+ E ++G 
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  102 bits (254), Expect = 2e-25
 Identities = 36/206 (17%), Positives = 67/206 (32%), Gaps = 35/206 (16%)

Query: 548 NKLGQGGFGIVYKGRLLEGQEIAVK--RLSRNSGQ--------GIEEFKNEVRLIAKLQH 597
             +G+G    V+     +  E  VK  ++   S +        G   F       A+ + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 598 RNLVRLLGCCV----EMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARG 653
           R L +L G  V      +   ++ E +           +     +       ++  I   
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELI--------DAKELYRVRVENPDE--VLDMILEE 115

Query: 654 LLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQNTKR-VVGTYGY 712
           +   +      I+H DL   N+L+  E    I DF  +   G +   +  +R V     Y
Sbjct: 116 VAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITY 171

Query: 713 MSPEYAMDGLFSVKSDVFSFGVLLLE 738
            S  Y        + D+ S    +L+
Sbjct: 172 FSRTY------RTEKDINSAIDRILQ 191

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

 Score = 76.9 bits (189), Expect = 2e-17
 Identities = 21/122 (17%), Positives = 43/122 (35%), Gaps = 16/122 (13%)

Query: 58  DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLA 117
           + LT  + L  G++L           +         + ++  +    T VW +N      
Sbjct: 2   NLLTNGEGLYAGQSLDV-------EPYHFIMQEDCNLVLYDHS----TSVWASNTGILGK 50

Query: 118 NSSGVLRIINQRIGLFDGSQNLVWSSNQTKAT-NPVAQLQDSGNFVLKEAGSDEILWQSF 176
                +   +    ++D     +W+S+  +   N V  LQ+ GN V+        +W + 
Sbjct: 51  KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY----GSDIWSTG 106

Query: 177 DY 178
            Y
Sbjct: 107 TY 108

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 64.4 bits (156), Expect = 4e-13
 Identities = 19/124 (15%), Positives = 42/124 (33%), Gaps = 13/124 (10%)

Query: 58  DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLA 117
           D L +   L  G +L      +     +  +       + Y N      VW +  +   +
Sbjct: 2   DRLNSGHQLDTGGSLAEGG--YLFIIQNDCNL------VLYDN---NRAVWASGTNGKAS 50

Query: 118 NSSGVLRIINQRIGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQSFD 177
                ++     + ++ GS+ +  S+   +  N    LQ   N V+    S+  +W +  
Sbjct: 51  GCVLKMQNDGN-LVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIY-DNSNNAIWATHT 108

Query: 178 YPTD 181
              +
Sbjct: 109 NVGN 112

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 63.0 bits (153), Expect = 1e-12
 Identities = 16/92 (17%), Positives = 29/92 (31%), Gaps = 4/92 (4%)

Query: 96  IWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDGSQNLVWSSNQTKATNPVAQ 154
           I Y       +    +    L  S   L +     + LFD    +  ++   K T   A 
Sbjct: 12  ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAV 71

Query: 155 LQDSGNFVLKEAGSDEILWQSFD--YPTDTLL 184
           LQ +G   +     +  +W S +       + 
Sbjct: 72  LQPNGRMDVLT-NQNIAVWTSGNSRSAGRYVF 102

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

 Score = 58.9 bits (142), Expect = 3e-11
 Identities = 18/122 (14%), Positives = 38/122 (31%), Gaps = 17/122 (13%)

Query: 58  DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLA 117
           + L + + L+ G+ L      F        +   + +             W  N      
Sbjct: 2   NILYSGETLSTGEFLNYGS--FVFIMQEDCNLVLYDVDKPI---------WATNTGGLSR 50

Query: 118 NSSGVLRIINQRIGLFDGSQNLVWSSNQTKAT-NPVAQLQDSGNFVLKEAGSDEILWQSF 176
           +    ++     + +++ S   +W+SN      N V  LQ   N V+         W + 
Sbjct: 51  SCFLSMQTDGNLV-VYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIY----GTDRWATG 105

Query: 177 DY 178
            +
Sbjct: 106 TH 107

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 54.6 bits (131), Expect = 1e-09
 Identities = 23/122 (18%), Positives = 39/122 (31%), Gaps = 19/122 (15%)

Query: 58  DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLA 117
             L AT++L     ++    V+     +  +       + Y N      +W  N      
Sbjct: 15  QILHATESLE----ILFGTHVYRFIMQTDCNL------VLYDN---NNPIWATNTGGLGN 61

Query: 118 NSSGVLRIINQRIGLFDGSQNLVWSSNQT-KATNPVAQLQDSGNFVLKEAGSDEILWQSF 176
               VL+     + +       VW S    KA + V  LQ   N V+      + LW + 
Sbjct: 62  GCRAVLQPDGVLV-VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI----YGDALWATQ 116

Query: 177 DY 178
             
Sbjct: 117 TV 118

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 49.2 bits (117), Expect = 1e-07
 Identities = 22/82 (26%), Positives = 33/82 (40%), Gaps = 3/82 (3%)

Query: 96  IWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDGSQNLVWSSNQTKATNPVAQ 154
           I +    + ++    +    L  SS    + +   + LFD     VW+SN   AT   A 
Sbjct: 3   ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAV 61

Query: 155 LQDSGNFVLKEAGSDEILWQSF 176
           LQ  G  V+  A  + I W S 
Sbjct: 62  LQSDGLLVILTA-QNTIRWSSG 82

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	862
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.84
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	99.75
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	99.73
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	99.71
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.56
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.39
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	99.35
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.04
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	98.68
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	98.45
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.44
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	98.36
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	98.34
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	98.19
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.76
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.38
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.48
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.34
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.42
d1emoa2	39	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	91.06
d2vj3a1	42	Neurogenic locus notch homolog protein 1, Notch1 {	83.45
d2qj2a1	91	Hepatocyte growth factor {Human (Homo sapiens) [Ta	81.32

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-49  Score=417.73  Aligned_cols=264  Identities=27%  Similarity=0.456  Sum_probs=207.9

Q ss_pred             cccccccceeeccccEEEEEeEecCCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .++|+..++||+|+||+||+|+..  ..||||+++..  .....++|.+|+.++++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            357888999999999999999864  36999998654  34567889999999999999999999998754 56899999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+++|+|.+++...  ...+++..++.|+.|||+||+|||+.+   ||||||||+||||+.++.+||+|||+|+......
T Consensus        84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            99999999999643  235899999999999999999999987   9999999999999999999999999998765444


Q ss_pred             cccccccccccccccChhhhcC---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMD---GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      .........||+.|||||++.+   ..++.++|||||||+||||+||+.||......   .   .+......+...    
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~---~---~~~~~~~~~~~~----  228 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---D---QIIFMVGRGYLS----  228 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---H---HHHHHHHHTSCC----
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH---H---HHHHHHhcCCCC----
Confidence            4444455789999999999864   35899999999999999999999997532211   1   122222222211    


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCCC
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMP  822 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~  822 (862)
                      +.+...+...+.++.+|+.+||+.||++||||+||++.|+.+...+|
T Consensus       229 p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            11223344556788999999999999999999999999998755544

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-48  Score=409.64  Aligned_cols=255  Identities=28%  Similarity=0.431  Sum_probs=202.3

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      ++|+..++||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|+|.+.+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            468888999999999999999988899999999754 3445789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +|+|.+++...  ...+++..+++++.|||+||+|||+.+   |+||||||+||||++++.+||+|||+++.+...... 
T Consensus        84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-  157 (263)
T d1sm2a_          84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  157 (263)
T ss_dssp             TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence            99999998543  345899999999999999999999998   999999999999999999999999999876433222 


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY  781 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~  781 (862)
                      ......||+.|+|||++.+..++.++|||||||++|||+|+..|+..  .........    .+..+..        ...
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~--~~~~~~~~~----~i~~~~~--------~~~  223 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE--NRSNSEVVE----DISTGFR--------LYK  223 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC--SCCHHHHHH----HHHHTCC--------CCC
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC--CCCHHHHHH----HHHhcCC--------CCC
Confidence            22335789999999999999999999999999999999996555322  122222222    2222211        122


Q ss_pred             ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          782 PANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       782 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      +...+.++.+++.+||+.||++||||+||++.|+++
T Consensus       224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            344566889999999999999999999999999876

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=406.03  Aligned_cols=252  Identities=26%  Similarity=0.323  Sum_probs=205.1

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ++|+..++||+|+||+||+|+.. +++.||||++.... ....+++.+|++++++++|||||++++++.+.+..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57899999999999999999875 58999999997543 33456799999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++|+|.+++..   ...+++.++..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus        85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            999999999853   335999999999999999999999998   99999999999999999999999999998754444


Q ss_pred             ccccccccccccccChhhhcCCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLF-SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                      .......+||+.|||||++.+..+ +.++|||||||++|||++|+.||.......  ...    .......       ..
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~----~~~~~~~-------~~  225 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEY----SDWKEKK-------TY  225 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHH----HHHHTTC-------TT
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHH----HHHhcCC-------CC
Confidence            444455789999999999988876 578999999999999999999975432211  111    1111111       01


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .......+.++.+|+.+||+.||++|||++|+++
T Consensus       226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1122334567889999999999999999999865

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-48  Score=409.03  Aligned_cols=255  Identities=29%  Similarity=0.440  Sum_probs=209.0

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      ++|+..++||+|+||.||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            5788889999999999999999888899999996543 445789999999999999999999998754 56799999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +|+|.+++.... ...+++.++++|+.||++||+|||+.+   |+||||||+||||++++.+||+|||+|+.+..... .
T Consensus        91 ~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~  165 (272)
T d1qpca_          91 NGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T  165 (272)
T ss_dssp             TCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred             CCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-c
Confidence            999999875433 234899999999999999999999988   99999999999999999999999999998754322 2


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY  781 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~  781 (862)
                      ......||+.|+|||++.+..++.++|||||||++|||+||..|+...  ......    ...+..+..        ...
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~--~~~~~~----~~~i~~~~~--------~~~  231 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNPEV----IQNLERGYR--------MVR  231 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHH----HHHHHTTCC--------CCC
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC--CCHHHH----HHHHHhcCC--------CCC
Confidence            223457899999999999999999999999999999999977664321  222222    222222211        122


Q ss_pred             ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          782 PANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       782 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      +...+.++.+|+.+||+.||++||||+||++.|+..
T Consensus       232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            344566789999999999999999999999998764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.7e-48  Score=413.25  Aligned_cols=258  Identities=27%  Similarity=0.399  Sum_probs=214.1

Q ss_pred             cccccccceeeccccEEEEEeEecC-CcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      .++|+..++||+|+||+||+|++.. ++.||||+++... ...++|.+|+++|++++|||||+++++|.+.+..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            4578888999999999999998865 8889999996543 4567899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +++|+|.+++.... ...+++..++.|+.|||+||+|||+++   |+||||||+||||++++.+||+|||+++.......
T Consensus        95 ~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          95 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             ccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            99999999986543 346899999999999999999999998   99999999999999999999999999987644322


Q ss_pred             ccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                       .......|++.|+|||++.+..++.++|||||||++|||++|+.|+..  ..+.    ..+.+.+..+..        .
T Consensus       171 -~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~--~~~~----~~~~~~i~~~~~--------~  235 (287)
T d1opja_         171 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP--GIDL----SQVYELLEKDYR--------M  235 (287)
T ss_dssp             -EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST--TCCH----HHHHHHHHTTCC--------C
T ss_pred             -eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC--cchH----HHHHHHHhcCCC--------C
Confidence             222335688999999999999999999999999999999998777432  1121    122222322211        2


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      ..+...+.++.+|+.+||+.||++||||+||++.|+.+.
T Consensus       236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            234445678899999999999999999999999998763

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.2e-48  Score=414.65  Aligned_cols=257  Identities=26%  Similarity=0.405  Sum_probs=199.3

Q ss_pred             ccccccceeeccccEEEEEeEecC-C---cEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-G---QEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ++|+..++||+|+||+||+|++.. +   ..||||++... .....++|.+|+++|++++|||||+++|++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            345667899999999999998753 2   25899988654 344567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++|+|.+++...  ...+++.++++++.|||+||+|||+.+   |+||||||+||||+.++.+||+|||+++.+..
T Consensus       106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            9999999999988543  335899999999999999999999988   99999999999999999999999999987754


Q ss_pred             CCcccc---cccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          697 DQTEQN---TKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       697 ~~~~~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      ......   .....||+.|+|||.+.+..++.++|||||||++|||+| |+.|+...   ....+.    ..+..+..  
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~---~~~~~~----~~i~~~~~--  251 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVI----NAIEQDYR--  251 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHH----HHHHTTCC--
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC---CHHHHH----HHHHcCCC--
Confidence            332221   222457899999999999999999999999999999998 88886432   112222    22222211  


Q ss_pred             eecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                            ...+...+.++.+|+.+||+.||++||+|.||++.|+++.
T Consensus       252 ------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         252 ------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                  1234456678899999999999999999999999998763

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=402.92  Aligned_cols=249  Identities=25%  Similarity=0.404  Sum_probs=209.2

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      ++|+..++||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999864 58999999998766666788999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++|+|.+++...    .+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+....  
T Consensus       100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--  170 (293)
T d1yhwa1         100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  170 (293)
T ss_dssp             TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence            999999987542    4899999999999999999999998   9999999999999999999999999999874332  


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||...   ...   .........+..      . ..
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~---~~~~~~~~~~~~------~-~~  237 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE---NPL---RALYLIATNGTP------E-LQ  237 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHH---HHHHHHHHHCSC------C-CS
T ss_pred             ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC---CHH---HHHHHHHhCCCC------C-CC
Confidence            2233467999999999999999999999999999999999999997422   111   122222222110      0 12


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            23445678899999999999999999999985

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-47  Score=401.69  Aligned_cols=245  Identities=26%  Similarity=0.355  Sum_probs=207.0

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|++.+.||+|+||.||+|+.. +++.||||++.+.   .....+++.+|++++++++|||||++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57899999999999999999886 4889999998643   2345678899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++|+|.+++....   .+++.++..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            9999999999996543   4899999999999999999999998   999999999999999999999999999865432


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||..   .......    +......        
T Consensus       160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~---~~~~~~~----~~i~~~~--------  220 (263)
T d2j4za1         160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETY----KRISRVE--------  220 (263)
T ss_dssp             ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC---SSHHHHH----HHHHTTC--------
T ss_pred             ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC---CCHHHHH----HHHHcCC--------
Confidence                22346799999999999999999999999999999999999999742   2222222    2222211        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       ...+...+.++.+|+.+||+.||++|||++|+++
T Consensus       221 -~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence             1233445678889999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-47  Score=397.81  Aligned_cols=253  Identities=27%  Similarity=0.418  Sum_probs=212.5

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      ++|+..++||+|+||+||+|+..+++.||||+++... ...++|.+|+.++++++||||++++|+|.+.+..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            5788999999999999999999888899999997654 345789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +|+|..++....  ..+++..+++++.|||+||+|||+.+   |+||||||+|||+++++.+||+|||+++.+...... 
T Consensus        83 ~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          83 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             TEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             CCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence            999999975443  35889999999999999999999998   999999999999999999999999999876543322 


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      ......||+.|+|||++.+..++.++|||||||++|||+| |+.||....   .....    ..+..+..        ..
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~---~~~~~----~~i~~~~~--------~~  221 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETA----EHIAQGLR--------LY  221 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHH----HHHHTTCC--------CC
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC---HHHHH----HHHHhCCC--------CC
Confidence            2333578999999999999999999999999999999998 788864332   12222    22222211        12


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      .+...+.++.+|+.+||+.||++|||++||++.|.+
T Consensus       222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            234455688999999999999999999999999865

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=402.16  Aligned_cols=251  Identities=26%  Similarity=0.370  Sum_probs=208.2

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      +.|++.++||+|+||.||+|+.. +++.||||+++.......++|.+|+++|++++|||||++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46888999999999999999875 48899999998777777889999999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++|+|.+++.+..  ..+++.++..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+|+.....  .
T Consensus        92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~  164 (288)
T d2jfla1          92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--I  164 (288)
T ss_dssp             TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--H
T ss_pred             CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--c
Confidence            9999999885432  35899999999999999999999998   999999999999999999999999999765321  1


Q ss_pred             cccccccccccccChhhhc-----CCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          701 QNTKRVVGTYGYMSPEYAM-----DGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      .......||+.|+|||++.     +..|+.++|||||||++|||++|+.||....   ....+..+   .... .     
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~---~~~~~~~i---~~~~-~-----  232 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN---PMRVLLKI---AKSE-P-----  232 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC---GGGHHHHH---HHSC-C-----
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC---HHHHHHHH---HcCC-C-----
Confidence            2223467999999999984     4568999999999999999999999975322   22222221   1111 0     


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                       .....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       233 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         233 -PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             011223445678899999999999999999999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-47  Score=404.37  Aligned_cols=265  Identities=27%  Similarity=0.396  Sum_probs=210.2

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEecc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYME  621 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~  621 (862)
                      ++|++.+.||+|+||.||+|++.+++.||||+++.. ....++|.+|+.++++++|||||++++++. .+..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence            578999999999999999999988889999999654 344578999999999999999999999985 466899999999


Q ss_pred             CCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCccc
Q 002969          622 NRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTEQ  701 (862)
Q Consensus       622 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  701 (862)
                      +|+|..++..... ..++|.+++.|+.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.+..... .
T Consensus        95 ~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~  169 (285)
T d1fmka3          95 KGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  169 (285)
T ss_dssp             TCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence            9999998865432 34999999999999999999999998   99999999999999999999999999987643322 2


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDNY  781 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~  781 (862)
                      ......||+.|+|||++.++.++.++||||||+++|||++|+.|+...  ......+.    .+..+..        ...
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~--~~~~~~~~----~i~~~~~--------~~~  235 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLD----QVERGYR--------MPC  235 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHH----HHHTTCC--------CCC
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC--CCHHHHHH----HHHhcCC--------CCC
Confidence            223357899999999999999999999999999999999987764322  22222222    2222211        123


Q ss_pred             ChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcCCCCCCCCC
Q 002969          782 PANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETATMPQPKTP  827 (862)
Q Consensus       782 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~p~~p  827 (862)
                      +...+.++.+++.+||+.||++||+|++|+++|+......+++..|
T Consensus       236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p  281 (285)
T d1fmka3         236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP  281 (285)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred             CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence            4445668899999999999999999999999999875554444334

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-47  Score=412.13  Aligned_cols=258  Identities=26%  Similarity=0.422  Sum_probs=209.3

Q ss_pred             cccccccceeeccccEEEEEeEecCC------cEEEEEEeccC-CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCc
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLEG------QEIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDE  612 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~~------~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~  612 (862)
                      .++|+..++||+|+||+||+|+....      ..||||++... .....+.+.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            35788999999999999999986432      36999998654 344567899999999998 89999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhccC--------------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCC
Q 002969          613 KMLVYEYMENRSLDSVIFDKAR--------------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKA  672 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp  672 (862)
                      .++||||+++|+|.++|.....                    ...+++..++.++.||++||+|||+.+   |+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999965432                    235899999999999999999999998   99999999


Q ss_pred             cceEecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCC
Q 002969          673 SNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHS  751 (862)
Q Consensus       673 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~  751 (862)
                      +|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++ |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654443333445678999999999999999999999999999999998 8888753322


Q ss_pred             CcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 002969          752 NNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLS  815 (862)
Q Consensus       752 ~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  815 (862)
                      ..      .+.+....+..        ...+...+.++.+|+.+||+.||++||||+||+++|.
T Consensus       273 ~~------~~~~~~~~~~~--------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DA------NFYKLIQNGFK--------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SH------HHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH------HHHHHHhcCCC--------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            21      12222222211        1234455678899999999999999999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-47  Score=404.26  Aligned_cols=254  Identities=27%  Similarity=0.380  Sum_probs=197.2

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEe--CCceEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE--MDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~lV  616 (862)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++....  ....+.+.+|++++++++|||||++++++.+  .+..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57999999999999999999875 48899999997653  3345679999999999999999999999865  4567999


Q ss_pred             EEeccCCChhhhhhhcc-CCCCCCHhhHHHHHHHHHHHhHHhhhcCC--CcEEecccCCcceEecCCCCeeEecccceee
Q 002969          617 YEYMENRSLDSVIFDKA-RSSILNWQRRFNIICGIARGLLYLHQDSR--FRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~--~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      |||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+.  .+|+||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999986532 34569999999999999999999998652  3599999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeee
Q 002969          694 FGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       694 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  773 (862)
                      +....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...   +...+.    ..+.++..   
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~---~~~~~~----~~i~~~~~---  231 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELA----GKIREGKF---  231 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHH----HHHHHTCC---
T ss_pred             cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC---CHHHHH----HHHHcCCC---
Confidence            64322  2233468999999999999999999999999999999999999997432   222222    22222221   


Q ss_pred             ecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       774 id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                           ...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       232 -----~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 -----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                 2233445667899999999999999999999975

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-47  Score=404.35  Aligned_cols=258  Identities=28%  Similarity=0.433  Sum_probs=203.6

Q ss_pred             ccccccceeeccccEEEEEeEecCC-----cEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEG-----QEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      ..|+..++||+|+||.||+|++...     ..||||+++... ....++|.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577789999999999999987542     369999997653 3345679999999999999999999999999999999


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||+.+++|.+++...  ...+++.++++++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999999887543  345999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcc-cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          696 GDQTE-QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       696 ~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|..|+....  ...    .+.+.+.++..    
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~--~~~----~~~~~i~~~~~----  231 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNH----EVMKAINDGFR----  231 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHH----HHHHHHHTTCC----
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC--CHH----HHHHHHhccCC----
Confidence            43222 22233568999999999999999999999999999999999777643221  111    22223333221    


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                          ...+...+.++.+|+.+||+.||++||+|.||+++|+.+.
T Consensus       232 ----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         232 ----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             ----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence                2234456678899999999999999999999999998864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=400.78  Aligned_cols=255  Identities=27%  Similarity=0.410  Sum_probs=208.2

Q ss_pred             ccccccc-eeeccccEEEEEeEec---CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          542 DNFTDYN-KLGQGGFGIVYKGRLL---EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ++|...+ +||+|+||.||+|...   ++..||||+++... ....++|.+|+++|++++|||||+++|++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4566666 4999999999999764   24579999997653 3456789999999999999999999999864 568999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++|+|.+++...  ...+++.++.+++.|||+||+|||+.+   |+||||||+||||+.++.+||+|||+++.+..
T Consensus        87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            9999999999987443  345899999999999999999999998   99999999999999999999999999998754


Q ss_pred             CCcc-cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          697 DQTE-QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       697 ~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      .... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.....   .+    +...+..+..    
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~----~~~~i~~~~~----  230 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PE----VMAFIEQGKR----  230 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HH----HHHHHHTTCC----
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HH----HHHHHHcCCC----
Confidence            4322 22234568999999999999999999999999999999998 8999753321   12    2222333322    


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                          ...+...+.++.+|+.+||+.||++||+|.+|++.|+..
T Consensus       231 ----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         231 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                123445667889999999999999999999999998764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=402.44  Aligned_cols=248  Identities=24%  Similarity=0.338  Sum_probs=204.8

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|++.+.||+|+||.||+|+.. +++.||||++...   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999875 5889999999653   2345678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+||||++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999886543   4899999999999999999999998   999999999999999999999999999987654


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      ..........||+.|+|||++.+..++.++|||||||++|||++|+.||..   .+.......    .....        
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~~~~~~~~----i~~~~--------  226 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEYLIFQK----IIKLE--------  226 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHH----HHTTC--------
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC---cCHHHHHHH----HHcCC--------
Confidence            444444556899999999999999999999999999999999999999743   222222222    12211        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVV  811 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  811 (862)
                       ..++...+.++.+|+.+||+.||++|||++|++
T Consensus       227 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         227 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             -CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence             123344566788999999999999999999864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=400.04  Aligned_cols=247  Identities=30%  Similarity=0.426  Sum_probs=200.2

Q ss_pred             ceeeccccEEEEEeEecC---CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEeccC
Q 002969          548 NKLGQGGFGIVYKGRLLE---GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYMEN  622 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~  622 (862)
                      ++||+|+||+||+|.+.+   ++.||||+++..  .....++|.+|+++|++++|||||+++++|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999997643   467999999654  23345789999999999999999999999854 567899999999


Q ss_pred             CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc-c
Q 002969          623 RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE-Q  701 (862)
Q Consensus       623 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~  701 (862)
                      |+|.+++...   ..+++.++++++.|||+||+|||+.+   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus        92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            9999998643   34899999999999999999999998   999999999999999999999999999987544332 2


Q ss_pred             ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCCC
Q 002969          702 NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVDN  780 (862)
Q Consensus       702 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~~  780 (862)
                      ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||....   ...    +...+..+..        ..
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~---~~~----~~~~i~~~~~--------~~  230 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSE----VTAMLEKGER--------MG  230 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHH----HHHHHHTTCC--------CC
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC---HHH----HHHHHHcCCC--------CC
Confidence            2334578999999999999999999999999999999998 899875321   111    2222333221        22


Q ss_pred             CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 002969          781 YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSS  816 (862)
Q Consensus       781 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  816 (862)
                      .+...+.++.+|+.+||+.||++||+|++|++.|+.
T Consensus       231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            344556788999999999999999999999988865

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-46  Score=404.98  Aligned_cols=262  Identities=24%  Similarity=0.335  Sum_probs=204.0

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .++|+..++||+|+||+||+|+.. +++.||+|+++... ....+++.+|+.+|++++|||||+++++|.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            468999999999999999999875 48899999997653 3445789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc-CCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      |+++|+|.+++.+..   .+++..+..++.||++||.|||+. +   |+||||||+||||+.++.+||+|||+|+.+.. 
T Consensus        85 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  157 (322)
T ss_dssp             CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence            999999999996543   489999999999999999999974 6   99999999999999999999999999986532 


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHH-HHHHh--------cC
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHV-WRLWK--------EG  768 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~-~~~~~--------~~  768 (862)
                         ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......+........ .....        ..
T Consensus       158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             ---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence               2223468999999999999999999999999999999999999997543222110000000 00000        00


Q ss_pred             ce--------------eeee----cccCCCC-ChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          769 KV--------------LEMV----DSSVDNY-PANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       769 ~~--------------~~~i----d~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..              .+..    ....... ....+.++.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            00              0000    0000011 1123467889999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-46  Score=403.63  Aligned_cols=260  Identities=25%  Similarity=0.403  Sum_probs=212.7

Q ss_pred             HcccccccceeeccccEEEEEeEec------CCcEEEEEEeccCCc-cchHHHHHHHHHHHhcccCCceEEEEEEEeCCc
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRNSG-QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE  612 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  612 (862)
                      ..++|+..++||+|+||+||+|+..      +++.||||+++.... ...++|.+|++++++++||||++++++|...+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            4568999999999999999999864      356899999976533 346789999999999999999999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhcc---------------------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccC
Q 002969          613 KMLVYEYMENRSLDSVIFDKA---------------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLK  671 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlk  671 (862)
                      .+++|||+++|+|.+++....                     ....+++..++.|+.||++||+|||+.+   |||||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence            999999999999999986432                     1234889999999999999999999998   9999999


Q ss_pred             CcceEecCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCC-CCCCC
Q 002969          672 ASNILLDKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKN-RGFYH  750 (862)
Q Consensus       672 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p-~~~~~  750 (862)
                      |+||||+.++.+||+|||+++.+.............|++.|+|||.+.+..++.++|||||||++|||++|..| +..  
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~--  245 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG--  245 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT--
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC--
Confidence            99999999999999999999876544444444456789999999999999999999999999999999999754 322  


Q ss_pred             CCcchhHHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          751 SNNELNLLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       751 ~~~~~~l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                       ......    ...+.++..        ...+...+.++.+|+.+||+.+|++||||.||+++|+++
T Consensus       246 -~~~~e~----~~~v~~~~~--------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         246 -MAHEEV----IYYVRDGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             -SCHHHH----HHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             -CCHHHH----HHHHHcCCC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence             222222    222333332        223444566889999999999999999999999999876

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=390.72  Aligned_cols=246  Identities=26%  Similarity=0.387  Sum_probs=196.9

Q ss_pred             cccceeeccccEEEEEeEecC-CcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEe----CCceEEEE
Q 002969          545 TDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE----MDEKMLVY  617 (862)
Q Consensus       545 ~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----~~~~~lV~  617 (862)
                      +..++||+|+||+||+|+... ++.||+|++...  .....+.|.+|+++|++++|||||++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            555789999999999998764 789999998654  33456789999999999999999999999875    34578999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec-CCCCeeEecccceeecCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD-KEMTPKISDFGMARIFGG  696 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~  696 (862)
                      ||+++|+|.+++...   ..+++..+..++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+++....
T Consensus        92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            999999999999654   34899999999999999999999875 4599999999999996 578999999999976432


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      .    ......||+.|+|||++.+ .++.++|||||||++|||++|+.||....  ..    ..+.+.+..+...     
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~~----~~~~~~i~~~~~~-----  231 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NA----AQIYRRVTSGVKP-----  231 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SH----HHHHHHHTTTCCC-----
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc--cH----HHHHHHHHcCCCC-----
Confidence            2    2234689999999998865 59999999999999999999999974321  11    1122222222111     


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        ...+...+.++.+|+.+||+.||++|||++|+++
T Consensus       232 --~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         232 --ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             --GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence              1112233456889999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1e-44  Score=398.61  Aligned_cols=253  Identities=23%  Similarity=0.322  Sum_probs=209.5

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      .++|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999875 5889999999877666678899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec--CCCCeeEecccceeecCCC
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD--KEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kL~DFGla~~~~~~  697 (862)
                      +++|+|.+++...  ...+++.++..|+.||+.||+|||+.+   |+||||||+||||+  .++.+||+|||+++.+...
T Consensus       105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            9999999998543  235999999999999999999999998   99999999999995  4678999999999886433


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      .   ......||+.|||||++.+..++.++|||||||++|||++|+.||..   ......+..+    ..... ..    
T Consensus       180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~---~~~~~~~~~i----~~~~~-~~----  244 (350)
T d1koaa2         180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG---ENDDETLRNV----KSCDW-NM----  244 (350)
T ss_dssp             S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHH----HHTCC-CS----
T ss_pred             c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC---CCHHHHHHHH----HhCCC-CC----
Confidence            2   23346799999999999999999999999999999999999999742   2222222222    11110 00    


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ........+.++.+|+.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            011123345678899999999999999999999984

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-45  Score=392.85  Aligned_cols=261  Identities=28%  Similarity=0.408  Sum_probs=202.5

Q ss_pred             HcccccccceeeccccEEEEEeEecC------CcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeC-
Q 002969          540 ATDNFTDYNKLGQGGFGIVYKGRLLE------GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM-  610 (862)
Q Consensus       540 ~~~~f~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~-  610 (862)
                      ..++|+..++||+|+||.||+|+...      ++.||||+++... ....+++.+|..++.++ +|+||+++++++.+. 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            34679999999999999999997532      4689999997543 34456788888888887 689999999998765 


Q ss_pred             CceEEEEEeccCCChhhhhhhccC-------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl  677 (862)
                      ...++||||+++|+|.+++.....             ...+++.+++.++.||++||+|||+.+   |+||||||+||||
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl  167 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL  167 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence            468999999999999999965432             235899999999999999999999998   9999999999999


Q ss_pred             cCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCC-CCCCCCCCcchh
Q 002969          678 DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKK-NRGFYHSNNELN  756 (862)
Q Consensus       678 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~-p~~~~~~~~~~~  756 (862)
                      ++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|.. |+......    
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~----  243 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----  243 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS----
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH----
Confidence            9999999999999987655544444555789999999999999999999999999999999999765 54322211    


Q ss_pred             HHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       757 l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                        ..+...+.++...        ..+...+.++.+++.+||+.||++|||++||+++|+++
T Consensus       244 --~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         244 --EEFCRRLKEGTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             --HHHHHHHHHTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHHHHHhcCCCC--------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              1122223333211        22344556789999999999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-45  Score=394.80  Aligned_cols=255  Identities=26%  Similarity=0.457  Sum_probs=203.9

Q ss_pred             ccccccceeeccccEEEEEeEecC-Cc----EEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ----EIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      .+|+..++||+|+||+||+|++.. |+    +||+|+++.. .....++|.+|++++++++|||||+++|+|.+ +..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence            358899999999999999998753 43    5899998654 34567889999999999999999999999986 45778


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ++||+.+++|.+++...  ...+++..+++++.|||+||+|||+++   |+||||||+||||+.++.+||+|||+++.+.
T Consensus        88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            89999999999988553  345899999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      ............||+.|+|||++.++.++.++|||||||++|||+| |+.|+......   .+.    ..+..+..    
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~----~~i~~~~~----  231 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EIS----SILEKGER----  231 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHH----HHHHHTCC----
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHH----HHHHcCCC----
Confidence            5544444445678999999999999999999999999999999998 67776432221   222    22222211    


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                          ...+...+.++.+|+.+||+.||++|||+.||++.|+.+
T Consensus       232 ----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         232 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             ----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence                123445667889999999999999999999999988775

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.2e-45  Score=393.03  Aligned_cols=252  Identities=22%  Similarity=0.283  Sum_probs=191.3

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .+.|+..++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            356899999999999999999875 48899999997553 2334678899999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec---CCCCeeEecccceeecC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFG  695 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kL~DFGla~~~~  695 (862)
                      |+++|+|.+++...   ..+++.++..++.||+.||+|||+.+   |+||||||+|||+.   +++.+||+|||+++...
T Consensus        88 ~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            99999999999543   35999999999999999999999998   99999999999994   57899999999998653


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD  775 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  775 (862)
                      ...   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..   .........    ...+.. ..  
T Consensus       162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~~~~~~~~----i~~~~~-~~--  228 (307)
T d1a06a_         162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQ----ILKAEY-EF--  228 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHH----HHTTCC-CC--
T ss_pred             CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC---CCHHHHHHH----HhccCC-CC--
Confidence            322   22346799999999999999999999999999999999999999742   222222222    222111 00  


Q ss_pred             ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          776 SSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       776 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                        ........+.++.+|+.+||+.||++|||++|+++.
T Consensus       229 --~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         229 --DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             --CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence              012233455678999999999999999999999983

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.6e-45  Score=392.20  Aligned_cols=245  Identities=29%  Similarity=0.438  Sum_probs=201.1

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      +.|+.+++||+|+||.||+|+.. +++.||||+++...   ....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35899999999999999999865 57889999997653   234567899999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++|+|..++...   ..+++.++..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.... 
T Consensus        95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            999999998766433   35899999999999999999999998   99999999999999999999999999986532 


Q ss_pred             CcccccccccccccccChhhhcC---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMD---GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                           .....||+.|+|||++.+   ..|+.++|||||||++|||++|+.|+...   ...   ....+..... ..   
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~---~~~---~~~~~i~~~~-~~---  232 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAM---SALYHIAQNE-SP---  232 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHH---HHHHHHHHSC-CC---
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC---CHH---HHHHHHHhCC-CC---
Confidence                 223579999999999864   46899999999999999999999996422   111   1122222211 11   


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                          ...+...+.++.+|+.+||+.||++|||++|+++
T Consensus       233 ----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         233 ----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ----CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                1112234567889999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.3e-44  Score=393.99  Aligned_cols=252  Identities=23%  Similarity=0.292  Sum_probs=209.1

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~  620 (862)
                      ++|++.++||+|+||.||+|+.. +++.||||+++.......+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999875 58999999998766556678899999999999999999999999999999999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec--CCCCeeEecccceeecCCCC
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD--KEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kL~DFGla~~~~~~~  698 (862)
                      ++|+|.+++...  ...+++.++..|+.||++||+|||+.+   |+||||||+||||+  .++.+||+|||+|+.+....
T Consensus       109 ~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            999998877432  335999999999999999999999998   99999999999997  67899999999999875432


Q ss_pred             cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||..   ......+..+    ..... .    ..
T Consensus       184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~---~~~~~~~~~i----~~~~~-~----~~  248 (352)
T d1koba_         184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNV----KRCDW-E----FD  248 (352)
T ss_dssp             ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC---SSHHHHHHHH----HHCCC-C----CC
T ss_pred             ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC---CCHHHHHHHH----HhCCC-C----CC
Confidence               23345789999999999999999999999999999999999999742   2222222222    11110 0    01


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      .......+.++.+|+.+||+.||++|||+.|+++.
T Consensus       249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            12233456678899999999999999999999874

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-45  Score=387.01  Aligned_cols=255  Identities=22%  Similarity=0.313  Sum_probs=198.0

Q ss_pred             cccccccceeeccccEEEEEeEecC----CcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE----GQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKML  615 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~l  615 (862)
                      .++|+..++||+|+||.||+|++..    +..||||+++... ....+.|.+|++++++++|||||++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3578889999999999999998653    3468999986543 334678999999999999999999999985 467899


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecC
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFG  695 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  695 (862)
                      ||||+++|+|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+.
T Consensus        85 v~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            99999999999987543  345899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeee
Q 002969          696 GDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMV  774 (862)
Q Consensus       696 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  774 (862)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++ |.+|+.....   ......    +..+..    
T Consensus       160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~----i~~~~~----  227 (273)
T d1mp8a_         160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGR----IENGER----  227 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHH----HHTTCC----
T ss_pred             CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH---HHHHHH----HHcCCC----
Confidence            3322 22334578999999999999999999999999999999998 7887643322   222222    222221    


Q ss_pred             cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          775 DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       775 d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                          ...+...+.++.+|+.+||+.||++|||+.||++.|+.+
T Consensus       228 ----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         228 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                123445567889999999999999999999999998765

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-44  Score=384.67  Aligned_cols=250  Identities=24%  Similarity=0.325  Sum_probs=204.8

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC------ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS------GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  614 (862)
                      ++|+..++||+|+||.||+|+.. +|+.||||++++..      ....+.+.+|+.+|++++|||||++++++.+.+..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57999999999999999999875 58999999986532      224578999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC----CeeEecccc
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM----TPKISDFGM  690 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kL~DFGl  690 (862)
                      +||||+++|+|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++    .+||+|||+
T Consensus        90 iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence            9999999999999996543   4999999999999999999999998   99999999999998776    599999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV  770 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  770 (862)
                      ++.+....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||..   .........    ......
T Consensus       164 a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~---~~~~~~~~~----i~~~~~  233 (293)
T d1jksa_         164 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG---DTKQETLAN----VSAVNY  233 (293)
T ss_dssp             CEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHH----HHTTCC
T ss_pred             hhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC---CCHHHHHHH----HHhcCC
Confidence            98764332   22335789999999999999999999999999999999999999743   222222221    111110


Q ss_pred             eeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          771 LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       771 ~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      . .    ....+...+..+.+|+.+||+.||++|||++|+++
T Consensus       234 ~-~----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 E-F----EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             C-C----CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C-C----CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0 0    00111234557889999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-45  Score=384.52  Aligned_cols=249  Identities=27%  Similarity=0.400  Sum_probs=198.7

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeC-CceEEEEEec
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-DEKMLVYEYM  620 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~lV~E~~  620 (862)
                      ++|+..++||+|+||.||+|++ .|..||||+++..  ...++|.+|++++++++||||++++|+|.+. +..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            5678889999999999999998 5788999999653  3457899999999999999999999999654 5689999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++|+|.+++.... ...+++..+++|+.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence            9999999996543 234899999999999999999999987   999999999999999999999999999865322   


Q ss_pred             cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccCC
Q 002969          701 QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSVD  779 (862)
Q Consensus       701 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~~  779 (862)
                        .....++..|+|||++.+..++.++||||||+++|||++ |+.|+...   ...+....    +..+..        .
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~---~~~~~~~~----i~~~~~--------~  219 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPR----VEKGYK--------M  219 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS---CGGGHHHH----HTTTCC--------C
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC---CHHHHHHH----HHcCCC--------C
Confidence              223467889999999999999999999999999999998 56664432   22222222    222211        2


Q ss_pred             CCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          780 NYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       780 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ..+...+.++.+|+.+||+.||++||||.||+++|+.+
T Consensus       220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            23444557888999999999999999999999999875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-44  Score=392.36  Aligned_cols=248  Identities=23%  Similarity=0.293  Sum_probs=208.5

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      .++|+++++||+|+||.||+|+.. +++.||||++++.   .....+++.+|+.+|++++||||+++++++.+.+..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            367999999999999999999875 5899999999754   234567899999999999999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+|+....
T Consensus        84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            99999999999986543   4889999999999999999999998   99999999999999999999999999987543


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ..  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.|+...   +...+.    +....+.       
T Consensus       158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~---~~~~~~----~~i~~~~-------  221 (337)
T d1o6la_         158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLF----ELILMEE-------  221 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHH----HHHHHCC-------
T ss_pred             CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc---CHHHHH----HHHhcCC-------
Confidence            22  2233468999999999999999999999999999999999999996432   222222    2222221       


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPT-----MASVVL  812 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  812 (862)
                        ..++...+.++.+|+.+||+.||++||+     ++|+++
T Consensus       222 --~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence              1234455677899999999999999994     888886

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-44  Score=387.29  Aligned_cols=258  Identities=28%  Similarity=0.411  Sum_probs=212.9

Q ss_pred             ccccccceeeccccEEEEEeEec------CCcEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL------EGQEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  614 (862)
                      ++|+..++||+|+||.||+|.+.      .+..||||+++.. .......|.+|+.++++++||||+++++++...+..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            57888899999999999999763      2568999999754 3344567999999999999999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhcc-------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEec
Q 002969          615 LVYEYMENRSLDSVIFDKA-------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISD  687 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  687 (862)
                      +||||+++|+|.+++....       ....+++..+.+++.|+|+||.|||+.+   |+||||||+||||++++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence            9999999999999986432       2234789999999999999999999987   99999999999999999999999


Q ss_pred             ccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCC-CCCCCCCCcchhHHHHHHHHHh
Q 002969          688 FGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKK-NRGFYHSNNELNLLGHVWRLWK  766 (862)
Q Consensus       688 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~-p~~~~~~~~~~~l~~~~~~~~~  766 (862)
                      ||+++.+.............||+.|+|||.+.+..++.++||||||+++|||+||.. |+..   ......    ...+.
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~---~~~~~~----~~~i~  249 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQV----LRFVM  249 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT---SCHHHH----HHHHH
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC---CCHHHH----HHHHH
Confidence            999987755444444455678999999999999999999999999999999999964 4322   222122    22222


Q ss_pred             cCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          767 EGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       767 ~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      .+..        ...+...+..+.+++.+||+.+|++||||+||+++|++.
T Consensus       250 ~~~~--------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         250 EGGL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             TTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             hCCC--------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            3221        222344557899999999999999999999999999887

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=382.32  Aligned_cols=256  Identities=28%  Similarity=0.392  Sum_probs=198.3

Q ss_pred             ccccccceeeccccEEEEEeEecC--C--cEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE--G--QEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~--~--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  614 (862)
                      ++|+..+.||+|+||.||+|+...  +  ..||||++...   .....++|.+|+.+|++++||||++++|+|.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            568899999999999999998643  2  36899998654   33456789999999999999999999999965 5678


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      +||||+++|+|.+.+....  ..+++..+++++.|||+||.|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus        87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            9999999999999886543  35899999999999999999999988   999999999999999999999999999987


Q ss_pred             CCCCccc-ccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchhHHHHHHHHHhcCceee
Q 002969          695 GGDQTEQ-NTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELNLLGHVWRLWKEGKVLE  772 (862)
Q Consensus       695 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  772 (862)
                      ....... ......|+..|+|||++.+..++.++||||||+++|||++ |+.||..   .........   ...++..  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~---~~~~~~~~~---i~~~~~~--  233 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG---LNGSQILHK---IDKEGER--  233 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHHHH---HHTSCCC--
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC---cCHHHHHHH---HHhCCCC--
Confidence            5543322 2334567889999999999999999999999999999998 8888642   222222222   2222211  


Q ss_pred             eecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          773 MVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       773 ~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                            ...+...+.++.+|+.+||+.||++||||.||++.|.+.
T Consensus       234 ------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         234 ------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                  122334456788999999999999999999999998763

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-44  Score=388.85  Aligned_cols=258  Identities=28%  Similarity=0.408  Sum_probs=206.5

Q ss_pred             ccccccceeeccccEEEEEeEecC-Cc--EEEEEEeccC-CccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCceEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQ--EIAVKRLSRN-SGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ++|+..++||+|+||.||+|++.+ +.  .||||+++.. .....++|.+|+++|+++ +|||||+++++|.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            567888999999999999998765 33  4788888654 344567899999999999 799999999999999999999


Q ss_pred             EEeccCCChhhhhhhc-------------cCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCe
Q 002969          617 YEYMENRSLDSVIFDK-------------ARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTP  683 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~  683 (862)
                      |||+++|+|.++|...             .....+++.++++++.|||+||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999653             23456999999999999999999999998   9999999999999999999


Q ss_pred             eEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHH
Q 002969          684 KISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWR  763 (862)
Q Consensus       684 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~  763 (862)
                      ||+|||+++.....   .......||..|+|||.+.+..++.++|||||||++|||++|..|+.  .......    +..
T Consensus       167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~--~~~~~~~----~~~  237 (309)
T d1fvra_         167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAE----LYE  237 (309)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT--TTCCHHH----HHH
T ss_pred             EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCC--CCCCHHH----HHH
Confidence            99999999865322   22223568999999999999999999999999999999999876421  1122212    222


Q ss_pred             HHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCcC
Q 002969          764 LWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSETA  819 (862)
Q Consensus       764 ~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  819 (862)
                      .+.++..        ...+...+.++.+|+.+||+.||++||+|+||++.|+++..
T Consensus       238 ~i~~~~~--------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         238 KLPQGYR--------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             HGGGTCC--------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcCC--------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            2222211        22344566789999999999999999999999999988743

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-44  Score=387.36  Aligned_cols=260  Identities=27%  Similarity=0.416  Sum_probs=210.7

Q ss_pred             cccccccceeeccccEEEEEeEecC--------CcEEEEEEeccCCc-cchHHHHHHHHHHHhc-ccCCceEEEEEEEeC
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLLE--------GQEIAVKRLSRNSG-QGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEM  610 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~  610 (862)
                      .++|+..++||+|+||.||+|+...        +..||||+++.... ....++.+|+..+.++ +|||||+++++|.+.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3578888999999999999997533        24699999976543 4567899999999998 799999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhccC-------------CCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEe
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKAR-------------SSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILL  677 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl  677 (862)
                      +..++||||+++|+|.+++.....             ...+++.++++++.||+.||+|||+.+   ||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            999999999999999999965432             245899999999999999999999998   9999999999999


Q ss_pred             cCCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCcchh
Q 002969          678 DKEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVS-GKKNRGFYHSNNELN  756 (862)
Q Consensus       678 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~  756 (862)
                      +.++.+||+|||+++...............+++.|+|||.+.++.|+.++||||||+++|||++ |..|+...   ..  
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~---~~--  243 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---PV--  243 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CH--
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC---CH--
Confidence            9999999999999998765554444555788999999999999999999999999999999998 56665321   11  


Q ss_pred             HHHHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          757 LLGHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       757 l~~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                        ..+++.+..+...        ..+...+.++.+|+.+||+.||++|||+.||++.|+++.
T Consensus       244 --~~~~~~i~~~~~~--------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         244 --EELFKLLKEGHRM--------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             --HHHHHHHHTTCCC--------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHHHHHcCCCC--------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence              2233333333221        223345567899999999999999999999999998874

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=390.13  Aligned_cols=260  Identities=25%  Similarity=0.378  Sum_probs=212.2

Q ss_pred             ccccccceeeccccEEEEEeEe------cCCcEEEEEEeccCC-ccchHHHHHHHHHHHhc-ccCCceEEEEEEEeCCce
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRL------LEGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVEMDEK  613 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~  613 (862)
                      ++|+..++||+|+||.||+|++      ..++.||||+++... .....+|.+|+.+++++ +|||||+++++|.+....
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            5788889999999999999975      235689999997653 33456799999999999 699999999999999999


Q ss_pred             EEEEEeccCCChhhhhhhcc---------------CCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec
Q 002969          614 MLVYEYMENRSLDSVIFDKA---------------RSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD  678 (862)
Q Consensus       614 ~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~  678 (862)
                      ++||||+++|+|.+++....               ....+++..+.+++.||++||+|||+++   ++||||||+|||++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence            99999999999999996543               1235899999999999999999999998   99999999999999


Q ss_pred             CCCCeeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHH
Q 002969          679 KEMTPKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLL  758 (862)
Q Consensus       679 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~  758 (862)
                      .++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++++.|+.......     
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-----  254 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-----  254 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-----
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-----
Confidence            999999999999998755444444455688999999999999999999999999999999999555532221111     


Q ss_pred             HHHHHHHhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          759 GHVWRLWKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       759 ~~~~~~~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ..+.+.+..+..        ...+...+.++.+|+.+||+.||++||||.||+++|++.
T Consensus       255 ~~~~~~i~~~~~--------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         255 SKFYKMIKEGFR--------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             HHHHHHHHHTCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCC--------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            112222222211        122334567789999999999999999999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.1e-44  Score=386.33  Aligned_cols=244  Identities=25%  Similarity=0.327  Sum_probs=205.4

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|++.++||+|+||+||+|+.. +|+.||||++++.   .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57899999999999999999875 4899999999653   2345678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+++|+|..++....   .+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999999885443   4788888899999999999999998   999999999999999999999999999876432


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||..   .+.......    ...+.        
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~---~~~~~~~~~----i~~~~--------  217 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEK----ILNAE--------  217 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC---SSHHHHHHH----HHHCC--------
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC---cCHHHHHHH----HHcCC--------
Confidence                 2346899999999999999999999999999999999999999743   222222222    11111        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERP-----TMASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  812 (862)
                       ...+...+.++.+++.+||+.||++||     +++|+++
T Consensus       218 -~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         218 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence             122344556788999999999999996     8999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=384.76  Aligned_cols=253  Identities=28%  Similarity=0.417  Sum_probs=204.0

Q ss_pred             cceeeccccEEEEEeEecCC----cEEEEEEeccC-CccchHHHHHHHHHHHhcccCCceEEEEEEEeC-CceEEEEEec
Q 002969          547 YNKLGQGGFGIVYKGRLLEG----QEIAVKRLSRN-SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-DEKMLVYEYM  620 (862)
Q Consensus       547 ~~~LG~G~fg~Vy~~~~~~~----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~lV~E~~  620 (862)
                      .++||+|+||+||+|++.++    ..||||+++.. .....++|.+|++++++++||||++++|++.+. ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999987542    25899999754 445668899999999999999999999998764 5789999999


Q ss_pred             cCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCcc
Q 002969          621 ENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQTE  700 (862)
Q Consensus       621 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  700 (862)
                      ++|+|.+++...  ...+++..+++++.|+|+||.|||+.+   |+||||||+||||++++.+||+|||+++.+......
T Consensus       112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            999999988543  345788899999999999999999998   999999999999999999999999999877543322


Q ss_pred             --cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecccC
Q 002969          701 --QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSSV  778 (862)
Q Consensus       701 --~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~~  778 (862)
                        .......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.....  ..+...    .+..+...       
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~----~i~~g~~~-------  253 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITV----YLLQGRRL-------  253 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH----HHHTTCCC-------
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHH----HHHcCCCC-------
Confidence              222335789999999999999999999999999999999998888543221  111111    22222211       


Q ss_pred             CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          779 DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       779 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                       ..+...+.++.+|+.+||+.||++||+|.||++.|+++.
T Consensus       254 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         254 -LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence             123344567889999999999999999999999999874

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2e-43  Score=376.87  Aligned_cols=259  Identities=26%  Similarity=0.349  Sum_probs=202.2

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCc----
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDE----  612 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~----  612 (862)
                      .++|++.+.||+|+||.||+|+.. +++.||||+++...   ....++|.+|++++++++||||+++++++...+.    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            357999999999999999999864 58899999997543   2345679999999999999999999999987543    


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      .++||||+++++|.+++....   .+++.++..++.||++||+|||+.+   |+||||||+||||+.++..+|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            789999999999999885543   4899999999999999999999998   9999999999999999999999999987


Q ss_pred             ecCCCC-cccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          693 IFGGDQ-TEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       693 ~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      ...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||...   ..   .+...+....+...
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~---~~~~~~~~~~~~~~  233 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD---SP---VSVAYQHVREDPIP  233 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SH---HHHHHHHHHCCCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc---CH---HHHHHHHHhcCCCC
Confidence            654332 222334467999999999999999999999999999999999999997432   21   12222223322211


Q ss_pred             eeecccCCCCChHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhccC
Q 002969          772 EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERP-TMASVVLMLSSE  817 (862)
Q Consensus       772 ~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~  817 (862)
                      .      .......+.++.+++.+||+.||++|| +++++++.|.++
T Consensus       234 ~------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         234 P------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             G------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             C------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            0      111233456788999999999999999 899999887654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-43  Score=379.26  Aligned_cols=261  Identities=25%  Similarity=0.308  Sum_probs=199.9

Q ss_pred             ccceeeccccEEEEEeEecC-CcEEEEEEeccCCc-----cchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          546 DYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRNSG-----QGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       546 ~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      .+++||+|+||+||+|+... ++.||||+++....     ...+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            35789999999999998754 88999999865422     2245789999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      ++++++..++.   ....+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            99887776653   2345889999999999999999999998   99999999999999999999999999987643322


Q ss_pred             ccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeec---
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVD---  775 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id---  775 (862)
                        .....+||+.|+|||++... .++.++|||||||++|||++|+.||..   ....+.+..+.+...........+   
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~---~~~~~~l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC---CCHHHHHHHHHHhcCCCChhhccchhc
Confidence              22335789999999998754 679999999999999999999988642   333344444433322111000000   


Q ss_pred             -------ccCCCC-----ChHHHHHHHHHHHhccccCCCCCCCHHHHHH--HhccC
Q 002969          776 -------SSVDNY-----PANEVLRCIHVGLLCVQENAEERPTMASVVL--MLSSE  817 (862)
Q Consensus       776 -------~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~  817 (862)
                             ......     ....+.++.+|+.+||+.||++|||++|+++  .+.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence                   000011     1233467889999999999999999999997  35544

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.6e-43  Score=385.66  Aligned_cols=244  Identities=23%  Similarity=0.303  Sum_probs=206.6

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC---CccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN---SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~  617 (862)
                      ++|+.+++||+|+||.||+|+.. +|+.||||++.+.   .....+.+.+|+++|+.++|||||++++++.+....++|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999875 5899999998643   2345678999999999999999999999999999999999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGD  697 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  697 (862)
                      ||+.+|+|..++....   .+++.++..++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+|+.+...
T Consensus       121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999999986543   4899999999999999999999998   999999999999999999999999999986432


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                           .....||+.|||||++.+..++.++|||||||++|||++|+.||..   .+.......+    ..+.        
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~---~~~~~~~~~i----~~~~--------  254 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA---DQPIQIYEKI----VSGK--------  254 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHH----HHCC--------
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC---cCHHHHHHHH----hcCC--------
Confidence                 2246799999999999999999999999999999999999999742   2222222222    1111        


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCC-----CCHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEER-----PTMASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~R-----Pt~~evl~  812 (862)
                       ...+...+.++.+++.+||+.||.+|     |+++|+++
T Consensus       255 -~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence             12234456678899999999999999     48999986

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-43  Score=379.90  Aligned_cols=265  Identities=24%  Similarity=0.320  Sum_probs=199.5

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHH--HHHHHHhcccCCceEEEEEEEeCC----ceEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKN--EVRLIAKLQHRNLVRLLGCCVEMD----EKML  615 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~--E~~~l~~l~HpnIv~l~g~~~~~~----~~~l  615 (862)
                      ++|...++||+|+||.||+|++ +|+.||||+++...   .+++..  |+..+.+++||||++++++|.+.+    ..++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            4567778999999999999986 68899999996432   233444  455556789999999999998754    5789


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcC-----CCcEEecccCCcceEecCCCCeeEecccc
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDS-----RFRIIHRDLKASNILLDKEMTPKISDFGM  690 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDlkp~NILl~~~~~~kL~DFGl  690 (862)
                      ||||+++|+|.++|.+.    .++|.++++++.|+|.||+|||+..     ..+|+||||||+||||+.++.+||+|||+
T Consensus        79 v~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            99999999999999643    4899999999999999999999741     23599999999999999999999999999


Q ss_pred             eeecCCCCcc--cccccccccccccChhhhcCCC------CCccccchhHHHHHHHHHhCCCCCCCCCCCcc--------
Q 002969          691 ARIFGGDQTE--QNTKRVVGTYGYMSPEYAMDGL------FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNE--------  754 (862)
Q Consensus       691 a~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~------~s~ksDVwSlGvil~elltG~~p~~~~~~~~~--------  754 (862)
                      ++........  .......||+.|+|||++.+..      ++.++|||||||+||||+||..|+........        
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            9877543322  2233467999999999987653      56789999999999999999887643221110        


Q ss_pred             hhHHHHHHHHHhcCceeeeecccCCC--CChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccCc
Q 002969          755 LNLLGHVWRLWKEGKVLEMVDSSVDN--YPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSET  818 (862)
Q Consensus       755 ~~l~~~~~~~~~~~~~~~~id~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  818 (862)
                      ............++.    .++.+..  ...+....+.+|+.+||+.||++||||.||++.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         235 DPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             SCCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            111222222222222    1222211  12345567889999999999999999999999998763

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.6e-43  Score=385.94  Aligned_cols=248  Identities=24%  Similarity=0.304  Sum_probs=199.7

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC---ccchHHHHHH---HHHHHhcccCCceEEEEEEEeCCceE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS---GQGIEEFKNE---VRLIAKLQHRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E---~~~l~~l~HpnIv~l~g~~~~~~~~~  614 (862)
                      ++|++.++||+|+||.||+|+.. +|+.||||++.+..   ......+.+|   +.+++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999875 48999999986431   2223344444   56666678999999999999999999


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      +||||+++|+|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+|+.+
T Consensus        84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            9999999999999996543   4789999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeee
Q 002969          695 GGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEM  773 (862)
Q Consensus       695 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  773 (862)
                      ....    .....||+.|+|||++.. ..++.++|||||||+||||++|+.||......+..    .+.+...       
T Consensus       158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~~~~~~-------  222 (364)
T d1omwa3         158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTL-------  222 (364)
T ss_dssp             SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH----HHHHHSS-------
T ss_pred             CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhcc-------
Confidence            4332    234579999999999975 56899999999999999999999997643332211    1111111       


Q ss_pred             ecccCCCCChHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 002969          774 VDSSVDNYPANEVLRCIHVGLLCVQENAEERPT-----MASVVL  812 (862)
Q Consensus       774 id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  812 (862)
                        ......+...+.++.+|+.+||+.||++|||     ++|+++
T Consensus       223 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         223 --TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             --SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             --cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence              1112233445667899999999999999999     688875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.4e-42  Score=369.35  Aligned_cols=250  Identities=23%  Similarity=0.303  Sum_probs=204.1

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc---------cchHHHHHHHHHHHhcc-cCCceEEEEEEEeC
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG---------QGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEM  610 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~  610 (862)
                      ++|+..++||+|+||+||+|+.. +++.||||+++....         ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            57899999999999999999874 588999999976431         12346889999999997 99999999999999


Q ss_pred             CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccc
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  690 (862)
                      +..++||||+++|+|.+++....   .+++.++..++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999996543   4899999999999999999999998   99999999999999999999999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcC------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHH
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMD------GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRL  764 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~  764 (862)
                      ++.+....   ......||+.|+|||++.+      ..++.++||||+||++|||++|+.||...   ......    +.
T Consensus       157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~---~~~~~~----~~  226 (277)
T d1phka_         157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR---KQMLML----RM  226 (277)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHH----HH
T ss_pred             eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC---CHHHHH----HH
Confidence            99875432   2234679999999999853      35788999999999999999999997532   222222    22


Q ss_pred             HhcCceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          765 WKEGKVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       765 ~~~~~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ...+... .    ........+.++.+|+.+||+.||++||++.||++
T Consensus       227 i~~~~~~-~----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         227 IMSGNYQ-F----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHTCCC-C----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHhCCCC-C----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            2222110 0    01122345678899999999999999999999975

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-43  Score=383.43  Aligned_cols=247  Identities=26%  Similarity=0.350  Sum_probs=203.7

Q ss_pred             ccccccceeeccccEEEEEeEecC-CcEEEEEEeccC---CccchHHHHHHHHHHH-hcccCCceEEEEEEEeCCceEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN---SGQGIEEFKNEVRLIA-KLQHRNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~HpnIv~l~g~~~~~~~~~lV  616 (862)
                      ++|++.++||+|+||+||+|+... ++.||||++++.   .....+.+..|..++. .++|||||++++++.+.+..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            578999999999999999998764 889999999753   2344566777777765 68999999999999999999999


Q ss_pred             EEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCC
Q 002969          617 YEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGG  696 (862)
Q Consensus       617 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  696 (862)
                      |||+++|+|.+++....   .+++.++..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            99999999999996543   3889999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeecc
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDS  776 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  776 (862)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||..   .....+..    ....+.       
T Consensus       156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~---~~~~~~~~----~i~~~~-------  219 (320)
T d1xjda_         156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEELFH----SIRMDN-------  219 (320)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHH----HHHHCC-------
T ss_pred             cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC---CCHHHHHH----HHHcCC-------
Confidence            22  223346799999999999999999999999999999999999999742   22222222    222211       


Q ss_pred             cCCCCChHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 002969          777 SVDNYPANEVLRCIHVGLLCVQENAEERPTMA-SVVL  812 (862)
Q Consensus       777 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~  812 (862)
                        ...+...+.++.+|+.+||+.||++||++. ||++
T Consensus       220 --~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         220 --PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             --CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence              122344566789999999999999999995 7764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=373.87  Aligned_cols=269  Identities=23%  Similarity=0.351  Sum_probs=204.3

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ++|+.+++||+|+||+||+|+.. +++.||||+++...  ....+++.+|++++++++|||||++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57999999999999999999874 58999999996542  3346789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      |+.++.+. ++... ....+++.++..++.||+.||+|||+.+   ||||||||+|||++.++.+||+|||+|+......
T Consensus        82 ~~~~~~~~-~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKK-FMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHH-HHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhh-hhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99765444 43222 2345999999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccccccccccccccChhhhcCCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce------e
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV------L  771 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~  771 (862)
                        .......||+.|+|||.+.... ++.++|||||||++|||++|+.||..   .+..+....+.+.......      .
T Consensus       157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (298)
T d1gz8a_         157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIFRTLGTPDEVVWPGVT  231 (298)
T ss_dssp             --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC---CCHHHHHHHHHHhcCCCchhhccccc
Confidence              2233457999999999987765 57899999999999999999999743   2222333333222211100      0


Q ss_pred             eeec--ccCCC--------CChHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hccCcCC
Q 002969          772 EMVD--SSVDN--------YPANEVLRCIHVGLLCVQENAEERPTMASVVLM--LSSETAT  820 (862)
Q Consensus       772 ~~id--~~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~~  820 (862)
                      ...+  .....        .....+.++.+|+.+||+.||++|||++|+++.  +.++..+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            0000  00000        011234578899999999999999999999985  6655333

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-42  Score=375.96  Aligned_cols=251  Identities=19%  Similarity=0.278  Sum_probs=203.8

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      .++|++.++||+|+||+||+|+.. +++.||||+++... .....+.+|+++|++++|||||++++++.+.+..++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            367999999999999999999876 47889999997653 3345688999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC--CCeeEecccceeecCCC
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE--MTPKISDFGMARIFGGD  697 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kL~DFGla~~~~~~  697 (862)
                      +++|+|.+++...  ...+++.++..++.||++||+|||+.+   |+||||||+|||++.+  ..+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            9999999998543  235899999999999999999999998   9999999999999854  58999999999876432


Q ss_pred             CcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCceeeeeccc
Q 002969          698 QTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVLEMVDSS  777 (862)
Q Consensus       698 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  777 (862)
                      .   ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...   .....+..+    ..+... ...  
T Consensus       158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~---~~~~~~~~i----~~~~~~-~~~--  224 (321)
T d1tkia_         158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENI----MNAEYT-FDE--  224 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHH----HHTCCC-CCH--
T ss_pred             C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC---CHHHHHHHH----HhCCCC-CCh--
Confidence            2   233457899999999999999999999999999999999999997432   222222222    111100 000  


Q ss_pred             CCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          778 VDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       778 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                        ......+.++.+|+.+||+.||++|||+.|+++
T Consensus       225 --~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         225 --EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             --HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              001123457889999999999999999999997

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-42  Score=374.61  Aligned_cols=247  Identities=21%  Similarity=0.245  Sum_probs=196.5

Q ss_pred             ccccccc-eeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhc-ccCCceEEEEEEEe----CCceE
Q 002969          542 DNFTDYN-KLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKL-QHRNLVRLLGCCVE----MDEKM  614 (862)
Q Consensus       542 ~~f~~~~-~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~----~~~~~  614 (862)
                      ++|.+.+ .||+|+||.||+|+.. +++.||||+++.     .+.+.+|+.++.++ +|||||++++++.+    ....+
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            5788765 5999999999999874 588999999964     35678899987665 89999999999875    45689


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC---CCCeeEecccce
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK---EMTPKISDFGMA  691 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DFGla  691 (862)
                      +||||+++|+|.+++.... ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.   ++.+||+|||+|
T Consensus        86 ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence            9999999999999996532 245999999999999999999999998   999999999999975   567999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL  771 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  771 (862)
                      +.......   .....||+.|+|||++.+..|+.++|||||||+||||++|+.||.......   ......         
T Consensus       162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~---~~~~~~---------  226 (335)
T d2ozaa1         162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMK---------  226 (335)
T ss_dssp             EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------
T ss_pred             eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH---HHHHHH---------
Confidence            87654322   234679999999999999999999999999999999999999975322211   111110         


Q ss_pred             eeecccCCCCC----hHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          772 EMVDSSVDNYP----ANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       772 ~~id~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ..+.......+    ...+.++.+|+.+||+.||++|||+.|+++
T Consensus       227 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         227 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11111111111    234567899999999999999999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.4e-42  Score=366.98  Aligned_cols=260  Identities=23%  Similarity=0.358  Sum_probs=202.7

Q ss_pred             ccccccceeeccccEEEEEeEecCCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEEe
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYEY  619 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~  619 (862)
                      ++|+.+++||+|+||+||+|+..+++.||||+++...  ....+++.+|+.+|++++||||+++++++...+..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5899999999999999999999889999999996542  33467899999999999999999999999999999999999


Q ss_pred             ccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCCc
Q 002969          620 MENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQT  699 (862)
Q Consensus       620 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  699 (862)
                      +.++.+..+...   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-  154 (286)
T d1ob3a_          82 LDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (286)
T ss_dssp             CSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence            998777766533   345999999999999999999999988   9999999999999999999999999998764322 


Q ss_pred             ccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee------e
Q 002969          700 EQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL------E  772 (862)
Q Consensus       700 ~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------~  772 (862)
                       .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||..   ....+....+.+........      +
T Consensus       155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG---VSEADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC---CCHHHHHHHHHHhhCCCChhhccchhh
Confidence             222334689999999998765 568999999999999999999999743   22223333333222111000      0


Q ss_pred             e--ecccC--------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          773 M--VDSSV--------DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       773 ~--id~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .  .....        .......+.++.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0  00000        1112234567889999999999999999999985

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-42  Score=366.06  Aligned_cols=239  Identities=24%  Similarity=0.362  Sum_probs=195.7

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCc------cchHHHHHHHHHHHhcc--cCCceEEEEEEEeCCc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSG------QGIEEFKNEVRLIAKLQ--HRNLVRLLGCCVEMDE  612 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--HpnIv~l~g~~~~~~~  612 (862)
                      ++|++.++||+|+||.||+|+.. +++.||||++.....      ....++.+|+.++++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999875 589999999975421      12345789999999996  8999999999999999


Q ss_pred             eEEEEEeccC-CChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCC-CCeeEecccc
Q 002969          613 KMLVYEYMEN-RSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKE-MTPKISDFGM  690 (862)
Q Consensus       613 ~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFGl  690 (862)
                      .++||||+.+ +++.+++...   ..+++.++..++.||++||+|||+.+   |+||||||+|||++.+ +.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 5777777543   34899999999999999999999998   9999999999999854 7999999999


Q ss_pred             eeecCCCCcccccccccccccccChhhhcCCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc
Q 002969          691 ARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLF-SVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK  769 (862)
Q Consensus       691 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  769 (862)
                      ++.....    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...         ..+   . .+.
T Consensus       158 a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---------~~i---~-~~~  220 (273)
T d1xwsa_         158 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---------EEI---I-RGQ  220 (273)
T ss_dssp             CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---------HHH---H-HCC
T ss_pred             ceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---------hHH---h-hcc
Confidence            9875322    2234679999999999987765 57789999999999999999997421         011   1 111


Q ss_pred             eeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          770 VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       770 ~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                               ...+...+.++.+|+.+||+.||++|||++|+++
T Consensus       221 ---------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 ---------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                     1122334567889999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-41  Score=365.81  Aligned_cols=261  Identities=23%  Similarity=0.347  Sum_probs=200.0

Q ss_pred             cccccccceeeccccEEEEEeEec-C-CcEEEEEEeccCC--ccchHHHHHHHHHHHhc---ccCCceEEEEEEEe----
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-E-GQEIAVKRLSRNS--GQGIEEFKNEVRLIAKL---QHRNLVRLLGCCVE----  609 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~HpnIv~l~g~~~~----  609 (862)
                      .++|+++++||+|+||+||+|+.. . ++.||||+++...  ......+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999874 3 5679999986542  23345677888888776   79999999999863    


Q ss_pred             -CCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecc
Q 002969          610 -MDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDF  688 (862)
Q Consensus       610 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF  688 (862)
                       ....++++||++++.+.....  .....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             346799999999887765443  23345889999999999999999999998   999999999999999999999999


Q ss_pred             cceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcC
Q 002969          689 GMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG  768 (862)
Q Consensus       689 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  768 (862)
                      |+++....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||..   ....+.+..+.+.....
T Consensus       161 g~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~---~~~~~~~~~i~~~~~~~  234 (305)
T d1blxa_         161 GLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG---SSDVDQLGKILDVIGLP  234 (305)
T ss_dssp             CSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHHHHCCC
T ss_pred             hhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCC---CCHHHHHHHHHHhhCCC
Confidence            99876432   2233456899999999999999999999999999999999999999743   22333333333322111


Q ss_pred             cee--------------eeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          769 KVL--------------EMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       769 ~~~--------------~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      ...              ..............+..+.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000              00000011223334567889999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-40  Score=363.86  Aligned_cols=257  Identities=22%  Similarity=0.295  Sum_probs=195.6

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCceEEEEEEEeC------CceEE
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM------DEKML  615 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~------~~~~l  615 (862)
                      +|+..++||+|+||+||+|+.. .++.||||++.....    .+.+|+++|++++||||+++++++...      .+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5888899999999999999976 489999999975432    234799999999999999999998643      34689


Q ss_pred             EEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC-CeeEecccceeec
Q 002969          616 VYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIF  694 (862)
Q Consensus       616 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~  694 (862)
                      ||||++++.+..+.........+++.++..++.||++||+|||+++   |+||||||+|||++.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987755555443444556999999999999999999999998   99999999999999775 8999999999876


Q ss_pred             CCCCcccccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcC-----
Q 002969          695 GGDQTEQNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG-----  768 (862)
Q Consensus       695 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-----  768 (862)
                      .....   .....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...   ...+.+..+.+.....     
T Consensus       174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~---~~~~~l~~i~~~~g~~~~~~~  247 (350)
T d1q5ka_         174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD---SGVDQLVEIIKVLGTPTREQI  247 (350)
T ss_dssp             CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS---SHHHHHHHHHHHHCCCCHHHH
T ss_pred             cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC---CHHHHHHHHHHHhCCChHHhh
Confidence            43322   223578999999998875 46899999999999999999999997432   2222222222211110     


Q ss_pred             -----ceeeeecccC------CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          769 -----KVLEMVDSSV------DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       769 -----~~~~~id~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                           ......-+..      .......+.++.+|+.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0000000000      1112334567889999999999999999999996

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-40  Score=362.02  Aligned_cols=262  Identities=24%  Similarity=0.352  Sum_probs=196.3

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEeCC------
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD------  611 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~------  611 (862)
                      .++|+.+++||+|+||+||+|+.. +++.||||+++..  .....+.+.+|+++|++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            358999999999999999999875 4899999999754  2334568899999999999999999999997654      


Q ss_pred             ceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccce
Q 002969          612 EKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMA  691 (862)
Q Consensus       612 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  691 (862)
                      +.++||||+ +.+|..++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            469999999 5667766632    34999999999999999999999998   999999999999999999999999999


Q ss_pred             eecCCCCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc-
Q 002969          692 RIFGGDQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK-  769 (862)
Q Consensus       692 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-  769 (862)
                      +.....     .....||+.|+|||++.+. .++.++||||+||++|||++|+.|+...   +....+........... 
T Consensus       169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~---~~~~~~~~~~~~~~~~~~  240 (346)
T d1cm8a_         169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS---DHLDQLKEIMKVTGTPPA  240 (346)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCH
T ss_pred             eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC---ChHHHHHHHHhccCCCcH
Confidence            876432     2345789999999998764 5789999999999999999999997432   22222211111110000 


Q ss_pred             -----------------eeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hccCc
Q 002969          770 -----------------VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM--LSSET  818 (862)
Q Consensus       770 -----------------~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~  818 (862)
                                       ..+................+.+|+.+||+.||++|||++|+++.  +..+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                             00000011111223345678899999999999999999999984  65553

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.4e-40  Score=353.62  Aligned_cols=261  Identities=19%  Similarity=0.247  Sum_probs=198.5

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCce-EEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV-RLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~g~~~~~~~~~lV~E  618 (862)
                      .++|+..++||+|+||.||+|+.. +++.||||++....  ..+++..|++++++++|+|++ .+..+..+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            357999999999999999999874 48899999986543  235688999999999877655 55566677888899999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEec---CCCCeeEecccceeecC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLD---KEMTPKISDFGMARIFG  695 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kL~DFGla~~~~  695 (862)
                      |+. ++|...+...  ...+++..+..++.|+++||+|||+++   |+||||||+|||++   .+..+||+|||+|+.+.
T Consensus        84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LLG-PSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CCC-CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EcC-Cchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            994 5666655332  345899999999999999999999998   99999999999985   45679999999999875


Q ss_pred             CCCcc-----cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce
Q 002969          696 GDQTE-----QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV  770 (862)
Q Consensus       696 ~~~~~-----~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  770 (862)
                      .....     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....................... 
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-  236 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-  236 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-
Confidence            43321     223346799999999999999999999999999999999999999865444333222222111111100 


Q ss_pred             eeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          771 LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       771 ~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                             ........+.++.+++..||+.+|++||+++++.+.|+..
T Consensus       237 -------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         237 -------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             -------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             -------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                   0011123446788999999999999999999998888764

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=9.6e-40  Score=350.94  Aligned_cols=261  Identities=17%  Similarity=0.212  Sum_probs=208.0

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhccc-CCceEEEEEEEeCCceEEEEE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH-RNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~lV~E  618 (862)
                      .++|++.++||+|+||.||+|+.. +++.||||++....  ..+.+.+|++.++.++| +|++.+++++.+....++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            367999999999999999999875 48899999986543  23567889999999975 899999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecC-----CCCeeEecccceee
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDK-----EMTPKISDFGMARI  693 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~-----~~~~kL~DFGla~~  693 (862)
                      |+ +++|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.     ++.+||+|||+|+.
T Consensus        82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            99 68999888543  335899999999999999999999998   999999999999964     57899999999998


Q ss_pred             cCCCCcc-----cccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcC
Q 002969          694 FGGDQTE-----QNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEG  768 (862)
Q Consensus       694 ~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  768 (862)
                      +......     .......||+.|||||.+.+..++.++||||||+++|||++|+.||..............+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            7543221     22334679999999999999999999999999999999999999986544443333322222111111


Q ss_pred             ceeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccC
Q 002969          769 KVLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVLMLSSE  817 (862)
Q Consensus       769 ~~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  817 (862)
                      ..    .    ......+.++.+++..|++.+|++||+++.+.+.|+++
T Consensus       236 ~~----~----~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         236 PL----R----ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             CH----H----HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             Ch----H----HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            10    0    11122345688999999999999999999998888765

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-40  Score=358.31  Aligned_cols=263  Identities=21%  Similarity=0.306  Sum_probs=196.5

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccC--CccchHHHHHHHHHHHhcccCCceEEEEEEEe--------C
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRN--SGQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE--------M  610 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--------~  610 (862)
                      ++|+..++||+|+||+||+|+.. +++.||||++...  .....+++.+|+.+|++++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            68999999999999999999875 5899999998654  33456788999999999999999999999855        3


Q ss_pred             CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccc
Q 002969          611 DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGM  690 (862)
Q Consensus       611 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  690 (862)
                      ...++||||++++.+.....   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence            45799999999887765542   2335888899999999999999999998   99999999999999999999999999


Q ss_pred             eeecCCCCcc--cccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhc
Q 002969          691 ARIFGGDQTE--QNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKE  767 (862)
Q Consensus       691 a~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  767 (862)
                      ++.+......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..   .........+.+....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~---~~~~~~~~~i~~~~~~  240 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQLALISQLCGS  240 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHHHHCC
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC---CCHHHHHHHHHHhcCC
Confidence            9876543221  222335799999999998765 689999999999999999999999743   2222222222222211


Q ss_pred             Cc-----------eeeeecccC-CCCCh-------HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          768 GK-----------VLEMVDSSV-DNYPA-------NEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       768 ~~-----------~~~~id~~~-~~~~~-------~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                      ..           ....+.... .....       .....+.+|+.+||+.||++|||++|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            00           000000000 00011       113356789999999999999999999974

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-39  Score=350.26  Aligned_cols=261  Identities=21%  Similarity=0.299  Sum_probs=206.9

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeCCceEEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~lV~E  618 (862)
                      ++|+.+++||+|+||+||+|+.. +++.||||+++...  ....+++.+|+.++++++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999875 57889999996543  3456789999999999999999999999999999999999


Q ss_pred             eccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeecCCCC
Q 002969          619 YMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIFGGDQ  698 (862)
Q Consensus       619 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  698 (862)
                      ++.+++|..++...   ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            99999998877433   35889999999999999999999998   9999999999999999999999999998764332


Q ss_pred             cccccccccccccccChhhhcCCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc--------
Q 002969          699 TEQNTKRVVGTYGYMSPEYAMDGL-FSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK--------  769 (862)
Q Consensus       699 ~~~~~~~~~gt~~y~APE~l~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--------  769 (862)
                      .  ......+++.|+|||++.... ++.++|||||||++|||++|+.|+.  ...+..+....+........        
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF--PGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC--CCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC--CCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            2  222345788999999987765 6899999999999999999999963  33333333333332222110        


Q ss_pred             ------eeeee--cccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          770 ------VLEMV--DSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       770 ------~~~~i--d~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                            .....  ..............+.+|+.+||+.||++|||++||++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  00000  01112223344567889999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-40  Score=355.13  Aligned_cols=252  Identities=23%  Similarity=0.321  Sum_probs=203.7

Q ss_pred             ccccccceeeccccEEEEEeEec----CCcEEEEEEeccCC----ccchHHHHHHHHHHHhccc-CCceEEEEEEEeCCc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL----EGQEIAVKRLSRNS----GQGIEEFKNEVRLIAKLQH-RNLVRLLGCCVEMDE  612 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~~~  612 (862)
                      ++|++.++||+|+||+||+|+..    .|+.||||++++..    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            57999999999999999999752    37899999986532    2345678999999999977 899999999999999


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      .++++||+.+|+|.+++....   .+.+.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999986544   3678888999999999999999998   9999999999999999999999999998


Q ss_pred             ecCCCCcccccccccccccccChhhhcCC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCce
Q 002969          693 IFGGDQTEQNTKRVVGTYGYMSPEYAMDG--LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKV  770 (862)
Q Consensus       693 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  770 (862)
                      .+...... ......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||......+   ....+.+...... 
T Consensus       178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~---~~~~i~~~~~~~~-  252 (322)
T d1vzoa_         178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSE-  252 (322)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---CHHHHHHHHHHCC-
T ss_pred             hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcccCC-
Confidence            76433222 23346789999999999765  46889999999999999999999975433322   2222222222111 


Q ss_pred             eeeecccCCCCChHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 002969          771 LEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERP-----TMASVVL  812 (862)
Q Consensus       771 ~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  812 (862)
                              ...+...+.++.+|+.+||+.||++||     |++|+++
T Consensus       253 --------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 --------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             --------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                    123445677889999999999999999     5899986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-40  Score=360.13  Aligned_cols=263  Identities=21%  Similarity=0.307  Sum_probs=196.9

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC-ccchHHHHHHHHHHHhcccCCceEEEEEEEeCC----ceE
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS-GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEMD----EKM  614 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~----~~~  614 (862)
                      +++|+.+++||+|+||+||+|+.. +++.||||++.... ....+++.+|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            457999999999999999999864 68999999997543 344668899999999999999999999997643    235


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEecccceeec
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMARIF  694 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  694 (862)
                      ++++|+.+|+|.+++...    .+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus        87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            566777899999998542    4899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcc-cccccccccccccChhhhcC-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCcee-
Q 002969          695 GGDQTE-QNTKRVVGTYGYMSPEYAMD-GLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGKVL-  771 (862)
Q Consensus       695 ~~~~~~-~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-  771 (862)
                      ...... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||....   ..+............... 
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH---YLDQLNHILGILGSPSQED  236 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCSCCHHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC---HHHHHHHHhhhccCCChhh
Confidence            443222 22344679999999999855 567899999999999999999999974321   111111111111110000 


Q ss_pred             ----------eee--cccCCCC-----ChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          772 ----------EMV--DSSVDNY-----PANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       772 ----------~~i--d~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                                ...  .+.....     ......++.+|+.+||+.||++|||++|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                      000  0000011     11223468899999999999999999999974

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.2e-38  Score=348.14  Aligned_cols=254  Identities=20%  Similarity=0.296  Sum_probs=196.7

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcc-cCCceEEEEEEEeC--CceEEEE
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEM--DEKMLVY  617 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~--~~~~lV~  617 (862)
                      ++|++.++||+|+||+||+|+.. +++.||||+++..   ..+++.+|+++|++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999875 5889999999653   3567889999999995 99999999999754  5689999


Q ss_pred             EeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCC-CeeEecccceeecCC
Q 002969          618 EYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEM-TPKISDFGMARIFGG  696 (862)
Q Consensus       618 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~  696 (862)
                      ||+++++|..+.      ..+++.++..++.||++||+|||+++   |+||||||+|||++.++ .+||+|||+++.+..
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999997764      24899999999999999999999998   99999999999998765 589999999987643


Q ss_pred             CCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH---------h
Q 002969          697 DQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW---------K  766 (862)
Q Consensus       697 ~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~---------~  766 (862)
                      ...   .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.|+......  .+....+.+..         .
T Consensus       183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~--~~~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHH
T ss_pred             CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh--HHHHHHHHHHHCCchhhhhhh
Confidence            322   2345789999999998775 4799999999999999999999997543222  11111111111         0


Q ss_pred             cCcee--e----e--------ecccC-CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 002969          767 EGKVL--E----M--------VDSSV-DNYPANEVLRCIHVGLLCVQENAEERPTMASVVL  812 (862)
Q Consensus       767 ~~~~~--~----~--------id~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  812 (862)
                      .....  .    .        ..... .......+.++.+|+.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000  0    0        00001 1112234567889999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-38  Score=350.51  Aligned_cols=257  Identities=23%  Similarity=0.293  Sum_probs=189.5

Q ss_pred             ccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEe------CCc
Q 002969          542 DNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVE------MDE  612 (862)
Q Consensus       542 ~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------~~~  612 (862)
                      ++|++.++||+|+||+||+|+.. +++.||||+++...  ....+++.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999876 48999999997543  3345678999999999999999999999964      367


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      .++||||+.++.+.. +.     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~~-~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQV-IQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHHH-HT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHHh-hh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            899999997665543 32     24889999999999999999999998   9999999999999999999999999988


Q ss_pred             ecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHH-------
Q 002969          693 IFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLW-------  765 (862)
Q Consensus       693 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~-------  765 (862)
                      .....   .......+|+.|+|||++.+..++.++||||+||+++||++|+.||...   +.......+....       
T Consensus       168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~---~~~~~~~~i~~~~~~~~~~~  241 (355)
T d2b1pa1         168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR---DYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCHHH
T ss_pred             ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC---CHHHHHHHHHHhccCCCHHH
Confidence            65432   2233457899999999999999999999999999999999999987422   2222211111111       


Q ss_pred             -----------hcCce-e------eeecccC----CCCChHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 002969          766 -----------KEGKV-L------EMVDSSV----DNYPANEVLRCIHVGLLCVQENAEERPTMASVVLM  813 (862)
Q Consensus       766 -----------~~~~~-~------~~id~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  813 (862)
                                 ..... .      .......    .......+.++.+|+.+||+.||++|||++||++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                       00100 0      0000000    11123346678999999999999999999999863

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-38  Score=350.60  Aligned_cols=262  Identities=23%  Similarity=0.329  Sum_probs=197.4

Q ss_pred             cccccccceeeccccEEEEEeEec-CCcEEEEEEeccCC--ccchHHHHHHHHHHHhcccCCceEEEEEEEeC-----Cc
Q 002969          541 TDNFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNS--GQGIEEFKNEVRLIAKLQHRNLVRLLGCCVEM-----DE  612 (862)
Q Consensus       541 ~~~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~~  612 (862)
                      .++|+..++||+|+||+||+|+.. +++.||||+++...  ....+++.+|+++|++++|||+|++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            468999999999999999999864 58999999997543  33456789999999999999999999998643     34


Q ss_pred             eEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          613 KMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       613 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      .+++++|+.+|+|.+++..    ..+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            5777888899999999843    24999999999999999999999998   9999999999999999999999999997


Q ss_pred             ecCCCCcccccccccccccccChhhhcCC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCcchhHHHHHHHHHhcCc--
Q 002969          693 IFGGDQTEQNTKRVVGTYGYMSPEYAMDG-LFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNELNLLGHVWRLWKEGK--  769 (862)
Q Consensus       693 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--  769 (862)
                      ...     .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||..   .+.......+.+......  
T Consensus       170 ~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~---~~~~~~~~~i~~~~~~~~~~  241 (348)
T d2gfsa1         170 HTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG---TDHIDQLKLILRLVGTPGAE  241 (348)
T ss_dssp             CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHHHHCCCCHH
T ss_pred             ccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC---CCHHHHHHHHHHhcCCCChH
Confidence            542     222345789999999987775 468999999999999999999999643   222222222222111100  


Q ss_pred             ----------------eeeeecccCCCCChHHHHHHHHHHHhccccCCCCCCCHHHHHH--HhccC
Q 002969          770 ----------------VLEMVDSSVDNYPANEVLRCIHVGLLCVQENAEERPTMASVVL--MLSSE  817 (862)
Q Consensus       770 ----------------~~~~id~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~  817 (862)
                                      ..+...............++.+|+.+||+.||++|||++|+++  .+.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence                            0000000000011223456889999999999999999999997  45444

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.2e-34  Score=318.53  Aligned_cols=262  Identities=19%  Similarity=0.262  Sum_probs=193.5

Q ss_pred             cccccceeeccccEEEEEeEec-CCcEEEEEEeccCCccchHHHHHHHHHHHhcc-----------cCCceEEEEEEEeC
Q 002969          543 NFTDYNKLGQGGFGIVYKGRLL-EGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-----------HRNLVRLLGCCVEM  610 (862)
Q Consensus       543 ~f~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~g~~~~~  610 (862)
                      +|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.++++++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            5899999999999999999874 58999999996542 23467788999998886           57899999888653


Q ss_pred             --CceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhh-cCCCcEEecccCCcceEecCCCC-----
Q 002969          611 --DEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQ-DSRFRIIHRDLKASNILLDKEMT-----  682 (862)
Q Consensus       611 --~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDlkp~NILl~~~~~-----  682 (862)
                        ...+++++++..+..............+++..+..++.||++||+|||+ .+   |+||||||+||||+.++.     
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence              4567777777666555444444555668899999999999999999998 65   999999999999986653     


Q ss_pred             -eeEecccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHHHHHhCCCCCCCCCCCcch---hHH
Q 002969          683 -PKISDFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLLETVSGKKNRGFYHSNNEL---NLL  758 (862)
Q Consensus       683 -~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~---~l~  758 (862)
                       ++++|||.+.....     ......||+.|+|||++....++.++||||+||+++||++|+.||.........   +..
T Consensus       170 ~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         170 QIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence             89999999986532     123457899999999999999999999999999999999999997543222111   111


Q ss_pred             HHHHHHHhc--------C----------ceeeeec-----------ccCCCCChHHHHHHHHHHHhccccCCCCCCCHHH
Q 002969          759 GHVWRLWKE--------G----------KVLEMVD-----------SSVDNYPANEVLRCIHVGLLCVQENAEERPTMAS  809 (862)
Q Consensus       759 ~~~~~~~~~--------~----------~~~~~id-----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e  809 (862)
                      ......+..        .          .....+.           ..........+.++.+|+.+||+.||++|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            111111110        0          0000000           0012234566788999999999999999999999


Q ss_pred             HHHH
Q 002969          810 VVLM  813 (862)
Q Consensus       810 vl~~  813 (862)
                      +++.
T Consensus       325 ~L~H  328 (362)
T d1q8ya_         325 LVNH  328 (362)
T ss_dssp             HHTC
T ss_pred             HhcC
Confidence            9974

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.84  E-value=1.5e-21  Score=194.53  Aligned_cols=170  Identities=19%  Similarity=0.181  Sum_probs=121.6

Q ss_pred             cccceeeccccEEEEEeEecCCcEEEEEEeccCCc------------------cchHHHHHHHHHHHhcccCCceEEEEE
Q 002969          545 TDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSG------------------QGIEEFKNEVRLIAKLQHRNLVRLLGC  606 (862)
Q Consensus       545 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~HpnIv~l~g~  606 (862)
                      .+.++||+|+||.||+|+..+|+.||||+++....                  ........|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            34689999999999999988899999998753210                  011234568889999999999998866


Q ss_pred             EEeCCceEEEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhcCCCcEEecccCCcceEecCCCCeeEe
Q 002969          607 CVEMDEKMLVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQDSRFRIIHRDLKASNILLDKEMTPKIS  686 (862)
Q Consensus       607 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~  686 (862)
                      .    ..+++|||+++..+..          ++......++.|++++|+|||+.+   |+||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence            3    3479999998765533          344556789999999999999998   9999999999999865 58999


Q ss_pred             cccceeecCCCCcccccccccccccccChhhhcCCCCCccccchhHHHHHH
Q 002969          687 DFGMARIFGGDQTEQNTKRVVGTYGYMSPEYAMDGLFSVKSDVFSFGVLLL  737 (862)
Q Consensus       687 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwSlGvil~  737 (862)
                      |||+|.............+   .... -.|. ..+.|..++|+||..--+.
T Consensus       145 DFG~a~~~~~~~~~~~l~r---d~~~-~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         145 DFPQSVEVGEEGWREILER---DVRN-IITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCTTCEETTSTTHHHHHHH---HHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             ECCCcccCCCCCcHHHHHH---HHHH-HHHH-HcCCCCCcccHHHHHHHHh
Confidence            9999987532211110000   0000 0111 2356788999999765443

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=99.75  E-value=2.1e-18  Score=155.26  Aligned_cols=110  Identities=19%  Similarity=0.385  Sum_probs=90.3

Q ss_pred             ccccCCCCccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcce-eEEEcC
Q 002969           57 VDTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFDG  135 (862)
Q Consensus        57 ~~~~~~~~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~~-~~l~~~  135 (862)
                      +|+|.+||.|..|++|+|  |.|+|+|...|+     |.|++.    .++||.||++.|..  ...+.+..+| ++|+|.
T Consensus         1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~~----~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~   67 (112)
T d1xd5a_           1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDN----NRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG   67 (112)
T ss_dssp             CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEET----TEEEEECCCTTSCS--SEEEEECTTSCEEEEET
T ss_pred             CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEcC----CcEEEEccCccCCC--CcEEEEeccccEEEEec
Confidence            499999999999999974  999999998877     777653    58999999998854  3578888875 667786


Q ss_pred             CCCeEEccCCCC-CCccEEEEecCCCeEEEecCCCceeeeecCCCCC
Q 002969          136 SQNLVWSSNQTK-ATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTD  181 (862)
Q Consensus       136 ~~~~vWst~~~~-~~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtD  181 (862)
                       +..+|++++.. ....+|+|+|+|||||++. ++.++|||+.+|+|
T Consensus        68 -~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~-~~~~~W~S~t~~~n  112 (112)
T d1xd5a_          68 -SRAIWASNTNRQNGNYYLILQRDRNVVIYDN-SNNAIWATHTNVGN  112 (112)
T ss_dssp             -TEEEEECCCCCSCCCCEEEECTTSCEEEECT-TSCEEEECCCCCCC
T ss_pred             -CCeEEEEeeccCCCceEEEEcCCCCEEEECC-CCcEEecCCCccCC
Confidence             55677776553 3567899999999999986 57899999999986

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=99.73  E-value=4.9e-18  Score=151.44  Aligned_cols=104  Identities=19%  Similarity=0.271  Sum_probs=87.7

Q ss_pred             cccCCCCccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc-eeEEEcCC
Q 002969           58 DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDGS  136 (862)
Q Consensus        58 ~~~~~~~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~-~~~l~~~~  136 (862)
                      |+|.+||.|..|+.|.  +|.|.|+|+.+|+     |.||..    .++||.||++.|-  +...+.+..+ +++|.|++
T Consensus         2 ~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~~----~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~~   68 (108)
T d1jpca_           2 NILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYDV----DKPIWATNTGGLS--RSCFLSMQTDGNLVVYNPS   68 (108)
T ss_dssp             CEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEET----TEEEEECCCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred             CCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEeC----CceeeEeCCCCCC--CccEEEEeccceEEEECCC
Confidence            7899999999999995  6999999999887     888763    4789999999884  3457888776 57788999


Q ss_pred             CCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeeecCC
Q 002969          137 QNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDY  178 (862)
Q Consensus       137 ~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~  178 (862)
                      |.+||+|++... ...+|+|+|+|||||++.    .+||||+|
T Consensus        69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~----~~W~S~t~  107 (108)
T d1jpca_          69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT----DRWATGTH  107 (108)
T ss_dssp             CCEEEECCCCCSCSCEEEEECTTSCEEEEEC----CCCCCCCC
T ss_pred             ccceEEccccCCCCcEEEEEcCCCCEEEeCC----CcccCCCC
Confidence            999999997654 445789999999999964    48999988

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=99.71  E-value=1.4e-17  Score=148.40  Aligned_cols=105  Identities=20%  Similarity=0.332  Sum_probs=87.8

Q ss_pred             cccCCCCccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc-eeEEEcCC
Q 002969           58 DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDGS  136 (862)
Q Consensus        58 ~~~~~~~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~-~~~l~~~~  136 (862)
                      |+|.+||.|..|+.|.  +|.|.|+|...|+     |.++.    ..++||+||++.|... .+.+.+.++ +|+|+|++
T Consensus         2 ~~L~~g~~L~~g~~l~--~g~~~l~~q~dgn-----Lvl~~----~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~~   69 (109)
T d1kj1a_           2 NLLTNGEGLYAGQSLD--VEPYHFIMQEDCN-----LVLYD----HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAE   69 (109)
T ss_dssp             CEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECSS
T ss_pred             CCccCCCEEeCCCEEE--eCCEEEEecCCCe-----EEEEe----CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEeCC
Confidence            7899999999999996  5889999987766     66654    3589999999999865 466888876 57788999


Q ss_pred             CCeEEccCCCC-CCccEEEEecCCCeEEEecCCCceeeeecCC
Q 002969          137 QNLVWSSNQTK-ATNPVAQLQDSGNFVLKEAGSDEILWQSFDY  178 (862)
Q Consensus       137 ~~~vWst~~~~-~~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~  178 (862)
                      |.+||+|+++. ....+|+|+|+|||||++.    .+|||+-|
T Consensus        70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~----~~W~S~t~  108 (109)
T d1kj1a_          70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYGS----DIWSTGTY  108 (109)
T ss_dssp             SCEEEECCCCCCSSCCEEEECTTSCEEEECC----EEEECCCC
T ss_pred             CcEEEEEeeECCCCCEEEEEeCCCcEEEECC----CEecCCCc
Confidence            99999999874 4566899999999999963    59999875

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.56  E-value=2.7e-15  Score=135.72  Aligned_cols=99  Identities=23%  Similarity=0.242  Sum_probs=81.4

Q ss_pred             EEEeecCCceeEEeeCCCCCCCCCCceEEEEcce-eEEEcCCCCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceee
Q 002969           96 IWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILW  173 (862)
Q Consensus        96 Iw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~~-~~l~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lW  173 (862)
                      |||.++++++.+|++|++.|+....-+|.+..+| |+|.++ +.++|++++... ....|.|+++|||||++. +++++|
T Consensus        12 il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~-~~~~lW   89 (120)
T d1dlpa2          12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTN-QNIAVW   89 (120)
T ss_dssp             ECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEET-TTEEEE
T ss_pred             EEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcC-CCCEEE
Confidence            8999999999999999999999877789998875 566665 678999998754 457899999999999987 578999


Q ss_pred             eecCCCCCccCCcCcccceeecCCeeEEEecCCCCCCCCCCcEEEeccCCCcce
Q 002969          174 QSFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEG  227 (862)
Q Consensus       174 qSFd~PtDTlLpg~klg~~~~tg~~~~L~Sw~s~~dps~G~~s~~l~~~g~~~~  227 (862)
                      |||+                               +.++|.|.+.|+++|...+
T Consensus        90 ~S~t-------------------------------~~~~~~~~l~Lq~DGnlvl  112 (120)
T d1dlpa2          90 TSGN-------------------------------SRSAGRYVFVLQPDRNLAI  112 (120)
T ss_dssp             ECCC-------------------------------CCSSSCCEEEECSSSCEEE
T ss_pred             EeCC-------------------------------CCCCCcEEEEECCCCcEEE
Confidence            9972                               3557889999999997543

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.39  E-value=6.8e-14  Score=125.01  Aligned_cols=109  Identities=26%  Similarity=0.273  Sum_probs=89.6

Q ss_pred             EEEeecCCceeEEeeCCCCCCCCCCceEEEEcce-eEEEcCCCCeEEccCCCCCCccEEEEecCCCeEEEecCCCceeee
Q 002969           96 IWYKNIAQRTYVWVANRDDPLANSSGVLRIINQR-IGLFDGSQNLVWSSNQTKATNPVAQLQDSGNFVLKEAGSDEILWQ  174 (862)
Q Consensus        96 Iw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~~-~~l~~~~~~~vWst~~~~~~~~~a~l~d~GNlVl~~~~~~~~lWq  174 (862)
                      |||.-.++.|..|+.+.+.++.+..-+|.+..|| |||.+ .+.++|++++.+..+..|.|+|+|||||++. ++.++||
T Consensus         3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~-~~~~vWs   80 (115)
T d1dlpa1           3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTA-QNTIRWS   80 (115)
T ss_dssp             CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCT-TTCCSCC
T ss_pred             EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEcc-CCCEEEE
Confidence            7888788889999999999998877889998775 66666 5789999998876778999999999999986 5788999


Q ss_pred             ecCCCCCccCCcCcccceeecCCeeEEEecCCCCCCCCCCcEEEeccCCCcceEeecCCcceeecCC
Q 002969          175 SFDYPTDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGP  241 (862)
Q Consensus       175 SFd~PtDTlLpg~klg~~~~tg~~~~L~Sw~s~~dps~G~~s~~l~~~g~~~~~~~~~~~~~~rsg~  241 (862)
                      |+.                               +.+.|.|.+.|+++|..  +++  +.++|.+|.
T Consensus        81 S~t-------------------------------~~~~g~y~l~Lq~DGNl--vlY--~~~~Wssgt  112 (115)
T d1dlpa1          81 SGT-------------------------------KGSIGNYVLVLQPDRTV--TIY--GPGLWDSGT  112 (115)
T ss_dssp             CCC-------------------------------CCCSSCCEEEECSSSCE--EEE--CSEEEECSC
T ss_pred             cCC-------------------------------CCCCCCEEEEECCCCcE--EEe--CCCeecCCC
Confidence            862                               35689999999999985  344  347888765

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.35  E-value=2.5e-12  Score=115.49  Aligned_cols=102  Identities=17%  Similarity=0.264  Sum_probs=78.7

Q ss_pred             cccCCCCccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc-eeEEEcCC
Q 002969           58 DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDGS  136 (862)
Q Consensus        58 ~~~~~~~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~-~~~l~~~~  136 (862)
                      ++|.++|+|    .+.+..|.|.|.|...|+     |.++ +   ..++||.||+..|..  ...+.+..+ +|+|.|++
T Consensus        15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVLy-~---~~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~~   79 (119)
T d1b2pa_          15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVLY-D---NNNPIWATNTGGLGN--GCRAVLQPDGVLVVITNE   79 (119)
T ss_dssp             CEEETTCEE----EEEETTEEEEEEECTTSC-----EEEE-E---TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTT
T ss_pred             CEEeCCCeE----EEecCCceEEEEECCCCc-----EEEE-E---CCeEEEEecCCCCCc--ceEEEEEeCCCEEEECCC
Confidence            455555555    346779999999998887     6554 3   358899999987743  367888876 47788999


Q ss_pred             CCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeeecCC
Q 002969          137 QNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDY  178 (862)
Q Consensus       137 ~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~  178 (862)
                      |.+||++++... ...+|+|+|+|||||++    ..+|||-.+
T Consensus        80 g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg----~~~W~S~T~  118 (119)
T d1b2pa_          80 NVTVWQSPVAGKAGHYVLVLQPDRNVVIYG----DALWATQTV  118 (119)
T ss_dssp             CCEEEECSCCCCSSCEEEEECTTSCEEEEE----SEEEECCCC
T ss_pred             CcEEEECCCcCCCCceEEEEcCCCCEEEEC----CCEeccCCc
Confidence            999999998754 45579999999999985    369999643

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.04  E-value=2.3e-10  Score=101.66  Aligned_cols=96  Identities=19%  Similarity=0.266  Sum_probs=72.4

Q ss_pred             CccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc-eeEEEcCCCCeEEc
Q 002969           64 QNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDGSQNLVWS  142 (862)
Q Consensus        64 ~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~-~~~l~~~~~~~vWs  142 (862)
                      |.|..++.|  .+|.|.|.|...|+     |.|+..    .++||.+|...+   ....+.+.++ +|+|.|.++.+||+
T Consensus        15 ~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~~----~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~vWs   80 (115)
T d1dlpa1          15 QTLHAAQSL--ELSSFRFTMQSDCN-----LVLFDS----DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWS   80 (115)
T ss_dssp             SCCCTTCEE--CSTTEEEEECTTSC-----EEEEES----SSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCC
T ss_pred             ceecCCCcE--EcCCEEEEECCCCe-----EEEEcC----CeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEEEE
Confidence            445555555  46779999998887     778652    478999997543   3456777766 57788999999999


Q ss_pred             cCCCC-CCccEEEEecCCCeEEEecCCCceeeeecC
Q 002969          143 SNQTK-ATNPVAQLQDSGNFVLKEAGSDEILWQSFD  177 (862)
Q Consensus       143 t~~~~-~~~~~a~l~d~GNlVl~~~~~~~~lWqSFd  177 (862)
                      +++.. ....+++|+++|||||++    ..+|+|-.
T Consensus        81 S~t~~~~g~y~l~Lq~DGNlvlY~----~~~Wssgt  112 (115)
T d1dlpa1          81 SGTKGSIGNYVLVLQPDRTVTIYG----PGLWDSGT  112 (115)
T ss_dssp             CCCCCCSSCCEEEECSSSCEEEEC----SEEEECSC
T ss_pred             cCCCCCCCCEEEEECCCCcEEEeC----CCeecCCC
Confidence            98874 355679999999999984    37999843

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.68  E-value=3e-08  Score=88.61  Aligned_cols=95  Identities=22%  Similarity=0.364  Sum_probs=67.7

Q ss_pred             cccCCCCccCCCCEEecCCCeEEEEeecCCCCCCeEEEEEEeecCCceeEEeeCCCCCCCCCCceEEEEcc-eeEEEcCC
Q 002969           58 DTLTATQNLTYGKTLVSSDDVFELGFFSPGSSGKWYIGIWYKNIAQRTYVWVANRDDPLANSSGVLRIINQ-RIGLFDGS  136 (862)
Q Consensus        58 ~~~~~~~~l~~~~~lvS~~g~f~lGFf~~~~~~~~y~gIw~~~~~~~t~vWvAnr~~p~~~~~~~l~~~~~-~~~l~~~~  136 (862)
                      ++|.++|+|..        |.|.|.|-..|+     |.|+.    ...+||.+|-.  .......+.+.++ +++|.|.+
T Consensus        24 ~~l~~~q~l~~--------g~y~L~~q~DGN-----LvL~~----~~~~vW~s~t~--~~~~~~~~~l~~~GnLvl~d~~   84 (120)
T d1dlpa2          24 QTLHATQSLQL--------SPYRLSMETDCN-----LVLFD----RDDRVWSTNTA--GKGTGCRAVLQPNGRMDVLTNQ   84 (120)
T ss_dssp             CEECSSCCCBC--------SSCEEEEETTTE-----EEEEB----TTBCCSCCCCC--SSCSSCEEEEETTTEEEEEETT
T ss_pred             cEEcCCCeeEc--------CCEEEEEcCCCc-----EEEec----CCcEEEEEccc--cCCCcEEEEEeCCeeEEEEcCC
Confidence            55666666654        557777765554     66653    24678998743  3344567888775 67888999


Q ss_pred             CCeEEccCCCC-CCccEEEEecCCCeEEEecCCCceeeee
Q 002969          137 QNLVWSSNQTK-ATNPVAQLQDSGNFVLKEAGSDEILWQS  175 (862)
Q Consensus       137 ~~~vWst~~~~-~~~~~a~l~d~GNlVl~~~~~~~~lWqS  175 (862)
                      +.+||++++.. ....++.|+++|||||++.    .+|.|
T Consensus        85 ~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~~----~~W~t  120 (120)
T d1dlpa2          85 NIAVWTSGNSRSAGRYVFVLQPDRNLAIYGG----ALWTT  120 (120)
T ss_dssp             TEEEEECCCCCSSSCCEEEECSSSCEEEECC----CCCBC
T ss_pred             CCEEEEeCCCCCCCcEEEEECCCCcEEEeCC----CcccC
Confidence            99999999864 3556899999999999853    58875

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=98.45  E-value=3.7e-07  Score=79.85  Aligned_cols=83  Identities=18%  Similarity=0.394  Sum_probs=57.9

Q ss_pred             eEEEEcc-eeEEEcCCCCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeeecCCCCCccCCcCcccceeecCCee
Q 002969          122 VLRIINQ-RIGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEW  199 (862)
Q Consensus       122 ~l~~~~~-~~~l~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtDTlLpg~klg~~~~tg~~~  199 (862)
                      .|.+..| +|+|.+ .+.+||++++... ....+.|.++|||||++. .+.++|.|                        
T Consensus        22 ~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~-~g~~vWsS------------------------   75 (108)
T d1jpca_          22 VFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNP-SNKPIWAS------------------------   75 (108)
T ss_dssp             EEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECT-TCCEEEEC------------------------
T ss_pred             EEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECC-CccceEEc------------------------
Confidence            3555555 566666 4679999998754 456899999999999987 57889986                        


Q ss_pred             EEEecCCCCCCCCCCcEEEeccCCCcceEeecCCcceeecCC
Q 002969          200 YLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGP  241 (862)
Q Consensus       200 ~L~Sw~s~~dps~G~~s~~l~~~g~~~~~~~~~~~~~~rsg~  241 (862)
                             ....+.+.|.+.|+.+|...  ++.  .+.|.|+.
T Consensus        76 -------~t~~~~~~~~l~L~ddGNlV--ly~--~~~W~S~t  106 (108)
T d1jpca_          76 -------NTGGQNGNYVCILQKDRNVV--IYG--TDRWATGT  106 (108)
T ss_dssp             -------CCCCSCSCEEEEECTTSCEE--EEE--CCCCCCCC
T ss_pred             -------cccCCCCcEEEEEcCCCCEE--EeC--CCcccCCC
Confidence                   11123467788999999754  442  34676653

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.44  E-value=7.1e-07  Score=91.03  Aligned_cols=149  Identities=15%  Similarity=0.078  Sum_probs=103.6

Q ss_pred             HHHHHcccccccceeeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcc-cCCceEEEEEEEeCCceE
Q 002969          536 TIVRATDNFTDYNKLGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQ-HRNLVRLLGCCVEMDEKM  614 (862)
Q Consensus       536 ~i~~~~~~f~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~  614 (862)
                      ++....+.|+..+..+.++.+.||+... +++.++||+...........+.+|+..+..+. +--+.+++.+..+.+..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            3444445666555444444578998864 56778899887665555667888999988884 444778888888888999


Q ss_pred             EEEEeccCCChhhhhhhccCCCCCCHhhHHHHHHHHHHHhHHhhhc----------------------------------
Q 002969          615 LVYEYMENRSLDSVIFDKARSSILNWQRRFNIICGIARGLLYLHQD----------------------------------  660 (862)
Q Consensus       615 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~----------------------------------  660 (862)
                      +||+++++.++.+....        ......++.++++.++.||+.                                  
T Consensus        87 lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            99999999888654421        112233455555555555532                                  


Q ss_pred             ----------------------CCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          661 ----------------------SRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       661 ----------------------~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                                            ....++|+|+.|.|||+++++.+-|.||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                  112379999999999999876677999998754

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.36  E-value=5.5e-07  Score=79.97  Aligned_cols=82  Identities=18%  Similarity=0.294  Sum_probs=58.0

Q ss_pred             EEEEcc-eeEEEcCCCCeEEccCCCCC-CccEEEEecCCCeEEEecCCCceeeeecCCCCCccCCcCcccceeecCCeeE
Q 002969          123 LRIINQ-RIGLFDGSQNLVWSSNQTKA-TNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFEWY  200 (862)
Q Consensus       123 l~~~~~-~~~l~~~~~~~vWst~~~~~-~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtDTlLpg~klg~~~~tg~~~~  200 (862)
                      |.+-.| +|||.++ +.++|++++.+. ....+.|.++|||||++. .+.++|+|.                        
T Consensus        34 l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~-~g~~vWsS~------------------------   87 (119)
T d1b2pa_          34 FIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN-ENVTVWQSP------------------------   87 (119)
T ss_dssp             EEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT-TCCEEEECS------------------------
T ss_pred             EEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECC-CCcEEEECC------------------------
Confidence            444455 5666665 568999998754 457899999999999986 577899862                        


Q ss_pred             EEecCCCCCCCCCCcEEEeccCCCcceEeecCCcceeecCC
Q 002969          201 LTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGP  241 (862)
Q Consensus       201 L~Sw~s~~dps~G~~s~~l~~~g~~~~~~~~~~~~~~rsg~  241 (862)
                             ..-+.|.|.+.|+.+|...  ++  +.+.|.|+.
T Consensus        88 -------t~~~~~~~~l~Lq~DGNlv--lY--g~~~W~S~T  117 (119)
T d1b2pa_          88 -------VAGKAGHYVLVLQPDRNVV--IY--GDALWATQT  117 (119)
T ss_dssp             -------CCCCSSCEEEEECTTSCEE--EE--ESEEEECCC
T ss_pred             -------CcCCCCceEEEEcCCCCEE--EE--CCCEeccCC
Confidence                   1112457889999999754  44  346787754

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=98.34  E-value=9.2e-07  Score=77.34  Aligned_cols=83  Identities=25%  Similarity=0.419  Sum_probs=57.6

Q ss_pred             eEEEEcce-eEEEcCCCCeEEccCCCC--CCccEEEEecCCCeEEEecCCCceeeeecCCCCCccCCcCcccceeecCCe
Q 002969          122 VLRIINQR-IGLFDGSQNLVWSSNQTK--ATNPVAQLQDSGNFVLKEAGSDEILWQSFDYPTDTLLPQMKIGWDLKTGFE  198 (862)
Q Consensus       122 ~l~~~~~~-~~l~~~~~~~vWst~~~~--~~~~~a~l~d~GNlVl~~~~~~~~lWqSFd~PtDTlLpg~klg~~~~tg~~  198 (862)
                      .|.+..|| ++|.+ .+.+||++|+..  .....+.|.++|||||++. .+.++|+|                       
T Consensus        22 ~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~s-----------------------   76 (109)
T d1kj1a_          22 HFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDA-EGRSLWAS-----------------------   76 (109)
T ss_dssp             EEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECS-SSCEEEEC-----------------------
T ss_pred             EEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeC-CCcEEEEE-----------------------
Confidence            34555554 55554 668999998773  3456799999999999987 57889987                       


Q ss_pred             eEEEecCCCCCCCCCCcEEEeccCCCcceEeecCCcceeecCC
Q 002969          199 WYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGP  241 (862)
Q Consensus       199 ~~L~Sw~s~~dps~G~~s~~l~~~g~~~~~~~~~~~~~~rsg~  241 (862)
                              ...-+.|.|.+.|+++|+.  +++.  .+.|.|+.
T Consensus        77 --------~t~~~~~~~~l~L~ddGNl--vly~--~~~W~S~t  107 (109)
T d1kj1a_          77 --------HSVRGNGNYVLVLQEDGNV--VIYG--SDIWSTGT  107 (109)
T ss_dssp             --------CCCCCSSCCEEEECTTSCE--EEEC--CEEEECCC
T ss_pred             --------eeECCCCCEEEEEeCCCcE--EEEC--CCEecCCC
Confidence                    1112246788999999975  4443  35777654

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=98.19  E-value=2e-06  Score=75.59  Aligned_cols=111  Identities=16%  Similarity=0.132  Sum_probs=69.7

Q ss_pred             CCccCCcCcccceeecCCeeEEEecCCCCCCCCCCcEEEeccCCCcceEeecCCcceeecCCCCceeecCcCCCcccccc
Q 002969          180 TDTLLPQMKIGWDLKTGFEWYLTSWKSTDDPSTGDNSFKLDFHGFPEGFLWNKQERKYRSGPWNGVRFSGVPEMKPIEGI  259 (862)
Q Consensus       180 tDTlLpg~klg~~~~tg~~~~L~Sw~s~~dps~G~~s~~l~~~g~~~~~~~~~~~~~~rsg~w~g~~~~g~p~~~~~~~~  259 (862)
                      ||||+|||.|..+..      |+         .|.|.|.++.+|.  ++++....++|.++..+...  + +.+.....-
T Consensus         1 tDtL~~gq~L~~g~~------l~---------~g~~~l~~q~DGN--Lvly~~~~~vW~s~~~~~~~--~-~~l~l~~dG   60 (112)
T d1xd5a_           1 SDRLNSGHQLDTGGS------LA---------EGGYLFIIQNDCN--LVLYDNNRAVWASGTNGKAS--G-CVLKMQNDG   60 (112)
T ss_dssp             CCEEETTEEECTTCE------EE---------ETTEEEEECTTSC--EEEEETTEEEEECCCTTSCS--S-EEEEECTTS
T ss_pred             CCEecCCCEecCCCE------EE---------ECCEEEEEcCCCC--EEEEcCCcEEEEccCccCCC--C-cEEEEeccc
Confidence            799999999976543      54         3999999999997  45677788899876543210  0 111111111


Q ss_pred             ceEEEEeCCCceEEEEeecCCCceeEEEECcCCceEEEEeeccCCceeEEEccCCccC
Q 002969          260 NFEFFIDQDHDVYYSFFIENKNLFSRLIVSPDGFLQRFTWIEANKIWNPFWYAPKDQC  317 (862)
Q Consensus       260 ~~~~~~~~~~e~~~~~~~~~~~~~~rl~l~~~G~l~~~~w~~~~~~W~~~~~~p~~~C  317 (862)
                      .  +++.+.....+...........+++|+.||+|++|.-     .....|+...+.|
T Consensus        61 n--Lvl~~~~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~-----~~~~~W~S~t~~~  111 (112)
T d1xd5a_          61 N--LVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDN-----SNNAIWATHTNVG  111 (112)
T ss_dssp             C--EEEEETTEEEEECCCCCSCCCCEEEECTTSCEEEECT-----TSCEEEECCCCCC
T ss_pred             c--EEEEecCCeEEEEeeccCCCceEEEEcCCCCEEEECC-----CCcEEecCCCccC
Confidence            2  2333344444443333344557999999999999841     2356787766655

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.76  E-value=7.3e-05  Score=75.07  Aligned_cols=131  Identities=15%  Similarity=0.145  Sum_probs=87.3

Q ss_pred             eeeccc-cEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhccc--CCceEEEEEEEeCCceEEEEEeccCCCh
Q 002969          549 KLGQGG-FGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQH--RNLVRLLGCCVEMDEKMLVYEYMENRSL  625 (862)
Q Consensus       549 ~LG~G~-fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gsL  625 (862)
                      .+..|. -..||+....++..+++|......   ...+..|+..++.+..  -.+++++.+..+.+..++|||++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            445554 367999988778888999765432   3456788888888853  3467788888888889999999998776


Q ss_pred             hhhhhhccCCCCCCHhhHHHHHHHHHHH---------------------------------------------------h
Q 002969          626 DSVIFDKARSSILNWQRRFNIICGIARG---------------------------------------------------L  654 (862)
Q Consensus       626 ~~~l~~~~~~~~l~~~~~~~i~~qia~g---------------------------------------------------L  654 (862)
                      .+...        .   ...++.++++.                                                   +
T Consensus        94 ~~~~~--------~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSHL--------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSCC--------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             ccccc--------c---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            43210        0   00011112222                                                   2


Q ss_pred             HHhhhc----CCCcEEecccCCcceEecCCCCeeEecccceee
Q 002969          655 LYLHQD----SRFRIIHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       655 ~yLH~~----~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      ..+...    .++.++|+|+.|.|||++++..+-|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            222221    223489999999999999876678999997753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.38  E-value=0.00055  Score=73.47  Aligned_cols=76  Identities=14%  Similarity=0.216  Sum_probs=51.4

Q ss_pred             ceeeccccEEEEEeEecC-CcEEEEEEeccC-------CccchHHHHHHHHHHHhcc-c--CCceEEEEEEEeCCceEEE
Q 002969          548 NKLGQGGFGIVYKGRLLE-GQEIAVKRLSRN-------SGQGIEEFKNEVRLIAKLQ-H--RNLVRLLGCCVEMDEKMLV  616 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~-H--pnIv~l~g~~~~~~~~~lV  616 (862)
                      +.||.|....||+....+ ++.++||.-...       .....++...|++.|+.+. +  ..+++++.+  +.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            578999999999998765 678999965321       1223455677888888773 3  346666654  45667899


Q ss_pred             EEeccCCCh
Q 002969          617 YEYMENRSL  625 (862)
Q Consensus       617 ~E~~~~gsL  625 (862)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.48  E-value=0.0062  Score=63.10  Aligned_cols=135  Identities=14%  Similarity=0.134  Sum_probs=79.3

Q ss_pred             EEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCce--EEE-----EEEEeCCceEEEEEeccCCChhhh
Q 002969          556 GIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV--RLL-----GCCVEMDEKMLVYEYMENRSLDSV  628 (862)
Q Consensus       556 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv--~l~-----g~~~~~~~~~lV~E~~~~gsL~~~  628 (862)
                      -.||+++..+|+.+++|+.+.. ....+++..|...+..|...++.  ..+     .........+.++++++|..+...
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            4799999999999999998654 23456788899999888643322  111     122345667889999887554210


Q ss_pred             -----------h---hhc------cCCCCCCH-------------------hhHHHHHHHHHHHhHHhhh----cCCCcE
Q 002969          629 -----------I---FDK------ARSSILNW-------------------QRRFNIICGIARGLLYLHQ----DSRFRI  665 (862)
Q Consensus       629 -----------l---~~~------~~~~~l~~-------------------~~~~~i~~qia~gL~yLH~----~~~~~i  665 (862)
                                 +   +..      .....+++                   ..+-.+...+.+.++.+..    ..+..+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                       0   100      00111111                   1111122222233333322    223568


Q ss_pred             EecccCCcceEecCCCCeeEecccceee
Q 002969          666 IHRDLKASNILLDKEMTPKISDFGMARI  693 (862)
Q Consensus       666 vHrDlkp~NILl~~~~~~kL~DFGla~~  693 (862)
                      +|+|+.+.|||++++  ..+.||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999743  45899997753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.34  E-value=0.0075  Score=64.28  Aligned_cols=73  Identities=19%  Similarity=0.253  Sum_probs=50.0

Q ss_pred             ceeeccccEEEEEeEecCC--------cEEEEEEeccCCccchHHHHHHHHHHHhcccCC-ceEEEEEEEeCCceEEEEE
Q 002969          548 NKLGQGGFGIVYKGRLLEG--------QEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRN-LVRLLGCCVEMDEKMLVYE  618 (862)
Q Consensus       548 ~~LG~G~fg~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~g~~~~~~~~~lV~E  618 (862)
                      +.|+.|-.=.+|+....++        +.|.+++.. ... ......+|..+++.+.-.+ .+++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            6788888889999886543        456666654 322 2344568999999885334 4578887743    68899


Q ss_pred             eccCCChh
Q 002969          619 YMENRSLD  626 (862)
Q Consensus       619 ~~~~gsL~  626 (862)
                      |+++..|.
T Consensus       122 fi~g~~l~  129 (395)
T d1nw1a_         122 YIPSRPLS  129 (395)
T ss_dssp             CCCEEECC
T ss_pred             EeccccCC
Confidence            99876553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.42  E-value=0.053  Score=55.19  Aligned_cols=158  Identities=11%  Similarity=-0.000  Sum_probs=83.4

Q ss_pred             cChHHHHHHcccccccce-----eeccccEEEEEeEecCCcEEEEEEeccCCccchHHHHHHHHHHHhcccCCce--EEE
Q 002969          532 FDFETIVRATDNFTDYNK-----LGQGGFGIVYKGRLLEGQEIAVKRLSRNSGQGIEEFKNEVRLIAKLQHRNLV--RLL  604 (862)
Q Consensus       532 ~~~~~i~~~~~~f~~~~~-----LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~HpnIv--~l~  604 (862)
                      .+.+++.....+|...+.     |..|---+.|+.+..+| .+++|+.....  ..++...|+.++..|.+.++.  ..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            345666666777765443     34555577899887665 58999885432  234556677788887543321  111


Q ss_pred             E------EEEeCCceEEEEEeccCCChhhhh--------------hhccC------CC------------------CCCH
Q 002969          605 G------CCVEMDEKMLVYEYMENRSLDSVI--------------FDKAR------SS------------------ILNW  640 (862)
Q Consensus       605 g------~~~~~~~~~lV~E~~~~gsL~~~l--------------~~~~~------~~------------------~l~~  640 (862)
                      .      +.........++.+..+......-              +....      ..                  ....
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            1      112234556677776654432110              00000      00                  0001


Q ss_pred             hhHHHHHHHHHHHhHHhhhc-CCCcEEecccCCcceEecCCCCeeEeccccee
Q 002969          641 QRRFNIICGIARGLLYLHQD-SRFRIIHRDLKASNILLDKEMTPKISDFGMAR  692 (862)
Q Consensus       641 ~~~~~i~~qia~gL~yLH~~-~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  692 (862)
                      ......+..+...+...+.. -+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            11112222222222222221 23469999999999999988777899999875

>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.06  E-value=0.038  Score=35.49  Aligned_cols=32  Identities=38%  Similarity=0.864  Sum_probs=25.9

Q ss_pred             ccCcCCCCCCCCccccCC-CCCccCCCCCccccC
Q 002969          315 DQCDNYGECGPFGICDTN-ASPVCQCMRGFEPKD  347 (862)
Q Consensus       315 ~~Cd~yg~CG~~g~C~~~-~~~~C~Cl~Gf~~~~  347 (862)
                      |.|.+-..|| ||.|+.- ..-.|.|-.||+|..
T Consensus         2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp   34 (39)
T d1emoa2           2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP   34 (39)
T ss_dssp             CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred             CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence            7899999999 7889654 345799999999864

>d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Neurogenic locus notch homolog protein 1, Notch1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.45  E-value=0.15  Score=34.84  Aligned_cols=30  Identities=33%  Similarity=0.802  Sum_probs=24.0

Q ss_pred             ccCcC-CCCCCCCccccCC-CCCccCCCCCcc
Q 002969          315 DQCDN-YGECGPFGICDTN-ASPVCQCMRGFE  344 (862)
Q Consensus       315 ~~Cd~-yg~CG~~g~C~~~-~~~~C~Cl~Gf~  344 (862)
                      |.|.. ...|..+|.|... .+-+|.|++||+
T Consensus         4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~   35 (42)
T d2vj3a1           4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT   35 (42)
T ss_dssp             CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred             ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence            67775 4679999999655 456899999997

>d2qj2a1 g.10.1.1 (A:36-126) Hepatocyte growth factor {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Hairpin loop containing domain-like
superfamily: Hairpin loop containing domain-like
family: Hairpin loop containing domain
domain: Hepatocyte growth factor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=81.32  E-value=0.77  Score=36.98  Aligned_cols=54  Identities=17%  Similarity=0.349  Sum_probs=34.2

Q ss_pred             cceeeeecccCCCCcccccc---cccCHHHHHHHHhh----cCccccccccccCCCcceeecc
Q 002969          371 DKFLQLKNMKLPDTTTSFVD---YNMTLKECEAFCSR----NCSCTAYANTNITGGTGCVTWT  426 (862)
Q Consensus       371 d~f~~~~~~~~p~~~~~~~~---~~~sl~~C~~~Cl~----~CsC~a~~~~~~~gg~~C~~w~  426 (862)
                      |+|.+..+..|.........   ...+.++|++.|++    +=.|.+|.|..  ....|.+-.
T Consensus         5 ~dy~kt~~~~L~~~~~~~~~~~~~~~s~eeCA~rC~~~~~~~f~CrSF~y~~--~~~~C~Ls~   65 (91)
T d2qj2a1           5 HEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDK--ARKQCLWFP   65 (91)
T ss_dssp             GGEEEETTEEEEECSTTCCCEEEECSCHHHHHHHHHTTTTCSSCCCEEEEET--TTTEEEEES
T ss_pred             HhhhhcCCceEeccCccccccccccCCHHHHHHHHHccCCCCceEEeEEEEC--CCCeEEEcc
Confidence            56777777666433222111   22489999999987    35699999863  334587644